data_2nc8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nc8 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 N--CA 1.434 -1.274 0 N-CA-C 108.773 -0.825 . . . . 74.12 108.773 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.0 t -121.91 113.71 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.142 -1.429 . . . . 74.51 107.142 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -124.51 113.81 18.6 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.143 0.497 . . . . 74.12 109.71 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.09 113.75 27.14 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.407 -1.331 . . . . 74.11 107.407 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 140' ' ' THR . 37.8 m -125.18 114.51 19.09 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.931 -1.137 . . . . 75.34 107.931 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 pp -130.33 147.1 33.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.323 -0.398 . . . . 73.03 110.274 -173.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 78.3 m -125.68 123.63 39.34 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 109.27 -0.641 . . . . 74.24 109.27 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.466 ' O ' ' HD2' ' A' ' 144' ' ' PRO . 8.5 tt -114.69 131.47 66.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.944 -0.571 . . . . 74.51 111.031 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -96.55 149.95 36.44 Favored Pre-proline 0 N--CA 1.419 -1.977 0 N-CA-C 108.91 -0.774 . . . . 65.01 108.91 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.12 2.41 2.22 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.133 2.555 . . . . 70.12 112.699 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -86.74 5.82 34.44 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 123.722 0.809 . . . . 70.33 110.87 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 t70 70.83 29.48 3.11 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 123.183 1.468 . . . . 71.14 107.558 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.52 128.79 55.76 Favored 'General case' 0 N--CA 1.399 -3.018 0 CA-C-N 113.174 -1.83 . . . . 74.5 107.121 -177.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.443 HG12 HD21 ' A' ' 95' ' ' LEU . 8.1 t -124.29 144.9 32.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.095 -0.502 . . . . 73.35 110.071 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -149.21 161.26 42.36 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.791 -0.818 . . . . 72.43 108.791 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.26 -165.31 35.96 Favored Glycine 0 C--N 1.312 -0.786 0 C-N-CA 119.266 -1.445 . . . . 64.15 113.019 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -150.52 140.19 21.68 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.009 0.433 . . . . 73.23 109.853 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.3 mt -125.41 116.68 47.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.511 -0.922 . . . . 71.35 108.511 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.26 123.43 63.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.618 -0.512 . . . . 61.4 109.618 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.42 108.46 14.58 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.326 -1.361 . . . . 61.55 107.326 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.09 135.65 54.83 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.985 0.421 . . . . 72.53 111.616 -174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.48 158.67 41.48 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.885 -0.783 . . . . 65.31 108.885 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 pttt . . . . . 0 C--N 1.318 -0.804 0 C-N-CA 118.653 -1.219 . . . . 73.0 109.775 177.18 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.503 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 4.2 t . . . . . 0 N--CA 1.431 -1.411 0 N-CA-C 107.299 -1.371 . . . . 65.31 107.299 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.08 112.64 0.29 Allowed Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 109.875 -1.29 . . . . 72.53 109.875 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -52.36 128.91 29.39 Favored 'Trans proline' 0 C--N 1.355 0.915 0 CA-C-N 119.879 1.839 . . . . 74.1 109.089 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.628 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -95.87 151.95 18.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 114.169 1.174 . . . . 72.41 114.169 -167.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.414 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 83.4 mt -85.23 141.49 30.09 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.322 -1.308 . . . . 74.4 108.952 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -106.43 99.9 9.45 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.546 -1.279 . . . . 74.42 107.546 177.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.69 69.37 0.33 Allowed Glycine 0 C--N 1.287 -2.188 0 C-N-CA 120.041 -1.076 . . . . 55.04 114.023 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.65 95.51 6.59 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.18 -1.415 . . . . 74.1 107.18 172.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.31 159.28 29.98 Favored Pre-proline 0 C--N 1.293 -1.885 0 CA-C-N 115.088 -0.96 . . . . 73.3 109.823 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.56 -16.74 55.09 Favored 'Trans proline' 0 N--CA 1.481 0.741 0 C-N-CA 122.739 2.292 . . . . 64.15 113.153 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -115.79 33.37 5.53 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.058 -0.519 . . . . 73.44 110.597 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 p -57.63 -28.24 63.52 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 121.222 0.534 . . . . 74.43 112.375 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -66.94 -20.05 65.83 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.235 0.541 . . . . 74.43 110.351 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -101.03 -2.77 30.77 Favored 'General case' 0 C--O 1.257 1.492 0 CA-C-N 115.846 -0.615 . . . . 75.21 110.233 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.41 118.87 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.12 0.962 . . . . 74.42 110.817 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.95 106.0 17.99 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.477 -0.783 . . . . 61.51 109.209 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.21 130.93 45.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 106.784 -1.561 . . . . 75.22 106.784 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.1 t -145.67 171.77 14.24 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.89 -0.781 . . . . 71.4 108.89 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -84.53 137.9 33.06 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.14 -0.689 . . . . 74.33 109.14 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 77.0 t80 -107.38 124.96 50.6 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.473 -0.936 . . . . 75.23 108.473 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -139.0 98.84 3.62 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.553 -1.277 . . . . 74.43 107.553 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.521 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 70.3 m -160.22 148.48 16.79 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.779 -0.452 . . . . 55.32 109.779 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 67.64 8.22 6.21 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.733 1.213 . . . . 75.3 112.056 173.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.59 4.99 65.3 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.003 -0.839 . . . . 72.24 111.003 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -104.71 142.91 33.85 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.191 -1.041 . . . . 74.41 108.191 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.8 m -124.78 139.18 51.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.547 -0.909 . . . . 65.22 108.547 175.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.26 -153.8 10.6 Favored Glycine 0 C--N 1.266 -3.353 0 N-CA-C 110.309 -1.117 . . . . 74.43 110.309 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.628 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 69.3 m -132.48 151.07 52.03 Favored 'General case' 0 C--N 1.266 -3.034 0 CA-C-O 121.289 0.566 . . . . 74.33 111.804 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -131.35 141.14 49.86 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.708 -0.678 . . . . 74.14 109.894 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.35 114.66 26.95 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.941 -1.133 . . . . 62.22 107.941 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.51 113.1 43.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.752 -1.203 . . . . 72.4 107.752 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.46 ' CD2' HD13 ' A' ' 90' ' ' LEU . 40.6 p90 -120.42 156.23 31.84 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 120.745 0.307 . . . . 75.1 111.648 -173.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 p -160.7 149.54 16.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.876 -0.602 . . . . 75.52 111.089 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 67.23 32.16 6.2 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.467 1.107 . . . . 73.3 110.822 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' A' ' 87' ' ' PHE . 19.6 mt -89.52 169.22 11.54 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.687 -0.688 . . . . 72.22 109.621 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.8 t -124.82 171.14 10.38 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.698 -0.482 . . . . 73.01 109.698 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -56.36 -36.37 68.72 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.856 0.862 . . . . 75.13 112.366 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.56 -25.6 63.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.15 0.5 . . . . 74.1 111.811 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -81.07 -21.25 40.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 112.126 0.417 . . . . 75.14 112.126 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.443 HD21 HG12 ' A' ' 40' ' ' VAL . 18.8 mt -54.53 -49.77 89.15 Favored Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 115.697 1.74 . . . . 73.12 115.697 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -54.92 -45.84 37.88 Favored 'Trans proline' 0 C--N 1.365 1.441 0 CA-C-N 120.816 1.327 . . . . 72.33 111.269 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.505 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 22.0 mt-30 -68.46 -32.87 73.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.948 0.88 . . . . 74.45 110.407 -174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.42 -40.58 89.62 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.296 -1.32 . . . . 74.3 108.829 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.75 -25.38 67.9 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.932 -1.031 . . . . 74.42 111.118 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 97' ' ' GLN . 84.2 m-20 -59.35 -55.55 33.3 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.404 0.44 . . . . 73.34 109.901 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 29.7 ttp -54.36 -48.93 70.91 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.706 0.629 . . . . 75.21 110.222 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -53.13 -41.95 65.57 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 114.964 -1.016 . . . . 71.23 111.363 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.9 m -67.23 -21.4 65.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.83 -0.623 . . . . 71.43 112.003 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.14 -28.59 70.17 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 121.38 0.61 . . . . 74.42 109.753 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -112.65 -2.55 14.51 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.823 -0.626 . . . . 72.14 110.916 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.7 -47.59 3.86 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.153 -0.619 . . . . 73.22 112.52 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.44 28.97 66.71 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.218 -0.992 . . . . 71.04 112.007 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.4 m -123.1 173.56 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.594 -0.521 . . . . 74.31 109.594 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -126.23 130.34 50.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.891 0.314 . . . . 73.21 110.912 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.05 136.16 53.42 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.06 -0.718 . . . . 63.01 109.06 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -143.34 120.21 11.27 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.933 -0.395 . . . . 64.12 109.933 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.3 145.9 36.64 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.08 -0.648 . . . . 74.42 109.262 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.4 mtm-85 -147.41 151.33 36.29 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.55 -0.75 . . . . 62.22 109.571 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -97.16 137.6 35.95 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 120.126 -0.63 . . . . 74.1 111.42 173.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -117.77 92.26 3.79 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 106.534 -1.654 . . . . 73.43 106.534 174.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.94 -98.24 1.18 Allowed Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 110.694 -0.962 . . . . 62.43 110.694 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -130.64 6.28 4.74 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.809 1.29 . . . . 71.04 108.216 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 pp -108.51 145.06 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 106.695 -1.595 . . . . 73.13 106.695 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.9 t -105.48 136.44 39.51 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.831 0 N-CA-C 109.675 -0.491 . . . . 75.31 109.675 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.426 HG22 ' HG2' ' A' ' 175' ' ' GLN . 33.5 pt -111.69 133.57 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.318 0 N-CA-C 107.531 -1.285 . . . . 73.44 107.531 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.6 tt -115.03 123.76 49.88 Favored 'General case' 0 C--N 1.255 -3.534 0 N-CA-C 108.385 -0.968 . . . . 74.41 108.385 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -116.49 131.2 57.01 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 113.913 -1.494 . . . . 72.23 107.052 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -152.64 148.26 18.91 Favored Glycine 0 N--CA 1.413 -2.837 0 C-N-CA 119.735 -1.222 . . . . 74.13 110.301 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.58 137.47 43.77 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.103 -0.703 . . . . 74.15 109.103 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.38 109.14 13.52 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 108.633 -0.877 . . . . 64.44 108.633 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.11 98.6 7.45 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.543 -1.651 . . . . 61.41 106.543 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.13 36.99 4.49 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 123.024 1.392 . . . . 75.4 108.542 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 49.8 p . . . . . 0 C--N 1.288 -2.093 0 CA-C-N 113.515 -1.675 . . . . 71.44 110.538 178.574 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 . . . . . 0 C--O 1.243 0.728 0 N-CA-C 112.014 0.376 . . . . 75.12 112.014 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -71.92 136.0 46.72 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.92 -0.582 . . . . 71.53 109.567 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -131.06 114.43 15.16 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.846 -0.428 . . . . 74.31 109.846 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 89.4 t -109.96 126.63 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 107.163 -1.421 . . . . 71.23 107.163 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -134.79 129.14 34.12 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 120.939 0.4 . . . . 71.45 111.206 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.9 tp -117.79 129.48 55.7 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.178 -0.464 . . . . 74.51 109.905 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 31' ' ' SER . 18.4 m -127.05 122.56 34.7 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.074 -1.084 . . . . 73.55 108.074 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 97.1 t -118.07 122.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.413 -0.588 . . . . 74.4 109.413 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.07 130.6 56.56 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.23 -0.655 . . . . 74.53 109.23 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.688 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.2 p90 -135.33 127.1 17.71 Favored Pre-proline 0 C--N 1.286 -2.178 0 CA-C-O 119.424 -0.322 . . . . 74.4 111.587 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 58.5 Cg_endo -75.15 36.63 0.45 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.569 2.179 . . . . 74.42 112.029 177.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -117.54 -103.19 0.41 Allowed 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 109.665 -0.495 . . . . 53.31 109.665 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.87 131.05 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.931 -1.137 . . . . 73.44 107.931 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.59 133.84 28.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.049 0.452 . . . . 75.34 109.969 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.3 p -89.19 -46.41 8.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.246 0.546 . . . . 72.03 109.623 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.6 m -152.05 133.88 14.85 Favored 'General case' 0 C--O 1.207 -1.178 0 CA-C-N 115.586 -0.733 . . . . 64.31 110.055 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 t -139.0 160.9 38.67 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.869 -0.519 . . . . 72.53 110.446 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 29.2 t-20 -132.26 89.56 2.68 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.723 -1.954 . . . . 75.15 105.723 174.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.35 -147.97 9.96 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 108.235 -1.946 . . . . 72.2 108.235 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -118.36 100.63 7.61 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 117.829 0.814 . . . . 64.41 110.301 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -83.26 123.44 29.6 Favored 'General case' 0 N--CA 1.413 -2.313 0 C-N-CA 119.884 -0.726 . . . . 75.42 111.354 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.56 -46.93 17.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.236 -1.394 . . . . 75.2 107.236 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -123.53 165.02 24.88 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 107.739 -1.208 . . . . 74.51 107.739 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -72.23 -0.16 8.22 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.429 2.086 . . . . 75.34 110.931 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.688 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.9 pt-20 -135.46 6.3 3.25 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.166 -0.925 . . . . 74.44 111.9 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.92 120.85 6.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 108.126 -1.064 . . . . 73.33 108.126 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 36.9 t -125.19 146.57 30.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 109.448 -0.575 . . . . 74.24 109.448 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -133.03 146.11 51.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 109.45 -0.574 . . . . 75.54 109.45 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.437 ' CZ2' ' HB1' ' A' ' 174' ' ' ALA . 29.7 m-90 -128.19 129.35 46.34 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.639 -0.71 . . . . 72.54 109.245 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 163' ' ' LYS . 1.0 OUTLIER -102.73 103.0 13.21 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 122.149 0.976 . . . . 74.31 111.005 176.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.5 mm? -90.73 116.22 28.42 Favored 'General case' 0 C--O 1.264 1.829 0 CA-C-O 121.827 0.822 . . . . 74.33 108.891 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 10.8 mmpt? -104.73 143.5 26.83 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 114.272 -1.331 . . . . 62.11 111.269 -172.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 168' ' ' VAL . 58.5 Cg_endo -69.85 150.22 67.35 Favored 'Trans proline' 0 C--O 1.248 1.013 0 C-N-CA 123.963 3.109 . . . . 74.32 111.722 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.49 -30.64 3.06 Favored Glycine 0 C--N 1.321 -0.288 0 C-N-CA 120.913 -0.66 . . . . 74.34 112.213 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 35.3 m -105.63 165.79 3.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 110.011 -0.366 . . . . 73.23 110.011 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.69 142.26 26.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.215 -1.031 . . . . 71.54 108.215 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 63.7 m -142.34 140.89 32.26 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.204 0.526 . . . . 73.13 110.823 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 50.5 p -103.34 141.3 36.17 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.962 -1.125 . . . . 74.21 107.962 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -123.79 126.58 46.72 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.919 -0.4 . . . . 63.12 109.919 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 35.4 t -138.79 144.15 39.24 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.829 -0.434 . . . . 53.32 109.829 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.437 ' HB1' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.42 127.94 10.74 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.318 -0.993 . . . . 75.25 108.318 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.426 ' HG2' HG22 ' A' ' 120' ' ' ILE . 44.8 mt-30 -128.47 131.95 48.37 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 108.703 -0.851 . . . . 75.52 108.703 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.73 159.9 43.79 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.822 -0.436 . . . . 73.43 109.822 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.96 126.81 34.95 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.674 -0.491 . . . . 73.13 109.674 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -143.11 125.24 15.37 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 109.589 -0.523 . . . . 74.41 109.589 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.35 114.07 1.84 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 124.29 0.994 . . . . 73.34 111.831 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.2 t70 . . . . . 0 C--O 1.213 -0.868 0 N-CA-C 108.322 -0.992 . . . . 72.03 108.322 177.495 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 . . . . . 0 N--CA 1.417 -2.086 0 N-CA-C 108.956 -0.757 . . . . 73.22 108.956 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.22 114.51 46.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.805 -1.183 . . . . 75.25 107.805 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -116.82 113.93 23.21 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.65 -1.159 . . . . 74.5 109.608 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.59 121.36 42.39 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 109.11 -0.7 . . . . 73.14 109.11 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.6 m -127.12 114.7 18.06 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.048 -1.093 . . . . 72.42 108.048 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -128.15 147.26 32.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.716 -0.475 . . . . 74.23 109.716 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.5 m -130.49 122.25 27.31 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 121.162 0.506 . . . . 74.24 110.221 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.61 117.64 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.771 0.796 . . . . 74.54 109.51 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 37' ' ' ASP . 28.8 t -77.76 150.54 78.84 Favored Pre-proline 0 N--CA 1.419 -1.987 0 CA-C-N 114.781 -1.099 . . . . 74.44 108.784 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -65.26 2.37 1.5 Allowed 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 123.555 2.837 . . . . 73.54 112.03 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 35' ' ' SER . 3.6 t70 -89.4 -0.31 57.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.324 1.05 . . . . 74.41 108.243 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 29.3 t70 68.96 29.11 4.99 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.58 1.552 . . . . 71.12 108.523 -178.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.38 126.99 53.49 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 113.583 -1.644 . . . . 73.55 107.505 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 t -107.73 138.95 31.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 109.315 -0.624 . . . . 74.43 109.315 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.4 p -147.28 158.68 44.05 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.256 -1.387 . . . . 64.41 107.256 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.7 -172.07 41.78 Favored Glycine 0 CA--C 1.489 -1.589 0 C-N-CA 119.433 -1.365 . . . . 63.34 112.197 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.6 133.39 17.96 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.33 0.586 . . . . 74.21 109.635 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 68.2 mt -117.23 116.22 51.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.952 -1.129 . . . . 64.31 107.952 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.39 120.45 62.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.398 -0.593 . . . . 74.02 109.398 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.488 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.32 107.6 16.93 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 106.462 -1.681 . . . . 65.21 106.462 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . . . -117.39 123.59 46.8 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.787 -0.449 . . . . 72.24 109.787 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.27 157.5 19.4 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.554 0.692 . . . . 72.22 112.22 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 N--CA 1.441 -0.907 0 CA-C-N 113.404 -1.726 . . . . 75.22 110.328 179.685 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 N--CA 1.429 -1.493 0 N-CA-C 107.247 -1.39 . . . . 72.04 107.247 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.621 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 174.04 97.96 0.11 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.105 -1.198 . . . . 72.53 110.105 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.526 ' O ' ' HB3' ' A' ' 83' ' ' SER . 15.7 Cg_exo -68.32 159.07 54.85 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.571 2.18 . . . . 75.41 111.672 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.62 154.48 24.82 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.196 -0.668 . . . . 63.13 109.196 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 mt -74.77 152.39 39.03 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.371 0.605 . . . . 73.31 111.908 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -107.94 99.49 8.94 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.056 -0.975 . . . . 64.22 109.183 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.467 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -160.22 92.76 0.12 Allowed Glycine 0 C--N 1.29 -2.011 0 C-N-CA 120.36 -0.924 . . . . 71.13 113.525 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -86.48 112.58 21.65 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.253 -1.017 . . . . 74.41 108.253 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.09 162.08 54.36 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 116.269 -0.423 . . . . 65.42 110.499 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.18 -21.13 67.69 Favored 'Trans proline' 0 N--CA 1.478 0.593 0 C-N-CA 122.401 2.067 . . . . 71.21 112.043 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -109.87 27.99 9.03 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.632 -0.713 . . . . 73.44 111.855 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.4 m -52.19 -31.51 32.02 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.281 0.474 . . . . 71.51 112.281 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -61.65 -22.09 64.98 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.007 0.523 . . . . 75.31 111.819 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 88' ' ' SER . 32.7 mmtp -98.85 -10.08 23.4 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 122.287 -0.258 . . . . 74.02 111.134 -176.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.69 120.04 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 119.693 -0.803 . . . . 72.52 110.861 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.13 113.21 25.68 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.686 -0.688 . . . . 44.1 109.266 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.47 124.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 108.282 -1.007 . . . . 73.51 108.282 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 m -128.55 165.04 21.52 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.024 -0.989 . . . . 73.32 109.8 -172.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.621 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 5.9 t30 -77.51 136.5 38.33 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.109 -0.95 . . . . 75.41 109.132 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -110.62 119.41 39.06 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 108.64 -0.874 . . . . 70.34 108.64 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -138.86 100.01 3.94 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.528 -0.915 . . . . 61.22 108.528 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 t -163.0 143.92 9.59 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.389 -0.597 . . . . 73.44 109.389 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.92 12.05 8.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.912 0.885 . . . . 73.23 113.357 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.62 -3.61 65.7 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.33 -0.938 . . . . 72.41 111.485 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 29.8 m-85 -94.74 145.46 24.85 Favored 'General case' 0 C--O 1.254 1.316 0 N-CA-C 108.218 -1.031 . . . . 74.53 108.218 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.3 m -128.94 136.63 59.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.611 -0.885 . . . . 75.43 108.611 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.94 -155.25 9.96 Favored Glycine 0 N--CA 1.414 -2.808 0 C-N-CA 119.98 -1.105 . . . . 62.4 111.899 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.526 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 24.4 p -121.94 152.0 40.15 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.131 -0.535 . . . . 74.54 110.473 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.8 pt20 -138.73 129.4 26.23 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.571 -0.452 . . . . 75.12 110.59 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.3 114.49 28.56 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.011 -1.477 . . . . 63.42 107.011 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.33 116.26 51.87 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.735 -1.209 . . . . 75.22 107.735 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.409 ' CD2' HD12 ' A' ' 90' ' ' LEU . 41.8 p90 -117.88 157.61 26.35 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.08 0.467 . . . . 74.33 111.286 -174.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 16.5 p -158.62 152.7 23.79 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.354 -0.839 . . . . 71.32 109.616 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 t70 62.5 47.24 5.16 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 122.959 1.361 . . . . 71.33 111.26 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.409 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.4 mt -108.06 163.32 13.25 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.572 -1.194 . . . . 74.34 110.003 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -112.15 174.03 6.08 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.367 -0.605 . . . . 75.14 109.367 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.417 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 61.9 t80 -50.53 -48.36 57.22 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.18 0.992 . . . . 75.13 111.308 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.68 -25.43 66.36 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.433 0.693 . . . . 70.41 112.193 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -86.65 -16.44 36.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 116.138 -0.483 . . . . 74.32 112.3 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.639 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 5.4 tt -64.52 -52.18 54.41 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 119.54 -0.267 . . . . 73.53 110.441 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.85 -30.89 39.85 Favored 'Trans proline' 0 C--N 1.367 1.541 0 CA-C-N 120.951 1.376 . . . . 73.33 110.529 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -67.42 -31.16 71.16 Favored 'General case' 0 N--CA 1.424 -1.744 0 O-C-N 121.957 -0.464 . . . . 75.22 110.889 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -77.84 -19.16 55.37 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.175 0.512 . . . . 73.32 109.975 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.87 -13.49 61.68 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.555 -0.748 . . . . 75.02 110.653 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -66.37 -57.89 6.47 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.241 -1.022 . . . . 74.22 108.241 172.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.467 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.8 ttp -55.85 -50.48 70.46 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.252 0.548 . . . . 75.23 110.131 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.54 -37.74 65.77 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 114.456 -1.247 . . . . 73.41 111.712 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.7 p -62.35 -31.73 72.42 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 119.942 -0.703 . . . . 63.33 111.248 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.37 -25.0 67.38 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.498 0.666 . . . . 72.24 111.263 -173.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.44 -13.77 15.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.22 -0.592 . . . . 74.51 111.283 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.27 -41.47 5.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.115 0.783 . . . . 75.35 113.115 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.98 19.92 58.55 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.498 -1.041 . . . . 74.1 110.498 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 m -104.36 155.44 5.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.19 0.519 . . . . 74.15 111.154 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.18 137.33 54.25 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.096 -1.816 . . . . 74.12 106.096 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -134.92 111.52 9.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.055 0.455 . . . . 71.42 112.143 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.8 t -119.37 122.27 41.42 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.75 -0.833 . . . . 74.2 108.75 176.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -139.31 142.88 37.67 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 116.06 -0.518 . . . . 74.52 109.738 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -141.14 149.6 41.72 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.523 -1.217 . . . . 75.13 109.568 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 ttm105 -98.92 137.86 36.88 Favored 'General case' 0 N--CA 1.409 -2.492 0 N-CA-C 108.527 -0.916 . . . . 73.24 108.527 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -122.63 94.58 4.33 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.11 -1.441 . . . . 63.24 107.11 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.75 -103.87 1.36 Allowed Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.856 -0.898 . . . . 73.51 110.856 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.584 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 11.2 t30 -113.99 -8.55 13.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.227 1.013 . . . . 72.3 109.422 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -99.54 149.87 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 C-N-CA 119.36 -0.936 . . . . 74.25 109.408 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.2 t -119.02 138.86 48.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 O-C-N 121.923 -0.486 . . . . 74.03 111.195 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.6 pt -117.05 132.96 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.344 -0.844 . . . . 71.2 109.209 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.2 tt -129.22 130.93 46.92 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 115.971 -0.559 . . . . 64.15 109.717 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.32 133.23 34.69 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.971 -0.559 . . . . 73.52 110.002 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.74 171.97 32.49 Favored Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 120.161 -1.018 . . . . 71.0 112.002 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -138.53 158.11 44.88 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.417 -0.586 . . . . 75.12 109.417 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.94 113.26 18.23 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.626 -0.879 . . . . 74.31 108.626 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -111.96 93.81 4.64 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.878 0.847 . . . . 75.52 111.506 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 166' ' ' PRO . 1.1 pt? -134.98 30.92 3.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 123.88 1.8 . . . . 74.51 107.045 176.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 37.1 p . . . . . 0 C--N 1.296 -1.72 0 CA-C-N 111.863 -2.426 . . . . 71.35 112.596 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 C--O 1.237 0.395 0 CA-C-O 122.043 0.925 . . . . 71.23 109.827 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.88 140.93 28.98 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.935 -1.03 . . . . 55.34 111.831 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -132.1 141.79 49.29 Favored 'General case' 0 C--O 1.265 1.919 0 CA-C-N 115.699 -0.682 . . . . 75.31 110.124 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 60.2 t -106.4 116.23 49.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.229 -1.026 . . . . 64.34 108.229 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -115.47 120.71 40.42 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.871 -0.418 . . . . 75.05 109.871 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -118.54 115.74 25.2 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.531 -1.285 . . . . 72.32 107.531 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.5 m -120.82 128.33 52.76 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.146 -0.479 . . . . 71.42 109.732 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.4 t -120.74 127.18 75.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.353 -0.61 . . . . 65.41 109.353 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.24 124.55 52.79 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 109.503 -0.555 . . . . 74.12 109.503 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.618 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.3 p90 -134.36 112.46 11.98 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 122.909 0.484 . . . . 73.24 111.208 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -67.82 42.75 0.24 Allowed 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.484 2.789 . . . . 75.43 113.118 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.09 -92.94 0.51 Allowed 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.559 -0.534 . . . . 54.33 109.559 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.01 126.77 0.02 OUTLIER 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.939 0.896 . . . . 75.31 108.829 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.25 123.89 38.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.144 0.497 . . . . 74.04 110.07 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.7 p -86.4 -36.35 19.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.771 0.319 . . . . 70.22 111.01 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.6 m -161.99 132.92 5.08 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 107.859 -1.163 . . . . 62.42 107.859 176.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -139.03 152.29 47.48 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.903 -0.498 . . . . 72.24 110.938 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -115.73 92.03 3.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.988 -1.856 . . . . 72.31 105.988 172.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.34 -149.77 12.07 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.139 -1.984 . . . . 75.14 108.139 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -116.54 99.76 7.38 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 117.887 0.844 . . . . 72.1 109.569 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -77.94 119.77 21.86 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 119.679 -0.809 . . . . 73.42 109.538 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.5 mm -86.81 -44.97 16.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.192 -1.411 . . . . 71.25 107.192 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -118.45 162.43 30.43 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 105.215 -2.143 . . . . 73.14 105.215 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -74.37 -0.8 10.15 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.901 1.734 . . . . 75.44 110.956 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.618 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.3 pt-20 -131.95 3.82 4.1 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.129 -0.941 . . . . 71.34 111.35 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.87 121.13 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 108.463 -0.94 . . . . 75.01 108.463 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.0 t -122.46 148.29 26.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.538 -0.541 . . . . 75.41 109.538 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -131.94 138.86 48.5 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.515 -0.55 . . . . 71.32 109.515 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.8 m-90 -119.63 130.39 55.06 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.701 -0.851 . . . . 72.33 108.701 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -109.88 104.24 13.14 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.957 0.884 . . . . 74.31 108.648 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 0.5 OUTLIER -100.98 131.19 46.97 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.818 -0.808 . . . . 74.35 108.818 -174.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -117.36 149.61 44.95 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 115.802 -0.636 . . . . 74.1 112.598 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.418 ' HA ' ' HG ' ' A' ' 127' ' ' LEU . 17.0 Cg_exo -67.45 154.94 72.31 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.878 2.386 . . . . 70.25 111.743 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 84.43 -39.31 2.91 Favored Glycine 0 C--N 1.311 -0.828 0 CA-C-N 115.83 -0.623 . . . . 73.5 112.541 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.34 151.86 6.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.981 -0.378 . . . . 72.22 109.981 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.79 110.44 24.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.733 0.778 . . . . 73.4 109.15 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.9 m -101.31 131.04 47.55 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.688 -0.687 . . . . 73.41 109.689 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 37.6 p -105.41 145.2 31.14 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.109 -0.496 . . . . 75.24 109.708 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 25.1 ptp -126.66 134.05 50.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.8 -0.815 . . . . 73.43 108.8 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.1 m -141.69 146.94 36.69 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.236 -1.024 . . . . 74.42 108.236 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -156.31 120.59 4.49 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.787 -0.449 . . . . 65.54 109.787 -175.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -123.01 131.87 53.89 Favored 'General case' 0 C--N 1.264 -3.136 0 N-CA-C 107.391 -1.337 . . . . 74.11 107.391 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -160.31 153.06 21.18 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.978 -1.119 . . . . 74.01 107.978 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 38.5 ptt180 -92.87 131.49 37.85 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.2 -1.0 . . . . 75.31 109.685 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -126.38 118.42 24.98 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.718 -1.215 . . . . 75.14 107.718 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.584 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -53.25 109.97 0.49 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 124.905 1.378 . . . . 72.11 112.538 -177.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.6 t0 . . . . . 0 CA--C 1.502 -0.877 0 N-CA-C 107.589 -1.263 . . . . 74.34 107.589 -179.523 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 109.441 -0.577 . . . . 72.11 109.441 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.42 HG13 ' HA ' ' A' ' 46' ' ' ALA . 33.1 m -125.08 129.86 73.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.964 -0.694 . . . . 75.22 109.95 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.476 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 15.5 ptt180 -139.35 122.25 16.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.52 0.676 . . . . 75.34 111.038 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.66 138.56 49.29 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.54 -0.755 . . . . 62.31 109.287 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.7 m -134.17 115.25 13.99 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.075 -1.083 . . . . 74.33 108.075 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 11.6 pt -129.04 149.1 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-O 121.359 0.599 . . . . 73.21 110.178 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 88.8 m -124.51 126.67 46.24 Favored 'General case' 0 C--N 1.264 -3.112 0 N-CA-C 108.976 -0.75 . . . . 74.2 108.976 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.402 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.8 tt -113.26 120.03 62.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.793 0.806 . . . . 73.44 109.752 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 37' ' ' ASP . 26.3 t -81.4 151.99 69.73 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 114.639 -1.164 . . . . 61.51 109.056 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.65 2.31 2.09 Favored 'Trans proline' 0 C--N 1.364 1.351 0 C-N-CA 123.291 2.66 . . . . 70.23 111.524 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 35' ' ' SER . 14.3 t70 -82.52 -7.99 59.63 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.703 1.201 . . . . 63.32 108.318 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.9 t70 72.22 29.26 2.28 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 123.444 1.592 . . . . 70.44 107.413 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.24 135.38 51.09 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 113.125 -1.852 . . . . 74.11 107.491 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 t -117.03 142.01 32.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.173 -0.677 . . . . 62.1 109.173 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.1 p -149.66 157.57 43.36 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.501 -1.296 . . . . 75.54 107.501 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.77 -162.84 34.88 Favored Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 118.481 -1.818 . . . . 71.11 112.949 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -150.44 133.69 16.29 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.361 0.6 . . . . 73.34 110.108 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.8 116.37 52.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.614 -1.254 . . . . 70.51 107.614 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 29' ' ' ARG . 2.0 mp -103.19 120.97 53.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 120.862 0.363 . . . . 75.42 110.258 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -119.73 108.8 14.87 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.533 -1.284 . . . . 73.03 107.533 174.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.6 146.52 46.89 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.448 0.642 . . . . 70.1 112.06 -173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.83 139.28 50.15 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.438 -0.949 . . . . 73.13 108.438 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 tttm . . . . . 0 C--N 1.31 -1.134 0 N-CA-C 107.886 -1.153 . . . . 75.3 107.886 179.244 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.453 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 20.7 p . . . . . 0 N--CA 1.427 -1.604 0 N-CA-C 107.616 -1.253 . . . . 74.01 107.616 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.08 103.62 0.17 Allowed Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 114.582 -1.19 . . . . 73.32 110.202 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.43 134.77 53.05 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.746 2.297 . . . . 55.11 110.434 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.94 148.25 25.21 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 114.802 1.408 . . . . 72.22 114.802 -168.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.606 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 92.7 mt -89.08 161.66 16.41 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 114.201 -1.363 . . . . 75.13 108.57 174.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -110.62 90.78 3.42 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.437 0.637 . . . . 74.3 109.827 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.43 51.7 1.58 Allowed Glycine 0 C--N 1.302 -1.333 0 CA-C-N 115.685 -0.689 . . . . 74.44 112.697 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -96.44 98.85 10.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.352 0.596 . . . . 73.31 110.542 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.68 171.74 7.23 Favored Pre-proline 0 C--N 1.311 -1.1 0 C-N-CA 123.569 0.748 . . . . 73.51 109.951 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.09 -19.25 34.78 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.857 1.705 . . . . 72.11 111.612 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.411 ' CE1' ' HG2' ' A' ' 97' ' ' GLN . 15.6 p90 -111.29 36.28 3.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.855 -0.612 . . . . 64.13 110.606 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.5 m -60.41 -27.7 67.67 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 122.064 -0.397 . . . . 65.12 111.814 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.4 pm0 -71.99 -9.33 58.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.487 -0.758 . . . . 74.23 110.383 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -95.95 -20.09 19.01 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.895 -0.593 . . . . 75.44 109.701 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 p -130.69 117.88 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 122.157 0.98 . . . . 73.35 110.993 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.98 124.58 47.84 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.684 -0.689 . . . . 74.15 110.326 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.93 120.61 47.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.676 -1.231 . . . . 61.55 107.676 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -124.91 168.88 12.67 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.626 -0.715 . . . . 65.01 110.258 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -79.98 150.29 30.51 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.042 -0.725 . . . . 64.23 109.042 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 93.2 t80 -127.35 129.5 47.73 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.063 -0.517 . . . . 72.12 109.738 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -138.19 98.26 3.58 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.577 -1.268 . . . . 73.31 107.577 176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 67.7 m -164.66 155.57 14.84 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.265 -0.643 . . . . 72.33 109.265 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 69.87 4.38 4.74 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.571 1.148 . . . . 73.11 110.932 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.76 -4.07 71.76 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.205 -0.758 . . . . 65.42 111.205 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -104.44 144.05 32.19 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.527 -0.545 . . . . 75.02 109.527 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.5 m -118.2 145.53 24.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.259 -1.015 . . . . 73.42 108.259 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.19 -153.74 12.85 Favored Glycine 0 CA--C 1.459 -3.416 0 C-N-CA 118.692 -1.718 . . . . 73.33 112.14 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.606 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 4.3 p -123.72 145.06 49.28 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-O 121.721 0.772 . . . . 73.15 111.732 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -125.64 131.73 52.6 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.466 -0.788 . . . . 75.55 109.873 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.8 114.19 26.64 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.267 -1.383 . . . . 72.24 107.267 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.1 t -107.39 113.55 43.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.111 -1.07 . . . . 70.43 108.111 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CD2' HD12 ' A' ' 90' ' ' LEU . 51.7 p90 -116.03 151.45 35.48 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.846 -0.427 . . . . 73.01 109.846 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.1 m -154.06 153.96 32.82 Favored 'General case' 0 C--N 1.292 -1.891 0 C-N-CA 120.449 -0.5 . . . . 70.13 111.099 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.22 36.18 15.0 Favored 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 124.443 1.089 . . . . 72.44 111.07 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 87' ' ' PHE . 37.6 mt -97.78 168.53 10.27 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 114.854 -1.067 . . . . 65.51 109.14 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -125.43 -179.92 4.83 Favored 'General case' 0 C--N 1.268 -2.968 0 N-CA-C 108.641 -0.874 . . . . 72.45 108.641 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.424 ' CZ ' ' HG ' ' A' ' 112' ' ' LEU . 43.6 t80 -51.19 -48.2 62.02 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 124.766 1.227 . . . . 72.31 110.559 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.58 -25.85 66.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.892 0.701 . . . . 73.31 112.892 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.42 -17.46 27.16 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 122.069 -0.394 . . . . 64.53 111.48 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 38.0 tp -66.47 -51.8 39.92 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 113.472 0.916 . . . . 73.32 113.472 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.96 -33.88 73.03 Favored 'Trans proline' 0 C--N 1.368 1.59 0 CA-C-N 120.829 1.332 . . . . 53.4 110.389 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.411 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 9.4 tt0 -66.61 -36.26 82.16 Favored 'General case' 0 N--CA 1.41 -2.464 0 CA-C-N 115.226 -0.897 . . . . 75.25 110.871 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -75.69 -19.3 59.21 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.325 0.583 . . . . 64.5 110.041 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.91 -20.57 61.75 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.825 -0.625 . . . . 75.2 110.565 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -56.31 -58.05 9.63 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 123.417 0.448 . . . . 75.1 111.177 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -59.46 -46.63 88.23 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.318 0.58 . . . . 74.05 110.194 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -57.26 -34.79 68.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.376 -1.284 . . . . 73.01 110.962 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.9 m -63.32 -33.5 75.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.553 -0.459 . . . . 73.11 110.905 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.93 -20.04 63.36 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.791 0.805 . . . . 64.44 110.479 -175.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.34 -19.13 17.95 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.697 -0.683 . . . . 62.24 110.506 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.91 -47.69 3.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.591 0.96 . . . . 65.13 113.591 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.52 28.17 25.25 Favored Glycine 0 C--O 1.238 0.403 0 N-CA-C 110.436 -1.066 . . . . 73.51 110.436 -173.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.43 160.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.412 -0.394 . . . . 74.31 110.699 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -119.32 142.77 47.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.381 -1.34 . . . . 73.3 107.381 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.7 mt -139.43 144.39 38.05 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 123.355 0.409 . . . . 72.25 110.28 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 m -142.83 117.33 9.71 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.356 -0.979 . . . . 75.31 108.356 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.424 ' HG ' ' CZ ' ' A' ' 92' ' ' PHE . 52.0 tp -121.9 125.93 47.53 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.076 -0.511 . . . . 73.42 110.375 -176.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -141.7 148.52 39.21 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.197 -0.668 . . . . 75.44 109.197 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -98.69 128.05 44.83 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 108.39 -0.967 . . . . 73.21 108.39 172.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -102.27 86.11 2.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.84 -1.171 . . . . 74.42 107.84 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.29 -98.98 0.54 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.143 -0.935 . . . . 74.33 111.709 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.54 ' HA ' ' OD1' ' A' ' 180' ' ' ASP . 3.4 t-20 -107.63 -15.19 14.65 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.307 1.051 . . . . 74.41 109.651 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 pp -110.0 148.62 13.46 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.758 0 O-C-N 121.115 -0.99 . . . . 74.5 108.749 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.6 t -105.91 137.62 35.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 O-C-N 121.639 -0.663 . . . . 74.0 110.25 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.0 pt -117.14 130.66 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 121.84 0.828 . . . . 72.23 110.064 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.25 128.58 44.95 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 115.161 -0.927 . . . . 64.41 109.352 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -129.18 147.68 51.05 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.614 -0.884 . . . . 74.53 108.614 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.55 166.25 37.18 Favored Glycine 0 N--CA 1.407 -3.298 0 N-CA-C 111.259 -0.736 . . . . 74.31 111.259 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -136.4 145.91 45.83 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.342 -0.985 . . . . 75.35 108.342 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 164' ' ' LEU . . . -124.29 110.15 14.25 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.932 -1.136 . . . . 71.41 107.932 174.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -99.11 105.87 18.01 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.822 -0.807 . . . . 75.32 108.822 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.424 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.8 mm? -116.86 30.65 7.21 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.37 -0.974 . . . . 73.34 108.37 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 121.588 0.708 . . . . 75.24 111.209 -177.077 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 CA--C 1.516 -0.33 0 CA-C-O 120.792 0.33 . . . . 74.42 111.105 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.524 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -85.79 122.29 29.66 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.979 -0.378 . . . . 61.31 109.979 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.37 139.43 53.28 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.221 -0.659 . . . . 74.34 109.221 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 84.4 t -113.4 113.06 42.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.712 -1.218 . . . . 73.2 107.712 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 38.5 mt-10 -117.52 123.49 46.4 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-O 120.97 0.414 . . . . 74.31 110.497 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tt -118.69 128.15 54.24 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.29 -1.744 . . . . 72.2 106.29 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.3 m -126.24 128.39 47.13 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.064 -0.717 . . . . 75.2 109.064 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 61.7 t -124.06 125.38 70.71 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.113 -0.699 . . . . 74.1 109.113 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.17 125.89 54.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.083 -1.08 . . . . 75.15 108.083 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.4 p90 -134.36 122.54 16.0 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 112.348 0.499 . . . . 75.22 112.348 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -70.4 61.19 2.07 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 122.365 2.044 . . . . 74.21 111.13 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.61 -132.46 0.08 Allowed 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.79 -1.189 . . . . 72.4 107.79 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -160.3 122.9 3.33 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.166 -1.05 . . . . 64.2 108.166 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.55 133.21 31.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 109.092 -0.707 . . . . 73.44 109.092 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.9 p -89.4 -44.43 10.19 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.997 -0.742 . . . . 74.13 108.997 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.0 m -159.01 133.47 7.9 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.097 -0.502 . . . . 73.02 109.759 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -138.24 155.25 48.82 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.098 0.475 . . . . 75.15 110.346 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -121.6 90.92 3.4 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 104.263 -2.495 . . . . 72.12 104.263 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 171.96 -161.95 34.03 Favored Glycine 0 N--CA 1.411 -2.997 0 N-CA-C 106.702 -2.559 . . . . 55.14 106.702 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -100.08 99.75 10.52 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 118.257 1.028 . . . . 71.03 110.412 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -80.11 107.79 13.18 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-O 121.552 0.691 . . . . 72.24 110.306 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.0 mt -80.51 -49.1 19.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.533 -1.284 . . . . 73.22 107.533 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.57 164.7 34.59 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.318 -1.364 . . . . 73.31 107.318 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.61 -3.5 13.21 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.1 1.866 . . . . 74.43 111.112 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.633 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.8 pt-20 -131.86 5.87 4.27 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.017 -0.538 . . . . 72.32 112.386 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.7 t -143.18 121.41 7.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 108.772 -0.825 . . . . 75.12 108.772 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.75 148.15 32.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.665 -0.495 . . . . 73.13 109.665 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -133.75 141.12 47.37 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.716 -0.476 . . . . 74.11 109.716 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 138' ' ' GLU . 32.9 m-90 -117.92 119.78 35.87 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.941 -0.762 . . . . 72.52 108.941 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -109.54 98.32 7.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.154 -1.054 . . . . 72.14 108.154 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 14.1 mt -98.28 138.89 34.88 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 114.592 -1.185 . . . . 73.53 108.696 -172.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -117.47 162.48 28.28 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 114.702 1.371 . . . . 73.44 114.702 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 72.3 Cg_endo -76.18 156.64 37.87 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.363 2.709 . . . . 71.54 112.43 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.92 -33.54 2.86 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 111.289 -0.724 . . . . 74.43 111.289 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' A' ' 166' ' ' PRO . 18.4 m -105.12 148.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 123.688 0.795 . . . . 74.35 110.131 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.76 113.78 37.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.498 -1.297 . . . . 73.31 107.498 174.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.6 p -107.62 146.48 31.91 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.909 -0.587 . . . . 74.11 111.515 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.0 p -103.13 151.68 22.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.861 -0.609 . . . . 72.34 111.334 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 70.4 mtm -123.22 119.78 31.2 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.24 -1.393 . . . . 74.1 107.24 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.7 t -136.92 135.61 37.91 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.781 -1.192 . . . . 75.4 107.781 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.442 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.03 118.31 5.98 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.353 -0.61 . . . . 60.31 109.353 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -122.47 130.66 53.29 Favored 'General case' 0 C--N 1.269 -2.899 0 N-CA-C 106.403 -1.703 . . . . 74.04 106.403 175.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.77 148.87 30.47 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.883 -0.327 . . . . 63.1 110.321 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -88.08 127.21 35.41 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 120.333 -0.547 . . . . 71.2 109.94 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.21 152.0 47.96 Favored 'General case' 0 CA--C 1.482 -1.638 0 C-N-CA 120.788 -0.365 . . . . 72.41 110.1 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.0 p -77.4 120.75 22.84 Favored 'General case' 0 C--N 1.262 -3.233 0 N-CA-C 109.794 -0.447 . . . . 73.54 109.794 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.54 ' OD1' ' HA ' ' A' ' 117' ' ' ASN . 4.9 m-20 . . . . . 0 C--N 1.313 -0.997 0 CA-C-N 115.854 -0.612 . . . . 72.2 110.522 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 . . . . . 0 N--CA 1.43 -1.463 0 N-CA-C 109.285 -0.635 . . . . 74.22 109.285 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.18 114.07 43.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.743 0.782 . . . . 75.11 109.783 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 41.8 mtp85 -113.63 118.76 35.29 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.493 -0.776 . . . . 75.21 111.849 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.77 108.67 19.98 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.0 -1.111 . . . . 54.3 108.0 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 p -117.39 115.67 25.66 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 109.304 -0.628 . . . . 71.22 109.304 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 16.7 pt -129.4 149.05 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-O 121.336 0.589 . . . . 73.42 110.711 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 53.6 m -123.46 124.68 43.42 Favored 'General case' 0 C--N 1.272 -2.792 0 N-CA-C 108.657 -0.868 . . . . 75.51 108.657 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 143' ' ' PHE . 12.2 tt -108.38 109.96 30.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 122.027 0.918 . . . . 74.41 109.414 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.7 m -76.66 152.12 82.95 Favored Pre-proline 0 N--CA 1.423 -1.796 0 CA-C-N 114.635 -1.166 . . . . 75.33 109.962 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.23 -3.32 1.18 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 124.112 3.208 . . . . 74.53 114.438 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -85.84 -0.56 55.66 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 124.175 0.99 . . . . 74.34 109.853 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 38.2 t0 68.6 34.71 3.43 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 123.781 1.753 . . . . 75.12 107.536 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.82 126.1 53.44 Favored 'General case' 0 N--CA 1.397 -3.121 0 CA-C-N 112.426 -2.17 . . . . 74.41 107.701 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 t -104.87 137.22 35.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.337 -0.986 . . . . 75.11 108.337 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.1 p -143.43 149.05 37.08 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 105.946 -1.872 . . . . 71.23 105.946 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.54 -169.56 40.02 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 117.626 -2.226 . . . . 72.23 113.157 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -152.84 142.38 21.79 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.352 0.596 . . . . 73.54 111.497 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.67 116.82 53.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.869 -1.16 . . . . 74.3 107.869 174.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.55 114.92 45.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.466 -0.939 . . . . 74.32 108.466 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.501 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.51 108.0 19.12 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.32 -1.733 . . . . 71.11 106.32 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.75 119.92 29.22 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.645 0.736 . . . . 73.34 111.048 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.91 148.0 34.65 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.21 -0.905 . . . . 74.2 109.247 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.2 tttp . . . . . 0 C--N 1.306 -1.283 0 N-CA-C 105.982 -1.859 . . . . 75.33 105.982 175.438 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.633 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 16.1 p . . . . . 0 N--CA 1.42 -1.967 0 CA-C-O 120.566 0.222 . . . . 74.15 111.19 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.55 115.13 0.36 Allowed Glycine 0 N--CA 1.425 -2.048 0 C-N-CA 119.69 -1.243 . . . . 70.14 113.842 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.484 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 35.0 Cg_exo -66.76 129.37 20.83 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 CA-C-N 119.975 1.887 . . . . 74.42 108.221 168.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.73 163.22 28.2 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 113.695 0.998 . . . . 74.5 113.695 -171.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 mt -124.72 141.24 52.25 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.461 -0.94 . . . . 75.35 108.461 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -88.28 86.3 7.05 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.875 -0.787 . . . . 75.3 108.875 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.74 39.47 2.73 Favored Glycine 0 C--N 1.29 -1.986 0 CA-C-N 114.785 -1.098 . . . . 63.31 111.396 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -94.1 101.3 13.31 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.838 -1.171 . . . . 75.11 107.838 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.3 m -139.6 163.12 47.25 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 115.395 -0.821 . . . . 75.1 109.025 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.03 -24.9 51.99 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 122.435 2.09 . . . . 72.54 111.917 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -99.7 41.45 1.16 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.023 -0.535 . . . . 75.44 111.176 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p -57.47 -29.3 64.12 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.113 0.783 . . . . 74.03 113.113 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -72.5 -15.15 61.79 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-O 121.417 0.627 . . . . 75.44 109.929 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -94.89 -12.77 26.27 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.343 -0.844 . . . . 74.11 109.927 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.07 123.41 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.916 0.865 . . . . 74.53 112.296 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.43 105.77 16.83 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.212 -0.904 . . . . 72.14 108.87 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.2 t -98.06 130.16 47.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.066 -1.457 . . . . 73.23 107.066 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -148.16 172.07 14.89 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.551 -0.537 . . . . 74.5 109.551 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -87.21 153.25 21.64 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.482 -0.562 . . . . 65.22 109.482 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 71.7 t80 -123.09 129.57 51.63 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.544 0.738 . . . . 72.01 109.631 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -138.17 104.06 5.11 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.57 -1.27 . . . . 75.32 107.57 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 47.8 t -171.84 150.25 2.61 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.569 -0.9 . . . . 55.13 108.569 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 70.36 8.77 6.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.721 0.808 . . . . 72.54 111.4 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.77 -0.32 76.52 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 115.414 -0.812 . . . . 75.35 111.157 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -104.42 146.73 28.43 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.573 -0.529 . . . . 73.34 109.573 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.633 ' HB ' ' O ' ' A' ' 56' ' ' THR . 27.4 m -124.18 138.5 53.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.239 -1.023 . . . . 73.43 108.239 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -174.91 -155.16 11.95 Favored Glycine 0 CA--C 1.464 -3.12 0 C-N-CA 119.178 -1.487 . . . . 70.03 112.47 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.7 m -126.03 147.55 49.53 Favored 'General case' 0 C--N 1.274 -2.681 0 CA-C-O 121.145 0.498 . . . . 74.22 110.081 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.5 141.18 51.47 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.918 -0.583 . . . . 72.44 109.89 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.21 114.34 23.52 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.627 -1.249 . . . . 72.23 107.627 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.7 t -109.18 111.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.827 -1.175 . . . . 72.33 107.827 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.472 ' CD2' HD13 ' A' ' 90' ' ' LEU . 53.7 p90 -113.16 157.78 21.25 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 120.924 0.392 . . . . 73.25 110.606 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 p -154.68 150.6 27.82 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.799 -0.637 . . . . 63.01 110.81 -174.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.7 t70 61.42 45.99 7.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.864 1.265 . . . . 74.44 111.819 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.472 HD13 ' CD2' ' A' ' 87' ' ' PHE . 43.3 mt -109.22 169.32 8.76 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.525 -0.761 . . . . 74.21 109.659 177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 t -128.41 -179.79 5.22 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.85 -0.74 . . . . 73.15 111.925 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.429 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 55.0 t80 -50.01 -43.87 50.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.784 2.034 . . . . 73.52 111.406 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.54 -25.59 64.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.779 -0.646 . . . . 61.44 111.747 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -89.34 -15.18 33.99 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.961 -0.563 . . . . 74.25 110.628 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.578 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.7 tm? -54.12 -56.12 29.36 Favored Pre-proline 0 CA--C 1.569 1.692 0 C-N-CA 123.802 0.841 . . . . 74.04 111.887 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.59 -35.72 57.58 Favored 'Trans proline' 0 C--N 1.372 1.785 0 CA-C-N 120.912 1.362 . . . . 72.32 111.08 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -63.03 -40.37 97.54 Favored 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 124.307 1.043 . . . . 74.53 110.398 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -76.05 -19.88 58.24 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.076 0.465 . . . . 61.03 109.783 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.1 -22.32 60.58 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.998 -0.546 . . . . 74.52 110.616 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -56.89 -48.82 77.31 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 109.68 -0.489 . . . . 74.03 109.68 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 24.4 ttm -53.57 -55.69 23.51 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.958 -1.019 . . . . 73.43 108.931 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -56.18 -36.58 68.53 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.299 -1.319 . . . . 72.21 111.622 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.5 m -65.59 -25.36 67.36 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 116.153 -0.476 . . . . 74.51 111.273 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.88 -27.65 66.87 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-O 121.447 0.642 . . . . 72.22 109.875 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -112.01 -13.1 13.64 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.823 -0.626 . . . . 71.11 111.305 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.17 -48.76 3.4 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.149 1.166 . . . . 64.53 114.149 -171.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.61 7.0 78.75 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.144 -0.551 . . . . 75.25 112.468 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -81.2 133.96 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.475 -0.935 . . . . 75.04 108.475 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.45 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 28.7 m-80 -97.41 121.39 39.26 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.029 -1.1 . . . . 73.15 108.029 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.6 115.42 29.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.635 0.255 . . . . 62.43 110.483 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.3 m -109.49 135.89 49.78 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.656 -0.868 . . . . 72.23 108.656 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.3 tp -139.41 133.48 31.09 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 121.239 -0.184 . . . . 71.05 111.014 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -142.24 150.84 41.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.134 0.574 . . . . 75.42 110.654 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.415 HH22 ' CG ' ' A' ' 38' ' ' ASP . 39.5 ttm180 -112.02 135.8 52.2 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.389 -0.967 . . . . 75.02 108.389 174.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -127.94 93.06 3.59 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.69 -1.226 . . . . 74.35 107.69 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.4 -115.76 6.98 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 115.054 -0.975 . . . . 71.11 110.808 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.31 -17.81 24.21 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.54 0.686 . . . . 71.32 109.91 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 0.7 OUTLIER -103.43 148.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 C-N-CA 118.071 -1.452 . . . . 74.5 109.652 -174.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.9 t -120.1 135.78 59.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 110.086 -0.338 . . . . 74.13 110.086 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.6 pt -113.56 130.63 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-O 121.719 0.771 . . . . 73.32 109.966 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.6 tt -125.91 129.64 49.71 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 107.677 -1.231 . . . . 74.41 107.677 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.76 123.76 24.11 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.824 -0.625 . . . . 73.14 109.567 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -132.76 147.44 18.91 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 110.653 -0.979 . . . . 64.31 110.653 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.28 125.95 27.12 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.539 -0.541 . . . . 74.14 109.539 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -99.82 109.94 22.33 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.683 -0.689 . . . . 73.52 110.001 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -99.95 93.22 5.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.276 -0.639 . . . . 74.04 109.276 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.0 24.28 10.25 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.541 -0.754 . . . . 72.2 109.197 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.7 p . . . . . 0 C--N 1.304 -1.375 0 CA-C-O 121.104 0.478 . . . . 72.21 111.546 -177.262 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 121.329 0.585 . . . . 75.45 111.189 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.26 135.52 33.41 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.46 -1.311 . . . . 71.32 107.46 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -131.62 115.19 15.75 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.596 -0.842 . . . . 74.45 109.376 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 51.2 t -106.51 122.67 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.428 -0.953 . . . . 71.24 108.428 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 31.9 tt0 -137.86 130.96 30.33 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.143 -0.688 . . . . 74.45 109.143 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.5 tt -128.88 135.52 49.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.307 -0.627 . . . . 63.1 109.307 -173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.1 m -127.2 133.95 50.2 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.268 -0.642 . . . . 72.32 109.268 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 87.2 t -125.8 125.63 68.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.247 -0.649 . . . . 75.15 109.247 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -110.89 126.83 55.12 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 108.889 -0.782 . . . . 73.04 108.889 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.561 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.06 105.75 11.43 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 109.305 -0.628 . . . . 74.13 109.305 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.66 43.64 0.19 Allowed 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 123.521 2.814 . . . . 64.41 114.139 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.3 -91.25 0.56 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 123.152 0.581 . . . . 71.22 110.931 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 177.85 123.82 0.04 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.253 0.621 . . . . 75.44 110.042 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.3 p -80.89 141.81 14.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.688 -0.856 . . . . 74.44 108.688 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.9 p -99.59 -39.73 8.16 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.561 -0.533 . . . . 74.53 109.561 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.9 m -161.66 134.07 5.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.813 -0.63 . . . . 74.11 109.591 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.427 ' OG1' HG13 ' A' ' 160' ' ' VAL . 7.6 t -137.91 149.09 45.92 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.231 0.539 . . . . 75.32 111.036 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -112.5 87.53 2.6 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 106.518 -1.66 . . . . 74.31 106.518 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.436 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.71 -153.79 22.34 Favored Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 108.036 -2.026 . . . . 74.41 108.036 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -112.43 106.02 14.42 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 117.522 0.661 . . . . 73.54 110.751 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -80.05 126.34 30.94 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.736 -0.665 . . . . 75.53 109.794 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.2 mt -85.69 -42.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.885 -1.524 . . . . 74.12 106.885 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -135.28 170.02 12.24 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 113.964 -1.471 . . . . 64.24 107.387 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.98 0.05 8.36 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.295 1.997 . . . . 63.34 110.841 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.6 pt-20 -131.89 3.55 4.1 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.837 -0.62 . . . . 74.13 111.803 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.6 t -141.47 121.86 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.688 -0.856 . . . . 72.25 108.688 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.427 HG13 ' OG1' ' A' ' 150' ' ' THR . 40.5 t -127.4 149.15 32.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.739 -0.467 . . . . 74.24 109.739 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -134.15 144.0 48.27 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.599 -0.519 . . . . 64.42 109.599 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.436 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.3 m-90 -127.25 135.55 50.77 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.842 -0.617 . . . . 74.24 111.356 -178.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.04 104.96 14.8 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.068 -0.969 . . . . 75.23 108.686 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 47.1 mt -101.65 119.76 39.28 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.211 -1.033 . . . . 75.21 108.211 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.458 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 74.3 mmtt -114.24 156.64 44.01 Favored Pre-proline 0 C--N 1.31 -1.149 0 N-CA-C 112.591 0.589 . . . . 75.21 112.591 -169.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 168' ' ' VAL . 5.2 Cg_exo -76.02 155.97 38.42 Favored 'Trans proline' 0 C--N 1.365 1.426 0 C-N-CA 123.025 2.483 . . . . 73.02 110.631 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.8 -32.67 2.17 Favored Glycine 0 C--N 1.312 -0.765 0 N-CA-C 112.134 -0.386 . . . . 71.12 112.134 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 21.3 m -105.72 161.4 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-O 120.94 0.4 . . . . 64.41 109.997 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.2 p -106.58 110.43 31.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.795 -1.187 . . . . 74.34 107.795 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.6 m -97.78 128.88 44.73 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.447 0.641 . . . . 63.12 110.313 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.2 p -101.63 137.87 39.38 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.352 -0.84 . . . . 71.23 109.991 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.4 ptm -131.62 133.09 44.59 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.718 -0.674 . . . . 73.54 109.586 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m -143.34 148.8 36.84 Favored 'General case' 0 C--N 1.276 -2.588 0 O-C-N 121.762 -0.586 . . . . 71.12 109.573 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.98 119.71 6.56 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.281 -1.007 . . . . 73.33 108.281 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -121.75 130.45 53.43 Favored 'General case' 0 C--N 1.262 -3.231 0 N-CA-C 106.292 -1.744 . . . . 74.31 106.292 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.14 160.18 41.79 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.548 -0.538 . . . . 73.24 109.548 -175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 65.0 mtp180 -88.05 125.92 34.82 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.244 -1.021 . . . . 75.32 108.244 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -123.02 127.69 49.15 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.776 -1.194 . . . . 73.31 107.776 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.5 p -63.59 107.47 1.16 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.395 -0.82 . . . . 73.5 110.216 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 CA--C 1.505 -0.784 0 CA-C-N 115.893 -0.594 . . . . 60.33 110.536 -174.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 107.919 -1.141 . . . . 71.25 107.919 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.13 127.57 72.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.499 0.666 . . . . 64.2 110.461 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -122.75 115.41 22.0 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.98 -1.009 . . . . 73.4 109.268 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.51 108.27 19.51 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.172 -1.048 . . . . 70.24 108.172 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.7 t -108.92 115.74 30.65 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 107.767 -1.197 . . . . 74.32 107.767 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.6 pp -129.91 146.07 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 C-N-CA 120.037 -0.665 . . . . 65.44 109.627 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.9 m -122.82 129.39 51.63 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.242 -1.022 . . . . 71.23 108.242 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -119.27 125.94 74.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.724 0.773 . . . . 74.21 110.511 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.7 m -97.56 142.72 24.99 Favored Pre-proline 0 N--CA 1.415 -2.213 0 CA-C-N 115.2 -0.909 . . . . 74.44 109.349 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.45 2.7 0.24 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 124.104 3.203 . . . . 75.35 114.095 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.67 1.0 40.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 123.737 0.815 . . . . 72.24 110.027 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 91' ' ' THR . 11.5 t70 71.96 35.36 1.33 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 105.738 -1.949 . . . . 73.25 105.738 -176.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 1.7 tp -119.63 126.0 50.11 Favored 'General case' 0 N--CA 1.396 -3.164 0 CA-C-N 113.686 -1.597 . . . . 63.34 108.443 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.6 t -120.44 134.11 64.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.753 -0.832 . . . . 73.4 108.753 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.0 p -144.61 144.14 31.13 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.422 -0.955 . . . . 75.42 108.422 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.45 -166.68 37.28 Favored Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 119.311 -1.423 . . . . 42.11 112.065 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -151.94 135.91 16.47 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.48 0.657 . . . . 62.32 111.048 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.9 mt -111.95 116.63 53.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.107 -1.071 . . . . 74.43 108.107 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.71 114.92 48.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.331 -0.618 . . . . 72.23 109.331 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.52 108.22 19.43 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.178 -1.786 . . . . 73.41 106.178 174.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.8 128.28 50.22 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 120.023 -0.671 . . . . 73.31 112.42 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.05 157.48 24.61 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.306 -0.861 . . . . 75.43 109.509 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttm . . . . . 0 C--N 1.301 -1.514 0 C-N-CA 120.353 -0.539 . . . . 74.32 110.541 175.008 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.405 -2.689 0 N-CA-C 111.458 0.17 . . . . 73.32 111.458 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.0 123.93 0.75 Allowed Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 119.523 -1.322 . . . . 74.31 113.806 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.15 159.28 53.82 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.443 2.095 . . . . 73.22 109.842 170.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.02 126.32 55.03 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 122.06 -0.4 . . . . 73.03 111.735 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 90.3 mt -87.34 162.51 17.33 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.812 -0.631 . . . . 74.43 109.98 175.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -101.88 96.6 7.16 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.762 0.792 . . . . 74.4 109.197 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -108.77 45.25 1.34 Allowed Glycine 0 C--N 1.288 -2.093 0 CA-C-N 114.609 -1.178 . . . . 72.04 110.327 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -100.05 110.03 22.33 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.141 -0.53 . . . . 74.14 109.815 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -152.66 169.33 9.78 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 124.738 1.215 . . . . 74.22 109.088 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.81 -14.87 34.5 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.527 2.151 . . . . 73.44 112.343 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -116.09 29.4 8.0 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.965 -0.561 . . . . 75.02 111.822 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.5 m -57.86 -27.87 63.63 Favored 'General case' 0 C--O 1.209 -1.03 0 N-CA-C 113.221 0.823 . . . . 74.4 113.221 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -73.12 -8.75 57.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.392 0.615 . . . . 74.3 110.542 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -99.81 -15.52 18.4 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.696 -0.684 . . . . 74.53 109.584 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.4 118.84 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 122.154 0.978 . . . . 63.44 111.951 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.52 120.16 40.63 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.525 -0.761 . . . . 74.34 110.146 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.0 139.75 20.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.96 -0.756 . . . . 72.45 108.96 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.5 m -148.01 172.19 14.62 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.488 -0.93 . . . . 73.45 108.488 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -85.88 154.05 21.8 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.389 -0.924 . . . . 71.44 108.69 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -112.25 120.69 42.61 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.703 -0.851 . . . . 74.3 108.703 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -138.64 98.5 3.58 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.073 -1.454 . . . . 65.2 107.073 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.9 t -175.41 160.93 2.65 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.021 -1.474 . . . . 65.4 107.021 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.26 11.7 8.09 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.054 0.941 . . . . 73.44 111.851 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.97 1.11 87.04 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.967 -0.635 . . . . 73.31 111.76 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -104.84 167.41 9.73 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.501 -0.411 . . . . 64.24 109.988 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -134.33 136.13 53.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.524 -1.287 . . . . 74.11 107.524 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.07 -154.63 9.17 Favored Glycine 0 C--N 1.276 -2.796 0 C-N-CA 119.634 -1.27 . . . . 54.43 112.514 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 9.4 p -122.47 147.89 45.8 Favored 'General case' 0 C--N 1.273 -2.747 0 C-N-CA 123.549 0.74 . . . . 73.31 109.915 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -139.55 143.09 37.2 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.899 -0.501 . . . . 71.41 110.8 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.91 114.66 20.11 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.28 -1.378 . . . . 63.43 107.28 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.14 121.52 61.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.592 -0.892 . . . . 64.02 108.592 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.446 ' CD2' HD11 ' A' ' 90' ' ' LEU . 49.2 p90 -123.54 155.56 37.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.978 0.418 . . . . 74.2 111.52 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.0 p -156.7 157.81 35.82 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.831 -0.622 . . . . 71.31 111.357 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 64.47 31.53 12.44 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.472 1.107 . . . . 64.41 110.764 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.446 HD11 ' CD2' ' A' ' 87' ' ' PHE . 26.8 mt -93.24 163.89 13.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 121.653 -0.655 . . . . 72.4 111.026 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 45.0 p -109.46 169.64 8.57 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.397 -0.365 . . . . 75.15 110.314 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -61.73 -31.7 71.89 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.264 -0.426 . . . . 74.35 110.548 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.65 -25.7 63.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.969 0.414 . . . . 75.02 110.957 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.74 -16.79 33.24 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.208 0.447 . . . . 64.34 112.208 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.6 tt -60.82 -49.48 89.2 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 119.232 -0.413 . . . . 75.24 111.271 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.81 -35.52 88.33 Favored 'Trans proline' 0 C--N 1.376 1.989 0 CA-C-N 121.038 1.406 . . . . 51.34 110.707 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.35 -35.78 81.23 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.29 -0.868 . . . . 74.34 111.601 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -73.11 -18.96 61.24 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 120.941 0.401 . . . . 75.33 110.671 176.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.02 -19.2 62.54 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.259 -0.428 . . . . 71.54 110.354 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -65.83 -52.98 45.91 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.183 -1.043 . . . . 62.32 108.183 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.446 ' O ' ' HB3' ' A' ' 104' ' ' ASP . 14.2 mtp -54.15 -52.39 61.26 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.702 -0.681 . . . . 72.32 109.583 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -56.49 -39.45 73.27 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.11 -0.95 . . . . 74.21 112.053 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.8 p -70.96 -21.08 62.37 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 119.282 -0.967 . . . . 73.23 111.198 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 101' ' ' MET . 6.0 t70 -61.72 -27.28 68.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.761 -0.654 . . . . 63.3 110.46 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.14 -5.41 13.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 116.071 -0.513 . . . . 71.13 111.117 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.96 -46.17 3.99 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.488 0.921 . . . . 62.35 113.488 -173.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.98 22.81 58.74 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 120.495 -0.86 . . . . 75.12 111.284 -174.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -120.39 172.3 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.789 -0.819 . . . . 74.22 108.789 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.508 ' OD1' ' HB2' ' A' ' 124' ' ' ARG . 3.7 p-10 -132.82 145.41 50.95 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.854 -0.338 . . . . 74.1 110.667 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.2 112.43 17.05 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.246 -0.65 . . . . 74.44 109.246 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -115.59 112.56 22.34 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.602 -0.518 . . . . 74.22 109.602 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -137.4 148.07 45.91 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.597 0.713 . . . . 72.35 112.007 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -147.53 155.74 42.16 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.417 -1.265 . . . . 75.44 109.53 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -106.6 131.99 53.11 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 106.891 -1.522 . . . . 72.43 106.891 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -118.2 103.49 9.9 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.765 -1.198 . . . . 64.53 107.765 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.91 -107.08 2.25 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 109.372 -1.491 . . . . 72.14 109.372 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -122.2 2.96 9.82 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.788 1.28 . . . . 71.4 108.505 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -107.04 142.92 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 118.74 -1.184 . . . . 63.43 108.157 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 81.9 t -105.9 138.27 31.98 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 O-C-N 122.099 -0.376 . . . . 73.43 111.175 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.02 131.25 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-N 115.499 -0.773 . . . . 74.34 109.012 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.4 131.62 48.49 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 115.46 -0.791 . . . . 75.32 110.296 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -139.95 115.58 10.09 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.781 0.8 . . . . 75.23 108.908 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -113.19 157.99 14.58 Favored Glycine 0 C--N 1.265 -3.364 0 N-CA-C 107.564 -2.214 . . . . 71.31 107.564 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.508 ' HB2' ' OD1' ' A' ' 109' ' ' ASN . 98.5 mtt180 -130.72 125.6 34.32 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 118.397 1.099 . . . . 65.35 109.249 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -118.68 110.33 17.17 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.919 -0.582 . . . . 72.33 110.206 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -105.57 100.04 9.62 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.154 -1.054 . . . . 65.3 108.154 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.26 17.65 21.96 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.687 -0.486 . . . . 72.31 109.687 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.0 p . . . . . 0 C--O 1.215 -0.737 0 N-CA-C 112.603 0.594 . . . . 72.15 112.603 -173.43 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 C--O 1.242 0.71 0 CA-C-O 122.132 0.968 . . . . 74.41 110.163 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.45 145.33 26.32 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.92 -1.036 . . . . 74.25 109.895 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -131.63 141.79 49.71 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.897 0.479 . . . . 74.23 110.113 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.9 t -120.86 112.79 37.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.429 -1.322 . . . . 75.23 107.429 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -121.41 125.29 46.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.777 -0.453 . . . . 74.55 109.777 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 tt -118.46 120.48 37.69 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.41 -1.33 . . . . 73.12 107.41 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.4 m -115.72 126.7 54.42 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.005 -0.739 . . . . 71.25 109.005 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 92.2 t -122.0 121.25 63.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.544 -0.539 . . . . 75.25 109.544 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -111.72 128.02 55.96 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.031 -0.729 . . . . 61.2 109.031 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.551 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.3 p90 -134.25 120.04 14.71 Favored Pre-proline 0 C--N 1.29 -2.005 0 C-N-CA 122.189 0.196 . . . . 72.32 111.298 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.95 55.65 2.87 Favored 'Trans proline' 0 CA--C 1.551 1.353 0 C-N-CA 122.618 2.212 . . . . 74.03 111.35 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.45 -110.53 0.15 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.719 -0.673 . . . . 73.35 110.009 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.1 128.34 0.46 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.856 -0.794 . . . . 75.53 108.856 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.76 133.85 28.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 109.377 -0.601 . . . . 74.33 109.377 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.7 p -90.45 -40.12 12.22 Favored 'General case' 0 N--CA 1.42 -1.967 0 C-N-CA 120.359 -0.537 . . . . 71.51 109.716 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 51.0 m -156.98 132.81 9.48 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 109.002 -0.74 . . . . 73.41 109.002 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.1 t -139.23 159.59 41.8 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.759 -0.46 . . . . 75.35 109.759 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 42.9 t30 -132.54 94.43 3.41 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.561 -1.644 . . . . 72.53 106.561 174.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.08 -136.67 2.92 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 108.643 -1.783 . . . . 63.51 108.643 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -119.25 99.25 6.59 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.899 -0.778 . . . . 71.43 108.899 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -77.9 110.42 12.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.701 -0.682 . . . . 73.32 110.828 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.98 -47.54 20.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.552 -1.277 . . . . 73.2 107.552 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.37 166.59 25.7 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.185 -1.413 . . . . 73.42 107.185 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.46 0.52 7.95 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.098 1.865 . . . . 71.24 111.187 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.7 pt-20 -133.05 4.97 3.82 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 115.593 -0.73 . . . . 74.33 110.394 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.4 t -144.64 120.73 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.578 -0.897 . . . . 74.41 108.578 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.01 146.52 30.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.231 -0.655 . . . . 73.33 109.231 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -126.72 138.58 53.41 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 124.173 0.989 . . . . 73.33 109.008 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.41 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 31.8 m-90 -119.25 109.45 15.85 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.059 -1.089 . . . . 74.4 108.059 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -104.44 98.38 8.17 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 122.498 1.142 . . . . 74.42 109.112 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 19.3 mt -99.14 137.67 37.33 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.562 -1.653 . . . . 73.34 109.925 -170.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -117.73 153.74 50.79 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 114.905 -1.043 . . . . 75.54 111.422 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.34 159.11 54.71 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.515 2.143 . . . . 72.11 111.034 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.16 -34.89 3.18 Favored Glycine 0 C--N 1.303 -1.274 0 C-N-CA 120.964 -0.636 . . . . 72.3 111.564 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.6 m -105.48 159.23 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.4 0.619 . . . . 73.11 112.067 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.1 141.22 31.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.153 -1.054 . . . . 73.41 108.153 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.9 m -150.87 145.77 25.88 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.324 -0.621 . . . . 72.3 109.324 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 38.5 p -105.29 139.12 40.42 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.597 -0.519 . . . . 74.11 109.597 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -89.92 116.52 28.05 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.409 -1.7 . . . . 74.4 106.409 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 10.9 t -125.78 135.88 52.52 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 117.946 -1.502 . . . . 71.44 109.298 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.41 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.49 120.97 6.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.416 -0.957 . . . . 73.25 108.416 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -124.64 131.21 53.48 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.635 -1.246 . . . . 74.54 107.635 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.12 152.52 26.46 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.467 -0.568 . . . . 73.22 109.467 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 56.1 mtt180 -87.91 129.94 35.07 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.851 -0.74 . . . . 74.53 109.217 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -131.93 129.12 39.86 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 107.622 -1.251 . . . . 73.21 107.622 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.9 p -54.61 104.95 0.13 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 124.485 1.116 . . . . 74.33 111.954 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.701 -0.681 . . . . 74.53 109.554 -178.698 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 136' ' ' ASP . 16.1 tpt180 . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 105.986 -1.857 . . . . 74.32 105.986 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.14 114.26 41.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.172 -1.047 . . . . 70.43 108.172 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -129.59 115.18 17.03 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.692 0.758 . . . . 75.12 110.99 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.51 129.75 55.72 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.692 -1.14 . . . . 73.54 108.936 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.9 m -131.16 115.2 16.06 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.083 -1.08 . . . . 75.52 108.083 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.35 147.16 28.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 109.804 -0.443 . . . . 73.32 109.804 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 57.2 m -127.99 124.56 37.51 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 109.11 -0.7 . . . . 74.31 109.11 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -112.77 119.67 60.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.703 0.764 . . . . 75.41 110.362 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.5 m -89.43 151.43 46.2 Favored Pre-proline 0 C--N 1.288 -2.098 0 CA-C-N 115.064 -0.971 . . . . 52.21 109.879 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.85 2.92 0.83 Allowed 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.819 3.013 . . . . 63.23 113.284 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 17.8 t70 -82.55 -2.65 54.23 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.702 -1.221 . . . . 74.4 107.702 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.1 t70 72.54 29.91 1.99 Allowed 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.458 -1.682 . . . . 72.23 106.458 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 1.0 OUTLIER -106.71 138.19 43.35 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 112.728 -2.033 . . . . 75.45 108.341 -177.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.07 140.67 46.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 109.501 -0.555 . . . . 74.43 109.501 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -147.74 160.98 42.13 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.09 -1.078 . . . . 61.11 108.09 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.48 -170.03 40.85 Favored Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.067 -1.54 . . . . 64.13 113.006 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.34 133.68 18.5 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.254 0.55 . . . . 72.42 109.91 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.01 116.68 52.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.872 -1.159 . . . . 72.25 107.872 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.14 116.7 53.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 110.319 -0.252 . . . . 72.1 110.319 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.76 108.03 18.24 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 106.854 -1.535 . . . . 74.34 106.854 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.453 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . . . -118.74 141.79 48.29 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.114 -0.494 . . . . 74.43 110.234 -175.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.35 158.2 31.6 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.697 -0.853 . . . . 73.2 108.697 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.3 mttt . . . . . 0 C--N 1.3 -1.55 0 N-CA-C 108.537 -0.912 . . . . 75.43 108.537 175.932 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.559 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 9.2 t . . . . . 0 N--CA 1.423 -1.79 0 N-CA-C 108.94 -0.763 . . . . 74.44 108.94 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.41 125.33 0.84 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 118.82 -0.989 . . . . 73.44 111.88 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.418 ' CD ' ' HA2' ' A' ' 82' ' ' GLY . 32.3 Cg_exo -61.4 154.26 60.09 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.069 1.846 . . . . 74.13 109.836 174.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.38 109.01 16.24 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 111.993 0.368 . . . . 72.31 111.993 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.3 mt -90.82 124.55 35.24 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.827 -0.749 . . . . 75.24 110.108 173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.46 99.41 8.19 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.406 -0.816 . . . . 73.13 110.283 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.96 75.87 0.29 Allowed Glycine 0 C--N 1.29 -2.021 0 CA-C-N 114.96 -1.018 . . . . 72.14 111.616 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.64 91.36 7.98 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 108.883 -0.784 . . . . 74.22 108.883 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.4 m -134.83 160.1 69.66 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 107.838 -1.171 . . . . 75.23 107.838 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.56 -22.74 37.89 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 121.88 1.72 . . . . 71.14 112.157 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -97.69 40.77 1.15 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.061 -0.518 . . . . 71.21 112.309 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -56.02 -35.92 67.39 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 123.052 0.541 . . . . 75.43 110.353 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -64.53 -15.18 60.49 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.55 0.74 . . . . 74.51 111.635 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -100.7 -17.66 16.87 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 116.082 -0.508 . . . . 72.53 110.828 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.83 120.09 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 122.022 0.915 . . . . 73.41 112.273 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.51 112.74 24.9 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.534 -0.757 . . . . 64.34 109.026 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.16 114.23 39.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.935 -1.135 . . . . 70.21 107.935 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 168.54 14.57 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.856 -0.794 . . . . 71.43 108.856 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -84.48 153.76 23.13 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 119.571 -0.852 . . . . 72.31 109.009 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 83.9 t80 -120.73 124.68 45.73 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 109.837 -0.431 . . . . 73.24 109.837 -177.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.17 98.14 3.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.982 -1.118 . . . . 73.34 107.982 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 49.5 m -165.28 164.27 19.96 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.3 -1.37 . . . . 74.51 107.3 -176.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 67.78 6.58 5.15 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 124.64 1.176 . . . . 75.03 111.946 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.04 5.81 85.55 Favored Glycine 0 C--N 1.314 -0.662 0 N-CA-C 110.065 -1.214 . . . . 73.14 110.065 -174.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -105.7 163.1 12.96 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 124.767 1.227 . . . . 74.31 110.927 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 56' ' ' THR . 16.8 m -134.48 136.55 52.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.525 -0.917 . . . . 75.31 108.525 173.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -169.72 -155.13 9.77 Favored Glycine 0 N--CA 1.423 -2.22 0 C-N-CA 119.855 -1.164 . . . . 71.13 113.033 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -132.17 140.85 48.89 Favored 'General case' 0 C--N 1.289 -2.056 0 C-N-CA 124.007 0.923 . . . . 72.22 109.696 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -128.65 146.16 50.95 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 116.274 -0.421 . . . . 62.12 110.529 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.73 114.42 23.3 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.488 -1.301 . . . . 61.4 107.488 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.35 122.04 62.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.064 -1.087 . . . . 72.15 108.064 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -123.07 153.81 39.4 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.006 -0.678 . . . . 75.14 111.469 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.3 p -156.11 153.52 29.48 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.528 -0.76 . . . . 71.22 110.728 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 64.33 37.51 8.45 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.328 1.017 . . . . 73.3 112.876 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 34.8 mt -101.02 176.32 5.3 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.169 -0.678 . . . . 74.42 109.169 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.439 HG23 ' OE1' ' A' ' 94' ' ' GLU . 9.8 t -121.76 171.08 9.14 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.369 -0.532 . . . . 73.54 110.398 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 114' ' ' ARG . 53.9 t80 -50.02 -44.78 51.41 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.751 1.621 . . . . 70.04 111.517 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.1 -25.63 66.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.63 0.604 . . . . 70.04 112.63 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' OE1' HG23 ' A' ' 91' ' ' THR . 49.5 mt-10 -85.76 -15.96 40.42 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.164 0.431 . . . . 74.41 112.164 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 7.0 tt -55.74 -52.48 71.85 Favored Pre-proline 0 CA--C 1.564 1.5 0 N-CA-C 111.88 0.326 . . . . 72.21 111.88 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.425 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 21.1 Cg_endo -65.1 -29.92 56.12 Favored 'Trans proline' 0 C--N 1.359 1.11 0 CA-C-N 120.6 1.25 . . . . 75.35 111.7 175.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -69.04 -35.92 77.13 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 123.279 0.631 . . . . 75.54 110.401 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -77.02 -19.28 57.42 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.351 0.596 . . . . 74.23 109.495 176.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 96' ' ' PRO . . . -73.19 -17.69 61.34 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.484 -0.78 . . . . 75.4 109.56 -177.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.04 -54.59 42.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.771 -0.65 . . . . 72.03 109.591 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 67.5 mtm -54.24 -52.31 61.74 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.82 0.819 . . . . 72.23 109.232 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -54.3 -31.6 54.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.824 -1.535 . . . . 75.44 111.694 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.8 m -58.46 -33.7 70.04 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 119.304 -0.379 . . . . 71.11 111.915 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.1 -21.94 66.88 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.438 0.533 . . . . 75.35 112.438 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.16 -4.9 13.06 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.723 -0.391 . . . . 72.13 110.629 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.48 -48.27 3.72 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.981 -0.688 . . . . 73.23 112.697 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.8 28.28 73.21 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 119.94 -1.124 . . . . 71.14 110.541 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.1 t -122.05 134.6 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 109.039 -0.726 . . . . 73.51 109.039 -176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -93.55 122.37 35.91 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.087 -0.708 . . . . 73.14 109.087 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.46 137.2 53.34 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.594 0.59 . . . . 73.1 112.594 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.4 t -138.01 142.43 40.41 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.151 -1.055 . . . . 72.54 108.151 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -148.25 127.3 12.82 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.265 -1.013 . . . . 74.05 108.265 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -144.92 149.41 35.21 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 113.615 0.969 . . . . 71.43 113.615 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -101.94 117.28 34.49 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.526 -1.657 . . . . 74.13 106.526 177.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -109.96 92.7 4.15 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 107.81 -1.182 . . . . 74.33 107.81 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.92 -114.16 6.19 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 108.845 -1.702 . . . . 33.2 108.845 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.493 ' OD1' ' HD2' ' A' ' 177' ' ' ARG . 29.4 t-20 -100.33 -14.73 18.27 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.441 0.639 . . . . 64.03 110.633 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.473 ' HA ' ' CB ' ' A' ' 177' ' ' ARG . 1.3 pp -96.05 146.58 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 C-N-CA 118.978 -1.089 . . . . 75.53 109.106 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.663 HG22 ' CD2' ' A' ' 178' ' ' TYR . 89.0 t -115.74 141.19 34.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.587 -0.696 . . . . 73.32 110.391 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.0 pt -122.3 140.67 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 115.328 -0.851 . . . . 75.45 109.493 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.03 127.47 47.93 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 107.636 -1.246 . . . . 74.2 107.636 172.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -127.92 118.61 23.92 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.715 -1.13 . . . . 71.13 108.497 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -144.94 133.47 5.16 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.295 -0.955 . . . . 51.54 111.169 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.433 ' HG2' HG21 ' A' ' 171' ' ' THR . 68.3 mtt85 -120.63 127.02 51.7 Favored 'General case' 0 C--N 1.28 -2.436 0 O-C-N 122.38 -0.482 . . . . 74.13 110.053 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -117.75 113.61 22.1 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.611 -0.722 . . . . 70.02 110.024 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -111.74 107.49 16.6 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.617 -1.253 . . . . 60.24 107.617 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.74 27.28 9.81 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.872 -0.418 . . . . 75.12 109.872 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.4 p . . . . . 0 C--N 1.313 -0.984 0 C-N-CA 120.046 -0.662 . . . . 75.55 111.885 -176.755 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--O 1.238 0.458 0 CA-C-O 121.187 0.518 . . . . 73.33 110.608 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.35 142.25 52.17 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.882 -0.599 . . . . 73.21 110.761 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.434 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 10.1 t70 -132.03 116.31 16.93 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.042 -1.836 . . . . 74.33 106.042 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.8 t -114.35 136.51 50.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.467 -0.568 . . . . 74.34 109.467 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -133.42 131.66 40.23 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.908 -0.404 . . . . 75.34 109.908 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -122.67 118.54 28.36 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 106.817 -1.549 . . . . 74.13 106.817 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.4 m -121.62 133.36 54.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.954 -0.387 . . . . 73.43 109.954 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.37 124.04 66.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 108.697 -0.853 . . . . 74.12 108.697 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -115.16 132.51 56.58 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.577 -0.897 . . . . 72.24 108.577 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.687 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -134.43 120.37 14.69 Favored Pre-proline 0 C--N 1.28 -2.42 0 CA-C-N 116.337 -0.392 . . . . 74.43 110.147 178.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.92 37.69 0.11 Allowed 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 123.928 3.085 . . . . 73.41 114.654 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.28 -97.1 0.46 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.302 -0.629 . . . . 72.14 109.302 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.44 136.81 0.06 Allowed 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.793 -1.188 . . . . 73.54 107.793 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.31 128.5 38.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.548 -0.538 . . . . 75.54 109.548 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 43.6 p -88.35 -43.85 11.21 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.686 -0.688 . . . . 75.1 110.159 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.2 m -150.64 132.51 15.09 Favored 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.4 -0.963 . . . . 74.43 108.4 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.2 t -140.28 152.31 45.8 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.889 -0.724 . . . . 72.41 111.276 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -123.79 91.16 3.41 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.369 -2.086 . . . . 64.33 105.369 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.505 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.14 -139.35 5.38 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 110.202 -1.159 . . . . 74.13 110.202 -177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 161' ' ' GLN . 24.3 t70 -115.18 99.57 7.51 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.613 0.721 . . . . 75.14 110.589 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -84.33 116.35 22.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 116.131 -0.486 . . . . 74.32 110.808 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.474 HD12 ' NE2' ' A' ' 161' ' ' GLN . 54.8 mt -93.42 -49.29 12.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.679 -0.86 . . . . 71.51 108.679 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -126.36 159.58 62.19 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.552 -1.277 . . . . 73.33 107.552 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.04 -18.61 51.63 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.568 2.179 . . . . 74.23 111.907 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.8 OUTLIER -120.22 7.65 10.79 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.842 0.682 . . . . 72.52 112.842 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.9 t -138.43 121.45 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-O 121.074 0.464 . . . . 75.04 110.812 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.7 t -125.04 144.87 33.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.962 -0.563 . . . . 75.24 109.664 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.474 ' NE2' HD12 ' A' ' 155' ' ' ILE . 9.2 tt0 -133.57 152.03 51.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.273 -1.01 . . . . 71.04 108.273 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.505 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.0 m-90 -128.64 123.92 34.47 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 108.42 -0.956 . . . . 74.13 108.42 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 109.04 20.76 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.813 0.816 . . . . 74.41 109.983 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 66.1 mt -97.33 126.27 42.45 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.677 -1.147 . . . . 73.01 109.226 -174.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -115.22 152.19 46.54 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 115.091 -0.959 . . . . 74.32 112.266 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 168' ' ' VAL . 23.5 Cg_exo -68.97 158.44 57.92 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 123.192 2.595 . . . . 74.1 111.212 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 73.3 -19.82 1.33 Allowed Glycine 0 C--N 1.313 -0.746 0 N-CA-C 114.299 0.48 . . . . 63.12 114.299 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 166' ' ' PRO . 13.4 m -111.63 169.25 4.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.4 0.619 . . . . 75.31 110.781 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.63 139.61 38.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.142 -1.429 . . . . 74.43 107.142 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 27.1 m -134.77 134.89 41.4 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.358 0.599 . . . . 64.52 110.55 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.433 HG21 ' HG2' ' A' ' 124' ' ' ARG . 9.7 p -103.11 126.53 50.33 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.085 -0.961 . . . . 75.45 108.727 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 56.7 mtm -108.86 126.95 53.6 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.21 -1.033 . . . . 73.24 108.21 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.9 t -141.65 138.09 32.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.339 -0.986 . . . . 73.42 108.339 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.4 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -146.03 133.39 20.68 Favored 'General case' 0 CA--C 1.469 -2.16 0 N-CA-C 108.052 -1.092 . . . . 71.31 108.052 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.89 131.14 51.22 Favored 'General case' 0 C--N 1.263 -3.177 0 N-CA-C 108.039 -1.097 . . . . 74.15 108.039 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 119' ' ' VAL . . . -159.79 129.45 5.35 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 106.566 -1.642 . . . . 74.4 106.566 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.493 ' HD2' ' OD1' ' A' ' 117' ' ' ASN . 17.7 ptt180 -88.05 146.86 25.25 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 118.43 -1.308 . . . . 74.32 110.117 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.663 ' CD2' HG22 ' A' ' 119' ' ' VAL . 19.6 m-30 -119.53 137.05 54.07 Favored 'General case' 0 CA--C 1.465 -2.317 0 N-CA-C 108.187 -1.042 . . . . 74.01 108.187 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.7 p -71.36 103.82 3.0 Favored 'General case' 0 N--CA 1.394 -3.236 0 CA-C-N 115.269 -0.878 . . . . 65.43 110.431 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 . . . . . 0 N--CA 1.446 -0.643 0 CA-C-N 115.13 -0.941 . . . . 75.11 111.145 176.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 . . . . . 0 N--CA 1.416 -2.132 0 N-CA-C 107.741 -1.207 . . . . 72.35 107.741 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 48.9 t -118.97 114.19 43.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 106.913 -1.514 . . . . 75.15 106.913 177.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 22.4 ttt180 -129.32 116.94 19.85 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 121.519 0.676 . . . . 72.11 110.708 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.35 108.84 20.57 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.26 -1.385 . . . . 73.4 107.26 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.9 m -113.47 114.16 26.16 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.698 -1.593 . . . . 62.31 106.698 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.8 pp -131.76 146.07 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 C-N-CA 120.2 -0.6 . . . . 71.23 109.811 -175.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 87.3 m -126.43 122.49 35.44 Favored 'General case' 0 C--N 1.27 -2.883 0 N-CA-C 109.251 -0.648 . . . . 74.24 109.251 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 tt -110.93 118.76 58.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.652 0.739 . . . . 62.54 109.796 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.7 m -89.33 150.78 45.4 Favored Pre-proline 0 N--CA 1.411 -2.411 0 N-CA-C 108.429 -0.952 . . . . 71.33 108.429 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.03 0.9 0.36 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.792 2.995 . . . . 75.04 115.135 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -83.32 -3.25 57.3 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.783 -0.821 . . . . 72.23 108.783 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 t70 72.77 29.84 1.87 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 105.812 -1.921 . . . . 74.12 105.812 -173.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tp -100.19 124.61 45.83 Favored 'General case' 0 N--CA 1.389 -3.493 0 CA-C-N 113.3 -1.773 . . . . 74.13 107.354 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 t -116.34 133.08 64.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 109.078 -0.712 . . . . 75.32 109.078 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.8 p -146.96 157.55 43.66 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.635 -0.876 . . . . 64.22 108.635 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.3 -165.19 38.68 Favored Glycine 0 N--CA 1.428 -1.855 0 C-N-CA 119.207 -1.473 . . . . 70.21 112.987 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.55 133.83 21.74 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 123.28 0.632 . . . . 72.33 109.873 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.94 116.01 50.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.892 -1.151 . . . . 74.42 107.892 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.93 126.03 65.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.046 -0.525 . . . . 74.32 109.829 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -120.72 107.93 13.37 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.282 -1.747 . . . . 74.12 106.282 171.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.87 127.51 51.95 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.26 -0.427 . . . . 73.42 111.003 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.77 148.88 42.35 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 116.48 -0.327 . . . . 64.21 110.244 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.31 -1.14 0 N-CA-C 108.433 -0.951 . . . . 70.44 108.433 173.535 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.427 -1.59 0 N-CA-C 109.865 -0.42 . . . . 72.33 109.865 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.488 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 172.24 99.01 0.12 Allowed Glycine 0 N--CA 1.431 -1.671 0 CA-C-O 118.69 -1.061 . . . . 72.5 112.545 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 31.2 Cg_exo -59.84 128.52 27.1 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 CA-C-N 119.872 1.836 . . . . 72.44 109.052 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.71 151.43 21.85 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.803 0.668 . . . . 72.42 112.803 -171.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.438 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 67.3 mt -82.46 138.97 34.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.828 -0.623 . . . . 71.21 109.526 174.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -110.6 101.97 10.59 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.633 -1.618 . . . . 72.11 106.633 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.85 75.13 0.19 Allowed Glycine 0 C--N 1.29 -1.979 0 C-N-CA 120.581 -0.818 . . . . 71.41 112.857 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.01 112.2 19.55 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.56 -0.533 . . . . 73.41 109.56 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.435 HG12 ' SD ' ' A' ' 101' ' ' MET . 17.6 m -124.21 157.13 65.35 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 115.939 -0.573 . . . . 74.21 109.841 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.51 -10.09 27.56 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 122.751 2.3 . . . . 72.24 112.886 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -110.26 39.46 2.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.388 -0.369 . . . . 70.41 110.974 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 m -53.68 -32.36 51.39 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.055 0.391 . . . . 74.24 112.055 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -67.76 -11.88 59.38 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.273 0.559 . . . . 75.43 110.981 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -98.62 -20.61 16.9 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.673 -0.694 . . . . 74.35 111.071 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.22 119.79 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.731 0.777 . . . . 73.3 112.155 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 123.28 45.7 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.465 -0.789 . . . . 63.23 109.075 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.66 130.99 46.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.952 -0.758 . . . . 72.42 108.952 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 m -132.66 171.98 13.13 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.947 -0.39 . . . . 72.43 109.947 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.488 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 5.8 t30 -93.03 134.87 34.73 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.051 -1.092 . . . . 73.22 108.051 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.526 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 87.8 t80 -99.96 126.35 46.11 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.946 -0.39 . . . . 75.34 109.946 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -135.29 101.44 4.84 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.082 -1.081 . . . . 74.35 108.082 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 47.0 t -173.22 155.85 3.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.939 -1.134 . . . . 73.25 107.939 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 70.57 6.86 6.0 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.687 1.195 . . . . 73.53 110.811 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.76 6.0 87.51 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.021 -0.831 . . . . 74.52 111.021 -173.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -104.59 148.15 26.83 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.417 0.687 . . . . 75.33 110.094 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.7 137.45 55.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.833 -0.803 . . . . 73.41 108.833 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.466 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -167.86 -154.31 8.61 Favored Glycine 0 CA--C 1.458 -3.473 0 N-CA-C 110.555 -1.018 . . . . 71.44 110.555 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.438 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . 32.7 t -134.19 149.13 50.99 Favored 'General case' 0 C--N 1.26 -3.296 0 N-CA-C 108.656 -0.868 . . . . 73.21 108.656 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -134.82 133.88 40.25 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 115.618 -0.719 . . . . 74.43 110.207 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.67 115.61 30.62 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.24 -1.022 . . . . 71.13 108.24 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.64 116.21 48.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 107.599 -1.26 . . . . 72.53 107.599 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.477 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.5 p90 -120.76 157.04 30.57 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.595 -0.442 . . . . 74.14 110.609 -175.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.2 m -159.25 157.19 30.16 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.933 -0.576 . . . . 75.32 110.06 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 64.06 32.85 12.56 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.24 0.963 . . . . 73.44 112.242 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.477 HD12 ' CD2' ' A' ' 87' ' ' PHE . 22.9 mt -90.31 153.26 20.59 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.625 -0.716 . . . . 75.02 110.503 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.7 p -108.04 172.33 6.89 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.338 -0.846 . . . . 75.04 109.686 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -60.84 -26.55 67.44 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.183 0.516 . . . . 75.43 111.007 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.64 -29.5 66.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.534 0.683 . . . . 74.04 109.847 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.403 ' CB ' HD23 ' A' ' 90' ' ' LEU . 38.9 mt-10 -93.07 -15.95 25.53 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.315 -0.857 . . . . 74.54 111.77 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.4 mt -51.98 -52.34 62.62 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 114.008 1.114 . . . . 74.24 114.008 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -64.54 -34.41 52.82 Favored 'Trans proline' 0 C--N 1.363 1.325 0 CA-C-N 120.624 1.259 . . . . 73.04 110.31 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -64.26 -38.74 92.11 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.085 -0.962 . . . . 75.13 111.385 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -70.78 -19.7 62.67 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.091 0.472 . . . . 75.52 110.601 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.27 -16.07 59.87 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.033 -0.531 . . . . 73.23 110.643 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -62.32 -57.92 9.58 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 120.8 -0.36 . . . . 74.43 110.065 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.435 ' SD ' HG12 ' A' ' 64' ' ' VAL . 3.7 mpp? -56.49 -45.74 80.84 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.133 0.492 . . . . 73.42 109.896 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -52.95 -45.01 67.53 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 114.203 -1.362 . . . . 75.2 111.386 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.7 p -66.03 -28.3 68.76 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 120.291 -0.564 . . . . 61.54 110.937 -170.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.1 -26.04 66.51 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.16 0.505 . . . . 65.5 110.597 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.88 -9.81 17.74 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.956 -0.566 . . . . 71.43 110.594 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.26 -44.75 4.47 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.213 0.82 . . . . 63.3 113.213 -172.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.39 27.64 35.57 Favored Glycine 0 C--N 1.316 -0.548 0 N-CA-C 110.297 -1.121 . . . . 74.42 110.297 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.9 m -111.11 168.26 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.389 -0.406 . . . . 74.11 110.104 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -135.45 124.96 25.0 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.676 -0.861 . . . . 74.14 108.676 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -119.49 141.07 49.5 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 123.335 0.397 . . . . 72.31 110.283 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 49.2 m -141.56 116.39 9.79 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.534 -0.913 . . . . 74.03 108.534 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.72 146.16 51.5 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.137 -0.625 . . . . 75.35 111.337 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -139.13 154.67 48.15 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.632 -1.167 . . . . 74.34 109.034 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -100.25 137.8 38.19 Favored 'General case' 0 N--CA 1.393 -3.309 0 N-CA-C 107.661 -1.237 . . . . 74.23 107.661 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -123.26 89.36 3.09 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 106.638 -1.615 . . . . 75.51 106.638 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.71 -118.12 6.91 Favored Glycine 0 N--CA 1.423 -2.224 0 N-CA-C 110.042 -1.223 . . . . 75.11 110.042 -176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.547 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 8.1 t30 -103.96 7.31 36.66 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.086 0.946 . . . . 74.21 108.925 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 pp -119.33 149.16 21.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 120.799 -1.188 . . . . 72.14 109.079 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.8 137.91 36.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 O-C-N 121.845 -0.534 . . . . 73.31 110.037 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.0 pt -118.42 132.66 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 109.291 -0.633 . . . . 73.21 109.291 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 tt -124.61 129.24 50.19 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 115.549 -0.75 . . . . 72.41 109.438 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.31 124.17 29.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.526 -1.657 . . . . 74.12 106.526 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -149.58 171.9 29.63 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.392 -0.908 . . . . 74.14 112.695 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -138.79 153.79 48.43 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.634 0.774 . . . . 75.03 109.365 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.07 109.04 10.2 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.475 -0.935 . . . . 54.54 108.475 174.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -112.6 95.69 5.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.785 0.802 . . . . 74.3 110.742 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.88 27.97 5.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 123.393 1.568 . . . . 72.14 107.79 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 C--N 1.304 -1.388 0 CA-C-N 112.562 -2.108 . . . . 72.31 112.017 -179.483 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 121.495 0.664 . . . . 72.42 110.186 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.33 138.92 58.25 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.82 -1.082 . . . . 72.23 113.863 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -131.33 130.38 42.65 Favored 'General case' 0 C--O 1.257 1.486 0 N-CA-C 107.784 -1.191 . . . . 72.22 107.784 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 47.2 t -105.9 112.72 40.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.134 -1.432 . . . . 65.3 107.134 175.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 37.0 mt-10 -108.19 120.42 42.31 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.081 -0.711 . . . . 75.25 109.081 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 3.0 tt -115.17 122.81 47.18 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 105.976 -1.861 . . . . 70.24 105.976 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.0 m -126.92 126.01 42.53 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 109.198 -0.667 . . . . 74.34 109.198 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 57.8 t -120.11 124.03 71.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.961 -0.755 . . . . 74.32 108.961 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.4 127.36 55.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.706 -0.85 . . . . 75.34 108.706 177.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.505 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.54 121.76 15.34 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 112.187 0.44 . . . . 74.24 112.187 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.73 46.9 1.11 Allowed 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.997 2.464 . . . . 75.03 110.809 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -128.36 -106.84 0.3 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.943 -0.571 . . . . 72.43 109.867 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.59 126.75 0.07 Allowed 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.742 -0.836 . . . . 61.03 108.742 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.91 135.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.868 -0.79 . . . . 75.54 108.868 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.4 p -90.5 -42.7 10.7 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 109.459 -0.571 . . . . 74.14 109.459 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.5 m -159.38 133.12 7.34 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.095 -0.502 . . . . 73.42 109.963 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.6 t -139.16 157.12 46.5 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 121.987 -0.445 . . . . 72.14 110.313 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -128.23 95.86 4.29 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.656 -1.979 . . . . 72.13 105.656 173.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.52 -145.21 8.14 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 107.788 -2.125 . . . . 73.42 107.788 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -110.61 99.83 8.73 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 118.294 1.047 . . . . 73.22 110.232 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -78.96 110.45 14.19 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 121.886 0.85 . . . . 74.35 109.531 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.8 mt -80.39 -38.0 17.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.149 -1.426 . . . . 63.51 107.149 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.76 163.86 38.08 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.222 -1.77 . . . . 65.45 106.222 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.09 0.23 7.56 Favored 'Trans proline' 0 N--CA 1.481 0.789 0 C-N-CA 122.588 2.192 . . . . 75.03 110.846 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.0 pt-20 -128.94 -0.42 5.3 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 114.88 -1.054 . . . . 73.0 111.297 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.7 t -142.18 120.8 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.547 -0.908 . . . . 73.53 108.547 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -127.41 143.79 39.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.532 -0.544 . . . . 75.22 109.532 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 36.1 tt0 -129.93 147.08 51.65 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.373 0.606 . . . . 73.11 110.17 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.457 ' CZ2' ' HB1' ' A' ' 174' ' ' ALA . 30.3 m-90 -123.63 117.86 25.97 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.142 -1.059 . . . . 75.41 108.142 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -104.07 98.21 8.07 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.752 0.787 . . . . 71.42 109.407 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 18.3 mt -93.42 130.12 39.34 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.555 -1.202 . . . . 73.53 109.225 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.2 152.32 50.42 Favored Pre-proline 0 C--N 1.302 -1.468 0 CA-C-N 115.904 -0.589 . . . . 73.13 111.15 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.68 153.48 73.22 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.329 2.019 . . . . 73.15 111.06 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.09 -23.96 2.56 Favored Glycine 0 C--N 1.304 -1.201 0 C-N-CA 121.046 -0.597 . . . . 71.5 113.842 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.1 m -104.45 147.78 10.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.223 0.535 . . . . 74.11 110.698 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 82.6 t -85.38 127.9 39.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.584 -0.735 . . . . 74.1 109.504 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 10.1 p -138.44 133.07 32.31 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-O 121.424 0.63 . . . . 73.25 111.715 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.3 p -114.83 147.38 39.93 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 108.614 -0.884 . . . . 62.3 108.614 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.412 ' SD ' HD13 ' A' ' 164' ' ' LEU . 70.2 mtm -120.5 133.31 55.42 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.645 -0.502 . . . . 73.32 109.645 -176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.9 t -143.02 137.06 29.01 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.313 -0.625 . . . . 72.41 109.313 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.457 ' HB1' ' CZ2' ' A' ' 162' ' ' TRP . . . -148.12 118.71 7.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.943 -0.762 . . . . 72.54 108.943 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -122.75 130.97 53.55 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 106.62 -1.622 . . . . 74.5 106.62 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.44 160.93 41.89 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.035 0.21 . . . . 72.44 111.261 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.8 mtt-85 -87.39 127.29 35.21 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.862 -0.422 . . . . 74.42 109.862 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -143.5 119.54 10.7 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 117.757 0.253 . . . . 72.04 110.529 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.547 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -58.63 119.42 7.04 Favored 'General case' 0 C--N 1.288 -2.1 0 O-C-N 124.226 0.954 . . . . 75.21 112.423 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.56 -0.746 . . . . 74.53 109.894 -179.133 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 N--CA 1.423 -1.821 0 N-CA-C 107.348 -1.353 . . . . 73.45 107.348 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.57 114.69 39.06 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 CA-C-O 121.876 0.846 . . . . 74.14 109.436 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 61.7 mtp85 -119.22 116.69 26.81 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.549 -1.205 . . . . 73.31 110.345 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 139' ' ' LEU . . . -103.66 109.52 21.24 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.769 -1.197 . . . . 75.15 107.769 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 m -114.8 115.42 26.98 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.767 -0.827 . . . . 72.33 108.767 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -129.0 141.68 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 N-CA-C 108.892 -0.781 . . . . 64.21 108.892 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.2 m -121.39 120.94 36.47 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.652 -0.87 . . . . 74.13 108.652 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -105.44 120.79 56.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 121.657 0.741 . . . . 74.45 109.822 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.4 m -84.17 155.92 63.5 Favored Pre-proline 0 C--N 1.295 -1.782 0 CA-C-N 115.177 -0.92 . . . . 60.53 108.974 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.68 2.1 3.79 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.927 2.418 . . . . 75.13 112.531 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -89.36 2.35 54.54 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 124.635 1.174 . . . . 63.32 109.524 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.8 t70 69.21 29.4 4.64 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 123.664 1.697 . . . . 74.22 107.622 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.36 125.47 52.4 Favored 'General case' 0 N--CA 1.393 -3.299 0 CA-C-N 113.032 -1.894 . . . . 74.32 107.471 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.52 134.07 57.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 115.902 -0.59 . . . . 74.53 109.535 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.2 p -140.96 128.67 21.55 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.56 -1.274 . . . . 71.45 107.56 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.67 -171.9 30.49 Favored Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 119.487 -1.34 . . . . 63.0 112.648 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -149.21 133.67 17.57 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.173 -0.677 . . . . 64.54 109.173 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 58.4 mt -111.72 115.33 49.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 106.918 -1.512 . . . . 74.1 106.918 176.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.39 114.22 46.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.357 -0.609 . . . . 74.21 109.357 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -106.61 107.68 18.82 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.814 -1.921 . . . . 75.53 105.814 172.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.64 116.93 24.66 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.7 0.762 . . . . 51.52 110.064 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.65 139.91 50.37 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.534 -0.757 . . . . 73.33 111.304 -174.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.7 tttt . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 104.604 -2.369 . . . . 74.34 104.604 168.326 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.439 -1.005 0 N-CA-C 108.049 -1.093 . . . . 61.43 108.049 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.8 96.6 0.1 Allowed Glycine 0 N--CA 1.42 -2.38 0 CA-C-N 113.474 -1.693 . . . . 72.12 109.295 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 49.2 Cg_exo -55.88 128.95 32.39 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.563 2.175 . . . . 75.45 110.569 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -85.21 159.86 20.02 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.618 0.97 . . . . 71.01 113.618 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.3 mt -107.98 127.51 53.83 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 108.035 -1.098 . . . . 74.51 108.035 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -112.94 97.64 6.66 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.009 0.433 . . . . 75.1 111.174 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.62 136.06 8.64 Favored Glycine 0 C--N 1.284 -2.327 0 N-CA-C 110.788 -0.925 . . . . 74.05 110.788 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.57 120.54 38.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.264 0.554 . . . . 73.23 111.184 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 m -137.81 161.47 59.89 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.531 -0.759 . . . . 62.31 109.063 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.8 -22.05 24.15 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.155 1.903 . . . . 74.3 111.768 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -100.37 42.52 1.11 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.771 -0.65 . . . . 75.11 111.593 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 m -54.03 -36.56 63.17 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.475 0.71 . . . . 63.3 111.489 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -69.55 -13.68 62.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.541 0.686 . . . . 73.23 110.289 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.71 -12.77 21.96 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.431 -0.804 . . . . 75.33 110.434 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.8 119.46 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 122.303 1.049 . . . . 74.25 111.595 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.58 112.99 26.16 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.179 -0.919 . . . . 75.15 109.873 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.7 p -98.0 133.11 41.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.25 -1.018 . . . . 73.12 108.25 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.6 m -147.46 163.24 37.15 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.266 -1.013 . . . . 74.35 108.266 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -76.87 143.42 39.68 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.473 0.654 . . . . 73.44 110.808 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 73.4 t80 -108.3 123.09 48.27 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.552 -1.277 . . . . 64.31 107.552 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -138.25 99.17 3.79 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 107.659 -1.237 . . . . 74.15 107.659 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 65.2 m -162.5 149.15 13.12 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.865 -1.161 . . . . 75.42 107.865 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 69.73 4.41 4.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.876 0.87 . . . . 62.04 113.316 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.55 4.76 65.58 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.998 -0.841 . . . . 24.33 110.998 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -104.93 142.34 34.94 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.297 -1.001 . . . . 62.43 108.297 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.4 m -124.38 136.45 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 121.544 0.688 . . . . 71.52 109.481 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -173.44 -153.41 9.61 Favored Glycine 0 CA--C 1.461 -3.331 0 N-CA-C 110.088 -1.205 . . . . 75.53 110.088 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.557 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 62.9 m -134.95 149.85 50.29 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 121.506 0.67 . . . . 74.1 111.485 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.9 pt20 -124.58 132.14 53.45 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.873 -1.058 . . . . 75.13 109.576 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.04 113.95 27.65 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.584 -1.636 . . . . 73.11 106.584 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.69 112.74 41.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.374 -0.973 . . . . 75.14 108.374 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.501 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.5 p90 -115.71 153.68 30.92 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.978 -0.556 . . . . 72.23 110.954 -175.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -154.85 158.16 38.95 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.581 -0.736 . . . . 62.2 111.297 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 65.15 30.88 11.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 122.568 1.175 . . . . 71.45 110.824 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.501 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.4 mt -96.08 164.23 12.78 Favored 'General case' 0 N--CA 1.426 -1.628 0 O-C-N 121.275 -0.891 . . . . 71.11 111.11 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -115.22 171.34 7.75 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 116.254 -0.43 . . . . 74.12 110.686 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -57.0 -36.79 70.81 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.031 0.443 . . . . 65.13 110.181 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.05 70.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.686 -0.688 . . . . 74.41 111.019 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.87 -16.08 39.77 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 112.593 0.59 . . . . 73.4 112.593 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.1 mt -52.56 -53.4 54.15 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 114.322 1.23 . . . . 74.32 114.322 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.08 -42.29 44.93 Favored 'Trans proline' 0 C--N 1.369 1.607 0 CA-C-N 120.57 1.239 . . . . 72.45 110.497 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -60.08 -39.72 87.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.317 -0.856 . . . . 73.13 111.76 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -78.34 -21.86 48.89 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 120.745 -0.382 . . . . 74.55 110.728 177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.84 -26.85 61.63 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.148 -0.686 . . . . 73.51 109.148 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -57.73 -54.33 48.12 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.318 -0.855 . . . . 73.54 109.909 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.1 mtm -54.11 -49.98 67.91 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.205 0.526 . . . . 72.43 110.313 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -55.36 -37.27 67.3 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.402 -1.272 . . . . 74.34 110.117 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.7 m -60.72 -32.89 72.13 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.503 -0.317 . . . . 73.44 111.092 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -68.82 -15.63 63.55 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.531 0.682 . . . . 75.22 111.557 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.15 -11.95 12.59 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.202 -0.454 . . . . 62.45 110.607 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.52 -47.53 3.75 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.658 0.984 . . . . 74.11 113.658 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.86 22.09 77.48 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.454 -1.058 . . . . 64.33 110.454 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.3 t -111.93 143.89 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.127 0.971 . . . . 74.14 108.576 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -102.18 131.38 48.74 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.052 -0.351 . . . . 75.22 110.052 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.19 104.84 7.3 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.39 -0.967 . . . . 55.14 108.39 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.5 m -117.58 137.6 52.49 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.607 -0.886 . . . . 74.1 108.607 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -147.96 149.28 31.88 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.94 -0.704 . . . . 73.11 112.449 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -148.39 163.07 38.21 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.039 -0.982 . . . . 75.33 111.001 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 114' ' ' ARG . 45.8 mtt85 -102.57 139.76 37.75 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.029 0.443 . . . . 73.1 110.315 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -121.7 83.71 2.13 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.983 -1.488 . . . . 75.23 106.983 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.95 -115.7 8.25 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.971 -1.013 . . . . 72.02 110.697 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -85.08 -20.27 30.63 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.504 0.668 . . . . 74.52 110.929 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.2 pp -102.64 148.71 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 C-N-CA 118.088 -1.445 . . . . 72.35 109.174 -175.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.418 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 92.8 t -116.81 140.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 O-C-N 122.008 -0.432 . . . . 72.15 110.054 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.3 pt -117.35 138.11 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 115.972 -0.558 . . . . 75.21 110.088 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.3 tt -127.3 127.94 45.15 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.143 -1.058 . . . . 74.3 108.143 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -128.26 117.95 22.41 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.485 -0.932 . . . . 61.03 108.485 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.13 169.57 25.31 Favored Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 121.059 -0.591 . . . . 64.1 112.201 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -151.05 153.24 34.72 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.19 -0.67 . . . . 74.31 109.19 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -135.57 108.62 7.67 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.634 -0.876 . . . . 74.32 108.634 171.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -113.11 97.24 6.38 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.933 0.873 . . . . 74.52 110.994 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.76 34.74 4.59 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.448 -1.251 . . . . 72.31 108.193 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 C--N 1.314 -0.943 0 N-CA-C 113.143 0.794 . . . . 75.45 113.143 -175.599 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.241 0.646 0 N-CA-C 115.133 1.531 . . . . 74.42 115.133 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.17 135.89 40.91 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.894 -1.048 . . . . 74.43 108.714 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -131.39 130.48 42.65 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 118.089 0.404 . . . . 74.32 110.419 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 46.5 t -115.91 126.9 73.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.311 -0.626 . . . . 62.41 109.311 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 162' ' ' TRP . 50.6 mt-10 -128.65 133.06 48.14 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.962 0.41 . . . . 75.45 110.179 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 52.2 tp -114.44 121.43 43.54 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.683 -0.858 . . . . 75.11 108.683 174.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.3 m -115.8 108.82 16.81 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.988 -1.116 . . . . 73.42 107.988 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.1 t -107.92 123.59 63.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.727 -0.472 . . . . 75.52 109.727 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.16 127.07 55.83 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.318 -0.623 . . . . 62.0 109.318 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.06 120.42 15.12 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 116.38 -0.373 . . . . 71.31 111.79 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.83 45.26 0.87 Allowed 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 122.866 2.378 . . . . 73.04 111.729 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -123.36 -95.59 0.47 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 119.18 -0.438 . . . . 70.33 110.869 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 173.19 123.63 0.02 OUTLIER 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.502 0.721 . . . . 51.51 109.361 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -80.28 130.58 35.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.434 -0.95 . . . . 71.32 108.434 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.3 p -88.15 -39.79 14.26 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.831 -0.433 . . . . 73.03 109.831 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.6 m -163.17 132.9 4.25 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 123.633 0.773 . . . . 74.54 109.156 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -138.38 154.37 48.93 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.983 -0.448 . . . . 73.12 110.971 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 28.9 t-20 -121.31 94.89 4.48 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.029 -1.841 . . . . 72.12 106.029 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.24 -149.75 10.08 Favored Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 107.852 -2.099 . . . . 62.11 107.852 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -117.74 99.89 7.24 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.416 -1.327 . . . . 73.02 107.416 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -81.12 132.27 35.35 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 120.113 -0.635 . . . . 74.14 110.565 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.64 -43.17 14.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.309 -1.367 . . . . 74.02 107.309 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -136.92 170.43 10.8 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.01 -1.478 . . . . 73.34 107.01 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -72.15 0.77 6.79 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.583 2.188 . . . . 64.34 110.985 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.5 pt-20 -130.33 -0.13 4.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.532 -0.758 . . . . 73.45 111.467 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 88.8 t -141.58 121.06 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.461 -0.94 . . . . 73.14 108.461 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.06 146.63 33.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 109.578 -0.526 . . . . 74.52 109.578 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 29.2 tt0 -134.01 136.74 44.29 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 121.612 0.72 . . . . 74.31 110.937 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.518 ' O ' ' HA ' ' A' ' 138' ' ' GLU . 32.2 m-90 -112.62 125.83 54.71 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.593 -0.73 . . . . 75.11 109.953 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -104.6 99.21 8.88 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.36 -0.978 . . . . 75.04 108.36 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.496 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 1.8 mm? -95.89 121.84 38.06 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.701 -0.851 . . . . 72.4 108.701 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -116.25 151.04 46.32 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 115.394 -0.821 . . . . 73.12 110.991 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.48 162.83 32.89 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.032 2.488 . . . . 74.12 109.836 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.45 -40.12 2.94 Favored Glycine 0 C--O 1.245 0.802 0 N-CA-C 111.145 -0.782 . . . . 62.24 111.145 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.33 158.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 123.043 0.537 . . . . 75.33 109.61 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -109.56 136.98 43.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.836 -1.172 . . . . 74.13 107.836 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.7 t -137.71 141.28 41.04 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 119.363 -0.935 . . . . 64.23 111.093 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.3 p -99.76 145.85 27.22 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.393 -1.276 . . . . 61.54 109.303 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 82.8 mtp -121.81 119.93 33.11 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.091 -1.077 . . . . 65.05 108.091 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 30.4 t -133.76 138.79 45.95 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.914 -1.143 . . . . 63.22 107.914 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.97 116.35 5.03 Favored 'General case' 0 CA--C 1.471 -2.093 0 N-CA-C 108.926 -0.768 . . . . 72.14 108.926 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -121.83 130.31 53.28 Favored 'General case' 0 C--N 1.263 -3.187 0 N-CA-C 106.916 -1.513 . . . . 75.43 106.916 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -149.45 149.84 31.43 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.145 -1.058 . . . . 72.22 108.145 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 7.3 ppt_? -93.45 145.82 24.21 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.578 -0.849 . . . . 74.31 109.237 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.418 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 96.4 m-85 -139.72 152.34 46.58 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.723 -0.843 . . . . 74.45 108.723 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.32 93.57 2.4 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 109.693 -0.484 . . . . 72.44 109.693 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.2 t0 . . . . . 0 CA--C 1.5 -0.975 0 CA-C-N 114.548 -1.205 . . . . 63.24 108.961 -179.15 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 . . . . . 0 N--CA 1.41 -2.468 0 N-CA-C 107.968 -1.123 . . . . 74.54 107.968 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 47.6 t -120.05 114.49 44.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.692 -1.225 . . . . 74.12 107.692 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -118.01 114.1 22.64 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.955 -0.757 . . . . 74.15 108.955 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.4 108.96 20.55 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 107.799 -1.186 . . . . 75.33 107.799 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 m -113.58 114.67 26.79 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.433 -1.321 . . . . 74.0 107.433 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -125.43 146.57 30.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.061 -0.718 . . . . 60.31 109.061 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 43.6 m -129.63 123.43 31.22 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-O 121.197 0.523 . . . . 64.42 109.635 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 tt -112.77 121.1 64.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.652 0.739 . . . . 74.13 110.594 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -86.69 154.04 55.75 Favored Pre-proline 0 N--CA 1.425 -1.696 0 CA-C-N 115.178 -0.919 . . . . 71.25 109.517 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.76 2.64 1.91 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.134 2.556 . . . . 73.34 113.052 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -88.74 1.94 54.28 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.93 -1.137 . . . . 73.31 107.93 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 71.43 29.73 2.65 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 123.314 1.531 . . . . 75.12 107.811 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.91 128.33 53.11 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 112.938 -1.937 . . . . 74.12 107.772 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.44 138.11 49.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.424 -0.584 . . . . 55.41 109.424 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 p -142.32 163.45 32.8 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.518 -1.29 . . . . 75.14 107.518 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.77 -171.79 43.94 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.534 -1.793 . . . . 75.45 113.407 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -148.05 133.4 18.53 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 123.855 0.862 . . . . 73.0 108.915 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.32 115.83 47.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.416 -1.327 . . . . 72.31 107.416 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 2.3 mp -115.42 114.86 47.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.61 -0.515 . . . . 73.35 109.61 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.85 108.13 17.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.874 -1.528 . . . . 73.52 106.874 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -122.56 128.6 50.94 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 120.799 -0.361 . . . . 74.13 110.899 -174.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.68 152.46 36.07 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 116.114 -0.494 . . . . 63.25 110.442 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--N 1.309 -1.19 0 C-N-CA 119.473 -0.891 . . . . 73.12 109.065 171.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.436 -1.156 0 N-CA-C 108.463 -0.94 . . . . 73.41 108.463 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.24 97.29 0.16 Allowed Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.56 -1.305 . . . . 74.24 113.174 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.48 159.13 32.53 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.759 2.306 . . . . 73.33 110.263 172.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.6 133.77 53.01 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.748 -0.464 . . . . 74.41 109.748 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.94 153.23 19.62 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.587 -0.523 . . . . 71.23 109.587 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -83.54 84.26 7.6 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.874 -1.158 . . . . 75.41 107.874 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.82 42.76 1.6 Allowed Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 114.904 -1.044 . . . . 62.52 111.598 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.11 88.15 7.15 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.661 -1.237 . . . . 73.35 107.661 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.438 HG13 ' SD ' ' A' ' 101' ' ' MET . 17.3 m -122.78 160.23 49.92 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-N 114.628 -1.169 . . . . 73.5 111.391 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.82 -7.87 12.24 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.489 2.793 . . . . 74.23 113.572 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -124.42 28.86 6.5 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 122.21 -0.306 . . . . 71.34 111.006 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.1 m -55.72 -27.85 52.66 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 111.971 0.36 . . . . 72.05 111.971 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -71.96 -7.97 51.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.212 0.53 . . . . 72.34 110.932 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -112.39 -6.76 14.0 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.065 -0.516 . . . . 74.23 110.15 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 p -127.58 118.53 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.892 0.854 . . . . 71.44 109.963 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.69 104.58 16.51 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.451 -0.795 . . . . 62.24 109.44 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.09 132.93 42.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.238 -1.393 . . . . 71.22 107.238 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.1 m -154.19 172.35 17.73 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.714 -0.847 . . . . 72.14 108.714 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -80.57 154.6 27.37 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.298 0.57 . . . . 75.23 110.105 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 70.7 t80 -118.23 123.39 45.34 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.957 -1.127 . . . . 73.41 107.957 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -138.22 100.35 4.11 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.04 -1.837 . . . . 75.3 106.04 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.3 t -165.23 143.78 6.35 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.768 -0.456 . . . . 74.3 109.768 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.1 t70 66.9 14.38 9.8 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.078 1.351 . . . . 70.25 109.339 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.63 -0.73 77.62 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.767 -0.73 . . . . 71.24 111.683 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.436 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 7.9 m-85 -94.0 146.04 24.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.424 -0.584 . . . . 74.22 109.424 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 m -125.56 136.96 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 108.265 -1.013 . . . . 74.42 108.265 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.69 -154.61 10.45 Favored Glycine 0 C--N 1.271 -3.037 0 N-CA-C 110.439 -1.064 . . . . 51.43 110.439 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 m -129.82 150.9 50.92 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 120.967 0.413 . . . . 73.45 110.42 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -133.64 145.26 49.82 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.083 0.468 . . . . 75.3 110.613 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.6 114.76 21.06 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.458 -1.312 . . . . 74.13 107.458 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.31 115.27 49.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.734 -0.839 . . . . 65.42 108.734 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.478 ' CD2' HD11 ' A' ' 90' ' ' LEU . 47.1 p90 -121.09 151.0 40.36 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.47 -0.492 . . . . 74.03 111.227 -174.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -153.15 156.49 38.72 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.415 -0.357 . . . . 70.51 111.202 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.4 t70 63.53 31.21 14.92 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.5 1.12 . . . . 72.53 111.046 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.478 HD11 ' CD2' ' A' ' 87' ' ' PHE . 39.4 mt -94.69 170.14 9.67 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.89 -0.595 . . . . 75.43 109.938 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t -128.08 179.72 5.44 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 120.636 -0.426 . . . . 64.42 110.617 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -54.69 -42.23 71.18 Favored 'General case' 0 C--O 1.209 -1.035 0 C-N-CA 123.794 0.837 . . . . 74.21 112.17 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.62 -29.11 69.03 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.342 0.592 . . . . 74.04 111.566 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.66 -15.97 29.44 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 115.57 -0.741 . . . . 72.02 111.285 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.9 tt -60.35 -51.46 80.0 Favored Pre-proline 0 CA--C 1.568 1.662 0 CA-C-O 119.202 -0.428 . . . . 72.31 111.205 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.52 -36.65 75.61 Favored 'Trans proline' 0 C--N 1.373 1.863 0 CA-C-N 120.976 1.384 . . . . 74.53 110.838 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -66.44 -37.73 85.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.215 -0.902 . . . . 75.51 110.097 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -78.09 -19.99 53.1 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.393 0.616 . . . . 73.2 109.736 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.34 -18.08 60.74 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.601 -0.727 . . . . 54.52 109.063 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.18 -57.22 12.29 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 116.012 -0.54 . . . . 74.14 109.737 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.438 ' SD ' HG13 ' A' ' 64' ' ' VAL . 3.2 mpp? -55.73 -45.25 78.0 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 123.674 0.609 . . . . 72.44 109.718 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -52.88 -42.48 65.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.524 -1.217 . . . . 72.21 111.412 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.9 m -63.51 -31.76 73.01 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.179 -0.464 . . . . 72.25 110.725 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.6 -20.77 63.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.184 0.516 . . . . 74.42 110.686 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.91 -9.82 16.94 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.485 -0.486 . . . . 71.32 110.382 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.41 -47.64 3.89 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.414 0.524 . . . . 65.52 112.414 -173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.21 28.77 19.29 Favored Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 119.962 -1.114 . . . . 60.11 110.933 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.8 m -124.38 165.11 21.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 122.767 -0.255 . . . . 62.31 110.544 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.93 124.18 47.62 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.816 -1.179 . . . . 73.02 107.816 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.19 123.15 49.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.165 0.439 . . . . 75.32 111.08 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -120.93 117.56 27.64 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.346 -0.983 . . . . 71.3 108.346 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.443 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 2.2 pt? -133.35 147.43 51.82 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.223 -0.591 . . . . 74.1 111.006 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.443 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 2.1 mpt_? -142.11 155.23 45.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.968 -1.493 . . . . 75.44 106.968 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.511 ' NE ' ' HB2' ' A' ' 180' ' ' ASP . 9.4 ttt180 -108.85 137.53 46.63 Favored 'General case' 0 N--CA 1.396 -3.126 0 N-CA-C 106.69 -1.596 . . . . 74.54 106.69 173.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -127.42 99.6 5.69 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 107.98 -1.119 . . . . 71.3 107.98 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.9 -115.71 6.75 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.845 -0.902 . . . . 61.0 110.845 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.542 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 8.9 t30 -110.6 12.89 22.67 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.304 1.049 . . . . 72.34 109.342 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.51 149.25 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 121.234 -0.916 . . . . 74.15 109.069 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.5 t -110.66 137.88 41.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 109.987 -0.375 . . . . 75.44 109.987 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.0 pt -116.26 129.06 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 N-CA-C 108.636 -0.876 . . . . 73.52 108.636 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -128.3 125.73 39.39 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.959 -0.564 . . . . 75.43 109.653 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.48 115.96 18.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.361 0.6 . . . . 75.14 109.769 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -116.52 130.4 8.96 Favored Glycine 0 C--N 1.294 -1.789 0 N-CA-C 110.075 -1.21 . . . . 73.24 110.075 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -114.6 132.9 56.19 Favored 'General case' 0 C--N 1.282 -2.332 0 O-C-N 122.153 -0.616 . . . . 72.53 109.8 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.0 114.37 19.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.679 -0.691 . . . . 75.14 112.052 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.69 97.25 6.45 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.434 -0.95 . . . . 75.11 108.434 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.45 28.21 8.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.685 -0.857 . . . . 74.23 108.685 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 20.5 p . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.254 -0.885 . . . . 63.21 112.944 -175.741 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 . . . . . 0 CA--C 1.501 -0.92 0 CA-C-O 120.561 0.219 . . . . 74.11 111.463 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.31 140.3 38.81 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.156 0.503 . . . . 72.11 110.808 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -131.85 110.43 10.81 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.278 -0.874 . . . . 74.43 109.29 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 77.8 t -104.89 113.66 42.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.379 -0.971 . . . . 73.13 108.379 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -108.54 121.08 44.23 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.109 -1.071 . . . . 61.42 108.109 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.49 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.9 tm? -110.81 115.7 29.99 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 105.784 -1.932 . . . . 74.02 105.784 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.9 m -123.69 127.53 48.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.501 -0.555 . . . . 71.03 109.501 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 76.9 t -124.95 126.82 71.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.182 -0.673 . . . . 72.12 109.182 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -115.95 130.93 57.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.704 -0.85 . . . . 74.52 108.704 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.702 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.2 p90 -135.06 122.84 15.39 Favored Pre-proline 0 C--N 1.283 -2.318 0 N-CA-C 112.002 0.371 . . . . 75.44 112.002 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -70.15 35.61 0.24 Allowed 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 122.57 2.18 . . . . 74.3 111.681 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -115.77 -99.31 0.44 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 123.132 0.573 . . . . 71.22 109.869 -177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.42 129.97 0.02 OUTLIER 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.304 -0.998 . . . . 73.53 108.304 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.87 138.08 20.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.704 -0.85 . . . . 75.23 108.704 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.8 p -94.09 -43.04 8.68 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 109.051 -0.722 . . . . 64.41 109.051 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.0 m -160.08 133.12 6.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.505 -0.924 . . . . 64.41 108.505 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 t -139.24 149.42 44.32 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.683 -0.635 . . . . 70.11 111.099 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -114.67 93.07 4.16 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 104.71 -2.33 . . . . 62.41 104.71 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.456 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.13 -148.86 11.57 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 107.999 -2.04 . . . . 74.41 107.999 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -114.09 100.02 8.07 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 117.587 0.693 . . . . 64.24 110.473 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -76.95 119.87 21.28 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.159 -0.616 . . . . 75.24 109.354 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.8 mt -83.98 -37.43 13.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.317 -1.364 . . . . 74.02 107.317 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.402 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . 39.3 mt-10 -145.69 161.9 38.59 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 106.766 -1.568 . . . . 65.22 106.766 -178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.31 -10.6 29.2 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.445 2.097 . . . . 72.05 112.212 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.702 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.4 OUTLIER -122.18 5.58 9.75 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 112.656 0.613 . . . . 74.21 112.656 177.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.5 t -139.84 120.95 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.56 -0.533 . . . . 70.22 109.56 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.77 148.04 31.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.482 -0.562 . . . . 73.03 109.482 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -138.55 149.58 45.46 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.298 -0.63 . . . . 74.55 109.298 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.497 ' CZ2' ' HB1' ' A' ' 174' ' ' ALA . 28.2 m-90 -124.92 142.07 51.7 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.822 -0.807 . . . . 73.11 108.822 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -108.73 105.12 14.57 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.93 -1.507 . . . . 74.13 106.93 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 9.4 mp -100.57 119.18 38.15 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.926 0.87 . . . . 75.5 110.884 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.471 ' HD3' ' HD2' ' A' ' 166' ' ' PRO . 1.6 mmtm -118.42 140.75 28.61 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 114.231 -1.35 . . . . 75.12 108.85 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.471 ' HD2' ' HD3' ' A' ' 165' ' ' LYS . 39.1 Cg_exo -66.64 167.71 18.46 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.693 1.595 . . . . 74.44 110.729 171.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.97 -36.82 3.01 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 120.857 -0.687 . . . . 63.13 111.656 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.8 m -104.94 157.06 5.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.163 0.506 . . . . 75.43 110.093 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.6 p -114.06 127.02 71.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.914 -1.143 . . . . 74.34 107.914 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 46.6 m -145.57 143.54 29.97 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.912 -0.492 . . . . 70.15 110.863 -177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.1 p -109.23 125.91 52.75 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 115.841 -0.618 . . . . 74.42 109.651 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -101.3 134.66 44.02 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.606 -0.887 . . . . 75.44 108.606 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.0 m -143.26 140.72 30.78 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.616 -0.678 . . . . 72.42 110.907 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.497 ' HB1' ' CZ2' ' A' ' 162' ' ' TRP . . . -143.05 132.18 23.11 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.358 -0.383 . . . . 73.53 109.982 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.1 131.32 54.19 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.82 -1.548 . . . . 72.1 106.82 170.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.84 156.24 42.05 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.21 -0.663 . . . . 74.5 109.21 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -87.91 134.48 33.7 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 120.362 -0.535 . . . . 75.01 109.895 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -143.72 122.72 12.81 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 109.337 -0.616 . . . . 75.45 109.337 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.542 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -58.97 109.08 0.76 Allowed 'General case' 0 C--N 1.279 -2.477 0 O-C-N 124.389 1.055 . . . . 75.1 111.536 -178.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.511 ' HB2' ' NE ' ' A' ' 114' ' ' ARG . 27.0 t70 . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 108.888 -0.782 . . . . 71.4 108.888 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 . . . . . 0 N--CA 1.424 -1.743 0 N-CA-C 106.867 -1.531 . . . . 72.45 106.867 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.1 t -119.48 113.63 41.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 106.96 -1.496 . . . . 74.4 106.96 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -127.67 113.5 16.12 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.041 0.448 . . . . 73.14 109.958 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.67 108.78 20.18 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.981 -0.748 . . . . 71.02 108.981 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.6 t -108.4 114.16 27.79 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.694 -1.595 . . . . 71.5 106.694 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -132.98 147.17 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.379 0.609 . . . . 75.22 110.483 -174.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.3 m -129.73 128.38 42.35 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 116.024 -0.535 . . . . 73.42 109.865 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.6 tt -113.96 125.69 71.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.299 0.571 . . . . 74.22 110.748 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 31.3 t -93.49 151.67 40.34 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.533 -0.758 . . . . 71.23 109.888 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.39 1.08 1.42 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.793 2.995 . . . . 74.21 112.922 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.71 -3.69 54.33 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.818 -1.179 . . . . 72.33 107.818 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.3 t70 72.25 29.02 2.3 Favored 'General case' 0 C--N 1.347 0.473 0 N-CA-C 106.858 -1.534 . . . . 72.45 106.858 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.3 OUTLIER -112.73 140.83 47.18 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.441 -1.254 . . . . 75.32 108.985 -178.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 t -115.63 144.71 22.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.549 -0.75 . . . . 75.11 109.126 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.2 p -149.29 158.71 44.4 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.079 -1.082 . . . . 73.03 108.079 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.48 -166.73 36.06 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 119.884 -1.15 . . . . 74.21 112.748 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -154.61 139.21 16.94 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.353 0.597 . . . . 73.43 111.064 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 46.6 mt -114.51 116.53 52.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.543 -0.91 . . . . 64.11 108.543 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.16 126.01 61.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.371 -0.603 . . . . 74.42 109.371 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.511 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -123.61 108.6 12.77 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.777 -1.194 . . . . 74.52 107.777 173.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.87 126.54 52.58 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.85 0.357 . . . . 72.21 111.585 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.38 158.91 30.06 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.765 -0.652 . . . . 72.41 109.755 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 118.974 -1.091 . . . . 75.23 109.298 175.263 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.427 -1.598 0 N-CA-C 108.684 -0.858 . . . . 71.14 108.684 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.447 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 174.15 112.04 0.28 Allowed Glycine 0 N--CA 1.425 -2.082 0 CA-C-N 115.261 -0.881 . . . . 74.21 112.046 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.04 160.33 45.02 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 123.047 2.498 . . . . 73.03 111.351 173.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.43 131.07 37.14 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.798 -0.816 . . . . 64.3 108.798 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.423 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 69.0 mt -84.87 143.66 28.9 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.423 -0.584 . . . . 73.51 109.423 176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -100.43 93.79 5.83 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.478 0.656 . . . . 72.52 109.66 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.609 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -140.6 72.59 0.41 Allowed Glycine 0 C--N 1.28 -2.56 0 CA-C-N 115.168 -0.924 . . . . 72.32 111.116 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -82.29 91.32 6.75 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.834 -0.802 . . . . 62.24 108.834 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.6 m -122.29 154.1 62.04 Favored Pre-proline 0 C--N 1.299 -1.606 0 CA-C-N 114.744 -1.117 . . . . 71.11 110.739 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.84 -21.39 70.32 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 123.595 2.863 . . . . 72.23 112.916 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -102.75 32.45 3.64 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.146 -0.479 . . . . 75.12 111.063 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 p -55.8 -34.08 64.99 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 116.29 -0.413 . . . . 75.5 111.543 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -65.29 -16.69 63.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.301 0.572 . . . . 73.42 111.47 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 88' ' ' SER . 33.3 mmtp -98.75 -16.0 19.11 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 116.157 -0.474 . . . . 74.23 110.524 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.17 118.89 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-O 122.195 0.998 . . . . 72.34 111.18 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -105.62 122.6 46.38 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.888 -1.051 . . . . 73.3 109.27 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.3 t -98.23 131.43 45.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.954 -1.128 . . . . 74.13 107.954 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 m -139.65 169.8 17.07 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.451 -0.574 . . . . 75.41 109.451 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.447 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 1.7 p-10 -83.64 142.56 30.71 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.097 0.475 . . . . 73.32 109.771 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 82.5 t80 -107.92 121.74 45.4 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.657 -1.238 . . . . 75.13 107.657 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.28 101.11 4.3 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.158 -1.053 . . . . 72.12 108.158 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 36.6 t -165.8 147.57 7.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.043 -1.095 . . . . 65.22 108.043 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 71.94 10.15 6.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.976 0.91 . . . . 64.45 111.167 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.55 1.06 83.76 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.557 -0.747 . . . . 73.0 111.967 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -104.95 147.06 28.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.454 -0.943 . . . . 63.12 108.454 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -123.85 139.0 51.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.218 -1.031 . . . . 74.51 108.218 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -167.44 -155.13 8.98 Favored Glycine 0 C--N 1.26 -3.677 0 C-N-CA 119.797 -1.192 . . . . 71.55 111.178 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.423 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 7.8 t -123.81 152.77 41.89 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 108.858 -0.793 . . . . 70.02 108.858 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.8 pt20 -140.67 130.71 24.72 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 120.999 0.428 . . . . 73.22 110.363 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.04 115.31 29.96 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.735 -0.839 . . . . 75.32 108.735 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.89 116.75 50.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.903 -0.777 . . . . 75.2 108.903 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.423 ' CD2' HD11 ' A' ' 90' ' ' LEU . 54.2 p90 -121.67 146.95 46.49 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 120.982 0.42 . . . . 74.11 110.944 -176.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 46.1 m -152.04 158.54 43.18 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 116.018 -0.537 . . . . 74.45 109.78 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.8 t70 60.47 38.82 18.93 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 122.31 1.052 . . . . 75.25 111.64 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 87' ' ' PHE . 25.3 mt -97.47 166.53 11.48 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.238 -0.892 . . . . 74.43 109.878 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -115.08 173.72 6.35 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.875 0.307 . . . . 71.33 110.264 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -49.84 -50.49 45.26 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.223 1.409 . . . . 72.2 111.461 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.31 68.11 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.156 0.582 . . . . 74.15 112.251 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -84.3 -16.34 43.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.67 -0.241 . . . . 73.11 111.619 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.692 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.8 tt -64.52 -54.98 33.01 Favored Pre-proline 0 CA--C 1.558 1.273 0 CA-C-O 119.392 -0.337 . . . . 71.41 111.312 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.41 -33.28 88.88 Favored 'Trans proline' 0 C--N 1.367 1.54 0 CA-C-N 120.744 1.301 . . . . 65.35 111.017 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -66.57 -36.06 81.73 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.95 -0.568 . . . . 74.51 110.697 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.0 pp -75.9 -19.21 59.01 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 109.498 -0.556 . . . . 75.51 109.498 175.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.01 -15.99 62.05 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.004 -0.544 . . . . 74.55 110.342 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -63.79 -56.93 11.82 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.452 -0.944 . . . . 73.42 108.452 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.609 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 31.9 ttp -54.33 -49.67 69.18 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.664 -0.698 . . . . 73.52 109.805 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -53.33 -41.98 66.27 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.849 -1.069 . . . . 75.11 110.887 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.3 p -72.37 -20.73 61.41 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 119.421 -0.912 . . . . 75.32 112.199 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.2 -20.36 62.28 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.482 0.658 . . . . 72.23 109.703 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.91 -10.41 20.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.792 -0.64 . . . . 71.12 110.378 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.67 -48.4 3.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.667 0.618 . . . . 64.43 112.667 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.64 20.62 59.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.481 -0.648 . . . . 73.11 111.481 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.84 168.19 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 109.476 -0.565 . . . . 73.12 109.476 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -102.77 135.52 44.29 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.887 0.312 . . . . 72.54 110.407 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.25 125.65 23.42 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.38 -0.6 . . . . 70.1 109.38 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.2 p -144.34 143.12 30.81 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.756 0.313 . . . . 74.41 111.268 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.54 125.78 23.14 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.741 0.816 . . . . 72.34 108.894 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -142.01 168.33 20.0 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.302 0.241 . . . . 71.42 110.378 -174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.408 ' CG ' HG21 ' A' ' 119' ' ' VAL . 26.6 mtt85 -101.14 138.68 37.85 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 113.866 1.061 . . . . 73.21 113.866 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.427 ' O ' HG13 ' A' ' 118' ' ' ILE . 7.0 t30 -123.96 94.36 4.2 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 105.764 -1.939 . . . . 74.12 105.764 174.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.42 -114.03 4.95 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 110.106 -1.197 . . . . 72.33 110.106 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -110.7 -1.37 16.74 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.721 1.248 . . . . 73.14 108.768 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.5 pp -103.19 148.97 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 C-N-CA 118.892 -1.123 . . . . 75.24 108.323 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.408 HG21 ' CG ' ' A' ' 114' ' ' ARG . 89.1 t -108.92 136.53 44.49 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.984 0 N-CA-C 109.853 -0.425 . . . . 75.41 109.853 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.7 pt -116.01 132.14 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-O 121.921 0.867 . . . . 71.45 109.201 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 tt -114.4 130.95 56.73 Favored 'General case' 0 C--N 1.255 -3.513 0 N-CA-C 105.646 -1.983 . . . . 74.54 105.646 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -140.74 130.67 24.54 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.727 -0.842 . . . . 75.43 108.727 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.92 168.05 38.26 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 111.199 -0.76 . . . . 64.3 111.199 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -140.2 141.83 35.91 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.364 -0.976 . . . . 74.43 108.364 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.69 108.78 12.37 Favored 'General case' 0 N--CA 1.413 -2.279 0 N-CA-C 108.352 -0.981 . . . . 72.04 108.352 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -112.66 111.72 22.72 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.034 -1.099 . . . . 73.34 108.034 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 0.1 OUTLIER -127.75 34.47 4.64 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.082 -1.451 . . . . 75.21 107.082 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 113.654 0.983 . . . . 74.24 113.654 -175.151 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 121.23 0.538 . . . . 71.33 111.872 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.2 148.15 28.6 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.987 -1.116 . . . . 73.42 107.987 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -132.68 124.58 28.5 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.888 -0.412 . . . . 71.21 109.888 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.476 ' HB ' ' HG ' ' A' ' 164' ' ' LEU . 82.6 t -117.16 121.05 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 120.161 -0.616 . . . . 73.44 110.113 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.73 138.02 51.52 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.95 -0.568 . . . . 64.33 110.686 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 tt -127.64 125.46 40.19 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 105.237 -2.134 . . . . 74.33 105.237 170.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 13.6 m -126.57 122.94 36.53 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.144 -0.687 . . . . 75.03 109.144 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 94.1 t -118.24 123.5 71.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 110.131 -0.322 . . . . 73.11 110.131 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -111.78 127.49 55.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.074 -0.713 . . . . 63.21 109.074 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.489 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.0 p90 -134.46 121.31 15.17 Favored Pre-proline 0 C--N 1.295 -1.779 0 C-N-CA 122.695 0.398 . . . . 74.22 112.004 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.59 39.17 0.41 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.874 2.382 . . . . 75.41 112.108 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.61 -97.92 0.46 Allowed 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 119.307 -0.378 . . . . 62.42 110.482 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.59 123.8 0.03 OUTLIER 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.406 -0.59 . . . . 74.05 109.406 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.48 136.15 23.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.483 -0.932 . . . . 73.32 108.483 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.8 p -95.31 -44.97 7.34 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.204 -0.665 . . . . 64.12 109.204 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 62.5 m -158.82 133.3 7.98 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.935 -0.575 . . . . 72.42 109.536 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.2 t -138.32 159.27 42.49 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.835 -0.54 . . . . 74.52 110.113 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -126.18 94.56 4.12 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 105.343 -2.095 . . . . 73.44 105.343 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.34 -150.19 10.37 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.051 -2.02 . . . . 63.04 108.051 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.68 99.01 7.02 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.608 -0.886 . . . . 74.31 108.608 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -74.66 137.63 42.32 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.906 -0.588 . . . . 72.1 111.307 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.4 mt -100.87 -48.45 11.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.242 -1.392 . . . . 73.22 107.242 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -133.72 169.0 15.09 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 107.561 -1.274 . . . . 73.24 107.561 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.87 0.81 7.2 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.625 2.216 . . . . 72.42 111.078 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.4 pt-20 -132.75 3.7 3.83 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.946 -1.024 . . . . 73.45 110.747 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.8 t -144.6 120.82 4.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.912 -0.773 . . . . 71.2 108.912 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.97 147.83 31.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.084 -0.71 . . . . 74.34 109.084 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -130.05 143.38 50.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.111 -0.7 . . . . 70.43 109.111 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.489 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 32.6 m-90 -122.66 116.73 24.31 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 108.731 -0.841 . . . . 73.14 108.731 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.25 98.27 8.68 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.554 -0.906 . . . . 64.22 108.554 175.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.476 ' HG ' ' HB ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -96.45 131.52 42.94 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-O 122.338 1.066 . . . . 64.24 110.082 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -119.52 151.03 51.05 Favored Pre-proline 0 C--N 1.279 -2.499 0 CA-C-N 113.248 -1.796 . . . . 72.0 112.858 -170.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 20.3 Cg_exo -70.97 156.56 59.96 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.868 2.379 . . . . 71.34 110.644 174.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.34 -36.17 2.94 Favored Glycine 0 C--N 1.309 -0.925 0 C-N-CA 121.278 -0.487 . . . . 73.14 112.129 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.3 m -105.82 166.27 3.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 123.008 0.523 . . . . 74.35 110.223 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.0 p -113.82 142.33 26.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.348 -0.982 . . . . 72.25 108.348 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.1 m -138.53 141.95 39.32 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.937 -0.477 . . . . 74.33 109.841 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.3 p -103.43 130.01 50.68 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.871 -0.788 . . . . 74.4 108.871 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 44.2 ttp -104.02 116.34 32.05 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.653 -0.869 . . . . 75.42 108.653 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.1 m -140.33 139.52 35.44 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.693 -0.803 . . . . 64.33 109.305 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -149.2 120.68 7.94 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 108.507 -0.923 . . . . 40.24 108.507 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -120.7 130.74 54.21 Favored 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 106.691 -1.596 . . . . 74.12 106.691 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -155.76 150.93 26.68 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.405 -0.961 . . . . 73.22 108.405 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 177' ' ' ARG . 5.8 ppt_? -88.2 126.41 35.13 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.81 -0.756 . . . . 74.1 110.671 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 16.5 m-30 -135.05 118.71 17.06 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 107.741 -1.207 . . . . 64.01 107.741 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.63 113.25 0.67 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 125.171 1.545 . . . . 74.11 112.274 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.5 t0 . . . . . 0 CA--C 1.501 -0.926 0 C-N-CA 124.422 1.089 . . . . 74.24 109.082 -176.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 . . . . . 0 N--CA 1.44 -0.929 0 CA-C-O 121.121 0.486 . . . . 74.44 111.418 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.08 114.44 41.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.729 -0.841 . . . . 75.22 108.729 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -119.5 119.3 33.45 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.553 -0.748 . . . . 74.35 111.961 -176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.08 108.35 19.4 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.481 -1.303 . . . . 73.53 107.481 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 140' ' ' THR . 20.3 m -120.71 115.11 22.7 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.618 -0.512 . . . . 72.52 109.618 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.9 pp -124.45 147.47 28.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.017 0.437 . . . . 75.44 110.44 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 62.7 m -129.82 122.04 27.95 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 121.053 0.454 . . . . 63.13 110.097 -176.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -113.92 122.73 68.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 121.463 0.649 . . . . 73.31 110.439 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 37' ' ' ASP . 14.1 m -86.99 151.64 52.19 Favored Pre-proline 0 N--CA 1.417 -2.112 0 CA-C-N 115.336 -0.847 . . . . 64.23 109.46 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.96 2.13 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.312 2.675 . . . . 74.41 112.349 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 35' ' ' SER . 25.7 t70 -85.19 -2.22 57.79 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.139 0.975 . . . . 73.23 109.385 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.9 t70 72.76 28.96 2.01 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 123.469 1.605 . . . . 74.21 107.621 -174.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -107.51 125.84 51.78 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 113.671 -1.604 . . . . 64.13 108.25 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 t -108.97 137.12 42.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.256 -0.646 . . . . 74.43 109.256 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.2 p -146.84 165.43 29.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.722 -1.214 . . . . 74.03 107.722 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.26 -173.97 41.78 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.617 -1.278 . . . . 73.53 112.764 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 10.2 pt-20 -157.51 133.42 9.37 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.409 0.623 . . . . 75.03 110.804 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 2.0 mp -113.18 116.5 52.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.992 -1.114 . . . . 74.54 107.992 175.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mp -113.9 115.6 50.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.195 0.521 . . . . 64.23 109.698 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.584 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -108.7 125.85 52.35 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.509 -1.663 . . . . 74.41 106.509 174.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.87 116.79 14.19 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.578 0.704 . . . . 75.24 109.476 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.84 159.34 31.28 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 115.059 -0.973 . . . . 74.1 110.789 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 mttp . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 106.713 -1.588 . . . . 73.24 106.713 171.29 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.443 -0.799 0 CA-C-O 120.563 0.22 . . . . 74.51 111.045 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.45 97.79 0.11 Allowed Glycine 0 N--CA 1.434 -1.47 0 C-N-CA 120.053 -1.07 . . . . 62.13 111.98 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.56 159.83 35.42 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.635 2.223 . . . . 73.44 111.454 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.96 140.47 52.3 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.452 -0.573 . . . . 72.45 109.452 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.89 149.19 45.1 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.566 0.541 . . . . 70.55 110.208 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -82.38 85.1 6.95 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.571 -0.899 . . . . 63.4 108.571 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.504 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -122.4 120.88 4.47 Favored Glycine 0 N--CA 1.417 -2.631 0 CA-C-N 114.558 -1.201 . . . . 75.24 113.746 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -139.95 112.79 8.06 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.757 -0.831 . . . . 73.24 108.757 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.51 161.6 57.93 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.662 -0.866 . . . . 74.03 108.662 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.62 -11.86 24.36 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.047 1.831 . . . . 73.22 111.536 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -114.03 41.61 2.21 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.837 -0.619 . . . . 71.4 111.595 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.2 m -58.64 -27.23 64.53 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-N 116.211 -0.449 . . . . 65.34 111.508 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -68.84 -15.82 63.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.522 0.677 . . . . 71.42 110.405 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -95.4 -17.63 21.4 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.245 -0.889 . . . . 74.12 110.565 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.55 118.97 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-O 122.246 1.022 . . . . 64.33 111.92 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.94 101.85 14.41 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.042 -0.981 . . . . 74.22 108.39 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.21 125.5 51.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.594 -1.262 . . . . 73.31 107.594 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 m -142.09 172.26 12.93 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.888 -0.782 . . . . 74.21 108.888 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -83.59 151.92 25.1 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.818 -1.178 . . . . 74.2 107.818 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -110.35 123.57 50.09 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.94 -1.504 . . . . 73.4 106.94 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -138.55 99.53 3.85 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 106.97 -1.493 . . . . 71.15 106.97 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.4 t -171.94 155.21 3.74 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.556 -1.276 . . . . 73.25 107.556 -174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 70.62 7.26 6.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.942 0.897 . . . . 73.44 111.383 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.1 -2.04 80.99 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.453 -1.059 . . . . 63.14 110.453 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -104.56 155.67 18.62 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.216 0.606 . . . . 75.32 111.288 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.64 136.69 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 108.438 -0.949 . . . . 71.14 108.438 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -163.45 -154.06 7.55 Favored Glycine 0 N--CA 1.397 -3.931 0 C-N-CA 120.056 -1.069 . . . . 62.21 111.051 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 m -131.25 143.6 50.68 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 115.462 -0.369 . . . . 63.32 110.078 -176.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.9 pt20 -132.74 138.15 47.1 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.706 0.289 . . . . 74.01 110.731 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -121.03 114.4 21.44 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.295 -1.372 . . . . 74.34 107.295 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.7 113.18 43.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 108.225 -1.028 . . . . 62.22 108.225 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.407 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.8 p90 -123.41 154.68 38.69 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.186 -0.606 . . . . 73.52 111.865 -175.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -157.1 165.61 35.58 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.229 -0.896 . . . . 74.14 109.499 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 65.19 31.7 10.62 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.276 0.985 . . . . 71.51 111.767 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 87' ' ' PHE . 47.9 mt -101.58 164.55 11.7 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.273 -0.422 . . . . 75.25 110.447 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -117.86 178.08 4.54 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.816 0.341 . . . . 73.33 111.082 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -54.06 -38.87 65.73 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 125.595 1.558 . . . . 64.01 111.063 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.22 -25.95 62.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.948 -0.569 . . . . 72.21 111.503 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -89.72 -17.07 29.0 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.299 -0.409 . . . . 74.14 111.564 -176.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 43.1 tp -57.84 -48.32 97.36 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 112.771 0.656 . . . . 74.21 112.771 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.444 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 40.2 Cg_exo -63.12 -37.02 54.8 Favored 'Trans proline' 0 C--N 1.367 1.53 0 CA-C-N 120.658 1.271 . . . . 74.11 110.892 174.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -68.49 -34.8 76.55 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.456 -0.793 . . . . 75.22 111.507 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -78.36 -19.44 53.39 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.501 -0.555 . . . . 74.13 109.501 176.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 96' ' ' PRO . . . -70.62 -27.15 63.85 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 115.585 -0.734 . . . . 73.14 109.933 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -57.1 -57.4 12.72 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.985 0.803 . . . . 73.52 109.675 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.504 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.6 ttp -53.58 -50.35 65.77 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.352 -0.84 . . . . 74.53 110.468 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -60.31 -33.0 71.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.227 -0.897 . . . . 73.41 111.609 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.9 m -63.99 -28.14 69.61 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 121.079 -0.249 . . . . 73.32 110.945 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.82 -26.18 68.23 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-O 121.424 0.631 . . . . 74.23 110.582 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.47 -6.64 16.05 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 116.143 -0.481 . . . . 73.13 110.669 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.52 -41.6 5.44 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.203 -0.599 . . . . 60.12 112.433 -173.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.56 26.02 68.68 Favored Glycine 0 C--O 1.242 0.638 0 C-N-CA 120.473 -0.87 . . . . 74.51 110.962 -175.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.56 160.81 9.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 121.056 0.455 . . . . 71.13 110.238 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -113.14 122.44 47.54 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.94 -1.874 . . . . 71.4 105.94 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.9 mt -119.68 123.24 43.33 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 117.82 0.282 . . . . 74.2 111.349 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.8 m -123.46 141.39 52.05 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.475 -0.565 . . . . 64.25 109.475 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.5 tp -134.92 131.85 37.77 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.259 -0.428 . . . . 75.13 110.426 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -143.03 153.68 43.2 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.406 -0.961 . . . . 71.13 108.406 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.566 ' NH1' ' HA ' ' A' ' 180' ' ' ASP . 19.8 ttm180 -112.02 132.44 54.8 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 108.763 -0.828 . . . . 75.54 108.763 171.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -110.06 89.3 2.98 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.104 -1.443 . . . . 72.34 107.104 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.26 -108.95 2.64 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.326 -1.11 . . . . 75.34 110.326 -176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -107.63 -6.31 16.98 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.213 1.006 . . . . 73.11 109.39 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.6 pp -104.39 143.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 C-N-CA 118.202 -1.399 . . . . 75.25 109.202 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.442 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 72.8 t -105.79 138.76 29.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 O-C-N 122.003 -0.435 . . . . 63.55 110.287 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.2 pt -121.15 135.92 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-O 121.626 0.726 . . . . 74.22 109.893 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.3 tt -128.06 125.32 39.07 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 107.475 -1.306 . . . . 73.32 107.475 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -125.83 121.84 34.43 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.857 -1.534 . . . . 63.12 106.857 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.99 161.21 27.57 Favored Glycine 0 N--CA 1.407 -3.259 0 C-N-CA 120.719 -0.753 . . . . 74.34 111.567 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -139.44 138.38 36.41 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.44 -0.948 . . . . 72.34 108.44 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.23 117.19 33.47 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.532 -0.303 . . . . 74.24 111.253 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -104.16 97.42 7.38 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.013 -1.106 . . . . 75.12 108.013 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 3.1 mm? -112.21 12.83 20.42 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.451 -0.574 . . . . 71.32 109.451 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 p . . . . . 0 C--N 1.309 -1.191 0 N-CA-C 113.431 0.901 . . . . 62.41 113.431 -175.241 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 120.57 0.224 . . . . 72.14 111.412 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.52 131.3 44.86 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.164 -0.68 . . . . 73.34 109.164 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -122.12 118.26 28.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.311 -1.366 . . . . 53.43 107.311 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 53.5 t -109.73 129.92 63.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.344 -0.542 . . . . 71.24 110.657 -173.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -134.53 130.71 37.01 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.861 -0.422 . . . . 74.5 109.861 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 HD12 ' SD ' ' A' ' 172' ' ' MET . 5.6 tt -120.15 128.98 53.93 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.307 -1.738 . . . . 73.32 106.307 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 31' ' ' SER . 29.8 m -126.98 131.65 50.99 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.548 -0.538 . . . . 74.14 109.548 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 80.2 t -121.9 125.87 73.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.513 -0.921 . . . . 73.53 108.513 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -116.63 128.69 55.61 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 108.637 -0.875 . . . . 75.02 108.637 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.671 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.12 117.78 13.81 Favored Pre-proline 0 C--N 1.281 -2.379 0 CA-C-N 116.545 -0.298 . . . . 74.12 111.072 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.8 38.25 0.18 Allowed 'Trans proline' 0 CA--C 1.554 1.521 0 C-N-CA 123.024 2.483 . . . . 70.45 112.929 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -122.04 -102.0 0.41 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 110.048 -0.353 . . . . 52.13 110.048 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.73 128.12 0.08 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.665 -0.865 . . . . 70.43 108.665 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.49 141.3 15.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.521 -0.918 . . . . 73.4 108.521 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.3 t -103.54 -32.79 9.28 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 120.205 -0.598 . . . . 75.0 109.643 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 54.9 m -161.12 133.37 5.94 Favored 'General case' 0 C--O 1.202 -1.405 0 N-CA-C 109.598 -0.519 . . . . 73.15 109.598 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.8 t -138.52 168.78 19.04 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.695 -0.628 . . . . 74.12 109.599 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -139.76 87.7 2.19 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.065 -2.198 . . . . 61.42 105.065 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.9 -144.39 5.94 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.264 -1.534 . . . . 65.1 109.264 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -117.94 99.65 7.05 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.545 -0.909 . . . . 75.24 108.545 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 34.8 ptt180 -82.42 133.19 35.21 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 119.298 -0.961 . . . . 74.22 110.986 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.17 -37.74 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.582 -1.266 . . . . 70.35 107.582 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -139.71 165.04 34.02 Favored Pre-proline 0 N--CA 1.427 -1.582 0 N-CA-C 106.207 -1.775 . . . . 65.43 106.207 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.78 0.17 6.05 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.5 2.133 . . . . 74.43 111.366 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.671 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.0 pt-20 -134.41 8.38 3.66 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.819 -0.628 . . . . 74.42 111.88 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 86.9 t -142.7 121.06 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 109.131 -0.692 . . . . 61.32 109.131 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 44.9 t -130.58 146.28 34.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 110.167 -0.309 . . . . 53.51 110.167 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -132.75 152.58 51.72 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 121.12 0.486 . . . . 74.24 110.359 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 31.2 m-90 -125.28 119.43 28.4 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.296 -1.002 . . . . 75.23 108.296 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -98.99 106.5 18.77 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.963 0.887 . . . . 70.43 110.075 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 76.9 mt -101.44 135.51 42.82 Favored 'General case' 0 C--O 1.264 1.826 0 CA-C-N 114.907 -1.042 . . . . 74.31 111.216 -173.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 10.7 mmpt? -115.12 150.61 44.58 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 114.143 -1.39 . . . . 74.42 109.189 -175.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 11.3 Cg_exo -73.6 156.78 49.22 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.61 2.207 . . . . 63.1 111.283 176.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.79 -24.83 3.13 Favored Glycine 0 C--N 1.314 -0.688 0 O-C-N 122.318 -0.239 . . . . 74.23 112.665 176.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 166' ' ' PRO . 31.7 m -106.05 160.83 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.264 0.554 . . . . 75.14 112.096 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.73 144.14 21.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.764 -1.198 . . . . 75.12 107.764 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 32.8 t -148.6 152.71 37.23 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.991 -0.374 . . . . 73.45 109.991 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.1 p -96.03 154.78 17.05 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.893 -0.594 . . . . 75.0 109.547 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.455 ' SD ' HD12 ' A' ' 139' ' ' LEU . 37.4 ttp -144.1 116.27 8.44 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.396 0.617 . . . . 71.33 109.408 -176.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.4 m -134.61 141.7 46.69 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.188 -0.605 . . . . 73.44 109.58 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -146.66 116.25 7.14 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.114 -1.069 . . . . 54.44 108.114 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -124.13 129.88 51.59 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.438 -1.319 . . . . 63.53 107.438 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.98 155.66 38.46 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.139 -0.689 . . . . 71.15 109.139 -175.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 16.5 ptm180 -91.85 132.75 36.23 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 120.624 -0.431 . . . . 74.0 111.078 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.442 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 63.5 m-85 -140.52 129.76 23.69 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 109.091 -0.707 . . . . 74.44 109.091 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.5 110.8 0.38 Allowed 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 125.211 1.404 . . . . 74.31 111.982 -178.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.566 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 35.9 t70 . . . . . 0 C--N 1.311 -1.089 0 CA-C-N 114.692 -1.14 . . . . 74.14 110.419 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 52.4 ttt180 . . . . . 0 N--CA 1.423 -1.811 0 N-CA-C 109.254 -0.647 . . . . 73.54 109.254 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.08 114.08 44.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 106.669 -1.604 . . . . 74.23 106.669 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.91 113.3 18.92 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.36 -1.348 . . . . 72.21 107.36 -175.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.62 136.86 52.58 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.811 -0.631 . . . . 71.11 109.905 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -138.03 115.24 11.0 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.112 -0.699 . . . . 70.34 109.112 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 14.5 pt -126.55 149.14 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 121.25 0.548 . . . . 74.31 111.038 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 m -126.51 123.68 38.33 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 108.439 -0.948 . . . . 74.13 108.439 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 tt -113.49 125.02 70.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.478 0.656 . . . . 73.55 110.642 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.8 t -88.74 150.96 46.99 Favored Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 115.114 -0.948 . . . . 74.31 109.243 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.92 2.78 2.79 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 123.436 2.757 . . . . 71.32 111.894 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -89.08 4.53 48.1 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.058 -0.719 . . . . 75.44 109.058 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 t70 71.5 29.44 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.124 1.44 . . . . 72.33 107.144 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.42 124.93 51.83 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 113.882 -1.508 . . . . 72.01 107.938 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.7 t -111.58 138.81 38.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.765 -0.828 . . . . 73.45 108.765 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 p -149.64 157.92 43.69 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.626 -0.879 . . . . 64.41 108.626 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.28 -165.08 34.21 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 119.516 -1.326 . . . . 74.0 112.432 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.2 141.97 21.04 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.207 0.527 . . . . 74.42 110.265 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.8 mt -124.31 117.01 49.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.99 -1.115 . . . . 73.2 107.99 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.13 116.05 51.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.327 -0.62 . . . . 75.01 109.327 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.5 107.77 18.95 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.946 -1.501 . . . . 72.54 106.946 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.49 127.72 49.93 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.249 0.547 . . . . 73.12 109.884 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.82 153.02 29.83 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 109.269 -0.641 . . . . 72.14 109.269 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.3 tttt . . . . . 0 C--N 1.287 -2.139 0 N-CA-C 105.837 -1.912 . . . . 73.24 105.837 175.238 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 108.286 -1.005 . . . . 70.05 108.286 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.479 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 173.1 104.76 0.18 Allowed Glycine 0 N--CA 1.417 -2.578 0 CA-C-O 118.472 -1.182 . . . . 75.3 111.163 176.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -52.45 132.78 46.42 Favored 'Trans proline' 0 C--O 1.243 0.771 0 CA-C-N 119.914 1.857 . . . . 74.25 110.772 173.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.97 155.83 39.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.055 -0.52 . . . . 70.31 111.718 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.6 tp -103.0 160.14 14.89 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.243 -1.021 . . . . 73.42 108.243 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -111.05 95.3 5.45 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.505 -0.924 . . . . 75.44 108.505 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -105.3 -106.3 3.11 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 120.726 -0.75 . . . . 64.22 112.136 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.0 t70 60.98 91.99 0.05 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 125.062 1.345 . . . . 61.22 112.028 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.68 157.72 77.24 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 114.393 -1.276 . . . . 75.11 108.136 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.82 -18.55 61.45 Favored 'Trans proline' 0 N--CA 1.479 0.634 0 C-N-CA 122.669 2.246 . . . . 73.35 112.326 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.4 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 42.1 p90 -111.16 32.35 5.38 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.559 -0.746 . . . . 73.22 112.114 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.5 m -55.92 -33.02 64.31 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 112.052 0.39 . . . . 75.02 112.052 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.39 -11.07 60.51 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.034 -0.416 . . . . 63.53 111.586 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HE3' HD23 ' A' ' 90' ' ' LEU . 24.3 mtpp -105.49 -4.45 21.27 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-N 116.168 -0.469 . . . . 73.34 109.905 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.6 p -125.98 119.03 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 122.179 0.99 . . . . 73.12 110.377 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.02 102.37 15.02 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.593 -0.73 . . . . 52.22 109.755 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.22 128.84 49.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.734 -0.839 . . . . 72.34 108.734 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.9 m -146.48 171.8 14.5 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 116.079 -0.509 . . . . 73.03 110.297 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.479 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 7.3 t30 -82.89 139.1 33.62 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.37 -0.604 . . . . 75.35 109.37 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -110.51 123.15 49.39 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.734 -0.839 . . . . 74.42 108.734 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -138.34 99.97 3.99 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.889 -1.523 . . . . 75.52 106.889 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.4 t -172.68 154.2 2.96 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.98 -0.378 . . . . 73.02 109.98 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 70.78 7.65 6.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.282 1.033 . . . . 63.33 111.632 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.65 -9.15 64.23 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.073 -0.811 . . . . 72.53 111.073 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -104.66 149.71 25.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.048 0.451 . . . . 72.53 110.692 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.83 137.74 56.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 109.082 -0.71 . . . . 74.54 109.082 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.43 -153.81 11.04 Favored Glycine 0 C--N 1.285 -2.305 0 C-N-CA 120.209 -0.996 . . . . 74.41 111.719 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 p -126.77 149.03 49.86 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 121.268 0.556 . . . . 62.0 110.848 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -132.44 142.37 49.23 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.489 -0.323 . . . . 74.12 110.5 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.44 114.41 22.84 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.02 -1.104 . . . . 52.22 108.02 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.19 111.92 38.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.41 -0.959 . . . . 75.34 108.41 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' A' ' 90' ' ' LEU . 49.7 p90 -118.47 162.41 18.38 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 112.516 0.561 . . . . 74.54 112.516 -172.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 p -164.24 160.29 20.98 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.474 -0.785 . . . . 72.32 110.345 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.0 t70 65.65 30.99 10.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 124.366 1.041 . . . . 73.01 110.699 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.431 HD23 ' HE3' ' A' ' 69' ' ' LYS . 55.8 mt -95.69 159.69 14.86 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 121.662 -0.649 . . . . 75.22 110.636 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.403 HG22 ' OE1' ' A' ' 94' ' ' GLU . 8.9 t -106.09 171.41 7.36 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.526 -0.546 . . . . 73.31 109.526 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -52.49 -40.02 61.89 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.638 0.775 . . . . 75.32 111.313 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.39 -24.9 65.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.752 -0.658 . . . . 52.22 111.92 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.403 ' OE1' HG22 ' A' ' 91' ' ' THR . 54.4 mt-10 -87.53 -16.83 33.54 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.461 -0.336 . . . . 74.14 111.634 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.586 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 49.2 tp -61.67 -51.4 76.72 Favored Pre-proline 0 CA--C 1.562 1.422 0 N-CA-C 113.174 0.805 . . . . 71.15 113.174 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -70.32 -29.08 21.74 Favored 'Trans proline' 0 C--N 1.361 1.213 0 CA-C-N 120.887 1.353 . . . . 75.34 110.132 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -67.95 -35.52 78.55 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.404 -0.816 . . . . 71.42 110.438 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -75.62 -19.29 59.31 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 109.783 -0.451 . . . . 75.13 109.783 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.01 -20.89 63.25 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.171 -0.468 . . . . 75.11 110.159 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -58.4 -57.14 14.23 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.234 -0.654 . . . . 72.41 109.234 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.4 ttp -53.79 -51.25 64.06 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 115.633 -0.712 . . . . 74.43 110.162 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -55.67 -41.51 73.77 Favored 'General case' 0 C--O 1.251 1.178 0 CA-C-N 114.954 -1.021 . . . . 65.25 111.272 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.3 p -65.9 -25.27 67.08 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.187 -0.605 . . . . 75.25 111.675 -171.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.74 -26.59 68.72 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 121.228 0.537 . . . . 72.13 110.518 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.37 -12.58 15.3 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 120.235 -0.586 . . . . 65.13 111.185 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.0 -29.16 9.59 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 114.295 1.22 . . . . 75.4 114.295 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.61 20.88 76.02 Favored Glycine 0 C--O 1.243 0.686 0 C-N-CA 120.535 -0.841 . . . . 43.43 111.491 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.7 m -96.68 156.41 3.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.153 -0.523 . . . . 63.54 111.547 -176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -132.1 122.19 25.0 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.253 -1.388 . . . . 63.52 107.253 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.08 123.36 40.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.064 0.393 . . . . 75.21 111.952 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.9 t -104.53 125.01 50.29 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 107.183 -1.414 . . . . 72.32 107.183 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.581 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 48.7 tp -128.72 123.08 32.14 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.162 -0.681 . . . . 75.42 109.162 -178.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.581 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 3.2 mpt_? -135.7 146.5 47.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.853 -0.425 . . . . 73.41 109.853 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.47 ' HG3' HG22 ' A' ' 119' ' ' VAL . 3.3 ttt180 -99.39 138.11 36.95 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 108.057 -1.09 . . . . 73.34 108.057 174.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -123.8 83.74 2.18 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.96 -1.496 . . . . 74.42 106.96 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.75 -122.61 22.69 Favored Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 114.137 -1.392 . . . . 64.32 110.97 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -75.74 -20.53 58.24 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 123.932 0.893 . . . . 72.14 110.617 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 0.8 OUTLIER -102.58 149.08 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 119.287 -0.965 . . . . 74.21 110.403 -172.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.47 HG22 ' HG3' ' A' ' 114' ' ' ARG . 59.4 t -117.73 139.81 43.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.784 -0.45 . . . . 74.03 109.784 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.3 pt -126.03 135.18 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 CA-C-O 121.709 0.766 . . . . 75.24 110.584 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.29 128.88 47.83 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 107.363 -1.347 . . . . 74.14 107.363 174.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.79 114.59 12.78 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 105.783 -1.932 . . . . 72.04 105.783 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.08 160.52 27.16 Favored Glycine 0 N--CA 1.41 -3.083 0 N-CA-C 110.925 -0.87 . . . . 71.02 110.925 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -141.01 150.47 43.07 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.59 -1.263 . . . . 75.21 107.59 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.41 128.83 52.59 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.957 -0.386 . . . . 70.35 109.957 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -111.83 93.56 4.52 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 118.716 -1.194 . . . . 72.02 109.991 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -123.26 15.52 9.78 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 113.926 -1.488 . . . . 75.42 107.482 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.477 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.423 -1.779 0 CA-C-N 113.409 -1.723 . . . . 73.22 109.01 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t0 . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 121.545 0.688 . . . . 73.02 110.33 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.01 145.23 55.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 70.43 111.921 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 26.8 t70 -132.34 118.05 18.93 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.852 -0.613 . . . . 62.31 109.972 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 97.6 t -116.57 133.96 61.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.004 -1.11 . . . . 54.53 108.004 175.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -138.9 138.96 37.88 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.47 -0.567 . . . . 73.31 109.47 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 tt -133.42 128.23 35.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.061 -1.459 . . . . 72.13 107.061 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.0 m -126.21 134.21 51.3 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.694 -0.854 . . . . 71.14 108.694 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 57.6 t -129.02 125.22 62.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.636 -0.505 . . . . 74.13 109.636 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.08 128.39 56.48 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.008 -0.738 . . . . 75.41 109.008 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -134.46 129.67 19.69 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 112.917 0.71 . . . . 73.4 112.917 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -71.86 49.47 1.25 Allowed 'Trans proline' 0 CA--C 1.551 1.363 0 C-N-CA 123.317 2.678 . . . . 74.14 111.286 172.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.69 -133.78 0.13 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.241 -1.392 . . . . 73.34 107.241 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -161.88 135.13 6.24 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.027 -1.472 . . . . 75.21 107.027 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.18 127.65 41.75 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.117 0.484 . . . . 65.41 110.356 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.4 t -88.08 -37.53 16.18 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.883 -0.414 . . . . 74.22 109.883 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.1 m -152.6 133.27 13.9 Favored 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 109.561 -0.533 . . . . 74.33 109.561 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -139.36 161.93 36.24 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 121.95 -0.469 . . . . 72.44 109.79 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.61 91.18 2.96 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 104.47 -2.418 . . . . 75.1 104.47 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.8 -147.47 8.76 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 109.296 -1.522 . . . . 74.21 109.296 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -119.66 99.82 6.89 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.62 -0.881 . . . . 74.24 108.62 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -82.11 129.49 34.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 119.513 -0.875 . . . . 73.34 111.981 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.9 mt -83.71 -42.36 17.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.351 -1.351 . . . . 74.23 107.351 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -138.71 167.2 20.37 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 106.646 -1.613 . . . . 74.14 106.646 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.54 0.14 8.51 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.095 1.864 . . . . 74.53 111.504 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -128.4 3.91 5.67 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.337 0.589 . . . . 71.14 111.008 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 65.8 t -145.13 120.59 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.377 -0.971 . . . . 74.35 108.377 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.94 149.83 28.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.432 -0.581 . . . . 74.33 109.432 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -136.23 143.64 44.44 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 109.131 -0.692 . . . . 75.22 109.131 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -122.17 130.27 53.06 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 109.65 -0.5 . . . . 75.22 109.65 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.37 111.64 24.07 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.433 -0.951 . . . . 74.15 108.433 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.7 mm? -94.81 122.33 37.32 Favored 'General case' 0 C--O 1.276 2.461 0 CA-C-N 114.726 -1.125 . . . . 72.34 107.966 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -117.08 130.94 24.25 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 114.637 -1.165 . . . . 73.33 110.293 -170.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 168' ' ' VAL . 42.4 Cg_endo -67.57 155.37 70.46 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.328 2.685 . . . . 75.23 112.576 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 73.01 -14.6 2.72 Favored Glycine 0 N--CA 1.466 0.652 0 CA-C-N 115.805 -0.634 . . . . 64.04 113.796 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.433 ' H ' ' C ' ' A' ' 166' ' ' PRO . 35.9 m -120.81 162.83 19.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.447 -0.946 . . . . 75.35 108.447 172.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.1 p -99.25 128.3 51.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.32 0.581 . . . . 74.22 110.353 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.3 m -116.8 137.73 52.0 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.127 -1.064 . . . . 73.32 108.127 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.6 p -116.09 148.03 40.68 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 110.086 -0.338 . . . . 74.25 110.086 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.412 ' SD ' HD12 ' A' ' 164' ' ' LEU . 2.7 mpp? -126.83 116.84 21.5 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.147 -0.686 . . . . 72.01 109.147 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.0 t -132.42 138.25 47.58 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.953 -1.128 . . . . 70.11 107.953 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -145.56 120.66 10.1 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.243 -1.021 . . . . 62.41 108.243 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -125.17 130.19 51.65 Favored 'General case' 0 C--N 1.272 -2.798 0 N-CA-C 107.204 -1.406 . . . . 63.45 107.204 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -155.89 153.92 30.42 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.85 -0.796 . . . . 62.44 108.85 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 60.1 mtt180 -88.19 132.52 34.32 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.94 -0.763 . . . . 73.42 108.94 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -135.87 129.85 32.96 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 109.282 -0.636 . . . . 74.53 109.282 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.78 104.21 0.14 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.943 0.777 . . . . 74.55 111.91 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 CA--C 1.503 -0.842 0 CA-C-N 114.879 -1.055 . . . . 65.45 109.238 178.728 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.927 0 N-CA-C 107.42 -1.326 . . . . 74.24 107.42 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.75 122.77 47.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 C-N-CA 119.546 -0.862 . . . . 75.22 112.058 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -110.22 134.82 51.85 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.336 -0.987 . . . . 71.14 108.336 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.25 108.8 12.1 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.565 -0.902 . . . . 64.03 108.565 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 p -116.7 115.05 24.92 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.295 -1.002 . . . . 65.12 108.295 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.83 146.63 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 121.154 0.502 . . . . 74.33 109.813 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 87.4 m -126.31 127.8 46.12 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 109.678 -0.49 . . . . 75.11 109.678 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -110.47 118.26 56.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.61 -0.723 . . . . 75.31 109.852 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.2 m -84.71 155.16 62.0 Favored Pre-proline 0 C--N 1.296 -1.741 0 CA-C-N 115.446 -0.797 . . . . 75.21 109.683 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.63 0.68 4.51 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 123.225 2.616 . . . . 64.02 112.142 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.58 0.32 43.34 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 124.348 1.059 . . . . 53.24 109.831 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.9 t70 70.27 29.71 3.57 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 123.29 1.519 . . . . 75.12 107.073 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.75 138.86 52.38 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 113.02 -1.9 . . . . 74.54 107.959 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.7 t -120.32 140.26 44.98 Favored 'Isoleucine or valine' 0 C--O 1.259 1.564 0 CA-C-O 121.052 0.453 . . . . 72.45 109.977 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.1 p -147.33 142.88 27.58 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.629 -0.878 . . . . 54.44 108.629 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.86 -169.06 40.33 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 119.33 -1.414 . . . . 71.43 112.677 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -151.11 133.8 15.66 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.125 0.488 . . . . 71.35 110.661 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -116.72 116.17 51.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.456 -1.313 . . . . 74.31 107.456 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.04 114.84 47.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.763 -0.458 . . . . 74.4 109.763 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.61 108.68 20.07 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.364 -1.347 . . . . 71.44 107.364 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.62 119.36 32.64 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.7 0.762 . . . . 74.44 110.244 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.68 145.64 37.63 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.649 -0.705 . . . . 73.45 110.164 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.0 tttt . . . . . 0 N--CA 1.42 -1.948 0 N-CA-C 102.999 -2.963 . . . . 75.11 102.999 171.667 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.415 -2.197 0 N-CA-C 109.818 -0.438 . . . . 73.33 109.818 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.14 97.69 0.11 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 119.908 -1.139 . . . . 73.45 112.936 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.68 153.3 26.27 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 123.216 2.611 . . . . 62.32 111.461 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -113.38 157.28 22.08 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.598 -0.519 . . . . 54.41 109.598 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.462 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 65.1 mt -88.81 135.76 33.36 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.857 -0.423 . . . . 65.05 109.857 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.53 87.41 3.82 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.852 -0.613 . . . . 73.23 110.059 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.45 ' HA3' ' HG3' ' A' ' 101' ' ' MET . . . -161.82 156.6 28.18 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 110.885 -0.886 . . . . 71.44 110.885 176.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -144.22 129.08 18.39 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.102 -0.703 . . . . 74.05 109.102 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.06 147.56 61.21 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.458 -0.571 . . . . 72.43 109.458 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.15 -8.99 21.88 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.203 2.602 . . . . 75.11 113.215 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -110.45 42.23 1.61 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.428 0.632 . . . . 74.15 110.286 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 m -57.97 -34.6 70.12 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.605 -0.725 . . . . 63.52 110.945 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -71.27 -9.16 57.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.266 0.555 . . . . 71.25 110.851 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.28 -17.29 17.37 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.793 -0.639 . . . . 74.34 110.019 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 p -130.39 118.1 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.912 0.863 . . . . 75.14 111.015 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.89 112.41 24.18 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.035 -0.984 . . . . 75.02 109.151 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.0 t -98.16 130.52 46.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 106.949 -1.501 . . . . 75.44 106.949 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.9 t -144.04 172.7 12.52 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.112 0.482 . . . . 65.14 110.792 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -80.19 141.74 35.36 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 124.874 1.27 . . . . 73.13 109.323 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -119.76 120.14 35.69 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.635 -0.876 . . . . 72.52 108.635 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -138.7 103.99 4.98 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.655 -0.868 . . . . 75.01 108.655 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.2 t -164.75 142.25 6.35 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.705 -0.398 . . . . 73.04 110.692 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 65.24 13.54 8.83 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.391 1.476 . . . . 74.53 112.223 174.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.41 -3.11 59.47 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.865 -0.683 . . . . 72.3 111.908 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -99.84 148.04 24.86 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.856 -0.794 . . . . 75.53 108.856 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.23 136.76 59.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.328 -0.99 . . . . 75.42 108.328 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -166.03 -154.69 8.34 Favored Glycine 0 N--CA 1.413 -2.834 0 C-N-CA 120.112 -1.042 . . . . 70.41 112.478 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.462 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 6.7 m -126.08 148.37 49.37 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.888 -0.782 . . . . 64.02 108.888 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -129.81 132.14 46.4 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 120.556 -0.457 . . . . 73.32 110.363 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.78 113.92 26.88 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.702 -1.592 . . . . 73.42 106.702 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.68 112.36 39.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.732 -0.84 . . . . 73.12 108.732 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.432 ' CD2' HD13 ' A' ' 90' ' ' LEU . 45.3 p90 -120.02 152.8 36.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.292 0.567 . . . . 71.21 111.633 -173.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.6 p -159.73 157.38 29.35 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.276 -0.874 . . . . 75.44 109.727 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 67.28 31.69 6.41 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.592 1.157 . . . . 53.34 110.295 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.432 HD13 ' CD2' ' A' ' 87' ' ' PHE . 30.1 mt -96.23 164.44 12.67 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.813 -0.631 . . . . 65.15 110.091 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m -107.79 160.22 15.89 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 109.392 -0.596 . . . . 74.12 109.392 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -49.91 -43.15 49.44 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.192 1.397 . . . . 74.13 110.628 176.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.39 -30.45 71.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.865 -0.607 . . . . 65.31 111.441 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -82.91 -15.44 51.39 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.792 -0.64 . . . . 74.53 111.589 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.5 tm? -54.03 -56.2 28.35 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 123.056 0.542 . . . . 75.02 111.269 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.78 -36.13 75.37 Favored 'Trans proline' 0 C--N 1.371 1.723 0 CA-C-N 120.61 1.254 . . . . 74.12 111.072 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.409 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 23.6 mt-30 -62.8 -37.41 86.59 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.691 -0.686 . . . . 74.23 111.818 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -75.54 -20.41 58.7 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.184 0.516 . . . . 72.42 110.045 177.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.49 -20.21 57.2 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.717 -0.674 . . . . 70.4 109.537 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 97' ' ' GLN . 87.7 m-20 -62.77 -55.06 29.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.85 -0.613 . . . . 75.34 110.114 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.45 ' HG3' ' HA3' ' A' ' 62' ' ' GLY . 24.3 ttp -53.97 -51.27 64.41 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.167 0.292 . . . . 72.41 110.72 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.66 -35.27 72.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.846 -0.615 . . . . 73.44 110.429 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.4 t -59.86 -39.86 86.65 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.015 -0.735 . . . . 71.31 109.015 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -63.22 -25.24 68.24 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 115.339 -0.846 . . . . 72.34 110.943 -172.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.11 -20.09 13.52 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 119.949 -0.7 . . . . 65.22 111.591 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.19 -42.1 5.17 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 114.237 1.199 . . . . 74.11 114.237 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.97 25.76 18.81 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.635 -0.986 . . . . 53.24 110.635 -172.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.2 m -109.34 157.26 9.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.68 -0.489 . . . . 73.44 109.68 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -142.66 128.26 19.13 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.803 -0.814 . . . . 74.51 108.803 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -130.03 128.98 43.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.581 0.229 . . . . 72.52 110.664 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.8 m -118.05 134.19 55.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.301 -1.0 . . . . 74.04 108.301 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.2 tp -133.13 123.4 25.61 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.188 -0.671 . . . . 74.01 109.188 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.3 mtp180 -134.23 153.02 52.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.155 0.502 . . . . 74.15 111.703 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.443 HH11 ' HB2' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -106.4 122.11 45.61 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 124.33 1.052 . . . . 73.33 108.935 179.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.41 ' O ' HG13 ' A' ' 118' ' ' ILE . 6.8 t30 -118.14 101.23 8.07 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.779 -1.193 . . . . 71.32 107.779 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.34 -120.06 7.52 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 108.441 -1.864 . . . . 72.44 108.441 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.28 -2.07 22.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.718 -1.216 . . . . 72.22 107.718 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -100.28 148.96 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 C-N-CA 119.37 -0.932 . . . . 63.11 109.068 -175.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.71 140.5 40.57 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-O 120.793 0.33 . . . . 75.5 111.18 -175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.3 pt -119.79 135.37 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.624 -0.717 . . . . 74.3 109.36 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.79 127.07 45.57 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.542 -0.754 . . . . 74.53 109.39 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.29 122.24 31.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.202 -0.908 . . . . 74.55 108.95 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -136.35 146.65 18.63 Favored Glycine 0 N--CA 1.422 -2.277 0 N-CA-C 110.573 -1.011 . . . . 73.22 110.573 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -139.55 144.58 37.89 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.174 -0.676 . . . . 75.31 109.174 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.48 118.82 22.72 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.046 -0.724 . . . . 73.44 109.046 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -102.35 94.04 5.49 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.768 -0.773 . . . . 62.4 111.421 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.71 16.87 13.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.984 -1.487 . . . . 73.35 106.984 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.516 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 1.3 m . . . . . 0 C--N 1.319 -0.745 0 C-N-CA 125.778 1.631 . . . . 75.2 112.733 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.614 0.721 . . . . 74.24 109.835 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.45 129.49 38.92 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.741 -0.663 . . . . 75.44 110.754 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -131.73 111.65 11.84 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.695 -1.224 . . . . 75.2 107.695 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 49.2 t -111.94 127.66 68.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.956 -0.757 . . . . 62.22 108.956 -177.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -112.07 121.25 44.47 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.337 -0.616 . . . . 75.44 109.337 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.29 116.31 28.09 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.593 -1.262 . . . . 75.44 107.593 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.6 m -126.44 130.77 51.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 110.133 -0.321 . . . . 63.12 110.133 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.5 t -123.65 125.77 71.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.464 -0.569 . . . . 74.43 109.464 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.3 131.16 56.62 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.028 -0.73 . . . . 73.42 109.028 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.678 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.3 p90 -134.31 122.93 16.29 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.406 -0.361 . . . . 71.24 110.918 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -69.02 47.4 0.44 Allowed 'Trans proline' 0 CA--C 1.56 1.819 0 C-N-CA 123.008 2.472 . . . . 71.02 112.297 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -132.86 -108.13 0.24 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 122.823 0.449 . . . . 64.14 110.538 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.21 131.19 0.14 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.722 -0.844 . . . . 75.43 108.722 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.09 128.73 38.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.14 -0.689 . . . . 73.24 109.14 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.0 t -88.62 -36.04 16.5 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.246 -0.434 . . . . 64.44 110.012 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.5 m -157.71 133.03 8.9 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 108.938 -0.764 . . . . 62.32 108.938 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 t -138.92 165.39 27.19 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 121.98 -0.45 . . . . 74.11 109.824 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 45.4 t30 -137.05 93.43 2.83 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 105.585 -2.006 . . . . 75.41 105.585 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.81 -147.0 10.45 Favored Glycine 0 N--CA 1.416 -2.67 0 N-CA-C 109.045 -1.622 . . . . 61.41 109.045 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -111.79 100.06 8.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.251 -0.648 . . . . 55.13 109.251 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -78.28 115.75 18.22 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.965 0.412 . . . . 74.21 110.684 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.0 mt -82.21 -48.99 17.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.217 -1.401 . . . . 75.24 107.217 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -130.92 159.74 70.0 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.095 -1.446 . . . . 74.32 107.095 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.74 -13.49 34.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.375 2.05 . . . . 63.42 112.187 176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.678 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -122.39 8.0 9.62 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 112.816 0.673 . . . . 74.05 112.816 176.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.8 t -140.73 120.93 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 109.61 -0.515 . . . . 74.13 109.61 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.28 147.58 31.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.707 -0.479 . . . . 74.21 109.707 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -132.47 149.8 52.27 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.097 0.475 . . . . 65.24 109.898 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.43 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 23.8 m-90 -131.65 133.27 44.73 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.323 -1.362 . . . . 74.13 107.323 174.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -107.09 114.74 28.99 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.974 -0.75 . . . . 74.3 108.974 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.6 mp -88.9 125.57 35.0 Favored 'General case' 0 C--O 1.273 2.309 0 CA-C-N 114.212 -1.358 . . . . 75.34 110.572 -173.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -118.59 147.15 41.42 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 113.304 -1.771 . . . . 75.13 110.771 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 168' ' ' VAL . 2.7 Cg_exo -76.39 159.31 36.39 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.437 2.091 . . . . 74.3 112.356 174.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 74.06 -14.72 3.62 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 123.136 0.398 . . . . 71.34 113.822 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.433 ' H ' ' C ' ' A' ' 166' ' ' PRO . 19.6 m -120.33 145.43 26.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.229 -1.026 . . . . 72.4 108.229 171.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.4 110.06 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 108.42 -0.956 . . . . 74.01 108.42 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.6 m -76.84 130.7 37.98 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.375 -0.83 . . . . 62.34 108.93 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.6 p -115.84 125.73 53.04 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.623 -0.717 . . . . 72.24 110.129 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -112.33 117.07 31.46 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.989 -1.115 . . . . 73.33 107.989 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 13.7 m -135.48 137.05 41.76 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.426 -1.31 . . . . 75.11 110.411 176.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -149.43 135.25 18.74 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.566 -0.901 . . . . 61.43 108.566 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -131.38 130.01 42.06 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 107.127 -1.435 . . . . 74.45 107.127 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -153.57 159.82 42.29 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.622 -0.881 . . . . 62.53 108.622 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 40.0 mtt180 -95.32 127.18 41.16 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.388 -0.925 . . . . 73.25 108.946 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -130.37 127.86 40.24 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.164 -1.05 . . . . 74.22 108.164 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.29 104.74 0.1 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 124.83 1.331 . . . . 73.24 112.675 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 N--CA 1.482 1.127 0 CA-C-N 114.684 -1.144 . . . . 64.5 111.728 -177.325 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 . . . . . 0 N--CA 1.416 -2.169 0 N-CA-C 108.0 -1.111 . . . . 74.31 108.0 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.9 t -107.26 114.72 46.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.398 -0.964 . . . . 73.24 108.398 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -112.25 113.15 25.23 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.422 -0.955 . . . . 72.25 108.422 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.16 108.63 14.02 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.052 -1.092 . . . . 52.53 108.052 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 140' ' ' THR . 20.2 m -122.11 114.32 20.74 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.125 -0.694 . . . . 72.35 109.125 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.5 pt -126.61 148.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 O-C-N 121.891 -0.506 . . . . 75.53 109.84 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.2 m -127.92 119.93 26.6 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 116.089 -0.505 . . . . 75.41 109.783 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.617 HG21 ' OH ' ' A' ' 178' ' ' TYR . 8.7 tt -104.41 125.62 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 108.64 -0.874 . . . . 75.12 108.64 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 37' ' ' ASP . 18.7 m -94.66 152.65 40.02 Favored Pre-proline 0 C--N 1.281 -2.383 0 CA-C-N 115.754 -0.657 . . . . 62.14 109.557 -176.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.93 2.56 0.57 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 123.934 3.089 . . . . 73.04 113.475 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 33.5 t70 -82.0 -7.55 59.62 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.425 1.09 . . . . 72.31 109.582 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 73.16 28.69 1.83 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 123.374 1.559 . . . . 72.22 107.269 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -111.34 132.16 54.61 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.296 -1.774 . . . . 75.41 109.148 178.513 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.95 143.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.116 -0.698 . . . . 73.43 109.116 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 p -149.69 155.24 39.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.052 -1.462 . . . . 61.14 107.052 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.84 -174.59 44.06 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 118.287 -1.911 . . . . 73.5 114.343 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.38 133.26 36.57 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 124.327 1.051 . . . . 74.11 108.721 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.9 mt -119.89 115.54 47.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 105.663 -1.977 . . . . 73.12 105.663 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.8 mt -126.45 114.74 39.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 109.671 -0.492 . . . . 73.4 109.671 -172.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.516 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.02 109.27 19.3 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.391 -1.337 . . . . 74.12 107.391 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -119.69 126.47 51.19 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.453 -0.499 . . . . 71.24 111.53 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.9 157.35 27.83 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.531 -0.759 . . . . 72.23 109.316 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 C--N 1.288 -2.095 0 N-CA-C 106.999 -1.482 . . . . 74.51 106.999 172.182 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.435 -1.189 0 N-CA-C 112.94 0.719 . . . . 74.45 112.94 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.61 98.03 0.11 Allowed Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 120.196 -1.002 . . . . 73.2 112.148 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.51 ' O ' ' HB3' ' A' ' 83' ' ' SER . 67.9 Cg_exo -54.87 159.19 9.65 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.802 2.335 . . . . 75.43 111.368 173.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.99 157.11 21.1 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.923 -0.486 . . . . 71.23 111.027 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.487 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 81.6 mt -109.9 139.12 45.35 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.82 -0.807 . . . . 71.01 108.82 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -108.27 98.78 8.27 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.097 -1.075 . . . . 73.13 108.097 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.482 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -109.63 95.96 0.92 Allowed Glycine 0 C--N 1.283 -2.386 0 CA-C-N 115.109 -0.95 . . . . 72.15 112.531 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -87.01 89.39 7.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.235 -1.024 . . . . 72.21 108.235 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.39 154.13 78.35 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 109.47 -0.567 . . . . 74.51 109.47 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.22 -28.67 18.31 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.325 2.017 . . . . 73.44 112.152 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -91.21 38.23 0.96 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.746 -0.661 . . . . 74.44 112.07 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.73 -45.07 58.43 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.523 1.129 . . . . 75.11 113.535 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -12.13 60.77 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.051 0.453 . . . . 73.52 111.099 -174.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 88' ' ' SER . 69.1 mmtt -93.35 -9.61 38.19 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 116.198 -0.455 . . . . 64.11 110.115 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -115.41 118.52 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 C-N-CA 118.518 -1.273 . . . . 74.33 110.063 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.44 102.6 14.4 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.998 -1.001 . . . . 64.24 108.871 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.7 t -98.27 135.74 31.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.462 -1.31 . . . . 75.12 107.462 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 t -155.52 171.87 19.21 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.693 -0.854 . . . . 62.44 108.693 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -83.58 142.78 30.59 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.689 -0.856 . . . . 71.44 108.689 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -99.06 122.38 42.22 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.313 -0.995 . . . . 74.34 108.313 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -138.99 99.62 3.82 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.187 -0.672 . . . . 53.44 109.187 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.2 t -172.88 149.74 1.97 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.612 -0.514 . . . . 64.15 109.612 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.91 16.2 8.83 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.393 1.077 . . . . 63.53 111.674 173.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.5 1.55 85.68 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.442 -0.663 . . . . 64.43 111.442 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.413 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 91.8 m-85 -104.29 145.51 30.12 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 109.5 -0.556 . . . . 71.42 109.5 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.2 136.67 60.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.797 -1.186 . . . . 72.34 107.797 173.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -165.47 -154.97 8.34 Favored Glycine 0 C--N 1.27 -3.115 0 C-N-CA 119.65 -1.262 . . . . 70.35 111.638 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 21.2 p -123.84 143.23 50.46 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 109.604 -0.517 . . . . 71.33 109.604 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -138.37 142.59 39.63 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 120.406 -0.518 . . . . 74.43 110.954 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.37 114.9 18.83 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.197 -1.038 . . . . 71.33 108.197 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -105.97 115.0 46.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 108.62 -0.881 . . . . 74.5 108.62 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -118.34 154.43 32.36 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 120.393 -0.523 . . . . 74.14 110.938 -175.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 80.8 p -157.53 171.35 20.51 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 109.335 -0.617 . . . . 64.21 109.335 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 62.15 30.59 17.78 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.438 1.087 . . . . 75.22 110.62 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt -101.15 164.24 11.89 Favored 'General case' 0 N--CA 1.42 -1.926 0 C-N-CA 120.165 -0.614 . . . . 75.45 111.116 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -113.04 170.79 7.95 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.235 -0.654 . . . . 74.2 109.235 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -54.57 -38.25 66.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.407 1.083 . . . . 74.41 111.746 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.51 65.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.236 -0.438 . . . . 72.44 111.876 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -86.46 -16.51 36.86 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.904 0.383 . . . . 73.15 111.665 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.603 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.7 tt -62.35 -47.71 88.8 Favored Pre-proline 0 CA--C 1.569 1.685 0 CA-C-N 116.236 -0.438 . . . . 75.35 111.378 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.55 -40.15 76.63 Favored 'Trans proline' 0 C--N 1.38 2.232 0 CA-C-N 120.831 1.333 . . . . 72.33 110.768 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -61.16 -41.8 97.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.236 -0.893 . . . . 73.52 111.534 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -72.36 -20.39 61.47 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.376 -0.375 . . . . 74.52 110.635 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.01 -26.13 60.27 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.21 -0.663 . . . . 75.3 109.21 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -62.87 -52.06 64.57 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.58 -0.896 . . . . 62.13 108.58 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.482 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 32.2 ttp -53.89 -51.59 63.2 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.478 -0.783 . . . . 72.42 109.78 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -55.22 -35.0 64.44 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.192 -0.913 . . . . 74.53 111.076 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -58.96 -32.57 69.75 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 119.234 -0.413 . . . . 72.54 111.465 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.26 -25.7 67.98 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.269 0.557 . . . . 74.52 111.233 -173.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.37 -14.48 14.43 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.809 -0.632 . . . . 74.15 111.01 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.3 -43.79 4.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.309 0.855 . . . . 74.33 113.309 -171.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.37 22.69 69.84 Favored Glycine 0 C--N 1.317 -0.481 0 N-CA-C 111.122 -0.791 . . . . 64.43 111.122 -173.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.3 m -103.87 161.53 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.576 -0.527 . . . . 70.11 109.576 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -123.31 121.62 36.28 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.67 -1.604 . . . . 75.02 106.67 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.0 mt -122.77 107.23 11.67 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.266 -0.642 . . . . 72.33 109.266 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.1 m -115.87 141.02 48.65 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.88 -0.785 . . . . 74.44 108.88 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -149.92 155.38 39.89 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.9 -0.32 . . . . 71.44 110.478 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -156.09 161.84 40.34 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.339 -0.985 . . . . 75.13 108.339 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -106.47 133.09 51.7 Favored 'General case' 0 N--CA 1.398 -3.031 0 N-CA-C 107.322 -1.362 . . . . 75.45 107.322 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -118.81 100.24 7.27 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 106.839 -1.541 . . . . 70.12 106.839 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.91 -113.05 4.98 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.325 -1.11 . . . . 61.43 110.325 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -114.32 12.09 17.51 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.932 1.348 . . . . 73.04 109.477 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.23 148.86 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 O-C-N 120.445 -1.41 . . . . 73.42 108.868 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 82.4 t -106.41 136.0 42.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 CA-C-O 120.761 0.315 . . . . 73.43 110.398 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.1 pt -116.94 134.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 108.876 -0.787 . . . . 65.44 108.876 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 tt -127.84 126.25 41.28 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.279 -1.008 . . . . 73.34 108.279 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -128.63 114.86 17.21 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.828 0.823 . . . . 75.44 109.142 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.39 139.4 14.13 Favored Glycine 0 N--CA 1.4 -3.747 0 N-CA-C 108.777 -1.729 . . . . 54.33 108.777 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -140.23 131.09 25.96 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.633 -1.618 . . . . 74.02 106.633 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -139.5 144.8 38.1 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.688 0.756 . . . . 73.13 112.871 -172.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.24 93.43 5.69 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.513 -1.221 . . . . 74.13 107.937 174.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.13 0.27 56.22 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.929 0.871 . . . . 73.02 108.827 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.431 -1.378 0 CA-C-N 114.452 -1.249 . . . . 64.03 111.409 -179.464 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 . . . . . 0 N--CA 1.44 -0.95 0 CA-C-O 121.034 0.445 . . . . 75.34 111.236 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.02 140.37 29.81 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.42 -0.354 . . . . 75.52 111.863 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -133.06 139.67 47.29 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.492 -0.929 . . . . 72.44 108.492 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.77 113.89 44.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.126 -0.694 . . . . 75.23 109.126 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -113.29 120.13 40.11 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.21 0.529 . . . . 74.41 109.949 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 39.9 tp -112.18 120.6 42.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.306 -0.998 . . . . 74.52 108.306 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 31' ' ' SER . 17.4 m -120.89 112.62 19.01 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.566 -0.901 . . . . 51.15 108.566 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.49 120.77 61.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.508 -0.923 . . . . 73.43 108.508 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -105.73 126.92 52.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.523 -0.917 . . . . 63.12 108.523 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.438 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 0.3 OUTLIER -134.25 103.36 11.58 Favored Pre-proline 0 C--N 1.274 -2.697 0 CA-C-N 115.591 -0.731 . . . . 70.34 110.349 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.34 45.2 0.4 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 123.574 2.849 . . . . 74.53 112.277 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -118.53 -86.26 0.64 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.457 -0.571 . . . . 71.24 109.457 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.55 113.47 0.01 OUTLIER 'General case' 0 C--O 1.247 0.972 0 C-N-CA 123.72 0.808 . . . . 74.13 109.112 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.438 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 9.4 p -75.66 130.83 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.768 -1.197 . . . . 75.11 107.768 174.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.8 t -103.8 -28.71 11.46 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.296 -0.962 . . . . 73.04 110.852 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.7 m -159.28 132.96 7.33 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 107.406 -1.331 . . . . 74.24 107.406 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -139.75 162.14 35.85 Favored 'General case' 0 C--N 1.282 -2.331 0 O-C-N 122.104 -0.372 . . . . 74.55 110.414 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -130.04 90.55 2.98 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 104.927 -2.249 . . . . 64.11 104.927 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.35 -147.93 10.31 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 109.471 -1.452 . . . . 72.43 109.471 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -116.59 99.66 7.3 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 117.501 0.65 . . . . 65.11 109.481 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -72.58 131.89 43.06 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 121.287 0.565 . . . . 75.33 110.328 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.5 mm -96.07 -49.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 106.958 -1.497 . . . . 75.43 106.958 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -134.73 166.42 29.33 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 105.857 -1.905 . . . . 70.33 105.857 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.96 -2.39 11.44 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.309 2.006 . . . . 75.34 110.86 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.82 10.76 5.11 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.187 -0.915 . . . . 53.52 111.076 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.0 t -147.02 120.71 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.507 -0.923 . . . . 75.33 108.507 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.6 147.01 30.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.751 -0.833 . . . . 72.02 108.751 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 8.5 tt0 -132.92 142.44 48.9 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-O 121.595 0.712 . . . . 75.21 110.207 -174.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.444 ' CZ2' ' HB3' ' A' ' 174' ' ' ALA . 29.1 m-90 -123.63 116.02 22.42 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.095 -1.076 . . . . 72.35 108.095 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.401 ' HD3' ' H ' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -112.36 98.42 7.27 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.017 0.913 . . . . 72.34 109.478 -178.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.75 147.4 23.66 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.221 -1.354 . . . . 75.13 110.084 -171.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -117.11 150.19 45.66 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 115.587 -0.733 . . . . 74.4 112.105 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 168' ' ' VAL . 32.1 Cg_exo -66.06 157.48 59.32 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 123.318 2.679 . . . . 74.52 111.466 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.48 -27.26 2.51 Favored Glycine 0 C--N 1.313 -0.744 0 C-N-CA 121.54 -0.362 . . . . 33.34 112.899 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.419 ' H ' ' C ' ' A' ' 166' ' ' PRO . 35.3 m -105.85 167.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 120.723 0.297 . . . . 74.54 110.624 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.6 p -114.05 143.97 22.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.112 -0.699 . . . . 72.43 109.112 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 44.5 m -153.09 150.26 28.94 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 121.992 -0.443 . . . . 75.04 110.186 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 27.7 p -120.37 126.41 50.43 Favored 'General case' 0 N--CA 1.428 -1.557 0 C-N-CA 122.94 0.496 . . . . 73.42 110.0 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -98.14 121.39 40.01 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.591 -0.522 . . . . 72.04 109.591 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.3 m -137.98 138.44 38.91 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.865 -1.147 . . . . 74.51 111.369 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.444 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . . . -145.31 128.77 16.97 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 115.811 -0.631 . . . . 75.43 109.675 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -117.19 130.69 56.76 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 107.006 -1.479 . . . . 74.22 107.006 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -140.85 152.28 44.99 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.497 -0.557 . . . . 43.12 109.497 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -90.74 126.28 35.95 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.406 -0.961 . . . . 74.42 108.406 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.617 ' OH ' HG21 ' A' ' 34' ' ' ILE . 5.4 m-85 -126.26 126.7 44.44 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 113.059 0.763 . . . . 73.31 113.059 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 35.7 p -67.79 105.17 1.86 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.606 -1.179 . . . . 65.22 108.484 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 CA--C 1.506 -0.721 0 O-C-N 123.773 0.671 . . . . 73.52 110.114 -178.127 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 50.0 mtm105 . . . . . 0 CA--C 1.507 -0.692 0 N-CA-C 110.244 -0.28 . . . . 74.33 110.244 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.58 114.71 39.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.495 0.664 . . . . 74.13 109.559 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -123.8 119.08 28.68 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.413 0.625 . . . . 74.32 110.706 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.38 108.87 19.57 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.295 -1.002 . . . . 65.42 108.295 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 p -117.52 115.89 26.03 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.32 -0.622 . . . . 73.12 109.32 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.72 146.91 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.518 -0.549 . . . . 63.13 109.518 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.1 m -123.78 130.63 52.93 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 109.094 -0.706 . . . . 54.14 109.094 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -112.94 120.27 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 121.679 0.752 . . . . 62.23 110.553 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -92.74 158.29 38.29 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 115.054 -0.975 . . . . 55.13 110.438 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HB3' ' OG1' ' A' ' 179' ' ' THR . 25.1 Cg_exo -65.53 2.39 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.997 3.131 . . . . 75.12 113.614 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 31.7 t70 -89.85 -0.32 57.49 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.973 -0.751 . . . . 71.12 108.973 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 22.0 t70 70.79 29.19 3.22 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 105.51 -2.033 . . . . 74.42 105.51 -174.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 7.0 tp -101.69 125.02 48.27 Favored 'General case' 1 N--CA 1.379 -4.023 0 CA-C-N 112.175 -2.284 . . . . 74.12 108.472 -177.247 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.6 t -115.47 130.64 69.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.629 -0.878 . . . . 73.13 108.629 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 p -145.23 151.81 38.97 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.033 -0.729 . . . . 75.23 109.033 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.51 -164.7 36.45 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 118.971 -1.585 . . . . 74.05 112.965 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.05 133.97 15.84 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.247 0.546 . . . . 71.24 110.571 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 68.0 mt -114.27 115.84 50.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.885 -1.154 . . . . 72.43 107.885 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -109.95 116.71 52.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 109.762 -0.458 . . . . 63.34 109.762 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.481 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -112.89 108.47 17.43 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.909 -1.515 . . . . 73.24 106.909 174.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -123.35 125.36 44.86 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.236 0.541 . . . . 72.4 111.672 -174.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.86 159.92 32.5 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.441 -0.8 . . . . 64.21 109.165 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.494 0 C-N-CA 119.144 -1.022 . . . . 74.34 110.36 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.432 -1.366 0 CA-C-O 121.7 0.762 . . . . 75.1 109.103 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.77 99.5 0.12 Allowed Glycine 0 N--CA 1.416 -2.639 0 CA-C-O 118.289 -1.284 . . . . 63.33 111.725 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.05 127.75 26.98 Favored 'Trans proline' 0 C--N 1.355 0.88 0 CA-C-N 120.044 1.922 . . . . 71.44 107.5 170.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.1 151.52 22.47 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 113.573 0.953 . . . . 72.2 113.573 -166.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.483 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 96.1 mt -94.35 150.48 20.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.047 -0.979 . . . . 72.32 109.301 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -107.07 93.68 4.69 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.389 -0.967 . . . . 73.42 108.389 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.38 120.01 5.87 Favored Glycine 0 N--CA 1.42 -2.39 0 CA-C-N 114.442 -1.254 . . . . 64.13 111.219 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -136.68 111.47 8.78 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.918 -0.771 . . . . 63.41 108.918 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.15 166.88 14.55 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.173 -1.047 . . . . 74.2 108.173 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -66.98 -32.67 34.55 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 121.406 1.404 . . . . 72.53 110.586 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -97.13 39.2 1.19 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.257 -0.883 . . . . 71.53 112.825 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.8 m -55.14 -27.8 48.09 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 112.784 0.661 . . . . 74.54 112.784 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -73.02 -7.89 53.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.217 0.532 . . . . 73.35 111.232 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.5 -13.13 18.8 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.117 -0.492 . . . . 75.3 110.383 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.2 p -125.31 119.99 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.882 0.849 . . . . 64.45 111.663 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.98 112.08 24.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.774 -0.825 . . . . 73.42 108.774 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.35 127.76 50.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.083 -1.081 . . . . 75.41 108.083 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 m -140.01 172.78 12.27 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.534 -0.543 . . . . 74.44 109.534 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -86.03 149.24 25.31 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.064 -0.654 . . . . 72.12 109.539 174.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 79.6 t80 -101.93 120.56 40.59 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.571 -1.64 . . . . 74.43 106.571 174.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -138.49 99.13 3.75 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 108.423 -0.954 . . . . 72.4 108.423 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.3 t -174.07 153.48 2.08 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.869 -1.16 . . . . 71.3 107.869 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 66.89 15.14 10.07 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.915 0.886 . . . . 73.34 112.166 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.38 -8.25 80.25 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.575 -0.61 . . . . 64.53 111.575 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.439 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 47.9 m-85 -93.05 153.22 18.83 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.419 -0.586 . . . . 65.21 109.419 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 31.0 m -134.81 136.31 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.064 -1.088 . . . . 75.31 108.064 171.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.8 -153.85 8.86 Favored Glycine 0 C--N 1.259 -3.75 0 N-CA-C 110.505 -1.038 . . . . 73.14 110.505 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.483 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.1 p -126.43 146.76 49.96 Favored 'General case' 0 C--N 1.264 -3.141 0 CA-C-O 121.317 0.58 . . . . 64.54 111.518 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 4.4 pt20 -136.97 127.78 27.3 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.97 -0.559 . . . . 64.01 110.496 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.42 115.25 29.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.287 -1.005 . . . . 75.32 108.287 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.68 117.77 54.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.057 -1.09 . . . . 74.44 108.057 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.438 ' CD2' HD12 ' A' ' 90' ' ' LEU . 50.7 p90 -124.29 154.77 39.75 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 120.803 0.335 . . . . 72.53 110.236 -175.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.5 m -157.56 159.73 37.44 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 116.234 -0.439 . . . . 64.22 110.222 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 67.14 31.13 6.95 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.505 1.145 . . . . 71.44 110.486 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.438 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.0 mt -96.24 160.44 14.43 Favored 'General case' 0 N--CA 1.428 -1.54 0 O-C-N 121.627 -0.671 . . . . 73.52 111.304 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 m -104.78 166.53 10.32 Favored 'General case' 0 N--CA 1.401 -2.912 0 N-CA-C 109.391 -0.596 . . . . 73.23 109.391 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.482 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 60.8 t80 -50.66 -48.62 58.31 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.228 1.011 . . . . 74.24 110.674 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.07 -24.66 67.24 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.268 -0.878 . . . . 64.34 112.245 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -87.66 -16.93 33.03 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 116.272 -0.422 . . . . 73.53 111.754 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.3 tt -61.89 -52.36 68.8 Favored Pre-proline 0 CA--C 1.559 1.294 0 O-C-N 123.254 0.346 . . . . 73.21 111.228 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -65.72 -32.98 45.95 Favored 'Trans proline' 0 C--N 1.369 1.654 0 CA-C-N 120.794 1.319 . . . . 73.21 110.63 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.63 -36.06 83.04 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.642 -0.708 . . . . 72.34 110.977 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -77.59 -19.84 54.95 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.871 -0.418 . . . . 72.25 109.871 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.78 -24.24 61.71 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.97 -0.559 . . . . 74.32 110.25 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -56.18 -49.75 73.14 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 109.561 -0.533 . . . . 74.41 109.561 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.5 mtm -54.37 -51.46 64.71 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.232 0.539 . . . . 74.45 110.161 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -56.58 -34.93 67.65 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.992 -1.004 . . . . 74.35 111.598 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.3 m -62.09 -30.21 70.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.269 -0.423 . . . . 54.52 110.243 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.18 -31.57 70.25 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 123.926 0.767 . . . . 73.03 110.674 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.09 -11.89 15.53 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 116.233 -0.44 . . . . 74.13 111.38 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.69 -47.86 3.65 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.646 0.98 . . . . 72.45 113.646 -172.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.07 25.81 33.11 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.814 -0.708 . . . . 72.42 111.784 -174.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 m -109.27 155.41 10.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 122.486 -0.42 . . . . 74.15 111.7 -175.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -124.28 124.79 43.17 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.088 0.555 . . . . 72.44 109.555 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.8 mp -117.56 143.66 45.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.124 0.488 . . . . 74.11 111.056 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.1 m -129.74 109.57 11.06 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.065 -0.717 . . . . 74.31 109.065 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.566 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 61.0 tp -119.87 123.84 44.59 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.526 -0.306 . . . . 74.32 110.646 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.566 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 2.8 mpt_? -137.47 147.94 45.69 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.783 0.433 . . . . 74.31 110.194 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -102.0 137.54 40.15 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 107.101 -1.444 . . . . 75.22 107.101 175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -128.47 90.0 2.99 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.664 -0.865 . . . . 71.33 108.664 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.79 -113.22 4.89 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.052 -0.976 . . . . 75.32 110.874 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.29 -13.67 21.82 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.843 0.83 . . . . 75.24 109.07 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.4 pp -103.59 149.86 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 C-N-CA 119.69 -0.804 . . . . 74.0 110.009 -176.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.548 HG22 ' CD2' ' A' ' 178' ' ' TYR . 92.7 t -118.31 138.68 48.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 O-C-N 121.911 -0.493 . . . . 72.21 110.141 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.0 pt -120.05 129.43 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 122.101 0.953 . . . . 65.14 109.802 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.2 136.25 49.89 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 114.907 -1.042 . . . . 75.3 108.56 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -143.28 166.15 25.52 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 108.835 -0.802 . . . . 65.42 108.835 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.84 158.98 30.96 Favored Glycine 0 N--CA 1.405 -3.415 0 N-CA-C 109.72 -1.352 . . . . 71.0 109.72 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -134.31 125.23 27.23 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.234 -1.765 . . . . 75.53 106.234 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.15 117.51 16.63 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 120.996 0.427 . . . . 74.23 111.618 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 169' ' ' VAL . 0.0 OUTLIER -108.85 134.02 52.1 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 105.154 -2.165 . . . . 71.14 105.154 170.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.9 mm? -117.85 32.38 6.18 Favored 'General case' 0 C--N 1.267 -2.99 0 N-CA-C 108.754 -0.832 . . . . 74.41 108.754 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 N--CA 1.446 -0.638 0 CA-C-N 115.965 -0.561 . . . . 71.45 110.487 -176.129 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 121.159 0.504 . . . . 71.34 111.283 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.0 143.91 28.08 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.137 -0.69 . . . . 60.02 109.137 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -132.11 130.52 41.29 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.276 -1.009 . . . . 75.44 108.276 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.1 t -113.54 126.11 70.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.863 -0.421 . . . . 64.43 109.863 -175.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.35 121.99 30.45 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.866 0.365 . . . . 65.43 111.356 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.484 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -111.22 121.54 45.54 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.885 -1.894 . . . . 74.01 105.885 174.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.3 m -126.6 130.96 51.52 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.243 -0.28 . . . . 44.22 110.243 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 99.4 t -123.86 126.12 72.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 109.036 -0.728 . . . . 74.4 109.036 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.84 127.57 56.21 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.324 -0.621 . . . . 74.41 109.324 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.583 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.8 p90 -134.38 123.68 16.68 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 116.362 -0.381 . . . . 75.53 111.789 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -68.27 41.07 0.24 Allowed 'Trans proline' 0 CA--C 1.557 1.635 0 C-N-CA 123.447 2.765 . . . . 64.41 113.795 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.49 -100.44 0.39 Allowed 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.985 -0.447 . . . . 73.54 110.807 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 178.92 130.75 0.08 Allowed 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.745 -0.835 . . . . 53.52 108.745 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.7 133.03 30.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.049 -0.723 . . . . 75.4 109.049 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.2 p -94.03 -43.3 8.58 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-O 121.225 0.536 . . . . 74.42 109.701 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 17.0 m -150.04 131.32 14.59 Favored 'General case' 0 C--O 1.212 -0.904 0 N-CA-C 108.407 -0.961 . . . . 71.22 108.407 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -140.91 152.32 44.94 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.39 -0.524 . . . . 73.34 111.241 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -119.5 90.97 3.44 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.162 -2.162 . . . . 62.33 105.162 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.62 -159.26 28.97 Favored Glycine 0 N--CA 1.416 -2.672 0 N-CA-C 107.345 -2.302 . . . . 74.13 107.345 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.12 102.84 11.01 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 117.846 0.823 . . . . 73.44 109.542 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -76.28 122.01 23.79 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-O 121.218 0.532 . . . . 74.13 109.877 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.16 -41.06 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 106.989 -1.486 . . . . 64.23 106.989 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -136.08 166.29 29.24 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.118 -1.401 . . . . 74.43 107.245 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.12 -4.75 15.53 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 122.351 2.034 . . . . 75.31 110.721 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.6 pt-20 -128.27 6.2 5.84 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.613 -0.722 . . . . 70.54 111.36 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.5 t -141.66 120.57 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.256 -1.016 . . . . 75.34 108.256 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 50.1 t -123.53 145.53 30.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.772 -0.455 . . . . 75.34 109.772 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -136.09 142.72 44.34 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.362 0.601 . . . . 73.35 110.202 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.484 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.6 m-90 -118.7 113.35 21.04 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.432 -0.804 . . . . 71.1 109.106 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.23 99.07 11.08 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 122.316 1.055 . . . . 74.34 108.716 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 61.1 mt -97.68 147.48 24.3 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 113.676 -1.602 . . . . 75.34 109.428 -173.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -117.63 146.44 38.67 Favored Pre-proline 0 C--N 1.295 -1.766 0 CA-C-N 115.637 -0.711 . . . . 73.41 112.302 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.442 ' HA ' ' CB ' ' A' ' 127' ' ' LEU . 71.8 Cg_endo -71.54 160.02 49.59 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.573 2.182 . . . . 72.02 110.341 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.34 -26.87 2.15 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 121.096 -0.573 . . . . 73.43 113.22 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.7 170.1 3.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.008 0.432 . . . . 75.03 112.082 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 126' ' ' ASP . 8.3 p -114.07 142.94 24.92 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 CA-C-N 115.812 -0.631 . . . . 74.41 109.87 176.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.5 p -149.75 140.57 22.74 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.048 0.451 . . . . 72.22 111.975 -176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.8 p -96.67 138.11 34.73 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.201 -0.666 . . . . 70.42 109.201 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 22.4 ptm -118.63 133.1 56.11 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.944 -1.132 . . . . 75.3 107.944 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -143.55 147.93 35.19 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.613 -0.835 . . . . 74.22 111.398 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.435 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -154.89 130.29 9.75 Favored 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 123.05 0.54 . . . . 74.13 109.862 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -132.54 131.83 41.97 Favored 'General case' 0 C--N 1.264 -3.147 0 N-CA-C 106.753 -1.573 . . . . 73.04 106.753 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.18 149.83 23.3 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.832 -1.173 . . . . 63.14 107.832 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 0.8 OUTLIER -95.52 138.86 32.6 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.447 -1.686 . . . . 70.42 106.447 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.548 ' CD2' HG22 ' A' ' 119' ' ' VAL . 22.4 m-30 -121.17 151.78 39.53 Favored 'General case' 0 CA--C 1.483 -1.611 0 C-N-CA 119.926 -0.71 . . . . 74.44 109.331 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -76.81 86.03 3.4 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-O 121.462 0.648 . . . . 74.3 110.097 175.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.5 t70 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 114.451 -1.249 . . . . 74.42 110.815 179.505 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? . . . . . 0 N--CA 1.434 -1.245 0 N-CA-C 108.913 -0.773 . . . . 74.02 108.913 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.32 117.76 56.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.45 -0.944 . . . . 71.33 108.45 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -123.05 114.06 19.87 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.342 0.591 . . . . 72.33 109.457 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.29 126.76 55.6 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.583 -0.895 . . . . 75.31 108.583 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.9 t -131.64 114.79 15.24 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.046 -1.464 . . . . 73.33 107.046 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.63 146.62 29.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.367 -0.605 . . . . 44.32 109.367 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.5 m -126.8 125.21 41.32 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.258 0.551 . . . . 75.13 109.854 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 tt -113.39 110.35 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-O 121.851 0.834 . . . . 72.33 110.097 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -76.99 158.55 80.06 Favored Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 114.761 -1.109 . . . . 75.12 109.747 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.5 0.81 2.55 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 123.363 2.709 . . . . 62.11 112.999 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -88.89 2.33 53.92 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 124.066 0.947 . . . . 73.4 110.156 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 t70 67.89 29.44 6.61 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 123.55 1.643 . . . . 74.43 106.872 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.36 124.77 50.88 Favored 'General case' 0 N--CA 1.382 -3.841 0 CA-C-N 113.904 -1.498 . . . . 71.14 107.297 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.78 136.29 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 108.471 -0.937 . . . . 72.41 108.471 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.8 p -144.13 154.93 43.68 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 105.966 -1.865 . . . . 62.21 105.966 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.25 -172.04 44.26 Favored Glycine 0 CA--C 1.49 -1.524 0 C-N-CA 117.913 -2.089 . . . . 64.33 113.725 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.43 134.22 28.75 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.438 0.695 . . . . 75.01 110.041 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 60.0 mt -120.75 115.7 47.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.018 -1.475 . . . . 74.44 107.018 174.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.2 114.61 46.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 120.935 0.398 . . . . 75.32 109.954 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.01 108.3 18.48 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.277 -1.749 . . . . 65.33 106.277 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . . . -121.34 125.66 47.55 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 120.246 -0.582 . . . . 74.31 111.257 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.64 155.73 22.93 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.934 -0.765 . . . . 64.13 108.934 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.6 tttm . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 104.983 -2.229 . . . . 73.52 104.983 176.131 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.427 -1.575 0 N-CA-C 108.723 -0.843 . . . . 74.44 108.723 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.91 98.18 0.11 Allowed Glycine 0 N--CA 1.414 -2.787 0 CA-C-N 114.824 -1.08 . . . . 65.34 112.54 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.74 159.09 53.81 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 122.673 2.248 . . . . 71.43 111.579 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.95 155.25 41.65 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.079 -0.341 . . . . 71.01 110.079 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.552 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 94.3 mt -101.15 153.47 19.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.159 -0.682 . . . . 71.22 109.159 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.92 88.07 5.6 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.878 -1.527 . . . . 74.34 106.878 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.86 50.66 0.78 Allowed Glycine 0 N--CA 1.414 -2.792 0 CA-C-N 115.077 -0.965 . . . . 75.01 112.89 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -91.6 95.46 9.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.251 -1.018 . . . . 71.15 108.251 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 m -122.37 162.21 39.16 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 114.15 -1.386 . . . . 64.53 107.609 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.86 -19.61 32.37 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.673 2.249 . . . . 71.32 112.831 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -112.52 29.58 7.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.417 -0.356 . . . . 70.32 111.659 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.9 m -56.48 -27.82 58.13 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.497 0.554 . . . . 74.24 112.497 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -70.15 -10.78 59.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.394 0.616 . . . . 73.33 110.752 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 88' ' ' SER . 68.0 mmtt -106.68 -9.83 16.36 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 116.18 -0.464 . . . . 75.44 111.486 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.74 118.27 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 119.382 -0.927 . . . . 75.13 111.102 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.76 103.4 15.31 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 115.051 -0.977 . . . . 71.25 108.794 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.3 134.79 35.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.161 -1.052 . . . . 71.41 108.161 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.0 m -149.46 171.56 16.38 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 120.847 0.356 . . . . 75.01 111.047 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -76.85 132.09 38.97 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.125 -0.943 . . . . 73.21 109.089 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 74.0 t80 -102.62 119.92 39.66 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.287 -1.375 . . . . 75.13 107.287 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -137.6 99.61 3.99 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.513 -0.921 . . . . 74.41 108.513 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.0 t -168.42 149.1 4.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.38 -0.971 . . . . 73.15 108.38 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 69.85 13.75 8.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.979 0.911 . . . . 71.22 112.167 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.76 1.48 67.95 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.764 -0.653 . . . . 53.23 111.692 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 59.4 m-85 -102.79 151.07 22.84 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 122.506 0.322 . . . . 71.43 110.28 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 29.4 m -129.3 136.23 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 107.342 -1.355 . . . . 72.23 107.342 168.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.1 -154.95 10.51 Favored Glycine 0 C--N 1.272 -2.977 0 C-N-CA 119.965 -1.112 . . . . 41.14 111.019 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.552 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 13.0 m -126.69 145.12 50.7 Favored 'General case' 0 C--N 1.27 -2.863 0 CA-C-O 121.185 0.517 . . . . 51.03 110.39 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -131.17 138.8 49.59 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.957 -0.565 . . . . 74.13 109.919 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.14 114.63 22.76 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.502 -1.296 . . . . 61.55 107.502 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.6 t -112.44 113.4 44.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.206 -1.035 . . . . 74.42 108.206 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CD2' HD11 ' A' ' 90' ' ' LEU . 44.3 p90 -114.27 159.55 20.04 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.008 0.433 . . . . 74.01 111.858 -173.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 6.1 p -156.68 155.18 31.29 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.256 -0.884 . . . . 73.32 110.13 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 67.03 30.01 7.69 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 124.629 1.172 . . . . 70.31 111.945 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.452 HD11 ' CD2' ' A' ' 87' ' ' PHE . 39.2 mt -97.27 165.99 11.77 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 119.387 -0.925 . . . . 72.33 110.114 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.45 HG23 ' OE1' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -125.3 178.93 5.32 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.905 -1.146 . . . . 75.42 107.905 -178.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -47.54 -35.63 9.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.851 1.26 . . . . 64.52 112.452 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -25.72 60.98 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.9 0.704 . . . . 75.24 112.9 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.45 ' OE1' HG23 ' A' ' 91' ' ' THR . 14.6 mp0 -91.74 -16.97 26.1 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.797 -0.761 . . . . 74.32 112.749 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.3 tt -58.51 -50.65 86.88 Favored Pre-proline 0 CA--C 1.569 1.677 0 O-C-N 123.241 0.338 . . . . 75.32 111.456 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -68.81 -30.83 26.43 Favored 'Trans proline' 0 C--N 1.365 1.408 0 CA-C-N 120.731 1.297 . . . . 74.13 111.281 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -67.88 -33.13 74.14 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 123.534 0.734 . . . . 74.04 111.121 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.6 pp -75.54 -19.23 59.46 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.988 0.423 . . . . 71.12 110.256 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -71.63 -18.29 62.21 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.933 -0.576 . . . . 73.23 109.977 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.23 -57.24 10.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.9 -0.591 . . . . 74.23 109.85 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 14.8 ttm -54.38 -52.7 60.83 Favored 'General case' 0 C--O 1.271 2.189 0 CA-C-O 122.518 1.152 . . . . 74.34 108.428 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 6.3 t30 -52.84 -27.04 16.49 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 112.435 -2.166 . . . . 64.25 112.805 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -54.47 -45.89 73.25 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.886 -0.326 . . . . 74.31 110.557 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -69.47 -11.84 61.16 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.307 0.855 . . . . 72.51 113.307 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.38 -27.62 11.36 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.098 0.475 . . . . 73.42 110.359 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.11 -47.68 3.63 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 113.314 0.857 . . . . 72.43 113.314 -170.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.26 21.53 51.65 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.667 -0.973 . . . . 61.43 110.667 -172.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.6 m -118.97 155.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 122.306 -0.526 . . . . 74.4 110.617 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -125.71 141.4 52.03 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.91 -1.145 . . . . 74.23 107.91 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.0 mt -129.27 119.55 24.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.915 -0.772 . . . . 75.21 108.915 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -118.94 135.74 54.43 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.03 -1.1 . . . . 74.51 108.03 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.33 157.81 43.82 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 112.631 0.604 . . . . 73.22 112.631 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -145.67 150.87 37.1 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.844 -1.071 . . . . 73.11 111.267 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.529 ' NH2' ' HA ' ' A' ' 180' ' ' ASP . 3.9 tpt180 -96.49 106.56 18.83 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 106.401 -1.703 . . . . 74.34 106.401 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -96.8 89.23 4.83 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 108.097 -1.075 . . . . 65.34 108.097 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.13 -96.86 0.9 Allowed Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.086 -1.205 . . . . 65.34 110.086 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -124.42 -2.42 8.0 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.672 1.225 . . . . 71.03 109.33 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.62 148.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 O-C-N 121.087 -1.008 . . . . 73.24 108.703 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.419 HG23 ' HD3' ' A' ' 114' ' ' ARG . 96.8 t -102.89 131.77 50.44 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 O-C-N 122.06 -0.4 . . . . 72.3 110.32 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.4 pt -107.56 130.98 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 N-CA-C 106.784 -1.562 . . . . 72.54 106.784 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 tt -127.93 131.42 49.34 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 115.869 -0.605 . . . . 63.34 109.467 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -132.19 115.47 15.75 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.602 -0.888 . . . . 75.1 108.602 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -118.03 157.88 14.96 Favored Glycine 0 C--N 1.281 -2.503 0 N-CA-C 109.99 -1.244 . . . . 62.31 109.99 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -139.53 127.54 22.28 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 117.542 0.671 . . . . 75.31 110.208 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -113.58 109.98 19.5 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.401 -0.592 . . . . 64.42 109.401 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -109.68 97.76 7.24 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.439 -0.948 . . . . 71.1 108.439 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.82 28.57 8.46 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.557 -0.905 . . . . 72.14 108.557 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 69.4 p . . . . . 0 N--CA 1.447 -0.619 0 CA-C-N 115.883 -0.599 . . . . 75.3 112.599 -175.238 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.8 t70 . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 122.071 0.939 . . . . 75.23 110.594 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.53 141.26 36.83 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.276 -0.875 . . . . 74.23 111.7 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -131.48 136.64 48.09 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 108.527 -0.916 . . . . 75.54 108.527 177.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.8 t -127.57 118.48 49.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.292 -0.633 . . . . 73.44 109.292 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -109.37 123.55 49.51 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.603 -0.517 . . . . 74.34 109.603 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -110.94 111.83 23.23 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.949 -1.5 . . . . 64.32 106.949 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.6 m -117.9 133.62 55.74 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.858 0.463 . . . . 65.35 110.45 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.83 123.62 63.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.89 -0.781 . . . . 71.21 108.89 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.51 127.49 56.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.107 -0.701 . . . . 64.4 109.107 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.52 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.43 118.47 13.74 Favored Pre-proline 0 C--N 1.286 -2.179 0 CA-C-N 116.529 -0.305 . . . . 64.13 111.477 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.94 40.46 0.36 Allowed 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 122.993 2.462 . . . . 72.31 111.935 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -117.53 -94.09 0.5 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-O 119.288 -0.387 . . . . 64.34 110.224 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 174.03 120.77 0.02 OUTLIER 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.3 0.64 . . . . 64.11 109.873 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.458 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 7.4 p -84.03 126.22 40.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.814 -0.81 . . . . 72.23 108.814 174.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.6 t -95.35 -33.46 12.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 119.775 -0.77 . . . . 74.14 110.647 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.8 m -154.48 132.37 11.58 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 108.399 -0.963 . . . . 74.45 108.399 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 t -140.53 157.85 44.88 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 110.246 -0.279 . . . . 65.03 110.246 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.529 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 26.9 t-20 -126.95 97.89 5.13 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.193 -2.151 . . . . 73.43 105.193 170.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.19 -147.43 11.11 Favored Glycine 0 N--CA 1.417 -2.601 0 N-CA-C 108.238 -1.945 . . . . 62.31 108.238 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -114.89 99.78 7.73 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 117.835 0.817 . . . . 73.12 109.476 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -80.09 113.95 18.64 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-O 121.482 0.658 . . . . 74.43 109.66 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.15 -35.52 15.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 107.454 -1.313 . . . . 73.33 107.454 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -143.46 166.5 19.54 Favored Pre-proline 0 N--CA 1.431 -1.389 0 N-CA-C 107.446 -1.316 . . . . 73.44 107.446 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -72.59 -0.05 8.26 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.342 2.028 . . . . 64.34 111.279 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 11.5 pt-20 -129.83 5.88 5.05 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.729 -0.668 . . . . 74.22 110.864 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 90.6 t -144.81 121.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.44 -0.578 . . . . 71.54 109.44 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.17 145.55 33.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 109.183 -0.673 . . . . 74.13 109.183 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -134.93 146.34 49.05 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.817 -0.808 . . . . 72.33 108.817 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 29.6 m-90 -121.95 122.35 39.16 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.295 -1.002 . . . . 73.04 108.295 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -88.07 109.5 19.91 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.173 -1.047 . . . . 75.3 108.173 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 30.9 mt -102.07 125.1 48.68 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 121.486 0.66 . . . . 75.45 110.271 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 5.4 mmpt? -118.03 150.23 47.0 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 114.903 -1.044 . . . . 64.23 110.553 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -72.07 159.46 50.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.134 1.889 . . . . 75.42 110.775 173.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.97 -35.63 2.91 Favored Glycine 0 C--N 1.312 -0.785 0 N-CA-C 111.7 -0.56 . . . . 72.33 111.7 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.28 155.06 6.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.438 -0.381 . . . . 64.04 110.139 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.6 p -113.09 116.03 51.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.055 -0.721 . . . . 71.45 109.055 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.1 m -116.3 144.47 44.2 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.01 -0.737 . . . . 74.43 109.01 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 45.0 p -115.6 152.18 33.57 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-O 121.015 0.436 . . . . 74.44 110.762 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -102.3 116.79 33.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.48 -1.304 . . . . 74.41 107.48 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 18.0 t -120.27 130.2 54.38 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 107.231 -1.396 . . . . 75.42 107.231 173.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -152.53 132.14 13.08 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 109.344 -0.613 . . . . 75.31 109.344 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -133.1 129.75 38.38 Favored 'General case' 0 C--N 1.268 -2.938 0 N-CA-C 107.511 -1.292 . . . . 75.24 107.511 174.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -150.59 155.28 39.12 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.955 -0.566 . . . . 74.51 110.097 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -87.76 125.31 34.35 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.912 -1.144 . . . . 72.23 107.912 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -132.03 123.31 27.01 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 108.986 -0.746 . . . . 71.02 108.986 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.41 113.99 2.96 Favored 'General case' 0 C--N 1.276 -2.621 0 O-C-N 124.085 0.865 . . . . 75.4 110.913 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' HA ' ' NH2' ' A' ' 114' ' ' ARG . 1.8 m-20 . . . . . 0 C--O 1.212 -0.886 0 CA-C-N 114.953 -1.021 . . . . 73.33 110.341 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 55.1 mtm180 . . . . . 0 N--CA 1.413 -2.316 0 N-CA-C 109.22 -0.659 . . . . 74.05 109.22 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.94 114.14 44.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.057 -1.46 . . . . 74.2 107.057 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -114.54 113.29 24.22 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.633 -0.877 . . . . 74.45 108.633 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -106.93 107.74 18.91 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.238 -1.393 . . . . 74.44 107.238 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 140' ' ' THR . 22.5 m -119.08 115.36 24.13 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 109.224 -0.658 . . . . 62.15 109.224 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 2.1 pp -123.41 146.47 28.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 120.39 -0.524 . . . . 75.11 110.238 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 31.5 m -123.52 121.02 34.59 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 108.468 -0.938 . . . . 63.43 108.468 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -116.06 118.63 59.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.91 0.862 . . . . 74.0 111.313 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 37' ' ' ASP . 17.9 m -87.26 148.39 44.64 Favored Pre-proline 0 N--CA 1.417 -2.12 0 CA-C-N 114.775 -1.102 . . . . 74.33 108.93 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.74 2.88 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 124.392 3.395 . . . . 72.24 113.755 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 35' ' ' SER . 8.0 t70 -91.02 1.61 56.95 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.226 1.01 . . . . 74.12 108.511 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' THR . 9.0 t70 72.48 28.73 2.21 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.015 1.726 . . . . 75.23 107.017 -176.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.56 124.5 49.42 Favored 'General case' 0 N--CA 1.389 -3.501 0 CA-C-N 113.887 -1.506 . . . . 73.2 107.688 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.62 136.17 53.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.144 -1.058 . . . . 65.55 108.144 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.3 p -141.41 160.53 39.93 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 106.131 -1.803 . . . . 54.31 106.131 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.3 -165.82 39.19 Favored Glycine 0 CA--C 1.489 -1.541 0 C-N-CA 117.826 -2.13 . . . . 71.31 113.635 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -157.08 133.58 9.92 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 123.51 0.724 . . . . 70.32 110.218 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mp -117.53 115.45 48.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 105.919 -1.882 . . . . 75.4 105.919 170.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 mm -108.41 121.37 61.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.348 -0.982 . . . . 73.03 108.348 -175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.492 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.98 108.86 16.77 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.33 -0.989 . . . . 62.11 108.33 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.11 122.87 38.4 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.762 0.315 . . . . 73.13 111.046 -176.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.66 158.96 28.9 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.665 -0.698 . . . . 64.31 110.913 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--N 1.319 -0.748 0 N-CA-C 107.49 -1.3 . . . . 73.15 107.49 171.53 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.587 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 4.1 t . . . . . 0 N--CA 1.422 -1.847 0 CA-C-O 120.396 0.141 . . . . 74.11 110.643 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.08 131.09 1.31 Allowed Glycine 0 N--CA 1.423 -2.204 0 CA-C-O 118.294 -1.281 . . . . 54.53 111.184 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -52.49 128.84 29.4 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 120.127 1.964 . . . . 73.31 109.205 169.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.04 163.39 14.92 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.903 0.705 . . . . 70.21 112.903 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 mt -121.61 124.52 44.52 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.37 -0.974 . . . . 74.42 108.37 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -112.51 90.39 3.33 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.063 0.459 . . . . 75.3 110.497 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.98 79.63 0.3 Allowed Glycine 0 C--N 1.3 -1.42 0 C-N-CA 121.021 -0.609 . . . . 70.15 111.802 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -87.88 105.18 17.25 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.685 0.755 . . . . 73.43 108.968 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.9 m -109.08 163.82 16.12 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 114.651 -1.159 . . . . 74.32 109.43 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.4 -16.91 50.25 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.744 2.296 . . . . 75.14 112.554 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -113.15 36.01 3.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.588 -0.733 . . . . 71.53 111.076 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.2 m -59.66 -29.08 67.81 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 112.463 0.542 . . . . 65.13 112.463 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' H ' ' NE2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -74.46 -7.85 54.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.912 -0.715 . . . . 74.3 111.667 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.81 -11.5 26.76 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.797 -0.446 . . . . 71.23 109.797 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.73 120.76 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 122.135 0.969 . . . . 75.11 111.847 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.48 106.43 18.4 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.451 -0.795 . . . . 73.43 108.931 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.2 t -98.24 132.25 43.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.465 -1.309 . . . . 72.43 107.465 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.9 m -144.76 165.35 28.33 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.629 0.252 . . . . 75.34 111.538 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.66 128.9 35.28 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.419 -0.956 . . . . 73.44 108.419 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 60.6 t80 -92.66 125.26 37.21 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 123.88 0.872 . . . . 74.54 109.858 -177.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -140.06 98.91 3.55 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.894 -1.15 . . . . 64.21 107.894 171.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 53.2 m -163.75 153.09 14.37 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.491 -1.3 . . . . 72.23 107.491 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.72 4.03 4.54 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.885 0.874 . . . . 72.21 111.574 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.08 0.72 73.77 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.591 -1.003 . . . . 72.45 110.591 -174.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -100.79 151.29 21.86 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 109.181 -0.674 . . . . 74.01 109.181 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.587 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.7 m -127.81 138.77 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 109.074 -0.713 . . . . 72.11 109.074 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -171.72 -153.54 9.19 Favored Glycine 0 C--N 1.277 -2.721 0 N-CA-C 110.89 -0.884 . . . . 73.45 110.89 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.4 m -140.64 145.22 36.33 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 109.812 -0.44 . . . . 51.24 109.812 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.49 155.72 43.29 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 120.586 -0.446 . . . . 74.3 110.442 177.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.47 114.35 21.12 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.695 -1.224 . . . . 73.3 107.695 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.21 113.13 43.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.691 -0.855 . . . . 74.01 108.691 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.468 ' CD2' HD11 ' A' ' 90' ' ' LEU . 54.3 p90 -113.0 164.19 13.76 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.928 -0.709 . . . . 74.32 112.4 -174.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 p -157.91 155.75 30.09 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.655 -1.157 . . . . 71.31 109.931 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 67.12 30.88 7.11 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.011 1.115 . . . . 73.34 114.011 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.468 HD11 ' CD2' ' A' ' 87' ' ' PHE . 52.1 mt -103.01 166.7 10.29 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.456 -0.498 . . . . 73.42 111.438 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 41.1 p -113.78 172.64 6.86 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.693 -0.231 . . . . 73.31 111.613 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -54.94 -37.63 66.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.626 0.77 . . . . 72.51 109.767 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.43 -25.77 62.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.094 -0.503 . . . . 74.11 111.844 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.29 -16.88 28.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.801 0.334 . . . . 72.41 111.635 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 44.0 tp -58.16 -48.11 97.63 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 113.1 0.778 . . . . 65.23 113.1 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.24 -34.96 76.76 Favored 'Trans proline' 0 C--N 1.372 1.812 0 CA-C-N 120.826 1.331 . . . . 74.23 110.794 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -64.65 -40.89 96.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.134 -0.484 . . . . 64.34 111.263 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -74.64 -19.36 60.32 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.687 -0.486 . . . . 73.03 109.687 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.97 -20.7 63.3 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.993 -0.549 . . . . 74.34 110.024 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -61.53 -57.93 10.14 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.257 -1.016 . . . . 74.13 108.257 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 33.6 ttp -56.38 -45.41 80.55 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.813 -0.631 . . . . 74.31 110.249 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -53.13 -44.54 67.79 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.086 -0.961 . . . . 74.52 111.046 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 p -68.73 -22.34 64.33 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.972 -0.691 . . . . 63.01 111.832 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.58 -25.15 67.28 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 121.192 0.52 . . . . 74.34 110.035 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.67 -11.16 16.42 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.007 -0.542 . . . . 63.55 110.432 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.55 -47.3 3.96 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.982 0.734 . . . . 73.01 112.982 -171.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.05 28.42 54.11 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.256 -0.973 . . . . 72.43 111.05 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.12 170.42 13.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 120.77 0.319 . . . . 72.25 110.682 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.68 126.28 51.57 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.822 -1.547 . . . . 75.01 106.822 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.71 134.23 53.74 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.985 -0.746 . . . . 71.34 108.985 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.2 m -144.13 142.37 30.54 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.739 -0.467 . . . . 74.0 109.739 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.93 146.4 30.12 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.321 -0.622 . . . . 73.25 109.321 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -138.03 148.54 45.2 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.74 -0.664 . . . . 72.35 110.613 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.403 ' CG ' HG22 ' A' ' 119' ' ' VAL . 6.6 mtt85 -90.1 137.75 32.09 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.5 -0.556 . . . . 74.25 109.5 171.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.415 ' O ' HG13 ' A' ' 118' ' ' ILE . 43.3 t30 -135.36 101.36 4.8 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.653 -0.869 . . . . 74.21 108.653 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.55 -106.97 2.03 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 109.935 -1.266 . . . . 52.05 109.935 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -115.96 -5.45 11.99 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.503 1.144 . . . . 70.15 108.864 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -105.25 149.54 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 115.513 -0.767 . . . . 75.01 109.62 -175.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.403 HG22 ' CG ' ' A' ' 114' ' ' ARG . 99.1 t -111.12 134.76 52.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 109.816 -0.439 . . . . 74.32 109.816 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.417 HG22 ' HG2' ' A' ' 175' ' ' GLN . 47.4 pt -108.47 137.7 38.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.048 -1.094 . . . . 74.03 108.048 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.08 131.44 49.07 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 108.988 -0.745 . . . . 70.31 108.988 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -135.52 122.03 20.68 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.291 -0.868 . . . . 72.45 109.655 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.68 136.73 8.65 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.451 -0.881 . . . . 73.33 111.533 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -121.34 137.61 54.62 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 118.001 0.901 . . . . 75.22 109.645 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -130.16 110.15 11.36 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.21 0.529 . . . . 74.22 111.11 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.69 107.4 17.42 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.129 -1.063 . . . . 64.44 108.129 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.14 21.98 16.11 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.931 0.396 . . . . 74.34 109.993 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 167' ' ' GLY . 39.2 p . . . . . 0 C--N 1.31 -1.128 0 N-CA-C 113.05 0.759 . . . . 73.23 113.05 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.0 t0 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 122.558 1.171 . . . . 75.22 109.28 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.48 154.8 17.62 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.525 -1.216 . . . . 74.41 111.097 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 8.5 m-20 -133.07 132.54 41.89 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.193 -0.317 . . . . 71.55 111.151 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 86.5 t -117.03 124.43 73.0 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 108.463 -0.94 . . . . 73.45 108.463 176.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -121.23 133.92 55.18 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.336 -0.227 . . . . 71.55 110.568 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.518 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.7 tm? -119.8 118.12 29.99 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.697 -1.964 . . . . 73.43 105.697 176.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' SER . 18.2 m -126.6 131.55 51.48 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.356 -0.609 . . . . 74.03 109.356 -177.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 65.8 t -124.87 126.59 71.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.467 -0.568 . . . . 65.35 109.467 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.09 126.17 54.79 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.33 -0.989 . . . . 75.12 108.33 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.581 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.8 p90 -134.1 120.91 15.34 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 112.576 0.584 . . . . 72.14 112.576 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 35' ' ' SER . 26.2 Cg_exo -67.83 39.64 0.2 Allowed 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 123.59 2.86 . . . . 74.41 112.798 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -124.62 -107.23 0.33 Allowed 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.529 -0.545 . . . . 75.41 109.529 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.81 129.18 0.11 Allowed 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.601 -0.889 . . . . 61.34 108.601 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.59 134.91 26.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.594 -0.891 . . . . 64.33 108.594 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.5 p -92.36 -38.52 11.98 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.229 0.537 . . . . 74.32 109.684 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.4 m -161.37 132.96 5.55 Favored 'General case' 0 C--O 1.208 -1.12 0 C-N-CA 123.212 0.605 . . . . 74.51 109.466 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.2 t -139.7 155.67 47.24 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.121 -0.632 . . . . 74.31 111.124 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -123.13 95.4 4.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 104.898 -2.26 . . . . 65.42 104.898 172.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.435 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.33 -155.51 24.48 Favored Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 107.508 -2.237 . . . . 42.32 107.508 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -107.01 99.85 9.38 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.131 0.965 . . . . 63.33 110.579 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -79.43 114.38 18.32 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.86 -0.609 . . . . 75.32 109.718 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.5 mt -80.85 -39.48 17.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.42 -1.326 . . . . 73.51 107.42 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -135.17 168.9 15.41 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 106.472 -1.677 . . . . 73.21 106.472 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.22 0.33 9.51 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.042 1.828 . . . . 64.35 109.822 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.5 pt-20 -134.89 10.03 3.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.2 -0.909 . . . . 72.43 112.109 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.9 t -145.87 120.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.813 -1.18 . . . . 72.41 107.813 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.99 147.4 32.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.87 -0.789 . . . . 73.15 108.87 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -137.63 146.65 44.17 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.318 -0.401 . . . . 72.52 110.019 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.518 ' CE3' HD12 ' A' ' 139' ' ' LEU . 22.8 m-90 -130.1 130.97 45.51 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.995 -1.113 . . . . 74.13 107.995 176.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -112.59 105.39 13.58 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.638 0.732 . . . . 75.4 110.632 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.3 mm? -94.03 134.5 36.38 Favored 'General case' 0 C--O 1.271 2.222 0 CA-C-N 115.64 -0.709 . . . . 73.45 110.493 -175.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.411 ' O ' HG21 ' A' ' 168' ' ' VAL . 1.4 tpmt? -103.31 145.65 30.99 Favored Pre-proline 0 N--CA 1.419 -2.01 0 C-N-CA 124.063 0.945 . . . . 74.4 108.98 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -68.25 157.76 60.44 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.789 2.326 . . . . 74.34 110.813 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.533 ' O ' HG23 ' A' ' 128' ' ' THR . . . 77.61 -22.39 2.74 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 121.054 -0.593 . . . . 73.22 113.483 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 165' ' ' LYS . 5.7 m -106.07 167.8 3.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.485 0.659 . . . . 71.13 111.636 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.89 135.94 53.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.833 -1.173 . . . . 73.13 107.833 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.7 m -149.05 163.9 36.21 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.626 -0.509 . . . . 75.41 109.626 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 t -139.01 146.14 40.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.403 0.62 . . . . 72.0 111.311 175.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.2 ptp -112.88 142.91 44.99 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.389 -1.278 . . . . 74.23 108.763 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.4 m -143.14 147.09 34.39 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 120.044 -0.662 . . . . 74.34 110.027 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -154.33 147.55 24.81 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 109.1 -0.704 . . . . 73.1 109.1 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.417 ' HG2' HG22 ' A' ' 120' ' ' ILE . 42.0 mt-30 -141.15 131.52 25.15 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 107.436 -1.32 . . . . 74.22 107.436 174.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.22 149.16 26.71 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.279 -1.378 . . . . 72.24 107.279 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 16.3 ptt180 -93.27 146.65 23.55 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 118.581 -1.248 . . . . 71.31 110.925 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.4 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 98.6 m-85 -142.33 129.19 20.6 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 109.316 -0.624 . . . . 70.14 109.316 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 p -67.58 121.16 15.26 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.403 -0.817 . . . . 75.33 111.317 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.31 -1.129 0 CA-C-N 115.413 -0.812 . . . . 62.13 109.238 174.174 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.0 mtp180 . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 108.126 -1.064 . . . . 75.14 108.126 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.5 t -117.09 115.02 47.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.317 -0.994 . . . . 71.5 108.317 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -115.5 120.87 40.95 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 121.074 0.464 . . . . 75.03 110.432 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -115.25 108.64 16.84 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.443 -0.947 . . . . 75.5 108.443 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.9 m -117.7 117.37 29.17 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.854 -1.165 . . . . 64.32 107.854 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -125.73 146.65 31.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 109.776 -0.453 . . . . 74.23 109.776 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.8 m -125.65 122.58 36.8 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.344 0.593 . . . . 73.55 109.908 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 tt -101.98 119.01 49.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 108.714 -0.847 . . . . 73.11 108.714 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.5 m -87.43 160.64 47.67 Favored Pre-proline 0 N--CA 1.424 -1.757 0 CA-C-N 115.658 -0.701 . . . . 75.11 110.158 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -64.92 2.1 1.52 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 123.777 2.984 . . . . 74.55 113.595 -177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.18 -7.21 57.23 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.192 -0.669 . . . . 75.53 109.192 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.4 t70 72.54 29.12 2.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 106.86 -1.533 . . . . 74.25 106.86 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.4 146.76 37.78 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.945 -1.502 . . . . 73.54 106.945 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.39 140.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-O 121.066 0.46 . . . . 54.21 110.096 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.0 p -137.22 161.82 35.15 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.624 -1.621 . . . . 72.31 106.624 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.64 -176.35 46.9 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 119.407 -1.377 . . . . 73.44 112.158 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.54 133.41 14.05 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.412 0.625 . . . . 62.2 110.273 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 65.0 mt -121.14 116.01 48.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.835 -1.172 . . . . 74.41 107.835 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.66 119.01 60.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.334 -0.617 . . . . 74.44 109.334 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.21 108.63 18.83 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.612 -1.625 . . . . 52.22 106.612 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.86 131.51 55.29 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 120.885 0.374 . . . . 71.1 111.088 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.58 158.35 44.26 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.478 -0.783 . . . . 62.22 112.763 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.6 mttt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 115.655 1.724 . . . . 75.11 115.655 168.302 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.421 -1.882 0 N-CA-C 109.789 -0.449 . . . . 60.54 109.789 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.8 97.81 0.11 Allowed Glycine 0 N--CA 1.42 -2.37 0 C-N-CA 118.846 -1.645 . . . . 52.23 113.694 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.598 ' O ' ' HB2' ' A' ' 83' ' ' SER . 74.7 Cg_exo -55.55 151.36 38.6 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.391 2.06 . . . . 75.4 109.927 166.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.83 119.66 19.48 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.758 -0.46 . . . . 71.43 109.758 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 81.9 mt -69.63 137.3 52.13 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 123.54 0.525 . . . . 74.44 110.421 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -97.34 100.04 11.49 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.452 -0.944 . . . . 70.42 108.452 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.644 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -150.24 92.28 0.14 Allowed Glycine 0 C--N 1.277 -2.721 0 C-N-CA 120.156 -1.021 . . . . 72.41 113.233 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -106.15 99.67 9.24 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.048 -1.093 . . . . 74.53 108.048 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.73 155.89 48.47 Favored Pre-proline 0 C--N 1.286 -2.182 0 CA-C-N 115.501 -0.772 . . . . 73.24 108.958 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.27 -19.08 48.48 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.911 2.407 . . . . 71.5 112.941 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -107.82 32.75 4.5 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.792 -0.64 . . . . 72.34 112.212 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.4 m -56.58 -25.64 53.1 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.552 0.215 . . . . 65.04 111.406 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -64.72 -16.83 63.49 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.116 0.484 . . . . 74.14 110.599 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -103.11 -15.81 15.94 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.676 -0.693 . . . . 72.44 110.633 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 p -123.97 118.27 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-O 122.106 0.955 . . . . 75.12 111.406 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.03 109.01 21.1 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.603 -1.181 . . . . 74.44 109.319 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.5 t -97.95 114.36 35.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.812 -1.551 . . . . 72.4 106.812 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 m -125.68 171.8 10.3 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.729 -0.668 . . . . 72.43 109.796 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -88.25 151.1 22.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.397 -1.334 . . . . 73.43 107.397 174.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 67.7 t80 -115.3 125.05 52.8 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 108.299 -1.0 . . . . 71.13 108.299 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -138.69 99.61 3.85 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.566 -2.013 . . . . 60.21 105.566 174.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 42.6 t -172.51 148.04 1.95 Allowed 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.403 -0.962 . . . . 75.1 108.403 -174.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 69.32 10.04 7.59 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.998 0.919 . . . . 63.04 111.079 174.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.02 -3.78 67.31 Favored Glycine 0 N--CA 1.423 -2.173 0 CA-C-N 115.279 -0.873 . . . . 73.14 111.782 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -104.2 146.28 29.0 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.374 0.587 . . . . 74.32 110.491 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 28.1 m -114.77 136.5 51.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 172.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.416 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -167.1 -155.17 8.89 Favored Glycine 0 C--N 1.263 -3.492 0 C-N-CA 118.863 -1.637 . . . . 52.1 112.512 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.598 ' HB2' ' O ' ' A' ' 58' ' ' PRO . 24.0 t -136.97 143.73 42.97 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 108.641 -0.874 . . . . 71.52 108.641 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -131.86 137.42 48.05 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.952 -0.567 . . . . 72.32 110.947 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.21 114.21 27.26 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.743 -1.577 . . . . 75.1 106.743 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.96 120.7 62.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.966 -1.124 . . . . 75.22 107.966 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.462 ' CD2' HD13 ' A' ' 90' ' ' LEU . 45.2 p90 -126.73 149.48 49.58 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.786 -0.765 . . . . 73.34 111.62 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.4 m -156.23 152.09 27.36 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.765 -0.652 . . . . 74.1 109.484 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.3 t70 64.46 48.75 2.62 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 122.577 1.18 . . . . 62.03 111.111 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' A' ' 87' ' ' PHE . 23.2 mt -112.07 169.88 8.54 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.041 -0.982 . . . . 74.22 108.584 175.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.504 HG21 ' OE1' ' A' ' 94' ' ' GLU . 13.1 t -128.38 -178.84 4.72 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.923 -1.111 . . . . 70.35 110.955 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -50.32 -42.84 53.35 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.329 1.452 . . . . 75.52 111.146 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.37 -27.97 69.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.46 0.541 . . . . 54.5 112.46 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.504 ' OE1' HG21 ' A' ' 91' ' ' THR . 3.9 mp0 -88.48 -17.61 29.98 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 112.559 0.577 . . . . 73.31 112.559 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.4 tp -57.62 -47.38 99.06 Favored Pre-proline 0 CA--C 1.567 1.629 0 N-CA-C 113.807 1.04 . . . . 74.13 113.807 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.64 -32.32 7.76 Favored 'Trans proline' 0 C--N 1.359 1.1 0 CA-C-N 120.72 1.293 . . . . 74.42 110.96 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -68.92 -34.68 75.78 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.992 -0.549 . . . . 75.35 111.29 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -74.16 -19.13 60.66 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.9 0.381 . . . . 75.13 110.189 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.26 -22.64 63.82 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.873 -0.603 . . . . 65.44 110.678 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -58.5 -57.87 11.02 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.638 -0.875 . . . . 72.11 108.638 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.644 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.5 ttp -54.46 -50.33 67.95 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.436 -0.802 . . . . 73.44 110.062 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -55.03 -40.07 69.81 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 114.854 -1.066 . . . . 71.31 111.367 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.9 p -69.47 -19.25 63.76 Favored 'General case' 0 N--CA 1.42 -1.967 0 C-N-CA 119.63 -0.828 . . . . 72.23 112.631 -171.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.34 -28.29 69.9 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 121.583 0.706 . . . . 72.04 110.06 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.7 -8.2 16.97 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.932 -0.577 . . . . 75.12 110.829 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.19 -34.29 7.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.557 0.947 . . . . 44.23 113.557 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.69 26.77 66.52 Favored Glycine 0 N--CA 1.46 0.264 0 N-CA-C 111.125 -0.79 . . . . 74.23 111.125 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.22 156.35 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.673 0.749 . . . . 75.1 112.376 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.426 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.7 OUTLIER -117.56 121.45 40.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.964 -2.606 . . . . 74.34 103.964 171.082 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.9 mt -123.29 134.39 54.07 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 118.382 0.537 . . . . 73.0 111.185 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.7 m -126.66 128.04 46.11 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.575 -0.898 . . . . 75.42 108.575 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 tp -125.86 125.25 42.53 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.577 -0.527 . . . . 72.44 109.577 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -138.02 145.76 42.24 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.663 -0.495 . . . . 73.5 109.663 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -98.85 137.95 36.68 Favored 'General case' 0 N--CA 1.399 -3.008 0 N-CA-C 107.71 -1.219 . . . . 74.1 107.71 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.401 ' O ' HG13 ' A' ' 118' ' ' ILE . 46.8 t30 -124.77 87.08 2.65 Favored 'General case' 0 C--N 1.269 -2.897 0 N-CA-C 107.469 -1.308 . . . . 75.14 107.469 -177.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.52 -115.99 5.57 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.576 -1.41 . . . . 63.22 109.576 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -104.95 -1.88 25.27 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.106 0.955 . . . . 74.24 108.889 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.416 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -101.84 148.99 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.799 -1.186 . . . . 75.21 107.799 179.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.1 t -117.28 138.53 47.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 O-C-N 121.762 -0.586 . . . . 72.12 110.59 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.5 pt -120.5 135.49 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-O 121.542 0.687 . . . . 75.15 109.81 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.9 tt -128.18 127.0 42.11 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.351 -1.351 . . . . 64.04 107.351 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.99 139.58 41.55 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.671 -0.863 . . . . 74.21 108.671 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.98 -175.57 34.99 Favored Glycine 0 N--CA 1.402 -3.625 0 C-N-CA 120.345 -0.931 . . . . 61.03 111.472 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -145.47 157.3 44.03 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.117 -1.068 . . . . 72.13 108.117 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.3 109.54 11.56 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.797 -0.446 . . . . 53.52 109.797 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -112.7 93.63 4.52 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.641 -0.874 . . . . 53.25 108.641 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.348 0.0 OUTLIER -125.36 54.64 1.45 Allowed 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 124.257 1.979 . . . . 74.3 109.677 176.065 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 N--CA 1.427 -1.599 0 CA-C-N 112.235 -2.257 . . . . 74.41 111.499 -175.474 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 120.929 0.395 . . . . 75.44 110.521 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.69 129.17 45.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.221 -0.445 . . . . 72.13 111.73 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -133.76 127.08 32.02 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.27 -1.011 . . . . 64.52 108.27 171.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 66.3 t -114.53 112.97 42.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.94 -1.133 . . . . 64.21 107.94 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -107.51 122.07 45.91 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.612 -0.514 . . . . 71.51 109.612 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.532 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.8 tm? -111.8 119.16 37.66 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.383 -1.71 . . . . 74.04 106.383 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.1 m -126.8 130.58 50.53 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.328 -0.619 . . . . 73.13 109.328 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 85.0 t -122.67 124.83 71.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.259 -0.645 . . . . 73.21 109.259 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.21 127.34 55.57 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.383 -0.599 . . . . 70.35 109.383 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.472 ' C ' ' H ' ' A' ' 145' ' ' ALA . 2.9 p90 -134.55 117.16 13.08 Favored Pre-proline 0 C--N 1.287 -2.128 0 CA-C-N 116.232 -0.44 . . . . 75.11 111.207 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.49 27.32 0.14 Allowed 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 122.846 2.364 . . . . 72.4 113.234 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -106.63 -92.34 0.4 Allowed 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.036 -0.728 . . . . 74.31 109.036 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.22 131.07 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.537 1.135 . . . . 73.2 107.987 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.92 137.95 20.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.689 -0.856 . . . . 72.43 108.689 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.7 p -91.94 -45.78 8.17 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.391 -0.596 . . . . 65.34 109.391 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.1 m -150.24 132.95 15.89 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.373 -0.83 . . . . 74.23 109.119 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.404 ' OG1' HG12 ' A' ' 160' ' ' VAL . 6.9 t -139.07 159.34 42.37 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.677 -0.64 . . . . 62.22 110.248 175.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 25.5 t-20 -131.01 97.91 4.44 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 104.723 -2.325 . . . . 75.12 104.723 172.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.459 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.69 -141.81 6.59 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.167 -1.573 . . . . 72.4 109.167 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -118.65 99.07 6.55 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 117.587 0.693 . . . . 70.41 110.129 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -75.16 130.33 39.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.853 -0.53 . . . . 75.23 111.087 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 61.1 mt -90.32 -48.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.65 -1.611 . . . . 72.23 106.65 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -136.28 171.94 7.9 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.136 -1.801 . . . . 74.24 106.136 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -75.97 -1.56 11.56 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.594 1.529 . . . . 51.34 111.082 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.27 1.96 7.8 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.707 -0.679 . . . . 72.45 111.457 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 68.1 t -143.77 120.96 5.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.576 -0.898 . . . . 64.55 108.576 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.404 HG12 ' OG1' ' A' ' 150' ' ' THR . 56.7 t -123.98 148.3 28.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.06 -0.719 . . . . 74.43 109.06 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -135.93 151.42 49.94 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.174 -0.676 . . . . 75.12 109.174 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.532 ' CE3' HD12 ' A' ' 139' ' ' LEU . 26.3 m-90 -132.47 128.68 37.94 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.222 -1.399 . . . . 64.41 107.222 175.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.17 105.29 15.2 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.919 0.866 . . . . 75.25 110.681 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.3 mp -87.8 130.56 34.82 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.478 -1.237 . . . . 74.54 109.664 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -118.15 146.89 40.33 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 115.204 -0.907 . . . . 74.02 111.144 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 168' ' ' VAL . 56.7 Cg_endo -65.93 149.86 86.04 Favored 'Trans proline' 0 N--CA 1.476 0.448 0 C-N-CA 123.389 2.726 . . . . 64.14 111.985 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.71 -27.43 2.57 Favored Glycine 0 C--N 1.308 -1.027 0 C-N-CA 121.218 -0.515 . . . . 75.24 113.169 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.401 ' H ' ' C ' ' A' ' 166' ' ' PRO . 28.5 m -105.57 154.44 6.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.198 0.523 . . . . 72.13 111.275 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 p -98.08 143.87 12.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.926 -0.768 . . . . 75.43 108.926 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 30.7 m -134.38 153.69 51.76 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.653 -0.499 . . . . 71.51 109.653 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.1 p -106.94 153.77 22.06 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.702 0.287 . . . . 75.52 111.063 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 40.1 tpp -124.95 116.87 22.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.031 -0.729 . . . . 75.45 109.031 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 8.3 t -143.57 132.5 22.8 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.022 -1.071 . . . . 74.44 109.876 172.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.83 122.94 8.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.759 -0.83 . . . . 73.33 108.759 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -127.94 132.01 49.28 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.635 -0.876 . . . . 74.32 108.635 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -156.75 158.09 36.26 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.902 -0.407 . . . . 43.03 109.902 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.416 ' HG2' HG22 ' A' ' 118' ' ' ILE . 70.2 mtp180 -89.13 136.66 32.89 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.756 -0.461 . . . . 74.55 109.756 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -142.68 128.39 19.26 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 109.472 -0.566 . . . . 65.24 109.472 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 12.8 p -56.38 109.96 0.69 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 124.231 0.957 . . . . 73.44 112.727 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 CA--C 1.51 -0.592 0 O-C-N 123.951 0.782 . . . . 72.5 109.476 177.363 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 28.8 ttm180 . . . . . 0 N--CA 1.412 -2.334 0 N-CA-C 109.09 -0.707 . . . . 74.0 109.09 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.36 113.77 45.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 105.543 -2.021 . . . . 74.53 105.543 176.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 35.1 ttt180 -126.34 118.65 25.48 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-O 121.504 0.668 . . . . 74.24 110.369 -177.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.94 109.84 19.52 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.677 -1.147 . . . . 75.33 108.054 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.4 m -110.94 115.42 29.48 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 107.42 -1.326 . . . . 75.12 107.42 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -127.8 146.3 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 109.532 -0.544 . . . . 70.31 109.532 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.6 m -124.42 125.03 43.59 Favored 'General case' 0 C--N 1.272 -2.803 0 CA-C-N 115.928 -0.578 . . . . 64.42 109.596 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.9 tt -114.92 124.79 71.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.531 0.681 . . . . 74.13 109.62 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m -100.07 157.36 34.0 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 115.75 -0.659 . . . . 74.24 110.674 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -58.24 -2.51 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 124.355 3.37 . . . . 64.23 113.476 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -82.08 -0.19 43.41 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 125.278 1.431 . . . . 65.2 110.732 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.2 t70 66.86 29.81 8.14 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.855 -1.535 . . . . 71.53 106.855 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -120.92 136.95 54.82 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 112.999 -1.909 . . . . 74.12 108.602 -175.026 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.35 137.19 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 115.106 -0.952 . . . . 72.12 109.3 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.3 p -138.49 149.9 45.88 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.681 -1.229 . . . . 65.24 107.681 174.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.09 -175.7 47.43 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 118.012 -2.042 . . . . 43.03 113.884 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.99 133.73 28.85 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.348 -0.926 . . . . 60.43 108.879 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.5 mt -121.19 116.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 107.776 -1.194 . . . . 72.34 107.776 176.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -120.08 115.54 47.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 120.762 0.315 . . . . 74.02 110.247 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.92 108.21 19.26 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.444 -1.687 . . . . 74.52 106.444 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.42 ' HB1' ' CB ' ' A' ' 80' ' ' TYR . . . -122.82 126.22 46.96 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.309 0.576 . . . . 72.42 112.511 -172.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.98 157.81 21.97 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.573 -0.899 . . . . 53.34 108.573 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 tttp . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 106.706 -1.591 . . . . 74.53 106.706 178.266 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.44 -0.929 0 CA-C-O 121.162 0.506 . . . . 73.01 110.817 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.518 ' HA3' ' ND2' ' A' ' 74' ' ' ASN . . . 172.31 97.62 0.11 Allowed Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.678 -0.772 . . . . 65.12 111.547 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.28 159.4 52.43 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.18 1.92 . . . . 73.5 110.836 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.23 154.13 33.87 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.574 -0.528 . . . . 75.2 109.574 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -68.95 145.97 53.17 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 120.95 0.405 . . . . 73.5 111.52 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -112.52 108.88 18.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.281 -0.872 . . . . 64.53 109.187 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.9 -72.55 0.01 OUTLIER Glycine 0 C--N 1.265 -3.369 0 C-N-CA 120.194 -1.003 . . . . 75.31 112.103 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 71.17 124.54 0.03 OUTLIER 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.392 1.077 . . . . 61.34 110.519 -173.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.67 162.15 56.69 Favored Pre-proline 0 C--N 1.293 -1.877 0 CA-C-N 115.222 -0.899 . . . . 64.34 108.911 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.79 -16.25 47.77 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 122.882 2.388 . . . . 74.43 113.187 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -116.01 48.66 1.2 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.429 0.633 . . . . 74.2 111.786 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m -55.85 -37.43 68.74 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.53 0.567 . . . . 75.14 112.53 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -67.56 -11.57 58.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.5 0.667 . . . . 73.11 111.426 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -95.56 -18.02 20.93 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.577 -0.738 . . . . 71.3 110.176 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.6 119.76 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.913 0.863 . . . . 71.02 111.66 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.62 111.48 23.81 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.545 -0.752 . . . . 75.25 109.575 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.28 139.25 20.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.096 -1.075 . . . . 73.24 108.096 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -150.9 170.3 19.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.196 0.522 . . . . 71.25 110.948 -170.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.518 ' ND2' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -84.16 128.98 34.91 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.122 -1.436 . . . . 71.32 107.122 178.384 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 88.3 t80 -108.83 122.05 46.37 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.61 -0.436 . . . . 72.43 110.279 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -138.77 109.49 6.65 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.913 -1.143 . . . . 72.34 107.913 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 46.6 t -168.68 147.61 4.21 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.657 -0.701 . . . . 71.4 109.329 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.87 19.28 11.66 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.644 0.979 . . . . 74.11 113.644 171.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.87 0.31 62.24 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 120.543 -0.836 . . . . 64.52 111.794 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . 49.9 m-85 -104.77 161.14 14.42 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 120.755 0.312 . . . . 65.12 110.181 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.98 136.46 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 106.049 -1.834 . . . . 75.11 106.049 163.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.82 -155.22 9.51 Favored Glycine 0 N--CA 1.408 -3.207 0 C-N-CA 119.605 -1.283 . . . . 72.11 112.957 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 m -118.12 141.36 48.57 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 114.531 -0.835 . . . . 54.41 109.918 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.42 148.72 47.92 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.702 -0.799 . . . . 75.54 111.132 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -131.81 115.1 15.52 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.427 -1.323 . . . . 53.13 107.427 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.1 t -108.74 117.82 54.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.386 -0.968 . . . . 72.25 108.386 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 90' ' ' LEU . 51.2 p90 -121.05 151.91 39.26 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.069 0.461 . . . . 71.4 110.651 -175.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -155.36 160.41 40.68 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.223 -0.444 . . . . 74.15 111.383 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 60.93 30.2 19.48 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.895 1.278 . . . . 74.55 110.867 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.435 HD12 ' CD2' ' A' ' 87' ' ' PHE . 17.7 mt -87.79 161.08 17.76 Favored 'General case' 0 N--CA 1.413 -2.301 0 CA-C-N 115.914 -0.584 . . . . 74.04 109.62 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -122.53 177.6 5.35 Favored 'General case' 0 C--N 1.258 -3.375 0 N-CA-C 109.311 -0.626 . . . . 73.42 109.311 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -55.9 -35.42 66.52 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 123.977 0.911 . . . . 73.45 111.776 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.66 -26.29 62.48 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.27 0.557 . . . . 63.32 111.861 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 90' ' ' LEU . 46.4 mt-10 -88.26 -20.49 25.39 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.032 0.444 . . . . 75.32 109.855 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 54.9 tp -58.91 -54.69 53.96 Favored Pre-proline 0 CA--C 1.566 1.577 0 N-CA-C 114.453 1.279 . . . . 72.33 114.453 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -74.11 -28.34 10.97 Favored 'Trans proline' 0 C--N 1.362 1.276 0 CA-C-N 121.23 1.475 . . . . 74.13 110.292 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -70.03 -29.61 66.69 Favored 'General case' 0 N--CA 1.402 -2.845 0 CA-C-N 114.932 -1.031 . . . . 72.14 110.842 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -75.82 -22.69 56.06 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 109.388 -0.597 . . . . 74.5 109.388 175.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -17.72 62.42 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.812 -0.631 . . . . 64.35 111.118 -175.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -63.61 -57.61 9.54 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.912 -0.773 . . . . 74.32 108.912 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 38.6 ttp -59.86 -47.44 85.72 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.641 -0.708 . . . . 75.3 110.386 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -57.51 -29.78 64.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.077 -0.965 . . . . 73.02 111.144 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -60.91 -37.35 81.97 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.889 -0.411 . . . . 62.43 109.889 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.5 -20.5 65.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.258 0.551 . . . . 73.14 111.073 -175.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.59 -21.27 15.33 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 120.282 -0.567 . . . . 74.44 110.826 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.42 -47.95 3.81 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.103 -0.639 . . . . 75.41 112.166 -171.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.03 12.1 60.64 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 121.014 -0.612 . . . . 72.12 111.787 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.5 m -106.64 162.65 5.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 120.81 0.338 . . . . 74.12 110.832 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -123.07 125.22 44.79 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.613 -0.884 . . . . 74.2 108.613 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 87.4 mt -125.77 111.73 15.23 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 110.007 -0.368 . . . . 73.12 110.007 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.6 t -105.45 138.29 41.88 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.076 -1.453 . . . . 72.41 107.076 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 pp -149.96 153.95 37.44 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.968 -0.693 . . . . 74.4 112.248 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -158.58 167.85 28.49 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.316 -1.311 . . . . 73.53 110.245 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.407 ' HG3' HG21 ' A' ' 119' ' ' VAL . 5.4 ttt180 -112.71 138.2 49.89 Favored 'General case' 0 N--CA 1.389 -3.506 0 N-CA-C 107.645 -1.243 . . . . 75.21 107.645 172.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -115.29 89.79 3.18 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 106.625 -1.621 . . . . 70.23 106.625 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.32 -103.83 1.01 Allowed Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.661 -0.976 . . . . 60.13 110.661 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -99.79 -24.71 14.6 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.83 0.824 . . . . 73.03 110.333 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -96.13 140.11 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 C-N-CA 118.664 -1.214 . . . . 73.22 109.607 -173.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.407 HG21 ' HG3' ' A' ' 114' ' ' ARG . 90.2 t -102.27 136.29 35.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.53 0 N-CA-C 109.617 -0.512 . . . . 73.2 109.617 -177.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.1 pt -117.7 133.36 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 121.642 0.734 . . . . 75.55 109.924 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 tt -128.22 122.33 31.54 Favored 'General case' 0 C--N 1.273 -2.747 0 N-CA-C 107.873 -1.158 . . . . 65.13 107.873 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.34 127.27 37.3 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.755 -0.831 . . . . 73.44 108.755 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.62 -178.74 23.96 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 119.56 -1.305 . . . . 43.42 112.434 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.1 mtp85 -144.23 155.58 43.94 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 123.986 0.915 . . . . 74.11 109.103 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.73 108.47 11.55 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 107.067 -1.457 . . . . 74.31 107.067 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -107.31 92.35 4.04 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.742 -1.207 . . . . 73.24 107.742 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.4 mt -120.7 12.11 11.35 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.803 -1.544 . . . . 75.32 108.811 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.421 ' HA ' ' CA ' ' A' ' 167' ' ' GLY . 1.3 m . . . . . 0 C--N 1.291 -1.969 0 CA-C-N 114.71 -1.132 . . . . 73.21 112.11 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 121.03 0.443 . . . . 73.42 110.938 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.28 145.22 11.3 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.519 1.127 . . . . 63.51 113.855 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 2.5 m-20 -125.89 120.04 29.38 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-N 115.248 -0.887 . . . . 61.3 109.088 176.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 69.3 t -106.69 113.11 42.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.96 -1.126 . . . . 71.41 107.96 174.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 44.7 mt-10 -108.37 120.73 43.24 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.268 -0.642 . . . . 65.41 109.268 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.464 HD13 ' CE3' ' A' ' 162' ' ' TRP . 2.9 tm? -111.03 118.08 35.08 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 105.302 -2.11 . . . . 74.34 105.302 175.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.2 m -123.39 125.38 44.87 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.555 -0.535 . . . . 72.44 109.555 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 98.1 t -118.46 125.21 74.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.471 -0.566 . . . . 72.41 109.471 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.99 127.68 56.29 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.658 -0.867 . . . . 63.52 108.658 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.676 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.6 p90 -134.76 120.81 14.55 Favored Pre-proline 0 C--N 1.287 -2.124 0 CA-C-N 116.589 -0.278 . . . . 74.21 111.359 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.8 40.62 0.36 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.605 2.204 . . . . 71.52 112.523 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -125.5 -110.03 0.31 Allowed 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.86 -0.609 . . . . 65.12 109.531 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -176.32 131.51 0.22 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.578 -0.526 . . . . 73.15 109.578 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.97 144.23 10.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.304 -0.862 . . . . 72.0 109.316 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.4 t -110.22 -30.67 7.63 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.457 -0.497 . . . . 71.41 110.457 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.6 m -156.64 131.82 9.18 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.66 -0.867 . . . . 73.41 108.66 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.5 t -139.74 161.2 38.11 Favored 'General case' 0 C--N 1.285 -2.2 0 O-C-N 122.022 -0.424 . . . . 61.25 110.569 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -133.19 87.63 2.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 104.845 -2.28 . . . . 74.12 104.845 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.27 -144.54 8.05 Favored Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 108.905 -1.678 . . . . 65.32 108.905 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -118.28 107.73 14.26 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 118.112 0.956 . . . . 71.23 111.407 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -82.08 118.02 22.71 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.484 0.659 . . . . 64.22 110.307 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.89 -40.01 16.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.186 -1.412 . . . . 74.1 107.186 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -137.18 167.15 22.1 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 106.461 -1.681 . . . . 74.22 106.461 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.07 -0.21 8.76 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.896 1.731 . . . . 72.14 110.947 177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.676 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 7.8 pt-20 -130.73 3.72 4.53 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.006 -0.997 . . . . 73.35 111.329 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.42 121.39 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.132 -0.692 . . . . 75.23 109.132 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.32 143.66 39.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.226 -0.657 . . . . 75.12 109.226 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.96 151.46 52.06 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.363 -0.606 . . . . 74.53 109.363 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.464 ' CE3' HD13 ' A' ' 139' ' ' LEU . 28.0 m-90 -132.68 128.62 37.4 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.24 -0.652 . . . . 74.34 109.24 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -100.14 113.66 26.47 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.372 0.606 . . . . 74.12 109.796 171.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 22.4 mt -102.09 133.18 47.35 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.468 -0.938 . . . . 74.42 108.468 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -117.93 145.45 36.76 Favored Pre-proline 0 C--N 1.309 -1.168 0 CA-C-N 115.935 -0.575 . . . . 74.41 112.117 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 168' ' ' VAL . 24.2 Cg_exo -68.24 161.44 44.61 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.574 2.183 . . . . 73.52 110.705 173.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 128' ' ' THR . . . 68.79 -9.93 1.74 Allowed Glycine 0 N--CA 1.472 1.072 0 N-CA-C 114.381 0.512 . . . . 65.12 114.381 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.426 ' H ' ' C ' ' A' ' 166' ' ' PRO . 34.2 m -120.66 171.09 9.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.484 -0.561 . . . . 64.53 109.484 173.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.88 142.02 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.624 -0.88 . . . . 74.1 108.624 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 40.9 m -140.81 143.74 35.0 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.91 -0.494 . . . . 72.14 110.905 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.8 p -108.12 141.14 40.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.368 -0.604 . . . . 74.15 109.368 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 80.4 mtp -123.66 130.03 52.02 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.276 -0.639 . . . . 74.52 109.276 -175.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.5 m -143.74 140.18 29.83 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.902 -0.719 . . . . 74.14 110.806 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . . . -147.64 120.44 8.68 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.044 -1.095 . . . . 74.24 108.044 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -127.73 130.15 48.3 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 107.632 -1.247 . . . . 75.51 107.632 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.33 153.69 38.97 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.733 -0.469 . . . . 71.5 109.733 -175.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 48.9 mtm180 -96.66 126.26 41.7 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.983 -0.747 . . . . 75.01 108.983 -176.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -134.01 150.03 51.22 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.34 -0.985 . . . . 75.43 108.34 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.99 108.57 1.24 Allowed 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 120.971 0.415 . . . . 75.24 110.931 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 . . . . . 0 N--CA 1.434 -1.273 0 N-CA-C 113.564 0.95 . . . . 73.42 113.564 -177.417 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 16.6 ptp180 . . . . . 0 N--CA 1.418 -2.071 0 CA-C-O 121.245 0.545 . . . . 73.22 110.44 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.09 114.66 47.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.42 -0.809 . . . . 73.53 108.906 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -115.58 114.18 24.6 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.441 -0.799 . . . . 73.42 109.475 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.54 108.77 18.84 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 107.66 -1.237 . . . . 63.52 107.66 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.3 t -119.71 115.36 23.75 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.989 -1.115 . . . . 75.15 107.989 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -127.98 147.17 32.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.157 0.503 . . . . 63.24 110.089 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.8 m -129.29 132.73 47.21 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 109.742 -0.466 . . . . 71.21 109.742 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.529 ' O ' ' HD2' ' A' ' 144' ' ' PRO . 10.8 tt -118.61 111.12 32.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.952 0.882 . . . . 74.52 111.023 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.2 m -76.62 163.97 62.5 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 114.177 -1.374 . . . . 70.51 111.214 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.67 0.61 5.32 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.865 2.377 . . . . 73.12 113.323 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -91.46 -0.49 57.63 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.026 -1.102 . . . . 61.55 108.026 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.6 ' O ' ' HA ' ' A' ' 91' ' ' THR . 25.6 t70 67.79 33.45 4.83 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.612 -1.625 . . . . 73.2 106.612 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -97.73 124.65 42.16 Favored 'General case' 0 N--CA 1.391 -3.411 0 CA-C-N 113.082 -1.872 . . . . 74.43 106.541 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.0 t -110.34 129.7 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 108.549 -0.908 . . . . 70.42 108.549 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.1 p -139.92 144.21 37.01 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 107.443 -1.317 . . . . 65.43 107.443 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.07 -174.77 41.18 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 118.861 -1.638 . . . . 72.14 112.412 -177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -145.27 133.37 21.49 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.011 -0.594 . . . . 70.52 109.879 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.0 mt -118.86 115.69 48.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 106.977 -1.49 . . . . 74.14 106.977 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.31 116.05 51.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.723 -0.473 . . . . 74.33 109.723 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -108.22 108.32 19.31 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.689 -1.597 . . . . 73.24 106.689 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 129.46 54.07 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.692 0.282 . . . . 75.33 111.024 -176.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.84 144.02 49.48 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.519 -0.919 . . . . 73.33 108.519 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 tttp . . . . . 0 C--N 1.292 -1.93 0 N-CA-C 107.746 -1.205 . . . . 74.32 107.746 177.4 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.43 -1.449 0 CA-C-O 121.019 0.438 . . . . 74.44 109.863 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.64 97.11 0.11 Allowed Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.778 -0.725 . . . . 75.33 113.081 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -73.13 160.55 45.22 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.355 2.703 . . . . 74.55 110.844 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -131.24 133.93 45.93 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.863 -0.421 . . . . 71.31 109.863 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.465 ' O ' HG11 ' A' ' 72' ' ' VAL . 94.6 mt -75.82 140.87 42.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.754 -0.461 . . . . 73.43 109.754 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -111.63 99.86 8.51 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.226 0.536 . . . . 34.02 109.557 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.652 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -115.01 94.77 0.68 Allowed Glycine 0 C--N 1.274 -2.914 0 N-CA-C 110.952 -0.859 . . . . 70.44 110.952 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.54 96.55 10.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.956 -0.757 . . . . 74.21 108.956 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.91 161.61 45.76 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.203 -0.908 . . . . 70.34 109.145 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.68 -26.68 82.91 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.443 2.095 . . . . 63.35 111.313 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.73 41.96 1.43 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.419 -0.809 . . . . 71.22 111.905 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.1 m -59.5 -28.09 66.73 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 111.72 0.267 . . . . 74.33 111.72 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -66.58 -18.6 65.45 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.421 0.629 . . . . 71.4 110.824 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -89.64 -19.81 24.43 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.61 -0.723 . . . . 74.31 109.993 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.67 121.19 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.855 0.835 . . . . 74.41 112.552 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.14 114.48 28.81 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.08 -0.963 . . . . 71.22 108.843 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 60' ' ' LEU . 58.1 t -98.27 141.52 16.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.004 -1.11 . . . . 75.32 108.004 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 m -148.51 167.93 24.07 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.275 -0.639 . . . . 71.14 109.275 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -82.76 154.12 24.92 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.446 -1.316 . . . . 71.01 107.446 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 75.2 t80 -116.65 124.55 50.01 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 109.281 -0.637 . . . . 73.3 109.281 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -138.62 99.6 3.86 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.013 -1.106 . . . . 74.41 108.013 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.2 m -156.59 137.9 13.83 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.238 -0.437 . . . . 74.03 110.014 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.03 0.41 2.38 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.182 1.393 . . . . 74.44 112.893 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.34 9.83 43.36 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.876 -1.154 . . . . 71.25 111.23 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -105.04 142.5 34.72 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.368 -0.975 . . . . 73.14 108.368 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 33.8 m -124.09 136.79 59.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.315 -0.994 . . . . 74.53 108.315 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -165.6 -155.14 8.47 Favored Glycine 0 C--N 1.262 -3.583 0 C-N-CA 119.077 -1.535 . . . . 44.44 111.791 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 p -128.75 137.4 51.54 Favored 'General case' 0 C--N 1.267 -3.011 0 O-C-N 124.43 0.723 . . . . 75.32 110.354 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.12 146.09 50.81 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 120.815 0.34 . . . . 73.14 110.897 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -124.41 115.03 20.29 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.55 -1.278 . . . . 62.53 107.55 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.0 t -108.03 119.39 57.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 107.712 -1.218 . . . . 72.31 107.712 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.47 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.1 p90 -118.2 155.98 29.57 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.689 -0.404 . . . . 73.43 111.137 -175.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.4 p -156.53 157.63 35.74 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.791 -0.64 . . . . 73.23 110.488 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 63.98 35.12 10.93 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.59 1.186 . . . . 74.05 111.319 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.47 HD12 ' CD2' ' A' ' 87' ' ' PHE . 52.7 mt -96.9 167.11 11.29 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.728 -0.669 . . . . 73.32 110.34 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 4.9 t -126.3 169.99 12.35 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.521 -1.659 . . . . 72.54 106.521 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -57.14 -33.53 67.49 Favored 'General case' 0 C--O 1.205 -1.279 0 CA-C-N 118.928 0.786 . . . . 73.13 112.443 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.57 -29.67 70.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.707 0.765 . . . . 72.44 111.304 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.03 -16.82 34.5 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.536 -0.756 . . . . 72.14 110.318 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.65 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 51.5 tp -62.31 -54.84 45.53 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 114.053 1.131 . . . . 74.21 114.053 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.32 -33.59 69.99 Favored 'Trans proline' 0 C--N 1.368 1.6 0 CA-C-N 121.357 1.52 . . . . 70.45 110.598 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.68 -35.08 78.18 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-N 114.882 -1.054 . . . . 75.11 110.755 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.7 pp -78.24 -20.13 52.33 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.909 -0.774 . . . . 74.31 108.909 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.64 -21.24 62.64 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.636 -0.711 . . . . 73.23 110.691 -174.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -58.87 -57.11 14.5 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 108.468 -0.938 . . . . 75.32 108.468 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.652 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 35.4 ttp -55.44 -47.25 76.29 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.2 -0.909 . . . . 72.24 110.508 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -54.75 -39.25 68.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.354 -0.839 . . . . 74.14 110.671 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 m -66.79 -27.64 67.75 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.311 -0.404 . . . . 75.01 111.355 -174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -70.66 -17.46 62.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.369 0.604 . . . . 73.24 110.42 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.28 -9.72 16.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.97 -0.559 . . . . 72.32 110.46 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.71 -44.82 4.56 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.512 0.56 . . . . 74.1 112.512 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.93 27.2 42.15 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 110.492 -1.043 . . . . 70.3 110.492 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.75 155.64 20.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.479 -0.934 . . . . 62.12 108.479 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.429 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 39.5 t30 -103.99 121.5 43.29 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.865 -1.161 . . . . 73.34 107.865 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -108.87 137.65 46.46 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 123.304 0.377 . . . . 74.14 110.689 -177.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -144.24 116.94 8.69 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.414 -0.958 . . . . 74.53 108.414 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -144.57 149.94 36.67 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.806 -0.559 . . . . 74.13 110.785 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -151.19 157.99 43.37 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 124.47 1.106 . . . . 73.21 111.065 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.429 ' HD3' HG23 ' A' ' 119' ' ' VAL . 2.0 tpp180 -94.33 109.07 20.93 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.438 -1.319 . . . . 73.43 107.438 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -93.03 92.21 7.72 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.133 -1.062 . . . . 75.33 108.133 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.57 -115.48 5.64 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.601 -1.4 . . . . 73.11 109.601 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -108.64 3.27 22.66 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.707 1.241 . . . . 70.22 109.223 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 pp -112.05 149.54 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 121.066 -1.021 . . . . 64.24 108.675 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.616 HG21 ' CD2' ' A' ' 178' ' ' TYR . 76.5 t -106.89 139.34 28.74 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 O-C-N 121.76 -0.588 . . . . 72.01 111.407 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 120' ' ' ILE . 2.8 pp -119.45 119.34 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 107.186 -1.413 . . . . 70.31 107.186 174.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 tt -125.34 130.0 51.08 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.862 -0.421 . . . . 73.24 109.862 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -131.84 151.87 51.39 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.548 0.69 . . . . 71.21 110.376 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -151.07 129.93 3.03 Favored Glycine 0 N--CA 1.407 -3.268 0 N-CA-C 108.712 -1.755 . . . . 65.43 108.712 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.5 mtt180 -116.25 125.41 52.18 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.33 -0.989 . . . . 72.41 108.33 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -108.51 123.26 48.63 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.449 -0.796 . . . . 72.02 112.331 -171.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -96.13 93.7 7.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.158 -1.423 . . . . 63.15 107.158 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -101.69 2.1 38.26 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.102 -0.703 . . . . 72.13 109.102 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 167' ' ' GLY . 23.4 p . . . . . 0 N--CA 1.426 -1.671 0 CA-C-N 116.235 -0.438 . . . . 74.43 111.074 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 . . . . . 0 C--O 1.242 0.696 0 N-CA-C 113.346 0.869 . . . . 74.52 113.346 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.44 135.9 42.32 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.416 0.15 . . . . 64.04 110.664 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.1 t70 -131.93 125.0 30.57 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.445 -0.576 . . . . 73.41 109.445 176.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 86.9 t -114.62 119.82 62.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 107.943 -1.132 . . . . 73.42 107.943 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -129.75 121.32 26.64 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.055 0.455 . . . . 74.1 110.501 -174.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.574 HD13 ' CE3' ' A' ' 162' ' ' TRP . 2.1 tm? -116.99 121.3 40.97 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.84 -1.541 . . . . 74.04 106.84 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.3 m -126.63 130.34 50.28 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.474 -0.565 . . . . 71.1 109.474 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.3 t -129.01 128.87 67.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 109.567 -0.531 . . . . 72.05 109.567 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -119.17 124.72 47.5 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.251 -0.648 . . . . 74.33 109.251 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.551 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.5 p90 -134.42 113.35 12.12 Favored Pre-proline 0 C--N 1.288 -2.108 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.178 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 58.0 Cg_endo -68.67 30.79 0.16 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.086 2.524 . . . . 72.11 114.039 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.55 -95.18 0.36 Allowed 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.92 -0.77 . . . . 64.15 108.92 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 178.68 126.06 0.06 Allowed 'General case' 0 C--O 1.249 1.076 0 N-CA-C 109.542 -0.54 . . . . 53.31 109.542 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.37 139.15 18.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.465 -1.309 . . . . 75.54 107.465 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.0 t -104.47 -30.16 10.23 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.33 -0.948 . . . . 75.43 110.016 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.0 m -157.49 132.3 8.67 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.138 -1.06 . . . . 75.03 108.138 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -139.94 151.63 45.71 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.662 -0.649 . . . . 72.51 112.292 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -118.67 85.81 2.43 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 105.7 -1.963 . . . . 71.41 105.7 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.444 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 173.88 -151.11 12.56 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 108.458 -1.857 . . . . 63.23 108.458 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -114.59 106.28 14.07 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 118.352 1.076 . . . . 72.42 109.596 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -80.43 123.76 28.32 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.099 -0.955 . . . . 73.54 110.534 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 67.5 mt -88.49 -47.74 15.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.232 -1.396 . . . . 75.41 107.232 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -134.63 169.75 13.03 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 106.992 -1.485 . . . . 72.05 106.992 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -73.34 -0.19 8.86 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.981 1.787 . . . . 64.42 111.322 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.2 pt-20 -130.27 3.52 4.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.456 0.646 . . . . 72.23 111.401 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.09 121.09 14.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 108.735 -0.839 . . . . 72.33 108.735 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.0 144.4 38.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.865 -0.791 . . . . 75.14 108.865 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -138.15 144.88 40.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.592 -0.522 . . . . 74.34 109.592 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.574 ' CE3' HD13 ' A' ' 139' ' ' LEU . 28.0 m-90 -122.85 124.98 44.51 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.238 -0.652 . . . . 73.34 109.238 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -105.83 107.2 18.07 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.059 0.933 . . . . 74.24 109.413 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.7 mm? -101.37 120.5 40.36 Favored 'General case' 0 C--O 1.26 1.642 0 CA-C-N 114.803 -1.09 . . . . 72.54 110.14 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -103.65 146.2 32.05 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 115.633 -0.712 . . . . 73.42 110.986 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 168' ' ' VAL . 68.9 Cg_endo -72.06 155.26 57.27 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 123.035 2.49 . . . . 74.52 111.599 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 128' ' ' THR . . . 81.27 -30.9 2.67 Favored Glycine 0 C--N 1.302 -1.345 0 C-N-CA 121.365 -0.445 . . . . 72.32 112.355 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 35.4 m -105.34 164.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 110.05 -0.352 . . . . 64.14 110.05 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.2 p -113.79 143.8 22.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.975 -0.38 . . . . 61.4 109.975 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 45.3 m -154.82 144.4 21.41 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.828 -0.434 . . . . 72.31 109.828 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.0 p -97.57 153.82 17.93 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 123.971 0.908 . . . . 73.34 109.75 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.0 ptp -125.17 125.21 43.32 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.989 -1.486 . . . . 74.21 106.989 174.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.2 m -143.39 145.66 32.84 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.37 -0.831 . . . . 74.33 110.107 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -151.61 125.94 9.37 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.312 -0.995 . . . . 75.24 108.312 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -124.61 130.16 51.91 Favored 'General case' 0 C--N 1.262 -3.21 0 N-CA-C 106.439 -1.689 . . . . 54.44 106.439 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.77 160.19 43.67 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.869 -0.419 . . . . 73.23 109.869 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -96.62 128.61 43.72 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.676 -1.231 . . . . 75.11 107.676 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.616 ' CD2' HG21 ' A' ' 119' ' ' VAL . 17.0 m-30 -121.58 152.15 39.57 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 118.388 0.54 . . . . 72.32 109.874 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 21.0 p -87.84 100.33 12.79 Favored 'General case' 0 C--N 1.261 -3.264 0 N-CA-C 109.475 -0.565 . . . . 70.14 109.475 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.3 t0 . . . . . 0 C--O 1.218 -0.586 0 N-CA-C 107.506 -1.294 . . . . 62.45 107.506 178.552 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 46.1 ttm-85 . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 108.63 -0.878 . . . . 73.24 108.63 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.439 ' HB ' HG11 ' A' ' 137' ' ' VAL . 62.9 t -117.37 118.96 60.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.998 -0.741 . . . . 74.51 108.998 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -108.35 113.17 26.03 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.527 -1.286 . . . . 73.21 107.527 178.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.05 120.15 36.36 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.509 -1.293 . . . . 73.21 107.509 177.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 140' ' ' THR . 21.9 m -137.19 115.09 11.42 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 109.192 -0.67 . . . . 74.13 109.192 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.8 pp -127.82 147.11 32.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.635 -0.506 . . . . 74.41 109.635 -175.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.8 m -125.64 128.37 47.75 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 120.974 0.416 . . . . 73.42 109.919 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.0 tt -113.39 119.51 60.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.526 0.679 . . . . 72.03 109.579 179.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -84.42 160.97 55.67 Favored Pre-proline 0 C--N 1.296 -1.761 0 CA-C-N 115.389 -0.823 . . . . 61.24 109.913 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.82 2.06 2.82 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 123.367 2.711 . . . . 73.32 112.166 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.55 -8.0 59.62 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.398 1.079 . . . . 74.52 108.403 177.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.3 t70 71.96 28.48 2.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.338 1.455 . . . . 74.41 107.131 -175.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.2 139.84 44.95 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.769 -1.559 . . . . 71.33 107.6 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 t -117.26 140.45 40.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.239 -0.652 . . . . 74.04 109.239 -177.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.7 p -146.94 142.74 27.88 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.623 -1.251 . . . . 74.32 107.623 176.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.9 -171.53 41.4 Favored Glycine 0 N--CA 1.422 -2.273 0 C-N-CA 119.125 -1.512 . . . . 70.43 113.079 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -145.74 133.87 21.58 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.03 -0.73 . . . . 73.02 109.03 -175.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.0 mt -123.66 115.81 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.994 -1.113 . . . . 70.21 107.994 175.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.36 114.95 48.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.494 -0.558 . . . . 75.21 109.494 -178.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.66 108.52 19.42 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.285 -1.376 . . . . 74.32 107.285 175.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . . . -113.85 135.81 53.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.169 0.509 . . . . 71.12 111.592 -175.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.49 156.33 29.26 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.238 -0.892 . . . . 71.33 109.76 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? . . . . . 0 C--N 1.308 -1.214 0 N-CA-C 105.875 -1.898 . . . . 64.34 105.875 175.954 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.434 -1.238 0 CA-C-O 121.601 0.715 . . . . 62.31 110.502 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.02 119.85 0.56 Allowed Glycine 0 N--CA 1.424 -2.157 0 CA-C-O 118.669 -1.073 . . . . 75.43 111.122 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.529 ' O ' ' HB3' ' A' ' 83' ' ' SER . 4.5 Cg_endo -52.74 138.81 59.52 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.839 2.359 . . . . 71.45 111.771 174.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.01 125.6 35.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.27 -0.423 . . . . 52.1 110.256 -178.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.2 mt -88.55 129.94 35.36 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.873 -0.417 . . . . 74.5 109.873 176.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.86 84.62 6.65 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.875 0.845 . . . . 65.22 108.866 178.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -141.1 59.2 0.56 Allowed Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.867 -1.061 . . . . 73.51 113.059 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -90.26 93.47 9.36 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.676 -0.861 . . . . 74.42 108.676 176.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.88 161.41 22.92 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 115.191 -0.913 . . . . 74.23 111.36 -176.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.42 -9.62 26.69 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.117 2.545 . . . . 75.23 112.93 -177.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -110.62 30.76 6.52 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.881 -0.599 . . . . 74.32 109.735 176.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 p -57.31 -29.71 64.14 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.391 -0.822 . . . . 73.0 112.643 -178.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -67.98 -14.86 63.3 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.301 0.572 . . . . 71.14 110.276 -178.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -98.09 -20.4 17.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 116.058 -0.519 . . . . 73.21 110.676 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.13 118.1 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.85 0.833 . . . . 73.11 110.896 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.34 114.64 28.31 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.448 -0.796 . . . . 73.3 109.564 -177.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.72 137.02 27.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.699 -1.223 . . . . 75.41 107.699 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.6 m -151.28 172.02 16.53 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 122.054 -0.404 . . . . 75.12 109.984 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.59 151.31 23.57 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.028 -1.101 . . . . 74.31 108.028 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 89.4 t80 -116.75 129.02 55.86 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.261 -0.644 . . . . 75.43 109.261 -178.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.38 98.83 3.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.42 -0.955 . . . . 74.13 108.42 176.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 74.6 m -166.94 158.91 12.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.309 1.044 . . . . 72.34 108.895 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 68.72 9.25 7.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.711 1.205 . . . . 74.43 111.492 173.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.05 0.13 85.66 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.242 -0.743 . . . . 71.4 111.242 -175.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -105.37 158.75 16.42 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 123.232 0.613 . . . . 73.21 110.432 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.88 140.53 48.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.351 -1.352 . . . . 72.43 107.351 174.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -162.68 -160.91 11.56 Favored Glycine 0 N--CA 1.411 -2.999 0 C-N-CA 118.871 -1.633 . . . . 74.34 113.241 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 33.6 p -123.11 140.64 52.82 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 108.719 -0.845 . . . . 70.41 108.719 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -131.41 141.15 49.79 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 120.553 -0.459 . . . . 74.2 111.125 178.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.22 115.07 22.32 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.217 -1.401 . . . . 64.44 107.217 175.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -111.55 120.2 61.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.677 -0.86 . . . . 65.44 108.677 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 90' ' ' LEU . 41.4 p90 -124.37 150.41 45.58 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.042 0.449 . . . . 73.43 110.91 -174.049 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 m -154.79 156.85 37.03 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.509 -0.552 . . . . 74.22 109.509 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.0 t70 66.68 31.13 7.82 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 122.311 1.053 . . . . 74.21 110.683 175.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 87' ' ' PHE . 34.8 mt -98.52 171.38 8.19 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.402 -0.817 . . . . 75.2 109.518 177.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 p -121.59 172.65 7.95 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 122.833 0.083 . . . . 74.42 111.166 -178.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.575 ' CZ ' HD12 ' A' ' 112' ' ' LEU . 86.7 t80 -57.25 -35.66 69.99 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.415 0.447 . . . . 71.41 110.447 175.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.6 -27.12 68.73 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.39 0.614 . . . . 74.42 110.521 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.443 ' HG2' ' NE2' ' A' ' 97' ' ' GLN . 43.5 mt-10 -88.32 -15.5 35.54 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.769 -0.65 . . . . 73.14 112.596 -177.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -50.49 -52.19 57.67 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 113.522 0.934 . . . . 74.53 113.522 175.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -56.45 -45.56 36.51 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 121.312 1.341 . . . . 63.31 110.24 175.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.443 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 24.3 mt-30 -58.87 -44.19 91.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.905 -1.043 . . . . 73.34 111.76 -176.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.72 -19.96 58.71 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.059 0.457 . . . . 72.4 111.011 178.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.38 -14.04 60.1 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.08 -0.509 . . . . 53.15 110.615 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -65.27 -57.34 8.71 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.185 -0.606 . . . . 75.42 109.96 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -56.31 -49.17 75.06 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.667 0.604 . . . . 75.22 110.221 -176.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.08 -37.5 71.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.007 -0.997 . . . . 73.44 111.528 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.6 t -65.33 -30.67 71.53 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 116.294 -0.412 . . . . 75.34 110.077 -172.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.38 -15.37 63.29 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 121.225 0.536 . . . . 71.34 111.216 -174.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.46 -12.1 11.73 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.228 -0.589 . . . . 75.31 110.875 177.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.93 -48.47 3.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.277 0.843 . . . . 64.2 113.277 -172.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.56 28.43 19.34 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.245 -0.979 . . . . 62.45 110.802 -172.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.1 m -97.44 151.56 4.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.42 -0.39 . . . . 73.44 109.949 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -129.1 121.89 28.74 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.408 -1.33 . . . . 75.12 107.408 176.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.7 mt -121.24 139.89 52.78 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.709 0.29 . . . . 75.5 110.275 -177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -136.31 121.85 19.55 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.899 -1.519 . . . . 74.41 106.899 177.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.575 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 2.7 pp -135.51 155.51 50.39 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-O 121.037 0.446 . . . . 75.44 111.679 -177.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -150.62 155.71 39.93 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.096 -0.956 . . . . 64.43 112.521 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -94.51 128.87 41.38 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.512 -1.222 . . . . 75.34 108.597 173.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -122.49 82.85 2.03 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.533 -1.654 . . . . 72.24 106.533 175.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 57.72 -130.25 50.73 Favored Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 114.372 -1.285 . . . . 64.22 110.502 -173.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.591 ' HA ' ' OD1' ' A' ' 180' ' ' ASP . 23.7 t-20 -71.14 -13.4 61.93 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.642 0.734 . . . . 72.41 111.581 -178.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.465 HG23 ' HG2' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -110.63 146.32 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 C-N-CA 117.831 -1.548 . . . . 71.12 110.756 -176.747 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.2 t -107.18 133.56 51.49 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.726 0 CA-C-N 115.348 -0.842 . . . . 74.3 110.016 -178.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.1 pt -116.29 131.38 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 121.49 0.662 . . . . 72.4 109.685 175.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 tt -128.45 131.53 48.41 Favored 'General case' 0 C--N 1.278 -2.541 0 CA-C-N 115.276 -0.875 . . . . 72.23 110.148 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -129.2 146.2 51.17 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.126 -1.065 . . . . 74.35 108.126 174.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.13 160.39 33.34 Favored Glycine 0 N--CA 1.407 -3.297 0 N-CA-C 111.402 -0.679 . . . . 50.43 111.402 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -137.49 133.44 34.59 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.881 -0.785 . . . . 74.21 108.881 177.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -103.92 110.07 22.07 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.31 -0.996 . . . . 42.14 108.31 178.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -103.2 93.75 5.16 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 122.365 1.079 . . . . 72.4 110.703 -177.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -124.29 21.39 8.75 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.138 -1.392 . . . . 73.23 107.512 177.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.422 ' HA ' ' C ' ' A' ' 167' ' ' GLY . 2.6 m . . . . . 0 CA--C 1.552 1.037 0 CA-C-N 113.039 -1.891 . . . . 63.11 110.248 177.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 C--O 1.237 0.438 0 CA-C-O 121.422 0.63 . . . . 62.13 111.224 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.41 138.99 58.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.485 -0.779 . . . . 62.44 111.658 179.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 28.3 t70 -131.5 121.96 25.36 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.571 -0.529 . . . . 74.21 109.571 177.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 90.1 t -119.71 126.98 75.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.855 -0.424 . . . . 75.31 109.855 -178.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.45 123.47 41.37 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.227 -0.657 . . . . 72.32 109.227 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 tt -113.94 118.29 33.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.003 -1.48 . . . . 73.11 107.003 176.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 31' ' ' SER . 6.7 m -117.48 128.44 54.98 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.213 -0.662 . . . . 75.3 109.213 -175.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 84.1 t -122.33 127.87 75.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.625 -0.509 . . . . 74.3 109.625 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -116.74 132.47 56.68 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.071 -0.714 . . . . 71.32 109.071 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.581 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.2 p90 -134.93 127.63 18.36 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 116.412 -0.358 . . . . 75.12 111.785 177.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -70.15 51.27 1.0 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 123.24 2.627 . . . . 65.44 110.879 172.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.11 -128.57 0.09 Allowed 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.3 -1.37 . . . . 75.32 107.3 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -167.21 134.75 2.44 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.645 -1.613 . . . . 63.42 106.645 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.519 ' HB ' ' CZ ' ' A' ' 143' ' ' PHE . 7.7 p -85.93 123.43 39.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 108.577 -0.897 . . . . 64.24 108.577 177.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.7 t -81.73 -33.02 31.31 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.22 -0.592 . . . . 73.32 111.358 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 64.0 m -152.84 133.01 13.5 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 109.672 -0.492 . . . . 72.34 109.672 175.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.7 t -138.77 158.87 43.43 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.946 -0.471 . . . . 74.55 111.339 177.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 2.9 t-20 -127.61 89.8 3.01 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.018 -1.845 . . . . 75.3 106.018 175.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 174.44 -140.35 5.36 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 109.582 -1.407 . . . . 73.43 109.582 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.82 99.98 7.29 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 117.235 0.517 . . . . 75.13 109.702 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -82.13 115.92 21.46 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.534 0.683 . . . . 73.44 110.31 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.4 mt -81.57 -47.56 19.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.151 -1.426 . . . . 74.12 107.151 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.83 160.48 67.28 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 107.119 -1.437 . . . . 73.33 107.119 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.52 -19.63 65.42 Favored 'Trans proline' 0 C--N 1.328 -0.539 0 C-N-CA 122.054 1.836 . . . . 75.43 111.948 175.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -114.55 4.09 15.07 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.381 0.882 . . . . 73.41 113.381 178.75 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.2 t -140.34 120.28 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.995 -0.742 . . . . 73.33 108.995 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.93 149.33 31.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.049 -0.723 . . . . 75.53 109.049 -177.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -133.68 146.9 51.27 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.62 -0.882 . . . . 75.32 108.62 -178.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -119.62 122.37 41.39 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 109.446 -0.576 . . . . 71.43 109.446 177.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -89.32 114.0 25.35 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.896 0.855 . . . . 73.45 110.01 177.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 10.2 mp -101.49 118.64 37.37 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.957 -1.02 . . . . 73.12 109.493 178.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.421 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 75.5 mmtt -117.45 143.51 32.25 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 114.447 -1.251 . . . . 71.13 108.978 -176.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.43 150.46 64.16 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.377 2.052 . . . . 74.41 111.355 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.422 ' C ' ' HA ' ' A' ' 128' ' ' THR . . . 73.42 -11.88 4.95 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 116.495 -0.321 . . . . 71.21 113.864 176.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 33.2 m -117.01 145.46 22.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 109.344 -0.613 . . . . 74.23 109.344 171.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.76 129.07 40.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.085 -0.709 . . . . 75.41 109.085 178.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.7 t -111.45 136.93 49.92 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 120.048 -0.661 . . . . 73.12 109.552 -178.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.6 p -100.1 138.76 36.73 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.505 -0.77 . . . . 64.32 110.626 -179.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 23.0 ttt -125.68 117.48 23.58 Favored 'General case' 0 C--O 1.193 -1.899 0 CA-C-N 115.756 -0.656 . . . . 71.43 109.681 -177.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 24.7 t -142.92 144.83 32.56 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.542 -0.911 . . . . 73.03 108.542 174.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -154.53 128.12 8.62 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.073 -1.084 . . . . 73.5 108.073 -177.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -129.04 130.27 46.36 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.028 -1.101 . . . . 64.03 108.028 176.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -152.78 158.21 41.92 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 120.803 -0.359 . . . . 73.41 110.084 -178.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.465 ' HG2' HG23 ' A' ' 118' ' ' ILE . 96.1 mtt180 -87.3 136.3 32.99 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.633 -0.877 . . . . 71.2 108.633 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -143.25 147.2 34.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.991 -0.744 . . . . 74.23 108.991 176.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.47 112.07 5.07 Favored 'General case' 0 N--CA 1.414 -2.248 0 C-N-CA 122.849 0.459 . . . . 64.52 110.507 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.591 ' OD1' ' HA ' ' A' ' 117' ' ' ASN . 2.6 m-20 . . . . . 0 C--N 1.308 -1.221 0 C-N-CA 124.714 1.206 . . . . 74.52 112.23 178.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 . . . . . 0 N--CA 1.441 -0.908 0 N-CA-C 109.517 -0.549 . . . . 74.32 109.517 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 p -124.77 123.42 65.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 120.267 -0.573 . . . . 75.14 110.02 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -125.1 126.61 45.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.942 -0.572 . . . . 74.21 109.474 -176.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.77 108.35 16.97 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 106.366 -1.716 . . . . 74.43 106.366 172.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -117.6 114.65 23.72 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.63 -1.618 . . . . 62.33 106.63 -178.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -129.64 146.68 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-O 121.255 0.55 . . . . 70.43 109.869 -174.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.5 m -127.8 119.55 25.93 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-O 121.366 0.603 . . . . 75.31 109.749 -177.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -105.96 124.36 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.417 -0.811 . . . . 73.12 109.674 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 m -98.88 150.37 36.63 Favored Pre-proline 0 C--N 1.288 -2.07 0 CA-C-N 115.44 -0.8 . . . . 75.24 109.703 -176.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.99 1.96 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 124.038 3.159 . . . . 61.24 114.975 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 30.3 t70 -83.85 -2.66 56.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.15 -0.685 . . . . 74.15 109.15 177.089 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.7 t70 72.72 29.29 1.98 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 106.125 -1.806 . . . . 73.34 106.125 -173.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 2.1 tp -104.09 125.58 50.53 Favored 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 112.682 -2.054 . . . . 74.13 109.006 -178.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.36 135.76 50.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.675 -0.861 . . . . 74.22 108.675 177.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 p -147.47 152.81 38.67 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.119 -1.067 . . . . 74.4 108.119 178.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.09 -171.24 44.31 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 118.74 -1.695 . . . . 54.24 113.782 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.66 133.69 30.95 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.672 0.789 . . . . 75.31 109.646 -176.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.9 mt -121.0 116.09 48.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.918 -1.142 . . . . 74.31 107.918 176.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.71 121.3 66.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 123.135 0.574 . . . . 73.33 110.016 -176.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.411 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.91 108.46 16.3 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.255 -1.387 . . . . 75.43 107.255 175.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.79 132.82 56.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.403 0.621 . . . . 73.34 112.602 -174.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.29 158.43 35.8 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.405 -0.961 . . . . 74.35 108.405 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.553 0 N-CA-C 104.551 -2.389 . . . . 65.14 104.551 173.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 109.623 -0.51 . . . . 72.42 109.623 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.26 96.47 0.1 Allowed Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.829 -0.909 . . . . 73.43 110.829 176.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.413 ' O ' ' HB3' ' A' ' 83' ' ' SER . 26.1 Cg_endo -68.52 159.6 52.83 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.931 2.42 . . . . 71.1 113.046 177.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.25 140.39 50.33 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.593 -0.892 . . . . 72.2 108.593 176.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.419 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 90.2 mt -79.92 140.78 36.56 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.703 0.287 . . . . 45.02 111.337 -178.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.16 96.61 6.77 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.263 1.03 . . . . 72.41 108.473 177.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -113.45 -71.01 0.55 Allowed Glycine 0 C--N 1.292 -1.872 0 CA-C-N 114.415 -1.266 . . . . 72.12 113.117 -177.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 58.59 86.02 0.09 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.23 1.014 . . . . 74.01 112.404 -176.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 m -115.81 158.63 41.66 Favored Pre-proline 0 C--N 1.29 -1.993 0 CA-C-N 114.652 -1.158 . . . . 75.15 108.686 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.57 -16.84 50.6 Favored 'Trans proline' 0 N--CA 1.483 0.884 0 C-N-CA 122.747 2.298 . . . . 72.5 112.354 179.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -113.45 25.22 11.47 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.543 -0.753 . . . . 73.33 112.037 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.8 m -56.36 -24.01 41.35 Favored 'General case' 0 C--O 1.21 -1.004 0 N-CA-C 111.753 0.279 . . . . 71.24 111.753 177.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -62.57 -23.17 66.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.18 0.514 . . . . 72.02 110.456 178.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.646 ' HB3' ' O ' ' A' ' 88' ' ' SER . 33.4 mmtp -95.51 -14.44 23.67 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.246 0.546 . . . . 74.32 110.104 -178.23 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 49.8 t -108.19 121.05 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 116.081 -0.509 . . . . 74.44 110.407 -177.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 110.67 22.69 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.171 -0.677 . . . . 73.24 109.171 177.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.96 137.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.98 -1.119 . . . . 64.14 107.98 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 t -148.2 172.22 14.68 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.803 -0.814 . . . . 74.23 108.803 -174.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -92.02 141.23 28.84 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.132 -1.062 . . . . 75.1 108.132 177.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 93.0 t80 -102.24 127.36 49.24 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.374 -0.602 . . . . 74.41 109.374 -178.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.56 99.63 4.12 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.568 -0.901 . . . . 71.34 108.568 176.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 30.9 t -170.0 155.76 5.75 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.276 -1.009 . . . . 63.33 108.276 -179.067 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 71.06 6.72 5.95 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.803 1.241 . . . . 74.34 111.604 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.91 4.51 84.63 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.659 -1.376 . . . . 73.44 109.659 -173.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -104.31 149.34 25.44 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 124.164 0.986 . . . . 72.02 110.049 -179.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -125.5 136.06 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 108.015 -1.106 . . . . 70.12 108.015 174.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -163.12 -155.42 8.1 Favored Glycine 0 C--N 1.27 -3.09 0 C-N-CA 119.4 -1.381 . . . . 62.53 112.19 -178.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 13.4 p -124.1 140.95 52.47 Favored 'General case' 0 C--N 1.274 -2.715 0 CA-C-N 115.096 -0.552 . . . . 72.22 109.729 -178.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.53 141.68 45.28 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 120.816 0.341 . . . . 72.14 110.649 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.35 115.56 21.86 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.027 -0.731 . . . . 75.51 109.027 178.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.4 t -106.01 112.53 39.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.165 -1.05 . . . . 73.53 108.165 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 50.7 p90 -112.87 153.96 27.08 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 120.708 -0.397 . . . . 73.21 110.746 -174.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.646 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 42.4 m -153.61 161.49 42.14 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.822 -0.351 . . . . 73.33 110.932 -177.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.1 t70 59.68 37.82 22.14 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.471 1.129 . . . . 74.52 111.574 173.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.8 mt -103.29 164.76 11.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.33 -0.85 . . . . 73.2 110.922 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -114.21 174.02 6.16 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.052 0.453 . . . . 74.51 110.742 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -56.49 -34.28 66.8 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 125.58 1.552 . . . . 72.21 111.021 -178.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.4 -25.26 61.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.98 -0.555 . . . . 70.31 111.185 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -88.77 -16.45 32.12 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 116.107 -0.497 . . . . 75.31 111.648 -176.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.648 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.6 tm? -52.73 -56.44 23.12 Favored Pre-proline 0 CA--C 1.569 1.696 0 C-N-CA 123.442 0.697 . . . . 72.11 111.756 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.18 -37.14 33.38 Favored 'Trans proline' 0 C--N 1.372 1.795 0 CA-C-N 120.741 1.3 . . . . 73.01 111.232 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.55 -34.67 78.79 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 124.437 1.095 . . . . 74.42 110.857 -176.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -78.38 -23.01 47.02 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.384 0.611 . . . . 74.22 109.543 175.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.34 -22.95 59.0 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 115.577 -0.738 . . . . 62.4 109.842 -175.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -62.06 -46.79 87.56 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.445 -0.798 . . . . 74.12 109.659 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.6 mtm -55.95 -49.67 72.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.282 0.563 . . . . 75.4 109.711 177.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -54.49 -35.63 63.29 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 114.726 -1.124 . . . . 75.03 110.96 178.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.4 m -60.65 -29.21 69.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.786 -0.643 . . . . 64.31 110.86 -173.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.81 -30.29 69.98 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 123.558 0.536 . . . . 71.12 111.345 -175.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.87 -10.86 15.47 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.085 -0.507 . . . . 75.45 110.89 -177.258 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.69 -47.8 3.67 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 113.44 0.904 . . . . 64.13 113.44 -172.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.42 24.9 41.38 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.428 -1.069 . . . . 73.54 110.428 -173.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 m -106.42 163.09 5.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.393 -0.404 . . . . 74.52 110.319 -178.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -128.56 122.2 30.5 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.597 -1.26 . . . . 74.53 107.597 176.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.1 mt -119.09 122.48 42.2 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.957 0.408 . . . . 74.45 111.209 -178.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 p -137.22 139.5 41.07 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.984 -0.553 . . . . 74.21 109.736 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.87 150.67 32.27 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 122.075 -0.391 . . . . 63.21 110.042 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 113' ' ' ARG . 3.3 mmp_? -143.51 155.04 44.22 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.109 -0.496 . . . . 74.52 110.683 -176.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -92.31 138.53 31.45 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 121.587 0.708 . . . . 74.41 111.333 173.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.43 ' O ' HG13 ' A' ' 118' ' ' ILE . 6.8 t30 -123.9 88.02 2.84 Favored 'General case' 0 C--N 1.269 -2.908 0 N-CA-C 105.665 -1.976 . . . . 74.33 105.665 175.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.71 -120.23 6.81 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 109.646 -1.381 . . . . 74.23 109.646 -175.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -104.54 12.45 33.14 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.509 1.147 . . . . 71.01 108.635 178.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.2 pp -119.26 149.46 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 O-C-N 120.951 -1.093 . . . . 63.34 109.041 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.27 138.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 CA-C-O 120.951 0.405 . . . . 74.35 110.352 -178.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.9 pt -110.6 129.29 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.361 0 N-CA-C 107.132 -1.433 . . . . 74.32 107.132 172.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.24 129.53 50.93 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 109.391 -0.596 . . . . 73.24 109.391 -178.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -134.8 119.23 17.91 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.913 0.863 . . . . 72.12 111.27 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.38 148.36 17.85 Favored Glycine 0 N--CA 1.418 -2.527 0 N-CA-C 110.834 -0.906 . . . . 74.34 110.834 178.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.438 ' HG2' HG23 ' A' ' 171' ' ' THR . 75.7 mtt180 -123.63 140.21 53.22 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 109.256 -0.646 . . . . 72.42 109.256 179.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.92 109.24 14.86 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 109.293 -0.632 . . . . 72.43 109.293 178.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -112.64 94.39 4.89 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.06 -1.089 . . . . 73.53 108.06 176.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -122.96 37.01 4.52 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 122.937 1.351 . . . . 75.01 108.313 177.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 75.6 p . . . . . 0 C--N 1.31 -1.148 0 CA-C-N 113.385 -1.734 . . . . 74.44 110.59 179.436 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 112.733 0.642 . . . . 70.13 112.733 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.82 48.48 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.687 0.995 . . . . 74.12 113.687 -177.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -132.9 136.45 46.18 Favored 'General case' 0 C--O 1.26 1.614 0 CA-C-N 115.69 -0.686 . . . . 62.41 109.684 171.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.82 114.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.979 -1.119 . . . . 75.44 107.979 176.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.32 124.42 52.19 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 120.694 -0.402 . . . . 74.24 111.444 -178.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 50.7 tp -111.08 124.52 52.35 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.697 -1.223 . . . . 73.55 107.697 170.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.5 m -126.05 112.55 16.0 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.898 -0.778 . . . . 64.32 108.898 178.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 82.1 t -107.51 120.81 59.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 109.33 -0.618 . . . . 75.41 109.33 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.33 127.81 55.76 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.207 -0.664 . . . . 63.52 109.207 178.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.5 p90 -135.1 122.2 14.98 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 112.266 0.469 . . . . 72.12 112.266 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -67.78 42.32 0.23 Allowed 'Trans proline' 0 CA--C 1.566 2.113 0 C-N-CA 123.162 2.575 . . . . 72.34 112.443 173.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.41 -108.68 0.31 Allowed 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 122.977 0.511 . . . . 64.44 109.806 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.85 133.96 0.13 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.966 -0.753 . . . . 62.2 108.966 -177.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.3 p -88.38 141.11 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 109.235 -0.654 . . . . 75.23 109.235 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 39.5 p -102.15 -38.14 7.83 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.027 0.441 . . . . 63.12 110.411 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.9 m -155.75 132.39 10.41 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 108.625 -0.879 . . . . 43.32 108.625 178.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.2 t -139.97 152.83 46.62 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 120.144 -0.622 . . . . 75.43 112.103 176.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -118.98 88.15 2.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.325 -2.102 . . . . 75.55 105.325 175.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 171.09 -145.03 8.62 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 108.644 -1.782 . . . . 75.4 108.644 -177.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -118.27 99.99 7.21 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 118.129 0.964 . . . . 71.42 110.8 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.26 109.23 13.41 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.537 0.684 . . . . 74.21 109.449 176.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 61.9 mt -80.12 -46.96 21.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.096 -1.446 . . . . 73.23 107.096 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -121.63 163.42 30.97 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 106.802 -1.555 . . . . 74.01 106.802 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.93 -1.18 10.09 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.164 1.909 . . . . 72.22 111.376 178.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.635 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.5 pt-20 -137.07 9.66 3.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.439 -0.8 . . . . 72.05 111.66 -177.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.7 t -145.07 120.7 3.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.907 -1.146 . . . . 75.32 107.907 178.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.84 143.72 38.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.284 -0.635 . . . . 50.44 109.284 -177.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -130.86 143.34 50.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-O 121.252 0.548 . . . . 74.22 110.155 -177.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 30.3 m-90 -126.45 121.31 32.06 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.845 -0.798 . . . . 75.34 108.845 179.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 105.07 13.15 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.36 0.6 . . . . 73.33 110.234 176.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.54 147.82 24.92 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.373 -0.831 . . . . 75.43 110.281 -174.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -117.68 155.45 50.59 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.984 -0.553 . . . . 73.35 112.391 -176.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.81 157.4 51.84 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.901 2.401 . . . . 74.23 110.97 178.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.84 -35.22 2.91 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.666 -0.778 . . . . 62.24 111.574 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 20.7 m -104.76 145.13 13.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.039 0.447 . . . . 74.41 110.232 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.2 p -101.52 144.0 13.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 107.804 -1.184 . . . . 72.3 107.804 178.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 50.0 m -149.32 153.61 37.73 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.066 0.46 . . . . 74.13 111.459 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.438 HG23 ' HG2' ' A' ' 124' ' ' ARG . 2.6 p -106.56 128.37 54.07 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.307 -0.86 . . . . 72.2 109.889 177.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 23.5 ptp -106.93 122.06 45.66 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.614 -1.624 . . . . 72.21 106.614 178.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.5 m -141.47 148.01 38.79 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.558 -1.257 . . . . 71.54 111.737 -176.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.96 136.69 18.04 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 115.234 -0.894 . . . . 75.01 108.69 -176.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -130.79 131.05 44.44 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 105.866 -1.901 . . . . 73.41 105.866 175.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 178' ' ' TYR . . . -157.45 160.66 38.55 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 120.876 -0.33 . . . . 75.41 110.348 -175.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -87.52 129.05 35.22 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.729 -0.841 . . . . 74.33 108.729 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 176' ' ' ALA . 99.2 m-85 -140.73 124.69 17.26 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 108.762 -0.829 . . . . 74.14 108.762 178.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.07 122.73 9.96 Favored 'General case' 0 N--CA 1.404 -2.739 0 O-C-N 124.795 1.309 . . . . 75.14 111.564 -177.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 106.952 -1.499 . . . . 74.31 106.952 175.444 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 108.946 -0.761 . . . . 75.23 108.946 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.17 114.01 45.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.08 -1.822 . . . . 73.33 106.08 172.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -123.75 115.66 21.75 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 120.955 0.407 . . . . 74.12 110.93 -175.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.31 108.55 17.07 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.786 -1.19 . . . . 55.24 107.786 175.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.3 t -114.39 115.53 27.47 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.671 -1.233 . . . . 74.4 107.671 -178.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.8 pp -127.96 146.42 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.092 0.472 . . . . 75.31 109.822 -178.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 88.9 m -126.08 128.5 47.47 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.98 -0.748 . . . . 64.13 108.98 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.4 tt -114.76 114.83 47.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-O 121.622 0.725 . . . . 72.33 110.067 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -82.29 153.11 68.64 Favored Pre-proline 0 N--CA 1.423 -1.775 0 CA-C-N 115.215 -0.902 . . . . 70.42 109.564 -176.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.62 1.99 0.46 Allowed 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 123.765 2.977 . . . . 74.51 114.006 178.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.53 -8.27 59.62 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.387 -0.968 . . . . 71.13 108.387 174.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 72.78 29.27 1.95 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.567 1.547 . . . . 75.14 107.338 -174.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.26 126.49 51.42 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 113.55 -1.659 . . . . 73.34 107.512 178.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.33 140.1 23.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 107.871 -1.159 . . . . 75.41 107.871 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.5 p -148.47 158.97 44.46 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.318 -1.364 . . . . 73.21 107.318 -178.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.24 -167.8 39.0 Favored Glycine 0 CA--C 1.488 -1.641 0 C-N-CA 118.509 -1.805 . . . . 71.04 113.028 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -152.89 135.14 14.96 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 123.176 0.591 . . . . 75.24 110.228 -177.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 66.6 mt -115.53 115.89 50.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 107.838 -1.171 . . . . 74.1 107.838 177.054 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.26 116.59 52.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.726 -0.842 . . . . 75.12 108.726 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.541 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.25 108.32 16.43 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.927 -1.509 . . . . 72.1 106.927 175.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.47 118.98 33.68 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.324 -0.621 . . . . 73.31 109.324 -177.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.91 158.04 21.61 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 115.637 -0.71 . . . . 73.24 111.308 -174.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt . . . . . 0 N--CA 1.432 -1.356 0 N-CA-C 105.932 -1.877 . . . . 74.5 105.932 172.371 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 107.575 -1.268 . . . . 74.34 107.575 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.511 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 172.88 104.05 0.17 Allowed Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 119.807 -1.187 . . . . 54.2 113.49 174.14 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -60.72 159.6 27.94 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.837 2.358 . . . . 75.35 110.743 173.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.2 163.14 14.23 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.902 -0.499 . . . . 53.1 110.473 178.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 83' ' ' SER . 3.6 mm? -77.72 136.28 38.15 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.111 -0.495 . . . . 73.15 109.672 177.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -110.54 95.08 5.35 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.404 0.621 . . . . 73.02 109.518 -178.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.62 94.01 0.1 OUTLIER Glycine 0 C--N 1.286 -2.207 0 N-CA-C 109.93 -1.268 . . . . 74.34 109.93 179.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.18 93.97 2.39 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.086 0.47 . . . . 65.02 111.165 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.5 m -85.79 151.95 56.0 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.439 -0.801 . . . . 73.13 109.764 178.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.06 -31.84 83.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.414 2.076 . . . . 61.15 111.707 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -96.11 38.27 1.2 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.791 -0.64 . . . . 73.13 112.095 -177.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 m -59.66 -24.48 63.92 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.563 0.579 . . . . 74.44 112.563 -178.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -70.52 -17.87 62.94 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 121.235 0.541 . . . . 74.15 110.425 -178.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -90.1 -16.63 29.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.708 -0.678 . . . . 75.54 109.731 -178.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.03 120.06 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 122.029 0.918 . . . . 74.03 112.492 -176.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.73 108.0 20.0 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.091 -0.958 . . . . 54.22 108.634 178.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.8 t -98.08 142.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.514 -1.291 . . . . 74.02 107.514 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.7 t -157.42 172.7 18.11 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 108.742 -0.836 . . . . 72.12 108.742 -175.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.511 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 4.1 p-10 -86.55 146.7 26.26 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.847 -0.797 . . . . 65.31 108.847 178.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -108.2 119.1 38.5 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.592 -1.262 . . . . 70.14 107.592 175.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -138.43 99.85 3.95 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.358 -1.719 . . . . 64.01 106.358 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.7 t -174.76 159.1 2.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.858 -1.164 . . . . 72.24 107.858 -176.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 72.76 -5.43 1.88 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.874 0.869 . . . . 74.41 112.535 172.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.28 -5.28 58.94 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 109.877 -1.289 . . . . 73.41 109.877 -174.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.5 155.04 19.15 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 123.592 0.757 . . . . 74.05 109.696 -177.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.62 140.28 49.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 109.059 -0.719 . . . . 74.25 109.059 178.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -170.04 -154.83 9.63 Favored Glycine 0 N--CA 1.411 -3.001 0 C-N-CA 119.721 -1.228 . . . . 53.1 112.647 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.414 ' HB2' HD22 ' A' ' 60' ' ' LEU . 28.1 p -122.2 147.46 46.16 Favored 'General case' 0 C--N 1.278 -2.538 0 C-N-CA 123.391 0.677 . . . . 60.41 110.709 -176.107 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -137.32 143.2 41.96 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.995 0.426 . . . . 75.5 110.987 175.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.99 115.09 16.63 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.525 -1.287 . . . . 61.24 107.525 175.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.9 t -109.89 116.92 53.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.54 -0.911 . . . . 74.11 108.54 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' A' ' 90' ' ' LEU . 48.7 p90 -121.15 155.32 34.77 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.463 0.649 . . . . 74.03 111.832 -175.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 p -156.08 148.36 23.5 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.361 -0.836 . . . . 64.02 109.662 -177.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 t70 60.42 62.28 1.59 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.703 1.24 . . . . 72.53 112.175 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' A' ' 87' ' ' PHE . 25.6 mt -121.13 162.38 20.18 Favored 'General case' 0 N--CA 1.413 -2.301 0 CA-C-N 114.204 -1.362 . . . . 73.4 108.335 174.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -112.17 173.22 6.47 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 119.564 -0.854 . . . . 72.12 109.443 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -50.27 -46.71 55.25 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.272 1.029 . . . . 72.35 111.636 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.48 -25.35 68.22 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.607 -0.724 . . . . 73.44 112.337 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -85.72 -17.32 36.28 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 111.859 0.318 . . . . 72.22 111.859 -177.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.584 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 50.6 tp -61.96 -52.95 64.23 Favored Pre-proline 0 CA--C 1.558 1.288 0 N-CA-C 113.2 0.815 . . . . 72.23 113.2 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -62.05 -37.13 66.61 Favored 'Trans proline' 0 C--N 1.365 1.419 0 CA-C-N 120.75 1.304 . . . . 73.32 110.731 176.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.13 -36.4 84.14 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 115.067 -0.97 . . . . 74.33 111.302 -176.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -74.29 -19.51 60.45 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 120.818 0.342 . . . . 74.22 110.391 177.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.86 -23.27 63.25 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.201 -0.454 . . . . 70.44 110.523 -177.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -59.74 -48.45 81.61 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 109.584 -0.524 . . . . 64.02 109.584 176.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 17.0 ttm -56.19 -52.11 65.6 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.65 -0.704 . . . . 70.24 109.385 -179.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -55.19 -33.36 62.96 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 114.646 -1.161 . . . . 74.21 110.901 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -65.11 -18.08 65.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 118.796 -0.621 . . . . 71.25 112.473 -174.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.34 -30.38 66.68 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.535 0.683 . . . . 74.02 109.823 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.67 -11.57 13.99 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.272 -0.876 . . . . 64.45 110.908 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.73 -48.45 3.41 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.947 1.091 . . . . 74.23 113.947 -172.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.89 18.63 79.66 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 116.289 -0.414 . . . . 72.54 112.849 -175.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.2 178.62 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.634 0.605 . . . . 72.44 112.634 -176.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -142.11 126.76 17.97 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.03 0.532 . . . . 73.13 109.583 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.5 mp -127.23 115.93 19.81 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.427 -0.212 . . . . 73.22 110.427 178.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.5 m -111.27 109.79 19.97 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.128 -0.693 . . . . 74.23 109.128 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -129.42 148.37 51.33 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.555 0.693 . . . . 64.33 111.9 -178.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -152.65 169.96 21.41 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.465 -1.243 . . . . 74.45 110.964 -177.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -101.79 137.52 39.98 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 115.628 -0.714 . . . . 61.12 109.715 171.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -118.36 87.35 2.71 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.406 -1.331 . . . . 73.31 107.406 177.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.61 -98.52 0.85 Allowed Glycine 0 N--CA 1.428 -1.86 0 CA-C-N 115.044 -0.98 . . . . 52.51 111.962 -177.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -120.12 4.08 10.88 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.811 1.291 . . . . 73.1 108.563 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.3 pp -118.84 149.38 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 108.325 -0.991 . . . . 74.12 108.325 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -105.4 135.38 43.76 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 110.005 -0.368 . . . . 73.43 110.005 -178.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.6 pt -113.57 131.47 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 108.733 -0.84 . . . . 71.4 108.733 177.153 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -128.61 123.61 33.74 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 115.534 -0.757 . . . . 74.1 108.979 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.71 124.86 12.89 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.722 0.772 . . . . 74.42 110.972 177.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.58 -178.68 25.68 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.891 -0.671 . . . . 55.24 111.607 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.418 ' HG2' HG21 ' A' ' 171' ' ' THR . 96.8 mtt180 -140.8 159.26 42.6 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.753 -0.462 . . . . 71.54 109.753 -176.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.46 108.52 10.61 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 106.019 -1.845 . . . . 72.13 106.019 171.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -111.86 93.51 4.49 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.505 0.669 . . . . 75.34 109.297 -178.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.401 HD21 ' HA ' ' A' ' 166' ' ' PRO 0.334 0.0 OUTLIER -126.17 63.9 1.24 Allowed 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 123.492 1.615 . . . . 70.13 109.202 171.429 . . . . . . . . 4 4 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.432 -1.358 0 CA-C-N 112.683 -2.053 . . . . 73.52 112.489 -173.032 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 N--CA 1.441 -0.925 0 CA-C-O 120.766 0.317 . . . . 72.54 110.679 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.03 141.57 28.26 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.726 -0.39 . . . . 75.53 111.341 -177.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -127.48 135.45 50.41 Favored 'General case' 0 C--O 1.261 1.694 0 N-CA-C 107.009 -1.478 . . . . 65.31 107.009 172.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 55.3 t -108.7 115.14 48.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.3 -1.0 . . . . 72.35 108.3 178.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.55 120.1 40.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.968 -0.753 . . . . 74.43 108.968 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.13 111.98 21.86 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.949 -1.5 . . . . 71.23 106.949 178.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.2 m -114.15 128.51 56.4 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.435 -0.58 . . . . 75.2 109.435 -176.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 88.3 t -120.93 123.63 70.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.031 -0.729 . . . . 75.35 109.031 178.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.57 127.5 56.1 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.002 -0.74 . . . . 72.35 109.002 177.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.603 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.01 118.82 14.34 Favored Pre-proline 0 C--N 1.291 -1.949 0 N-CA-C 111.795 0.294 . . . . 71.11 111.795 178.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.37 41.42 0.36 Allowed 'Trans proline' 0 CA--C 1.555 1.561 0 C-N-CA 123.223 2.615 . . . . 71.24 112.563 175.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.08 -92.85 0.53 Allowed 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 110.148 -0.315 . . . . 63.24 110.148 178.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 168.24 133.68 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.522 1.129 . . . . 74.21 108.192 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.09 142.86 12.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 108.866 -0.791 . . . . 74.33 108.866 175.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.7 t -103.75 -33.74 8.82 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.2 -0.667 . . . . 75.22 109.2 178.153 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.0 m -158.3 132.31 7.9 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 108.833 -0.803 . . . . 74.55 108.833 175.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -139.23 159.49 42.04 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 109.559 -0.534 . . . . 75.23 109.559 174.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.558 ' HB3' ' OG ' ' A' ' 173' ' ' SER . 57.6 t30 -135.58 103.17 5.35 Favored 'General case' 0 C--O 1.274 2.365 0 N-CA-C 105.982 -1.858 . . . . 72.23 105.982 169.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.27 -140.75 6.06 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 107.614 -2.195 . . . . 74.12 107.614 -178.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.5 99.45 6.83 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 118.417 1.108 . . . . 73.24 110.041 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -75.53 131.12 39.84 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.719 -0.673 . . . . 63.12 110.64 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.9 mt -95.68 -44.51 13.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.257 -1.386 . . . . 73.53 107.257 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.96 170.37 9.22 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 105.928 -1.879 . . . . 75.51 105.928 176.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.24 -0.44 8.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.169 1.913 . . . . 53.41 111.39 177.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.603 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.8 pt-20 -128.62 5.75 5.61 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.046 -0.524 . . . . 63.15 111.207 178.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.4 t -143.22 120.8 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.799 -0.815 . . . . 74.02 108.799 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.86 147.15 33.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.364 -0.606 . . . . 62.42 109.364 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -131.01 145.35 52.02 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.147 0.499 . . . . 74.25 109.72 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.459 ' CZ2' ' HB1' ' A' ' 174' ' ' ALA . 30.2 m-90 -121.45 124.63 44.93 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.032 -1.099 . . . . 73.23 108.032 174.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -104.64 99.41 9.08 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.885 -1.154 . . . . 55.41 107.885 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 1.3 mm? -89.2 133.42 34.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.527 -0.761 . . . . 75.44 109.272 -174.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -117.58 150.59 47.03 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 116.139 -0.482 . . . . 74.22 111.854 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.401 ' HA ' HD21 ' A' ' 127' ' ' LEU . 72.2 Cg_endo -76.76 156.96 35.44 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 123.087 2.525 . . . . 64.15 111.85 177.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.47 -36.73 2.93 Favored Glycine 0 C--N 1.31 -0.91 0 CA-C-N 115.977 -0.556 . . . . 71.25 111.798 178.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.49 149.98 8.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.789 -0.819 . . . . 74.23 108.789 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -86.22 114.51 25.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.608 -0.886 . . . . 71.14 108.608 177.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.1 m -104.61 141.99 35.45 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.575 -0.528 . . . . 74.41 109.575 -177.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.418 HG21 ' HG2' ' A' ' 124' ' ' ARG . 67.1 p -116.22 156.84 25.84 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 120.738 0.304 . . . . 75.34 110.564 -177.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.444 ' HA ' ' CD1' ' A' ' 162' ' ' TRP . 23.4 ptp -128.95 117.45 20.98 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.132 -1.062 . . . . 64.25 108.132 175.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.558 ' OG ' ' HB3' ' A' ' 151' ' ' ASN . 2.9 p -138.33 132.93 32.34 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.936 -0.706 . . . . 74.42 112.084 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.459 ' HB1' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.71 139.88 19.36 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 123.664 0.785 . . . . 75.45 109.341 -176.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -137.99 130.59 29.51 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.464 -1.31 . . . . 63.44 107.464 174.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.459 ' HB3' ' CE1' ' A' ' 178' ' ' TYR . . . -148.55 153.1 37.93 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.912 -0.315 . . . . 65.32 110.409 -177.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -89.55 126.25 35.53 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.547 -0.908 . . . . 72.31 108.547 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.459 ' CE1' ' HB3' ' A' ' 176' ' ' ALA . 85.3 m-85 -124.69 152.86 43.18 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-O 120.988 0.423 . . . . 74.31 111.107 -176.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.2 p -78.34 94.38 4.84 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 116.138 -0.483 . . . . 70.32 111.518 177.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.384 0 C-N-CA 125.259 1.424 . . . . 74.14 113.773 175.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 37.4 ttm180 . . . . . 0 N--CA 1.408 -2.527 0 N-CA-C 108.992 -0.744 . . . . 74.42 108.992 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.19 113.62 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 N-CA-C 106.036 -1.838 . . . . 72.51 106.036 176.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -120.21 114.36 21.81 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 121.249 0.547 . . . . 72.11 109.807 -178.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 139' ' ' LEU . . . -104.63 108.37 19.78 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.093 -1.077 . . . . 63.12 108.093 178.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 140' ' ' THR . 21.2 m -119.39 115.32 23.86 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.163 -1.051 . . . . 74.43 108.163 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.9 pp -125.64 146.42 31.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.275 0.559 . . . . 73.22 109.819 -177.045 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 43.0 m -126.31 125.38 42.2 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 108.307 -0.997 . . . . 74.24 108.307 -178.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.503 HG22 ' OH ' ' A' ' 178' ' ' TYR . 8.4 tt -116.74 129.62 72.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.278 0.561 . . . . 74.31 110.073 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -105.34 149.63 37.98 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 116.116 -0.493 . . . . 75.34 111.514 -175.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.53 -7.14 0.73 Allowed 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 124.995 3.797 . . . . 72.54 116.078 -178.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 3.32 30.11 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.997 -0.44 . . . . 71.31 110.319 177.331 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.1 t70 71.74 34.44 1.58 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 123.993 1.854 . . . . 73.43 106.378 -175.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.17 125.05 50.52 Favored 'General case' 0 N--CA 1.392 -3.34 0 CA-C-N 113.26 -1.791 . . . . 73.44 107.459 -177.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.55 140.56 34.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.804 -0.813 . . . . 74.34 108.804 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.8 p -150.67 159.87 44.22 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.537 -0.912 . . . . 70.11 108.537 179.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.82 -173.44 43.39 Favored Glycine 0 CA--C 1.49 -1.522 0 C-N-CA 118.682 -1.723 . . . . 54.34 113.03 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.6 133.41 14.0 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.121 0.486 . . . . 72.32 110.488 -176.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.08 115.94 50.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 106.839 -1.541 . . . . 75.22 106.839 174.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.02 118.74 57.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.891 -0.781 . . . . 75.13 108.891 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.1 107.37 17.18 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 106.087 -1.819 . . . . 72.31 106.087 174.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.86 133.47 51.93 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 116.184 -0.462 . . . . 64.12 111.048 -174.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.79 157.89 33.02 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.174 -0.921 . . . . 72.33 109.975 -177.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt . . . . . 0 C--N 1.312 -1.064 0 N-CA-C 107.525 -1.287 . . . . 72.41 107.525 173.391 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 61.1 m . . . . . 1 N--CA 1.378 -4.069 0 N-CA-C 108.263 -1.014 . . . . 72.21 108.263 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.44 126.89 0.91 Allowed Glycine 0 N--CA 1.422 -2.267 0 CA-C-O 118.51 -1.161 . . . . 63.3 111.611 174.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 6.9 Cg_endo -56.51 148.15 65.01 Favored 'Trans proline' 0 CA--C 1.553 1.437 0 CA-C-N 120.518 2.159 . . . . 74.54 108.839 166.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.95 128.39 54.89 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.292 0.849 . . . . 54.21 113.292 -172.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 90.5 mt -94.57 133.22 38.44 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.77 -0.65 . . . . 75.41 109.503 176.047 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -111.62 83.64 1.81 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.556 0.693 . . . . 73.55 111.85 176.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.579 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -88.72 87.62 1.5 Allowed Glycine 0 N--CA 1.423 -2.174 0 CA-C-N 114.677 -1.147 . . . . 53.21 111.239 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.47 104.75 16.87 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.523 0.678 . . . . 73.5 110.667 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.36 160.58 68.09 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.123 -1.066 . . . . 75.44 108.123 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.64 -8.61 23.74 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 122.52 2.146 . . . . 74.41 112.64 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -120.63 39.63 3.71 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.64 -0.709 . . . . 72.13 110.951 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.2 m -56.45 -32.97 65.44 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 116.407 -0.36 . . . . 70.34 111.867 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -68.53 -12.5 61.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.213 0.53 . . . . 65.51 111.168 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -100.64 -9.2 22.14 Favored 'General case' 0 C--O 1.26 1.628 0 CA-C-N 116.046 -0.525 . . . . 71.21 110.249 -178.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 5.6 p -129.64 119.33 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.097 0.951 . . . . 72.32 111.209 177.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.67 110.63 21.96 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.225 -0.898 . . . . 72.02 109.815 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.01 114.42 35.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.995 -1.483 . . . . 74.2 106.995 177.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 m -123.78 164.38 19.29 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.776 -0.647 . . . . 72.12 109.79 -172.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -86.86 125.55 34.07 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.198 -1.408 . . . . 74.54 107.198 175.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 82.6 t80 -92.7 120.12 32.79 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.167 -0.679 . . . . 74.02 109.167 -175.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -138.52 99.21 3.77 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 106.776 -1.564 . . . . 72.22 106.776 174.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.7 t -174.36 153.35 1.92 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.024 -1.102 . . . . 74.22 108.024 -174.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.53 16.4 10.49 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.835 0.854 . . . . 74.21 111.501 174.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.27 85.1 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 116.065 -0.516 . . . . 54.41 112.793 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -104.07 153.63 20.66 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.116 -0.698 . . . . 74.34 109.116 -178.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 56' ' ' THR . 27.1 m -124.33 141.51 44.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.036 -1.098 . . . . 75.33 108.036 172.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -177.69 -154.21 12.03 Favored Glycine 0 N--CA 1.407 -3.24 0 C-N-CA 119.981 -1.104 . . . . 65.12 111.568 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.601 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 1.7 p -130.5 150.04 51.89 Favored 'General case' 0 C--N 1.26 -3.288 0 CA-C-O 121.351 0.596 . . . . 74.24 110.971 178.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -138.61 138.98 38.39 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 116.15 -0.477 . . . . 74.31 110.373 -175.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.97 114.1 25.71 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.593 -1.262 . . . . 73.11 107.593 175.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -115.23 112.09 38.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 109.422 -0.585 . . . . 70.24 109.422 -177.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.417 ' C ' ' HG ' ' A' ' 88' ' ' SER . 43.1 p90 -112.47 151.85 29.43 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 110.0 -0.371 . . . . 70.32 110.0 -175.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.417 ' HG ' ' C ' ' A' ' 87' ' ' PHE . 37.2 m -154.31 145.68 23.01 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 120.484 -0.487 . . . . 71.51 109.705 -175.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t0 60.13 62.39 1.63 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.471 1.129 . . . . 62.15 112.155 178.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.5 mt -119.23 170.97 8.63 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.675 -1.148 . . . . 73.51 108.908 175.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.465 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.2 t -113.59 169.12 9.2 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.825 -0.805 . . . . 74.21 108.825 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.48 -30.13 68.31 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.224 0.535 . . . . 75.2 111.077 -178.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.97 -25.56 67.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.975 -0.557 . . . . 63.42 111.433 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.465 ' OE1' HG22 ' A' ' 91' ' ' THR . 49.5 mt-10 -86.66 -16.57 36.21 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 112.468 0.544 . . . . 70.43 112.468 -176.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 11.6 mt -51.22 -55.19 30.6 Favored Pre-proline 0 N--CA 1.483 1.218 0 N-CA-C 115.382 1.623 . . . . 74.31 115.382 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.32 -40.66 56.69 Favored 'Trans proline' 0 C--N 1.366 1.452 0 CA-C-N 120.894 1.355 . . . . 71.15 110.954 -179.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -63.07 -40.0 96.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.88 -1.054 . . . . 74.15 111.511 -177.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -76.18 -19.89 58.02 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 120.604 -0.438 . . . . 74.44 110.586 177.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.09 -21.62 59.83 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.2 -0.667 . . . . 75.21 109.2 -177.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.03 -57.54 11.23 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.468 -0.787 . . . . 71.21 108.957 175.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.579 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 33.3 ttp -54.2 -49.09 70.17 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.764 -0.653 . . . . 72.23 110.094 178.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -53.9 -42.75 69.05 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.427 -0.806 . . . . 62.31 111.286 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.2 p -67.78 -24.92 65.38 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 120.018 -0.673 . . . . 70.44 111.603 -173.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.05 -25.14 66.11 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 120.914 0.388 . . . . 74.0 110.182 -177.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -103.4 -7.89 20.64 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.536 -0.466 . . . . 63.21 110.712 -179.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.63 -43.63 4.88 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.444 -0.503 . . . . 64.14 112.219 -173.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.92 12.72 80.81 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.694 -0.765 . . . . 64.22 111.688 -177.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 m -112.21 169.35 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.985 -0.746 . . . . 71.12 108.985 -178.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -114.07 124.76 52.9 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.854 -0.339 . . . . 64.22 110.708 -178.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.42 132.66 55.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.881 -0.785 . . . . 74.41 108.881 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.1 m -144.11 131.77 21.22 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.457 -0.571 . . . . 75.21 109.457 177.056 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 157.82 43.97 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.211 0.529 . . . . 74.41 112.405 -175.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -155.66 165.56 36.16 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.472 -1.24 . . . . 72.0 110.697 178.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -99.06 137.72 37.19 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 106.355 -1.72 . . . . 75.24 106.355 171.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -118.44 94.45 4.48 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 107.53 -1.285 . . . . 65.14 107.53 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.07 -114.44 5.25 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.406 -1.478 . . . . 71.01 109.406 -175.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -112.32 14.7 20.47 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.723 1.249 . . . . 73.44 108.922 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.5 pp -123.26 148.99 26.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 120.396 -1.44 . . . . 74.41 108.383 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 175' ' ' GLN . 70.8 t -99.55 135.99 32.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 O-C-N 122.18 -0.325 . . . . 73.32 110.544 -177.331 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.9 pt -118.86 130.23 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-O 121.767 0.794 . . . . 74.24 109.235 176.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 tt -126.91 131.61 51.09 Favored 'General case' 0 C--N 1.266 -3.064 0 CA-C-N 115.352 -0.84 . . . . 73.33 109.26 177.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -123.27 146.44 47.87 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.094 -1.076 . . . . 74.15 108.094 177.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.32 155.59 27.01 Favored Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 110.534 -1.026 . . . . 70.51 110.534 177.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.34 139.04 33.5 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.161 -1.051 . . . . 75.12 108.161 175.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.55 114.28 15.88 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.833 -0.622 . . . . 74.05 109.463 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -111.28 108.54 18.19 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.273 -1.01 . . . . 61.14 108.273 178.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.09 29.52 7.91 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.601 -0.518 . . . . 72.23 109.601 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 120.122 -0.631 . . . . 73.21 110.563 -179.059 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 113.093 0.775 . . . . 74.1 113.093 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.85 136.88 38.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.907 -1.886 . . . . 72.11 105.907 171.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.9 t70 -132.21 125.94 32.36 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 120.553 -0.459 . . . . 72.34 110.047 -172.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 67.5 t -116.38 127.88 73.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.54 -0.864 . . . . 74.51 109.775 -179.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -128.53 141.13 51.47 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.134 -0.691 . . . . 72.42 109.134 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 5.6 tt -132.23 122.67 25.6 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.895 -1.52 . . . . 74.2 106.895 175.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 31' ' ' SER . 2.2 m -124.86 132.52 53.31 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.994 -1.113 . . . . 74.01 107.994 -176.149 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 71.8 t -124.08 125.98 71.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 109.549 -0.537 . . . . 75.04 109.549 178.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -109.41 121.1 44.44 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.745 -1.206 . . . . 61.33 107.745 175.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -133.82 105.83 11.67 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 111.756 0.28 . . . . 75.15 111.756 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -67.05 34.69 0.14 Allowed 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 123.604 2.869 . . . . 74.04 113.329 178.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -109.26 -90.39 0.46 Allowed 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.093 -0.706 . . . . 73.01 109.093 178.338 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.12 124.0 0.01 OUTLIER 'General case' 0 C--N 1.362 1.117 0 C-N-CA 124.196 0.998 . . . . 72.54 109.682 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.9 p -80.02 138.46 19.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.746 -0.835 . . . . 74.3 108.746 175.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.8 t -104.43 -27.58 11.85 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.678 -0.409 . . . . 63.41 110.371 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.6 m -159.48 132.33 6.84 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 108.049 -1.093 . . . . 63.1 108.049 174.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.1 t -140.42 150.75 44.24 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 118.531 0.605 . . . . 72.33 111.925 174.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -120.69 93.11 3.93 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 105.719 -1.956 . . . . 61.23 105.719 174.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.01 -142.73 6.41 Favored Glycine 0 C--N 1.296 -1.651 0 N-CA-C 107.347 -2.301 . . . . 65.01 107.347 -178.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -118.45 104.35 10.62 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 118.603 1.202 . . . . 71.14 109.88 177.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -84.87 113.57 21.47 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.945 -0.571 . . . . 75.41 111.094 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.5 mt -80.66 -46.62 21.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.52 -1.289 . . . . 75.04 107.52 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -134.0 160.76 67.3 Favored Pre-proline 0 C--N 1.295 -1.789 0 CA-C-N 114.317 -1.311 . . . . 75.34 107.491 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.411 ' HD2' ' OE2' ' A' ' 158' ' ' GLU . 48.6 Cg_exo -61.5 -17.13 52.06 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.496 2.131 . . . . 73.22 111.577 173.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 1.4 pm0 -115.13 2.42 14.13 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 113.484 0.92 . . . . 73.22 113.484 177.054 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.79 120.44 16.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 121.621 -0.674 . . . . 74.12 109.612 178.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.8 t -129.36 147.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 109.304 -0.628 . . . . 74.15 109.304 -177.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -136.77 143.61 43.33 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.31 0.576 . . . . 75.2 111.049 -178.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.407 ' CZ2' ' HB1' ' A' ' 174' ' ' ALA . 30.5 m-90 -119.79 123.93 44.89 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.468 -0.938 . . . . 62.14 108.468 177.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -101.15 110.34 22.35 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.296 0.569 . . . . 74.41 109.756 177.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.0 mm? -97.4 116.87 30.42 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 122.279 1.038 . . . . 72.13 108.723 -177.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -117.08 138.92 25.26 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 113.637 -1.619 . . . . 73.04 110.584 -169.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.06 156.63 61.68 Favored 'Trans proline' 0 C--O 1.244 0.81 0 C-N-CA 122.442 2.095 . . . . 72.34 111.351 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.55 -33.39 3.24 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 116.128 -0.487 . . . . 61.03 111.991 177.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 32.7 m -108.02 165.49 4.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.348 0.594 . . . . 74.22 111.656 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.42 144.14 22.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.723 -1.214 . . . . 73.32 107.723 175.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.9 m -139.29 142.86 37.71 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.651 -0.656 . . . . 73.24 111.549 179.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 13.3 p -96.25 150.36 20.63 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.337 -0.847 . . . . 74.4 108.917 177.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 76.2 mtp -129.65 128.75 43.23 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.863 -0.792 . . . . 75.12 108.863 -178.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.7 t -143.62 142.66 31.14 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.939 -1.134 . . . . 52.11 107.939 174.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.407 ' HB1' ' CZ2' ' A' ' 162' ' ' TRP . . . -155.18 116.63 4.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.879 -0.785 . . . . 73.44 108.879 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 48.3 mt-30 -125.53 130.56 51.97 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 108.022 -1.103 . . . . 72.24 108.022 176.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -143.44 158.97 43.21 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 116.533 -0.303 . . . . 71.42 110.969 -176.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -87.37 125.04 34.01 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.76 -0.376 . . . . 75.32 110.085 178.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.503 ' OH ' HG22 ' A' ' 34' ' ' ILE . 8.0 m-85 -134.86 120.29 19.13 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 114.371 1.249 . . . . 75.51 114.371 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.2 p -61.13 105.48 0.49 Allowed 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 113.937 -1.483 . . . . 65.33 110.51 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 36.7 t70 . . . . . 0 C--N 1.3 -1.577 0 CA-C-N 113.944 -1.48 . . . . 71.33 110.646 -176.377 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.91 0 N-CA-C 110.183 -0.302 . . . . 74.23 110.183 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.22 115.5 47.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.582 0.706 . . . . 75.42 109.359 177.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -113.12 119.0 36.32 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.776 -0.647 . . . . 72.13 110.749 -179.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.96 108.22 16.74 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.561 -1.274 . . . . 62.15 107.561 175.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 m -114.79 114.98 26.29 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.376 -1.342 . . . . 52.01 107.376 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.5 pp -126.83 146.18 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 109.419 -0.586 . . . . 74.22 109.419 -177.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.6 m -126.35 137.51 53.47 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 108.566 -0.902 . . . . 64.04 108.566 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.81 125.02 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 109.032 -0.729 . . . . 74.22 109.032 -176.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 m -105.78 152.08 40.08 Favored Pre-proline 0 N--CA 1.425 -1.689 0 CA-C-N 115.762 -0.653 . . . . 74.22 110.232 -177.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.62 2.42 0.98 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 123.904 3.069 . . . . 73.02 114.577 -176.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -87.99 3.54 48.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.222 -1.029 . . . . 75.4 108.222 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 91' ' ' THR . 15.0 t70 72.07 28.68 2.47 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 126.298 1.839 . . . . 71.35 106.227 -175.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 tp -102.02 129.04 48.23 Favored 'General case' 0 N--CA 1.381 -3.919 0 CA-C-N 112.689 -2.05 . . . . 73.44 109.164 -176.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.95 132.43 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 N-CA-C 107.827 -1.175 . . . . 74.54 107.827 176.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.2 p -142.52 151.42 41.62 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.621 -1.251 . . . . 71.42 107.621 177.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.53 -176.42 47.11 Favored Glycine 0 N--CA 1.418 -2.525 0 C-N-CA 118.722 -1.704 . . . . 73.31 112.7 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.65 133.58 25.66 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.736 -0.732 . . . . 73.1 109.878 -175.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.8 mt -120.42 115.7 47.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.218 -1.401 . . . . 75.34 107.218 175.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.83 115.31 48.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.115 0.483 . . . . 74.12 109.98 -178.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.494 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -105.93 108.42 19.92 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.116 -1.809 . . . . 75.42 106.116 173.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . . . -125.06 132.38 53.19 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.312 -0.555 . . . . 74.2 111.418 -175.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.45 129.44 41.19 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.931 -1.031 . . . . 73.45 110.866 -178.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt . . . . . 0 C--N 1.323 -0.562 0 N-CA-C 107.269 -1.382 . . . . 74.54 107.269 171.784 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.422 -1.863 0 N-CA-C 108.119 -1.067 . . . . 75.14 108.119 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.36 96.82 0.1 Allowed Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.595 -0.812 . . . . 73.02 112.845 176.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.77 160.57 45.93 Favored 'Trans proline' 0 C--O 1.248 1.025 0 C-N-CA 123.487 2.791 . . . . 74.34 111.932 174.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.83 158.49 28.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.765 0.317 . . . . 70.15 111.096 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 95.2 mt -102.25 154.99 18.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 106.62 -1.622 . . . . 74.32 106.62 173.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -93.03 86.35 5.38 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.227 1.013 . . . . 71.21 109.703 -177.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.503 ' HA2' ' SD ' ' A' ' 101' ' ' MET . . . -85.16 84.31 1.6 Allowed Glycine 0 N--CA 1.413 -2.888 0 CA-C-N 114.101 -1.408 . . . . 72.42 111.958 -178.011 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -112.05 97.6 6.77 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.986 0.422 . . . . 72.1 110.244 178.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 m -146.1 159.45 46.01 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 123.995 0.918 . . . . 74.43 108.815 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.18 -9.02 22.9 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.106 1.871 . . . . 74.32 112.05 176.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -114.79 42.05 2.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 74.33 111.994 -178.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.6 m -55.3 -28.32 52.83 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 111.776 0.287 . . . . 72.42 111.776 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -65.65 -20.32 66.26 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 121.276 0.56 . . . . 74.32 110.813 -178.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -90.85 -18.26 25.14 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.645 -0.707 . . . . 75.34 110.535 -177.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.98 119.59 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 121.964 0.887 . . . . 54.12 112.532 -176.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.67 104.79 16.11 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.273 -0.876 . . . . 75.23 109.58 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.8 p -98.95 133.04 43.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.054 -0.721 . . . . 74.31 109.054 177.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -154.74 173.46 16.39 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 123.335 0.654 . . . . 72.14 109.612 -175.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -77.72 153.62 32.82 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.495 0.664 . . . . 75.24 110.308 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 76.9 t80 -114.39 122.55 46.99 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 108.022 -1.103 . . . . 72.41 108.022 176.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -138.62 102.85 4.7 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.913 -1.514 . . . . 72.3 106.913 177.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -164.13 141.88 7.03 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.147 -0.686 . . . . 72.32 109.147 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 67.05 10.45 7.7 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.887 0.875 . . . . 64.15 111.996 174.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.88 -0.36 64.6 Favored Glycine 0 N--CA 1.426 -2.026 0 N-CA-C 111.238 -0.745 . . . . 72.11 111.238 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 12.6 m-85 -96.95 142.0 29.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.454 -0.943 . . . . 75.1 108.454 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 35.3 m -123.85 136.92 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 108.26 -1.015 . . . . 72.34 108.26 174.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.34 -155.34 9.44 Favored Glycine 0 N--CA 1.402 -3.612 0 C-N-CA 119.189 -1.482 . . . . 44.43 112.051 179.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.405 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 16.0 p -126.62 134.42 50.78 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 114.84 -0.68 . . . . 74.2 110.749 -177.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.412 ' NE2' ' HD1' ' A' ' 75' ' ' TYR . 3.7 pt20 -126.74 143.12 51.34 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.06 0.457 . . . . 74.53 111.317 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -124.35 114.54 19.68 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.272 -1.381 . . . . 64.45 107.272 174.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.76 115.17 48.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 107.845 -1.169 . . . . 74.22 107.845 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.47 ' CD2' HD11 ' A' ' 90' ' ' LEU . 49.8 p90 -115.45 152.43 32.94 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.153 0.501 . . . . 72.34 110.473 -176.013 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 p -159.27 155.3 26.69 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.906 -0.588 . . . . 61.21 109.641 -176.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.24 31.32 6.69 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.076 0.86 . . . . 74.04 111.386 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.47 HD11 ' CD2' ' A' ' 87' ' ' PHE . 25.2 mt -91.76 156.56 17.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 116.106 -0.497 . . . . 74.55 109.785 176.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 40.1 p -108.0 171.9 7.14 Favored 'General case' 0 C--N 1.277 -2.556 0 O-C-N 123.801 0.688 . . . . 73.11 109.933 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -57.01 -35.95 69.85 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.998 0.519 . . . . 74.02 109.729 179.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.08 -28.5 66.57 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.859 -0.61 . . . . 72.22 111.372 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.425 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 41.0 mt-10 -86.33 -17.03 35.6 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.212 0.449 . . . . 55.34 112.212 -176.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.68 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.9 tt -61.36 -48.65 90.5 Favored Pre-proline 0 CA--C 1.569 1.68 0 N-CA-C 112.355 0.502 . . . . 72.52 112.355 -178.084 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.91 -37.9 82.61 Favored 'Trans proline' 0 C--N 1.376 2.009 0 CA-C-N 121.049 1.41 . . . . 74.54 110.316 176.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.425 ' NE2' ' HA ' ' A' ' 94' ' ' GLU . 20.7 mt-30 -63.91 -38.76 92.27 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.93 -1.032 . . . . 72.23 111.129 -177.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.5 pp -70.11 -23.84 63.1 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 120.669 -0.412 . . . . 72.34 110.103 177.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.4 -20.78 63.8 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.094 -0.503 . . . . 64.02 110.587 -175.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -63.27 -57.95 8.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.404 -0.591 . . . . 73.34 109.404 176.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.503 ' SD ' ' HA2' ' A' ' 62' ' ' GLY . 65.3 mtm -56.68 -48.97 76.46 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.436 0.636 . . . . 75.35 109.507 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -53.93 -40.57 66.86 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.264 -1.335 . . . . 75.44 111.644 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.8 p -65.22 -26.87 68.31 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 119.906 -0.717 . . . . 75.45 111.077 -172.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.04 -33.26 74.05 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 116.15 -0.477 . . . . 74.4 110.71 -176.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.41 -9.57 20.17 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.287 -0.565 . . . . 70.2 111.058 -176.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.96 -47.64 3.66 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.143 0.794 . . . . 53.25 113.143 -173.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.79 7.3 64.73 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.861 -0.896 . . . . 54.14 110.861 -173.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.6 m -101.51 172.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 O-C-N 122.427 -0.455 . . . . 75.21 110.493 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -138.93 141.08 38.48 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.409 -1.33 . . . . 64.54 107.409 176.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.87 132.29 38.37 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.744 -0.836 . . . . 75.2 108.744 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.2 m -134.76 134.12 40.61 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.343 -0.984 . . . . 73.41 108.343 178.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -141.85 147.91 37.96 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.328 0.585 . . . . 61.04 111.551 -178.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -146.02 154.87 42.36 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.402 -1.272 . . . . 75.01 110.658 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.7 mtt85 -88.61 138.68 31.21 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.627 -0.715 . . . . 75.24 109.926 171.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.455 ' O ' HG13 ' A' ' 118' ' ' ILE . 51.7 t30 -123.11 90.04 3.22 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 105.486 -2.042 . . . . 63.42 105.486 176.017 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.5 -118.7 8.66 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 108.857 -1.697 . . . . 42.24 108.857 -170.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 9.5 t30 -105.95 1.31 26.52 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.706 1.241 . . . . 72.42 108.94 178.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -103.9 148.98 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 118.818 -1.153 . . . . 74.4 108.19 178.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.74 140.47 32.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 121.972 -0.455 . . . . 72.42 111.45 -176.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.438 HD11 ' O ' ' A' ' 120' ' ' ILE . 2.9 pp -121.41 121.52 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 115.058 -0.974 . . . . 73.42 109.161 178.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.33 127.8 50.25 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.127 -0.694 . . . . 74.1 109.127 179.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -125.97 135.71 52.15 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.36 -0.836 . . . . 73.35 109.469 177.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -145.74 158.07 27.56 Favored Glycine 0 N--CA 1.416 -2.67 0 N-CA-C 110.86 -0.896 . . . . 74.2 110.86 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.43 145.42 43.14 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.808 -0.442 . . . . 74.41 109.808 177.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -111.06 119.42 38.97 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.073 0.463 . . . . 74.31 111.336 -176.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -112.89 93.53 4.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.277 -0.419 . . . . 73.41 110.209 179.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -142.75 26.24 1.75 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.197 1.475 . . . . 75.41 108.398 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.5 p . . . . . 0 C--N 1.284 -2.257 0 CA-C-N 113.272 -1.785 . . . . 75.0 112.008 -176.849 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 112.001 0.371 . . . . 72.31 112.001 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.68 116.51 2.34 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.423 0.63 . . . . 71.33 112.569 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -118.59 126.74 52.62 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.888 -1.893 . . . . 62.43 105.888 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 42.5 t -110.97 117.07 54.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 121.136 -0.226 . . . . 63.54 110.497 -175.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -109.97 120.32 42.09 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.644 -0.502 . . . . 73.22 109.644 176.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.485 HD11 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -114.1 116.24 28.81 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.553 -2.017 . . . . 72.21 105.553 175.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 19.4 m -122.52 131.23 53.75 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.71 -0.478 . . . . 61.2 109.71 -177.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 94.4 t -122.68 122.83 66.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.75 -0.833 . . . . 73.03 108.75 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.8 126.63 55.64 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.999 0.428 . . . . 74.22 110.29 178.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.625 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.5 p90 -133.83 123.07 16.91 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.876 -0.602 . . . . 73.53 110.068 177.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -74.43 35.46 0.4 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.61 2.207 . . . . 74.3 113.503 -178.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.74 -100.47 0.43 Allowed 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 122.192 -0.318 . . . . 64.5 110.772 -177.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -177.3 128.76 0.16 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.951 -0.759 . . . . 45.34 108.951 -177.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.38 133.24 29.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.539 -0.755 . . . . 73.15 109.324 177.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 p -88.81 -38.92 14.26 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.376 0.607 . . . . 74.33 109.456 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 74.5 m -159.52 133.18 7.25 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 115.707 -0.679 . . . . 72.55 109.811 176.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.455 ' OG1' HG13 ' A' ' 160' ' ' VAL . 8.1 t -137.97 155.96 48.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.349 -0.611 . . . . 73.33 109.349 174.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -126.69 93.89 3.9 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 105.987 -1.857 . . . . 73.42 105.987 175.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.59 -144.51 8.2 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 108.555 -1.818 . . . . 75.03 108.555 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -114.29 99.97 7.99 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 117.653 0.726 . . . . 73.52 109.367 -178.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -77.51 126.93 31.66 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-N 115.752 -0.658 . . . . 65.2 109.794 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.16 -37.49 9.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.225 -1.398 . . . . 72.32 107.225 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -142.65 166.64 19.62 Favored Pre-proline 0 N--CA 1.425 -1.713 0 N-CA-C 106.451 -1.685 . . . . 73.44 106.451 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.84 0.55 6.29 Favored 'Trans proline' 0 C--O 1.21 -0.88 0 C-N-CA 122.475 2.117 . . . . 74.3 110.684 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.6 pt-20 -130.12 0.12 4.67 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.902 -0.59 . . . . 73.2 111.689 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 82.2 t -140.65 120.89 13.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.469 -0.937 . . . . 72.02 108.469 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.455 HG13 ' OG1' ' A' ' 150' ' ' THR . 41.6 t -125.57 147.23 30.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.345 -0.613 . . . . 71.42 109.345 -177.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -137.25 143.57 42.29 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.416 0.627 . . . . 72.12 110.074 -177.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.485 ' CE3' HD11 ' A' ' 139' ' ' LEU . 25.6 m-90 -123.67 120.2 32.04 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 108.075 -1.083 . . . . 75.34 108.075 177.082 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.0 pttt -108.95 102.47 11.47 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.352 -0.84 . . . . 63.41 109.081 -178.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 9.5 mt -101.13 138.24 38.43 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.818 -1.083 . . . . 72.25 110.166 -171.469 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -118.56 151.71 50.15 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 115.566 -0.743 . . . . 75.11 110.884 177.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.95 157.43 47.16 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.298 1.998 . . . . 75.11 111.096 178.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 86.55 -36.15 3.27 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.432 -0.89 . . . . 75.14 111.637 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.75 153.9 6.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 109.584 -0.524 . . . . 74.4 109.584 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.39 143.46 12.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.811 -0.44 . . . . 74.23 109.811 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 48.5 m -146.52 143.0 28.62 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.329 -0.989 . . . . 72.1 108.329 176.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -125.49 156.96 38.14 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.811 -0.811 . . . . 72.12 108.811 178.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -126.32 137.8 53.52 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.523 0.677 . . . . 75.43 112.028 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.7 t -134.48 136.92 43.51 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.141 -1.429 . . . . 75.35 107.141 173.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -148.09 116.38 6.54 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.634 -0.876 . . . . 62.54 108.634 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -127.08 131.25 50.93 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 107.216 -1.401 . . . . 74.21 107.216 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -159.44 154.13 24.44 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.445 -0.946 . . . . 72.51 108.445 -176.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 29.2 ptt180 -87.96 129.29 35.29 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.168 -1.013 . . . . 75.24 110.776 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.05 116.27 19.76 Favored 'General case' 0 CA--C 1.477 -1.828 0 N-CA-C 107.721 -1.214 . . . . 75.0 107.721 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.467 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 18.0 p -67.0 123.78 21.18 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.873 -1.058 . . . . 75.53 112.242 -175.106 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.321 -0.662 0 O-C-N 124.071 0.857 . . . . 71.43 108.766 172.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.318 0 CA-C-O 120.833 0.349 . . . . 74.24 110.83 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -113.86 113.4 43.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 105.564 -2.013 . . . . 71.32 105.564 173.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -120.73 114.61 21.9 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.026 -0.731 . . . . 75.21 109.026 -177.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.45 124.46 51.81 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.215 -0.902 . . . . 72.24 109.347 -178.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -124.79 115.69 21.09 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.49 -1.3 . . . . 73.1 107.49 177.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.6 pp -122.36 138.71 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.883 -0.784 . . . . 74.25 108.883 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 93.5 m -119.33 121.68 40.13 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 108.845 -0.798 . . . . 51.51 108.845 -179.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 tt -109.76 115.62 50.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-O 121.675 0.75 . . . . 73.42 109.729 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 37' ' ' ASP . 15.8 m -80.08 148.17 67.14 Favored Pre-proline 0 N--CA 1.412 -2.349 0 N-CA-C 107.985 -1.117 . . . . 75.01 107.985 -179.072 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.85 2.87 0.85 Allowed 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 123.73 2.953 . . . . 75.21 112.972 -179.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 35' ' ' SER . 25.3 t70 -87.11 -1.82 58.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.609 -0.885 . . . . 71.13 108.609 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 12.8 t70 73.05 29.46 1.77 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.054 1.742 . . . . 63.2 108.135 -175.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.11 124.76 50.08 Favored 'General case' 0 N--CA 1.394 -3.24 0 CA-C-N 113.946 -1.479 . . . . 71.34 107.653 178.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.72 129.87 63.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.835 -0.802 . . . . 72.03 108.835 -178.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.6 p -143.79 131.55 21.38 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.286 -1.005 . . . . 72.44 108.286 179.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.27 -175.34 32.2 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 118.967 -1.587 . . . . 71.31 113.178 -176.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.39 133.3 16.02 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 123.503 0.721 . . . . 73.01 109.529 -176.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 60.9 mt -120.11 116.13 49.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 107.88 -1.155 . . . . 71.24 107.88 177.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.11 116.62 53.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.712 -0.477 . . . . 72.33 109.712 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.56 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.79 108.49 17.92 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.387 -1.338 . . . . 73.24 107.387 175.462 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.51 122.09 40.87 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.754 -0.461 . . . . 54.21 109.754 -177.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.92 158.07 22.49 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.76 -0.654 . . . . 71.42 111.811 -176.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 N--CA 1.439 -1.023 0 CA-C-N 114.579 -1.191 . . . . 73.35 109.911 175.846 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 106.034 -1.839 . . . . 74.4 106.034 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.23 98.24 0.11 Allowed Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 108.792 -1.723 . . . . 61.22 108.792 175.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -52.52 128.51 28.23 Favored 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 122.121 1.881 . . . . 75.52 110.237 177.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.57 157.94 16.72 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.593 0.96 . . . . 74.3 113.593 -169.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.571 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 71.1 mt -102.45 138.1 39.81 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.164 -0.925 . . . . 74.21 109.742 176.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.7 89.15 3.4 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.502 0.668 . . . . 75.24 111.352 178.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.488 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -120.47 113.87 2.52 Favored Glycine 0 N--CA 1.409 -3.108 0 CA-C-N 115.17 -0.923 . . . . 75.34 111.525 177.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -116.9 107.62 14.82 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.606 -0.887 . . . . 73.45 108.606 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.4 m -136.97 151.61 72.46 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.534 -0.913 . . . . 75.44 108.534 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -73.12 -8.82 22.67 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 122.61 2.207 . . . . 73.22 112.484 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -108.93 36.64 2.8 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.416 0.627 . . . . 74.14 109.834 176.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -57.71 -30.26 65.38 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.425 -0.807 . . . . 73.44 112.454 -179.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -69.51 -18.39 63.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.359 0.6 . . . . 74.34 110.325 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -89.55 -16.03 31.57 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.437 -0.801 . . . . 72.42 109.944 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.6 p -118.52 118.88 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 122.515 1.15 . . . . 75.3 111.235 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.74 104.95 16.9 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.162 -0.926 . . . . 73.11 108.864 -179.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 t -97.99 131.16 45.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.942 -1.503 . . . . 62.33 106.942 179.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.1 m -144.33 171.76 13.88 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.358 -0.979 . . . . 70.32 108.358 -176.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -88.63 153.87 20.77 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 118.968 -1.093 . . . . 73.12 108.259 178.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -112.6 123.27 49.92 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.792 -1.188 . . . . 75.34 107.792 177.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -139.11 99.18 3.69 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.624 0.726 . . . . 72.12 109.361 177.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.9 m -165.29 161.23 19.03 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.956 -1.127 . . . . 63.03 107.956 -179.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 70.51 3.32 4.45 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.253 1.021 . . . . 75.4 110.914 178.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.51 1.15 83.75 Favored Glycine 0 C--O 1.22 -0.76 0 N-CA-C 110.197 -1.161 . . . . 73.2 110.197 -172.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -104.82 150.49 24.77 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.317 0.647 . . . . 74.23 110.629 -179.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.11 138.18 55.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.466 0.65 . . . . 63.23 110.032 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.32 -153.36 8.15 Favored Glycine 0 C--N 1.276 -2.794 0 N-CA-C 109.946 -1.261 . . . . 54.24 109.946 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.571 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 p -131.45 159.47 37.98 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-O 121.256 0.551 . . . . 72.21 110.933 179.065 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -138.39 140.35 39.35 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.023 -0.535 . . . . 75.33 110.435 179.015 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.81 114.68 24.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.683 -1.229 . . . . 73.45 107.683 175.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.78 111.65 37.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.476 -0.935 . . . . 74.4 108.476 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -113.35 152.81 29.47 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.785 -0.366 . . . . 75.12 110.903 -174.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 p -151.65 154.35 36.2 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.215 -0.448 . . . . 73.41 111.218 -173.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.91 30.63 16.5 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 124.157 0.983 . . . . 72.51 112.877 173.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.2 mt -92.49 160.13 15.2 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 116.202 -0.454 . . . . 74.22 109.798 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.1 t -112.83 175.08 5.59 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 108.819 -0.808 . . . . 75.12 108.819 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.44 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 84.8 t80 -49.38 -44.21 44.8 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.034 0.934 . . . . 65.23 110.82 178.805 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.14 69.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.468 -0.787 . . . . 53.32 112.517 -178.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.35 -16.8 32.03 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.26 0.467 . . . . 74.53 112.26 -174.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 3.9 tt -65.91 -50.03 55.18 Favored Pre-proline 0 CA--C 1.567 1.623 0 CA-C-O 119.228 -0.415 . . . . 74.25 111.544 -178.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.46 -36.52 86.18 Favored 'Trans proline' 0 C--N 1.375 1.94 0 CA-C-N 121.199 1.464 . . . . 64.42 110.698 175.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -63.66 -38.8 92.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 73.13 111.523 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.0 pp -74.06 -19.94 60.45 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.782 -0.451 . . . . 74.12 109.782 177.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.09 -27.5 62.7 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.181 -0.674 . . . . 73.4 109.181 -178.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -61.09 -53.52 56.03 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.758 -0.83 . . . . 74.03 108.758 176.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.488 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 22.7 ttp -53.79 -51.85 62.16 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.518 -0.764 . . . . 70.42 110.054 176.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -55.41 -36.07 66.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.283 -0.871 . . . . 74.1 111.014 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.7 m -62.48 -37.61 86.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 110.182 -0.303 . . . . 73.23 110.182 -175.132 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -73.66 -13.22 60.95 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.355 0.598 . . . . 71.51 110.628 -171.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.43 -19.31 13.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.151 -0.62 . . . . 74.15 110.443 179.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.93 -44.18 4.48 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.572 0.953 . . . . 75.41 113.572 -172.497 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.04 21.43 49.86 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.135 -0.786 . . . . 71.14 111.135 -173.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.5 171.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.265 -0.643 . . . . 72.44 109.265 -178.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -128.64 138.28 52.1 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 117.644 0.202 . . . . 73.2 111.236 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.82 130.97 40.51 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.909 -1.145 . . . . 72.03 107.909 176.027 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.2 t -144.07 151.97 40.35 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.451 -0.944 . . . . 73.13 108.451 177.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.8 148.02 28.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.825 -0.806 . . . . 72.32 108.825 178.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -143.91 156.67 44.52 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.826 -0.625 . . . . 74.2 109.587 -176.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -91.22 138.09 31.86 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 121.521 0.677 . . . . 73.13 112.241 175.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.409 ' O ' HG13 ' A' ' 118' ' ' ILE . 30.7 t30 -127.56 91.9 3.39 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 113.978 -1.464 . . . . 71.22 107.248 177.279 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.54 -106.77 2.23 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 109.579 -1.409 . . . . 74.24 109.579 -175.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -123.73 10.12 8.97 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.841 1.305 . . . . 75.11 108.107 175.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.8 pp -112.88 149.51 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.025 -1.102 . . . . 74.22 108.025 177.139 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.3 t -107.0 133.63 51.07 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 CA-C-O 120.948 0.404 . . . . 62.14 109.996 -176.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.8 pt -105.68 137.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 107.627 -1.249 . . . . 74.53 107.627 176.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.72 127.08 45.66 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 109.048 -0.723 . . . . 74.31 109.048 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -127.71 115.31 18.52 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.347 -1.297 . . . . 72.23 108.19 -177.048 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.3 141.84 11.16 Favored Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 109.854 -1.298 . . . . 62.04 109.854 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -137.05 135.25 37.37 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.388 -0.968 . . . . 73.12 108.388 -177.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.9 110.2 19.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.909 -0.587 . . . . 63.43 111.183 -174.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -105.22 98.59 8.28 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.473 0.654 . . . . 73.11 110.379 177.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.7 mm? -113.26 23.95 12.76 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.602 -0.888 . . . . 75.05 108.602 178.395 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 45.5 p . . . . . 0 CA--C 1.545 0.754 0 N-CA-C 113.83 1.048 . . . . 75.31 113.83 -173.854 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 110.478 -0.193 . . . . 74.21 110.478 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -89.15 123.39 33.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.529 -0.305 . . . . 73.45 111.656 -176.356 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.77 122.63 38.55 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.182 -0.673 . . . . 75.02 109.182 173.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 61.5 t -111.53 120.88 63.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.266 -1.012 . . . . 72.33 108.266 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -121.34 126.53 49.69 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.122 -0.696 . . . . 74.03 109.122 -176.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -119.13 123.56 44.69 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.443 -0.947 . . . . 73.4 108.443 -178.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.7 m -123.87 134.29 53.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.047 -0.723 . . . . 75.23 109.047 179.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 90.3 t -120.68 125.64 74.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.879 -0.785 . . . . 73.45 108.879 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.83 126.27 55.26 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.829 -0.804 . . . . 63.43 108.829 177.489 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.0 p90 -134.47 119.24 14.05 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 112.044 0.387 . . . . 75.44 112.044 178.558 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -68.0 42.97 0.25 Allowed 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.166 2.577 . . . . 74.54 112.425 174.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.0 -106.84 0.33 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 122.732 0.413 . . . . 63.12 110.068 179.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -179.62 131.82 0.1 Allowed 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.401 -0.592 . . . . 72.24 109.401 -177.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -85.26 133.14 30.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.88 -0.785 . . . . 75.53 108.88 177.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.1 p -92.55 -34.71 13.94 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.363 -0.38 . . . . 65.14 110.432 -177.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.3 m -162.73 133.28 4.7 Favored 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 123.875 0.87 . . . . 73.22 109.216 177.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.1 t -139.01 163.92 31.13 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.489 -0.757 . . . . 72.43 111.217 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.552 ' HB3' ' OG ' ' A' ' 173' ' ' SER . 27.4 t-20 -136.41 98.38 3.81 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.23 -2.137 . . . . 73.14 105.23 171.097 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.3 -150.04 10.69 Favored Glycine 0 N--CA 1.412 -2.927 0 N-CA-C 107.157 -2.377 . . . . 65.22 107.157 -179.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -116.69 99.21 6.97 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.196 -1.409 . . . . 75.33 107.196 -178.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . 0.264 6.3 ppt_? -86.34 139.34 31.06 Favored 'General case' 0 N--CA 1.414 -2.272 0 C-N-CA 119.325 -0.95 . . . . 74.04 113.28 -178.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 69.8 mt -94.46 -43.11 13.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.244 -1.344 . . . . 74.52 108.015 -178.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -137.75 172.68 6.39 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 107.54 -1.281 . . . . 74.3 107.54 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -74.22 0.61 8.26 Favored 'Trans proline' 0 C--O 1.21 -0.919 0 C-N-CA 122.197 1.932 . . . . 74.22 110.044 172.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 11.2 pt-20 -130.3 3.23 4.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.228 0.537 . . . . 64.42 111.867 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.3 t -142.09 121.11 9.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.487 -0.931 . . . . 73.22 108.487 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.94 147.64 32.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 109.549 -0.537 . . . . 73.44 109.549 -178.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -132.58 145.13 50.87 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.193 0.521 . . . . 72.5 110.259 -176.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.442 ' CD2' ' HG3' ' A' ' 172' ' ' MET . 27.8 m-90 -130.25 128.74 42.22 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.694 -0.484 . . . . 74.13 109.694 177.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -102.66 112.67 25.54 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.69 0.757 . . . . 74.12 110.019 177.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 33.2 mt -101.41 123.42 45.45 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.025 -0.989 . . . . 72.23 109.022 -176.392 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -118.07 156.38 50.4 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 115.882 -0.599 . . . . 75.2 112.052 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.436 ' HA ' ' CB ' ' A' ' 127' ' ' LEU . 59.8 Cg_endo -74.41 156.47 45.69 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.79 2.327 . . . . 70.14 111.552 177.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.94 -30.92 2.86 Favored Glycine 0 C--N 1.317 -0.527 0 C-N-CA 121.288 -0.482 . . . . 71.41 112.4 177.538 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 166' ' ' PRO . 34.3 m -105.82 160.96 5.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 120.902 0.382 . . . . 71.34 110.42 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.4 p -113.62 110.15 31.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 122.102 0.954 . . . . 72.14 108.787 176.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 32.8 t -101.09 141.5 33.88 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.597 -0.729 . . . . 72.33 109.981 -175.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.1 p -106.42 126.55 52.39 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.584 -0.734 . . . . 74.52 110.526 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.442 ' HG3' ' CD2' ' A' ' 162' ' ' TRP . 39.5 ttm -107.68 116.16 31.44 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.758 -1.201 . . . . 74.45 107.758 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.552 ' OG ' ' HB3' ' A' ' 151' ' ' ASN . 11.7 p -142.85 139.41 30.85 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 118.303 -1.359 . . . . 74.34 111.07 177.068 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -151.26 146.83 26.32 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 108.28 -1.007 . . . . 73.33 108.28 -176.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -138.36 130.72 28.9 Favored 'General case' 0 C--N 1.261 -3.246 0 N-CA-C 105.834 -1.913 . . . . 74.32 105.834 173.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.3 158.88 44.36 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.674 -0.491 . . . . 63.41 109.674 -177.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -91.34 135.2 33.98 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.155 -0.683 . . . . 73.31 109.155 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -143.05 123.82 14.2 Favored 'General case' 0 CA--C 1.47 -2.119 0 C-N-CA 120.119 -0.632 . . . . 75.52 109.93 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.3 p -65.14 104.05 0.85 Allowed 'General case' 0 C--N 1.284 -2.281 0 O-C-N 124.514 1.134 . . . . 72.11 111.232 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.24 0.583 0 CA-C-N 115.078 -0.964 . . . . 73.53 109.889 178.949 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 . . . . . 0 N--CA 1.439 -0.998 0 CA-C-O 120.882 0.372 . . . . 63.14 110.739 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.2 t -123.38 114.83 43.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.548 -0.908 . . . . 70.24 108.548 178.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -126.0 118.93 26.38 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.154 0.502 . . . . 75.33 110.203 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.52 118.65 35.04 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.647 -0.706 . . . . 75.22 109.155 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 t -117.05 114.59 23.96 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.26 -1.385 . . . . 73.13 107.26 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.5 pp -129.25 147.03 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-O 121.453 0.644 . . . . 72.45 109.723 -177.688 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.3 m -128.75 134.71 48.5 Favored 'General case' 0 C--N 1.265 -3.074 0 N-CA-C 109.481 -0.563 . . . . 71.14 109.481 -177.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.9 tt -124.72 123.14 65.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.497 0.665 . . . . 73.34 110.318 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 m -91.73 152.37 43.17 Favored Pre-proline 0 N--CA 1.42 -1.963 0 N-CA-C 108.551 -0.907 . . . . 75.33 108.551 -179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.29 2.49 0.86 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.566 2.844 . . . . 74.35 113.841 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -88.31 0.41 56.19 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.169 -0.678 . . . . 62.55 109.169 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 t70 72.64 29.72 1.96 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.778 -1.564 . . . . 71.21 106.778 -174.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tp -101.71 124.97 48.25 Favored 'General case' 0 N--CA 1.389 -3.484 0 CA-C-N 113.676 -1.602 . . . . 65.23 107.251 177.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.35 135.6 58.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 109.169 -0.678 . . . . 72.4 109.169 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.7 p -143.91 156.28 44.38 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.872 -1.159 . . . . 71.23 107.872 175.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.05 44.23 Favored Glycine 0 N--CA 1.425 -2.041 0 C-N-CA 119.064 -1.541 . . . . 63.32 112.265 179.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.75 133.38 17.78 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 109.368 -0.604 . . . . 74.14 109.368 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 58.7 mt -116.6 116.16 51.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.952 -1.129 . . . . 71.0 107.952 177.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.22 116.19 51.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.992 -0.373 . . . . 74.23 109.992 -177.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.18 108.1 17.66 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.377 -1.712 . . . . 54.43 106.377 173.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.82 131.34 53.72 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.252 0.549 . . . . 73.33 111.078 -174.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.75 158.03 37.59 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.397 -0.82 . . . . 71.44 110.445 -177.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.941 0 N-CA-C 106.522 -1.659 . . . . 74.0 106.522 170.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.418 -2.063 0 N-CA-C 109.871 -0.418 . . . . 74.3 109.871 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.48 102.1 0.15 Allowed Glycine 0 N--CA 1.433 -1.501 0 CA-C-O 118.267 -1.296 . . . . 74.11 111.583 178.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -54.2 128.72 31.1 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 119.961 1.88 . . . . 72.42 110.148 173.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -93.74 148.77 21.81 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 113.074 0.768 . . . . 75.42 113.074 -171.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 83.2 mt -100.15 160.11 14.58 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.236 -1.024 . . . . 73.34 108.236 174.111 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -90.78 86.87 6.46 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.888 -0.782 . . . . 73.22 108.888 -178.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.35 78.27 1.94 Allowed Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 114.622 -1.172 . . . . 64.24 110.963 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -138.27 99.13 3.78 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.458 -0.371 . . . . 64.41 110.993 -176.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 m -151.51 144.65 17.14 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 124.461 1.104 . . . . 73.13 108.658 178.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.51 -32.72 54.43 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.326 2.684 . . . . 73.34 113.254 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -88.52 44.08 1.18 Allowed 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 111.954 0.353 . . . . 75.53 111.954 -179.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.8 m -53.44 -32.27 49.09 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 113.362 0.875 . . . . 72.33 113.362 -176.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -75.82 -12.56 60.19 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.465 -0.772 . . . . 74.24 110.616 -176.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -89.77 -18.25 26.67 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.699 -0.682 . . . . 73.44 109.462 177.54 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.54 119.26 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 122.407 1.098 . . . . 64.2 112.613 -177.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.81 108.99 21.82 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.859 -1.064 . . . . 63.42 108.583 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.7 t -97.62 127.89 49.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 106.709 -1.589 . . . . 72.32 106.709 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -141.39 167.48 22.08 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.26 -0.645 . . . . 70.11 109.26 -172.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.27 135.52 34.72 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.592 -0.892 . . . . 74.41 108.592 179.034 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 87.3 t80 -105.44 120.78 42.46 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.741 -0.837 . . . . 75.32 108.741 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -138.45 99.26 3.79 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 106.992 -1.485 . . . . 72.41 106.992 175.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 32.9 t -173.01 163.25 4.75 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.066 -1.457 . . . . 74.12 107.066 -176.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.1 t70 66.21 9.04 6.01 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.515 1.126 . . . . 75.15 110.765 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.53 -1.89 84.32 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.683 -0.69 . . . . 65.43 111.683 -177.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.43 157.17 17.53 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 122.509 0.323 . . . . 74.22 110.545 -178.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -124.65 137.18 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.775 -0.824 . . . . 65.54 108.775 174.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.28 -153.21 10.0 Favored Glycine 0 C--N 1.269 -3.191 0 N-CA-C 109.817 -1.313 . . . . 64.43 109.817 -177.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.517 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 64.3 m -133.31 154.39 50.75 Favored 'General case' 0 C--N 1.272 -2.778 0 CA-C-O 121.162 0.506 . . . . 73.31 111.383 178.423 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.9 pt20 -133.57 142.69 48.27 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.782 -0.645 . . . . 73.32 110.381 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.9 114.36 27.25 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.434 -1.321 . . . . 63.31 107.434 174.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.12 110.88 32.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.828 -1.175 . . . . 74.25 107.828 -179.229 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.411 ' CD2' HD12 ' A' ' 90' ' ' LEU . 52.1 p90 -120.77 155.29 34.3 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.766 -0.373 . . . . 64.45 110.898 -174.619 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 87' ' ' PHE . 58.6 m -160.74 160.71 31.67 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.059 -0.719 . . . . 75.41 109.059 -178.188 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 63.4 30.65 15.41 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.07 0.948 . . . . 73.25 111.628 178.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.411 HD12 ' CD2' ' A' ' 87' ' ' PHE . 21.6 mt -88.31 156.98 18.89 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.72 -0.392 . . . . 72.54 110.501 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -113.64 168.02 10.12 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.998 -1.482 . . . . 75.31 106.998 177.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -52.76 -37.04 58.93 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 123.485 0.714 . . . . 72.42 111.812 -178.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.39 -26.75 64.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.192 -0.458 . . . . 74.23 112.12 -178.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -88.15 -17.82 30.12 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.309 -0.244 . . . . 64.41 111.228 -177.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 98' ' ' LEU . 45.7 tp -61.45 -52.08 72.74 Favored Pre-proline 0 CA--C 1.564 1.488 0 N-CA-C 113.474 0.916 . . . . 74.42 113.474 -178.107 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.13 -32.68 74.6 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 121.255 1.303 . . . . 72.43 111.338 176.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.91 -31.25 67.83 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 122.264 1.031 . . . . 74.03 109.071 -175.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 25.9 tp -71.5 -30.79 66.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.376 -1.284 . . . . 75.42 109.795 173.463 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.43 -24.04 63.77 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 115.477 -0.783 . . . . 74.43 109.893 -175.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -56.18 -53.91 51.51 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 123.877 0.736 . . . . 72.32 110.672 179.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.2 mtm -55.63 -49.15 73.62 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.486 0.66 . . . . 72.12 109.882 178.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -57.27 -35.28 69.57 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.907 -1.042 . . . . 72.14 111.498 178.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.2 m -61.48 -32.09 72.09 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 109.696 -0.483 . . . . 72.33 109.696 -175.485 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.51 -27.97 66.64 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.351 -0.84 . . . . 75.21 111.534 -175.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.05 -14.25 14.26 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 120.591 -0.444 . . . . 62.11 111.344 -178.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.86 -48.09 3.58 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.988 1.107 . . . . 72.34 113.988 -171.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.76 28.72 41.48 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.095 -1.05 . . . . 73.34 110.88 -173.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 11.1 p -107.26 141.29 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-O 120.759 0.314 . . . . 70.3 110.335 -179.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.432 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 40.5 t30 -113.13 121.27 44.04 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.408 -0.96 . . . . 72.44 108.408 177.343 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.29 106.02 14.47 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.235 -0.654 . . . . 73.53 109.235 178.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.0 m -101.4 108.98 20.73 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.8 -1.185 . . . . 64.55 107.8 177.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -129.93 145.89 51.63 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.858 -0.61 . . . . 74.35 109.654 -176.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -144.37 151.9 39.95 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.553 -0.749 . . . . 74.51 111.853 -177.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.586 ' NH2' ' HA ' ' A' ' 180' ' ' ASP . 5.9 tpt180 -96.7 107.37 19.81 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 106.492 -1.669 . . . . 74.13 106.492 178.208 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.96 97.3 7.9 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.34 -0.985 . . . . 71.4 108.34 -177.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.13 -94.74 0.81 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 110.914 -0.874 . . . . 73.03 110.914 -177.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -135.55 13.62 3.46 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 123.26 1.505 . . . . 74.31 108.729 177.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.9 pp -121.18 149.27 24.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.908 -1.12 . . . . 75.34 109.054 177.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.455 HG22 ' HD3' ' A' ' 114' ' ' ARG . 95.7 t -107.12 132.79 53.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-O 120.995 0.426 . . . . 74.33 110.622 -177.232 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.0 pt -115.19 129.27 71.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.114 -1.069 . . . . 73.43 108.114 175.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 tt -128.95 129.76 45.86 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 115.935 -0.575 . . . . 73.22 110.675 -179.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -126.71 135.1 50.68 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.307 -0.997 . . . . 71.02 108.307 173.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -142.38 129.65 3.95 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.217 -0.992 . . . . 63.13 111.948 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.13 132.57 51.83 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.354 -0.497 . . . . 75.34 110.655 176.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 108' ' ' VAL . . . -113.26 131.03 56.07 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.007 -0.542 . . . . 73.4 111.534 -177.253 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -96.25 92.91 6.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.968 -1.123 . . . . 73.34 107.968 175.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -133.71 17.41 3.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.234 1.016 . . . . 73.2 110.086 -177.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.291 -1.949 0 CA-C-N 114.748 -1.115 . . . . 75.23 109.593 175.888 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 . . . . . 0 C--O 1.243 0.729 0 N-CA-C 112.994 0.738 . . . . 74.12 112.994 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.24 115.55 28.59 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.915 1.08 . . . . 74.3 113.915 -169.691 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.5 137.76 32.47 Favored 'General case' 0 C--O 1.265 1.917 0 N-CA-C 107.64 -1.244 . . . . 55.22 107.64 170.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.6 t -105.89 112.15 37.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.352 -0.981 . . . . 72.31 108.352 178.389 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -102.86 121.36 42.34 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.95 -0.568 . . . . 73.1 109.564 -177.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.422 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -112.69 119.22 37.35 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.721 -1.585 . . . . 74.12 106.721 178.51 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.7 m -123.12 127.35 48.58 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.521 -0.548 . . . . 74.42 109.521 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 58.8 t -119.8 126.99 75.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.352 -0.611 . . . . 72.42 109.352 179.048 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.51 125.58 54.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.799 -0.815 . . . . 53.32 108.799 177.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.493 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.0 p90 -134.33 124.16 17.04 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 111.774 0.287 . . . . 74.51 111.774 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -70.83 31.81 0.22 Allowed 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.972 2.448 . . . . 75.34 112.556 176.555 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -115.16 -107.37 0.38 Allowed 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.342 -0.614 . . . . 74.53 109.342 -177.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.66 129.87 0.08 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.597 -0.89 . . . . 73.2 108.597 -178.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.9 p -83.29 136.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.654 -0.869 . . . . 74.31 108.654 176.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.3 t -93.69 -43.3 8.72 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 119.572 -0.851 . . . . 75.13 109.21 176.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.3 m -150.24 131.14 14.23 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.062 -0.718 . . . . 64.42 109.062 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 t -140.46 154.09 46.5 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.759 -0.46 . . . . 73.31 109.759 175.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -123.41 98.07 5.69 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 104.839 -2.282 . . . . 72.43 104.839 170.156 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.403 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.89 -155.44 23.83 Favored Glycine 0 N--CA 1.41 -3.061 0 N-CA-C 106.521 -2.631 . . . . 75.44 106.521 -177.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -110.52 103.04 11.59 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 118.345 1.072 . . . . 74.43 110.23 -178.217 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -74.58 114.21 12.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.816 -0.629 . . . . 75.04 109.81 176.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.4 mt -79.93 -44.64 22.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.296 -1.742 . . . . 73.02 106.296 179.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -128.7 165.97 27.98 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 105.459 -2.052 . . . . 73.14 105.459 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.49 0.18 9.4 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 121.925 1.75 . . . . 71.21 110.422 174.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.1 pt-20 -132.09 5.33 4.16 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.384 -1.28 . . . . 73.42 111.049 -177.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -146.15 120.94 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 107.996 -1.112 . . . . 71.15 107.996 178.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.06 147.3 30.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.648 -0.501 . . . . 71.43 109.648 -176.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -135.08 143.11 46.47 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.063 0.459 . . . . 61.25 109.848 -178.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.422 ' CE3' HD12 ' A' ' 139' ' ' LEU . 26.8 m-90 -126.78 139.1 53.37 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.624 -0.88 . . . . 74.14 108.624 177.714 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -111.75 104.34 12.68 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.317 -0.994 . . . . 75.32 108.317 174.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.3 mp -83.02 116.32 22.23 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.147 -1.427 . . . . 73.43 107.147 177.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -107.34 134.75 19.82 Favored Pre-proline 0 C--N 1.278 -2.504 0 CA-C-N 114.936 -1.029 . . . . 73.34 111.021 -172.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.05 154.29 66.75 Favored 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 123.491 2.794 . . . . 60.31 111.745 -179.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.6 -37.61 2.93 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 121.082 -0.58 . . . . 74.02 111.934 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.45 160.86 5.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.167 -0.679 . . . . 75.11 109.167 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -83.5 127.87 39.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.908 -0.775 . . . . 73.44 108.908 178.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.8 m -120.94 128.85 53.14 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.232 -0.655 . . . . 71.23 109.232 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -121.67 154.27 37.06 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.038 -0.983 . . . . 74.11 108.576 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.9 ptm -144.39 139.66 28.55 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.697 -0.401 . . . . 73.32 110.745 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 76.1 p -143.55 148.12 35.47 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.168 -0.613 . . . . 73.42 110.194 173.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.14 130.49 12.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.771 -0.825 . . . . 75.21 108.771 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -129.87 130.48 45.28 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 107.243 -1.392 . . . . 71.11 107.243 176.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -153.95 159.67 41.79 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.816 -0.438 . . . . 73.02 109.816 -178.223 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -90.92 130.24 36.87 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 109.091 -0.707 . . . . 73.24 109.091 -177.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -143.09 122.32 12.98 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 118.007 0.367 . . . . 74.14 110.871 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.71 106.77 0.43 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.247 0.967 . . . . 75.24 111.871 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.586 ' HA ' ' NH2' ' A' ' 114' ' ' ARG . 14.8 t70 . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 114.46 -1.245 . . . . 73.54 110.031 179.077 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 . . . . . 0 N--CA 1.429 -1.502 0 N-CA-C 110.081 -0.34 . . . . 73.11 110.081 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -107.6 113.86 44.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 106.531 -1.655 . . . . 75.15 106.531 175.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -121.31 117.77 27.83 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 109.228 -0.656 . . . . 72.4 109.228 -175.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.77 119.7 36.27 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.003 -0.74 . . . . 74.53 109.003 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.6 m -120.09 114.99 22.8 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.637 -1.246 . . . . 51.42 107.637 177.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.0 146.13 34.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.095 -0.705 . . . . 74.42 109.095 -177.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.6 m -129.46 122.16 28.75 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-O 121.06 0.457 . . . . 74.32 110.118 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.7 tt -107.19 119.56 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.773 0.796 . . . . 73.25 109.755 178.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 m -89.57 157.31 47.09 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.164 -0.926 . . . . 73.42 109.328 -177.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.42 2.15 1.33 Allowed 'Trans proline' 0 N--CA 1.488 1.167 0 C-N-CA 123.53 2.82 . . . . 74.41 114.279 -176.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.85 4.5 53.74 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.608 -0.886 . . . . 64.44 108.608 178.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 27.2 t70 68.48 31.21 4.97 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 123.566 1.65 . . . . 73.45 107.333 -175.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.06 124.1 42.4 Favored 'General case' 0 N--CA 1.39 -3.473 0 N-CA-C 106.084 -1.821 . . . . 71.0 106.084 178.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 t -112.95 134.17 56.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.318 -0.993 . . . . 75.44 108.318 -177.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.2 p -140.62 158.43 44.0 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.983 -1.488 . . . . 63.31 106.983 178.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.69 -174.31 42.72 Favored Glycine 0 N--CA 1.415 -2.703 0 C-N-CA 118.997 -1.573 . . . . 64.11 112.859 177.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -147.43 133.91 19.73 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 108.916 -0.772 . . . . 73.14 108.916 -177.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 52.6 mt -119.52 115.91 49.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.728 -1.212 . . . . 75.41 107.728 176.226 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.31 120.54 62.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.105 -0.702 . . . . 75.02 109.105 -177.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.38 107.31 16.97 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.763 -1.94 . . . . 74.11 105.763 172.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . . . -118.93 132.47 56.09 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.049 0.452 . . . . 52.24 111.13 -174.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.17 158.25 37.59 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.54 -0.755 . . . . 74.03 110.321 -177.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--N 1.323 -0.577 0 C-N-CA 119.783 -0.767 . . . . 74.32 109.288 173.603 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.423 -1.823 0 N-CA-C 107.45 -1.315 . . . . 71.12 107.45 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.571 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 173.7 116.65 0.43 Allowed Glycine 0 N--CA 1.409 -3.127 0 CA-C-N 114.845 -1.07 . . . . 53.42 110.427 177.047 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 75.0 Cg_exo -52.04 134.22 48.77 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.332 2.022 . . . . 74.44 109.313 170.591 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.79 149.58 23.68 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 111.654 0.242 . . . . 73.13 111.654 -173.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.541 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 66.1 mt -91.77 151.03 20.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.279 -0.419 . . . . 75.44 109.969 177.311 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -109.64 102.45 11.28 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.08 -1.082 . . . . 75.22 108.08 177.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -148.84 142.61 10.06 Favored Glycine 0 C--N 1.283 -2.367 0 C-N-CA 120.58 -0.819 . . . . 71.4 112.873 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -151.35 114.27 4.71 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.543 -0.91 . . . . 75.44 108.543 176.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.66 159.62 71.06 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 109.925 -0.398 . . . . 70.01 109.925 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.98 -13.92 42.1 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.245 1.963 . . . . 70.15 112.532 178.089 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -113.64 28.69 8.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.62 -0.264 . . . . 75.3 111.466 -177.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.8 m -57.49 -26.86 61.93 Favored 'General case' 0 C--O 1.205 -1.253 0 N-CA-C 111.947 0.351 . . . . 71.34 111.947 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.452 ' HG3' ' HG3' ' A' ' 69' ' ' LYS . 29.7 pt20 -65.56 -12.26 51.37 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.395 0.617 . . . . 74.11 110.96 176.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 24.6 mtpp -110.81 -7.51 14.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.636 0.774 . . . . 75.33 110.519 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 p -132.36 117.74 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 122.029 0.918 . . . . 63.12 110.409 173.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.32 116.31 28.83 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.687 -0.688 . . . . 75.14 109.964 -177.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.95 124.38 50.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 106.177 -1.786 . . . . 75.41 106.177 177.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.7 m -137.97 166.89 22.96 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.298 -0.41 . . . . 74.4 111.293 -172.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.571 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 57.5 t30 -80.2 140.78 36.16 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.311 -0.859 . . . . 64.41 108.799 177.067 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 77.0 t80 -119.3 121.35 39.4 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.862 -0.422 . . . . 72.4 109.862 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -138.62 114.79 10.24 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.843 -1.169 . . . . 74.14 107.843 172.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.4 t -174.51 148.09 1.17 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.903 -1.517 . . . . 74.21 106.903 -175.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 72.28 10.33 5.89 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.844 0.858 . . . . 74.24 111.027 173.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.66 5.06 82.19 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.477 -0.649 . . . . 70.01 111.477 -175.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 11.8 m-85 -104.09 149.28 25.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.617 -0.512 . . . . 74.34 109.617 179.014 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.73 136.79 58.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.987 -1.116 . . . . 74.1 107.987 174.207 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -173.5 -154.94 11.06 Favored Glycine 0 C--N 1.274 -2.873 0 N-CA-C 110.682 -0.967 . . . . 41.41 110.682 -178.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.541 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 p -129.62 153.25 48.28 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-O 121.208 0.528 . . . . 50.32 111.848 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 4.1 pt20 -134.62 141.97 46.76 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.835 -0.62 . . . . 75.14 110.791 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.88 114.2 26.61 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.645 -1.613 . . . . 71.15 106.645 173.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.21 115.14 48.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.658 -0.867 . . . . 74.55 108.658 -178.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -119.53 151.77 38.06 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.205 0.526 . . . . 74.42 111.085 -174.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 p -155.59 154.83 32.28 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.5 -0.773 . . . . 75.21 110.286 -177.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.3 t70 65.74 30.98 9.96 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.089 0.947 . . . . 73.3 110.457 175.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.441 HD23 ' HE3' ' A' ' 69' ' ' LYS . 18.1 mt -94.91 170.22 9.58 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.875 -0.602 . . . . 75.4 111.785 -178.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.431 HG22 ' OE1' ' A' ' 94' ' ' GLU . 12.5 t -126.61 172.79 9.97 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.059 -0.719 . . . . 73.21 109.059 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.42 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 78.1 t80 -51.92 -40.67 61.12 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.011 1.324 . . . . 71.32 112.152 -176.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.09 72.16 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.255 0.465 . . . . 72.54 112.255 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.431 ' OE1' HG22 ' A' ' 91' ' ' THR . 48.3 mt-10 -86.08 -18.77 31.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.003 -0.544 . . . . 72.35 111.838 -174.35 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.632 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tt -60.62 -54.59 53.28 Favored Pre-proline 0 CA--C 1.566 1.584 0 CA-C-N 116.094 -0.503 . . . . 75.21 112.22 -177.372 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.26 -34.17 36.75 Favored 'Trans proline' 0 C--N 1.367 1.518 0 CA-C-N 120.76 1.307 . . . . 75.21 111.095 178.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -62.87 -39.65 95.08 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.362 -0.835 . . . . 73.31 111.504 -176.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -70.67 -19.62 62.77 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.081 0.467 . . . . 75.23 111.053 177.7 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.31 -24.45 59.22 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.505 -0.478 . . . . 74.43 110.191 -176.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -59.17 -51.89 68.06 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 123.305 0.378 . . . . 72.22 110.649 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.543 ' SD ' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -54.29 -52.65 60.79 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-O 121.638 0.732 . . . . 75.31 110.472 -177.593 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.21 -27.28 68.95 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 115.024 -0.989 . . . . 73.25 111.28 -177.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -63.55 -22.9 67.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 118.622 -0.704 . . . . 65.41 112.08 -177.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.48 -27.64 67.73 Favored 'General case' 0 C--N 1.357 0.913 0 CA-C-O 121.215 0.531 . . . . 60.21 109.776 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.77 -12.5 13.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.721 -0.672 . . . . 74.52 111.093 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.98 -48.68 3.44 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 113.941 1.089 . . . . 71.52 113.941 -172.211 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.43 24.0 48.72 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.658 -0.782 . . . . 42.33 112.144 -174.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -87.93 147.39 5.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 O-C-N 122.332 -0.51 . . . . 75.33 110.735 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -135.28 129.05 32.97 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.846 -1.168 . . . . 75.54 107.846 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 mp -130.21 117.05 19.27 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.558 0.218 . . . . 74.44 110.544 -178.188 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.4 m -108.27 114.22 27.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.151 -1.055 . . . . 70.02 108.151 176.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.78 153.16 49.34 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 122.027 -0.421 . . . . 74.32 110.738 -176.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -148.68 154.0 39.04 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.721 -0.672 . . . . 74.44 110.199 -177.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -108.57 106.53 16.65 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 105.722 -1.955 . . . . 74.03 105.722 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -101.38 97.33 7.83 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.44 -0.578 . . . . 73.35 109.44 -176.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.19 -82.72 0.64 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.304 -0.718 . . . . 62.54 111.304 -178.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -143.52 5.35 1.41 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.714 1.245 . . . . 74.42 109.148 178.198 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.6 pp -113.58 148.87 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 O-C-N 121.339 -0.851 . . . . 73.32 108.779 -179.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.31 133.82 54.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-O 121.378 0.608 . . . . 74.13 111.04 -177.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.5 pt -117.33 132.86 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 N-CA-C 107.945 -1.132 . . . . 73.21 107.945 173.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.2 tt -128.12 125.33 38.97 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 115.926 -0.579 . . . . 74.42 109.771 177.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -127.15 115.08 18.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.039 -0.982 . . . . 70.3 108.559 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.7 156.08 21.92 Favored Glycine 0 C--N 1.291 -1.942 0 C-N-CA 120.458 -0.877 . . . . 64.45 112.409 -177.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -139.9 125.71 19.5 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.953 -1.128 . . . . 71.44 107.953 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -101.77 111.7 24.05 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.644 -0.502 . . . . 74.22 109.644 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -104.84 93.61 4.82 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 123.031 1.396 . . . . 63.44 111.519 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.47 ' CD2' ' HA ' ' A' ' 166' ' ' PRO 0.278 0.0 OUTLIER -126.75 42.86 3.23 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-O 124.21 1.957 . . . . 71.33 107.444 171.775 . . . . . . . . 4 4 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.429 -1.49 0 CA-C-N 111.419 -2.628 . . . . 73.0 110.791 179.434 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 CA--C 1.503 -0.834 0 N-CA-C 113.748 1.018 . . . . 75.0 113.748 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -96.47 124.56 40.5 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.618 -0.433 . . . . 72.2 110.902 -175.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -131.94 127.87 37.29 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.731 -0.84 . . . . 72.45 108.731 178.122 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 58.2 t -121.81 128.57 75.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 119.367 -0.933 . . . . 74.33 110.104 -177.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.75 121.12 31.09 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.914 0.387 . . . . 74.24 110.289 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 20.5 tp -115.11 120.75 40.86 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.215 -0.448 . . . . 74.22 109.807 177.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.6 m -117.45 114.31 23.32 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.032 -0.729 . . . . 73.4 109.032 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 96.5 t -108.4 120.79 60.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.932 -0.766 . . . . 74.4 108.932 178.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -110.86 130.71 55.5 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.587 -0.523 . . . . 74.42 109.587 179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.6 p90 -134.52 124.76 17.23 Favored Pre-proline 0 C--N 1.292 -1.927 0 CA-C-N 116.349 -0.387 . . . . 73.2 111.209 177.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.76 37.65 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.476 2.784 . . . . 74.42 112.603 176.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -125.9 -115.8 0.28 Allowed 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 108.522 -0.918 . . . . 74.22 108.522 -179.487 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.75 137.84 0.62 Allowed 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.71 -1.219 . . . . 73.44 107.71 -178.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.468 ' HB ' ' CE2' ' A' ' 143' ' ' PHE . 7.6 p -89.48 127.21 42.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.548 -0.908 . . . . 74.03 108.548 178.321 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.5 p -81.31 -38.73 26.3 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.585 0.707 . . . . 74.01 110.337 -177.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 49.0 m -156.56 133.1 10.09 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.08 -0.711 . . . . 71.4 109.08 178.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.511 ' HG1' HG12 ' A' ' 160' ' ' VAL . 9.4 t -138.45 169.72 17.29 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.669 -0.644 . . . . 63.24 111.307 177.875 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 8.0 t30 -139.0 87.17 2.19 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.751 -1.944 . . . . 63.23 105.751 175.414 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.09 -146.4 6.66 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 109.221 -1.551 . . . . 75.41 109.221 -178.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -118.55 99.63 6.93 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.054 -0.721 . . . . 71.54 109.054 178.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -79.03 128.72 33.62 Favored 'General case' 0 N--CA 1.422 -1.831 0 O-C-N 121.562 -0.712 . . . . 74.13 110.589 179.231 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.1 mt -87.33 -39.42 13.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.723 -1.584 . . . . 74.0 106.723 177.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.23 164.96 35.35 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.023 -1.843 . . . . 71.4 106.023 -179.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.23 -0.12 8.71 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.84 1.693 . . . . 75.23 111.128 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.3 pt-20 -129.34 4.18 5.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.566 -0.743 . . . . 75.25 111.802 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.89 120.19 8.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.028 -1.101 . . . . 74.32 108.028 178.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.511 HG12 ' HG1' ' A' ' 150' ' ' THR . 45.5 t -125.74 143.56 38.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.924 -0.398 . . . . 75.14 109.924 -177.002 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.8 tt0 -128.14 138.28 52.44 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-O 121.304 0.573 . . . . 71.32 109.667 -177.39 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -114.87 114.86 26.07 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 115.862 -0.608 . . . . 64.42 109.405 178.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -98.67 98.35 9.5 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.168 -1.049 . . . . 72.14 108.168 178.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.511 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 26.2 mt -93.68 146.62 23.7 Favored 'General case' 0 C--O 1.281 2.747 0 CA-C-N 114.878 -1.056 . . . . 73.52 109.927 -172.279 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -117.02 151.25 47.28 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.245 -0.889 . . . . 74.22 111.323 -173.253 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.47 ' HA ' ' CD2' ' A' ' 127' ' ' LEU . 84.7 Cg_endo -77.94 154.93 30.03 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.874 2.383 . . . . 71.14 112.424 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.65 -28.14 2.81 Favored Glycine 0 CA--C 1.499 -0.938 0 C-N-CA 121.159 -0.543 . . . . 73.14 112.533 175.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.47 ' H ' ' C ' ' A' ' 166' ' ' PRO . 32.6 m -106.03 156.14 6.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 109.443 -0.577 . . . . 72.34 109.443 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.3 p -92.53 109.24 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 108.106 -1.072 . . . . 73.32 108.106 177.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.4 m -92.85 130.27 38.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.561 -0.745 . . . . 74.11 109.678 -176.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 44.0 p -99.12 139.01 35.4 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.633 0.73 . . . . 71.44 111.711 -178.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 21.3 ttt -118.02 122.45 43.22 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.027 -1.101 . . . . 73.14 108.027 178.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 4.2 m -136.44 136.92 39.91 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.54 -1.264 . . . . 53.25 108.53 174.105 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.02 131.89 15.12 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.189 -1.041 . . . . 74.22 108.189 -179.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -133.33 131.49 40.19 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.474 -1.306 . . . . 72.23 107.474 177.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -162.53 154.29 18.36 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.347 -0.983 . . . . 63.34 108.347 -178.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 35.8 ptt180 -92.93 141.58 28.25 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.268 -0.973 . . . . 74.22 110.187 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.59 130.13 24.07 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 121.038 0.446 . . . . 75.11 110.044 -176.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.65 101.14 0.32 Allowed 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 114.721 -1.127 . . . . 73.25 112.643 -178.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 CA--C 1.505 -0.788 0 CA-C-N 115.425 -0.807 . . . . 65.33 111.96 172.768 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 22.8 mtp-105 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 109.682 -0.488 . . . . 74.5 109.682 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.99 116.8 53.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 115.496 -0.774 . . . . 73.5 108.957 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.4 mtp85 -106.94 114.34 28.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.228 0.537 . . . . 73.22 109.669 176.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.23 111.65 23.37 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.263 -1.014 . . . . 73.12 108.263 177.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -119.52 114.55 22.45 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.54 -1.282 . . . . 73.45 107.54 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.11 146.26 34.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.814 -0.81 . . . . 75.32 108.814 -178.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 85.6 m -131.36 126.41 35.17 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-O 121.067 0.46 . . . . 72.14 110.573 -178.654 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -108.81 112.14 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 121.898 0.856 . . . . 73.31 109.428 177.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 37' ' ' ASP . 25.9 m -76.62 158.11 81.38 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 114.74 -1.118 . . . . 64.43 110.511 -175.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.12 2.72 0.99 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 123.747 2.965 . . . . 75.15 112.702 177.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 35' ' ' SER . 9.0 t70 -87.57 -7.15 57.88 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.306 -0.998 . . . . 73.03 108.306 177.382 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 72.07 29.1 2.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.761 1.625 . . . . 63.42 108.004 -175.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.63 138.95 47.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.918 -1.492 . . . . 72.43 107.408 179.499 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.402 HG22 ' HG ' ' A' ' 95' ' ' LEU . 11.1 t -113.74 135.52 53.1 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.242 0.544 . . . . 75.51 109.543 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.9 p -142.77 137.75 29.95 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.566 -1.272 . . . . 70.22 107.566 177.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.36 -169.5 35.84 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 119.256 -1.449 . . . . 71.41 112.428 -177.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -149.84 133.6 16.84 Favored 'General case' 0 N--CA 1.418 -2.027 0 C-N-CA 123.263 0.625 . . . . 64.43 109.53 -177.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.1 mt -116.45 115.49 49.23 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 105.658 -1.979 . . . . 75.11 105.658 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.5 mt -120.37 114.27 43.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-N 116.196 -0.457 . . . . 75.3 110.005 -172.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.565 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.55 108.56 18.11 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.742 -0.836 . . . . 72.23 108.742 179.227 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . . . -111.37 118.01 34.68 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 109.035 -0.728 . . . . 75.43 109.035 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.97 158.74 21.62 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-O 122.006 0.908 . . . . 74.31 112.288 -174.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt . . . . . 0 C--N 1.294 -1.843 0 CA-C-N 113.807 -1.542 . . . . 74.54 107.808 170.903 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.42 -1.929 0 N-CA-C 109.836 -0.431 . . . . 73.22 109.836 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.622 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 175.29 98.02 0.11 Allowed Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.146 -1.502 . . . . 61.11 113.711 178.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 83' ' ' SER . 38.9 Cg_exo -60.36 159.8 25.79 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 123.646 2.898 . . . . 74.14 112.639 174.315 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.68 153.25 35.87 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.619 -0.719 . . . . 55.22 109.425 177.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.0 mt -99.46 138.91 35.89 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.274 -0.421 . . . . 71.31 110.52 178.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -110.95 87.9 2.65 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.401 1.096 . . . . 75.25 110.898 176.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.07 78.11 0.35 Allowed Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 109.817 -1.313 . . . . 71.35 109.817 177.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -80.8 93.37 6.22 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.841 0.829 . . . . 75.54 109.428 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -105.54 158.38 32.41 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 114.067 -1.424 . . . . 72.5 109.841 -176.604 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.29 -20.99 71.94 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 123.114 2.543 . . . . 63.3 112.984 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -107.03 44.04 1.1 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.562 -0.745 . . . . 75.31 111.671 -178.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m -51.84 -39.12 58.29 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.146 0.578 . . . . 75.31 111.87 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -69.82 -15.87 63.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.94 0.4 . . . . 74.42 111.144 -175.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -91.1 -14.38 31.34 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.855 -0.611 . . . . 74.15 110.231 -179.06 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.66 120.05 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 119.643 -0.823 . . . . 75.22 111.788 -179.455 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.44 113.96 27.74 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.078 -0.712 . . . . 65.5 109.078 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.79 133.81 39.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.617 -0.883 . . . . 74.04 108.617 -179.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 m -141.73 171.94 13.37 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.15 0.5 . . . . 70.14 111.273 -177.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.622 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 7.2 t30 -83.39 136.95 34.14 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 124.473 1.109 . . . . 74.3 110.461 -177.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -116.09 119.9 37.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.822 -0.807 . . . . 63.12 108.822 177.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -139.2 110.44 6.93 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.349 -2.093 . . . . 62.12 105.349 177.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 75.8 m -148.13 113.21 5.5 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 110.383 -0.229 . . . . 73.11 110.383 -178.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 t0 68.87 9.65 7.5 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.06 1.344 . . . . 75.44 111.397 176.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.24 5.06 50.01 Favored Glycine 0 N--CA 1.424 -2.141 0 C-N-CA 120.166 -1.016 . . . . 65.3 112.546 -176.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 72.0 m-85 -84.71 140.78 31.05 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.161 -2.163 . . . . 75.13 105.161 166.181 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.52 135.75 62.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.481 -0.888 . . . . 73.4 109.266 174.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -167.77 -155.9 9.66 Favored Glycine 0 N--CA 1.403 -3.541 0 C-N-CA 120.519 -0.848 . . . . 72.24 111.468 178.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 9.3 p -135.88 150.41 49.35 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.084 0.469 . . . . 72.53 110.31 -177.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.49 127.99 40.29 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.725 -0.67 . . . . 75.15 110.95 -178.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.03 114.17 28.21 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.917 -1.512 . . . . 53.52 106.917 174.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.7 t -112.75 112.07 38.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.452 -1.314 . . . . 75.3 107.452 -178.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.9 p90 -116.09 155.17 28.64 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.286 -0.415 . . . . 74.03 111.181 -172.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.5 p -156.92 157.12 34.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.99 -0.55 . . . . 71.21 110.922 -176.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 t70 64.79 31.84 11.45 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.783 1.233 . . . . 74.43 111.055 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.432 HD12 ' CD2' ' A' ' 87' ' ' PHE . 27.6 mt -93.53 173.21 7.81 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.665 -0.698 . . . . 74.5 109.288 176.125 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -126.26 175.03 8.1 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 120.113 -0.635 . . . . 72.11 110.227 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' HD12 ' A' ' 112' ' ' LEU . 86.9 t80 -54.56 -39.93 68.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.698 1.199 . . . . 75.31 112.126 -176.085 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.31 -25.76 67.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.29 0.567 . . . . 75.21 111.537 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -84.68 -16.18 42.71 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 112.471 0.545 . . . . 72.45 112.471 -174.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 10.3 mt -53.09 -55.69 31.27 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.671 1.36 . . . . 73.11 114.671 178.137 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.41 -37.1 51.37 Favored 'Trans proline' 0 C--N 1.36 1.148 0 CA-C-N 120.465 1.202 . . . . 73.44 110.577 177.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.51 -36.84 85.49 Favored 'General case' 0 N--CA 1.417 -2.082 0 C-N-CA 123.769 0.828 . . . . 74.32 111.181 -177.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -78.16 -20.22 52.44 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.991 -0.374 . . . . 74.45 109.991 175.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.98 -21.41 63.23 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.929 -0.578 . . . . 54.54 110.772 -177.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -61.21 -53.35 57.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.198 -0.667 . . . . 73.34 109.198 175.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 32.5 ttp -58.3 -47.27 84.21 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.48 0.657 . . . . 75.23 109.786 177.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -53.16 -31.06 40.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.153 -1.385 . . . . 64.33 111.149 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -56.22 -35.0 66.84 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.965 -0.541 . . . . 75.4 111.786 -174.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.52 -26.81 68.16 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.265 0.555 . . . . 64.33 111.805 -174.2 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.97 -16.16 14.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 120.401 -0.519 . . . . 52.14 110.821 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.8 -47.88 3.63 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.656 0.984 . . . . 72.24 113.656 -170.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.18 28.32 64.42 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.762 -0.935 . . . . 53.4 110.762 -172.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.446 HG13 ' CB ' ' A' ' 125' ' ' ALA . 13.2 m -114.62 161.45 13.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 75.51 110.989 -176.156 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -127.61 139.7 52.57 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.179 -1.415 . . . . 64.2 107.179 174.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -128.3 133.32 48.71 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.464 -0.569 . . . . 75.54 109.464 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.3 t -132.71 137.6 46.95 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 107.745 -1.206 . . . . 74.42 107.745 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.47 ' O ' ' HD2' ' A' ' 113' ' ' ARG . 1.3 pp -149.24 152.14 35.46 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.782 1.03 . . . . 74.2 113.782 -176.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 112' ' ' LEU . 9.6 mpt_? -144.09 154.3 43.06 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.205 -1.361 . . . . 73.32 111.642 178.74 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -90.25 137.95 31.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 107.569 -1.271 . . . . 70.44 107.569 167.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.439 ' O ' HG13 ' A' ' 118' ' ' ILE . 46.9 t30 -123.18 90.56 3.31 Favored 'General case' 0 C--N 1.258 -3.383 0 N-CA-C 107.134 -1.432 . . . . 74.42 107.134 173.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.93 -100.31 0.83 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 109.759 -1.336 . . . . 60.13 109.759 -173.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -121.84 -4.32 9.15 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.429 1.109 . . . . 71.24 109.0 178.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.6 pp -99.24 150.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.389 -0.967 . . . . 74.23 108.389 179.076 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.475 HG22 ' CD2' ' A' ' 178' ' ' TYR . 79.7 t -110.36 136.17 47.16 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 O-C-N 121.847 -0.533 . . . . 75.13 111.539 -176.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.3 pt -117.06 128.96 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 115.202 -0.908 . . . . 75.55 108.997 175.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -128.42 131.83 48.47 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 108.578 -0.897 . . . . 74.3 108.578 179.64 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -144.7 139.8 28.18 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.224 -0.658 . . . . 72.31 109.224 179.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.38 -178.12 36.83 Favored Glycine 0 C--N 1.298 -1.541 0 C-N-CA 120.398 -0.906 . . . . 75.31 111.689 179.523 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -139.35 150.95 45.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 120.967 0.413 . . . . 73.23 110.904 -179.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.446 ' CB ' HG13 ' A' ' 108' ' ' VAL . . . -122.87 120.54 33.79 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.05 -0.977 . . . . 60.53 108.6 178.204 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.13 107.33 18.38 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.368 -0.975 . . . . 75.03 108.368 178.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -107.99 15.47 24.32 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.731 -0.841 . . . . 62.11 108.731 178.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 167' ' ' GLY . 42.3 p . . . . . 0 N--CA 1.438 -1.045 0 N-CA-C 108.096 -1.076 . . . . 54.31 108.096 179.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--O 1.239 0.535 0 N-CA-C 111.834 0.309 . . . . 75.0 111.834 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.558 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -98.45 116.2 30.17 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.451 -0.341 . . . . 54.23 110.644 -175.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 4.4 m-20 -123.6 140.54 52.9 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.557 -0.534 . . . . 74.4 109.557 179.052 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 60.4 t -124.84 131.62 72.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.795 -0.817 . . . . 73.44 108.795 178.513 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.35 122.66 44.47 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.514 -0.921 . . . . 72.13 108.514 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 46.2 tp -110.9 120.25 41.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.742 -0.836 . . . . 74.54 108.742 177.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.3 m -124.42 110.14 14.17 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 108.71 -0.848 . . . . 74.51 108.71 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 87.7 t -109.37 124.49 66.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.699 -0.852 . . . . 75.23 108.699 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.47 130.61 56.29 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 108.803 -0.814 . . . . 73.44 108.803 178.168 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.552 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -133.98 102.56 12.15 Favored Pre-proline 0 C--N 1.266 -3.038 0 N-CA-C 108.34 -0.985 . . . . 71.43 108.34 175.303 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.36 47.28 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 123.871 3.047 . . . . 73.12 113.379 -178.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.82 -78.94 0.58 Allowed 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 109.47 -0.567 . . . . 74.43 109.47 178.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.16 118.34 0.01 OUTLIER 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.881 1.272 . . . . 74.21 108.559 179.378 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.08 134.23 29.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 109.783 -0.451 . . . . 75.42 109.783 177.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.2 p -101.11 -41.66 6.67 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.156 0.503 . . . . 74.32 109.851 178.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.2 m -158.25 133.36 8.59 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 109.377 -0.601 . . . . 72.01 109.377 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.411 ' OG1' HG11 ' A' ' 160' ' ' VAL . 10.0 t -138.95 157.11 46.61 Favored 'General case' 0 C--N 1.285 -2.22 0 O-C-N 121.796 -0.565 . . . . 75.12 110.172 177.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -124.67 88.75 2.95 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 105.524 -2.028 . . . . 73.11 105.524 174.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.84 -150.97 15.84 Favored Glycine 0 N--CA 1.419 -2.491 0 N-CA-C 107.275 -2.33 . . . . 74.04 107.275 -177.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -113.68 104.36 12.15 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 118.297 1.049 . . . . 75.04 111.587 -177.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -77.52 117.35 18.88 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.212 0.53 . . . . 75.33 110.168 176.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.2 mt -86.38 -48.75 15.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.611 -1.626 . . . . 74.01 106.611 177.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -123.41 162.06 42.12 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 114.245 -1.343 . . . . 63.13 107.917 -177.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.63 -4.01 11.3 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.847 2.365 . . . . 73.45 112.398 177.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.7 OUTLIER -132.68 5.16 3.95 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.263 0.468 . . . . 72.35 112.263 175.211 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.66 121.0 29.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 N-CA-C 109.32 -0.622 . . . . 63.03 109.32 -179.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.411 HG11 ' OG1' ' A' ' 150' ' ' THR . 57.3 t -124.75 143.14 39.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.507 -0.553 . . . . 72.12 109.507 -178.035 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -128.67 146.07 50.98 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.17 0.509 . . . . 74.14 110.034 -177.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -124.32 127.83 48.19 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.788 -1.19 . . . . 73.41 107.788 176.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.14 107.15 19.62 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.529 -0.545 . . . . 74.44 109.529 179.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.1 mm? -92.58 124.5 36.66 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.61 -0.723 . . . . 75.31 109.111 -177.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -117.09 141.69 28.83 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.869 -1.06 . . . . 71.44 110.689 -171.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 28.5 Cg_endo -60.79 153.13 64.85 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.879 2.386 . . . . 74.23 112.909 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 128' ' ' THR . . . 80.29 -27.21 2.82 Favored Glycine 0 C--N 1.315 -0.635 0 CA-C-N 115.813 -0.63 . . . . 72.02 113.566 175.438 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.16 162.9 4.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.715 0.769 . . . . 74.33 112.243 -179.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.44 131.45 66.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.012 -1.107 . . . . 73.53 108.012 176.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.4 m -119.79 145.46 46.58 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.812 0.339 . . . . 72.13 110.82 -175.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 p -104.92 126.35 51.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.056 -0.72 . . . . 73.43 109.056 175.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -110.1 131.94 54.6 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.023 -0.732 . . . . 71.31 109.023 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.5 m -141.53 140.59 33.49 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.975 -0.69 . . . . 64.32 109.408 175.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -149.09 121.65 8.56 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.106 -0.702 . . . . 74.32 109.106 -177.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -124.22 132.16 53.58 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 107.873 -1.158 . . . . 64.45 107.873 178.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.17 151.48 31.97 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.539 -0.541 . . . . 74.13 109.539 -175.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -88.92 130.15 35.48 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.221 -1.029 . . . . 75.34 108.221 -179.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.475 ' CD2' HG22 ' A' ' 119' ' ' VAL . 7.4 m-30 -118.2 153.64 33.53 Favored 'General case' 0 CA--C 1.465 -2.298 0 CA-C-N 118.527 0.603 . . . . 73.43 110.191 -174.692 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.6 p -96.89 91.09 5.47 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 109.247 -0.649 . . . . 73.33 109.247 173.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 110.025 -0.361 . . . . 73.21 110.025 179.978 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 . . . . . 0 N--CA 1.435 -1.204 0 N-CA-C 109.502 -0.555 . . . . 75.43 109.502 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.45 ' CG2' HG22 ' A' ' 137' ' ' VAL . 21.7 m -130.09 113.77 27.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 108.446 -0.946 . . . . 74.01 108.446 170.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -115.56 116.31 27.93 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.03 -0.986 . . . . 63.21 109.433 -177.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.09 108.02 16.1 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 106.458 -1.682 . . . . 73.34 106.458 172.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 140' ' ' THR . 23.1 t -125.9 115.65 20.29 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.038 -1.097 . . . . 74.34 108.038 -177.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -120.43 146.86 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 109.521 -0.548 . . . . 73.42 109.521 -177.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.9 m -128.91 122.63 30.69 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 109.83 -0.433 . . . . 71.42 109.83 -177.545 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -114.34 121.76 67.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.577 0.703 . . . . 73.42 110.858 -178.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.3 m -95.52 155.93 38.09 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 115.407 -0.815 . . . . 75.33 110.028 -177.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.14 2.34 0.47 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 124.144 3.23 . . . . 75.0 114.1 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 29.0 t70 -84.66 -4.0 58.8 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.801 -0.814 . . . . 75.12 108.801 178.385 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 72.2 29.38 2.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.895 1.678 . . . . 73.4 106.59 -174.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.4 OUTLIER -101.04 125.2 47.64 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 112.967 -1.924 . . . . 74.13 108.254 -178.743 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.29 133.72 58.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 N-CA-C 108.34 -0.985 . . . . 73.23 108.34 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.6 p -140.42 161.39 37.82 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.462 -1.681 . . . . 74.34 106.462 177.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.53 -178.12 46.44 Favored Glycine 0 CA--C 1.483 -1.929 0 C-N-CA 118.684 -1.722 . . . . 74.21 112.888 178.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -145.87 133.62 21.12 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 123.08 0.552 . . . . 55.34 109.53 -176.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.88 115.61 46.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.103 -1.443 . . . . 74.41 107.103 176.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.62 118.1 56.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 109.659 -0.497 . . . . 72.52 109.659 -178.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.464 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -114.49 108.61 17.09 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.564 -1.273 . . . . 64.52 107.564 175.764 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.81 124.12 43.41 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.507 -0.553 . . . . 65.43 109.507 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.07 158.71 23.72 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.919 -0.582 . . . . 74.12 111.905 -174.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.4 pttt . . . . . 0 N--CA 1.443 -0.812 0 CA-C-N 114.306 -1.316 . . . . 74.44 109.357 173.013 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.421 -1.88 0 N-CA-C 109.288 -0.634 . . . . 73.41 109.288 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.45 97.81 0.11 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 120.717 -0.754 . . . . 74.1 111.851 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 83' ' ' SER . 39.4 Cg_exo -63.35 159.5 39.6 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.753 2.302 . . . . 72.32 111.478 176.173 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.41 120.93 36.49 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.548 -0.908 . . . . 53.43 108.548 178.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.1 mt -72.32 126.94 31.06 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.513 0.673 . . . . 73.24 110.642 176.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.85 87.21 6.39 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.101 -1.409 . . . . 75.12 108.374 -173.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.496 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -165.62 82.37 0.11 Allowed Glycine 0 N--CA 1.407 -3.251 0 CA-C-N 114.78 -1.1 . . . . 72.24 112.328 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -98.14 97.5 8.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.669 -1.234 . . . . 73.31 107.669 174.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -110.36 158.17 36.06 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.011 -0.995 . . . . 74.45 110.522 -174.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.57 -23.53 71.44 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 122.762 2.308 . . . . 71.41 111.634 177.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -103.92 30.92 4.8 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.51 -0.768 . . . . 63.43 111.658 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.6 m -58.73 -23.91 60.64 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 121.152 0.501 . . . . 65.34 110.99 176.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -66.76 -18.87 65.6 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.806 -0.633 . . . . 74.55 110.069 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -97.62 -11.91 23.06 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.739 -0.664 . . . . 74.13 110.711 -178.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.62 119.27 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 122.069 0.938 . . . . 73.14 111.772 178.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.27 103.46 15.92 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.37 -0.832 . . . . 73.52 108.786 178.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.13 131.21 45.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.633 -1.247 . . . . 74.01 107.633 178.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -146.16 171.41 14.97 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.283 -0.636 . . . . 75.53 109.283 -173.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -85.59 151.93 23.53 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.979 -1.119 . . . . 75.52 107.979 175.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 63.0 t80 -113.21 122.62 48.02 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.585 -0.895 . . . . 63.3 108.585 -179.623 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -138.67 97.9 3.45 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.096 -1.446 . . . . 71.34 107.096 176.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 48.1 m -166.24 157.22 13.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.246 -1.39 . . . . 75.11 107.246 -176.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.25 1.71 3.37 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.233 1.013 . . . . 75.13 112.757 173.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.99 -4.76 65.67 Favored Glycine 0 C--O 1.213 -1.212 0 N-CA-C 110.707 -0.957 . . . . 74.22 110.707 -174.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.92 156.84 16.92 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 123.61 0.764 . . . . 75.13 109.283 -176.164 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.35 137.45 56.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.335 -0.617 . . . . 72.23 109.335 173.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -171.2 -154.17 9.53 Favored Glycine 0 N--CA 1.416 -2.665 0 C-N-CA 119.99 -1.1 . . . . 71.24 112.373 -177.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 12.4 p -129.68 148.04 51.52 Favored 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 123.441 0.696 . . . . 73.32 110.195 -177.269 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.78 145.18 44.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.674 0.273 . . . . 72.43 110.769 178.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -127.07 114.92 18.39 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.565 -1.272 . . . . 41.42 107.565 174.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.7 t -114.39 117.97 57.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.557 -0.905 . . . . 75.11 108.557 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 90' ' ' LEU . 48.8 p90 -120.51 154.61 35.05 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 120.817 0.341 . . . . 75.14 111.076 -174.674 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.5 m -158.15 158.37 34.5 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.16 -0.473 . . . . 60.1 110.39 -179.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.7 t70 67.34 31.89 6.21 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.532 1.158 . . . . 75.44 111.348 176.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 87' ' ' PHE . 31.6 mt -97.4 159.91 14.64 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.633 -0.712 . . . . 75.24 111.483 178.034 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.5 m -96.2 158.11 15.59 Favored 'General case' 0 N--CA 1.412 -2.343 0 C-N-CA 124.554 1.142 . . . . 75.02 109.23 -177.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.8 -38.81 70.46 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.837 0.351 . . . . 73.41 110.655 175.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.3 -25.48 68.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.964 -0.562 . . . . 73.52 111.598 178.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -88.14 -16.35 33.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.905 0.383 . . . . 54.13 111.318 -178.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 43.7 tp -56.6 -48.64 96.79 Favored Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 112.89 0.7 . . . . 72.33 112.89 179.091 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.32 -35.87 81.95 Favored 'Trans proline' 0 C--N 1.369 1.652 0 CA-C-N 120.847 1.338 . . . . 74.13 111.318 174.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -64.63 -39.76 94.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.283 0.563 . . . . 74.22 110.817 -177.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -77.09 -19.67 56.73 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.622 -0.51 . . . . 73.35 109.622 177.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.13 -21.62 59.8 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.197 -0.668 . . . . 73.1 109.197 -177.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.09 -55.77 22.59 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.26 -1.015 . . . . 75.11 108.26 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.496 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.4 ttp -53.64 -51.31 63.52 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.508 -0.769 . . . . 65.15 109.865 178.108 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -53.07 -42.62 66.0 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.015 -0.993 . . . . 71.23 109.838 179.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -62.08 -41.02 97.76 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.916 -0.584 . . . . 70.2 109.498 -172.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.33 -11.16 59.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.451 -0.795 . . . . 71.31 110.097 -169.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.86 -17.57 14.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.858 -0.61 . . . . 74.33 110.559 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.68 -43.69 4.65 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.126 0.787 . . . . 64.05 113.126 -173.532 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.97 19.44 28.82 Favored Glycine 0 C--N 1.317 -0.49 0 N-CA-C 110.03 -1.228 . . . . 71.51 110.03 -172.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -110.18 142.44 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.449 -0.574 . . . . 64.41 109.449 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -107.86 122.48 46.88 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.426 -1.324 . . . . 73.24 107.426 177.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.4 mt -120.55 127.67 52.37 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 121.09 -0.244 . . . . 74.02 110.356 -177.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -130.34 136.68 49.37 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.609 -1.256 . . . . 73.5 107.609 177.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -146.0 149.65 34.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.409 0.623 . . . . 75.31 111.013 -178.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -144.67 156.51 44.13 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.868 -1.06 . . . . 74.55 108.884 -179.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.442 ' NH1' ' HA ' ' A' ' 180' ' ' ASP . 17.0 ttm180 -114.03 130.94 56.52 Favored 'General case' 0 N--CA 1.398 -3.037 0 N-CA-C 108.196 -1.039 . . . . 74.53 108.196 172.082 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -113.06 100.76 8.86 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.899 -1.519 . . . . 75.23 106.899 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.63 -113.32 5.2 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 110.575 -1.01 . . . . 74.23 110.575 -176.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -109.1 1.77 20.67 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.025 0.917 . . . . 70.01 109.436 179.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.4 pp -110.39 146.62 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 118.217 -1.393 . . . . 71.1 109.514 179.25 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.449 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 76.3 t -110.89 143.51 20.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-O 120.972 0.415 . . . . 73.2 110.629 -177.213 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.1 pt -124.13 133.75 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 108.822 -0.807 . . . . 73.13 108.822 178.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.45 127.1 41.87 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.785 -0.82 . . . . 71.24 108.785 178.113 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -131.54 123.34 27.79 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.452 -1.314 . . . . 63.55 107.452 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -143.51 164.4 27.36 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.423 -0.894 . . . . 54.2 112.982 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -134.01 130.27 37.34 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.323 -0.621 . . . . 72.15 109.323 -178.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.19 110.46 21.69 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.766 -0.457 . . . . 74.15 109.766 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.85 93.68 5.02 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 122.03 0.919 . . . . 75.43 108.691 177.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -114.75 23.39 12.69 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-O 122.924 1.345 . . . . 65.2 109.057 177.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 C--N 1.311 -1.068 0 N-CA-C 106.249 -1.76 . . . . 74.01 106.249 171.596 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 112.2 0.445 . . . . 75.22 112.2 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.87 144.69 31.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.351 0.5 . . . . 73.53 112.351 -172.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -131.21 116.58 17.85 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 105.845 -1.909 . . . . 72.13 105.845 171.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 56.6 t -108.0 124.17 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 C-N-CA 120.017 -0.673 . . . . 75.11 110.463 -172.638 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.96 120.19 31.77 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.365 -0.606 . . . . 73.5 109.365 177.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.558 HD11 ' CE3' ' A' ' 162' ' ' TRP . 2.6 tm? -111.79 117.07 31.81 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.223 -1.769 . . . . 73.5 106.223 177.394 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.5 m -126.01 136.91 53.52 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 120.879 0.371 . . . . 71.13 110.263 -176.428 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.6 t -128.22 120.89 54.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.034 -1.099 . . . . 74.23 108.034 176.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.07 127.37 56.19 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.269 -0.641 . . . . 63.24 109.269 179.554 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -135.09 122.02 14.88 Favored Pre-proline 0 C--N 1.288 -2.093 0 N-CA-C 112.449 0.537 . . . . 75.35 112.449 179.186 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.88 40.81 0.44 Allowed 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 122.822 2.348 . . . . 74.04 111.527 172.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.52 -91.86 0.53 Allowed 'General case' 0 N--CA 1.434 -1.226 0 O-C-N 122.062 -0.399 . . . . 75.42 110.656 -178.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 170.31 120.29 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 124.046 0.938 . . . . 62.21 108.596 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.06 118.38 16.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 122.357 1.075 . . . . 73.54 109.999 175.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 176' ' ' ALA . 33.4 m -75.99 -45.81 32.75 Favored 'General case' 1 N--CA 1.367 -4.583 0 CA-C-N 113.981 -1.463 . . . . 74.31 110.498 -178.657 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.3 m -163.2 133.32 4.4 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.036 0.934 . . . . 64.12 108.949 174.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -138.58 157.53 45.97 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.467 -0.771 . . . . 73.14 111.993 177.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -127.42 95.73 4.35 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 104.984 -2.228 . . . . 72.33 104.984 173.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.452 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 170.04 -148.43 11.74 Favored Glycine 0 N--CA 1.414 -2.827 0 N-CA-C 108.106 -1.998 . . . . 75.23 108.106 -178.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -115.59 99.25 7.2 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.864 0.84 . . . . 75.4 109.937 -176.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -82.88 117.06 22.47 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-N 115.526 -0.761 . . . . 74.25 111.013 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.3 -39.92 19.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.977 -1.49 . . . . 55.24 106.977 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -138.24 167.82 18.43 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 114.474 -1.239 . . . . 75.41 107.889 176.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -72.63 0.49 7.51 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.724 2.283 . . . . 70.33 111.086 174.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -127.69 -2.41 6.03 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.418 -0.81 . . . . 74.32 111.379 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.6 t -140.41 120.38 12.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.578 -0.897 . . . . 74.43 108.578 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.89 144.29 34.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.054 -0.721 . . . . 71.23 109.054 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -138.08 144.61 41.01 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.457 0.646 . . . . 74.41 109.464 -177.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.558 ' CE3' HD11 ' A' ' 139' ' ' LEU . 29.1 m-90 -119.05 114.57 22.71 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 108.017 -1.105 . . . . 73.32 108.017 176.345 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.53 107.37 18.08 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.04 0.924 . . . . 74.21 109.2 178.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 77.4 mt -101.51 127.4 48.22 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 114.493 -1.231 . . . . 72.13 110.207 -174.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -114.09 131.36 23.23 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 114.01 -1.45 . . . . 74.01 110.966 -173.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -54.07 151.0 29.29 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.383 2.722 . . . . 74.22 112.583 178.037 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.17 -33.47 2.92 Favored Glycine 0 C--N 1.304 -1.207 0 C-N-CA 120.98 -0.629 . . . . 74.34 112.963 176.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.22 155.6 6.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 120.997 0.427 . . . . 74.53 110.864 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.99 144.26 14.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.32 -0.622 . . . . 72.31 109.32 -178.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 m -145.19 141.12 28.41 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.611 -0.514 . . . . 61.45 109.611 177.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 63.1 p -105.23 135.07 47.27 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.207 -0.664 . . . . 74.12 109.207 177.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.4 131.79 50.2 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.72 -0.474 . . . . 73.01 109.72 177.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.4 m -137.24 139.03 40.74 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 119.659 -0.816 . . . . 74.14 109.972 174.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.99 133.05 15.23 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 108.62 -0.881 . . . . 55.33 108.62 -175.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -133.7 131.57 39.63 Favored 'General case' 0 C--N 1.26 -3.312 0 N-CA-C 107.353 -1.351 . . . . 74.14 107.353 176.346 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.532 ' HA ' ' OG1' ' A' ' 148' ' ' THR . . . -156.68 146.3 20.74 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.563 -0.532 . . . . 74.21 109.563 -177.23 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 19.1 ptt85 -86.22 135.25 33.64 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.999 -0.546 . . . . 75.33 110.616 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.449 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 95.3 m-85 -137.65 135.84 36.9 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 108.744 -0.836 . . . . 74.15 108.744 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.2 p -58.71 109.24 0.77 Allowed 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.066 0.854 . . . . 72.14 111.547 -178.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.442 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 22.3 t70 . . . . . 0 CA--C 1.489 -1.403 0 CA-C-N 115.166 -0.925 . . . . 71.22 108.69 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.129 0 N-CA-C 110.976 -0.849 . . . . 73.54 110.976 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 64.97 86.77 0.12 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.492 1.117 . . . . 74.41 112.336 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.37 172.16 7.5 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 104.773 -2.306 . . . . 74.32 104.773 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -74.57 87.26 2.12 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.23 -1.026 . . . . 75.14 108.23 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.4 mt -112.76 90.4 3.33 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.935 -0.575 . . . . 73.4 110.193 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -158.11 117.71 3.24 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.213 -1.773 . . . . 74.33 106.213 172.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -124.96 133.1 53.15 Favored 'General case' 0 C--N 1.283 -2.317 0 O-C-N 123.687 0.617 . . . . 74.52 109.629 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -81.88 159.84 23.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.882 -1.525 . . . . 72.02 106.882 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.48 -69.9 1.33 Allowed Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 119.91 -1.138 . . . . 74.21 111.318 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.643 ' HA ' ' CG ' ' A' ' 132' ' ' ASP . 82.6 m-70 65.73 96.94 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.866 0.866 . . . . 72.52 112.282 -176.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.5 ttm 71.14 71.11 0.18 Allowed 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.35 1.46 . . . . 71.1 109.088 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 pp -109.79 147.26 33.58 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 113.753 -1.567 . . . . 72.33 108.109 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -120.86 123.93 43.75 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.773 -0.825 . . . . 74.12 108.773 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.0 t -121.91 113.71 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.142 -1.429 . . . . 74.51 107.142 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -124.51 113.81 18.6 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.143 0.497 . . . . 74.12 109.71 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.09 113.75 27.14 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.407 -1.331 . . . . 74.11 107.407 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 140' ' ' THR . 37.8 m -125.18 114.51 19.09 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.931 -1.137 . . . . 75.34 107.931 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 pp -130.33 147.1 33.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.323 -0.398 . . . . 73.03 110.274 -173.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 78.3 m -125.68 123.63 39.34 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 109.27 -0.641 . . . . 74.24 109.27 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.466 ' O ' ' HD2' ' A' ' 144' ' ' PRO . 8.5 tt -114.69 131.47 66.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.944 -0.571 . . . . 74.51 111.031 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -96.55 149.95 36.44 Favored Pre-proline 0 N--CA 1.419 -1.977 0 N-CA-C 108.91 -0.774 . . . . 65.01 108.91 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.12 2.41 2.22 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.133 2.555 . . . . 70.12 112.699 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -86.74 5.82 34.44 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 123.722 0.809 . . . . 70.33 110.87 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 t70 70.83 29.48 3.11 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 123.183 1.468 . . . . 71.14 107.558 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.52 128.79 55.76 Favored 'General case' 0 N--CA 1.399 -3.018 0 CA-C-N 113.174 -1.83 . . . . 74.5 107.121 -177.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.443 HG12 HD21 ' A' ' 95' ' ' LEU . 8.1 t -124.29 144.9 32.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.095 -0.502 . . . . 73.35 110.071 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -149.21 161.26 42.36 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.791 -0.818 . . . . 72.43 108.791 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.26 -165.31 35.96 Favored Glycine 0 C--N 1.312 -0.786 0 C-N-CA 119.266 -1.445 . . . . 64.15 113.019 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -150.52 140.19 21.68 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.009 0.433 . . . . 73.23 109.853 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.3 mt -125.41 116.68 47.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.511 -0.922 . . . . 71.35 108.511 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.26 123.43 63.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.618 -0.512 . . . . 61.4 109.618 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.42 108.46 14.58 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.326 -1.361 . . . . 61.55 107.326 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.09 135.65 54.83 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.985 0.421 . . . . 72.53 111.616 -174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.48 158.67 41.48 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.885 -0.783 . . . . 65.31 108.885 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -77.23 138.74 64.32 Favored Pre-proline 0 C--N 1.318 -0.804 0 C-N-CA 118.653 -1.219 . . . . 73.0 109.775 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.07 -58.91 1.3 Allowed 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.516 2.81 . . . . 74.12 115.742 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt 67.46 -44.34 0.47 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 115.099 1.518 . . . . 75.33 115.099 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.502 ' ND2' ' HG2' ' A' ' 54' ' ' LYS . 60.5 t30 -126.25 146.16 50.11 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.418 -0.586 . . . . 64.03 109.418 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.4 m -71.15 -12.51 61.53 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 114.002 1.112 . . . . 72.34 114.002 -172.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.502 ' HG2' ' ND2' ' A' ' 52' ' ' ASN . 10.6 ptmm? -76.35 -17.91 59.16 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.052 0.453 . . . . 75.55 110.564 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.82 128.96 49.36 Favored 'General case' 0 N--CA 1.401 -2.899 0 N-CA-C 113.305 0.854 . . . . 72.15 113.305 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.503 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 4.2 t -106.08 -17.53 14.3 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.911 -1.495 . . . . 65.31 107.299 174.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.08 112.64 0.29 Allowed Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 109.875 -1.29 . . . . 72.53 109.875 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -52.36 128.91 29.39 Favored 'Trans proline' 0 C--N 1.355 0.915 0 CA-C-N 119.879 1.839 . . . . 74.1 109.089 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.628 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -95.87 151.95 18.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 114.169 1.174 . . . . 72.41 114.169 -167.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.414 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 83.4 mt -85.23 141.49 30.09 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.322 -1.308 . . . . 74.4 108.952 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -106.43 99.9 9.45 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.546 -1.279 . . . . 74.42 107.546 177.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.69 69.37 0.33 Allowed Glycine 0 C--N 1.287 -2.188 0 C-N-CA 120.041 -1.076 . . . . 55.04 114.023 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.65 95.51 6.59 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.18 -1.415 . . . . 74.1 107.18 172.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.31 159.28 29.98 Favored Pre-proline 0 C--N 1.293 -1.885 0 CA-C-N 115.088 -0.96 . . . . 73.3 109.823 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.56 -16.74 55.09 Favored 'Trans proline' 0 N--CA 1.481 0.741 0 C-N-CA 122.739 2.292 . . . . 64.15 113.153 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -115.79 33.37 5.53 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.058 -0.519 . . . . 73.44 110.597 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 p -57.63 -28.24 63.52 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 121.222 0.534 . . . . 74.43 112.375 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -66.94 -20.05 65.83 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.235 0.541 . . . . 74.43 110.351 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -101.03 -2.77 30.77 Favored 'General case' 0 C--O 1.257 1.492 0 CA-C-N 115.846 -0.615 . . . . 75.21 110.233 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.41 118.87 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.12 0.962 . . . . 74.42 110.817 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.95 106.0 17.99 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.477 -0.783 . . . . 61.51 109.209 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.21 130.93 45.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 106.784 -1.561 . . . . 75.22 106.784 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.1 t -145.67 171.77 14.24 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.89 -0.781 . . . . 71.4 108.89 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -84.53 137.9 33.06 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.14 -0.689 . . . . 74.33 109.14 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.521 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 77.0 t80 -107.38 124.96 50.6 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.473 -0.936 . . . . 75.23 108.473 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -139.0 98.84 3.62 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.553 -1.277 . . . . 74.43 107.553 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.521 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 70.3 m -160.22 148.48 16.79 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.779 -0.452 . . . . 55.32 109.779 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 67.64 8.22 6.21 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.733 1.213 . . . . 75.3 112.056 173.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.59 4.99 65.3 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.003 -0.839 . . . . 72.24 111.003 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -104.71 142.91 33.85 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.191 -1.041 . . . . 74.41 108.191 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.8 m -124.78 139.18 51.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.547 -0.909 . . . . 65.22 108.547 175.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.26 -153.8 10.6 Favored Glycine 0 C--N 1.266 -3.353 0 N-CA-C 110.309 -1.117 . . . . 74.43 110.309 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.628 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 69.3 m -132.48 151.07 52.03 Favored 'General case' 0 C--N 1.266 -3.034 0 CA-C-O 121.289 0.566 . . . . 74.33 111.804 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -131.35 141.14 49.86 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.708 -0.678 . . . . 74.14 109.894 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.35 114.66 26.95 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.941 -1.133 . . . . 62.22 107.941 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.51 113.1 43.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.752 -1.203 . . . . 72.4 107.752 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.46 ' CD2' HD13 ' A' ' 90' ' ' LEU . 40.6 p90 -120.42 156.23 31.84 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 120.745 0.307 . . . . 75.1 111.648 -173.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 p -160.7 149.54 16.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.876 -0.602 . . . . 75.52 111.089 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 67.23 32.16 6.2 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.467 1.107 . . . . 73.3 110.822 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' A' ' 87' ' ' PHE . 19.6 mt -89.52 169.22 11.54 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.687 -0.688 . . . . 72.22 109.621 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.8 t -124.82 171.14 10.38 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.698 -0.482 . . . . 73.01 109.698 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -56.36 -36.37 68.72 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.856 0.862 . . . . 75.13 112.366 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.56 -25.6 63.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.15 0.5 . . . . 74.1 111.811 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -81.07 -21.25 40.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 112.126 0.417 . . . . 75.14 112.126 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.443 HD21 HG12 ' A' ' 40' ' ' VAL . 18.8 mt -54.53 -49.77 89.15 Favored Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 115.697 1.74 . . . . 73.12 115.697 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -54.92 -45.84 37.88 Favored 'Trans proline' 0 C--N 1.365 1.441 0 CA-C-N 120.816 1.327 . . . . 72.33 111.269 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.505 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 22.0 mt-30 -68.46 -32.87 73.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.948 0.88 . . . . 74.45 110.407 -174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.42 -40.58 89.62 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.296 -1.32 . . . . 74.3 108.829 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.75 -25.38 67.9 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.932 -1.031 . . . . 74.42 111.118 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' A' ' 97' ' ' GLN . 84.2 m-20 -59.35 -55.55 33.3 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.404 0.44 . . . . 73.34 109.901 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 29.7 ttp -54.36 -48.93 70.91 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.706 0.629 . . . . 75.21 110.222 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -53.13 -41.95 65.57 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 114.964 -1.016 . . . . 71.23 111.363 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.9 m -67.23 -21.4 65.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.83 -0.623 . . . . 71.43 112.003 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.14 -28.59 70.17 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 121.38 0.61 . . . . 74.42 109.753 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -112.65 -2.55 14.51 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.823 -0.626 . . . . 72.14 110.916 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.7 -47.59 3.86 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.153 -0.619 . . . . 73.22 112.52 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.44 28.97 66.71 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.218 -0.992 . . . . 71.04 112.007 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.4 m -123.1 173.56 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.594 -0.521 . . . . 74.31 109.594 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -126.23 130.34 50.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.891 0.314 . . . . 73.21 110.912 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.05 136.16 53.42 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.06 -0.718 . . . . 63.01 109.06 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -143.34 120.21 11.27 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.933 -0.395 . . . . 64.12 109.933 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.3 145.9 36.64 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.08 -0.648 . . . . 74.42 109.262 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.4 mtm-85 -147.41 151.33 36.29 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.55 -0.75 . . . . 62.22 109.571 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -97.16 137.6 35.95 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 120.126 -0.63 . . . . 74.1 111.42 173.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -117.77 92.26 3.79 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 106.534 -1.654 . . . . 73.43 106.534 174.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 185' ' ' SER . . . 75.94 -98.24 1.18 Allowed Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 110.694 -0.962 . . . . 62.43 110.694 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -130.64 6.28 4.74 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.809 1.29 . . . . 71.04 108.216 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 pp -108.51 145.06 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 106.695 -1.595 . . . . 73.13 106.695 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.9 t -105.48 136.44 39.51 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.831 0 N-CA-C 109.675 -0.491 . . . . 75.31 109.675 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.426 HG22 ' HG2' ' A' ' 175' ' ' GLN . 33.5 pt -111.69 133.57 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.318 0 N-CA-C 107.531 -1.285 . . . . 73.44 107.531 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.6 tt -115.03 123.76 49.88 Favored 'General case' 0 C--N 1.255 -3.534 0 N-CA-C 108.385 -0.968 . . . . 74.41 108.385 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -116.49 131.2 57.01 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 113.913 -1.494 . . . . 72.23 107.052 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -152.64 148.26 18.91 Favored Glycine 0 N--CA 1.413 -2.837 0 C-N-CA 119.735 -1.222 . . . . 74.13 110.301 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.58 137.47 43.77 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.103 -0.703 . . . . 74.15 109.103 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.38 109.14 13.52 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 108.633 -0.877 . . . . 64.44 108.633 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.11 98.6 7.45 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.543 -1.651 . . . . 61.41 106.543 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.13 36.99 4.49 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 123.024 1.392 . . . . 75.4 108.542 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 49.8 p -65.89 -40.46 91.57 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 113.515 -1.675 . . . . 71.44 110.538 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.2 m -84.33 16.51 3.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.002 0.921 . . . . 70.14 112.44 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.448 HG13 ' CB ' ' A' ' 166' ' ' PRO . 8.6 p -68.98 147.46 12.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 N-CA-C 108.803 -0.814 . . . . 71.15 108.803 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.5 m -91.98 0.66 57.47 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 120.672 0.272 . . . . 74.43 111.25 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.643 ' CG ' ' HA ' ' A' ' 24' ' ' HIS . 26.2 t70 -128.85 122.74 21.61 Favored Pre-proline 0 C--N 1.308 -1.229 0 N-CA-C 112.13 0.418 . . . . 73.21 112.13 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.28 -17.83 18.64 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.886 2.39 . . . . 72.15 113.468 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -96.12 10.42 37.72 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 121.995 -0.441 . . . . 75.12 112.014 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -71.92 136.0 46.72 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.92 -0.582 . . . . 71.53 109.567 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -131.06 114.43 15.16 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.846 -0.428 . . . . 74.31 109.846 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 89.4 t -109.96 126.63 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 107.163 -1.421 . . . . 71.23 107.163 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -134.79 129.14 34.12 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 120.939 0.4 . . . . 71.45 111.206 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.9 tp -117.79 129.48 55.7 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.178 -0.464 . . . . 74.51 109.905 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 31' ' ' SER . 18.4 m -127.05 122.56 34.7 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.074 -1.084 . . . . 73.55 108.074 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 97.1 t -118.07 122.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.413 -0.588 . . . . 74.4 109.413 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.07 130.6 56.56 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.23 -0.655 . . . . 74.53 109.23 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.688 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.2 p90 -135.33 127.1 17.71 Favored Pre-proline 0 C--N 1.286 -2.178 0 CA-C-O 119.424 -0.322 . . . . 74.4 111.587 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 58.5 Cg_endo -75.15 36.63 0.45 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.569 2.179 . . . . 74.42 112.029 177.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -117.54 -103.19 0.41 Allowed 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 109.665 -0.495 . . . . 53.31 109.665 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.87 131.05 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.931 -1.137 . . . . 73.44 107.931 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.59 133.84 28.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.049 0.452 . . . . 75.34 109.969 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.3 p -89.19 -46.41 8.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.246 0.546 . . . . 72.03 109.623 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.6 m -152.05 133.88 14.85 Favored 'General case' 0 C--O 1.207 -1.178 0 CA-C-N 115.586 -0.733 . . . . 64.31 110.055 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 t -139.0 160.9 38.67 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.869 -0.519 . . . . 72.53 110.446 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 29.2 t-20 -132.26 89.56 2.68 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.723 -1.954 . . . . 75.15 105.723 174.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.35 -147.97 9.96 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 108.235 -1.946 . . . . 72.2 108.235 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -118.36 100.63 7.61 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 117.829 0.814 . . . . 64.41 110.301 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -83.26 123.44 29.6 Favored 'General case' 0 N--CA 1.413 -2.313 0 C-N-CA 119.884 -0.726 . . . . 75.42 111.354 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.56 -46.93 17.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.236 -1.394 . . . . 75.2 107.236 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -123.53 165.02 24.88 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 107.739 -1.208 . . . . 74.51 107.739 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -72.23 -0.16 8.22 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.429 2.086 . . . . 75.34 110.931 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.688 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.9 pt-20 -135.46 6.3 3.25 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.166 -0.925 . . . . 74.44 111.9 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.92 120.85 6.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 108.126 -1.064 . . . . 73.33 108.126 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 36.9 t -125.19 146.57 30.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 109.448 -0.575 . . . . 74.24 109.448 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -133.03 146.11 51.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 109.45 -0.574 . . . . 75.54 109.45 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.437 ' CZ2' ' HB1' ' A' ' 174' ' ' ALA . 29.7 m-90 -128.19 129.35 46.34 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.639 -0.71 . . . . 72.54 109.245 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 163' ' ' LYS . 1.0 OUTLIER -102.73 103.0 13.21 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 122.149 0.976 . . . . 74.31 111.005 176.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.5 mm? -90.73 116.22 28.42 Favored 'General case' 0 C--O 1.264 1.829 0 CA-C-O 121.827 0.822 . . . . 74.33 108.891 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 10.8 mmpt? -104.73 143.5 26.83 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 114.272 -1.331 . . . . 62.11 111.269 -172.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.448 ' CB ' HG13 ' A' ' 130' ' ' VAL . 58.5 Cg_endo -69.85 150.22 67.35 Favored 'Trans proline' 0 C--O 1.248 1.013 0 C-N-CA 123.963 3.109 . . . . 74.32 111.722 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.49 -30.64 3.06 Favored Glycine 0 C--N 1.321 -0.288 0 C-N-CA 120.913 -0.66 . . . . 74.34 112.213 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 35.3 m -105.63 165.79 3.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 110.011 -0.366 . . . . 73.23 110.011 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.69 142.26 26.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.215 -1.031 . . . . 71.54 108.215 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 63.7 m -142.34 140.89 32.26 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.204 0.526 . . . . 73.13 110.823 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 50.5 p -103.34 141.3 36.17 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.962 -1.125 . . . . 74.21 107.962 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -123.79 126.58 46.72 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.919 -0.4 . . . . 63.12 109.919 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 35.4 t -138.79 144.15 39.24 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.829 -0.434 . . . . 53.32 109.829 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.437 ' HB1' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.42 127.94 10.74 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.318 -0.993 . . . . 75.25 108.318 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.426 ' HG2' HG22 ' A' ' 120' ' ' ILE . 44.8 mt-30 -128.47 131.95 48.37 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 108.703 -0.851 . . . . 75.52 108.703 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.73 159.9 43.79 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.822 -0.436 . . . . 73.43 109.822 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.96 126.81 34.95 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.674 -0.491 . . . . 73.13 109.674 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -143.11 125.24 15.37 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 109.589 -0.523 . . . . 74.41 109.589 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.35 114.07 1.84 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 124.29 0.994 . . . . 73.34 111.831 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -68.61 138.04 90.88 Favored Pre-proline 0 C--O 1.213 -0.868 0 N-CA-C 108.322 -0.992 . . . . 72.03 108.322 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.39 -35.99 88.8 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.43 2.087 . . . . 74.15 113.153 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -84.61 -19.82 32.38 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.162 -1.051 . . . . 71.32 108.162 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.295 33.2 p 61.04 53.99 3.5 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 125.368 1.467 . . . . 73.3 111.713 -175.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -90.75 -177.53 5.01 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.613 -1.63 . . . . 75.35 109.437 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.559 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 70.7 m . . . . . 0 N--CA 1.417 -2.117 0 N-CA-C 107.496 -1.298 . . . . 75.33 107.496 172.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.537 0 N-CA-C 111.995 -0.442 . . . . 74.43 111.995 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.9 -4.26 42.89 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.719 0.759 . . . . 75.53 110.35 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.59 8.55 41.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.788 -0.642 . . . . 75.34 111.629 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -80.6 112.1 17.65 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 106.696 -1.594 . . . . 54.42 106.696 172.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.6 tp -69.84 99.09 1.32 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.226 0.824 . . . . 73.41 113.226 -171.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -141.64 63.99 1.41 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.049 -1.463 . . . . 75.34 107.049 170.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -149.91 -74.23 0.17 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 105.186 -2.153 . . . . 72.3 105.186 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.453 ' HA ' ' OD1' ' A' ' 134' ' ' ASP . 63.8 tt0 51.0 86.27 0.03 OUTLIER 'General case' 0 C--O 1.245 0.828 0 C-N-CA 125.57 1.548 . . . . 71.44 113.306 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.34 9.49 1.26 Allowed Glycine 0 C--N 1.292 -1.866 0 CA-C-N 115.137 -0.938 . . . . 63.11 111.318 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 51.62 32.89 9.78 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.392 1.477 . . . . 73.22 110.547 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 10.5 tpt -79.86 0.59 30.46 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.292 -1.322 . . . . 73.41 112.245 -167.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 4.3 tt -128.3 108.12 10.33 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 104.846 -2.279 . . . . 72.44 104.846 172.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -134.04 124.77 26.78 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.956 -0.757 . . . . 73.22 108.956 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.22 114.51 46.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.805 -1.183 . . . . 75.25 107.805 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -116.82 113.93 23.21 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.65 -1.159 . . . . 74.5 109.608 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.59 121.36 42.39 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 109.11 -0.7 . . . . 73.14 109.11 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.6 m -127.12 114.7 18.06 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.048 -1.093 . . . . 72.42 108.048 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -128.15 147.26 32.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.716 -0.475 . . . . 74.23 109.716 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.5 m -130.49 122.25 27.31 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 121.162 0.506 . . . . 74.24 110.221 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.61 117.64 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.771 0.796 . . . . 74.54 109.51 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 37' ' ' ASP . 28.8 t -77.76 150.54 78.84 Favored Pre-proline 0 N--CA 1.419 -1.987 0 CA-C-N 114.781 -1.099 . . . . 74.44 108.784 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -65.26 2.37 1.5 Allowed 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 123.555 2.837 . . . . 73.54 112.03 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 35' ' ' SER . 3.6 t70 -89.4 -0.31 57.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.324 1.05 . . . . 74.41 108.243 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 29.3 t70 68.96 29.11 4.99 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.58 1.552 . . . . 71.12 108.523 -178.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.38 126.99 53.49 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 113.583 -1.644 . . . . 73.55 107.505 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 t -107.73 138.95 31.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 109.315 -0.624 . . . . 74.43 109.315 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.4 p -147.28 158.68 44.05 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.256 -1.387 . . . . 64.41 107.256 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.7 -172.07 41.78 Favored Glycine 0 CA--C 1.489 -1.589 0 C-N-CA 119.433 -1.365 . . . . 63.34 112.197 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.6 133.39 17.96 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.33 0.586 . . . . 74.21 109.635 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 68.2 mt -117.23 116.22 51.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.952 -1.129 . . . . 64.31 107.952 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.39 120.45 62.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.398 -0.593 . . . . 74.02 109.398 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.488 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.32 107.6 16.93 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 106.462 -1.681 . . . . 65.21 106.462 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . . . -117.39 123.59 46.8 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.787 -0.449 . . . . 72.24 109.787 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.27 157.5 19.4 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.554 0.692 . . . . 72.22 112.22 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -64.01 146.8 97.11 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 113.404 -1.726 . . . . 75.22 110.328 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.42 44.72 0.31 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 124.055 3.17 . . . . 72.24 114.155 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -96.07 -4.17 43.41 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 123.629 0.772 . . . . 75.42 109.111 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 3.4 m120 -54.07 123.69 13.38 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.52 1.528 . . . . 74.31 110.363 -176.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.8 m -78.81 -51.45 9.73 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.259 0.552 . . . . 62.2 111.074 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -110.24 -15.4 13.99 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.245 0.461 . . . . 75.3 112.245 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 52' ' ' ASN . 38.5 m-20 -89.2 132.21 34.97 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 113.809 1.04 . . . . 73.42 113.809 -170.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.2 p -102.81 -20.72 14.21 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.247 -1.39 . . . . 72.04 107.247 172.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.621 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 174.04 97.96 0.11 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.105 -1.198 . . . . 72.53 110.105 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.526 ' O ' ' HB3' ' A' ' 83' ' ' SER . 15.7 Cg_exo -68.32 159.07 54.85 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.571 2.18 . . . . 75.41 111.672 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.62 154.48 24.82 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.196 -0.668 . . . . 63.13 109.196 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 mt -74.77 152.39 39.03 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.371 0.605 . . . . 73.31 111.908 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -107.94 99.49 8.94 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.056 -0.975 . . . . 64.22 109.183 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.467 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -160.22 92.76 0.12 Allowed Glycine 0 C--N 1.29 -2.011 0 C-N-CA 120.36 -0.924 . . . . 71.13 113.525 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -86.48 112.58 21.65 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.253 -1.017 . . . . 74.41 108.253 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.09 162.08 54.36 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 116.269 -0.423 . . . . 65.42 110.499 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.18 -21.13 67.69 Favored 'Trans proline' 0 N--CA 1.478 0.593 0 C-N-CA 122.401 2.067 . . . . 71.21 112.043 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -109.87 27.99 9.03 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.632 -0.713 . . . . 73.44 111.855 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.4 m -52.19 -31.51 32.02 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.281 0.474 . . . . 71.51 112.281 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -61.65 -22.09 64.98 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.007 0.523 . . . . 75.31 111.819 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 88' ' ' SER . 32.7 mmtp -98.85 -10.08 23.4 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 122.287 -0.258 . . . . 74.02 111.134 -176.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.69 120.04 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 119.693 -0.803 . . . . 72.52 110.861 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.13 113.21 25.68 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.686 -0.688 . . . . 44.1 109.266 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.47 124.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 108.282 -1.007 . . . . 73.51 108.282 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 m -128.55 165.04 21.52 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.024 -0.989 . . . . 73.32 109.8 -172.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.621 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 5.9 t30 -77.51 136.5 38.33 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.109 -0.95 . . . . 75.41 109.132 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -110.62 119.41 39.06 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 108.64 -0.874 . . . . 70.34 108.64 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -138.86 100.01 3.94 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.528 -0.915 . . . . 61.22 108.528 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 t -163.0 143.92 9.59 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.389 -0.597 . . . . 73.44 109.389 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.92 12.05 8.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.912 0.885 . . . . 73.23 113.357 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.62 -3.61 65.7 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.33 -0.938 . . . . 72.41 111.485 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 29.8 m-85 -94.74 145.46 24.85 Favored 'General case' 0 C--O 1.254 1.316 0 N-CA-C 108.218 -1.031 . . . . 74.53 108.218 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.3 m -128.94 136.63 59.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.611 -0.885 . . . . 75.43 108.611 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.94 -155.25 9.96 Favored Glycine 0 N--CA 1.414 -2.808 0 C-N-CA 119.98 -1.105 . . . . 62.4 111.899 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.526 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 24.4 p -121.94 152.0 40.15 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.131 -0.535 . . . . 74.54 110.473 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.8 pt20 -138.73 129.4 26.23 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.571 -0.452 . . . . 75.12 110.59 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.3 114.49 28.56 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.011 -1.477 . . . . 63.42 107.011 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.33 116.26 51.87 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.735 -1.209 . . . . 75.22 107.735 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.409 ' CD2' HD12 ' A' ' 90' ' ' LEU . 41.8 p90 -117.88 157.61 26.35 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.08 0.467 . . . . 74.33 111.286 -174.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 16.5 p -158.62 152.7 23.79 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.354 -0.839 . . . . 71.32 109.616 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 t70 62.5 47.24 5.16 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 122.959 1.361 . . . . 71.33 111.26 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.409 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.4 mt -108.06 163.32 13.25 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.572 -1.194 . . . . 74.34 110.003 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -112.15 174.03 6.08 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.367 -0.605 . . . . 75.14 109.367 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.417 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 61.9 t80 -50.53 -48.36 57.22 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.18 0.992 . . . . 75.13 111.308 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.68 -25.43 66.36 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.433 0.693 . . . . 70.41 112.193 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -86.65 -16.44 36.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 116.138 -0.483 . . . . 74.32 112.3 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.639 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 5.4 tt -64.52 -52.18 54.41 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 119.54 -0.267 . . . . 73.53 110.441 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.85 -30.89 39.85 Favored 'Trans proline' 0 C--N 1.367 1.541 0 CA-C-N 120.951 1.376 . . . . 73.33 110.529 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -67.42 -31.16 71.16 Favored 'General case' 0 N--CA 1.424 -1.744 0 O-C-N 121.957 -0.464 . . . . 75.22 110.889 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -77.84 -19.16 55.37 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.175 0.512 . . . . 73.32 109.975 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.87 -13.49 61.68 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.555 -0.748 . . . . 75.02 110.653 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -66.37 -57.89 6.47 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.241 -1.022 . . . . 74.22 108.241 172.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.467 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.8 ttp -55.85 -50.48 70.46 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.252 0.548 . . . . 75.23 110.131 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.54 -37.74 65.77 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 114.456 -1.247 . . . . 73.41 111.712 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.7 p -62.35 -31.73 72.42 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 119.942 -0.703 . . . . 63.33 111.248 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.37 -25.0 67.38 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.498 0.666 . . . . 72.24 111.263 -173.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.44 -13.77 15.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.22 -0.592 . . . . 74.51 111.283 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.27 -41.47 5.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.115 0.783 . . . . 75.35 113.115 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.98 19.92 58.55 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.498 -1.041 . . . . 74.1 110.498 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 m -104.36 155.44 5.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.19 0.519 . . . . 74.15 111.154 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.18 137.33 54.25 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.096 -1.816 . . . . 74.12 106.096 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -134.92 111.52 9.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.055 0.455 . . . . 71.42 112.143 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.8 t -119.37 122.27 41.42 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.75 -0.833 . . . . 74.2 108.75 176.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -139.31 142.88 37.67 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 116.06 -0.518 . . . . 74.52 109.738 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -141.14 149.6 41.72 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.523 -1.217 . . . . 75.13 109.568 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 ttm105 -98.92 137.86 36.88 Favored 'General case' 0 N--CA 1.409 -2.492 0 N-CA-C 108.527 -0.916 . . . . 73.24 108.527 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -122.63 94.58 4.33 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.11 -1.441 . . . . 63.24 107.11 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.75 -103.87 1.36 Allowed Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.856 -0.898 . . . . 73.51 110.856 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.584 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 11.2 t30 -113.99 -8.55 13.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.227 1.013 . . . . 72.3 109.422 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -99.54 149.87 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 C-N-CA 119.36 -0.936 . . . . 74.25 109.408 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.2 t -119.02 138.86 48.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 O-C-N 121.923 -0.486 . . . . 74.03 111.195 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.6 pt -117.05 132.96 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.344 -0.844 . . . . 71.2 109.209 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.2 tt -129.22 130.93 46.92 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 115.971 -0.559 . . . . 64.15 109.717 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.32 133.23 34.69 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.971 -0.559 . . . . 73.52 110.002 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.74 171.97 32.49 Favored Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 120.161 -1.018 . . . . 71.0 112.002 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -138.53 158.11 44.88 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.417 -0.586 . . . . 75.12 109.417 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.94 113.26 18.23 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.626 -0.879 . . . . 74.31 108.626 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -111.96 93.81 4.64 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.878 0.847 . . . . 75.52 111.506 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 166' ' ' PRO . 1.1 pt? -134.98 30.92 3.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 123.88 1.8 . . . . 74.51 107.045 176.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 37.1 p -62.54 -21.08 65.28 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 111.863 -2.426 . . . . 71.35 112.596 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.5 m -72.72 -12.84 61.18 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 123.763 0.825 . . . . 75.1 111.171 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t 68.05 83.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.237 1.015 . . . . 75.11 109.976 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.5 m -72.15 -37.65 69.34 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.843 -1.072 . . . . 73.21 109.972 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -165.0 130.75 2.07 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 106.228 -1.768 . . . . 72.31 106.228 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.01 -12.88 21.52 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.747 2.298 . . . . 60.43 114.118 -176.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.453 ' OD1' ' HA ' ' A' ' 22' ' ' GLN . 38.6 t70 -104.52 2.82 31.29 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 122.043 0.925 . . . . 71.23 109.827 -176.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -92.88 140.93 28.98 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.935 -1.03 . . . . 55.34 111.831 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -132.1 141.79 49.29 Favored 'General case' 0 C--O 1.265 1.919 0 CA-C-N 115.699 -0.682 . . . . 75.31 110.124 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 60.2 t -106.4 116.23 49.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.229 -1.026 . . . . 64.34 108.229 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -115.47 120.71 40.42 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.871 -0.418 . . . . 75.05 109.871 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -118.54 115.74 25.2 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.531 -1.285 . . . . 72.32 107.531 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.5 m -120.82 128.33 52.76 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.146 -0.479 . . . . 71.42 109.732 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.4 t -120.74 127.18 75.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.353 -0.61 . . . . 65.41 109.353 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.24 124.55 52.79 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 109.503 -0.555 . . . . 74.12 109.503 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.618 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.3 p90 -134.36 112.46 11.98 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 122.909 0.484 . . . . 73.24 111.208 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -67.82 42.75 0.24 Allowed 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.484 2.789 . . . . 75.43 113.118 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.09 -92.94 0.51 Allowed 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.559 -0.534 . . . . 54.33 109.559 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.01 126.77 0.02 OUTLIER 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.939 0.896 . . . . 75.31 108.829 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.25 123.89 38.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.144 0.497 . . . . 74.04 110.07 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.7 p -86.4 -36.35 19.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.771 0.319 . . . . 70.22 111.01 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.6 m -161.99 132.92 5.08 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 107.859 -1.163 . . . . 62.42 107.859 176.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -139.03 152.29 47.48 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.903 -0.498 . . . . 72.24 110.938 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -115.73 92.03 3.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.988 -1.856 . . . . 72.31 105.988 172.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.34 -149.77 12.07 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.139 -1.984 . . . . 75.14 108.139 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -116.54 99.76 7.38 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 117.887 0.844 . . . . 72.1 109.569 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -77.94 119.77 21.86 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 119.679 -0.809 . . . . 73.42 109.538 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.5 mm -86.81 -44.97 16.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.192 -1.411 . . . . 71.25 107.192 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -118.45 162.43 30.43 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 105.215 -2.143 . . . . 73.14 105.215 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -74.37 -0.8 10.15 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.901 1.734 . . . . 75.44 110.956 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.618 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.3 pt-20 -131.95 3.82 4.1 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.129 -0.941 . . . . 71.34 111.35 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.87 121.13 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 108.463 -0.94 . . . . 75.01 108.463 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.0 t -122.46 148.29 26.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.538 -0.541 . . . . 75.41 109.538 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -131.94 138.86 48.5 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.515 -0.55 . . . . 71.32 109.515 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.8 m-90 -119.63 130.39 55.06 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.701 -0.851 . . . . 72.33 108.701 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -109.88 104.24 13.14 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.957 0.884 . . . . 74.31 108.648 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 0.5 OUTLIER -100.98 131.19 46.97 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.818 -0.808 . . . . 74.35 108.818 -174.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -117.36 149.61 44.95 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 115.802 -0.636 . . . . 74.1 112.598 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.418 ' HA ' ' HG ' ' A' ' 127' ' ' LEU . 17.0 Cg_exo -67.45 154.94 72.31 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.878 2.386 . . . . 70.25 111.743 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 84.43 -39.31 2.91 Favored Glycine 0 C--N 1.311 -0.828 0 CA-C-N 115.83 -0.623 . . . . 73.5 112.541 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.34 151.86 6.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.981 -0.378 . . . . 72.22 109.981 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.79 110.44 24.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.733 0.778 . . . . 73.4 109.15 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.9 m -101.31 131.04 47.55 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.688 -0.687 . . . . 73.41 109.689 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 37.6 p -105.41 145.2 31.14 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.109 -0.496 . . . . 75.24 109.708 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 25.1 ptp -126.66 134.05 50.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.8 -0.815 . . . . 73.43 108.8 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.1 m -141.69 146.94 36.69 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.236 -1.024 . . . . 74.42 108.236 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -156.31 120.59 4.49 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.787 -0.449 . . . . 65.54 109.787 -175.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -123.01 131.87 53.89 Favored 'General case' 0 C--N 1.264 -3.136 0 N-CA-C 107.391 -1.337 . . . . 74.11 107.391 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -160.31 153.06 21.18 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.978 -1.119 . . . . 74.01 107.978 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 38.5 ptt180 -92.87 131.49 37.85 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.2 -1.0 . . . . 75.31 109.685 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -126.38 118.42 24.98 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.718 -1.215 . . . . 75.14 107.718 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.584 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -53.25 109.97 0.49 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 124.905 1.378 . . . . 72.11 112.538 -177.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.465 ' OD1' ' HD2' ' A' ' 181' ' ' PRO . 32.6 t0 -70.11 125.13 91.86 Favored Pre-proline 0 CA--C 1.502 -0.877 0 N-CA-C 107.589 -1.263 . . . . 74.34 107.589 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.465 ' HD2' ' OD1' ' A' ' 180' ' ' ASP . 18.8 Cg_endo -61.18 -43.26 30.24 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.897 2.398 . . . . 72.11 112.368 -176.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.404 ' C ' ' HG1' ' A' ' 183' ' ' THR . 1.4 p-10 -84.49 -9.12 58.64 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 123.902 0.881 . . . . 73.44 110.991 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 182' ' ' ASN . 60.1 p 61.46 70.19 0.61 Allowed 'General case' 0 C--O 1.248 0.987 0 N-CA-C 115.421 1.637 . . . . 74.44 115.421 174.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -90.06 -179.88 5.78 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.91 0.862 . . . . 74.12 113.05 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.421 -1.878 0 N-CA-C 106.18 -1.785 . . . . 74.15 106.18 175.164 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.658 0 N-CA-C 109.142 -1.583 . . . . 51.1 109.142 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -82.95 101.24 10.93 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.51 -1.293 . . . . 74.33 107.51 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -79.93 113.48 18.13 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.281 -0.872 . . . . 75.41 109.779 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -118.0 128.28 54.63 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.908 -1.145 . . . . 63.02 107.908 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.29 88.14 5.54 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.073 0.463 . . . . 75.21 111.636 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -70.13 134.22 47.93 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.805 -0.634 . . . . 74.24 109.861 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.4 t80 77.89 96.54 0.06 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.581 1.553 . . . . 72.33 112.858 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.463 ' HB3' HD22 ' A' ' 52' ' ' ASN . 0.2 OUTLIER -167.86 106.62 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 105.49 -2.041 . . . . 73.32 105.49 172.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.13 73.91 0.23 Allowed Glycine 0 N--CA 1.423 -2.181 0 N-CA-C 110.779 -0.928 . . . . 74.21 110.779 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -60.93 117.01 4.92 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.125 -0.694 . . . . 74.55 109.125 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.9 mtt 69.6 93.48 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.475 1.109 . . . . 65.2 111.468 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 4.0 pp -112.13 148.04 34.82 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.575 -0.528 . . . . 72.43 109.575 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -143.93 129.91 19.51 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.441 -0.577 . . . . 72.11 109.441 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.42 HG13 ' HA ' ' A' ' 46' ' ' ALA . 33.1 m -125.08 129.86 73.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.964 -0.694 . . . . 75.22 109.95 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.476 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 15.5 ptt180 -139.35 122.25 16.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.52 0.676 . . . . 75.34 111.038 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.66 138.56 49.29 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.54 -0.755 . . . . 62.31 109.287 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.7 m -134.17 115.25 13.99 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.075 -1.083 . . . . 74.33 108.075 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 11.6 pt -129.04 149.1 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-O 121.359 0.599 . . . . 73.21 110.178 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 88.8 m -124.51 126.67 46.24 Favored 'General case' 0 C--N 1.264 -3.112 0 N-CA-C 108.976 -0.75 . . . . 74.2 108.976 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.402 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.8 tt -113.26 120.03 62.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.793 0.806 . . . . 73.44 109.752 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 37' ' ' ASP . 26.3 t -81.4 151.99 69.73 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 114.639 -1.164 . . . . 61.51 109.056 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.65 2.31 2.09 Favored 'Trans proline' 0 C--N 1.364 1.351 0 C-N-CA 123.291 2.66 . . . . 70.23 111.524 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 35' ' ' SER . 14.3 t70 -82.52 -7.99 59.63 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.703 1.201 . . . . 63.32 108.318 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.9 t70 72.22 29.26 2.28 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 123.444 1.592 . . . . 70.44 107.413 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.24 135.38 51.09 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 113.125 -1.852 . . . . 74.11 107.491 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 t -117.03 142.01 32.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.173 -0.677 . . . . 62.1 109.173 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.1 p -149.66 157.57 43.36 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.501 -1.296 . . . . 75.54 107.501 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.77 -162.84 34.88 Favored Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 118.481 -1.818 . . . . 71.11 112.949 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -150.44 133.69 16.29 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.361 0.6 . . . . 73.34 110.108 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.8 116.37 52.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.614 -1.254 . . . . 70.51 107.614 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 29' ' ' ARG . 2.0 mp -103.19 120.97 53.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 120.862 0.363 . . . . 75.42 110.258 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -119.73 108.8 14.87 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.533 -1.284 . . . . 73.03 107.533 174.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.6 146.52 46.89 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.448 0.642 . . . . 70.1 112.06 -173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.83 139.28 50.15 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.438 -0.949 . . . . 73.13 108.438 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -74.31 122.2 86.99 Favored Pre-proline 0 C--N 1.31 -1.134 0 N-CA-C 107.886 -1.153 . . . . 75.3 107.886 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -36.74 -79.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 124.851 3.701 . . . . 75.21 116.862 -167.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.559 ' O ' ' HE2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 68.31 -53.99 0.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.846 1.258 . . . . 74.33 110.065 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.463 HD22 ' HB3' ' A' ' 22' ' ' GLN . 80.8 m-20 -77.36 142.12 39.5 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 123.29 0.636 . . . . 74.24 109.885 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.1 m -78.31 -17.12 57.0 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.95 -0.568 . . . . 74.23 110.841 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -87.19 -20.24 27.26 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 116.346 -0.388 . . . . 73.51 111.884 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -95.34 109.2 21.38 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 113.214 0.82 . . . . 64.34 113.214 -171.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.453 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 20.7 p -90.75 -21.83 21.37 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.616 -1.253 . . . . 74.01 107.616 172.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.08 103.62 0.17 Allowed Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 114.582 -1.19 . . . . 73.32 110.202 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.43 134.77 53.05 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.746 2.297 . . . . 55.11 110.434 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.94 148.25 25.21 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 114.802 1.408 . . . . 72.22 114.802 -168.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.606 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 92.7 mt -89.08 161.66 16.41 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 114.201 -1.363 . . . . 75.13 108.57 174.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -110.62 90.78 3.42 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.437 0.637 . . . . 74.3 109.827 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.43 51.7 1.58 Allowed Glycine 0 C--N 1.302 -1.333 0 CA-C-N 115.685 -0.689 . . . . 74.44 112.697 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -96.44 98.85 10.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.352 0.596 . . . . 73.31 110.542 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.68 171.74 7.23 Favored Pre-proline 0 C--N 1.311 -1.1 0 C-N-CA 123.569 0.748 . . . . 73.51 109.951 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.09 -19.25 34.78 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.857 1.705 . . . . 72.11 111.612 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.411 ' CE1' ' HG2' ' A' ' 97' ' ' GLN . 15.6 p90 -111.29 36.28 3.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.855 -0.612 . . . . 64.13 110.606 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.5 m -60.41 -27.7 67.67 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 122.064 -0.397 . . . . 65.12 111.814 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.4 pm0 -71.99 -9.33 58.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.487 -0.758 . . . . 74.23 110.383 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -95.95 -20.09 19.01 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.895 -0.593 . . . . 75.44 109.701 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 p -130.69 117.88 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 122.157 0.98 . . . . 73.35 110.993 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.98 124.58 47.84 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.684 -0.689 . . . . 74.15 110.326 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.93 120.61 47.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.676 -1.231 . . . . 61.55 107.676 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -124.91 168.88 12.67 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.626 -0.715 . . . . 65.01 110.258 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -79.98 150.29 30.51 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.042 -0.725 . . . . 64.23 109.042 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 93.2 t80 -127.35 129.5 47.73 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.063 -0.517 . . . . 72.12 109.738 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -138.19 98.26 3.58 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.577 -1.268 . . . . 73.31 107.577 176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 67.7 m -164.66 155.57 14.84 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.265 -0.643 . . . . 72.33 109.265 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 69.87 4.38 4.74 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.571 1.148 . . . . 73.11 110.932 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.76 -4.07 71.76 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.205 -0.758 . . . . 65.42 111.205 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -104.44 144.05 32.19 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.527 -0.545 . . . . 75.02 109.527 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.5 m -118.2 145.53 24.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.259 -1.015 . . . . 73.42 108.259 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.19 -153.74 12.85 Favored Glycine 0 CA--C 1.459 -3.416 0 C-N-CA 118.692 -1.718 . . . . 73.33 112.14 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.606 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 4.3 p -123.72 145.06 49.28 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-O 121.721 0.772 . . . . 73.15 111.732 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -125.64 131.73 52.6 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.466 -0.788 . . . . 75.55 109.873 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.8 114.19 26.64 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.267 -1.383 . . . . 72.24 107.267 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.1 t -107.39 113.55 43.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.111 -1.07 . . . . 70.43 108.111 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CD2' HD12 ' A' ' 90' ' ' LEU . 51.7 p90 -116.03 151.45 35.48 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.846 -0.427 . . . . 73.01 109.846 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.1 m -154.06 153.96 32.82 Favored 'General case' 0 C--N 1.292 -1.891 0 C-N-CA 120.449 -0.5 . . . . 70.13 111.099 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.22 36.18 15.0 Favored 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 124.443 1.089 . . . . 72.44 111.07 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 87' ' ' PHE . 37.6 mt -97.78 168.53 10.27 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 114.854 -1.067 . . . . 65.51 109.14 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -125.43 -179.92 4.83 Favored 'General case' 0 C--N 1.268 -2.968 0 N-CA-C 108.641 -0.874 . . . . 72.45 108.641 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.424 ' CZ ' ' HG ' ' A' ' 112' ' ' LEU . 43.6 t80 -51.19 -48.2 62.02 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 124.766 1.227 . . . . 72.31 110.559 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.58 -25.85 66.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.892 0.701 . . . . 73.31 112.892 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.42 -17.46 27.16 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 122.069 -0.394 . . . . 64.53 111.48 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 38.0 tp -66.47 -51.8 39.92 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 113.472 0.916 . . . . 73.32 113.472 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.96 -33.88 73.03 Favored 'Trans proline' 0 C--N 1.368 1.59 0 CA-C-N 120.829 1.332 . . . . 53.4 110.389 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.411 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 9.4 tt0 -66.61 -36.26 82.16 Favored 'General case' 0 N--CA 1.41 -2.464 0 CA-C-N 115.226 -0.897 . . . . 75.25 110.871 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -75.69 -19.3 59.21 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.325 0.583 . . . . 64.5 110.041 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.91 -20.57 61.75 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.825 -0.625 . . . . 75.2 110.565 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -56.31 -58.05 9.63 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 123.417 0.448 . . . . 75.1 111.177 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -59.46 -46.63 88.23 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.318 0.58 . . . . 74.05 110.194 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -57.26 -34.79 68.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.376 -1.284 . . . . 73.01 110.962 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.9 m -63.32 -33.5 75.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.553 -0.459 . . . . 73.11 110.905 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.93 -20.04 63.36 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.791 0.805 . . . . 64.44 110.479 -175.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.34 -19.13 17.95 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.697 -0.683 . . . . 62.24 110.506 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.91 -47.69 3.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.591 0.96 . . . . 65.13 113.591 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.52 28.17 25.25 Favored Glycine 0 C--O 1.238 0.403 0 N-CA-C 110.436 -1.066 . . . . 73.51 110.436 -173.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.43 160.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.412 -0.394 . . . . 74.31 110.699 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -119.32 142.77 47.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.381 -1.34 . . . . 73.3 107.381 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.7 mt -139.43 144.39 38.05 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 123.355 0.409 . . . . 72.25 110.28 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 m -142.83 117.33 9.71 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.356 -0.979 . . . . 75.31 108.356 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.424 ' HG ' ' CZ ' ' A' ' 92' ' ' PHE . 52.0 tp -121.9 125.93 47.53 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.076 -0.511 . . . . 73.42 110.375 -176.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -141.7 148.52 39.21 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.197 -0.668 . . . . 75.44 109.197 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -98.69 128.05 44.83 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 108.39 -0.967 . . . . 73.21 108.39 172.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -102.27 86.11 2.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.84 -1.171 . . . . 74.42 107.84 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.29 -98.98 0.54 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.143 -0.935 . . . . 74.33 111.709 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.54 ' HA ' ' OD1' ' A' ' 180' ' ' ASP . 3.4 t-20 -107.63 -15.19 14.65 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.307 1.051 . . . . 74.41 109.651 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 pp -110.0 148.62 13.46 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.758 0 O-C-N 121.115 -0.99 . . . . 74.5 108.749 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.6 t -105.91 137.62 35.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 O-C-N 121.639 -0.663 . . . . 74.0 110.25 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.0 pt -117.14 130.66 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 121.84 0.828 . . . . 72.23 110.064 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.25 128.58 44.95 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 115.161 -0.927 . . . . 64.41 109.352 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -129.18 147.68 51.05 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.614 -0.884 . . . . 74.53 108.614 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.55 166.25 37.18 Favored Glycine 0 N--CA 1.407 -3.298 0 N-CA-C 111.259 -0.736 . . . . 74.31 111.259 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -136.4 145.91 45.83 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.342 -0.985 . . . . 75.35 108.342 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 164' ' ' LEU . . . -124.29 110.15 14.25 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.932 -1.136 . . . . 71.41 107.932 174.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -99.11 105.87 18.01 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.822 -0.807 . . . . 75.32 108.822 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.424 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.8 mm? -116.86 30.65 7.21 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.37 -0.974 . . . . 73.34 108.37 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 76.8 p -72.0 -8.35 54.0 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.588 0.708 . . . . 75.24 111.209 -177.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.2 p -70.79 -16.12 62.72 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 125.119 1.367 . . . . 60.25 109.89 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.3 t 74.99 -65.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.029 1.732 . . . . 74.03 111.258 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.1 t 67.54 -73.9 0.08 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.165 0.986 . . . . 71.41 110.315 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -147.73 133.38 9.4 Favored Pre-proline 0 N--CA 1.434 -1.253 0 N-CA-C 106.09 -1.819 . . . . 72.24 106.09 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.22 -19.73 50.15 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 121.292 1.328 . . . . 71.42 110.696 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -86.0 3.48 42.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.07 -0.968 . . . . 74.42 111.105 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.524 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -85.79 122.29 29.66 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.979 -0.378 . . . . 61.31 109.979 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.37 139.43 53.28 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.221 -0.659 . . . . 74.34 109.221 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 84.4 t -113.4 113.06 42.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.712 -1.218 . . . . 73.2 107.712 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 38.5 mt-10 -117.52 123.49 46.4 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-O 120.97 0.414 . . . . 74.31 110.497 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tt -118.69 128.15 54.24 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.29 -1.744 . . . . 72.2 106.29 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.3 m -126.24 128.39 47.13 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.064 -0.717 . . . . 75.2 109.064 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 61.7 t -124.06 125.38 70.71 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.113 -0.699 . . . . 74.1 109.113 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.17 125.89 54.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.083 -1.08 . . . . 75.15 108.083 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.4 p90 -134.36 122.54 16.0 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 112.348 0.499 . . . . 75.22 112.348 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -70.4 61.19 2.07 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 122.365 2.044 . . . . 74.21 111.13 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.61 -132.46 0.08 Allowed 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.79 -1.189 . . . . 72.4 107.79 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -160.3 122.9 3.33 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.166 -1.05 . . . . 64.2 108.166 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.55 133.21 31.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 109.092 -0.707 . . . . 73.44 109.092 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.9 p -89.4 -44.43 10.19 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.997 -0.742 . . . . 74.13 108.997 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.0 m -159.01 133.47 7.9 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.097 -0.502 . . . . 73.02 109.759 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -138.24 155.25 48.82 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.098 0.475 . . . . 75.15 110.346 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -121.6 90.92 3.4 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 104.263 -2.495 . . . . 72.12 104.263 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 171.96 -161.95 34.03 Favored Glycine 0 N--CA 1.411 -2.997 0 N-CA-C 106.702 -2.559 . . . . 55.14 106.702 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -100.08 99.75 10.52 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 118.257 1.028 . . . . 71.03 110.412 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -80.11 107.79 13.18 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-O 121.552 0.691 . . . . 72.24 110.306 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.0 mt -80.51 -49.1 19.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.533 -1.284 . . . . 73.22 107.533 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.57 164.7 34.59 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.318 -1.364 . . . . 73.31 107.318 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.61 -3.5 13.21 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.1 1.866 . . . . 74.43 111.112 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.633 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.8 pt-20 -131.86 5.87 4.27 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.017 -0.538 . . . . 72.32 112.386 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.7 t -143.18 121.41 7.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 108.772 -0.825 . . . . 75.12 108.772 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.75 148.15 32.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.665 -0.495 . . . . 73.13 109.665 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -133.75 141.12 47.37 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.716 -0.476 . . . . 74.11 109.716 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 138' ' ' GLU . 32.9 m-90 -117.92 119.78 35.87 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.941 -0.762 . . . . 72.52 108.941 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -109.54 98.32 7.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.154 -1.054 . . . . 72.14 108.154 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 14.1 mt -98.28 138.89 34.88 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 114.592 -1.185 . . . . 73.53 108.696 -172.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -117.47 162.48 28.28 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 114.702 1.371 . . . . 73.44 114.702 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 72.3 Cg_endo -76.18 156.64 37.87 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.363 2.709 . . . . 71.54 112.43 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.92 -33.54 2.86 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 111.289 -0.724 . . . . 74.43 111.289 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' A' ' 166' ' ' PRO . 18.4 m -105.12 148.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 123.688 0.795 . . . . 74.35 110.131 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.76 113.78 37.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.498 -1.297 . . . . 73.31 107.498 174.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.6 p -107.62 146.48 31.91 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.909 -0.587 . . . . 74.11 111.515 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.0 p -103.13 151.68 22.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.861 -0.609 . . . . 72.34 111.334 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 70.4 mtm -123.22 119.78 31.2 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.24 -1.393 . . . . 74.1 107.24 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.7 t -136.92 135.61 37.91 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.781 -1.192 . . . . 75.4 107.781 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.442 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.03 118.31 5.98 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.353 -0.61 . . . . 60.31 109.353 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -122.47 130.66 53.29 Favored 'General case' 0 C--N 1.269 -2.899 0 N-CA-C 106.403 -1.703 . . . . 74.04 106.403 175.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.77 148.87 30.47 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.883 -0.327 . . . . 63.1 110.321 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -88.08 127.21 35.41 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 120.333 -0.547 . . . . 71.2 109.94 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.21 152.0 47.96 Favored 'General case' 0 CA--C 1.482 -1.638 0 C-N-CA 120.788 -0.365 . . . . 72.41 110.1 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.0 p -77.4 120.75 22.84 Favored 'General case' 0 C--N 1.262 -3.233 0 N-CA-C 109.794 -0.447 . . . . 73.54 109.794 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.54 ' OD1' ' HA ' ' A' ' 117' ' ' ASN . 4.9 m-20 -72.88 123.27 89.38 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.854 -0.612 . . . . 72.2 110.522 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.76 -28.88 19.87 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 121.766 1.644 . . . . 64.32 109.87 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -84.61 -20.2 31.78 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.938 -1.028 . . . . 65.21 110.056 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.2 p 57.31 94.86 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.725 1.61 . . . . 73.35 112.307 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.458 ' HG2' ' N ' ' A' ' 185' ' ' SER . 71.1 ttt180 -115.33 158.35 22.52 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-O 121.624 0.726 . . . . 75.01 110.081 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.458 ' N ' ' HG2' ' A' ' 184' ' ' ARG . 50.8 m . . . . . 0 C--N 1.274 -2.706 0 N-CA-C 105.453 -2.055 . . . . 71.52 105.453 175.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.407 0 N-CA-C 109.633 -1.387 . . . . 65.03 109.633 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -92.04 -43.71 9.26 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.773 -0.454 . . . . 70.2 109.773 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 58.93 -79.8 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.097 1.359 . . . . 72.34 111.584 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -153.9 143.59 21.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.148 -1.056 . . . . 73.53 108.148 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -82.5 113.59 20.34 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 104.879 -2.267 . . . . 74.04 104.879 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -84.88 75.37 10.37 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.78 0.8 . . . . 73.45 112.906 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -83.28 87.71 6.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.412 1.101 . . . . 74.51 108.408 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -107.4 -170.01 1.63 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.681 -1.145 . . . . 73.32 108.706 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' O ' ' HE3' ' A' ' 51' ' ' LYS . . . -78.83 79.51 1.57 Allowed Glycine 0 C--N 1.306 -1.092 0 N-CA-C 110.872 -0.891 . . . . 73.4 110.872 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.7 151.02 51.6 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.267 -0.642 . . . . 75.04 109.267 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.1 ptm -82.11 137.96 34.88 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.228 0.537 . . . . 73.33 111.388 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -133.3 119.15 19.39 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.477 -0.783 . . . . 74.32 109.826 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -107.42 124.36 49.74 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.259 -0.882 . . . . 74.22 109.285 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.18 114.07 43.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.743 0.782 . . . . 75.11 109.783 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 41.8 mtp85 -113.63 118.76 35.29 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.493 -0.776 . . . . 75.21 111.849 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.77 108.67 19.98 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.0 -1.111 . . . . 54.3 108.0 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 p -117.39 115.67 25.66 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 109.304 -0.628 . . . . 71.22 109.304 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 16.7 pt -129.4 149.05 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-O 121.336 0.589 . . . . 73.42 110.711 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 53.6 m -123.46 124.68 43.42 Favored 'General case' 0 C--N 1.272 -2.792 0 N-CA-C 108.657 -0.868 . . . . 75.51 108.657 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 143' ' ' PHE . 12.2 tt -108.38 109.96 30.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 122.027 0.918 . . . . 74.41 109.414 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.7 m -76.66 152.12 82.95 Favored Pre-proline 0 N--CA 1.423 -1.796 0 CA-C-N 114.635 -1.166 . . . . 75.33 109.962 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.23 -3.32 1.18 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 124.112 3.208 . . . . 74.53 114.438 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -85.84 -0.56 55.66 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 124.175 0.99 . . . . 74.34 109.853 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 38.2 t0 68.6 34.71 3.43 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 123.781 1.753 . . . . 75.12 107.536 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.82 126.1 53.44 Favored 'General case' 0 N--CA 1.397 -3.121 0 CA-C-N 112.426 -2.17 . . . . 74.41 107.701 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 t -104.87 137.22 35.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.337 -0.986 . . . . 75.11 108.337 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.1 p -143.43 149.05 37.08 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 105.946 -1.872 . . . . 71.23 105.946 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.54 -169.56 40.02 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 117.626 -2.226 . . . . 72.23 113.157 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -152.84 142.38 21.79 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.352 0.596 . . . . 73.54 111.497 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.67 116.82 53.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.869 -1.16 . . . . 74.3 107.869 174.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.55 114.92 45.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.466 -0.939 . . . . 74.32 108.466 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.501 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.51 108.0 19.12 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.32 -1.733 . . . . 71.11 106.32 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.75 119.92 29.22 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.645 0.736 . . . . 73.34 111.048 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.91 148.0 34.65 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.21 -0.905 . . . . 74.2 109.247 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -74.88 124.38 89.53 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 105.982 -1.859 . . . . 75.33 105.982 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -44.7 -76.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.923 3.082 . . . . 64.04 115.166 -170.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 23' ' ' GLY . 25.8 ttmm 68.65 -51.04 0.57 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.854 1.262 . . . . 74.33 111.33 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 55' ' ' ASP . 16.8 t30 -77.94 111.94 14.32 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.431 -1.322 . . . . 73.34 107.431 172.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.3 m -48.74 -35.45 14.19 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.993 1.479 . . . . 73.31 114.993 -173.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -95.0 -5.04 45.48 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 119.327 -0.949 . . . . 74.53 112.2 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.473 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 4.0 t0 -91.55 123.89 35.3 Favored 'General case' 0 CA--C 1.492 -1.259 0 C-N-CA 118.879 -1.128 . . . . 75.42 110.187 -172.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.633 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 16.1 p -113.13 0.67 15.02 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 115.328 -0.851 . . . . 74.15 111.19 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.55 115.13 0.36 Allowed Glycine 0 N--CA 1.425 -2.048 0 C-N-CA 119.69 -1.243 . . . . 70.14 113.842 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.484 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 35.0 Cg_exo -66.76 129.37 20.83 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 CA-C-N 119.975 1.887 . . . . 74.42 108.221 168.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.73 163.22 28.2 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 113.695 0.998 . . . . 74.5 113.695 -171.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 mt -124.72 141.24 52.25 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.461 -0.94 . . . . 75.35 108.461 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -88.28 86.3 7.05 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.875 -0.787 . . . . 75.3 108.875 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.74 39.47 2.73 Favored Glycine 0 C--N 1.29 -1.986 0 CA-C-N 114.785 -1.098 . . . . 63.31 111.396 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -94.1 101.3 13.31 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.838 -1.171 . . . . 75.11 107.838 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.3 m -139.6 163.12 47.25 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 115.395 -0.821 . . . . 75.1 109.025 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.03 -24.9 51.99 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 122.435 2.09 . . . . 72.54 111.917 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -99.7 41.45 1.16 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.023 -0.535 . . . . 75.44 111.176 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p -57.47 -29.3 64.12 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.113 0.783 . . . . 74.03 113.113 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -72.5 -15.15 61.79 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-O 121.417 0.627 . . . . 75.44 109.929 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -94.89 -12.77 26.27 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.343 -0.844 . . . . 74.11 109.927 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.07 123.41 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.916 0.865 . . . . 74.53 112.296 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.43 105.77 16.83 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.212 -0.904 . . . . 72.14 108.87 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.2 t -98.06 130.16 47.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.066 -1.457 . . . . 73.23 107.066 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -148.16 172.07 14.89 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.551 -0.537 . . . . 74.5 109.551 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -87.21 153.25 21.64 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.482 -0.562 . . . . 65.22 109.482 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 71.7 t80 -123.09 129.57 51.63 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.544 0.738 . . . . 72.01 109.631 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -138.17 104.06 5.11 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.57 -1.27 . . . . 75.32 107.57 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 47.8 t -171.84 150.25 2.61 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.569 -0.9 . . . . 55.13 108.569 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 70.36 8.77 6.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.721 0.808 . . . . 72.54 111.4 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.77 -0.32 76.52 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 115.414 -0.812 . . . . 75.35 111.157 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -104.42 146.73 28.43 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.573 -0.529 . . . . 73.34 109.573 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.633 ' HB ' ' O ' ' A' ' 56' ' ' THR . 27.4 m -124.18 138.5 53.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.239 -1.023 . . . . 73.43 108.239 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -174.91 -155.16 11.95 Favored Glycine 0 CA--C 1.464 -3.12 0 C-N-CA 119.178 -1.487 . . . . 70.03 112.47 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.7 m -126.03 147.55 49.53 Favored 'General case' 0 C--N 1.274 -2.681 0 CA-C-O 121.145 0.498 . . . . 74.22 110.081 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.5 141.18 51.47 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.918 -0.583 . . . . 72.44 109.89 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.21 114.34 23.52 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.627 -1.249 . . . . 72.23 107.627 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.7 t -109.18 111.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.827 -1.175 . . . . 72.33 107.827 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.472 ' CD2' HD13 ' A' ' 90' ' ' LEU . 53.7 p90 -113.16 157.78 21.25 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 120.924 0.392 . . . . 73.25 110.606 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 p -154.68 150.6 27.82 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.799 -0.637 . . . . 63.01 110.81 -174.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.7 t70 61.42 45.99 7.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.864 1.265 . . . . 74.44 111.819 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.472 HD13 ' CD2' ' A' ' 87' ' ' PHE . 43.3 mt -109.22 169.32 8.76 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.525 -0.761 . . . . 74.21 109.659 177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 t -128.41 -179.79 5.22 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.85 -0.74 . . . . 73.15 111.925 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.429 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 55.0 t80 -50.01 -43.87 50.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.784 2.034 . . . . 73.52 111.406 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.54 -25.59 64.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.779 -0.646 . . . . 61.44 111.747 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -89.34 -15.18 33.99 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.961 -0.563 . . . . 74.25 110.628 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.578 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.7 tm? -54.12 -56.12 29.36 Favored Pre-proline 0 CA--C 1.569 1.692 0 C-N-CA 123.802 0.841 . . . . 74.04 111.887 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.59 -35.72 57.58 Favored 'Trans proline' 0 C--N 1.372 1.785 0 CA-C-N 120.912 1.362 . . . . 72.32 111.08 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -63.03 -40.37 97.54 Favored 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 124.307 1.043 . . . . 74.53 110.398 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -76.05 -19.88 58.24 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.076 0.465 . . . . 61.03 109.783 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.1 -22.32 60.58 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.998 -0.546 . . . . 74.52 110.616 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -56.89 -48.82 77.31 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 109.68 -0.489 . . . . 74.03 109.68 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 24.4 ttm -53.57 -55.69 23.51 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.958 -1.019 . . . . 73.43 108.931 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -56.18 -36.58 68.53 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.299 -1.319 . . . . 72.21 111.622 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.5 m -65.59 -25.36 67.36 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 116.153 -0.476 . . . . 74.51 111.273 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.88 -27.65 66.87 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-O 121.447 0.642 . . . . 72.22 109.875 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -112.01 -13.1 13.64 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.823 -0.626 . . . . 71.11 111.305 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.17 -48.76 3.4 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.149 1.166 . . . . 64.53 114.149 -171.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.61 7.0 78.75 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.144 -0.551 . . . . 75.25 112.468 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -81.2 133.96 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.475 -0.935 . . . . 75.04 108.475 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.45 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 28.7 m-80 -97.41 121.39 39.26 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.029 -1.1 . . . . 73.15 108.029 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.6 115.42 29.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.635 0.255 . . . . 62.43 110.483 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.3 m -109.49 135.89 49.78 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.656 -0.868 . . . . 72.23 108.656 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.3 tp -139.41 133.48 31.09 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 121.239 -0.184 . . . . 71.05 111.014 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -142.24 150.84 41.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.134 0.574 . . . . 75.42 110.654 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.415 HH22 ' CG ' ' A' ' 38' ' ' ASP . 39.5 ttm180 -112.02 135.8 52.2 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.389 -0.967 . . . . 75.02 108.389 174.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -127.94 93.06 3.59 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.69 -1.226 . . . . 74.35 107.69 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.4 -115.76 6.98 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 115.054 -0.975 . . . . 71.11 110.808 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.31 -17.81 24.21 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.54 0.686 . . . . 71.32 109.91 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 0.7 OUTLIER -103.43 148.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 C-N-CA 118.071 -1.452 . . . . 74.5 109.652 -174.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.9 t -120.1 135.78 59.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 110.086 -0.338 . . . . 74.13 110.086 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.6 pt -113.56 130.63 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-O 121.719 0.771 . . . . 73.32 109.966 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.6 tt -125.91 129.64 49.71 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 107.677 -1.231 . . . . 74.41 107.677 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.76 123.76 24.11 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.824 -0.625 . . . . 73.14 109.567 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -132.76 147.44 18.91 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 110.653 -0.979 . . . . 64.31 110.653 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.28 125.95 27.12 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.539 -0.541 . . . . 74.14 109.539 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -99.82 109.94 22.33 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.683 -0.689 . . . . 73.52 110.001 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -99.95 93.22 5.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.276 -0.639 . . . . 74.04 109.276 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.529 ' O ' HG13 ' A' ' 130' ' ' VAL . 3.6 mm? -121.0 24.28 10.25 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.541 -0.754 . . . . 72.2 109.197 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.7 p -68.21 -36.92 80.29 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.104 0.478 . . . . 72.21 111.546 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 m -101.48 20.05 16.75 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.585 -0.734 . . . . 71.11 111.622 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 127' ' ' LEU . 8.9 p -81.39 139.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.45 -0.944 . . . . 75.32 108.45 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.9 p -90.28 6.31 43.47 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.723 -0.391 . . . . 74.43 111.525 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -113.62 98.9 48.5 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 110.08 -0.341 . . . . 63.23 110.08 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.74 -12.9 22.13 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.491 2.127 . . . . 72.33 112.41 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -98.47 18.62 16.16 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.329 0.585 . . . . 75.45 111.189 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.26 135.52 33.41 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.46 -1.311 . . . . 71.32 107.46 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -131.62 115.19 15.75 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.596 -0.842 . . . . 74.45 109.376 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 51.2 t -106.51 122.67 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.428 -0.953 . . . . 71.24 108.428 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 31.9 tt0 -137.86 130.96 30.33 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.143 -0.688 . . . . 74.45 109.143 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.5 tt -128.88 135.52 49.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.307 -0.627 . . . . 63.1 109.307 -173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.1 m -127.2 133.95 50.2 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.268 -0.642 . . . . 72.32 109.268 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 87.2 t -125.8 125.63 68.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.247 -0.649 . . . . 75.15 109.247 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -110.89 126.83 55.12 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 108.889 -0.782 . . . . 73.04 108.889 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.561 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.06 105.75 11.43 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 109.305 -0.628 . . . . 74.13 109.305 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.66 43.64 0.19 Allowed 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 123.521 2.814 . . . . 64.41 114.139 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.3 -91.25 0.56 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 123.152 0.581 . . . . 71.22 110.931 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 177.85 123.82 0.04 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.253 0.621 . . . . 75.44 110.042 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.3 p -80.89 141.81 14.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.688 -0.856 . . . . 74.44 108.688 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.9 p -99.59 -39.73 8.16 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.561 -0.533 . . . . 74.53 109.561 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.9 m -161.66 134.07 5.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.813 -0.63 . . . . 74.11 109.591 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.427 ' OG1' HG13 ' A' ' 160' ' ' VAL . 7.6 t -137.91 149.09 45.92 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.231 0.539 . . . . 75.32 111.036 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -112.5 87.53 2.6 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 106.518 -1.66 . . . . 74.31 106.518 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.436 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.71 -153.79 22.34 Favored Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 108.036 -2.026 . . . . 74.41 108.036 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -112.43 106.02 14.42 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 117.522 0.661 . . . . 73.54 110.751 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -80.05 126.34 30.94 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.736 -0.665 . . . . 75.53 109.794 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.2 mt -85.69 -42.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.885 -1.524 . . . . 74.12 106.885 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -135.28 170.02 12.24 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 113.964 -1.471 . . . . 64.24 107.387 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.98 0.05 8.36 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.295 1.997 . . . . 63.34 110.841 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.6 pt-20 -131.89 3.55 4.1 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.837 -0.62 . . . . 74.13 111.803 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.6 t -141.47 121.86 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.688 -0.856 . . . . 72.25 108.688 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.427 HG13 ' OG1' ' A' ' 150' ' ' THR . 40.5 t -127.4 149.15 32.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.739 -0.467 . . . . 74.24 109.739 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -134.15 144.0 48.27 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.599 -0.519 . . . . 64.42 109.599 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.436 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.3 m-90 -127.25 135.55 50.77 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.842 -0.617 . . . . 74.24 111.356 -178.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.04 104.96 14.8 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.068 -0.969 . . . . 75.23 108.686 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 47.1 mt -101.65 119.76 39.28 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.211 -1.033 . . . . 75.21 108.211 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.458 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 74.3 mmtt -114.24 156.64 44.01 Favored Pre-proline 0 C--N 1.31 -1.149 0 N-CA-C 112.591 0.589 . . . . 75.21 112.591 -169.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 168' ' ' VAL . 5.2 Cg_exo -76.02 155.97 38.42 Favored 'Trans proline' 0 C--N 1.365 1.426 0 C-N-CA 123.025 2.483 . . . . 73.02 110.631 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.8 -32.67 2.17 Favored Glycine 0 C--N 1.312 -0.765 0 N-CA-C 112.134 -0.386 . . . . 71.12 112.134 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 21.3 m -105.72 161.4 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-O 120.94 0.4 . . . . 64.41 109.997 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.2 p -106.58 110.43 31.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.795 -1.187 . . . . 74.34 107.795 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.6 m -97.78 128.88 44.73 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.447 0.641 . . . . 63.12 110.313 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.2 p -101.63 137.87 39.38 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.352 -0.84 . . . . 71.23 109.991 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.4 ptm -131.62 133.09 44.59 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.718 -0.674 . . . . 73.54 109.586 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m -143.34 148.8 36.84 Favored 'General case' 0 C--N 1.276 -2.588 0 O-C-N 121.762 -0.586 . . . . 71.12 109.573 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.98 119.71 6.56 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.281 -1.007 . . . . 73.33 108.281 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -121.75 130.45 53.43 Favored 'General case' 0 C--N 1.262 -3.231 0 N-CA-C 106.292 -1.744 . . . . 74.31 106.292 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.14 160.18 41.79 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.548 -0.538 . . . . 73.24 109.548 -175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 65.0 mtp180 -88.05 125.92 34.82 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.244 -1.021 . . . . 75.32 108.244 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -123.02 127.69 49.15 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.776 -1.194 . . . . 73.31 107.776 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.5 p -63.59 107.47 1.16 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.395 -0.82 . . . . 73.5 110.216 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.417 ' OD2' ' HG3' ' A' ' 184' ' ' ARG . 27.7 t70 -65.8 132.06 94.76 Favored Pre-proline 0 CA--C 1.505 -0.784 0 CA-C-N 115.893 -0.594 . . . . 60.33 110.536 -174.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.89 -46.84 2.17 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 122.68 2.253 . . . . 72.34 113.292 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . 0.285 0.2 OUTLIER -84.36 -7.75 59.21 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 112.842 0.682 . . . . 74.34 112.842 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 47.6 p 62.25 62.17 1.21 Allowed 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.898 1.279 . . . . 74.34 112.372 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.417 ' HG3' ' OD2' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -85.24 161.62 19.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.064 -1.425 . . . . 75.33 112.587 178.383 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 108.181 -1.044 . . . . 65.23 108.181 179.885 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.365 0 N-CA-C 109.514 -1.434 . . . . 70.11 109.514 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 61.46 70.96 0.57 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.981 0.912 . . . . 73.44 109.973 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -93.38 114.45 26.87 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.458 -0.337 . . . . 73.44 110.367 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -70.57 107.18 3.76 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 106.794 -1.558 . . . . 75.1 106.794 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.3 mt -69.92 -64.17 0.94 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.703 -0.68 . . . . 72.2 111.257 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -93.4 88.37 5.93 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.557 -1.275 . . . . 75.34 107.557 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -75.84 74.4 2.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.759 1.266 . . . . 72.13 112.839 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -81.92 122.58 27.94 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 113.972 -1.467 . . . . 75.13 108.455 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.95 73.06 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.866 0 C-N-CA 120.24 -0.981 . . . . 73.32 111.334 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -134.3 17.72 3.71 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.567 -0.901 . . . . 74.22 108.567 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -77.91 96.45 5.01 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.923 -1.035 . . . . 73.41 109.756 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 48' ' ' ALA . 2.4 pt? -113.16 125.44 54.35 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.347 0.594 . . . . 74.34 110.474 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.93 124.57 52.03 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.919 -1.141 . . . . 71.25 107.919 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.13 127.57 72.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.499 0.666 . . . . 64.2 110.461 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -122.75 115.41 22.0 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.98 -1.009 . . . . 73.4 109.268 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.51 108.27 19.51 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.172 -1.048 . . . . 70.24 108.172 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.7 t -108.92 115.74 30.65 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 107.767 -1.197 . . . . 74.32 107.767 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.6 pp -129.91 146.07 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 C-N-CA 120.037 -0.665 . . . . 65.44 109.627 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.9 m -122.82 129.39 51.63 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.242 -1.022 . . . . 71.23 108.242 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -119.27 125.94 74.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.724 0.773 . . . . 74.21 110.511 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.7 m -97.56 142.72 24.99 Favored Pre-proline 0 N--CA 1.415 -2.213 0 CA-C-N 115.2 -0.909 . . . . 74.44 109.349 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.45 2.7 0.24 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 124.104 3.203 . . . . 75.35 114.095 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.67 1.0 40.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 123.737 0.815 . . . . 72.24 110.027 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 91' ' ' THR . 11.5 t70 71.96 35.36 1.33 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 105.738 -1.949 . . . . 73.25 105.738 -176.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 1.7 tp -119.63 126.0 50.11 Favored 'General case' 0 N--CA 1.396 -3.164 0 CA-C-N 113.686 -1.597 . . . . 63.34 108.443 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.6 t -120.44 134.11 64.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.753 -0.832 . . . . 73.4 108.753 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.0 p -144.61 144.14 31.13 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.422 -0.955 . . . . 75.42 108.422 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.45 -166.68 37.28 Favored Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 119.311 -1.423 . . . . 42.11 112.065 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -151.94 135.91 16.47 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.48 0.657 . . . . 62.32 111.048 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.9 mt -111.95 116.63 53.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.107 -1.071 . . . . 74.43 108.107 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.71 114.92 48.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.331 -0.618 . . . . 72.23 109.331 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.52 108.22 19.43 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.178 -1.786 . . . . 73.41 106.178 174.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.8 128.28 50.22 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 120.023 -0.671 . . . . 73.31 112.42 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . . . -116.05 157.48 24.61 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.306 -0.861 . . . . 75.43 109.509 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -70.32 151.43 95.78 Favored Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 120.353 -0.539 . . . . 74.32 110.541 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -18.84 -50.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.284 1 C-N-CA 127.378 5.385 . . . . 65.23 118.293 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER 72.57 -68.79 0.21 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.736 0.814 . . . . 75.1 110.405 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -155.25 145.07 21.47 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.291 -1.374 . . . . 74.32 107.291 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.1 m -56.59 -19.85 18.0 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.593 1.331 . . . . 73.23 114.593 -172.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.548 ' HD3' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -80.02 -25.01 40.4 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 122.068 -0.395 . . . . 71.23 111.885 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.548 ' N ' ' HD3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -77.27 105.05 8.13 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 122.478 1.132 . . . . 74.34 112.59 -169.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.73 -30.01 19.41 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 113.253 -1.794 . . . . 73.32 111.458 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.0 123.93 0.75 Allowed Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 119.523 -1.322 . . . . 74.31 113.806 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.15 159.28 53.82 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.443 2.095 . . . . 73.22 109.842 170.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.02 126.32 55.03 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 122.06 -0.4 . . . . 73.03 111.735 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 90.3 mt -87.34 162.51 17.33 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.812 -0.631 . . . . 74.43 109.98 175.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -101.88 96.6 7.16 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.762 0.792 . . . . 74.4 109.197 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -108.77 45.25 1.34 Allowed Glycine 0 C--N 1.288 -2.093 0 CA-C-N 114.609 -1.178 . . . . 72.04 110.327 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -100.05 110.03 22.33 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.141 -0.53 . . . . 74.14 109.815 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -152.66 169.33 9.78 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 124.738 1.215 . . . . 74.22 109.088 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.81 -14.87 34.5 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.527 2.151 . . . . 73.44 112.343 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -116.09 29.4 8.0 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.965 -0.561 . . . . 75.02 111.822 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.5 m -57.86 -27.87 63.63 Favored 'General case' 0 C--O 1.209 -1.03 0 N-CA-C 113.221 0.823 . . . . 74.4 113.221 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -73.12 -8.75 57.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.392 0.615 . . . . 74.3 110.542 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -99.81 -15.52 18.4 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.696 -0.684 . . . . 74.53 109.584 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.4 118.84 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 122.154 0.978 . . . . 63.44 111.951 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.52 120.16 40.63 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.525 -0.761 . . . . 74.34 110.146 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.0 139.75 20.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.96 -0.756 . . . . 72.45 108.96 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.5 m -148.01 172.19 14.62 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.488 -0.93 . . . . 73.45 108.488 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -85.88 154.05 21.8 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.389 -0.924 . . . . 71.44 108.69 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -112.25 120.69 42.61 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.703 -0.851 . . . . 74.3 108.703 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -138.64 98.5 3.58 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.073 -1.454 . . . . 65.2 107.073 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.9 t -175.41 160.93 2.65 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.021 -1.474 . . . . 65.4 107.021 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.26 11.7 8.09 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.054 0.941 . . . . 73.44 111.851 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.97 1.11 87.04 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.967 -0.635 . . . . 73.31 111.76 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -104.84 167.41 9.73 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.501 -0.411 . . . . 64.24 109.988 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -134.33 136.13 53.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.524 -1.287 . . . . 74.11 107.524 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.07 -154.63 9.17 Favored Glycine 0 C--N 1.276 -2.796 0 C-N-CA 119.634 -1.27 . . . . 54.43 112.514 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 9.4 p -122.47 147.89 45.8 Favored 'General case' 0 C--N 1.273 -2.747 0 C-N-CA 123.549 0.74 . . . . 73.31 109.915 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -139.55 143.09 37.2 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.899 -0.501 . . . . 71.41 110.8 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.91 114.66 20.11 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.28 -1.378 . . . . 63.43 107.28 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.14 121.52 61.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.592 -0.892 . . . . 64.02 108.592 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.446 ' CD2' HD11 ' A' ' 90' ' ' LEU . 49.2 p90 -123.54 155.56 37.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.978 0.418 . . . . 74.2 111.52 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.0 p -156.7 157.81 35.82 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.831 -0.622 . . . . 71.31 111.357 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 64.47 31.53 12.44 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.472 1.107 . . . . 64.41 110.764 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.446 HD11 ' CD2' ' A' ' 87' ' ' PHE . 26.8 mt -93.24 163.89 13.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 121.653 -0.655 . . . . 72.4 111.026 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 45.0 p -109.46 169.64 8.57 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.397 -0.365 . . . . 75.15 110.314 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -61.73 -31.7 71.89 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.264 -0.426 . . . . 74.35 110.548 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.65 -25.7 63.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.969 0.414 . . . . 75.02 110.957 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.74 -16.79 33.24 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.208 0.447 . . . . 64.34 112.208 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.6 tt -60.82 -49.48 89.2 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 119.232 -0.413 . . . . 75.24 111.271 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.81 -35.52 88.33 Favored 'Trans proline' 0 C--N 1.376 1.989 0 CA-C-N 121.038 1.406 . . . . 51.34 110.707 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.35 -35.78 81.23 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.29 -0.868 . . . . 74.34 111.601 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -73.11 -18.96 61.24 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 120.941 0.401 . . . . 75.33 110.671 176.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.02 -19.2 62.54 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.259 -0.428 . . . . 71.54 110.354 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -65.83 -52.98 45.91 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.183 -1.043 . . . . 62.32 108.183 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.446 ' O ' ' HB3' ' A' ' 104' ' ' ASP . 14.2 mtp -54.15 -52.39 61.26 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.702 -0.681 . . . . 72.32 109.583 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -56.49 -39.45 73.27 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.11 -0.95 . . . . 74.21 112.053 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.8 p -70.96 -21.08 62.37 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 119.282 -0.967 . . . . 73.23 111.198 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 101' ' ' MET . 6.0 t70 -61.72 -27.28 68.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.761 -0.654 . . . . 63.3 110.46 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.14 -5.41 13.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 116.071 -0.513 . . . . 71.13 111.117 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.96 -46.17 3.99 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.488 0.921 . . . . 62.35 113.488 -173.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.98 22.81 58.74 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 120.495 -0.86 . . . . 75.12 111.284 -174.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -120.39 172.3 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.789 -0.819 . . . . 74.22 108.789 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.508 ' OD1' ' HB2' ' A' ' 124' ' ' ARG . 3.7 p-10 -132.82 145.41 50.95 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.854 -0.338 . . . . 74.1 110.667 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.2 112.43 17.05 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.246 -0.65 . . . . 74.44 109.246 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -115.59 112.56 22.34 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.602 -0.518 . . . . 74.22 109.602 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -137.4 148.07 45.91 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.597 0.713 . . . . 72.35 112.007 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -147.53 155.74 42.16 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.417 -1.265 . . . . 75.44 109.53 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -106.6 131.99 53.11 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 106.891 -1.522 . . . . 72.43 106.891 172.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -118.2 103.49 9.9 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.765 -1.198 . . . . 64.53 107.765 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.91 -107.08 2.25 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 109.372 -1.491 . . . . 72.14 109.372 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -122.2 2.96 9.82 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.788 1.28 . . . . 71.4 108.505 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -107.04 142.92 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 118.74 -1.184 . . . . 63.43 108.157 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 81.9 t -105.9 138.27 31.98 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 O-C-N 122.099 -0.376 . . . . 73.43 111.175 -176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.02 131.25 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-N 115.499 -0.773 . . . . 74.34 109.012 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.4 131.62 48.49 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 115.46 -0.791 . . . . 75.32 110.296 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -139.95 115.58 10.09 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.781 0.8 . . . . 75.23 108.908 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -113.19 157.99 14.58 Favored Glycine 0 C--N 1.265 -3.364 0 N-CA-C 107.564 -2.214 . . . . 71.31 107.564 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.508 ' HB2' ' OD1' ' A' ' 109' ' ' ASN . 98.5 mtt180 -130.72 125.6 34.32 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 118.397 1.099 . . . . 65.35 109.249 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -118.68 110.33 17.17 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.919 -0.582 . . . . 72.33 110.206 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -105.57 100.04 9.62 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.154 -1.054 . . . . 65.3 108.154 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.26 17.65 21.96 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.687 -0.486 . . . . 72.31 109.687 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.0 p -63.79 -27.07 68.93 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 112.603 0.594 . . . . 72.15 112.603 -173.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.7 m -75.79 -11.2 59.94 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.02 0.378 . . . . 74.53 112.02 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.1 t 61.35 101.93 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.661 1.184 . . . . 73.3 113.907 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.5 m -71.29 -44.75 64.58 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.073 -1.084 . . . . 74.04 108.073 173.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -166.23 139.24 3.29 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 105.979 -1.86 . . . . 71.41 105.979 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.33 -23.37 71.95 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.796 2.331 . . . . 70.32 114.194 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -100.03 9.34 43.03 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 122.132 0.968 . . . . 74.41 110.163 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.45 145.33 26.32 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.92 -1.036 . . . . 74.25 109.895 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -131.63 141.79 49.71 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.897 0.479 . . . . 74.23 110.113 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.9 t -120.86 112.79 37.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.429 -1.322 . . . . 75.23 107.429 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -121.41 125.29 46.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.777 -0.453 . . . . 74.55 109.777 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 tt -118.46 120.48 37.69 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.41 -1.33 . . . . 73.12 107.41 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.4 m -115.72 126.7 54.42 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.005 -0.739 . . . . 71.25 109.005 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 92.2 t -122.0 121.25 63.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.544 -0.539 . . . . 75.25 109.544 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -111.72 128.02 55.96 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.031 -0.729 . . . . 61.2 109.031 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.551 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.3 p90 -134.25 120.04 14.71 Favored Pre-proline 0 C--N 1.29 -2.005 0 C-N-CA 122.189 0.196 . . . . 72.32 111.298 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.95 55.65 2.87 Favored 'Trans proline' 0 CA--C 1.551 1.353 0 C-N-CA 122.618 2.212 . . . . 74.03 111.35 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.45 -110.53 0.15 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.719 -0.673 . . . . 73.35 110.009 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.1 128.34 0.46 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.856 -0.794 . . . . 75.53 108.856 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.76 133.85 28.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 109.377 -0.601 . . . . 74.33 109.377 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.7 p -90.45 -40.12 12.22 Favored 'General case' 0 N--CA 1.42 -1.967 0 C-N-CA 120.359 -0.537 . . . . 71.51 109.716 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 51.0 m -156.98 132.81 9.48 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 109.002 -0.74 . . . . 73.41 109.002 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.1 t -139.23 159.59 41.8 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.759 -0.46 . . . . 75.35 109.759 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.404 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 42.9 t30 -132.54 94.43 3.41 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.561 -1.644 . . . . 72.53 106.561 174.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.08 -136.67 2.92 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 108.643 -1.783 . . . . 63.51 108.643 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -119.25 99.25 6.59 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.899 -0.778 . . . . 71.43 108.899 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -77.9 110.42 12.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.701 -0.682 . . . . 73.32 110.828 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.98 -47.54 20.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.552 -1.277 . . . . 73.2 107.552 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.37 166.59 25.7 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.185 -1.413 . . . . 73.42 107.185 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.46 0.52 7.95 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.098 1.865 . . . . 71.24 111.187 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.7 pt-20 -133.05 4.97 3.82 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 115.593 -0.73 . . . . 74.33 110.394 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.4 t -144.64 120.73 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.578 -0.897 . . . . 74.41 108.578 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.01 146.52 30.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.231 -0.655 . . . . 73.33 109.231 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -126.72 138.58 53.41 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 124.173 0.989 . . . . 73.33 109.008 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.41 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 31.8 m-90 -119.25 109.45 15.85 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.059 -1.089 . . . . 74.4 108.059 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -104.44 98.38 8.17 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 122.498 1.142 . . . . 74.42 109.112 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 19.3 mt -99.14 137.67 37.33 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.562 -1.653 . . . . 73.34 109.925 -170.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -117.73 153.74 50.79 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 114.905 -1.043 . . . . 75.54 111.422 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.34 159.11 54.71 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.515 2.143 . . . . 72.11 111.034 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.16 -34.89 3.18 Favored Glycine 0 C--N 1.303 -1.274 0 C-N-CA 120.964 -0.636 . . . . 72.3 111.564 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.6 m -105.48 159.23 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.4 0.619 . . . . 73.11 112.067 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.1 141.22 31.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.153 -1.054 . . . . 73.41 108.153 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.9 m -150.87 145.77 25.88 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.324 -0.621 . . . . 72.3 109.324 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 38.5 p -105.29 139.12 40.42 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.597 -0.519 . . . . 74.11 109.597 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -89.92 116.52 28.05 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.409 -1.7 . . . . 74.4 106.409 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 10.9 t -125.78 135.88 52.52 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 117.946 -1.502 . . . . 71.44 109.298 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.41 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.49 120.97 6.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.416 -0.957 . . . . 73.25 108.416 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -124.64 131.21 53.48 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.635 -1.246 . . . . 74.54 107.635 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.12 152.52 26.46 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.467 -0.568 . . . . 73.22 109.467 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 56.1 mtt180 -87.91 129.94 35.07 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.851 -0.74 . . . . 74.53 109.217 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -131.93 129.12 39.86 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 107.622 -1.251 . . . . 73.21 107.622 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.9 p -54.61 104.95 0.13 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 124.485 1.116 . . . . 74.33 111.954 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.62 141.06 97.71 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.701 -0.681 . . . . 74.53 109.554 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.06 -47.47 12.5 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.042 1.828 . . . . 73.42 113.537 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.95 -10.84 54.49 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.9 -0.5 . . . . 73.45 112.232 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 71.8 p 63.07 93.83 0.05 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.445 1.498 . . . . 70.23 113.859 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.24 161.04 20.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.916 -0.583 . . . . 65.34 109.548 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 65.3 m . . . . . 0 C--O 1.26 1.637 0 CA-C-O 117.952 -1.023 . . . . 73.22 109.293 -172.38 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.689 0 N-CA-C 111.825 -0.51 . . . . 71.31 111.825 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -64.64 113.19 3.57 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.879 0.471 . . . . 74.35 110.803 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 60.11 29.51 19.07 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.083 0.944 . . . . 74.34 109.524 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.54 -42.1 18.8 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.514 -0.766 . . . . 74.44 110.271 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.76 117.98 22.04 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.197 -1.038 . . . . 74.12 108.197 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -70.75 101.13 2.02 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.023 -1.102 . . . . 75.13 108.023 175.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -54.78 -62.32 1.74 Allowed 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 123.529 0.518 . . . . 73.3 110.972 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -157.93 141.39 15.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.553 -0.906 . . . . 71.44 108.553 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.03 55.05 0.71 Allowed Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 109.316 -1.514 . . . . 62.32 109.316 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.462 ' HB3' ' OD2' ' A' ' 132' ' ' ASP . 87.6 m-70 -135.94 -174.92 3.8 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 123.031 0.533 . . . . 74.22 111.053 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 62.1 mtt 67.41 92.75 0.08 Allowed 'General case' 0 C--O 1.246 0.888 0 C-N-CA 125.525 1.53 . . . . 65.52 112.439 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 2.2 pt? -136.74 164.31 28.55 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.501 -0.772 . . . . 75.21 112.228 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 136' ' ' ASP . 16.1 tpt180 -133.46 124.22 26.66 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.986 -1.857 . . . . 74.32 105.986 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.14 114.26 41.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.172 -1.047 . . . . 70.43 108.172 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -129.59 115.18 17.03 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.692 0.758 . . . . 75.12 110.99 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.51 129.75 55.72 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.692 -1.14 . . . . 73.54 108.936 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.9 m -131.16 115.2 16.06 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.083 -1.08 . . . . 75.52 108.083 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.35 147.16 28.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 109.804 -0.443 . . . . 73.32 109.804 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 57.2 m -127.99 124.56 37.51 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 109.11 -0.7 . . . . 74.31 109.11 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -112.77 119.67 60.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.703 0.764 . . . . 75.41 110.362 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.5 m -89.43 151.43 46.2 Favored Pre-proline 0 C--N 1.288 -2.098 0 CA-C-N 115.064 -0.971 . . . . 52.21 109.879 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.85 2.92 0.83 Allowed 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.819 3.013 . . . . 63.23 113.284 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 17.8 t70 -82.55 -2.65 54.23 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.702 -1.221 . . . . 74.4 107.702 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.1 t70 72.54 29.91 1.99 Allowed 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.458 -1.682 . . . . 72.23 106.458 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 1.0 OUTLIER -106.71 138.19 43.35 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 112.728 -2.033 . . . . 75.45 108.341 -177.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.07 140.67 46.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 109.501 -0.555 . . . . 74.43 109.501 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -147.74 160.98 42.13 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.09 -1.078 . . . . 61.11 108.09 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.48 -170.03 40.85 Favored Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.067 -1.54 . . . . 64.13 113.006 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.34 133.68 18.5 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.254 0.55 . . . . 72.42 109.91 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.01 116.68 52.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.872 -1.159 . . . . 72.25 107.872 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.14 116.7 53.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 110.319 -0.252 . . . . 72.1 110.319 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.76 108.03 18.24 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 106.854 -1.535 . . . . 74.34 106.854 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.453 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . . . -118.74 141.79 48.29 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.114 -0.494 . . . . 74.43 110.234 -175.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.35 158.2 31.6 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.697 -0.853 . . . . 73.2 108.697 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -74.26 137.29 75.23 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.537 -0.912 . . . . 75.43 108.537 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -60.35 123.78 13.81 Favored 'Trans proline' 0 C--O 1.251 1.127 0 C-N-CA 122.697 2.264 . . . . 70.05 111.155 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.618 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 18.5 pttm -155.73 139.04 15.72 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.325 -1.731 . . . . 75.43 106.325 -175.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.533 HD22 ' HG2' ' A' ' 54' ' ' LYS . 6.2 t30 70.49 138.68 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 121.728 0.775 . . . . 74.11 112.965 177.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -50.6 -34.69 26.9 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 115.912 1.819 . . . . 70.25 115.912 -172.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.533 ' HG2' HD22 ' A' ' 52' ' ' ASN . 19.8 ptmt -99.3 3.13 46.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.619 -1.232 . . . . 74.24 112.373 -175.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.618 ' HB3' ' O ' ' A' ' 51' ' ' LYS . 29.7 t70 -93.09 100.6 12.98 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.85 -1.14 . . . . 74.01 113.06 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.559 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 9.2 t -121.44 -7.64 9.19 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 114.148 -1.387 . . . . 74.44 108.94 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.41 125.33 0.84 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 118.82 -0.989 . . . . 73.44 111.88 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.418 ' CD ' ' HA2' ' A' ' 82' ' ' GLY . 32.3 Cg_exo -61.4 154.26 60.09 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.069 1.846 . . . . 74.13 109.836 174.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.38 109.01 16.24 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 111.993 0.368 . . . . 72.31 111.993 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.3 mt -90.82 124.55 35.24 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.827 -0.749 . . . . 75.24 110.108 173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.46 99.41 8.19 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.406 -0.816 . . . . 73.13 110.283 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.96 75.87 0.29 Allowed Glycine 0 C--N 1.29 -2.021 0 CA-C-N 114.96 -1.018 . . . . 72.14 111.616 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.64 91.36 7.98 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 108.883 -0.784 . . . . 74.22 108.883 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.4 m -134.83 160.1 69.66 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 107.838 -1.171 . . . . 75.23 107.838 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.56 -22.74 37.89 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 121.88 1.72 . . . . 71.14 112.157 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -97.69 40.77 1.15 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.061 -0.518 . . . . 71.21 112.309 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -56.02 -35.92 67.39 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 123.052 0.541 . . . . 75.43 110.353 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -64.53 -15.18 60.49 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.55 0.74 . . . . 74.51 111.635 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -100.7 -17.66 16.87 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 116.082 -0.508 . . . . 72.53 110.828 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.83 120.09 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 122.022 0.915 . . . . 73.41 112.273 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.51 112.74 24.9 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.534 -0.757 . . . . 64.34 109.026 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.16 114.23 39.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.935 -1.135 . . . . 70.21 107.935 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 168.54 14.57 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.856 -0.794 . . . . 71.43 108.856 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -84.48 153.76 23.13 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 119.571 -0.852 . . . . 72.31 109.009 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 83.9 t80 -120.73 124.68 45.73 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 109.837 -0.431 . . . . 73.24 109.837 -177.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.17 98.14 3.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.982 -1.118 . . . . 73.34 107.982 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 49.5 m -165.28 164.27 19.96 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.3 -1.37 . . . . 74.51 107.3 -176.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 67.78 6.58 5.15 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 124.64 1.176 . . . . 75.03 111.946 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.04 5.81 85.55 Favored Glycine 0 C--N 1.314 -0.662 0 N-CA-C 110.065 -1.214 . . . . 73.14 110.065 -174.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -105.7 163.1 12.96 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 124.767 1.227 . . . . 74.31 110.927 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 56' ' ' THR . 16.8 m -134.48 136.55 52.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.525 -0.917 . . . . 75.31 108.525 173.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -169.72 -155.13 9.77 Favored Glycine 0 N--CA 1.423 -2.22 0 C-N-CA 119.855 -1.164 . . . . 71.13 113.033 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -132.17 140.85 48.89 Favored 'General case' 0 C--N 1.289 -2.056 0 C-N-CA 124.007 0.923 . . . . 72.22 109.696 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -128.65 146.16 50.95 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 116.274 -0.421 . . . . 62.12 110.529 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.73 114.42 23.3 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.488 -1.301 . . . . 61.4 107.488 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.35 122.04 62.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.064 -1.087 . . . . 72.15 108.064 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -123.07 153.81 39.4 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.006 -0.678 . . . . 75.14 111.469 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.3 p -156.11 153.52 29.48 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.528 -0.76 . . . . 71.22 110.728 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 64.33 37.51 8.45 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.328 1.017 . . . . 73.3 112.876 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 34.8 mt -101.02 176.32 5.3 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.169 -0.678 . . . . 74.42 109.169 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.439 HG23 ' OE1' ' A' ' 94' ' ' GLU . 9.8 t -121.76 171.08 9.14 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.369 -0.532 . . . . 73.54 110.398 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 114' ' ' ARG . 53.9 t80 -50.02 -44.78 51.41 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.751 1.621 . . . . 70.04 111.517 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.1 -25.63 66.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.63 0.604 . . . . 70.04 112.63 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' OE1' HG23 ' A' ' 91' ' ' THR . 49.5 mt-10 -85.76 -15.96 40.42 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.164 0.431 . . . . 74.41 112.164 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 7.0 tt -55.74 -52.48 71.85 Favored Pre-proline 0 CA--C 1.564 1.5 0 N-CA-C 111.88 0.326 . . . . 72.21 111.88 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.425 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 21.1 Cg_endo -65.1 -29.92 56.12 Favored 'Trans proline' 0 C--N 1.359 1.11 0 CA-C-N 120.6 1.25 . . . . 75.35 111.7 175.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -69.04 -35.92 77.13 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 123.279 0.631 . . . . 75.54 110.401 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -77.02 -19.28 57.42 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.351 0.596 . . . . 74.23 109.495 176.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 96' ' ' PRO . . . -73.19 -17.69 61.34 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.484 -0.78 . . . . 75.4 109.56 -177.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.04 -54.59 42.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.771 -0.65 . . . . 72.03 109.591 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 67.5 mtm -54.24 -52.31 61.74 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.82 0.819 . . . . 72.23 109.232 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -54.3 -31.6 54.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.824 -1.535 . . . . 75.44 111.694 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.8 m -58.46 -33.7 70.04 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 119.304 -0.379 . . . . 71.11 111.915 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.1 -21.94 66.88 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.438 0.533 . . . . 75.35 112.438 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.16 -4.9 13.06 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.723 -0.391 . . . . 72.13 110.629 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.48 -48.27 3.72 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.981 -0.688 . . . . 73.23 112.697 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.8 28.28 73.21 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 119.94 -1.124 . . . . 71.14 110.541 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.1 t -122.05 134.6 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 109.039 -0.726 . . . . 73.51 109.039 -176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -93.55 122.37 35.91 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.087 -0.708 . . . . 73.14 109.087 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.46 137.2 53.34 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.594 0.59 . . . . 73.1 112.594 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.4 t -138.01 142.43 40.41 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.151 -1.055 . . . . 72.54 108.151 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -148.25 127.3 12.82 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.265 -1.013 . . . . 74.05 108.265 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -144.92 149.41 35.21 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 113.615 0.969 . . . . 71.43 113.615 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -101.94 117.28 34.49 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.526 -1.657 . . . . 74.13 106.526 177.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -109.96 92.7 4.15 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 107.81 -1.182 . . . . 74.33 107.81 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.92 -114.16 6.19 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 108.845 -1.702 . . . . 33.2 108.845 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.493 ' OD1' ' HD2' ' A' ' 177' ' ' ARG . 29.4 t-20 -100.33 -14.73 18.27 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.441 0.639 . . . . 64.03 110.633 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.473 ' HA ' ' CB ' ' A' ' 177' ' ' ARG . 1.3 pp -96.05 146.58 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 C-N-CA 118.978 -1.089 . . . . 75.53 109.106 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.663 HG22 ' CD2' ' A' ' 178' ' ' TYR . 89.0 t -115.74 141.19 34.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.587 -0.696 . . . . 73.32 110.391 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.0 pt -122.3 140.67 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 115.328 -0.851 . . . . 75.45 109.493 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.03 127.47 47.93 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 107.636 -1.246 . . . . 74.2 107.636 172.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -127.92 118.61 23.92 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.715 -1.13 . . . . 71.13 108.497 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -144.94 133.47 5.16 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.295 -0.955 . . . . 51.54 111.169 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.433 ' HG2' HG21 ' A' ' 171' ' ' THR . 68.3 mtt85 -120.63 127.02 51.7 Favored 'General case' 0 C--N 1.28 -2.436 0 O-C-N 122.38 -0.482 . . . . 74.13 110.053 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -117.75 113.61 22.1 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.611 -0.722 . . . . 70.02 110.024 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -111.74 107.49 16.6 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.617 -1.253 . . . . 60.24 107.617 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.558 ' O ' HG12 ' A' ' 130' ' ' VAL . 2.7 mm? -111.74 27.28 9.81 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.872 -0.418 . . . . 75.12 109.872 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.4 p -71.52 -27.8 63.44 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.046 -0.662 . . . . 75.55 111.885 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.0 m -100.36 10.25 41.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.259 -0.428 . . . . 72.21 111.391 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 127' ' ' LEU . 8.4 p -73.81 140.15 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 119.62 -0.832 . . . . 73.23 108.834 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.2 m -86.8 11.92 12.12 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.953 0.406 . . . . 73.11 111.455 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 24' ' ' HIS . 4.9 m-20 -129.76 100.65 19.16 Favored Pre-proline 0 CA--C 1.489 -1.368 0 N-CA-C 112.249 0.463 . . . . 74.35 112.249 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -74.78 -15.67 21.21 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.97 1.78 . . . . 74.22 110.003 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -83.14 -11.77 57.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.392 -1.276 . . . . 73.33 110.608 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -70.35 142.25 52.17 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.882 -0.599 . . . . 73.21 110.761 -177.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.434 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 10.1 t70 -132.03 116.31 16.93 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.042 -1.836 . . . . 74.33 106.042 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.8 t -114.35 136.51 50.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.467 -0.568 . . . . 74.34 109.467 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -133.42 131.66 40.23 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.908 -0.404 . . . . 75.34 109.908 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -122.67 118.54 28.36 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 106.817 -1.549 . . . . 74.13 106.817 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.4 m -121.62 133.36 54.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.954 -0.387 . . . . 73.43 109.954 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.37 124.04 66.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 108.697 -0.853 . . . . 74.12 108.697 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -115.16 132.51 56.58 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.577 -0.897 . . . . 72.24 108.577 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.687 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -134.43 120.37 14.69 Favored Pre-proline 0 C--N 1.28 -2.42 0 CA-C-N 116.337 -0.392 . . . . 74.43 110.147 178.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.92 37.69 0.11 Allowed 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 123.928 3.085 . . . . 73.41 114.654 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.28 -97.1 0.46 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.302 -0.629 . . . . 72.14 109.302 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.44 136.81 0.06 Allowed 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.793 -1.188 . . . . 73.54 107.793 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.31 128.5 38.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.548 -0.538 . . . . 75.54 109.548 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 43.6 p -88.35 -43.85 11.21 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.686 -0.688 . . . . 75.1 110.159 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.2 m -150.64 132.51 15.09 Favored 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.4 -0.963 . . . . 74.43 108.4 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.2 t -140.28 152.31 45.8 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.889 -0.724 . . . . 72.41 111.276 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -123.79 91.16 3.41 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.369 -2.086 . . . . 64.33 105.369 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.505 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.14 -139.35 5.38 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 110.202 -1.159 . . . . 74.13 110.202 -177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 161' ' ' GLN . 24.3 t70 -115.18 99.57 7.51 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.613 0.721 . . . . 75.14 110.589 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -84.33 116.35 22.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 116.131 -0.486 . . . . 74.32 110.808 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.474 HD12 ' NE2' ' A' ' 161' ' ' GLN . 54.8 mt -93.42 -49.29 12.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.679 -0.86 . . . . 71.51 108.679 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -126.36 159.58 62.19 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.552 -1.277 . . . . 73.33 107.552 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.04 -18.61 51.63 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.568 2.179 . . . . 74.23 111.907 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.8 OUTLIER -120.22 7.65 10.79 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.842 0.682 . . . . 72.52 112.842 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.9 t -138.43 121.45 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-O 121.074 0.464 . . . . 75.04 110.812 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.7 t -125.04 144.87 33.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.962 -0.563 . . . . 75.24 109.664 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.474 ' NE2' HD12 ' A' ' 155' ' ' ILE . 9.2 tt0 -133.57 152.03 51.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.273 -1.01 . . . . 71.04 108.273 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.505 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.0 m-90 -128.64 123.92 34.47 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 108.42 -0.956 . . . . 74.13 108.42 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 109.04 20.76 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.813 0.816 . . . . 74.41 109.983 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 66.1 mt -97.33 126.27 42.45 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.677 -1.147 . . . . 73.01 109.226 -174.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -115.22 152.19 46.54 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 115.091 -0.959 . . . . 74.32 112.266 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 168' ' ' VAL . 23.5 Cg_exo -68.97 158.44 57.92 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 123.192 2.595 . . . . 74.1 111.212 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 73.3 -19.82 1.33 Allowed Glycine 0 C--N 1.313 -0.746 0 N-CA-C 114.299 0.48 . . . . 63.12 114.299 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 166' ' ' PRO . 13.4 m -111.63 169.25 4.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.4 0.619 . . . . 75.31 110.781 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.63 139.61 38.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.142 -1.429 . . . . 74.43 107.142 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 27.1 m -134.77 134.89 41.4 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.358 0.599 . . . . 64.52 110.55 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.433 HG21 ' HG2' ' A' ' 124' ' ' ARG . 9.7 p -103.11 126.53 50.33 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.085 -0.961 . . . . 75.45 108.727 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 56.7 mtm -108.86 126.95 53.6 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.21 -1.033 . . . . 73.24 108.21 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.9 t -141.65 138.09 32.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.339 -0.986 . . . . 73.42 108.339 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.4 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -146.03 133.39 20.68 Favored 'General case' 0 CA--C 1.469 -2.16 0 N-CA-C 108.052 -1.092 . . . . 71.31 108.052 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.89 131.14 51.22 Favored 'General case' 0 C--N 1.263 -3.177 0 N-CA-C 108.039 -1.097 . . . . 74.15 108.039 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 119' ' ' VAL . . . -159.79 129.45 5.35 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 106.566 -1.642 . . . . 74.4 106.566 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.493 ' HD2' ' OD1' ' A' ' 117' ' ' ASN . 17.7 ptt180 -88.05 146.86 25.25 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 118.43 -1.308 . . . . 74.32 110.117 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.663 ' CD2' HG22 ' A' ' 119' ' ' VAL . 19.6 m-30 -119.53 137.05 54.07 Favored 'General case' 0 CA--C 1.465 -2.317 0 N-CA-C 108.187 -1.042 . . . . 74.01 108.187 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.7 p -71.36 103.82 3.0 Favored 'General case' 0 N--CA 1.394 -3.236 0 CA-C-N 115.269 -0.878 . . . . 65.43 110.431 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.412 ' HB3' ' ND2' ' A' ' 182' ' ' ASN . 35.4 m-20 -54.02 134.99 58.22 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.13 -0.941 . . . . 75.11 111.145 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -69.2 -20.97 36.79 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.425 2.75 . . . . 73.4 111.716 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.412 ' ND2' ' HB3' ' A' ' 180' ' ' ASP . 10.9 p30 -74.19 -21.27 59.89 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 109.227 -0.657 . . . . 62.44 109.227 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.7 p 51.51 98.1 0.01 OUTLIER 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.275 1.43 . . . . 63.5 113.433 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -120.31 175.83 5.77 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.997 -1.001 . . . . 64.31 111.599 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 108.189 -1.041 . . . . 64.54 108.189 -179.027 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.64 0 N-CA-C 110.55 -1.02 . . . . 53.32 110.55 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -81.27 133.4 35.43 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 108.051 -1.092 . . . . 74.1 108.051 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -143.11 149.68 38.46 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.802 -0.759 . . . . 74.3 109.8 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.7 t30 65.13 91.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.859 1.264 . . . . 72.23 110.816 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 mp -89.51 81.05 6.59 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.571 -0.741 . . . . 73.11 110.901 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -86.75 124.64 33.23 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.908 -1.042 . . . . 73.22 110.508 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.2 t80 53.06 62.16 2.81 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 125.04 1.336 . . . . 71.53 111.419 -175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.406 ' OE1' ' HG3' ' A' ' 51' ' ' LYS . 78.6 mm-40 -112.78 31.79 6.12 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.988 -1.486 . . . . 75.22 106.988 174.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.45 103.29 0.93 Allowed Glycine 0 N--CA 1.424 -2.127 0 CA-C-N 113.045 -1.889 . . . . 75.32 110.179 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -101.53 -154.83 0.49 Allowed 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 114.442 -0.879 . . . . 74.4 109.254 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.4 ptp -168.31 133.78 1.81 Allowed 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.598 -2.371 . . . . 74.44 104.598 172.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 135' ' ' ALA 0.301 0.0 OUTLIER -132.44 144.75 50.7 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 114.044 1.128 . . . . 73.33 114.044 -177.032 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 -113.15 124.23 52.08 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 114.236 -1.347 . . . . 72.35 107.741 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 48.9 t -118.97 114.19 43.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 106.913 -1.514 . . . . 75.15 106.913 177.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 22.4 ttt180 -129.32 116.94 19.85 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 121.519 0.676 . . . . 72.11 110.708 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.35 108.84 20.57 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.26 -1.385 . . . . 73.4 107.26 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.9 m -113.47 114.16 26.16 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.698 -1.593 . . . . 62.31 106.698 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.8 pp -131.76 146.07 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 C-N-CA 120.2 -0.6 . . . . 71.23 109.811 -175.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 87.3 m -126.43 122.49 35.44 Favored 'General case' 0 C--N 1.27 -2.883 0 N-CA-C 109.251 -0.648 . . . . 74.24 109.251 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 tt -110.93 118.76 58.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.652 0.739 . . . . 62.54 109.796 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.7 m -89.33 150.78 45.4 Favored Pre-proline 0 N--CA 1.411 -2.411 0 N-CA-C 108.429 -0.952 . . . . 71.33 108.429 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.03 0.9 0.36 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.792 2.995 . . . . 75.04 115.135 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -83.32 -3.25 57.3 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.783 -0.821 . . . . 72.23 108.783 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 t70 72.77 29.84 1.87 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 105.812 -1.921 . . . . 74.12 105.812 -173.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 tp -100.19 124.61 45.83 Favored 'General case' 0 N--CA 1.389 -3.493 0 CA-C-N 113.3 -1.773 . . . . 74.13 107.354 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 t -116.34 133.08 64.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 109.078 -0.712 . . . . 75.32 109.078 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.8 p -146.96 157.55 43.66 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.635 -0.876 . . . . 64.22 108.635 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.3 -165.19 38.68 Favored Glycine 0 N--CA 1.428 -1.855 0 C-N-CA 119.207 -1.473 . . . . 70.21 112.987 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.55 133.83 21.74 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 123.28 0.632 . . . . 72.33 109.873 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.94 116.01 50.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.892 -1.151 . . . . 74.42 107.892 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.93 126.03 65.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.046 -0.525 . . . . 74.32 109.829 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -120.72 107.93 13.37 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.282 -1.747 . . . . 74.12 106.282 171.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.87 127.51 51.95 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.26 -0.427 . . . . 73.42 111.003 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.77 148.88 42.35 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 116.48 -0.327 . . . . 64.21 110.244 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.82 128.88 93.44 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.433 -0.951 . . . . 70.44 108.433 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -57.95 111.94 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.161 1.907 . . . . 72.54 110.719 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.406 ' HG3' ' OE1' ' A' ' 22' ' ' GLN . 0.5 OUTLIER -121.51 -32.07 3.9 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.051 0.453 . . . . 75.01 110.034 -177.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -85.0 130.5 34.61 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.736 -1.209 . . . . 74.25 107.736 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.4 m -55.41 -43.4 75.24 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 124.119 0.968 . . . . 63.51 113.222 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -83.97 -7.2 59.47 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.779 0.288 . . . . 73.44 111.779 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' OD2' ' HD3' ' A' ' 58' ' ' PRO . 35.8 t70 -86.07 125.62 33.58 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 113.639 0.977 . . . . 73.21 113.639 -168.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -121.58 4.04 10.14 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.649 -1.16 . . . . 72.33 109.865 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.488 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 172.24 99.01 0.12 Allowed Glycine 0 N--CA 1.431 -1.671 0 CA-C-O 118.69 -1.061 . . . . 72.5 112.545 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 31.2 Cg_exo -59.84 128.52 27.1 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 CA-C-N 119.872 1.836 . . . . 72.44 109.052 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.71 151.43 21.85 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.803 0.668 . . . . 72.42 112.803 -171.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.438 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 67.3 mt -82.46 138.97 34.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.828 -0.623 . . . . 71.21 109.526 174.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -110.6 101.97 10.59 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.633 -1.618 . . . . 72.11 106.633 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.85 75.13 0.19 Allowed Glycine 0 C--N 1.29 -1.979 0 C-N-CA 120.581 -0.818 . . . . 71.41 112.857 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.01 112.2 19.55 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.56 -0.533 . . . . 73.41 109.56 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.435 HG12 ' SD ' ' A' ' 101' ' ' MET . 17.6 m -124.21 157.13 65.35 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 115.939 -0.573 . . . . 74.21 109.841 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.51 -10.09 27.56 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 122.751 2.3 . . . . 72.24 112.886 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -110.26 39.46 2.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.388 -0.369 . . . . 70.41 110.974 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 m -53.68 -32.36 51.39 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.055 0.391 . . . . 74.24 112.055 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -67.76 -11.88 59.38 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.273 0.559 . . . . 75.43 110.981 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -98.62 -20.61 16.9 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.673 -0.694 . . . . 74.35 111.071 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.22 119.79 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.731 0.777 . . . . 73.3 112.155 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 123.28 45.7 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.465 -0.789 . . . . 63.23 109.075 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.66 130.99 46.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.952 -0.758 . . . . 72.42 108.952 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 m -132.66 171.98 13.13 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.947 -0.39 . . . . 72.43 109.947 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.488 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 5.8 t30 -93.03 134.87 34.73 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.051 -1.092 . . . . 73.22 108.051 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.526 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 87.8 t80 -99.96 126.35 46.11 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.946 -0.39 . . . . 75.34 109.946 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -135.29 101.44 4.84 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.082 -1.081 . . . . 74.35 108.082 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 47.0 t -173.22 155.85 3.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.939 -1.134 . . . . 73.25 107.939 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 70.57 6.86 6.0 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.687 1.195 . . . . 73.53 110.811 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.76 6.0 87.51 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.021 -0.831 . . . . 74.52 111.021 -173.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -104.59 148.15 26.83 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.417 0.687 . . . . 75.33 110.094 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.7 137.45 55.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.833 -0.803 . . . . 73.41 108.833 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.466 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -167.86 -154.31 8.61 Favored Glycine 0 CA--C 1.458 -3.473 0 N-CA-C 110.555 -1.018 . . . . 71.44 110.555 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.438 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . 32.7 t -134.19 149.13 50.99 Favored 'General case' 0 C--N 1.26 -3.296 0 N-CA-C 108.656 -0.868 . . . . 73.21 108.656 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -134.82 133.88 40.25 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 115.618 -0.719 . . . . 74.43 110.207 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.67 115.61 30.62 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.24 -1.022 . . . . 71.13 108.24 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.64 116.21 48.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 107.599 -1.26 . . . . 72.53 107.599 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.477 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.5 p90 -120.76 157.04 30.57 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.595 -0.442 . . . . 74.14 110.609 -175.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.2 m -159.25 157.19 30.16 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.933 -0.576 . . . . 75.32 110.06 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 64.06 32.85 12.56 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.24 0.963 . . . . 73.44 112.242 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.477 HD12 ' CD2' ' A' ' 87' ' ' PHE . 22.9 mt -90.31 153.26 20.59 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.625 -0.716 . . . . 75.02 110.503 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.7 p -108.04 172.33 6.89 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.338 -0.846 . . . . 75.04 109.686 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -60.84 -26.55 67.44 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.183 0.516 . . . . 75.43 111.007 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.64 -29.5 66.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.534 0.683 . . . . 74.04 109.847 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.403 ' CB ' HD23 ' A' ' 90' ' ' LEU . 38.9 mt-10 -93.07 -15.95 25.53 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.315 -0.857 . . . . 74.54 111.77 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.4 mt -51.98 -52.34 62.62 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 114.008 1.114 . . . . 74.24 114.008 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -64.54 -34.41 52.82 Favored 'Trans proline' 0 C--N 1.363 1.325 0 CA-C-N 120.624 1.259 . . . . 73.04 110.31 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -64.26 -38.74 92.11 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.085 -0.962 . . . . 75.13 111.385 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -70.78 -19.7 62.67 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.091 0.472 . . . . 75.52 110.601 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.27 -16.07 59.87 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.033 -0.531 . . . . 73.23 110.643 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -62.32 -57.92 9.58 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 120.8 -0.36 . . . . 74.43 110.065 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.435 ' SD ' HG12 ' A' ' 64' ' ' VAL . 3.7 mpp? -56.49 -45.74 80.84 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.133 0.492 . . . . 73.42 109.896 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -52.95 -45.01 67.53 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 114.203 -1.362 . . . . 75.2 111.386 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.7 p -66.03 -28.3 68.76 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 120.291 -0.564 . . . . 61.54 110.937 -170.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.1 -26.04 66.51 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.16 0.505 . . . . 65.5 110.597 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.88 -9.81 17.74 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.956 -0.566 . . . . 71.43 110.594 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.26 -44.75 4.47 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.213 0.82 . . . . 63.3 113.213 -172.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.39 27.64 35.57 Favored Glycine 0 C--N 1.316 -0.548 0 N-CA-C 110.297 -1.121 . . . . 74.42 110.297 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.9 m -111.11 168.26 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.389 -0.406 . . . . 74.11 110.104 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -135.45 124.96 25.0 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.676 -0.861 . . . . 74.14 108.676 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -119.49 141.07 49.5 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 123.335 0.397 . . . . 72.31 110.283 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 49.2 m -141.56 116.39 9.79 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.534 -0.913 . . . . 74.03 108.534 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.72 146.16 51.5 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.137 -0.625 . . . . 75.35 111.337 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -139.13 154.67 48.15 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.632 -1.167 . . . . 74.34 109.034 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -100.25 137.8 38.19 Favored 'General case' 0 N--CA 1.393 -3.309 0 N-CA-C 107.661 -1.237 . . . . 74.23 107.661 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -123.26 89.36 3.09 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 106.638 -1.615 . . . . 75.51 106.638 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.71 -118.12 6.91 Favored Glycine 0 N--CA 1.423 -2.224 0 N-CA-C 110.042 -1.223 . . . . 75.11 110.042 -176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.547 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 8.1 t30 -103.96 7.31 36.66 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.086 0.946 . . . . 74.21 108.925 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 pp -119.33 149.16 21.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 120.799 -1.188 . . . . 72.14 109.079 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.9 t -107.8 137.91 36.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 O-C-N 121.845 -0.534 . . . . 73.31 110.037 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.0 pt -118.42 132.66 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 109.291 -0.633 . . . . 73.21 109.291 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 tt -124.61 129.24 50.19 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 115.549 -0.75 . . . . 72.41 109.438 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.31 124.17 29.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.526 -1.657 . . . . 74.12 106.526 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -149.58 171.9 29.63 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.392 -0.908 . . . . 74.14 112.695 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -138.79 153.79 48.43 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.634 0.774 . . . . 75.03 109.365 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.07 109.04 10.2 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.475 -0.935 . . . . 54.54 108.475 174.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -112.6 95.69 5.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.785 0.802 . . . . 74.3 110.742 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.88 27.97 5.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 123.393 1.568 . . . . 72.14 107.79 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.0 p -63.95 -25.7 68.26 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.562 -2.108 . . . . 72.31 112.017 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 p -69.45 -23.72 63.71 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.849 0.86 . . . . 74.24 111.361 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.9 t 71.21 86.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 125.107 1.363 . . . . 72.44 111.676 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 p -75.37 -36.39 60.93 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.77 -1.104 . . . . 74.33 109.09 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -148.77 128.55 6.5 Favored Pre-proline 0 N--CA 1.438 -1.059 0 N-CA-C 107.825 -1.176 . . . . 73.55 107.825 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.9 -12.59 21.74 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.872 2.381 . . . . 74.4 115.72 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -107.39 -11.79 15.46 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.164 -0.96 . . . . 72.42 110.186 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -61.33 138.92 58.25 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.82 -1.082 . . . . 72.23 113.863 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -131.33 130.38 42.65 Favored 'General case' 0 C--O 1.257 1.486 0 N-CA-C 107.784 -1.191 . . . . 72.22 107.784 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 47.2 t -105.9 112.72 40.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.134 -1.432 . . . . 65.3 107.134 175.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 37.0 mt-10 -108.19 120.42 42.31 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.081 -0.711 . . . . 75.25 109.081 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 3.0 tt -115.17 122.81 47.18 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 105.976 -1.861 . . . . 70.24 105.976 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.0 m -126.92 126.01 42.53 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 109.198 -0.667 . . . . 74.34 109.198 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 57.8 t -120.11 124.03 71.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.961 -0.755 . . . . 74.32 108.961 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.4 127.36 55.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.706 -0.85 . . . . 75.34 108.706 177.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.505 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.54 121.76 15.34 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 112.187 0.44 . . . . 74.24 112.187 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.73 46.9 1.11 Allowed 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.997 2.464 . . . . 75.03 110.809 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -128.36 -106.84 0.3 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.943 -0.571 . . . . 72.43 109.867 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.59 126.75 0.07 Allowed 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.742 -0.836 . . . . 61.03 108.742 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.91 135.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.868 -0.79 . . . . 75.54 108.868 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.4 p -90.5 -42.7 10.7 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 109.459 -0.571 . . . . 74.14 109.459 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.5 m -159.38 133.12 7.34 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.095 -0.502 . . . . 73.42 109.963 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.6 t -139.16 157.12 46.5 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 121.987 -0.445 . . . . 72.14 110.313 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -128.23 95.86 4.29 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.656 -1.979 . . . . 72.13 105.656 173.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.52 -145.21 8.14 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 107.788 -2.125 . . . . 73.42 107.788 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -110.61 99.83 8.73 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 118.294 1.047 . . . . 73.22 110.232 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -78.96 110.45 14.19 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 121.886 0.85 . . . . 74.35 109.531 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.8 mt -80.39 -38.0 17.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.149 -1.426 . . . . 63.51 107.149 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.76 163.86 38.08 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.222 -1.77 . . . . 65.45 106.222 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.09 0.23 7.56 Favored 'Trans proline' 0 N--CA 1.481 0.789 0 C-N-CA 122.588 2.192 . . . . 75.03 110.846 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.0 pt-20 -128.94 -0.42 5.3 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 114.88 -1.054 . . . . 73.0 111.297 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.7 t -142.18 120.8 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.547 -0.908 . . . . 73.53 108.547 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -127.41 143.79 39.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.532 -0.544 . . . . 75.22 109.532 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 36.1 tt0 -129.93 147.08 51.65 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.373 0.606 . . . . 73.11 110.17 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.457 ' CZ2' ' HB1' ' A' ' 174' ' ' ALA . 30.3 m-90 -123.63 117.86 25.97 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.142 -1.059 . . . . 75.41 108.142 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -104.07 98.21 8.07 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.752 0.787 . . . . 71.42 109.407 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 18.3 mt -93.42 130.12 39.34 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.555 -1.202 . . . . 73.53 109.225 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.2 152.32 50.42 Favored Pre-proline 0 C--N 1.302 -1.468 0 CA-C-N 115.904 -0.589 . . . . 73.13 111.15 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.68 153.48 73.22 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.329 2.019 . . . . 73.15 111.06 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.09 -23.96 2.56 Favored Glycine 0 C--N 1.304 -1.201 0 C-N-CA 121.046 -0.597 . . . . 71.5 113.842 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.1 m -104.45 147.78 10.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.223 0.535 . . . . 74.11 110.698 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 82.6 t -85.38 127.9 39.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.584 -0.735 . . . . 74.1 109.504 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 10.1 p -138.44 133.07 32.31 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-O 121.424 0.63 . . . . 73.25 111.715 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.3 p -114.83 147.38 39.93 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 108.614 -0.884 . . . . 62.3 108.614 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.412 ' SD ' HD13 ' A' ' 164' ' ' LEU . 70.2 mtm -120.5 133.31 55.42 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.645 -0.502 . . . . 73.32 109.645 -176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.9 t -143.02 137.06 29.01 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.313 -0.625 . . . . 72.41 109.313 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.457 ' HB1' ' CZ2' ' A' ' 162' ' ' TRP . . . -148.12 118.71 7.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.943 -0.762 . . . . 72.54 108.943 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -122.75 130.97 53.55 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 106.62 -1.622 . . . . 74.5 106.62 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.44 160.93 41.89 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.035 0.21 . . . . 72.44 111.261 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.8 mtt-85 -87.39 127.29 35.21 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.862 -0.422 . . . . 74.42 109.862 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -143.5 119.54 10.7 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 117.757 0.253 . . . . 72.04 110.529 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.547 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -58.63 119.42 7.04 Favored 'General case' 0 C--N 1.288 -2.1 0 O-C-N 124.226 0.954 . . . . 75.21 112.423 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.8 136.87 70.09 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.56 -0.746 . . . . 74.53 109.894 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.3 -41.87 11.5 Favored 'Trans proline' 0 CA--C 1.555 1.575 0 C-N-CA 122.688 2.259 . . . . 73.55 114.372 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -84.89 -12.14 54.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.62 -0.675 . . . . 74.23 109.278 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.29 45.2 p 70.6 95.62 0.07 Allowed 'General case' 0 C--O 1.242 0.688 0 C-N-CA 126.535 1.934 . . . . 75.31 114.806 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -131.81 151.35 51.73 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.726 -1.124 . . . . 73.51 108.039 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.315 -0.933 0 C-N-CA 123.873 0.869 . . . . 71.04 110.326 177.839 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.665 0 N-CA-C 110.25 -1.14 . . . . 71.21 110.25 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 67.09 12.75 9.15 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.66 1.184 . . . . 75.15 112.239 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -107.56 85.17 2.08 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.638 -0.875 . . . . 74.04 108.638 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -112.27 108.21 17.34 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 107.154 -1.424 . . . . 74.25 107.154 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.2 pt? -89.39 4.61 48.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.129 0.49 . . . . 74.2 111.497 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -82.52 127.62 33.5 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.81 -1.181 . . . . 71.44 107.81 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.455 ' HB2' ' CG ' ' A' ' 134' ' ' ASP . 19.0 p90 -114.84 -176.59 2.93 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.989 -0.551 . . . . 73.25 111.021 -176.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.52 -55.46 10.12 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 120.789 -0.364 . . . . 71.3 110.494 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.55 20.09 0.03 OUTLIER Glycine 0 C--O 1.25 1.147 0 C-N-CA 118.262 -1.923 . . . . 71.54 114.842 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -146.24 -175.13 4.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.57 -0.9 . . . . 74.31 108.57 179.105 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.8 mtt -139.42 115.78 10.52 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.43 -0.952 . . . . 65.3 108.43 170.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.8 tt -106.63 107.23 18.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.145 -1.798 . . . . 73.22 106.145 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -104.66 123.24 47.24 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.348 -1.353 . . . . 73.45 107.348 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.57 114.69 39.06 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 CA-C-O 121.876 0.846 . . . . 74.14 109.436 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 61.7 mtp85 -119.22 116.69 26.81 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.549 -1.205 . . . . 73.31 110.345 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 139' ' ' LEU . . . -103.66 109.52 21.24 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.769 -1.197 . . . . 75.15 107.769 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 m -114.8 115.42 26.98 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.767 -0.827 . . . . 72.33 108.767 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -129.0 141.68 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 N-CA-C 108.892 -0.781 . . . . 64.21 108.892 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.2 m -121.39 120.94 36.47 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.652 -0.87 . . . . 74.13 108.652 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -105.44 120.79 56.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 121.657 0.741 . . . . 74.45 109.822 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.4 m -84.17 155.92 63.5 Favored Pre-proline 0 C--N 1.295 -1.782 0 CA-C-N 115.177 -0.92 . . . . 60.53 108.974 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.68 2.1 3.79 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.927 2.418 . . . . 75.13 112.531 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -89.36 2.35 54.54 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 124.635 1.174 . . . . 63.32 109.524 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.8 t70 69.21 29.4 4.64 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 123.664 1.697 . . . . 74.22 107.622 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.36 125.47 52.4 Favored 'General case' 0 N--CA 1.393 -3.299 0 CA-C-N 113.032 -1.894 . . . . 74.32 107.471 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.52 134.07 57.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 115.902 -0.59 . . . . 74.53 109.535 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.2 p -140.96 128.67 21.55 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.56 -1.274 . . . . 71.45 107.56 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.67 -171.9 30.49 Favored Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 119.487 -1.34 . . . . 63.0 112.648 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -149.21 133.67 17.57 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.173 -0.677 . . . . 64.54 109.173 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 58.4 mt -111.72 115.33 49.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 106.918 -1.512 . . . . 74.1 106.918 176.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.39 114.22 46.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.357 -0.609 . . . . 74.21 109.357 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -106.61 107.68 18.82 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.814 -1.921 . . . . 75.53 105.814 172.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.64 116.93 24.66 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.7 0.762 . . . . 51.52 110.064 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.65 139.91 50.37 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.534 -0.757 . . . . 73.33 111.304 -174.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 24' ' ' HIS . 79.7 tttt -60.77 127.23 86.96 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 104.604 -2.369 . . . . 74.34 104.604 168.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -35.65 97.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 124.154 3.236 . . . . 75.12 114.463 -173.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -83.17 -35.11 25.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.637 -1.165 . . . . 74.5 110.164 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.483 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 48.8 t-20 -124.72 123.63 40.43 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.257 -1.757 . . . . 65.05 106.257 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.6 m -61.62 -18.64 60.28 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 114.113 1.153 . . . . 73.31 114.113 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 20.8 pttp -80.88 -16.23 54.19 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.623 -0.831 . . . . 75.44 110.151 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -96.7 113.47 25.03 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-O 121.735 0.778 . . . . 74.53 112.979 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 p -90.32 3.35 53.92 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.541 -1.209 . . . . 61.43 108.049 172.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.8 96.6 0.1 Allowed Glycine 0 N--CA 1.42 -2.38 0 CA-C-N 113.474 -1.693 . . . . 72.12 109.295 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 49.2 Cg_exo -55.88 128.95 32.39 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.563 2.175 . . . . 75.45 110.569 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -85.21 159.86 20.02 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.618 0.97 . . . . 71.01 113.618 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.3 mt -107.98 127.51 53.83 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 108.035 -1.098 . . . . 74.51 108.035 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -112.94 97.64 6.66 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.009 0.433 . . . . 75.1 111.174 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.62 136.06 8.64 Favored Glycine 0 C--N 1.284 -2.327 0 N-CA-C 110.788 -0.925 . . . . 74.05 110.788 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.57 120.54 38.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.264 0.554 . . . . 73.23 111.184 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 m -137.81 161.47 59.89 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.531 -0.759 . . . . 62.31 109.063 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.8 -22.05 24.15 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.155 1.903 . . . . 74.3 111.768 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -100.37 42.52 1.11 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.771 -0.65 . . . . 75.11 111.593 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 m -54.03 -36.56 63.17 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.475 0.71 . . . . 63.3 111.489 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -69.55 -13.68 62.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.541 0.686 . . . . 73.23 110.289 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.71 -12.77 21.96 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.431 -0.804 . . . . 75.33 110.434 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.8 119.46 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 122.303 1.049 . . . . 74.25 111.595 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.58 112.99 26.16 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.179 -0.919 . . . . 75.15 109.873 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.7 p -98.0 133.11 41.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.25 -1.018 . . . . 73.12 108.25 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.6 m -147.46 163.24 37.15 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.266 -1.013 . . . . 74.35 108.266 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -76.87 143.42 39.68 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.473 0.654 . . . . 73.44 110.808 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 73.4 t80 -108.3 123.09 48.27 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.552 -1.277 . . . . 64.31 107.552 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -138.25 99.17 3.79 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 107.659 -1.237 . . . . 74.15 107.659 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 65.2 m -162.5 149.15 13.12 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.865 -1.161 . . . . 75.42 107.865 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 69.73 4.41 4.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.876 0.87 . . . . 62.04 113.316 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.55 4.76 65.58 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.998 -0.841 . . . . 24.33 110.998 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -104.93 142.34 34.94 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.297 -1.001 . . . . 62.43 108.297 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.4 m -124.38 136.45 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 121.544 0.688 . . . . 71.52 109.481 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -173.44 -153.41 9.61 Favored Glycine 0 CA--C 1.461 -3.331 0 N-CA-C 110.088 -1.205 . . . . 75.53 110.088 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.557 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 62.9 m -134.95 149.85 50.29 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 121.506 0.67 . . . . 74.1 111.485 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.9 pt20 -124.58 132.14 53.45 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.873 -1.058 . . . . 75.13 109.576 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.04 113.95 27.65 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.584 -1.636 . . . . 73.11 106.584 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.69 112.74 41.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.374 -0.973 . . . . 75.14 108.374 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.501 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.5 p90 -115.71 153.68 30.92 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.978 -0.556 . . . . 72.23 110.954 -175.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -154.85 158.16 38.95 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.581 -0.736 . . . . 62.2 111.297 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 65.15 30.88 11.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 122.568 1.175 . . . . 71.45 110.824 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.501 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.4 mt -96.08 164.23 12.78 Favored 'General case' 0 N--CA 1.426 -1.628 0 O-C-N 121.275 -0.891 . . . . 71.11 111.11 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -115.22 171.34 7.75 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 116.254 -0.43 . . . . 74.12 110.686 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -57.0 -36.79 70.81 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.031 0.443 . . . . 65.13 110.181 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.05 70.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.686 -0.688 . . . . 74.41 111.019 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.87 -16.08 39.77 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 112.593 0.59 . . . . 73.4 112.593 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.1 mt -52.56 -53.4 54.15 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 114.322 1.23 . . . . 74.32 114.322 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.08 -42.29 44.93 Favored 'Trans proline' 0 C--N 1.369 1.607 0 CA-C-N 120.57 1.239 . . . . 72.45 110.497 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -60.08 -39.72 87.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.317 -0.856 . . . . 73.13 111.76 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -78.34 -21.86 48.89 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 120.745 -0.382 . . . . 74.55 110.728 177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.84 -26.85 61.63 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.148 -0.686 . . . . 73.51 109.148 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -57.73 -54.33 48.12 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.318 -0.855 . . . . 73.54 109.909 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.1 mtm -54.11 -49.98 67.91 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.205 0.526 . . . . 72.43 110.313 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -55.36 -37.27 67.3 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.402 -1.272 . . . . 74.34 110.117 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.7 m -60.72 -32.89 72.13 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.503 -0.317 . . . . 73.44 111.092 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -68.82 -15.63 63.55 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.531 0.682 . . . . 75.22 111.557 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.15 -11.95 12.59 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.202 -0.454 . . . . 62.45 110.607 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.52 -47.53 3.75 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.658 0.984 . . . . 74.11 113.658 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.86 22.09 77.48 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.454 -1.058 . . . . 64.33 110.454 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.3 t -111.93 143.89 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.127 0.971 . . . . 74.14 108.576 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -102.18 131.38 48.74 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.052 -0.351 . . . . 75.22 110.052 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.19 104.84 7.3 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.39 -0.967 . . . . 55.14 108.39 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.5 m -117.58 137.6 52.49 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.607 -0.886 . . . . 74.1 108.607 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -147.96 149.28 31.88 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.94 -0.704 . . . . 73.11 112.449 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -148.39 163.07 38.21 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.039 -0.982 . . . . 75.33 111.001 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 114' ' ' ARG . 45.8 mtt85 -102.57 139.76 37.75 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.029 0.443 . . . . 73.1 110.315 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -121.7 83.71 2.13 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.983 -1.488 . . . . 75.23 106.983 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.95 -115.7 8.25 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.971 -1.013 . . . . 72.02 110.697 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -85.08 -20.27 30.63 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.504 0.668 . . . . 74.52 110.929 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.2 pp -102.64 148.71 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 C-N-CA 118.088 -1.445 . . . . 72.35 109.174 -175.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.418 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 92.8 t -116.81 140.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 O-C-N 122.008 -0.432 . . . . 72.15 110.054 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.3 pt -117.35 138.11 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 115.972 -0.558 . . . . 75.21 110.088 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.3 tt -127.3 127.94 45.15 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.143 -1.058 . . . . 74.3 108.143 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -128.26 117.95 22.41 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.485 -0.932 . . . . 61.03 108.485 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.13 169.57 25.31 Favored Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 121.059 -0.591 . . . . 64.1 112.201 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -151.05 153.24 34.72 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.19 -0.67 . . . . 74.31 109.19 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -135.57 108.62 7.67 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.634 -0.876 . . . . 74.32 108.634 171.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -113.11 97.24 6.38 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.933 0.873 . . . . 74.52 110.994 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.76 34.74 4.59 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.448 -1.251 . . . . 72.31 108.193 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.4 p -66.44 -32.73 74.29 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.143 0.794 . . . . 75.45 113.143 -175.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.1 m -99.69 18.39 18.23 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.085 0.402 . . . . 72.31 112.085 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.458 HG13 ' CB ' ' A' ' 166' ' ' PRO . 5.2 p -66.61 158.09 5.43 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 N-CA-C 110.141 -0.318 . . . . 75.11 110.141 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.6 p -87.4 -47.13 9.02 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 120.775 0.322 . . . . 72.22 110.371 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -96.9 108.72 45.1 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 123.85 0.86 . . . . 74.45 112.588 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.68 -11.24 18.54 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.811 3.007 . . . . 75.55 113.315 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 24' ' ' HIS . 0.5 OUTLIER -80.19 15.32 1.58 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 115.133 1.531 . . . . 74.42 115.133 -171.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.17 135.89 40.91 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.894 -1.048 . . . . 74.43 108.714 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -131.39 130.48 42.65 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 118.089 0.404 . . . . 74.32 110.419 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 46.5 t -115.91 126.9 73.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.311 -0.626 . . . . 62.41 109.311 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 162' ' ' TRP . 50.6 mt-10 -128.65 133.06 48.14 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.962 0.41 . . . . 75.45 110.179 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 52.2 tp -114.44 121.43 43.54 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.683 -0.858 . . . . 75.11 108.683 174.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.3 m -115.8 108.82 16.81 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.988 -1.116 . . . . 73.42 107.988 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.1 t -107.92 123.59 63.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.727 -0.472 . . . . 75.52 109.727 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.16 127.07 55.83 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.318 -0.623 . . . . 62.0 109.318 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.06 120.42 15.12 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 116.38 -0.373 . . . . 71.31 111.79 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.83 45.26 0.87 Allowed 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 122.866 2.378 . . . . 73.04 111.729 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -123.36 -95.59 0.47 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 119.18 -0.438 . . . . 70.33 110.869 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 173.19 123.63 0.02 OUTLIER 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.502 0.721 . . . . 51.51 109.361 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -80.28 130.58 35.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.434 -0.95 . . . . 71.32 108.434 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.3 p -88.15 -39.79 14.26 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.831 -0.433 . . . . 73.03 109.831 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.6 m -163.17 132.9 4.25 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 123.633 0.773 . . . . 74.54 109.156 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -138.38 154.37 48.93 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.983 -0.448 . . . . 73.12 110.971 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 28.9 t-20 -121.31 94.89 4.48 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.029 -1.841 . . . . 72.12 106.029 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.24 -149.75 10.08 Favored Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 107.852 -2.099 . . . . 62.11 107.852 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -117.74 99.89 7.24 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.416 -1.327 . . . . 73.02 107.416 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -81.12 132.27 35.35 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 120.113 -0.635 . . . . 74.14 110.565 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.64 -43.17 14.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.309 -1.367 . . . . 74.02 107.309 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -136.92 170.43 10.8 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.01 -1.478 . . . . 73.34 107.01 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -72.15 0.77 6.79 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.583 2.188 . . . . 64.34 110.985 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.5 pt-20 -130.33 -0.13 4.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.532 -0.758 . . . . 73.45 111.467 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 88.8 t -141.58 121.06 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.461 -0.94 . . . . 73.14 108.461 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.06 146.63 33.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 109.578 -0.526 . . . . 74.52 109.578 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 29.2 tt0 -134.01 136.74 44.29 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 121.612 0.72 . . . . 74.31 110.937 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.518 ' O ' ' HA ' ' A' ' 138' ' ' GLU . 32.2 m-90 -112.62 125.83 54.71 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.593 -0.73 . . . . 75.11 109.953 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -104.6 99.21 8.88 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.36 -0.978 . . . . 75.04 108.36 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.496 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 1.8 mm? -95.89 121.84 38.06 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.701 -0.851 . . . . 72.4 108.701 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -116.25 151.04 46.32 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 115.394 -0.821 . . . . 73.12 110.991 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.458 ' CB ' HG13 ' A' ' 130' ' ' VAL . 7.7 Cg_exo -76.48 162.83 32.89 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.032 2.488 . . . . 74.12 109.836 173.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.45 -40.12 2.94 Favored Glycine 0 C--O 1.245 0.802 0 N-CA-C 111.145 -0.782 . . . . 62.24 111.145 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.33 158.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 123.043 0.537 . . . . 75.33 109.61 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -109.56 136.98 43.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.836 -1.172 . . . . 74.13 107.836 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.7 t -137.71 141.28 41.04 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 119.363 -0.935 . . . . 64.23 111.093 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.3 p -99.76 145.85 27.22 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.393 -1.276 . . . . 61.54 109.303 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 82.8 mtp -121.81 119.93 33.11 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.091 -1.077 . . . . 65.05 108.091 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 30.4 t -133.76 138.79 45.95 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.914 -1.143 . . . . 63.22 107.914 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.97 116.35 5.03 Favored 'General case' 0 CA--C 1.471 -2.093 0 N-CA-C 108.926 -0.768 . . . . 72.14 108.926 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -121.83 130.31 53.28 Favored 'General case' 0 C--N 1.263 -3.187 0 N-CA-C 106.916 -1.513 . . . . 75.43 106.916 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -149.45 149.84 31.43 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.145 -1.058 . . . . 72.22 108.145 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 7.3 ppt_? -93.45 145.82 24.21 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.578 -0.849 . . . . 74.31 109.237 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.418 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 96.4 m-85 -139.72 152.34 46.58 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.723 -0.843 . . . . 74.45 108.723 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.32 93.57 2.4 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 109.693 -0.484 . . . . 72.44 109.693 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.401 ' OD2' ' HG2' ' A' ' 184' ' ' ARG . 29.2 t0 -55.82 121.65 41.32 Favored Pre-proline 0 CA--C 1.5 -0.975 0 CA-C-N 114.548 -1.205 . . . . 63.24 108.961 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.94 -37.75 18.71 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.117 1.878 . . . . 73.3 112.819 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -85.34 -17.75 35.85 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.857 -0.611 . . . . 74.51 111.738 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.254 15.7 p 56.83 70.74 0.62 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 114.032 1.123 . . . . 70.05 114.032 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.401 ' HG2' ' OD2' ' A' ' 180' ' ' ASP . 14.3 ptm180 -101.87 -179.51 4.03 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.006 -0.997 . . . . 73.52 110.036 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 C--N 1.293 -1.865 0 N-CA-C 106.939 -1.504 . . . . 63.33 106.939 173.533 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.735 0 N-CA-C 110.145 -1.182 . . . . 70.1 110.145 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.439 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -90.27 36.64 0.88 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 117.052 0.426 . . . . 74.23 111.339 -175.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -75.32 105.34 6.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.681 -0.488 . . . . 73.5 109.681 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -121.14 75.83 1.18 Allowed 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.139 -1.43 . . . . 74.14 107.139 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.3 tp -83.95 83.11 8.06 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.541 -1.209 . . . . 74.42 109.54 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -101.08 -16.96 16.91 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.388 -1.278 . . . . 73.1 110.168 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.72 101.21 13.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.131 0.789 . . . . 73.44 113.131 -175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -89.41 -167.53 1.89 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.607 -1.179 . . . . 75.31 107.841 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.66 36.38 9.47 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 120.128 -1.034 . . . . 74.54 110.885 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -81.85 140.22 34.26 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.521 -0.471 . . . . 73.35 111.033 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.52 98.91 4.08 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.197 -1.408 . . . . 74.33 107.197 175.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 52.4 tp -101.65 122.56 44.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.674 -1.148 . . . . 75.25 109.116 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -121.69 124.04 43.31 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 107.968 -1.123 . . . . 74.54 107.968 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 47.6 t -120.05 114.49 44.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.692 -1.225 . . . . 74.12 107.692 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -118.01 114.1 22.64 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.955 -0.757 . . . . 74.15 108.955 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.4 108.96 20.55 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 107.799 -1.186 . . . . 75.33 107.799 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 m -113.58 114.67 26.79 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.433 -1.321 . . . . 74.0 107.433 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -125.43 146.57 30.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.061 -0.718 . . . . 60.31 109.061 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 43.6 m -129.63 123.43 31.22 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-O 121.197 0.523 . . . . 64.42 109.635 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 tt -112.77 121.1 64.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.652 0.739 . . . . 74.13 110.594 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -86.69 154.04 55.75 Favored Pre-proline 0 N--CA 1.425 -1.696 0 CA-C-N 115.178 -0.919 . . . . 71.25 109.517 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.76 2.64 1.91 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.134 2.556 . . . . 73.34 113.052 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -88.74 1.94 54.28 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.93 -1.137 . . . . 73.31 107.93 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 71.43 29.73 2.65 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 123.314 1.531 . . . . 75.12 107.811 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.91 128.33 53.11 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 112.938 -1.937 . . . . 74.12 107.772 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.44 138.11 49.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.424 -0.584 . . . . 55.41 109.424 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 p -142.32 163.45 32.8 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.518 -1.29 . . . . 75.14 107.518 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.77 -171.79 43.94 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.534 -1.793 . . . . 75.45 113.407 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -148.05 133.4 18.53 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 123.855 0.862 . . . . 73.0 108.915 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.32 115.83 47.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.416 -1.327 . . . . 72.31 107.416 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 2.3 mp -115.42 114.86 47.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.61 -0.515 . . . . 73.35 109.61 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.85 108.13 17.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.874 -1.528 . . . . 73.52 106.874 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -122.56 128.6 50.94 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 120.799 -0.361 . . . . 74.13 110.899 -174.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.68 152.46 36.07 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 116.114 -0.494 . . . . 63.25 110.442 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -77.17 121.92 85.4 Favored Pre-proline 0 C--N 1.309 -1.19 0 C-N-CA 119.473 -0.891 . . . . 73.12 109.065 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.86 111.12 0.64 Allowed 'Trans proline' 0 C--O 1.252 1.181 0 C-N-CA 123.947 3.098 . . . . 72.44 114.904 -171.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -93.79 -25.76 17.25 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.795 -0.639 . . . . 73.34 109.403 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.483 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 49.6 t-20 -100.92 138.9 37.35 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.207 -1.034 . . . . 74.01 108.207 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.9 p -72.63 -27.41 62.12 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 112.38 0.511 . . . . 75.13 112.38 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.483 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 21.7 ptmt -88.02 -12.61 43.88 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.865 0.364 . . . . 70.23 110.864 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.417 ' CB ' ' HB3' ' A' ' 52' ' ' ASN . 38.8 t70 -87.42 100.43 12.74 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.244 0.831 . . . . 64.14 113.244 -167.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 t -121.31 -15.63 8.07 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.568 -1.196 . . . . 73.41 108.463 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.24 97.29 0.16 Allowed Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.56 -1.305 . . . . 74.24 113.174 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.48 159.13 32.53 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.759 2.306 . . . . 73.33 110.263 172.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.6 133.77 53.01 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.748 -0.464 . . . . 74.41 109.748 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.94 153.23 19.62 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.587 -0.523 . . . . 71.23 109.587 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -83.54 84.26 7.6 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.874 -1.158 . . . . 75.41 107.874 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.82 42.76 1.6 Allowed Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 114.904 -1.044 . . . . 62.52 111.598 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.11 88.15 7.15 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.661 -1.237 . . . . 73.35 107.661 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.438 HG13 ' SD ' ' A' ' 101' ' ' MET . 17.3 m -122.78 160.23 49.92 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-N 114.628 -1.169 . . . . 73.5 111.391 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.82 -7.87 12.24 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.489 2.793 . . . . 74.23 113.572 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -124.42 28.86 6.5 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 122.21 -0.306 . . . . 71.34 111.006 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.1 m -55.72 -27.85 52.66 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 111.971 0.36 . . . . 72.05 111.971 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -71.96 -7.97 51.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.212 0.53 . . . . 72.34 110.932 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -112.39 -6.76 14.0 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.065 -0.516 . . . . 74.23 110.15 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 p -127.58 118.53 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.892 0.854 . . . . 71.44 109.963 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.69 104.58 16.51 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.451 -0.795 . . . . 62.24 109.44 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.09 132.93 42.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.238 -1.393 . . . . 71.22 107.238 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.1 m -154.19 172.35 17.73 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.714 -0.847 . . . . 72.14 108.714 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -80.57 154.6 27.37 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.298 0.57 . . . . 75.23 110.105 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 70.7 t80 -118.23 123.39 45.34 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.957 -1.127 . . . . 73.41 107.957 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -138.22 100.35 4.11 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.04 -1.837 . . . . 75.3 106.04 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.3 t -165.23 143.78 6.35 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.768 -0.456 . . . . 74.3 109.768 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.1 t70 66.9 14.38 9.8 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.078 1.351 . . . . 70.25 109.339 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.63 -0.73 77.62 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.767 -0.73 . . . . 71.24 111.683 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.436 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 7.9 m-85 -94.0 146.04 24.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.424 -0.584 . . . . 74.22 109.424 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 m -125.56 136.96 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 108.265 -1.013 . . . . 74.42 108.265 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.69 -154.61 10.45 Favored Glycine 0 C--N 1.271 -3.037 0 N-CA-C 110.439 -1.064 . . . . 51.43 110.439 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 m -129.82 150.9 50.92 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 120.967 0.413 . . . . 73.45 110.42 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -133.64 145.26 49.82 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.083 0.468 . . . . 75.3 110.613 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.6 114.76 21.06 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.458 -1.312 . . . . 74.13 107.458 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.31 115.27 49.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.734 -0.839 . . . . 65.42 108.734 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.478 ' CD2' HD11 ' A' ' 90' ' ' LEU . 47.1 p90 -121.09 151.0 40.36 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.47 -0.492 . . . . 74.03 111.227 -174.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -153.15 156.49 38.72 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.415 -0.357 . . . . 70.51 111.202 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.4 t70 63.53 31.21 14.92 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.5 1.12 . . . . 72.53 111.046 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.478 HD11 ' CD2' ' A' ' 87' ' ' PHE . 39.4 mt -94.69 170.14 9.67 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.89 -0.595 . . . . 75.43 109.938 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t -128.08 179.72 5.44 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 120.636 -0.426 . . . . 64.42 110.617 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -54.69 -42.23 71.18 Favored 'General case' 0 C--O 1.209 -1.035 0 C-N-CA 123.794 0.837 . . . . 74.21 112.17 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.62 -29.11 69.03 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.342 0.592 . . . . 74.04 111.566 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.66 -15.97 29.44 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 115.57 -0.741 . . . . 72.02 111.285 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.9 tt -60.35 -51.46 80.0 Favored Pre-proline 0 CA--C 1.568 1.662 0 CA-C-O 119.202 -0.428 . . . . 72.31 111.205 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.52 -36.65 75.61 Favored 'Trans proline' 0 C--N 1.373 1.863 0 CA-C-N 120.976 1.384 . . . . 74.53 110.838 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -66.44 -37.73 85.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.215 -0.902 . . . . 75.51 110.097 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -78.09 -19.99 53.1 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.393 0.616 . . . . 73.2 109.736 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.34 -18.08 60.74 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.601 -0.727 . . . . 54.52 109.063 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.18 -57.22 12.29 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 116.012 -0.54 . . . . 74.14 109.737 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.438 ' SD ' HG13 ' A' ' 64' ' ' VAL . 3.2 mpp? -55.73 -45.25 78.0 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 123.674 0.609 . . . . 72.44 109.718 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -52.88 -42.48 65.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.524 -1.217 . . . . 72.21 111.412 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.9 m -63.51 -31.76 73.01 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.179 -0.464 . . . . 72.25 110.725 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.6 -20.77 63.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.184 0.516 . . . . 74.42 110.686 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.91 -9.82 16.94 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.485 -0.486 . . . . 71.32 110.382 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.41 -47.64 3.89 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.414 0.524 . . . . 65.52 112.414 -173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.21 28.77 19.29 Favored Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 119.962 -1.114 . . . . 60.11 110.933 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.8 m -124.38 165.11 21.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 122.767 -0.255 . . . . 62.31 110.544 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.93 124.18 47.62 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.816 -1.179 . . . . 73.02 107.816 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.19 123.15 49.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.165 0.439 . . . . 75.32 111.08 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -120.93 117.56 27.64 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.346 -0.983 . . . . 71.3 108.346 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.443 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 2.2 pt? -133.35 147.43 51.82 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.223 -0.591 . . . . 74.1 111.006 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.443 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 2.1 mpt_? -142.11 155.23 45.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.968 -1.493 . . . . 75.44 106.968 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.511 ' NE ' ' HB2' ' A' ' 180' ' ' ASP . 9.4 ttt180 -108.85 137.53 46.63 Favored 'General case' 0 N--CA 1.396 -3.126 0 N-CA-C 106.69 -1.596 . . . . 74.54 106.69 173.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -127.42 99.6 5.69 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 107.98 -1.119 . . . . 71.3 107.98 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 184' ' ' ARG . . . 68.9 -115.71 6.75 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.845 -0.902 . . . . 61.0 110.845 -177.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.542 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 8.9 t30 -110.6 12.89 22.67 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.304 1.049 . . . . 72.34 109.342 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.51 149.25 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 121.234 -0.916 . . . . 74.15 109.069 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.5 t -110.66 137.88 41.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 109.987 -0.375 . . . . 75.44 109.987 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.0 pt -116.26 129.06 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 N-CA-C 108.636 -0.876 . . . . 73.52 108.636 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -128.3 125.73 39.39 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.959 -0.564 . . . . 75.43 109.653 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.48 115.96 18.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.361 0.6 . . . . 75.14 109.769 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -116.52 130.4 8.96 Favored Glycine 0 C--N 1.294 -1.789 0 N-CA-C 110.075 -1.21 . . . . 73.24 110.075 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -114.6 132.9 56.19 Favored 'General case' 0 C--N 1.282 -2.332 0 O-C-N 122.153 -0.616 . . . . 72.53 109.8 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.0 114.37 19.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.679 -0.691 . . . . 75.14 112.052 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.69 97.25 6.45 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.434 -0.95 . . . . 75.11 108.434 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.45 28.21 8.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.685 -0.857 . . . . 74.23 108.685 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 20.5 p -69.13 -9.17 51.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.254 -0.885 . . . . 63.21 112.944 -175.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.2 m -70.28 -18.85 63.13 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.845 0.355 . . . . 73.41 110.536 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.1 t 69.06 -88.12 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.786 1.235 . . . . 70.32 111.549 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.8 m 66.77 -55.54 0.42 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.001 1.32 . . . . 72.31 111.494 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 135' ' ' ALA . 1.9 p30 -136.74 104.79 9.03 Favored Pre-proline 0 C--N 1.309 -1.172 0 C-N-CA 123.691 0.797 . . . . 75.52 109.817 173.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.75 -12.52 22.07 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.637 2.225 . . . . 64.51 112.214 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -85.65 4.59 35.71 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.514 -0.766 . . . . 74.11 111.463 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -78.31 140.3 38.81 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.156 0.503 . . . . 72.11 110.808 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -131.85 110.43 10.81 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.278 -0.874 . . . . 74.43 109.29 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 77.8 t -104.89 113.66 42.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.379 -0.971 . . . . 73.13 108.379 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -108.54 121.08 44.23 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.109 -1.071 . . . . 61.42 108.109 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.49 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.9 tm? -110.81 115.7 29.99 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 105.784 -1.932 . . . . 74.02 105.784 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.9 m -123.69 127.53 48.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.501 -0.555 . . . . 71.03 109.501 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 76.9 t -124.95 126.82 71.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.182 -0.673 . . . . 72.12 109.182 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -115.95 130.93 57.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.704 -0.85 . . . . 74.52 108.704 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.702 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.2 p90 -135.06 122.84 15.39 Favored Pre-proline 0 C--N 1.283 -2.318 0 N-CA-C 112.002 0.371 . . . . 75.44 112.002 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -70.15 35.61 0.24 Allowed 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 122.57 2.18 . . . . 74.3 111.681 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -115.77 -99.31 0.44 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 123.132 0.573 . . . . 71.22 109.869 -177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.42 129.97 0.02 OUTLIER 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.304 -0.998 . . . . 73.53 108.304 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.87 138.08 20.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.704 -0.85 . . . . 75.23 108.704 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.8 p -94.09 -43.04 8.68 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 109.051 -0.722 . . . . 64.41 109.051 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.0 m -160.08 133.12 6.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.505 -0.924 . . . . 64.41 108.505 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 t -139.24 149.42 44.32 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.683 -0.635 . . . . 70.11 111.099 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -114.67 93.07 4.16 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 104.71 -2.33 . . . . 62.41 104.71 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.456 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.13 -148.86 11.57 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 107.999 -2.04 . . . . 74.41 107.999 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -114.09 100.02 8.07 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 117.587 0.693 . . . . 64.24 110.473 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -76.95 119.87 21.28 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.159 -0.616 . . . . 75.24 109.354 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.8 mt -83.98 -37.43 13.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.317 -1.364 . . . . 74.02 107.317 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.402 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . 39.3 mt-10 -145.69 161.9 38.59 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 106.766 -1.568 . . . . 65.22 106.766 -178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.31 -10.6 29.2 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.445 2.097 . . . . 72.05 112.212 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.702 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.4 OUTLIER -122.18 5.58 9.75 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 112.656 0.613 . . . . 74.21 112.656 177.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.5 t -139.84 120.95 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.56 -0.533 . . . . 70.22 109.56 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.77 148.04 31.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.482 -0.562 . . . . 73.03 109.482 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -138.55 149.58 45.46 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.298 -0.63 . . . . 74.55 109.298 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.497 ' CZ2' ' HB1' ' A' ' 174' ' ' ALA . 28.2 m-90 -124.92 142.07 51.7 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.822 -0.807 . . . . 73.11 108.822 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -108.73 105.12 14.57 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.93 -1.507 . . . . 74.13 106.93 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 9.4 mp -100.57 119.18 38.15 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.926 0.87 . . . . 75.5 110.884 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.471 ' HD3' ' HD2' ' A' ' 166' ' ' PRO . 1.6 mmtm -118.42 140.75 28.61 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 114.231 -1.35 . . . . 75.12 108.85 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.471 ' HD2' ' HD3' ' A' ' 165' ' ' LYS . 39.1 Cg_exo -66.64 167.71 18.46 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.693 1.595 . . . . 74.44 110.729 171.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.97 -36.82 3.01 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 120.857 -0.687 . . . . 63.13 111.656 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.8 m -104.94 157.06 5.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.163 0.506 . . . . 75.43 110.093 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.6 p -114.06 127.02 71.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.914 -1.143 . . . . 74.34 107.914 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 46.6 m -145.57 143.54 29.97 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.912 -0.492 . . . . 70.15 110.863 -177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.1 p -109.23 125.91 52.75 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 115.841 -0.618 . . . . 74.42 109.651 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -101.3 134.66 44.02 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.606 -0.887 . . . . 75.44 108.606 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.0 m -143.26 140.72 30.78 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.616 -0.678 . . . . 72.42 110.907 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.497 ' HB1' ' CZ2' ' A' ' 162' ' ' TRP . . . -143.05 132.18 23.11 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.358 -0.383 . . . . 73.53 109.982 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.1 131.32 54.19 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.82 -1.548 . . . . 72.1 106.82 170.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.84 156.24 42.05 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.21 -0.663 . . . . 74.5 109.21 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -87.91 134.48 33.7 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 120.362 -0.535 . . . . 75.01 109.895 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -143.72 122.72 12.81 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 109.337 -0.616 . . . . 75.45 109.337 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.542 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -58.97 109.08 0.76 Allowed 'General case' 0 C--N 1.279 -2.477 0 O-C-N 124.389 1.055 . . . . 75.1 111.536 -178.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.511 ' HB2' ' NE ' ' A' ' 114' ' ' ARG . 27.0 t70 -88.63 133.09 36.82 Favored Pre-proline 0 CA--C 1.49 -1.362 0 N-CA-C 108.888 -0.782 . . . . 71.4 108.888 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.96 -38.02 72.21 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.924 2.416 . . . . 74.35 113.092 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -86.16 -30.18 22.68 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.791 0.805 . . . . 74.13 109.777 -176.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.403 26.4 p 65.95 64.19 0.56 Allowed 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 113.603 -1.635 . . . . 73.42 110.469 -167.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.503 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 28.3 mmt180 -60.19 172.38 0.83 Allowed 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 111.413 -2.63 . . . . 75.02 113.589 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.411 -2.421 0 N-CA-C 104.389 -2.448 . . . . 74.53 104.389 179.857 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 110.294 -1.122 . . . . 61.11 110.294 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -120.38 150.77 40.24 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.054 -1.091 . . . . 73.31 108.054 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 69.4 93.8 0.08 Allowed 'General case' 0 C--O 1.239 0.54 0 O-C-N 124.262 0.976 . . . . 73.13 111.967 -176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -72.09 129.36 38.33 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.012 -0.994 . . . . 72.31 110.206 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tt -142.89 135.49 27.71 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 105.278 -2.119 . . . . 75.11 105.278 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -86.09 -71.55 0.54 Allowed 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 120.476 -0.49 . . . . 74.54 110.11 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -149.04 137.35 20.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.458 -0.571 . . . . 63.22 109.458 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -81.04 107.59 13.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.464 -0.569 . . . . 74.3 109.464 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.3 -142.83 3.55 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 109.529 -1.429 . . . . 73.01 109.529 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.471 ' HA ' ' OD2' ' A' ' 132' ' ' ASP . 83.7 m-70 69.0 95.21 0.07 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.84 1.256 . . . . 75.22 112.175 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 23.9 ttt 69.49 89.72 0.1 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.594 -1.639 . . . . 64.03 111.028 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.438 ' H ' HD21 ' A' ' 26' ' ' LEU . 2.1 pt? -112.8 136.67 52.16 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.652 -1.24 . . . . 75.35 107.652 175.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -101.52 123.97 46.43 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 106.867 -1.531 . . . . 72.45 106.867 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.1 t -119.48 113.63 41.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 106.96 -1.496 . . . . 74.4 106.96 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -127.67 113.5 16.12 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.041 0.448 . . . . 73.14 109.958 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.67 108.78 20.18 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.981 -0.748 . . . . 71.02 108.981 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.6 t -108.4 114.16 27.79 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.694 -1.595 . . . . 71.5 106.694 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -132.98 147.17 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.379 0.609 . . . . 75.22 110.483 -174.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.3 m -129.73 128.38 42.35 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 116.024 -0.535 . . . . 73.42 109.865 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.6 tt -113.96 125.69 71.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.299 0.571 . . . . 74.22 110.748 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 31.3 t -93.49 151.67 40.34 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.533 -0.758 . . . . 71.23 109.888 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.39 1.08 1.42 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.793 2.995 . . . . 74.21 112.922 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.71 -3.69 54.33 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.818 -1.179 . . . . 72.33 107.818 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.3 t70 72.25 29.02 2.3 Favored 'General case' 0 C--N 1.347 0.473 0 N-CA-C 106.858 -1.534 . . . . 72.45 106.858 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.3 OUTLIER -112.73 140.83 47.18 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.441 -1.254 . . . . 75.32 108.985 -178.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 t -115.63 144.71 22.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.549 -0.75 . . . . 75.11 109.126 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.2 p -149.29 158.71 44.4 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.079 -1.082 . . . . 73.03 108.079 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.48 -166.73 36.06 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 119.884 -1.15 . . . . 74.21 112.748 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -154.61 139.21 16.94 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.353 0.597 . . . . 73.43 111.064 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 46.6 mt -114.51 116.53 52.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.543 -0.91 . . . . 64.11 108.543 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.16 126.01 61.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.371 -0.603 . . . . 74.42 109.371 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.511 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -123.61 108.6 12.77 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.777 -1.194 . . . . 74.52 107.777 173.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.87 126.54 52.58 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.85 0.357 . . . . 72.21 111.585 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.38 158.91 30.06 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.765 -0.652 . . . . 72.41 109.755 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -72.65 130.56 85.41 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 118.974 -1.091 . . . . 75.23 109.298 175.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.2 -82.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.481 2.787 . . . . 75.14 115.456 -174.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt 60.6 22.72 12.51 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.899 0.88 . . . . 73.12 111.217 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -152.5 118.28 5.4 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.413 -1.267 . . . . 73.31 107.656 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.1 m -66.4 -20.59 66.11 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.998 1.111 . . . . 71.12 113.998 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HB2' ' NZ ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -97.55 -11.75 23.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.189 -1.004 . . . . 74.42 112.186 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -88.51 107.44 18.88 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 119.207 -0.997 . . . . 73.34 111.025 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t -114.28 -8.85 12.88 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.249 -0.887 . . . . 71.14 108.684 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.447 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 174.15 112.04 0.28 Allowed Glycine 0 N--CA 1.425 -2.082 0 CA-C-N 115.261 -0.881 . . . . 74.21 112.046 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.04 160.33 45.02 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 123.047 2.498 . . . . 73.03 111.351 173.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.43 131.07 37.14 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.798 -0.816 . . . . 64.3 108.798 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.423 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 69.0 mt -84.87 143.66 28.9 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.423 -0.584 . . . . 73.51 109.423 176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -100.43 93.79 5.83 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.478 0.656 . . . . 72.52 109.66 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.609 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -140.6 72.59 0.41 Allowed Glycine 0 C--N 1.28 -2.56 0 CA-C-N 115.168 -0.924 . . . . 72.32 111.116 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -82.29 91.32 6.75 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.834 -0.802 . . . . 62.24 108.834 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.6 m -122.29 154.1 62.04 Favored Pre-proline 0 C--N 1.299 -1.606 0 CA-C-N 114.744 -1.117 . . . . 71.11 110.739 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.84 -21.39 70.32 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 123.595 2.863 . . . . 72.23 112.916 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -102.75 32.45 3.64 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.146 -0.479 . . . . 75.12 111.063 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 p -55.8 -34.08 64.99 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 116.29 -0.413 . . . . 75.5 111.543 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -65.29 -16.69 63.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.301 0.572 . . . . 73.42 111.47 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 88' ' ' SER . 33.3 mmtp -98.75 -16.0 19.11 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 116.157 -0.474 . . . . 74.23 110.524 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.17 118.89 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-O 122.195 0.998 . . . . 72.34 111.18 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -105.62 122.6 46.38 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.888 -1.051 . . . . 73.3 109.27 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.3 t -98.23 131.43 45.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.954 -1.128 . . . . 74.13 107.954 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 m -139.65 169.8 17.07 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.451 -0.574 . . . . 75.41 109.451 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.447 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 1.7 p-10 -83.64 142.56 30.71 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.097 0.475 . . . . 73.32 109.771 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 82.5 t80 -107.92 121.74 45.4 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.657 -1.238 . . . . 75.13 107.657 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.28 101.11 4.3 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.158 -1.053 . . . . 72.12 108.158 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 36.6 t -165.8 147.57 7.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.043 -1.095 . . . . 65.22 108.043 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 71.94 10.15 6.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.976 0.91 . . . . 64.45 111.167 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.55 1.06 83.76 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.557 -0.747 . . . . 73.0 111.967 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -104.95 147.06 28.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.454 -0.943 . . . . 63.12 108.454 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -123.85 139.0 51.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.218 -1.031 . . . . 74.51 108.218 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -167.44 -155.13 8.98 Favored Glycine 0 C--N 1.26 -3.677 0 C-N-CA 119.797 -1.192 . . . . 71.55 111.178 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.423 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 7.8 t -123.81 152.77 41.89 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 108.858 -0.793 . . . . 70.02 108.858 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.8 pt20 -140.67 130.71 24.72 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 120.999 0.428 . . . . 73.22 110.363 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.04 115.31 29.96 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.735 -0.839 . . . . 75.32 108.735 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.89 116.75 50.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.903 -0.777 . . . . 75.2 108.903 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.423 ' CD2' HD11 ' A' ' 90' ' ' LEU . 54.2 p90 -121.67 146.95 46.49 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 120.982 0.42 . . . . 74.11 110.944 -176.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 46.1 m -152.04 158.54 43.18 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 116.018 -0.537 . . . . 74.45 109.78 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.8 t70 60.47 38.82 18.93 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 122.31 1.052 . . . . 75.25 111.64 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 87' ' ' PHE . 25.3 mt -97.47 166.53 11.48 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.238 -0.892 . . . . 74.43 109.878 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -115.08 173.72 6.35 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.875 0.307 . . . . 71.33 110.264 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -49.84 -50.49 45.26 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.223 1.409 . . . . 72.2 111.461 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.31 68.11 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.156 0.582 . . . . 74.15 112.251 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -84.3 -16.34 43.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.67 -0.241 . . . . 73.11 111.619 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.692 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.8 tt -64.52 -54.98 33.01 Favored Pre-proline 0 CA--C 1.558 1.273 0 CA-C-O 119.392 -0.337 . . . . 71.41 111.312 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.41 -33.28 88.88 Favored 'Trans proline' 0 C--N 1.367 1.54 0 CA-C-N 120.744 1.301 . . . . 65.35 111.017 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -66.57 -36.06 81.73 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.95 -0.568 . . . . 74.51 110.697 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.0 pp -75.9 -19.21 59.01 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 109.498 -0.556 . . . . 75.51 109.498 175.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.01 -15.99 62.05 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.004 -0.544 . . . . 74.55 110.342 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -63.79 -56.93 11.82 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.452 -0.944 . . . . 73.42 108.452 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.609 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 31.9 ttp -54.33 -49.67 69.18 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.664 -0.698 . . . . 73.52 109.805 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -53.33 -41.98 66.27 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.849 -1.069 . . . . 75.11 110.887 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.3 p -72.37 -20.73 61.41 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 119.421 -0.912 . . . . 75.32 112.199 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.2 -20.36 62.28 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.482 0.658 . . . . 72.23 109.703 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.91 -10.41 20.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.792 -0.64 . . . . 71.12 110.378 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.67 -48.4 3.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.667 0.618 . . . . 64.43 112.667 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.64 20.62 59.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.481 -0.648 . . . . 73.11 111.481 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.84 168.19 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 109.476 -0.565 . . . . 73.12 109.476 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -102.77 135.52 44.29 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.887 0.312 . . . . 72.54 110.407 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.25 125.65 23.42 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.38 -0.6 . . . . 70.1 109.38 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.2 p -144.34 143.12 30.81 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.756 0.313 . . . . 74.41 111.268 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.54 125.78 23.14 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.741 0.816 . . . . 72.34 108.894 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -142.01 168.33 20.0 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.302 0.241 . . . . 71.42 110.378 -174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.408 ' CG ' HG21 ' A' ' 119' ' ' VAL . 26.6 mtt85 -101.14 138.68 37.85 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 113.866 1.061 . . . . 73.21 113.866 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.427 ' O ' HG13 ' A' ' 118' ' ' ILE . 7.0 t30 -123.96 94.36 4.2 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 105.764 -1.939 . . . . 74.12 105.764 174.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.42 -114.03 4.95 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 110.106 -1.197 . . . . 72.33 110.106 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -110.7 -1.37 16.74 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.721 1.248 . . . . 73.14 108.768 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.5 pp -103.19 148.97 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 C-N-CA 118.892 -1.123 . . . . 75.24 108.323 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG21 ' CG ' ' A' ' 114' ' ' ARG . 89.1 t -108.92 136.53 44.49 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.984 0 N-CA-C 109.853 -0.425 . . . . 75.41 109.853 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.7 pt -116.01 132.14 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-O 121.921 0.867 . . . . 71.45 109.201 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.5 tt -114.4 130.95 56.73 Favored 'General case' 0 C--N 1.255 -3.513 0 N-CA-C 105.646 -1.983 . . . . 74.54 105.646 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -140.74 130.67 24.54 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.727 -0.842 . . . . 75.43 108.727 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.92 168.05 38.26 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 111.199 -0.76 . . . . 64.3 111.199 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -140.2 141.83 35.91 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.364 -0.976 . . . . 74.43 108.364 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.69 108.78 12.37 Favored 'General case' 0 N--CA 1.413 -2.279 0 N-CA-C 108.352 -0.981 . . . . 72.04 108.352 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -112.66 111.72 22.72 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.034 -1.099 . . . . 73.34 108.034 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 0.1 OUTLIER -127.75 34.47 4.64 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.082 -1.451 . . . . 75.21 107.082 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.2 p -66.08 -12.6 56.56 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.654 0.983 . . . . 74.24 113.654 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.9 m -70.77 -12.26 61.45 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.521 0.677 . . . . 72.12 110.341 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.0 t 75.97 -70.6 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.259 1.423 . . . . 75.34 113.099 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.8 m 64.84 -76.23 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.828 0.851 . . . . 72.25 109.639 -171.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.471 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 42.5 m-20 -131.14 110.38 15.37 Favored Pre-proline 0 CA--C 1.494 -1.192 0 N-CA-C 107.576 -1.268 . . . . 73.12 107.576 176.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.9 -20.41 45.28 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 122.24 1.96 . . . . 72.01 112.59 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -96.08 11.25 34.84 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.774 -0.648 . . . . 71.33 111.872 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.2 148.15 28.6 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.987 -1.116 . . . . 73.42 107.987 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -132.68 124.58 28.5 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.888 -0.412 . . . . 71.21 109.888 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.476 ' HB ' ' HG ' ' A' ' 164' ' ' LEU . 82.6 t -117.16 121.05 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 120.161 -0.616 . . . . 73.44 110.113 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.73 138.02 51.52 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.95 -0.568 . . . . 64.33 110.686 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 tt -127.64 125.46 40.19 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 105.237 -2.134 . . . . 74.33 105.237 170.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 13.6 m -126.57 122.94 36.53 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.144 -0.687 . . . . 75.03 109.144 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 94.1 t -118.24 123.5 71.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 110.131 -0.322 . . . . 73.11 110.131 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -111.78 127.49 55.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.074 -0.713 . . . . 63.21 109.074 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.489 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.0 p90 -134.46 121.31 15.17 Favored Pre-proline 0 C--N 1.295 -1.779 0 C-N-CA 122.695 0.398 . . . . 74.22 112.004 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.59 39.17 0.41 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.874 2.382 . . . . 75.41 112.108 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.61 -97.92 0.46 Allowed 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 119.307 -0.378 . . . . 62.42 110.482 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.59 123.8 0.03 OUTLIER 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.406 -0.59 . . . . 74.05 109.406 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.48 136.15 23.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.483 -0.932 . . . . 73.32 108.483 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.8 p -95.31 -44.97 7.34 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.204 -0.665 . . . . 64.12 109.204 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 62.5 m -158.82 133.3 7.98 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.935 -0.575 . . . . 72.42 109.536 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.2 t -138.32 159.27 42.49 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.835 -0.54 . . . . 74.52 110.113 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -126.18 94.56 4.12 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 105.343 -2.095 . . . . 73.44 105.343 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.34 -150.19 10.37 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.051 -2.02 . . . . 63.04 108.051 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.68 99.01 7.02 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.608 -0.886 . . . . 74.31 108.608 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -74.66 137.63 42.32 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.906 -0.588 . . . . 72.1 111.307 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.4 mt -100.87 -48.45 11.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.242 -1.392 . . . . 73.22 107.242 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -133.72 169.0 15.09 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 107.561 -1.274 . . . . 73.24 107.561 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.87 0.81 7.2 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.625 2.216 . . . . 72.42 111.078 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.4 pt-20 -132.75 3.7 3.83 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.946 -1.024 . . . . 73.45 110.747 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.8 t -144.6 120.82 4.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.912 -0.773 . . . . 71.2 108.912 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.97 147.83 31.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.084 -0.71 . . . . 74.34 109.084 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -130.05 143.38 50.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.111 -0.7 . . . . 70.43 109.111 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.489 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 32.6 m-90 -122.66 116.73 24.31 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 108.731 -0.841 . . . . 73.14 108.731 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.25 98.27 8.68 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.554 -0.906 . . . . 64.22 108.554 175.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.476 ' HG ' ' HB ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -96.45 131.52 42.94 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-O 122.338 1.066 . . . . 64.24 110.082 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -119.52 151.03 51.05 Favored Pre-proline 0 C--N 1.279 -2.499 0 CA-C-N 113.248 -1.796 . . . . 72.0 112.858 -170.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 20.3 Cg_exo -70.97 156.56 59.96 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.868 2.379 . . . . 71.34 110.644 174.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.34 -36.17 2.94 Favored Glycine 0 C--N 1.309 -0.925 0 C-N-CA 121.278 -0.487 . . . . 73.14 112.129 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.3 m -105.82 166.27 3.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 123.008 0.523 . . . . 74.35 110.223 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.0 p -113.82 142.33 26.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.348 -0.982 . . . . 72.25 108.348 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.1 m -138.53 141.95 39.32 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.937 -0.477 . . . . 74.33 109.841 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.3 p -103.43 130.01 50.68 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.871 -0.788 . . . . 74.4 108.871 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 44.2 ttp -104.02 116.34 32.05 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.653 -0.869 . . . . 75.42 108.653 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.1 m -140.33 139.52 35.44 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.693 -0.803 . . . . 64.33 109.305 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -149.2 120.68 7.94 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 108.507 -0.923 . . . . 40.24 108.507 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -120.7 130.74 54.21 Favored 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 106.691 -1.596 . . . . 74.12 106.691 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -155.76 150.93 26.68 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.405 -0.961 . . . . 73.22 108.405 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.525 ' O ' ' HD2' ' A' ' 177' ' ' ARG . 5.8 ppt_? -88.2 126.41 35.13 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.81 -0.756 . . . . 74.1 110.671 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 16.5 m-30 -135.05 118.71 17.06 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 107.741 -1.207 . . . . 64.01 107.741 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.63 113.25 0.67 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 125.171 1.545 . . . . 74.11 112.274 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.26 123.35 85.9 Favored Pre-proline 0 CA--C 1.501 -0.926 0 C-N-CA 124.422 1.089 . . . . 74.24 109.082 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -73.07 -41.99 1.15 Allowed 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 121.7 1.6 . . . . 74.5 113.0 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.26 -22.05 30.9 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.825 0.45 . . . . 75.12 111.475 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 69.3 p 67.33 87.27 0.12 Allowed 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 126.322 1.849 . . . . 75.22 115.065 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -96.11 159.58 14.89 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.07 -0.514 . . . . 74.01 111.294 174.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.3 -1.547 0 N-CA-C 107.469 -1.308 . . . . 75.45 107.469 177.625 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.831 0 N-CA-C 111.262 -0.735 . . . . 43.05 111.262 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -122.98 30.4 6.4 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.693 0.758 . . . . 74.35 109.737 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -99.39 -1.27 39.16 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.377 -0.829 . . . . 72.43 110.914 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -88.42 83.06 6.87 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.086 0.946 . . . . 74.31 112.466 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.0 tp -151.04 91.38 1.7 Allowed 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 114.04 -1.436 . . . . 65.32 108.391 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -87.6 86.67 7.23 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.679 0.752 . . . . 74.23 111.407 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -83.49 -25.07 31.44 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.924 -1.035 . . . . 74.22 109.901 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -103.76 136.26 43.78 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.629 -0.714 . . . . 75.25 109.747 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.4 81.33 1.26 Allowed Glycine 0 N--CA 1.433 -1.567 0 C-N-CA 120.767 -0.73 . . . . 65.24 111.355 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -94.52 117.23 29.8 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.771 0.796 . . . . 73.5 111.814 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.486 ' HB3' ' O ' ' A' ' 134' ' ' ASP . 1.5 mpt? -116.06 -165.38 1.04 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.934 0.894 . . . . 62.52 110.395 -177.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -89.77 115.23 26.97 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.435 -1.691 . . . . 73.02 106.435 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -106.0 132.77 51.69 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.237 -0.585 . . . . 74.44 111.418 -173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.08 114.44 41.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.729 -0.841 . . . . 75.22 108.729 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -119.5 119.3 33.45 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.553 -0.748 . . . . 74.35 111.961 -176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.08 108.35 19.4 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.481 -1.303 . . . . 73.53 107.481 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 140' ' ' THR . 20.3 m -120.71 115.11 22.7 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.618 -0.512 . . . . 72.52 109.618 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.9 pp -124.45 147.47 28.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.017 0.437 . . . . 75.44 110.44 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 62.7 m -129.82 122.04 27.95 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 121.053 0.454 . . . . 63.13 110.097 -176.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -113.92 122.73 68.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 121.463 0.649 . . . . 73.31 110.439 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 37' ' ' ASP . 14.1 m -86.99 151.64 52.19 Favored Pre-proline 0 N--CA 1.417 -2.112 0 CA-C-N 115.336 -0.847 . . . . 64.23 109.46 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.96 2.13 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.312 2.675 . . . . 74.41 112.349 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 35' ' ' SER . 25.7 t70 -85.19 -2.22 57.79 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.139 0.975 . . . . 73.23 109.385 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.9 t70 72.76 28.96 2.01 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 123.469 1.605 . . . . 74.21 107.621 -174.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -107.51 125.84 51.78 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 113.671 -1.604 . . . . 64.13 108.25 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 t -108.97 137.12 42.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.256 -0.646 . . . . 74.43 109.256 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.2 p -146.84 165.43 29.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.722 -1.214 . . . . 74.03 107.722 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.26 -173.97 41.78 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.617 -1.278 . . . . 73.53 112.764 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 10.2 pt-20 -157.51 133.42 9.37 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.409 0.623 . . . . 75.03 110.804 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 2.0 mp -113.18 116.5 52.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.992 -1.114 . . . . 74.54 107.992 175.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mp -113.9 115.6 50.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.195 0.521 . . . . 64.23 109.698 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.584 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -108.7 125.85 52.35 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.509 -1.663 . . . . 74.41 106.509 174.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.87 116.79 14.19 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.578 0.704 . . . . 75.24 109.476 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.84 159.34 31.28 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 115.059 -0.973 . . . . 74.1 110.789 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -64.27 137.84 97.24 Favored Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 106.713 -1.588 . . . . 73.24 106.713 171.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -43.42 -41.03 10.4 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 123.994 3.13 . . . . 72.21 115.668 -172.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 62.47 76.2 0.37 Allowed 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 108.843 -0.799 . . . . 74.33 108.843 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 81.46 137.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.538 -1.665 . . . . 73.42 110.17 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.6 m -57.03 -9.98 1.0 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 126.082 1.753 . . . . 62.53 114.799 -176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -73.33 -19.28 61.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.741 0.416 . . . . 75.32 111.057 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -99.68 125.59 45.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 120.06 -0.656 . . . . 74.35 110.128 -173.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -114.72 -17.45 11.61 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.156 -0.474 . . . . 74.51 111.045 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.45 97.79 0.11 Allowed Glycine 0 N--CA 1.434 -1.47 0 C-N-CA 120.053 -1.07 . . . . 62.13 111.98 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.56 159.83 35.42 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.635 2.223 . . . . 73.44 111.454 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.96 140.47 52.3 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.452 -0.573 . . . . 72.45 109.452 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.89 149.19 45.1 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.566 0.541 . . . . 70.55 110.208 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -82.38 85.1 6.95 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.571 -0.899 . . . . 63.4 108.571 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.504 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -122.4 120.88 4.47 Favored Glycine 0 N--CA 1.417 -2.631 0 CA-C-N 114.558 -1.201 . . . . 75.24 113.746 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -139.95 112.79 8.06 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.757 -0.831 . . . . 73.24 108.757 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.51 161.6 57.93 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.662 -0.866 . . . . 74.03 108.662 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.62 -11.86 24.36 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.047 1.831 . . . . 73.22 111.536 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -114.03 41.61 2.21 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.837 -0.619 . . . . 71.4 111.595 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.2 m -58.64 -27.23 64.53 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-N 116.211 -0.449 . . . . 65.34 111.508 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -68.84 -15.82 63.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.522 0.677 . . . . 71.42 110.405 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -95.4 -17.63 21.4 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.245 -0.889 . . . . 74.12 110.565 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.55 118.97 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-O 122.246 1.022 . . . . 64.33 111.92 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.94 101.85 14.41 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.042 -0.981 . . . . 74.22 108.39 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.21 125.5 51.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.594 -1.262 . . . . 73.31 107.594 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 m -142.09 172.26 12.93 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.888 -0.782 . . . . 74.21 108.888 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -83.59 151.92 25.1 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.818 -1.178 . . . . 74.2 107.818 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -110.35 123.57 50.09 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.94 -1.504 . . . . 73.4 106.94 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -138.55 99.53 3.85 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 106.97 -1.493 . . . . 71.15 106.97 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.4 t -171.94 155.21 3.74 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.556 -1.276 . . . . 73.25 107.556 -174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 70.62 7.26 6.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.942 0.897 . . . . 73.44 111.383 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.1 -2.04 80.99 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.453 -1.059 . . . . 63.14 110.453 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -104.56 155.67 18.62 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.216 0.606 . . . . 75.32 111.288 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.64 136.69 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 108.438 -0.949 . . . . 71.14 108.438 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -163.45 -154.06 7.55 Favored Glycine 0 N--CA 1.397 -3.931 0 C-N-CA 120.056 -1.069 . . . . 62.21 111.051 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 m -131.25 143.6 50.68 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 115.462 -0.369 . . . . 63.32 110.078 -176.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.9 pt20 -132.74 138.15 47.1 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.706 0.289 . . . . 74.01 110.731 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -121.03 114.4 21.44 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.295 -1.372 . . . . 74.34 107.295 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.7 113.18 43.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 108.225 -1.028 . . . . 62.22 108.225 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.407 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.8 p90 -123.41 154.68 38.69 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.186 -0.606 . . . . 73.52 111.865 -175.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -157.1 165.61 35.58 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.229 -0.896 . . . . 74.14 109.499 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 65.19 31.7 10.62 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.276 0.985 . . . . 71.51 111.767 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 87' ' ' PHE . 47.9 mt -101.58 164.55 11.7 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.273 -0.422 . . . . 75.25 110.447 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -117.86 178.08 4.54 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.816 0.341 . . . . 73.33 111.082 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -54.06 -38.87 65.73 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 125.595 1.558 . . . . 64.01 111.063 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.22 -25.95 62.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.948 -0.569 . . . . 72.21 111.503 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -89.72 -17.07 29.0 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.299 -0.409 . . . . 74.14 111.564 -176.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 43.1 tp -57.84 -48.32 97.36 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 112.771 0.656 . . . . 74.21 112.771 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.444 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 40.2 Cg_exo -63.12 -37.02 54.8 Favored 'Trans proline' 0 C--N 1.367 1.53 0 CA-C-N 120.658 1.271 . . . . 74.11 110.892 174.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -68.49 -34.8 76.55 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.456 -0.793 . . . . 75.22 111.507 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -78.36 -19.44 53.39 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.501 -0.555 . . . . 74.13 109.501 176.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 96' ' ' PRO . . . -70.62 -27.15 63.85 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 115.585 -0.734 . . . . 73.14 109.933 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -57.1 -57.4 12.72 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.985 0.803 . . . . 73.52 109.675 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.504 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.6 ttp -53.58 -50.35 65.77 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.352 -0.84 . . . . 74.53 110.468 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -60.31 -33.0 71.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.227 -0.897 . . . . 73.41 111.609 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.9 m -63.99 -28.14 69.61 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 121.079 -0.249 . . . . 73.32 110.945 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.82 -26.18 68.23 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-O 121.424 0.631 . . . . 74.23 110.582 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.47 -6.64 16.05 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 116.143 -0.481 . . . . 73.13 110.669 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.52 -41.6 5.44 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.203 -0.599 . . . . 60.12 112.433 -173.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.56 26.02 68.68 Favored Glycine 0 C--O 1.242 0.638 0 C-N-CA 120.473 -0.87 . . . . 74.51 110.962 -175.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.56 160.81 9.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 121.056 0.455 . . . . 71.13 110.238 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -113.14 122.44 47.54 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.94 -1.874 . . . . 71.4 105.94 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.9 mt -119.68 123.24 43.33 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 117.82 0.282 . . . . 74.2 111.349 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.8 m -123.46 141.39 52.05 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.475 -0.565 . . . . 64.25 109.475 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.5 tp -134.92 131.85 37.77 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.259 -0.428 . . . . 75.13 110.426 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -143.03 153.68 43.2 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.406 -0.961 . . . . 71.13 108.406 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.566 ' NH1' ' HA ' ' A' ' 180' ' ' ASP . 19.8 ttm180 -112.02 132.44 54.8 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 108.763 -0.828 . . . . 75.54 108.763 171.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -110.06 89.3 2.98 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.104 -1.443 . . . . 72.34 107.104 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.26 -108.95 2.64 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.326 -1.11 . . . . 75.34 110.326 -176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -107.63 -6.31 16.98 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.213 1.006 . . . . 73.11 109.39 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.6 pp -104.39 143.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 C-N-CA 118.202 -1.399 . . . . 75.25 109.202 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.442 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 72.8 t -105.79 138.76 29.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 O-C-N 122.003 -0.435 . . . . 63.55 110.287 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.2 pt -121.15 135.92 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-O 121.626 0.726 . . . . 74.22 109.893 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.3 tt -128.06 125.32 39.07 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 107.475 -1.306 . . . . 73.32 107.475 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -125.83 121.84 34.43 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.857 -1.534 . . . . 63.12 106.857 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.99 161.21 27.57 Favored Glycine 0 N--CA 1.407 -3.259 0 C-N-CA 120.719 -0.753 . . . . 74.34 111.567 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -139.44 138.38 36.41 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.44 -0.948 . . . . 72.34 108.44 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.23 117.19 33.47 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.532 -0.303 . . . . 74.24 111.253 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -104.16 97.42 7.38 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.013 -1.106 . . . . 75.12 108.013 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 3.1 mm? -112.21 12.83 20.42 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.451 -0.574 . . . . 71.32 109.451 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 p -66.79 -28.45 68.4 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 113.431 0.901 . . . . 62.41 113.431 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.7 m -86.99 -5.12 59.19 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.098 0.475 . . . . 73.2 110.603 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.2 t -84.24 104.38 12.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.086 -1.079 . . . . 60.3 108.086 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.489 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 12.9 m -90.26 1.89 56.02 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.897 -0.592 . . . . 73.31 110.94 -177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.1 103.33 5.5 Favored Pre-proline 0 CA--C 1.515 -0.394 0 N-CA-C 108.573 -0.899 . . . . 72.41 108.573 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 131' ' ' SER . 8.3 Cg_exo -75.04 -12.12 21.42 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.58 2.187 . . . . 74.13 111.647 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 25' ' ' MET . 4.6 m-20 -80.12 1.78 26.66 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.987 -1.006 . . . . 72.14 111.412 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.52 131.3 44.86 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.164 -0.68 . . . . 73.34 109.164 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -122.12 118.26 28.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.311 -1.366 . . . . 53.43 107.311 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 53.5 t -109.73 129.92 63.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.344 -0.542 . . . . 71.24 110.657 -173.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -134.53 130.71 37.01 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.861 -0.422 . . . . 74.5 109.861 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 HD12 ' SD ' ' A' ' 172' ' ' MET . 5.6 tt -120.15 128.98 53.93 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.307 -1.738 . . . . 73.32 106.307 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 31' ' ' SER . 29.8 m -126.98 131.65 50.99 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.548 -0.538 . . . . 74.14 109.548 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 80.2 t -121.9 125.87 73.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.513 -0.921 . . . . 73.53 108.513 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -116.63 128.69 55.61 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 108.637 -0.875 . . . . 75.02 108.637 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.671 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.12 117.78 13.81 Favored Pre-proline 0 C--N 1.281 -2.379 0 CA-C-N 116.545 -0.298 . . . . 74.12 111.072 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.8 38.25 0.18 Allowed 'Trans proline' 0 CA--C 1.554 1.521 0 C-N-CA 123.024 2.483 . . . . 70.45 112.929 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -122.04 -102.0 0.41 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 110.048 -0.353 . . . . 52.13 110.048 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.73 128.12 0.08 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.665 -0.865 . . . . 70.43 108.665 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.49 141.3 15.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.521 -0.918 . . . . 73.4 108.521 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.3 t -103.54 -32.79 9.28 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 120.205 -0.598 . . . . 75.0 109.643 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 54.9 m -161.12 133.37 5.94 Favored 'General case' 0 C--O 1.202 -1.405 0 N-CA-C 109.598 -0.519 . . . . 73.15 109.598 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.8 t -138.52 168.78 19.04 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.695 -0.628 . . . . 74.12 109.599 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -139.76 87.7 2.19 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.065 -2.198 . . . . 61.42 105.065 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.9 -144.39 5.94 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.264 -1.534 . . . . 65.1 109.264 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -117.94 99.65 7.05 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.545 -0.909 . . . . 75.24 108.545 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 34.8 ptt180 -82.42 133.19 35.21 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 119.298 -0.961 . . . . 74.22 110.986 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.17 -37.74 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.582 -1.266 . . . . 70.35 107.582 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -139.71 165.04 34.02 Favored Pre-proline 0 N--CA 1.427 -1.582 0 N-CA-C 106.207 -1.775 . . . . 65.43 106.207 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.78 0.17 6.05 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.5 2.133 . . . . 74.43 111.366 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.671 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.0 pt-20 -134.41 8.38 3.66 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.819 -0.628 . . . . 74.42 111.88 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 86.9 t -142.7 121.06 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 109.131 -0.692 . . . . 61.32 109.131 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 44.9 t -130.58 146.28 34.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 110.167 -0.309 . . . . 53.51 110.167 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -132.75 152.58 51.72 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 121.12 0.486 . . . . 74.24 110.359 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 31.2 m-90 -125.28 119.43 28.4 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.296 -1.002 . . . . 75.23 108.296 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -98.99 106.5 18.77 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.963 0.887 . . . . 70.43 110.075 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 76.9 mt -101.44 135.51 42.82 Favored 'General case' 0 C--O 1.264 1.826 0 CA-C-N 114.907 -1.042 . . . . 74.31 111.216 -173.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 10.7 mmpt? -115.12 150.61 44.58 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 114.143 -1.39 . . . . 74.42 109.189 -175.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 11.3 Cg_exo -73.6 156.78 49.22 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.61 2.207 . . . . 63.1 111.283 176.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.79 -24.83 3.13 Favored Glycine 0 C--N 1.314 -0.688 0 O-C-N 122.318 -0.239 . . . . 74.23 112.665 176.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 166' ' ' PRO . 31.7 m -106.05 160.83 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.264 0.554 . . . . 75.14 112.096 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.73 144.14 21.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.764 -1.198 . . . . 75.12 107.764 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 32.8 t -148.6 152.71 37.23 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.991 -0.374 . . . . 73.45 109.991 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.1 p -96.03 154.78 17.05 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.893 -0.594 . . . . 75.0 109.547 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.455 ' SD ' HD12 ' A' ' 139' ' ' LEU . 37.4 ttp -144.1 116.27 8.44 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.396 0.617 . . . . 71.33 109.408 -176.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.4 m -134.61 141.7 46.69 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.188 -0.605 . . . . 73.44 109.58 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -146.66 116.25 7.14 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.114 -1.069 . . . . 54.44 108.114 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -124.13 129.88 51.59 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.438 -1.319 . . . . 63.53 107.438 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.98 155.66 38.46 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.139 -0.689 . . . . 71.15 109.139 -175.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 16.5 ptm180 -91.85 132.75 36.23 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 120.624 -0.431 . . . . 74.0 111.078 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.442 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 63.5 m-85 -140.52 129.76 23.69 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 109.091 -0.707 . . . . 74.44 109.091 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.5 110.8 0.38 Allowed 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 125.211 1.404 . . . . 74.31 111.982 -178.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.566 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 35.9 t70 -69.35 133.22 89.35 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 114.692 -1.14 . . . . 74.14 110.419 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.41 -45.19 7.51 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.619 2.212 . . . . 73.03 113.981 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -83.65 -15.98 46.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.042 0.449 . . . . 71.31 110.143 -176.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.429 74.8 p 79.57 66.46 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.379 1.871 . . . . 75.34 115.293 173.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -114.22 155.7 25.65 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.886 -1.506 . . . . 72.32 109.426 171.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 C--N 1.299 -1.621 0 N-CA-C 107.581 -1.266 . . . . 71.51 107.581 177.085 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.181 0 N-CA-C 110.562 -1.015 . . . . 43.05 110.562 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -75.41 131.04 39.91 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.538 -0.542 . . . . 75.41 109.538 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -95.92 135.84 37.13 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.713 -0.676 . . . . 72.3 110.825 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 179.98 112.82 0.05 OUTLIER 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.04 -1.466 . . . . 62.03 107.04 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.2 mt -120.78 28.15 8.1 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.311 0.577 . . . . 72.25 109.561 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -86.03 -72.31 0.5 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.473 -0.785 . . . . 62.31 109.945 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -94.83 6.7 48.22 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.739 -0.664 . . . . 75.55 111.574 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -76.81 91.88 3.55 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.205 -0.665 . . . . 75.42 109.205 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.73 84.59 0.2 Allowed Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 108.748 -1.741 . . . . 70.23 108.748 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -81.34 129.48 34.64 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.77 -0.456 . . . . 75.42 109.77 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -166.2 128.09 1.87 Allowed 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.081 -0.711 . . . . 73.44 109.081 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -114.78 135.81 53.76 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.463 -0.939 . . . . 74.13 108.463 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 52.4 ttt180 -129.57 123.41 31.29 Favored 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 119.865 -0.734 . . . . 73.54 109.254 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.08 114.08 44.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 106.669 -1.604 . . . . 74.23 106.669 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.91 113.3 18.92 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.36 -1.348 . . . . 72.21 107.36 -175.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.62 136.86 52.58 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.811 -0.631 . . . . 71.11 109.905 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -138.03 115.24 11.0 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.112 -0.699 . . . . 70.34 109.112 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 14.5 pt -126.55 149.14 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 121.25 0.548 . . . . 74.31 111.038 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 m -126.51 123.68 38.33 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 108.439 -0.948 . . . . 74.13 108.439 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 tt -113.49 125.02 70.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.478 0.656 . . . . 73.55 110.642 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.8 t -88.74 150.96 46.99 Favored Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 115.114 -0.948 . . . . 74.31 109.243 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.92 2.78 2.79 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 123.436 2.757 . . . . 71.32 111.894 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -89.08 4.53 48.1 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.058 -0.719 . . . . 75.44 109.058 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 t70 71.5 29.44 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.124 1.44 . . . . 72.33 107.144 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.42 124.93 51.83 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 113.882 -1.508 . . . . 72.01 107.938 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.7 t -111.58 138.81 38.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.765 -0.828 . . . . 73.45 108.765 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 p -149.64 157.92 43.69 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.626 -0.879 . . . . 64.41 108.626 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.28 -165.08 34.21 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 119.516 -1.326 . . . . 74.0 112.432 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.2 141.97 21.04 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.207 0.527 . . . . 74.42 110.265 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.8 mt -124.31 117.01 49.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.99 -1.115 . . . . 73.2 107.99 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.13 116.05 51.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.327 -0.62 . . . . 75.01 109.327 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.5 107.77 18.95 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.946 -1.501 . . . . 72.54 106.946 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.49 127.72 49.93 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.249 0.547 . . . . 73.12 109.884 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.82 153.02 29.83 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 109.269 -0.641 . . . . 72.14 109.269 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.512 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 80.3 tttt -79.04 128.68 75.51 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 105.837 -1.912 . . . . 73.24 105.837 175.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 52' ' ' ASN . 22.6 Cg_exo -21.63 -70.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.573 1 C-N-CA 126.03 4.487 . . . . 74.11 117.607 -171.064 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 60.6 mtpt 69.18 -31.64 0.21 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 124.669 1.188 . . . . 73.24 113.206 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 50' ' ' PRO . 45.1 m-80 -130.69 142.98 50.44 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.824 -1.547 . . . . 62.11 106.824 176.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 m -77.42 -18.64 57.07 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.062 0.458 . . . . 72.32 111.273 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.66 -17.28 54.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.395 0.617 . . . . 73.42 109.965 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.36 99.43 8.68 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 113.272 0.842 . . . . 65.22 113.272 -173.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -91.35 -13.99 31.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.935 -1.03 . . . . 70.05 108.286 171.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.479 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 173.1 104.76 0.18 Allowed Glycine 0 N--CA 1.417 -2.578 0 CA-C-O 118.472 -1.182 . . . . 75.3 111.163 176.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -52.45 132.78 46.42 Favored 'Trans proline' 0 C--O 1.243 0.771 0 CA-C-N 119.914 1.857 . . . . 74.25 110.772 173.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.97 155.83 39.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.055 -0.52 . . . . 70.31 111.718 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.6 tp -103.0 160.14 14.89 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.243 -1.021 . . . . 73.42 108.243 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -111.05 95.3 5.45 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.505 -0.924 . . . . 75.44 108.505 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -105.3 -106.3 3.11 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 120.726 -0.75 . . . . 64.22 112.136 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.0 t70 60.98 91.99 0.05 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 125.062 1.345 . . . . 61.22 112.028 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.68 157.72 77.24 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 114.393 -1.276 . . . . 75.11 108.136 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.82 -18.55 61.45 Favored 'Trans proline' 0 N--CA 1.479 0.634 0 C-N-CA 122.669 2.246 . . . . 73.35 112.326 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.4 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 42.1 p90 -111.16 32.35 5.38 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.559 -0.746 . . . . 73.22 112.114 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.5 m -55.92 -33.02 64.31 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 112.052 0.39 . . . . 75.02 112.052 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.39 -11.07 60.51 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.034 -0.416 . . . . 63.53 111.586 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HE3' HD23 ' A' ' 90' ' ' LEU . 24.3 mtpp -105.49 -4.45 21.27 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-N 116.168 -0.469 . . . . 73.34 109.905 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.6 p -125.98 119.03 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 122.179 0.99 . . . . 73.12 110.377 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.02 102.37 15.02 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.593 -0.73 . . . . 52.22 109.755 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.22 128.84 49.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.734 -0.839 . . . . 72.34 108.734 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.9 m -146.48 171.8 14.5 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 116.079 -0.509 . . . . 73.03 110.297 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.479 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 7.3 t30 -82.89 139.1 33.62 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.37 -0.604 . . . . 75.35 109.37 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -110.51 123.15 49.39 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.734 -0.839 . . . . 74.42 108.734 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -138.34 99.97 3.99 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.889 -1.523 . . . . 75.52 106.889 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.4 t -172.68 154.2 2.96 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.98 -0.378 . . . . 73.02 109.98 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 70.78 7.65 6.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.282 1.033 . . . . 63.33 111.632 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.65 -9.15 64.23 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.073 -0.811 . . . . 72.53 111.073 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -104.66 149.71 25.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.048 0.451 . . . . 72.53 110.692 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.83 137.74 56.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 109.082 -0.71 . . . . 74.54 109.082 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.43 -153.81 11.04 Favored Glycine 0 C--N 1.285 -2.305 0 C-N-CA 120.209 -0.996 . . . . 74.41 111.719 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 p -126.77 149.03 49.86 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 121.268 0.556 . . . . 62.0 110.848 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -132.44 142.37 49.23 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.489 -0.323 . . . . 74.12 110.5 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.44 114.41 22.84 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.02 -1.104 . . . . 52.22 108.02 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.19 111.92 38.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.41 -0.959 . . . . 75.34 108.41 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' A' ' 90' ' ' LEU . 49.7 p90 -118.47 162.41 18.38 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 112.516 0.561 . . . . 74.54 112.516 -172.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 p -164.24 160.29 20.98 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.474 -0.785 . . . . 72.32 110.345 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.0 t70 65.65 30.99 10.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 124.366 1.041 . . . . 73.01 110.699 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.431 HD23 ' HE3' ' A' ' 69' ' ' LYS . 55.8 mt -95.69 159.69 14.86 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 121.662 -0.649 . . . . 75.22 110.636 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.403 HG22 ' OE1' ' A' ' 94' ' ' GLU . 8.9 t -106.09 171.41 7.36 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.526 -0.546 . . . . 73.31 109.526 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -52.49 -40.02 61.89 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.638 0.775 . . . . 75.32 111.313 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.39 -24.9 65.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.752 -0.658 . . . . 52.22 111.92 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.403 ' OE1' HG22 ' A' ' 91' ' ' THR . 54.4 mt-10 -87.53 -16.83 33.54 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.461 -0.336 . . . . 74.14 111.634 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.586 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 49.2 tp -61.67 -51.4 76.72 Favored Pre-proline 0 CA--C 1.562 1.422 0 N-CA-C 113.174 0.805 . . . . 71.15 113.174 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -70.32 -29.08 21.74 Favored 'Trans proline' 0 C--N 1.361 1.213 0 CA-C-N 120.887 1.353 . . . . 75.34 110.132 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -67.95 -35.52 78.55 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.404 -0.816 . . . . 71.42 110.438 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -75.62 -19.29 59.31 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 109.783 -0.451 . . . . 75.13 109.783 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.01 -20.89 63.25 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.171 -0.468 . . . . 75.11 110.159 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -58.4 -57.14 14.23 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.234 -0.654 . . . . 72.41 109.234 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.4 ttp -53.79 -51.25 64.06 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 115.633 -0.712 . . . . 74.43 110.162 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -55.67 -41.51 73.77 Favored 'General case' 0 C--O 1.251 1.178 0 CA-C-N 114.954 -1.021 . . . . 65.25 111.272 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.3 p -65.9 -25.27 67.08 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.187 -0.605 . . . . 75.25 111.675 -171.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.74 -26.59 68.72 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 121.228 0.537 . . . . 72.13 110.518 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.37 -12.58 15.3 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 120.235 -0.586 . . . . 65.13 111.185 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.0 -29.16 9.59 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 114.295 1.22 . . . . 75.4 114.295 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.61 20.88 76.02 Favored Glycine 0 C--O 1.243 0.686 0 C-N-CA 120.535 -0.841 . . . . 43.43 111.491 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.7 m -96.68 156.41 3.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.153 -0.523 . . . . 63.54 111.547 -176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -132.1 122.19 25.0 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.253 -1.388 . . . . 63.52 107.253 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.08 123.36 40.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.064 0.393 . . . . 75.21 111.952 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.9 t -104.53 125.01 50.29 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 107.183 -1.414 . . . . 72.32 107.183 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.581 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 48.7 tp -128.72 123.08 32.14 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.162 -0.681 . . . . 75.42 109.162 -178.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.581 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 3.2 mpt_? -135.7 146.5 47.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.853 -0.425 . . . . 73.41 109.853 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.47 ' HG3' HG22 ' A' ' 119' ' ' VAL . 3.3 ttt180 -99.39 138.11 36.95 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 108.057 -1.09 . . . . 73.34 108.057 174.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -123.8 83.74 2.18 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.96 -1.496 . . . . 74.42 106.96 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.75 -122.61 22.69 Favored Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 114.137 -1.392 . . . . 64.32 110.97 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -75.74 -20.53 58.24 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 123.932 0.893 . . . . 72.14 110.617 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 0.8 OUTLIER -102.58 149.08 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 119.287 -0.965 . . . . 74.21 110.403 -172.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.47 HG22 ' HG3' ' A' ' 114' ' ' ARG . 59.4 t -117.73 139.81 43.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.784 -0.45 . . . . 74.03 109.784 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.3 pt -126.03 135.18 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 CA-C-O 121.709 0.766 . . . . 75.24 110.584 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.29 128.88 47.83 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 107.363 -1.347 . . . . 74.14 107.363 174.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.79 114.59 12.78 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 105.783 -1.932 . . . . 72.04 105.783 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.08 160.52 27.16 Favored Glycine 0 N--CA 1.41 -3.083 0 N-CA-C 110.925 -0.87 . . . . 71.02 110.925 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -141.01 150.47 43.07 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.59 -1.263 . . . . 75.21 107.59 -176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.41 128.83 52.59 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.957 -0.386 . . . . 70.35 109.957 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -111.83 93.56 4.52 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 118.716 -1.194 . . . . 72.02 109.991 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.9 pt? -123.26 15.52 9.78 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 113.926 -1.488 . . . . 75.42 107.482 176.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.477 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 0.2 OUTLIER -65.27 -47.43 76.71 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 113.409 -1.723 . . . . 73.22 109.01 177.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.9 t -87.99 14.9 8.05 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.472 -0.785 . . . . 63.53 112.589 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 127' ' ' LEU . 32.6 m -76.38 173.46 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 119.257 -0.977 . . . . 74.14 109.702 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.2 t -112.36 14.29 20.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.19 0.519 . . . . 64.1 109.622 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.55 99.17 51.49 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 116.034 -0.53 . . . . 71.51 109.955 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.37 -12.13 18.94 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.152 2.568 . . . . 61.21 113.753 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -102.25 0.43 34.37 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.545 0.688 . . . . 73.02 110.33 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.01 145.23 55.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 70.43 111.921 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 26.8 t70 -132.34 118.05 18.93 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.852 -0.613 . . . . 62.31 109.972 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 97.6 t -116.57 133.96 61.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.004 -1.11 . . . . 54.53 108.004 175.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -138.9 138.96 37.88 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.47 -0.567 . . . . 73.31 109.47 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 tt -133.42 128.23 35.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.061 -1.459 . . . . 72.13 107.061 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.0 m -126.21 134.21 51.3 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.694 -0.854 . . . . 71.14 108.694 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 57.6 t -129.02 125.22 62.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.636 -0.505 . . . . 74.13 109.636 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.08 128.39 56.48 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.008 -0.738 . . . . 75.41 109.008 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -134.46 129.67 19.69 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 112.917 0.71 . . . . 73.4 112.917 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -71.86 49.47 1.25 Allowed 'Trans proline' 0 CA--C 1.551 1.363 0 C-N-CA 123.317 2.678 . . . . 74.14 111.286 172.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.69 -133.78 0.13 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.241 -1.392 . . . . 73.34 107.241 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -161.88 135.13 6.24 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.027 -1.472 . . . . 75.21 107.027 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.18 127.65 41.75 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.117 0.484 . . . . 65.41 110.356 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.4 t -88.08 -37.53 16.18 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.883 -0.414 . . . . 74.22 109.883 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.1 m -152.6 133.27 13.9 Favored 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 109.561 -0.533 . . . . 74.33 109.561 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -139.36 161.93 36.24 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 121.95 -0.469 . . . . 72.44 109.79 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.61 91.18 2.96 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 104.47 -2.418 . . . . 75.1 104.47 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.8 -147.47 8.76 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 109.296 -1.522 . . . . 74.21 109.296 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -119.66 99.82 6.89 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.62 -0.881 . . . . 74.24 108.62 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -82.11 129.49 34.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 119.513 -0.875 . . . . 73.34 111.981 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.9 mt -83.71 -42.36 17.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.351 -1.351 . . . . 74.23 107.351 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -138.71 167.2 20.37 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 106.646 -1.613 . . . . 74.14 106.646 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.54 0.14 8.51 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.095 1.864 . . . . 74.53 111.504 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -128.4 3.91 5.67 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.337 0.589 . . . . 71.14 111.008 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 65.8 t -145.13 120.59 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.377 -0.971 . . . . 74.35 108.377 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.94 149.83 28.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.432 -0.581 . . . . 74.33 109.432 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -136.23 143.64 44.44 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 109.131 -0.692 . . . . 75.22 109.131 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -122.17 130.27 53.06 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 109.65 -0.5 . . . . 75.22 109.65 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.37 111.64 24.07 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.433 -0.951 . . . . 74.15 108.433 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.7 mm? -94.81 122.33 37.32 Favored 'General case' 0 C--O 1.276 2.461 0 CA-C-N 114.726 -1.125 . . . . 72.34 107.966 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -117.08 130.94 24.25 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 114.637 -1.165 . . . . 73.33 110.293 -170.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 168' ' ' VAL . 42.4 Cg_endo -67.57 155.37 70.46 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.328 2.685 . . . . 75.23 112.576 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 73.01 -14.6 2.72 Favored Glycine 0 N--CA 1.466 0.652 0 CA-C-N 115.805 -0.634 . . . . 64.04 113.796 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.433 ' H ' ' C ' ' A' ' 166' ' ' PRO . 35.9 m -120.81 162.83 19.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.447 -0.946 . . . . 75.35 108.447 172.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.1 p -99.25 128.3 51.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.32 0.581 . . . . 74.22 110.353 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.3 m -116.8 137.73 52.0 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.127 -1.064 . . . . 73.32 108.127 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.6 p -116.09 148.03 40.68 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 110.086 -0.338 . . . . 74.25 110.086 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.412 ' SD ' HD12 ' A' ' 164' ' ' LEU . 2.7 mpp? -126.83 116.84 21.5 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.147 -0.686 . . . . 72.01 109.147 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.0 t -132.42 138.25 47.58 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.953 -1.128 . . . . 70.11 107.953 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -145.56 120.66 10.1 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.243 -1.021 . . . . 62.41 108.243 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -125.17 130.19 51.65 Favored 'General case' 0 C--N 1.272 -2.798 0 N-CA-C 107.204 -1.406 . . . . 63.45 107.204 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -155.89 153.92 30.42 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.85 -0.796 . . . . 62.44 108.85 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 60.1 mtt180 -88.19 132.52 34.32 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.94 -0.763 . . . . 73.42 108.94 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -135.87 129.85 32.96 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 109.282 -0.636 . . . . 74.53 109.282 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.78 104.21 0.14 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.943 0.777 . . . . 74.55 111.91 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.62 130.37 94.08 Favored Pre-proline 0 CA--C 1.503 -0.842 0 CA-C-N 114.879 -1.055 . . . . 65.45 109.238 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.64 -40.0 10.93 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.212 1.942 . . . . 70.25 112.214 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -9.19 58.84 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 123.684 0.794 . . . . 75.3 111.704 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.337 50.9 p 65.2 68.83 0.49 Allowed 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 116.612 2.079 . . . . 71.43 116.612 172.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -85.89 151.09 24.06 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.574 -1.639 . . . . 73.12 106.574 168.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 C--N 1.296 -1.752 0 N-CA-C 109.709 -0.478 . . . . 74.22 109.709 -179.235 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.713 0 N-CA-C 109.391 -1.483 . . . . 54.41 109.391 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -97.19 83.76 3.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.193 -0.669 . . . . 75.23 109.193 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.35 161.21 31.14 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.185 -0.916 . . . . 74.01 110.141 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -91.22 111.34 22.77 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.712 0.768 . . . . 60.3 109.72 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 mp -96.09 98.75 10.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.246 -1.02 . . . . 71.11 108.246 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -91.96 119.08 31.37 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.563 -0.855 . . . . 71.3 109.943 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -68.5 138.52 55.27 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.831 -0.803 . . . . 70.1 108.831 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -103.91 130.59 51.53 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.68 -0.859 . . . . 74.32 108.68 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.75 158.65 34.75 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.877 -0.602 . . . . 63.11 111.599 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -138.43 119.05 13.96 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.261 -1.385 . . . . 74.15 107.261 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 17.6 ptp -150.45 138.15 19.87 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.13 -0.628 . . . . 74.54 111.348 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD21 ' H ' ' A' ' 26' ' ' LEU . 2.1 pt? -118.5 109.58 16.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.089 -1.448 . . . . 75.51 107.089 171.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.01 123.83 49.75 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.42 -1.326 . . . . 74.24 107.42 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.75 122.77 47.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 C-N-CA 119.546 -0.862 . . . . 75.22 112.058 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -110.22 134.82 51.85 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.336 -0.987 . . . . 71.14 108.336 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.25 108.8 12.1 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.565 -0.902 . . . . 64.03 108.565 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 p -116.7 115.05 24.92 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.295 -1.002 . . . . 65.12 108.295 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.83 146.63 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 121.154 0.502 . . . . 74.33 109.813 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 87.4 m -126.31 127.8 46.12 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 109.678 -0.49 . . . . 75.11 109.678 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -110.47 118.26 56.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.61 -0.723 . . . . 75.31 109.852 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.2 m -84.71 155.16 62.0 Favored Pre-proline 0 C--N 1.296 -1.741 0 CA-C-N 115.446 -0.797 . . . . 75.21 109.683 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.63 0.68 4.51 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 123.225 2.616 . . . . 64.02 112.142 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.58 0.32 43.34 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 124.348 1.059 . . . . 53.24 109.831 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.9 t70 70.27 29.71 3.57 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 123.29 1.519 . . . . 75.12 107.073 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.75 138.86 52.38 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 113.02 -1.9 . . . . 74.54 107.959 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.7 t -120.32 140.26 44.98 Favored 'Isoleucine or valine' 0 C--O 1.259 1.564 0 CA-C-O 121.052 0.453 . . . . 72.45 109.977 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.1 p -147.33 142.88 27.58 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.629 -0.878 . . . . 54.44 108.629 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.86 -169.06 40.33 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 119.33 -1.414 . . . . 71.43 112.677 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -151.11 133.8 15.66 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.125 0.488 . . . . 71.35 110.661 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -116.72 116.17 51.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.456 -1.313 . . . . 74.31 107.456 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.04 114.84 47.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.763 -0.458 . . . . 74.4 109.763 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.61 108.68 20.07 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.364 -1.347 . . . . 71.44 107.364 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.62 119.36 32.64 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.7 0.762 . . . . 74.44 110.244 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.68 145.64 37.63 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.649 -0.705 . . . . 73.45 110.164 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -80.27 114.74 49.54 Favored Pre-proline 0 N--CA 1.42 -1.948 0 N-CA-C 102.999 -2.963 . . . . 75.11 102.999 171.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -31.64 104.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 124.926 3.751 . . . . 74.02 114.615 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -84.64 -25.93 28.19 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.488 0.661 . . . . 74.33 109.983 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -104.41 129.76 52.35 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.096 -1.076 . . . . 73.24 108.096 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 m -63.8 -27.85 69.46 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 123.383 0.673 . . . . 61.45 111.756 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -87.08 -8.82 56.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.113 0.482 . . . . 75.23 110.359 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.93 120.06 30.0 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.631 0.729 . . . . 75.43 112.585 -169.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -121.85 7.34 9.88 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 114.614 -1.175 . . . . 73.33 109.818 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.14 97.69 0.11 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 119.908 -1.139 . . . . 73.45 112.936 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.68 153.3 26.27 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 123.216 2.611 . . . . 62.32 111.461 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -113.38 157.28 22.08 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.598 -0.519 . . . . 54.41 109.598 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.462 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 65.1 mt -88.81 135.76 33.36 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.857 -0.423 . . . . 65.05 109.857 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.53 87.41 3.82 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.852 -0.613 . . . . 73.23 110.059 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.45 ' HA3' ' HG3' ' A' ' 101' ' ' MET . . . -161.82 156.6 28.18 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 110.885 -0.886 . . . . 71.44 110.885 176.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -144.22 129.08 18.39 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.102 -0.703 . . . . 74.05 109.102 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.06 147.56 61.21 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.458 -0.571 . . . . 72.43 109.458 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.15 -8.99 21.88 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.203 2.602 . . . . 75.11 113.215 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -110.45 42.23 1.61 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.428 0.632 . . . . 74.15 110.286 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 m -57.97 -34.6 70.12 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.605 -0.725 . . . . 63.52 110.945 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -71.27 -9.16 57.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.266 0.555 . . . . 71.25 110.851 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.28 -17.29 17.37 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.793 -0.639 . . . . 74.34 110.019 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 p -130.39 118.1 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.912 0.863 . . . . 75.14 111.015 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.89 112.41 24.18 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.035 -0.984 . . . . 75.02 109.151 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.0 t -98.16 130.52 46.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 106.949 -1.501 . . . . 75.44 106.949 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.9 t -144.04 172.7 12.52 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.112 0.482 . . . . 65.14 110.792 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -80.19 141.74 35.36 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 124.874 1.27 . . . . 73.13 109.323 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -119.76 120.14 35.69 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.635 -0.876 . . . . 72.52 108.635 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -138.7 103.99 4.98 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.655 -0.868 . . . . 75.01 108.655 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.2 t -164.75 142.25 6.35 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.705 -0.398 . . . . 73.04 110.692 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 65.24 13.54 8.83 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.391 1.476 . . . . 74.53 112.223 174.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.41 -3.11 59.47 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.865 -0.683 . . . . 72.3 111.908 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -99.84 148.04 24.86 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.856 -0.794 . . . . 75.53 108.856 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.23 136.76 59.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.328 -0.99 . . . . 75.42 108.328 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -166.03 -154.69 8.34 Favored Glycine 0 N--CA 1.413 -2.834 0 C-N-CA 120.112 -1.042 . . . . 70.41 112.478 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.462 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 6.7 m -126.08 148.37 49.37 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.888 -0.782 . . . . 64.02 108.888 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -129.81 132.14 46.4 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 120.556 -0.457 . . . . 73.32 110.363 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.78 113.92 26.88 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.702 -1.592 . . . . 73.42 106.702 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.68 112.36 39.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.732 -0.84 . . . . 73.12 108.732 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.432 ' CD2' HD13 ' A' ' 90' ' ' LEU . 45.3 p90 -120.02 152.8 36.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.292 0.567 . . . . 71.21 111.633 -173.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.6 p -159.73 157.38 29.35 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.276 -0.874 . . . . 75.44 109.727 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 67.28 31.69 6.41 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.592 1.157 . . . . 53.34 110.295 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.432 HD13 ' CD2' ' A' ' 87' ' ' PHE . 30.1 mt -96.23 164.44 12.67 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.813 -0.631 . . . . 65.15 110.091 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m -107.79 160.22 15.89 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 109.392 -0.596 . . . . 74.12 109.392 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -49.91 -43.15 49.44 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.192 1.397 . . . . 74.13 110.628 176.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.39 -30.45 71.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.865 -0.607 . . . . 65.31 111.441 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -82.91 -15.44 51.39 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.792 -0.64 . . . . 74.53 111.589 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.5 tm? -54.03 -56.2 28.35 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 123.056 0.542 . . . . 75.02 111.269 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.78 -36.13 75.37 Favored 'Trans proline' 0 C--N 1.371 1.723 0 CA-C-N 120.61 1.254 . . . . 74.12 111.072 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.409 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 23.6 mt-30 -62.8 -37.41 86.59 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.691 -0.686 . . . . 74.23 111.818 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -75.54 -20.41 58.7 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.184 0.516 . . . . 72.42 110.045 177.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.49 -20.21 57.2 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.717 -0.674 . . . . 70.4 109.537 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 97' ' ' GLN . 87.7 m-20 -62.77 -55.06 29.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.85 -0.613 . . . . 75.34 110.114 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.45 ' HG3' ' HA3' ' A' ' 62' ' ' GLY . 24.3 ttp -53.97 -51.27 64.41 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.167 0.292 . . . . 72.41 110.72 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.66 -35.27 72.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.846 -0.615 . . . . 73.44 110.429 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.4 t -59.86 -39.86 86.65 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.015 -0.735 . . . . 71.31 109.015 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -63.22 -25.24 68.24 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 115.339 -0.846 . . . . 72.34 110.943 -172.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.11 -20.09 13.52 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 119.949 -0.7 . . . . 65.22 111.591 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.19 -42.1 5.17 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 114.237 1.199 . . . . 74.11 114.237 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.97 25.76 18.81 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.635 -0.986 . . . . 53.24 110.635 -172.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.2 m -109.34 157.26 9.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.68 -0.489 . . . . 73.44 109.68 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -142.66 128.26 19.13 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.803 -0.814 . . . . 74.51 108.803 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -130.03 128.98 43.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.581 0.229 . . . . 72.52 110.664 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.8 m -118.05 134.19 55.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.301 -1.0 . . . . 74.04 108.301 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.2 tp -133.13 123.4 25.61 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.188 -0.671 . . . . 74.01 109.188 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.3 mtp180 -134.23 153.02 52.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.155 0.502 . . . . 74.15 111.703 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.443 HH11 ' HB2' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -106.4 122.11 45.61 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 124.33 1.052 . . . . 73.33 108.935 179.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.41 ' O ' HG13 ' A' ' 118' ' ' ILE . 6.8 t30 -118.14 101.23 8.07 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.779 -1.193 . . . . 71.32 107.779 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.34 -120.06 7.52 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 108.441 -1.864 . . . . 72.44 108.441 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.28 -2.07 22.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.718 -1.216 . . . . 72.22 107.718 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -100.28 148.96 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 C-N-CA 119.37 -0.932 . . . . 63.11 109.068 -175.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.71 140.5 40.57 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-O 120.793 0.33 . . . . 75.5 111.18 -175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.3 pt -119.79 135.37 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.624 -0.717 . . . . 74.3 109.36 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.79 127.07 45.57 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.542 -0.754 . . . . 74.53 109.39 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.29 122.24 31.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.202 -0.908 . . . . 74.55 108.95 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -136.35 146.65 18.63 Favored Glycine 0 N--CA 1.422 -2.277 0 N-CA-C 110.573 -1.011 . . . . 73.22 110.573 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -139.55 144.58 37.89 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.174 -0.676 . . . . 75.31 109.174 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.48 118.82 22.72 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.046 -0.724 . . . . 73.44 109.046 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -102.35 94.04 5.49 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.768 -0.773 . . . . 62.4 111.421 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.71 16.87 13.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.984 -1.487 . . . . 73.35 106.984 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.516 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 1.3 m -60.74 -30.97 70.31 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.778 1.631 . . . . 75.2 112.733 -174.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.0 m -80.99 0.63 34.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.179 0.514 . . . . 72.12 110.073 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.5 t 65.67 75.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 125.32 1.448 . . . . 74.32 110.451 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.9 m -63.16 -42.69 99.46 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.606 -1.179 . . . . 63.32 108.701 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -150.38 132.99 8.24 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 106.045 -1.835 . . . . 74.32 106.045 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.41 -19.96 18.85 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.061 1.841 . . . . 73.15 114.613 -175.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -108.22 13.02 26.14 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.614 0.721 . . . . 74.24 109.835 -173.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.45 129.49 38.92 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.741 -0.663 . . . . 75.44 110.754 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -131.73 111.65 11.84 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.695 -1.224 . . . . 75.2 107.695 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 49.2 t -111.94 127.66 68.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.956 -0.757 . . . . 62.22 108.956 -177.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -112.07 121.25 44.47 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.337 -0.616 . . . . 75.44 109.337 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.29 116.31 28.09 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.593 -1.262 . . . . 75.44 107.593 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.6 m -126.44 130.77 51.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 110.133 -0.321 . . . . 63.12 110.133 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.5 t -123.65 125.77 71.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.464 -0.569 . . . . 74.43 109.464 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.3 131.16 56.62 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.028 -0.73 . . . . 73.42 109.028 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.678 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.3 p90 -134.31 122.93 16.29 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.406 -0.361 . . . . 71.24 110.918 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -69.02 47.4 0.44 Allowed 'Trans proline' 0 CA--C 1.56 1.819 0 C-N-CA 123.008 2.472 . . . . 71.02 112.297 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -132.86 -108.13 0.24 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 122.823 0.449 . . . . 64.14 110.538 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.21 131.19 0.14 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.722 -0.844 . . . . 75.43 108.722 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.09 128.73 38.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.14 -0.689 . . . . 73.24 109.14 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.0 t -88.62 -36.04 16.5 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.246 -0.434 . . . . 64.44 110.012 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.5 m -157.71 133.03 8.9 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 108.938 -0.764 . . . . 62.32 108.938 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 t -138.92 165.39 27.19 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 121.98 -0.45 . . . . 74.11 109.824 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 45.4 t30 -137.05 93.43 2.83 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 105.585 -2.006 . . . . 75.41 105.585 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.81 -147.0 10.45 Favored Glycine 0 N--CA 1.416 -2.67 0 N-CA-C 109.045 -1.622 . . . . 61.41 109.045 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -111.79 100.06 8.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.251 -0.648 . . . . 55.13 109.251 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -78.28 115.75 18.22 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.965 0.412 . . . . 74.21 110.684 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.0 mt -82.21 -48.99 17.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.217 -1.401 . . . . 75.24 107.217 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -130.92 159.74 70.0 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.095 -1.446 . . . . 74.32 107.095 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.74 -13.49 34.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.375 2.05 . . . . 63.42 112.187 176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.678 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -122.39 8.0 9.62 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 112.816 0.673 . . . . 74.05 112.816 176.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.8 t -140.73 120.93 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 109.61 -0.515 . . . . 74.13 109.61 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.28 147.58 31.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.707 -0.479 . . . . 74.21 109.707 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -132.47 149.8 52.27 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.097 0.475 . . . . 65.24 109.898 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.43 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 23.8 m-90 -131.65 133.27 44.73 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.323 -1.362 . . . . 74.13 107.323 174.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -107.09 114.74 28.99 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.974 -0.75 . . . . 74.3 108.974 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.6 mp -88.9 125.57 35.0 Favored 'General case' 0 C--O 1.273 2.309 0 CA-C-N 114.212 -1.358 . . . . 75.34 110.572 -173.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -118.59 147.15 41.42 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 113.304 -1.771 . . . . 75.13 110.771 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 168' ' ' VAL . 2.7 Cg_exo -76.39 159.31 36.39 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.437 2.091 . . . . 74.3 112.356 174.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 74.06 -14.72 3.62 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 123.136 0.398 . . . . 71.34 113.822 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.433 ' H ' ' C ' ' A' ' 166' ' ' PRO . 19.6 m -120.33 145.43 26.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.229 -1.026 . . . . 72.4 108.229 171.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.4 110.06 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 108.42 -0.956 . . . . 74.01 108.42 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.6 m -76.84 130.7 37.98 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.375 -0.83 . . . . 62.34 108.93 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.6 p -115.84 125.73 53.04 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.623 -0.717 . . . . 72.24 110.129 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -112.33 117.07 31.46 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.989 -1.115 . . . . 73.33 107.989 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 13.7 m -135.48 137.05 41.76 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.426 -1.31 . . . . 75.11 110.411 176.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -149.43 135.25 18.74 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.566 -0.901 . . . . 61.43 108.566 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -131.38 130.01 42.06 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 107.127 -1.435 . . . . 74.45 107.127 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -153.57 159.82 42.29 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.622 -0.881 . . . . 62.53 108.622 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 40.0 mtt180 -95.32 127.18 41.16 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.388 -0.925 . . . . 73.25 108.946 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -130.37 127.86 40.24 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.164 -1.05 . . . . 74.22 108.164 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.29 104.74 0.1 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 124.83 1.331 . . . . 73.24 112.675 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.11 138.87 96.0 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 114.684 -1.144 . . . . 64.5 111.728 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.59 -40.72 1.39 Allowed 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 122.801 2.334 . . . . 71.01 114.276 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.06 -13.43 53.13 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.432 0.634 . . . . 74.5 109.39 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.462 64.4 p 81.32 68.89 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 126.972 2.109 . . . . 65.33 115.294 172.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -97.15 154.77 17.16 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 113.26 -1.791 . . . . 75.22 108.464 171.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--N 1.297 -1.683 0 N-CA-C 107.589 -1.263 . . . . 61.43 107.589 178.807 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.105 0 N-CA-C 109.473 -1.451 . . . . 43.05 109.473 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 61.35 15.05 6.2 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 117.609 0.704 . . . . 74.52 112.28 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -97.94 85.92 3.62 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 122.151 0.977 . . . . 70.43 111.289 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.18 95.46 4.9 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.727 -1.212 . . . . 73.22 107.727 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -133.51 135.85 44.68 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.404 -0.816 . . . . 74.31 109.922 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -139.45 127.37 22.19 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.042 -0.725 . . . . 74.53 109.042 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.46 ' HB3' ' O ' ' A' ' 51' ' ' LYS . 73.6 m-85 -127.55 102.53 6.89 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.073 -1.084 . . . . 75.21 108.073 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -113.34 107.95 16.57 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.136 -0.484 . . . . 73.3 111.186 -173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.79 69.46 0.25 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.863 -0.684 . . . . 63.03 113.08 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -111.28 26.67 10.43 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 122.148 0.975 . . . . 73.55 110.395 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.409 ' SD ' ' HE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -107.34 103.37 12.71 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.059 -1.83 . . . . 62.25 106.059 175.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.2 tp -122.68 116.23 23.43 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.021 -0.733 . . . . 75.42 109.021 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -109.81 123.93 50.42 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 108.0 -1.111 . . . . 74.31 108.0 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.9 t -107.26 114.72 46.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.398 -0.964 . . . . 73.24 108.398 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -112.25 113.15 25.23 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.422 -0.955 . . . . 72.25 108.422 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.16 108.63 14.02 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.052 -1.092 . . . . 52.53 108.052 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 140' ' ' THR . 20.2 m -122.11 114.32 20.74 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.125 -0.694 . . . . 72.35 109.125 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.5 pt -126.61 148.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 O-C-N 121.891 -0.506 . . . . 75.53 109.84 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.2 m -127.92 119.93 26.6 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 116.089 -0.505 . . . . 75.41 109.783 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.617 HG21 ' OH ' ' A' ' 178' ' ' TYR . 8.7 tt -104.41 125.62 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 108.64 -0.874 . . . . 75.12 108.64 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 37' ' ' ASP . 18.7 m -94.66 152.65 40.02 Favored Pre-proline 0 C--N 1.281 -2.383 0 CA-C-N 115.754 -0.657 . . . . 62.14 109.557 -176.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.93 2.56 0.57 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 123.934 3.089 . . . . 73.04 113.475 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 33.5 t70 -82.0 -7.55 59.62 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.425 1.09 . . . . 72.31 109.582 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 73.16 28.69 1.83 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 123.374 1.559 . . . . 72.22 107.269 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -111.34 132.16 54.61 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.296 -1.774 . . . . 75.41 109.148 178.513 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.95 143.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.116 -0.698 . . . . 73.43 109.116 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 p -149.69 155.24 39.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.052 -1.462 . . . . 61.14 107.052 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.84 -174.59 44.06 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 118.287 -1.911 . . . . 73.5 114.343 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.38 133.26 36.57 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 124.327 1.051 . . . . 74.11 108.721 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.9 mt -119.89 115.54 47.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 105.663 -1.977 . . . . 73.12 105.663 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.8 mt -126.45 114.74 39.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 109.671 -0.492 . . . . 73.4 109.671 -172.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.516 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.02 109.27 19.3 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.391 -1.337 . . . . 74.12 107.391 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -119.69 126.47 51.19 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.453 -0.499 . . . . 71.24 111.53 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.9 157.35 27.83 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.531 -0.759 . . . . 72.23 109.316 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -83.44 126.35 71.72 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 106.999 -1.482 . . . . 74.51 106.999 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -33.57 111.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 124.806 3.671 . . . . 62.15 113.49 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' PHE . 59.7 pttt -91.26 -6.64 52.95 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.775 -0.648 . . . . 75.13 112.658 -173.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -155.84 159.63 39.54 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.329 -0.989 . . . . 72.44 108.329 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 p -57.27 -43.11 82.79 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 123.93 0.892 . . . . 73.02 111.975 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -90.56 -1.24 57.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.943 -0.571 . . . . 73.24 111.886 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.28 99.53 5.54 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.3 -0.629 . . . . 74.31 109.3 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 p -116.81 -19.44 9.89 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.304 -0.862 . . . . 74.45 112.94 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.61 98.03 0.11 Allowed Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 120.196 -1.002 . . . . 73.2 112.148 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.51 ' O ' ' HB3' ' A' ' 83' ' ' SER . 67.9 Cg_exo -54.87 159.19 9.65 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.802 2.335 . . . . 75.43 111.368 173.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.99 157.11 21.1 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.923 -0.486 . . . . 71.23 111.027 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.487 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 81.6 mt -109.9 139.12 45.35 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.82 -0.807 . . . . 71.01 108.82 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -108.27 98.78 8.27 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.097 -1.075 . . . . 73.13 108.097 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.482 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -109.63 95.96 0.92 Allowed Glycine 0 C--N 1.283 -2.386 0 CA-C-N 115.109 -0.95 . . . . 72.15 112.531 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -87.01 89.39 7.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.235 -1.024 . . . . 72.21 108.235 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.39 154.13 78.35 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 109.47 -0.567 . . . . 74.51 109.47 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.22 -28.67 18.31 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.325 2.017 . . . . 73.44 112.152 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -91.21 38.23 0.96 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.746 -0.661 . . . . 74.44 112.07 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.73 -45.07 58.43 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.523 1.129 . . . . 75.11 113.535 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -12.13 60.77 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.051 0.453 . . . . 73.52 111.099 -174.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 88' ' ' SER . 69.1 mmtt -93.35 -9.61 38.19 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 116.198 -0.455 . . . . 64.11 110.115 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -115.41 118.52 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 C-N-CA 118.518 -1.273 . . . . 74.33 110.063 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.44 102.6 14.4 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.998 -1.001 . . . . 64.24 108.871 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.7 t -98.27 135.74 31.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.462 -1.31 . . . . 75.12 107.462 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 t -155.52 171.87 19.21 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.693 -0.854 . . . . 62.44 108.693 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -83.58 142.78 30.59 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.689 -0.856 . . . . 71.44 108.689 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -99.06 122.38 42.22 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.313 -0.995 . . . . 74.34 108.313 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -138.99 99.62 3.82 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.187 -0.672 . . . . 53.44 109.187 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.2 t -172.88 149.74 1.97 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.612 -0.514 . . . . 64.15 109.612 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.91 16.2 8.83 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.393 1.077 . . . . 63.53 111.674 173.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.5 1.55 85.68 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.442 -0.663 . . . . 64.43 111.442 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.413 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 91.8 m-85 -104.29 145.51 30.12 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 109.5 -0.556 . . . . 71.42 109.5 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.2 136.67 60.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.797 -1.186 . . . . 72.34 107.797 173.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -165.47 -154.97 8.34 Favored Glycine 0 C--N 1.27 -3.115 0 C-N-CA 119.65 -1.262 . . . . 70.35 111.638 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 21.2 p -123.84 143.23 50.46 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 109.604 -0.517 . . . . 71.33 109.604 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -138.37 142.59 39.63 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 120.406 -0.518 . . . . 74.43 110.954 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.37 114.9 18.83 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.197 -1.038 . . . . 71.33 108.197 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -105.97 115.0 46.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 108.62 -0.881 . . . . 74.5 108.62 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -118.34 154.43 32.36 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 120.393 -0.523 . . . . 74.14 110.938 -175.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 80.8 p -157.53 171.35 20.51 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 109.335 -0.617 . . . . 64.21 109.335 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 62.15 30.59 17.78 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.438 1.087 . . . . 75.22 110.62 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt -101.15 164.24 11.89 Favored 'General case' 0 N--CA 1.42 -1.926 0 C-N-CA 120.165 -0.614 . . . . 75.45 111.116 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -113.04 170.79 7.95 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.235 -0.654 . . . . 74.2 109.235 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -54.57 -38.25 66.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.407 1.083 . . . . 74.41 111.746 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.51 65.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.236 -0.438 . . . . 72.44 111.876 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -86.46 -16.51 36.86 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.904 0.383 . . . . 73.15 111.665 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.603 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.7 tt -62.35 -47.71 88.8 Favored Pre-proline 0 CA--C 1.569 1.685 0 CA-C-N 116.236 -0.438 . . . . 75.35 111.378 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.55 -40.15 76.63 Favored 'Trans proline' 0 C--N 1.38 2.232 0 CA-C-N 120.831 1.333 . . . . 72.33 110.768 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -61.16 -41.8 97.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.236 -0.893 . . . . 73.52 111.534 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -72.36 -20.39 61.47 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.376 -0.375 . . . . 74.52 110.635 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.01 -26.13 60.27 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.21 -0.663 . . . . 75.3 109.21 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -62.87 -52.06 64.57 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.58 -0.896 . . . . 62.13 108.58 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.482 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 32.2 ttp -53.89 -51.59 63.2 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.478 -0.783 . . . . 72.42 109.78 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -55.22 -35.0 64.44 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.192 -0.913 . . . . 74.53 111.076 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -58.96 -32.57 69.75 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 119.234 -0.413 . . . . 72.54 111.465 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.26 -25.7 67.98 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.269 0.557 . . . . 74.52 111.233 -173.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.37 -14.48 14.43 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.809 -0.632 . . . . 74.15 111.01 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.3 -43.79 4.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.309 0.855 . . . . 74.33 113.309 -171.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.37 22.69 69.84 Favored Glycine 0 C--N 1.317 -0.481 0 N-CA-C 111.122 -0.791 . . . . 64.43 111.122 -173.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.3 m -103.87 161.53 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.576 -0.527 . . . . 70.11 109.576 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -123.31 121.62 36.28 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.67 -1.604 . . . . 75.02 106.67 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.0 mt -122.77 107.23 11.67 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.266 -0.642 . . . . 72.33 109.266 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.1 m -115.87 141.02 48.65 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.88 -0.785 . . . . 74.44 108.88 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -149.92 155.38 39.89 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.9 -0.32 . . . . 71.44 110.478 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -156.09 161.84 40.34 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.339 -0.985 . . . . 75.13 108.339 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -106.47 133.09 51.7 Favored 'General case' 0 N--CA 1.398 -3.031 0 N-CA-C 107.322 -1.362 . . . . 75.45 107.322 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -118.81 100.24 7.27 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 106.839 -1.541 . . . . 70.12 106.839 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.91 -113.05 4.98 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.325 -1.11 . . . . 61.43 110.325 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -114.32 12.09 17.51 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.932 1.348 . . . . 73.04 109.477 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.23 148.86 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 O-C-N 120.445 -1.41 . . . . 73.42 108.868 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 82.4 t -106.41 136.0 42.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 CA-C-O 120.761 0.315 . . . . 73.43 110.398 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.1 pt -116.94 134.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 108.876 -0.787 . . . . 65.44 108.876 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 tt -127.84 126.25 41.28 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.279 -1.008 . . . . 73.34 108.279 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -128.63 114.86 17.21 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.828 0.823 . . . . 75.44 109.142 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.39 139.4 14.13 Favored Glycine 0 N--CA 1.4 -3.747 0 N-CA-C 108.777 -1.729 . . . . 54.33 108.777 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -140.23 131.09 25.96 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.633 -1.618 . . . . 74.02 106.633 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -139.5 144.8 38.1 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.688 0.756 . . . . 73.13 112.871 -172.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.24 93.43 5.69 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.513 -1.221 . . . . 74.13 107.937 174.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.13 0.27 56.22 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.929 0.871 . . . . 73.02 108.827 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.5 p -65.03 -21.26 66.81 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.452 -1.249 . . . . 64.03 111.409 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.9 t -85.01 -21.72 29.34 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 116.008 -0.542 . . . . 70.22 110.613 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.6 t -68.99 113.39 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.541 -0.911 . . . . 73.23 108.541 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.8 m -101.38 9.97 41.02 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.321 0.489 . . . . 73.23 112.321 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -86.36 111.97 42.78 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.537 -0.912 . . . . 73.55 108.537 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -68.98 -18.91 40.5 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.61 2.207 . . . . 63.14 113.504 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -107.58 18.59 21.28 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.034 0.445 . . . . 75.34 111.236 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.02 140.37 29.81 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.42 -0.354 . . . . 75.52 111.863 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -133.06 139.67 47.29 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.492 -0.929 . . . . 72.44 108.492 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.77 113.89 44.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.126 -0.694 . . . . 75.23 109.126 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -113.29 120.13 40.11 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.21 0.529 . . . . 74.41 109.949 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 39.9 tp -112.18 120.6 42.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.306 -0.998 . . . . 74.52 108.306 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 31' ' ' SER . 17.4 m -120.89 112.62 19.01 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.566 -0.901 . . . . 51.15 108.566 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.49 120.77 61.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.508 -0.923 . . . . 73.43 108.508 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -105.73 126.92 52.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.523 -0.917 . . . . 63.12 108.523 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.438 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 0.3 OUTLIER -134.25 103.36 11.58 Favored Pre-proline 0 C--N 1.274 -2.697 0 CA-C-N 115.591 -0.731 . . . . 70.34 110.349 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.34 45.2 0.4 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 123.574 2.849 . . . . 74.53 112.277 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -118.53 -86.26 0.64 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.457 -0.571 . . . . 71.24 109.457 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.55 113.47 0.01 OUTLIER 'General case' 0 C--O 1.247 0.972 0 C-N-CA 123.72 0.808 . . . . 74.13 109.112 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.438 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 9.4 p -75.66 130.83 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.768 -1.197 . . . . 75.11 107.768 174.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.8 t -103.8 -28.71 11.46 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.296 -0.962 . . . . 73.04 110.852 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.7 m -159.28 132.96 7.33 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 107.406 -1.331 . . . . 74.24 107.406 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -139.75 162.14 35.85 Favored 'General case' 0 C--N 1.282 -2.331 0 O-C-N 122.104 -0.372 . . . . 74.55 110.414 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -130.04 90.55 2.98 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 104.927 -2.249 . . . . 64.11 104.927 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.35 -147.93 10.31 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 109.471 -1.452 . . . . 72.43 109.471 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -116.59 99.66 7.3 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 117.501 0.65 . . . . 65.11 109.481 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -72.58 131.89 43.06 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 121.287 0.565 . . . . 75.33 110.328 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.5 mm -96.07 -49.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 106.958 -1.497 . . . . 75.43 106.958 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -134.73 166.42 29.33 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 105.857 -1.905 . . . . 70.33 105.857 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.96 -2.39 11.44 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.309 2.006 . . . . 75.34 110.86 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.82 10.76 5.11 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.187 -0.915 . . . . 53.52 111.076 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.0 t -147.02 120.71 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.507 -0.923 . . . . 75.33 108.507 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.6 147.01 30.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.751 -0.833 . . . . 72.02 108.751 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 8.5 tt0 -132.92 142.44 48.9 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-O 121.595 0.712 . . . . 75.21 110.207 -174.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.444 ' CZ2' ' HB3' ' A' ' 174' ' ' ALA . 29.1 m-90 -123.63 116.02 22.42 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.095 -1.076 . . . . 72.35 108.095 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.401 ' HD3' ' H ' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -112.36 98.42 7.27 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.017 0.913 . . . . 72.34 109.478 -178.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.75 147.4 23.66 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.221 -1.354 . . . . 75.13 110.084 -171.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -117.11 150.19 45.66 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 115.587 -0.733 . . . . 74.4 112.105 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 168' ' ' VAL . 32.1 Cg_exo -66.06 157.48 59.32 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 123.318 2.679 . . . . 74.52 111.466 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.48 -27.26 2.51 Favored Glycine 0 C--N 1.313 -0.744 0 C-N-CA 121.54 -0.362 . . . . 33.34 112.899 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.419 ' H ' ' C ' ' A' ' 166' ' ' PRO . 35.3 m -105.85 167.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 120.723 0.297 . . . . 74.54 110.624 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.6 p -114.05 143.97 22.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.112 -0.699 . . . . 72.43 109.112 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 44.5 m -153.09 150.26 28.94 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 121.992 -0.443 . . . . 75.04 110.186 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 27.7 p -120.37 126.41 50.43 Favored 'General case' 0 N--CA 1.428 -1.557 0 C-N-CA 122.94 0.496 . . . . 73.42 110.0 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -98.14 121.39 40.01 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.591 -0.522 . . . . 72.04 109.591 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.3 m -137.98 138.44 38.91 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.865 -1.147 . . . . 74.51 111.369 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.444 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . . . -145.31 128.77 16.97 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 115.811 -0.631 . . . . 75.43 109.675 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -117.19 130.69 56.76 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 107.006 -1.479 . . . . 74.22 107.006 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -140.85 152.28 44.99 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.497 -0.557 . . . . 43.12 109.497 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -90.74 126.28 35.95 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.406 -0.961 . . . . 74.42 108.406 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.617 ' OH ' HG21 ' A' ' 34' ' ' ILE . 5.4 m-85 -126.26 126.7 44.44 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 113.059 0.763 . . . . 73.31 113.059 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 35.7 p -67.79 105.17 1.86 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.606 -1.179 . . . . 65.22 108.484 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.49 132.69 88.42 Favored Pre-proline 0 CA--C 1.506 -0.721 0 O-C-N 123.773 0.671 . . . . 73.52 110.114 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.02 -46.72 7.76 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.261 1.974 . . . . 74.34 113.673 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -84.9 -12.08 54.19 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.858 0.361 . . . . 74.42 110.522 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.272 60.1 p 72.64 47.47 0.24 Allowed 'General case' 0 C--O 1.254 1.296 0 C-N-CA 126.122 1.769 . . . . 74.32 112.685 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.49 150.93 39.63 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.161 -1.381 . . . . 73.42 109.183 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.27 -2.881 0 N-CA-C 107.527 -1.286 . . . . 75.02 107.527 -179.79 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.87 0 N-CA-C 111.324 -0.711 . . . . 53.42 111.324 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.32 101.52 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.863 0.331 . . . . 73.45 110.294 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.71 -48.9 7.87 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.213 -2.143 . . . . 74.25 105.213 171.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.3 m-20 37.8 76.07 0.06 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.491 1.916 . . . . 72.11 114.27 171.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 47.6 tp -80.42 104.01 10.67 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.666 -0.864 . . . . 70.22 108.666 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 18' ' ' ASN . 46.6 m-85 -90.22 150.46 21.96 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.757 -0.656 . . . . 71.4 111.779 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.449 ' CE2' ' HA ' ' A' ' 53' ' ' SER . 97.3 m-85 -131.08 135.38 47.47 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.907 -1.145 . . . . 64.42 107.907 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -150.65 163.3 38.87 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.202 0.314 . . . . 75.52 110.347 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.98 136.94 2.17 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 110.216 -1.153 . . . . 62.31 110.216 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -98.35 -22.85 15.88 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.509 0.929 . . . . 75.45 113.509 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 134' ' ' ASP . 26.3 ptm -148.61 175.89 10.8 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.552 -0.859 . . . . 72.54 111.857 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -131.66 146.08 52.0 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.102 -1.073 . . . . 74.4 108.102 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 50.0 mtm105 -139.37 138.19 36.38 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 122.507 0.323 . . . . 74.33 110.244 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.58 114.71 39.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.495 0.664 . . . . 74.13 109.559 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -123.8 119.08 28.68 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.413 0.625 . . . . 74.32 110.706 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.38 108.87 19.57 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.295 -1.002 . . . . 65.42 108.295 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 p -117.52 115.89 26.03 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.32 -0.622 . . . . 73.12 109.32 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.72 146.91 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.518 -0.549 . . . . 63.13 109.518 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.1 m -123.78 130.63 52.93 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 109.094 -0.706 . . . . 54.14 109.094 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -112.94 120.27 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 121.679 0.752 . . . . 62.23 110.553 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -92.74 158.29 38.29 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 115.054 -0.975 . . . . 55.13 110.438 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HB3' ' OG1' ' A' ' 179' ' ' THR . 25.1 Cg_exo -65.53 2.39 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.997 3.131 . . . . 75.12 113.614 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 31.7 t70 -89.85 -0.32 57.49 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.973 -0.751 . . . . 71.12 108.973 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 22.0 t70 70.79 29.19 3.22 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 105.51 -2.033 . . . . 74.42 105.51 -174.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 7.0 tp -101.69 125.02 48.27 Favored 'General case' 1 N--CA 1.379 -4.023 0 CA-C-N 112.175 -2.284 . . . . 74.12 108.472 -177.247 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.6 t -115.47 130.64 69.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.629 -0.878 . . . . 73.13 108.629 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 p -145.23 151.81 38.97 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.033 -0.729 . . . . 75.23 109.033 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.51 -164.7 36.45 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 118.971 -1.585 . . . . 74.05 112.965 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.05 133.97 15.84 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.247 0.546 . . . . 71.24 110.571 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 68.0 mt -114.27 115.84 50.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.885 -1.154 . . . . 72.43 107.885 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -109.95 116.71 52.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 109.762 -0.458 . . . . 63.34 109.762 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.481 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -112.89 108.47 17.43 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.909 -1.515 . . . . 73.24 106.909 174.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -123.35 125.36 44.86 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.236 0.541 . . . . 72.4 111.672 -174.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.86 159.92 32.5 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.441 -0.8 . . . . 64.21 109.165 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 139.29 80.41 Favored Pre-proline 0 C--N 1.302 -1.494 0 C-N-CA 119.144 -1.022 . . . . 74.34 110.36 176.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -47.83 132.72 21.98 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 124.435 3.423 . . . . 73.23 114.481 -174.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -86.03 -56.64 3.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.793 -0.64 . . . . 75.32 110.462 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -127.53 -176.52 3.78 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.014 -0.539 . . . . 74.3 110.575 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.449 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 15.7 m -74.06 -32.26 63.22 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.069 0.461 . . . . 64.41 110.848 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -74.45 -20.23 60.1 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 121.797 0.808 . . . . 74.22 109.703 177.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -81.49 96.17 7.33 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.089 -1.414 . . . . 71.33 110.955 -168.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.3 p -109.06 -1.33 18.94 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.001 -1.454 . . . . 75.1 109.103 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.77 99.5 0.12 Allowed Glycine 0 N--CA 1.416 -2.639 0 CA-C-O 118.289 -1.284 . . . . 63.33 111.725 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.05 127.75 26.98 Favored 'Trans proline' 0 C--N 1.355 0.88 0 CA-C-N 120.044 1.922 . . . . 71.44 107.5 170.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.1 151.52 22.47 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 113.573 0.953 . . . . 72.2 113.573 -166.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.483 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 96.1 mt -94.35 150.48 20.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.047 -0.979 . . . . 72.32 109.301 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -107.07 93.68 4.69 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.389 -0.967 . . . . 73.42 108.389 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.38 120.01 5.87 Favored Glycine 0 N--CA 1.42 -2.39 0 CA-C-N 114.442 -1.254 . . . . 64.13 111.219 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -136.68 111.47 8.78 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.918 -0.771 . . . . 63.41 108.918 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.15 166.88 14.55 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.173 -1.047 . . . . 74.2 108.173 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -66.98 -32.67 34.55 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 121.406 1.404 . . . . 72.53 110.586 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -97.13 39.2 1.19 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.257 -0.883 . . . . 71.53 112.825 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.8 m -55.14 -27.8 48.09 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 112.784 0.661 . . . . 74.54 112.784 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -73.02 -7.89 53.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.217 0.532 . . . . 73.35 111.232 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.5 -13.13 18.8 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.117 -0.492 . . . . 75.3 110.383 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.2 p -125.31 119.99 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.882 0.849 . . . . 64.45 111.663 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.98 112.08 24.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.774 -0.825 . . . . 73.42 108.774 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.35 127.76 50.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.083 -1.081 . . . . 75.41 108.083 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 m -140.01 172.78 12.27 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.534 -0.543 . . . . 74.44 109.534 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -86.03 149.24 25.31 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.064 -0.654 . . . . 72.12 109.539 174.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 79.6 t80 -101.93 120.56 40.59 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.571 -1.64 . . . . 74.43 106.571 174.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -138.49 99.13 3.75 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 108.423 -0.954 . . . . 72.4 108.423 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.3 t -174.07 153.48 2.08 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.869 -1.16 . . . . 71.3 107.869 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 66.89 15.14 10.07 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.915 0.886 . . . . 73.34 112.166 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.38 -8.25 80.25 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.575 -0.61 . . . . 64.53 111.575 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.439 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 47.9 m-85 -93.05 153.22 18.83 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.419 -0.586 . . . . 65.21 109.419 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 31.0 m -134.81 136.31 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.064 -1.088 . . . . 75.31 108.064 171.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.8 -153.85 8.86 Favored Glycine 0 C--N 1.259 -3.75 0 N-CA-C 110.505 -1.038 . . . . 73.14 110.505 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.483 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.1 p -126.43 146.76 49.96 Favored 'General case' 0 C--N 1.264 -3.141 0 CA-C-O 121.317 0.58 . . . . 64.54 111.518 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 4.4 pt20 -136.97 127.78 27.3 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.97 -0.559 . . . . 64.01 110.496 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.42 115.25 29.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.287 -1.005 . . . . 75.32 108.287 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.68 117.77 54.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.057 -1.09 . . . . 74.44 108.057 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.438 ' CD2' HD12 ' A' ' 90' ' ' LEU . 50.7 p90 -124.29 154.77 39.75 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 120.803 0.335 . . . . 72.53 110.236 -175.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.5 m -157.56 159.73 37.44 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 116.234 -0.439 . . . . 64.22 110.222 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 67.14 31.13 6.95 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.505 1.145 . . . . 71.44 110.486 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.438 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.0 mt -96.24 160.44 14.43 Favored 'General case' 0 N--CA 1.428 -1.54 0 O-C-N 121.627 -0.671 . . . . 73.52 111.304 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 m -104.78 166.53 10.32 Favored 'General case' 0 N--CA 1.401 -2.912 0 N-CA-C 109.391 -0.596 . . . . 73.23 109.391 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.482 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 60.8 t80 -50.66 -48.62 58.31 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.228 1.011 . . . . 74.24 110.674 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.07 -24.66 67.24 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.268 -0.878 . . . . 64.34 112.245 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -87.66 -16.93 33.03 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 116.272 -0.422 . . . . 73.53 111.754 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.3 tt -61.89 -52.36 68.8 Favored Pre-proline 0 CA--C 1.559 1.294 0 O-C-N 123.254 0.346 . . . . 73.21 111.228 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -65.72 -32.98 45.95 Favored 'Trans proline' 0 C--N 1.369 1.654 0 CA-C-N 120.794 1.319 . . . . 73.21 110.63 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.63 -36.06 83.04 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.642 -0.708 . . . . 72.34 110.977 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -77.59 -19.84 54.95 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.871 -0.418 . . . . 72.25 109.871 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.78 -24.24 61.71 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.97 -0.559 . . . . 74.32 110.25 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -56.18 -49.75 73.14 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 109.561 -0.533 . . . . 74.41 109.561 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.5 mtm -54.37 -51.46 64.71 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.232 0.539 . . . . 74.45 110.161 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -56.58 -34.93 67.65 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.992 -1.004 . . . . 74.35 111.598 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.3 m -62.09 -30.21 70.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.269 -0.423 . . . . 54.52 110.243 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.18 -31.57 70.25 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 123.926 0.767 . . . . 73.03 110.674 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.09 -11.89 15.53 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 116.233 -0.44 . . . . 74.13 111.38 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.69 -47.86 3.65 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.646 0.98 . . . . 72.45 113.646 -172.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.07 25.81 33.11 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.814 -0.708 . . . . 72.42 111.784 -174.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 m -109.27 155.41 10.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 122.486 -0.42 . . . . 74.15 111.7 -175.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -124.28 124.79 43.17 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.088 0.555 . . . . 72.44 109.555 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.8 mp -117.56 143.66 45.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.124 0.488 . . . . 74.11 111.056 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.1 m -129.74 109.57 11.06 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.065 -0.717 . . . . 74.31 109.065 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.566 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 61.0 tp -119.87 123.84 44.59 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.526 -0.306 . . . . 74.32 110.646 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.566 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 2.8 mpt_? -137.47 147.94 45.69 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.783 0.433 . . . . 74.31 110.194 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -102.0 137.54 40.15 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 107.101 -1.444 . . . . 75.22 107.101 175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -128.47 90.0 2.99 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.664 -0.865 . . . . 71.33 108.664 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.79 -113.22 4.89 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.052 -0.976 . . . . 75.32 110.874 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.29 -13.67 21.82 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.843 0.83 . . . . 75.24 109.07 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.4 pp -103.59 149.86 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 C-N-CA 119.69 -0.804 . . . . 74.0 110.009 -176.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.548 HG22 ' CD2' ' A' ' 178' ' ' TYR . 92.7 t -118.31 138.68 48.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 O-C-N 121.911 -0.493 . . . . 72.21 110.141 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.0 pt -120.05 129.43 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 122.101 0.953 . . . . 65.14 109.802 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.2 136.25 49.89 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 114.907 -1.042 . . . . 75.3 108.56 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -143.28 166.15 25.52 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 108.835 -0.802 . . . . 65.42 108.835 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.84 158.98 30.96 Favored Glycine 0 N--CA 1.405 -3.415 0 N-CA-C 109.72 -1.352 . . . . 71.0 109.72 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -134.31 125.23 27.23 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.234 -1.765 . . . . 75.53 106.234 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.15 117.51 16.63 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 120.996 0.427 . . . . 74.23 111.618 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 169' ' ' VAL . 0.0 OUTLIER -108.85 134.02 52.1 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 105.154 -2.165 . . . . 71.14 105.154 170.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.9 mm? -117.85 32.38 6.18 Favored 'General case' 0 C--N 1.267 -2.99 0 N-CA-C 108.754 -0.832 . . . . 74.41 108.754 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.7 p -73.01 -23.87 60.67 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.965 -0.561 . . . . 71.45 110.487 -176.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.3 m -74.76 -12.34 60.38 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 116.051 -0.522 . . . . 62.3 111.249 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -77.41 110.82 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.138 -1.43 . . . . 75.4 107.138 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.4 t -88.45 29.5 0.98 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.116 -0.493 . . . . 73.1 111.064 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -135.1 120.02 13.77 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 109.808 -0.442 . . . . 51.21 109.808 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.86 -20.77 16.89 Favored 'Trans proline' 0 C--O 1.22 -0.419 0 C-N-CA 122.514 2.143 . . . . 74.23 112.175 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 25' ' ' MET . 7.0 m-20 -88.27 18.89 4.06 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.159 0.504 . . . . 71.34 111.283 -176.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.0 143.91 28.08 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.137 -0.69 . . . . 60.02 109.137 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -132.11 130.52 41.29 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.276 -1.009 . . . . 75.44 108.276 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.1 t -113.54 126.11 70.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.863 -0.421 . . . . 64.43 109.863 -175.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.35 121.99 30.45 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.866 0.365 . . . . 65.43 111.356 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.484 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -111.22 121.54 45.54 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.885 -1.894 . . . . 74.01 105.885 174.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.3 m -126.6 130.96 51.52 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.243 -0.28 . . . . 44.22 110.243 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 99.4 t -123.86 126.12 72.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 109.036 -0.728 . . . . 74.4 109.036 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.84 127.57 56.21 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.324 -0.621 . . . . 74.41 109.324 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.583 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.8 p90 -134.38 123.68 16.68 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 116.362 -0.381 . . . . 75.53 111.789 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -68.27 41.07 0.24 Allowed 'Trans proline' 0 CA--C 1.557 1.635 0 C-N-CA 123.447 2.765 . . . . 64.41 113.795 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.49 -100.44 0.39 Allowed 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.985 -0.447 . . . . 73.54 110.807 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 178.92 130.75 0.08 Allowed 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.745 -0.835 . . . . 53.52 108.745 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.7 133.03 30.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.049 -0.723 . . . . 75.4 109.049 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.2 p -94.03 -43.3 8.58 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-O 121.225 0.536 . . . . 74.42 109.701 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 17.0 m -150.04 131.32 14.59 Favored 'General case' 0 C--O 1.212 -0.904 0 N-CA-C 108.407 -0.961 . . . . 71.22 108.407 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -140.91 152.32 44.94 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.39 -0.524 . . . . 73.34 111.241 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -119.5 90.97 3.44 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.162 -2.162 . . . . 62.33 105.162 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.62 -159.26 28.97 Favored Glycine 0 N--CA 1.416 -2.672 0 N-CA-C 107.345 -2.302 . . . . 74.13 107.345 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.12 102.84 11.01 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 117.846 0.823 . . . . 73.44 109.542 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -76.28 122.01 23.79 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-O 121.218 0.532 . . . . 74.13 109.877 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.16 -41.06 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 106.989 -1.486 . . . . 64.23 106.989 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -136.08 166.29 29.24 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.118 -1.401 . . . . 74.43 107.245 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.12 -4.75 15.53 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 122.351 2.034 . . . . 75.31 110.721 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.6 pt-20 -128.27 6.2 5.84 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.613 -0.722 . . . . 70.54 111.36 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.5 t -141.66 120.57 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.256 -1.016 . . . . 75.34 108.256 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 50.1 t -123.53 145.53 30.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.772 -0.455 . . . . 75.34 109.772 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -136.09 142.72 44.34 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.362 0.601 . . . . 73.35 110.202 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.484 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.6 m-90 -118.7 113.35 21.04 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.432 -0.804 . . . . 71.1 109.106 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -95.23 99.07 11.08 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 122.316 1.055 . . . . 74.34 108.716 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 61.1 mt -97.68 147.48 24.3 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 113.676 -1.602 . . . . 75.34 109.428 -173.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -117.63 146.44 38.67 Favored Pre-proline 0 C--N 1.295 -1.766 0 CA-C-N 115.637 -0.711 . . . . 73.41 112.302 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.442 ' HA ' ' CB ' ' A' ' 127' ' ' LEU . 71.8 Cg_endo -71.54 160.02 49.59 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.573 2.182 . . . . 72.02 110.341 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.34 -26.87 2.15 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 121.096 -0.573 . . . . 73.43 113.22 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.7 170.1 3.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.008 0.432 . . . . 75.03 112.082 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 126' ' ' ASP . 8.3 p -114.07 142.94 24.92 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 CA-C-N 115.812 -0.631 . . . . 74.41 109.87 176.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.5 p -149.75 140.57 22.74 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.048 0.451 . . . . 72.22 111.975 -176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.8 p -96.67 138.11 34.73 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.201 -0.666 . . . . 70.42 109.201 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 22.4 ptm -118.63 133.1 56.11 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.944 -1.132 . . . . 75.3 107.944 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -143.55 147.93 35.19 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.613 -0.835 . . . . 74.22 111.398 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.435 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -154.89 130.29 9.75 Favored 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 123.05 0.54 . . . . 74.13 109.862 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -132.54 131.83 41.97 Favored 'General case' 0 C--N 1.264 -3.147 0 N-CA-C 106.753 -1.573 . . . . 73.04 106.753 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.18 149.83 23.3 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.832 -1.173 . . . . 63.14 107.832 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 0.8 OUTLIER -95.52 138.86 32.6 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.447 -1.686 . . . . 70.42 106.447 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.548 ' CD2' HG22 ' A' ' 119' ' ' VAL . 22.4 m-30 -121.17 151.78 39.53 Favored 'General case' 0 CA--C 1.483 -1.611 0 C-N-CA 119.926 -0.71 . . . . 74.44 109.331 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -76.81 86.03 3.4 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-O 121.462 0.648 . . . . 74.3 110.097 175.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -56.51 134.86 77.12 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.451 -1.249 . . . . 74.42 110.815 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.64 -27.82 21.81 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.091 1.861 . . . . 72.32 112.969 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -84.12 -21.1 31.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.917 -1.142 . . . . 75.53 107.917 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.344 69.7 p 68.54 49.73 0.74 Allowed 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 126.99 2.116 . . . . 75.43 112.567 -175.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -70.88 150.65 45.55 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.933 -1.485 . . . . 75.23 108.102 173.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 C--N 1.298 -1.645 0 N-CA-C 106.96 -1.496 . . . . 72.25 106.96 -177.462 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.818 0 N-CA-C 110.807 -0.917 . . . . 73.14 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.81 98.84 6.46 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.771 -1.196 . . . . 75.53 107.771 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.498 ' HG2' ' H ' ' A' ' 18' ' ' ASN . 30.6 tt0 61.0 -175.37 0.12 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.462 1.105 . . . . 65.14 110.247 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.498 ' H ' ' HG2' ' A' ' 17' ' ' GLU . 83.3 m-20 -121.42 122.1 39.04 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.662 -1.607 . . . . 72.34 106.662 176.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.64 76.74 5.71 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.967 -0.753 . . . . 74.33 108.967 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.6 t80 75.58 157.5 0.19 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.935 1.694 . . . . 71.13 109.728 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 69.28 95.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.914 1.079 . . . . 73.55 113.914 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -90.37 89.33 7.56 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.234 -1.395 . . . . 75.43 107.234 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.34 153.86 18.24 Favored Glycine 0 CA--C 1.48 -2.109 0 N-CA-C 110.189 -1.164 . . . . 73.12 110.189 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 27' ' ' ARG . 56.9 m80 71.75 33.14 1.81 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.243 1.017 . . . . 75.04 109.106 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.83 100.32 11.24 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 112.813 0.671 . . . . 75.12 112.813 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 48' ' ' ALA . 6.7 tt 75.38 100.19 0.07 Allowed 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.232 -1.349 . . . . 74.04 112.876 173.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 24' ' ' HIS . 3.1 mpt_? -131.72 127.99 37.99 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.102 -0.954 . . . . 74.02 108.913 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.32 117.76 56.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.45 -0.944 . . . . 71.33 108.45 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -123.05 114.06 19.87 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.342 0.591 . . . . 72.33 109.457 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.29 126.76 55.6 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.583 -0.895 . . . . 75.31 108.583 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.9 t -131.64 114.79 15.24 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.046 -1.464 . . . . 73.33 107.046 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.63 146.62 29.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.367 -0.605 . . . . 44.32 109.367 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.5 m -126.8 125.21 41.32 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.258 0.551 . . . . 75.13 109.854 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 tt -113.39 110.35 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-O 121.851 0.834 . . . . 72.33 110.097 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -76.99 158.55 80.06 Favored Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 114.761 -1.109 . . . . 75.12 109.747 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.5 0.81 2.55 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 123.363 2.709 . . . . 62.11 112.999 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -88.89 2.33 53.92 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 124.066 0.947 . . . . 73.4 110.156 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 t70 67.89 29.44 6.61 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 123.55 1.643 . . . . 74.43 106.872 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.36 124.77 50.88 Favored 'General case' 0 N--CA 1.382 -3.841 0 CA-C-N 113.904 -1.498 . . . . 71.14 107.297 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.78 136.29 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 108.471 -0.937 . . . . 72.41 108.471 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.8 p -144.13 154.93 43.68 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 105.966 -1.865 . . . . 62.21 105.966 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.25 -172.04 44.26 Favored Glycine 0 CA--C 1.49 -1.524 0 C-N-CA 117.913 -2.089 . . . . 64.33 113.725 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.43 134.22 28.75 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.438 0.695 . . . . 75.01 110.041 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 60.0 mt -120.75 115.7 47.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.018 -1.475 . . . . 74.44 107.018 174.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.2 114.61 46.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 120.935 0.398 . . . . 75.32 109.954 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.01 108.3 18.48 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.277 -1.749 . . . . 65.33 106.277 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . . . -121.34 125.66 47.55 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 120.246 -0.582 . . . . 74.31 111.257 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . . . -111.64 155.73 22.93 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.934 -0.765 . . . . 64.13 108.934 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -91.68 120.51 68.08 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 104.983 -2.229 . . . . 73.52 104.983 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -31.18 106.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 125.069 3.846 . . . . 70.44 114.302 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.21 -44.27 6.31 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.877 -0.601 . . . . 74.25 110.767 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.483 ' HB2' ' CG ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER -87.12 158.14 19.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.838 -1.171 . . . . 74.54 107.838 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 m -75.02 -20.75 59.48 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.444 0.64 . . . . 75.22 109.401 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -81.99 -14.82 55.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.353 -0.839 . . . . 74.23 109.399 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.483 ' CG ' ' HB2' ' A' ' 52' ' ' ASN . 85.7 m-20 -69.45 96.76 0.92 Allowed 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.766 0.793 . . . . 71.4 112.607 -170.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -113.34 -26.76 8.21 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.311 -1.313 . . . . 74.44 108.723 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.91 98.18 0.11 Allowed Glycine 0 N--CA 1.414 -2.787 0 CA-C-N 114.824 -1.08 . . . . 65.34 112.54 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.74 159.09 53.81 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 122.673 2.248 . . . . 71.43 111.579 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.95 155.25 41.65 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.079 -0.341 . . . . 71.01 110.079 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.552 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 94.3 mt -101.15 153.47 19.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.159 -0.682 . . . . 71.22 109.159 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.92 88.07 5.6 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.878 -1.527 . . . . 74.34 106.878 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.86 50.66 0.78 Allowed Glycine 0 N--CA 1.414 -2.792 0 CA-C-N 115.077 -0.965 . . . . 75.01 112.89 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -91.6 95.46 9.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.251 -1.018 . . . . 71.15 108.251 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 m -122.37 162.21 39.16 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 114.15 -1.386 . . . . 64.53 107.609 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.86 -19.61 32.37 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.673 2.249 . . . . 71.32 112.831 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -112.52 29.58 7.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.417 -0.356 . . . . 70.32 111.659 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.9 m -56.48 -27.82 58.13 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.497 0.554 . . . . 74.24 112.497 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -70.15 -10.78 59.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.394 0.616 . . . . 73.33 110.752 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 88' ' ' SER . 68.0 mmtt -106.68 -9.83 16.36 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 116.18 -0.464 . . . . 75.44 111.486 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.74 118.27 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 119.382 -0.927 . . . . 75.13 111.102 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.76 103.4 15.31 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 115.051 -0.977 . . . . 71.25 108.794 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.3 134.79 35.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.161 -1.052 . . . . 71.41 108.161 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.0 m -149.46 171.56 16.38 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 120.847 0.356 . . . . 75.01 111.047 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -76.85 132.09 38.97 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.125 -0.943 . . . . 73.21 109.089 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 74.0 t80 -102.62 119.92 39.66 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.287 -1.375 . . . . 75.13 107.287 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -137.6 99.61 3.99 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.513 -0.921 . . . . 74.41 108.513 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.0 t -168.42 149.1 4.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.38 -0.971 . . . . 73.15 108.38 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 69.85 13.75 8.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.979 0.911 . . . . 71.22 112.167 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.76 1.48 67.95 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.764 -0.653 . . . . 53.23 111.692 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 59.4 m-85 -102.79 151.07 22.84 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 122.506 0.322 . . . . 71.43 110.28 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 29.4 m -129.3 136.23 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 107.342 -1.355 . . . . 72.23 107.342 168.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.1 -154.95 10.51 Favored Glycine 0 C--N 1.272 -2.977 0 C-N-CA 119.965 -1.112 . . . . 41.14 111.019 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.552 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 13.0 m -126.69 145.12 50.7 Favored 'General case' 0 C--N 1.27 -2.863 0 CA-C-O 121.185 0.517 . . . . 51.03 110.39 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -131.17 138.8 49.59 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.957 -0.565 . . . . 74.13 109.919 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.14 114.63 22.76 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.502 -1.296 . . . . 61.55 107.502 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.6 t -112.44 113.4 44.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.206 -1.035 . . . . 74.42 108.206 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CD2' HD11 ' A' ' 90' ' ' LEU . 44.3 p90 -114.27 159.55 20.04 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.008 0.433 . . . . 74.01 111.858 -173.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 6.1 p -156.68 155.18 31.29 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.256 -0.884 . . . . 73.32 110.13 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 67.03 30.01 7.69 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 124.629 1.172 . . . . 70.31 111.945 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.452 HD11 ' CD2' ' A' ' 87' ' ' PHE . 39.2 mt -97.27 165.99 11.77 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 119.387 -0.925 . . . . 72.33 110.114 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.45 HG23 ' OE1' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -125.3 178.93 5.32 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.905 -1.146 . . . . 75.42 107.905 -178.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -47.54 -35.63 9.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.851 1.26 . . . . 64.52 112.452 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.1 -25.72 60.98 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.9 0.704 . . . . 75.24 112.9 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.45 ' OE1' HG23 ' A' ' 91' ' ' THR . 14.6 mp0 -91.74 -16.97 26.1 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.797 -0.761 . . . . 74.32 112.749 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.3 tt -58.51 -50.65 86.88 Favored Pre-proline 0 CA--C 1.569 1.677 0 O-C-N 123.241 0.338 . . . . 75.32 111.456 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -68.81 -30.83 26.43 Favored 'Trans proline' 0 C--N 1.365 1.408 0 CA-C-N 120.731 1.297 . . . . 74.13 111.281 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -67.88 -33.13 74.14 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 123.534 0.734 . . . . 74.04 111.121 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.6 pp -75.54 -19.23 59.46 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.988 0.423 . . . . 71.12 110.256 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -71.63 -18.29 62.21 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.933 -0.576 . . . . 73.23 109.977 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.23 -57.24 10.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.9 -0.591 . . . . 74.23 109.85 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 14.8 ttm -54.38 -52.7 60.83 Favored 'General case' 0 C--O 1.271 2.189 0 CA-C-O 122.518 1.152 . . . . 74.34 108.428 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 6.3 t30 -52.84 -27.04 16.49 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 112.435 -2.166 . . . . 64.25 112.805 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -54.47 -45.89 73.25 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.886 -0.326 . . . . 74.31 110.557 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -69.47 -11.84 61.16 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.307 0.855 . . . . 72.51 113.307 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.38 -27.62 11.36 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.098 0.475 . . . . 73.42 110.359 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.11 -47.68 3.63 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 113.314 0.857 . . . . 72.43 113.314 -170.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.26 21.53 51.65 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.667 -0.973 . . . . 61.43 110.667 -172.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.6 m -118.97 155.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 122.306 -0.526 . . . . 74.4 110.617 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -125.71 141.4 52.03 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.91 -1.145 . . . . 74.23 107.91 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.0 mt -129.27 119.55 24.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.915 -0.772 . . . . 75.21 108.915 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -118.94 135.74 54.43 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.03 -1.1 . . . . 74.51 108.03 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.33 157.81 43.82 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 112.631 0.604 . . . . 73.22 112.631 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -145.67 150.87 37.1 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.844 -1.071 . . . . 73.11 111.267 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.529 ' NH2' ' HA ' ' A' ' 180' ' ' ASP . 3.9 tpt180 -96.49 106.56 18.83 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 106.401 -1.703 . . . . 74.34 106.401 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -96.8 89.23 4.83 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 108.097 -1.075 . . . . 65.34 108.097 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.13 -96.86 0.9 Allowed Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.086 -1.205 . . . . 65.34 110.086 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -124.42 -2.42 8.0 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.672 1.225 . . . . 71.03 109.33 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.62 148.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 O-C-N 121.087 -1.008 . . . . 73.24 108.703 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.419 HG23 ' HD3' ' A' ' 114' ' ' ARG . 96.8 t -102.89 131.77 50.44 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 O-C-N 122.06 -0.4 . . . . 72.3 110.32 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.4 pt -107.56 130.98 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 N-CA-C 106.784 -1.562 . . . . 72.54 106.784 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 tt -127.93 131.42 49.34 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 115.869 -0.605 . . . . 63.34 109.467 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -132.19 115.47 15.75 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.602 -0.888 . . . . 75.1 108.602 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -118.03 157.88 14.96 Favored Glycine 0 C--N 1.281 -2.503 0 N-CA-C 109.99 -1.244 . . . . 62.31 109.99 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -139.53 127.54 22.28 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 117.542 0.671 . . . . 75.31 110.208 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -113.58 109.98 19.5 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.401 -0.592 . . . . 64.42 109.401 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -109.68 97.76 7.24 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.439 -0.948 . . . . 71.1 108.439 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.82 28.57 8.46 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.557 -0.905 . . . . 72.14 108.557 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 69.4 p -66.32 -27.7 68.11 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.883 -0.599 . . . . 75.3 112.599 -175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.8 m -72.48 -12.07 60.93 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 111.89 0.33 . . . . 74.12 111.89 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.0 t 68.0 102.98 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.773 1.229 . . . . 72.45 113.188 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 t -68.45 -47.51 66.97 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.527 -1.286 . . . . 73.34 107.527 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -170.15 140.42 1.61 Allowed Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.013 -1.476 . . . . 73.41 107.013 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.69 -20.06 56.42 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 122.863 2.375 . . . . 75.14 115.03 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -94.54 2.86 55.67 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.071 0.939 . . . . 75.23 110.594 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -79.53 141.26 36.83 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.276 -0.875 . . . . 74.23 111.7 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -131.48 136.64 48.09 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 108.527 -0.916 . . . . 75.54 108.527 177.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.8 t -127.57 118.48 49.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.292 -0.633 . . . . 73.44 109.292 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -109.37 123.55 49.51 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.603 -0.517 . . . . 74.34 109.603 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -110.94 111.83 23.23 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.949 -1.5 . . . . 64.32 106.949 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.6 m -117.9 133.62 55.74 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.858 0.463 . . . . 65.35 110.45 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.83 123.62 63.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.89 -0.781 . . . . 71.21 108.89 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.51 127.49 56.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.107 -0.701 . . . . 64.4 109.107 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.52 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.43 118.47 13.74 Favored Pre-proline 0 C--N 1.286 -2.179 0 CA-C-N 116.529 -0.305 . . . . 64.13 111.477 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.94 40.46 0.36 Allowed 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 122.993 2.462 . . . . 72.31 111.935 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -117.53 -94.09 0.5 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-O 119.288 -0.387 . . . . 64.34 110.224 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 174.03 120.77 0.02 OUTLIER 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.3 0.64 . . . . 64.11 109.873 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.458 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 7.4 p -84.03 126.22 40.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.814 -0.81 . . . . 72.23 108.814 174.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.6 t -95.35 -33.46 12.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 119.775 -0.77 . . . . 74.14 110.647 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.8 m -154.48 132.37 11.58 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 108.399 -0.963 . . . . 74.45 108.399 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 t -140.53 157.85 44.88 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 110.246 -0.279 . . . . 65.03 110.246 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.529 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 26.9 t-20 -126.95 97.89 5.13 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.193 -2.151 . . . . 73.43 105.193 170.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.19 -147.43 11.11 Favored Glycine 0 N--CA 1.417 -2.601 0 N-CA-C 108.238 -1.945 . . . . 62.31 108.238 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -114.89 99.78 7.73 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 117.835 0.817 . . . . 73.12 109.476 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -80.09 113.95 18.64 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-O 121.482 0.658 . . . . 74.43 109.66 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.15 -35.52 15.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 107.454 -1.313 . . . . 73.33 107.454 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -143.46 166.5 19.54 Favored Pre-proline 0 N--CA 1.431 -1.389 0 N-CA-C 107.446 -1.316 . . . . 73.44 107.446 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -72.59 -0.05 8.26 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.342 2.028 . . . . 64.34 111.279 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 11.5 pt-20 -129.83 5.88 5.05 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.729 -0.668 . . . . 74.22 110.864 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 90.6 t -144.81 121.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.44 -0.578 . . . . 71.54 109.44 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.17 145.55 33.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 109.183 -0.673 . . . . 74.13 109.183 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -134.93 146.34 49.05 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.817 -0.808 . . . . 72.33 108.817 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 29.6 m-90 -121.95 122.35 39.16 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.295 -1.002 . . . . 73.04 108.295 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -88.07 109.5 19.91 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.173 -1.047 . . . . 75.3 108.173 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 30.9 mt -102.07 125.1 48.68 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 121.486 0.66 . . . . 75.45 110.271 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 5.4 mmpt? -118.03 150.23 47.0 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 114.903 -1.044 . . . . 64.23 110.553 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -72.07 159.46 50.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.134 1.889 . . . . 75.42 110.775 173.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.97 -35.63 2.91 Favored Glycine 0 C--N 1.312 -0.785 0 N-CA-C 111.7 -0.56 . . . . 72.33 111.7 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.28 155.06 6.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.438 -0.381 . . . . 64.04 110.139 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.6 p -113.09 116.03 51.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.055 -0.721 . . . . 71.45 109.055 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.1 m -116.3 144.47 44.2 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.01 -0.737 . . . . 74.43 109.01 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 45.0 p -115.6 152.18 33.57 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-O 121.015 0.436 . . . . 74.44 110.762 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -102.3 116.79 33.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.48 -1.304 . . . . 74.41 107.48 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 18.0 t -120.27 130.2 54.38 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 107.231 -1.396 . . . . 75.42 107.231 173.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -152.53 132.14 13.08 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 109.344 -0.613 . . . . 75.31 109.344 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -133.1 129.75 38.38 Favored 'General case' 0 C--N 1.268 -2.938 0 N-CA-C 107.511 -1.292 . . . . 75.24 107.511 174.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -150.59 155.28 39.12 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.955 -0.566 . . . . 74.51 110.097 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -87.76 125.31 34.35 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.912 -1.144 . . . . 72.23 107.912 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -132.03 123.31 27.01 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 108.986 -0.746 . . . . 71.02 108.986 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.41 113.99 2.96 Favored 'General case' 0 C--N 1.276 -2.621 0 O-C-N 124.085 0.865 . . . . 75.4 110.913 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' HA ' ' NH2' ' A' ' 114' ' ' ARG . 1.8 m-20 -54.51 146.16 35.24 Favored Pre-proline 0 C--O 1.212 -0.886 0 CA-C-N 114.953 -1.021 . . . . 73.33 110.341 176.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.21 -33.36 90.45 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 122.935 2.423 . . . . 72.34 111.401 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.558 ' ND2' ' HG2' ' A' ' 184' ' ' ARG . 0.2 OUTLIER -83.61 -10.39 58.27 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.743 -1.117 . . . . 75.34 111.458 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.462 ' N ' HD21 ' A' ' 182' ' ' ASN . 51.9 p 49.84 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.608 1.563 . . . . 72.13 114.029 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.558 ' HG2' ' ND2' ' A' ' 182' ' ' ASN . 26.6 mmt180 -121.6 149.97 42.37 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 116.006 -0.543 . . . . 75.51 111.213 -176.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 107.512 -1.292 . . . . 75.4 107.512 176.445 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.146 0 N-CA-C 110.689 -0.964 . . . . 43.05 110.689 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -81.67 100.08 9.26 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.189 -1.412 . . . . 73.11 107.189 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -138.91 111.82 7.84 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 113.211 0.819 . . . . 74.5 113.211 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -168.44 157.59 9.06 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 104.499 -2.408 . . . . 73.31 104.499 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.16 -70.85 0.16 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.727 -0.842 . . . . 73.35 108.727 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.9 t80 66.34 111.65 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.33 1.052 . . . . 75.53 110.833 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -144.44 157.06 44.43 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.069 -0.394 . . . . 71.12 110.896 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 74.58 133.28 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.477 1.511 . . . . 65.14 112.656 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.52 -12.56 1.2 Allowed Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.669 -0.777 . . . . 70.13 112.22 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 69.44 -73.11 0.09 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.564 1.546 . . . . 75.34 107.805 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.539 ' HG3' ' OD2' ' A' ' 134' ' ' ASP . 35.6 mtt -105.69 87.69 2.65 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 109.042 -0.725 . . . . 72.15 109.042 172.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 pp -104.82 122.46 45.79 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 107.856 -1.164 . . . . 74.32 107.856 173.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 55.1 mtm180 -114.0 124.29 51.78 Favored 'General case' 0 C--N 1.269 -2.916 0 N-CA-C 109.22 -0.659 . . . . 74.05 109.22 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.94 114.14 44.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.057 -1.46 . . . . 74.2 107.057 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -114.54 113.29 24.22 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.633 -0.877 . . . . 74.45 108.633 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -106.93 107.74 18.91 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.238 -1.393 . . . . 74.44 107.238 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 140' ' ' THR . 22.5 m -119.08 115.36 24.13 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 109.224 -0.658 . . . . 62.15 109.224 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 2.1 pp -123.41 146.47 28.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 120.39 -0.524 . . . . 75.11 110.238 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 31.5 m -123.52 121.02 34.59 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 108.468 -0.938 . . . . 63.43 108.468 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -116.06 118.63 59.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.91 0.862 . . . . 74.0 111.313 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 37' ' ' ASP . 17.9 m -87.26 148.39 44.64 Favored Pre-proline 0 N--CA 1.417 -2.12 0 CA-C-N 114.775 -1.102 . . . . 74.33 108.93 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.74 2.88 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 124.392 3.395 . . . . 72.24 113.755 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 35' ' ' SER . 8.0 t70 -91.02 1.61 56.95 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.226 1.01 . . . . 74.12 108.511 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' THR . 9.0 t70 72.48 28.73 2.21 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.015 1.726 . . . . 75.23 107.017 -176.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.56 124.5 49.42 Favored 'General case' 0 N--CA 1.389 -3.501 0 CA-C-N 113.887 -1.506 . . . . 73.2 107.688 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.62 136.17 53.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.144 -1.058 . . . . 65.55 108.144 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.3 p -141.41 160.53 39.93 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 106.131 -1.803 . . . . 54.31 106.131 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.3 -165.82 39.19 Favored Glycine 0 CA--C 1.489 -1.541 0 C-N-CA 117.826 -2.13 . . . . 71.31 113.635 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -157.08 133.58 9.92 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 123.51 0.724 . . . . 70.32 110.218 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mp -117.53 115.45 48.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 105.919 -1.882 . . . . 75.4 105.919 170.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 mm -108.41 121.37 61.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.348 -0.982 . . . . 73.03 108.348 -175.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.492 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.98 108.86 16.77 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.33 -0.989 . . . . 62.11 108.33 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.11 122.87 38.4 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.762 0.315 . . . . 73.13 111.046 -176.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.66 158.96 28.9 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.665 -0.698 . . . . 64.31 110.913 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -66.2 136.85 95.43 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 107.49 -1.3 . . . . 73.15 107.49 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.64 112.61 1.11 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.375 2.05 . . . . 71.22 111.052 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -84.24 -25.58 29.31 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.999 0.428 . . . . 71.32 110.98 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -128.92 171.66 12.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.286 -0.259 . . . . 63.01 110.636 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -69.06 -52.58 27.09 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.424 0.63 . . . . 74.41 111.057 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -87.41 7.89 27.05 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.816 -0.629 . . . . 71.05 110.932 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 52' ' ' ASN . 13.3 t0 -73.02 108.91 6.18 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 115.551 -0.75 . . . . 75.43 109.845 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.587 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 4.1 t -90.65 -29.71 17.58 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.562 -1.199 . . . . 74.11 110.643 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.08 131.09 1.31 Allowed Glycine 0 N--CA 1.423 -2.204 0 CA-C-O 118.294 -1.281 . . . . 54.53 111.184 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -52.49 128.84 29.4 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 120.127 1.964 . . . . 73.31 109.205 169.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.04 163.39 14.92 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.903 0.705 . . . . 70.21 112.903 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 mt -121.61 124.52 44.52 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.37 -0.974 . . . . 74.42 108.37 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -112.51 90.39 3.33 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.063 0.459 . . . . 75.3 110.497 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.98 79.63 0.3 Allowed Glycine 0 C--N 1.3 -1.42 0 C-N-CA 121.021 -0.609 . . . . 70.15 111.802 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -87.88 105.18 17.25 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.685 0.755 . . . . 73.43 108.968 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.9 m -109.08 163.82 16.12 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 114.651 -1.159 . . . . 74.32 109.43 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.4 -16.91 50.25 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.744 2.296 . . . . 75.14 112.554 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -113.15 36.01 3.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.588 -0.733 . . . . 71.53 111.076 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.2 m -59.66 -29.08 67.81 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 112.463 0.542 . . . . 65.13 112.463 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' H ' ' NE2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -74.46 -7.85 54.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.912 -0.715 . . . . 74.3 111.667 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.81 -11.5 26.76 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.797 -0.446 . . . . 71.23 109.797 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.73 120.76 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 122.135 0.969 . . . . 75.11 111.847 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.48 106.43 18.4 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.451 -0.795 . . . . 73.43 108.931 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.2 t -98.24 132.25 43.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.465 -1.309 . . . . 72.43 107.465 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.9 m -144.76 165.35 28.33 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.629 0.252 . . . . 75.34 111.538 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.66 128.9 35.28 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.419 -0.956 . . . . 73.44 108.419 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 60.6 t80 -92.66 125.26 37.21 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 123.88 0.872 . . . . 74.54 109.858 -177.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -140.06 98.91 3.55 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.894 -1.15 . . . . 64.21 107.894 171.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 53.2 m -163.75 153.09 14.37 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.491 -1.3 . . . . 72.23 107.491 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.72 4.03 4.54 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.885 0.874 . . . . 72.21 111.574 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.08 0.72 73.77 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.591 -1.003 . . . . 72.45 110.591 -174.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -100.79 151.29 21.86 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 109.181 -0.674 . . . . 74.01 109.181 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.587 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.7 m -127.81 138.77 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 109.074 -0.713 . . . . 72.11 109.074 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -171.72 -153.54 9.19 Favored Glycine 0 C--N 1.277 -2.721 0 N-CA-C 110.89 -0.884 . . . . 73.45 110.89 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.4 m -140.64 145.22 36.33 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 109.812 -0.44 . . . . 51.24 109.812 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.49 155.72 43.29 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 120.586 -0.446 . . . . 74.3 110.442 177.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.47 114.35 21.12 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.695 -1.224 . . . . 73.3 107.695 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.21 113.13 43.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.691 -0.855 . . . . 74.01 108.691 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.468 ' CD2' HD11 ' A' ' 90' ' ' LEU . 54.3 p90 -113.0 164.19 13.76 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.928 -0.709 . . . . 74.32 112.4 -174.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 p -157.91 155.75 30.09 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.655 -1.157 . . . . 71.31 109.931 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 67.12 30.88 7.11 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.011 1.115 . . . . 73.34 114.011 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.468 HD11 ' CD2' ' A' ' 87' ' ' PHE . 52.1 mt -103.01 166.7 10.29 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.456 -0.498 . . . . 73.42 111.438 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 41.1 p -113.78 172.64 6.86 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.693 -0.231 . . . . 73.31 111.613 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -54.94 -37.63 66.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.626 0.77 . . . . 72.51 109.767 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.43 -25.77 62.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.094 -0.503 . . . . 74.11 111.844 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.29 -16.88 28.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.801 0.334 . . . . 72.41 111.635 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 44.0 tp -58.16 -48.11 97.63 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 113.1 0.778 . . . . 65.23 113.1 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.24 -34.96 76.76 Favored 'Trans proline' 0 C--N 1.372 1.812 0 CA-C-N 120.826 1.331 . . . . 74.23 110.794 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -64.65 -40.89 96.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.134 -0.484 . . . . 64.34 111.263 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -74.64 -19.36 60.32 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.687 -0.486 . . . . 73.03 109.687 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.97 -20.7 63.3 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.993 -0.549 . . . . 74.34 110.024 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -61.53 -57.93 10.14 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.257 -1.016 . . . . 74.13 108.257 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 33.6 ttp -56.38 -45.41 80.55 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.813 -0.631 . . . . 74.31 110.249 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -53.13 -44.54 67.79 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.086 -0.961 . . . . 74.52 111.046 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 p -68.73 -22.34 64.33 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.972 -0.691 . . . . 63.01 111.832 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.58 -25.15 67.28 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 121.192 0.52 . . . . 74.34 110.035 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.67 -11.16 16.42 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.007 -0.542 . . . . 63.55 110.432 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.55 -47.3 3.96 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.982 0.734 . . . . 73.01 112.982 -171.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.05 28.42 54.11 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.256 -0.973 . . . . 72.43 111.05 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.12 170.42 13.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 120.77 0.319 . . . . 72.25 110.682 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.68 126.28 51.57 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.822 -1.547 . . . . 75.01 106.822 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.71 134.23 53.74 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.985 -0.746 . . . . 71.34 108.985 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.2 m -144.13 142.37 30.54 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.739 -0.467 . . . . 74.0 109.739 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.93 146.4 30.12 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.321 -0.622 . . . . 73.25 109.321 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -138.03 148.54 45.2 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.74 -0.664 . . . . 72.35 110.613 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.403 ' CG ' HG22 ' A' ' 119' ' ' VAL . 6.6 mtt85 -90.1 137.75 32.09 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.5 -0.556 . . . . 74.25 109.5 171.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.415 ' O ' HG13 ' A' ' 118' ' ' ILE . 43.3 t30 -135.36 101.36 4.8 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.653 -0.869 . . . . 74.21 108.653 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.55 -106.97 2.03 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 109.935 -1.266 . . . . 52.05 109.935 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -115.96 -5.45 11.99 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.503 1.144 . . . . 70.15 108.864 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -105.25 149.54 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 115.513 -0.767 . . . . 75.01 109.62 -175.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.403 HG22 ' CG ' ' A' ' 114' ' ' ARG . 99.1 t -111.12 134.76 52.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 109.816 -0.439 . . . . 74.32 109.816 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.417 HG22 ' HG2' ' A' ' 175' ' ' GLN . 47.4 pt -108.47 137.7 38.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.048 -1.094 . . . . 74.03 108.048 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.08 131.44 49.07 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 108.988 -0.745 . . . . 70.31 108.988 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -135.52 122.03 20.68 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.291 -0.868 . . . . 72.45 109.655 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.68 136.73 8.65 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.451 -0.881 . . . . 73.33 111.533 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -121.34 137.61 54.62 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 118.001 0.901 . . . . 75.22 109.645 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -130.16 110.15 11.36 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.21 0.529 . . . . 74.22 111.11 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.69 107.4 17.42 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.129 -1.063 . . . . 64.44 108.129 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.576 ' O ' HG12 ' A' ' 130' ' ' VAL . 2.7 mm? -110.14 21.98 16.11 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.931 0.396 . . . . 74.34 109.993 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 167' ' ' GLY . 39.2 p -64.75 -25.64 68.02 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 113.05 0.759 . . . . 73.23 113.05 -177.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.1 t -84.03 -19.92 33.6 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 112.583 0.586 . . . . 73.15 112.583 -175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 127' ' ' LEU . 11.9 p -70.82 135.32 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 119.786 -0.766 . . . . 75.55 110.438 -176.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 17.4 m -98.02 14.75 26.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.094 0.473 . . . . 74.11 111.532 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' H ' HG21 ' A' ' 130' ' ' VAL . 10.1 m-20 -110.62 90.7 10.9 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 107.908 -1.145 . . . . 74.41 107.908 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 131' ' ' SER . 6.7 Cg_exo -75.19 -13.51 21.01 Favored 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.024 2.483 . . . . 75.14 113.14 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.539 ' OD2' ' HG3' ' A' ' 25' ' ' MET . 27.0 t0 -99.16 18.44 17.47 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.558 1.171 . . . . 75.22 109.28 -173.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.48 154.8 17.62 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.525 -1.216 . . . . 74.41 111.097 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 8.5 m-20 -133.07 132.54 41.89 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.193 -0.317 . . . . 71.55 111.151 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 86.5 t -117.03 124.43 73.0 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 108.463 -0.94 . . . . 73.45 108.463 176.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -121.23 133.92 55.18 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.336 -0.227 . . . . 71.55 110.568 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.518 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.7 tm? -119.8 118.12 29.99 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.697 -1.964 . . . . 73.43 105.697 176.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' SER . 18.2 m -126.6 131.55 51.48 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.356 -0.609 . . . . 74.03 109.356 -177.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 65.8 t -124.87 126.59 71.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.467 -0.568 . . . . 65.35 109.467 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.09 126.17 54.79 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.33 -0.989 . . . . 75.12 108.33 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.581 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.8 p90 -134.1 120.91 15.34 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 112.576 0.584 . . . . 72.14 112.576 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 35' ' ' SER . 26.2 Cg_exo -67.83 39.64 0.2 Allowed 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 123.59 2.86 . . . . 74.41 112.798 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -124.62 -107.23 0.33 Allowed 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.529 -0.545 . . . . 75.41 109.529 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.81 129.18 0.11 Allowed 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.601 -0.889 . . . . 61.34 108.601 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.59 134.91 26.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.594 -0.891 . . . . 64.33 108.594 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.5 p -92.36 -38.52 11.98 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.229 0.537 . . . . 74.32 109.684 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.4 m -161.37 132.96 5.55 Favored 'General case' 0 C--O 1.208 -1.12 0 C-N-CA 123.212 0.605 . . . . 74.51 109.466 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.2 t -139.7 155.67 47.24 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.121 -0.632 . . . . 74.31 111.124 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -123.13 95.4 4.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 104.898 -2.26 . . . . 65.42 104.898 172.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.435 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.33 -155.51 24.48 Favored Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 107.508 -2.237 . . . . 42.32 107.508 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -107.01 99.85 9.38 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.131 0.965 . . . . 63.33 110.579 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -79.43 114.38 18.32 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.86 -0.609 . . . . 75.32 109.718 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.5 mt -80.85 -39.48 17.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.42 -1.326 . . . . 73.51 107.42 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -135.17 168.9 15.41 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 106.472 -1.677 . . . . 73.21 106.472 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.22 0.33 9.51 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.042 1.828 . . . . 64.35 109.822 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.5 pt-20 -134.89 10.03 3.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.2 -0.909 . . . . 72.43 112.109 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.9 t -145.87 120.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.813 -1.18 . . . . 72.41 107.813 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.99 147.4 32.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.87 -0.789 . . . . 73.15 108.87 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -137.63 146.65 44.17 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.318 -0.401 . . . . 72.52 110.019 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.518 ' CE3' HD12 ' A' ' 139' ' ' LEU . 22.8 m-90 -130.1 130.97 45.51 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.995 -1.113 . . . . 74.13 107.995 176.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -112.59 105.39 13.58 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.638 0.732 . . . . 75.4 110.632 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.3 mm? -94.03 134.5 36.38 Favored 'General case' 0 C--O 1.271 2.222 0 CA-C-N 115.64 -0.709 . . . . 73.45 110.493 -175.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.411 ' O ' HG21 ' A' ' 168' ' ' VAL . 1.4 tpmt? -103.31 145.65 30.99 Favored Pre-proline 0 N--CA 1.419 -2.01 0 C-N-CA 124.063 0.945 . . . . 74.4 108.98 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -68.25 157.76 60.44 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.789 2.326 . . . . 74.34 110.813 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.533 ' O ' HG23 ' A' ' 128' ' ' THR . . . 77.61 -22.39 2.74 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 121.054 -0.593 . . . . 73.22 113.483 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 165' ' ' LYS . 5.7 m -106.07 167.8 3.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.485 0.659 . . . . 71.13 111.636 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.89 135.94 53.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.833 -1.173 . . . . 73.13 107.833 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.7 m -149.05 163.9 36.21 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.626 -0.509 . . . . 75.41 109.626 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 t -139.01 146.14 40.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.403 0.62 . . . . 72.0 111.311 175.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.2 ptp -112.88 142.91 44.99 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.389 -1.278 . . . . 74.23 108.763 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.4 m -143.14 147.09 34.39 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 120.044 -0.662 . . . . 74.34 110.027 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -154.33 147.55 24.81 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 109.1 -0.704 . . . . 73.1 109.1 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.417 ' HG2' HG22 ' A' ' 120' ' ' ILE . 42.0 mt-30 -141.15 131.52 25.15 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 107.436 -1.32 . . . . 74.22 107.436 174.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.22 149.16 26.71 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.279 -1.378 . . . . 72.24 107.279 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 16.3 ptt180 -93.27 146.65 23.55 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 118.581 -1.248 . . . . 71.31 110.925 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.4 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 98.6 m-85 -142.33 129.19 20.6 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 109.316 -0.624 . . . . 70.14 109.316 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 p -67.58 121.16 15.26 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.403 -0.817 . . . . 75.33 111.317 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.08 126.77 88.25 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 115.413 -0.812 . . . . 62.13 109.238 174.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.74 -24.44 34.74 Favored 'Trans proline' 0 C--N 1.329 -0.484 0 C-N-CA 122.678 2.252 . . . . 74.05 110.531 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -84.29 -11.25 56.73 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.453 -1.249 . . . . 73.02 109.861 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p 51.94 89.05 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.41 1.484 . . . . 75.13 112.411 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.76 158.1 17.04 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.38 0.61 . . . . 72.32 112.43 -176.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.413 -2.276 0 N-CA-C 106.712 -1.588 . . . . 71.13 106.712 176.681 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.578 0 N-CA-C 111.554 -0.618 . . . . 61.01 111.554 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -104.5 -63.63 1.19 Allowed 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.254 -0.647 . . . . 74.21 109.254 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -145.98 57.34 1.21 Allowed 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 106.062 -1.829 . . . . 64.44 106.062 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -94.07 6.45 48.49 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.452 -1.704 . . . . 70.32 109.631 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.4 mt -84.48 77.85 9.94 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.199 -1.037 . . . . 73.32 108.199 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -129.33 80.16 1.95 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.415 -0.811 . . . . 73.42 109.112 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -123.11 84.72 2.31 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-O 121.97 0.89 . . . . 73.32 110.384 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -116.91 165.64 13.1 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 114.35 -1.295 . . . . 74.24 109.318 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.45 -96.92 0.13 Allowed Glycine 0 N--CA 1.416 -2.665 0 N-CA-C 109.395 -1.482 . . . . 71.03 109.395 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.473 ' O ' ' HG3' ' A' ' 25' ' ' MET . 48.2 m-70 46.5 62.08 2.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.397 1.258 . . . . 75.41 114.397 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.569 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 34.8 mtt -174.43 102.61 0.1 Allowed 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 126.831 2.053 . . . . 65.14 107.106 176.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.4 OUTLIER -144.11 98.54 3.23 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 122.074 0.94 . . . . 74.24 110.678 177.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.0 mtp180 -121.57 134.32 55.02 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.126 -1.064 . . . . 75.14 108.126 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.5 t -117.09 115.02 47.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.317 -0.994 . . . . 71.5 108.317 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -115.5 120.87 40.95 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 121.074 0.464 . . . . 75.03 110.432 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -115.25 108.64 16.84 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.443 -0.947 . . . . 75.5 108.443 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.9 m -117.7 117.37 29.17 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.854 -1.165 . . . . 64.32 107.854 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -125.73 146.65 31.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 109.776 -0.453 . . . . 74.23 109.776 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.8 m -125.65 122.58 36.8 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.344 0.593 . . . . 73.55 109.908 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 tt -101.98 119.01 49.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 108.714 -0.847 . . . . 73.11 108.714 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.5 m -87.43 160.64 47.67 Favored Pre-proline 0 N--CA 1.424 -1.757 0 CA-C-N 115.658 -0.701 . . . . 75.11 110.158 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -64.92 2.1 1.52 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 123.777 2.984 . . . . 74.55 113.595 -177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.18 -7.21 57.23 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.192 -0.669 . . . . 75.53 109.192 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.4 t70 72.54 29.12 2.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 106.86 -1.533 . . . . 74.25 106.86 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.4 146.76 37.78 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.945 -1.502 . . . . 73.54 106.945 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.39 140.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-O 121.066 0.46 . . . . 54.21 110.096 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.0 p -137.22 161.82 35.15 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.624 -1.621 . . . . 72.31 106.624 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.64 -176.35 46.9 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 119.407 -1.377 . . . . 73.44 112.158 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.54 133.41 14.05 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.412 0.625 . . . . 62.2 110.273 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 65.0 mt -121.14 116.01 48.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.835 -1.172 . . . . 74.41 107.835 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.66 119.01 60.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.334 -0.617 . . . . 74.44 109.334 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.21 108.63 18.83 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.612 -1.625 . . . . 52.22 106.612 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.86 131.51 55.29 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 120.885 0.374 . . . . 71.1 111.088 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 25' ' ' MET . . . -139.58 158.35 44.26 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.478 -0.783 . . . . 62.22 112.763 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 49.43 101.12 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 115.655 1.724 . . . . 75.11 115.655 168.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.756 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 83.7 Cg_exo -51.84 -52.23 9.44 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.14 2.56 . . . . 63.41 112.488 178.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -151.64 116.65 5.22 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.6 -0.518 . . . . 75.43 109.6 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -126.22 158.22 36.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.56 -1.274 . . . . 73.31 107.56 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 p -66.31 -55.38 16.28 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 122.983 0.513 . . . . 73.21 112.256 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -105.7 -16.18 14.76 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.516 0.562 . . . . 74.34 112.516 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -96.88 101.62 13.24 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.055 -0.721 . . . . 73.35 109.055 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t -119.08 2.09 11.43 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.885 -1.052 . . . . 60.54 109.789 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.8 97.81 0.11 Allowed Glycine 0 N--CA 1.42 -2.37 0 C-N-CA 118.846 -1.645 . . . . 52.23 113.694 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.598 ' O ' ' HB2' ' A' ' 83' ' ' SER . 74.7 Cg_exo -55.55 151.36 38.6 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.391 2.06 . . . . 75.4 109.927 166.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.83 119.66 19.48 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.758 -0.46 . . . . 71.43 109.758 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 81.9 mt -69.63 137.3 52.13 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 123.54 0.525 . . . . 74.44 110.421 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -97.34 100.04 11.49 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.452 -0.944 . . . . 70.42 108.452 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.644 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -150.24 92.28 0.14 Allowed Glycine 0 C--N 1.277 -2.721 0 C-N-CA 120.156 -1.021 . . . . 72.41 113.233 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -106.15 99.67 9.24 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.048 -1.093 . . . . 74.53 108.048 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.73 155.89 48.47 Favored Pre-proline 0 C--N 1.286 -2.182 0 CA-C-N 115.501 -0.772 . . . . 73.24 108.958 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.27 -19.08 48.48 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.911 2.407 . . . . 71.5 112.941 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -107.82 32.75 4.5 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.792 -0.64 . . . . 72.34 112.212 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.4 m -56.58 -25.64 53.1 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.552 0.215 . . . . 65.04 111.406 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -64.72 -16.83 63.49 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.116 0.484 . . . . 74.14 110.599 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -103.11 -15.81 15.94 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.676 -0.693 . . . . 72.44 110.633 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 p -123.97 118.27 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-O 122.106 0.955 . . . . 75.12 111.406 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.03 109.01 21.1 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.603 -1.181 . . . . 74.44 109.319 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.5 t -97.95 114.36 35.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.812 -1.551 . . . . 72.4 106.812 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 m -125.68 171.8 10.3 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.729 -0.668 . . . . 72.43 109.796 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -88.25 151.1 22.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.397 -1.334 . . . . 73.43 107.397 174.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 67.7 t80 -115.3 125.05 52.8 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 108.299 -1.0 . . . . 71.13 108.299 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -138.69 99.61 3.85 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.566 -2.013 . . . . 60.21 105.566 174.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 42.6 t -172.51 148.04 1.95 Allowed 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.403 -0.962 . . . . 75.1 108.403 -174.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 69.32 10.04 7.59 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.998 0.919 . . . . 63.04 111.079 174.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.756 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 95.02 -3.78 67.31 Favored Glycine 0 N--CA 1.423 -2.173 0 CA-C-N 115.279 -0.873 . . . . 73.14 111.782 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -104.2 146.28 29.0 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.374 0.587 . . . . 74.32 110.491 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 28.1 m -114.77 136.5 51.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 172.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.416 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -167.1 -155.17 8.89 Favored Glycine 0 C--N 1.263 -3.492 0 C-N-CA 118.863 -1.637 . . . . 52.1 112.512 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.598 ' HB2' ' O ' ' A' ' 58' ' ' PRO . 24.0 t -136.97 143.73 42.97 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 108.641 -0.874 . . . . 71.52 108.641 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -131.86 137.42 48.05 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.952 -0.567 . . . . 72.32 110.947 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.21 114.21 27.26 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.743 -1.577 . . . . 75.1 106.743 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.96 120.7 62.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.966 -1.124 . . . . 75.22 107.966 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.462 ' CD2' HD13 ' A' ' 90' ' ' LEU . 45.2 p90 -126.73 149.48 49.58 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.786 -0.765 . . . . 73.34 111.62 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.4 m -156.23 152.09 27.36 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.765 -0.652 . . . . 74.1 109.484 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.3 t70 64.46 48.75 2.62 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 122.577 1.18 . . . . 62.03 111.111 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' A' ' 87' ' ' PHE . 23.2 mt -112.07 169.88 8.54 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.041 -0.982 . . . . 74.22 108.584 175.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.504 HG21 ' OE1' ' A' ' 94' ' ' GLU . 13.1 t -128.38 -178.84 4.72 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.923 -1.111 . . . . 70.35 110.955 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -50.32 -42.84 53.35 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.329 1.452 . . . . 75.52 111.146 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.37 -27.97 69.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.46 0.541 . . . . 54.5 112.46 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.504 ' OE1' HG21 ' A' ' 91' ' ' THR . 3.9 mp0 -88.48 -17.61 29.98 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 112.559 0.577 . . . . 73.31 112.559 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.4 tp -57.62 -47.38 99.06 Favored Pre-proline 0 CA--C 1.567 1.629 0 N-CA-C 113.807 1.04 . . . . 74.13 113.807 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.64 -32.32 7.76 Favored 'Trans proline' 0 C--N 1.359 1.1 0 CA-C-N 120.72 1.293 . . . . 74.42 110.96 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -68.92 -34.68 75.78 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.992 -0.549 . . . . 75.35 111.29 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -74.16 -19.13 60.66 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.9 0.381 . . . . 75.13 110.189 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.26 -22.64 63.82 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.873 -0.603 . . . . 65.44 110.678 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -58.5 -57.87 11.02 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.638 -0.875 . . . . 72.11 108.638 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.644 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.5 ttp -54.46 -50.33 67.95 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.436 -0.802 . . . . 73.44 110.062 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -55.03 -40.07 69.81 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 114.854 -1.066 . . . . 71.31 111.367 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.9 p -69.47 -19.25 63.76 Favored 'General case' 0 N--CA 1.42 -1.967 0 C-N-CA 119.63 -0.828 . . . . 72.23 112.631 -171.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.34 -28.29 69.9 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 121.583 0.706 . . . . 72.04 110.06 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.7 -8.2 16.97 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.932 -0.577 . . . . 75.12 110.829 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.19 -34.29 7.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.557 0.947 . . . . 44.23 113.557 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.69 26.77 66.52 Favored Glycine 0 N--CA 1.46 0.264 0 N-CA-C 111.125 -0.79 . . . . 74.23 111.125 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.22 156.35 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.673 0.749 . . . . 75.1 112.376 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.426 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.7 OUTLIER -117.56 121.45 40.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.964 -2.606 . . . . 74.34 103.964 171.082 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.9 mt -123.29 134.39 54.07 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 118.382 0.537 . . . . 73.0 111.185 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.7 m -126.66 128.04 46.11 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.575 -0.898 . . . . 75.42 108.575 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 tp -125.86 125.25 42.53 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.577 -0.527 . . . . 72.44 109.577 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -138.02 145.76 42.24 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.663 -0.495 . . . . 73.5 109.663 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -98.85 137.95 36.68 Favored 'General case' 0 N--CA 1.399 -3.008 0 N-CA-C 107.71 -1.219 . . . . 74.1 107.71 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.401 ' O ' HG13 ' A' ' 118' ' ' ILE . 46.8 t30 -124.77 87.08 2.65 Favored 'General case' 0 C--N 1.269 -2.897 0 N-CA-C 107.469 -1.308 . . . . 75.14 107.469 -177.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.52 -115.99 5.57 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.576 -1.41 . . . . 63.22 109.576 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -104.95 -1.88 25.27 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.106 0.955 . . . . 74.24 108.889 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.416 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -101.84 148.99 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.799 -1.186 . . . . 75.21 107.799 179.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.1 t -117.28 138.53 47.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 O-C-N 121.762 -0.586 . . . . 72.12 110.59 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.5 pt -120.5 135.49 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-O 121.542 0.687 . . . . 75.15 109.81 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.9 tt -128.18 127.0 42.11 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.351 -1.351 . . . . 64.04 107.351 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.99 139.58 41.55 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.671 -0.863 . . . . 74.21 108.671 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.98 -175.57 34.99 Favored Glycine 0 N--CA 1.402 -3.625 0 C-N-CA 120.345 -0.931 . . . . 61.03 111.472 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -145.47 157.3 44.03 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.117 -1.068 . . . . 72.13 108.117 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.3 109.54 11.56 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.797 -0.446 . . . . 53.52 109.797 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -112.7 93.63 4.52 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.641 -0.874 . . . . 53.25 108.641 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.348 0.0 OUTLIER -125.36 54.64 1.45 Allowed 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 124.257 1.979 . . . . 74.3 109.677 176.065 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.4 p -84.58 -30.41 25.05 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.235 -2.257 . . . . 74.41 111.499 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.6 m -71.05 -24.95 62.44 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.414 -0.357 . . . . 75.35 111.909 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.65 119.1 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 106.952 -1.499 . . . . 70.24 106.952 173.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.3 t -117.84 8.89 12.76 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.09 -0.644 . . . . 73.03 111.232 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.01 116.06 11.38 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.351 -0.611 . . . . 72.12 109.351 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.68 -12.75 37.17 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 122.92 2.413 . . . . 74.13 113.552 -173.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -97.21 14.4 26.08 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 123.568 0.747 . . . . 75.44 110.521 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -98.69 129.17 45.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.221 -0.445 . . . . 72.13 111.73 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -133.76 127.08 32.02 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.27 -1.011 . . . . 64.52 108.27 171.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 66.3 t -114.53 112.97 42.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.94 -1.133 . . . . 64.21 107.94 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -107.51 122.07 45.91 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.612 -0.514 . . . . 71.51 109.612 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.532 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.8 tm? -111.8 119.16 37.66 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.383 -1.71 . . . . 74.04 106.383 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.1 m -126.8 130.58 50.53 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.328 -0.619 . . . . 73.13 109.328 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 85.0 t -122.67 124.83 71.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.259 -0.645 . . . . 73.21 109.259 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.21 127.34 55.57 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.383 -0.599 . . . . 70.35 109.383 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.472 ' C ' ' H ' ' A' ' 145' ' ' ALA . 2.9 p90 -134.55 117.16 13.08 Favored Pre-proline 0 C--N 1.287 -2.128 0 CA-C-N 116.232 -0.44 . . . . 75.11 111.207 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.49 27.32 0.14 Allowed 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 122.846 2.364 . . . . 72.4 113.234 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -106.63 -92.34 0.4 Allowed 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.036 -0.728 . . . . 74.31 109.036 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.22 131.07 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.537 1.135 . . . . 73.2 107.987 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.92 137.95 20.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.689 -0.856 . . . . 72.43 108.689 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.7 p -91.94 -45.78 8.17 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.391 -0.596 . . . . 65.34 109.391 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.1 m -150.24 132.95 15.89 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.373 -0.83 . . . . 74.23 109.119 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.404 ' OG1' HG12 ' A' ' 160' ' ' VAL . 6.9 t -139.07 159.34 42.37 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.677 -0.64 . . . . 62.22 110.248 175.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 25.5 t-20 -131.01 97.91 4.44 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 104.723 -2.325 . . . . 75.12 104.723 172.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.459 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.69 -141.81 6.59 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.167 -1.573 . . . . 72.4 109.167 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -118.65 99.07 6.55 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 117.587 0.693 . . . . 70.41 110.129 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -75.16 130.33 39.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.853 -0.53 . . . . 75.23 111.087 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 61.1 mt -90.32 -48.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.65 -1.611 . . . . 72.23 106.65 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -136.28 171.94 7.9 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.136 -1.801 . . . . 74.24 106.136 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -75.97 -1.56 11.56 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.594 1.529 . . . . 51.34 111.082 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.27 1.96 7.8 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.707 -0.679 . . . . 72.45 111.457 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 68.1 t -143.77 120.96 5.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.576 -0.898 . . . . 64.55 108.576 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.404 HG12 ' OG1' ' A' ' 150' ' ' THR . 56.7 t -123.98 148.3 28.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.06 -0.719 . . . . 74.43 109.06 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -135.93 151.42 49.94 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.174 -0.676 . . . . 75.12 109.174 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.532 ' CE3' HD12 ' A' ' 139' ' ' LEU . 26.3 m-90 -132.47 128.68 37.94 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.222 -1.399 . . . . 64.41 107.222 175.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.17 105.29 15.2 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.919 0.866 . . . . 75.25 110.681 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.3 mp -87.8 130.56 34.82 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.478 -1.237 . . . . 74.54 109.664 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -118.15 146.89 40.33 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 115.204 -0.907 . . . . 74.02 111.144 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 168' ' ' VAL . 56.7 Cg_endo -65.93 149.86 86.04 Favored 'Trans proline' 0 N--CA 1.476 0.448 0 C-N-CA 123.389 2.726 . . . . 64.14 111.985 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.71 -27.43 2.57 Favored Glycine 0 C--N 1.308 -1.027 0 C-N-CA 121.218 -0.515 . . . . 75.24 113.169 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.401 ' H ' ' C ' ' A' ' 166' ' ' PRO . 28.5 m -105.57 154.44 6.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.198 0.523 . . . . 72.13 111.275 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 p -98.08 143.87 12.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.926 -0.768 . . . . 75.43 108.926 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 30.7 m -134.38 153.69 51.76 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.653 -0.499 . . . . 71.51 109.653 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.1 p -106.94 153.77 22.06 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.702 0.287 . . . . 75.52 111.063 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 40.1 tpp -124.95 116.87 22.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.031 -0.729 . . . . 75.45 109.031 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 8.3 t -143.57 132.5 22.8 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.022 -1.071 . . . . 74.44 109.876 172.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.83 122.94 8.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.759 -0.83 . . . . 73.33 108.759 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -127.94 132.01 49.28 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.635 -0.876 . . . . 74.32 108.635 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -156.75 158.09 36.26 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.902 -0.407 . . . . 43.03 109.902 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.416 ' HG2' HG22 ' A' ' 118' ' ' ILE . 70.2 mtp180 -89.13 136.66 32.89 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.756 -0.461 . . . . 74.55 109.756 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -142.68 128.39 19.26 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 109.472 -0.566 . . . . 65.24 109.472 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 12.8 p -56.38 109.96 0.69 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 124.231 0.957 . . . . 73.44 112.727 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.09 130.29 79.67 Favored Pre-proline 0 CA--C 1.51 -0.592 0 O-C-N 123.951 0.782 . . . . 72.5 109.476 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.06 -46.4 10.45 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 123.034 2.49 . . . . 75.23 114.203 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.29 -17.44 39.61 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 122.337 -0.227 . . . . 72.34 110.546 -176.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.276 69.3 p 71.18 72.18 0.18 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.578 1.551 . . . . 74.33 111.549 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -45.59 144.8 1.47 Allowed 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 113.31 -1.768 . . . . 73.22 111.623 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 34.4 m . . . . . 0 C--N 1.25 -3.757 0 CA-C-N 113.385 -1.734 . . . . 74.32 108.323 -177.317 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.641 0 N-CA-C 111.405 -0.678 . . . . 71.05 111.405 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -92.04 122.59 34.69 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.52 -1.289 . . . . 74.05 107.52 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -83.17 122.78 28.83 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.211 0.529 . . . . 70.35 110.893 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -108.95 135.11 50.68 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.375 -0.972 . . . . 72.13 108.375 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.4 105.14 12.34 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.695 -0.854 . . . . 72.52 108.695 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -83.44 84.08 7.65 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.656 0.741 . . . . 74.41 110.424 -174.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -96.37 -52.35 4.01 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.127 -0.942 . . . . 75.41 108.989 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -117.83 168.21 10.69 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.674 -1.148 . . . . 63.12 108.355 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.68 95.27 1.93 Allowed Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 108.719 -1.752 . . . . 62.41 108.719 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -58.52 132.11 52.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.15 0.5 . . . . 71.32 111.542 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.7 ttt -60.02 -39.27 85.29 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 114.45 -1.25 . . . . 65.53 109.531 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.2 tp 31.56 89.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.506 1.922 . . . . 71.43 114.747 173.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 28.8 ttm180 -109.33 124.16 50.49 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 118.388 -1.325 . . . . 74.0 109.09 177.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.36 113.77 45.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 105.543 -2.021 . . . . 74.53 105.543 176.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 35.1 ttt180 -126.34 118.65 25.48 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-O 121.504 0.668 . . . . 74.24 110.369 -177.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.94 109.84 19.52 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.677 -1.147 . . . . 75.33 108.054 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.4 m -110.94 115.42 29.48 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 107.42 -1.326 . . . . 75.12 107.42 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -127.8 146.3 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 109.532 -0.544 . . . . 70.31 109.532 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.6 m -124.42 125.03 43.59 Favored 'General case' 0 C--N 1.272 -2.803 0 CA-C-N 115.928 -0.578 . . . . 64.42 109.596 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.9 tt -114.92 124.79 71.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.531 0.681 . . . . 74.13 109.62 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m -100.07 157.36 34.0 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 115.75 -0.659 . . . . 74.24 110.674 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -58.24 -2.51 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 124.355 3.37 . . . . 64.23 113.476 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -82.08 -0.19 43.41 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 125.278 1.431 . . . . 65.2 110.732 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.2 t70 66.86 29.81 8.14 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.855 -1.535 . . . . 71.53 106.855 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -120.92 136.95 54.82 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 112.999 -1.909 . . . . 74.12 108.602 -175.026 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.35 137.19 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 115.106 -0.952 . . . . 72.12 109.3 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.3 p -138.49 149.9 45.88 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.681 -1.229 . . . . 65.24 107.681 174.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.09 -175.7 47.43 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 118.012 -2.042 . . . . 43.03 113.884 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.99 133.73 28.85 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.348 -0.926 . . . . 60.43 108.879 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.5 mt -121.19 116.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 107.776 -1.194 . . . . 72.34 107.776 176.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -120.08 115.54 47.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 120.762 0.315 . . . . 74.02 110.247 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.92 108.21 19.26 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.444 -1.687 . . . . 74.52 106.444 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.42 ' HB1' ' CB ' ' A' ' 80' ' ' TYR . . . -122.82 126.22 46.96 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.309 0.576 . . . . 72.42 112.511 -172.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.98 157.81 21.97 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.573 -0.899 . . . . 53.34 108.573 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -87.28 123.9 69.12 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 106.706 -1.591 . . . . 74.53 106.706 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.45 79.71 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.557 2.838 . . . . 75.31 115.59 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -106.66 -1.11 23.13 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.89 0.853 . . . . 71.35 109.943 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.49 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 49.1 t-20 -94.44 105.51 17.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.806 -2.294 . . . . 73.33 104.806 172.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.3 m -59.24 -14.51 11.23 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 114.833 1.42 . . . . 72.21 114.833 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.49 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 65.7 pttt -96.97 -19.14 18.99 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.766 -0.773 . . . . 74.33 112.73 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.38 137.31 43.4 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 118.697 -1.201 . . . . 75.21 113.068 -170.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 p -111.09 -19.84 12.59 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.39 -1.277 . . . . 73.01 110.817 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.518 ' HA3' ' ND2' ' A' ' 74' ' ' ASN . . . 172.31 97.62 0.11 Allowed Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.678 -0.772 . . . . 65.12 111.547 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.28 159.4 52.43 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.18 1.92 . . . . 73.5 110.836 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.23 154.13 33.87 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.574 -0.528 . . . . 75.2 109.574 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mp -68.95 145.97 53.17 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 120.95 0.405 . . . . 73.5 111.52 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -112.52 108.88 18.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.281 -0.872 . . . . 64.53 109.187 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.9 -72.55 0.01 OUTLIER Glycine 0 C--N 1.265 -3.369 0 C-N-CA 120.194 -1.003 . . . . 75.31 112.103 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 71.17 124.54 0.03 OUTLIER 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.392 1.077 . . . . 61.34 110.519 -173.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.67 162.15 56.69 Favored Pre-proline 0 C--N 1.293 -1.877 0 CA-C-N 115.222 -0.899 . . . . 64.34 108.911 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.79 -16.25 47.77 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 122.882 2.388 . . . . 74.43 113.187 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -116.01 48.66 1.2 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.429 0.633 . . . . 74.2 111.786 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m -55.85 -37.43 68.74 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.53 0.567 . . . . 75.14 112.53 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -67.56 -11.57 58.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.5 0.667 . . . . 73.11 111.426 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -95.56 -18.02 20.93 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.577 -0.738 . . . . 71.3 110.176 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.6 119.76 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.913 0.863 . . . . 71.02 111.66 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.62 111.48 23.81 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.545 -0.752 . . . . 75.25 109.575 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.4 p -98.28 139.25 20.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.096 -1.075 . . . . 73.24 108.096 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -150.9 170.3 19.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.196 0.522 . . . . 71.25 110.948 -170.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.518 ' ND2' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -84.16 128.98 34.91 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.122 -1.436 . . . . 71.32 107.122 178.384 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 88.3 t80 -108.83 122.05 46.37 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.61 -0.436 . . . . 72.43 110.279 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -138.77 109.49 6.65 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.913 -1.143 . . . . 72.34 107.913 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 46.6 t -168.68 147.61 4.21 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.657 -0.701 . . . . 71.4 109.329 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.87 19.28 11.66 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.644 0.979 . . . . 74.11 113.644 171.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.87 0.31 62.24 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 120.543 -0.836 . . . . 64.52 111.794 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . 49.9 m-85 -104.77 161.14 14.42 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 120.755 0.312 . . . . 65.12 110.181 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.98 136.46 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 106.049 -1.834 . . . . 75.11 106.049 163.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.82 -155.22 9.51 Favored Glycine 0 N--CA 1.408 -3.207 0 C-N-CA 119.605 -1.283 . . . . 72.11 112.957 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 m -118.12 141.36 48.57 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 114.531 -0.835 . . . . 54.41 109.918 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.42 148.72 47.92 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.702 -0.799 . . . . 75.54 111.132 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -131.81 115.1 15.52 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.427 -1.323 . . . . 53.13 107.427 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.1 t -108.74 117.82 54.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.386 -0.968 . . . . 72.25 108.386 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 90' ' ' LEU . 51.2 p90 -121.05 151.91 39.26 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.069 0.461 . . . . 71.4 110.651 -175.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -155.36 160.41 40.68 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.223 -0.444 . . . . 74.15 111.383 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 60.93 30.2 19.48 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.895 1.278 . . . . 74.55 110.867 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.435 HD12 ' CD2' ' A' ' 87' ' ' PHE . 17.7 mt -87.79 161.08 17.76 Favored 'General case' 0 N--CA 1.413 -2.301 0 CA-C-N 115.914 -0.584 . . . . 74.04 109.62 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -122.53 177.6 5.35 Favored 'General case' 0 C--N 1.258 -3.375 0 N-CA-C 109.311 -0.626 . . . . 73.42 109.311 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -55.9 -35.42 66.52 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 123.977 0.911 . . . . 73.45 111.776 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.66 -26.29 62.48 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.27 0.557 . . . . 63.32 111.861 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 90' ' ' LEU . 46.4 mt-10 -88.26 -20.49 25.39 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.032 0.444 . . . . 75.32 109.855 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 54.9 tp -58.91 -54.69 53.96 Favored Pre-proline 0 CA--C 1.566 1.577 0 N-CA-C 114.453 1.279 . . . . 72.33 114.453 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -74.11 -28.34 10.97 Favored 'Trans proline' 0 C--N 1.362 1.276 0 CA-C-N 121.23 1.475 . . . . 74.13 110.292 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -70.03 -29.61 66.69 Favored 'General case' 0 N--CA 1.402 -2.845 0 CA-C-N 114.932 -1.031 . . . . 72.14 110.842 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -75.82 -22.69 56.06 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 109.388 -0.597 . . . . 74.5 109.388 175.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -17.72 62.42 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.812 -0.631 . . . . 64.35 111.118 -175.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -63.61 -57.61 9.54 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.912 -0.773 . . . . 74.32 108.912 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 38.6 ttp -59.86 -47.44 85.72 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.641 -0.708 . . . . 75.3 110.386 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -57.51 -29.78 64.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.077 -0.965 . . . . 73.02 111.144 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -60.91 -37.35 81.97 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.889 -0.411 . . . . 62.43 109.889 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.5 -20.5 65.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.258 0.551 . . . . 73.14 111.073 -175.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.59 -21.27 15.33 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 120.282 -0.567 . . . . 74.44 110.826 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.42 -47.95 3.81 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.103 -0.639 . . . . 75.41 112.166 -171.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.03 12.1 60.64 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 121.014 -0.612 . . . . 72.12 111.787 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.5 m -106.64 162.65 5.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 120.81 0.338 . . . . 74.12 110.832 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -123.07 125.22 44.79 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.613 -0.884 . . . . 74.2 108.613 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 87.4 mt -125.77 111.73 15.23 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 110.007 -0.368 . . . . 73.12 110.007 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.6 t -105.45 138.29 41.88 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.076 -1.453 . . . . 72.41 107.076 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 pp -149.96 153.95 37.44 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.968 -0.693 . . . . 74.4 112.248 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -158.58 167.85 28.49 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.316 -1.311 . . . . 73.53 110.245 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.407 ' HG3' HG21 ' A' ' 119' ' ' VAL . 5.4 ttt180 -112.71 138.2 49.89 Favored 'General case' 0 N--CA 1.389 -3.506 0 N-CA-C 107.645 -1.243 . . . . 75.21 107.645 172.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -115.29 89.79 3.18 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 106.625 -1.621 . . . . 70.23 106.625 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.32 -103.83 1.01 Allowed Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.661 -0.976 . . . . 60.13 110.661 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -99.79 -24.71 14.6 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.83 0.824 . . . . 73.03 110.333 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -96.13 140.11 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 C-N-CA 118.664 -1.214 . . . . 73.22 109.607 -173.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.407 HG21 ' HG3' ' A' ' 114' ' ' ARG . 90.2 t -102.27 136.29 35.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.53 0 N-CA-C 109.617 -0.512 . . . . 73.2 109.617 -177.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.1 pt -117.7 133.36 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 121.642 0.734 . . . . 75.55 109.924 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 tt -128.22 122.33 31.54 Favored 'General case' 0 C--N 1.273 -2.747 0 N-CA-C 107.873 -1.158 . . . . 65.13 107.873 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.34 127.27 37.3 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.755 -0.831 . . . . 73.44 108.755 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.62 -178.74 23.96 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 119.56 -1.305 . . . . 43.42 112.434 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.1 mtp85 -144.23 155.58 43.94 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 123.986 0.915 . . . . 74.11 109.103 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.73 108.47 11.55 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 107.067 -1.457 . . . . 74.31 107.067 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -107.31 92.35 4.04 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.742 -1.207 . . . . 73.24 107.742 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.45 ' O ' HG22 ' A' ' 130' ' ' VAL . 70.4 mt -120.7 12.11 11.35 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.803 -1.544 . . . . 75.32 108.811 -175.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.421 ' HA ' ' CA ' ' A' ' 167' ' ' GLY . 1.3 m -62.38 -22.29 66.02 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 114.71 -1.132 . . . . 73.21 112.11 -175.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.2 m -113.68 3.34 15.57 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 112.733 0.642 . . . . 53.35 112.733 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 127' ' ' LEU . 17.5 m -80.6 164.43 3.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 C-N-CA 119.83 -0.748 . . . . 71.33 112.065 -176.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.1 m -82.74 162.79 21.64 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.28 -0.873 . . . . 72.01 111.404 -176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 71.09 99.25 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 125.123 1.369 . . . . 72.52 112.37 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.12 -26.34 10.82 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.142 2.561 . . . . 73.02 115.146 -172.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -84.68 -11.37 56.01 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.03 0.443 . . . . 73.42 110.938 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.28 145.22 11.3 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.519 1.127 . . . . 63.51 113.855 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 2.5 m-20 -125.89 120.04 29.38 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-N 115.248 -0.887 . . . . 61.3 109.088 176.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 69.3 t -106.69 113.11 42.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.96 -1.126 . . . . 71.41 107.96 174.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 44.7 mt-10 -108.37 120.73 43.24 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.268 -0.642 . . . . 65.41 109.268 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.464 HD13 ' CE3' ' A' ' 162' ' ' TRP . 2.9 tm? -111.03 118.08 35.08 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 105.302 -2.11 . . . . 74.34 105.302 175.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.2 m -123.39 125.38 44.87 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.555 -0.535 . . . . 72.44 109.555 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 98.1 t -118.46 125.21 74.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.471 -0.566 . . . . 72.41 109.471 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.99 127.68 56.29 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.658 -0.867 . . . . 63.52 108.658 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.676 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.6 p90 -134.76 120.81 14.55 Favored Pre-proline 0 C--N 1.287 -2.124 0 CA-C-N 116.589 -0.278 . . . . 74.21 111.359 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.8 40.62 0.36 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.605 2.204 . . . . 71.52 112.523 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -125.5 -110.03 0.31 Allowed 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.86 -0.609 . . . . 65.12 109.531 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -176.32 131.51 0.22 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.578 -0.526 . . . . 73.15 109.578 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.97 144.23 10.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.304 -0.862 . . . . 72.0 109.316 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.4 t -110.22 -30.67 7.63 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.457 -0.497 . . . . 71.41 110.457 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.6 m -156.64 131.82 9.18 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.66 -0.867 . . . . 73.41 108.66 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.5 t -139.74 161.2 38.11 Favored 'General case' 0 C--N 1.285 -2.2 0 O-C-N 122.022 -0.424 . . . . 61.25 110.569 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -133.19 87.63 2.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 104.845 -2.28 . . . . 74.12 104.845 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.27 -144.54 8.05 Favored Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 108.905 -1.678 . . . . 65.32 108.905 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -118.28 107.73 14.26 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 118.112 0.956 . . . . 71.23 111.407 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -82.08 118.02 22.71 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.484 0.659 . . . . 64.22 110.307 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.89 -40.01 16.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.186 -1.412 . . . . 74.1 107.186 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -137.18 167.15 22.1 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 106.461 -1.681 . . . . 74.22 106.461 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.07 -0.21 8.76 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.896 1.731 . . . . 72.14 110.947 177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.676 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 7.8 pt-20 -130.73 3.72 4.53 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.006 -0.997 . . . . 73.35 111.329 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.42 121.39 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.132 -0.692 . . . . 75.23 109.132 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.32 143.66 39.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.226 -0.657 . . . . 75.12 109.226 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.96 151.46 52.06 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.363 -0.606 . . . . 74.53 109.363 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.464 ' CE3' HD13 ' A' ' 139' ' ' LEU . 28.0 m-90 -132.68 128.62 37.4 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.24 -0.652 . . . . 74.34 109.24 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -100.14 113.66 26.47 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.372 0.606 . . . . 74.12 109.796 171.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 22.4 mt -102.09 133.18 47.35 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.468 -0.938 . . . . 74.42 108.468 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -117.93 145.45 36.76 Favored Pre-proline 0 C--N 1.309 -1.168 0 CA-C-N 115.935 -0.575 . . . . 74.41 112.117 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 168' ' ' VAL . 24.2 Cg_exo -68.24 161.44 44.61 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.574 2.183 . . . . 73.52 110.705 173.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 128' ' ' THR . . . 68.79 -9.93 1.74 Allowed Glycine 0 N--CA 1.472 1.072 0 N-CA-C 114.381 0.512 . . . . 65.12 114.381 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.426 ' H ' ' C ' ' A' ' 166' ' ' PRO . 34.2 m -120.66 171.09 9.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.484 -0.561 . . . . 64.53 109.484 173.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.88 142.02 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.624 -0.88 . . . . 74.1 108.624 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 40.9 m -140.81 143.74 35.0 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.91 -0.494 . . . . 72.14 110.905 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.8 p -108.12 141.14 40.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.368 -0.604 . . . . 74.15 109.368 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 80.4 mtp -123.66 130.03 52.02 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.276 -0.639 . . . . 74.52 109.276 -175.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.5 m -143.74 140.18 29.83 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.902 -0.719 . . . . 74.14 110.806 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 162' ' ' TRP . . . -147.64 120.44 8.68 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.044 -1.095 . . . . 74.24 108.044 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -127.73 130.15 48.3 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 107.632 -1.247 . . . . 75.51 107.632 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.33 153.69 38.97 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.733 -0.469 . . . . 71.5 109.733 -175.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 48.9 mtm180 -96.66 126.26 41.7 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.983 -0.747 . . . . 75.01 108.983 -176.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -134.01 150.03 51.22 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.34 -0.985 . . . . 75.43 108.34 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.99 108.57 1.24 Allowed 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 120.971 0.415 . . . . 75.24 110.931 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.626 ' OD2' ' HA ' ' A' ' 183' ' ' THR . 19.2 p-10 -82.09 122.5 79.68 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 113.564 0.95 . . . . 73.42 113.564 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.04 -20.02 19.73 Favored 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 123.278 2.652 . . . . 73.4 110.414 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -81.39 -25.58 36.15 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.373 -1.285 . . . . 74.54 110.353 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.626 ' HA ' ' OD2' ' A' ' 180' ' ' ASP 0.317 26.4 p 47.95 76.12 0.12 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 114.646 1.35 . . . . 71.1 114.646 -178.675 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -121.65 164.04 17.99 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.751 -1.113 . . . . 63.13 109.917 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 108.611 -0.885 . . . . 53.14 108.611 -179.821 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.183 0 N-CA-C 110.2 -1.16 . . . . 74.31 110.2 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -84.5 83.3 8.05 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.21 1.005 . . . . 74.31 109.268 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.45 83.26 2.14 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.791 -1.559 . . . . 74.44 106.791 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -82.58 94.8 7.58 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.107 -0.951 . . . . 70.44 110.11 -175.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.4 mt -111.3 22.28 15.35 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.716 -1.129 . . . . 64.55 108.382 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -77.0 90.19 3.57 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.826 -1.079 . . . . 72.54 111.334 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -96.29 156.42 16.35 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.085 -0.962 . . . . 74.33 108.564 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -84.31 95.48 8.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.278 -0.638 . . . . 75.11 109.278 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.76 103.9 2.37 Favored Glycine 0 N--CA 1.427 -1.952 0 N-CA-C 108.672 -1.771 . . . . 73.11 108.672 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -70.21 150.09 46.82 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 123.662 0.272 . . . . 72.44 111.33 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 62.9 mtt 70.93 83.1 0.15 Allowed 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 125.111 1.507 . . . . 75.34 108.996 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -132.99 128.21 35.86 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.64 -1.164 . . . . 64.54 108.083 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 16.6 ptp180 -132.32 125.9 32.06 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 115.757 -0.656 . . . . 73.22 110.44 -176.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.09 114.66 47.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.42 -0.809 . . . . 73.53 108.906 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -115.58 114.18 24.6 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.441 -0.799 . . . . 73.42 109.475 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.54 108.77 18.84 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 107.66 -1.237 . . . . 63.52 107.66 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.3 t -119.71 115.36 23.75 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.989 -1.115 . . . . 75.15 107.989 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -127.98 147.17 32.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.157 0.503 . . . . 63.24 110.089 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.8 m -129.29 132.73 47.21 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 109.742 -0.466 . . . . 71.21 109.742 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.529 ' O ' ' HD2' ' A' ' 144' ' ' PRO . 10.8 tt -118.61 111.12 32.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.952 0.882 . . . . 74.52 111.023 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.2 m -76.62 163.97 62.5 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 114.177 -1.374 . . . . 70.51 111.214 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.67 0.61 5.32 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.865 2.377 . . . . 73.12 113.323 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -91.46 -0.49 57.63 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.026 -1.102 . . . . 61.55 108.026 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.6 ' O ' ' HA ' ' A' ' 91' ' ' THR . 25.6 t70 67.79 33.45 4.83 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.612 -1.625 . . . . 73.2 106.612 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -97.73 124.65 42.16 Favored 'General case' 0 N--CA 1.391 -3.411 0 CA-C-N 113.082 -1.872 . . . . 74.43 106.541 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.0 t -110.34 129.7 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 108.549 -0.908 . . . . 70.42 108.549 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.1 p -139.92 144.21 37.01 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 107.443 -1.317 . . . . 65.43 107.443 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.07 -174.77 41.18 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 118.861 -1.638 . . . . 72.14 112.412 -177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -145.27 133.37 21.49 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.011 -0.594 . . . . 70.52 109.879 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.0 mt -118.86 115.69 48.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 106.977 -1.49 . . . . 74.14 106.977 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.31 116.05 51.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.723 -0.473 . . . . 74.33 109.723 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -108.22 108.32 19.31 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.689 -1.597 . . . . 73.24 106.689 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 129.46 54.07 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.692 0.282 . . . . 75.33 111.024 -176.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.84 144.02 49.48 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.519 -0.919 . . . . 73.33 108.519 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -81.54 120.75 78.81 Favored Pre-proline 0 C--N 1.292 -1.93 0 N-CA-C 107.746 -1.205 . . . . 74.32 107.746 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -33.79 -63.28 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 125.284 3.989 . . . . 74.02 116.422 -168.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.9 tttt 67.01 -54.26 0.45 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.463 1.105 . . . . 73.01 112.58 -176.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.41 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 23.6 t-20 -108.14 145.69 33.78 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.411 -0.588 . . . . 55.33 109.411 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -59.08 -16.77 20.9 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.322 1.449 . . . . 74.24 113.815 -175.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 12.2 ptmm? -75.85 -20.69 57.91 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.781 0.324 . . . . 63.12 111.765 -174.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.9 110.19 22.46 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 115.22 1.563 . . . . 73.22 115.22 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 t -121.34 -16.48 7.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.52 -1.218 . . . . 74.44 109.863 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.64 97.11 0.11 Allowed Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.778 -0.725 . . . . 75.33 113.081 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -73.13 160.55 45.22 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.355 2.703 . . . . 74.55 110.844 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -131.24 133.93 45.93 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.863 -0.421 . . . . 71.31 109.863 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.465 ' O ' HG11 ' A' ' 72' ' ' VAL . 94.6 mt -75.82 140.87 42.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.754 -0.461 . . . . 73.43 109.754 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -111.63 99.86 8.51 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.226 0.536 . . . . 34.02 109.557 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.652 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -115.01 94.77 0.68 Allowed Glycine 0 C--N 1.274 -2.914 0 N-CA-C 110.952 -0.859 . . . . 70.44 110.952 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.54 96.55 10.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.956 -0.757 . . . . 74.21 108.956 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.91 161.61 45.76 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.203 -0.908 . . . . 70.34 109.145 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.68 -26.68 82.91 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.443 2.095 . . . . 63.35 111.313 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.73 41.96 1.43 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.419 -0.809 . . . . 71.22 111.905 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.1 m -59.5 -28.09 66.73 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 111.72 0.267 . . . . 74.33 111.72 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -66.58 -18.6 65.45 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.421 0.629 . . . . 71.4 110.824 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -89.64 -19.81 24.43 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.61 -0.723 . . . . 74.31 109.993 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.67 121.19 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.855 0.835 . . . . 74.41 112.552 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.14 114.48 28.81 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.08 -0.963 . . . . 71.22 108.843 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 60' ' ' LEU . 58.1 t -98.27 141.52 16.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.004 -1.11 . . . . 75.32 108.004 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 m -148.51 167.93 24.07 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.275 -0.639 . . . . 71.14 109.275 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -82.76 154.12 24.92 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.446 -1.316 . . . . 71.01 107.446 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 75.2 t80 -116.65 124.55 50.01 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 109.281 -0.637 . . . . 73.3 109.281 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -138.62 99.6 3.86 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.013 -1.106 . . . . 74.41 108.013 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.2 m -156.59 137.9 13.83 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.238 -0.437 . . . . 74.03 110.014 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.03 0.41 2.38 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.182 1.393 . . . . 74.44 112.893 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.34 9.83 43.36 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.876 -1.154 . . . . 71.25 111.23 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -105.04 142.5 34.72 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.368 -0.975 . . . . 73.14 108.368 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 33.8 m -124.09 136.79 59.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.315 -0.994 . . . . 74.53 108.315 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -165.6 -155.14 8.47 Favored Glycine 0 C--N 1.262 -3.583 0 C-N-CA 119.077 -1.535 . . . . 44.44 111.791 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 p -128.75 137.4 51.54 Favored 'General case' 0 C--N 1.267 -3.011 0 O-C-N 124.43 0.723 . . . . 75.32 110.354 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.12 146.09 50.81 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 120.815 0.34 . . . . 73.14 110.897 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -124.41 115.03 20.29 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.55 -1.278 . . . . 62.53 107.55 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.0 t -108.03 119.39 57.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 107.712 -1.218 . . . . 72.31 107.712 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.47 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.1 p90 -118.2 155.98 29.57 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.689 -0.404 . . . . 73.43 111.137 -175.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.4 p -156.53 157.63 35.74 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.791 -0.64 . . . . 73.23 110.488 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 63.98 35.12 10.93 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.59 1.186 . . . . 74.05 111.319 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.47 HD12 ' CD2' ' A' ' 87' ' ' PHE . 52.7 mt -96.9 167.11 11.29 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.728 -0.669 . . . . 73.32 110.34 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 4.9 t -126.3 169.99 12.35 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.521 -1.659 . . . . 72.54 106.521 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -57.14 -33.53 67.49 Favored 'General case' 0 C--O 1.205 -1.279 0 CA-C-N 118.928 0.786 . . . . 73.13 112.443 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.57 -29.67 70.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.707 0.765 . . . . 72.44 111.304 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.03 -16.82 34.5 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.536 -0.756 . . . . 72.14 110.318 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.65 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 51.5 tp -62.31 -54.84 45.53 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 114.053 1.131 . . . . 74.21 114.053 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.32 -33.59 69.99 Favored 'Trans proline' 0 C--N 1.368 1.6 0 CA-C-N 121.357 1.52 . . . . 70.45 110.598 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.68 -35.08 78.18 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-N 114.882 -1.054 . . . . 75.11 110.755 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.7 pp -78.24 -20.13 52.33 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.909 -0.774 . . . . 74.31 108.909 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.64 -21.24 62.64 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.636 -0.711 . . . . 73.23 110.691 -174.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -58.87 -57.11 14.5 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 108.468 -0.938 . . . . 75.32 108.468 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.652 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 35.4 ttp -55.44 -47.25 76.29 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.2 -0.909 . . . . 72.24 110.508 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -54.75 -39.25 68.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.354 -0.839 . . . . 74.14 110.671 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 m -66.79 -27.64 67.75 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.311 -0.404 . . . . 75.01 111.355 -174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -70.66 -17.46 62.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.369 0.604 . . . . 73.24 110.42 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.28 -9.72 16.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.97 -0.559 . . . . 72.32 110.46 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.71 -44.82 4.56 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.512 0.56 . . . . 74.1 112.512 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.93 27.2 42.15 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 110.492 -1.043 . . . . 70.3 110.492 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.75 155.64 20.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.479 -0.934 . . . . 62.12 108.479 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.429 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 39.5 t30 -103.99 121.5 43.29 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.865 -1.161 . . . . 73.34 107.865 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -108.87 137.65 46.46 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 123.304 0.377 . . . . 74.14 110.689 -177.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -144.24 116.94 8.69 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.414 -0.958 . . . . 74.53 108.414 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -144.57 149.94 36.67 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.806 -0.559 . . . . 74.13 110.785 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -151.19 157.99 43.37 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 124.47 1.106 . . . . 73.21 111.065 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.429 ' HD3' HG23 ' A' ' 119' ' ' VAL . 2.0 tpp180 -94.33 109.07 20.93 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.438 -1.319 . . . . 73.43 107.438 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -93.03 92.21 7.72 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.133 -1.062 . . . . 75.33 108.133 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.57 -115.48 5.64 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.601 -1.4 . . . . 73.11 109.601 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -108.64 3.27 22.66 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.707 1.241 . . . . 70.22 109.223 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 pp -112.05 149.54 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 121.066 -1.021 . . . . 64.24 108.675 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.616 HG21 ' CD2' ' A' ' 178' ' ' TYR . 76.5 t -106.89 139.34 28.74 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 O-C-N 121.76 -0.588 . . . . 72.01 111.407 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 120' ' ' ILE . 2.8 pp -119.45 119.34 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 107.186 -1.413 . . . . 70.31 107.186 174.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 tt -125.34 130.0 51.08 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.862 -0.421 . . . . 73.24 109.862 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -131.84 151.87 51.39 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.548 0.69 . . . . 71.21 110.376 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -151.07 129.93 3.03 Favored Glycine 0 N--CA 1.407 -3.268 0 N-CA-C 108.712 -1.755 . . . . 65.43 108.712 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.5 mtt180 -116.25 125.41 52.18 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.33 -0.989 . . . . 72.41 108.33 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -108.51 123.26 48.63 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.449 -0.796 . . . . 72.02 112.331 -171.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -96.13 93.7 7.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.158 -1.423 . . . . 63.15 107.158 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -101.69 2.1 38.26 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.102 -0.703 . . . . 72.13 109.102 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 167' ' ' GLY . 23.4 p -78.17 -16.84 57.53 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 116.235 -0.438 . . . . 74.43 111.074 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.9 m -72.47 -24.63 61.21 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.319 -0.401 . . . . 52.44 111.5 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.44 124.4 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.304 -0.999 . . . . 71.2 108.304 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 31.2 m -111.07 9.88 22.04 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 115.05 1.5 . . . . 75.44 115.05 -170.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -95.08 150.49 37.78 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 118.593 -1.243 . . . . 71.23 108.946 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.17 -11.8 19.36 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.903 2.402 . . . . 65.53 113.862 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -88.46 -12.11 44.01 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 113.346 0.869 . . . . 74.52 113.346 -169.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.44 135.9 42.32 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.416 0.15 . . . . 64.04 110.664 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.1 t70 -131.93 125.0 30.57 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.445 -0.576 . . . . 73.41 109.445 176.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 86.9 t -114.62 119.82 62.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 107.943 -1.132 . . . . 73.42 107.943 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -129.75 121.32 26.64 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.055 0.455 . . . . 74.1 110.501 -174.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.574 HD13 ' CE3' ' A' ' 162' ' ' TRP . 2.1 tm? -116.99 121.3 40.97 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.84 -1.541 . . . . 74.04 106.84 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.3 m -126.63 130.34 50.28 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.474 -0.565 . . . . 71.1 109.474 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.3 t -129.01 128.87 67.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 109.567 -0.531 . . . . 72.05 109.567 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -119.17 124.72 47.5 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.251 -0.648 . . . . 74.33 109.251 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.551 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.5 p90 -134.42 113.35 12.12 Favored Pre-proline 0 C--N 1.288 -2.108 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.178 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 58.0 Cg_endo -68.67 30.79 0.16 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.086 2.524 . . . . 72.11 114.039 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.55 -95.18 0.36 Allowed 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.92 -0.77 . . . . 64.15 108.92 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 178.68 126.06 0.06 Allowed 'General case' 0 C--O 1.249 1.076 0 N-CA-C 109.542 -0.54 . . . . 53.31 109.542 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.37 139.15 18.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.465 -1.309 . . . . 75.54 107.465 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.0 t -104.47 -30.16 10.23 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.33 -0.948 . . . . 75.43 110.016 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.0 m -157.49 132.3 8.67 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.138 -1.06 . . . . 75.03 108.138 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -139.94 151.63 45.71 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.662 -0.649 . . . . 72.51 112.292 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -118.67 85.81 2.43 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 105.7 -1.963 . . . . 71.41 105.7 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.444 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 173.88 -151.11 12.56 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 108.458 -1.857 . . . . 63.23 108.458 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -114.59 106.28 14.07 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 118.352 1.076 . . . . 72.42 109.596 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -80.43 123.76 28.32 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.099 -0.955 . . . . 73.54 110.534 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 67.5 mt -88.49 -47.74 15.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.232 -1.396 . . . . 75.41 107.232 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -134.63 169.75 13.03 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 106.992 -1.485 . . . . 72.05 106.992 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -73.34 -0.19 8.86 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.981 1.787 . . . . 64.42 111.322 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.2 pt-20 -130.27 3.52 4.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.456 0.646 . . . . 72.23 111.401 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.09 121.09 14.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 108.735 -0.839 . . . . 72.33 108.735 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.0 144.4 38.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.865 -0.791 . . . . 75.14 108.865 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -138.15 144.88 40.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.592 -0.522 . . . . 74.34 109.592 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.574 ' CE3' HD13 ' A' ' 139' ' ' LEU . 28.0 m-90 -122.85 124.98 44.51 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.238 -0.652 . . . . 73.34 109.238 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -105.83 107.2 18.07 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.059 0.933 . . . . 74.24 109.413 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.7 mm? -101.37 120.5 40.36 Favored 'General case' 0 C--O 1.26 1.642 0 CA-C-N 114.803 -1.09 . . . . 72.54 110.14 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -103.65 146.2 32.05 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 115.633 -0.712 . . . . 73.42 110.986 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 168' ' ' VAL . 68.9 Cg_endo -72.06 155.26 57.27 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 123.035 2.49 . . . . 74.52 111.599 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 128' ' ' THR . . . 81.27 -30.9 2.67 Favored Glycine 0 C--N 1.302 -1.345 0 C-N-CA 121.365 -0.445 . . . . 72.32 112.355 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 35.4 m -105.34 164.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 110.05 -0.352 . . . . 64.14 110.05 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.2 p -113.79 143.8 22.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.975 -0.38 . . . . 61.4 109.975 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 45.3 m -154.82 144.4 21.41 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.828 -0.434 . . . . 72.31 109.828 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.0 p -97.57 153.82 17.93 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 123.971 0.908 . . . . 73.34 109.75 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.0 ptp -125.17 125.21 43.32 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.989 -1.486 . . . . 74.21 106.989 174.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.2 m -143.39 145.66 32.84 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.37 -0.831 . . . . 74.33 110.107 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -151.61 125.94 9.37 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.312 -0.995 . . . . 75.24 108.312 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -124.61 130.16 51.91 Favored 'General case' 0 C--N 1.262 -3.21 0 N-CA-C 106.439 -1.689 . . . . 54.44 106.439 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.77 160.19 43.67 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.869 -0.419 . . . . 73.23 109.869 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -96.62 128.61 43.72 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.676 -1.231 . . . . 75.11 107.676 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.616 ' CD2' HG21 ' A' ' 119' ' ' VAL . 17.0 m-30 -121.58 152.15 39.57 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 118.388 0.54 . . . . 72.32 109.874 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 21.0 p -87.84 100.33 12.79 Favored 'General case' 0 C--N 1.261 -3.264 0 N-CA-C 109.475 -0.565 . . . . 70.14 109.475 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -61.61 138.15 95.06 Favored Pre-proline 0 C--O 1.218 -0.586 0 N-CA-C 107.506 -1.294 . . . . 62.45 107.506 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -52.78 -46.02 36.53 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 123.125 2.55 . . . . 73.1 112.724 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -84.8 -10.64 56.99 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.064 -1.425 . . . . 75.44 110.756 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.1 p 59.4 81.46 0.17 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.498 1.519 . . . . 61.42 111.944 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -90.31 151.8 21.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.619 -0.719 . . . . 74.25 110.534 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 72.3 m . . . . . 0 C--N 1.295 -1.787 0 C-N-CA 128.1 2.56 . . . . 73.12 105.207 178.99 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.324 0 N-CA-C 109.574 -1.41 . . . . 53.41 109.574 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -132.27 58.14 1.76 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.665 0.745 . . . . 74.25 111.89 179.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.94 104.38 16.8 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.444 -0.798 . . . . 75.42 109.974 176.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.22 147.39 27.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.628 -1.619 . . . . 63.02 106.628 175.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.1 mt -76.63 111.73 12.43 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.316 0.579 . . . . 73.01 109.751 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -63.2 136.73 57.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.43 -1.259 . . . . 64.44 112.813 -173.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 65.23 94.82 0.06 Allowed 'General case' 0 C--O 1.25 1.084 0 C-N-CA 125.329 1.452 . . . . 70.54 111.602 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.422 ' HA ' ' HG2' ' A' ' 51' ' ' LYS . 16.7 tt0 -79.08 92.07 4.97 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.28 -0.873 . . . . 75.22 109.068 -178.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.21 147.54 5.04 Favored Glycine 0 N--CA 1.415 -2.75 0 C-N-CA 120.075 -1.06 . . . . 75.13 112.255 177.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -153.83 -41.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 124.617 1.167 . . . . 74.11 109.724 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 92.5 mtp -156.74 144.58 19.31 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.586 -0.894 . . . . 71.12 108.586 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 99.0 mt -125.55 137.09 53.92 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.097 -1.075 . . . . 74.4 108.097 173.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 46.1 ttm-85 -136.8 124.51 22.44 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.63 -0.878 . . . . 73.24 108.63 172.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.439 ' HB ' HG11 ' A' ' 137' ' ' VAL . 62.9 t -117.37 118.96 60.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.998 -0.741 . . . . 74.51 108.998 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -108.35 113.17 26.03 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.527 -1.286 . . . . 73.21 107.527 178.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.05 120.15 36.36 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.509 -1.293 . . . . 73.21 107.509 177.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 140' ' ' THR . 21.9 m -137.19 115.09 11.42 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 109.192 -0.67 . . . . 74.13 109.192 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.8 pp -127.82 147.11 32.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.635 -0.506 . . . . 74.41 109.635 -175.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.8 m -125.64 128.37 47.75 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 120.974 0.416 . . . . 73.42 109.919 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.0 tt -113.39 119.51 60.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.526 0.679 . . . . 72.03 109.579 179.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -84.42 160.97 55.67 Favored Pre-proline 0 C--N 1.296 -1.761 0 CA-C-N 115.389 -0.823 . . . . 61.24 109.913 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.82 2.06 2.82 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 123.367 2.711 . . . . 73.32 112.166 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.55 -8.0 59.62 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.398 1.079 . . . . 74.52 108.403 177.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.3 t70 71.96 28.48 2.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.338 1.455 . . . . 74.41 107.131 -175.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.2 139.84 44.95 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.769 -1.559 . . . . 71.33 107.6 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 t -117.26 140.45 40.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.239 -0.652 . . . . 74.04 109.239 -177.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.7 p -146.94 142.74 27.88 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.623 -1.251 . . . . 74.32 107.623 176.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.9 -171.53 41.4 Favored Glycine 0 N--CA 1.422 -2.273 0 C-N-CA 119.125 -1.512 . . . . 70.43 113.079 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -145.74 133.87 21.58 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.03 -0.73 . . . . 73.02 109.03 -175.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.0 mt -123.66 115.81 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.994 -1.113 . . . . 70.21 107.994 175.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.36 114.95 48.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.494 -0.558 . . . . 75.21 109.494 -178.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.66 108.52 19.42 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.285 -1.376 . . . . 74.32 107.285 175.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . . . -113.85 135.81 53.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.169 0.509 . . . . 71.12 111.592 -175.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.49 156.33 29.26 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.238 -0.892 . . . . 71.33 109.76 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -77.46 111.28 16.2 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 105.875 -1.898 . . . . 64.34 105.875 175.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 80' ' ' TYR . 52.9 Cg_exo -30.52 -71.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.021 1 C-N-CA 125.737 4.292 . . . . 74.11 116.195 -171.068 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 22' ' ' GLN . 56.6 tptt 66.96 -65.92 0.2 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.781 1.232 . . . . 71.34 111.168 -178.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.512 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 49.9 t-20 -69.65 133.24 47.33 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.967 0.907 . . . . 75.33 108.759 -178.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 t -73.12 -21.82 60.66 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.507 -0.315 . . . . 75.31 111.793 -176.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.512 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 22.4 ptmt -102.62 -0.06 32.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.248 -0.581 . . . . 72.43 111.68 -177.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.41 103.19 15.9 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.104 -0.638 . . . . 75.31 111.054 -175.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 p -93.59 -20.49 20.16 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.196 -0.911 . . . . 62.31 110.502 179.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.02 119.85 0.56 Allowed Glycine 0 N--CA 1.424 -2.157 0 CA-C-O 118.669 -1.073 . . . . 75.43 111.122 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.529 ' O ' ' HB3' ' A' ' 83' ' ' SER . 4.5 Cg_endo -52.74 138.81 59.52 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.839 2.359 . . . . 71.45 111.771 174.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.01 125.6 35.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.27 -0.423 . . . . 52.1 110.256 -178.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.2 mt -88.55 129.94 35.36 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.873 -0.417 . . . . 74.5 109.873 176.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.86 84.62 6.65 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.875 0.845 . . . . 65.22 108.866 178.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -141.1 59.2 0.56 Allowed Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.867 -1.061 . . . . 73.51 113.059 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -90.26 93.47 9.36 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.676 -0.861 . . . . 74.42 108.676 176.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.88 161.41 22.92 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 115.191 -0.913 . . . . 74.23 111.36 -176.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.42 -9.62 26.69 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.117 2.545 . . . . 75.23 112.93 -177.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -110.62 30.76 6.52 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.881 -0.599 . . . . 74.32 109.735 176.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 p -57.31 -29.71 64.14 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.391 -0.822 . . . . 73.0 112.643 -178.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -67.98 -14.86 63.3 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.301 0.572 . . . . 71.14 110.276 -178.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -98.09 -20.4 17.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 116.058 -0.519 . . . . 73.21 110.676 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.13 118.1 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.85 0.833 . . . . 73.11 110.896 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.34 114.64 28.31 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.448 -0.796 . . . . 73.3 109.564 -177.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.72 137.02 27.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.699 -1.223 . . . . 75.41 107.699 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.6 m -151.28 172.02 16.53 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 122.054 -0.404 . . . . 75.12 109.984 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.59 151.31 23.57 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.028 -1.101 . . . . 74.31 108.028 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 89.4 t80 -116.75 129.02 55.86 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.261 -0.644 . . . . 75.43 109.261 -178.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.38 98.83 3.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.42 -0.955 . . . . 74.13 108.42 176.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 74.6 m -166.94 158.91 12.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.309 1.044 . . . . 72.34 108.895 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 68.72 9.25 7.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.711 1.205 . . . . 74.43 111.492 173.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.05 0.13 85.66 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.242 -0.743 . . . . 71.4 111.242 -175.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 99.2 m-85 -105.37 158.75 16.42 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 123.232 0.613 . . . . 73.21 110.432 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.88 140.53 48.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.351 -1.352 . . . . 72.43 107.351 174.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -162.68 -160.91 11.56 Favored Glycine 0 N--CA 1.411 -2.999 0 C-N-CA 118.871 -1.633 . . . . 74.34 113.241 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.529 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 33.6 p -123.11 140.64 52.82 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 108.719 -0.845 . . . . 70.41 108.719 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -131.41 141.15 49.79 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 120.553 -0.459 . . . . 74.2 111.125 178.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.22 115.07 22.32 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.217 -1.401 . . . . 64.44 107.217 175.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -111.55 120.2 61.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.677 -0.86 . . . . 65.44 108.677 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 90' ' ' LEU . 41.4 p90 -124.37 150.41 45.58 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.042 0.449 . . . . 73.43 110.91 -174.049 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 m -154.79 156.85 37.03 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.509 -0.552 . . . . 74.22 109.509 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.0 t70 66.68 31.13 7.82 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 122.311 1.053 . . . . 74.21 110.683 175.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 87' ' ' PHE . 34.8 mt -98.52 171.38 8.19 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.402 -0.817 . . . . 75.2 109.518 177.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 p -121.59 172.65 7.95 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 122.833 0.083 . . . . 74.42 111.166 -178.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.575 ' CZ ' HD12 ' A' ' 112' ' ' LEU . 86.7 t80 -57.25 -35.66 69.99 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.415 0.447 . . . . 71.41 110.447 175.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.6 -27.12 68.73 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.39 0.614 . . . . 74.42 110.521 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.443 ' HG2' ' NE2' ' A' ' 97' ' ' GLN . 43.5 mt-10 -88.32 -15.5 35.54 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.769 -0.65 . . . . 73.14 112.596 -177.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -50.49 -52.19 57.67 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 113.522 0.934 . . . . 74.53 113.522 175.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -56.45 -45.56 36.51 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 121.312 1.341 . . . . 63.31 110.24 175.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.443 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 24.3 mt-30 -58.87 -44.19 91.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.905 -1.043 . . . . 73.34 111.76 -176.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.72 -19.96 58.71 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.059 0.457 . . . . 72.4 111.011 178.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.38 -14.04 60.1 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.08 -0.509 . . . . 53.15 110.615 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -65.27 -57.34 8.71 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.185 -0.606 . . . . 75.42 109.96 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -56.31 -49.17 75.06 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.667 0.604 . . . . 75.22 110.221 -176.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.08 -37.5 71.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.007 -0.997 . . . . 73.44 111.528 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.6 t -65.33 -30.67 71.53 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 116.294 -0.412 . . . . 75.34 110.077 -172.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.38 -15.37 63.29 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 121.225 0.536 . . . . 71.34 111.216 -174.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.46 -12.1 11.73 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.228 -0.589 . . . . 75.31 110.875 177.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.93 -48.47 3.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.277 0.843 . . . . 64.2 113.277 -172.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.56 28.43 19.34 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.245 -0.979 . . . . 62.45 110.802 -172.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.1 m -97.44 151.56 4.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.42 -0.39 . . . . 73.44 109.949 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -129.1 121.89 28.74 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.408 -1.33 . . . . 75.12 107.408 176.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.7 mt -121.24 139.89 52.78 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.709 0.29 . . . . 75.5 110.275 -177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -136.31 121.85 19.55 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.899 -1.519 . . . . 74.41 106.899 177.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.575 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 2.7 pp -135.51 155.51 50.39 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-O 121.037 0.446 . . . . 75.44 111.679 -177.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -150.62 155.71 39.93 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.096 -0.956 . . . . 64.43 112.521 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -94.51 128.87 41.38 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.512 -1.222 . . . . 75.34 108.597 173.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -122.49 82.85 2.03 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.533 -1.654 . . . . 72.24 106.533 175.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 57.72 -130.25 50.73 Favored Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 114.372 -1.285 . . . . 64.22 110.502 -173.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.591 ' HA ' ' OD1' ' A' ' 180' ' ' ASP . 23.7 t-20 -71.14 -13.4 61.93 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.642 0.734 . . . . 72.41 111.581 -178.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.465 HG23 ' HG2' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -110.63 146.32 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 C-N-CA 117.831 -1.548 . . . . 71.12 110.756 -176.747 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.2 t -107.18 133.56 51.49 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.726 0 CA-C-N 115.348 -0.842 . . . . 74.3 110.016 -178.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.1 pt -116.29 131.38 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 121.49 0.662 . . . . 72.4 109.685 175.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 tt -128.45 131.53 48.41 Favored 'General case' 0 C--N 1.278 -2.541 0 CA-C-N 115.276 -0.875 . . . . 72.23 110.148 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -129.2 146.2 51.17 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.126 -1.065 . . . . 74.35 108.126 174.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.13 160.39 33.34 Favored Glycine 0 N--CA 1.407 -3.297 0 N-CA-C 111.402 -0.679 . . . . 50.43 111.402 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -137.49 133.44 34.59 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.881 -0.785 . . . . 74.21 108.881 177.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -103.92 110.07 22.07 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.31 -0.996 . . . . 42.14 108.31 178.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -103.2 93.75 5.16 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 122.365 1.079 . . . . 72.4 110.703 -177.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -124.29 21.39 8.75 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.138 -1.392 . . . . 73.23 107.512 177.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.422 ' HA ' ' C ' ' A' ' 167' ' ' GLY . 2.6 m -63.7 -14.12 49.31 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.039 -1.891 . . . . 63.11 110.248 177.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.6 p -74.69 -4.59 38.25 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.455 1.102 . . . . 65.33 110.057 177.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.7 t 81.67 -64.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 126.208 1.803 . . . . 75.11 112.146 176.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.1 m 67.63 -62.96 0.32 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.215 1.006 . . . . 73.32 111.336 -177.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 11.5 t70 -143.0 115.34 5.98 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 106.569 -1.641 . . . . 73.21 106.569 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.53 -26.29 63.11 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.272 2.648 . . . . 74.34 116.12 -174.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -107.71 8.82 29.14 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.857 -0.737 . . . . 62.13 111.224 -175.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -61.41 138.99 58.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.485 -0.779 . . . . 62.44 111.658 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 28.3 t70 -131.5 121.96 25.36 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.571 -0.529 . . . . 74.21 109.571 177.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 90.1 t -119.71 126.98 75.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.855 -0.424 . . . . 75.31 109.855 -178.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.45 123.47 41.37 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.227 -0.657 . . . . 72.32 109.227 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 tt -113.94 118.29 33.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.003 -1.48 . . . . 73.11 107.003 176.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 31' ' ' SER . 6.7 m -117.48 128.44 54.98 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.213 -0.662 . . . . 75.3 109.213 -175.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 84.1 t -122.33 127.87 75.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.625 -0.509 . . . . 74.3 109.625 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -116.74 132.47 56.68 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.071 -0.714 . . . . 71.32 109.071 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.581 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.2 p90 -134.93 127.63 18.36 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 116.412 -0.358 . . . . 75.12 111.785 177.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -70.15 51.27 1.0 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 123.24 2.627 . . . . 65.44 110.879 172.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.11 -128.57 0.09 Allowed 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.3 -1.37 . . . . 75.32 107.3 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -167.21 134.75 2.44 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.645 -1.613 . . . . 63.42 106.645 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.519 ' HB ' ' CZ ' ' A' ' 143' ' ' PHE . 7.7 p -85.93 123.43 39.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 108.577 -0.897 . . . . 64.24 108.577 177.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.7 t -81.73 -33.02 31.31 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.22 -0.592 . . . . 73.32 111.358 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 64.0 m -152.84 133.01 13.5 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 109.672 -0.492 . . . . 72.34 109.672 175.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.7 t -138.77 158.87 43.43 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.946 -0.471 . . . . 74.55 111.339 177.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 2.9 t-20 -127.61 89.8 3.01 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.018 -1.845 . . . . 75.3 106.018 175.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 174.44 -140.35 5.36 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 109.582 -1.407 . . . . 73.43 109.582 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.82 99.98 7.29 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 117.235 0.517 . . . . 75.13 109.702 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -82.13 115.92 21.46 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.534 0.683 . . . . 73.44 110.31 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.4 mt -81.57 -47.56 19.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.151 -1.426 . . . . 74.12 107.151 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.83 160.48 67.28 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 107.119 -1.437 . . . . 73.33 107.119 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.52 -19.63 65.42 Favored 'Trans proline' 0 C--N 1.328 -0.539 0 C-N-CA 122.054 1.836 . . . . 75.43 111.948 175.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -114.55 4.09 15.07 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.381 0.882 . . . . 73.41 113.381 178.75 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.2 t -140.34 120.28 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.995 -0.742 . . . . 73.33 108.995 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.93 149.33 31.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.049 -0.723 . . . . 75.53 109.049 -177.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -133.68 146.9 51.27 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.62 -0.882 . . . . 75.32 108.62 -178.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -119.62 122.37 41.39 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 109.446 -0.576 . . . . 71.43 109.446 177.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -89.32 114.0 25.35 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.896 0.855 . . . . 73.45 110.01 177.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 10.2 mp -101.49 118.64 37.37 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.957 -1.02 . . . . 73.12 109.493 178.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.421 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 75.5 mmtt -117.45 143.51 32.25 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 114.447 -1.251 . . . . 71.13 108.978 -176.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.43 150.46 64.16 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.377 2.052 . . . . 74.41 111.355 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.422 ' C ' ' HA ' ' A' ' 128' ' ' THR . . . 73.42 -11.88 4.95 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 116.495 -0.321 . . . . 71.21 113.864 176.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 33.2 m -117.01 145.46 22.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 109.344 -0.613 . . . . 74.23 109.344 171.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.76 129.07 40.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.085 -0.709 . . . . 75.41 109.085 178.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.7 t -111.45 136.93 49.92 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 120.048 -0.661 . . . . 73.12 109.552 -178.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.6 p -100.1 138.76 36.73 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.505 -0.77 . . . . 64.32 110.626 -179.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 23.0 ttt -125.68 117.48 23.58 Favored 'General case' 0 C--O 1.193 -1.899 0 CA-C-N 115.756 -0.656 . . . . 71.43 109.681 -177.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 24.7 t -142.92 144.83 32.56 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.542 -0.911 . . . . 73.03 108.542 174.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -154.53 128.12 8.62 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.073 -1.084 . . . . 73.5 108.073 -177.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -129.04 130.27 46.36 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.028 -1.101 . . . . 64.03 108.028 176.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -152.78 158.21 41.92 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 120.803 -0.359 . . . . 73.41 110.084 -178.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.465 ' HG2' HG23 ' A' ' 118' ' ' ILE . 96.1 mtt180 -87.3 136.3 32.99 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.633 -0.877 . . . . 71.2 108.633 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -143.25 147.2 34.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.991 -0.744 . . . . 74.23 108.991 176.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.47 112.07 5.07 Favored 'General case' 0 N--CA 1.414 -2.248 0 C-N-CA 122.849 0.459 . . . . 64.52 110.507 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.591 ' OD1' ' HA ' ' A' ' 117' ' ' ASN . 2.6 m-20 -56.47 132.77 76.91 Favored Pre-proline 0 C--N 1.308 -1.221 0 C-N-CA 124.714 1.206 . . . . 74.52 112.23 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.43 -26.5 14.2 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.541 1.494 . . . . 75.3 108.925 169.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -84.9 -12.3 53.73 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 125.659 1.584 . . . . 74.52 110.772 -179.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 53.2 p 55.63 83.1 0.09 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.674 1.589 . . . . 73.43 114.934 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -132.06 169.88 15.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.027 0.531 . . . . 74.03 110.011 178.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.435 -1.197 0 N-CA-C 106.544 -1.65 . . . . 74.35 106.544 179.807 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 N-CA-C 111.238 -0.745 . . . . 75.32 111.238 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -131.18 127.94 39.01 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 122.795 -0.238 . . . . 75.43 110.563 -177.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 71.82 -52.64 0.69 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.884 1.273 . . . . 72.3 114.379 174.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 73.15 -179.72 0.21 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.634 1.174 . . . . 65.33 110.971 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.8 tp 60.28 50.57 6.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.903 1.281 . . . . 72.2 111.809 174.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -82.02 -56.44 3.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.459 0.647 . . . . 72.4 109.812 177.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -134.57 15.05 3.71 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.964 -1.016 . . . . 73.42 108.643 -179.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 67.12 -88.38 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.808 -1.542 . . . . 74.41 112.296 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.92 -87.14 0.28 Allowed Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 119.858 -1.163 . . . . 72.14 114.737 -175.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 175.0 -45.61 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.802 -1.185 . . . . 71.02 107.802 -171.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.55 ' HB3' ' OH ' ' A' ' 80' ' ' TYR . 18.8 ttt -172.68 -64.71 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.728 0 CA-C-N 113.897 -1.501 . . . . 73.44 108.304 -176.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 mt 74.7 115.39 0.06 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.856 1.262 . . . . 75.04 108.233 -175.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -119.53 126.22 50.73 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.517 -0.549 . . . . 74.32 109.517 -176.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 p -124.77 123.42 65.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 120.267 -0.573 . . . . 75.14 110.02 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -125.1 126.61 45.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.942 -0.572 . . . . 74.21 109.474 -176.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.77 108.35 16.97 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 106.366 -1.716 . . . . 74.43 106.366 172.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -117.6 114.65 23.72 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.63 -1.618 . . . . 62.33 106.63 -178.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -129.64 146.68 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-O 121.255 0.55 . . . . 70.43 109.869 -174.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.5 m -127.8 119.55 25.93 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-O 121.366 0.603 . . . . 75.31 109.749 -177.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -105.96 124.36 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.417 -0.811 . . . . 73.12 109.674 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 m -98.88 150.37 36.63 Favored Pre-proline 0 C--N 1.288 -2.07 0 CA-C-N 115.44 -0.8 . . . . 75.24 109.703 -176.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.99 1.96 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 124.038 3.159 . . . . 61.24 114.975 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 30.3 t70 -83.85 -2.66 56.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.15 -0.685 . . . . 74.15 109.15 177.089 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.7 t70 72.72 29.29 1.98 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 106.125 -1.806 . . . . 73.34 106.125 -173.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 2.1 tp -104.09 125.58 50.53 Favored 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 112.682 -2.054 . . . . 74.13 109.006 -178.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.36 135.76 50.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.675 -0.861 . . . . 74.22 108.675 177.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 p -147.47 152.81 38.67 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.119 -1.067 . . . . 74.4 108.119 178.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.09 -171.24 44.31 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 118.74 -1.695 . . . . 54.24 113.782 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.66 133.69 30.95 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.672 0.789 . . . . 75.31 109.646 -176.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.9 mt -121.0 116.09 48.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.918 -1.142 . . . . 74.31 107.918 176.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.71 121.3 66.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 123.135 0.574 . . . . 73.33 110.016 -176.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.411 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.91 108.46 16.3 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.255 -1.387 . . . . 75.43 107.255 175.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.79 132.82 56.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.403 0.621 . . . . 73.34 112.602 -174.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.29 158.43 35.8 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.405 -0.961 . . . . 74.35 108.405 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.75 153.81 83.26 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 104.551 -2.389 . . . . 65.14 104.551 173.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.42 103.67 0.06 OUTLIER 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 122.299 1.999 . . . . 63.31 111.766 -179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -77.6 -36.9 51.34 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.867 0.692 . . . . 73.42 112.867 -169.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.417 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 45.3 t30 -151.8 167.72 27.34 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.878 -0.786 . . . . 65.15 108.878 -176.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -58.87 -28.1 65.81 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.92 1.288 . . . . 73.44 112.683 -175.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -90.8 -6.11 54.74 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.868 -0.52 . . . . 74.14 110.017 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.417 ' HB3' ' H ' ' A' ' 52' ' ' ASN . 33.5 t70 -99.45 96.76 7.91 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.609 0.719 . . . . 75.31 111.103 -172.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t -122.25 -11.05 8.45 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.698 -1.137 . . . . 72.42 109.623 175.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.26 96.47 0.1 Allowed Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.829 -0.909 . . . . 73.43 110.829 176.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.413 ' O ' ' HB3' ' A' ' 83' ' ' SER . 26.1 Cg_endo -68.52 159.6 52.83 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.931 2.42 . . . . 71.1 113.046 177.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.25 140.39 50.33 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.593 -0.892 . . . . 72.2 108.593 176.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.419 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 90.2 mt -79.92 140.78 36.56 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.703 0.287 . . . . 45.02 111.337 -178.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.16 96.61 6.77 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.263 1.03 . . . . 72.41 108.473 177.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -113.45 -71.01 0.55 Allowed Glycine 0 C--N 1.292 -1.872 0 CA-C-N 114.415 -1.266 . . . . 72.12 113.117 -177.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 58.59 86.02 0.09 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.23 1.014 . . . . 74.01 112.404 -176.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 m -115.81 158.63 41.66 Favored Pre-proline 0 C--N 1.29 -1.993 0 CA-C-N 114.652 -1.158 . . . . 75.15 108.686 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.57 -16.84 50.6 Favored 'Trans proline' 0 N--CA 1.483 0.884 0 C-N-CA 122.747 2.298 . . . . 72.5 112.354 179.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -113.45 25.22 11.47 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.543 -0.753 . . . . 73.33 112.037 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.8 m -56.36 -24.01 41.35 Favored 'General case' 0 C--O 1.21 -1.004 0 N-CA-C 111.753 0.279 . . . . 71.24 111.753 177.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -62.57 -23.17 66.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.18 0.514 . . . . 72.02 110.456 178.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.646 ' HB3' ' O ' ' A' ' 88' ' ' SER . 33.4 mmtp -95.51 -14.44 23.67 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.246 0.546 . . . . 74.32 110.104 -178.23 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 49.8 t -108.19 121.05 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 116.081 -0.509 . . . . 74.44 110.407 -177.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 110.67 22.69 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.171 -0.677 . . . . 73.24 109.171 177.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.96 137.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.98 -1.119 . . . . 64.14 107.98 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 t -148.2 172.22 14.68 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.803 -0.814 . . . . 74.23 108.803 -174.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -92.02 141.23 28.84 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.132 -1.062 . . . . 75.1 108.132 177.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 93.0 t80 -102.24 127.36 49.24 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.374 -0.602 . . . . 74.41 109.374 -178.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.56 99.63 4.12 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.568 -0.901 . . . . 71.34 108.568 176.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 30.9 t -170.0 155.76 5.75 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.276 -1.009 . . . . 63.33 108.276 -179.067 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 71.06 6.72 5.95 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.803 1.241 . . . . 74.34 111.604 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.91 4.51 84.63 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.659 -1.376 . . . . 73.44 109.659 -173.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.55 ' OH ' ' HB3' ' A' ' 25' ' ' MET . 6.2 m-85 -104.31 149.34 25.44 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 124.164 0.986 . . . . 72.02 110.049 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -125.5 136.06 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 108.015 -1.106 . . . . 70.12 108.015 174.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -163.12 -155.42 8.1 Favored Glycine 0 C--N 1.27 -3.09 0 C-N-CA 119.4 -1.381 . . . . 62.53 112.19 -178.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 13.4 p -124.1 140.95 52.47 Favored 'General case' 0 C--N 1.274 -2.715 0 CA-C-N 115.096 -0.552 . . . . 72.22 109.729 -178.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.53 141.68 45.28 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 120.816 0.341 . . . . 72.14 110.649 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.35 115.56 21.86 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.027 -0.731 . . . . 75.51 109.027 178.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.4 t -106.01 112.53 39.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.165 -1.05 . . . . 73.53 108.165 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 50.7 p90 -112.87 153.96 27.08 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 120.708 -0.397 . . . . 73.21 110.746 -174.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.646 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 42.4 m -153.61 161.49 42.14 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.822 -0.351 . . . . 73.33 110.932 -177.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.1 t70 59.68 37.82 22.14 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.471 1.129 . . . . 74.52 111.574 173.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.8 mt -103.29 164.76 11.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.33 -0.85 . . . . 73.2 110.922 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -114.21 174.02 6.16 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.052 0.453 . . . . 74.51 110.742 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -56.49 -34.28 66.8 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 125.58 1.552 . . . . 72.21 111.021 -178.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.4 -25.26 61.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.98 -0.555 . . . . 70.31 111.185 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -88.77 -16.45 32.12 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 116.107 -0.497 . . . . 75.31 111.648 -176.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.648 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.6 tm? -52.73 -56.44 23.12 Favored Pre-proline 0 CA--C 1.569 1.696 0 C-N-CA 123.442 0.697 . . . . 72.11 111.756 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.18 -37.14 33.38 Favored 'Trans proline' 0 C--N 1.372 1.795 0 CA-C-N 120.741 1.3 . . . . 73.01 111.232 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.55 -34.67 78.79 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 124.437 1.095 . . . . 74.42 110.857 -176.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -78.38 -23.01 47.02 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.384 0.611 . . . . 74.22 109.543 175.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.34 -22.95 59.0 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 115.577 -0.738 . . . . 62.4 109.842 -175.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -62.06 -46.79 87.56 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.445 -0.798 . . . . 74.12 109.659 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.6 mtm -55.95 -49.67 72.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.282 0.563 . . . . 75.4 109.711 177.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -54.49 -35.63 63.29 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 114.726 -1.124 . . . . 75.03 110.96 178.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.4 m -60.65 -29.21 69.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.786 -0.643 . . . . 64.31 110.86 -173.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.81 -30.29 69.98 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 123.558 0.536 . . . . 71.12 111.345 -175.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.87 -10.86 15.47 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.085 -0.507 . . . . 75.45 110.89 -177.258 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.69 -47.8 3.67 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 113.44 0.904 . . . . 64.13 113.44 -172.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.42 24.9 41.38 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.428 -1.069 . . . . 73.54 110.428 -173.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 m -106.42 163.09 5.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.393 -0.404 . . . . 74.52 110.319 -178.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -128.56 122.2 30.5 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.597 -1.26 . . . . 74.53 107.597 176.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.1 mt -119.09 122.48 42.2 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.957 0.408 . . . . 74.45 111.209 -178.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 p -137.22 139.5 41.07 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.984 -0.553 . . . . 74.21 109.736 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.87 150.67 32.27 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 122.075 -0.391 . . . . 63.21 110.042 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 113' ' ' ARG . 3.3 mmp_? -143.51 155.04 44.22 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.109 -0.496 . . . . 74.52 110.683 -176.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -92.31 138.53 31.45 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 121.587 0.708 . . . . 74.41 111.333 173.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.43 ' O ' HG13 ' A' ' 118' ' ' ILE . 6.8 t30 -123.9 88.02 2.84 Favored 'General case' 0 C--N 1.269 -2.908 0 N-CA-C 105.665 -1.976 . . . . 74.33 105.665 175.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 185' ' ' SER . . . 73.71 -120.23 6.81 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 109.646 -1.381 . . . . 74.23 109.646 -175.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -104.54 12.45 33.14 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.509 1.147 . . . . 71.01 108.635 178.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.2 pp -119.26 149.46 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 O-C-N 120.951 -1.093 . . . . 63.34 109.041 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.27 138.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 CA-C-O 120.951 0.405 . . . . 74.35 110.352 -178.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.9 pt -110.6 129.29 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.361 0 N-CA-C 107.132 -1.433 . . . . 74.32 107.132 172.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.24 129.53 50.93 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 109.391 -0.596 . . . . 73.24 109.391 -178.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -134.8 119.23 17.91 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.913 0.863 . . . . 72.12 111.27 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.38 148.36 17.85 Favored Glycine 0 N--CA 1.418 -2.527 0 N-CA-C 110.834 -0.906 . . . . 74.34 110.834 178.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.438 ' HG2' HG23 ' A' ' 171' ' ' THR . 75.7 mtt180 -123.63 140.21 53.22 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 109.256 -0.646 . . . . 72.42 109.256 179.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.92 109.24 14.86 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 109.293 -0.632 . . . . 72.43 109.293 178.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -112.64 94.39 4.89 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.06 -1.089 . . . . 73.53 108.06 176.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -122.96 37.01 4.52 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 122.937 1.351 . . . . 75.01 108.313 177.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 75.6 p -69.96 -8.74 51.44 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.385 -1.734 . . . . 74.44 110.59 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.5 p -73.7 -24.63 59.96 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 125.231 1.413 . . . . 72.04 110.461 178.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.8 t 66.28 93.23 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.544 1.137 . . . . 75.24 112.083 178.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 m -63.27 -49.57 73.56 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 108.555 -0.905 . . . . 73.2 108.555 176.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -148.52 140.61 14.6 Favored Pre-proline 0 CA--C 1.495 -1.139 0 N-CA-C 104.55 -2.389 . . . . 72.31 104.55 174.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -49.63 -32.05 26.9 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.121 2.548 . . . . 75.03 115.146 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 25' ' ' MET . 9.2 t70 -107.96 18.97 20.63 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.258 -0.977 . . . . 70.13 112.733 -173.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.82 48.48 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.687 0.995 . . . . 74.12 113.687 -177.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -132.9 136.45 46.18 Favored 'General case' 0 C--O 1.26 1.614 0 CA-C-N 115.69 -0.686 . . . . 62.41 109.684 171.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.82 114.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.979 -1.119 . . . . 75.44 107.979 176.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.32 124.42 52.19 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 120.694 -0.402 . . . . 74.24 111.444 -178.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 50.7 tp -111.08 124.52 52.35 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.697 -1.223 . . . . 73.55 107.697 170.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.5 m -126.05 112.55 16.0 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.898 -0.778 . . . . 64.32 108.898 178.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 82.1 t -107.51 120.81 59.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 109.33 -0.618 . . . . 75.41 109.33 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.33 127.81 55.76 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.207 -0.664 . . . . 63.52 109.207 178.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.5 p90 -135.1 122.2 14.98 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 112.266 0.469 . . . . 72.12 112.266 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -67.78 42.32 0.23 Allowed 'Trans proline' 0 CA--C 1.566 2.113 0 C-N-CA 123.162 2.575 . . . . 72.34 112.443 173.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.41 -108.68 0.31 Allowed 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 122.977 0.511 . . . . 64.44 109.806 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.85 133.96 0.13 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.966 -0.753 . . . . 62.2 108.966 -177.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.3 p -88.38 141.11 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 109.235 -0.654 . . . . 75.23 109.235 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 39.5 p -102.15 -38.14 7.83 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.027 0.441 . . . . 63.12 110.411 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.9 m -155.75 132.39 10.41 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 108.625 -0.879 . . . . 43.32 108.625 178.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.2 t -139.97 152.83 46.62 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 120.144 -0.622 . . . . 75.43 112.103 176.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -118.98 88.15 2.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.325 -2.102 . . . . 75.55 105.325 175.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 171.09 -145.03 8.62 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 108.644 -1.782 . . . . 75.4 108.644 -177.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -118.27 99.99 7.21 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 118.129 0.964 . . . . 71.42 110.8 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.26 109.23 13.41 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.537 0.684 . . . . 74.21 109.449 176.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 61.9 mt -80.12 -46.96 21.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.096 -1.446 . . . . 73.23 107.096 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -121.63 163.42 30.97 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 106.802 -1.555 . . . . 74.01 106.802 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.93 -1.18 10.09 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.164 1.909 . . . . 72.22 111.376 178.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.635 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.5 pt-20 -137.07 9.66 3.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.439 -0.8 . . . . 72.05 111.66 -177.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.7 t -145.07 120.7 3.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.907 -1.146 . . . . 75.32 107.907 178.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.84 143.72 38.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.284 -0.635 . . . . 50.44 109.284 -177.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -130.86 143.34 50.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-O 121.252 0.548 . . . . 74.22 110.155 -177.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 30.3 m-90 -126.45 121.31 32.06 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.845 -0.798 . . . . 75.34 108.845 179.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 105.07 13.15 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.36 0.6 . . . . 73.33 110.234 176.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.54 147.82 24.92 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.373 -0.831 . . . . 75.43 110.281 -174.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -117.68 155.45 50.59 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.984 -0.553 . . . . 73.35 112.391 -176.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.81 157.4 51.84 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.901 2.401 . . . . 74.23 110.97 178.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.84 -35.22 2.91 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.666 -0.778 . . . . 62.24 111.574 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 20.7 m -104.76 145.13 13.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.039 0.447 . . . . 74.41 110.232 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.2 p -101.52 144.0 13.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 107.804 -1.184 . . . . 72.3 107.804 178.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 50.0 m -149.32 153.61 37.73 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.066 0.46 . . . . 74.13 111.459 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.438 HG23 ' HG2' ' A' ' 124' ' ' ARG . 2.6 p -106.56 128.37 54.07 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.307 -0.86 . . . . 72.2 109.889 177.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 23.5 ptp -106.93 122.06 45.66 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.614 -1.624 . . . . 72.21 106.614 178.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.5 m -141.47 148.01 38.79 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.558 -1.257 . . . . 71.54 111.737 -176.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.96 136.69 18.04 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 115.234 -0.894 . . . . 75.01 108.69 -176.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -130.79 131.05 44.44 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 105.866 -1.901 . . . . 73.41 105.866 175.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 178' ' ' TYR . . . -157.45 160.66 38.55 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 120.876 -0.33 . . . . 75.41 110.348 -175.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -87.52 129.05 35.22 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.729 -0.841 . . . . 74.33 108.729 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 176' ' ' ALA . 99.2 m-85 -140.73 124.69 17.26 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 108.762 -0.829 . . . . 74.14 108.762 178.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.07 122.73 9.96 Favored 'General case' 0 N--CA 1.404 -2.739 0 O-C-N 124.795 1.309 . . . . 75.14 111.564 -177.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -75.65 135.07 71.89 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 106.952 -1.499 . . . . 74.31 106.952 175.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.69 -39.21 75.82 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 122.176 1.917 . . . . 74.11 112.527 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -84.51 -19.23 33.57 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 123.689 0.796 . . . . 73.41 108.961 -175.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 65.4 p 65.38 31.97 10.02 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.817 1.647 . . . . 71.43 111.423 -177.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -100.43 156.71 17.11 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.643 -1.162 . . . . 71.44 110.304 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.401 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 48.3 m . . . . . 0 N--CA 1.42 -1.943 0 N-CA-C 107.144 -1.428 . . . . 73.44 107.144 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.583 0 N-CA-C 111.27 -0.732 . . . . 72.13 111.27 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -150.44 126.64 10.62 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.752 -1.573 . . . . 73.35 106.752 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.98 160.37 18.68 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.396 -0.521 . . . . 75.22 110.243 178.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -116.37 128.8 55.84 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.848 -1.168 . . . . 75.41 107.848 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.44 131.46 36.19 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.923 -0.58 . . . . 72.41 109.751 -175.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -92.34 133.91 35.41 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.106 -0.497 . . . . 71.4 110.78 -174.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -98.62 141.34 31.57 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.909 -0.404 . . . . 72.13 109.909 178.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -114.45 -75.23 0.59 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 114.818 1.414 . . . . 74.02 114.818 -170.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.08 26.47 2.47 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 116.479 1.352 . . . . 62.44 116.479 -168.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.49 ' HB2' ' HH ' ' A' ' 80' ' ' TYR . 51.0 m80 -142.7 -56.16 0.43 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.287 -1.005 . . . . 70.53 108.287 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.4 mmt 71.56 -171.27 0.15 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 114.703 -1.135 . . . . 74.55 111.022 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.484 ' H ' HD21 ' A' ' 26' ' ' LEU . 1.9 pt? -75.29 127.41 33.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.038 0.447 . . . . 74.23 109.962 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -113.47 124.34 52.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.946 -0.761 . . . . 75.23 108.946 -175.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.17 114.01 45.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.08 -1.822 . . . . 73.33 106.08 172.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -123.75 115.66 21.75 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 120.955 0.407 . . . . 74.12 110.93 -175.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.31 108.55 17.07 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.786 -1.19 . . . . 55.24 107.786 175.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.3 t -114.39 115.53 27.47 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.671 -1.233 . . . . 74.4 107.671 -178.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.8 pp -127.96 146.42 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.092 0.472 . . . . 75.31 109.822 -178.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 88.9 m -126.08 128.5 47.47 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.98 -0.748 . . . . 64.13 108.98 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.4 tt -114.76 114.83 47.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-O 121.622 0.725 . . . . 72.33 110.067 179.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -82.29 153.11 68.64 Favored Pre-proline 0 N--CA 1.423 -1.775 0 CA-C-N 115.215 -0.902 . . . . 70.42 109.564 -176.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.62 1.99 0.46 Allowed 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 123.765 2.977 . . . . 74.51 114.006 178.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.53 -8.27 59.62 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.387 -0.968 . . . . 71.13 108.387 174.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 72.78 29.27 1.95 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.567 1.547 . . . . 75.14 107.338 -174.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.26 126.49 51.42 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 113.55 -1.659 . . . . 73.34 107.512 178.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.33 140.1 23.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 107.871 -1.159 . . . . 75.41 107.871 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.5 p -148.47 158.97 44.46 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.318 -1.364 . . . . 73.21 107.318 -178.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.24 -167.8 39.0 Favored Glycine 0 CA--C 1.488 -1.641 0 C-N-CA 118.509 -1.805 . . . . 71.04 113.028 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -152.89 135.14 14.96 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 123.176 0.591 . . . . 75.24 110.228 -177.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 66.6 mt -115.53 115.89 50.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 107.838 -1.171 . . . . 74.1 107.838 177.054 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.26 116.59 52.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.726 -0.842 . . . . 75.12 108.726 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.541 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.25 108.32 16.43 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.927 -1.509 . . . . 72.1 106.927 175.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.47 118.98 33.68 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.324 -0.621 . . . . 73.31 109.324 -177.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HA ' ' CB ' ' A' ' 26' ' ' LEU . . . -113.91 158.04 21.61 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 115.637 -0.71 . . . . 73.24 111.308 -174.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -65.71 127.99 93.47 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 105.932 -1.877 . . . . 74.5 105.932 172.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -65.78 90.7 0.24 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.691 1.594 . . . . 65.35 112.343 -178.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -71.69 -54.21 11.06 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 106.232 -1.766 . . . . 74.31 106.232 172.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -82.86 97.57 8.72 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 106.245 -1.761 . . . . 62.13 106.245 174.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.5 t -64.42 -12.24 41.21 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 123.327 0.651 . . . . 74.55 112.609 -175.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -76.73 -18.08 58.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.971 0.415 . . . . 74.44 110.342 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -86.95 130.23 34.55 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 112.52 0.563 . . . . 71.03 112.52 -174.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -104.01 -23.21 13.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.575 -1.268 . . . . 74.34 107.575 172.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.511 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 172.88 104.05 0.17 Allowed Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 119.807 -1.187 . . . . 54.2 113.49 174.14 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -60.72 159.6 27.94 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.837 2.358 . . . . 75.35 110.743 173.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.2 163.14 14.23 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.902 -0.499 . . . . 53.1 110.473 178.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 83' ' ' SER . 3.6 mm? -77.72 136.28 38.15 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.111 -0.495 . . . . 73.15 109.672 177.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -110.54 95.08 5.35 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.404 0.621 . . . . 73.02 109.518 -178.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.62 94.01 0.1 OUTLIER Glycine 0 C--N 1.286 -2.207 0 N-CA-C 109.93 -1.268 . . . . 74.34 109.93 179.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.18 93.97 2.39 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.086 0.47 . . . . 65.02 111.165 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.5 m -85.79 151.95 56.0 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.439 -0.801 . . . . 73.13 109.764 178.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.06 -31.84 83.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.414 2.076 . . . . 61.15 111.707 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -96.11 38.27 1.2 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.791 -0.64 . . . . 73.13 112.095 -177.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 m -59.66 -24.48 63.92 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.563 0.579 . . . . 74.44 112.563 -178.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -70.52 -17.87 62.94 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 121.235 0.541 . . . . 74.15 110.425 -178.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -90.1 -16.63 29.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.708 -0.678 . . . . 75.54 109.731 -178.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.03 120.06 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 122.029 0.918 . . . . 74.03 112.492 -176.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.73 108.0 20.0 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.091 -0.958 . . . . 54.22 108.634 178.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.8 t -98.08 142.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.514 -1.291 . . . . 74.02 107.514 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.7 t -157.42 172.7 18.11 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 108.742 -0.836 . . . . 72.12 108.742 -175.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.511 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 4.1 p-10 -86.55 146.7 26.26 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.847 -0.797 . . . . 65.31 108.847 178.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -108.2 119.1 38.5 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.592 -1.262 . . . . 70.14 107.592 175.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -138.43 99.85 3.95 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.358 -1.719 . . . . 64.01 106.358 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.7 t -174.76 159.1 2.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.858 -1.164 . . . . 72.24 107.858 -176.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 72.76 -5.43 1.88 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.874 0.869 . . . . 74.41 112.535 172.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.28 -5.28 58.94 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 109.877 -1.289 . . . . 73.41 109.877 -174.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.49 ' HH ' ' HB2' ' A' ' 24' ' ' HIS . 89.3 m-85 -104.5 155.04 19.15 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 123.592 0.757 . . . . 74.05 109.696 -177.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.62 140.28 49.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 109.059 -0.719 . . . . 74.25 109.059 178.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -170.04 -154.83 9.63 Favored Glycine 0 N--CA 1.411 -3.001 0 C-N-CA 119.721 -1.228 . . . . 53.1 112.647 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.414 ' HB2' HD22 ' A' ' 60' ' ' LEU . 28.1 p -122.2 147.46 46.16 Favored 'General case' 0 C--N 1.278 -2.538 0 C-N-CA 123.391 0.677 . . . . 60.41 110.709 -176.107 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -137.32 143.2 41.96 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.995 0.426 . . . . 75.5 110.987 175.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.99 115.09 16.63 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.525 -1.287 . . . . 61.24 107.525 175.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.9 t -109.89 116.92 53.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.54 -0.911 . . . . 74.11 108.54 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' A' ' 90' ' ' LEU . 48.7 p90 -121.15 155.32 34.77 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.463 0.649 . . . . 74.03 111.832 -175.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 p -156.08 148.36 23.5 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.361 -0.836 . . . . 64.02 109.662 -177.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 t70 60.42 62.28 1.59 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.703 1.24 . . . . 72.53 112.175 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' A' ' 87' ' ' PHE . 25.6 mt -121.13 162.38 20.18 Favored 'General case' 0 N--CA 1.413 -2.301 0 CA-C-N 114.204 -1.362 . . . . 73.4 108.335 174.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -112.17 173.22 6.47 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 119.564 -0.854 . . . . 72.12 109.443 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -50.27 -46.71 55.25 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.272 1.029 . . . . 72.35 111.636 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.48 -25.35 68.22 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.607 -0.724 . . . . 73.44 112.337 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -85.72 -17.32 36.28 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 111.859 0.318 . . . . 72.22 111.859 -177.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.584 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 50.6 tp -61.96 -52.95 64.23 Favored Pre-proline 0 CA--C 1.558 1.288 0 N-CA-C 113.2 0.815 . . . . 72.23 113.2 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -62.05 -37.13 66.61 Favored 'Trans proline' 0 C--N 1.365 1.419 0 CA-C-N 120.75 1.304 . . . . 73.32 110.731 176.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.13 -36.4 84.14 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 115.067 -0.97 . . . . 74.33 111.302 -176.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -74.29 -19.51 60.45 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 120.818 0.342 . . . . 74.22 110.391 177.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.86 -23.27 63.25 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.201 -0.454 . . . . 70.44 110.523 -177.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -59.74 -48.45 81.61 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 109.584 -0.524 . . . . 64.02 109.584 176.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 17.0 ttm -56.19 -52.11 65.6 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.65 -0.704 . . . . 70.24 109.385 -179.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -55.19 -33.36 62.96 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 114.646 -1.161 . . . . 74.21 110.901 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -65.11 -18.08 65.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 118.796 -0.621 . . . . 71.25 112.473 -174.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.34 -30.38 66.68 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.535 0.683 . . . . 74.02 109.823 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.67 -11.57 13.99 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.272 -0.876 . . . . 64.45 110.908 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.73 -48.45 3.41 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.947 1.091 . . . . 74.23 113.947 -172.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.89 18.63 79.66 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 116.289 -0.414 . . . . 72.54 112.849 -175.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.2 178.62 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.634 0.605 . . . . 72.44 112.634 -176.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -142.11 126.76 17.97 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.03 0.532 . . . . 73.13 109.583 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.5 mp -127.23 115.93 19.81 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.427 -0.212 . . . . 73.22 110.427 178.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.5 m -111.27 109.79 19.97 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.128 -0.693 . . . . 74.23 109.128 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -129.42 148.37 51.33 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.555 0.693 . . . . 64.33 111.9 -178.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -152.65 169.96 21.41 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.465 -1.243 . . . . 74.45 110.964 -177.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -101.79 137.52 39.98 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 115.628 -0.714 . . . . 61.12 109.715 171.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -118.36 87.35 2.71 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.406 -1.331 . . . . 73.31 107.406 177.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.61 -98.52 0.85 Allowed Glycine 0 N--CA 1.428 -1.86 0 CA-C-N 115.044 -0.98 . . . . 52.51 111.962 -177.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -120.12 4.08 10.88 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.811 1.291 . . . . 73.1 108.563 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.3 pp -118.84 149.38 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 108.325 -0.991 . . . . 74.12 108.325 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -105.4 135.38 43.76 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 110.005 -0.368 . . . . 73.43 110.005 -178.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.6 pt -113.57 131.47 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 108.733 -0.84 . . . . 71.4 108.733 177.153 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -128.61 123.61 33.74 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 115.534 -0.757 . . . . 74.1 108.979 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.71 124.86 12.89 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.722 0.772 . . . . 74.42 110.972 177.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.58 -178.68 25.68 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.891 -0.671 . . . . 55.24 111.607 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.418 ' HG2' HG21 ' A' ' 171' ' ' THR . 96.8 mtt180 -140.8 159.26 42.6 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.753 -0.462 . . . . 71.54 109.753 -176.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.46 108.52 10.61 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 106.019 -1.845 . . . . 72.13 106.019 171.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -111.86 93.51 4.49 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.505 0.669 . . . . 75.34 109.297 -178.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.401 HD21 ' HA ' ' A' ' 166' ' ' PRO 0.334 0.0 OUTLIER -126.17 63.9 1.24 Allowed 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 123.492 1.615 . . . . 70.13 109.202 171.429 . . . . . . . . 4 4 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.3 p -83.62 -21.9 32.38 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 112.683 -2.053 . . . . 73.52 112.489 -173.032 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.7 m -78.43 -17.53 56.24 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.861 -0.422 . . . . 74.24 109.861 178.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.2 t 72.49 111.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 124.621 1.168 . . . . 73.31 113.172 174.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.3 m -91.6 -49.68 6.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.285 -1.376 . . . . 62.31 107.285 172.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -130.65 117.93 17.68 Favored Pre-proline 0 CA--C 1.488 -1.412 0 CA-C-N 115.19 -0.914 . . . . 73.22 108.578 175.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.58 -12.28 22.42 Favored 'Trans proline' 0 C--N 1.327 -0.59 0 C-N-CA 122.24 1.96 . . . . 73.45 111.463 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -101.81 3.57 39.5 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.351 -0.841 . . . . 72.54 110.679 -177.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.03 141.57 28.26 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.726 -0.39 . . . . 75.53 111.341 -177.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -127.48 135.45 50.41 Favored 'General case' 0 C--O 1.261 1.694 0 N-CA-C 107.009 -1.478 . . . . 65.31 107.009 172.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 55.3 t -108.7 115.14 48.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.3 -1.0 . . . . 72.35 108.3 178.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.55 120.1 40.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.968 -0.753 . . . . 74.43 108.968 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.13 111.98 21.86 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.949 -1.5 . . . . 71.23 106.949 178.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.2 m -114.15 128.51 56.4 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.435 -0.58 . . . . 75.2 109.435 -176.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 88.3 t -120.93 123.63 70.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.031 -0.729 . . . . 75.35 109.031 178.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.57 127.5 56.1 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.002 -0.74 . . . . 72.35 109.002 177.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.603 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.01 118.82 14.34 Favored Pre-proline 0 C--N 1.291 -1.949 0 N-CA-C 111.795 0.294 . . . . 71.11 111.795 178.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.37 41.42 0.36 Allowed 'Trans proline' 0 CA--C 1.555 1.561 0 C-N-CA 123.223 2.615 . . . . 71.24 112.563 175.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.08 -92.85 0.53 Allowed 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 110.148 -0.315 . . . . 63.24 110.148 178.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 168.24 133.68 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.522 1.129 . . . . 74.21 108.192 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.09 142.86 12.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 108.866 -0.791 . . . . 74.33 108.866 175.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.7 t -103.75 -33.74 8.82 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.2 -0.667 . . . . 75.22 109.2 178.153 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.0 m -158.3 132.31 7.9 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 108.833 -0.803 . . . . 74.55 108.833 175.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -139.23 159.49 42.04 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 109.559 -0.534 . . . . 75.23 109.559 174.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.558 ' HB3' ' OG ' ' A' ' 173' ' ' SER . 57.6 t30 -135.58 103.17 5.35 Favored 'General case' 0 C--O 1.274 2.365 0 N-CA-C 105.982 -1.858 . . . . 72.23 105.982 169.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.27 -140.75 6.06 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 107.614 -2.195 . . . . 74.12 107.614 -178.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.5 99.45 6.83 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 118.417 1.108 . . . . 73.24 110.041 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -75.53 131.12 39.84 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.719 -0.673 . . . . 63.12 110.64 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.9 mt -95.68 -44.51 13.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.257 -1.386 . . . . 73.53 107.257 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.96 170.37 9.22 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 105.928 -1.879 . . . . 75.51 105.928 176.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.24 -0.44 8.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.169 1.913 . . . . 53.41 111.39 177.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.603 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.8 pt-20 -128.62 5.75 5.61 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.046 -0.524 . . . . 63.15 111.207 178.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.4 t -143.22 120.8 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.799 -0.815 . . . . 74.02 108.799 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.86 147.15 33.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.364 -0.606 . . . . 62.42 109.364 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -131.01 145.35 52.02 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.147 0.499 . . . . 74.25 109.72 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.459 ' CZ2' ' HB1' ' A' ' 174' ' ' ALA . 30.2 m-90 -121.45 124.63 44.93 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.032 -1.099 . . . . 73.23 108.032 174.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -104.64 99.41 9.08 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.885 -1.154 . . . . 55.41 107.885 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 1.3 mm? -89.2 133.42 34.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.527 -0.761 . . . . 75.44 109.272 -174.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -117.58 150.59 47.03 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 116.139 -0.482 . . . . 74.22 111.854 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.401 ' HA ' HD21 ' A' ' 127' ' ' LEU . 72.2 Cg_endo -76.76 156.96 35.44 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 123.087 2.525 . . . . 64.15 111.85 177.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.47 -36.73 2.93 Favored Glycine 0 C--N 1.31 -0.91 0 CA-C-N 115.977 -0.556 . . . . 71.25 111.798 178.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.49 149.98 8.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.789 -0.819 . . . . 74.23 108.789 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -86.22 114.51 25.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.608 -0.886 . . . . 71.14 108.608 177.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.1 m -104.61 141.99 35.45 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.575 -0.528 . . . . 74.41 109.575 -177.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.418 HG21 ' HG2' ' A' ' 124' ' ' ARG . 67.1 p -116.22 156.84 25.84 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 120.738 0.304 . . . . 75.34 110.564 -177.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.444 ' HA ' ' CD1' ' A' ' 162' ' ' TRP . 23.4 ptp -128.95 117.45 20.98 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.132 -1.062 . . . . 64.25 108.132 175.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.558 ' OG ' ' HB3' ' A' ' 151' ' ' ASN . 2.9 p -138.33 132.93 32.34 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.936 -0.706 . . . . 74.42 112.084 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.459 ' HB1' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.71 139.88 19.36 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 123.664 0.785 . . . . 75.45 109.341 -176.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -137.99 130.59 29.51 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.464 -1.31 . . . . 63.44 107.464 174.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.459 ' HB3' ' CE1' ' A' ' 178' ' ' TYR . . . -148.55 153.1 37.93 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.912 -0.315 . . . . 65.32 110.409 -177.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -89.55 126.25 35.53 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.547 -0.908 . . . . 72.31 108.547 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.459 ' CE1' ' HB3' ' A' ' 176' ' ' ALA . 85.3 m-85 -124.69 152.86 43.18 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-O 120.988 0.423 . . . . 74.31 111.107 -176.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.2 p -78.34 94.38 4.84 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 116.138 -0.483 . . . . 70.32 111.518 177.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 183' ' ' THR . 0.5 OUTLIER -55.88 110.84 2.55 Favored Pre-proline 0 N--CA 1.467 0.384 0 C-N-CA 125.259 1.424 . . . . 74.14 113.773 175.483 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -75.71 -34.02 3.53 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.645 1.563 . . . . 73.44 109.496 168.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -80.02 -23.7 41.3 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.215 -1.357 . . . . 75.55 110.965 -177.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 180' ' ' ASP . 36.5 p 54.88 88.37 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.156 1.382 . . . . 72.53 114.186 177.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.598 ' NE ' ' HA ' ' A' ' 184' ' ' ARG . 3.1 mmp_? -108.26 176.31 5.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.308 -0.406 . . . . 74.34 111.567 176.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.31 -1.111 0 N-CA-C 108.995 -0.743 . . . . 72.32 108.995 -179.889 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.719 0 N-CA-C 110.263 -1.135 . . . . 53.31 110.263 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -96.79 -65.73 0.95 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.384 0.611 . . . . 74.32 111.005 178.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -126.83 107.76 10.41 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.997 -1.001 . . . . 74.12 110.571 -170.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -80.44 103.56 10.38 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.574 -0.898 . . . . 72.12 108.574 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.423 HD21 ' H ' ' A' ' 19' ' ' LEU . 2.3 pt? -101.36 87.33 3.18 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.467 1.284 . . . . 74.44 114.467 -173.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.26 45.98 2.71 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 104.297 -2.483 . . . . 73.13 104.297 169.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -77.46 165.4 24.43 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.082 -1.872 . . . . 63.15 110.674 -172.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -52.66 123.38 11.07 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 113.052 0.76 . . . . 64.5 113.052 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.15 77.01 2.14 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 114.937 -1.029 . . . . 75.23 112.44 -177.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -74.41 125.08 27.76 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.552 -1.277 . . . . 73.54 107.552 177.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.525 ' SD ' ' HE3' ' A' ' 49' ' ' LYS . 33.9 mtt 60.38 27.21 16.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.358 0.663 . . . . 73.2 112.225 -171.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.85 100.53 2.43 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.294 0.569 . . . . 75.15 110.189 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 37.4 ttm180 -103.47 123.96 47.85 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.992 -0.744 . . . . 74.42 108.992 175.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.19 113.62 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 N-CA-C 106.036 -1.838 . . . . 72.51 106.036 176.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -120.21 114.36 21.81 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 121.249 0.547 . . . . 72.11 109.807 -178.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 139' ' ' LEU . . . -104.63 108.37 19.78 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.093 -1.077 . . . . 63.12 108.093 178.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 140' ' ' THR . 21.2 m -119.39 115.32 23.86 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.163 -1.051 . . . . 74.43 108.163 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.9 pp -125.64 146.42 31.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.275 0.559 . . . . 73.22 109.819 -177.045 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 43.0 m -126.31 125.38 42.2 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 108.307 -0.997 . . . . 74.24 108.307 -178.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.503 HG22 ' OH ' ' A' ' 178' ' ' TYR . 8.4 tt -116.74 129.62 72.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.278 0.561 . . . . 74.31 110.073 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -105.34 149.63 37.98 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 116.116 -0.493 . . . . 75.34 111.514 -175.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.53 -7.14 0.73 Allowed 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 124.995 3.797 . . . . 72.54 116.078 -178.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 3.32 30.11 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.997 -0.44 . . . . 71.31 110.319 177.331 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.1 t70 71.74 34.44 1.58 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 123.993 1.854 . . . . 73.43 106.378 -175.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.17 125.05 50.52 Favored 'General case' 0 N--CA 1.392 -3.34 0 CA-C-N 113.26 -1.791 . . . . 73.44 107.459 -177.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.55 140.56 34.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.804 -0.813 . . . . 74.34 108.804 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.8 p -150.67 159.87 44.22 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.537 -0.912 . . . . 70.11 108.537 179.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.82 -173.44 43.39 Favored Glycine 0 CA--C 1.49 -1.522 0 C-N-CA 118.682 -1.723 . . . . 54.34 113.03 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.6 133.41 14.0 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.121 0.486 . . . . 72.32 110.488 -176.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.08 115.94 50.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 106.839 -1.541 . . . . 75.22 106.839 174.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.02 118.74 57.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.891 -0.781 . . . . 75.13 108.891 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.1 107.37 17.18 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 106.087 -1.819 . . . . 72.31 106.087 174.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.86 133.47 51.93 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 116.184 -0.462 . . . . 64.12 111.048 -174.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.79 157.89 33.02 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.174 -0.921 . . . . 72.33 109.975 -177.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.525 ' HE3' ' SD ' ' A' ' 25' ' ' MET . 36.8 ttmt -74.55 126.93 88.21 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 107.525 -1.287 . . . . 72.41 107.525 173.391 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -48.75 111.37 0.46 Allowed 'Trans proline' 0 C--N 1.363 1.315 0 C-N-CA 122.957 2.438 . . . . 74.11 110.63 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -109.78 -20.41 12.8 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.592 0.71 . . . . 73.15 109.768 -173.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 37.2 m-80 -97.92 161.32 13.79 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.81 -0.811 . . . . 74.53 108.81 178.197 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 m -74.72 -34.76 62.63 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.635 0.731 . . . . 43.13 109.867 -177.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -94.87 9.68 38.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.381 -0.827 . . . . 74.02 109.744 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 2.3 t0 -63.68 98.77 0.2 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.703 -0.681 . . . . 71.35 111.759 -171.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 61.1 m -103.98 -31.74 9.58 Favored 'General case' 1 N--CA 1.378 -4.069 0 N-CA-C 108.263 -1.014 . . . . 72.21 108.263 177.574 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.44 126.89 0.91 Allowed Glycine 0 N--CA 1.422 -2.267 0 CA-C-O 118.51 -1.161 . . . . 63.3 111.611 174.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 6.9 Cg_endo -56.51 148.15 65.01 Favored 'Trans proline' 0 CA--C 1.553 1.437 0 CA-C-N 120.518 2.159 . . . . 74.54 108.839 166.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.95 128.39 54.89 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.292 0.849 . . . . 54.21 113.292 -172.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 90.5 mt -94.57 133.22 38.44 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.77 -0.65 . . . . 75.41 109.503 176.047 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -111.62 83.64 1.81 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.556 0.693 . . . . 73.55 111.85 176.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.579 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -88.72 87.62 1.5 Allowed Glycine 0 N--CA 1.423 -2.174 0 CA-C-N 114.677 -1.147 . . . . 53.21 111.239 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.47 104.75 16.87 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.523 0.678 . . . . 73.5 110.667 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.36 160.58 68.09 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.123 -1.066 . . . . 75.44 108.123 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.64 -8.61 23.74 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 122.52 2.146 . . . . 74.41 112.64 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -120.63 39.63 3.71 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.64 -0.709 . . . . 72.13 110.951 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.2 m -56.45 -32.97 65.44 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 116.407 -0.36 . . . . 70.34 111.867 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -68.53 -12.5 61.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.213 0.53 . . . . 65.51 111.168 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -100.64 -9.2 22.14 Favored 'General case' 0 C--O 1.26 1.628 0 CA-C-N 116.046 -0.525 . . . . 71.21 110.249 -178.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 5.6 p -129.64 119.33 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.097 0.951 . . . . 72.32 111.209 177.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.67 110.63 21.96 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.225 -0.898 . . . . 72.02 109.815 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.01 114.42 35.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.995 -1.483 . . . . 74.2 106.995 177.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 m -123.78 164.38 19.29 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.776 -0.647 . . . . 72.12 109.79 -172.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -86.86 125.55 34.07 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.198 -1.408 . . . . 74.54 107.198 175.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 82.6 t80 -92.7 120.12 32.79 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.167 -0.679 . . . . 74.02 109.167 -175.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -138.52 99.21 3.77 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 106.776 -1.564 . . . . 72.22 106.776 174.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.7 t -174.36 153.35 1.92 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.024 -1.102 . . . . 74.22 108.024 -174.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.53 16.4 10.49 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.835 0.854 . . . . 74.21 111.501 174.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.27 85.1 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 116.065 -0.516 . . . . 54.41 112.793 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -104.07 153.63 20.66 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.116 -0.698 . . . . 74.34 109.116 -178.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 56' ' ' THR . 27.1 m -124.33 141.51 44.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.036 -1.098 . . . . 75.33 108.036 172.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -177.69 -154.21 12.03 Favored Glycine 0 N--CA 1.407 -3.24 0 C-N-CA 119.981 -1.104 . . . . 65.12 111.568 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.601 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 1.7 p -130.5 150.04 51.89 Favored 'General case' 0 C--N 1.26 -3.288 0 CA-C-O 121.351 0.596 . . . . 74.24 110.971 178.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -138.61 138.98 38.39 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 116.15 -0.477 . . . . 74.31 110.373 -175.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.97 114.1 25.71 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.593 -1.262 . . . . 73.11 107.593 175.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -115.23 112.09 38.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 109.422 -0.585 . . . . 70.24 109.422 -177.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.417 ' C ' ' HG ' ' A' ' 88' ' ' SER . 43.1 p90 -112.47 151.85 29.43 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 110.0 -0.371 . . . . 70.32 110.0 -175.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.417 ' HG ' ' C ' ' A' ' 87' ' ' PHE . 37.2 m -154.31 145.68 23.01 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 120.484 -0.487 . . . . 71.51 109.705 -175.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t0 60.13 62.39 1.63 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.471 1.129 . . . . 62.15 112.155 178.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.5 mt -119.23 170.97 8.63 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.675 -1.148 . . . . 73.51 108.908 175.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.465 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.2 t -113.59 169.12 9.2 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.825 -0.805 . . . . 74.21 108.825 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.48 -30.13 68.31 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.224 0.535 . . . . 75.2 111.077 -178.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.97 -25.56 67.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.975 -0.557 . . . . 63.42 111.433 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.465 ' OE1' HG22 ' A' ' 91' ' ' THR . 49.5 mt-10 -86.66 -16.57 36.21 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 112.468 0.544 . . . . 70.43 112.468 -176.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 11.6 mt -51.22 -55.19 30.6 Favored Pre-proline 0 N--CA 1.483 1.218 0 N-CA-C 115.382 1.623 . . . . 74.31 115.382 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.32 -40.66 56.69 Favored 'Trans proline' 0 C--N 1.366 1.452 0 CA-C-N 120.894 1.355 . . . . 71.15 110.954 -179.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -63.07 -40.0 96.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.88 -1.054 . . . . 74.15 111.511 -177.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -76.18 -19.89 58.02 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 120.604 -0.438 . . . . 74.44 110.586 177.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.09 -21.62 59.83 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.2 -0.667 . . . . 75.21 109.2 -177.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.03 -57.54 11.23 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.468 -0.787 . . . . 71.21 108.957 175.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.579 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 33.3 ttp -54.2 -49.09 70.17 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.764 -0.653 . . . . 72.23 110.094 178.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -53.9 -42.75 69.05 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.427 -0.806 . . . . 62.31 111.286 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.2 p -67.78 -24.92 65.38 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 120.018 -0.673 . . . . 70.44 111.603 -173.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.05 -25.14 66.11 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 120.914 0.388 . . . . 74.0 110.182 -177.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -103.4 -7.89 20.64 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.536 -0.466 . . . . 63.21 110.712 -179.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.63 -43.63 4.88 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.444 -0.503 . . . . 64.14 112.219 -173.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.92 12.72 80.81 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.694 -0.765 . . . . 64.22 111.688 -177.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 m -112.21 169.35 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.985 -0.746 . . . . 71.12 108.985 -178.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -114.07 124.76 52.9 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.854 -0.339 . . . . 64.22 110.708 -178.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.42 132.66 55.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.881 -0.785 . . . . 74.41 108.881 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.1 m -144.11 131.77 21.22 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.457 -0.571 . . . . 75.21 109.457 177.056 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 157.82 43.97 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.211 0.529 . . . . 74.41 112.405 -175.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -155.66 165.56 36.16 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.472 -1.24 . . . . 72.0 110.697 178.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -99.06 137.72 37.19 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 106.355 -1.72 . . . . 75.24 106.355 171.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -118.44 94.45 4.48 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 107.53 -1.285 . . . . 65.14 107.53 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.07 -114.44 5.25 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.406 -1.478 . . . . 71.01 109.406 -175.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -112.32 14.7 20.47 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.723 1.249 . . . . 73.44 108.922 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.5 pp -123.26 148.99 26.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 120.396 -1.44 . . . . 74.41 108.383 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 175' ' ' GLN . 70.8 t -99.55 135.99 32.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 O-C-N 122.18 -0.325 . . . . 73.32 110.544 -177.331 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.9 pt -118.86 130.23 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-O 121.767 0.794 . . . . 74.24 109.235 176.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 tt -126.91 131.61 51.09 Favored 'General case' 0 C--N 1.266 -3.064 0 CA-C-N 115.352 -0.84 . . . . 73.33 109.26 177.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -123.27 146.44 47.87 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.094 -1.076 . . . . 74.15 108.094 177.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.32 155.59 27.01 Favored Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 110.534 -1.026 . . . . 70.51 110.534 177.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.34 139.04 33.5 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.161 -1.051 . . . . 75.12 108.161 175.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.55 114.28 15.88 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.833 -0.622 . . . . 74.05 109.463 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -111.28 108.54 18.19 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.273 -1.01 . . . . 61.14 108.273 178.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.09 29.52 7.91 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.601 -0.518 . . . . 72.23 109.601 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.7 p -74.3 -13.92 60.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.122 -0.631 . . . . 73.21 110.563 -179.059 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.4 m -73.01 -9.84 59.16 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.46 -0.791 . . . . 72.3 109.491 174.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . 0.36 14.9 p 59.05 -59.16 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 128.127 2.571 . . . . 72.21 116.32 177.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.2 t 69.12 -66.24 0.26 Allowed 'General case' 0 C--O 1.251 1.164 0 C-N-CA 124.504 1.122 . . . . 74.15 110.593 -176.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -146.25 122.62 5.78 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 107.441 -1.318 . . . . 73.44 107.441 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -48.77 -43.03 35.86 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 123.845 3.03 . . . . 72.01 115.091 -176.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -99.52 17.47 20.29 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.093 0.775 . . . . 74.1 113.093 -174.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.85 136.88 38.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.907 -1.886 . . . . 72.11 105.907 171.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.9 t70 -132.21 125.94 32.36 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 120.553 -0.459 . . . . 72.34 110.047 -172.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 67.5 t -116.38 127.88 73.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.54 -0.864 . . . . 74.51 109.775 -179.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -128.53 141.13 51.47 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.134 -0.691 . . . . 72.42 109.134 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 5.6 tt -132.23 122.67 25.6 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.895 -1.52 . . . . 74.2 106.895 175.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 31' ' ' SER . 2.2 m -124.86 132.52 53.31 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.994 -1.113 . . . . 74.01 107.994 -176.149 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 71.8 t -124.08 125.98 71.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 109.549 -0.537 . . . . 75.04 109.549 178.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -109.41 121.1 44.44 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.745 -1.206 . . . . 61.33 107.745 175.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -133.82 105.83 11.67 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 111.756 0.28 . . . . 75.15 111.756 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -67.05 34.69 0.14 Allowed 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 123.604 2.869 . . . . 74.04 113.329 178.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -109.26 -90.39 0.46 Allowed 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.093 -0.706 . . . . 73.01 109.093 178.338 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.12 124.0 0.01 OUTLIER 'General case' 0 C--N 1.362 1.117 0 C-N-CA 124.196 0.998 . . . . 72.54 109.682 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.9 p -80.02 138.46 19.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.746 -0.835 . . . . 74.3 108.746 175.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.8 t -104.43 -27.58 11.85 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.678 -0.409 . . . . 63.41 110.371 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.6 m -159.48 132.33 6.84 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 108.049 -1.093 . . . . 63.1 108.049 174.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.1 t -140.42 150.75 44.24 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 118.531 0.605 . . . . 72.33 111.925 174.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -120.69 93.11 3.93 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 105.719 -1.956 . . . . 61.23 105.719 174.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.01 -142.73 6.41 Favored Glycine 0 C--N 1.296 -1.651 0 N-CA-C 107.347 -2.301 . . . . 65.01 107.347 -178.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -118.45 104.35 10.62 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 118.603 1.202 . . . . 71.14 109.88 177.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -84.87 113.57 21.47 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.945 -0.571 . . . . 75.41 111.094 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.5 mt -80.66 -46.62 21.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.52 -1.289 . . . . 75.04 107.52 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -134.0 160.76 67.3 Favored Pre-proline 0 C--N 1.295 -1.789 0 CA-C-N 114.317 -1.311 . . . . 75.34 107.491 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.411 ' HD2' ' OE2' ' A' ' 158' ' ' GLU . 48.6 Cg_exo -61.5 -17.13 52.06 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.496 2.131 . . . . 73.22 111.577 173.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 1.4 pm0 -115.13 2.42 14.13 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 113.484 0.92 . . . . 73.22 113.484 177.054 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.79 120.44 16.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 121.621 -0.674 . . . . 74.12 109.612 178.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.8 t -129.36 147.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 109.304 -0.628 . . . . 74.15 109.304 -177.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -136.77 143.61 43.33 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.31 0.576 . . . . 75.2 111.049 -178.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.407 ' CZ2' ' HB1' ' A' ' 174' ' ' ALA . 30.5 m-90 -119.79 123.93 44.89 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.468 -0.938 . . . . 62.14 108.468 177.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -101.15 110.34 22.35 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.296 0.569 . . . . 74.41 109.756 177.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.0 mm? -97.4 116.87 30.42 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 122.279 1.038 . . . . 72.13 108.723 -177.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -117.08 138.92 25.26 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 113.637 -1.619 . . . . 73.04 110.584 -169.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.06 156.63 61.68 Favored 'Trans proline' 0 C--O 1.244 0.81 0 C-N-CA 122.442 2.095 . . . . 72.34 111.351 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.55 -33.39 3.24 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 116.128 -0.487 . . . . 61.03 111.991 177.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 32.7 m -108.02 165.49 4.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.348 0.594 . . . . 74.22 111.656 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.42 144.14 22.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.723 -1.214 . . . . 73.32 107.723 175.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.9 m -139.29 142.86 37.71 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.651 -0.656 . . . . 73.24 111.549 179.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 13.3 p -96.25 150.36 20.63 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.337 -0.847 . . . . 74.4 108.917 177.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 76.2 mtp -129.65 128.75 43.23 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.863 -0.792 . . . . 75.12 108.863 -178.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.7 t -143.62 142.66 31.14 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.939 -1.134 . . . . 52.11 107.939 174.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.407 ' HB1' ' CZ2' ' A' ' 162' ' ' TRP . . . -155.18 116.63 4.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.879 -0.785 . . . . 73.44 108.879 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 48.3 mt-30 -125.53 130.56 51.97 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 108.022 -1.103 . . . . 72.24 108.022 176.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -143.44 158.97 43.21 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 116.533 -0.303 . . . . 71.42 110.969 -176.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -87.37 125.04 34.01 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.76 -0.376 . . . . 75.32 110.085 178.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.503 ' OH ' HG22 ' A' ' 34' ' ' ILE . 8.0 m-85 -134.86 120.29 19.13 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 114.371 1.249 . . . . 75.51 114.371 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.2 p -61.13 105.48 0.49 Allowed 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 113.937 -1.483 . . . . 65.33 110.51 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.55 139.76 94.32 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 113.944 -1.48 . . . . 71.33 110.646 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.55 -46.81 8.54 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.229 1.953 . . . . 72.34 113.33 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . 0.319 0.2 OUTLIER -84.21 -7.67 59.28 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 112.883 0.698 . . . . 74.14 112.883 -179.046 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.356 70.6 p 72.37 68.41 0.13 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 126.519 1.928 . . . . 72.42 115.158 172.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -84.11 155.64 22.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.92 -1.491 . . . . 73.1 108.637 174.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.297 -1.688 0 N-CA-C 108.15 -1.056 . . . . 63.21 108.15 179.128 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.533 0 N-CA-C 111.704 -0.558 . . . . 54.14 111.704 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -117.84 115.55 25.18 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.394 -0.965 . . . . 74.33 108.394 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -76.14 110.97 11.07 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.34 -0.615 . . . . 72.23 109.34 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -65.54 144.3 57.09 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.541 -0.754 . . . . 75.03 109.676 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mp -78.57 71.11 5.02 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.592 0.711 . . . . 74.12 111.794 -179.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -89.31 109.99 20.82 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.395 -0.965 . . . . 74.41 108.395 176.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -127.58 156.27 42.52 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.411 -0.589 . . . . 64.31 109.411 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.75 119.94 23.99 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.474 -0.936 . . . . 71.34 108.474 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.629 ' HA2' ' OD1' ' A' ' 134' ' ' ASP . . . -72.7 56.58 1.7 Allowed Glycine 0 C--N 1.32 -0.323 0 N-CA-C 116.296 1.278 . . . . 72.13 116.296 -171.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.484 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 27.8 m170 -146.1 26.97 1.19 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 123.777 0.831 . . . . 73.41 109.325 178.124 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 48.6 ttm -86.93 -57.2 3.06 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.816 -0.353 . . . . 74.25 111.626 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.74 148.59 34.32 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.257 0.466 . . . . 74.41 112.257 -178.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' NH2' ' HA ' ' A' ' 24' ' ' HIS . 0.0 OUTLIER -158.78 155.64 28.29 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.049 -0.523 . . . . 74.23 110.183 179.575 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.22 115.5 47.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.582 0.706 . . . . 75.42 109.359 177.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -113.12 119.0 36.32 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.776 -0.647 . . . . 72.13 110.749 -179.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.96 108.22 16.74 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.561 -1.274 . . . . 62.15 107.561 175.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 m -114.79 114.98 26.29 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.376 -1.342 . . . . 52.01 107.376 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.5 pp -126.83 146.18 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 109.419 -0.586 . . . . 74.22 109.419 -177.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.6 m -126.35 137.51 53.47 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 108.566 -0.902 . . . . 64.04 108.566 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.81 125.02 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 109.032 -0.729 . . . . 74.22 109.032 -176.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 m -105.78 152.08 40.08 Favored Pre-proline 0 N--CA 1.425 -1.689 0 CA-C-N 115.762 -0.653 . . . . 74.22 110.232 -177.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.62 2.42 0.98 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 123.904 3.069 . . . . 73.02 114.577 -176.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -87.99 3.54 48.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.222 -1.029 . . . . 75.4 108.222 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 91' ' ' THR . 15.0 t70 72.07 28.68 2.47 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 126.298 1.839 . . . . 71.35 106.227 -175.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 tp -102.02 129.04 48.23 Favored 'General case' 0 N--CA 1.381 -3.919 0 CA-C-N 112.689 -2.05 . . . . 73.44 109.164 -176.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.95 132.43 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 N-CA-C 107.827 -1.175 . . . . 74.54 107.827 176.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.2 p -142.52 151.42 41.62 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.621 -1.251 . . . . 71.42 107.621 177.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.53 -176.42 47.11 Favored Glycine 0 N--CA 1.418 -2.525 0 C-N-CA 118.722 -1.704 . . . . 73.31 112.7 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.65 133.58 25.66 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.736 -0.732 . . . . 73.1 109.878 -175.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.8 mt -120.42 115.7 47.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.218 -1.401 . . . . 75.34 107.218 175.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.83 115.31 48.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.115 0.483 . . . . 74.12 109.98 -178.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.494 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -105.93 108.42 19.92 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.116 -1.809 . . . . 75.42 106.116 173.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . . . -125.06 132.38 53.19 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.312 -0.555 . . . . 74.2 111.418 -175.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.45 129.44 41.19 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.931 -1.031 . . . . 73.45 110.866 -178.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 24' ' ' HIS . 54.3 mtmt -68.45 121.14 79.53 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 107.269 -1.382 . . . . 74.54 107.269 171.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -20.84 88.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 1 C-N-CA 126.418 4.745 . . . . 75.12 117.716 -168.017 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -82.69 -28.45 30.57 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.499 -0.773 . . . . 74.25 108.98 175.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -105.97 127.22 53.01 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.685 -1.143 . . . . 73.14 108.094 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.4 t -63.88 -25.63 68.24 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 124.003 0.921 . . . . 55.24 112.19 -173.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -103.03 6.14 38.57 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.992 0.738 . . . . 75.54 112.992 -177.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.38 116.13 28.7 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 114.633 1.346 . . . . 71.21 114.633 -175.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -110.4 -7.92 14.74 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.529 -1.214 . . . . 75.14 108.119 173.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.36 96.82 0.1 Allowed Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.595 -0.812 . . . . 73.02 112.845 176.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.77 160.57 45.93 Favored 'Trans proline' 0 C--O 1.248 1.025 0 C-N-CA 123.487 2.791 . . . . 74.34 111.932 174.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.83 158.49 28.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.765 0.317 . . . . 70.15 111.096 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 95.2 mt -102.25 154.99 18.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 106.62 -1.622 . . . . 74.32 106.62 173.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -93.03 86.35 5.38 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.227 1.013 . . . . 71.21 109.703 -177.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.503 ' HA2' ' SD ' ' A' ' 101' ' ' MET . . . -85.16 84.31 1.6 Allowed Glycine 0 N--CA 1.413 -2.888 0 CA-C-N 114.101 -1.408 . . . . 72.42 111.958 -178.011 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -112.05 97.6 6.77 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.986 0.422 . . . . 72.1 110.244 178.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 m -146.1 159.45 46.01 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 123.995 0.918 . . . . 74.43 108.815 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.18 -9.02 22.9 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.106 1.871 . . . . 74.32 112.05 176.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -114.79 42.05 2.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 74.33 111.994 -178.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.6 m -55.3 -28.32 52.83 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 111.776 0.287 . . . . 72.42 111.776 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -65.65 -20.32 66.26 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 121.276 0.56 . . . . 74.32 110.813 -178.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -90.85 -18.26 25.14 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.645 -0.707 . . . . 75.34 110.535 -177.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.98 119.59 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 121.964 0.887 . . . . 54.12 112.532 -176.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.67 104.79 16.11 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.273 -0.876 . . . . 75.23 109.58 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.8 p -98.95 133.04 43.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.054 -0.721 . . . . 74.31 109.054 177.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -154.74 173.46 16.39 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 123.335 0.654 . . . . 72.14 109.612 -175.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -77.72 153.62 32.82 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.495 0.664 . . . . 75.24 110.308 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 76.9 t80 -114.39 122.55 46.99 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 108.022 -1.103 . . . . 72.41 108.022 176.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -138.62 102.85 4.7 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.913 -1.514 . . . . 72.3 106.913 177.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -164.13 141.88 7.03 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.147 -0.686 . . . . 72.32 109.147 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 67.05 10.45 7.7 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.887 0.875 . . . . 64.15 111.996 174.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.88 -0.36 64.6 Favored Glycine 0 N--CA 1.426 -2.026 0 N-CA-C 111.238 -0.745 . . . . 72.11 111.238 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 12.6 m-85 -96.95 142.0 29.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.454 -0.943 . . . . 75.1 108.454 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 35.3 m -123.85 136.92 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 108.26 -1.015 . . . . 72.34 108.26 174.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.34 -155.34 9.44 Favored Glycine 0 N--CA 1.402 -3.612 0 C-N-CA 119.189 -1.482 . . . . 44.43 112.051 179.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.405 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 16.0 p -126.62 134.42 50.78 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 114.84 -0.68 . . . . 74.2 110.749 -177.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.412 ' NE2' ' HD1' ' A' ' 75' ' ' TYR . 3.7 pt20 -126.74 143.12 51.34 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.06 0.457 . . . . 74.53 111.317 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -124.35 114.54 19.68 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.272 -1.381 . . . . 64.45 107.272 174.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.76 115.17 48.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 107.845 -1.169 . . . . 74.22 107.845 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.47 ' CD2' HD11 ' A' ' 90' ' ' LEU . 49.8 p90 -115.45 152.43 32.94 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.153 0.501 . . . . 72.34 110.473 -176.013 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 p -159.27 155.3 26.69 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.906 -0.588 . . . . 61.21 109.641 -176.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.24 31.32 6.69 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.076 0.86 . . . . 74.04 111.386 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.47 HD11 ' CD2' ' A' ' 87' ' ' PHE . 25.2 mt -91.76 156.56 17.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 116.106 -0.497 . . . . 74.55 109.785 176.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 40.1 p -108.0 171.9 7.14 Favored 'General case' 0 C--N 1.277 -2.556 0 O-C-N 123.801 0.688 . . . . 73.11 109.933 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -57.01 -35.95 69.85 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.998 0.519 . . . . 74.02 109.729 179.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.08 -28.5 66.57 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.859 -0.61 . . . . 72.22 111.372 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.425 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 41.0 mt-10 -86.33 -17.03 35.6 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.212 0.449 . . . . 55.34 112.212 -176.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.68 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.9 tt -61.36 -48.65 90.5 Favored Pre-proline 0 CA--C 1.569 1.68 0 N-CA-C 112.355 0.502 . . . . 72.52 112.355 -178.084 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.91 -37.9 82.61 Favored 'Trans proline' 0 C--N 1.376 2.009 0 CA-C-N 121.049 1.41 . . . . 74.54 110.316 176.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.425 ' NE2' ' HA ' ' A' ' 94' ' ' GLU . 20.7 mt-30 -63.91 -38.76 92.27 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.93 -1.032 . . . . 72.23 111.129 -177.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.5 pp -70.11 -23.84 63.1 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 120.669 -0.412 . . . . 72.34 110.103 177.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.4 -20.78 63.8 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.094 -0.503 . . . . 64.02 110.587 -175.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -63.27 -57.95 8.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.404 -0.591 . . . . 73.34 109.404 176.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.503 ' SD ' ' HA2' ' A' ' 62' ' ' GLY . 65.3 mtm -56.68 -48.97 76.46 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.436 0.636 . . . . 75.35 109.507 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -53.93 -40.57 66.86 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.264 -1.335 . . . . 75.44 111.644 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.8 p -65.22 -26.87 68.31 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 119.906 -0.717 . . . . 75.45 111.077 -172.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.04 -33.26 74.05 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 116.15 -0.477 . . . . 74.4 110.71 -176.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.41 -9.57 20.17 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.287 -0.565 . . . . 70.2 111.058 -176.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.96 -47.64 3.66 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.143 0.794 . . . . 53.25 113.143 -173.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.79 7.3 64.73 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.861 -0.896 . . . . 54.14 110.861 -173.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.6 m -101.51 172.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 O-C-N 122.427 -0.455 . . . . 75.21 110.493 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -138.93 141.08 38.48 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.409 -1.33 . . . . 64.54 107.409 176.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.87 132.29 38.37 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.744 -0.836 . . . . 75.2 108.744 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.2 m -134.76 134.12 40.61 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.343 -0.984 . . . . 73.41 108.343 178.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -141.85 147.91 37.96 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.328 0.585 . . . . 61.04 111.551 -178.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -146.02 154.87 42.36 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.402 -1.272 . . . . 75.01 110.658 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.7 mtt85 -88.61 138.68 31.21 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.627 -0.715 . . . . 75.24 109.926 171.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.455 ' O ' HG13 ' A' ' 118' ' ' ILE . 51.7 t30 -123.11 90.04 3.22 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 105.486 -2.042 . . . . 63.42 105.486 176.017 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.5 -118.7 8.66 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 108.857 -1.697 . . . . 42.24 108.857 -170.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 9.5 t30 -105.95 1.31 26.52 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.706 1.241 . . . . 72.42 108.94 178.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -103.9 148.98 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 118.818 -1.153 . . . . 74.4 108.19 178.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.74 140.47 32.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 121.972 -0.455 . . . . 72.42 111.45 -176.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.438 HD11 ' O ' ' A' ' 120' ' ' ILE . 2.9 pp -121.41 121.52 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 115.058 -0.974 . . . . 73.42 109.161 178.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.33 127.8 50.25 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.127 -0.694 . . . . 74.1 109.127 179.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -125.97 135.71 52.15 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.36 -0.836 . . . . 73.35 109.469 177.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -145.74 158.07 27.56 Favored Glycine 0 N--CA 1.416 -2.67 0 N-CA-C 110.86 -0.896 . . . . 74.2 110.86 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.43 145.42 43.14 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.808 -0.442 . . . . 74.41 109.808 177.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -111.06 119.42 38.97 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.073 0.463 . . . . 74.31 111.336 -176.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -112.89 93.53 4.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.277 -0.419 . . . . 73.41 110.209 179.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -142.75 26.24 1.75 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.197 1.475 . . . . 75.41 108.398 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.5 p -68.64 -25.85 65.04 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 113.272 -1.785 . . . . 75.0 112.008 -176.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.1 m -82.97 5.58 21.58 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.343 0.592 . . . . 64.53 110.874 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.9 t 65.75 96.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.31 0 C-N-CA 124.823 1.249 . . . . 75.43 111.998 177.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.4 m -69.31 -44.36 71.88 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.575 0.702 . . . . 71.42 109.442 177.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 8.4 t70 -155.2 141.6 13.16 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 107.139 -1.43 . . . . 74.11 107.139 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.25 -26.97 79.0 Favored 'Trans proline' 0 CA--C 1.552 1.399 0 C-N-CA 123.322 2.681 . . . . 73.13 115.454 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.629 ' OD1' ' HA2' ' A' ' 23' ' ' GLY . 36.8 t70 -107.11 -11.23 15.68 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.522 0.601 . . . . 72.31 112.001 -176.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 132' ' ' ASP . . . -52.68 116.51 2.34 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.423 0.63 . . . . 71.33 112.569 -176.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -118.59 126.74 52.62 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.888 -1.893 . . . . 62.43 105.888 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 42.5 t -110.97 117.07 54.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 121.136 -0.226 . . . . 63.54 110.497 -175.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -109.97 120.32 42.09 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.644 -0.502 . . . . 73.22 109.644 176.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.485 HD11 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -114.1 116.24 28.81 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.553 -2.017 . . . . 72.21 105.553 175.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 19.4 m -122.52 131.23 53.75 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.71 -0.478 . . . . 61.2 109.71 -177.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 94.4 t -122.68 122.83 66.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.75 -0.833 . . . . 73.03 108.75 178.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.8 126.63 55.64 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.999 0.428 . . . . 74.22 110.29 178.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.625 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.5 p90 -133.83 123.07 16.91 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.876 -0.602 . . . . 73.53 110.068 177.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -74.43 35.46 0.4 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.61 2.207 . . . . 74.3 113.503 -178.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.74 -100.47 0.43 Allowed 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 122.192 -0.318 . . . . 64.5 110.772 -177.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -177.3 128.76 0.16 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.951 -0.759 . . . . 45.34 108.951 -177.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.38 133.24 29.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.539 -0.755 . . . . 73.15 109.324 177.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 p -88.81 -38.92 14.26 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.376 0.607 . . . . 74.33 109.456 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 74.5 m -159.52 133.18 7.25 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 115.707 -0.679 . . . . 72.55 109.811 176.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.455 ' OG1' HG13 ' A' ' 160' ' ' VAL . 8.1 t -137.97 155.96 48.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.349 -0.611 . . . . 73.33 109.349 174.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -126.69 93.89 3.9 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 105.987 -1.857 . . . . 73.42 105.987 175.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.59 -144.51 8.2 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 108.555 -1.818 . . . . 75.03 108.555 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -114.29 99.97 7.99 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 117.653 0.726 . . . . 73.52 109.367 -178.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -77.51 126.93 31.66 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-N 115.752 -0.658 . . . . 65.2 109.794 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.16 -37.49 9.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.225 -1.398 . . . . 72.32 107.225 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -142.65 166.64 19.62 Favored Pre-proline 0 N--CA 1.425 -1.713 0 N-CA-C 106.451 -1.685 . . . . 73.44 106.451 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.84 0.55 6.29 Favored 'Trans proline' 0 C--O 1.21 -0.88 0 C-N-CA 122.475 2.117 . . . . 74.3 110.684 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.6 pt-20 -130.12 0.12 4.67 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.902 -0.59 . . . . 73.2 111.689 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 82.2 t -140.65 120.89 13.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.469 -0.937 . . . . 72.02 108.469 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.455 HG13 ' OG1' ' A' ' 150' ' ' THR . 41.6 t -125.57 147.23 30.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.345 -0.613 . . . . 71.42 109.345 -177.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -137.25 143.57 42.29 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.416 0.627 . . . . 72.12 110.074 -177.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.485 ' CE3' HD11 ' A' ' 139' ' ' LEU . 25.6 m-90 -123.67 120.2 32.04 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 108.075 -1.083 . . . . 75.34 108.075 177.082 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.0 pttt -108.95 102.47 11.47 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.352 -0.84 . . . . 63.41 109.081 -178.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 9.5 mt -101.13 138.24 38.43 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.818 -1.083 . . . . 72.25 110.166 -171.469 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -118.56 151.71 50.15 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 115.566 -0.743 . . . . 75.11 110.884 177.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.95 157.43 47.16 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.298 1.998 . . . . 75.11 111.096 178.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 86.55 -36.15 3.27 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.432 -0.89 . . . . 75.14 111.637 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.75 153.9 6.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 109.584 -0.524 . . . . 74.4 109.584 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.39 143.46 12.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.811 -0.44 . . . . 74.23 109.811 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 48.5 m -146.52 143.0 28.62 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.329 -0.989 . . . . 72.1 108.329 176.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -125.49 156.96 38.14 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.811 -0.811 . . . . 72.12 108.811 178.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -126.32 137.8 53.52 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.523 0.677 . . . . 75.43 112.028 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.7 t -134.48 136.92 43.51 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.141 -1.429 . . . . 75.35 107.141 173.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -148.09 116.38 6.54 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.634 -0.876 . . . . 62.54 108.634 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -127.08 131.25 50.93 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 107.216 -1.401 . . . . 74.21 107.216 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -159.44 154.13 24.44 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.445 -0.946 . . . . 72.51 108.445 -176.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 29.2 ptt180 -87.96 129.29 35.29 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.168 -1.013 . . . . 75.24 110.776 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.05 116.27 19.76 Favored 'General case' 0 CA--C 1.477 -1.828 0 N-CA-C 107.721 -1.214 . . . . 75.0 107.721 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.467 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 18.0 p -67.0 123.78 21.18 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.873 -1.058 . . . . 75.53 112.242 -175.106 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.47 124.2 60.56 Favored Pre-proline 0 C--N 1.321 -0.662 0 O-C-N 124.071 0.857 . . . . 71.43 108.766 172.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -67.32 -24.81 43.01 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 122.325 2.017 . . . . 74.42 110.81 -179.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.04 -12.09 55.71 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.135 -1.393 . . . . 73.32 110.334 178.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.2 p 63.47 111.39 0.03 OUTLIER 'General case' 0 C--O 1.246 0.87 0 C-N-CA 126.252 1.821 . . . . 75.44 113.239 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -123.71 175.99 6.52 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.005 0.907 . . . . 74.33 112.609 -177.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.424 -1.754 0 CA-C-N 113.889 -1.505 . . . . 64.32 107.73 172.558 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.388 0 N-CA-C 109.949 -1.26 . . . . 43.31 109.949 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.0 ptt85 -108.27 -26.63 10.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.632 0.604 . . . . 74.22 112.632 -177.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -74.48 -46.83 37.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.98 0.419 . . . . 64.0 111.262 -175.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -128.12 101.13 6.14 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.32 0.581 . . . . 70.02 109.725 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.8 tp -141.73 102.28 4.14 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.926 -1.139 . . . . 73.14 107.926 178.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.4 t80 71.88 108.47 0.07 Allowed 'General case' 0 C--O 1.245 0.849 0 O-C-N 124.876 1.36 . . . . 72.3 110.046 -176.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -59.45 119.9 8.35 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.048 -0.978 . . . . 74.02 111.039 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -84.28 -53.85 5.2 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.213 -1.032 . . . . 73.43 108.213 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.04 108.47 3.18 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 109.221 -1.552 . . . . 61.15 109.221 -177.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -79.66 -62.41 1.69 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.402 0.519 . . . . 71.43 112.402 -174.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 23.7 ptm -145.86 -174.95 4.55 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 116.21 -0.45 . . . . 65.51 110.198 -171.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 48' ' ' ALA . 4.6 pp -133.65 141.86 47.8 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.873 -1.528 . . . . 75.34 106.873 175.022 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 141.4 39.91 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 119.056 -1.058 . . . . 74.24 110.83 -176.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.3 t -113.86 113.4 43.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 105.564 -2.013 . . . . 71.32 105.564 173.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -120.73 114.61 21.9 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.026 -0.731 . . . . 75.21 109.026 -177.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.45 124.46 51.81 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.215 -0.902 . . . . 72.24 109.347 -178.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -124.79 115.69 21.09 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.49 -1.3 . . . . 73.1 107.49 177.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.6 pp -122.36 138.71 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.883 -0.784 . . . . 74.25 108.883 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 93.5 m -119.33 121.68 40.13 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 108.845 -0.798 . . . . 51.51 108.845 -179.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 tt -109.76 115.62 50.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-O 121.675 0.75 . . . . 73.42 109.729 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 37' ' ' ASP . 15.8 m -80.08 148.17 67.14 Favored Pre-proline 0 N--CA 1.412 -2.349 0 N-CA-C 107.985 -1.117 . . . . 75.01 107.985 -179.072 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.85 2.87 0.85 Allowed 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 123.73 2.953 . . . . 75.21 112.972 -179.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 35' ' ' SER . 25.3 t70 -87.11 -1.82 58.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.609 -0.885 . . . . 71.13 108.609 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 12.8 t70 73.05 29.46 1.77 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.054 1.742 . . . . 63.2 108.135 -175.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.11 124.76 50.08 Favored 'General case' 0 N--CA 1.394 -3.24 0 CA-C-N 113.946 -1.479 . . . . 71.34 107.653 178.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 t -109.72 129.87 63.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.835 -0.802 . . . . 72.03 108.835 -178.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.6 p -143.79 131.55 21.38 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.286 -1.005 . . . . 72.44 108.286 179.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.27 -175.34 32.2 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 118.967 -1.587 . . . . 71.31 113.178 -176.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.39 133.3 16.02 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 123.503 0.721 . . . . 73.01 109.529 -176.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 60.9 mt -120.11 116.13 49.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 107.88 -1.155 . . . . 71.24 107.88 177.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.11 116.62 53.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.712 -0.477 . . . . 72.33 109.712 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.56 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.79 108.49 17.92 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.387 -1.338 . . . . 73.24 107.387 175.462 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.51 122.09 40.87 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.754 -0.461 . . . . 54.21 109.754 -177.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 26' ' ' LEU . . . -114.92 158.07 22.49 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.76 -0.654 . . . . 71.42 111.811 -176.088 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -69.01 123.32 87.9 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 114.579 -1.191 . . . . 73.35 109.911 175.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.63 132.3 24.89 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.592 2.195 . . . . 75.43 114.23 -174.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 10.8 tmtt? -91.23 -5.82 54.25 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 104.331 -2.47 . . . . 74.44 104.331 171.045 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 71.3 -63.22 0.43 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.006 2.122 . . . . 63.25 112.7 173.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.1 t -55.3 -37.74 67.76 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.589 0.756 . . . . 74.43 112.948 -173.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -103.35 -14.02 16.45 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.994 0.426 . . . . 72.32 110.489 178.201 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -102.99 96.94 7.13 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 114.473 1.286 . . . . 75.52 114.473 -166.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -96.9 -29.67 13.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.034 -1.839 . . . . 74.4 106.034 166.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.23 98.24 0.11 Allowed Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 108.792 -1.723 . . . . 61.22 108.792 175.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -52.52 128.51 28.23 Favored 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 122.121 1.881 . . . . 75.52 110.237 177.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.57 157.94 16.72 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.593 0.96 . . . . 74.3 113.593 -169.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.571 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 71.1 mt -102.45 138.1 39.81 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.164 -0.925 . . . . 74.21 109.742 176.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.7 89.15 3.4 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.502 0.668 . . . . 75.24 111.352 178.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.488 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -120.47 113.87 2.52 Favored Glycine 0 N--CA 1.409 -3.108 0 CA-C-N 115.17 -0.923 . . . . 75.34 111.525 177.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -116.9 107.62 14.82 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.606 -0.887 . . . . 73.45 108.606 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.4 m -136.97 151.61 72.46 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.534 -0.913 . . . . 75.44 108.534 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -73.12 -8.82 22.67 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 122.61 2.207 . . . . 73.22 112.484 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -108.93 36.64 2.8 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.416 0.627 . . . . 74.14 109.834 176.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -57.71 -30.26 65.38 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.425 -0.807 . . . . 73.44 112.454 -179.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -69.51 -18.39 63.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.359 0.6 . . . . 74.34 110.325 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -89.55 -16.03 31.57 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.437 -0.801 . . . . 72.42 109.944 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.6 p -118.52 118.88 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 122.515 1.15 . . . . 75.3 111.235 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.74 104.95 16.9 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.162 -0.926 . . . . 73.11 108.864 -179.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 t -97.99 131.16 45.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.942 -1.503 . . . . 62.33 106.942 179.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.1 m -144.33 171.76 13.88 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.358 -0.979 . . . . 70.32 108.358 -176.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -88.63 153.87 20.77 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 118.968 -1.093 . . . . 73.12 108.259 178.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -112.6 123.27 49.92 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.792 -1.188 . . . . 75.34 107.792 177.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -139.11 99.18 3.69 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.624 0.726 . . . . 72.12 109.361 177.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.9 m -165.29 161.23 19.03 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.956 -1.127 . . . . 63.03 107.956 -179.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 70.51 3.32 4.45 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.253 1.021 . . . . 75.4 110.914 178.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.51 1.15 83.75 Favored Glycine 0 C--O 1.22 -0.76 0 N-CA-C 110.197 -1.161 . . . . 73.2 110.197 -172.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -104.82 150.49 24.77 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.317 0.647 . . . . 74.23 110.629 -179.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.11 138.18 55.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.466 0.65 . . . . 63.23 110.032 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.32 -153.36 8.15 Favored Glycine 0 C--N 1.276 -2.794 0 N-CA-C 109.946 -1.261 . . . . 54.24 109.946 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.571 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 p -131.45 159.47 37.98 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-O 121.256 0.551 . . . . 72.21 110.933 179.065 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -138.39 140.35 39.35 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.023 -0.535 . . . . 75.33 110.435 179.015 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.81 114.68 24.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.683 -1.229 . . . . 73.45 107.683 175.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.78 111.65 37.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.476 -0.935 . . . . 74.4 108.476 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -113.35 152.81 29.47 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.785 -0.366 . . . . 75.12 110.903 -174.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 p -151.65 154.35 36.2 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.215 -0.448 . . . . 73.41 111.218 -173.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.91 30.63 16.5 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 124.157 0.983 . . . . 72.51 112.877 173.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.2 mt -92.49 160.13 15.2 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 116.202 -0.454 . . . . 74.22 109.798 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.1 t -112.83 175.08 5.59 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 108.819 -0.808 . . . . 75.12 108.819 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.44 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 84.8 t80 -49.38 -44.21 44.8 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.034 0.934 . . . . 65.23 110.82 178.805 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.14 69.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.468 -0.787 . . . . 53.32 112.517 -178.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.35 -16.8 32.03 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.26 0.467 . . . . 74.53 112.26 -174.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 3.9 tt -65.91 -50.03 55.18 Favored Pre-proline 0 CA--C 1.567 1.623 0 CA-C-O 119.228 -0.415 . . . . 74.25 111.544 -178.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.46 -36.52 86.18 Favored 'Trans proline' 0 C--N 1.375 1.94 0 CA-C-N 121.199 1.464 . . . . 64.42 110.698 175.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -63.66 -38.8 92.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 73.13 111.523 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.0 pp -74.06 -19.94 60.45 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.782 -0.451 . . . . 74.12 109.782 177.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.09 -27.5 62.7 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.181 -0.674 . . . . 73.4 109.181 -178.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -61.09 -53.52 56.03 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.758 -0.83 . . . . 74.03 108.758 176.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.488 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 22.7 ttp -53.79 -51.85 62.16 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.518 -0.764 . . . . 70.42 110.054 176.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -55.41 -36.07 66.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.283 -0.871 . . . . 74.1 111.014 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.7 m -62.48 -37.61 86.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 110.182 -0.303 . . . . 73.23 110.182 -175.132 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -73.66 -13.22 60.95 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.355 0.598 . . . . 71.51 110.628 -171.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.43 -19.31 13.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.151 -0.62 . . . . 74.15 110.443 179.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.93 -44.18 4.48 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.572 0.953 . . . . 75.41 113.572 -172.497 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.04 21.43 49.86 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.135 -0.786 . . . . 71.14 111.135 -173.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.5 171.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.265 -0.643 . . . . 72.44 109.265 -178.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -128.64 138.28 52.1 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 117.644 0.202 . . . . 73.2 111.236 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.82 130.97 40.51 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.909 -1.145 . . . . 72.03 107.909 176.027 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.2 t -144.07 151.97 40.35 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.451 -0.944 . . . . 73.13 108.451 177.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.8 148.02 28.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.825 -0.806 . . . . 72.32 108.825 178.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -143.91 156.67 44.52 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.826 -0.625 . . . . 74.2 109.587 -176.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -91.22 138.09 31.86 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 121.521 0.677 . . . . 73.13 112.241 175.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.409 ' O ' HG13 ' A' ' 118' ' ' ILE . 30.7 t30 -127.56 91.9 3.39 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 113.978 -1.464 . . . . 71.22 107.248 177.279 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 185' ' ' SER . . . 76.54 -106.77 2.23 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 109.579 -1.409 . . . . 74.24 109.579 -175.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -123.73 10.12 8.97 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.841 1.305 . . . . 75.11 108.107 175.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.8 pp -112.88 149.51 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.025 -1.102 . . . . 74.22 108.025 177.139 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.3 t -107.0 133.63 51.07 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 CA-C-O 120.948 0.404 . . . . 62.14 109.996 -176.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.8 pt -105.68 137.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 107.627 -1.249 . . . . 74.53 107.627 176.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.72 127.08 45.66 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 109.048 -0.723 . . . . 74.31 109.048 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -127.71 115.31 18.52 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.347 -1.297 . . . . 72.23 108.19 -177.048 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.3 141.84 11.16 Favored Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 109.854 -1.298 . . . . 62.04 109.854 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -137.05 135.25 37.37 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.388 -0.968 . . . . 73.12 108.388 -177.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.9 110.2 19.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.909 -0.587 . . . . 63.43 111.183 -174.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -105.22 98.59 8.28 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.473 0.654 . . . . 73.11 110.379 177.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.7 mm? -113.26 23.95 12.76 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.602 -0.888 . . . . 75.05 108.602 178.395 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 45.5 p -65.58 -19.11 65.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.83 1.048 . . . . 75.31 113.83 -173.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.1 m -72.95 -24.65 60.82 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.272 -0.268 . . . . 75.41 111.42 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.9 t 62.43 86.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.49 1.116 . . . . 75.3 111.788 179.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.7 m -79.2 -49.32 12.71 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.308 -0.997 . . . . 55.24 108.308 177.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.24 125.63 18.97 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.218 -1.03 . . . . 75.44 108.218 176.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.3 -15.6 31.47 Favored 'Trans proline' 0 C--O 1.22 -0.393 0 C-N-CA 121.958 1.772 . . . . 73.15 111.289 178.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.53 11.54 38.89 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.454 -0.794 . . . . 74.21 110.478 -178.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -89.15 123.39 33.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.529 -0.305 . . . . 73.45 111.656 -176.356 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.77 122.63 38.55 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.182 -0.673 . . . . 75.02 109.182 173.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 61.5 t -111.53 120.88 63.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.266 -1.012 . . . . 72.33 108.266 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -121.34 126.53 49.69 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.122 -0.696 . . . . 74.03 109.122 -176.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -119.13 123.56 44.69 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.443 -0.947 . . . . 73.4 108.443 -178.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.7 m -123.87 134.29 53.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.047 -0.723 . . . . 75.23 109.047 179.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 90.3 t -120.68 125.64 74.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.879 -0.785 . . . . 73.45 108.879 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.83 126.27 55.26 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.829 -0.804 . . . . 63.43 108.829 177.489 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.0 p90 -134.47 119.24 14.05 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 112.044 0.387 . . . . 75.44 112.044 178.558 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -68.0 42.97 0.25 Allowed 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.166 2.577 . . . . 74.54 112.425 174.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.0 -106.84 0.33 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 122.732 0.413 . . . . 63.12 110.068 179.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -179.62 131.82 0.1 Allowed 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.401 -0.592 . . . . 72.24 109.401 -177.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -85.26 133.14 30.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.88 -0.785 . . . . 75.53 108.88 177.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.1 p -92.55 -34.71 13.94 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.363 -0.38 . . . . 65.14 110.432 -177.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.3 m -162.73 133.28 4.7 Favored 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 123.875 0.87 . . . . 73.22 109.216 177.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.1 t -139.01 163.92 31.13 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.489 -0.757 . . . . 72.43 111.217 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.552 ' HB3' ' OG ' ' A' ' 173' ' ' SER . 27.4 t-20 -136.41 98.38 3.81 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.23 -2.137 . . . . 73.14 105.23 171.097 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.3 -150.04 10.69 Favored Glycine 0 N--CA 1.412 -2.927 0 N-CA-C 107.157 -2.377 . . . . 65.22 107.157 -179.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -116.69 99.21 6.97 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.196 -1.409 . . . . 75.33 107.196 -178.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . 0.264 6.3 ppt_? -86.34 139.34 31.06 Favored 'General case' 0 N--CA 1.414 -2.272 0 C-N-CA 119.325 -0.95 . . . . 74.04 113.28 -178.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 69.8 mt -94.46 -43.11 13.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.244 -1.344 . . . . 74.52 108.015 -178.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -137.75 172.68 6.39 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 107.54 -1.281 . . . . 74.3 107.54 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -74.22 0.61 8.26 Favored 'Trans proline' 0 C--O 1.21 -0.919 0 C-N-CA 122.197 1.932 . . . . 74.22 110.044 172.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 11.2 pt-20 -130.3 3.23 4.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.228 0.537 . . . . 64.42 111.867 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.3 t -142.09 121.11 9.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.487 -0.931 . . . . 73.22 108.487 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.94 147.64 32.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 109.549 -0.537 . . . . 73.44 109.549 -178.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -132.58 145.13 50.87 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.193 0.521 . . . . 72.5 110.259 -176.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.442 ' CD2' ' HG3' ' A' ' 172' ' ' MET . 27.8 m-90 -130.25 128.74 42.22 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.694 -0.484 . . . . 74.13 109.694 177.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -102.66 112.67 25.54 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.69 0.757 . . . . 74.12 110.019 177.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 33.2 mt -101.41 123.42 45.45 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.025 -0.989 . . . . 72.23 109.022 -176.392 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -118.07 156.38 50.4 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 115.882 -0.599 . . . . 75.2 112.052 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.436 ' HA ' ' CB ' ' A' ' 127' ' ' LEU . 59.8 Cg_endo -74.41 156.47 45.69 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.79 2.327 . . . . 70.14 111.552 177.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.94 -30.92 2.86 Favored Glycine 0 C--N 1.317 -0.527 0 C-N-CA 121.288 -0.482 . . . . 71.41 112.4 177.538 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 166' ' ' PRO . 34.3 m -105.82 160.96 5.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 120.902 0.382 . . . . 71.34 110.42 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.4 p -113.62 110.15 31.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 122.102 0.954 . . . . 72.14 108.787 176.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 32.8 t -101.09 141.5 33.88 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.597 -0.729 . . . . 72.33 109.981 -175.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.1 p -106.42 126.55 52.39 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.584 -0.734 . . . . 74.52 110.526 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.442 ' HG3' ' CD2' ' A' ' 162' ' ' TRP . 39.5 ttm -107.68 116.16 31.44 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.758 -1.201 . . . . 74.45 107.758 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.552 ' OG ' ' HB3' ' A' ' 151' ' ' ASN . 11.7 p -142.85 139.41 30.85 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 118.303 -1.359 . . . . 74.34 111.07 177.068 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -151.26 146.83 26.32 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 108.28 -1.007 . . . . 73.33 108.28 -176.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -138.36 130.72 28.9 Favored 'General case' 0 C--N 1.261 -3.246 0 N-CA-C 105.834 -1.913 . . . . 74.32 105.834 173.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.3 158.88 44.36 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.674 -0.491 . . . . 63.41 109.674 -177.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -91.34 135.2 33.98 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.155 -0.683 . . . . 73.31 109.155 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -143.05 123.82 14.2 Favored 'General case' 0 CA--C 1.47 -2.119 0 C-N-CA 120.119 -0.632 . . . . 75.52 109.93 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.3 p -65.14 104.05 0.85 Allowed 'General case' 0 C--N 1.284 -2.281 0 O-C-N 124.514 1.134 . . . . 72.11 111.232 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 184' ' ' ARG . 13.7 t70 -57.41 134.25 81.68 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 115.078 -0.964 . . . . 73.53 109.889 178.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.78 -38.99 2.04 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.64 2.227 . . . . 72.43 112.644 -178.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.88 -10.16 58.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.396 0.617 . . . . 75.4 110.454 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.304 51.1 p 68.23 72.15 0.3 Allowed 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 126.9 2.08 . . . . 73.13 114.075 172.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.42 ' HG2' ' OD2' ' A' ' 180' ' ' ASP . 7.9 ptm180 -99.95 168.74 9.67 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.772 -1.104 . . . . 73.51 109.587 175.462 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.522 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 49.5 m . . . . . 0 C--N 1.292 -1.905 0 N-CA-C 106.663 -1.606 . . . . 74.22 106.663 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.959 0 N-CA-C 109.714 -1.354 . . . . 43.05 109.714 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 70.43 -41.42 0.5 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.506 1.522 . . . . 73.21 111.894 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.87 106.16 4.09 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 105.95 -1.87 . . . . 73.43 105.95 172.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 68.22 85.41 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 124.427 1.08 . . . . 73.04 108.977 -170.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 tt -82.66 101.14 10.63 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.61 -1.626 . . . . 72.33 106.61 178.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -94.0 116.85 29.33 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.036 -0.983 . . . . 73.1 109.136 -174.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -97.03 107.44 19.97 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.387 -1.338 . . . . 72.14 107.387 176.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -95.28 162.96 13.47 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.65 -1.241 . . . . 62.53 107.65 -177.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.34 23.45 54.32 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 107.553 -2.219 . . . . 71.24 107.553 -171.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -131.79 145.45 51.59 Favored 'General case' 0 N--CA 1.418 -2.062 0 C-N-CA 126.364 1.866 . . . . 73.51 106.148 -175.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 66.8 mtt 80.15 -41.43 0.21 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.025 1.33 . . . . 75.55 110.318 -175.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 3.2 tt -147.56 131.92 17.57 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 104.658 -2.349 . . . . 73.11 104.658 172.11 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -146.2 137.44 24.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.882 0.372 . . . . 63.14 110.739 -176.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.2 t -123.38 114.83 43.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.548 -0.908 . . . . 70.24 108.548 178.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -126.0 118.93 26.38 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.154 0.502 . . . . 75.33 110.203 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.52 118.65 35.04 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.647 -0.706 . . . . 75.22 109.155 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 t -117.05 114.59 23.96 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.26 -1.385 . . . . 73.13 107.26 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.5 pp -129.25 147.03 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-O 121.453 0.644 . . . . 72.45 109.723 -177.688 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.3 m -128.75 134.71 48.5 Favored 'General case' 0 C--N 1.265 -3.074 0 N-CA-C 109.481 -0.563 . . . . 71.14 109.481 -177.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.9 tt -124.72 123.14 65.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.497 0.665 . . . . 73.34 110.318 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 m -91.73 152.37 43.17 Favored Pre-proline 0 N--CA 1.42 -1.963 0 N-CA-C 108.551 -0.907 . . . . 75.33 108.551 -179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.29 2.49 0.86 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.566 2.844 . . . . 74.35 113.841 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -88.31 0.41 56.19 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.169 -0.678 . . . . 62.55 109.169 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 t70 72.64 29.72 1.96 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.778 -1.564 . . . . 71.21 106.778 -174.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tp -101.71 124.97 48.25 Favored 'General case' 0 N--CA 1.389 -3.484 0 CA-C-N 113.676 -1.602 . . . . 65.23 107.251 177.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.35 135.6 58.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 109.169 -0.678 . . . . 72.4 109.169 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.7 p -143.91 156.28 44.38 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.872 -1.159 . . . . 71.23 107.872 175.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.05 44.23 Favored Glycine 0 N--CA 1.425 -2.041 0 C-N-CA 119.064 -1.541 . . . . 63.32 112.265 179.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.75 133.38 17.78 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 109.368 -0.604 . . . . 74.14 109.368 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 58.7 mt -116.6 116.16 51.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.952 -1.129 . . . . 71.0 107.952 177.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.22 116.19 51.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.992 -0.373 . . . . 74.23 109.992 -177.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.18 108.1 17.66 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.377 -1.712 . . . . 54.43 106.377 173.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.82 131.34 53.72 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.252 0.549 . . . . 73.33 111.078 -174.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.75 158.03 37.59 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.397 -0.82 . . . . 71.44 110.445 -177.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.14 144.65 92.82 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 106.522 -1.659 . . . . 74.0 106.522 170.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.05 114.92 0.74 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.711 2.274 . . . . 75.54 111.576 -178.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -61.16 -35.07 76.12 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 124.453 1.101 . . . . 74.41 112.837 -173.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.446 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 23.7 t-20 -158.73 172.95 17.32 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.995 -1.483 . . . . 62.5 106.995 -174.429 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.0 m -60.86 -27.57 68.21 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.282 0.563 . . . . 54.31 110.443 178.444 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.446 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -88.58 -2.54 58.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.59 . . . . 74.35 111.664 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -90.15 125.3 35.41 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.41 0.624 . . . . 71.03 111.816 -174.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -119.23 -13.3 9.34 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 114.745 -1.116 . . . . 74.3 109.871 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.48 102.1 0.15 Allowed Glycine 0 N--CA 1.433 -1.501 0 CA-C-O 118.267 -1.296 . . . . 74.11 111.583 178.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -54.2 128.72 31.1 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 119.961 1.88 . . . . 72.42 110.148 173.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -93.74 148.77 21.81 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 113.074 0.768 . . . . 75.42 113.074 -171.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 83.2 mt -100.15 160.11 14.58 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.236 -1.024 . . . . 73.34 108.236 174.111 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -90.78 86.87 6.46 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.888 -0.782 . . . . 73.22 108.888 -178.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.35 78.27 1.94 Allowed Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 114.622 -1.172 . . . . 64.24 110.963 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -138.27 99.13 3.78 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.458 -0.371 . . . . 64.41 110.993 -176.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 m -151.51 144.65 17.14 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 124.461 1.104 . . . . 73.13 108.658 178.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.51 -32.72 54.43 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.326 2.684 . . . . 73.34 113.254 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -88.52 44.08 1.18 Allowed 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 111.954 0.353 . . . . 75.53 111.954 -179.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.8 m -53.44 -32.27 49.09 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 113.362 0.875 . . . . 72.33 113.362 -176.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -75.82 -12.56 60.19 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.465 -0.772 . . . . 74.24 110.616 -176.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -89.77 -18.25 26.67 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.699 -0.682 . . . . 73.44 109.462 177.54 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.54 119.26 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 122.407 1.098 . . . . 64.2 112.613 -177.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.81 108.99 21.82 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.859 -1.064 . . . . 63.42 108.583 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.7 t -97.62 127.89 49.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 106.709 -1.589 . . . . 72.32 106.709 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -141.39 167.48 22.08 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.26 -0.645 . . . . 70.11 109.26 -172.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.27 135.52 34.72 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.592 -0.892 . . . . 74.41 108.592 179.034 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 87.3 t80 -105.44 120.78 42.46 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.741 -0.837 . . . . 75.32 108.741 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -138.45 99.26 3.79 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 106.992 -1.485 . . . . 72.41 106.992 175.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 32.9 t -173.01 163.25 4.75 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.066 -1.457 . . . . 74.12 107.066 -176.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.1 t70 66.21 9.04 6.01 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.515 1.126 . . . . 75.15 110.765 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.53 -1.89 84.32 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.683 -0.69 . . . . 65.43 111.683 -177.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.43 157.17 17.53 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 122.509 0.323 . . . . 74.22 110.545 -178.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -124.65 137.18 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.775 -0.824 . . . . 65.54 108.775 174.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.28 -153.21 10.0 Favored Glycine 0 C--N 1.269 -3.191 0 N-CA-C 109.817 -1.313 . . . . 64.43 109.817 -177.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.517 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 64.3 m -133.31 154.39 50.75 Favored 'General case' 0 C--N 1.272 -2.778 0 CA-C-O 121.162 0.506 . . . . 73.31 111.383 178.423 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.9 pt20 -133.57 142.69 48.27 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.782 -0.645 . . . . 73.32 110.381 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.9 114.36 27.25 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.434 -1.321 . . . . 63.31 107.434 174.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.12 110.88 32.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.828 -1.175 . . . . 74.25 107.828 -179.229 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.411 ' CD2' HD12 ' A' ' 90' ' ' LEU . 52.1 p90 -120.77 155.29 34.3 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.766 -0.373 . . . . 64.45 110.898 -174.619 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 87' ' ' PHE . 58.6 m -160.74 160.71 31.67 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.059 -0.719 . . . . 75.41 109.059 -178.188 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 63.4 30.65 15.41 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.07 0.948 . . . . 73.25 111.628 178.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.411 HD12 ' CD2' ' A' ' 87' ' ' PHE . 21.6 mt -88.31 156.98 18.89 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.72 -0.392 . . . . 72.54 110.501 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -113.64 168.02 10.12 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.998 -1.482 . . . . 75.31 106.998 177.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -52.76 -37.04 58.93 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 123.485 0.714 . . . . 72.42 111.812 -178.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.39 -26.75 64.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.192 -0.458 . . . . 74.23 112.12 -178.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -88.15 -17.82 30.12 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.309 -0.244 . . . . 64.41 111.228 -177.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 98' ' ' LEU . 45.7 tp -61.45 -52.08 72.74 Favored Pre-proline 0 CA--C 1.564 1.488 0 N-CA-C 113.474 0.916 . . . . 74.42 113.474 -178.107 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.13 -32.68 74.6 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 121.255 1.303 . . . . 72.43 111.338 176.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.91 -31.25 67.83 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 122.264 1.031 . . . . 74.03 109.071 -175.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 25.9 tp -71.5 -30.79 66.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.376 -1.284 . . . . 75.42 109.795 173.463 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.43 -24.04 63.77 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 115.477 -0.783 . . . . 74.43 109.893 -175.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -56.18 -53.91 51.51 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 123.877 0.736 . . . . 72.32 110.672 179.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.2 mtm -55.63 -49.15 73.62 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.486 0.66 . . . . 72.12 109.882 178.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -57.27 -35.28 69.57 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.907 -1.042 . . . . 72.14 111.498 178.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.2 m -61.48 -32.09 72.09 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 109.696 -0.483 . . . . 72.33 109.696 -175.485 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -59.51 -27.97 66.64 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.351 -0.84 . . . . 75.21 111.534 -175.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.05 -14.25 14.26 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 120.591 -0.444 . . . . 62.11 111.344 -178.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.86 -48.09 3.58 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.988 1.107 . . . . 72.34 113.988 -171.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.76 28.72 41.48 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.095 -1.05 . . . . 73.34 110.88 -173.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 11.1 p -107.26 141.29 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-O 120.759 0.314 . . . . 70.3 110.335 -179.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.432 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 40.5 t30 -113.13 121.27 44.04 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.408 -0.96 . . . . 72.44 108.408 177.343 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.29 106.02 14.47 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.235 -0.654 . . . . 73.53 109.235 178.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.0 m -101.4 108.98 20.73 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.8 -1.185 . . . . 64.55 107.8 177.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -129.93 145.89 51.63 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.858 -0.61 . . . . 74.35 109.654 -176.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -144.37 151.9 39.95 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.553 -0.749 . . . . 74.51 111.853 -177.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.586 ' NH2' ' HA ' ' A' ' 180' ' ' ASP . 5.9 tpt180 -96.7 107.37 19.81 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 106.492 -1.669 . . . . 74.13 106.492 178.208 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.96 97.3 7.9 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.34 -0.985 . . . . 71.4 108.34 -177.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.13 -94.74 0.81 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 110.914 -0.874 . . . . 73.03 110.914 -177.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -135.55 13.62 3.46 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 123.26 1.505 . . . . 74.31 108.729 177.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.9 pp -121.18 149.27 24.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.908 -1.12 . . . . 75.34 109.054 177.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.455 HG22 ' HD3' ' A' ' 114' ' ' ARG . 95.7 t -107.12 132.79 53.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-O 120.995 0.426 . . . . 74.33 110.622 -177.232 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.0 pt -115.19 129.27 71.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.114 -1.069 . . . . 73.43 108.114 175.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 tt -128.95 129.76 45.86 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 115.935 -0.575 . . . . 73.22 110.675 -179.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -126.71 135.1 50.68 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.307 -0.997 . . . . 71.02 108.307 173.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -142.38 129.65 3.95 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.217 -0.992 . . . . 63.13 111.948 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.13 132.57 51.83 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.354 -0.497 . . . . 75.34 110.655 176.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 108' ' ' VAL . . . -113.26 131.03 56.07 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.007 -0.542 . . . . 73.4 111.534 -177.253 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -96.25 92.91 6.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.968 -1.123 . . . . 73.34 107.968 175.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -133.71 17.41 3.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.234 1.016 . . . . 73.2 110.086 -177.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 p -67.25 -51.8 48.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.748 -1.115 . . . . 75.23 109.593 175.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.0 m -90.85 20.83 4.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.721 -1.127 . . . . 72.42 111.343 -179.41 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.27 154.98 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 C-N-CA 123.319 0.648 . . . . 73.43 111.49 -176.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.5 m -82.0 -29.33 32.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.417 0.525 . . . . 74.23 112.417 -179.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -112.02 103.91 55.63 Favored Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.147 -0.346 . . . . 75.11 110.791 -178.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.88 -12.21 21.75 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.251 2.634 . . . . 73.23 115.134 -176.321 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -87.82 -6.82 57.93 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.994 0.738 . . . . 74.12 112.994 -175.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -98.24 115.55 28.59 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.915 1.08 . . . . 74.3 113.915 -169.691 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.5 137.76 32.47 Favored 'General case' 0 C--O 1.265 1.917 0 N-CA-C 107.64 -1.244 . . . . 55.22 107.64 170.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.6 t -105.89 112.15 37.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.352 -0.981 . . . . 72.31 108.352 178.389 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -102.86 121.36 42.34 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.95 -0.568 . . . . 73.1 109.564 -177.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.422 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -112.69 119.22 37.35 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.721 -1.585 . . . . 74.12 106.721 178.51 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.7 m -123.12 127.35 48.58 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.521 -0.548 . . . . 74.42 109.521 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 58.8 t -119.8 126.99 75.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.352 -0.611 . . . . 72.42 109.352 179.048 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.51 125.58 54.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.799 -0.815 . . . . 53.32 108.799 177.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.493 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.0 p90 -134.33 124.16 17.04 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 111.774 0.287 . . . . 74.51 111.774 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -70.83 31.81 0.22 Allowed 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.972 2.448 . . . . 75.34 112.556 176.555 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -115.16 -107.37 0.38 Allowed 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.342 -0.614 . . . . 74.53 109.342 -177.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.66 129.87 0.08 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.597 -0.89 . . . . 73.2 108.597 -178.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.9 p -83.29 136.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.654 -0.869 . . . . 74.31 108.654 176.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.3 t -93.69 -43.3 8.72 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 119.572 -0.851 . . . . 75.13 109.21 176.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.3 m -150.24 131.14 14.23 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.062 -0.718 . . . . 64.42 109.062 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 t -140.46 154.09 46.5 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.759 -0.46 . . . . 73.31 109.759 175.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -123.41 98.07 5.69 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 104.839 -2.282 . . . . 72.43 104.839 170.156 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.403 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.89 -155.44 23.83 Favored Glycine 0 N--CA 1.41 -3.061 0 N-CA-C 106.521 -2.631 . . . . 75.44 106.521 -177.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -110.52 103.04 11.59 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 118.345 1.072 . . . . 74.43 110.23 -178.217 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -74.58 114.21 12.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.816 -0.629 . . . . 75.04 109.81 176.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.4 mt -79.93 -44.64 22.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.296 -1.742 . . . . 73.02 106.296 179.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -128.7 165.97 27.98 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 105.459 -2.052 . . . . 73.14 105.459 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.49 0.18 9.4 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 121.925 1.75 . . . . 71.21 110.422 174.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.1 pt-20 -132.09 5.33 4.16 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.384 -1.28 . . . . 73.42 111.049 -177.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -146.15 120.94 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 107.996 -1.112 . . . . 71.15 107.996 178.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.06 147.3 30.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.648 -0.501 . . . . 71.43 109.648 -176.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -135.08 143.11 46.47 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.063 0.459 . . . . 61.25 109.848 -178.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.422 ' CE3' HD12 ' A' ' 139' ' ' LEU . 26.8 m-90 -126.78 139.1 53.37 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.624 -0.88 . . . . 74.14 108.624 177.714 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -111.75 104.34 12.68 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.317 -0.994 . . . . 75.32 108.317 174.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.445 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.3 mp -83.02 116.32 22.23 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.147 -1.427 . . . . 73.43 107.147 177.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -107.34 134.75 19.82 Favored Pre-proline 0 C--N 1.278 -2.504 0 CA-C-N 114.936 -1.029 . . . . 73.34 111.021 -172.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.05 154.29 66.75 Favored 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 123.491 2.794 . . . . 60.31 111.745 -179.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.6 -37.61 2.93 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 121.082 -0.58 . . . . 74.02 111.934 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.45 160.86 5.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.167 -0.679 . . . . 75.11 109.167 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -83.5 127.87 39.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.908 -0.775 . . . . 73.44 108.908 178.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.8 m -120.94 128.85 53.14 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.232 -0.655 . . . . 71.23 109.232 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -121.67 154.27 37.06 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.038 -0.983 . . . . 74.11 108.576 -178.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.9 ptm -144.39 139.66 28.55 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.697 -0.401 . . . . 73.32 110.745 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 76.1 p -143.55 148.12 35.47 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.168 -0.613 . . . . 73.42 110.194 173.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.14 130.49 12.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.771 -0.825 . . . . 75.21 108.771 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -129.87 130.48 45.28 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 107.243 -1.392 . . . . 71.11 107.243 176.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -153.95 159.67 41.79 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.816 -0.438 . . . . 73.02 109.816 -178.223 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -90.92 130.24 36.87 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 109.091 -0.707 . . . . 73.24 109.091 -177.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -143.09 122.32 12.98 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 118.007 0.367 . . . . 74.14 110.871 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.71 106.77 0.43 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.247 0.967 . . . . 75.24 111.871 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.586 ' HA ' ' NH2' ' A' ' 114' ' ' ARG . 14.8 t70 -61.9 140.22 95.63 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 114.46 -1.245 . . . . 73.54 110.031 179.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.77 -47.3 13.62 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.112 1.875 . . . . 72.31 112.911 -179.261 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . 0.306 0.2 OUTLIER -86.23 -26.06 25.25 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 113.187 0.81 . . . . 75.12 113.187 176.894 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.275 4.8 t 36.52 83.44 0.02 OUTLIER 'General case' 0 C--O 1.244 0.811 0 C-N-CA 126.603 1.961 . . . . 73.41 113.578 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -109.66 161.98 14.87 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.802 -1.09 . . . . 72.34 111.747 -173.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.418 -2.069 0 N-CA-C 107.139 -1.43 . . . . 74.43 107.139 177.85 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.616 0 N-CA-C 110.065 -1.214 . . . . 64.25 110.065 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -106.52 -11.91 15.77 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 117.356 0.578 . . . . 74.42 110.337 178.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -106.41 115.86 30.94 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.94 0.4 . . . . 75.31 111.462 -175.118 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -165.08 152.15 10.78 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.106 -1.442 . . . . 72.13 107.106 175.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -122.63 153.27 39.56 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 112.09 0.404 . . . . 75.35 112.09 -174.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -158.92 -27.21 0.07 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.521 -0.763 . . . . 74.12 110.343 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -87.24 75.06 9.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.222 0.534 . . . . 75.22 110.157 -177.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -176.89 165.44 2.43 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.979 -1.489 . . . . 72.21 106.979 -177.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 49' ' ' LYS . . . 110.93 -75.06 0.21 Allowed Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.182 -1.008 . . . . 70.43 113.79 173.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 71.96 151.94 0.11 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.094 0.957 . . . . 74.31 111.348 -172.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.412 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 20.9 ttt 44.69 37.29 2.14 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.406 1.483 . . . . 74.42 110.556 -171.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.15 143.05 43.46 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.288 -0.869 . . . . 74.03 110.23 -178.153 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -130.14 125.45 35.09 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.704 -0.68 . . . . 73.11 110.081 -175.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -107.6 113.86 44.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 106.531 -1.655 . . . . 75.15 106.531 175.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -121.31 117.77 27.83 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 109.228 -0.656 . . . . 72.4 109.228 -175.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.77 119.7 36.27 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.003 -0.74 . . . . 74.53 109.003 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.6 m -120.09 114.99 22.8 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.637 -1.246 . . . . 51.42 107.637 177.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.0 146.13 34.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.095 -0.705 . . . . 74.42 109.095 -177.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.6 m -129.46 122.16 28.75 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-O 121.06 0.457 . . . . 74.32 110.118 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.7 tt -107.19 119.56 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.773 0.796 . . . . 73.25 109.755 178.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 m -89.57 157.31 47.09 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.164 -0.926 . . . . 73.42 109.328 -177.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.42 2.15 1.33 Allowed 'Trans proline' 0 N--CA 1.488 1.167 0 C-N-CA 123.53 2.82 . . . . 74.41 114.279 -176.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.85 4.5 53.74 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.608 -0.886 . . . . 64.44 108.608 178.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 27.2 t70 68.48 31.21 4.97 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 123.566 1.65 . . . . 73.45 107.333 -175.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.06 124.1 42.4 Favored 'General case' 0 N--CA 1.39 -3.473 0 N-CA-C 106.084 -1.821 . . . . 71.0 106.084 178.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 t -112.95 134.17 56.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.318 -0.993 . . . . 75.44 108.318 -177.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.2 p -140.62 158.43 44.0 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.983 -1.488 . . . . 63.31 106.983 178.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.69 -174.31 42.72 Favored Glycine 0 N--CA 1.415 -2.703 0 C-N-CA 118.997 -1.573 . . . . 64.11 112.859 177.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -147.43 133.91 19.73 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 108.916 -0.772 . . . . 73.14 108.916 -177.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 52.6 mt -119.52 115.91 49.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.728 -1.212 . . . . 75.41 107.728 176.226 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.31 120.54 62.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.105 -0.702 . . . . 75.02 109.105 -177.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.38 107.31 16.97 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.763 -1.94 . . . . 74.11 105.763 172.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . . . -118.93 132.47 56.09 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.049 0.452 . . . . 52.24 111.13 -174.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.17 158.25 37.59 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.54 -0.755 . . . . 74.03 110.321 -177.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.507 ' O ' ' HA2' ' A' ' 23' ' ' GLY . 98.4 mttt -72.4 137.85 81.03 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 119.783 -0.767 . . . . 74.32 109.288 173.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.97 -63.61 0.23 Allowed 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 123.348 2.699 . . . . 74.25 114.925 -174.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 67.98 -49.6 0.53 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.676 1.191 . . . . 70.24 113.097 -177.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.651 ' OD1' ' HG3' ' A' ' 54' ' ' LYS . 24.0 t-20 -105.54 152.98 22.37 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 122.428 0.291 . . . . 72.33 110.226 -176.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.0 m -78.55 -22.1 47.74 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.261 1.208 . . . . 72.31 114.261 -175.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.651 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -83.51 -24.39 31.72 Favored 'General case' 0 CA--C 1.471 -2.058 0 C-N-CA 118.806 -1.158 . . . . 72.03 110.409 177.879 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.508 ' N ' ' HD3' ' A' ' 54' ' ' LYS . 31.5 m-20 -68.48 95.05 0.6 Allowed 'General case' 0 N--CA 1.401 -2.889 0 CA-C-O 123.046 1.403 . . . . 74.23 112.374 -179.24 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -90.29 -22.54 21.52 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-N 112.498 -2.137 . . . . 71.12 107.45 174.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.571 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 173.7 116.65 0.43 Allowed Glycine 0 N--CA 1.409 -3.127 0 CA-C-N 114.845 -1.07 . . . . 53.42 110.427 177.047 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 75.0 Cg_exo -52.04 134.22 48.77 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.332 2.022 . . . . 74.44 109.313 170.591 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.79 149.58 23.68 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 111.654 0.242 . . . . 73.13 111.654 -173.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.541 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 66.1 mt -91.77 151.03 20.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.279 -0.419 . . . . 75.44 109.969 177.311 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -109.64 102.45 11.28 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.08 -1.082 . . . . 75.22 108.08 177.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -148.84 142.61 10.06 Favored Glycine 0 C--N 1.283 -2.367 0 C-N-CA 120.58 -0.819 . . . . 71.4 112.873 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -151.35 114.27 4.71 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.543 -0.91 . . . . 75.44 108.543 176.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.66 159.62 71.06 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 109.925 -0.398 . . . . 70.01 109.925 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.98 -13.92 42.1 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.245 1.963 . . . . 70.15 112.532 178.089 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -113.64 28.69 8.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.62 -0.264 . . . . 75.3 111.466 -177.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.8 m -57.49 -26.86 61.93 Favored 'General case' 0 C--O 1.205 -1.253 0 N-CA-C 111.947 0.351 . . . . 71.34 111.947 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.452 ' HG3' ' HG3' ' A' ' 69' ' ' LYS . 29.7 pt20 -65.56 -12.26 51.37 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.395 0.617 . . . . 74.11 110.96 176.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 24.6 mtpp -110.81 -7.51 14.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.636 0.774 . . . . 75.33 110.519 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 p -132.36 117.74 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 122.029 0.918 . . . . 63.12 110.409 173.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.32 116.31 28.83 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.687 -0.688 . . . . 75.14 109.964 -177.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.95 124.38 50.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 106.177 -1.786 . . . . 75.41 106.177 177.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.7 m -137.97 166.89 22.96 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.298 -0.41 . . . . 74.4 111.293 -172.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.571 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 57.5 t30 -80.2 140.78 36.16 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.311 -0.859 . . . . 64.41 108.799 177.067 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 77.0 t80 -119.3 121.35 39.4 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.862 -0.422 . . . . 72.4 109.862 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -138.62 114.79 10.24 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.843 -1.169 . . . . 74.14 107.843 172.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.4 t -174.51 148.09 1.17 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.903 -1.517 . . . . 74.21 106.903 -175.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 72.28 10.33 5.89 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.844 0.858 . . . . 74.24 111.027 173.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.66 5.06 82.19 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.477 -0.649 . . . . 70.01 111.477 -175.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 11.8 m-85 -104.09 149.28 25.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.617 -0.512 . . . . 74.34 109.617 179.014 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.73 136.79 58.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.987 -1.116 . . . . 74.1 107.987 174.207 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -173.5 -154.94 11.06 Favored Glycine 0 C--N 1.274 -2.873 0 N-CA-C 110.682 -0.967 . . . . 41.41 110.682 -178.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.541 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 p -129.62 153.25 48.28 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-O 121.208 0.528 . . . . 50.32 111.848 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 4.1 pt20 -134.62 141.97 46.76 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.835 -0.62 . . . . 75.14 110.791 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.88 114.2 26.61 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.645 -1.613 . . . . 71.15 106.645 173.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.21 115.14 48.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.658 -0.867 . . . . 74.55 108.658 -178.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -119.53 151.77 38.06 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.205 0.526 . . . . 74.42 111.085 -174.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 p -155.59 154.83 32.28 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.5 -0.773 . . . . 75.21 110.286 -177.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.3 t70 65.74 30.98 9.96 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.089 0.947 . . . . 73.3 110.457 175.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.441 HD23 ' HE3' ' A' ' 69' ' ' LYS . 18.1 mt -94.91 170.22 9.58 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.875 -0.602 . . . . 75.4 111.785 -178.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.431 HG22 ' OE1' ' A' ' 94' ' ' GLU . 12.5 t -126.61 172.79 9.97 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.059 -0.719 . . . . 73.21 109.059 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.42 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 78.1 t80 -51.92 -40.67 61.12 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.011 1.324 . . . . 71.32 112.152 -176.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.09 72.16 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.255 0.465 . . . . 72.54 112.255 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.431 ' OE1' HG22 ' A' ' 91' ' ' THR . 48.3 mt-10 -86.08 -18.77 31.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.003 -0.544 . . . . 72.35 111.838 -174.35 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.632 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tt -60.62 -54.59 53.28 Favored Pre-proline 0 CA--C 1.566 1.584 0 CA-C-N 116.094 -0.503 . . . . 75.21 112.22 -177.372 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.26 -34.17 36.75 Favored 'Trans proline' 0 C--N 1.367 1.518 0 CA-C-N 120.76 1.307 . . . . 75.21 111.095 178.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -62.87 -39.65 95.08 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.362 -0.835 . . . . 73.31 111.504 -176.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -70.67 -19.62 62.77 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.081 0.467 . . . . 75.23 111.053 177.7 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.31 -24.45 59.22 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.505 -0.478 . . . . 74.43 110.191 -176.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -59.17 -51.89 68.06 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 123.305 0.378 . . . . 72.22 110.649 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.543 ' SD ' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -54.29 -52.65 60.79 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-O 121.638 0.732 . . . . 75.31 110.472 -177.593 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.21 -27.28 68.95 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 115.024 -0.989 . . . . 73.25 111.28 -177.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -63.55 -22.9 67.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 118.622 -0.704 . . . . 65.41 112.08 -177.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.48 -27.64 67.73 Favored 'General case' 0 C--N 1.357 0.913 0 CA-C-O 121.215 0.531 . . . . 60.21 109.776 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.77 -12.5 13.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.721 -0.672 . . . . 74.52 111.093 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.98 -48.68 3.44 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 113.941 1.089 . . . . 71.52 113.941 -172.211 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.43 24.0 48.72 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.658 -0.782 . . . . 42.33 112.144 -174.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -87.93 147.39 5.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 O-C-N 122.332 -0.51 . . . . 75.33 110.735 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -135.28 129.05 32.97 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.846 -1.168 . . . . 75.54 107.846 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 mp -130.21 117.05 19.27 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.558 0.218 . . . . 74.44 110.544 -178.188 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.4 m -108.27 114.22 27.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.151 -1.055 . . . . 70.02 108.151 176.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.78 153.16 49.34 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 122.027 -0.421 . . . . 74.32 110.738 -176.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -148.68 154.0 39.04 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.721 -0.672 . . . . 74.44 110.199 -177.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -108.57 106.53 16.65 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 105.722 -1.955 . . . . 74.03 105.722 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -101.38 97.33 7.83 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.44 -0.578 . . . . 73.35 109.44 -176.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.19 -82.72 0.64 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.304 -0.718 . . . . 62.54 111.304 -178.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -143.52 5.35 1.41 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.714 1.245 . . . . 74.42 109.148 178.198 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.6 pp -113.58 148.87 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 O-C-N 121.339 -0.851 . . . . 73.32 108.779 -179.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.31 133.82 54.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-O 121.378 0.608 . . . . 74.13 111.04 -177.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.5 pt -117.33 132.86 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 N-CA-C 107.945 -1.132 . . . . 73.21 107.945 173.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.2 tt -128.12 125.33 38.97 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 115.926 -0.579 . . . . 74.42 109.771 177.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -127.15 115.08 18.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.039 -0.982 . . . . 70.3 108.559 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.7 156.08 21.92 Favored Glycine 0 C--N 1.291 -1.942 0 C-N-CA 120.458 -0.877 . . . . 64.45 112.409 -177.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -139.9 125.71 19.5 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.953 -1.128 . . . . 71.44 107.953 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -101.77 111.7 24.05 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.644 -0.502 . . . . 74.22 109.644 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -104.84 93.61 4.82 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 123.031 1.396 . . . . 63.44 111.519 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.47 ' CD2' ' HA ' ' A' ' 166' ' ' PRO 0.278 0.0 OUTLIER -126.75 42.86 3.23 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-O 124.21 1.957 . . . . 71.33 107.444 171.775 . . . . . . . . 4 4 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.4 p -68.2 -19.6 64.78 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 111.419 -2.628 . . . . 73.0 110.791 179.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.8 p -73.79 -19.53 60.74 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.449 -0.796 . . . . 64.52 110.512 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.3 t -83.01 93.41 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 108.34 -0.985 . . . . 73.33 108.34 178.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.2 t -92.12 14.51 15.82 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.02 0.914 . . . . 75.14 109.138 -178.045 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 29.8 m-20 -103.42 131.27 22.23 Favored Pre-proline 0 N--CA 1.432 -1.36 0 CA-C-N 115.766 -0.652 . . . . 73.31 110.094 -179.084 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 132' ' ' ASP . 23.4 Cg_exo -63.09 -9.68 17.96 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 124.129 3.219 . . . . 74.44 113.907 -178.273 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 25' ' ' MET . 5.0 m-20 -75.89 -11.89 60.05 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 113.748 1.018 . . . . 75.0 113.748 -170.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -96.47 124.56 40.5 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.618 -0.433 . . . . 72.2 110.902 -175.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -131.94 127.87 37.29 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.731 -0.84 . . . . 72.45 108.731 178.122 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 58.2 t -121.81 128.57 75.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 119.367 -0.933 . . . . 74.33 110.104 -177.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.75 121.12 31.09 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.914 0.387 . . . . 74.24 110.289 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 20.5 tp -115.11 120.75 40.86 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.215 -0.448 . . . . 74.22 109.807 177.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.6 m -117.45 114.31 23.32 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.032 -0.729 . . . . 73.4 109.032 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 96.5 t -108.4 120.79 60.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.932 -0.766 . . . . 74.4 108.932 178.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -110.86 130.71 55.5 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.587 -0.523 . . . . 74.42 109.587 179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.6 p90 -134.52 124.76 17.23 Favored Pre-proline 0 C--N 1.292 -1.927 0 CA-C-N 116.349 -0.387 . . . . 73.2 111.209 177.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.76 37.65 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.476 2.784 . . . . 74.42 112.603 176.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -125.9 -115.8 0.28 Allowed 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 108.522 -0.918 . . . . 74.22 108.522 -179.487 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.75 137.84 0.62 Allowed 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.71 -1.219 . . . . 73.44 107.71 -178.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.468 ' HB ' ' CE2' ' A' ' 143' ' ' PHE . 7.6 p -89.48 127.21 42.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.548 -0.908 . . . . 74.03 108.548 178.321 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.5 p -81.31 -38.73 26.3 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.585 0.707 . . . . 74.01 110.337 -177.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 49.0 m -156.56 133.1 10.09 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.08 -0.711 . . . . 71.4 109.08 178.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.511 ' HG1' HG12 ' A' ' 160' ' ' VAL . 9.4 t -138.45 169.72 17.29 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.669 -0.644 . . . . 63.24 111.307 177.875 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 8.0 t30 -139.0 87.17 2.19 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.751 -1.944 . . . . 63.23 105.751 175.414 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.09 -146.4 6.66 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 109.221 -1.551 . . . . 75.41 109.221 -178.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -118.55 99.63 6.93 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.054 -0.721 . . . . 71.54 109.054 178.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -79.03 128.72 33.62 Favored 'General case' 0 N--CA 1.422 -1.831 0 O-C-N 121.562 -0.712 . . . . 74.13 110.589 179.231 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.1 mt -87.33 -39.42 13.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.723 -1.584 . . . . 74.0 106.723 177.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.23 164.96 35.35 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.023 -1.843 . . . . 71.4 106.023 -179.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.23 -0.12 8.71 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.84 1.693 . . . . 75.23 111.128 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.3 pt-20 -129.34 4.18 5.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.566 -0.743 . . . . 75.25 111.802 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.89 120.19 8.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.028 -1.101 . . . . 74.32 108.028 178.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.511 HG12 ' HG1' ' A' ' 150' ' ' THR . 45.5 t -125.74 143.56 38.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.924 -0.398 . . . . 75.14 109.924 -177.002 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.8 tt0 -128.14 138.28 52.44 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-O 121.304 0.573 . . . . 71.32 109.667 -177.39 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -114.87 114.86 26.07 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 115.862 -0.608 . . . . 64.42 109.405 178.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -98.67 98.35 9.5 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.168 -1.049 . . . . 72.14 108.168 178.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.511 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 26.2 mt -93.68 146.62 23.7 Favored 'General case' 0 C--O 1.281 2.747 0 CA-C-N 114.878 -1.056 . . . . 73.52 109.927 -172.279 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -117.02 151.25 47.28 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.245 -0.889 . . . . 74.22 111.323 -173.253 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.47 ' HA ' ' CD2' ' A' ' 127' ' ' LEU . 84.7 Cg_endo -77.94 154.93 30.03 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.874 2.383 . . . . 71.14 112.424 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.65 -28.14 2.81 Favored Glycine 0 CA--C 1.499 -0.938 0 C-N-CA 121.159 -0.543 . . . . 73.14 112.533 175.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.47 ' H ' ' C ' ' A' ' 166' ' ' PRO . 32.6 m -106.03 156.14 6.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 109.443 -0.577 . . . . 72.34 109.443 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.3 p -92.53 109.24 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 108.106 -1.072 . . . . 73.32 108.106 177.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.4 m -92.85 130.27 38.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.561 -0.745 . . . . 74.11 109.678 -176.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 44.0 p -99.12 139.01 35.4 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.633 0.73 . . . . 71.44 111.711 -178.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 21.3 ttt -118.02 122.45 43.22 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.027 -1.101 . . . . 73.14 108.027 178.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 4.2 m -136.44 136.92 39.91 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.54 -1.264 . . . . 53.25 108.53 174.105 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.02 131.89 15.12 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.189 -1.041 . . . . 74.22 108.189 -179.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -133.33 131.49 40.19 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.474 -1.306 . . . . 72.23 107.474 177.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -162.53 154.29 18.36 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.347 -0.983 . . . . 63.34 108.347 -178.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 35.8 ptt180 -92.93 141.58 28.25 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.268 -0.973 . . . . 74.22 110.187 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.59 130.13 24.07 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 121.038 0.446 . . . . 75.11 110.044 -176.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.65 101.14 0.32 Allowed 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 114.721 -1.127 . . . . 73.25 112.643 -178.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.45 129.89 69.67 Favored Pre-proline 0 CA--C 1.505 -0.788 0 CA-C-N 115.425 -0.807 . . . . 65.33 111.96 172.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -71.26 -24.37 23.19 Favored 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 122.926 2.417 . . . . 74.51 109.997 175.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -84.07 -12.95 54.29 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.038 -1.437 . . . . 61.4 109.608 177.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.311 3.9 t 42.64 87.7 0.01 OUTLIER 'General case' 0 C--N 1.349 0.587 0 C-N-CA 127.231 2.213 . . . . 74.11 116.024 172.683 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -100.2 151.42 21.46 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.227 -1.351 . . . . 75.42 108.108 177.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 C--N 1.295 -1.761 0 N-CA-C 108.385 -0.969 . . . . 71.43 108.385 177.746 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.024 0 N-CA-C 109.705 -1.358 . . . . 75.15 109.705 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -100.71 -15.96 17.53 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.423 0.527 . . . . 74.51 112.423 178.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -87.91 83.6 7.07 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.203 -1.406 . . . . 71.12 107.203 173.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -77.75 102.61 7.24 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.171 1.175 . . . . 74.53 114.171 -171.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.6 tp -116.85 100.95 8.13 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.784 -1.932 . . . . 74.35 105.784 171.229 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -79.19 -53.88 6.53 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.396 -0.366 . . . . 75.31 111.706 -174.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -144.61 125.35 14.2 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.035 -0.728 . . . . 74.43 109.035 -175.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.07 128.45 35.5 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.511 -1.292 . . . . 71.32 107.511 174.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.29 -90.74 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 115.165 0.826 . . . . 73.01 115.165 -173.417 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' A' ' 49' ' ' LYS . 36.4 m80 -141.69 -162.45 1.39 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.285 0.564 . . . . 71.44 111.81 -170.69 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.456 ' HG2' ' OD2' ' A' ' 134' ' ' ASP . 77.3 mtp -89.31 -172.64 3.7 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.693 -1.139 . . . . 74.14 108.325 173.558 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.6 pt? -132.22 111.73 11.65 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.624 -0.88 . . . . 74.21 108.624 175.227 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 22.8 mtp-105 -127.19 133.85 50.22 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.094 -0.503 . . . . 74.5 109.682 -175.624 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.99 116.8 53.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 115.496 -0.774 . . . . 73.5 108.957 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.4 mtp85 -106.94 114.34 28.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.228 0.537 . . . . 73.22 109.669 176.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.23 111.65 23.37 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.263 -1.014 . . . . 73.12 108.263 177.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -119.52 114.55 22.45 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.54 -1.282 . . . . 73.45 107.54 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.11 146.26 34.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.814 -0.81 . . . . 75.32 108.814 -178.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 85.6 m -131.36 126.41 35.17 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-O 121.067 0.46 . . . . 72.14 110.573 -178.654 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.3 tt -108.81 112.14 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 121.898 0.856 . . . . 73.31 109.428 177.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 37' ' ' ASP . 25.9 m -76.62 158.11 81.38 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 114.74 -1.118 . . . . 64.43 110.511 -175.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.12 2.72 0.99 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 123.747 2.965 . . . . 75.15 112.702 177.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 35' ' ' SER . 9.0 t70 -87.57 -7.15 57.88 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.306 -0.998 . . . . 73.03 108.306 177.382 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 72.07 29.1 2.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.761 1.625 . . . . 63.42 108.004 -175.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.63 138.95 47.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.918 -1.492 . . . . 72.43 107.408 179.499 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.402 HG22 ' HG ' ' A' ' 95' ' ' LEU . 11.1 t -113.74 135.52 53.1 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.242 0.544 . . . . 75.51 109.543 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.9 p -142.77 137.75 29.95 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.566 -1.272 . . . . 70.22 107.566 177.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.36 -169.5 35.84 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 119.256 -1.449 . . . . 71.41 112.428 -177.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -149.84 133.6 16.84 Favored 'General case' 0 N--CA 1.418 -2.027 0 C-N-CA 123.263 0.625 . . . . 64.43 109.53 -177.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.1 mt -116.45 115.49 49.23 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 105.658 -1.979 . . . . 75.11 105.658 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.5 mt -120.37 114.27 43.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-N 116.196 -0.457 . . . . 75.3 110.005 -172.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.565 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.55 108.56 18.11 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.742 -0.836 . . . . 72.23 108.742 179.227 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 80' ' ' TYR . . . -111.37 118.01 34.68 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 109.035 -0.728 . . . . 75.43 109.035 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.97 158.74 21.62 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-O 122.006 0.908 . . . . 74.31 112.288 -174.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 24' ' ' HIS . 18.8 ptmt -62.94 135.05 95.95 Favored Pre-proline 0 C--N 1.294 -1.843 0 CA-C-N 113.807 -1.542 . . . . 74.54 107.808 170.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.17 101.05 0.09 OUTLIER 'Trans proline' 0 C--O 1.244 0.808 0 C-N-CA 121.978 1.785 . . . . 75.33 110.376 177.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -98.47 -16.7 19.11 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.734 0.778 . . . . 74.43 110.346 -174.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -123.28 117.5 25.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.076 -1.824 . . . . 71.3 106.076 176.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.3 m -56.96 -33.31 66.92 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.951 1.463 . . . . 71.34 114.951 -171.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -88.59 -15.94 33.79 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.621 -0.831 . . . . 74.53 109.611 -179.084 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.58 114.67 20.44 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.248 -0.887 . . . . 74.14 112.138 -172.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.5 t -110.81 11.87 22.45 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.754 -1.112 . . . . 73.22 109.836 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.622 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 175.29 98.02 0.11 Allowed Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.146 -1.502 . . . . 61.11 113.711 178.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 83' ' ' SER . 38.9 Cg_exo -60.36 159.8 25.79 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 123.646 2.898 . . . . 74.14 112.639 174.315 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.68 153.25 35.87 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.619 -0.719 . . . . 55.22 109.425 177.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.0 mt -99.46 138.91 35.89 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.274 -0.421 . . . . 71.31 110.52 178.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -110.95 87.9 2.65 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.401 1.096 . . . . 75.25 110.898 176.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.07 78.11 0.35 Allowed Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 109.817 -1.313 . . . . 71.35 109.817 177.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -80.8 93.37 6.22 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.841 0.829 . . . . 75.54 109.428 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -105.54 158.38 32.41 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 114.067 -1.424 . . . . 72.5 109.841 -176.604 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.29 -20.99 71.94 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 123.114 2.543 . . . . 63.3 112.984 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -107.03 44.04 1.1 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.562 -0.745 . . . . 75.31 111.671 -178.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m -51.84 -39.12 58.29 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.146 0.578 . . . . 75.31 111.87 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -69.82 -15.87 63.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.94 0.4 . . . . 74.42 111.144 -175.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -91.1 -14.38 31.34 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.855 -0.611 . . . . 74.15 110.231 -179.06 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.66 120.05 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 119.643 -0.823 . . . . 75.22 111.788 -179.455 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.44 113.96 27.74 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.078 -0.712 . . . . 65.5 109.078 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.79 133.81 39.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.617 -0.883 . . . . 74.04 108.617 -179.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 m -141.73 171.94 13.37 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.15 0.5 . . . . 70.14 111.273 -177.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.622 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 7.2 t30 -83.39 136.95 34.14 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 124.473 1.109 . . . . 74.3 110.461 -177.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -116.09 119.9 37.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.822 -0.807 . . . . 63.12 108.822 177.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -139.2 110.44 6.93 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.349 -2.093 . . . . 62.12 105.349 177.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 75.8 m -148.13 113.21 5.5 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 110.383 -0.229 . . . . 73.11 110.383 -178.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.415 ' O ' ' HE1' ' A' ' 24' ' ' HIS . 41.8 t0 68.87 9.65 7.5 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.06 1.344 . . . . 75.44 111.397 176.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.24 5.06 50.01 Favored Glycine 0 N--CA 1.424 -2.141 0 C-N-CA 120.166 -1.016 . . . . 65.3 112.546 -176.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . 72.0 m-85 -84.71 140.78 31.05 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.161 -2.163 . . . . 75.13 105.161 166.181 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.52 135.75 62.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.481 -0.888 . . . . 73.4 109.266 174.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -167.77 -155.9 9.66 Favored Glycine 0 N--CA 1.403 -3.541 0 C-N-CA 120.519 -0.848 . . . . 72.24 111.468 178.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 9.3 p -135.88 150.41 49.35 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.084 0.469 . . . . 72.53 110.31 -177.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.49 127.99 40.29 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.725 -0.67 . . . . 75.15 110.95 -178.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.03 114.17 28.21 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.917 -1.512 . . . . 53.52 106.917 174.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.7 t -112.75 112.07 38.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.452 -1.314 . . . . 75.3 107.452 -178.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.9 p90 -116.09 155.17 28.64 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.286 -0.415 . . . . 74.03 111.181 -172.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.5 p -156.92 157.12 34.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.99 -0.55 . . . . 71.21 110.922 -176.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 t70 64.79 31.84 11.45 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.783 1.233 . . . . 74.43 111.055 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.432 HD12 ' CD2' ' A' ' 87' ' ' PHE . 27.6 mt -93.53 173.21 7.81 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.665 -0.698 . . . . 74.5 109.288 176.125 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -126.26 175.03 8.1 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 120.113 -0.635 . . . . 72.11 110.227 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' HD12 ' A' ' 112' ' ' LEU . 86.9 t80 -54.56 -39.93 68.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.698 1.199 . . . . 75.31 112.126 -176.085 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.31 -25.76 67.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.29 0.567 . . . . 75.21 111.537 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -84.68 -16.18 42.71 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 112.471 0.545 . . . . 72.45 112.471 -174.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.464 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 10.3 mt -53.09 -55.69 31.27 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.671 1.36 . . . . 73.11 114.671 178.137 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.41 -37.1 51.37 Favored 'Trans proline' 0 C--N 1.36 1.148 0 CA-C-N 120.465 1.202 . . . . 73.44 110.577 177.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.51 -36.84 85.49 Favored 'General case' 0 N--CA 1.417 -2.082 0 C-N-CA 123.769 0.828 . . . . 74.32 111.181 -177.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -78.16 -20.22 52.44 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.991 -0.374 . . . . 74.45 109.991 175.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.98 -21.41 63.23 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.929 -0.578 . . . . 54.54 110.772 -177.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -61.21 -53.35 57.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.198 -0.667 . . . . 73.34 109.198 175.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 32.5 ttp -58.3 -47.27 84.21 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.48 0.657 . . . . 75.23 109.786 177.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -53.16 -31.06 40.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.153 -1.385 . . . . 64.33 111.149 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -56.22 -35.0 66.84 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.965 -0.541 . . . . 75.4 111.786 -174.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.52 -26.81 68.16 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.265 0.555 . . . . 64.33 111.805 -174.2 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.97 -16.16 14.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 120.401 -0.519 . . . . 52.14 110.821 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.8 -47.88 3.63 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.656 0.984 . . . . 72.24 113.656 -170.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.18 28.32 64.42 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.762 -0.935 . . . . 53.4 110.762 -172.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.446 HG13 ' CB ' ' A' ' 125' ' ' ALA . 13.2 m -114.62 161.45 13.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 75.51 110.989 -176.156 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -127.61 139.7 52.57 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.179 -1.415 . . . . 64.2 107.179 174.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -128.3 133.32 48.71 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.464 -0.569 . . . . 75.54 109.464 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.3 t -132.71 137.6 46.95 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 107.745 -1.206 . . . . 74.42 107.745 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.47 ' O ' ' HD2' ' A' ' 113' ' ' ARG . 1.3 pp -149.24 152.14 35.46 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.782 1.03 . . . . 74.2 113.782 -176.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 112' ' ' LEU . 9.6 mpt_? -144.09 154.3 43.06 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.205 -1.361 . . . . 73.32 111.642 178.74 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -90.25 137.95 31.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 107.569 -1.271 . . . . 70.44 107.569 167.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.439 ' O ' HG13 ' A' ' 118' ' ' ILE . 46.9 t30 -123.18 90.56 3.31 Favored 'General case' 0 C--N 1.258 -3.383 0 N-CA-C 107.134 -1.432 . . . . 74.42 107.134 173.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.93 -100.31 0.83 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 109.759 -1.336 . . . . 60.13 109.759 -173.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -121.84 -4.32 9.15 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.429 1.109 . . . . 71.24 109.0 178.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.6 pp -99.24 150.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.389 -0.967 . . . . 74.23 108.389 179.076 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.475 HG22 ' CD2' ' A' ' 178' ' ' TYR . 79.7 t -110.36 136.17 47.16 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 O-C-N 121.847 -0.533 . . . . 75.13 111.539 -176.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.3 pt -117.06 128.96 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 115.202 -0.908 . . . . 75.55 108.997 175.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -128.42 131.83 48.47 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 108.578 -0.897 . . . . 74.3 108.578 179.64 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -144.7 139.8 28.18 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.224 -0.658 . . . . 72.31 109.224 179.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.38 -178.12 36.83 Favored Glycine 0 C--N 1.298 -1.541 0 C-N-CA 120.398 -0.906 . . . . 75.31 111.689 179.523 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -139.35 150.95 45.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 120.967 0.413 . . . . 73.23 110.904 -179.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.446 ' CB ' HG13 ' A' ' 108' ' ' VAL . . . -122.87 120.54 33.79 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.05 -0.977 . . . . 60.53 108.6 178.204 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.13 107.33 18.38 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.368 -0.975 . . . . 75.03 108.368 178.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -107.99 15.47 24.32 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.731 -0.841 . . . . 62.11 108.731 178.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 167' ' ' GLY . 42.3 p -81.22 -21.05 39.81 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.096 -1.076 . . . . 54.31 108.096 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.3 m -92.95 17.53 10.53 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.555 -1.202 . . . . 73.33 111.58 -178.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.64 141.42 16.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 120.077 -0.649 . . . . 74.54 110.826 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.5 m -83.43 -21.28 32.99 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.022 -0.535 . . . . 75.35 111.208 -178.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -134.1 137.66 28.74 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 109.089 -0.708 . . . . 55.45 109.089 -175.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.18 -17.41 45.25 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.344 2.696 . . . . 73.13 113.83 -178.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.456 ' OD2' ' HG2' ' A' ' 25' ' ' MET . 2.7 m-20 -90.93 20.9 4.48 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.892 0.477 . . . . 75.0 111.834 -178.303 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.558 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -98.45 116.2 30.17 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.451 -0.341 . . . . 54.23 110.644 -175.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 4.4 m-20 -123.6 140.54 52.9 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.557 -0.534 . . . . 74.4 109.557 179.052 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 60.4 t -124.84 131.62 72.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.795 -0.817 . . . . 73.44 108.795 178.513 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.35 122.66 44.47 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.514 -0.921 . . . . 72.13 108.514 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 46.2 tp -110.9 120.25 41.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.742 -0.836 . . . . 74.54 108.742 177.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.3 m -124.42 110.14 14.17 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 108.71 -0.848 . . . . 74.51 108.71 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 87.7 t -109.37 124.49 66.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.699 -0.852 . . . . 75.23 108.699 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.47 130.61 56.29 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 108.803 -0.814 . . . . 73.44 108.803 178.168 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.552 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -133.98 102.56 12.15 Favored Pre-proline 0 C--N 1.266 -3.038 0 N-CA-C 108.34 -0.985 . . . . 71.43 108.34 175.303 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.36 47.28 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 123.871 3.047 . . . . 73.12 113.379 -178.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.82 -78.94 0.58 Allowed 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 109.47 -0.567 . . . . 74.43 109.47 178.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.16 118.34 0.01 OUTLIER 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.881 1.272 . . . . 74.21 108.559 179.378 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.08 134.23 29.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 109.783 -0.451 . . . . 75.42 109.783 177.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.2 p -101.11 -41.66 6.67 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.156 0.503 . . . . 74.32 109.851 178.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.2 m -158.25 133.36 8.59 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 109.377 -0.601 . . . . 72.01 109.377 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.411 ' OG1' HG11 ' A' ' 160' ' ' VAL . 10.0 t -138.95 157.11 46.61 Favored 'General case' 0 C--N 1.285 -2.22 0 O-C-N 121.796 -0.565 . . . . 75.12 110.172 177.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -124.67 88.75 2.95 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 105.524 -2.028 . . . . 73.11 105.524 174.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.84 -150.97 15.84 Favored Glycine 0 N--CA 1.419 -2.491 0 N-CA-C 107.275 -2.33 . . . . 74.04 107.275 -177.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -113.68 104.36 12.15 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 118.297 1.049 . . . . 75.04 111.587 -177.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -77.52 117.35 18.88 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.212 0.53 . . . . 75.33 110.168 176.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.2 mt -86.38 -48.75 15.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.611 -1.626 . . . . 74.01 106.611 177.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -123.41 162.06 42.12 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 114.245 -1.343 . . . . 63.13 107.917 -177.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.63 -4.01 11.3 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.847 2.365 . . . . 73.45 112.398 177.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.7 OUTLIER -132.68 5.16 3.95 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.263 0.468 . . . . 72.35 112.263 175.211 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.66 121.0 29.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 N-CA-C 109.32 -0.622 . . . . 63.03 109.32 -179.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.411 HG11 ' OG1' ' A' ' 150' ' ' THR . 57.3 t -124.75 143.14 39.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.507 -0.553 . . . . 72.12 109.507 -178.035 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -128.67 146.07 50.98 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.17 0.509 . . . . 74.14 110.034 -177.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -124.32 127.83 48.19 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.788 -1.19 . . . . 73.41 107.788 176.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.14 107.15 19.62 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.529 -0.545 . . . . 74.44 109.529 179.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.1 mm? -92.58 124.5 36.66 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.61 -0.723 . . . . 75.31 109.111 -177.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -117.09 141.69 28.83 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.869 -1.06 . . . . 71.44 110.689 -171.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 28.5 Cg_endo -60.79 153.13 64.85 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.879 2.386 . . . . 74.23 112.909 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 128' ' ' THR . . . 80.29 -27.21 2.82 Favored Glycine 0 C--N 1.315 -0.635 0 CA-C-N 115.813 -0.63 . . . . 72.02 113.566 175.438 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.16 162.9 4.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.715 0.769 . . . . 74.33 112.243 -179.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.44 131.45 66.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.012 -1.107 . . . . 73.53 108.012 176.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.4 m -119.79 145.46 46.58 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.812 0.339 . . . . 72.13 110.82 -175.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 p -104.92 126.35 51.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.056 -0.72 . . . . 73.43 109.056 175.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -110.1 131.94 54.6 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.023 -0.732 . . . . 71.31 109.023 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.5 m -141.53 140.59 33.49 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.975 -0.69 . . . . 64.32 109.408 175.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -149.09 121.65 8.56 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.106 -0.702 . . . . 74.32 109.106 -177.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -124.22 132.16 53.58 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 107.873 -1.158 . . . . 64.45 107.873 178.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.17 151.48 31.97 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.539 -0.541 . . . . 74.13 109.539 -175.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -88.92 130.15 35.48 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.221 -1.029 . . . . 75.34 108.221 -179.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.475 ' CD2' HG22 ' A' ' 119' ' ' VAL . 7.4 m-30 -118.2 153.64 33.53 Favored 'General case' 0 CA--C 1.465 -2.298 0 CA-C-N 118.527 0.603 . . . . 73.43 110.191 -174.692 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.6 p -96.89 91.09 5.47 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 109.247 -0.649 . . . . 73.33 109.247 173.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -55.68 132.28 72.02 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 110.025 -0.361 . . . . 73.21 110.025 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.21 -33.77 70.64 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.724 2.283 . . . . 62.55 112.771 -179.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -84.0 -16.93 42.19 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.242 -1.022 . . . . 75.32 108.242 -178.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 66.5 p 60.9 29.42 19.0 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.565 1.546 . . . . 74.12 111.217 -178.342 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -84.06 139.52 32.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.005 -1.452 . . . . 74.23 110.28 179.259 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 C--N 1.277 -2.586 0 N-CA-C 107.019 -1.474 . . . . 60.23 107.019 179.533 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.062 0 N-CA-C 109.993 -1.243 . . . . 72.42 109.993 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -98.82 106.69 18.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.651 -1.24 . . . . 74.04 107.651 177.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.72 160.09 17.49 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.892 -0.323 . . . . 75.54 111.833 -176.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 56.19 68.35 0.87 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.54 1.311 . . . . 73.21 114.54 174.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.6 tp -100.77 99.82 10.4 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.621 -1.252 . . . . 70.21 107.621 174.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -108.9 103.53 12.6 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.418 -0.586 . . . . 74.12 109.418 -178.226 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -72.27 135.58 46.04 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.048 -1.094 . . . . 75.42 108.048 177.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.11 -71.25 0.77 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.493 -0.558 . . . . 71.5 109.493 -177.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.25 -112.55 5.01 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.556 -0.618 . . . . 62.55 111.556 -178.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.424 ' CG ' ' HB2' ' A' ' 136' ' ' ASP . 21.7 m-70 -137.35 123.97 21.02 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.435 -1.32 . . . . 71.51 107.435 177.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 14.6 tpt -83.92 8.64 14.41 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.781 0.8 . . . . 73.41 112.184 -173.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 tt -137.19 118.81 14.93 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.403 -1.702 . . . . 73.41 106.403 174.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -121.5 136.91 54.92 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 109.502 -0.555 . . . . 75.43 109.502 -176.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.45 ' CG2' HG22 ' A' ' 137' ' ' VAL . 21.7 m -130.09 113.77 27.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 108.446 -0.946 . . . . 74.01 108.446 170.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -115.56 116.31 27.93 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.03 -0.986 . . . . 63.21 109.433 -177.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.09 108.02 16.1 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 106.458 -1.682 . . . . 73.34 106.458 172.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 140' ' ' THR . 23.1 t -125.9 115.65 20.29 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.038 -1.097 . . . . 74.34 108.038 -177.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -120.43 146.86 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 109.521 -0.548 . . . . 73.42 109.521 -177.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.9 m -128.91 122.63 30.69 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 109.83 -0.433 . . . . 71.42 109.83 -177.545 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -114.34 121.76 67.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.577 0.703 . . . . 73.42 110.858 -178.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.3 m -95.52 155.93 38.09 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 115.407 -0.815 . . . . 75.33 110.028 -177.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.14 2.34 0.47 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 124.144 3.23 . . . . 75.0 114.1 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 29.0 t70 -84.66 -4.0 58.8 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.801 -0.814 . . . . 75.12 108.801 178.385 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 72.2 29.38 2.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.895 1.678 . . . . 73.4 106.59 -174.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.4 OUTLIER -101.04 125.2 47.64 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 112.967 -1.924 . . . . 74.13 108.254 -178.743 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.29 133.72 58.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 N-CA-C 108.34 -0.985 . . . . 73.23 108.34 178.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.6 p -140.42 161.39 37.82 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.462 -1.681 . . . . 74.34 106.462 177.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.53 -178.12 46.44 Favored Glycine 0 CA--C 1.483 -1.929 0 C-N-CA 118.684 -1.722 . . . . 74.21 112.888 178.145 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -145.87 133.62 21.12 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 123.08 0.552 . . . . 55.34 109.53 -176.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.88 115.61 46.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.103 -1.443 . . . . 74.41 107.103 176.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.62 118.1 56.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 109.659 -0.497 . . . . 72.52 109.659 -178.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.464 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -114.49 108.61 17.09 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.564 -1.273 . . . . 64.52 107.564 175.764 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.81 124.12 43.41 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.507 -0.553 . . . . 65.43 109.507 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.07 158.71 23.72 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.919 -0.582 . . . . 74.12 111.905 -174.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -53.53 130.96 54.5 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 114.306 -1.316 . . . . 74.44 109.357 173.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.44 87.89 0.11 Allowed 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 122.59 2.193 . . . . 74.44 111.94 177.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -134.06 152.62 51.92 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 104.058 -2.571 . . . . 74.13 104.058 178.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 73.25 101.17 0.07 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 106.19 -1.781 . . . . 75.25 106.19 -168.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.2 m -56.71 -31.33 64.39 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 114.138 1.162 . . . . 65.43 114.138 -173.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -84.99 -8.09 58.88 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.725 -0.39 . . . . 75.22 111.752 -179.071 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -104.65 109.49 21.42 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.835 0.826 . . . . 75.13 112.625 -171.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 t -121.81 7.57 9.92 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.271 -1.331 . . . . 73.41 109.288 175.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.45 97.81 0.11 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 120.717 -0.754 . . . . 74.1 111.851 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 83' ' ' SER . 39.4 Cg_exo -63.35 159.5 39.6 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.753 2.302 . . . . 72.32 111.478 176.173 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.41 120.93 36.49 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.548 -0.908 . . . . 53.43 108.548 178.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.1 mt -72.32 126.94 31.06 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.513 0.673 . . . . 73.24 110.642 176.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.85 87.21 6.39 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.101 -1.409 . . . . 75.12 108.374 -173.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.496 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -165.62 82.37 0.11 Allowed Glycine 0 N--CA 1.407 -3.251 0 CA-C-N 114.78 -1.1 . . . . 72.24 112.328 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -98.14 97.5 8.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.669 -1.234 . . . . 73.31 107.669 174.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -110.36 158.17 36.06 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.011 -0.995 . . . . 74.45 110.522 -174.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.57 -23.53 71.44 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 122.762 2.308 . . . . 71.41 111.634 177.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -103.92 30.92 4.8 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.51 -0.768 . . . . 63.43 111.658 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.6 m -58.73 -23.91 60.64 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 121.152 0.501 . . . . 65.34 110.99 176.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -66.76 -18.87 65.6 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.806 -0.633 . . . . 74.55 110.069 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -97.62 -11.91 23.06 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.739 -0.664 . . . . 74.13 110.711 -178.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.62 119.27 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 122.069 0.938 . . . . 73.14 111.772 178.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.27 103.46 15.92 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.37 -0.832 . . . . 73.52 108.786 178.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.13 131.21 45.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.633 -1.247 . . . . 74.01 107.633 178.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -146.16 171.41 14.97 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.283 -0.636 . . . . 75.53 109.283 -173.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -85.59 151.93 23.53 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.979 -1.119 . . . . 75.52 107.979 175.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 63.0 t80 -113.21 122.62 48.02 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.585 -0.895 . . . . 63.3 108.585 -179.623 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -138.67 97.9 3.45 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.096 -1.446 . . . . 71.34 107.096 176.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 48.1 m -166.24 157.22 13.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.246 -1.39 . . . . 75.11 107.246 -176.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.25 1.71 3.37 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.233 1.013 . . . . 75.13 112.757 173.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.99 -4.76 65.67 Favored Glycine 0 C--O 1.213 -1.212 0 N-CA-C 110.707 -0.957 . . . . 74.22 110.707 -174.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.92 156.84 16.92 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 123.61 0.764 . . . . 75.13 109.283 -176.164 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.35 137.45 56.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.335 -0.617 . . . . 72.23 109.335 173.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -171.2 -154.17 9.53 Favored Glycine 0 N--CA 1.416 -2.665 0 C-N-CA 119.99 -1.1 . . . . 71.24 112.373 -177.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 12.4 p -129.68 148.04 51.52 Favored 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 123.441 0.696 . . . . 73.32 110.195 -177.269 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.78 145.18 44.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.674 0.273 . . . . 72.43 110.769 178.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -127.07 114.92 18.39 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.565 -1.272 . . . . 41.42 107.565 174.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.7 t -114.39 117.97 57.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.557 -0.905 . . . . 75.11 108.557 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 90' ' ' LEU . 48.8 p90 -120.51 154.61 35.05 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 120.817 0.341 . . . . 75.14 111.076 -174.674 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.5 m -158.15 158.37 34.5 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.16 -0.473 . . . . 60.1 110.39 -179.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.7 t70 67.34 31.89 6.21 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.532 1.158 . . . . 75.44 111.348 176.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 87' ' ' PHE . 31.6 mt -97.4 159.91 14.64 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.633 -0.712 . . . . 75.24 111.483 178.034 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.5 m -96.2 158.11 15.59 Favored 'General case' 0 N--CA 1.412 -2.343 0 C-N-CA 124.554 1.142 . . . . 75.02 109.23 -177.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.8 -38.81 70.46 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.837 0.351 . . . . 73.41 110.655 175.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.3 -25.48 68.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.964 -0.562 . . . . 73.52 111.598 178.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -88.14 -16.35 33.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.905 0.383 . . . . 54.13 111.318 -178.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 43.7 tp -56.6 -48.64 96.79 Favored Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 112.89 0.7 . . . . 72.33 112.89 179.091 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.32 -35.87 81.95 Favored 'Trans proline' 0 C--N 1.369 1.652 0 CA-C-N 120.847 1.338 . . . . 74.13 111.318 174.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -64.63 -39.76 94.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.283 0.563 . . . . 74.22 110.817 -177.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -77.09 -19.67 56.73 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.622 -0.51 . . . . 73.35 109.622 177.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.13 -21.62 59.8 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.197 -0.668 . . . . 73.1 109.197 -177.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.09 -55.77 22.59 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.26 -1.015 . . . . 75.11 108.26 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.496 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.4 ttp -53.64 -51.31 63.52 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.508 -0.769 . . . . 65.15 109.865 178.108 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -53.07 -42.62 66.0 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.015 -0.993 . . . . 71.23 109.838 179.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -62.08 -41.02 97.76 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.916 -0.584 . . . . 70.2 109.498 -172.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.33 -11.16 59.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.451 -0.795 . . . . 71.31 110.097 -169.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.86 -17.57 14.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.858 -0.61 . . . . 74.33 110.559 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.68 -43.69 4.65 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.126 0.787 . . . . 64.05 113.126 -173.532 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.97 19.44 28.82 Favored Glycine 0 C--N 1.317 -0.49 0 N-CA-C 110.03 -1.228 . . . . 71.51 110.03 -172.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -110.18 142.44 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.449 -0.574 . . . . 64.41 109.449 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -107.86 122.48 46.88 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.426 -1.324 . . . . 73.24 107.426 177.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.4 mt -120.55 127.67 52.37 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 121.09 -0.244 . . . . 74.02 110.356 -177.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -130.34 136.68 49.37 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.609 -1.256 . . . . 73.5 107.609 177.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -146.0 149.65 34.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.409 0.623 . . . . 75.31 111.013 -178.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -144.67 156.51 44.13 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.868 -1.06 . . . . 74.55 108.884 -179.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.442 ' NH1' ' HA ' ' A' ' 180' ' ' ASP . 17.0 ttm180 -114.03 130.94 56.52 Favored 'General case' 0 N--CA 1.398 -3.037 0 N-CA-C 108.196 -1.039 . . . . 74.53 108.196 172.082 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -113.06 100.76 8.86 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.899 -1.519 . . . . 75.23 106.899 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.63 -113.32 5.2 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 110.575 -1.01 . . . . 74.23 110.575 -176.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -109.1 1.77 20.67 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.025 0.917 . . . . 70.01 109.436 179.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.4 pp -110.39 146.62 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 118.217 -1.393 . . . . 71.1 109.514 179.25 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.449 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 76.3 t -110.89 143.51 20.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-O 120.972 0.415 . . . . 73.2 110.629 -177.213 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.1 pt -124.13 133.75 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 108.822 -0.807 . . . . 73.13 108.822 178.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.45 127.1 41.87 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.785 -0.82 . . . . 71.24 108.785 178.113 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -131.54 123.34 27.79 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.452 -1.314 . . . . 63.55 107.452 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -143.51 164.4 27.36 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.423 -0.894 . . . . 54.2 112.982 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -134.01 130.27 37.34 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.323 -0.621 . . . . 72.15 109.323 -178.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.19 110.46 21.69 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.766 -0.457 . . . . 74.15 109.766 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.85 93.68 5.02 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 122.03 0.919 . . . . 75.43 108.691 177.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -114.75 23.39 12.69 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-O 122.924 1.345 . . . . 65.2 109.057 177.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.3 p -77.04 -26.02 53.15 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.249 -1.76 . . . . 74.01 106.249 171.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.9 m -93.07 18.07 9.84 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.651 -1.613 . . . . 65.45 111.541 -177.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.65 132.44 31.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 N-CA-C 109.525 -0.546 . . . . 74.44 109.525 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.9 t -81.99 -42.97 18.63 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.1 -0.5 . . . . 74.1 110.413 -177.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.82 113.9 55.48 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-O 120.944 0.402 . . . . 65.11 110.406 179.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.27 -11.78 21.0 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.115 2.543 . . . . 75.03 113.26 -176.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.44 3.61 12.95 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.034 0.934 . . . . 75.22 112.2 -175.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.87 144.69 31.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.351 0.5 . . . . 73.53 112.351 -172.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.424 ' HB2' ' CG ' ' A' ' 24' ' ' HIS . 21.9 t0 -131.21 116.58 17.85 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 105.845 -1.909 . . . . 72.13 105.845 171.369 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 56.6 t -108.0 124.17 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 C-N-CA 120.017 -0.673 . . . . 75.11 110.463 -172.638 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.96 120.19 31.77 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.365 -0.606 . . . . 73.5 109.365 177.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.558 HD11 ' CE3' ' A' ' 162' ' ' TRP . 2.6 tm? -111.79 117.07 31.81 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.223 -1.769 . . . . 73.5 106.223 177.394 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.5 m -126.01 136.91 53.52 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 120.879 0.371 . . . . 71.13 110.263 -176.428 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.6 t -128.22 120.89 54.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.034 -1.099 . . . . 74.23 108.034 176.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.07 127.37 56.19 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.269 -0.641 . . . . 63.24 109.269 179.554 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -135.09 122.02 14.88 Favored Pre-proline 0 C--N 1.288 -2.093 0 N-CA-C 112.449 0.537 . . . . 75.35 112.449 179.186 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.88 40.81 0.44 Allowed 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 122.822 2.348 . . . . 74.04 111.527 172.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.52 -91.86 0.53 Allowed 'General case' 0 N--CA 1.434 -1.226 0 O-C-N 122.062 -0.399 . . . . 75.42 110.656 -178.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 170.31 120.29 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 124.046 0.938 . . . . 62.21 108.596 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.06 118.38 16.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 122.357 1.075 . . . . 73.54 109.999 175.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 176' ' ' ALA . 33.4 m -75.99 -45.81 32.75 Favored 'General case' 1 N--CA 1.367 -4.583 0 CA-C-N 113.981 -1.463 . . . . 74.31 110.498 -178.657 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.3 m -163.2 133.32 4.4 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.036 0.934 . . . . 64.12 108.949 174.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -138.58 157.53 45.97 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.467 -0.771 . . . . 73.14 111.993 177.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -127.42 95.73 4.35 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 104.984 -2.228 . . . . 72.33 104.984 173.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.452 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 170.04 -148.43 11.74 Favored Glycine 0 N--CA 1.414 -2.827 0 N-CA-C 108.106 -1.998 . . . . 75.23 108.106 -178.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -115.59 99.25 7.2 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.864 0.84 . . . . 75.4 109.937 -176.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -82.88 117.06 22.47 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-N 115.526 -0.761 . . . . 74.25 111.013 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.3 -39.92 19.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.977 -1.49 . . . . 55.24 106.977 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -138.24 167.82 18.43 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 114.474 -1.239 . . . . 75.41 107.889 176.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -72.63 0.49 7.51 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.724 2.283 . . . . 70.33 111.086 174.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -127.69 -2.41 6.03 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.418 -0.81 . . . . 74.32 111.379 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.6 t -140.41 120.38 12.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.578 -0.897 . . . . 74.43 108.578 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.89 144.29 34.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.054 -0.721 . . . . 71.23 109.054 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -138.08 144.61 41.01 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.457 0.646 . . . . 74.41 109.464 -177.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.558 ' CE3' HD11 ' A' ' 139' ' ' LEU . 29.1 m-90 -119.05 114.57 22.71 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 108.017 -1.105 . . . . 73.32 108.017 176.345 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.53 107.37 18.08 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.04 0.924 . . . . 74.21 109.2 178.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 77.4 mt -101.51 127.4 48.22 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 114.493 -1.231 . . . . 72.13 110.207 -174.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -114.09 131.36 23.23 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 114.01 -1.45 . . . . 74.01 110.966 -173.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -54.07 151.0 29.29 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.383 2.722 . . . . 74.22 112.583 178.037 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.17 -33.47 2.92 Favored Glycine 0 C--N 1.304 -1.207 0 C-N-CA 120.98 -0.629 . . . . 74.34 112.963 176.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.22 155.6 6.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 120.997 0.427 . . . . 74.53 110.864 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.99 144.26 14.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.32 -0.622 . . . . 72.31 109.32 -178.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 m -145.19 141.12 28.41 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.611 -0.514 . . . . 61.45 109.611 177.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 63.1 p -105.23 135.07 47.27 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.207 -0.664 . . . . 74.12 109.207 177.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.4 131.79 50.2 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.72 -0.474 . . . . 73.01 109.72 177.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.4 m -137.24 139.03 40.74 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 119.659 -0.816 . . . . 74.14 109.972 174.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.99 133.05 15.23 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 108.62 -0.881 . . . . 55.33 108.62 -175.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -133.7 131.57 39.63 Favored 'General case' 0 C--N 1.26 -3.312 0 N-CA-C 107.353 -1.351 . . . . 74.14 107.353 176.346 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.532 ' HA ' ' OG1' ' A' ' 148' ' ' THR . . . -156.68 146.3 20.74 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.563 -0.532 . . . . 74.21 109.563 -177.23 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 19.1 ptt85 -86.22 135.25 33.64 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.999 -0.546 . . . . 75.33 110.616 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.449 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 95.3 m-85 -137.65 135.84 36.9 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 108.744 -0.836 . . . . 74.15 108.744 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.2 p -58.71 109.24 0.77 Allowed 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.066 0.854 . . . . 72.14 111.547 -178.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.442 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 22.3 t70 -65.02 120.26 65.39 Favored Pre-proline 0 CA--C 1.489 -1.403 0 CA-C-N 115.166 -0.925 . . . . 71.22 108.69 -179.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.53 -45.13 12.13 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 122.14 1.893 . . . . 71.53 112.765 -175.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -84.69 -12.7 53.32 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.83 -1.077 . . . . 64.04 111.723 -176.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 75.8 p 60.26 56.62 3.19 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.862 1.265 . . . . 75.53 112.833 176.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -85.02 161.01 19.9 Favored 'General case' 0 N--CA 1.404 -2.734 0 CA-C-N 114.244 -1.344 . . . . 72.24 110.573 -178.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.27 -2.863 0 N-CA-C 106.247 -1.761 . . . . 73.44 106.247 176.741 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 N--CA 1.434 -1.274 0 N-CA-C 108.773 -0.825 . . . . 73.540000000000006 108.773 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.0 t -121.91 113.71 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.142 -1.429 . . . . 74.510000000000005 107.142 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -124.51 113.81 18.6 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.143 0.497 . . . . 73.519999999999996 109.71 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.09 113.75 27.14 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.407 -1.331 . . . . 74.109999999999999 107.407 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 140' ' ' THR . 37.8 m -125.18 114.51 19.09 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.931 -1.137 . . . . 75.25 107.931 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.401 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 2.1 pp -130.33 147.1 33.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.323 -0.398 . . . . 73.030000000000001 110.274 -173.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 78.3 m -125.68 123.63 39.34 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 109.27 -0.641 . . . . 74.239999999999995 109.27 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.492 ' O ' ' HD2' ' A' ' 144' ' ' PRO . 8.5 tt -114.69 131.47 66.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.944 -0.571 . . . . 74.510000000000005 111.031 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -96.55 149.95 36.44 Favored Pre-proline 0 N--CA 1.419 -1.977 0 N-CA-C 108.91 -0.774 . . . . 64.340000000000003 108.91 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.12 2.41 2.22 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.133 2.555 . . . . 70.120000000000005 112.699 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -86.74 5.82 34.44 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 123.722 0.809 . . . . 70.329999999999998 110.87 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 t70 70.83 29.48 3.11 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 123.183 1.468 . . . . 71.140000000000001 107.558 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.52 128.79 55.76 Favored 'General case' 0 N--CA 1.399 -3.018 0 CA-C-N 113.174 -1.83 . . . . 64.310000000000002 107.121 -177.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.513 HG11 HD21 ' A' ' 95' ' ' LEU . 8.1 t -124.29 144.9 32.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.095 -0.502 . . . . 51.140000000000001 110.071 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -149.21 161.26 42.36 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.791 -0.818 . . . . 65.150000000000006 108.791 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 162.26 -165.31 35.96 Favored Glycine 0 C--N 1.312 -0.786 0 C-N-CA 119.266 -1.445 . . . . 51.130000000000003 113.019 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -150.52 140.19 21.68 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.009 0.433 . . . . 72.329999999999998 109.853 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.3 mt -125.41 116.68 47.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.511 -0.922 . . . . 71.349999999999994 108.511 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.26 123.43 63.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.618 -0.512 . . . . 61.399999999999999 109.618 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.42 108.46 14.58 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.326 -1.361 . . . . 54.439999999999998 107.326 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -122.09 135.65 54.83 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.985 0.421 . . . . 72.530000000000001 111.616 -174.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.48 158.67 41.48 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.885 -0.783 . . . . 63.049999999999997 108.885 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 pttt . . . . . 0 C--N 1.318 -0.804 0 C-N-CA 118.653 -1.219 . . . . 73.0 109.775 177.18 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.493 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 4.2 t . . . . . 0 N--CA 1.431 -1.411 0 N-CA-C 107.299 -1.371 . . . . 53.420000000000002 107.299 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.08 112.64 0.29 Allowed Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 109.875 -1.29 . . . . 72.530000000000001 109.875 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -52.36 128.91 29.39 Favored 'Trans proline' 0 C--N 1.355 0.915 0 CA-C-N 119.879 1.839 . . . . 74.099999999999994 109.089 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.63 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -95.87 151.95 18.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 114.169 1.174 . . . . 72.409999999999997 114.169 -167.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 83.4 mt -85.23 141.49 30.09 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.322 -1.308 . . . . 51.530000000000001 108.952 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -106.43 99.9 9.45 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.546 -1.279 . . . . 71.549999999999997 107.546 177.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.4 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -149.69 69.37 0.33 Allowed Glycine 0 C--N 1.287 -2.188 0 C-N-CA 120.041 -1.076 . . . . 55.039999999999999 114.023 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.65 95.51 6.59 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.18 -1.415 . . . . 74.019999999999996 107.18 172.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.31 159.28 29.98 Favored Pre-proline 0 C--N 1.293 -1.885 0 CA-C-N 115.088 -0.96 . . . . 72.549999999999997 109.823 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.56 -16.74 55.09 Favored 'Trans proline' 0 N--CA 1.481 0.741 0 C-N-CA 122.739 2.292 . . . . 61.119999999999997 113.153 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -115.79 33.37 5.53 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.058 -0.519 . . . . 73.439999999999998 110.597 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 p -57.63 -28.24 63.52 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 121.222 0.534 . . . . 74.409999999999997 112.375 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -66.94 -20.05 65.83 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.235 0.541 . . . . 73.420000000000002 110.351 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -101.03 -2.77 30.77 Favored 'General case' 0 C--O 1.257 1.492 0 CA-C-N 115.846 -0.615 . . . . 73.140000000000001 110.233 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' A' ' 87' ' ' PHE . 4.3 p -132.41 118.87 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.12 0.962 . . . . 62.240000000000002 110.817 175.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.95 106.0 17.99 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.477 -0.783 . . . . 61.509999999999998 109.209 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.21 130.93 45.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 106.784 -1.561 . . . . 71.349999999999994 106.784 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.1 t -145.67 171.77 14.24 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.89 -0.781 . . . . 33.140000000000001 108.89 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -84.53 137.9 33.06 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.14 -0.689 . . . . 74.329999999999998 109.14 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 77.0 t80 -107.38 124.96 50.6 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.473 -0.936 . . . . 73.239999999999995 108.473 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -139.0 98.84 3.62 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.553 -1.277 . . . . 74.430000000000007 107.553 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 70.3 m -160.22 148.48 16.79 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.779 -0.452 . . . . 55.32 109.779 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 67.64 8.22 6.21 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.733 1.213 . . . . 75.299999999999997 112.056 173.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.59 4.99 65.3 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.003 -0.839 . . . . 55.509999999999998 111.003 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.498 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 2.9 m-85 -104.71 142.91 33.85 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.191 -1.041 . . . . 72.010000000000005 108.191 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.8 m -124.78 139.18 51.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.547 -0.909 . . . . 65.219999999999999 108.547 175.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.26 -153.8 10.6 Favored Glycine 0 C--N 1.266 -3.353 0 N-CA-C 110.309 -1.117 . . . . 62.409999999999997 110.309 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.63 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 69.3 m -132.48 151.07 52.03 Favored 'General case' 0 C--N 1.266 -3.034 0 CA-C-O 121.289 0.566 . . . . 74.329999999999998 111.804 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -131.35 141.14 49.86 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.708 -0.678 . . . . 74.140000000000001 109.894 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.35 114.66 26.95 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.941 -1.133 . . . . 62.219999999999999 107.941 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.51 113.1 43.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.752 -1.203 . . . . 72.230000000000004 107.752 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CD2' HD12 ' A' ' 90' ' ' LEU . 40.6 p90 -120.42 156.23 31.84 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 120.745 0.307 . . . . 75.099999999999994 111.648 -173.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 p -160.7 149.54 16.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.876 -0.602 . . . . 75.519999999999996 111.089 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 67.23 32.16 6.2 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.467 1.107 . . . . 73.299999999999997 110.822 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 87' ' ' PHE . 19.6 mt -89.52 169.22 11.54 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.687 -0.688 . . . . 72.219999999999999 109.621 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.401 HG22 ' OE1' ' A' ' 94' ' ' GLU . 10.8 t -124.82 171.14 10.38 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.698 -0.482 . . . . 64.409999999999997 109.698 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -56.36 -36.37 68.72 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.856 0.862 . . . . 75.129999999999995 112.366 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.56 -25.6 63.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.15 0.5 . . . . 74.099999999999994 111.811 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' OE1' HG22 ' A' ' 91' ' ' THR . 55.7 mt-10 -81.07 -21.25 40.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 112.126 0.417 . . . . 75.140000000000001 112.126 -176.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.513 HD21 HG11 ' A' ' 40' ' ' VAL . 18.8 mt -54.53 -49.77 89.15 Favored Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 115.697 1.74 . . . . 73.030000000000001 115.697 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -54.92 -45.84 37.88 Favored 'Trans proline' 0 C--N 1.365 1.441 0 CA-C-N 120.816 1.327 . . . . 72.329999999999998 111.269 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -68.46 -32.87 73.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.948 0.88 . . . . 65.129999999999995 110.407 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.42 -40.58 89.62 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.296 -1.32 . . . . 74.299999999999997 108.829 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.75 -25.38 67.9 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.932 -1.031 . . . . 71.329999999999998 111.118 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -59.35 -55.55 33.3 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.404 0.44 . . . . 73.340000000000003 109.901 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.4 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 29.7 ttp -54.36 -48.93 70.91 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.706 0.629 . . . . 70.319999999999993 110.222 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -53.13 -41.95 65.57 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 114.964 -1.016 . . . . 61.439999999999998 111.363 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.9 m -67.23 -21.4 65.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.83 -0.623 . . . . 71.430000000000007 112.003 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.14 -28.59 70.17 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 121.38 0.61 . . . . 64.310000000000002 109.753 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -112.65 -2.55 14.51 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.823 -0.626 . . . . 72.140000000000001 110.916 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.7 -47.59 3.86 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.153 -0.619 . . . . 73.219999999999999 112.52 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.44 28.97 66.71 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.218 -0.992 . . . . 71.040000000000006 112.007 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.4 m -123.1 173.56 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.594 -0.521 . . . . 62.32 109.594 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -126.23 130.34 50.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.891 0.314 . . . . 73.209999999999994 110.912 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.05 136.16 53.42 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.06 -0.718 . . . . 63.009999999999998 109.06 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -143.34 120.21 11.27 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.933 -0.395 . . . . 63.340000000000003 109.933 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.3 145.9 36.64 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.08 -0.648 . . . . 63.549999999999997 109.262 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HE ' HD11 ' A' ' 120' ' ' ILE . 84.4 mtm-85 -147.41 151.33 36.29 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.55 -0.75 . . . . 62.219999999999999 109.571 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.416 ' CG ' HG22 ' A' ' 119' ' ' VAL . 20.3 mtt85 -97.16 137.6 35.95 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 120.126 -0.63 . . . . 61.100000000000001 111.42 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -117.77 92.26 3.79 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 106.534 -1.654 . . . . 73.430000000000007 106.534 174.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.94 -98.24 1.18 Allowed Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 110.694 -0.962 . . . . 62.43 110.694 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -130.64 6.28 4.74 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.809 1.29 . . . . 71.040000000000006 108.216 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.544 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.2 pp -108.51 145.06 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 106.695 -1.595 . . . . 71.209999999999994 106.695 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.416 HG22 ' CG ' ' A' ' 114' ' ' ARG . 90.9 t -105.48 136.44 39.51 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.831 0 N-CA-C 109.675 -0.491 . . . . 75.310000000000002 109.675 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.497 HG22 ' HG2' ' A' ' 175' ' ' GLN . 33.5 pt -111.69 133.57 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.318 0 N-CA-C 107.531 -1.285 . . . . 70.510000000000005 107.531 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.6 tt -115.03 123.76 49.88 Favored 'General case' 0 C--N 1.255 -3.534 0 N-CA-C 108.385 -0.968 . . . . 73.109999999999999 108.385 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -116.49 131.2 57.01 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 113.913 -1.494 . . . . 72.230000000000004 107.052 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -152.64 148.26 18.91 Favored Glycine 0 N--CA 1.413 -2.837 0 C-N-CA 119.735 -1.222 . . . . 74.129999999999995 110.301 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.58 137.47 43.77 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.103 -0.703 . . . . 71.010000000000005 109.103 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.38 109.14 13.52 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 108.633 -0.877 . . . . 64.439999999999998 108.633 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.11 98.6 7.45 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.543 -1.651 . . . . 61.409999999999997 106.543 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.13 36.99 4.49 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 123.024 1.392 . . . . 75.400000000000006 108.542 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 49.8 p . . . . . 0 C--N 1.288 -2.093 0 CA-C-N 113.515 -1.675 . . . . 71.439999999999998 110.538 178.574 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 . . . . . 0 C--O 1.243 0.728 0 N-CA-C 112.014 0.376 . . . . 75.120000000000005 112.014 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -71.92 136.0 46.72 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.92 -0.582 . . . . 71.530000000000001 109.567 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -131.06 114.43 15.16 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.846 -0.428 . . . . 74.310000000000002 109.846 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 89.4 t -109.96 126.63 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 107.163 -1.421 . . . . 71.230000000000004 107.163 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -134.79 129.14 34.12 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 120.939 0.4 . . . . 71.450000000000003 111.206 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.9 tp -117.79 129.48 55.7 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.178 -0.464 . . . . 70.409999999999997 109.905 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' SER . 18.4 m -127.05 122.56 34.7 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.074 -1.084 . . . . 73.549999999999997 108.074 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 97.1 t -118.07 122.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.413 -0.588 . . . . 62.009999999999998 109.413 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.07 130.6 56.56 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.23 -0.655 . . . . 74.530000000000001 109.23 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.699 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.2 p90 -135.33 127.1 17.71 Favored Pre-proline 0 C--N 1.286 -2.178 0 CA-C-O 119.424 -0.322 . . . . 61.219999999999999 111.587 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 58.5 Cg_endo -75.15 36.63 0.45 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.569 2.179 . . . . 73.319999999999993 112.029 177.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.54 -103.19 0.41 Allowed 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 109.665 -0.495 . . . . 53.310000000000002 109.665 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.87 131.05 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.931 -1.137 . . . . 61.130000000000003 107.931 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.59 133.84 28.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.049 0.452 . . . . 75.219999999999999 109.969 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.3 p -89.19 -46.41 8.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.246 0.546 . . . . 72.030000000000001 109.623 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.6 m -152.05 133.88 14.85 Favored 'General case' 0 C--O 1.207 -1.178 0 CA-C-N 115.586 -0.733 . . . . 42.43 110.055 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 t -139.0 160.9 38.67 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.869 -0.519 . . . . 72.530000000000001 110.446 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 29.2 t-20 -132.26 89.56 2.68 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.723 -1.954 . . . . 75.150000000000006 105.723 174.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.35 -147.97 9.96 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 108.235 -1.946 . . . . 72.200000000000003 108.235 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -118.36 100.63 7.61 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 117.829 0.814 . . . . 64.409999999999997 110.301 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 21.0 ptt180 -83.26 123.44 29.6 Favored 'General case' 0 N--CA 1.413 -2.313 0 C-N-CA 119.884 -0.726 . . . . 73.420000000000002 111.354 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.56 -46.93 17.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.236 -1.394 . . . . 71.340000000000003 107.236 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -123.53 165.02 24.88 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 107.739 -1.208 . . . . 73.049999999999997 107.739 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -72.23 -0.16 8.22 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.429 2.086 . . . . 61.329999999999998 110.931 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.699 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.9 pt-20 -135.46 6.3 3.25 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.166 -0.925 . . . . 74.439999999999998 111.9 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.92 120.85 6.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 108.126 -1.064 . . . . 64.430000000000007 108.126 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 36.9 t -125.19 146.57 30.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 109.448 -0.575 . . . . 72.5 109.448 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -133.03 146.11 51.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 109.45 -0.574 . . . . 54.030000000000001 109.45 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 29.7 m-90 -128.19 129.35 46.34 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.639 -0.71 . . . . 72.540000000000006 109.245 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 1.0 OUTLIER -102.73 103.0 13.21 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 122.149 0.976 . . . . 74.310000000000002 111.005 176.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.5 mm? -90.73 116.22 28.42 Favored 'General case' 0 C--O 1.264 1.829 0 CA-C-O 121.827 0.822 . . . . 74.329999999999998 108.891 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 10.8 mmpt? -104.73 143.5 26.83 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 114.272 -1.331 . . . . 62.109999999999999 111.269 -172.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 58.5 Cg_endo -69.85 150.22 67.35 Favored 'Trans proline' 0 C--O 1.248 1.013 0 C-N-CA 123.963 3.109 . . . . 74.319999999999993 111.722 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.49 -30.64 3.06 Favored Glycine 0 C--N 1.321 -0.288 0 C-N-CA 120.913 -0.66 . . . . 41.020000000000003 112.213 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 35.3 m -105.63 165.79 3.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 110.011 -0.366 . . . . 73.230000000000004 110.011 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.69 142.26 26.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.215 -1.031 . . . . 63.310000000000002 108.215 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 63.7 m -142.34 140.89 32.26 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.204 0.526 . . . . 73.129999999999995 110.823 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 50.5 p -103.34 141.3 36.17 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.962 -1.125 . . . . 74.209999999999994 107.962 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -123.79 126.58 46.72 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.919 -0.4 . . . . 63.119999999999997 109.919 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 35.4 t -138.79 144.15 39.24 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.829 -0.434 . . . . 31.309999999999999 109.829 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.42 127.94 10.74 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.318 -0.993 . . . . 65.519999999999996 108.318 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' A' ' 120' ' ' ILE . 44.8 mt-30 -128.47 131.95 48.37 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 108.703 -0.851 . . . . 73.239999999999995 108.703 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.73 159.9 43.79 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.822 -0.436 . . . . 44.240000000000002 109.822 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.544 ' HG2' HG22 ' A' ' 118' ' ' ILE . 98.5 mtt180 -86.96 126.81 34.95 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.674 -0.491 . . . . 71.519999999999996 109.674 -177.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.401 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 74.9 m-85 -143.11 125.24 15.37 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 109.589 -0.523 . . . . 64.239999999999995 109.589 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.35 114.07 1.84 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 124.29 0.994 . . . . 73.340000000000003 111.831 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.2 t70 . . . . . 0 C--O 1.213 -0.868 0 N-CA-C 108.322 -0.992 . . . . 72.030000000000001 108.322 177.495 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 . . . . . 0 N--CA 1.417 -2.086 0 N-CA-C 108.956 -0.757 . . . . 73.099999999999994 108.956 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.22 114.51 46.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.805 -1.183 . . . . 75.25 107.805 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -116.82 113.93 23.21 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.65 -1.159 . . . . 71.219999999999999 109.608 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.59 121.36 42.39 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 109.11 -0.7 . . . . 64.450000000000003 109.11 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.6 m -127.12 114.7 18.06 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.048 -1.093 . . . . 72.420000000000002 108.048 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -128.15 147.26 32.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.716 -0.475 . . . . 71.329999999999998 109.716 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.5 m -130.49 122.25 27.31 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 121.162 0.506 . . . . 74.239999999999995 110.221 -177.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 143' ' ' PHE . 10.7 tt -106.61 117.64 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.771 0.796 . . . . 74.540000000000006 109.51 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.8 t -77.76 150.54 78.84 Favored Pre-proline 0 N--CA 1.419 -1.987 0 CA-C-N 114.781 -1.099 . . . . 42.32 108.784 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -65.26 2.37 1.5 Allowed 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 123.555 2.837 . . . . 72.340000000000003 112.03 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -89.4 -0.31 57.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.324 1.05 . . . . 74.409999999999997 108.243 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 29.3 t70 68.96 29.11 4.99 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.58 1.552 . . . . 71.120000000000005 108.523 -178.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.38 126.99 53.49 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 113.583 -1.644 . . . . 70.209999999999994 107.505 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 t -107.73 138.95 31.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 109.315 -0.624 . . . . 63.109999999999999 109.315 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.4 p -147.28 158.68 44.05 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.256 -1.387 . . . . 63.329999999999998 107.256 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.7 -172.07 41.78 Favored Glycine 0 CA--C 1.489 -1.589 0 C-N-CA 119.433 -1.365 . . . . 63.340000000000003 112.197 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.6 133.39 17.96 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.33 0.586 . . . . 24.449999999999999 109.635 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 68.2 mt -117.23 116.22 51.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.952 -1.129 . . . . 64.310000000000002 107.952 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.39 120.45 62.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.398 -0.593 . . . . 74.019999999999996 109.398 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.499 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.32 107.6 16.93 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 106.462 -1.681 . . . . 53.539999999999999 106.462 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -117.39 123.59 46.8 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.787 -0.449 . . . . 62.240000000000002 109.787 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.27 157.5 19.4 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.554 0.692 . . . . 72.219999999999999 112.22 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 N--CA 1.441 -0.907 0 CA-C-N 113.404 -1.726 . . . . 70.150000000000006 110.328 179.685 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 N--CA 1.429 -1.493 0 N-CA-C 107.247 -1.39 . . . . 61.130000000000003 107.247 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.625 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 174.04 97.96 0.11 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.105 -1.198 . . . . 72.530000000000001 110.105 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.535 ' O ' ' HB3' ' A' ' 83' ' ' SER . 15.7 Cg_exo -68.32 159.07 54.85 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.571 2.18 . . . . 75.409999999999997 111.672 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.62 154.48 24.82 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.196 -0.668 . . . . 50.100000000000001 109.196 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 85' ' ' ALA . 48.1 mt -74.77 152.39 39.03 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.371 0.605 . . . . 73.310000000000002 111.908 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -107.94 99.49 8.94 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.056 -0.975 . . . . 64.219999999999999 109.183 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.465 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -160.22 92.76 0.12 Allowed Glycine 0 C--N 1.29 -2.011 0 C-N-CA 120.36 -0.924 . . . . 71.129999999999995 113.525 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -86.48 112.58 21.65 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.253 -1.017 . . . . 74.409999999999997 108.253 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.09 162.08 54.36 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 116.269 -0.423 . . . . 54.200000000000003 110.499 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.18 -21.13 67.69 Favored 'Trans proline' 0 N--CA 1.478 0.593 0 C-N-CA 122.401 2.067 . . . . 71.209999999999994 112.043 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -109.87 27.99 9.03 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.632 -0.713 . . . . 52.450000000000003 111.855 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.4 m -52.19 -31.51 32.02 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.281 0.474 . . . . 71.510000000000005 112.281 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -61.65 -22.09 64.98 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.007 0.523 . . . . 75.310000000000002 111.819 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 88' ' ' SER . 32.7 mmtp -98.85 -10.08 23.4 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 122.287 -0.258 . . . . 72.340000000000003 111.134 -176.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.69 120.04 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 119.693 -0.803 . . . . 72.519999999999996 110.861 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.13 113.21 25.68 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.686 -0.688 . . . . 44.100000000000001 109.266 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.47 124.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 108.282 -1.007 . . . . 35.020000000000003 108.282 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 m -128.55 165.04 21.52 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.024 -0.989 . . . . 64.239999999999995 109.8 -172.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.625 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 5.9 t30 -77.51 136.5 38.33 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.109 -0.95 . . . . 74.549999999999997 109.132 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -110.62 119.41 39.06 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 108.64 -0.874 . . . . 70.340000000000003 108.64 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -138.86 100.01 3.94 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.528 -0.915 . . . . 43.119999999999997 108.528 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 t -163.0 143.92 9.59 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.389 -0.597 . . . . 62.409999999999997 109.389 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.92 12.05 8.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.912 0.885 . . . . 73.230000000000004 113.357 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.62 -3.61 65.7 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.33 -0.938 . . . . 53.100000000000001 111.485 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.558 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 29.8 m-85 -94.74 145.46 24.85 Favored 'General case' 0 C--O 1.254 1.316 0 N-CA-C 108.218 -1.031 . . . . 71.400000000000006 108.218 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.3 m -128.94 136.63 59.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.611 -0.885 . . . . 44.299999999999997 108.611 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.94 -155.25 9.96 Favored Glycine 0 N--CA 1.414 -2.808 0 C-N-CA 119.98 -1.105 . . . . 61.149999999999999 111.899 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 24.4 p -121.94 152.0 40.15 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.131 -0.535 . . . . 74.540000000000006 110.473 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.8 pt20 -138.73 129.4 26.23 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.571 -0.452 . . . . 62.329999999999998 110.59 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -107.3 114.49 28.56 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.011 -1.477 . . . . 63.420000000000002 107.011 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.33 116.26 51.87 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.735 -1.209 . . . . 71.099999999999994 107.735 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CD2' HD12 ' A' ' 90' ' ' LEU . 41.8 p90 -117.88 157.61 26.35 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.08 0.467 . . . . 64.120000000000005 111.286 -174.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 16.5 p -158.62 152.7 23.79 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.354 -0.839 . . . . 54.100000000000001 109.616 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 t70 62.5 47.24 5.16 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 122.959 1.361 . . . . 62.439999999999998 111.26 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.452 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.4 mt -108.06 163.32 13.25 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.572 -1.194 . . . . 74.340000000000003 110.003 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -112.15 174.03 6.08 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.367 -0.605 . . . . 64.510000000000005 109.367 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.425 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 61.9 t80 -50.53 -48.36 57.22 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.18 0.992 . . . . 74.219999999999999 111.308 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.68 -25.43 66.36 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.433 0.693 . . . . 44.350000000000001 112.193 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -86.65 -16.44 36.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 116.138 -0.483 . . . . 71.299999999999997 112.3 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 5.4 tt -64.52 -52.18 54.41 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 119.54 -0.267 . . . . 73.530000000000001 110.441 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.85 -30.89 39.85 Favored 'Trans proline' 0 C--N 1.367 1.541 0 CA-C-N 120.951 1.376 . . . . 65.0 110.529 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -67.42 -31.16 71.16 Favored 'General case' 0 N--CA 1.424 -1.744 0 O-C-N 121.957 -0.464 . . . . 75.219999999999999 110.889 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -77.84 -19.16 55.37 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.175 0.512 . . . . 73.319999999999993 109.975 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.87 -13.49 61.68 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.555 -0.748 . . . . 74.329999999999998 110.653 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -66.37 -57.89 6.47 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.241 -1.022 . . . . 74.219999999999999 108.241 172.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.465 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.8 ttp -55.85 -50.48 70.46 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.252 0.548 . . . . 73.340000000000003 110.131 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -54.54 -37.74 65.77 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 114.456 -1.247 . . . . 70.430000000000007 111.712 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.7 p -62.35 -31.73 72.42 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 119.942 -0.703 . . . . 51.420000000000002 111.248 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.37 -25.0 67.38 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.498 0.666 . . . . 70.140000000000001 111.263 -173.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.44 -13.77 15.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.22 -0.592 . . . . 42.310000000000002 111.283 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.27 -41.47 5.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.115 0.783 . . . . 75.349999999999994 113.115 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.98 19.92 58.55 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.498 -1.041 . . . . 74.099999999999994 110.498 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 m -104.36 155.44 5.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.19 0.519 . . . . 70.439999999999998 111.154 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -120.18 137.33 54.25 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.096 -1.816 . . . . 72.129999999999995 106.096 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -134.92 111.52 9.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.055 0.455 . . . . 71.25 112.143 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.8 t -119.37 122.27 41.42 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.75 -0.833 . . . . 64.319999999999993 108.75 176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -139.31 142.88 37.67 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 116.06 -0.518 . . . . 73.349999999999994 109.738 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -141.14 149.6 41.72 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.523 -1.217 . . . . 75.129999999999995 109.568 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 ttm105 -98.92 137.86 36.88 Favored 'General case' 0 N--CA 1.409 -2.492 0 N-CA-C 108.527 -0.916 . . . . 61.509999999999998 108.527 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -122.63 94.58 4.33 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.11 -1.441 . . . . 63.240000000000002 107.11 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.75 -103.87 1.36 Allowed Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.856 -0.898 . . . . 73.510000000000005 110.856 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.605 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 11.2 t30 -113.99 -8.55 13.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.227 1.013 . . . . 71.409999999999997 109.422 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -99.54 149.87 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 C-N-CA 119.36 -0.936 . . . . 74.25 109.408 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.2 t -119.02 138.86 48.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 O-C-N 121.923 -0.486 . . . . 74.030000000000001 111.195 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.6 pt -117.05 132.96 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.344 -0.844 . . . . 71.120000000000005 109.209 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.2 tt -129.22 130.93 46.92 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 115.971 -0.559 . . . . 64.150000000000006 109.717 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.32 133.23 34.69 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.971 -0.559 . . . . 73.519999999999996 110.002 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.74 171.97 32.49 Favored Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 120.161 -1.018 . . . . 71.0 112.002 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -138.53 158.11 44.88 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.417 -0.586 . . . . 75.120000000000005 109.417 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.94 113.26 18.23 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.626 -0.879 . . . . 74.310000000000002 108.626 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -111.96 93.81 4.64 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.878 0.847 . . . . 75.519999999999996 111.506 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 166' ' ' PRO . 1.1 pt? -134.98 30.92 3.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 123.88 1.8 . . . . 74.510000000000005 107.045 176.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.416 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 37.1 p . . . . . 0 C--N 1.296 -1.72 0 CA-C-N 111.863 -2.426 . . . . 71.349999999999994 112.596 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 C--O 1.237 0.395 0 CA-C-O 122.043 0.925 . . . . 65.450000000000003 109.827 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.88 140.93 28.98 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.935 -1.03 . . . . 43.43 111.831 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -132.1 141.79 49.29 Favored 'General case' 0 C--O 1.265 1.919 0 CA-C-N 115.699 -0.682 . . . . 75.310000000000002 110.124 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 60.2 t -106.4 116.23 49.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.229 -1.026 . . . . 55.340000000000003 108.229 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -115.47 120.71 40.42 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.871 -0.418 . . . . 72.010000000000005 109.871 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -118.54 115.74 25.2 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.531 -1.285 . . . . 70.400000000000006 107.531 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.5 m -120.82 128.33 52.76 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.146 -0.479 . . . . 71.420000000000002 109.732 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.4 t -120.74 127.18 75.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.353 -0.61 . . . . 64.219999999999999 109.353 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.24 124.55 52.79 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 109.503 -0.555 . . . . 74.120000000000005 109.503 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.627 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.3 p90 -134.36 112.46 11.98 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 122.909 0.484 . . . . 73.239999999999995 111.208 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -67.82 42.75 0.24 Allowed 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.484 2.789 . . . . 75.430000000000007 113.118 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.09 -92.94 0.51 Allowed 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.559 -0.534 . . . . 54.329999999999998 109.559 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.01 126.77 0.02 OUTLIER 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.939 0.896 . . . . 75.310000000000002 108.829 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.25 123.89 38.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.144 0.497 . . . . 74.040000000000006 110.07 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.7 p -86.4 -36.35 19.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.771 0.319 . . . . 65.230000000000004 111.01 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.6 m -161.99 132.92 5.08 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 107.859 -1.163 . . . . 44.109999999999999 107.859 176.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -139.03 152.29 47.48 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.903 -0.498 . . . . 72.239999999999995 110.938 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 27.8 t-20 -115.73 92.03 3.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.988 -1.856 . . . . 71.420000000000002 105.988 172.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.34 -149.77 12.07 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.139 -1.984 . . . . 75.140000000000001 108.139 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -116.54 99.76 7.38 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 117.887 0.844 . . . . 72.099999999999994 109.569 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -77.94 119.77 21.86 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 119.679 -0.809 . . . . 73.420000000000002 109.538 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.5 mm -86.81 -44.97 16.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.192 -1.411 . . . . 52.109999999999999 107.192 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -118.45 162.43 30.43 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 105.215 -2.143 . . . . 73.140000000000001 105.215 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -74.37 -0.8 10.15 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.901 1.734 . . . . 74.340000000000003 110.956 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.627 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.3 pt-20 -131.95 3.82 4.1 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.129 -0.941 . . . . 61.210000000000001 111.35 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.87 121.13 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 108.463 -0.94 . . . . 62.020000000000003 108.463 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.0 t -122.46 148.29 26.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.538 -0.541 . . . . 53.439999999999998 109.538 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -131.94 138.86 48.5 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.515 -0.55 . . . . 71.319999999999993 109.515 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.445 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.8 m-90 -119.63 130.39 55.06 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.701 -0.851 . . . . 70.200000000000003 108.701 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -109.88 104.24 13.14 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.957 0.884 . . . . 65.420000000000002 108.648 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 0.5 OUTLIER -100.98 131.19 46.97 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.818 -0.808 . . . . 72.299999999999997 108.818 -174.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 66.0 mttm -117.36 149.61 44.95 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 115.802 -0.636 . . . . 70.239999999999995 112.598 -173.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.441 ' HA ' ' HG ' ' A' ' 127' ' ' LEU . 17.0 Cg_exo -67.45 154.94 72.31 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.878 2.386 . . . . 70.25 111.743 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 84.43 -39.31 2.91 Favored Glycine 0 C--N 1.311 -0.828 0 CA-C-N 115.83 -0.623 . . . . 61.5 112.541 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.34 151.86 6.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.981 -0.378 . . . . 71.340000000000003 109.981 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.79 110.44 24.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.733 0.778 . . . . 73.400000000000006 109.15 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.405 ' HB2' HD12 ' A' ' 164' ' ' LEU . 14.9 m -101.31 131.04 47.55 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.688 -0.687 . . . . 70.209999999999994 109.689 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 37.6 p -105.41 145.2 31.14 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.109 -0.496 . . . . 63.420000000000002 109.708 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 25.1 ptp -126.66 134.05 50.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.8 -0.815 . . . . 73.430000000000007 108.8 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 9.1 m -141.69 146.94 36.69 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.236 -1.024 . . . . 64.310000000000002 108.236 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.445 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -156.31 120.59 4.49 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.787 -0.449 . . . . 61.5 109.787 -175.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -123.01 131.87 53.89 Favored 'General case' 0 C--N 1.264 -3.136 0 N-CA-C 107.391 -1.337 . . . . 72.329999999999998 107.391 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -160.31 153.06 21.18 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.978 -1.119 . . . . 72.239999999999995 107.978 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.602 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 38.5 ptt180 -92.87 131.49 37.85 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.2 -1.0 . . . . 74.510000000000005 109.685 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -126.38 118.42 24.98 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.718 -1.215 . . . . 75.140000000000001 107.718 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.605 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -53.25 109.97 0.49 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 124.905 1.378 . . . . 72.109999999999999 112.538 -177.357 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.6 t0 . . . . . 0 CA--C 1.502 -0.877 0 N-CA-C 107.589 -1.263 . . . . 74.099999999999994 107.589 -179.523 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 109.441 -0.577 . . . . 72.109999999999999 109.441 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 46' ' ' ALA . 33.1 m -125.08 129.86 73.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.964 -0.694 . . . . 75.219999999999999 109.95 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.496 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 15.5 ptt180 -139.35 122.25 16.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.52 0.676 . . . . 53.439999999999998 111.038 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.66 138.56 49.29 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.54 -0.755 . . . . 51.310000000000002 109.287 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.7 m -134.17 115.25 13.99 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.075 -1.083 . . . . 74.329999999999998 108.075 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 11.6 pt -129.04 149.1 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-O 121.359 0.599 . . . . 50.350000000000001 110.178 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 88.8 m -124.51 126.67 46.24 Favored 'General case' 0 C--N 1.264 -3.112 0 N-CA-C 108.976 -0.75 . . . . 74.200000000000003 108.976 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.482 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.8 tt -113.26 120.03 62.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.793 0.806 . . . . 52.329999999999998 109.752 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 37' ' ' ASP . 26.3 t -81.4 151.99 69.73 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 114.639 -1.164 . . . . 54.409999999999997 109.056 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.65 2.31 2.09 Favored 'Trans proline' 0 C--N 1.364 1.351 0 C-N-CA 123.291 2.66 . . . . 63.329999999999998 111.524 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 35' ' ' SER . 14.3 t70 -82.52 -7.99 59.63 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.703 1.201 . . . . 63.219999999999999 108.318 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.9 t70 72.22 29.26 2.28 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 123.444 1.592 . . . . 70.439999999999998 107.413 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.24 135.38 51.09 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 113.125 -1.852 . . . . 64.030000000000001 107.491 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.402 HG12 ' HE2' ' A' ' 87' ' ' PHE . 10.6 t -117.03 142.01 32.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.173 -0.677 . . . . 52.140000000000001 109.173 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.1 p -149.66 157.57 43.36 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.501 -1.296 . . . . 75.540000000000006 107.501 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.77 -162.84 34.88 Favored Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 118.481 -1.818 . . . . 41.109999999999999 112.949 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -150.44 133.69 16.29 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.361 0.6 . . . . 72.25 110.108 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.8 116.37 52.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.614 -1.254 . . . . 64.040000000000006 107.614 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 29' ' ' ARG . 2.0 mp -103.19 120.97 53.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 120.862 0.363 . . . . 75.040000000000006 110.258 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -119.73 108.8 14.87 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.533 -1.284 . . . . 33.509999999999998 107.533 174.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -121.6 146.52 46.89 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.448 0.642 . . . . 64.349999999999994 112.06 -173.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.83 139.28 50.15 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.438 -0.949 . . . . 65.439999999999998 108.438 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 tttm . . . . . 0 C--N 1.31 -1.134 0 N-CA-C 107.886 -1.153 . . . . 74.420000000000002 107.886 179.244 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.443 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 20.7 p . . . . . 0 N--CA 1.427 -1.604 0 N-CA-C 107.616 -1.253 . . . . 71.420000000000002 107.616 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.08 103.62 0.17 Allowed Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 114.582 -1.19 . . . . 73.319999999999993 110.202 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.43 134.77 53.05 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.746 2.297 . . . . 51.219999999999999 110.434 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.94 148.25 25.21 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 114.802 1.408 . . . . 72.219999999999999 114.802 -168.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 92.7 mt -89.08 161.66 16.41 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 114.201 -1.363 . . . . 62.43 108.57 174.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -110.62 90.78 3.42 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.437 0.637 . . . . 74.299999999999997 109.827 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.43 51.7 1.58 Allowed Glycine 0 C--N 1.302 -1.333 0 CA-C-N 115.685 -0.689 . . . . 74.439999999999998 112.697 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -96.44 98.85 10.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.352 0.596 . . . . 73.310000000000002 110.542 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.68 171.74 7.23 Favored Pre-proline 0 C--N 1.311 -1.1 0 C-N-CA 123.569 0.748 . . . . 50.210000000000001 109.951 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.09 -19.25 34.78 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.857 1.705 . . . . 70.219999999999999 111.612 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.44 ' CE1' ' HG2' ' A' ' 97' ' ' GLN . 15.6 p90 -111.29 36.28 3.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.855 -0.612 . . . . 61.310000000000002 110.606 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.5 m -60.41 -27.7 67.67 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 122.064 -0.397 . . . . 65.120000000000005 111.814 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.4 pm0 -71.99 -9.33 58.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.487 -0.758 . . . . 62.439999999999998 110.383 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.622 ' HB3' HD21 ' A' ' 90' ' ' LEU . 14.7 mmmm -95.95 -20.09 19.01 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.895 -0.593 . . . . 75.439999999999998 109.701 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 p -130.69 117.88 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 122.157 0.98 . . . . 63.329999999999998 110.993 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.98 124.58 47.84 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.684 -0.689 . . . . 74.150000000000006 110.326 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.93 120.61 47.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.676 -1.231 . . . . 61.549999999999997 107.676 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -124.91 168.88 12.67 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.626 -0.715 . . . . 65.010000000000005 110.258 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -79.98 150.29 30.51 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.042 -0.725 . . . . 63.210000000000001 109.042 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 93.2 t80 -127.35 129.5 47.73 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.063 -0.517 . . . . 72.120000000000005 109.738 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -138.19 98.26 3.58 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.577 -1.268 . . . . 73.310000000000002 107.577 176.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 67.7 m -164.66 155.57 14.84 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.265 -0.643 . . . . 65.030000000000001 109.265 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 69.87 4.38 4.74 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.571 1.148 . . . . 73.109999999999999 110.932 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.76 -4.07 71.76 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.205 -0.758 . . . . 42.020000000000003 111.205 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.444 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 66.4 m-85 -104.44 144.05 32.19 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.527 -0.545 . . . . 75.019999999999996 109.527 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.5 m -118.2 145.53 24.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.259 -1.015 . . . . 73.420000000000002 108.259 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.19 -153.74 12.85 Favored Glycine 0 CA--C 1.459 -3.416 0 C-N-CA 118.692 -1.718 . . . . 44.119999999999997 112.14 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.617 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 4.3 p -123.72 145.06 49.28 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-O 121.721 0.772 . . . . 73.150000000000006 111.732 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -125.64 131.73 52.6 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.466 -0.788 . . . . 71.310000000000002 109.873 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.8 114.19 26.64 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.267 -1.383 . . . . 72.239999999999995 107.267 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.1 t -107.39 113.55 43.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.111 -1.07 . . . . 70.200000000000003 108.111 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CD2' HD12 ' A' ' 90' ' ' LEU . 51.7 p90 -116.03 151.45 35.48 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.846 -0.427 . . . . 73.010000000000005 109.846 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.1 m -154.06 153.96 32.82 Favored 'General case' 0 C--N 1.292 -1.891 0 C-N-CA 120.449 -0.5 . . . . 70.129999999999995 111.099 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.22 36.18 15.0 Favored 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 124.443 1.089 . . . . 72.439999999999998 111.07 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.622 HD21 ' HB3' ' A' ' 69' ' ' LYS . 37.6 mt -97.78 168.53 10.27 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 114.854 -1.067 . . . . 63.219999999999999 109.14 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -125.43 -179.92 4.83 Favored 'General case' 0 C--N 1.268 -2.968 0 N-CA-C 108.641 -0.874 . . . . 53.509999999999998 108.641 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CZ ' ' HG ' ' A' ' 112' ' ' LEU . 43.6 t80 -51.19 -48.2 62.02 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 124.766 1.227 . . . . 72.310000000000002 110.559 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.58 -25.85 66.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.892 0.701 . . . . 73.310000000000002 112.892 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.42 -17.46 27.16 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 122.069 -0.394 . . . . 64.530000000000001 111.48 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 38.0 tp -66.47 -51.8 39.92 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 113.472 0.916 . . . . 73.239999999999995 113.472 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 92' ' ' PHE . 18.3 Cg_endo -62.96 -33.88 73.03 Favored 'Trans proline' 0 C--N 1.368 1.59 0 CA-C-N 120.829 1.332 . . . . 53.399999999999999 110.389 175.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.44 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 60.1 tt0 -66.61 -36.26 82.16 Favored 'General case' 0 N--CA 1.41 -2.464 0 CA-C-N 115.226 -0.897 . . . . 74.409999999999997 110.871 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -75.69 -19.3 59.21 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.325 0.583 . . . . 64.129999999999995 110.041 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.91 -20.57 61.75 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.825 -0.625 . . . . 73.209999999999994 110.565 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -56.31 -58.05 9.63 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 123.417 0.448 . . . . 75.099999999999994 111.177 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -59.46 -46.63 88.23 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.318 0.58 . . . . 50.109999999999999 110.194 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -57.26 -34.79 68.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.376 -1.284 . . . . 73.010000000000005 110.962 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.9 m -63.32 -33.5 75.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.553 -0.459 . . . . 71.329999999999998 110.905 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.93 -20.04 63.36 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.791 0.805 . . . . 64.439999999999998 110.479 -175.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.34 -19.13 17.95 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.697 -0.683 . . . . 62.240000000000002 110.506 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.91 -47.69 3.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.591 0.96 . . . . 63.140000000000001 113.591 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.52 28.17 25.25 Favored Glycine 0 C--O 1.238 0.403 0 N-CA-C 110.436 -1.066 . . . . 73.510000000000005 110.436 -173.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.43 160.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.412 -0.394 . . . . 74.310000000000002 110.699 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -119.32 142.77 47.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.381 -1.34 . . . . 73.299999999999997 107.381 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.7 mt -139.43 144.39 38.05 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 123.355 0.409 . . . . 72.25 110.28 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 m -142.83 117.33 9.71 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.356 -0.979 . . . . 61.310000000000002 108.356 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.43 ' HG ' ' CZ ' ' A' ' 92' ' ' PHE . 52.0 tp -121.9 125.93 47.53 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.076 -0.511 . . . . 73.420000000000002 110.375 -176.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -141.7 148.52 39.21 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.197 -0.668 . . . . 72.120000000000005 109.197 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 114' ' ' ARG . 16.8 ttm180 -98.69 128.05 44.83 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 108.39 -0.967 . . . . 71.140000000000001 108.39 172.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -102.27 86.11 2.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.84 -1.171 . . . . 72.530000000000001 107.84 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.29 -98.98 0.54 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.143 -0.935 . . . . 74.329999999999998 111.709 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.541 ' HA ' ' OD1' ' A' ' 180' ' ' ASP . 3.4 t-20 -107.63 -15.19 14.65 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.307 1.051 . . . . 74.409999999999997 109.651 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.7 pp -110.0 148.62 13.46 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.758 0 O-C-N 121.115 -0.99 . . . . 73.400000000000006 108.749 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 114' ' ' ARG . 73.6 t -105.91 137.62 35.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 O-C-N 121.639 -0.663 . . . . 64.540000000000006 110.25 -177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.408 HG22 ' HG2' ' A' ' 175' ' ' GLN . 47.0 pt -117.14 130.66 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 121.84 0.828 . . . . 71.340000000000003 110.064 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.25 128.58 44.95 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 115.161 -0.927 . . . . 63.219999999999999 109.352 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -129.18 147.68 51.05 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.614 -0.884 . . . . 74.530000000000001 108.614 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.55 166.25 37.18 Favored Glycine 0 N--CA 1.407 -3.298 0 N-CA-C 111.259 -0.736 . . . . 74.310000000000002 111.259 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -136.4 145.91 45.83 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.342 -0.985 . . . . 75.349999999999994 108.342 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 164' ' ' LEU . . . -124.29 110.15 14.25 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.932 -1.136 . . . . 71.409999999999997 107.932 174.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -99.11 105.87 18.01 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.822 -0.807 . . . . 75.319999999999993 108.822 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.8 mm? -116.86 30.65 7.21 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.37 -0.974 . . . . 64.129999999999995 108.37 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 121.588 0.708 . . . . 75.239999999999995 111.209 -177.077 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 CA--C 1.516 -0.33 0 CA-C-O 120.792 0.33 . . . . 74.420000000000002 111.105 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.527 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -85.79 122.29 29.66 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.979 -0.378 . . . . 54.130000000000003 109.979 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.37 139.43 53.28 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.221 -0.659 . . . . 61.32 109.221 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 84.4 t -113.4 113.06 42.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.712 -1.218 . . . . 73.200000000000003 107.712 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 38.5 mt-10 -117.52 123.49 46.4 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-O 120.97 0.414 . . . . 74.310000000000002 110.497 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tt -118.69 128.15 54.24 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.29 -1.744 . . . . 72.200000000000003 106.29 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.3 m -126.24 128.39 47.13 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.064 -0.717 . . . . 73.400000000000006 109.064 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.481 HG12 ' HD2' ' A' ' 143' ' ' PHE . 61.7 t -124.06 125.38 70.71 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.113 -0.699 . . . . 64.230000000000004 109.113 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.17 125.89 54.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.083 -1.08 . . . . 70.040000000000006 108.083 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.644 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.4 p90 -134.36 122.54 16.0 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 112.348 0.499 . . . . 75.219999999999999 112.348 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -70.4 61.19 2.07 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 122.365 2.044 . . . . 73.319999999999993 111.13 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.61 -132.46 0.08 Allowed 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.79 -1.189 . . . . 72.400000000000006 107.79 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -160.3 122.9 3.33 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.166 -1.05 . . . . 64.200000000000003 108.166 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.55 133.21 31.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 109.092 -0.707 . . . . 65.109999999999999 109.092 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.9 p -89.4 -44.43 10.19 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.997 -0.742 . . . . 62.229999999999997 108.997 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.0 m -159.01 133.47 7.9 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.097 -0.502 . . . . 71.420000000000002 109.759 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -138.24 155.25 48.82 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.098 0.475 . . . . 75.150000000000006 110.346 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.475 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 51.1 t-20 -121.6 90.92 3.4 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 104.263 -2.495 . . . . 72.120000000000005 104.263 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 171.96 -161.95 34.03 Favored Glycine 0 N--CA 1.411 -2.997 0 N-CA-C 106.702 -2.559 . . . . 55.140000000000001 106.702 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -100.08 99.75 10.52 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 118.257 1.028 . . . . 71.030000000000001 110.412 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -80.11 107.79 13.18 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-O 121.552 0.691 . . . . 72.239999999999995 110.306 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.0 mt -80.51 -49.1 19.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.533 -1.284 . . . . 64.230000000000004 107.533 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.57 164.7 34.59 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.318 -1.364 . . . . 71.230000000000004 107.318 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.61 -3.5 13.21 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.1 1.866 . . . . 71.519999999999996 111.112 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.644 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.8 pt-20 -131.86 5.87 4.27 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.017 -0.538 . . . . 72.219999999999999 112.386 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.7 t -143.18 121.41 7.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 108.772 -0.825 . . . . 70.209999999999994 108.772 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.75 148.15 32.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.665 -0.495 . . . . 32.310000000000002 109.665 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -133.75 141.12 47.37 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.716 -0.476 . . . . 74.109999999999999 109.716 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.476 ' O ' ' HA ' ' A' ' 138' ' ' GLU . 32.9 m-90 -117.92 119.78 35.87 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.941 -0.762 . . . . 72.230000000000004 108.941 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -109.54 98.32 7.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.154 -1.054 . . . . 65.049999999999997 108.154 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 14.1 mt -98.28 138.89 34.88 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 114.592 -1.185 . . . . 73.530000000000001 108.696 -172.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -117.47 162.48 28.28 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 114.702 1.371 . . . . 73.140000000000001 114.702 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 72.3 Cg_endo -76.18 156.64 37.87 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.363 2.709 . . . . 71.540000000000006 112.43 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.92 -33.54 2.86 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 111.289 -0.724 . . . . 71.140000000000001 111.289 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 166' ' ' PRO . 18.4 m -105.12 148.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 123.688 0.795 . . . . 74.349999999999994 110.131 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.76 113.78 37.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.498 -1.297 . . . . 73.310000000000002 107.498 174.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.6 p -107.62 146.48 31.91 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.909 -0.587 . . . . 74.109999999999999 111.515 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.0 p -103.13 151.68 22.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.861 -0.609 . . . . 72.340000000000003 111.334 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 70.4 mtm -123.22 119.78 31.2 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.24 -1.393 . . . . 74.099999999999994 107.24 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 11.7 t -136.92 135.61 37.91 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.781 -1.192 . . . . 75.049999999999997 107.781 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.03 118.31 5.98 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.353 -0.61 . . . . 60.310000000000002 109.353 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.408 ' HG2' HG22 ' A' ' 120' ' ' ILE . 40.6 mt-30 -122.47 130.66 53.29 Favored 'General case' 0 C--N 1.269 -2.899 0 N-CA-C 106.403 -1.703 . . . . 74.040000000000006 106.403 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.77 148.87 30.47 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.883 -0.327 . . . . 61.439999999999998 110.321 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 15.4 ptt180 -88.08 127.21 35.41 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 120.333 -0.547 . . . . 71.200000000000003 109.94 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.21 152.0 47.96 Favored 'General case' 0 CA--C 1.482 -1.638 0 C-N-CA 120.788 -0.365 . . . . 72.409999999999997 110.1 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.0 p -77.4 120.75 22.84 Favored 'General case' 0 C--N 1.262 -3.233 0 N-CA-C 109.794 -0.447 . . . . 73.540000000000006 109.794 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 117' ' ' ASN . 4.9 m-20 . . . . . 0 C--N 1.313 -0.997 0 CA-C-N 115.854 -0.612 . . . . 65.420000000000002 110.522 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 . . . . . 0 N--CA 1.43 -1.463 0 N-CA-C 109.285 -0.635 . . . . 74.219999999999999 109.285 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.18 114.07 43.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.743 0.782 . . . . 71.230000000000004 109.783 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 41.8 mtp85 -113.63 118.76 35.29 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.493 -0.776 . . . . 75.209999999999994 111.849 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.419 ' HB3' ' HG ' ' A' ' 139' ' ' LEU . . . -107.77 108.67 19.98 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.0 -1.111 . . . . 33.119999999999997 108.0 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 140' ' ' THR . 4.2 p -117.39 115.67 25.66 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 109.304 -0.628 . . . . 62.340000000000003 109.304 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 16.7 pt -129.4 149.05 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-O 121.336 0.589 . . . . 73.420000000000002 110.711 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 53.6 m -123.46 124.68 43.42 Favored 'General case' 0 C--N 1.272 -2.792 0 N-CA-C 108.657 -0.868 . . . . 75.510000000000005 108.657 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.2 tt -108.38 109.96 30.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 122.027 0.918 . . . . 65.200000000000003 109.414 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.7 m -76.66 152.12 82.95 Favored Pre-proline 0 N--CA 1.423 -1.796 0 CA-C-N 114.635 -1.166 . . . . 71.099999999999994 109.962 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.23 -3.32 1.18 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 124.112 3.208 . . . . 74.530000000000001 114.438 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 9.7 m-20 -85.84 -0.56 55.66 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 124.175 0.99 . . . . 62.130000000000003 109.853 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 38.2 t0 68.6 34.71 3.43 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 123.781 1.753 . . . . 63.100000000000001 107.536 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -109.82 126.1 53.44 Favored 'General case' 0 N--CA 1.397 -3.121 0 CA-C-N 112.426 -2.17 . . . . 65.340000000000003 107.701 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG11 HD23 ' A' ' 95' ' ' LEU . 10.9 t -104.87 137.22 35.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.337 -0.986 . . . . 75.109999999999999 108.337 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.1 p -143.43 149.05 37.08 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 105.946 -1.872 . . . . 71.040000000000006 105.946 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.54 -169.56 40.02 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 117.626 -2.226 . . . . 72.230000000000004 113.157 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -152.84 142.38 21.79 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.352 0.596 . . . . 73.540000000000006 111.497 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.67 116.82 53.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.869 -1.16 . . . . 72.530000000000001 107.869 174.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.55 114.92 45.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.466 -0.939 . . . . 74.319999999999993 108.466 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.51 108.0 19.12 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.32 -1.733 . . . . 55.210000000000001 106.32 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -125.75 119.92 29.22 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.645 0.736 . . . . 73.340000000000003 111.048 -174.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.91 148.0 34.65 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.21 -0.905 . . . . 74.200000000000003 109.247 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.2 tttp . . . . . 0 C--N 1.306 -1.283 0 N-CA-C 105.982 -1.859 . . . . 72.439999999999998 105.982 175.438 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.645 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 16.1 p . . . . . 0 N--CA 1.42 -1.967 0 CA-C-O 120.566 0.222 . . . . 74.150000000000006 111.19 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.406 ' HA2' ' HA2' ' A' ' 82' ' ' GLY . . . 172.55 115.13 0.36 Allowed Glycine 0 N--CA 1.425 -2.048 0 C-N-CA 119.69 -1.243 . . . . 70.140000000000001 113.842 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.581 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 35.0 Cg_exo -66.76 129.37 20.83 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 CA-C-N 119.975 1.887 . . . . 74.420000000000002 108.221 168.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.73 163.22 28.2 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 113.695 0.998 . . . . 62.310000000000002 113.695 -171.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 59.2 mt -124.72 141.24 52.25 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.461 -0.94 . . . . 75.349999999999994 108.461 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -88.28 86.3 7.05 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.875 -0.787 . . . . 52.219999999999999 108.875 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.74 39.47 2.73 Favored Glycine 0 C--N 1.29 -1.986 0 CA-C-N 114.785 -1.098 . . . . 63.310000000000002 111.396 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -94.1 101.3 13.31 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.838 -1.171 . . . . 75.109999999999999 107.838 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.3 m -139.6 163.12 47.25 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 115.395 -0.821 . . . . 63.409999999999997 109.025 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.03 -24.9 51.99 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 122.435 2.09 . . . . 72.540000000000006 111.917 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -99.7 41.45 1.16 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.023 -0.535 . . . . 75.439999999999998 111.176 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p -57.47 -29.3 64.12 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.113 0.783 . . . . 72.439999999999998 113.113 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -72.5 -15.15 61.79 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-O 121.417 0.627 . . . . 75.439999999999998 109.929 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -94.89 -12.77 26.27 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.343 -0.844 . . . . 72.120000000000005 109.927 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 7.1 p -124.07 123.41 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.916 0.865 . . . . 74.530000000000001 112.296 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.43 105.77 16.83 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.212 -0.904 . . . . 72.140000000000001 108.87 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.2 t -98.06 130.16 47.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.066 -1.457 . . . . 71.310000000000002 107.066 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -148.16 172.07 14.89 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.551 -0.537 . . . . 54.119999999999997 109.551 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -87.21 153.25 21.64 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.482 -0.562 . . . . 65.219999999999999 109.482 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 71.7 t80 -123.09 129.57 51.63 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.544 0.738 . . . . 53.140000000000001 109.631 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -138.17 104.06 5.11 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.57 -1.27 . . . . 72.439999999999998 107.57 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 47.8 t -171.84 150.25 2.61 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.569 -0.9 . . . . 55.130000000000003 108.569 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 70.36 8.77 6.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.721 0.808 . . . . 72.340000000000003 111.4 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.77 -0.32 76.52 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 115.414 -0.812 . . . . 75.349999999999994 111.157 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 72.7 m-85 -104.42 146.73 28.43 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.573 -0.529 . . . . 73.299999999999997 109.573 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 56' ' ' THR . 27.4 m -124.18 138.5 53.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.239 -1.023 . . . . 72.439999999999998 108.239 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.581 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -174.91 -155.16 11.95 Favored Glycine 0 CA--C 1.464 -3.12 0 C-N-CA 119.178 -1.487 . . . . 55.350000000000001 112.47 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.402 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 46.7 m -126.03 147.55 49.53 Favored 'General case' 0 C--N 1.274 -2.681 0 CA-C-O 121.145 0.498 . . . . 74.219999999999999 110.081 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -128.5 141.18 51.47 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.918 -0.583 . . . . 71.310000000000002 109.89 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.21 114.34 23.52 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.627 -1.249 . . . . 72.230000000000004 107.627 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.7 t -109.18 111.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.827 -1.175 . . . . 72.329999999999998 107.827 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.7 p90 -113.16 157.78 21.25 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 120.924 0.392 . . . . 73.25 110.606 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 p -154.68 150.6 27.82 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.799 -0.637 . . . . 63.009999999999998 110.81 -174.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.7 t70 61.42 45.99 7.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.864 1.265 . . . . 70.340000000000003 111.819 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.492 HD12 ' CD2' ' A' ' 87' ' ' PHE . 43.3 mt -109.22 169.32 8.76 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.525 -0.761 . . . . 63.030000000000001 109.659 177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 t -128.41 -179.79 5.22 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.85 -0.74 . . . . 73.150000000000006 111.925 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.437 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 55.0 t80 -50.01 -43.87 50.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.784 2.034 . . . . 71.129999999999995 111.406 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.54 -25.59 64.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.779 -0.646 . . . . 61.210000000000001 111.747 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -89.34 -15.18 33.99 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.961 -0.563 . . . . 71.409999999999997 110.628 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.7 tm? -54.12 -56.12 29.36 Favored Pre-proline 0 CA--C 1.569 1.692 0 C-N-CA 123.802 0.841 . . . . 72.219999999999999 111.887 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.59 -35.72 57.58 Favored 'Trans proline' 0 C--N 1.372 1.785 0 CA-C-N 120.912 1.362 . . . . 72.319999999999993 111.08 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -63.03 -40.37 97.54 Favored 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 124.307 1.043 . . . . 74.530000000000001 110.398 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -76.05 -19.88 58.24 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.076 0.465 . . . . 55.100000000000001 109.783 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.1 -22.32 60.58 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.998 -0.546 . . . . 73.120000000000005 110.616 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -56.89 -48.82 77.31 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 109.68 -0.489 . . . . 72.239999999999995 109.68 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.407 ' HE1' HG21 ' A' ' 70' ' ' VAL . 24.4 ttm -53.57 -55.69 23.51 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.958 -1.019 . . . . 61.119999999999997 108.931 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -56.18 -36.58 68.53 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.299 -1.319 . . . . 72.209999999999994 111.622 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.5 m -65.59 -25.36 67.36 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 116.153 -0.476 . . . . 74.510000000000005 111.273 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.88 -27.65 66.87 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-O 121.447 0.642 . . . . 72.219999999999999 109.875 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -112.01 -13.1 13.64 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.823 -0.626 . . . . 64.319999999999993 111.305 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.477 ' HB1' HG23 ' A' ' 108' ' ' VAL . . . -107.17 -48.76 3.4 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.149 1.166 . . . . 51.200000000000003 114.149 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.61 7.0 78.75 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.144 -0.551 . . . . 62.0 112.468 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.477 HG23 ' HB1' ' A' ' 106' ' ' ALA . 61.9 t -81.2 133.96 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.475 -0.935 . . . . 62.140000000000001 108.475 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.47 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 28.7 m-80 -97.41 121.39 39.26 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.029 -1.1 . . . . 71.120000000000005 108.029 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.6 115.42 29.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.635 0.255 . . . . 62.43 110.483 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.3 m -109.49 135.89 49.78 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.656 -0.868 . . . . 65.5 108.656 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.3 tp -139.41 133.48 31.09 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 121.239 -0.184 . . . . 71.049999999999997 111.014 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -142.24 150.84 41.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.134 0.574 . . . . 73.310000000000002 110.654 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.43 HH22 ' CG ' ' A' ' 38' ' ' ASP . 39.5 ttm180 -112.02 135.8 52.2 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.389 -0.967 . . . . 75.019999999999996 108.389 174.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -127.94 93.06 3.59 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.69 -1.226 . . . . 74.349999999999994 107.69 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.4 -115.76 6.98 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 115.054 -0.975 . . . . 71.109999999999999 110.808 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.31 -17.81 24.21 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.54 0.686 . . . . 63.030000000000001 109.91 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 0.7 OUTLIER -103.43 148.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 C-N-CA 118.071 -1.452 . . . . 72.420000000000002 109.652 -174.009 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.9 t -120.1 135.78 59.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 110.086 -0.338 . . . . 51.210000000000001 110.086 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 175' ' ' GLN . 44.6 pt -113.56 130.63 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-O 121.719 0.771 . . . . 70.219999999999999 109.966 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.6 tt -125.91 129.64 49.71 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 107.677 -1.231 . . . . 74.409999999999997 107.677 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.76 123.76 24.11 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.824 -0.625 . . . . 54.43 109.567 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -132.76 147.44 18.91 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 110.653 -0.979 . . . . 10.24 110.653 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.28 125.95 27.12 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.539 -0.541 . . . . 74.140000000000001 109.539 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -99.82 109.94 22.33 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.683 -0.689 . . . . 61.340000000000003 110.001 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -99.95 93.22 5.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.276 -0.639 . . . . 74.040000000000006 109.276 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.0 24.28 10.25 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.541 -0.754 . . . . 63.100000000000001 109.197 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.7 p . . . . . 0 C--N 1.304 -1.375 0 CA-C-O 121.104 0.478 . . . . 61.210000000000001 111.546 -177.262 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 121.329 0.585 . . . . 75.450000000000003 111.189 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.26 135.52 33.41 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.46 -1.311 . . . . 65.310000000000002 107.46 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -131.62 115.19 15.75 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.596 -0.842 . . . . 74.450000000000003 109.376 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 51.2 t -106.51 122.67 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.428 -0.953 . . . . 70.5 108.428 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 31.9 tt0 -137.86 130.96 30.33 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.143 -0.688 . . . . 74.450000000000003 109.143 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' A' ' 30' ' ' ALA . 6.5 tt -128.88 135.52 49.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.307 -0.627 . . . . 55.020000000000003 109.307 -173.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 12.1 m -127.2 133.95 50.2 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.268 -0.642 . . . . 72.319999999999993 109.268 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.409 HG12 ' HD2' ' A' ' 143' ' ' PHE . 87.2 t -125.8 125.63 68.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.247 -0.649 . . . . 72.439999999999998 109.247 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -110.89 126.83 55.12 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 108.889 -0.782 . . . . 73.040000000000006 108.889 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.575 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.06 105.75 11.43 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 109.305 -0.628 . . . . 71.239999999999995 109.305 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.66 43.64 0.19 Allowed 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 123.521 2.814 . . . . 64.409999999999997 114.139 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.3 -91.25 0.56 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 123.152 0.581 . . . . 71.219999999999999 110.931 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 177.85 123.82 0.04 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.253 0.621 . . . . 41.009999999999998 110.042 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.3 p -80.89 141.81 14.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.688 -0.856 . . . . 73.120000000000005 108.688 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.9 p -99.59 -39.73 8.16 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.561 -0.533 . . . . 74.530000000000001 109.561 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.9 m -161.66 134.07 5.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.813 -0.63 . . . . 74.109999999999999 109.591 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.44 ' OG1' HG11 ' A' ' 160' ' ' VAL . 7.6 t -137.91 149.09 45.92 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.231 0.539 . . . . 72.450000000000003 111.036 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -112.5 87.53 2.6 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 106.518 -1.66 . . . . 74.310000000000002 106.518 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.71 -153.79 22.34 Favored Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 108.036 -2.026 . . . . 74.409999999999997 108.036 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -112.43 106.02 14.42 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 117.522 0.661 . . . . 73.540000000000006 110.751 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -80.05 126.34 30.94 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.736 -0.665 . . . . 75.530000000000001 109.794 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.2 mt -85.69 -42.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.885 -1.524 . . . . 62.409999999999997 106.885 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -135.28 170.02 12.24 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 113.964 -1.471 . . . . 64.239999999999995 107.387 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.98 0.05 8.36 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.295 1.997 . . . . 53.420000000000002 110.841 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.6 pt-20 -131.89 3.55 4.1 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.837 -0.62 . . . . 64.439999999999998 111.803 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.6 t -141.47 121.86 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.688 -0.856 . . . . 72.25 108.688 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.44 HG11 ' OG1' ' A' ' 150' ' ' THR . 40.5 t -127.4 149.15 32.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.739 -0.467 . . . . 71.019999999999996 109.739 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -134.15 144.0 48.27 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.599 -0.519 . . . . 64.420000000000002 109.599 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.469 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.3 m-90 -127.25 135.55 50.77 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.842 -0.617 . . . . 73.209999999999994 111.356 -178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.04 104.96 14.8 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.068 -0.969 . . . . 74.530000000000001 108.686 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 47.1 mt -101.65 119.76 39.28 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.211 -1.033 . . . . 75.209999999999994 108.211 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.488 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 74.3 mmtt -114.24 156.64 44.01 Favored Pre-proline 0 C--N 1.31 -1.149 0 N-CA-C 112.591 0.589 . . . . 73.140000000000001 112.591 -169.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.02 155.97 38.42 Favored 'Trans proline' 0 C--N 1.365 1.426 0 C-N-CA 123.025 2.483 . . . . 73.019999999999996 110.631 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.8 -32.67 2.17 Favored Glycine 0 C--N 1.312 -0.765 0 N-CA-C 112.134 -0.386 . . . . 71.120000000000005 112.134 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.488 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 21.3 m -105.72 161.4 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-O 120.94 0.4 . . . . 63.310000000000002 109.997 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.2 p -106.58 110.43 31.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.795 -1.187 . . . . 71.219999999999999 107.795 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.6 m -97.78 128.88 44.73 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.447 0.641 . . . . 61.43 110.313 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.2 p -101.63 137.87 39.38 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.352 -0.84 . . . . 71.230000000000004 109.991 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.4 ptm -131.62 133.09 44.59 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.718 -0.674 . . . . 73.150000000000006 109.586 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m -143.34 148.8 36.84 Favored 'General case' 0 C--N 1.276 -2.588 0 O-C-N 121.762 -0.586 . . . . 71.120000000000005 109.573 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -150.98 119.71 6.56 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.281 -1.007 . . . . 73.329999999999998 108.281 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.425 ' HG2' HG22 ' A' ' 120' ' ' ILE . 42.1 mt-30 -121.75 130.45 53.43 Favored 'General case' 0 C--N 1.262 -3.231 0 N-CA-C 106.292 -1.744 . . . . 71.530000000000001 106.292 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.14 160.18 41.79 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.548 -0.538 . . . . 41.219999999999999 109.548 -175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 65.0 mtp180 -88.05 125.92 34.82 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.244 -1.021 . . . . 75.319999999999993 108.244 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -123.02 127.69 49.15 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.776 -1.194 . . . . 73.310000000000002 107.776 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.5 p -63.59 107.47 1.16 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.395 -0.82 . . . . 73.5 110.216 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 CA--C 1.505 -0.784 0 CA-C-N 115.893 -0.594 . . . . 50.420000000000002 110.536 -174.911 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 136' ' ' ASP . 99.3 mtt180 . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 107.919 -1.141 . . . . 71.25 107.919 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.13 127.57 72.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.499 0.666 . . . . 62.049999999999997 110.461 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 50.4 mtp85 -122.75 115.41 22.0 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.98 -1.009 . . . . 73.400000000000006 109.268 -178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.51 108.27 19.51 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.172 -1.048 . . . . 35.100000000000001 108.172 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.7 t -108.92 115.74 30.65 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 107.767 -1.197 . . . . 74.319999999999993 107.767 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.419 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.6 pp -129.91 146.07 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 C-N-CA 120.037 -0.665 . . . . 61.520000000000003 109.627 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 61.9 m -122.82 129.39 51.63 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.242 -1.022 . . . . 71.230000000000004 108.242 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -119.27 125.94 74.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.724 0.773 . . . . 74.209999999999994 110.511 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 46.7 m -97.56 142.72 24.99 Favored Pre-proline 0 N--CA 1.415 -2.213 0 CA-C-N 115.2 -0.909 . . . . 71.439999999999998 109.349 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 35' ' ' SER . 52.8 Cg_exo -59.45 2.7 0.24 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 124.104 3.203 . . . . 75.349999999999994 114.095 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.67 1.0 40.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 123.737 0.815 . . . . 51.439999999999998 110.027 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 91' ' ' THR . 11.5 t70 71.96 35.36 1.33 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 105.738 -1.949 . . . . 64.230000000000004 105.738 -176.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 1.7 tp -119.63 126.0 50.11 Favored 'General case' 0 N--CA 1.396 -3.164 0 CA-C-N 113.686 -1.597 . . . . 51.310000000000002 108.443 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.422 HG12 ' HE2' ' A' ' 87' ' ' PHE . 12.6 t -120.44 134.11 64.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.753 -0.832 . . . . 73.400000000000006 108.753 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.0 p -144.61 144.14 31.13 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.422 -0.955 . . . . 74.030000000000001 108.422 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 177.45 -166.68 37.28 Favored Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 119.311 -1.423 . . . . 34.100000000000001 112.065 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -151.94 135.91 16.47 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.48 0.657 . . . . 62.32 111.048 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.9 mt -111.95 116.63 53.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.107 -1.071 . . . . 74.430000000000007 108.107 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.71 114.92 48.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.331 -0.618 . . . . 64.450000000000003 109.331 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.52 108.22 19.43 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.178 -1.786 . . . . 73.409999999999997 106.178 174.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.417 ' HB1' ' CB ' ' A' ' 80' ' ' TYR . . . -122.8 128.28 50.22 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 120.023 -0.671 . . . . 73.310000000000002 112.42 -173.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.05 157.48 24.61 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.306 -0.861 . . . . 75.430000000000007 109.509 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttm . . . . . 0 C--N 1.301 -1.514 0 C-N-CA 120.353 -0.539 . . . . 74.239999999999995 110.541 175.008 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.405 -2.689 0 N-CA-C 111.458 0.17 . . . . 73.319999999999993 111.458 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 173.0 123.93 0.75 Allowed Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 119.523 -1.322 . . . . 74.310000000000002 113.806 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 83' ' ' SER . 22.6 Cg_exo -68.15 159.28 53.82 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.443 2.095 . . . . 73.219999999999999 109.842 170.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.02 126.32 55.03 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 122.06 -0.4 . . . . 73.030000000000001 111.735 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 90.3 mt -87.34 162.51 17.33 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.812 -0.631 . . . . 74.430000000000007 109.98 175.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -101.88 96.6 7.16 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.762 0.792 . . . . 74.400000000000006 109.197 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -108.77 45.25 1.34 Allowed Glycine 0 C--N 1.288 -2.093 0 CA-C-N 114.609 -1.178 . . . . 34.32 110.327 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -100.05 110.03 22.33 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.141 -0.53 . . . . 74.140000000000001 109.815 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -152.66 169.33 9.78 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 124.738 1.215 . . . . 72.099999999999994 109.088 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.81 -14.87 34.5 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.527 2.151 . . . . 61.140000000000001 112.343 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.41 ' HA ' HE22 ' A' ' 68' ' ' GLN . 43.8 p90 -116.09 29.4 8.0 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.965 -0.561 . . . . 74.409999999999997 111.822 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.5 m -57.86 -27.87 63.63 Favored 'General case' 0 C--O 1.209 -1.03 0 N-CA-C 113.221 0.823 . . . . 74.0 113.221 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.41 HE22 ' HA ' ' A' ' 66' ' ' PHE . 5.4 pm0 -73.12 -8.75 57.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.392 0.615 . . . . 73.230000000000004 110.542 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -99.81 -15.52 18.4 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.696 -0.684 . . . . 72.239999999999995 109.584 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.4 118.84 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 122.154 0.978 . . . . 61.039999999999999 111.951 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.52 120.16 40.63 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.525 -0.761 . . . . 71.5 110.146 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.0 139.75 20.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.96 -0.756 . . . . 54.229999999999997 108.96 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.5 m -148.01 172.19 14.62 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.488 -0.93 . . . . 73.450000000000003 108.488 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 23.0 p-10 -85.88 154.05 21.8 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.389 -0.924 . . . . 71.439999999999998 108.69 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -112.25 120.69 42.61 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.703 -0.851 . . . . 62.25 108.703 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -138.64 98.5 3.58 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.073 -1.454 . . . . 65.200000000000003 107.073 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.9 t -175.41 160.93 2.65 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.021 -1.474 . . . . 50.219999999999999 107.021 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.26 11.7 8.09 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.054 0.941 . . . . 73.439999999999998 111.851 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.97 1.11 87.04 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.967 -0.635 . . . . 72.219999999999999 111.76 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . 97.8 m-85 -104.84 167.41 9.73 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.501 -0.411 . . . . 63.049999999999997 109.988 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -134.33 136.13 53.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.524 -1.287 . . . . 73.510000000000005 107.524 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.07 -154.63 9.17 Favored Glycine 0 C--N 1.276 -2.796 0 C-N-CA 119.634 -1.27 . . . . 54.43 112.514 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.473 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 9.4 p -122.47 147.89 45.8 Favored 'General case' 0 C--N 1.273 -2.747 0 C-N-CA 123.549 0.74 . . . . 73.310000000000002 109.915 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -139.55 143.09 37.2 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.899 -0.501 . . . . 62.130000000000003 110.8 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.91 114.66 20.11 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.28 -1.378 . . . . 63.43 107.28 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.14 121.52 61.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.592 -0.892 . . . . 64.019999999999996 108.592 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.474 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.2 p90 -123.54 155.56 37.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.978 0.418 . . . . 73.299999999999997 111.52 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.0 p -156.7 157.81 35.82 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.831 -0.622 . . . . 71.310000000000002 111.357 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 64.47 31.53 12.44 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.472 1.107 . . . . 64.409999999999997 110.764 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.474 HD12 ' CD2' ' A' ' 87' ' ' PHE . 26.8 mt -93.24 163.89 13.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 121.653 -0.655 . . . . 63.310000000000002 111.026 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 45.0 p -109.46 169.64 8.57 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.397 -0.365 . . . . 75.150000000000006 110.314 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -61.73 -31.7 71.89 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.264 -0.426 . . . . 74.349999999999994 110.548 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.65 -25.7 63.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.969 0.414 . . . . 75.019999999999996 110.957 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.74 -16.79 33.24 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.208 0.447 . . . . 64.340000000000003 112.208 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.6 tt -60.82 -49.48 89.2 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 119.232 -0.413 . . . . 73.329999999999998 111.271 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.81 -35.52 88.33 Favored 'Trans proline' 0 C--N 1.376 1.989 0 CA-C-N 121.038 1.406 . . . . 25.129999999999999 110.707 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.35 -35.78 81.23 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.29 -0.868 . . . . 74.340000000000003 111.601 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -73.11 -18.96 61.24 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 120.941 0.401 . . . . 71.540000000000006 110.671 176.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.02 -19.2 62.54 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.259 -0.428 . . . . 70.230000000000004 110.354 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -65.83 -52.98 45.91 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.183 -1.043 . . . . 62.32 108.183 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.454 ' O ' ' HB3' ' A' ' 104' ' ' ASP . 14.2 mtp -54.15 -52.39 61.26 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.702 -0.681 . . . . 50.539999999999999 109.583 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -56.49 -39.45 73.27 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.11 -0.95 . . . . 74.209999999999994 112.053 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.8 p -70.96 -21.08 62.37 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 119.282 -0.967 . . . . 73.230000000000004 111.198 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 101' ' ' MET . 6.0 t70 -61.72 -27.28 68.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.761 -0.654 . . . . 63.299999999999997 110.46 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.14 -5.41 13.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 116.071 -0.513 . . . . 44.310000000000002 111.117 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.96 -46.17 3.99 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.488 0.921 . . . . 62.350000000000001 113.488 -173.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.98 22.81 58.74 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 120.495 -0.86 . . . . 75.120000000000005 111.284 -174.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -120.39 172.3 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.789 -0.819 . . . . 73.439999999999998 108.789 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.515 ' OD1' ' HB2' ' A' ' 124' ' ' ARG . 3.7 p-10 -132.82 145.41 50.95 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.854 -0.338 . . . . 74.099999999999994 110.667 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.2 112.43 17.05 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.246 -0.65 . . . . 53.329999999999998 109.246 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -115.59 112.56 22.34 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.602 -0.518 . . . . 63.549999999999997 109.602 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -137.4 148.07 45.91 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.597 0.713 . . . . 72.349999999999994 112.007 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -147.53 155.74 42.16 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.417 -1.265 . . . . 73.239999999999995 109.53 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 114' ' ' ARG . 45.3 ttm180 -106.6 131.99 53.11 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 106.891 -1.522 . . . . 72.430000000000007 106.891 172.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -118.2 103.49 9.9 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.765 -1.198 . . . . 60.43 107.765 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.91 -107.08 2.25 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 109.372 -1.491 . . . . 50.140000000000001 109.372 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -122.2 2.96 9.82 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.788 1.28 . . . . 71.400000000000006 108.505 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -107.04 142.92 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 118.74 -1.184 . . . . 62.140000000000001 108.157 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 114' ' ' ARG . 81.9 t -105.9 138.27 31.98 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 O-C-N 122.099 -0.376 . . . . 73.430000000000007 111.175 -176.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.02 131.25 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-N 115.499 -0.773 . . . . 74.340000000000003 109.012 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.4 131.62 48.49 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 115.46 -0.791 . . . . 73.099999999999994 110.296 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -139.95 115.58 10.09 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.781 0.8 . . . . 70.109999999999999 108.908 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -113.19 157.99 14.58 Favored Glycine 0 C--N 1.265 -3.364 0 N-CA-C 107.564 -2.214 . . . . 71.310000000000002 107.564 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.515 ' HB2' ' OD1' ' A' ' 109' ' ' ASN . 98.5 mtt180 -130.72 125.6 34.32 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 118.397 1.099 . . . . 55.140000000000001 109.249 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -118.68 110.33 17.17 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.919 -0.582 . . . . 72.329999999999998 110.206 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -105.57 100.04 9.62 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.154 -1.054 . . . . 65.299999999999997 108.154 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.26 17.65 21.96 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.687 -0.486 . . . . 72.310000000000002 109.687 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.0 p . . . . . 0 C--O 1.215 -0.737 0 N-CA-C 112.603 0.594 . . . . 50.439999999999998 112.603 -173.43 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 C--O 1.242 0.71 0 CA-C-O 122.132 0.968 . . . . 51.32 110.163 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.45 145.33 26.32 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.92 -1.036 . . . . 74.25 109.895 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.402 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 16.4 m-20 -131.63 141.79 49.71 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.897 0.479 . . . . 74.230000000000004 110.113 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.9 t -120.86 112.79 37.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.429 -1.322 . . . . 75.230000000000004 107.429 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.405 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 38.2 mt-10 -121.41 125.29 46.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.777 -0.453 . . . . 74.549999999999997 109.777 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 tt -118.46 120.48 37.69 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.41 -1.33 . . . . 73.120000000000005 107.41 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.4 m -115.72 126.7 54.42 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.005 -0.739 . . . . 64.299999999999997 109.005 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.444 HG12 ' HD2' ' A' ' 143' ' ' PHE . 92.2 t -122.0 121.25 63.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.544 -0.539 . . . . 75.25 109.544 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.72 128.02 55.96 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.031 -0.729 . . . . 55.200000000000003 109.031 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.559 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.3 p90 -134.25 120.04 14.71 Favored Pre-proline 0 C--N 1.29 -2.005 0 C-N-CA 122.189 0.196 . . . . 72.319999999999993 111.298 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.95 55.65 2.87 Favored 'Trans proline' 0 CA--C 1.551 1.353 0 C-N-CA 122.618 2.212 . . . . 73.349999999999994 111.35 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.45 -110.53 0.15 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.719 -0.673 . . . . 23.129999999999999 110.009 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.1 128.34 0.46 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.856 -0.794 . . . . 75.530000000000001 108.856 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.76 133.85 28.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 109.377 -0.601 . . . . 65.450000000000003 109.377 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.7 p -90.45 -40.12 12.22 Favored 'General case' 0 N--CA 1.42 -1.967 0 C-N-CA 120.359 -0.537 . . . . 41.539999999999999 109.716 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 51.0 m -156.98 132.81 9.48 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 109.002 -0.74 . . . . 73.409999999999997 109.002 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.1 t -139.23 159.59 41.8 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.759 -0.46 . . . . 75.349999999999994 109.759 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 42.9 t30 -132.54 94.43 3.41 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.561 -1.644 . . . . 72.230000000000004 106.561 174.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.08 -136.67 2.92 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 108.643 -1.783 . . . . 63.509999999999998 108.643 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -119.25 99.25 6.59 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.899 -0.778 . . . . 71.430000000000007 108.899 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 154' ' ' ARG . 15.0 ptt180 -77.9 110.42 12.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.701 -0.682 . . . . 73.319999999999993 110.828 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.98 -47.54 20.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.552 -1.277 . . . . 73.200000000000003 107.552 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.37 166.59 25.7 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.185 -1.413 . . . . 70.549999999999997 107.185 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.46 0.52 7.95 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.098 1.865 . . . . 51.210000000000001 111.187 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.7 pt-20 -133.05 4.97 3.82 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 115.593 -0.73 . . . . 72.099999999999994 110.394 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.4 t -144.64 120.73 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.578 -0.897 . . . . 74.409999999999997 108.578 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.01 146.52 30.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.231 -0.655 . . . . 73.329999999999998 109.231 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -126.72 138.58 53.41 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 124.173 0.989 . . . . 73.329999999999998 109.008 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.421 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 31.8 m-90 -119.25 109.45 15.85 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.059 -1.089 . . . . 73.439999999999998 108.059 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -104.44 98.38 8.17 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 122.498 1.142 . . . . 71.439999999999998 109.112 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 19.3 mt -99.14 137.67 37.33 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.562 -1.653 . . . . 73.340000000000003 109.925 -170.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -117.73 153.74 50.79 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 114.905 -1.043 . . . . 65.019999999999996 111.422 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.34 159.11 54.71 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.515 2.143 . . . . 70.129999999999995 111.034 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.16 -34.89 3.18 Favored Glycine 0 C--N 1.303 -1.274 0 C-N-CA 120.964 -0.636 . . . . 72.299999999999997 111.564 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.6 m -105.48 159.23 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.4 0.619 . . . . 70.409999999999997 112.067 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.1 141.22 31.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.153 -1.054 . . . . 53.109999999999999 108.153 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.9 m -150.87 145.77 25.88 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.324 -0.621 . . . . 72.299999999999997 109.324 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.458 HG22 ' HG2' ' A' ' 124' ' ' ARG . 38.5 p -105.29 139.12 40.42 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.597 -0.519 . . . . 74.109999999999999 109.597 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -89.92 116.52 28.05 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.409 -1.7 . . . . 60.32 106.409 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 10.9 t -125.78 135.88 52.52 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 117.946 -1.502 . . . . 71.439999999999998 109.298 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.421 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.49 120.97 6.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.416 -0.957 . . . . 73.25 108.416 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -124.64 131.21 53.48 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.635 -1.246 . . . . 74.540000000000006 107.635 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.12 152.52 26.46 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.467 -0.568 . . . . 61.100000000000001 109.467 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 56.1 mtt180 -87.91 129.94 35.07 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.851 -0.74 . . . . 74.530000000000001 109.217 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -131.93 129.12 39.86 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 107.622 -1.251 . . . . 73.209999999999994 107.622 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.9 p -54.61 104.95 0.13 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 124.485 1.116 . . . . 74.329999999999998 111.954 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.701 -0.681 . . . . 74.530000000000001 109.554 -178.698 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 136' ' ' ASP . 16.1 tpt180 . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 105.986 -1.857 . . . . 74.319999999999993 105.986 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.14 114.26 41.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.172 -1.047 . . . . 62.549999999999997 108.172 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -129.59 115.18 17.03 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.692 0.758 . . . . 63.329999999999998 110.99 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.51 129.75 55.72 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.692 -1.14 . . . . 63.310000000000002 108.936 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.9 m -131.16 115.2 16.06 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.083 -1.08 . . . . 75.519999999999996 108.083 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.411 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.8 pp -124.35 147.16 28.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 109.804 -0.443 . . . . 73.319999999999993 109.804 -177.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 57.2 m -127.99 124.56 37.51 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 109.11 -0.7 . . . . 62.140000000000001 109.11 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -112.77 119.67 60.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.703 0.764 . . . . 65.409999999999997 110.362 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.5 m -89.43 151.43 46.2 Favored Pre-proline 0 C--N 1.288 -2.098 0 CA-C-N 115.064 -0.971 . . . . 44.240000000000002 109.879 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.85 2.92 0.83 Allowed 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.819 3.013 . . . . 61.030000000000001 113.284 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 17.8 t70 -82.55 -2.65 54.23 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.702 -1.221 . . . . 74.400000000000006 107.702 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.1 t70 72.54 29.91 1.99 Allowed 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.458 -1.682 . . . . 72.230000000000004 106.458 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 1.0 OUTLIER -106.71 138.19 43.35 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 112.728 -2.033 . . . . 74.219999999999999 108.341 -177.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.07 140.67 46.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 109.501 -0.555 . . . . 74.430000000000007 109.501 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -147.74 160.98 42.13 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.09 -1.078 . . . . 61.109999999999999 108.09 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 166.48 -170.03 40.85 Favored Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.067 -1.54 . . . . 64.129999999999995 113.006 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.34 133.68 18.5 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.254 0.55 . . . . 72.420000000000002 109.91 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.01 116.68 52.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.872 -1.159 . . . . 61.310000000000002 107.872 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.14 116.7 53.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 110.319 -0.252 . . . . 64.230000000000004 110.319 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.76 108.03 18.24 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 106.854 -1.535 . . . . 74.340000000000003 106.854 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . . . -118.74 141.79 48.29 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.114 -0.494 . . . . 63.200000000000003 110.234 -175.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.35 158.2 31.6 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.697 -0.853 . . . . 63.109999999999999 108.697 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.3 mttt . . . . . 0 C--N 1.3 -1.55 0 N-CA-C 108.537 -0.912 . . . . 71.299999999999997 108.537 175.932 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.571 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 9.2 t . . . . . 0 N--CA 1.423 -1.79 0 N-CA-C 108.94 -0.763 . . . . 60.399999999999999 108.94 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.41 125.33 0.84 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 118.82 -0.989 . . . . 65.0 111.88 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 32.3 Cg_exo -61.4 154.26 60.09 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.069 1.846 . . . . 74.129999999999995 109.836 174.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.38 109.01 16.24 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 111.993 0.368 . . . . 64.109999999999999 111.993 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.3 mt -90.82 124.55 35.24 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.827 -0.749 . . . . 74.319999999999993 110.108 173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.46 99.41 8.19 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.406 -0.816 . . . . 73.129999999999995 110.283 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.96 75.87 0.29 Allowed Glycine 0 C--N 1.29 -2.021 0 CA-C-N 114.96 -1.018 . . . . 72.140000000000001 111.616 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.64 91.36 7.98 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 108.883 -0.784 . . . . 74.129999999999995 108.883 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.4 m -134.83 160.1 69.66 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 107.838 -1.171 . . . . 74.120000000000005 107.838 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.56 -22.74 37.89 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 121.88 1.72 . . . . 71.140000000000001 112.157 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -97.69 40.77 1.15 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.061 -0.518 . . . . 71.209999999999994 112.309 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -56.02 -35.92 67.39 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 123.052 0.541 . . . . 75.430000000000007 110.353 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -64.53 -15.18 60.49 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.55 0.74 . . . . 74.510000000000005 111.635 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -100.7 -17.66 16.87 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 116.082 -0.508 . . . . 72.530000000000001 110.828 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.83 120.09 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 122.022 0.915 . . . . 62.409999999999997 112.273 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.51 112.74 24.9 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.534 -0.757 . . . . 33.140000000000001 109.026 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.16 114.23 39.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.935 -1.135 . . . . 52.420000000000002 107.935 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 168.54 14.57 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.856 -0.794 . . . . 71.430000000000007 108.856 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -84.48 153.76 23.13 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 119.571 -0.852 . . . . 72.310000000000002 109.009 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 83.9 t80 -120.73 124.68 45.73 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 109.837 -0.431 . . . . 73.239999999999995 109.837 -177.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.17 98.14 3.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.982 -1.118 . . . . 55.140000000000001 107.982 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 49.5 m -165.28 164.27 19.96 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.3 -1.37 . . . . 63.43 107.3 -176.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 67.78 6.58 5.15 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 124.64 1.176 . . . . 74.540000000000006 111.946 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.04 5.81 85.55 Favored Glycine 0 C--N 1.314 -0.662 0 N-CA-C 110.065 -1.214 . . . . 73.140000000000001 110.065 -174.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.434 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 3.4 m-85 -105.7 163.1 12.96 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 124.767 1.227 . . . . 70.25 110.927 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 56' ' ' THR . 16.8 m -134.48 136.55 52.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.525 -0.917 . . . . 54.409999999999997 108.525 173.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -169.72 -155.13 9.77 Favored Glycine 0 N--CA 1.423 -2.22 0 C-N-CA 119.855 -1.164 . . . . 71.129999999999995 113.033 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -132.17 140.85 48.89 Favored 'General case' 0 C--N 1.289 -2.056 0 C-N-CA 124.007 0.923 . . . . 72.219999999999999 109.696 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -128.65 146.16 50.95 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 116.274 -0.421 . . . . 62.119999999999997 110.529 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.73 114.42 23.3 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.488 -1.301 . . . . 61.399999999999999 107.488 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.35 122.04 62.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.064 -1.087 . . . . 72.150000000000006 108.064 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -123.07 153.81 39.4 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.006 -0.678 . . . . 71.450000000000003 111.469 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.3 p -156.11 153.52 29.48 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.528 -0.76 . . . . 71.219999999999999 110.728 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 64.33 37.51 8.45 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.328 1.017 . . . . 73.299999999999997 112.876 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 90' ' ' LEU . 34.8 mt -101.02 176.32 5.3 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.169 -0.678 . . . . 70.340000000000003 109.169 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.447 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.8 t -121.76 171.08 9.14 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.369 -0.532 . . . . 73.540000000000006 110.398 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 114' ' ' ARG . 53.9 t80 -50.02 -44.78 51.41 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.751 1.621 . . . . 61.299999999999997 111.517 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.1 -25.63 66.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.63 0.604 . . . . 70.040000000000006 112.63 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.447 ' OE1' HG22 ' A' ' 91' ' ' THR . 49.5 mt-10 -85.76 -15.96 40.42 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.164 0.431 . . . . 62.299999999999997 112.164 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.649 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 7.0 tt -55.74 -52.48 71.85 Favored Pre-proline 0 CA--C 1.564 1.5 0 N-CA-C 111.88 0.326 . . . . 62.409999999999997 111.88 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 21.1 Cg_endo -65.1 -29.92 56.12 Favored 'Trans proline' 0 C--N 1.359 1.11 0 CA-C-N 120.6 1.25 . . . . 71.120000000000005 111.7 175.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -69.04 -35.92 77.13 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 123.279 0.631 . . . . 55.210000000000001 110.401 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -77.02 -19.28 57.42 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.351 0.596 . . . . 64.230000000000004 109.495 176.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 96' ' ' PRO . . . -73.19 -17.69 61.34 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.484 -0.78 . . . . 75.400000000000006 109.56 -177.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.04 -54.59 42.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.771 -0.65 . . . . 72.030000000000001 109.591 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 67.5 mtm -54.24 -52.31 61.74 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.82 0.819 . . . . 50.32 109.232 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -54.3 -31.6 54.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.824 -1.535 . . . . 71.120000000000005 111.694 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.8 m -58.46 -33.7 70.04 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 119.304 -0.379 . . . . 71.109999999999999 111.915 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.1 -21.94 66.88 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.438 0.533 . . . . 63.130000000000003 112.438 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.16 -4.9 13.06 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.723 -0.391 . . . . 62.140000000000001 110.629 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.48 -48.27 3.72 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.981 -0.688 . . . . 64.150000000000006 112.697 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.8 28.28 73.21 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 119.94 -1.124 . . . . 71.140000000000001 110.541 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.1 t -122.05 134.6 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 109.039 -0.726 . . . . 73.510000000000005 109.039 -176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -93.55 122.37 35.91 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.087 -0.708 . . . . 72.420000000000002 109.087 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.46 137.2 53.34 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.594 0.59 . . . . 61.240000000000002 112.594 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.4 t -138.01 142.43 40.41 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.151 -1.055 . . . . 72.540000000000006 108.151 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -148.25 127.3 12.82 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.265 -1.013 . . . . 70.129999999999995 108.265 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -144.92 149.41 35.21 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 113.615 0.969 . . . . 71.209999999999994 113.615 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.499 ' HD3' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -101.94 117.28 34.49 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.526 -1.657 . . . . 74.129999999999995 106.526 177.444 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -109.96 92.7 4.15 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 107.81 -1.182 . . . . 74.329999999999998 107.81 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.92 -114.16 6.19 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 108.845 -1.702 . . . . 33.200000000000003 108.845 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.499 ' OD1' ' HD2' ' A' ' 177' ' ' ARG . 29.4 t-20 -100.33 -14.73 18.27 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.441 0.639 . . . . 64.030000000000001 110.633 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.518 ' HA ' ' CB ' ' A' ' 177' ' ' ARG . 1.3 pp -96.05 146.58 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 C-N-CA 118.978 -1.089 . . . . 64.200000000000003 109.106 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.68 HG21 ' CD2' ' A' ' 178' ' ' TYR . 89.0 t -115.74 141.19 34.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.587 -0.696 . . . . 73.319999999999993 110.391 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.43 HG22 ' HG2' ' A' ' 175' ' ' GLN . 40.0 pt -122.3 140.67 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 115.328 -0.851 . . . . 61.420000000000002 109.493 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.03 127.47 47.93 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 107.636 -1.246 . . . . 74.200000000000003 107.636 172.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -127.92 118.61 23.92 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.715 -1.13 . . . . 71.129999999999995 108.497 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -144.94 133.47 5.16 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.295 -0.955 . . . . 50.409999999999997 111.169 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.48 ' HG2' HG22 ' A' ' 171' ' ' THR . 68.3 mtt85 -120.63 127.02 51.7 Favored 'General case' 0 C--N 1.28 -2.436 0 O-C-N 122.38 -0.482 . . . . 74.129999999999995 110.053 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -117.75 113.61 22.1 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.611 -0.722 . . . . 70.019999999999996 110.024 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -111.74 107.49 16.6 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.617 -1.253 . . . . 60.240000000000002 107.617 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.74 27.28 9.81 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.872 -0.418 . . . . 74.120000000000005 109.872 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.4 p . . . . . 0 C--N 1.313 -0.984 0 C-N-CA 120.046 -0.662 . . . . 75.549999999999997 111.885 -176.755 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--O 1.238 0.458 0 CA-C-O 121.187 0.518 . . . . 51.420000000000002 110.608 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.35 142.25 52.17 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.882 -0.599 . . . . 73.209999999999994 110.761 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.451 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 10.1 t70 -132.03 116.31 16.93 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.042 -1.836 . . . . 70.510000000000005 106.042 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.8 t -114.35 136.51 50.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.467 -0.568 . . . . 62.5 109.467 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -133.42 131.66 40.23 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.908 -0.404 . . . . 75.340000000000003 109.908 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -122.67 118.54 28.36 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 106.817 -1.549 . . . . 74.129999999999995 106.817 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.4 m -121.62 133.36 54.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.954 -0.387 . . . . 60.009999999999998 109.954 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.37 124.04 66.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 108.697 -0.853 . . . . 73.439999999999998 108.697 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -115.16 132.51 56.58 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.577 -0.897 . . . . 72.239999999999995 108.577 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.7 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -134.43 120.37 14.69 Favored Pre-proline 0 C--N 1.28 -2.42 0 CA-C-N 116.337 -0.392 . . . . 74.430000000000007 110.147 178.391 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 31.5 Cg_exo -64.92 37.69 0.11 Allowed 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 123.928 3.085 . . . . 73.409999999999997 114.654 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.28 -97.1 0.46 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.302 -0.629 . . . . 44.340000000000003 109.302 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.44 136.81 0.06 Allowed 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.793 -1.188 . . . . 73.340000000000003 107.793 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.31 128.5 38.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.548 -0.538 . . . . 75.540000000000006 109.548 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 43.6 p -88.35 -43.85 11.21 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.686 -0.688 . . . . 75.099999999999994 110.159 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.2 m -150.64 132.51 15.09 Favored 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.4 -0.963 . . . . 71.439999999999998 108.4 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.406 ' OG1' HG11 ' A' ' 160' ' ' VAL . 10.2 t -140.28 152.31 45.8 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.889 -0.724 . . . . 72.409999999999997 111.276 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -123.79 91.16 3.41 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.369 -2.086 . . . . 64.329999999999998 105.369 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.14 -139.35 5.38 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 110.202 -1.159 . . . . 51.020000000000003 110.202 -177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 161' ' ' GLN . 24.3 t70 -115.18 99.57 7.51 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.613 0.721 . . . . 71.230000000000004 110.589 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -84.33 116.35 22.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 116.131 -0.486 . . . . 63.329999999999998 110.808 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.8 mt -93.42 -49.29 12.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.679 -0.86 . . . . 71.510000000000005 108.679 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -126.36 159.58 62.19 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.552 -1.277 . . . . 65.239999999999995 107.552 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.04 -18.61 51.63 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.568 2.179 . . . . 51.509999999999998 111.907 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.7 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.8 OUTLIER -120.22 7.65 10.79 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.842 0.682 . . . . 72.519999999999996 112.842 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.9 t -138.43 121.45 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-O 121.074 0.464 . . . . 71.430000000000007 110.812 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.406 HG11 ' OG1' ' A' ' 150' ' ' THR . 79.7 t -125.04 144.87 33.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.962 -0.563 . . . . 70.140000000000001 109.664 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' A' ' 153' ' ' ASP . 63.1 tt0 -133.57 152.03 51.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.273 -1.01 . . . . 71.040000000000006 108.273 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.533 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.0 m-90 -128.64 123.92 34.47 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 108.42 -0.956 . . . . 74.129999999999995 108.42 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 109.04 20.76 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.813 0.816 . . . . 74.409999999999997 109.983 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 66.1 mt -97.33 126.27 42.45 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.677 -1.147 . . . . 73.010000000000005 109.226 -174.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -115.22 152.19 46.54 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 115.091 -0.959 . . . . 74.319999999999993 112.266 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -68.97 158.44 57.92 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 123.192 2.595 . . . . 74.099999999999994 111.212 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 73.3 -19.82 1.33 Allowed Glycine 0 C--N 1.313 -0.746 0 N-CA-C 114.299 0.48 . . . . 63.119999999999997 114.299 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.4 m -111.63 169.25 4.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.4 0.619 . . . . 54.240000000000002 110.781 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.63 139.61 38.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.142 -1.429 . . . . 74.430000000000007 107.142 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 27.1 m -134.77 134.89 41.4 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.358 0.599 . . . . 64.519999999999996 110.55 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.48 HG22 ' HG2' ' A' ' 124' ' ' ARG . 9.7 p -103.11 126.53 50.33 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.085 -0.961 . . . . 75.219999999999999 108.727 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 56.7 mtm -108.86 126.95 53.6 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.21 -1.033 . . . . 63.509999999999998 108.21 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.9 t -141.65 138.09 32.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.339 -0.986 . . . . 73.420000000000002 108.339 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.458 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -146.03 133.39 20.68 Favored 'General case' 0 CA--C 1.469 -2.16 0 N-CA-C 108.052 -1.092 . . . . 71.310000000000002 108.052 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.43 ' HG2' HG22 ' A' ' 120' ' ' ILE . 39.5 mt-30 -126.89 131.14 51.22 Favored 'General case' 0 C--N 1.263 -3.177 0 N-CA-C 108.039 -1.097 . . . . 74.150000000000006 108.039 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 119' ' ' VAL . . . -159.79 129.45 5.35 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 106.566 -1.642 . . . . 74.209999999999994 106.566 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.518 ' CB ' ' HA ' ' A' ' 118' ' ' ILE . 17.7 ptt180 -88.05 146.86 25.25 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 118.43 -1.308 . . . . 74.319999999999993 110.117 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.68 ' CD2' HG21 ' A' ' 119' ' ' VAL . 19.6 m-30 -119.53 137.05 54.07 Favored 'General case' 0 CA--C 1.465 -2.317 0 N-CA-C 108.187 -1.042 . . . . 74.010000000000005 108.187 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.7 p -71.36 103.82 3.0 Favored 'General case' 0 N--CA 1.394 -3.236 0 CA-C-N 115.269 -0.878 . . . . 65.430000000000007 110.431 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 . . . . . 0 N--CA 1.446 -0.643 0 CA-C-N 115.13 -0.941 . . . . 75.109999999999999 111.145 176.938 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 . . . . . 0 N--CA 1.416 -2.132 0 N-CA-C 107.741 -1.207 . . . . 72.329999999999998 107.741 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.97 114.19 43.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 106.913 -1.514 . . . . 75.150000000000006 106.913 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 22.4 ttt180 -129.32 116.94 19.85 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 121.519 0.676 . . . . 44.119999999999997 110.708 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.35 108.84 20.57 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.26 -1.385 . . . . 73.400000000000006 107.26 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.9 m -113.47 114.16 26.16 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.698 -1.593 . . . . 62.310000000000002 106.698 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.8 pp -131.76 146.07 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 C-N-CA 120.2 -0.6 . . . . 62.229999999999997 109.811 -175.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 87.3 m -126.43 122.49 35.44 Favored 'General case' 0 C--N 1.27 -2.883 0 N-CA-C 109.251 -0.648 . . . . 64.409999999999997 109.251 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 tt -110.93 118.76 58.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.652 0.739 . . . . 60.009999999999998 109.796 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.7 m -89.33 150.78 45.4 Favored Pre-proline 0 N--CA 1.411 -2.411 0 N-CA-C 108.429 -0.952 . . . . 64.319999999999993 108.429 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.03 0.9 0.36 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.792 2.995 . . . . 75.040000000000006 115.135 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 37.3 t70 -83.32 -3.25 57.3 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.783 -0.821 . . . . 72.230000000000004 108.783 176.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 t70 72.77 29.84 1.87 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 105.812 -1.921 . . . . 74.120000000000005 105.812 -173.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 2.4 tp -100.19 124.61 45.83 Favored 'General case' 0 N--CA 1.389 -3.493 0 CA-C-N 113.3 -1.773 . . . . 74.129999999999995 107.354 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG21 ' HG ' ' A' ' 95' ' ' LEU . 14.3 t -116.34 133.08 64.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 109.078 -0.712 . . . . 75.319999999999993 109.078 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.8 p -146.96 157.55 43.66 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.635 -0.876 . . . . 62.539999999999999 108.635 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.3 -165.19 38.68 Favored Glycine 0 N--CA 1.428 -1.855 0 C-N-CA 119.207 -1.473 . . . . 63.229999999999997 112.987 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.55 133.83 21.74 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 123.28 0.632 . . . . 72.329999999999998 109.873 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 102' ' ' ASN . 63.8 mt -116.94 116.01 50.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.892 -1.151 . . . . 72.400000000000006 107.892 176.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.93 126.03 65.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.046 -0.525 . . . . 74.319999999999993 109.829 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -120.72 107.93 13.37 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.282 -1.747 . . . . 70.0 106.282 171.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -120.87 127.51 51.95 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.26 -0.427 . . . . 73.310000000000002 111.003 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.77 148.88 42.35 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 116.48 -0.327 . . . . 45.420000000000002 110.244 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.31 -1.14 0 N-CA-C 108.433 -0.951 . . . . 64.209999999999994 108.433 173.535 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.427 -1.59 0 N-CA-C 109.865 -0.42 . . . . 72.329999999999998 109.865 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.496 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 172.24 99.01 0.12 Allowed Glycine 0 N--CA 1.431 -1.671 0 CA-C-O 118.69 -1.061 . . . . 61.340000000000003 112.545 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.51 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 31.2 Cg_exo -59.84 128.52 27.1 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 CA-C-N 119.872 1.836 . . . . 71.400000000000006 109.052 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 83' ' ' SER . . . -89.71 151.43 21.85 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.803 0.668 . . . . 72.420000000000002 112.803 -171.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 67.3 mt -82.46 138.97 34.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.828 -0.623 . . . . 71.209999999999994 109.526 174.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -110.6 101.97 10.59 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.633 -1.618 . . . . 72.109999999999999 106.633 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.85 75.13 0.19 Allowed Glycine 0 C--N 1.29 -1.979 0 C-N-CA 120.581 -0.818 . . . . 71.409999999999997 112.857 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.01 112.2 19.55 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.56 -0.533 . . . . 73.409999999999997 109.56 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG11 ' SD ' ' A' ' 101' ' ' MET . 17.6 m -124.21 157.13 65.35 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 115.939 -0.573 . . . . 71.019999999999996 109.841 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.51 -10.09 27.56 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 122.751 2.3 . . . . 72.239999999999995 112.886 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -110.26 39.46 2.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.388 -0.369 . . . . 64.140000000000001 110.974 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 m -53.68 -32.36 51.39 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.055 0.391 . . . . 43.310000000000002 112.055 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -67.76 -11.88 59.38 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.273 0.559 . . . . 72.5 110.981 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -98.62 -20.61 16.9 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.673 -0.694 . . . . 74.349999999999994 111.071 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.22 119.79 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.731 0.777 . . . . 73.299999999999997 112.155 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 123.28 45.7 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.465 -0.789 . . . . 63.229999999999997 109.075 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.66 130.99 46.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.952 -0.758 . . . . 52.340000000000003 108.952 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 m -132.66 171.98 13.13 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.947 -0.39 . . . . 64.129999999999995 109.947 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.496 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 5.8 t30 -93.03 134.87 34.73 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.051 -1.092 . . . . 73.219999999999999 108.051 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 87.8 t80 -99.96 126.35 46.11 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.946 -0.39 . . . . 75.340000000000003 109.946 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -135.29 101.44 4.84 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.082 -1.081 . . . . 71.409999999999997 108.082 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 47.0 t -173.22 155.85 3.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.939 -1.134 . . . . 71.420000000000002 107.939 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 70.57 6.86 6.0 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.687 1.195 . . . . 73.530000000000001 110.811 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.76 6.0 87.51 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.021 -0.831 . . . . 64.430000000000007 111.021 -173.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.502 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 4.1 m-85 -104.59 148.15 26.83 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.417 0.687 . . . . 73.219999999999999 110.094 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.7 137.45 55.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.833 -0.803 . . . . 73.409999999999997 108.833 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.51 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -167.86 -154.31 8.61 Favored Glycine 0 CA--C 1.458 -3.473 0 N-CA-C 110.555 -1.018 . . . . 71.439999999999998 110.555 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.5 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . 32.7 t -134.19 149.13 50.99 Favored 'General case' 0 C--N 1.26 -3.296 0 N-CA-C 108.656 -0.868 . . . . 73.209999999999994 108.656 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -134.82 133.88 40.25 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 115.618 -0.719 . . . . 73.319999999999993 110.207 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.67 115.61 30.62 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.24 -1.022 . . . . 71.129999999999995 108.24 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.64 116.21 48.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 107.599 -1.26 . . . . 72.530000000000001 107.599 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.5 p90 -120.76 157.04 30.57 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.595 -0.442 . . . . 74.140000000000001 110.609 -175.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.2 m -159.25 157.19 30.16 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.933 -0.576 . . . . 74.430000000000007 110.06 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 64.06 32.85 12.56 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.24 0.963 . . . . 73.439999999999998 112.242 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 87' ' ' PHE . 22.9 mt -90.31 153.26 20.59 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.625 -0.716 . . . . 62.119999999999997 110.503 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.7 p -108.04 172.33 6.89 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.338 -0.846 . . . . 63.299999999999997 109.686 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -60.84 -26.55 67.44 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.183 0.516 . . . . 72.340000000000003 111.007 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.64 -29.5 66.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.534 0.683 . . . . 74.040000000000006 109.847 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HB3' HD22 ' A' ' 90' ' ' LEU . 38.9 mt-10 -93.07 -15.95 25.53 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.315 -0.857 . . . . 74.540000000000006 111.77 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.4 mt -51.98 -52.34 62.62 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 114.008 1.114 . . . . 73.420000000000002 114.008 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -64.54 -34.41 52.82 Favored 'Trans proline' 0 C--N 1.363 1.325 0 CA-C-N 120.624 1.259 . . . . 73.040000000000006 110.31 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -64.26 -38.74 92.11 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.085 -0.962 . . . . 75.129999999999995 111.385 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -70.78 -19.7 62.67 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.091 0.472 . . . . 75.519999999999996 110.601 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.27 -16.07 59.87 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.033 -0.531 . . . . 73.230000000000004 110.643 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -62.32 -57.92 9.58 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 120.8 -0.36 . . . . 74.430000000000007 110.065 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.43 ' SD ' HG11 ' A' ' 64' ' ' VAL . 3.7 mpp? -56.49 -45.74 80.84 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.133 0.492 . . . . 73.420000000000002 109.896 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB2' HD13 ' A' ' 44' ' ' ILE . 27.1 t-20 -52.95 -45.01 67.53 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 114.203 -1.362 . . . . 63.030000000000001 111.386 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.7 p -66.03 -28.3 68.76 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 120.291 -0.564 . . . . 61.539999999999999 110.937 -170.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.1 -26.04 66.51 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.16 0.505 . . . . 65.5 110.597 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.88 -9.81 17.74 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.956 -0.566 . . . . 64.329999999999998 110.594 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.26 -44.75 4.47 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.213 0.82 . . . . 61.119999999999997 113.213 -172.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.39 27.64 35.57 Favored Glycine 0 C--N 1.316 -0.548 0 N-CA-C 110.297 -1.121 . . . . 74.420000000000002 110.297 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.9 m -111.11 168.26 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.389 -0.406 . . . . 73.340000000000003 110.104 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -135.45 124.96 25.0 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.676 -0.861 . . . . 74.140000000000001 108.676 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -119.49 141.07 49.5 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 123.335 0.397 . . . . 72.310000000000002 110.283 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 49.2 m -141.56 116.39 9.79 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.534 -0.913 . . . . 52.210000000000001 108.534 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.72 146.16 51.5 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.137 -0.625 . . . . 75.349999999999994 111.337 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -139.13 154.67 48.15 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.632 -1.167 . . . . 74.340000000000003 109.034 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.451 ' HG3' HG22 ' A' ' 119' ' ' VAL . 4.7 ttt180 -100.25 137.8 38.19 Favored 'General case' 0 N--CA 1.393 -3.309 0 N-CA-C 107.661 -1.237 . . . . 73.239999999999995 107.661 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -123.26 89.36 3.09 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 106.638 -1.615 . . . . 75.510000000000005 106.638 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.71 -118.12 6.91 Favored Glycine 0 N--CA 1.423 -2.224 0 N-CA-C 110.042 -1.223 . . . . 75.109999999999999 110.042 -176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 8.1 t30 -103.96 7.31 36.66 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.086 0.946 . . . . 74.209999999999994 108.925 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 pp -119.33 149.16 21.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 120.799 -1.188 . . . . 72.140000000000001 109.079 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.451 HG22 ' HG3' ' A' ' 114' ' ' ARG . 72.9 t -107.8 137.91 36.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 O-C-N 121.845 -0.534 . . . . 62.140000000000001 110.037 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.0 pt -118.42 132.66 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 109.291 -0.633 . . . . 73.209999999999994 109.291 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 tt -124.61 129.24 50.19 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 115.549 -0.75 . . . . 54.119999999999997 109.438 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.31 124.17 29.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.526 -1.657 . . . . 74.120000000000005 106.526 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -149.58 171.9 29.63 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.392 -0.908 . . . . 74.140000000000001 112.695 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.436 ' HG2' HG22 ' A' ' 171' ' ' THR . 74.2 mtt85 -138.79 153.79 48.43 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.634 0.774 . . . . 71.25 109.365 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.07 109.04 10.2 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.475 -0.935 . . . . 54.450000000000003 108.475 174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -112.6 95.69 5.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.785 0.802 . . . . 74.299999999999997 110.742 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.88 27.97 5.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 123.393 1.568 . . . . 71.340000000000003 107.79 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 C--N 1.304 -1.388 0 CA-C-N 112.562 -2.108 . . . . 72.310000000000002 112.017 -179.483 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 121.495 0.664 . . . . 72.420000000000002 110.186 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.33 138.92 58.25 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.82 -1.082 . . . . 64.109999999999999 113.863 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -131.33 130.38 42.65 Favored 'General case' 0 C--O 1.257 1.486 0 N-CA-C 107.784 -1.191 . . . . 61.240000000000002 107.784 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 47.2 t -105.9 112.72 40.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.134 -1.432 . . . . 62.039999999999999 107.134 175.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 37.0 mt-10 -108.19 120.42 42.31 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.081 -0.711 . . . . 75.25 109.081 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 3.0 tt -115.17 122.81 47.18 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 105.976 -1.861 . . . . 70.239999999999995 105.976 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.0 m -126.92 126.01 42.53 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 109.198 -0.667 . . . . 74.340000000000003 109.198 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.471 HG12 ' HD2' ' A' ' 143' ' ' PHE . 57.8 t -120.11 124.03 71.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.961 -0.755 . . . . 60.100000000000001 108.961 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.4 127.36 55.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.706 -0.85 . . . . 75.340000000000003 108.706 177.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.54 121.76 15.34 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 112.187 0.44 . . . . 74.239999999999995 112.187 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.73 46.9 1.11 Allowed 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.997 2.464 . . . . 75.030000000000001 110.809 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -128.36 -106.84 0.3 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.943 -0.571 . . . . 53.149999999999999 109.867 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.59 126.75 0.07 Allowed 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.742 -0.836 . . . . 61.030000000000001 108.742 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.91 135.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.868 -0.79 . . . . 75.540000000000006 108.868 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.4 p -90.5 -42.7 10.7 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 109.459 -0.571 . . . . 65.439999999999998 109.459 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.5 m -159.38 133.12 7.34 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.095 -0.502 . . . . 44.240000000000002 109.963 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.6 t -139.16 157.12 46.5 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 121.987 -0.445 . . . . 70.040000000000006 110.313 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -128.23 95.86 4.29 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.656 -1.979 . . . . 60.439999999999998 105.656 173.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.52 -145.21 8.14 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 107.788 -2.125 . . . . 71.040000000000006 107.788 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -110.61 99.83 8.73 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 118.294 1.047 . . . . 72.230000000000004 110.232 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -78.96 110.45 14.19 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 121.886 0.85 . . . . 63.439999999999998 109.531 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.8 mt -80.39 -38.0 17.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.149 -1.426 . . . . 61.329999999999998 107.149 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.76 163.86 38.08 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.222 -1.77 . . . . 65.450000000000003 106.222 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.09 0.23 7.56 Favored 'Trans proline' 0 N--CA 1.481 0.789 0 C-N-CA 122.588 2.192 . . . . 75.030000000000001 110.846 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.0 pt-20 -128.94 -0.42 5.3 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 114.88 -1.054 . . . . 55.310000000000002 111.297 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.7 t -142.18 120.8 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.547 -0.908 . . . . 73.530000000000001 108.547 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -127.41 143.79 39.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.532 -0.544 . . . . 75.219999999999999 109.532 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 36.1 tt0 -129.93 147.08 51.65 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.373 0.606 . . . . 71.439999999999998 110.17 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.467 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.3 m-90 -123.63 117.86 25.97 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.142 -1.059 . . . . 75.409999999999997 108.142 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -104.07 98.21 8.07 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.752 0.787 . . . . 70.230000000000004 109.407 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 18.3 mt -93.42 130.12 39.34 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.555 -1.202 . . . . 73.319999999999993 109.225 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.2 152.32 50.42 Favored Pre-proline 0 C--N 1.302 -1.468 0 CA-C-N 115.904 -0.589 . . . . 65.120000000000005 111.15 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.68 153.48 73.22 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.329 2.019 . . . . 73.150000000000006 111.06 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.09 -23.96 2.56 Favored Glycine 0 C--N 1.304 -1.201 0 C-N-CA 121.046 -0.597 . . . . 71.5 113.842 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.1 m -104.45 147.78 10.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.223 0.535 . . . . 74.109999999999999 110.698 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 82.6 t -85.38 127.9 39.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.584 -0.735 . . . . 74.099999999999994 109.504 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 10.1 p -138.44 133.07 32.31 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-O 121.424 0.63 . . . . 72.329999999999998 111.715 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 124' ' ' ARG . 21.3 p -114.83 147.38 39.93 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 108.614 -0.884 . . . . 62.299999999999997 108.614 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.405 ' SD ' HD11 ' A' ' 164' ' ' LEU . 70.2 mtm -120.5 133.31 55.42 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.645 -0.502 . . . . 73.319999999999993 109.645 -176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.9 t -143.02 137.06 29.01 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.313 -0.625 . . . . 72.409999999999997 109.313 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.467 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -148.12 118.71 7.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.943 -0.762 . . . . 72.540000000000006 108.943 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -122.75 130.97 53.55 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 106.62 -1.622 . . . . 74.5 106.62 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.44 160.93 41.89 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.035 0.21 . . . . 50.020000000000003 111.261 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.8 mtt-85 -87.39 127.29 35.21 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.862 -0.422 . . . . 72.430000000000007 109.862 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -143.5 119.54 10.7 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 117.757 0.253 . . . . 72.040000000000006 110.529 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.556 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -58.63 119.42 7.04 Favored 'General case' 0 C--N 1.288 -2.1 0 O-C-N 124.226 0.954 . . . . 75.209999999999994 112.423 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.56 -0.746 . . . . 63.200000000000003 109.894 -179.133 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 N--CA 1.423 -1.821 0 N-CA-C 107.348 -1.353 . . . . 71.450000000000003 107.348 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.57 114.69 39.06 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 CA-C-O 121.876 0.846 . . . . 74.140000000000001 109.436 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 61.7 mtp85 -119.22 116.69 26.81 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.549 -1.205 . . . . 73.239999999999995 110.345 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -103.66 109.52 21.24 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.769 -1.197 . . . . 62.439999999999998 107.769 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 m -114.8 115.42 26.98 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.767 -0.827 . . . . 65.150000000000006 108.767 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -129.0 141.68 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 N-CA-C 108.892 -0.781 . . . . 53.43 108.892 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.2 m -121.39 120.94 36.47 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.652 -0.87 . . . . 73.200000000000003 108.652 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.425 HG23 ' HB3' ' A' ' 143' ' ' PHE . 9.5 tt -105.44 120.79 56.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 121.657 0.741 . . . . 74.200000000000003 109.822 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.4 m -84.17 155.92 63.5 Favored Pre-proline 0 C--N 1.295 -1.782 0 CA-C-N 115.177 -0.92 . . . . 52.0 108.974 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.68 2.1 3.79 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.927 2.418 . . . . 75.129999999999995 112.531 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -89.36 2.35 54.54 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 124.635 1.174 . . . . 62.509999999999998 109.524 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.8 t70 69.21 29.4 4.64 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 123.664 1.697 . . . . 74.219999999999999 107.622 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.36 125.47 52.4 Favored 'General case' 0 N--CA 1.393 -3.299 0 CA-C-N 113.032 -1.894 . . . . 73.239999999999995 107.471 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.5 HG11 HD21 ' A' ' 95' ' ' LEU . 13.1 t -113.52 134.07 57.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 115.902 -0.59 . . . . 74.530000000000001 109.535 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.2 p -140.96 128.67 21.55 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.56 -1.274 . . . . 71.450000000000003 107.56 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.67 -171.9 30.49 Favored Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 119.487 -1.34 . . . . 61.109999999999999 112.648 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -149.21 133.67 17.57 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.173 -0.677 . . . . 64.540000000000006 109.173 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 58.4 mt -111.72 115.33 49.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 106.918 -1.512 . . . . 72.120000000000005 106.918 176.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.39 114.22 46.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.357 -0.609 . . . . 74.209999999999994 109.357 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -106.61 107.68 18.82 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.814 -1.921 . . . . 73.409999999999997 105.814 172.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.64 116.93 24.66 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.7 0.762 . . . . 51.520000000000003 110.064 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.65 139.91 50.37 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.534 -0.757 . . . . 73.329999999999998 111.304 -174.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.7 tttt . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 104.604 -2.369 . . . . 74.340000000000003 104.604 168.326 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.439 -1.005 0 N-CA-C 108.049 -1.093 . . . . 61.43 108.049 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.8 96.6 0.1 Allowed Glycine 0 N--CA 1.42 -2.38 0 CA-C-N 113.474 -1.693 . . . . 44.140000000000001 109.295 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 49.2 Cg_exo -55.88 128.95 32.39 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.563 2.175 . . . . 73.019999999999996 110.569 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.577 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -85.21 159.86 20.02 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.618 0.97 . . . . 71.010000000000005 113.618 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 80.3 mt -107.98 127.51 53.83 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 108.035 -1.098 . . . . 74.510000000000005 108.035 174.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -112.94 97.64 6.66 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.009 0.433 . . . . 75.099999999999994 111.174 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.62 136.06 8.64 Favored Glycine 0 C--N 1.284 -2.327 0 N-CA-C 110.788 -0.925 . . . . 62.25 110.788 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.57 120.54 38.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.264 0.554 . . . . 64.230000000000004 111.184 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 m -137.81 161.47 59.89 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.531 -0.759 . . . . 62.310000000000002 109.063 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.8 -22.05 24.15 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.155 1.903 . . . . 53.539999999999999 111.768 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -100.37 42.52 1.11 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.771 -0.65 . . . . 71.140000000000001 111.593 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 m -54.03 -36.56 63.17 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.475 0.71 . . . . 62.509999999999998 111.489 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -69.55 -13.68 62.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.541 0.686 . . . . 73.230000000000004 110.289 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.71 -12.77 21.96 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.431 -0.804 . . . . 74.420000000000002 110.434 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.8 119.46 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 122.303 1.049 . . . . 72.120000000000005 111.595 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.58 112.99 26.16 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.179 -0.919 . . . . 75.150000000000006 109.873 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.7 p -98.0 133.11 41.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.25 -1.018 . . . . 61.109999999999999 108.25 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.6 m -147.46 163.24 37.15 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.266 -1.013 . . . . 74.349999999999994 108.266 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -76.87 143.42 39.68 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.473 0.654 . . . . 73.439999999999998 110.808 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 73.4 t80 -108.3 123.09 48.27 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.552 -1.277 . . . . 61.030000000000001 107.552 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -138.25 99.17 3.79 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 107.659 -1.237 . . . . 74.150000000000006 107.659 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 65.2 m -162.5 149.15 13.12 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.865 -1.161 . . . . 75.420000000000002 107.865 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 69.73 4.41 4.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.876 0.87 . . . . 62.039999999999999 113.316 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.55 4.76 65.58 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.998 -0.841 . . . . 24.300000000000001 110.998 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -104.93 142.34 34.94 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.297 -1.001 . . . . 62.43 108.297 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.4 m -124.38 136.45 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 121.544 0.688 . . . . 64.129999999999995 109.481 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -173.44 -153.41 9.61 Favored Glycine 0 CA--C 1.461 -3.331 0 N-CA-C 110.088 -1.205 . . . . 75.530000000000001 110.088 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.577 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 62.9 m -134.95 149.85 50.29 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 121.506 0.67 . . . . 74.099999999999994 111.485 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 10.5 pt20 -124.58 132.14 53.45 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.873 -1.058 . . . . 75.129999999999995 109.576 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.04 113.95 27.65 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.584 -1.636 . . . . 73.109999999999999 106.584 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.69 112.74 41.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.374 -0.973 . . . . 72.340000000000003 108.374 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.532 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.5 p90 -115.71 153.68 30.92 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.978 -0.556 . . . . 72.230000000000004 110.954 -175.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -154.85 158.16 38.95 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.581 -0.736 . . . . 54.43 111.297 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 65.15 30.88 11.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 122.568 1.175 . . . . 71.450000000000003 110.824 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.532 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.4 mt -96.08 164.23 12.78 Favored 'General case' 0 N--CA 1.426 -1.628 0 O-C-N 121.275 -0.891 . . . . 71.109999999999999 111.11 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -115.22 171.34 7.75 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 116.254 -0.43 . . . . 63.039999999999999 110.686 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -57.0 -36.79 70.81 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.031 0.443 . . . . 55.109999999999999 110.181 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.05 70.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.686 -0.688 . . . . 74.409999999999997 111.019 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.87 -16.08 39.77 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 112.593 0.59 . . . . 73.400000000000006 112.593 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.5 HD21 HG11 ' A' ' 40' ' ' VAL . 17.1 mt -52.56 -53.4 54.15 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 114.322 1.23 . . . . 70.319999999999993 114.322 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.08 -42.29 44.93 Favored 'Trans proline' 0 C--N 1.369 1.607 0 CA-C-N 120.57 1.239 . . . . 72.450000000000003 110.497 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -60.08 -39.72 87.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.317 -0.856 . . . . 73.129999999999995 111.76 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -78.34 -21.86 48.89 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 120.745 -0.382 . . . . 74.549999999999997 110.728 177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.84 -26.85 61.63 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.148 -0.686 . . . . 63.039999999999999 109.148 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -57.73 -54.33 48.12 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.318 -0.855 . . . . 73.540000000000006 109.909 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.1 mtm -54.11 -49.98 67.91 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.205 0.526 . . . . 72.430000000000007 110.313 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -55.36 -37.27 67.3 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.402 -1.272 . . . . 74.340000000000003 110.117 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.7 m -60.72 -32.89 72.13 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.503 -0.317 . . . . 73.439999999999998 111.092 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -68.82 -15.63 63.55 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.531 0.682 . . . . 75.219999999999999 111.557 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.15 -11.95 12.59 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.202 -0.454 . . . . 51.409999999999997 110.607 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.52 -47.53 3.75 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.658 0.984 . . . . 72.25 113.658 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.86 22.09 77.48 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.454 -1.058 . . . . 51.100000000000001 110.454 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.3 t -111.93 143.89 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.127 0.971 . . . . 74.140000000000001 108.576 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -102.18 131.38 48.74 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.052 -0.351 . . . . 75.219999999999999 110.052 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.19 104.84 7.3 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.39 -0.967 . . . . 52.439999999999998 108.39 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.5 m -117.58 137.6 52.49 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.607 -0.886 . . . . 74.099999999999994 108.607 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -147.96 149.28 31.88 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.94 -0.704 . . . . 63.049999999999997 112.449 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -148.39 163.07 38.21 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.039 -0.982 . . . . 75.329999999999998 111.001 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.501 ' HG2' HG22 ' A' ' 119' ' ' VAL . 45.8 mtt85 -102.57 139.76 37.75 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.029 0.443 . . . . 64.530000000000001 110.315 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -121.7 83.71 2.13 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.983 -1.488 . . . . 74.219999999999999 106.983 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.95 -115.7 8.25 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.971 -1.013 . . . . 72.019999999999996 110.697 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -85.08 -20.27 30.63 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.504 0.668 . . . . 74.519999999999996 110.929 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.2 pp -102.64 148.71 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 C-N-CA 118.088 -1.445 . . . . 53.140000000000001 109.174 -175.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.501 HG22 ' HG2' ' A' ' 114' ' ' ARG . 92.8 t -116.81 140.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 O-C-N 122.008 -0.432 . . . . 72.150000000000006 110.054 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.43 HG22 ' HG2' ' A' ' 175' ' ' GLN . 44.3 pt -117.35 138.11 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 115.972 -0.558 . . . . 70.430000000000007 110.088 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 174' ' ' ALA . 7.3 tt -127.3 127.94 45.15 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.143 -1.058 . . . . 71.409999999999997 108.143 175.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -128.26 117.95 22.41 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.485 -0.932 . . . . 60.140000000000001 108.485 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.13 169.57 25.31 Favored Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 121.059 -0.591 . . . . 64.099999999999994 112.201 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -151.05 153.24 34.72 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.19 -0.67 . . . . 74.25 109.19 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -135.57 108.62 7.67 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.634 -0.876 . . . . 74.319999999999993 108.634 171.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -113.11 97.24 6.38 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.933 0.873 . . . . 74.519999999999996 110.994 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.76 34.74 4.59 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.448 -1.251 . . . . 71.409999999999997 108.193 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 C--N 1.314 -0.943 0 N-CA-C 113.143 0.794 . . . . 75.450000000000003 113.143 -175.599 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.241 0.646 0 N-CA-C 115.133 1.531 . . . . 74.420000000000002 115.133 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.17 135.89 40.91 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.894 -1.048 . . . . 74.430000000000007 108.714 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -131.39 130.48 42.65 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 118.089 0.404 . . . . 74.319999999999993 110.419 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 46.5 t -115.91 126.9 73.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.311 -0.626 . . . . 62.409999999999997 109.311 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 162' ' ' TRP . 50.6 mt-10 -128.65 133.06 48.14 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.962 0.41 . . . . 63.149999999999999 110.179 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 52.2 tp -114.44 121.43 43.54 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.683 -0.858 . . . . 50.350000000000001 108.683 174.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.3 m -115.8 108.82 16.81 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.988 -1.116 . . . . 73.420000000000002 107.988 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.1 t -107.92 123.59 63.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.727 -0.472 . . . . 72.230000000000004 109.727 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.16 127.07 55.83 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.318 -0.623 . . . . 62.0 109.318 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.06 120.42 15.12 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 116.38 -0.373 . . . . 71.25 111.79 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 16.1 Cg_exo -72.83 45.26 0.87 Allowed 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 122.866 2.378 . . . . 73.040000000000006 111.729 175.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -123.36 -95.59 0.47 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 119.18 -0.438 . . . . 70.329999999999998 110.869 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 173.19 123.63 0.02 OUTLIER 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.502 0.721 . . . . 51.509999999999998 109.361 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -80.28 130.58 35.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.434 -0.95 . . . . 71.319999999999993 108.434 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.3 p -88.15 -39.79 14.26 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.831 -0.433 . . . . 71.510000000000005 109.831 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.6 m -163.17 132.9 4.25 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 123.633 0.773 . . . . 73.040000000000006 109.156 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -138.38 154.37 48.93 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.983 -0.448 . . . . 73.120000000000005 110.971 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 28.9 t-20 -121.31 94.89 4.48 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.029 -1.841 . . . . 72.120000000000005 106.029 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.24 -149.75 10.08 Favored Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 107.852 -2.099 . . . . 62.109999999999999 107.852 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -117.74 99.89 7.24 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.416 -1.327 . . . . 73.019999999999996 107.416 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -81.12 132.27 35.35 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 120.113 -0.635 . . . . 73.340000000000003 110.565 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.64 -43.17 14.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.309 -1.367 . . . . 72.549999999999997 107.309 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -136.92 170.43 10.8 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.01 -1.478 . . . . 72.099999999999994 107.01 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -72.15 0.77 6.79 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.583 2.188 . . . . 45.439999999999998 110.985 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.5 pt-20 -130.33 -0.13 4.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.532 -0.758 . . . . 71.239999999999995 111.467 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 88.8 t -141.58 121.06 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.461 -0.94 . . . . 73.140000000000001 108.461 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.06 146.63 33.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 109.578 -0.526 . . . . 63.43 109.578 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 29.2 tt0 -134.01 136.74 44.29 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 121.612 0.72 . . . . 73.239999999999995 110.937 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 32.2 m-90 -112.62 125.83 54.71 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.593 -0.73 . . . . 65.109999999999999 109.953 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -104.6 99.21 8.88 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.36 -0.978 . . . . 75.040000000000006 108.36 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 1.8 mm? -95.89 121.84 38.06 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.701 -0.851 . . . . 71.549999999999997 108.701 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 59.3 mttm -116.25 151.04 46.32 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 115.394 -0.821 . . . . 73.120000000000005 110.991 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 165' ' ' LYS . 7.7 Cg_exo -76.48 162.83 32.89 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.032 2.488 . . . . 70.439999999999998 109.836 173.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.45 -40.12 2.94 Favored Glycine 0 C--O 1.245 0.802 0 N-CA-C 111.145 -0.782 . . . . 62.240000000000002 111.145 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.33 158.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 123.043 0.537 . . . . 53.229999999999997 109.61 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -109.56 136.98 43.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.836 -1.172 . . . . 63.530000000000001 107.836 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.7 t -137.71 141.28 41.04 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 119.363 -0.935 . . . . 62.329999999999998 111.093 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.3 p -99.76 145.85 27.22 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.393 -1.276 . . . . 54.530000000000001 109.303 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 82.8 mtp -121.81 119.93 33.11 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.091 -1.077 . . . . 65.049999999999997 108.091 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 30.4 t -133.76 138.79 45.95 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.914 -1.143 . . . . 62.329999999999998 107.914 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.553 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.97 116.35 5.03 Favored 'General case' 0 CA--C 1.471 -2.093 0 N-CA-C 108.926 -0.768 . . . . 44.210000000000001 108.926 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.43 ' HG2' HG22 ' A' ' 120' ' ' ILE . 49.1 mt-30 -121.83 130.31 53.28 Favored 'General case' 0 C--N 1.263 -3.187 0 N-CA-C 106.916 -1.513 . . . . 62.450000000000003 106.916 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -149.45 149.84 31.43 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.145 -1.058 . . . . 72.219999999999999 108.145 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 7.3 ppt_? -93.45 145.82 24.21 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.578 -0.849 . . . . 74.310000000000002 109.237 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.418 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 96.4 m-85 -139.72 152.34 46.58 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.723 -0.843 . . . . 72.409999999999997 108.723 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.32 93.57 2.4 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 109.693 -0.484 . . . . 53.530000000000001 109.693 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.2 t0 . . . . . 0 CA--C 1.5 -0.975 0 CA-C-N 114.548 -1.205 . . . . 63.240000000000002 108.961 -179.15 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 . . . . . 0 N--CA 1.41 -2.468 0 N-CA-C 107.968 -1.123 . . . . 74.540000000000006 107.968 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 47.6 t -120.05 114.49 44.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.692 -1.225 . . . . 74.120000000000005 107.692 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -118.01 114.1 22.64 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.955 -0.757 . . . . 74.150000000000006 108.955 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.4 108.96 20.55 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 107.799 -1.186 . . . . 51.240000000000002 107.799 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 m -113.58 114.67 26.79 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.433 -1.321 . . . . 62.509999999999998 107.433 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -125.43 146.57 30.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.061 -0.718 . . . . 60.310000000000002 109.061 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 43.6 m -129.63 123.43 31.22 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-O 121.197 0.523 . . . . 60.030000000000001 109.635 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 tt -112.77 121.1 64.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.652 0.739 . . . . 74.129999999999995 110.594 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -86.69 154.04 55.75 Favored Pre-proline 0 N--CA 1.425 -1.696 0 CA-C-N 115.178 -0.919 . . . . 71.25 109.517 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.76 2.64 1.91 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.134 2.556 . . . . 73.340000000000003 113.052 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -88.74 1.94 54.28 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.93 -1.137 . . . . 72.099999999999994 107.93 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 71.43 29.73 2.65 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 123.314 1.531 . . . . 71.019999999999996 107.811 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.91 128.33 53.11 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 112.938 -1.937 . . . . 74.120000000000005 107.772 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.44 138.11 49.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.424 -0.584 . . . . 52.140000000000001 109.424 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 p -142.32 163.45 32.8 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.518 -1.29 . . . . 75.140000000000001 107.518 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.77 -171.79 43.94 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.534 -1.793 . . . . 64.040000000000006 113.407 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -148.05 133.4 18.53 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 123.855 0.862 . . . . 60.530000000000001 108.915 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.32 115.83 47.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.416 -1.327 . . . . 64.450000000000003 107.416 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 2.3 mp -115.42 114.86 47.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.61 -0.515 . . . . 73.109999999999999 109.61 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.85 108.13 17.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.874 -1.528 . . . . 73.519999999999996 106.874 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -122.56 128.6 50.94 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 120.799 -0.361 . . . . 73.420000000000002 110.899 -174.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.68 152.46 36.07 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 116.114 -0.494 . . . . 53.340000000000003 110.442 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--N 1.309 -1.19 0 C-N-CA 119.473 -0.891 . . . . 62.229999999999997 109.065 171.981 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.436 -1.156 0 N-CA-C 108.463 -0.94 . . . . 73.409999999999997 108.463 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.24 97.29 0.16 Allowed Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.56 -1.305 . . . . 44.509999999999998 113.174 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.48 159.13 32.53 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.759 2.306 . . . . 73.329999999999998 110.263 172.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.6 133.77 53.01 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.748 -0.464 . . . . 74.120000000000005 109.748 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.94 153.23 19.62 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.587 -0.523 . . . . 71.230000000000004 109.587 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -83.54 84.26 7.6 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.874 -1.158 . . . . 71.129999999999995 107.874 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.82 42.76 1.6 Allowed Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 114.904 -1.044 . . . . 62.32 111.598 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.11 88.15 7.15 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.661 -1.237 . . . . 73.349999999999994 107.661 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.431 HG11 ' SD ' ' A' ' 101' ' ' MET . 17.3 m -122.78 160.23 49.92 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-N 114.628 -1.169 . . . . 65.230000000000004 111.391 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.82 -7.87 12.24 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.489 2.793 . . . . 74.230000000000004 113.572 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.402 ' HE1' ' HG2' ' A' ' 97' ' ' GLN . 46.2 p90 -124.42 28.86 6.5 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 122.21 -0.306 . . . . 63.329999999999998 111.006 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.1 m -55.72 -27.85 52.66 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 111.971 0.36 . . . . 62.409999999999997 111.971 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -71.96 -7.97 51.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.212 0.53 . . . . 72.340000000000003 110.932 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -112.39 -6.76 14.0 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.065 -0.516 . . . . 73.409999999999997 110.15 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 p -127.58 118.53 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.892 0.854 . . . . 54.450000000000003 109.963 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.69 104.58 16.51 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.451 -0.795 . . . . 62.240000000000002 109.44 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.09 132.93 42.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.238 -1.393 . . . . 71.219999999999999 107.238 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.1 m -154.19 172.35 17.73 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.714 -0.847 . . . . 72.140000000000001 108.714 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -80.57 154.6 27.37 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.298 0.57 . . . . 75.230000000000004 110.105 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 70.7 t80 -118.23 123.39 45.34 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.957 -1.127 . . . . 73.409999999999997 107.957 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -138.22 100.35 4.11 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.04 -1.837 . . . . 75.299999999999997 106.04 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.3 t -165.23 143.78 6.35 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.768 -0.456 . . . . 45.340000000000003 109.768 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.1 t70 66.9 14.38 9.8 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.078 1.351 . . . . 70.25 109.339 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.63 -0.73 77.62 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.767 -0.73 . . . . 52.109999999999999 111.683 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.549 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 7.9 m-85 -94.0 146.04 24.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.424 -0.584 . . . . 73.540000000000006 109.424 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 m -125.56 136.96 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 108.265 -1.013 . . . . 74.420000000000002 108.265 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.69 -154.61 10.45 Favored Glycine 0 C--N 1.271 -3.037 0 N-CA-C 110.439 -1.064 . . . . 51.43 110.439 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 m -129.82 150.9 50.92 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 120.967 0.413 . . . . 73.450000000000003 110.42 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -133.64 145.26 49.82 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.083 0.468 . . . . 75.299999999999997 110.613 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.6 114.76 21.06 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.458 -1.312 . . . . 74.099999999999994 107.458 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.31 115.27 49.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.734 -0.839 . . . . 65.420000000000002 108.734 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.512 ' CD2' HD12 ' A' ' 90' ' ' LEU . 47.1 p90 -121.09 151.0 40.36 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.47 -0.492 . . . . 74.030000000000001 111.227 -174.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -153.15 156.49 38.72 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.415 -0.357 . . . . 62.020000000000003 111.202 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.4 t70 63.53 31.21 14.92 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.5 1.12 . . . . 72.530000000000001 111.046 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.512 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.4 mt -94.69 170.14 9.67 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.89 -0.595 . . . . 75.430000000000007 109.938 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t -128.08 179.72 5.44 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 120.636 -0.426 . . . . 64.420000000000002 110.617 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -54.69 -42.23 71.18 Favored 'General case' 0 C--O 1.209 -1.035 0 C-N-CA 123.794 0.837 . . . . 61.420000000000002 112.17 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.62 -29.11 69.03 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.342 0.592 . . . . 70.219999999999999 111.566 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.66 -15.97 29.44 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 115.57 -0.741 . . . . 72.019999999999996 111.285 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.9 tt -60.35 -51.46 80.0 Favored Pre-proline 0 CA--C 1.568 1.662 0 CA-C-O 119.202 -0.428 . . . . 72.310000000000002 111.205 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.52 -36.65 75.61 Favored 'Trans proline' 0 C--N 1.373 1.863 0 CA-C-N 120.976 1.384 . . . . 74.530000000000001 110.838 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.402 ' HG2' ' HE1' ' A' ' 66' ' ' PHE . 29.0 tt0 -66.44 -37.73 85.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.215 -0.902 . . . . 75.510000000000005 110.097 -175.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -78.09 -19.99 53.1 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.393 0.616 . . . . 71.310000000000002 109.736 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.34 -18.08 60.74 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.601 -0.727 . . . . 54.420000000000002 109.063 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.18 -57.22 12.29 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 116.012 -0.54 . . . . 74.140000000000001 109.737 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 64' ' ' VAL . 3.2 mpp? -55.73 -45.25 78.0 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 123.674 0.609 . . . . 72.439999999999998 109.718 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -52.88 -42.48 65.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.524 -1.217 . . . . 60.310000000000002 111.412 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.9 m -63.51 -31.76 73.01 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.179 -0.464 . . . . 65.120000000000005 110.725 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.6 -20.77 63.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.184 0.516 . . . . 73.5 110.686 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.91 -9.82 16.94 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.485 -0.486 . . . . 71.319999999999993 110.382 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.41 -47.64 3.89 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.414 0.524 . . . . 63.119999999999997 112.414 -173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.21 28.77 19.29 Favored Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 119.962 -1.114 . . . . 60.109999999999999 110.933 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.8 m -124.38 165.11 21.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 122.767 -0.255 . . . . 62.100000000000001 110.544 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.93 124.18 47.62 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.816 -1.179 . . . . 73.019999999999996 107.816 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.19 123.15 49.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.165 0.439 . . . . 73.439999999999998 111.08 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -120.93 117.56 27.64 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.346 -0.983 . . . . 71.299999999999997 108.346 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.452 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 2.2 pt? -133.35 147.43 51.82 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.223 -0.591 . . . . 74.099999999999994 111.006 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.452 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 2.1 mpt_? -142.11 155.23 45.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.968 -1.493 . . . . 75.439999999999998 106.968 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.525 ' NE ' ' HB2' ' A' ' 180' ' ' ASP . 9.4 ttt180 -108.85 137.53 46.63 Favored 'General case' 0 N--CA 1.396 -3.126 0 N-CA-C 106.69 -1.596 . . . . 74.200000000000003 106.69 173.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -127.42 99.6 5.69 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 107.98 -1.119 . . . . 71.299999999999997 107.98 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.9 -115.71 6.75 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.845 -0.902 . . . . 61.0 110.845 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 8.9 t30 -110.6 12.89 22.67 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.304 1.049 . . . . 51.329999999999998 109.342 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.8 pp -122.51 149.25 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 121.234 -0.916 . . . . 74.150000000000006 109.069 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.513 HG22 ' HG3' ' A' ' 114' ' ' ARG . 76.5 t -110.66 137.88 41.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 109.987 -0.375 . . . . 74.299999999999997 109.987 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 120' ' ' ILE . 42.0 pt -116.26 129.06 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 N-CA-C 108.636 -0.876 . . . . 72.430000000000007 108.636 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -128.3 125.73 39.39 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.959 -0.564 . . . . 75.430000000000007 109.653 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.48 115.96 18.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.361 0.6 . . . . 73.129999999999995 109.769 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -116.52 130.4 8.96 Favored Glycine 0 C--N 1.294 -1.789 0 N-CA-C 110.075 -1.21 . . . . 62.549999999999997 110.075 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -114.6 132.9 56.19 Favored 'General case' 0 C--N 1.282 -2.332 0 O-C-N 122.153 -0.616 . . . . 71.150000000000006 109.8 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.0 114.37 19.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.679 -0.691 . . . . 70.420000000000002 112.052 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.69 97.25 6.45 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.434 -0.95 . . . . 74.310000000000002 108.434 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.45 28.21 8.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.685 -0.857 . . . . 73.129999999999995 108.685 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 20.5 p . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.254 -0.885 . . . . 45.219999999999999 112.944 -175.741 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 . . . . . 0 CA--C 1.501 -0.92 0 CA-C-O 120.561 0.219 . . . . 70.209999999999994 111.463 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.31 140.3 38.81 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.156 0.503 . . . . 72.109999999999999 110.808 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -131.85 110.43 10.81 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.278 -0.874 . . . . 74.430000000000007 109.29 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 77.8 t -104.89 113.66 42.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.379 -0.971 . . . . 62.420000000000002 108.379 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -108.54 121.08 44.23 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.109 -1.071 . . . . 61.109999999999999 108.109 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.524 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.9 tm? -110.81 115.7 29.99 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 105.784 -1.932 . . . . 74.019999999999996 105.784 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.9 m -123.69 127.53 48.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.501 -0.555 . . . . 53.32 109.501 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 76.9 t -124.95 126.82 71.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.182 -0.673 . . . . 72.120000000000005 109.182 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -115.95 130.93 57.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.704 -0.85 . . . . 53.439999999999998 108.704 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.713 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.2 p90 -135.06 122.84 15.39 Favored Pre-proline 0 C--N 1.283 -2.318 0 N-CA-C 112.002 0.371 . . . . 73.409999999999997 112.002 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -70.15 35.61 0.24 Allowed 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 122.57 2.18 . . . . 74.299999999999997 111.681 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -115.77 -99.31 0.44 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 123.132 0.573 . . . . 71.219999999999999 109.869 -177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.42 129.97 0.02 OUTLIER 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.304 -0.998 . . . . 54.229999999999997 108.304 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.87 138.08 20.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.704 -0.85 . . . . 75.219999999999999 108.704 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.8 p -94.09 -43.04 8.68 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 109.051 -0.722 . . . . 64.409999999999997 109.051 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.0 m -160.08 133.12 6.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.505 -0.924 . . . . 64.409999999999997 108.505 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 t -139.24 149.42 44.32 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.683 -0.635 . . . . 70.109999999999999 111.099 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -114.67 93.07 4.16 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 104.71 -2.33 . . . . 62.409999999999997 104.71 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.492 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.13 -148.86 11.57 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 107.999 -2.04 . . . . 74.409999999999997 107.999 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -114.09 100.02 8.07 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 117.587 0.693 . . . . 64.239999999999995 110.473 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -76.95 119.87 21.28 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.159 -0.616 . . . . 73.230000000000004 109.354 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.8 mt -83.98 -37.43 13.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.317 -1.364 . . . . 63.439999999999998 107.317 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.42 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . 39.3 mt-10 -145.69 161.9 38.59 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 106.766 -1.568 . . . . 65.219999999999999 106.766 -178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.31 -10.6 29.2 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.445 2.097 . . . . 72.049999999999997 112.212 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.713 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.4 OUTLIER -122.18 5.58 9.75 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 112.656 0.613 . . . . 71.310000000000002 112.656 177.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.5 t -139.84 120.95 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.56 -0.533 . . . . 64.319999999999993 109.56 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.77 148.04 31.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.482 -0.562 . . . . 71.120000000000005 109.482 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -138.55 149.58 45.46 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.298 -0.63 . . . . 61.119999999999997 109.298 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.524 ' CE3' HD12 ' A' ' 139' ' ' LEU . 28.2 m-90 -124.92 142.07 51.7 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.822 -0.807 . . . . 54.119999999999997 108.822 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -108.73 105.12 14.57 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.93 -1.507 . . . . 72.239999999999995 106.93 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 9.4 mp -100.57 119.18 38.15 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.926 0.87 . . . . 75.5 110.884 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.604 ' HD3' ' HD2' ' A' ' 166' ' ' PRO . 1.6 mmtm -118.42 140.75 28.61 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 114.231 -1.35 . . . . 63.240000000000002 108.85 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.604 ' HD2' ' HD3' ' A' ' 165' ' ' LYS . 39.1 Cg_exo -66.64 167.71 18.46 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.693 1.595 . . . . 74.439999999999998 110.729 171.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.97 -36.82 3.01 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 120.857 -0.687 . . . . 50.229999999999997 111.656 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.8 m -104.94 157.06 5.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.163 0.506 . . . . 72.319999999999993 110.093 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.6 p -114.06 127.02 71.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.914 -1.143 . . . . 74.340000000000003 107.914 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 46.6 m -145.57 143.54 29.97 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.912 -0.492 . . . . 70.150000000000006 110.863 -177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.1 p -109.23 125.91 52.75 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 115.841 -0.618 . . . . 74.420000000000002 109.651 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -101.3 134.66 44.02 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.606 -0.887 . . . . 75.439999999999998 108.606 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.0 m -143.26 140.72 30.78 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.616 -0.678 . . . . 72.420000000000002 110.907 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.507 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -143.05 132.18 23.11 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.358 -0.383 . . . . 70.200000000000003 109.982 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.1 131.32 54.19 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.82 -1.548 . . . . 72.099999999999994 106.82 170.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.84 156.24 42.05 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.21 -0.663 . . . . 74.5 109.21 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 28.4 ptt180 -87.91 134.48 33.7 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 120.362 -0.535 . . . . 71.209999999999994 109.895 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -143.72 122.72 12.81 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 109.337 -0.616 . . . . 75.450000000000003 109.337 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.572 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -58.97 109.08 0.76 Allowed 'General case' 0 C--N 1.279 -2.477 0 O-C-N 124.389 1.055 . . . . 75.099999999999994 111.536 -178.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' HB2' ' NE ' ' A' ' 114' ' ' ARG . 27.0 t70 . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 108.888 -0.782 . . . . 71.400000000000006 108.888 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 . . . . . 0 N--CA 1.424 -1.743 0 N-CA-C 106.867 -1.531 . . . . 72.340000000000003 106.867 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HB ' HG13 ' A' ' 137' ' ' VAL . 59.1 t -119.48 113.63 41.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 106.96 -1.496 . . . . 73.430000000000007 106.96 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 11.3 ttp180 -127.67 113.5 16.12 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.041 0.448 . . . . 73.140000000000001 109.958 -175.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.67 108.78 20.18 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.981 -0.748 . . . . 71.019999999999996 108.981 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.6 t -108.4 114.16 27.79 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.694 -1.595 . . . . 71.5 106.694 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.407 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.7 pp -132.98 147.17 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.379 0.609 . . . . 64.219999999999999 110.483 -174.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.3 m -129.73 128.38 42.35 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 116.024 -0.535 . . . . 71.299999999999997 109.865 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 143' ' ' PHE . 9.6 tt -113.96 125.69 71.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.299 0.571 . . . . 74.219999999999999 110.748 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.481 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 31.3 t -93.49 151.67 40.34 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.533 -0.758 . . . . 54.549999999999997 109.888 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.39 1.08 1.42 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.793 2.995 . . . . 74.209999999999994 112.922 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.71 -3.69 54.33 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.818 -1.179 . . . . 61.310000000000002 107.818 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.3 t70 72.25 29.02 2.3 Favored 'General case' 0 C--N 1.347 0.473 0 N-CA-C 106.858 -1.534 . . . . 72.450000000000003 106.858 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.3 OUTLIER -112.73 140.83 47.18 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.441 -1.254 . . . . 75.319999999999993 108.985 -178.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' A' ' 95' ' ' LEU . 17.8 t -115.63 144.71 22.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.549 -0.75 . . . . 75.109999999999999 109.126 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.2 p -149.29 158.71 44.4 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.079 -1.082 . . . . 73.030000000000001 108.079 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 161.48 -166.73 36.06 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 119.884 -1.15 . . . . 74.209999999999994 112.748 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -154.61 139.21 16.94 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.353 0.597 . . . . 73.430000000000007 111.064 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 46.6 mt -114.51 116.53 52.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.543 -0.91 . . . . 64.109999999999999 108.543 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.16 126.01 61.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.371 -0.603 . . . . 74.420000000000002 109.371 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.513 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -123.61 108.6 12.77 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.777 -1.194 . . . . 64.329999999999998 107.777 173.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.87 126.54 52.58 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.85 0.357 . . . . 63.25 111.585 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.38 158.91 30.06 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.765 -0.652 . . . . 70.150000000000006 109.755 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 118.974 -1.091 . . . . 74.030000000000001 109.298 175.263 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.427 -1.598 0 N-CA-C 108.684 -0.858 . . . . 71.140000000000001 108.684 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 174.15 112.04 0.28 Allowed Glycine 0 N--CA 1.425 -2.082 0 CA-C-N 115.261 -0.881 . . . . 74.209999999999994 112.046 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.04 160.33 45.02 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 123.047 2.498 . . . . 70.420000000000002 111.351 173.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.43 131.07 37.14 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.798 -0.816 . . . . 64.299999999999997 108.798 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.426 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 69.0 mt -84.87 143.66 28.9 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.423 -0.584 . . . . 71.109999999999999 109.423 176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -100.43 93.79 5.83 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.478 0.656 . . . . 72.519999999999996 109.66 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.623 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -140.6 72.59 0.41 Allowed Glycine 0 C--N 1.28 -2.56 0 CA-C-N 115.168 -0.924 . . . . 62.219999999999999 111.116 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -82.29 91.32 6.75 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.834 -0.802 . . . . 62.240000000000002 108.834 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.6 m -122.29 154.1 62.04 Favored Pre-proline 0 C--N 1.299 -1.606 0 CA-C-N 114.744 -1.117 . . . . 71.109999999999999 110.739 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.84 -21.39 70.32 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 123.595 2.863 . . . . 43.32 112.916 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -102.75 32.45 3.64 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 111.063 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 p -55.8 -34.08 64.99 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 116.29 -0.413 . . . . 64.019999999999996 111.543 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -65.29 -16.69 63.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.301 0.572 . . . . 73.420000000000002 111.47 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 88' ' ' SER . 33.3 mmtp -98.75 -16.0 19.11 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 116.157 -0.474 . . . . 72.310000000000002 110.524 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.17 118.89 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-O 122.195 0.998 . . . . 72.340000000000003 111.18 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -105.62 122.6 46.38 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.888 -1.051 . . . . 53.43 109.27 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.3 t -98.23 131.43 45.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.954 -1.128 . . . . 60.43 107.954 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 m -139.65 169.8 17.07 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.451 -0.574 . . . . 75.409999999999997 109.451 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.541 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 1.7 p-10 -83.64 142.56 30.71 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.097 0.475 . . . . 73.319999999999993 109.771 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 82.5 t80 -107.92 121.74 45.4 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.657 -1.238 . . . . 74.219999999999999 107.657 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.28 101.11 4.3 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.158 -1.053 . . . . 71.049999999999997 108.158 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 36.6 t -165.8 147.57 7.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.043 -1.095 . . . . 65.219999999999999 108.043 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 71.94 10.15 6.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.976 0.91 . . . . 64.450000000000003 111.167 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.55 1.06 83.76 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.557 -0.747 . . . . 73.0 111.967 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -104.95 147.06 28.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.454 -0.943 . . . . 63.119999999999997 108.454 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -123.85 139.0 51.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.218 -1.031 . . . . 73.200000000000003 108.218 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -167.44 -155.13 8.98 Favored Glycine 0 C--N 1.26 -3.677 0 C-N-CA 119.797 -1.192 . . . . 71.549999999999997 111.178 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.426 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 7.8 t -123.81 152.77 41.89 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 108.858 -0.793 . . . . 54.140000000000001 108.858 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 29.0 pt20 -140.67 130.71 24.72 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 120.999 0.428 . . . . 72.239999999999995 110.363 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.04 115.31 29.96 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.735 -0.839 . . . . 75.319999999999993 108.735 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.89 116.75 50.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.903 -0.777 . . . . 75.200000000000003 108.903 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.461 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.2 p90 -121.67 146.95 46.49 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 120.982 0.42 . . . . 74.109999999999999 110.944 -176.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 46.1 m -152.04 158.54 43.18 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 116.018 -0.537 . . . . 74.450000000000003 109.78 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.8 t70 60.47 38.82 18.93 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 122.31 1.052 . . . . 75.25 111.64 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.461 HD12 ' CD2' ' A' ' 87' ' ' PHE . 25.3 mt -97.47 166.53 11.48 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.238 -0.892 . . . . 74.430000000000007 109.878 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -115.08 173.72 6.35 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.875 0.307 . . . . 71.329999999999998 110.264 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -49.84 -50.49 45.26 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.223 1.409 . . . . 72.200000000000003 111.461 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.31 68.11 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.156 0.582 . . . . 74.150000000000006 112.251 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -84.3 -16.34 43.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.67 -0.241 . . . . 73.109999999999999 111.619 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.7 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.8 tt -64.52 -54.98 33.01 Favored Pre-proline 0 CA--C 1.558 1.273 0 CA-C-O 119.392 -0.337 . . . . 71.230000000000004 111.312 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.41 -33.28 88.88 Favored 'Trans proline' 0 C--N 1.367 1.54 0 CA-C-N 120.744 1.301 . . . . 65.349999999999994 111.017 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -66.57 -36.06 81.73 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.95 -0.568 . . . . 74.510000000000005 110.697 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.0 pp -75.9 -19.21 59.01 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 109.498 -0.556 . . . . 74.299999999999997 109.498 175.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.01 -15.99 62.05 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.004 -0.544 . . . . 74.549999999999997 110.342 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -63.79 -56.93 11.82 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.452 -0.944 . . . . 73.420000000000002 108.452 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.623 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 31.9 ttp -54.33 -49.67 69.18 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.664 -0.698 . . . . 73.519999999999996 109.805 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -53.33 -41.98 66.27 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.849 -1.069 . . . . 75.109999999999999 110.887 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.3 p -72.37 -20.73 61.41 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 119.421 -0.912 . . . . 74.140000000000001 112.199 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.2 -20.36 62.28 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.482 0.658 . . . . 72.230000000000004 109.703 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.91 -10.41 20.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.792 -0.64 . . . . 51.140000000000001 110.378 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.67 -48.4 3.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.667 0.618 . . . . 64.140000000000001 112.667 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.64 20.62 59.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.481 -0.648 . . . . 42.32 111.481 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.84 168.19 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 109.476 -0.565 . . . . 73.120000000000005 109.476 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -102.77 135.52 44.29 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.887 0.312 . . . . 72.540000000000006 110.407 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.25 125.65 23.42 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.38 -0.6 . . . . 70.099999999999994 109.38 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.2 p -144.34 143.12 30.81 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.756 0.313 . . . . 71.430000000000007 111.268 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.54 125.78 23.14 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.741 0.816 . . . . 60.25 108.894 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -142.01 168.33 20.0 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.302 0.241 . . . . 63.140000000000001 110.378 -174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.417 ' CG ' HG22 ' A' ' 119' ' ' VAL . 26.6 mtt85 -101.14 138.68 37.85 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 113.866 1.061 . . . . 72.140000000000001 113.866 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.434 ' O ' HG13 ' A' ' 118' ' ' ILE . 7.0 t30 -123.96 94.36 4.2 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 105.764 -1.939 . . . . 74.120000000000005 105.764 174.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.42 -114.03 4.95 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 110.106 -1.197 . . . . 72.329999999999998 110.106 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -110.7 -1.37 16.74 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.721 1.248 . . . . 73.140000000000001 108.768 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.5 pp -103.19 148.97 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 C-N-CA 118.892 -1.123 . . . . 75.239999999999995 108.323 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.417 HG22 ' CG ' ' A' ' 114' ' ' ARG . 89.1 t -108.92 136.53 44.49 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.984 0 N-CA-C 109.853 -0.425 . . . . 61.420000000000002 109.853 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.7 pt -116.01 132.14 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-O 121.921 0.867 . . . . 71.450000000000003 109.201 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 174' ' ' ALA . 5.5 tt -114.4 130.95 56.73 Favored 'General case' 0 C--N 1.255 -3.513 0 N-CA-C 105.646 -1.983 . . . . 51.310000000000002 105.646 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -140.74 130.67 24.54 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.727 -0.842 . . . . 75.430000000000007 108.727 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.92 168.05 38.26 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 111.199 -0.76 . . . . 31.25 111.199 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -140.2 141.83 35.91 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.364 -0.976 . . . . 73.0 108.364 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.69 108.78 12.37 Favored 'General case' 0 N--CA 1.413 -2.279 0 N-CA-C 108.352 -0.981 . . . . 71.120000000000005 108.352 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -112.66 111.72 22.72 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.034 -1.099 . . . . 53.140000000000001 108.034 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 0.1 OUTLIER -127.75 34.47 4.64 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.082 -1.451 . . . . 75.049999999999997 107.082 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 113.654 0.983 . . . . 74.239999999999995 113.654 -175.151 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 121.23 0.538 . . . . 64.519999999999996 111.872 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.2 148.15 28.6 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.987 -1.116 . . . . 70.109999999999999 107.987 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -132.68 124.58 28.5 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.888 -0.412 . . . . 71.209999999999994 109.888 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.511 ' HB ' ' HG ' ' A' ' 164' ' ' LEU . 82.6 t -117.16 121.05 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 120.161 -0.616 . . . . 73.439999999999998 110.113 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 45.3 mt-10 -115.73 138.02 51.52 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.95 -0.568 . . . . 55.399999999999999 110.686 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.407 HD13 ' SD ' ' A' ' 172' ' ' MET . 3.3 tt -127.64 125.46 40.19 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 105.237 -2.134 . . . . 70.010000000000005 105.237 170.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 13.6 m -126.57 122.94 36.53 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.144 -0.687 . . . . 75.030000000000001 109.144 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.443 HG12 ' HD2' ' A' ' 143' ' ' PHE . 94.1 t -118.24 123.5 71.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 110.131 -0.322 . . . . 63.009999999999998 110.131 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.78 127.49 55.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.074 -0.713 . . . . 41.219999999999999 109.074 176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.0 p90 -134.46 121.31 15.17 Favored Pre-proline 0 C--N 1.295 -1.779 0 C-N-CA 122.695 0.398 . . . . 73.329999999999998 112.004 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 15.0 Cg_exo -72.59 39.17 0.41 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.874 2.382 . . . . 73.219999999999999 112.108 176.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.61 -97.92 0.46 Allowed 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 119.307 -0.378 . . . . 62.420000000000002 110.482 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.59 123.8 0.03 OUTLIER 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.406 -0.59 . . . . 64.530000000000001 109.406 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.48 136.15 23.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.483 -0.932 . . . . 73.319999999999993 108.483 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.8 p -95.31 -44.97 7.34 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.204 -0.665 . . . . 63.130000000000003 109.204 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 62.5 m -158.82 133.3 7.98 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.935 -0.575 . . . . 62.549999999999997 109.536 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.2 t -138.32 159.27 42.49 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.835 -0.54 . . . . 74.319999999999993 110.113 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -126.18 94.56 4.12 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 105.343 -2.095 . . . . 71.209999999999994 105.343 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.34 -150.19 10.37 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.051 -2.02 . . . . 50.25 108.051 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.68 99.01 7.02 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.608 -0.886 . . . . 74.310000000000002 108.608 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -74.66 137.63 42.32 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.906 -0.588 . . . . 72.099999999999994 111.307 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.4 mt -100.87 -48.45 11.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.242 -1.392 . . . . 73.219999999999999 107.242 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -133.72 169.0 15.09 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 107.561 -1.274 . . . . 73.239999999999995 107.561 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.87 0.81 7.2 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.625 2.216 . . . . 72.420000000000002 111.078 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.4 pt-20 -132.75 3.7 3.83 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.946 -1.024 . . . . 73.450000000000003 110.747 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.421 HG23 ' HG3' ' A' ' 158' ' ' GLU . 59.8 t -144.6 120.82 4.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.912 -0.773 . . . . 61.520000000000003 108.912 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.97 147.83 31.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.084 -0.71 . . . . 74.340000000000003 109.084 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -130.05 143.38 50.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.111 -0.7 . . . . 64.400000000000006 109.111 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.536 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 32.6 m-90 -122.66 116.73 24.31 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 108.731 -0.841 . . . . 72.230000000000004 108.731 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.25 98.27 8.68 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.554 -0.906 . . . . 63.210000000000001 108.554 175.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.511 ' HG ' ' HB ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -96.45 131.52 42.94 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-O 122.338 1.066 . . . . 60.219999999999999 110.082 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 68.4 mttm -119.52 151.03 51.05 Favored Pre-proline 0 C--N 1.279 -2.499 0 CA-C-N 113.248 -1.796 . . . . 63.210000000000001 112.858 -170.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 20.3 Cg_exo -70.97 156.56 59.96 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.868 2.379 . . . . 71.340000000000003 110.644 174.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.34 -36.17 2.94 Favored Glycine 0 C--N 1.309 -0.925 0 C-N-CA 121.278 -0.487 . . . . 73.140000000000001 112.129 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.3 m -105.82 166.27 3.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 123.008 0.523 . . . . 74.349999999999994 110.223 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.0 p -113.82 142.33 26.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.348 -0.982 . . . . 64.510000000000005 108.348 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.1 m -138.53 141.95 39.32 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.937 -0.477 . . . . 72.129999999999995 109.841 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.3 p -103.43 130.01 50.68 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.871 -0.788 . . . . 74.400000000000006 108.871 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.407 ' SD ' HD13 ' A' ' 139' ' ' LEU . 44.2 ttp -104.02 116.34 32.05 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.653 -0.869 . . . . 72.030000000000001 108.653 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.1 m -140.33 139.52 35.44 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.693 -0.803 . . . . 64.329999999999998 109.305 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.536 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -149.2 120.68 7.94 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 108.507 -0.923 . . . . 40.240000000000002 108.507 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -120.7 130.74 54.21 Favored 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 106.691 -1.596 . . . . 70.340000000000003 106.691 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -155.76 150.93 26.68 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.405 -0.961 . . . . 73.219999999999999 108.405 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 5.8 ppt_? -88.2 126.41 35.13 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.81 -0.756 . . . . 74.099999999999994 110.671 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 16.5 m-30 -135.05 118.71 17.06 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 107.741 -1.207 . . . . 64.010000000000005 107.741 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.63 113.25 0.67 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 125.171 1.545 . . . . 52.409999999999997 112.274 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.5 t0 . . . . . 0 CA--C 1.501 -0.926 0 C-N-CA 124.422 1.089 . . . . 74.239999999999995 109.082 -176.872 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 . . . . . 0 N--CA 1.44 -0.929 0 CA-C-O 121.121 0.486 . . . . 74.439999999999998 111.418 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.08 114.44 41.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.729 -0.841 . . . . 64.150000000000006 108.729 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 58.6 mtp85 -119.5 119.3 33.45 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.553 -0.748 . . . . 74.349999999999994 111.961 -176.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.08 108.35 19.4 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.481 -1.303 . . . . 73.109999999999999 107.481 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 140' ' ' THR . 20.3 m -120.71 115.11 22.7 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.618 -0.512 . . . . 72.400000000000006 109.618 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.9 pp -124.45 147.47 28.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.017 0.437 . . . . 75.439999999999998 110.44 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 62.7 m -129.82 122.04 27.95 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 121.053 0.454 . . . . 63.130000000000003 110.097 -176.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -113.92 122.73 68.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 121.463 0.649 . . . . 63.439999999999998 110.439 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.1 m -86.99 151.64 52.19 Favored Pre-proline 0 N--CA 1.417 -2.112 0 CA-C-N 115.336 -0.847 . . . . 64.230000000000004 109.46 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.43 ' HG3' ' HB2' ' A' ' 145' ' ' ALA . 21.6 Cg_exo -65.96 2.13 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.312 2.675 . . . . 74.409999999999997 112.349 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 25.7 t70 -85.19 -2.22 57.79 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.139 0.975 . . . . 63.119999999999997 109.385 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.9 t70 72.76 28.96 2.01 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 123.469 1.605 . . . . 74.209999999999994 107.621 -174.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -107.51 125.84 51.78 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 113.671 -1.604 . . . . 64.129999999999995 108.25 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 t -108.97 137.12 42.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.256 -0.646 . . . . 63.149999999999999 109.256 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.2 p -146.84 165.43 29.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.722 -1.214 . . . . 74.030000000000001 107.722 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.26 -173.97 41.78 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.617 -1.278 . . . . 51.039999999999999 112.764 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 10.2 pt-20 -157.51 133.42 9.37 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.409 0.623 . . . . 75.030000000000001 110.804 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 2.0 mp -113.18 116.5 52.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.992 -1.114 . . . . 74.540000000000006 107.992 175.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mp -113.9 115.6 50.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.195 0.521 . . . . 64.230000000000004 109.698 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -108.7 125.85 52.35 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.509 -1.663 . . . . 74.409999999999997 106.509 174.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.87 116.79 14.19 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.578 0.704 . . . . 75.239999999999995 109.476 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.84 159.34 31.28 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 115.059 -0.973 . . . . 73.200000000000003 110.789 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 mttp . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 106.713 -1.588 . . . . 70.540000000000006 106.713 171.29 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.443 -0.799 0 CA-C-O 120.563 0.22 . . . . 74.510000000000005 111.045 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.45 97.79 0.11 Allowed Glycine 0 N--CA 1.434 -1.47 0 C-N-CA 120.053 -1.07 . . . . 62.130000000000003 111.98 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.56 159.83 35.42 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.635 2.223 . . . . 63.109999999999999 111.454 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.96 140.47 52.3 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.452 -0.573 . . . . 72.450000000000003 109.452 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.413 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 90.8 mt -62.89 149.19 45.1 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.566 0.541 . . . . 65.209999999999994 110.208 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -82.38 85.1 6.95 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.571 -0.899 . . . . 55.43 108.571 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.531 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -122.4 120.88 4.47 Favored Glycine 0 N--CA 1.417 -2.631 0 CA-C-N 114.558 -1.201 . . . . 75.239999999999995 113.746 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -139.95 112.79 8.06 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.757 -0.831 . . . . 73.239999999999995 108.757 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.51 161.6 57.93 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.662 -0.866 . . . . 74.030000000000001 108.662 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.62 -11.86 24.36 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.047 1.831 . . . . 73.219999999999999 111.536 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -114.03 41.61 2.21 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.837 -0.619 . . . . 71.400000000000006 111.595 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.2 m -58.64 -27.23 64.53 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-N 116.211 -0.449 . . . . 65.340000000000003 111.508 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -68.84 -15.82 63.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.522 0.677 . . . . 71.420000000000002 110.405 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -95.4 -17.63 21.4 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.245 -0.889 . . . . 73.010000000000005 110.565 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 87' ' ' PHE . 7.6 p -124.55 118.97 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-O 122.246 1.022 . . . . 53.210000000000001 111.92 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.94 101.85 14.41 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.042 -0.981 . . . . 64.129999999999995 108.39 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.21 125.5 51.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.594 -1.262 . . . . 71.040000000000006 107.594 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 m -142.09 172.26 12.93 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.888 -0.782 . . . . 74.209999999999994 108.888 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -83.59 151.92 25.1 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.818 -1.178 . . . . 74.200000000000003 107.818 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -110.35 123.57 50.09 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.94 -1.504 . . . . 73.400000000000006 106.94 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -138.55 99.53 3.85 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 106.97 -1.493 . . . . 71.150000000000006 106.97 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.4 t -171.94 155.21 3.74 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.556 -1.276 . . . . 73.25 107.556 -174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 70.62 7.26 6.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.942 0.897 . . . . 73.439999999999998 111.383 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.1 -2.04 80.99 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.453 -1.059 . . . . 63.140000000000001 110.453 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -104.56 155.67 18.62 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.216 0.606 . . . . 75.319999999999993 111.288 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.64 136.69 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 108.438 -0.949 . . . . 71.140000000000001 108.438 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -163.45 -154.06 7.55 Favored Glycine 0 N--CA 1.397 -3.931 0 C-N-CA 120.056 -1.069 . . . . 62.210000000000001 111.051 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.413 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 13.0 m -131.25 143.6 50.68 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 115.462 -0.369 . . . . 61.219999999999999 110.078 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 10.1 pt20 -132.74 138.15 47.1 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.706 0.289 . . . . 63.399999999999999 110.731 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -121.03 114.4 21.44 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.295 -1.372 . . . . 74.340000000000003 107.295 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.7 113.18 43.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 108.225 -1.028 . . . . 60.399999999999999 108.225 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.449 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.8 p90 -123.41 154.68 38.69 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.186 -0.606 . . . . 73.519999999999996 111.865 -175.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -157.1 165.61 35.58 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.229 -0.896 . . . . 74.140000000000001 109.499 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 65.19 31.7 10.62 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.276 0.985 . . . . 71.510000000000005 111.767 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.449 HD12 ' CD2' ' A' ' 87' ' ' PHE . 47.9 mt -101.58 164.55 11.7 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.273 -0.422 . . . . 44.340000000000003 110.447 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -117.86 178.08 4.54 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.816 0.341 . . . . 42.539999999999999 111.082 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -54.06 -38.87 65.73 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 125.595 1.558 . . . . 64.010000000000005 111.063 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.22 -25.95 62.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.948 -0.569 . . . . 72.209999999999994 111.503 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -89.72 -17.07 29.0 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.299 -0.409 . . . . 74.140000000000001 111.564 -176.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.534 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 43.1 tp -57.84 -48.32 97.36 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 112.771 0.656 . . . . 65.540000000000006 112.771 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 40.2 Cg_exo -63.12 -37.02 54.8 Favored 'Trans proline' 0 C--N 1.367 1.53 0 CA-C-N 120.658 1.271 . . . . 74.109999999999999 110.892 174.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -68.49 -34.8 76.55 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.456 -0.793 . . . . 75.219999999999999 111.507 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -78.36 -19.44 53.39 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.501 -0.555 . . . . 74.129999999999995 109.501 176.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 96' ' ' PRO . . . -70.62 -27.15 63.85 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 115.585 -0.734 . . . . 73.140000000000001 109.933 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -57.1 -57.4 12.72 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.985 0.803 . . . . 73.519999999999996 109.675 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.531 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.6 ttp -53.58 -50.35 65.77 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.352 -0.84 . . . . 74.530000000000001 110.468 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -60.31 -33.0 71.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.227 -0.897 . . . . 73.340000000000003 111.609 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.9 m -63.99 -28.14 69.61 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 121.079 -0.249 . . . . 73.319999999999993 110.945 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.82 -26.18 68.23 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-O 121.424 0.631 . . . . 64.010000000000005 110.582 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.47 -6.64 16.05 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 116.143 -0.481 . . . . 72.450000000000003 110.669 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.52 -41.6 5.44 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.203 -0.599 . . . . 60.119999999999997 112.433 -173.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.56 26.02 68.68 Favored Glycine 0 C--O 1.242 0.638 0 C-N-CA 120.473 -0.87 . . . . 73.340000000000003 110.962 -175.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.56 160.81 9.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 121.056 0.455 . . . . 65.340000000000003 110.238 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -113.14 122.44 47.54 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.94 -1.874 . . . . 71.400000000000006 105.94 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.9 mt -119.68 123.24 43.33 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 117.82 0.282 . . . . 74.200000000000003 111.349 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.8 m -123.46 141.39 52.05 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.475 -0.565 . . . . 64.25 109.475 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.5 tp -134.92 131.85 37.77 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.259 -0.428 . . . . 75.129999999999995 110.426 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -143.03 153.68 43.2 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.406 -0.961 . . . . 71.129999999999995 108.406 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.573 ' NH1' ' HA ' ' A' ' 180' ' ' ASP . 19.8 ttm180 -112.02 132.44 54.8 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 108.763 -0.828 . . . . 75.540000000000006 108.763 171.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -110.06 89.3 2.98 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.104 -1.443 . . . . 72.340000000000003 107.104 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.26 -108.95 2.64 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.326 -1.11 . . . . 64.340000000000003 110.326 -176.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -107.63 -6.31 16.98 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.213 1.006 . . . . 53.539999999999999 109.39 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.6 pp -104.39 143.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 C-N-CA 118.202 -1.399 . . . . 75.25 109.202 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.441 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 72.8 t -105.79 138.76 29.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 O-C-N 122.003 -0.435 . . . . 63.549999999999997 110.287 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.2 pt -121.15 135.92 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-O 121.626 0.726 . . . . 74.219999999999999 109.893 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.3 tt -128.06 125.32 39.07 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 107.475 -1.306 . . . . 73.319999999999993 107.475 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -125.83 121.84 34.43 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.857 -1.534 . . . . 53.520000000000003 106.857 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.99 161.21 27.57 Favored Glycine 0 N--CA 1.407 -3.259 0 C-N-CA 120.719 -0.753 . . . . 60.549999999999997 111.567 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -139.44 138.38 36.41 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.44 -0.948 . . . . 71.129999999999995 108.44 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.23 117.19 33.47 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.532 -0.303 . . . . 64.129999999999995 111.253 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -104.16 97.42 7.38 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.013 -1.106 . . . . 75.120000000000005 108.013 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 3.1 mm? -112.21 12.83 20.42 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.451 -0.574 . . . . 71.319999999999993 109.451 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 p . . . . . 0 C--N 1.309 -1.191 0 N-CA-C 113.431 0.901 . . . . 62.409999999999997 113.431 -175.241 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 120.57 0.224 . . . . 72.140000000000001 111.412 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.52 131.3 44.86 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.164 -0.68 . . . . 73.340000000000003 109.164 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -122.12 118.26 28.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.311 -1.366 . . . . 53.43 107.311 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 53.5 t -109.73 129.92 63.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.344 -0.542 . . . . 71.239999999999995 110.657 -173.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 44.9 mt-10 -134.53 130.71 37.01 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.861 -0.422 . . . . 74.5 109.861 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.464 HD13 ' SD ' ' A' ' 172' ' ' MET . 5.6 tt -120.15 128.98 53.93 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.307 -1.738 . . . . 73.319999999999993 106.307 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 31' ' ' SER . 29.8 m -126.98 131.65 50.99 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.548 -0.538 . . . . 74.140000000000001 109.548 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 80.2 t -121.9 125.87 73.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.513 -0.921 . . . . 73.530000000000001 108.513 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -116.63 128.69 55.61 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 108.637 -0.875 . . . . 75.019999999999996 108.637 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.683 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.12 117.78 13.81 Favored Pre-proline 0 C--N 1.281 -2.379 0 CA-C-N 116.545 -0.298 . . . . 72.109999999999999 111.072 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.8 38.25 0.18 Allowed 'Trans proline' 0 CA--C 1.554 1.521 0 C-N-CA 123.024 2.483 . . . . 70.450000000000003 112.929 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.43 ' HB2' ' HG3' ' A' ' 36' ' ' PRO . . . -122.04 -102.0 0.41 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 110.048 -0.353 . . . . 52.130000000000003 110.048 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.73 128.12 0.08 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.665 -0.865 . . . . 54.219999999999999 108.665 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.49 141.3 15.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.521 -0.918 . . . . 72.310000000000002 108.521 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.3 t -103.54 -32.79 9.28 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 120.205 -0.598 . . . . 75.0 109.643 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 54.9 m -161.12 133.37 5.94 Favored 'General case' 0 C--O 1.202 -1.405 0 N-CA-C 109.598 -0.519 . . . . 73.150000000000006 109.598 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.8 t -138.52 168.78 19.04 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.695 -0.628 . . . . 53.310000000000002 109.599 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -139.76 87.7 2.19 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.065 -2.198 . . . . 51.200000000000003 105.065 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.9 -144.39 5.94 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.264 -1.534 . . . . 52.219999999999999 109.264 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -117.94 99.65 7.05 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.545 -0.909 . . . . 72.329999999999998 108.545 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 34.8 ptt180 -82.42 133.19 35.21 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 119.298 -0.961 . . . . 74.219999999999999 110.986 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.17 -37.74 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.582 -1.266 . . . . 70.349999999999994 107.582 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -139.71 165.04 34.02 Favored Pre-proline 0 N--CA 1.427 -1.582 0 N-CA-C 106.207 -1.775 . . . . 45.509999999999998 106.207 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.78 0.17 6.05 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.5 2.133 . . . . 74.430000000000007 111.366 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.683 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.0 pt-20 -134.41 8.38 3.66 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.819 -0.628 . . . . 74.420000000000002 111.88 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 86.9 t -142.7 121.06 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 109.131 -0.692 . . . . 52.030000000000001 109.131 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 44.9 t -130.58 146.28 34.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 110.167 -0.309 . . . . 44.200000000000003 110.167 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -132.75 152.58 51.72 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 121.12 0.486 . . . . 74.239999999999995 110.359 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.417 ' CE2' ' HG3' ' A' ' 172' ' ' MET . 31.2 m-90 -125.28 119.43 28.4 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.296 -1.002 . . . . 75.230000000000004 108.296 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -98.99 106.5 18.77 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.963 0.887 . . . . 62.229999999999997 110.075 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 76.9 mt -101.44 135.51 42.82 Favored 'General case' 0 C--O 1.264 1.826 0 CA-C-N 114.907 -1.042 . . . . 74.310000000000002 111.216 -173.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 10.7 mmpt? -115.12 150.61 44.58 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 114.143 -1.39 . . . . 74.420000000000002 109.189 -175.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 11.3 Cg_exo -73.6 156.78 49.22 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.61 2.207 . . . . 54.0 111.283 176.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.79 -24.83 3.13 Favored Glycine 0 C--N 1.314 -0.688 0 O-C-N 122.318 -0.239 . . . . 74.230000000000004 112.665 176.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 31.7 m -106.05 160.83 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.264 0.554 . . . . 75.140000000000001 112.096 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.73 144.14 21.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.764 -1.198 . . . . 71.420000000000002 107.764 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 32.8 t -148.6 152.71 37.23 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.991 -0.374 . . . . 71.420000000000002 109.991 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.1 p -96.03 154.78 17.05 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.893 -0.594 . . . . 61.25 109.547 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.464 ' SD ' HD13 ' A' ' 139' ' ' LEU . 37.4 ttp -144.1 116.27 8.44 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.396 0.617 . . . . 71.329999999999998 109.408 -176.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.4 m -134.61 141.7 46.69 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.188 -0.605 . . . . 73.439999999999998 109.58 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -146.66 116.25 7.14 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.114 -1.069 . . . . 52.439999999999998 108.114 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -124.13 129.88 51.59 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.438 -1.319 . . . . 63.450000000000003 107.438 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.98 155.66 38.46 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.139 -0.689 . . . . 54.420000000000002 109.139 -175.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 16.5 ptm180 -91.85 132.75 36.23 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 120.624 -0.431 . . . . 72.310000000000002 111.078 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.441 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 63.5 m-85 -140.52 129.76 23.69 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 109.091 -0.707 . . . . 74.439999999999998 109.091 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.5 110.8 0.38 Allowed 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 125.211 1.404 . . . . 62.229999999999997 111.982 -178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.573 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 35.9 t70 . . . . . 0 C--N 1.311 -1.089 0 CA-C-N 114.692 -1.14 . . . . 74.140000000000001 110.419 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 52.4 ttt180 . . . . . 0 N--CA 1.423 -1.811 0 N-CA-C 109.254 -0.647 . . . . 73.540000000000006 109.254 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.08 114.08 44.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 106.669 -1.604 . . . . 64.239999999999995 106.669 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.91 113.3 18.92 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.36 -1.348 . . . . 63.509999999999998 107.36 -175.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.62 136.86 52.58 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.811 -0.631 . . . . 71.109999999999999 109.905 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -138.03 115.24 11.0 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.112 -0.699 . . . . 70.340000000000003 109.112 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 14.5 pt -126.55 149.14 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 121.25 0.548 . . . . 74.310000000000002 111.038 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 69.7 m -126.51 123.68 38.33 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 108.439 -0.948 . . . . 72.319999999999993 108.439 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 tt -113.49 125.02 70.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.478 0.656 . . . . 73.549999999999997 110.642 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 43.8 t -88.74 150.96 46.99 Favored Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 115.114 -0.948 . . . . 72.230000000000004 109.243 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 35' ' ' SER . 16.8 Cg_exo -68.92 2.78 2.79 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 123.436 2.757 . . . . 71.319999999999993 111.894 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -89.08 4.53 48.1 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.058 -0.719 . . . . 75.439999999999998 109.058 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 t70 71.5 29.44 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.124 1.44 . . . . 34.25 107.144 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.42 124.93 51.83 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 113.882 -1.508 . . . . 61.310000000000002 107.938 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.479 HG11 HD13 ' A' ' 95' ' ' LEU . 20.7 t -111.58 138.81 38.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.765 -0.828 . . . . 43.229999999999997 108.765 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 p -149.64 157.92 43.69 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.626 -0.879 . . . . 64.409999999999997 108.626 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 159.28 -165.08 34.21 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 119.516 -1.326 . . . . 72.109999999999999 112.432 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.2 141.97 21.04 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.207 0.527 . . . . 74.420000000000002 110.265 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.8 mt -124.31 117.01 49.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.99 -1.115 . . . . 73.200000000000003 107.99 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.13 116.05 51.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.327 -0.62 . . . . 75.010000000000005 109.327 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.5 107.77 18.95 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.946 -1.501 . . . . 62.420000000000002 106.946 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.49 127.72 49.93 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.249 0.547 . . . . 63.340000000000003 109.884 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.82 153.02 29.83 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 109.269 -0.641 . . . . 60.229999999999997 109.269 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.3 tttt . . . . . 0 C--N 1.287 -2.139 0 N-CA-C 105.837 -1.912 . . . . 73.239999999999995 105.837 175.238 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 108.286 -1.005 . . . . 70.049999999999997 108.286 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 173.1 104.76 0.18 Allowed Glycine 0 N--CA 1.417 -2.578 0 CA-C-O 118.472 -1.182 . . . . 74.129999999999995 111.163 176.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -52.45 132.78 46.42 Favored 'Trans proline' 0 C--O 1.243 0.771 0 CA-C-N 119.914 1.857 . . . . 74.25 110.772 173.084 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.97 155.83 39.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.055 -0.52 . . . . 60.409999999999997 111.718 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.6 tp -103.0 160.14 14.89 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.243 -1.021 . . . . 73.420000000000002 108.243 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -111.05 95.3 5.45 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.505 -0.924 . . . . 75.439999999999998 108.505 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -105.3 -106.3 3.11 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 120.726 -0.75 . . . . 64.219999999999999 112.136 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.0 t70 60.98 91.99 0.05 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 125.062 1.345 . . . . 61.219999999999999 112.028 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.68 157.72 77.24 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 114.393 -1.276 . . . . 72.439999999999998 108.136 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.82 -18.55 61.45 Favored 'Trans proline' 0 N--CA 1.479 0.634 0 C-N-CA 122.669 2.246 . . . . 70.530000000000001 112.326 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.464 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 42.1 p90 -111.16 32.35 5.38 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.559 -0.746 . . . . 73.219999999999999 112.114 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.5 m -55.92 -33.02 64.31 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 112.052 0.39 . . . . 60.409999999999997 112.052 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.39 -11.07 60.51 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.034 -0.416 . . . . 62.25 111.586 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HE3' HD23 ' A' ' 90' ' ' LEU . 24.3 mtpp -105.49 -4.45 21.27 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 109.905 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 87' ' ' PHE . 4.6 p -125.98 119.03 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 122.179 0.99 . . . . 71.120000000000005 110.377 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.02 102.37 15.02 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.593 -0.73 . . . . 52.219999999999999 109.755 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 7.4 p -98.22 128.84 49.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.734 -0.839 . . . . 70.209999999999994 108.734 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.9 m -146.48 171.8 14.5 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 116.079 -0.509 . . . . 54.149999999999999 110.297 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.465 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 7.3 t30 -82.89 139.1 33.62 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.37 -0.604 . . . . 75.349999999999994 109.37 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -110.51 123.15 49.39 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.734 -0.839 . . . . 72.299999999999997 108.734 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -138.34 99.97 3.99 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.889 -1.523 . . . . 75.519999999999996 106.889 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.4 t -172.68 154.2 2.96 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.98 -0.378 . . . . 73.019999999999996 109.98 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 70.78 7.65 6.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.282 1.033 . . . . 63.329999999999998 111.632 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.65 -9.15 64.23 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.073 -0.811 . . . . 72.530000000000001 111.073 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -104.66 149.71 25.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.048 0.451 . . . . 72.530000000000001 110.692 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.83 137.74 56.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 109.082 -0.71 . . . . 74.540000000000006 109.082 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.43 -153.81 11.04 Favored Glycine 0 C--N 1.285 -2.305 0 C-N-CA 120.209 -0.996 . . . . 74.409999999999997 111.719 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 p -126.77 149.03 49.86 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 121.268 0.556 . . . . 53.240000000000002 110.848 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 9.3 pt20 -132.44 142.37 49.23 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.489 -0.323 . . . . 71.340000000000003 110.5 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.44 114.41 22.84 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.02 -1.104 . . . . 52.219999999999999 108.02 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.19 111.92 38.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.41 -0.959 . . . . 75.340000000000003 108.41 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.45 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.7 p90 -118.47 162.41 18.38 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 112.516 0.561 . . . . 74.540000000000006 112.516 -172.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 p -164.24 160.29 20.98 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.474 -0.785 . . . . 72.319999999999993 110.345 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.0 t70 65.65 30.99 10.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 124.366 1.041 . . . . 73.010000000000005 110.699 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.507 HD23 ' HE3' ' A' ' 69' ' ' LYS . 55.8 mt -95.69 159.69 14.86 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 121.662 -0.649 . . . . 70.329999999999998 110.636 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.415 HG22 ' OE1' ' A' ' 94' ' ' GLU . 8.9 t -106.09 171.41 7.36 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.526 -0.546 . . . . 62.509999999999998 109.526 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -52.49 -40.02 61.89 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.638 0.775 . . . . 75.319999999999993 111.313 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.39 -24.9 65.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.752 -0.658 . . . . 52.219999999999999 111.92 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.415 ' OE1' HG22 ' A' ' 91' ' ' THR . 54.4 mt-10 -87.53 -16.83 33.54 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.461 -0.336 . . . . 74.140000000000001 111.634 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.596 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 49.2 tp -61.67 -51.4 76.72 Favored Pre-proline 0 CA--C 1.562 1.422 0 N-CA-C 113.174 0.805 . . . . 71.140000000000001 113.174 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.453 ' HD3' HD23 ' A' ' 112' ' ' LEU . 33.3 Cg_endo -70.32 -29.08 21.74 Favored 'Trans proline' 0 C--N 1.361 1.213 0 CA-C-N 120.887 1.353 . . . . 74.409999999999997 110.132 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -67.95 -35.52 78.55 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.404 -0.816 . . . . 62.149999999999999 110.438 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -75.62 -19.29 59.31 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 109.783 -0.451 . . . . 75.129999999999995 109.783 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.01 -20.89 63.25 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.171 -0.468 . . . . 75.109999999999999 110.159 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -58.4 -57.14 14.23 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.234 -0.654 . . . . 72.409999999999997 109.234 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.4 ttp -53.79 -51.25 64.06 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 115.633 -0.712 . . . . 74.430000000000007 110.162 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -55.67 -41.51 73.77 Favored 'General case' 0 C--O 1.251 1.178 0 CA-C-N 114.954 -1.021 . . . . 65.25 111.272 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.3 p -65.9 -25.27 67.08 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.187 -0.605 . . . . 75.25 111.675 -171.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.74 -26.59 68.72 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 121.228 0.537 . . . . 72.129999999999995 110.518 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.37 -12.58 15.3 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 120.235 -0.586 . . . . 45.030000000000001 111.185 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.0 -29.16 9.59 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 114.295 1.22 . . . . 75.400000000000006 114.295 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.61 20.88 76.02 Favored Glycine 0 C--O 1.243 0.686 0 C-N-CA 120.535 -0.841 . . . . 24.440000000000001 111.491 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 125' ' ' ALA . 34.7 m -96.68 156.41 3.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.153 -0.523 . . . . 53.329999999999998 111.547 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -132.1 122.19 25.0 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.253 -1.388 . . . . 62.200000000000003 107.253 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.08 123.36 40.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.064 0.393 . . . . 74.5 111.952 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.9 t -104.53 125.01 50.29 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 107.183 -1.414 . . . . 63.450000000000003 107.183 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.59 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 48.7 tp -128.72 123.08 32.14 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.162 -0.681 . . . . 75.420000000000002 109.162 -178.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.59 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 3.2 mpt_? -135.7 146.5 47.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.853 -0.425 . . . . 64.540000000000006 109.853 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.63 ' HG3' HG22 ' A' ' 119' ' ' VAL . 3.3 ttt180 -99.39 138.11 36.95 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 108.057 -1.09 . . . . 73.299999999999997 108.057 174.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -123.8 83.74 2.18 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.96 -1.496 . . . . 64.319999999999993 106.96 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.75 -122.61 22.69 Favored Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 114.137 -1.392 . . . . 54.200000000000003 110.97 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -75.74 -20.53 58.24 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 123.932 0.893 . . . . 72.140000000000001 110.617 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.531 HG22 ' HG2' ' A' ' 177' ' ' ARG . 0.8 OUTLIER -102.58 149.08 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 119.287 -0.965 . . . . 62.100000000000001 110.403 -172.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.63 HG22 ' HG3' ' A' ' 114' ' ' ARG . 59.4 t -117.73 139.81 43.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.784 -0.45 . . . . 74.030000000000001 109.784 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.3 pt -126.03 135.18 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 CA-C-O 121.709 0.766 . . . . 73.340000000000003 110.584 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.29 128.88 47.83 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 107.363 -1.347 . . . . 74.140000000000001 107.363 174.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.79 114.59 12.78 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 105.783 -1.932 . . . . 70.430000000000007 105.783 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.08 160.52 27.16 Favored Glycine 0 N--CA 1.41 -3.083 0 N-CA-C 110.925 -0.87 . . . . 55.350000000000001 110.925 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.469 ' HG2' HG22 ' A' ' 171' ' ' THR . 64.3 mtt180 -141.01 150.47 43.07 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.59 -1.263 . . . . 73.209999999999994 107.59 -176.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 108' ' ' VAL . . . -121.41 128.83 52.59 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.957 -0.386 . . . . 70.349999999999994 109.957 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -111.83 93.56 4.52 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 118.716 -1.194 . . . . 70.209999999999994 109.991 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.9 pt? -123.26 15.52 9.78 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 113.926 -1.488 . . . . 71.420000000000002 107.482 176.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.43 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.423 -1.779 0 CA-C-N 113.409 -1.723 . . . . 73.219999999999999 109.01 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t0 . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 121.545 0.688 . . . . 73.019999999999996 110.33 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.01 145.23 55.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 70.430000000000007 111.921 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 26.8 t70 -132.34 118.05 18.93 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.852 -0.613 . . . . 62.310000000000002 109.972 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 97.6 t -116.57 133.96 61.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.004 -1.11 . . . . 54.530000000000001 108.004 175.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -138.9 138.96 37.88 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.47 -0.567 . . . . 71.530000000000001 109.47 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 tt -133.42 128.23 35.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.061 -1.459 . . . . 72.129999999999995 107.061 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.0 m -126.21 134.21 51.3 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.694 -0.854 . . . . 71.140000000000001 108.694 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 57.6 t -129.02 125.22 62.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.636 -0.505 . . . . 74.129999999999995 109.636 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.08 128.39 56.48 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.008 -0.738 . . . . 75.409999999999997 109.008 177.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 3.4 p90 -134.46 129.67 19.69 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 112.917 0.71 . . . . 73.340000000000003 112.917 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 20.9 Cg_exo -71.86 49.47 1.25 Allowed 'Trans proline' 0 CA--C 1.551 1.363 0 C-N-CA 123.317 2.678 . . . . 74.140000000000001 111.286 172.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.69 -133.78 0.13 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.241 -1.392 . . . . 73.340000000000003 107.241 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -161.88 135.13 6.24 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.027 -1.472 . . . . 51.329999999999998 107.027 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.18 127.65 41.75 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.117 0.484 . . . . 64.319999999999993 110.356 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.4 t -88.08 -37.53 16.18 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.883 -0.414 . . . . 74.219999999999999 109.883 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.1 m -152.6 133.27 13.9 Favored 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 109.561 -0.533 . . . . 74.329999999999998 109.561 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -139.36 161.93 36.24 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 121.95 -0.469 . . . . 72.439999999999998 109.79 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.61 91.18 2.96 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 104.47 -2.418 . . . . 75.099999999999994 104.47 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.8 -147.47 8.76 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 109.296 -1.522 . . . . 23.420000000000002 109.296 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -119.66 99.82 6.89 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.62 -0.881 . . . . 74.239999999999995 108.62 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 12.4 ptt180 -82.11 129.49 34.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 119.513 -0.875 . . . . 73.340000000000003 111.981 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.9 mt -83.71 -42.36 17.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.351 -1.351 . . . . 73.140000000000001 107.351 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -138.71 167.2 20.37 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 106.646 -1.613 . . . . 74.140000000000001 106.646 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.54 0.14 8.51 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.095 1.864 . . . . 74.450000000000003 111.504 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -128.4 3.91 5.67 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.337 0.589 . . . . 71.140000000000001 111.008 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 65.8 t -145.13 120.59 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.377 -0.971 . . . . 74.349999999999994 108.377 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 40.9 t -123.94 149.83 28.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.432 -0.581 . . . . 74.140000000000001 109.432 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -136.23 143.64 44.44 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 109.131 -0.692 . . . . 65.25 109.131 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -122.17 130.27 53.06 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 109.65 -0.5 . . . . 71.099999999999994 109.65 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.37 111.64 24.07 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.433 -0.951 . . . . 40.399999999999999 108.433 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.7 mm? -94.81 122.33 37.32 Favored 'General case' 0 C--O 1.276 2.461 0 CA-C-N 114.726 -1.125 . . . . 54.530000000000001 107.966 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -117.08 130.94 24.25 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 114.637 -1.165 . . . . 73.329999999999998 110.293 -170.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.404 ' HA ' ' HG ' ' A' ' 127' ' ' LEU . 42.4 Cg_endo -67.57 155.37 70.46 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.328 2.685 . . . . 75.230000000000004 112.576 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 73.01 -14.6 2.72 Favored Glycine 0 N--CA 1.466 0.652 0 CA-C-N 115.805 -0.634 . . . . 64.040000000000006 113.796 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.9 m -120.81 162.83 19.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.447 -0.946 . . . . 70.329999999999998 108.447 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.1 p -99.25 128.3 51.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.32 0.581 . . . . 60.32 110.353 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.3 m -116.8 137.73 52.0 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.127 -1.064 . . . . 54.399999999999999 108.127 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 124' ' ' ARG . 20.6 p -116.09 148.03 40.68 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 110.086 -0.338 . . . . 72.129999999999995 110.086 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.432 ' SD ' HD11 ' A' ' 164' ' ' LEU . 2.7 mpp? -126.83 116.84 21.5 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.147 -0.686 . . . . 72.010000000000005 109.147 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.0 t -132.42 138.25 47.58 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.953 -1.128 . . . . 70.109999999999999 107.953 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -145.56 120.66 10.1 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.243 -1.021 . . . . 62.409999999999997 108.243 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -125.17 130.19 51.65 Favored 'General case' 0 C--N 1.272 -2.798 0 N-CA-C 107.204 -1.406 . . . . 62.450000000000003 107.204 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -155.89 153.92 30.42 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.85 -0.796 . . . . 62.439999999999998 108.85 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.531 ' HG2' HG22 ' A' ' 118' ' ' ILE . 60.1 mtt180 -88.19 132.52 34.32 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.94 -0.763 . . . . 61.399999999999999 108.94 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -135.87 129.85 32.96 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 109.282 -0.636 . . . . 74.530000000000001 109.282 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.78 104.21 0.14 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.943 0.777 . . . . 70.099999999999994 111.91 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 CA--C 1.503 -0.842 0 CA-C-N 114.879 -1.055 . . . . 65.450000000000003 109.238 178.728 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.927 0 N-CA-C 107.42 -1.326 . . . . 63.0 107.42 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.75 122.77 47.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 C-N-CA 119.546 -0.862 . . . . 75.219999999999999 112.058 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -110.22 134.82 51.85 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.336 -0.987 . . . . 71.140000000000001 108.336 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.25 108.8 12.1 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.565 -0.902 . . . . 63.310000000000002 108.565 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 p -116.7 115.05 24.92 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.295 -1.002 . . . . 62.109999999999999 108.295 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.83 146.63 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 121.154 0.502 . . . . 71.120000000000005 109.813 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 87.4 m -126.31 127.8 46.12 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 109.678 -0.49 . . . . 75.109999999999999 109.678 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -110.47 118.26 56.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.61 -0.723 . . . . 72.310000000000002 109.852 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.2 m -84.71 155.16 62.0 Favored Pre-proline 0 C--N 1.296 -1.741 0 CA-C-N 115.446 -0.797 . . . . 75.209999999999994 109.683 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.63 0.68 4.51 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 123.225 2.616 . . . . 64.019999999999996 112.142 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.58 0.32 43.34 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 124.348 1.059 . . . . 53.119999999999997 109.831 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.9 t70 70.27 29.71 3.57 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 123.29 1.519 . . . . 74.049999999999997 107.073 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.75 138.86 52.38 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 113.02 -1.9 . . . . 74.219999999999999 107.959 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.645 HG11 HD23 ' A' ' 95' ' ' LEU . 22.7 t -120.32 140.26 44.98 Favored 'Isoleucine or valine' 0 C--O 1.259 1.564 0 CA-C-O 121.052 0.453 . . . . 63.219999999999999 109.977 -176.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.1 p -147.33 142.88 27.58 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.629 -0.878 . . . . 52.340000000000003 108.629 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.86 -169.06 40.33 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 119.33 -1.414 . . . . 71.430000000000007 112.677 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -151.11 133.8 15.66 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.125 0.488 . . . . 71.349999999999994 110.661 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -116.72 116.17 51.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.456 -1.313 . . . . 74.219999999999999 107.456 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.04 114.84 47.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.763 -0.458 . . . . 70.430000000000007 109.763 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.61 108.68 20.07 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.364 -1.347 . . . . 61.340000000000003 107.364 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.62 119.36 32.64 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.7 0.762 . . . . 74.439999999999998 110.244 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.68 145.64 37.63 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.649 -0.705 . . . . 65.400000000000006 110.164 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.0 tttt . . . . . 0 N--CA 1.42 -1.948 0 N-CA-C 102.999 -2.963 . . . . 71.409999999999997 102.999 171.667 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.415 -2.197 0 N-CA-C 109.818 -0.438 . . . . 71.099999999999994 109.818 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.14 97.69 0.11 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 119.908 -1.139 . . . . 43.240000000000002 112.936 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.68 153.3 26.27 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 123.216 2.611 . . . . 44.43 111.461 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -113.38 157.28 22.08 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.598 -0.519 . . . . 54.409999999999997 109.598 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.467 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 65.1 mt -88.81 135.76 33.36 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.857 -0.423 . . . . 42.240000000000002 109.857 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.53 87.41 3.82 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.852 -0.613 . . . . 73.230000000000004 110.059 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.488 ' HA3' ' HG3' ' A' ' 101' ' ' MET . . . -161.82 156.6 28.18 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 110.885 -0.886 . . . . 71.439999999999998 110.885 176.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -144.22 129.08 18.39 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.102 -0.703 . . . . 61.340000000000003 109.102 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.06 147.56 61.21 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.458 -0.571 . . . . 72.430000000000007 109.458 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.15 -8.99 21.88 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.203 2.602 . . . . 70.420000000000002 113.215 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -110.45 42.23 1.61 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.428 0.632 . . . . 65.319999999999993 110.286 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 m -57.97 -34.6 70.12 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.605 -0.725 . . . . 63.520000000000003 110.945 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -71.27 -9.16 57.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.266 0.555 . . . . 62.030000000000001 110.851 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.28 -17.29 17.37 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.793 -0.639 . . . . 74.340000000000003 110.019 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 p -130.39 118.1 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.912 0.863 . . . . 75.140000000000001 111.015 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.89 112.41 24.18 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.035 -0.984 . . . . 75.019999999999996 109.151 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.0 t -98.16 130.52 46.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 106.949 -1.501 . . . . 64.310000000000002 106.949 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.9 t -144.04 172.7 12.52 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.112 0.482 . . . . 65.140000000000001 110.792 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -80.19 141.74 35.36 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 124.874 1.27 . . . . 64.310000000000002 109.323 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -119.76 120.14 35.69 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.635 -0.876 . . . . 72.519999999999996 108.635 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -138.7 103.99 4.98 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.655 -0.868 . . . . 75.010000000000005 108.655 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.2 t -164.75 142.25 6.35 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.705 -0.398 . . . . 73.040000000000006 110.692 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 65.24 13.54 8.83 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.391 1.476 . . . . 70.420000000000002 112.223 174.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.41 -3.11 59.47 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.865 -0.683 . . . . 72.299999999999997 111.908 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -99.84 148.04 24.86 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.856 -0.794 . . . . 75.530000000000001 108.856 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.23 136.76 59.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.328 -0.99 . . . . 75.420000000000002 108.328 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -166.03 -154.69 8.34 Favored Glycine 0 N--CA 1.413 -2.834 0 C-N-CA 120.112 -1.042 . . . . 70.409999999999997 112.478 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.467 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 6.7 m -126.08 148.37 49.37 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.888 -0.782 . . . . 64.019999999999996 108.888 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -129.81 132.14 46.4 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 120.556 -0.457 . . . . 73.319999999999993 110.363 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.78 113.92 26.88 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.702 -1.592 . . . . 73.420000000000002 106.702 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.68 112.36 39.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.732 -0.84 . . . . 72.340000000000003 108.732 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.484 ' HE2' HG12 ' A' ' 40' ' ' VAL . 45.3 p90 -120.02 152.8 36.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.292 0.567 . . . . 61.100000000000001 111.633 -173.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.6 p -159.73 157.38 29.35 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.276 -0.874 . . . . 72.329999999999998 109.727 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 67.28 31.69 6.41 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.592 1.157 . . . . 53.340000000000003 110.295 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.459 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.1 mt -96.23 164.44 12.67 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.813 -0.631 . . . . 65.150000000000006 110.091 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m -107.79 160.22 15.89 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 109.392 -0.596 . . . . 64.209999999999994 109.392 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -49.91 -43.15 49.44 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.192 1.397 . . . . 74.129999999999995 110.628 176.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.39 -30.45 71.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.865 -0.607 . . . . 65.310000000000002 111.441 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -82.91 -15.44 51.39 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.792 -0.64 . . . . 74.239999999999995 111.589 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.645 HD23 HG11 ' A' ' 40' ' ' VAL . 2.5 tm? -54.03 -56.2 28.35 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 123.056 0.542 . . . . 75.019999999999996 111.269 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.78 -36.13 75.37 Favored 'Trans proline' 0 C--N 1.371 1.723 0 CA-C-N 120.61 1.254 . . . . 61.409999999999997 111.072 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.433 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 70.7 mt-30 -62.8 -37.41 86.59 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.691 -0.686 . . . . 72.239999999999995 111.818 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -75.54 -20.41 58.7 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.184 0.516 . . . . 61.100000000000001 110.045 177.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.49 -20.21 57.2 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.717 -0.674 . . . . 45.140000000000001 109.537 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 97' ' ' GLN . 87.7 m-20 -62.77 -55.06 29.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.85 -0.613 . . . . 75.340000000000003 110.114 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.488 ' HG3' ' HA3' ' A' ' 62' ' ' GLY . 24.3 ttp -53.97 -51.27 64.41 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.167 0.292 . . . . 72.409999999999997 110.72 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.66 -35.27 72.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.846 -0.615 . . . . 73.439999999999998 110.429 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.4 t -59.86 -39.86 86.65 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.015 -0.735 . . . . 71.310000000000002 109.015 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -63.22 -25.24 68.24 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 115.339 -0.846 . . . . 72.340000000000003 110.943 -172.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.11 -20.09 13.52 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 119.949 -0.7 . . . . 65.219999999999999 111.591 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.19 -42.1 5.17 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 114.237 1.199 . . . . 74.109999999999999 114.237 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.97 25.76 18.81 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.635 -0.986 . . . . 52.43 110.635 -172.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.2 m -109.34 157.26 9.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.68 -0.489 . . . . 73.239999999999995 109.68 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -142.66 128.26 19.13 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.803 -0.814 . . . . 74.510000000000005 108.803 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -130.03 128.98 43.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.581 0.229 . . . . 63.009999999999998 110.664 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.8 m -118.05 134.19 55.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.301 -1.0 . . . . 74.040000000000006 108.301 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.469 HD22 ' HG ' ' A' ' 95' ' ' LEU . 53.2 tp -133.13 123.4 25.61 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.188 -0.671 . . . . 52.210000000000001 109.188 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.3 mtp180 -134.23 153.02 52.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.155 0.502 . . . . 74.019999999999996 111.703 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.502 HH11 ' HB2' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -106.4 122.11 45.61 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 124.33 1.052 . . . . 71.019999999999996 108.935 179.113 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.421 ' O ' HG13 ' A' ' 118' ' ' ILE . 6.8 t30 -118.14 101.23 8.07 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.779 -1.193 . . . . 64.219999999999999 107.779 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.34 -120.06 7.52 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 108.441 -1.864 . . . . 72.439999999999998 108.441 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.28 -2.07 22.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.718 -1.216 . . . . 43.420000000000002 107.718 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -100.28 148.96 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 C-N-CA 119.37 -0.932 . . . . 63.109999999999999 109.068 -175.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.71 140.5 40.57 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-O 120.793 0.33 . . . . 73.409999999999997 111.18 -175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.3 pt -119.79 135.37 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.624 -0.717 . . . . 73.209999999999994 109.36 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.79 127.07 45.57 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.542 -0.754 . . . . 74.019999999999996 109.39 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.29 122.24 31.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.202 -0.908 . . . . 74.549999999999997 108.95 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -136.35 146.65 18.63 Favored Glycine 0 N--CA 1.422 -2.277 0 N-CA-C 110.573 -1.011 . . . . 73.219999999999999 110.573 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -139.55 144.58 37.89 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.174 -0.676 . . . . 75.310000000000002 109.174 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.48 118.82 22.72 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.046 -0.724 . . . . 73.439999999999998 109.046 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -102.35 94.04 5.49 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.768 -0.773 . . . . 62.329999999999998 111.421 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.71 16.87 13.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.984 -1.487 . . . . 72.109999999999999 106.984 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.492 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 1.3 m . . . . . 0 C--N 1.319 -0.745 0 C-N-CA 125.778 1.631 . . . . 52.130000000000003 112.733 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.614 0.721 . . . . 74.239999999999995 109.835 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.45 129.49 38.92 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.741 -0.663 . . . . 75.439999999999998 110.754 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -131.73 111.65 11.84 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.695 -1.224 . . . . 73.329999999999998 107.695 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.717 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 49.2 t -111.94 127.66 68.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.956 -0.757 . . . . 62.219999999999999 108.956 -177.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -112.07 121.25 44.47 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.337 -0.616 . . . . 75.439999999999998 109.337 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.441 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.3 tm? -115.29 116.31 28.09 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.593 -1.262 . . . . 75.439999999999998 107.593 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.6 m -126.44 130.77 51.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 110.133 -0.321 . . . . 61.229999999999997 110.133 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.5 t -123.65 125.77 71.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.464 -0.569 . . . . 74.030000000000001 109.464 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.3 131.16 56.62 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.028 -0.73 . . . . 73.420000000000002 109.028 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.689 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.3 p90 -134.31 122.93 16.29 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.406 -0.361 . . . . 71.239999999999995 110.918 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -69.02 47.4 0.44 Allowed 'Trans proline' 0 CA--C 1.56 1.819 0 C-N-CA 123.008 2.472 . . . . 71.019999999999996 112.297 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -132.86 -108.13 0.24 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 122.823 0.449 . . . . 64.140000000000001 110.538 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.21 131.19 0.14 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.722 -0.844 . . . . 75.430000000000007 108.722 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.412 HG21 ' HB ' ' A' ' 150' ' ' THR . 8.4 p -85.09 128.73 38.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.14 -0.689 . . . . 73.239999999999995 109.14 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.0 t -88.62 -36.04 16.5 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.246 -0.434 . . . . 62.420000000000002 110.012 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.5 m -157.71 133.03 8.9 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 108.938 -0.764 . . . . 52.399999999999999 108.938 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.412 ' HB ' HG21 ' A' ' 147' ' ' VAL . 9.9 t -138.92 165.39 27.19 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 121.98 -0.45 . . . . 73.329999999999998 109.824 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 45.4 t30 -137.05 93.43 2.83 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 105.585 -2.006 . . . . 65.25 105.585 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.81 -147.0 10.45 Favored Glycine 0 N--CA 1.416 -2.67 0 N-CA-C 109.045 -1.622 . . . . 41.229999999999997 109.045 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -111.79 100.06 8.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.251 -0.648 . . . . 55.130000000000003 109.251 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -78.28 115.75 18.22 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.965 0.412 . . . . 71.439999999999998 110.684 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.0 mt -82.21 -48.99 17.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.217 -1.401 . . . . 73.239999999999995 107.217 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -130.92 159.74 70.0 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.095 -1.446 . . . . 74.319999999999993 107.095 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.404 ' O ' HG12 ' A' ' 147' ' ' VAL . 32.4 Cg_exo -62.74 -13.49 34.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.375 2.05 . . . . 54.229999999999997 112.187 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.689 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -122.39 8.0 9.62 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 112.816 0.673 . . . . 65.319999999999993 112.816 176.406 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.8 t -140.73 120.93 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 109.61 -0.515 . . . . 63.25 109.61 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.28 147.58 31.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.707 -0.479 . . . . 74.209999999999994 109.707 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -132.47 149.8 52.27 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.097 0.475 . . . . 55.100000000000001 109.898 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.462 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 23.8 m-90 -131.65 133.27 44.73 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.323 -1.362 . . . . 73.239999999999995 107.323 174.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -107.09 114.74 28.99 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.974 -0.75 . . . . 74.109999999999999 108.974 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.717 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.6 mp -88.9 125.57 35.0 Favored 'General case' 0 C--O 1.273 2.309 0 CA-C-N 114.212 -1.358 . . . . 75.340000000000003 110.572 -173.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 96.2 mttt -118.59 147.15 41.42 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 113.304 -1.771 . . . . 71.030000000000001 110.771 -171.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 165' ' ' LYS . 2.7 Cg_exo -76.39 159.31 36.39 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.437 2.091 . . . . 71.310000000000002 112.356 174.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 74.06 -14.72 3.62 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 123.136 0.398 . . . . 64.230000000000004 113.822 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.33 145.43 26.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.229 -1.026 . . . . 61.130000000000003 108.229 171.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.4 110.06 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 108.42 -0.956 . . . . 60.020000000000003 108.42 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.6 m -76.84 130.7 37.98 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.375 -0.83 . . . . 62.340000000000003 108.93 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.6 p -115.84 125.73 53.04 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.623 -0.717 . . . . 72.239999999999995 110.129 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -112.33 117.07 31.46 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.989 -1.115 . . . . 71.540000000000006 107.989 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 13.7 m -135.48 137.05 41.76 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.426 -1.31 . . . . 70.409999999999997 110.411 176.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -149.43 135.25 18.74 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.566 -0.901 . . . . 61.43 108.566 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -131.38 130.01 42.06 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 107.127 -1.435 . . . . 64.329999999999998 107.127 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -153.57 159.82 42.29 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.622 -0.881 . . . . 62.530000000000001 108.622 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 40.0 mtt180 -95.32 127.18 41.16 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.388 -0.925 . . . . 64.409999999999997 108.946 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -130.37 127.86 40.24 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.164 -1.05 . . . . 74.219999999999999 108.164 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.29 104.74 0.1 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 124.83 1.331 . . . . 64.150000000000006 112.675 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 N--CA 1.482 1.127 0 CA-C-N 114.684 -1.144 . . . . 64.5 111.728 -177.325 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 . . . . . 0 N--CA 1.416 -2.169 0 N-CA-C 108.0 -1.111 . . . . 62.350000000000001 108.0 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.9 t -107.26 114.72 46.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.398 -0.964 . . . . 63.530000000000001 108.398 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -112.25 113.15 25.23 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.422 -0.955 . . . . 64.409999999999997 108.422 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.16 108.63 14.02 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.052 -1.092 . . . . 52.530000000000001 108.052 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 140' ' ' THR . 20.2 m -122.11 114.32 20.74 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.125 -0.694 . . . . 72.129999999999995 109.125 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.5 pt -126.61 148.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 O-C-N 121.891 -0.506 . . . . 75.530000000000001 109.84 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.2 m -127.92 119.93 26.6 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 116.089 -0.505 . . . . 73.319999999999993 109.783 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.598 HG23 ' OH ' ' A' ' 178' ' ' TYR . 8.7 tt -104.41 125.62 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 108.64 -0.874 . . . . 72.230000000000004 108.64 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.7 m -94.66 152.65 40.02 Favored Pre-proline 0 C--N 1.281 -2.383 0 CA-C-N 115.754 -0.657 . . . . 42.119999999999997 109.557 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.93 2.56 0.57 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 123.934 3.089 . . . . 61.240000000000002 113.475 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 33.5 t70 -82.0 -7.55 59.62 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.425 1.09 . . . . 71.430000000000007 109.582 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 73.16 28.69 1.83 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 123.374 1.559 . . . . 72.219999999999999 107.269 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -111.34 132.16 54.61 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.296 -1.774 . . . . 75.409999999999997 109.148 178.513 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.95 143.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.116 -0.698 . . . . 73.430000000000007 109.116 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 p -149.69 155.24 39.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.052 -1.462 . . . . 61.140000000000001 107.052 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.84 -174.59 44.06 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 118.287 -1.911 . . . . 73.5 114.343 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.38 133.26 36.57 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 124.327 1.051 . . . . 73.329999999999998 108.721 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.9 mt -119.89 115.54 47.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 105.663 -1.977 . . . . 73.120000000000005 105.663 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.8 mt -126.45 114.74 39.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 109.671 -0.492 . . . . 73.400000000000006 109.671 -172.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.526 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.02 109.27 19.3 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.391 -1.337 . . . . 74.120000000000005 107.391 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -119.69 126.47 51.19 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.453 -0.499 . . . . 65.340000000000003 111.53 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.9 157.35 27.83 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.531 -0.759 . . . . 60.439999999999998 109.316 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 C--N 1.288 -2.095 0 N-CA-C 106.999 -1.482 . . . . 74.510000000000005 106.999 172.182 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.435 -1.189 0 N-CA-C 112.94 0.719 . . . . 52.020000000000003 112.94 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.61 98.03 0.11 Allowed Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 120.196 -1.002 . . . . 54.450000000000003 112.148 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 83' ' ' SER . 67.9 Cg_exo -54.87 159.19 9.65 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.802 2.335 . . . . 75.430000000000007 111.368 173.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.99 157.11 21.1 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.923 -0.486 . . . . 63.520000000000003 111.027 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 81.6 mt -109.9 139.12 45.35 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.82 -0.807 . . . . 71.010000000000005 108.82 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -108.27 98.78 8.27 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.097 -1.075 . . . . 64.340000000000003 108.097 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.5 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -109.63 95.96 0.92 Allowed Glycine 0 C--N 1.283 -2.386 0 CA-C-N 115.109 -0.95 . . . . 52.450000000000003 112.531 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -87.01 89.39 7.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.235 -1.024 . . . . 70.409999999999997 108.235 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.39 154.13 78.35 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 109.47 -0.567 . . . . 74.510000000000005 109.47 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.22 -28.67 18.31 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.325 2.017 . . . . 73.430000000000007 112.152 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -91.21 38.23 0.96 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.746 -0.661 . . . . 74.409999999999997 112.07 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.73 -45.07 58.43 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.523 1.129 . . . . 75.109999999999999 113.535 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -12.13 60.77 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.051 0.453 . . . . 73.040000000000006 111.099 -174.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 88' ' ' SER . 69.1 mmtt -93.35 -9.61 38.19 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 116.198 -0.455 . . . . 52.020000000000003 110.115 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -115.41 118.52 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 C-N-CA 118.518 -1.273 . . . . 74.329999999999998 110.063 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.44 102.6 14.4 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.998 -1.001 . . . . 64.239999999999995 108.871 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.7 t -98.27 135.74 31.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.462 -1.31 . . . . 71.099999999999994 107.462 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 t -155.52 171.87 19.21 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.693 -0.854 . . . . 33.539999999999999 108.693 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -83.58 142.78 30.59 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.689 -0.856 . . . . 71.439999999999998 108.689 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -99.06 122.38 42.22 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.313 -0.995 . . . . 74.340000000000003 108.313 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -138.99 99.62 3.82 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.187 -0.672 . . . . 53.439999999999998 109.187 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.2 t -172.88 149.74 1.97 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.612 -0.514 . . . . 62.549999999999997 109.612 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.91 16.2 8.83 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.393 1.077 . . . . 63.520000000000003 111.674 173.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.5 1.55 85.68 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.442 -0.663 . . . . 64.420000000000002 111.442 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.493 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 91.8 m-85 -104.29 145.51 30.12 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 109.5 -0.556 . . . . 71.420000000000002 109.5 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.2 136.67 60.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.797 -1.186 . . . . 53.329999999999998 107.797 173.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -165.47 -154.97 8.34 Favored Glycine 0 C--N 1.27 -3.115 0 C-N-CA 119.65 -1.262 . . . . 64.420000000000002 111.638 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.527 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 21.2 p -123.84 143.23 50.46 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 109.604 -0.517 . . . . 71.329999999999998 109.604 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -138.37 142.59 39.63 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 120.406 -0.518 . . . . 74.430000000000007 110.954 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.37 114.9 18.83 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.197 -1.038 . . . . 34.409999999999997 108.197 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -105.97 115.0 46.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 108.62 -0.881 . . . . 74.5 108.62 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -118.34 154.43 32.36 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 120.393 -0.523 . . . . 74.140000000000001 110.938 -175.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 80.8 p -157.53 171.35 20.51 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 109.335 -0.617 . . . . 64.209999999999994 109.335 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 62.15 30.59 17.78 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.438 1.087 . . . . 75.219999999999999 110.62 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt -101.15 164.24 11.89 Favored 'General case' 0 N--CA 1.42 -1.926 0 C-N-CA 120.165 -0.614 . . . . 62.329999999999998 111.116 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -113.04 170.79 7.95 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.235 -0.654 . . . . 73.510000000000005 109.235 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -54.57 -38.25 66.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.407 1.083 . . . . 74.409999999999997 111.746 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.51 65.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.236 -0.438 . . . . 72.439999999999998 111.876 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -86.46 -16.51 36.86 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.904 0.383 . . . . 55.32 111.665 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.7 tt -62.35 -47.71 88.8 Favored Pre-proline 0 CA--C 1.569 1.685 0 CA-C-N 116.236 -0.438 . . . . 75.349999999999994 111.378 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.55 -40.15 76.63 Favored 'Trans proline' 0 C--N 1.38 2.232 0 CA-C-N 120.831 1.333 . . . . 72.329999999999998 110.768 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -61.16 -41.8 97.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.236 -0.893 . . . . 73.519999999999996 111.534 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -72.36 -20.39 61.47 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.376 -0.375 . . . . 62.439999999999998 110.635 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.01 -26.13 60.27 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.21 -0.663 . . . . 73.030000000000001 109.21 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -62.87 -52.06 64.57 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.58 -0.896 . . . . 62.130000000000003 108.58 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.5 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 32.2 ttp -53.89 -51.59 63.2 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.478 -0.783 . . . . 72.420000000000002 109.78 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -55.22 -35.0 64.44 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.192 -0.913 . . . . 74.530000000000001 111.076 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -58.96 -32.57 69.75 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 119.234 -0.413 . . . . 72.540000000000006 111.465 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.26 -25.7 67.98 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.269 0.557 . . . . 65.099999999999994 111.233 -173.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.37 -14.48 14.43 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.809 -0.632 . . . . 74.150000000000006 111.01 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.414 ' HB1' HG13 ' A' ' 108' ' ' VAL . . . -106.3 -43.79 4.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.309 0.855 . . . . 74.329999999999998 113.309 -171.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.37 22.69 69.84 Favored Glycine 0 C--N 1.317 -0.481 0 N-CA-C 111.122 -0.791 . . . . 52.200000000000003 111.122 -173.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.414 HG13 ' HB1' ' A' ' 106' ' ' ALA . 18.3 m -103.87 161.53 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.576 -0.527 . . . . 62.219999999999999 109.576 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -123.31 121.62 36.28 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.67 -1.604 . . . . 73.109999999999999 106.67 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.0 mt -122.77 107.23 11.67 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.266 -0.642 . . . . 72.329999999999998 109.266 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.1 m -115.87 141.02 48.65 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.88 -0.785 . . . . 73.109999999999999 108.88 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -149.92 155.38 39.89 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.9 -0.32 . . . . 71.439999999999998 110.478 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -156.09 161.84 40.34 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.339 -0.985 . . . . 51.109999999999999 108.339 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -106.47 133.09 51.7 Favored 'General case' 0 N--CA 1.398 -3.031 0 N-CA-C 107.322 -1.362 . . . . 75.450000000000003 107.322 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -118.81 100.24 7.27 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 106.839 -1.541 . . . . 70.120000000000005 106.839 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.91 -113.05 4.98 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.325 -1.11 . . . . 53.240000000000002 110.325 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -114.32 12.09 17.51 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.932 1.348 . . . . 73.040000000000006 109.477 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.23 148.86 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 O-C-N 120.445 -1.41 . . . . 65.519999999999996 108.868 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 178' ' ' TYR . 82.4 t -106.41 136.0 42.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 CA-C-O 120.761 0.315 . . . . 73.430000000000007 110.398 -177.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.1 pt -116.94 134.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 108.876 -0.787 . . . . 65.439999999999998 108.876 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 tt -127.84 126.25 41.28 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.279 -1.008 . . . . 73.340000000000003 108.279 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -128.63 114.86 17.21 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.828 0.823 . . . . 73.340000000000003 109.142 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.39 139.4 14.13 Favored Glycine 0 N--CA 1.4 -3.747 0 N-CA-C 108.777 -1.729 . . . . 51.219999999999999 108.777 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -140.23 131.09 25.96 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.633 -1.618 . . . . 72.5 106.633 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -139.5 144.8 38.1 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.688 0.756 . . . . 51.32 112.871 -172.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.24 93.43 5.69 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.513 -1.221 . . . . 74.129999999999995 107.937 174.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.13 0.27 56.22 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.929 0.871 . . . . 70.129999999999995 108.827 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.431 -1.378 0 CA-C-N 114.452 -1.249 . . . . 64.030000000000001 111.409 -179.464 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 . . . . . 0 N--CA 1.44 -0.95 0 CA-C-O 121.034 0.445 . . . . 75.340000000000003 111.236 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.02 140.37 29.81 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.42 -0.354 . . . . 75.519999999999996 111.863 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -133.06 139.67 47.29 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.492 -0.929 . . . . 72.439999999999998 108.492 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.77 113.89 44.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.126 -0.694 . . . . 75.230000000000004 109.126 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -113.29 120.13 40.11 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.21 0.529 . . . . 74.409999999999997 109.949 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 39.9 tp -112.18 120.6 42.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.306 -0.998 . . . . 74.519999999999996 108.306 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 31' ' ' SER . 17.4 m -120.89 112.62 19.01 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.566 -0.901 . . . . 41.140000000000001 108.566 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.49 120.77 61.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.508 -0.923 . . . . 61.310000000000002 108.508 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -105.73 126.92 52.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.523 -0.917 . . . . 52.200000000000003 108.523 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.443 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 0.3 OUTLIER -134.25 103.36 11.58 Favored Pre-proline 0 C--N 1.274 -2.697 0 CA-C-N 115.591 -0.731 . . . . 70.340000000000003 110.349 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.34 45.2 0.4 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 123.574 2.849 . . . . 74.530000000000001 112.277 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.53 -86.26 0.64 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.457 -0.571 . . . . 64.420000000000002 109.457 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.55 113.47 0.01 OUTLIER 'General case' 0 C--O 1.247 0.972 0 C-N-CA 123.72 0.808 . . . . 74.129999999999995 109.112 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 9.4 p -75.66 130.83 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.768 -1.197 . . . . 65.340000000000003 107.768 174.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.8 t -103.8 -28.71 11.46 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.296 -0.962 . . . . 73.040000000000006 110.852 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.7 m -159.28 132.96 7.33 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 107.406 -1.331 . . . . 74.239999999999995 107.406 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -139.75 162.14 35.85 Favored 'General case' 0 C--N 1.282 -2.331 0 O-C-N 122.104 -0.372 . . . . 70.329999999999998 110.414 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -130.04 90.55 2.98 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 104.927 -2.249 . . . . 64.109999999999999 104.927 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 172.35 -147.93 10.31 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 109.471 -1.452 . . . . 72.430000000000007 109.471 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -116.59 99.66 7.3 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 117.501 0.65 . . . . 65.109999999999999 109.481 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -72.58 131.89 43.06 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 121.287 0.565 . . . . 53.009999999999998 110.328 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.5 mm -96.07 -49.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 106.958 -1.497 . . . . 74.140000000000001 106.958 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -134.73 166.42 29.33 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 105.857 -1.905 . . . . 70.329999999999998 105.857 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.96 -2.39 11.44 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.309 2.006 . . . . 75.340000000000003 110.86 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.82 10.76 5.11 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.187 -0.915 . . . . 53.520000000000003 111.076 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.0 t -147.02 120.71 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.507 -0.923 . . . . 75.329999999999998 108.507 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.6 147.01 30.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.751 -0.833 . . . . 72.019999999999996 108.751 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 53.3 tt0 -132.92 142.44 48.9 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-O 121.595 0.712 . . . . 74.310000000000002 110.207 -174.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.451 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 29.1 m-90 -123.63 116.02 22.42 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.095 -1.076 . . . . 72.349999999999994 108.095 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.554 ' HD3' ' H ' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -112.36 98.42 7.27 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.017 0.913 . . . . 53.43 109.478 -178.557 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 170' ' ' SER . 0.7 OUTLIER -95.75 147.4 23.66 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.221 -1.354 . . . . 54.329999999999998 110.084 -171.676 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 34.1 mttp -117.11 150.19 45.66 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 115.587 -0.733 . . . . 71.519999999999996 112.105 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 165' ' ' LYS . 32.1 Cg_exo -66.06 157.48 59.32 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 123.318 2.679 . . . . 74.519999999999996 111.466 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.48 -27.26 2.51 Favored Glycine 0 C--N 1.313 -0.744 0 C-N-CA 121.54 -0.362 . . . . 31.149999999999999 112.899 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.3 m -105.85 167.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 120.723 0.297 . . . . 74.540000000000006 110.624 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.6 p -114.05 143.97 22.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.112 -0.699 . . . . 72.430000000000007 109.112 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 164' ' ' LEU . 44.5 m -153.09 150.26 28.94 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 121.992 -0.443 . . . . 74.129999999999995 110.186 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 27.7 p -120.37 126.41 50.43 Favored 'General case' 0 N--CA 1.428 -1.557 0 C-N-CA 122.94 0.496 . . . . 73.420000000000002 110.0 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -98.14 121.39 40.01 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.591 -0.522 . . . . 72.040000000000006 109.591 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.3 m -137.98 138.44 38.91 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.865 -1.147 . . . . 74.510000000000005 111.369 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.451 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -145.31 128.77 16.97 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 115.811 -0.631 . . . . 63.109999999999999 109.675 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -117.19 130.69 56.76 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 107.006 -1.479 . . . . 74.219999999999999 107.006 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -140.85 152.28 44.99 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.497 -0.557 . . . . 31.02 109.497 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -90.74 126.28 35.95 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.406 -0.961 . . . . 74.420000000000002 108.406 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.598 ' OH ' HG23 ' A' ' 34' ' ' ILE . 5.4 m-85 -126.26 126.7 44.44 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 113.059 0.763 . . . . 73.310000000000002 113.059 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 35.7 p -67.79 105.17 1.86 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.606 -1.179 . . . . 54.32 108.484 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 CA--C 1.506 -0.721 0 O-C-N 123.773 0.671 . . . . 55.240000000000002 110.114 -178.127 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 50.0 mtm105 . . . . . 0 CA--C 1.507 -0.692 0 N-CA-C 110.244 -0.28 . . . . 74.329999999999998 110.244 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 46' ' ' ALA . 26.9 m -126.58 114.71 39.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.495 0.664 . . . . 62.100000000000001 109.559 177.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -123.8 119.08 28.68 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.413 0.625 . . . . 74.319999999999993 110.706 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -109.38 108.87 19.57 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.295 -1.002 . . . . 61.310000000000002 108.295 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 p -117.52 115.89 26.03 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.32 -0.622 . . . . 73.120000000000005 109.32 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.72 146.91 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.518 -0.549 . . . . 63.009999999999998 109.518 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.1 m -123.78 130.63 52.93 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 109.094 -0.706 . . . . 51.140000000000001 109.094 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -112.94 120.27 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 121.679 0.752 . . . . 62.229999999999997 110.553 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -92.74 158.29 38.29 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 115.054 -0.975 . . . . 51.119999999999997 110.438 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -65.53 2.39 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.997 3.131 . . . . 74.319999999999993 113.614 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 31.7 t70 -89.85 -0.32 57.49 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.973 -0.751 . . . . 52.439999999999998 108.973 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 22.0 t70 70.79 29.19 3.22 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 105.51 -2.033 . . . . 74.420000000000002 105.51 -174.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 7.0 tp -101.69 125.02 48.27 Favored 'General case' 1 N--CA 1.379 -4.023 0 CA-C-N 112.175 -2.284 . . . . 74.120000000000005 108.472 -177.247 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.6 t -115.47 130.64 69.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.629 -0.878 . . . . 71.439999999999998 108.629 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 p -145.23 151.81 38.97 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.033 -0.729 . . . . 75.230000000000004 109.033 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.51 -164.7 36.45 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 118.971 -1.585 . . . . 74.049999999999997 112.965 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.05 133.97 15.84 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.247 0.546 . . . . 71.010000000000005 110.571 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 68.0 mt -114.27 115.84 50.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.885 -1.154 . . . . 72.430000000000007 107.885 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -109.95 116.71 52.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 109.762 -0.458 . . . . 63.340000000000003 109.762 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.483 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -112.89 108.47 17.43 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.909 -1.515 . . . . 73.239999999999995 106.909 174.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -123.35 125.36 44.86 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.236 0.541 . . . . 72.400000000000006 111.672 -174.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.86 159.92 32.5 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.441 -0.8 . . . . 64.209999999999994 109.165 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.494 0 C-N-CA 119.144 -1.022 . . . . 74.25 110.36 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.432 -1.366 0 CA-C-O 121.7 0.762 . . . . 75.099999999999994 109.103 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 172.77 99.5 0.12 Allowed Glycine 0 N--CA 1.416 -2.639 0 CA-C-O 118.289 -1.284 . . . . 63.329999999999998 111.725 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 52.2 Cg_exo -54.05 127.75 26.98 Favored 'Trans proline' 0 C--N 1.355 0.88 0 CA-C-N 120.044 1.922 . . . . 71.439999999999998 107.5 170.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.1 151.52 22.47 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 113.573 0.953 . . . . 72.200000000000003 113.573 -166.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 96.1 mt -94.35 150.48 20.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.047 -0.979 . . . . 63.329999999999998 109.301 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -107.07 93.68 4.69 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.389 -0.967 . . . . 73.420000000000002 108.389 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.38 120.01 5.87 Favored Glycine 0 N--CA 1.42 -2.39 0 CA-C-N 114.442 -1.254 . . . . 63.130000000000003 111.219 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -136.68 111.47 8.78 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.918 -0.771 . . . . 63.409999999999997 108.918 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.15 166.88 14.55 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.173 -1.047 . . . . 71.430000000000007 108.173 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -66.98 -32.67 34.55 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 121.406 1.404 . . . . 72.530000000000001 110.586 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -97.13 39.2 1.19 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.257 -0.883 . . . . 71.530000000000001 112.825 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.8 m -55.14 -27.8 48.09 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 112.784 0.661 . . . . 35.43 112.784 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -73.02 -7.89 53.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.217 0.532 . . . . 73.109999999999999 111.232 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.5 -13.13 18.8 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.117 -0.492 . . . . 65.140000000000001 110.383 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.2 p -125.31 119.99 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.882 0.849 . . . . 64.450000000000003 111.663 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.98 112.08 24.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.774 -0.825 . . . . 73.420000000000002 108.774 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.35 127.76 50.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.083 -1.081 . . . . 74.129999999999995 108.083 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 m -140.01 172.78 12.27 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.534 -0.543 . . . . 74.439999999999998 109.534 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.426 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 22.6 p-10 -86.03 149.24 25.31 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.064 -0.654 . . . . 72.120000000000005 109.539 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 79.6 t80 -101.93 120.56 40.59 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.571 -1.64 . . . . 74.430000000000007 106.571 174.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -138.49 99.13 3.75 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 108.423 -0.954 . . . . 72.400000000000006 108.423 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.3 t -174.07 153.48 2.08 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.869 -1.16 . . . . 63.43 107.869 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 66.89 15.14 10.07 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.915 0.886 . . . . 73.340000000000003 112.166 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.38 -8.25 80.25 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.575 -0.61 . . . . 64.530000000000001 111.575 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.531 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 47.9 m-85 -93.05 153.22 18.83 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.419 -0.586 . . . . 64.239999999999995 109.419 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 31.0 m -134.81 136.31 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.064 -1.088 . . . . 52.310000000000002 108.064 171.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.8 -153.85 8.86 Favored Glycine 0 C--N 1.259 -3.75 0 N-CA-C 110.505 -1.038 . . . . 73.140000000000001 110.505 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.486 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.1 p -126.43 146.76 49.96 Favored 'General case' 0 C--N 1.264 -3.141 0 CA-C-O 121.317 0.58 . . . . 64.540000000000006 111.518 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 27.1 pt20 -136.97 127.78 27.3 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.97 -0.559 . . . . 61.420000000000002 110.496 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.42 115.25 29.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.287 -1.005 . . . . 24.309999999999999 108.287 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.68 117.77 54.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.057 -1.09 . . . . 55.109999999999999 108.057 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.468 ' CD2' HD12 ' A' ' 90' ' ' LEU . 50.7 p90 -124.29 154.77 39.75 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 120.803 0.335 . . . . 72.530000000000001 110.236 -175.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.5 m -157.56 159.73 37.44 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 116.234 -0.439 . . . . 63.340000000000003 110.222 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 67.14 31.13 6.95 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.505 1.145 . . . . 71.439999999999998 110.486 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.468 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.0 mt -96.24 160.44 14.43 Favored 'General case' 0 N--CA 1.428 -1.54 0 O-C-N 121.627 -0.671 . . . . 73.519999999999996 111.304 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 m -104.78 166.53 10.32 Favored 'General case' 0 N--CA 1.401 -2.912 0 N-CA-C 109.391 -0.596 . . . . 63.130000000000003 109.391 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.493 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 60.8 t80 -50.66 -48.62 58.31 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.228 1.011 . . . . 74.239999999999995 110.674 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.07 -24.66 67.24 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.268 -0.878 . . . . 55.039999999999999 112.245 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -87.66 -16.93 33.03 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 116.272 -0.422 . . . . 72.219999999999999 111.754 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.3 tt -61.89 -52.36 68.8 Favored Pre-proline 0 CA--C 1.559 1.294 0 O-C-N 123.254 0.346 . . . . 62.509999999999998 111.228 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 35.3 Cg_exo -65.72 -32.98 45.95 Favored 'Trans proline' 0 C--N 1.369 1.654 0 CA-C-N 120.794 1.319 . . . . 65.099999999999994 110.63 176.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.63 -36.06 83.04 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.642 -0.708 . . . . 72.340000000000003 110.977 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -77.59 -19.84 54.95 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.871 -0.418 . . . . 64.409999999999997 109.871 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.78 -24.24 61.71 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.97 -0.559 . . . . 64.040000000000006 110.25 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -56.18 -49.75 73.14 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 109.561 -0.533 . . . . 74.409999999999997 109.561 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.5 mtm -54.37 -51.46 64.71 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.232 0.539 . . . . 73.319999999999993 110.161 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -56.58 -34.93 67.65 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.992 -1.004 . . . . 74.349999999999994 111.598 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.3 m -62.09 -30.21 70.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.269 -0.423 . . . . 54.520000000000003 110.243 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.18 -31.57 70.25 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 123.926 0.767 . . . . 73.030000000000001 110.674 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.09 -11.89 15.53 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 116.233 -0.44 . . . . 74.129999999999995 111.38 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.69 -47.86 3.65 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.646 0.98 . . . . 54.420000000000002 113.646 -172.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.07 25.81 33.11 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.814 -0.708 . . . . 72.420000000000002 111.784 -174.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 m -109.27 155.41 10.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 122.486 -0.42 . . . . 65.310000000000002 111.7 -175.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -124.28 124.79 43.17 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.088 0.555 . . . . 72.329999999999998 109.555 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.8 mp -117.56 143.66 45.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.124 0.488 . . . . 74.109999999999999 111.056 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.1 m -129.74 109.57 11.06 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.065 -0.717 . . . . 70.319999999999993 109.065 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.573 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 61.0 tp -119.87 123.84 44.59 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.526 -0.306 . . . . 70.239999999999995 110.646 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.573 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 2.8 mpt_? -137.47 147.94 45.69 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.783 0.433 . . . . 74.310000000000002 110.194 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' ' 119' ' ' VAL . 37.3 ttm180 -102.0 137.54 40.15 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 107.101 -1.444 . . . . 64.540000000000006 107.101 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -128.47 90.0 2.99 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.664 -0.865 . . . . 71.329999999999998 108.664 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.79 -113.22 4.89 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.052 -0.976 . . . . 72.530000000000001 110.874 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.29 -13.67 21.82 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.843 0.83 . . . . 62.439999999999998 109.07 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.673 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.4 pp -103.59 149.86 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 C-N-CA 119.69 -0.804 . . . . 74.0 110.009 -176.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.545 HG21 ' CD2' ' A' ' 178' ' ' TYR . 92.7 t -118.31 138.68 48.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 O-C-N 121.911 -0.493 . . . . 72.209999999999994 110.141 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.0 pt -120.05 129.43 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 122.101 0.953 . . . . 65.140000000000001 109.802 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.2 136.25 49.89 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 114.907 -1.042 . . . . 75.299999999999997 108.56 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -143.28 166.15 25.52 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 108.835 -0.802 . . . . 65.420000000000002 108.835 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.84 158.98 30.96 Favored Glycine 0 N--CA 1.405 -3.415 0 N-CA-C 109.72 -1.352 . . . . 23.300000000000001 109.72 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -134.31 125.23 27.23 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.234 -1.765 . . . . 73.109999999999999 106.234 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.15 117.51 16.63 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 120.996 0.427 . . . . 72.040000000000006 111.618 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 169' ' ' VAL . 0.0 OUTLIER -108.85 134.02 52.1 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 105.154 -2.165 . . . . 71.140000000000001 105.154 170.427 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.9 mm? -117.85 32.38 6.18 Favored 'General case' 0 C--N 1.267 -2.99 0 N-CA-C 108.754 -0.832 . . . . 65.540000000000006 108.754 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 167' ' ' GLY . 42.7 p . . . . . 0 N--CA 1.446 -0.638 0 CA-C-N 115.965 -0.561 . . . . 55.539999999999999 110.487 -176.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 121.159 0.504 . . . . 71.340000000000003 111.283 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.0 143.91 28.08 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.137 -0.69 . . . . 45.100000000000001 109.137 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -132.11 130.52 41.29 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.276 -1.009 . . . . 75.439999999999998 108.276 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.1 t -113.54 126.11 70.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.863 -0.421 . . . . 64.430000000000007 109.863 -175.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.35 121.99 30.45 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.866 0.365 . . . . 54.539999999999999 111.356 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.516 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -111.22 121.54 45.54 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.885 -1.894 . . . . 63.549999999999997 105.885 174.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.3 m -126.6 130.96 51.52 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.243 -0.28 . . . . 43.439999999999998 110.243 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 99.4 t -123.86 126.12 72.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 109.036 -0.728 . . . . 71.120000000000005 109.036 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.84 127.57 56.21 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.324 -0.621 . . . . 65.519999999999996 109.324 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.8 p90 -134.38 123.68 16.68 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 116.362 -0.381 . . . . 75.530000000000001 111.789 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 29.2 Cg_exo -68.27 41.07 0.24 Allowed 'Trans proline' 0 CA--C 1.557 1.635 0 C-N-CA 123.447 2.765 . . . . 64.409999999999997 113.795 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.49 -100.44 0.39 Allowed 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.985 -0.447 . . . . 73.540000000000006 110.807 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 178.92 130.75 0.08 Allowed 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.745 -0.835 . . . . 53.520000000000003 108.745 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.7 133.03 30.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.049 -0.723 . . . . 62.210000000000001 109.049 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.2 p -94.03 -43.3 8.58 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-O 121.225 0.536 . . . . 65.329999999999998 109.701 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 17.0 m -150.04 131.32 14.59 Favored 'General case' 0 C--O 1.212 -0.904 0 N-CA-C 108.407 -0.961 . . . . 71.219999999999999 108.407 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -140.91 152.32 44.94 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.39 -0.524 . . . . 73.129999999999995 111.241 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -119.5 90.97 3.44 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.162 -2.162 . . . . 52.409999999999997 105.162 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.62 -159.26 28.97 Favored Glycine 0 N--CA 1.416 -2.672 0 N-CA-C 107.345 -2.302 . . . . 74.129999999999995 107.345 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.12 102.84 11.01 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 117.846 0.823 . . . . 73.439999999999998 109.542 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 18.0 ptt180 -76.28 122.01 23.79 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-O 121.218 0.532 . . . . 74.129999999999995 109.877 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.16 -41.06 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 106.989 -1.486 . . . . 64.230000000000004 106.989 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -136.08 166.29 29.24 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.118 -1.401 . . . . 74.319999999999993 107.245 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.12 -4.75 15.53 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 122.351 2.034 . . . . 75.310000000000002 110.721 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.6 pt-20 -128.27 6.2 5.84 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.613 -0.722 . . . . 64.209999999999994 111.36 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.5 t -141.66 120.57 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.256 -1.016 . . . . 75.340000000000003 108.256 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 50.1 t -123.53 145.53 30.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.772 -0.455 . . . . 74.209999999999994 109.772 -177.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -136.09 142.72 44.34 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.362 0.601 . . . . 73.349999999999994 110.202 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.516 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.6 m-90 -118.7 113.35 21.04 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.432 -0.804 . . . . 70.450000000000003 109.106 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 163' ' ' LYS . 7.8 ptpt -95.23 99.07 11.08 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 122.316 1.055 . . . . 74.340000000000003 108.716 177.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 61.1 mt -97.68 147.48 24.3 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 113.676 -1.602 . . . . 73.129999999999995 109.428 -173.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -117.63 146.44 38.67 Favored Pre-proline 0 C--N 1.295 -1.766 0 CA-C-N 115.637 -0.711 . . . . 73.409999999999997 112.302 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.457 ' HA ' ' CB ' ' A' ' 127' ' ' LEU . 71.8 Cg_endo -71.54 160.02 49.59 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.573 2.182 . . . . 72.019999999999996 110.341 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 128' ' ' THR . . . 78.34 -26.87 2.15 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 121.096 -0.573 . . . . 73.430000000000007 113.22 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.7 170.1 3.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.008 0.432 . . . . 73.25 112.082 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 126' ' ' ASP . 8.3 p -114.07 142.94 24.92 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 CA-C-N 115.812 -0.631 . . . . 74.409999999999997 109.87 176.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.5 p -149.75 140.57 22.74 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.048 0.451 . . . . 62.310000000000002 111.975 -176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.8 p -96.67 138.11 34.73 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.201 -0.666 . . . . 64.239999999999995 109.201 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 22.4 ptm -118.63 133.1 56.11 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.944 -1.132 . . . . 70.140000000000001 107.944 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -143.55 147.93 35.19 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.613 -0.835 . . . . 73.209999999999994 111.398 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.452 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -154.89 130.29 9.75 Favored 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 123.05 0.54 . . . . 64.430000000000007 109.862 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -132.54 131.83 41.97 Favored 'General case' 0 C--N 1.264 -3.147 0 N-CA-C 106.753 -1.573 . . . . 73.040000000000006 106.753 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.18 149.83 23.3 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.832 -1.173 . . . . 44.43 107.832 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 0.8 OUTLIER -95.52 138.86 32.6 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.447 -1.686 . . . . 70.420000000000002 106.447 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.545 ' CD2' HG21 ' A' ' 119' ' ' VAL . 22.4 m-30 -121.17 151.78 39.53 Favored 'General case' 0 CA--C 1.483 -1.611 0 C-N-CA 119.926 -0.71 . . . . 74.439999999999998 109.331 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.81 86.03 3.4 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-O 121.462 0.648 . . . . 74.299999999999997 110.097 175.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.5 t70 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 114.451 -1.249 . . . . 74.420000000000002 110.815 179.505 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.407 ' HG3' ' HB2' ' A' ' 136' ' ' ASP . 3.1 mpt_? . . . . . 0 N--CA 1.434 -1.245 0 N-CA-C 108.913 -0.773 . . . . 61.229999999999997 108.913 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.32 117.76 56.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.45 -0.944 . . . . 61.43 108.45 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -123.05 114.06 19.87 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.342 0.591 . . . . 71.319999999999993 109.457 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.29 126.76 55.6 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.583 -0.895 . . . . 75.310000000000002 108.583 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.9 t -131.64 114.79 15.24 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.046 -1.464 . . . . 73.329999999999998 107.046 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.63 146.62 29.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.367 -0.605 . . . . 43.539999999999999 109.367 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.5 m -126.8 125.21 41.32 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.258 0.551 . . . . 75.129999999999995 109.854 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.2 tt -113.39 110.35 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-O 121.851 0.834 . . . . 54.109999999999999 110.097 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -76.99 158.55 80.06 Favored Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 114.761 -1.109 . . . . 75.120000000000005 109.747 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.5 0.81 2.55 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 123.363 2.709 . . . . 62.109999999999999 112.999 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -88.89 2.33 53.92 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 124.066 0.947 . . . . 73.400000000000006 110.156 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 91' ' ' THR . 14.5 t70 67.89 29.44 6.61 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 123.55 1.643 . . . . 74.430000000000007 106.872 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.36 124.77 50.88 Favored 'General case' 0 N--CA 1.382 -3.841 0 CA-C-N 113.904 -1.498 . . . . 65.430000000000007 107.297 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.414 HG12 ' HE2' ' A' ' 87' ' ' PHE . 3.6 t -110.78 136.29 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 108.471 -0.937 . . . . 64.430000000000007 108.471 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.8 p -144.13 154.93 43.68 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 105.966 -1.865 . . . . 62.210000000000001 105.966 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.25 -172.04 44.26 Favored Glycine 0 CA--C 1.49 -1.524 0 C-N-CA 117.913 -2.089 . . . . 64.329999999999998 113.725 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.43 134.22 28.75 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.438 0.695 . . . . 75.010000000000005 110.041 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 60.0 mt -120.75 115.7 47.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.018 -1.475 . . . . 74.439999999999998 107.018 174.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.2 114.61 46.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 120.935 0.398 . . . . 62.539999999999999 109.954 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.01 108.3 18.48 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.277 -1.749 . . . . 65.329999999999998 106.277 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -121.34 125.66 47.55 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 120.246 -0.582 . . . . 70.019999999999996 111.257 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.64 155.73 22.93 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.934 -0.765 . . . . 64.040000000000006 108.934 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.6 tttm . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 104.983 -2.229 . . . . 73.519999999999996 104.983 176.131 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.427 -1.575 0 N-CA-C 108.723 -0.843 . . . . 74.439999999999998 108.723 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.91 98.18 0.11 Allowed Glycine 0 N--CA 1.414 -2.787 0 CA-C-N 114.824 -1.08 . . . . 65.340000000000003 112.54 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.74 159.09 53.81 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 122.673 2.248 . . . . 71.430000000000007 111.579 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.95 155.25 41.65 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.079 -0.341 . . . . 71.010000000000005 110.079 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.562 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 94.3 mt -101.15 153.47 19.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.159 -0.682 . . . . 71.219999999999999 109.159 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.92 88.07 5.6 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.878 -1.527 . . . . 74.340000000000003 106.878 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.86 50.66 0.78 Allowed Glycine 0 N--CA 1.414 -2.792 0 CA-C-N 115.077 -0.965 . . . . 54.32 112.89 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -91.6 95.46 9.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.251 -1.018 . . . . 71.150000000000006 108.251 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 m -122.37 162.21 39.16 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 114.15 -1.386 . . . . 64.209999999999994 107.609 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.86 -19.61 32.37 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.673 2.249 . . . . 54.43 112.831 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -112.52 29.58 7.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.417 -0.356 . . . . 70.319999999999993 111.659 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.9 m -56.48 -27.82 58.13 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.497 0.554 . . . . 74.239999999999995 112.497 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -70.15 -10.78 59.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.394 0.616 . . . . 73.329999999999998 110.752 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 88' ' ' SER . 68.0 mmtt -106.68 -9.83 16.36 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 111.486 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.74 118.27 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 119.382 -0.927 . . . . 75.129999999999995 111.102 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.76 103.4 15.31 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 115.051 -0.977 . . . . 52.420000000000002 108.794 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 60' ' ' LEU . 7.3 p -98.3 134.79 35.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.161 -1.052 . . . . 71.409999999999997 108.161 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.0 m -149.46 171.56 16.38 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 120.847 0.356 . . . . 75.010000000000005 111.047 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -76.85 132.09 38.97 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.125 -0.943 . . . . 63.229999999999997 109.089 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -102.62 119.92 39.66 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.287 -1.375 . . . . 75.129999999999995 107.287 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -137.6 99.61 3.99 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.513 -0.921 . . . . 74.409999999999997 108.513 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.0 t -168.42 149.1 4.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.38 -0.971 . . . . 73.120000000000005 108.38 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 69.85 13.75 8.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.979 0.911 . . . . 71.219999999999999 112.167 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.76 1.48 67.95 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.764 -0.653 . . . . 53.229999999999997 111.692 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.549 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 59.4 m-85 -102.79 151.07 22.84 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 122.506 0.322 . . . . 71.430000000000007 110.28 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.3 136.23 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 107.342 -1.355 . . . . 72.230000000000004 107.342 168.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.1 -154.95 10.51 Favored Glycine 0 C--N 1.272 -2.977 0 C-N-CA 119.965 -1.112 . . . . 34.030000000000001 111.019 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.562 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 13.0 m -126.69 145.12 50.7 Favored 'General case' 0 C--N 1.27 -2.863 0 CA-C-O 121.185 0.517 . . . . 51.030000000000001 110.39 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 9.4 pt20 -131.17 138.8 49.59 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.957 -0.565 . . . . 74.129999999999995 109.919 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.14 114.63 22.76 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.502 -1.296 . . . . 61.549999999999997 107.502 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.6 t -112.44 113.4 44.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.206 -1.035 . . . . 71.450000000000003 108.206 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.477 ' CD2' HD12 ' A' ' 90' ' ' LEU . 44.3 p90 -114.27 159.55 20.04 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.008 0.433 . . . . 74.010000000000005 111.858 -173.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 6.1 p -156.68 155.18 31.29 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.256 -0.884 . . . . 73.319999999999993 110.13 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 67.03 30.01 7.69 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 124.629 1.172 . . . . 64.129999999999995 111.945 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.477 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.2 mt -97.27 165.99 11.77 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 119.387 -0.925 . . . . 72.329999999999998 110.114 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.465 HG22 ' OE1' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -125.3 178.93 5.32 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.905 -1.146 . . . . 73.310000000000002 107.905 -178.513 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -47.54 -35.63 9.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.851 1.26 . . . . 62.310000000000002 112.452 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.451 ' H ' HG23 ' A' ' 91' ' ' THR . . . -73.1 -25.72 60.98 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.9 0.704 . . . . 75.239999999999995 112.9 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.467 ' HG2' HD22 ' A' ' 90' ' ' LEU . 14.6 mp0 -91.74 -16.97 26.1 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.797 -0.761 . . . . 74.319999999999993 112.749 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.3 tt -58.51 -50.65 86.88 Favored Pre-proline 0 CA--C 1.569 1.677 0 O-C-N 123.241 0.338 . . . . 72.409999999999997 111.456 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -68.81 -30.83 26.43 Favored 'Trans proline' 0 C--N 1.365 1.408 0 CA-C-N 120.731 1.297 . . . . 74.129999999999995 111.281 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -67.88 -33.13 74.14 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 123.534 0.734 . . . . 74.040000000000006 111.121 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.6 pp -75.54 -19.23 59.46 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.988 0.423 . . . . 70.310000000000002 110.256 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.438 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -71.63 -18.29 62.21 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.933 -0.576 . . . . 71.030000000000001 109.977 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.23 -57.24 10.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.9 -0.591 . . . . 74.230000000000004 109.85 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 14.8 ttm -54.38 -52.7 60.83 Favored 'General case' 0 C--O 1.271 2.189 0 CA-C-O 122.518 1.152 . . . . 74.340000000000003 108.428 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 6.3 t30 -52.84 -27.04 16.49 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 112.435 -2.166 . . . . 64.25 112.805 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -54.47 -45.89 73.25 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.886 -0.326 . . . . 40.219999999999999 110.557 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -69.47 -11.84 61.16 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.307 0.855 . . . . 72.510000000000005 113.307 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.38 -27.62 11.36 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.098 0.475 . . . . 54.420000000000002 110.359 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.11 -47.68 3.63 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 113.314 0.857 . . . . 72.430000000000007 113.314 -170.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.26 21.53 51.65 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.667 -0.973 . . . . 61.43 110.667 -172.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.6 m -118.97 155.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 122.306 -0.526 . . . . 51.020000000000003 110.617 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -125.71 141.4 52.03 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.91 -1.145 . . . . 74.230000000000004 107.91 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.0 mt -129.27 119.55 24.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.915 -0.772 . . . . 75.209999999999994 108.915 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -118.94 135.74 54.43 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.03 -1.1 . . . . 72.329999999999998 108.03 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.33 157.81 43.82 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 112.631 0.604 . . . . 73.219999999999999 112.631 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -145.67 150.87 37.1 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.844 -1.071 . . . . 53.520000000000003 111.267 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.544 ' NH2' ' HA ' ' A' ' 180' ' ' ASP . 3.9 tpt180 -96.49 106.56 18.83 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 106.401 -1.703 . . . . 62.520000000000003 106.401 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -96.8 89.23 4.83 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 108.097 -1.075 . . . . 63.039999999999999 108.097 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.13 -96.86 0.9 Allowed Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.086 -1.205 . . . . 65.340000000000003 110.086 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -124.42 -2.42 8.0 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.672 1.225 . . . . 70.310000000000002 109.33 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.62 148.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 O-C-N 121.087 -1.008 . . . . 70.310000000000002 108.703 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.441 HG22 ' HD3' ' A' ' 114' ' ' ARG . 96.8 t -102.89 131.77 50.44 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 O-C-N 122.06 -0.4 . . . . 64.140000000000001 110.32 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.414 HG22 ' HG2' ' A' ' 175' ' ' GLN . 44.4 pt -107.56 130.98 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 N-CA-C 106.784 -1.562 . . . . 72.209999999999994 106.784 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 tt -127.93 131.42 49.34 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 115.869 -0.605 . . . . 55.329999999999998 109.467 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -132.19 115.47 15.75 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.602 -0.888 . . . . 75.099999999999994 108.602 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -118.03 157.88 14.96 Favored Glycine 0 C--N 1.281 -2.503 0 N-CA-C 109.99 -1.244 . . . . 62.310000000000002 109.99 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.469 ' HG2' HG22 ' A' ' 171' ' ' THR . 84.0 mtt180 -139.53 127.54 22.28 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 117.542 0.671 . . . . 75.310000000000002 110.208 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -113.58 109.98 19.5 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.401 -0.592 . . . . 61.340000000000003 109.401 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -109.68 97.76 7.24 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.439 -0.948 . . . . 71.099999999999994 108.439 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.82 28.57 8.46 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.557 -0.905 . . . . 62.350000000000001 108.557 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 69.4 p . . . . . 0 N--CA 1.447 -0.619 0 CA-C-N 115.883 -0.599 . . . . 75.299999999999997 112.599 -175.238 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.8 t70 . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 122.071 0.939 . . . . 54.020000000000003 110.594 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.53 141.26 36.83 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.276 -0.875 . . . . 61.310000000000002 111.7 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 27' ' ' ARG . 11.2 m-20 -131.48 136.64 48.09 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 108.527 -0.916 . . . . 70.040000000000006 108.527 177.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.8 t -127.57 118.48 49.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.292 -0.633 . . . . 73.439999999999998 109.292 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.404 ' OE2' ' HB3' ' A' ' 136' ' ' ASP . 2.6 mp0 -109.37 123.55 49.51 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.603 -0.517 . . . . 74.310000000000002 109.603 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.407 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.5 tm? -110.94 111.83 23.23 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.949 -1.5 . . . . 64.319999999999993 106.949 176.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.6 m -117.9 133.62 55.74 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.858 0.463 . . . . 64.219999999999999 110.45 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.83 123.62 63.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.89 -0.781 . . . . 71.209999999999994 108.89 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.51 127.49 56.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.107 -0.701 . . . . 63.009999999999998 109.107 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.527 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.43 118.47 13.74 Favored Pre-proline 0 C--N 1.286 -2.179 0 CA-C-N 116.529 -0.305 . . . . 61.439999999999998 111.477 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.94 40.46 0.36 Allowed 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 122.993 2.462 . . . . 64.200000000000003 111.935 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.53 -94.09 0.5 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-O 119.288 -0.387 . . . . 63.520000000000003 110.224 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 174.03 120.77 0.02 OUTLIER 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.3 0.64 . . . . 54.409999999999997 109.873 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.472 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 7.4 p -84.03 126.22 40.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.814 -0.81 . . . . 72.230000000000004 108.814 174.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.6 t -95.35 -33.46 12.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 119.775 -0.77 . . . . 74.140000000000001 110.647 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.8 m -154.48 132.37 11.58 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 108.399 -0.963 . . . . 53.25 108.399 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 t -140.53 157.85 44.88 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 110.246 -0.279 . . . . 63.130000000000003 110.246 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 26.9 t-20 -126.95 97.89 5.13 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.193 -2.151 . . . . 62.119999999999997 105.193 170.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.19 -147.43 11.11 Favored Glycine 0 N--CA 1.417 -2.601 0 N-CA-C 108.238 -1.945 . . . . 62.310000000000002 108.238 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -114.89 99.78 7.73 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 117.835 0.817 . . . . 73.120000000000005 109.476 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -80.09 113.95 18.64 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-O 121.482 0.658 . . . . 73.040000000000006 109.66 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.15 -35.52 15.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 107.454 -1.313 . . . . 73.329999999999998 107.454 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -143.46 166.5 19.54 Favored Pre-proline 0 N--CA 1.431 -1.389 0 N-CA-C 107.446 -1.316 . . . . 73.439999999999998 107.446 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -72.59 -0.05 8.26 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.342 2.028 . . . . 64.129999999999995 111.279 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 11.5 pt-20 -129.83 5.88 5.05 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.729 -0.668 . . . . 74.219999999999999 110.864 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.413 HG23 ' HG3' ' A' ' 158' ' ' GLU . 90.6 t -144.81 121.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.44 -0.578 . . . . 71.540000000000006 109.44 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.17 145.55 33.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 109.183 -0.673 . . . . 71.25 109.183 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -134.93 146.34 49.05 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.817 -0.808 . . . . 72.329999999999998 108.817 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.407 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.6 m-90 -121.95 122.35 39.16 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.295 -1.002 . . . . 73.040000000000006 108.295 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -88.07 109.5 19.91 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.173 -1.047 . . . . 75.299999999999997 108.173 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 30.9 mt -102.07 125.1 48.68 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 121.486 0.66 . . . . 75.450000000000003 110.271 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 5.4 mmpt? -118.03 150.23 47.0 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 114.903 -1.044 . . . . 64.230000000000004 110.553 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.435 ' HD3' ' HE2' ' A' ' 165' ' ' LYS . 10.8 Cg_exo -72.07 159.46 50.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.134 1.889 . . . . 75.420000000000002 110.775 173.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.97 -35.63 2.91 Favored Glycine 0 C--N 1.312 -0.785 0 N-CA-C 111.7 -0.56 . . . . 72.329999999999998 111.7 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.28 155.06 6.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.438 -0.381 . . . . 54.549999999999997 110.139 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.6 p -113.09 116.03 51.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.055 -0.721 . . . . 54.329999999999998 109.055 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.1 m -116.3 144.47 44.2 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.01 -0.737 . . . . 74.430000000000007 109.01 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 124' ' ' ARG . 45.0 p -115.6 152.18 33.57 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-O 121.015 0.436 . . . . 73.340000000000003 110.762 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -102.3 116.79 33.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.48 -1.304 . . . . 63.310000000000002 107.48 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 18.0 t -120.27 130.2 54.38 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 107.231 -1.396 . . . . 75.420000000000002 107.231 173.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -152.53 132.14 13.08 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 109.344 -0.613 . . . . 75.310000000000002 109.344 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.414 ' HG2' HG22 ' A' ' 120' ' ' ILE . 47.3 mt-30 -133.1 129.75 38.38 Favored 'General case' 0 C--N 1.268 -2.938 0 N-CA-C 107.511 -1.292 . . . . 70.430000000000007 107.511 174.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -150.59 155.28 39.12 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.955 -0.566 . . . . 74.510000000000005 110.097 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 177' ' ' ARG . 42.3 mtt180 -87.76 125.31 34.35 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.912 -1.144 . . . . 54.020000000000003 107.912 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -132.03 123.31 27.01 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 108.986 -0.746 . . . . 70.5 108.986 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.41 113.99 2.96 Favored 'General case' 0 C--N 1.276 -2.621 0 O-C-N 124.085 0.865 . . . . 73.019999999999996 110.913 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.544 ' HA ' ' NH2' ' A' ' 114' ' ' ARG . 1.8 m-20 . . . . . 0 C--O 1.212 -0.886 0 CA-C-N 114.953 -1.021 . . . . 73.329999999999998 110.341 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 55.1 mtm180 . . . . . 0 N--CA 1.413 -2.316 0 N-CA-C 109.22 -0.659 . . . . 74.049999999999997 109.22 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.94 114.14 44.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.057 -1.46 . . . . 61.509999999999998 107.057 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -114.54 113.29 24.22 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.633 -0.877 . . . . 74.450000000000003 108.633 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -106.93 107.74 18.91 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.238 -1.393 . . . . 64.340000000000003 107.238 176.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 140' ' ' THR . 22.5 m -119.08 115.36 24.13 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 109.224 -0.658 . . . . 40.219999999999999 109.224 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 2.1 pp -123.41 146.47 28.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 120.39 -0.524 . . . . 51.299999999999997 110.238 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 31.5 m -123.52 121.02 34.59 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 108.468 -0.938 . . . . 63.43 108.468 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -116.06 118.63 59.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.91 0.862 . . . . 64.140000000000001 111.313 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HA ' ' HD2' ' A' ' 144' ' ' PRO . 17.9 m -87.26 148.39 44.64 Favored Pre-proline 0 N--CA 1.417 -2.12 0 CA-C-N 114.775 -1.102 . . . . 62.549999999999997 108.93 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.74 2.88 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 124.392 3.395 . . . . 71.340000000000003 113.755 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -91.02 1.61 56.95 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.226 1.01 . . . . 74.120000000000005 108.511 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 91' ' ' THR . 9.0 t70 72.48 28.73 2.21 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.015 1.726 . . . . 72.219999999999999 107.017 -176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.56 124.5 49.42 Favored 'General case' 0 N--CA 1.389 -3.501 0 CA-C-N 113.887 -1.506 . . . . 73.200000000000003 107.688 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.62 136.17 53.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.144 -1.058 . . . . 63.43 108.144 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.3 p -141.41 160.53 39.93 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 106.131 -1.803 . . . . 50.240000000000002 106.131 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.3 -165.82 39.19 Favored Glycine 0 CA--C 1.489 -1.541 0 C-N-CA 117.826 -2.13 . . . . 44.450000000000003 113.635 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HB2' HD11 ' A' ' 45' ' ' ILE . 10.5 pt-20 -157.08 133.58 9.92 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 123.51 0.724 . . . . 70.319999999999993 110.218 -175.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 3.4 mp -117.53 115.45 48.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 105.919 -1.882 . . . . 75.400000000000006 105.919 170.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 43' ' ' GLU . 5.0 mm -108.41 121.37 61.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.348 -0.982 . . . . 62.450000000000003 108.348 -175.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.493 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.98 108.86 16.77 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.33 -0.989 . . . . 61.310000000000002 108.33 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.11 122.87 38.4 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.762 0.315 . . . . 45.450000000000003 111.046 -176.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.66 158.96 28.9 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.665 -0.698 . . . . 64.310000000000002 110.913 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--N 1.319 -0.748 0 N-CA-C 107.49 -1.3 . . . . 73.150000000000006 107.49 171.53 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.586 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 4.1 t . . . . . 0 N--CA 1.422 -1.847 0 CA-C-O 120.396 0.141 . . . . 74.109999999999999 110.643 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.08 131.09 1.31 Allowed Glycine 0 N--CA 1.423 -2.204 0 CA-C-O 118.294 -1.281 . . . . 54.530000000000001 111.184 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -52.49 128.84 29.4 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 120.127 1.964 . . . . 73.310000000000002 109.205 169.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.04 163.39 14.92 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.903 0.705 . . . . 62.210000000000001 112.903 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 mt -121.61 124.52 44.52 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.37 -0.974 . . . . 74.420000000000002 108.37 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -112.51 90.39 3.33 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.063 0.459 . . . . 75.299999999999997 110.497 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.98 79.63 0.3 Allowed Glycine 0 C--N 1.3 -1.42 0 C-N-CA 121.021 -0.609 . . . . 14.41 111.802 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -87.88 105.18 17.25 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.685 0.755 . . . . 72.140000000000001 108.968 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.9 m -109.08 163.82 16.12 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 114.651 -1.159 . . . . 74.319999999999993 109.43 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.4 -16.91 50.25 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.744 2.296 . . . . 74.040000000000006 112.554 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -113.15 36.01 3.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.588 -0.733 . . . . 64.430000000000007 111.076 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.2 m -59.66 -29.08 67.81 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 112.463 0.542 . . . . 65.129999999999995 112.463 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -7.85 54.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.912 -0.715 . . . . 74.299999999999997 111.667 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.81 -11.5 26.76 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.797 -0.446 . . . . 70.109999999999999 109.797 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.73 120.76 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 122.135 0.969 . . . . 75.109999999999999 111.847 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.48 106.43 18.4 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.451 -0.795 . . . . 51.219999999999999 108.931 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.2 t -98.24 132.25 43.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.465 -1.309 . . . . 63.310000000000002 107.465 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.9 m -144.76 165.35 28.33 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.629 0.252 . . . . 43.25 111.538 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -87.66 128.9 35.28 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.419 -0.956 . . . . 73.439999999999998 108.419 178.798 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 60.6 t80 -92.66 125.26 37.21 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 123.88 0.872 . . . . 71.310000000000002 109.858 -177.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -140.06 98.91 3.55 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.894 -1.15 . . . . 64.209999999999994 107.894 171.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 53.2 m -163.75 153.09 14.37 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.491 -1.3 . . . . 72.230000000000004 107.491 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.72 4.03 4.54 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.885 0.874 . . . . 72.209999999999994 111.574 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.08 0.72 73.77 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.591 -1.003 . . . . 72.450000000000003 110.591 -174.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -100.79 151.29 21.86 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 109.181 -0.674 . . . . 73.230000000000004 109.181 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.7 m -127.81 138.77 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 109.074 -0.713 . . . . 72.109999999999999 109.074 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -171.72 -153.54 9.19 Favored Glycine 0 C--N 1.277 -2.721 0 N-CA-C 110.89 -0.884 . . . . 73.450000000000003 110.89 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.4 m -140.64 145.22 36.33 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 109.812 -0.44 . . . . 32.520000000000003 109.812 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.49 155.72 43.29 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 120.586 -0.446 . . . . 74.299999999999997 110.442 177.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.47 114.35 21.12 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.695 -1.224 . . . . 73.299999999999997 107.695 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.21 113.13 43.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.691 -0.855 . . . . 74.010000000000005 108.691 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.3 p90 -113.0 164.19 13.76 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.928 -0.709 . . . . 73.209999999999994 112.4 -174.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 p -157.91 155.75 30.09 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.655 -1.157 . . . . 45.420000000000002 109.931 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 67.12 30.88 7.11 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.011 1.115 . . . . 73.340000000000003 114.011 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 87' ' ' PHE . 52.1 mt -103.01 166.7 10.29 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.456 -0.498 . . . . 63.240000000000002 111.438 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 41.1 p -113.78 172.64 6.86 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.693 -0.231 . . . . 73.219999999999999 111.613 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -54.94 -37.63 66.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.626 0.77 . . . . 70.120000000000005 109.767 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.43 -25.77 62.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.094 -0.503 . . . . 74.109999999999999 111.844 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.29 -16.88 28.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.801 0.334 . . . . 63.240000000000002 111.635 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 44.0 tp -58.16 -48.11 97.63 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 113.1 0.778 . . . . 65.230000000000004 113.1 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.24 -34.96 76.76 Favored 'Trans proline' 0 C--N 1.372 1.812 0 CA-C-N 120.826 1.331 . . . . 74.230000000000004 110.794 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -64.65 -40.89 96.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.134 -0.484 . . . . 64.340000000000003 111.263 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -74.64 -19.36 60.32 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.687 -0.486 . . . . 73.030000000000001 109.687 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -69.97 -20.7 63.3 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.993 -0.549 . . . . 74.340000000000003 110.024 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -61.53 -57.93 10.14 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.257 -1.016 . . . . 62.240000000000002 108.257 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 33.6 ttp -56.38 -45.41 80.55 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.813 -0.631 . . . . 73.030000000000001 110.249 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 6.9 t30 -53.13 -44.54 67.79 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.086 -0.961 . . . . 74.519999999999996 111.046 177.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 p -68.73 -22.34 64.33 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.972 -0.691 . . . . 63.009999999999998 111.832 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.58 -25.15 67.28 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 121.192 0.52 . . . . 74.340000000000003 110.035 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.67 -11.16 16.42 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.007 -0.542 . . . . 63.549999999999997 110.432 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.55 -47.3 3.96 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.982 0.734 . . . . 73.010000000000005 112.982 -171.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.05 28.42 54.11 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.256 -0.973 . . . . 71.409999999999997 111.05 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.12 170.42 13.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 120.77 0.319 . . . . 64.510000000000005 110.682 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -118.68 126.28 51.57 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.822 -1.547 . . . . 75.010000000000005 106.822 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.71 134.23 53.74 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.985 -0.746 . . . . 71.340000000000003 108.985 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.2 m -144.13 142.37 30.54 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.739 -0.467 . . . . 73.25 109.739 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.93 146.4 30.12 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.321 -0.622 . . . . 73.25 109.321 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -138.03 148.54 45.2 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.74 -0.664 . . . . 72.349999999999994 110.613 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.427 ' CG ' HG22 ' A' ' 119' ' ' VAL . 6.6 mtt85 -90.1 137.75 32.09 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.5 -0.556 . . . . 71.439999999999998 109.5 171.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.422 ' O ' HG13 ' A' ' 118' ' ' ILE . 43.3 t30 -135.36 101.36 4.8 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.653 -0.869 . . . . 73.239999999999995 108.653 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.55 -106.97 2.03 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 109.935 -1.266 . . . . 52.049999999999997 109.935 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -115.96 -5.45 11.99 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.503 1.144 . . . . 62.509999999999998 108.864 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -105.25 149.54 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 115.513 -0.767 . . . . 74.099999999999994 109.62 -175.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.427 HG22 ' CG ' ' A' ' 114' ' ' ARG . 99.1 t -111.12 134.76 52.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 109.816 -0.439 . . . . 54.509999999999998 109.816 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.45 HG22 ' HG2' ' A' ' 175' ' ' GLN . 47.4 pt -108.47 137.7 38.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.048 -1.094 . . . . 74.030000000000001 108.048 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.08 131.44 49.07 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 108.988 -0.745 . . . . 70.310000000000002 108.988 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -135.52 122.03 20.68 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.291 -0.868 . . . . 63.020000000000003 109.655 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.68 136.73 8.65 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.451 -0.881 . . . . 73.329999999999998 111.533 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -121.34 137.61 54.62 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 118.001 0.901 . . . . 75.219999999999999 109.645 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -130.16 110.15 11.36 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.21 0.529 . . . . 74.219999999999999 111.11 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.69 107.4 17.42 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.129 -1.063 . . . . 64.439999999999998 108.129 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.14 21.98 16.11 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.931 0.396 . . . . 74.340000000000003 109.993 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 167' ' ' GLY . 39.2 p . . . . . 0 C--N 1.31 -1.128 0 N-CA-C 113.05 0.759 . . . . 73.230000000000004 113.05 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.0 t0 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 122.558 1.171 . . . . 63.25 109.28 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.48 154.8 17.62 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.525 -1.216 . . . . 74.409999999999997 111.097 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 8.5 m-20 -133.07 132.54 41.89 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.193 -0.317 . . . . 71.239999999999995 111.151 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 86.5 t -117.03 124.43 73.0 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 108.463 -0.94 . . . . 73.450000000000003 108.463 176.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -121.23 133.92 55.18 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.336 -0.227 . . . . 71.549999999999997 110.568 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.557 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.7 tm? -119.8 118.12 29.99 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.697 -1.964 . . . . 34.340000000000003 105.697 176.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 31' ' ' SER . 18.2 m -126.6 131.55 51.48 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.356 -0.609 . . . . 63.450000000000003 109.356 -177.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 65.8 t -124.87 126.59 71.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.467 -0.568 . . . . 65.349999999999994 109.467 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.09 126.17 54.79 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.33 -0.989 . . . . 44.020000000000003 108.33 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.597 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.8 p90 -134.1 120.91 15.34 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 112.576 0.584 . . . . 72.140000000000001 112.576 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 26.2 Cg_exo -67.83 39.64 0.2 Allowed 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 123.59 2.86 . . . . 74.409999999999997 112.798 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.62 -107.23 0.33 Allowed 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.529 -0.545 . . . . 64.420000000000002 109.529 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.81 129.18 0.11 Allowed 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.601 -0.889 . . . . 61.340000000000003 108.601 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.59 134.91 26.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.594 -0.891 . . . . 64.329999999999998 108.594 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.5 p -92.36 -38.52 11.98 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.229 0.537 . . . . 74.319999999999993 109.684 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.4 m -161.37 132.96 5.55 Favored 'General case' 0 C--O 1.208 -1.12 0 C-N-CA 123.212 0.605 . . . . 72.209999999999994 109.466 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.2 t -139.7 155.67 47.24 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.121 -0.632 . . . . 74.310000000000002 111.124 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -123.13 95.4 4.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 104.898 -2.26 . . . . 65.420000000000002 104.898 172.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.475 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.33 -155.51 24.48 Favored Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 107.508 -2.237 . . . . 42.32 107.508 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -107.01 99.85 9.38 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.131 0.965 . . . . 61.340000000000003 110.579 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -79.43 114.38 18.32 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.86 -0.609 . . . . 73.030000000000001 109.718 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.5 mt -80.85 -39.48 17.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.42 -1.326 . . . . 73.510000000000005 107.42 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -135.17 168.9 15.41 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 106.472 -1.677 . . . . 73.209999999999994 106.472 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.22 0.33 9.51 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.042 1.828 . . . . 64.349999999999994 109.822 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.5 pt-20 -134.89 10.03 3.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.2 -0.909 . . . . 72.430000000000007 112.109 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.9 t -145.87 120.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.813 -1.18 . . . . 53.020000000000003 107.813 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.99 147.4 32.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.87 -0.789 . . . . 73.150000000000006 108.87 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -137.63 146.65 44.17 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.318 -0.401 . . . . 72.519999999999996 110.019 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.557 ' CE3' HD12 ' A' ' 139' ' ' LEU . 22.8 m-90 -130.1 130.97 45.51 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.995 -1.113 . . . . 74.129999999999995 107.995 176.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -112.59 105.39 13.58 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.638 0.732 . . . . 75.400000000000006 110.632 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.3 mm? -94.03 134.5 36.38 Favored 'General case' 0 C--O 1.271 2.222 0 CA-C-N 115.64 -0.709 . . . . 73.450000000000003 110.493 -175.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 1.4 tpmt? -103.31 145.65 30.99 Favored Pre-proline 0 N--CA 1.419 -2.01 0 C-N-CA 124.063 0.945 . . . . 71.209999999999994 108.98 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -68.25 157.76 60.44 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.789 2.326 . . . . 74.129999999999995 110.813 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.524 ' O ' HG22 ' A' ' 128' ' ' THR . . . 77.61 -22.39 2.74 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 121.054 -0.593 . . . . 73.219999999999999 113.483 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 165' ' ' LYS . 5.7 m -106.07 167.8 3.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.485 0.659 . . . . 41.420000000000002 111.636 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.89 135.94 53.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.833 -1.173 . . . . 64.319999999999993 107.833 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.7 m -149.05 163.9 36.21 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.626 -0.509 . . . . 62.229999999999997 109.626 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 t -139.01 146.14 40.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.403 0.62 . . . . 71.420000000000002 111.311 175.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.2 ptp -112.88 142.91 44.99 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.389 -1.278 . . . . 74.230000000000004 108.763 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.4 m -143.14 147.09 34.39 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 120.044 -0.662 . . . . 74.340000000000003 110.027 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -154.33 147.55 24.81 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 109.1 -0.704 . . . . 73.099999999999994 109.1 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.45 ' HG2' HG22 ' A' ' 120' ' ' ILE . 42.0 mt-30 -141.15 131.52 25.15 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 107.436 -1.32 . . . . 74.219999999999999 107.436 174.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.22 149.16 26.71 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.279 -1.378 . . . . 63.340000000000003 107.279 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.593 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 16.3 ptt180 -93.27 146.65 23.55 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 118.581 -1.248 . . . . 63.119999999999997 110.925 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.402 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 98.6 m-85 -142.33 129.19 20.6 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 109.316 -0.624 . . . . 70.140000000000001 109.316 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 p -67.58 121.16 15.26 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.403 -0.817 . . . . 63.210000000000001 111.317 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.31 -1.129 0 CA-C-N 115.413 -0.812 . . . . 55.229999999999997 109.238 174.174 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.0 mtp180 . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 108.126 -1.064 . . . . 75.140000000000001 108.126 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.5 t -117.09 115.02 47.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.317 -0.994 . . . . 51.149999999999999 108.317 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -115.5 120.87 40.95 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 121.074 0.464 . . . . 61.310000000000002 110.432 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -115.25 108.64 16.84 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.443 -0.947 . . . . 75.5 108.443 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 140' ' ' THR . 34.9 m -117.7 117.37 29.17 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.854 -1.165 . . . . 64.319999999999993 107.854 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -125.73 146.65 31.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 109.776 -0.453 . . . . 74.230000000000004 109.776 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.8 m -125.65 122.58 36.8 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.344 0.593 . . . . 73.340000000000003 109.908 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 143' ' ' PHE . 10.2 tt -101.98 119.01 49.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 108.714 -0.847 . . . . 72.109999999999999 108.714 176.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.5 m -87.43 160.64 47.67 Favored Pre-proline 0 N--CA 1.424 -1.757 0 CA-C-N 115.658 -0.701 . . . . 71.319999999999993 110.158 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -64.92 2.1 1.52 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 123.777 2.984 . . . . 74.549999999999997 113.595 -177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.18 -7.21 57.23 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.192 -0.669 . . . . 75.530000000000001 109.192 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.4 t70 72.54 29.12 2.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 106.86 -1.533 . . . . 74.25 106.86 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.4 146.76 37.78 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.945 -1.502 . . . . 73.540000000000006 106.945 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.516 HG11 HD13 ' A' ' 95' ' ' LEU . 21.2 t -118.39 140.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-O 121.066 0.46 . . . . 54.210000000000001 110.096 -176.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.0 p -137.22 161.82 35.15 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.624 -1.621 . . . . 52.109999999999999 106.624 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.64 -176.35 46.9 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 119.407 -1.377 . . . . 73.439999999999998 112.158 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.54 133.41 14.05 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.412 0.625 . . . . 62.200000000000003 110.273 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 65.0 mt -121.14 116.01 48.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.835 -1.172 . . . . 74.120000000000005 107.835 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.66 119.01 60.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.334 -0.617 . . . . 61.549999999999997 109.334 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.419 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -110.21 108.63 18.83 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.612 -1.625 . . . . 44.32 106.612 174.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -119.86 131.51 55.29 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 120.885 0.374 . . . . 70.400000000000006 111.088 -175.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.58 158.35 44.26 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.478 -0.783 . . . . 44.350000000000001 112.763 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.6 mttt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 115.655 1.724 . . . . 55.210000000000001 115.655 168.302 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.421 -1.882 0 N-CA-C 109.789 -0.449 . . . . 52.25 109.789 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.8 97.81 0.11 Allowed Glycine 0 N--CA 1.42 -2.37 0 C-N-CA 118.846 -1.645 . . . . 52.229999999999997 113.694 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 83' ' ' SER . 74.7 Cg_exo -55.55 151.36 38.6 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.391 2.06 . . . . 71.530000000000001 109.927 166.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.83 119.66 19.48 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.758 -0.46 . . . . 33.350000000000001 109.758 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 81.9 mt -69.63 137.3 52.13 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 123.54 0.525 . . . . 71.129999999999995 110.421 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -97.34 100.04 11.49 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.452 -0.944 . . . . 70.420000000000002 108.452 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.656 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -150.24 92.28 0.14 Allowed Glycine 0 C--N 1.277 -2.721 0 C-N-CA 120.156 -1.021 . . . . 72.409999999999997 113.233 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -106.15 99.67 9.24 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.048 -1.093 . . . . 74.530000000000001 108.048 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.73 155.89 48.47 Favored Pre-proline 0 C--N 1.286 -2.182 0 CA-C-N 115.501 -0.772 . . . . 70.219999999999999 108.958 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.27 -19.08 48.48 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.911 2.407 . . . . 70.549999999999997 112.941 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -107.82 32.75 4.5 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.792 -0.64 . . . . 72.340000000000003 112.212 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.4 m -56.58 -25.64 53.1 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.552 0.215 . . . . 65.040000000000006 111.406 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -64.72 -16.83 63.49 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.116 0.484 . . . . 74.140000000000001 110.599 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -103.11 -15.81 15.94 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.676 -0.693 . . . . 72.439999999999998 110.633 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 p -123.97 118.27 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-O 122.106 0.955 . . . . 55.43 111.406 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.03 109.01 21.1 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.603 -1.181 . . . . 74.439999999999998 109.319 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.5 t -97.95 114.36 35.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.812 -1.551 . . . . 53.299999999999997 106.812 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 m -125.68 171.8 10.3 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.729 -0.668 . . . . 72.340000000000003 109.796 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -88.25 151.1 22.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.397 -1.334 . . . . 73.430000000000007 107.397 174.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 67.7 t80 -115.3 125.05 52.8 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 108.299 -1.0 . . . . 71.129999999999995 108.299 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -138.69 99.61 3.85 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.566 -2.013 . . . . 60.210000000000001 105.566 174.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 42.6 t -172.51 148.04 1.95 Allowed 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.403 -0.962 . . . . 75.099999999999994 108.403 -174.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 69.32 10.04 7.59 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.998 0.919 . . . . 63.039999999999999 111.079 174.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.02 -3.78 67.31 Favored Glycine 0 N--CA 1.423 -2.173 0 CA-C-N 115.279 -0.873 . . . . 73.140000000000001 111.782 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.538 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 41.5 m-85 -104.2 146.28 29.0 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.374 0.587 . . . . 74.319999999999993 110.491 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.77 136.5 51.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 N-CA-C 108.308 -0.997 . . . . 73.519999999999996 108.308 172.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -167.1 -155.17 8.89 Favored Glycine 0 C--N 1.263 -3.492 0 C-N-CA 118.863 -1.637 . . . . 52.100000000000001 112.512 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' A' ' 58' ' ' PRO . 24.0 t -136.97 143.73 42.97 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 108.641 -0.874 . . . . 71.519999999999996 108.641 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -131.86 137.42 48.05 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.952 -0.567 . . . . 72.319999999999993 110.947 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.21 114.21 27.26 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.743 -1.577 . . . . 75.099999999999994 106.743 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.96 120.7 62.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.966 -1.124 . . . . 75.219999999999999 107.966 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.497 ' CD2' HD12 ' A' ' 90' ' ' LEU . 45.2 p90 -126.73 149.48 49.58 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.786 -0.765 . . . . 63.350000000000001 111.62 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.4 m -156.23 152.09 27.36 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.765 -0.652 . . . . 74.099999999999994 109.484 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.3 t70 64.46 48.75 2.62 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 122.577 1.18 . . . . 61.340000000000003 111.111 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 87' ' ' PHE . 23.2 mt -112.07 169.88 8.54 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.041 -0.982 . . . . 74.030000000000001 108.584 175.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.507 HG22 ' OE1' ' A' ' 94' ' ' GLU . 13.1 t -128.38 -178.84 4.72 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.923 -1.111 . . . . 70.150000000000006 110.955 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -50.32 -42.84 53.35 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.329 1.452 . . . . 64.140000000000001 111.146 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.37 -27.97 69.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.46 0.541 . . . . 44.530000000000001 112.46 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.507 ' OE1' HG22 ' A' ' 91' ' ' THR . 3.9 mp0 -88.48 -17.61 29.98 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 112.559 0.577 . . . . 73.310000000000002 112.559 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.516 HD13 HG11 ' A' ' 40' ' ' VAL . 40.4 tp -57.62 -47.38 99.06 Favored Pre-proline 0 CA--C 1.567 1.629 0 N-CA-C 113.807 1.04 . . . . 74.129999999999995 113.807 -177.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.64 -32.32 7.76 Favored 'Trans proline' 0 C--N 1.359 1.1 0 CA-C-N 120.72 1.293 . . . . 41.100000000000001 110.96 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -68.92 -34.68 75.78 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.992 -0.549 . . . . 75.349999999999994 111.29 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -74.16 -19.13 60.66 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.9 0.381 . . . . 73.230000000000004 110.189 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.26 -22.64 63.82 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.873 -0.603 . . . . 65.439999999999998 110.678 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -58.5 -57.87 11.02 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.638 -0.875 . . . . 65.140000000000001 108.638 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.656 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.5 ttp -54.46 -50.33 67.95 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.436 -0.802 . . . . 73.439999999999998 110.062 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -55.03 -40.07 69.81 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 114.854 -1.066 . . . . 71.310000000000002 111.367 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.9 p -69.47 -19.25 63.76 Favored 'General case' 0 N--CA 1.42 -1.967 0 C-N-CA 119.63 -0.828 . . . . 72.230000000000004 112.631 -171.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.34 -28.29 69.9 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 121.583 0.706 . . . . 62.530000000000001 110.06 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.7 -8.2 16.97 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.932 -0.577 . . . . 75.120000000000005 110.829 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.19 -34.29 7.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.557 0.947 . . . . 43.539999999999999 113.557 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.69 26.77 66.52 Favored Glycine 0 N--CA 1.46 0.264 0 N-CA-C 111.125 -0.79 . . . . 74.230000000000004 111.125 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.22 156.35 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.673 0.749 . . . . 75.099999999999994 112.376 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -117.56 121.45 40.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.964 -2.606 . . . . 70.450000000000003 103.964 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.9 mt -123.29 134.39 54.07 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 118.382 0.537 . . . . 72.340000000000003 111.185 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.7 m -126.66 128.04 46.11 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.575 -0.898 . . . . 75.420000000000002 108.575 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 tp -125.86 125.25 42.53 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.577 -0.527 . . . . 63.439999999999998 109.577 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -138.02 145.76 42.24 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.663 -0.495 . . . . 73.5 109.663 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -98.85 137.95 36.68 Favored 'General case' 0 N--CA 1.399 -3.008 0 N-CA-C 107.71 -1.219 . . . . 74.099999999999994 107.71 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.413 ' O ' HG13 ' A' ' 118' ' ' ILE . 46.8 t30 -124.77 87.08 2.65 Favored 'General case' 0 C--N 1.269 -2.897 0 N-CA-C 107.469 -1.308 . . . . 63.420000000000002 107.469 -177.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.52 -115.99 5.57 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.576 -1.41 . . . . 61.539999999999999 109.576 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -104.95 -1.88 25.27 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.106 0.955 . . . . 74.239999999999995 108.889 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.549 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -101.84 148.99 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.799 -1.186 . . . . 53.520000000000003 107.799 179.099 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.1 t -117.28 138.53 47.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 O-C-N 121.762 -0.586 . . . . 72.120000000000005 110.59 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.5 pt -120.5 135.49 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-O 121.542 0.687 . . . . 75.150000000000006 109.81 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.9 tt -128.18 127.0 42.11 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.351 -1.351 . . . . 63.229999999999997 107.351 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.99 139.58 41.55 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.671 -0.863 . . . . 74.209999999999994 108.671 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.98 -175.57 34.99 Favored Glycine 0 N--CA 1.402 -3.625 0 C-N-CA 120.345 -0.931 . . . . 61.030000000000001 111.472 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -145.47 157.3 44.03 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.117 -1.068 . . . . 65.530000000000001 108.117 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.3 109.54 11.56 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.797 -0.446 . . . . 53.520000000000003 109.797 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -112.7 93.63 4.52 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.641 -0.874 . . . . 53.25 108.641 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.348 0.0 OUTLIER -125.36 54.64 1.45 Allowed 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 124.257 1.979 . . . . 74.019999999999996 109.677 176.065 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 N--CA 1.427 -1.599 0 CA-C-N 112.235 -2.257 . . . . 74.409999999999997 111.499 -175.474 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 120.929 0.395 . . . . 75.439999999999998 110.521 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.69 129.17 45.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 111.73 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -133.76 127.08 32.02 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.27 -1.011 . . . . 54.210000000000001 108.27 171.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 66.3 t -114.53 112.97 42.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.94 -1.133 . . . . 63.420000000000002 107.94 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -107.51 122.07 45.91 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.612 -0.514 . . . . 55.509999999999998 109.612 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.572 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.8 tm? -111.8 119.16 37.66 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.383 -1.71 . . . . 74.040000000000006 106.383 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 31' ' ' SER . 7.1 m -126.8 130.58 50.53 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.328 -0.619 . . . . 73.019999999999996 109.328 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 85.0 t -122.67 124.83 71.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.259 -0.645 . . . . 43.350000000000001 109.259 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.21 127.34 55.57 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.383 -0.599 . . . . 70.349999999999994 109.383 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.441 ' HB3' HG23 ' A' ' 34' ' ' ILE . 2.9 p90 -134.55 117.16 13.08 Favored Pre-proline 0 C--N 1.287 -2.128 0 CA-C-N 116.232 -0.44 . . . . 75.109999999999999 111.207 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.49 27.32 0.14 Allowed 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 122.846 2.364 . . . . 53.399999999999999 113.234 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -106.63 -92.34 0.4 Allowed 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.036 -0.728 . . . . 73.150000000000006 109.036 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.22 131.07 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.537 1.135 . . . . 73.200000000000003 107.987 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.92 137.95 20.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.689 -0.856 . . . . 71.239999999999995 108.689 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.7 p -91.94 -45.78 8.17 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.391 -0.596 . . . . 65.340000000000003 109.391 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.1 m -150.24 132.95 15.89 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.373 -0.83 . . . . 74.230000000000004 109.119 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.413 ' OG1' HG11 ' A' ' 160' ' ' VAL . 6.9 t -139.07 159.34 42.37 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.677 -0.64 . . . . 60.210000000000001 110.248 175.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 25.5 t-20 -131.01 97.91 4.44 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 104.723 -2.325 . . . . 60.450000000000003 104.723 172.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.69 -141.81 6.59 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.167 -1.573 . . . . 72.400000000000006 109.167 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -118.65 99.07 6.55 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 117.587 0.693 . . . . 70.409999999999997 110.129 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -75.16 130.33 39.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.853 -0.53 . . . . 71.450000000000003 111.087 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 61.1 mt -90.32 -48.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.65 -1.611 . . . . 44.219999999999999 106.65 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -136.28 171.94 7.9 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.136 -1.801 . . . . 74.239999999999995 106.136 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -75.97 -1.56 11.56 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.594 1.529 . . . . 51.119999999999997 111.082 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.27 1.96 7.8 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.707 -0.679 . . . . 71.049999999999997 111.457 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 68.1 t -143.77 120.96 5.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.576 -0.898 . . . . 64.549999999999997 108.576 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.413 HG11 ' OG1' ' A' ' 150' ' ' THR . 56.7 t -123.98 148.3 28.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.06 -0.719 . . . . 74.430000000000007 109.06 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -135.93 151.42 49.94 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.174 -0.676 . . . . 50.420000000000002 109.174 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.572 ' CE3' HD12 ' A' ' 139' ' ' LEU . 26.3 m-90 -132.47 128.68 37.94 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.222 -1.399 . . . . 64.409999999999997 107.222 175.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.17 105.29 15.2 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.919 0.866 . . . . 75.25 110.681 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.3 mp -87.8 130.56 34.82 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.478 -1.237 . . . . 72.239999999999995 109.664 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -118.15 146.89 40.33 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 115.204 -0.907 . . . . 74.019999999999996 111.144 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.93 149.86 86.04 Favored 'Trans proline' 0 N--CA 1.476 0.448 0 C-N-CA 123.389 2.726 . . . . 51.140000000000001 111.985 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.71 -27.43 2.57 Favored Glycine 0 C--N 1.308 -1.027 0 C-N-CA 121.218 -0.515 . . . . 75.239999999999995 113.169 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.5 m -105.57 154.44 6.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.198 0.523 . . . . 62.310000000000002 111.275 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 p -98.08 143.87 12.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.926 -0.768 . . . . 75.430000000000007 108.926 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 30.7 m -134.38 153.69 51.76 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.653 -0.499 . . . . 52.240000000000002 109.653 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.1 p -106.94 153.77 22.06 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.702 0.287 . . . . 75.519999999999996 111.063 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 40.1 tpp -124.95 116.87 22.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.031 -0.729 . . . . 74.319999999999993 109.031 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 8.3 t -143.57 132.5 22.8 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.022 -1.071 . . . . 74.439999999999998 109.876 172.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.83 122.94 8.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.759 -0.83 . . . . 63.329999999999998 108.759 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -127.94 132.01 49.28 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.635 -0.876 . . . . 71.450000000000003 108.635 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -156.75 158.09 36.26 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.902 -0.407 . . . . 43.030000000000001 109.902 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 118' ' ' ILE . 70.2 mtp180 -89.13 136.66 32.89 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.756 -0.461 . . . . 72.409999999999997 109.756 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -142.68 128.39 19.26 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 109.472 -0.566 . . . . 62.229999999999997 109.472 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 12.8 p -56.38 109.96 0.69 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 124.231 0.957 . . . . 63.210000000000001 112.727 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 CA--C 1.51 -0.592 0 O-C-N 123.951 0.782 . . . . 64.430000000000007 109.476 177.363 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HD3' ' OE1' ' A' ' 138' ' ' GLU . 28.8 ttm180 . . . . . 0 N--CA 1.412 -2.334 0 N-CA-C 109.09 -0.707 . . . . 74.0 109.09 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 61.8 t -109.36 113.77 45.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 105.543 -2.021 . . . . 74.129999999999995 105.543 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 35.1 ttt180 -126.34 118.65 25.48 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-O 121.504 0.668 . . . . 74.239999999999995 110.369 -177.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.94 109.84 19.52 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.677 -1.147 . . . . 63.439999999999998 108.054 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.4 m -110.94 115.42 29.48 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 107.42 -1.326 . . . . 75.120000000000005 107.42 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -127.8 146.3 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 109.532 -0.544 . . . . 62.219999999999999 109.532 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.6 m -124.42 125.03 43.59 Favored 'General case' 0 C--N 1.272 -2.803 0 CA-C-N 115.928 -0.578 . . . . 64.420000000000002 109.596 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.9 tt -114.92 124.79 71.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.531 0.681 . . . . 71.340000000000003 109.62 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m -100.07 157.36 34.0 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 115.75 -0.659 . . . . 74.239999999999995 110.674 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD3' ' HG2' ' A' ' 144' ' ' PRO . 64.6 Cg_exo -58.24 -2.51 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 124.355 3.37 . . . . 64.230000000000004 113.476 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 19.5 m-20 -82.08 -0.19 43.41 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 125.278 1.431 . . . . 65.200000000000003 110.732 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.2 t70 66.86 29.81 8.14 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.855 -1.535 . . . . 71.530000000000001 106.855 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -120.92 136.95 54.82 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 112.999 -1.909 . . . . 74.120000000000005 108.602 -175.026 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 95' ' ' LEU . 22.0 t -121.35 137.19 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 115.106 -0.952 . . . . 72.120000000000005 109.3 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.3 p -138.49 149.9 45.88 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.681 -1.229 . . . . 64.120000000000005 107.681 174.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.09 -175.7 47.43 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 118.012 -2.042 . . . . 24.329999999999998 113.884 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.99 133.73 28.85 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.348 -0.926 . . . . 60.43 108.879 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.5 mt -121.19 116.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 107.776 -1.194 . . . . 70.540000000000006 107.776 176.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -120.08 115.54 47.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 120.762 0.315 . . . . 74.019999999999996 110.247 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . . . -107.92 108.21 19.26 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.444 -1.687 . . . . 52.310000000000002 106.444 174.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.474 ' HB1' ' CB ' ' A' ' 80' ' ' TYR . . . -122.82 126.22 46.96 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.309 0.576 . . . . 72.420000000000002 112.511 -172.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.98 157.81 21.97 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.573 -0.899 . . . . 52.509999999999998 108.573 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 tttp . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 106.706 -1.591 . . . . 71.120000000000005 106.706 178.266 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.44 -0.929 0 CA-C-O 121.162 0.506 . . . . 73.010000000000005 110.817 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.414 ' HA3' ' CG ' ' A' ' 74' ' ' ASN . . . 172.31 97.62 0.11 Allowed Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.678 -0.772 . . . . 54.219999999999999 111.547 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.28 159.4 52.43 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.18 1.92 . . . . 73.5 110.836 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.23 154.13 33.87 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.574 -0.528 . . . . 74.129999999999995 109.574 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 83' ' ' SER . 6.6 mp -68.95 145.97 53.17 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 120.95 0.405 . . . . 73.5 111.52 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -112.52 108.88 18.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.281 -0.872 . . . . 62.140000000000001 109.187 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.9 -72.55 0.01 OUTLIER Glycine 0 C--N 1.265 -3.369 0 C-N-CA 120.194 -1.003 . . . . 54.350000000000001 112.103 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 71.17 124.54 0.03 OUTLIER 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.392 1.077 . . . . 42.530000000000001 110.519 -173.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.67 162.15 56.69 Favored Pre-proline 0 C--N 1.293 -1.877 0 CA-C-N 115.222 -0.899 . . . . 43.32 108.911 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.79 -16.25 47.77 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 122.882 2.388 . . . . 74.430000000000007 113.187 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.431 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 33.2 p90 -116.01 48.66 1.2 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.429 0.633 . . . . 72.299999999999997 111.786 -176.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m -55.85 -37.43 68.74 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.53 0.567 . . . . 75.140000000000001 112.53 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -67.56 -11.57 58.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.5 0.667 . . . . 63.43 111.426 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 66' ' ' PHE . 14.0 mmmm -95.56 -18.02 20.93 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.577 -0.738 . . . . 71.299999999999997 110.176 -177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.6 119.76 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.913 0.863 . . . . 71.019999999999996 111.66 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.62 111.48 23.81 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.545 -0.752 . . . . 75.25 109.575 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 85' ' ' ALA . 4.4 p -98.28 139.25 20.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.096 -1.075 . . . . 63.210000000000001 108.096 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -150.9 170.3 19.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.196 0.522 . . . . 64.450000000000003 110.948 -170.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.414 ' CG ' ' HA3' ' A' ' 57' ' ' GLY . 35.3 t-20 -84.16 128.98 34.91 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.122 -1.436 . . . . 71.319999999999993 107.122 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 88.3 t80 -108.83 122.05 46.37 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.61 -0.436 . . . . 72.420000000000002 110.279 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -138.77 109.49 6.65 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.913 -1.143 . . . . 72.340000000000003 107.913 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 46.6 t -168.68 147.61 4.21 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.657 -0.701 . . . . 71.400000000000006 109.329 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.87 19.28 11.66 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.644 0.979 . . . . 74.109999999999999 113.644 171.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.87 0.31 62.24 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 120.543 -0.836 . . . . 64.519999999999996 111.794 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.474 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . 49.9 m-85 -104.77 161.14 14.42 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 120.755 0.312 . . . . 65.120000000000005 110.181 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.98 136.46 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 106.049 -1.834 . . . . 75.109999999999999 106.049 163.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.82 -155.22 9.51 Favored Glycine 0 N--CA 1.408 -3.207 0 C-N-CA 119.605 -1.283 . . . . 72.109999999999999 112.957 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.484 ' HB3' HD12 ' A' ' 60' ' ' LEU . 5.3 m -118.12 141.36 48.57 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 114.531 -0.835 . . . . 42.32 109.918 -174.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.42 148.72 47.92 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.702 -0.799 . . . . 74.019999999999996 111.132 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . . . -131.81 115.1 15.52 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.427 -1.323 . . . . 40.329999999999998 107.427 175.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.1 t -108.74 117.82 54.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.386 -0.968 . . . . 72.25 108.386 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CD2' HD12 ' A' ' 90' ' ' LEU . 51.2 p90 -121.05 151.91 39.26 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.069 0.461 . . . . 71.400000000000006 110.651 -175.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -155.36 160.41 40.68 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.223 -0.444 . . . . 71.540000000000006 111.383 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 60.93 30.2 19.48 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.895 1.278 . . . . 74.549999999999997 110.867 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 87' ' ' PHE . 17.7 mt -87.79 161.08 17.76 Favored 'General case' 0 N--CA 1.413 -2.301 0 CA-C-N 115.914 -0.584 . . . . 71.340000000000003 109.62 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.407 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.7 t -122.53 177.6 5.35 Favored 'General case' 0 C--N 1.258 -3.375 0 N-CA-C 109.311 -0.626 . . . . 73.420000000000002 109.311 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -55.9 -35.42 66.52 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 123.977 0.911 . . . . 73.450000000000003 111.776 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.66 -26.29 62.48 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.27 0.557 . . . . 43.539999999999999 111.861 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' A' ' 90' ' ' LEU . 46.4 mt-10 -88.26 -20.49 25.39 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.032 0.444 . . . . 75.319999999999993 109.855 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 54.9 tp -58.91 -54.69 53.96 Favored Pre-proline 0 CA--C 1.566 1.577 0 N-CA-C 114.453 1.279 . . . . 65.010000000000005 114.453 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -74.11 -28.34 10.97 Favored 'Trans proline' 0 C--N 1.362 1.276 0 CA-C-N 121.23 1.475 . . . . 64.230000000000004 110.292 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -70.03 -29.61 66.69 Favored 'General case' 0 N--CA 1.402 -2.845 0 CA-C-N 114.932 -1.031 . . . . 72.140000000000001 110.842 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -75.82 -22.69 56.06 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 109.388 -0.597 . . . . 74.5 109.388 175.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -17.72 62.42 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.812 -0.631 . . . . 64.349999999999994 111.118 -175.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -63.61 -57.61 9.54 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.912 -0.773 . . . . 74.319999999999993 108.912 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 38.6 ttp -59.86 -47.44 85.72 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.641 -0.708 . . . . 44.200000000000003 110.386 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -57.51 -29.78 64.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.077 -0.965 . . . . 73.019999999999996 111.144 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -60.91 -37.35 81.97 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.889 -0.411 . . . . 62.43 109.889 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.5 -20.5 65.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.258 0.551 . . . . 73.140000000000001 111.073 -175.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.59 -21.27 15.33 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 120.282 -0.567 . . . . 52.100000000000001 110.826 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.42 -47.95 3.81 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.103 -0.639 . . . . 75.409999999999997 112.166 -171.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.03 12.1 60.64 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 121.014 -0.612 . . . . 72.120000000000005 111.787 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.5 m -106.64 162.65 5.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 120.81 0.338 . . . . 74.120000000000005 110.832 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -123.07 125.22 44.79 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.613 -0.884 . . . . 74.200000000000003 108.613 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 87.4 mt -125.77 111.73 15.23 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 110.007 -0.368 . . . . 73.120000000000005 110.007 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.6 t -105.45 138.29 41.88 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.076 -1.453 . . . . 71.519999999999996 107.076 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 pp -149.96 153.95 37.44 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.968 -0.693 . . . . 71.25 112.248 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -158.58 167.85 28.49 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.316 -1.311 . . . . 63.140000000000001 110.245 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HD2' HH11 ' A' ' 114' ' ' ARG . 5.4 ttt180 -112.71 138.2 49.89 Favored 'General case' 0 N--CA 1.389 -3.506 0 N-CA-C 107.645 -1.243 . . . . 71.019999999999996 107.645 172.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -115.29 89.79 3.18 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 106.625 -1.621 . . . . 70.230000000000004 106.625 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.32 -103.83 1.01 Allowed Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.661 -0.976 . . . . 60.130000000000003 110.661 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -99.79 -24.71 14.6 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.83 0.824 . . . . 73.030000000000001 110.333 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -96.13 140.11 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 C-N-CA 118.664 -1.214 . . . . 72.120000000000005 109.607 -173.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.2 t -102.27 136.29 35.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.53 0 N-CA-C 109.617 -0.512 . . . . 73.200000000000003 109.617 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.1 pt -117.7 133.36 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 121.642 0.734 . . . . 64.310000000000002 109.924 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 tt -128.22 122.33 31.54 Favored 'General case' 0 C--N 1.273 -2.747 0 N-CA-C 107.873 -1.158 . . . . 65.129999999999995 107.873 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.34 127.27 37.3 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.755 -0.831 . . . . 73.439999999999998 108.755 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.62 -178.74 23.96 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 119.56 -1.305 . . . . 43.420000000000002 112.434 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.1 mtp85 -144.23 155.58 43.94 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 123.986 0.915 . . . . 74.109999999999999 109.103 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.73 108.47 11.55 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 107.067 -1.457 . . . . 74.310000000000002 107.067 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -107.31 92.35 4.04 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.742 -1.207 . . . . 73.239999999999995 107.742 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.4 mt -120.7 12.11 11.35 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.803 -1.544 . . . . 71.430000000000007 108.811 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.467 ' HA ' ' CA ' ' A' ' 167' ' ' GLY . 1.3 m . . . . . 0 C--N 1.291 -1.969 0 CA-C-N 114.71 -1.132 . . . . 73.209999999999994 112.11 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 121.03 0.443 . . . . 64.25 110.938 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.28 145.22 11.3 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.519 1.127 . . . . 63.509999999999998 113.855 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 2.5 m-20 -125.89 120.04 29.38 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-N 115.248 -0.887 . . . . 54.520000000000003 109.088 176.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 69.3 t -106.69 113.11 42.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.96 -1.126 . . . . 70.230000000000004 107.96 174.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 44.7 mt-10 -108.37 120.73 43.24 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.268 -0.642 . . . . 44.450000000000003 109.268 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.495 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.9 tm? -111.03 118.08 35.08 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 105.302 -2.11 . . . . 61.25 105.302 175.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.2 m -123.39 125.38 44.87 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.555 -0.535 . . . . 25.43 109.555 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 98.1 t -118.46 125.21 74.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.471 -0.566 . . . . 54.130000000000003 109.471 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.99 127.68 56.29 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.658 -0.867 . . . . 63.520000000000003 108.658 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.686 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.6 p90 -134.76 120.81 14.55 Favored Pre-proline 0 C--N 1.287 -2.124 0 CA-C-N 116.589 -0.278 . . . . 74.209999999999994 111.359 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.422 ' HG2' ' HD3' ' A' ' 36' ' ' PRO . 19.7 Cg_endo -70.8 40.62 0.36 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.605 2.204 . . . . 71.519999999999996 112.523 176.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.5 -110.03 0.31 Allowed 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.86 -0.609 . . . . 40.5 109.531 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -176.32 131.51 0.22 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.578 -0.526 . . . . 61.340000000000003 109.578 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.97 144.23 10.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.304 -0.862 . . . . 63.439999999999998 109.316 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.4 t -110.22 -30.67 7.63 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.457 -0.497 . . . . 71.409999999999997 110.457 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.6 m -156.64 131.82 9.18 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.66 -0.867 . . . . 73.409999999999997 108.66 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.5 t -139.74 161.2 38.11 Favored 'General case' 0 C--N 1.285 -2.2 0 O-C-N 122.022 -0.424 . . . . 42.140000000000001 110.569 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -133.19 87.63 2.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 104.845 -2.28 . . . . 54.140000000000001 104.845 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.27 -144.54 8.05 Favored Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 108.905 -1.678 . . . . 63.329999999999998 108.905 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -118.28 107.73 14.26 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 118.112 0.956 . . . . 71.230000000000004 111.407 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -82.08 118.02 22.71 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.484 0.659 . . . . 64.219999999999999 110.307 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.89 -40.01 16.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.186 -1.412 . . . . 64.019999999999996 107.186 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 157' ' ' PRO . 51.2 mt-10 -137.18 167.15 22.1 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 106.461 -1.681 . . . . 72.409999999999997 106.461 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 156' ' ' GLU . 55.8 Cg_endo -73.07 -0.21 8.76 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.896 1.731 . . . . 72.140000000000001 110.947 177.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.686 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 7.8 pt-20 -130.73 3.72 4.53 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.006 -0.997 . . . . 73.349999999999994 111.329 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.42 121.39 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.132 -0.692 . . . . 64.099999999999994 109.132 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.32 143.66 39.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.226 -0.657 . . . . 75.120000000000005 109.226 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.96 151.46 52.06 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.363 -0.606 . . . . 70.439999999999998 109.363 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.495 ' CE3' HD12 ' A' ' 139' ' ' LEU . 28.0 m-90 -132.68 128.62 37.4 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.24 -0.652 . . . . 74.340000000000003 109.24 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -100.14 113.66 26.47 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.372 0.606 . . . . 74.120000000000005 109.796 171.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 22.4 mt -102.09 133.18 47.35 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.468 -0.938 . . . . 74.420000000000002 108.468 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -117.93 145.45 36.76 Favored Pre-proline 0 C--N 1.309 -1.168 0 CA-C-N 115.935 -0.575 . . . . 65.129999999999995 112.117 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.24 161.44 44.61 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.574 2.183 . . . . 73.340000000000003 110.705 173.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 128' ' ' THR . . . 68.79 -9.93 1.74 Allowed Glycine 0 N--CA 1.472 1.072 0 N-CA-C 114.381 0.512 . . . . 65.120000000000005 114.381 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.66 171.09 9.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.484 -0.561 . . . . 62.240000000000002 109.484 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.88 142.02 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.624 -0.88 . . . . 65.140000000000001 108.624 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 40.9 m -140.81 143.74 35.0 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.91 -0.494 . . . . 61.329999999999998 110.905 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.8 p -108.12 141.14 40.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.368 -0.604 . . . . 74.150000000000006 109.368 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 80.4 mtp -123.66 130.03 52.02 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.276 -0.639 . . . . 74.519999999999996 109.276 -175.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.5 m -143.74 140.18 29.83 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.902 -0.719 . . . . 72.409999999999997 110.806 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.467 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -147.64 120.44 8.68 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.044 -1.095 . . . . 74.239999999999995 108.044 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -127.73 130.15 48.3 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 107.632 -1.247 . . . . 74.109999999999999 107.632 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.33 153.69 38.97 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.733 -0.469 . . . . 71.5 109.733 -175.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 48.9 mtm180 -96.66 126.26 41.7 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.983 -0.747 . . . . 75.010000000000005 108.983 -176.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -134.01 150.03 51.22 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.34 -0.985 . . . . 73.510000000000005 108.34 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.99 108.57 1.24 Allowed 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 120.971 0.415 . . . . 75.239999999999995 110.931 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 . . . . . 0 N--CA 1.434 -1.273 0 N-CA-C 113.564 0.95 . . . . 73.420000000000002 113.564 -177.417 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 16.6 ptp180 . . . . . 0 N--CA 1.418 -2.071 0 CA-C-O 121.245 0.545 . . . . 65.409999999999997 110.44 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.09 114.66 47.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.42 -0.809 . . . . 73.530000000000001 108.906 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -115.58 114.18 24.6 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.441 -0.799 . . . . 73.150000000000006 109.475 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' HB3' HD22 ' A' ' 139' ' ' LEU . . . -110.54 108.77 18.84 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 107.66 -1.237 . . . . 52.229999999999997 107.66 176.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.3 t -119.71 115.36 23.75 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.989 -1.115 . . . . 65.329999999999998 107.989 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -127.98 147.17 32.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.157 0.503 . . . . 62.340000000000003 110.089 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.8 m -129.29 132.73 47.21 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 109.742 -0.466 . . . . 53.030000000000001 109.742 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.546 ' O ' ' HD2' ' A' ' 144' ' ' PRO . 10.8 tt -118.61 111.12 32.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.952 0.882 . . . . 74.519999999999996 111.023 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.2 m -76.62 163.97 62.5 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 114.177 -1.374 . . . . 70.510000000000005 111.214 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.67 0.61 5.32 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.865 2.377 . . . . 73.120000000000005 113.323 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 13.8 t70 -91.46 -0.49 57.63 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.026 -1.102 . . . . 60.409999999999997 108.026 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 91' ' ' THR . 25.6 t70 67.79 33.45 4.83 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.612 -1.625 . . . . 73.200000000000003 106.612 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -97.73 124.65 42.16 Favored 'General case' 0 N--CA 1.391 -3.411 0 CA-C-N 113.082 -1.872 . . . . 74.430000000000007 106.541 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.449 HG11 HD13 ' A' ' 95' ' ' LEU . 12.0 t -110.34 129.7 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 108.549 -0.908 . . . . 62.340000000000003 108.549 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.1 p -139.92 144.21 37.01 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 107.443 -1.317 . . . . 45.039999999999999 107.443 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.07 -174.77 41.18 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 118.861 -1.638 . . . . 72.140000000000001 112.412 -177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -145.27 133.37 21.49 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.011 -0.594 . . . . 70.519999999999996 109.879 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.0 mt -118.86 115.69 48.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 106.977 -1.49 . . . . 53.210000000000001 106.977 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.31 116.05 51.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.723 -0.473 . . . . 64.040000000000006 109.723 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.492 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -108.22 108.32 19.31 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.689 -1.597 . . . . 73.239999999999995 106.689 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -120.24 129.46 54.07 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.692 0.282 . . . . 70.329999999999998 111.024 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.84 144.02 49.48 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.519 -0.919 . . . . 73.329999999999998 108.519 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 tttp . . . . . 0 C--N 1.292 -1.93 0 N-CA-C 107.746 -1.205 . . . . 73.549999999999997 107.746 177.4 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.43 -1.449 0 CA-C-O 121.019 0.438 . . . . 74.439999999999998 109.863 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.64 97.11 0.11 Allowed Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.778 -0.725 . . . . 62.420000000000002 113.081 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -73.13 160.55 45.22 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.355 2.703 . . . . 74.549999999999997 110.844 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -131.24 133.93 45.93 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.863 -0.421 . . . . 64.030000000000001 109.863 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' O ' HG11 ' A' ' 72' ' ' VAL . 94.6 mt -75.82 140.87 42.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.754 -0.461 . . . . 72.340000000000003 109.754 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -111.63 99.86 8.51 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.226 0.536 . . . . 34.020000000000003 109.557 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.67 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -115.01 94.77 0.68 Allowed Glycine 0 C--N 1.274 -2.914 0 N-CA-C 110.952 -0.859 . . . . 65.129999999999995 110.952 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.54 96.55 10.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.956 -0.757 . . . . 74.209999999999994 108.956 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.91 161.61 45.76 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.203 -0.908 . . . . 65.319999999999993 109.145 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.68 -26.68 82.91 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.443 2.095 . . . . 63.350000000000001 111.313 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.429 ' HB2' ' CG ' ' A' ' 69' ' ' LYS . 31.6 p90 -107.73 41.96 1.43 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.419 -0.809 . . . . 71.219999999999999 111.905 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.1 m -59.5 -28.09 66.73 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 111.72 0.267 . . . . 74.329999999999998 111.72 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -66.58 -18.6 65.45 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.421 0.629 . . . . 71.400000000000006 110.824 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' CG ' ' HB2' ' A' ' 66' ' ' PHE . 32.7 mmtp -89.64 -19.81 24.43 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.61 -0.723 . . . . 62.439999999999998 109.993 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.67 121.19 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.855 0.835 . . . . 60.409999999999997 112.552 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.14 114.48 28.81 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.08 -0.963 . . . . 71.219999999999999 108.843 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 60' ' ' LEU . 58.1 t -98.27 141.52 16.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.004 -1.11 . . . . 75.319999999999993 108.004 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 m -148.51 167.93 24.07 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.275 -0.639 . . . . 71.140000000000001 109.275 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -82.76 154.12 24.92 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.446 -1.316 . . . . 71.010000000000005 107.446 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 75.2 t80 -116.65 124.55 50.01 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 109.281 -0.637 . . . . 73.219999999999999 109.281 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -138.62 99.6 3.86 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.013 -1.106 . . . . 73.140000000000001 108.013 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.2 m -156.59 137.9 13.83 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.238 -0.437 . . . . 71.010000000000005 110.014 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.03 0.41 2.38 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.182 1.393 . . . . 74.439999999999998 112.893 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.34 9.83 43.36 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.876 -1.154 . . . . 44.43 111.23 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.479 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 74.2 m-85 -105.04 142.5 34.72 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.368 -0.975 . . . . 73.140000000000001 108.368 171.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 33.8 m -124.09 136.79 59.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.315 -0.994 . . . . 61.420000000000002 108.315 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -165.6 -155.14 8.47 Favored Glycine 0 C--N 1.262 -3.583 0 C-N-CA 119.077 -1.535 . . . . 43.219999999999999 111.791 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.429 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 13.0 p -128.75 137.4 51.54 Favored 'General case' 0 C--N 1.267 -3.011 0 O-C-N 124.43 0.723 . . . . 73.010000000000005 110.354 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.12 146.09 50.81 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 120.815 0.34 . . . . 73.140000000000001 110.897 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -124.41 115.03 20.29 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.55 -1.278 . . . . 54.240000000000002 107.55 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.0 t -108.03 119.39 57.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 107.712 -1.218 . . . . 72.310000000000002 107.712 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.539 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.1 p90 -118.2 155.98 29.57 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.689 -0.404 . . . . 73.430000000000007 111.137 -175.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.4 p -156.53 157.63 35.74 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.791 -0.64 . . . . 63.149999999999999 110.488 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 63.98 35.12 10.93 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.59 1.186 . . . . 63.229999999999997 111.319 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.539 HD12 ' CD2' ' A' ' 87' ' ' PHE . 52.7 mt -96.9 167.11 11.29 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.728 -0.669 . . . . 73.319999999999993 110.34 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 4.9 t -126.3 169.99 12.35 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.521 -1.659 . . . . 54.310000000000002 106.521 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -57.14 -33.53 67.49 Favored 'General case' 0 C--O 1.205 -1.279 0 CA-C-N 118.928 0.786 . . . . 73.129999999999995 112.443 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.57 -29.67 70.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.707 0.765 . . . . 63.509999999999998 111.304 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.03 -16.82 34.5 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.536 -0.756 . . . . 64.420000000000002 110.318 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.658 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 51.5 tp -62.31 -54.84 45.53 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 114.053 1.131 . . . . 61.240000000000002 114.053 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.32 -33.59 69.99 Favored 'Trans proline' 0 C--N 1.368 1.6 0 CA-C-N 121.357 1.52 . . . . 70.450000000000003 110.598 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -67.68 -35.08 78.18 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-N 114.882 -1.054 . . . . 74.310000000000002 110.755 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.7 pp -78.24 -20.13 52.33 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.909 -0.774 . . . . 74.310000000000002 108.909 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.64 -21.24 62.64 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.636 -0.711 . . . . 53.200000000000003 110.691 -174.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -58.87 -57.11 14.5 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 108.468 -0.938 . . . . 75.319999999999993 108.468 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.67 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 35.4 ttp -55.44 -47.25 76.29 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.2 -0.909 . . . . 65.030000000000001 110.508 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -54.75 -39.25 68.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.354 -0.839 . . . . 62.509999999999998 110.671 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 m -66.79 -27.64 67.75 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.311 -0.404 . . . . 72.310000000000002 111.355 -174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -70.66 -17.46 62.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.369 0.604 . . . . 73.239999999999995 110.42 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.28 -9.72 16.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.97 -0.559 . . . . 72.319999999999993 110.46 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.71 -44.82 4.56 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.512 0.56 . . . . 61.530000000000001 112.512 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.93 27.2 42.15 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 110.492 -1.043 . . . . 51.020000000000003 110.492 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.75 155.64 20.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.479 -0.934 . . . . 62.119999999999997 108.479 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.436 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 39.5 t30 -103.99 121.5 43.29 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.865 -1.161 . . . . 61.439999999999998 107.865 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -108.87 137.65 46.46 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 123.304 0.377 . . . . 63.240000000000002 110.689 -177.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -144.24 116.94 8.69 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.414 -0.958 . . . . 63.149999999999999 108.414 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -144.57 149.94 36.67 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.806 -0.559 . . . . 74.129999999999995 110.785 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -151.19 157.99 43.37 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 124.47 1.106 . . . . 73.209999999999994 111.065 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HD3' HG22 ' A' ' 119' ' ' VAL . 2.0 tpp180 -94.33 109.07 20.93 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.438 -1.319 . . . . 73.200000000000003 107.438 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -93.03 92.21 7.72 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.133 -1.062 . . . . 75.329999999999998 108.133 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.57 -115.48 5.64 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.601 -1.4 . . . . 73.109999999999999 109.601 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -108.64 3.27 22.66 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.707 1.241 . . . . 60.140000000000001 109.223 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 pp -112.05 149.54 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 121.066 -1.021 . . . . 62.140000000000001 108.675 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 178' ' ' TYR . 76.5 t -106.89 139.34 28.74 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 O-C-N 121.76 -0.588 . . . . 64.040000000000006 111.407 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.431 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.8 pp -119.45 119.34 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 107.186 -1.413 . . . . 54.240000000000002 107.186 174.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 tt -125.34 130.0 51.08 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.862 -0.421 . . . . 72.310000000000002 109.862 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -131.84 151.87 51.39 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.548 0.69 . . . . 64.230000000000004 110.376 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -151.07 129.93 3.03 Favored Glycine 0 N--CA 1.407 -3.268 0 N-CA-C 108.712 -1.755 . . . . 65.430000000000007 108.712 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.5 mtt180 -116.25 125.41 52.18 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.33 -0.989 . . . . 60.399999999999999 108.33 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -108.51 123.26 48.63 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.449 -0.796 . . . . 72.019999999999996 112.331 -171.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -96.13 93.7 7.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.158 -1.423 . . . . 63.149999999999999 107.158 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 1.0 OUTLIER -101.69 2.1 38.26 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.102 -0.703 . . . . 72.129999999999995 109.102 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 167' ' ' GLY . 23.4 p . . . . . 0 N--CA 1.426 -1.671 0 CA-C-N 116.235 -0.438 . . . . 74.230000000000004 111.074 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 . . . . . 0 C--O 1.242 0.696 0 N-CA-C 113.346 0.869 . . . . 74.519999999999996 113.346 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.44 135.9 42.32 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.416 0.15 . . . . 63.520000000000003 110.664 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.1 t70 -131.93 125.0 30.57 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.445 -0.576 . . . . 73.409999999999997 109.445 176.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 86.9 t -114.62 119.82 62.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 107.943 -1.132 . . . . 71.430000000000007 107.943 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -129.75 121.32 26.64 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.055 0.455 . . . . 74.099999999999994 110.501 -174.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.611 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.1 tm? -116.99 121.3 40.97 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.84 -1.541 . . . . 74.040000000000006 106.84 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.3 m -126.63 130.34 50.28 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.474 -0.565 . . . . 71.099999999999994 109.474 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.3 t -129.01 128.87 67.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 109.567 -0.531 . . . . 72.049999999999997 109.567 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -119.17 124.72 47.5 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.251 -0.648 . . . . 74.329999999999998 109.251 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.564 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.5 p90 -134.42 113.35 12.12 Favored Pre-proline 0 C--N 1.288 -2.108 0 CA-C-N 116.219 -0.446 . . . . 64.040000000000006 110.178 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 58.0 Cg_endo -68.67 30.79 0.16 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.086 2.524 . . . . 50.32 114.039 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.55 -95.18 0.36 Allowed 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.92 -0.77 . . . . 64.150000000000006 108.92 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 178.68 126.06 0.06 Allowed 'General case' 0 C--O 1.249 1.076 0 N-CA-C 109.542 -0.54 . . . . 53.310000000000002 109.542 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.37 139.15 18.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.465 -1.309 . . . . 74.239999999999995 107.465 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.0 t -104.47 -30.16 10.23 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.33 -0.948 . . . . 63.329999999999998 110.016 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.0 m -157.49 132.3 8.67 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.138 -1.06 . . . . 75.030000000000001 108.138 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -139.94 151.63 45.71 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.662 -0.649 . . . . 62.130000000000003 112.292 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 27.5 t-20 -118.67 85.81 2.43 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 105.7 -1.963 . . . . 64.420000000000002 105.7 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.478 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 173.88 -151.11 12.56 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 108.458 -1.857 . . . . 61.25 108.458 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -114.59 106.28 14.07 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 118.352 1.076 . . . . 72.420000000000002 109.596 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -80.43 123.76 28.32 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.099 -0.955 . . . . 62.149999999999999 110.534 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 67.5 mt -88.49 -47.74 15.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.232 -1.396 . . . . 74.129999999999995 107.232 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -134.63 169.75 13.03 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 106.992 -1.485 . . . . 72.049999999999997 106.992 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -73.34 -0.19 8.86 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.981 1.787 . . . . 63.149999999999999 111.322 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.2 pt-20 -130.27 3.52 4.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.456 0.646 . . . . 72.230000000000004 111.401 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.09 121.09 14.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 108.735 -0.839 . . . . 63.329999999999998 108.735 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.0 144.4 38.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.865 -0.791 . . . . 75.140000000000001 108.865 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -138.15 144.88 40.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.592 -0.522 . . . . 74.340000000000003 109.592 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.611 ' CE3' HD12 ' A' ' 139' ' ' LEU . 28.0 m-90 -122.85 124.98 44.51 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.238 -0.652 . . . . 73.340000000000003 109.238 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -105.83 107.2 18.07 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.059 0.933 . . . . 74.239999999999995 109.413 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.608 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.7 mm? -101.37 120.5 40.36 Favored 'General case' 0 C--O 1.26 1.642 0 CA-C-N 114.803 -1.09 . . . . 72.540000000000006 110.14 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -103.65 146.2 32.05 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 115.633 -0.712 . . . . 73.420000000000002 110.986 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 68.9 Cg_endo -72.06 155.26 57.27 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 123.035 2.49 . . . . 74.519999999999996 111.599 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 128' ' ' THR . . . 81.27 -30.9 2.67 Favored Glycine 0 C--N 1.302 -1.345 0 C-N-CA 121.365 -0.445 . . . . 72.319999999999993 112.355 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 35.4 m -105.34 164.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 110.05 -0.352 . . . . 31.510000000000002 110.05 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.2 p -113.79 143.8 22.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.975 -0.38 . . . . 61.399999999999999 109.975 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 45.3 m -154.82 144.4 21.41 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.828 -0.434 . . . . 72.310000000000002 109.828 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.0 p -97.57 153.82 17.93 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 123.971 0.908 . . . . 64.109999999999999 109.75 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.0 ptp -125.17 125.21 43.32 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.989 -1.486 . . . . 54.43 106.989 174.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 35.2 m -143.39 145.66 32.84 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.37 -0.831 . . . . 74.329999999999998 110.107 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.61 125.94 9.37 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.312 -0.995 . . . . 74.109999999999999 108.312 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -124.61 130.16 51.91 Favored 'General case' 0 C--N 1.262 -3.21 0 N-CA-C 106.439 -1.689 . . . . 54.439999999999998 106.439 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.77 160.19 43.67 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.869 -0.419 . . . . 73.230000000000004 109.869 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -96.62 128.61 43.72 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.676 -1.231 . . . . 75.109999999999999 107.676 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.569 ' CD2' HG21 ' A' ' 119' ' ' VAL . 17.0 m-30 -121.58 152.15 39.57 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 118.388 0.54 . . . . 72.310000000000002 109.874 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 21.0 p -87.84 100.33 12.79 Favored 'General case' 0 C--N 1.261 -3.264 0 N-CA-C 109.475 -0.565 . . . . 70.140000000000001 109.475 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.3 t0 . . . . . 0 C--O 1.218 -0.586 0 N-CA-C 107.506 -1.294 . . . . 62.450000000000003 107.506 178.552 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 46.1 ttm-85 . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 108.63 -0.878 . . . . 71.239999999999995 108.63 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.508 ' HB ' HG13 ' A' ' 137' ' ' VAL . 62.9 t -117.37 118.96 60.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.998 -0.741 . . . . 74.510000000000005 108.998 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -108.35 113.17 26.03 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.527 -1.286 . . . . 73.209999999999994 107.527 178.331 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.05 120.15 36.36 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.509 -1.293 . . . . 73.209999999999994 107.509 177.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 140' ' ' THR . 21.9 m -137.19 115.09 11.42 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 109.192 -0.67 . . . . 74.129999999999995 109.192 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.42 HG13 HG22 ' A' ' 141' ' ' VAL . 1.8 pp -127.82 147.11 32.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.635 -0.506 . . . . 63.200000000000003 109.635 -175.521 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.8 m -125.64 128.37 47.75 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 120.974 0.416 . . . . 71.239999999999995 109.919 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.0 tt -113.39 119.51 60.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.526 0.679 . . . . 72.030000000000001 109.579 179.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -84.42 160.97 55.67 Favored Pre-proline 0 C--N 1.296 -1.761 0 CA-C-N 115.389 -0.823 . . . . 61.240000000000002 109.913 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.82 2.06 2.82 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 123.367 2.711 . . . . 41.020000000000003 112.166 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.55 -8.0 59.62 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.398 1.079 . . . . 74.519999999999996 108.403 177.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.3 t70 71.96 28.48 2.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.338 1.455 . . . . 74.409999999999997 107.131 -175.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.2 139.84 44.95 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.769 -1.559 . . . . 71.329999999999998 107.6 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.416 HG11 HD21 ' A' ' 95' ' ' LEU . 13.7 t -117.26 140.45 40.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.239 -0.652 . . . . 74.040000000000006 109.239 -177.251 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.7 p -146.94 142.74 27.88 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.623 -1.251 . . . . 74.319999999999993 107.623 176.31 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.9 -171.53 41.4 Favored Glycine 0 N--CA 1.422 -2.273 0 C-N-CA 119.125 -1.512 . . . . 70.430000000000007 113.079 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -145.74 133.87 21.58 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.03 -0.73 . . . . 73.019999999999996 109.03 -175.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.0 mt -123.66 115.81 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.994 -1.113 . . . . 62.310000000000002 107.994 175.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.36 114.95 48.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.494 -0.558 . . . . 75.209999999999994 109.494 -178.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.66 108.52 19.42 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.285 -1.376 . . . . 74.319999999999993 107.285 175.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . . . -113.85 135.81 53.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.169 0.509 . . . . 55.119999999999997 111.592 -175.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.49 156.33 29.26 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.238 -0.892 . . . . 52.32 109.76 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? . . . . . 0 C--N 1.308 -1.214 0 N-CA-C 105.875 -1.898 . . . . 64.340000000000003 105.875 175.954 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.434 -1.238 0 CA-C-O 121.601 0.715 . . . . 44.229999999999997 110.502 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . 174.02 119.85 0.56 Allowed Glycine 0 N--CA 1.424 -2.157 0 CA-C-O 118.669 -1.073 . . . . 75.430000000000007 111.122 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' HB3' ' A' ' 83' ' ' SER . 4.5 Cg_endo -52.74 138.81 59.52 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.839 2.359 . . . . 65.239999999999995 111.771 174.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.01 125.6 35.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.27 -0.423 . . . . 34.229999999999997 110.256 -178.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.2 mt -88.55 129.94 35.36 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.873 -0.417 . . . . 63.43 109.873 176.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.86 84.62 6.65 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.875 0.845 . . . . 65.219999999999999 108.866 178.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -141.1 59.2 0.56 Allowed Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.867 -1.061 . . . . 64.329999999999998 113.059 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -90.26 93.47 9.36 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.676 -0.861 . . . . 63.119999999999997 108.676 176.455 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.88 161.41 22.92 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 115.191 -0.913 . . . . 74.230000000000004 111.36 -176.272 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.42 -9.62 26.69 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.117 2.545 . . . . 75.230000000000004 112.93 -177.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -110.62 30.76 6.52 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.881 -0.599 . . . . 73.510000000000005 109.735 176.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 p -57.31 -29.71 64.14 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.391 -0.822 . . . . 70.340000000000003 112.643 -178.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -67.98 -14.86 63.3 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.301 0.572 . . . . 71.140000000000001 110.276 -178.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -98.09 -20.4 17.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 116.058 -0.519 . . . . 72.540000000000006 110.676 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.13 118.1 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.85 0.833 . . . . 73.109999999999999 110.896 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.34 114.64 28.31 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.448 -0.796 . . . . 73.299999999999997 109.564 -177.245 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.72 137.02 27.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.699 -1.223 . . . . 61.219999999999999 107.699 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.6 m -151.28 172.02 16.53 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 122.054 -0.404 . . . . 75.120000000000005 109.984 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.59 151.31 23.57 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.028 -1.101 . . . . 73.239999999999995 108.028 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 89.4 t80 -116.75 129.02 55.86 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.261 -0.644 . . . . 74.120000000000005 109.261 -178.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.38 98.83 3.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.42 -0.955 . . . . 72.299999999999997 108.42 176.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 74.6 m -166.94 158.91 12.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.309 1.044 . . . . 72.340000000000003 108.895 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 68.72 9.25 7.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.711 1.205 . . . . 62.43 111.492 173.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.05 0.13 85.66 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.242 -0.743 . . . . 71.400000000000006 111.242 -175.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -105.37 158.75 16.42 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 123.232 0.613 . . . . 73.209999999999994 110.432 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.88 140.53 48.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.351 -1.352 . . . . 70.209999999999994 107.351 174.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -162.68 -160.91 11.56 Favored Glycine 0 N--CA 1.411 -2.999 0 C-N-CA 118.871 -1.633 . . . . 74.340000000000003 113.241 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.548 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 33.6 p -123.11 140.64 52.82 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 108.719 -0.845 . . . . 70.409999999999997 108.719 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -131.41 141.15 49.79 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 120.553 -0.459 . . . . 71.420000000000002 111.125 178.455 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.22 115.07 22.32 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.217 -1.401 . . . . 60.450000000000003 107.217 175.096 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -111.55 120.2 61.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.677 -0.86 . . . . 65.439999999999998 108.677 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.473 ' CD2' HD12 ' A' ' 90' ' ' LEU . 41.4 p90 -124.37 150.41 45.58 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.042 0.449 . . . . 73.219999999999999 110.91 -174.049 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 m -154.79 156.85 37.03 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.509 -0.552 . . . . 74.219999999999999 109.509 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.0 t70 66.68 31.13 7.82 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 122.311 1.053 . . . . 74.209999999999994 110.683 175.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.473 HD12 ' CD2' ' A' ' 87' ' ' PHE . 34.8 mt -98.52 171.38 8.19 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.402 -0.817 . . . . 75.200000000000003 109.518 177.34 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 p -121.59 172.65 7.95 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 122.833 0.083 . . . . 73.420000000000002 111.166 -178.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.578 ' CZ ' HD13 ' A' ' 112' ' ' LEU . 86.7 t80 -57.25 -35.66 69.99 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.415 0.447 . . . . 71.409999999999997 110.447 175.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.6 -27.12 68.73 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.39 0.614 . . . . 74.420000000000002 110.521 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.32 -15.5 35.54 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.769 -0.65 . . . . 60.439999999999998 112.596 -177.351 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.416 HD21 HG11 ' A' ' 40' ' ' VAL . 22.8 mt -50.49 -52.19 57.67 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 113.522 0.934 . . . . 74.530000000000001 113.522 175.356 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -56.45 -45.56 36.51 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 121.312 1.341 . . . . 53.130000000000003 110.24 175.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -58.87 -44.19 91.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.905 -1.043 . . . . 73.340000000000003 111.76 -176.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.406 HD21 HD23 ' A' ' 95' ' ' LEU . 4.4 pp -75.72 -19.96 58.71 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.059 0.457 . . . . 72.400000000000006 111.011 178.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.38 -14.04 60.1 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.08 -0.509 . . . . 53.149999999999999 110.615 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -65.27 -57.34 8.71 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.185 -0.606 . . . . 62.020000000000003 109.96 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -56.31 -49.17 75.06 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.667 0.604 . . . . 75.219999999999999 110.221 -176.202 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -57.08 -37.5 71.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.007 -0.997 . . . . 73.439999999999998 111.528 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.6 t -65.33 -30.67 71.53 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 116.294 -0.412 . . . . 43.130000000000003 110.077 -172.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.38 -15.37 63.29 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 121.225 0.536 . . . . 64.519999999999996 111.216 -174.138 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.46 -12.1 11.73 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.228 -0.589 . . . . 75.310000000000002 110.875 177.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.93 -48.47 3.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.277 0.843 . . . . 64.200000000000003 113.277 -172.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.56 28.43 19.34 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.245 -0.979 . . . . 35.420000000000002 110.802 -172.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.1 m -97.44 151.56 4.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.42 -0.39 . . . . 73.109999999999999 109.949 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -129.1 121.89 28.74 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.408 -1.33 . . . . 74.319999999999993 107.408 176.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.426 HD23 ' HA3' ' A' ' 123' ' ' GLY . 91.7 mt -121.24 139.89 52.78 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.709 0.29 . . . . 61.340000000000003 110.275 -177.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -136.31 121.85 19.55 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.899 -1.519 . . . . 63.200000000000003 106.899 177.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.578 HD13 ' CZ ' ' A' ' 92' ' ' PHE . 2.7 pp -135.51 155.51 50.39 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-O 121.037 0.446 . . . . 65.549999999999997 111.679 -177.15 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -150.62 155.71 39.93 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.096 -0.956 . . . . 64.150000000000006 112.521 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -94.51 128.87 41.38 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.512 -1.222 . . . . 72.349999999999994 108.597 173.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -122.49 82.85 2.03 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.533 -1.654 . . . . 63.25 106.533 175.328 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 57.72 -130.25 50.73 Favored Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 114.372 -1.285 . . . . 42.340000000000003 110.502 -173.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.589 ' HA ' ' OD1' ' A' ' 180' ' ' ASP . 23.7 t-20 -71.14 -13.4 61.93 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.642 0.734 . . . . 61.32 111.581 -178.469 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.671 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -110.63 146.32 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 C-N-CA 117.831 -1.548 . . . . 71.120000000000005 110.756 -176.747 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.2 t -107.18 133.56 51.49 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.726 0 CA-C-N 115.348 -0.842 . . . . 74.299999999999997 110.016 -178.276 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.1 pt -116.29 131.38 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 121.49 0.662 . . . . 64.319999999999993 109.685 175.115 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 tt -128.45 131.53 48.41 Favored 'General case' 0 C--N 1.278 -2.541 0 CA-C-N 115.276 -0.875 . . . . 70.439999999999998 110.148 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -129.2 146.2 51.17 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.126 -1.065 . . . . 50.210000000000001 108.126 174.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.426 ' HA3' HD23 ' A' ' 110' ' ' LEU . . . -164.13 160.39 33.34 Favored Glycine 0 N--CA 1.407 -3.297 0 N-CA-C 111.402 -0.679 . . . . 23.25 111.402 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -137.49 133.44 34.59 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.881 -0.785 . . . . 74.209999999999994 108.881 177.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -103.92 110.07 22.07 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.31 -0.996 . . . . 42.140000000000001 108.31 178.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -103.2 93.75 5.16 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 122.365 1.079 . . . . 72.400000000000006 110.703 -177.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 127' ' ' LEU . 2.0 pt? -124.29 21.39 8.75 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.138 -1.392 . . . . 73.230000000000004 107.512 177.601 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.432 ' HA ' ' C ' ' A' ' 167' ' ' GLY . 2.6 m . . . . . 0 CA--C 1.552 1.037 0 CA-C-N 113.039 -1.891 . . . . 63.109999999999999 110.248 177.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 C--O 1.237 0.438 0 CA-C-O 121.422 0.63 . . . . 62.130000000000003 111.224 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.41 138.99 58.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.485 -0.779 . . . . 62.439999999999998 111.658 179.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 28.3 t70 -131.5 121.96 25.36 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.571 -0.529 . . . . 74.209999999999994 109.571 177.217 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 90.1 t -119.71 126.98 75.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.855 -0.424 . . . . 75.310000000000002 109.855 -178.734 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.45 123.47 41.37 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.227 -0.657 . . . . 72.319999999999993 109.227 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 tt -113.94 118.29 33.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.003 -1.48 . . . . 53.520000000000003 107.003 176.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 31' ' ' SER . 6.7 m -117.48 128.44 54.98 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.213 -0.662 . . . . 73.519999999999996 109.213 -175.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.42 HG22 HG13 ' A' ' 32' ' ' ILE . 84.1 t -122.33 127.87 75.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.625 -0.509 . . . . 74.239999999999995 109.625 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -116.74 132.47 56.68 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.071 -0.714 . . . . 65.049999999999997 109.071 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.593 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.2 p90 -134.93 127.63 18.36 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 116.412 -0.358 . . . . 75.120000000000005 111.785 177.46 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -70.15 51.27 1.0 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 123.24 2.627 . . . . 65.439999999999998 110.879 172.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.11 -128.57 0.09 Allowed 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.3 -1.37 . . . . 74.120000000000005 107.3 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -167.21 134.75 2.44 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.645 -1.613 . . . . 61.409999999999997 106.645 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.527 ' HB ' ' CZ ' ' A' ' 143' ' ' PHE . 7.7 p -85.93 123.43 39.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 108.577 -0.897 . . . . 64.239999999999995 108.577 177.592 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.7 t -81.73 -33.02 31.31 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.22 -0.592 . . . . 72.530000000000001 111.358 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 64.0 m -152.84 133.01 13.5 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 109.672 -0.492 . . . . 72.340000000000003 109.672 175.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.435 ' HB ' HG21 ' A' ' 147' ' ' VAL . 6.7 t -138.77 158.87 43.43 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.946 -0.471 . . . . 74.549999999999997 111.339 177.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 2.9 t-20 -127.61 89.8 3.01 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.018 -1.845 . . . . 75.299999999999997 106.018 175.291 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 174.44 -140.35 5.36 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 109.582 -1.407 . . . . 73.430000000000007 109.582 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.82 99.98 7.29 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 117.235 0.517 . . . . 75.129999999999995 109.702 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -82.13 115.92 21.46 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.534 0.683 . . . . 73.420000000000002 110.31 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.4 mt -81.57 -47.56 19.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.151 -1.426 . . . . 70.25 107.151 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.83 160.48 67.28 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 107.119 -1.437 . . . . 73.329999999999998 107.119 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.52 -19.63 65.42 Favored 'Trans proline' 0 C--N 1.328 -0.539 0 C-N-CA 122.054 1.836 . . . . 73.150000000000006 111.948 175.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.593 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -114.55 4.09 15.07 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.381 0.882 . . . . 71.109999999999999 113.381 178.75 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.2 t -140.34 120.28 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.995 -0.742 . . . . 54.439999999999998 108.995 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.93 149.33 31.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.049 -0.723 . . . . 73.409999999999997 109.049 -177.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -133.68 146.9 51.27 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.62 -0.882 . . . . 75.319999999999993 108.62 -178.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -119.62 122.37 41.39 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 109.446 -0.576 . . . . 62.229999999999997 109.446 177.206 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -89.32 114.0 25.35 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.896 0.855 . . . . 43.049999999999997 110.01 177.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 10.2 mp -101.49 118.64 37.37 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.957 -1.02 . . . . 73.120000000000005 109.493 178.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 75.5 mmtt -117.45 143.51 32.25 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 114.447 -1.251 . . . . 60.329999999999998 108.978 -176.3 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.43 150.46 64.16 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.377 2.052 . . . . 74.409999999999997 111.355 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.432 ' C ' ' HA ' ' A' ' 128' ' ' THR . . . 73.42 -11.88 4.95 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 116.495 -0.321 . . . . 71.209999999999994 113.864 176.111 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 33.2 m -117.01 145.46 22.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 109.344 -0.613 . . . . 74.230000000000004 109.344 171.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.76 129.07 40.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.085 -0.709 . . . . 71.420000000000002 109.085 178.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.7 t -111.45 136.93 49.92 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 120.048 -0.661 . . . . 73.109999999999999 109.552 -178.276 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.6 p -100.1 138.76 36.73 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.505 -0.77 . . . . 64.319999999999993 110.626 -179.413 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 23.0 ttt -125.68 117.48 23.58 Favored 'General case' 0 C--O 1.193 -1.899 0 CA-C-N 115.756 -0.656 . . . . 54.409999999999997 109.681 -177.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 24.7 t -142.92 144.83 32.56 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.542 -0.911 . . . . 71.209999999999994 108.542 174.3 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -154.53 128.12 8.62 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.073 -1.084 . . . . 73.5 108.073 -177.156 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -129.04 130.27 46.36 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.028 -1.101 . . . . 64.030000000000001 108.028 176.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -152.78 158.21 41.92 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 120.803 -0.359 . . . . 62.5 110.084 -178.286 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.671 ' HG2' HG22 ' A' ' 118' ' ' ILE . 96.1 mtt180 -87.3 136.3 32.99 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.633 -0.877 . . . . 71.200000000000003 108.633 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -143.25 147.2 34.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.991 -0.744 . . . . 61.420000000000002 108.991 176.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.47 112.07 5.07 Favored 'General case' 0 N--CA 1.414 -2.248 0 C-N-CA 122.849 0.459 . . . . 64.519999999999996 110.507 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 117' ' ' ASN . 2.6 m-20 . . . . . 0 C--N 1.308 -1.221 0 C-N-CA 124.714 1.206 . . . . 63.43 112.23 178.67 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 . . . . . 0 N--CA 1.441 -0.908 0 N-CA-C 109.517 -0.549 . . . . 62.549999999999997 109.517 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 p -124.77 123.42 65.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 120.267 -0.573 . . . . 75.140000000000001 110.02 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -125.1 126.61 45.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.942 -0.572 . . . . 74.209999999999994 109.474 -176.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.77 108.35 16.97 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 106.366 -1.716 . . . . 72.230000000000004 106.366 172.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -117.6 114.65 23.72 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.63 -1.618 . . . . 62.329999999999998 106.63 -178.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -129.64 146.68 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-O 121.255 0.55 . . . . 53.420000000000002 109.869 -174.01 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.5 m -127.8 119.55 25.93 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-O 121.366 0.603 . . . . 42.039999999999999 109.749 -177.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.436 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.0 tt -105.96 124.36 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.417 -0.811 . . . . 34.439999999999998 109.674 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 m -98.88 150.37 36.63 Favored Pre-proline 0 C--N 1.288 -2.07 0 CA-C-N 115.44 -0.8 . . . . 75.239999999999995 109.703 -176.051 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.99 1.96 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 124.038 3.159 . . . . 54.530000000000001 114.975 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 30.3 t70 -83.85 -2.66 56.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.15 -0.685 . . . . 61.420000000000002 109.15 177.089 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.7 t70 72.72 29.29 1.98 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 106.125 -1.806 . . . . 73.340000000000003 106.125 -173.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 2.1 tp -104.09 125.58 50.53 Favored 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 112.682 -2.054 . . . . 71.120000000000005 109.006 -178.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.583 HG11 HD23 ' A' ' 95' ' ' LEU . 21.8 t -112.36 135.76 50.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.675 -0.861 . . . . 74.219999999999999 108.675 177.516 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 p -147.47 152.81 38.67 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.119 -1.067 . . . . 74.400000000000006 108.119 178.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.09 -171.24 44.31 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 118.74 -1.695 . . . . 54.240000000000002 113.782 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.66 133.69 30.95 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.672 0.789 . . . . 75.310000000000002 109.646 -176.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 102' ' ' ASN . 58.9 mt -121.0 116.09 48.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.918 -1.142 . . . . 74.310000000000002 107.918 176.071 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.71 121.3 66.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 123.135 0.574 . . . . 71.319999999999993 110.016 -176.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.91 108.46 16.3 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.255 -1.387 . . . . 75.430000000000007 107.255 175.147 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -117.79 132.82 56.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.403 0.621 . . . . 73.340000000000003 112.602 -174.529 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.29 158.43 35.8 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.405 -0.961 . . . . 40.149999999999999 108.405 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.553 0 N-CA-C 104.551 -2.389 . . . . 61.5 104.551 173.174 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 109.623 -0.51 . . . . 70.349999999999994 109.623 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.26 96.47 0.1 Allowed Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.829 -0.909 . . . . 71.209999999999994 110.829 176.479 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.43 ' O ' ' HB3' ' A' ' 83' ' ' SER . 26.1 Cg_endo -68.52 159.6 52.83 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.931 2.42 . . . . 71.099999999999994 113.046 177.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.25 140.39 50.33 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.593 -0.892 . . . . 32.450000000000003 108.593 176.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 90.2 mt -79.92 140.78 36.56 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.703 0.287 . . . . 45.020000000000003 111.337 -178.383 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.16 96.61 6.77 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.263 1.03 . . . . 72.409999999999997 108.473 177.448 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -113.45 -71.01 0.55 Allowed Glycine 0 C--N 1.292 -1.872 0 CA-C-N 114.415 -1.266 . . . . 72.120000000000005 113.117 -177.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 58.59 86.02 0.09 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.23 1.014 . . . . 74.010000000000005 112.404 -176.091 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 m -115.81 158.63 41.66 Favored Pre-proline 0 C--N 1.29 -1.993 0 CA-C-N 114.652 -1.158 . . . . 73.319999999999993 108.686 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.57 -16.84 50.6 Favored 'Trans proline' 0 N--CA 1.483 0.884 0 C-N-CA 122.747 2.298 . . . . 72.5 112.354 179.285 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -113.45 25.22 11.47 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.543 -0.753 . . . . 73.329999999999998 112.037 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.8 m -56.36 -24.01 41.35 Favored 'General case' 0 C--O 1.21 -1.004 0 N-CA-C 111.753 0.279 . . . . 61.240000000000002 111.753 177.459 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -62.57 -23.17 66.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.18 0.514 . . . . 55.039999999999999 110.456 178.117 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 88' ' ' SER . 33.4 mmtp -95.51 -14.44 23.67 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.246 0.546 . . . . 55.240000000000002 110.104 -178.23 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 49.8 t -108.19 121.05 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 116.081 -0.509 . . . . 74.439999999999998 110.407 -177.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 110.67 22.69 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.171 -0.677 . . . . 73.239999999999995 109.171 177.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.96 137.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.98 -1.119 . . . . 64.140000000000001 107.98 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 t -148.2 172.22 14.68 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.803 -0.814 . . . . 74.230000000000004 108.803 -174.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -92.02 141.23 28.84 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.132 -1.062 . . . . 70.329999999999998 108.132 177.63 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 93.0 t80 -102.24 127.36 49.24 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.374 -0.602 . . . . 65.409999999999997 109.374 -178.408 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.56 99.63 4.12 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.568 -0.901 . . . . 71.340000000000003 108.568 176.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 30.9 t -170.0 155.76 5.75 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.276 -1.009 . . . . 63.329999999999998 108.276 -179.067 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 71.06 6.72 5.95 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.803 1.241 . . . . 74.340000000000003 111.604 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.91 4.51 84.63 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.659 -1.376 . . . . 73.439999999999998 109.659 -173.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.456 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 6.2 m-85 -104.31 149.34 25.44 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 124.164 0.986 . . . . 72.019999999999996 110.049 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -125.5 136.06 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 108.015 -1.106 . . . . 70.120000000000005 108.015 174.631 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -163.12 -155.42 8.1 Favored Glycine 0 C--N 1.27 -3.09 0 C-N-CA 119.4 -1.381 . . . . 62.530000000000001 112.19 -178.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 13.4 p -124.1 140.95 52.47 Favored 'General case' 0 C--N 1.274 -2.715 0 CA-C-N 115.096 -0.552 . . . . 72.219999999999999 109.729 -178.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -135.53 141.68 45.28 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 120.816 0.341 . . . . 72.140000000000001 110.649 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.35 115.56 21.86 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.027 -0.731 . . . . 75.510000000000005 109.027 178.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.4 t -106.01 112.53 39.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.165 -1.05 . . . . 63.420000000000002 108.165 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 50.7 p90 -112.87 153.96 27.08 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 120.708 -0.397 . . . . 72.430000000000007 110.746 -174.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 42.4 m -153.61 161.49 42.14 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.822 -0.351 . . . . 71.420000000000002 110.932 -177.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.1 t70 59.68 37.82 22.14 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.471 1.129 . . . . 74.420000000000002 111.574 173.563 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.424 HD12 ' CD2' ' A' ' 87' ' ' PHE . 35.8 mt -103.29 164.76 11.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.33 -0.85 . . . . 71.310000000000002 110.922 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -114.21 174.02 6.16 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.052 0.453 . . . . 74.510000000000005 110.742 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -56.49 -34.28 66.8 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 125.58 1.552 . . . . 72.209999999999994 111.021 -178.426 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.4 -25.26 61.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.98 -0.555 . . . . 43.119999999999997 111.185 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -88.77 -16.45 32.12 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 116.107 -0.497 . . . . 75.310000000000002 111.648 -176.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.6 tm? -52.73 -56.44 23.12 Favored Pre-proline 0 CA--C 1.569 1.696 0 C-N-CA 123.442 0.697 . . . . 70.120000000000005 111.756 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.18 -37.14 33.38 Favored 'Trans proline' 0 C--N 1.372 1.795 0 CA-C-N 120.741 1.3 . . . . 73.010000000000005 111.232 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -65.55 -34.67 78.79 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 124.437 1.095 . . . . 72.129999999999995 110.857 -176.389 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -78.38 -23.01 47.02 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.384 0.611 . . . . 74.219999999999999 109.543 175.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.34 -22.95 59.0 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 115.577 -0.738 . . . . 44.229999999999997 109.842 -175.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -62.06 -46.79 87.56 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.445 -0.798 . . . . 60.229999999999997 109.659 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.6 mtm -55.95 -49.67 72.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.282 0.563 . . . . 75.400000000000006 109.711 177.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' HB2' HD13 ' A' ' 44' ' ' ILE . 34.2 t30 -54.49 -35.63 63.29 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 114.726 -1.124 . . . . 75.030000000000001 110.96 178.121 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.4 m -60.65 -29.21 69.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.786 -0.643 . . . . 64.310000000000002 110.86 -173.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.81 -30.29 69.98 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 123.558 0.536 . . . . 71.120000000000005 111.345 -175.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.87 -10.86 15.47 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.085 -0.507 . . . . 75.450000000000003 110.89 -177.258 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.69 -47.8 3.67 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 113.44 0.904 . . . . 31.399999999999999 113.44 -172.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.42 24.9 41.38 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.428 -1.069 . . . . 73.209999999999994 110.428 -173.086 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 m -106.42 163.09 5.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.393 -0.404 . . . . 74.519999999999996 110.319 -178.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -128.56 122.2 30.5 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.597 -1.26 . . . . 74.530000000000001 107.597 176.295 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.1 mt -119.09 122.48 42.2 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.957 0.408 . . . . 74.450000000000003 111.209 -178.166 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 p -137.22 139.5 41.07 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.984 -0.553 . . . . 72.420000000000002 109.736 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.87 150.67 32.27 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 122.075 -0.391 . . . . 63.210000000000001 110.042 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -143.51 155.04 44.22 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.109 -0.496 . . . . 74.519999999999996 110.683 -176.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.431 ' HG2' HG22 ' A' ' 119' ' ' VAL . 40.6 mtt85 -92.31 138.53 31.45 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 121.587 0.708 . . . . 74.409999999999997 111.333 173.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.44 ' O ' HG13 ' A' ' 118' ' ' ILE . 6.8 t30 -123.9 88.02 2.84 Favored 'General case' 0 C--N 1.269 -2.908 0 N-CA-C 105.665 -1.976 . . . . 70.120000000000005 105.665 175.355 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.71 -120.23 6.81 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 109.646 -1.381 . . . . 74.230000000000004 109.646 -175.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -104.54 12.45 33.14 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.509 1.147 . . . . 71.010000000000005 108.635 178.513 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.561 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.2 pp -119.26 149.46 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 O-C-N 120.951 -1.093 . . . . 63.340000000000003 109.041 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.431 HG22 ' HG2' ' A' ' 114' ' ' ARG . 86.5 t -110.27 138.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 CA-C-O 120.951 0.405 . . . . 62.549999999999997 110.352 -178.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.9 pt -110.6 129.29 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.361 0 N-CA-C 107.132 -1.433 . . . . 74.099999999999994 107.132 172.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.24 129.53 50.93 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 109.391 -0.596 . . . . 73.239999999999995 109.391 -178.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -134.8 119.23 17.91 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.913 0.863 . . . . 72.120000000000005 111.27 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.38 148.36 17.85 Favored Glycine 0 N--CA 1.418 -2.527 0 N-CA-C 110.834 -0.906 . . . . 74.340000000000003 110.834 178.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.495 ' HG2' HG22 ' A' ' 171' ' ' THR . 75.7 mtt180 -123.63 140.21 53.22 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 109.256 -0.646 . . . . 71.549999999999997 109.256 179.012 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.92 109.24 14.86 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 109.293 -0.632 . . . . 72.430000000000007 109.293 178.476 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -112.64 94.39 4.89 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.06 -1.089 . . . . 73.530000000000001 108.06 176.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -122.96 37.01 4.52 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 122.937 1.351 . . . . 62.340000000000003 108.313 177.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 75.6 p . . . . . 0 C--N 1.31 -1.148 0 CA-C-N 113.385 -1.734 . . . . 64.340000000000003 110.59 179.436 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 112.733 0.642 . . . . 70.129999999999995 112.733 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.82 48.48 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.687 0.995 . . . . 73.209999999999994 113.687 -177.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -132.9 136.45 46.18 Favored 'General case' 0 C--O 1.26 1.614 0 CA-C-N 115.69 -0.686 . . . . 61.329999999999998 109.684 171.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.2 t -114.82 114.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.979 -1.119 . . . . 74.439999999999998 107.979 176.275 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.32 124.42 52.19 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 120.694 -0.402 . . . . 73.340000000000003 111.444 -178.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 50.7 tp -111.08 124.52 52.35 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.697 -1.223 . . . . 73.549999999999997 107.697 170.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.5 m -126.05 112.55 16.0 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.898 -0.778 . . . . 62.229999999999997 108.898 178.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.462 HG12 ' HD1' ' A' ' 143' ' ' PHE . 82.1 t -107.51 120.81 59.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 109.33 -0.618 . . . . 75.409999999999997 109.33 179.264 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.33 127.81 55.76 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.207 -0.664 . . . . 51.520000000000003 109.207 178.468 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.647 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.5 p90 -135.1 122.2 14.98 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 112.266 0.469 . . . . 55.32 112.266 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -67.78 42.32 0.23 Allowed 'Trans proline' 0 CA--C 1.566 2.113 0 C-N-CA 123.162 2.575 . . . . 72.340000000000003 112.443 173.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.41 -108.68 0.31 Allowed 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 122.977 0.511 . . . . 54.509999999999998 109.806 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.85 133.96 0.13 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.966 -0.753 . . . . 62.200000000000003 108.966 -177.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.3 p -88.38 141.11 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 109.235 -0.654 . . . . 75.230000000000004 109.235 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 39.5 p -102.15 -38.14 7.83 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.027 0.441 . . . . 54.409999999999997 110.411 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.9 m -155.75 132.39 10.41 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 108.625 -0.879 . . . . 43.32 108.625 178.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.2 t -139.97 152.83 46.62 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 120.144 -0.622 . . . . 75.430000000000007 112.103 176.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -118.98 88.15 2.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.325 -2.102 . . . . 75.549999999999997 105.325 175.095 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.414 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.09 -145.03 8.62 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 108.644 -1.782 . . . . 75.400000000000006 108.644 -177.015 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -118.27 99.99 7.21 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 118.129 0.964 . . . . 62.5 110.8 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.26 109.23 13.41 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.537 0.684 . . . . 74.209999999999994 109.449 176.085 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 61.9 mt -80.12 -46.96 21.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.096 -1.446 . . . . 64.530000000000001 107.096 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 159' ' ' VAL . 13.1 mm-40 -121.63 163.42 30.97 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 106.802 -1.555 . . . . 74.010000000000005 106.802 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.93 -1.18 10.09 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.164 1.909 . . . . 72.219999999999999 111.376 178.485 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.5 pt-20 -137.07 9.66 3.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.439 -0.8 . . . . 63.350000000000001 111.66 -177.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 156' ' ' GLU . 54.7 t -145.07 120.7 3.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.907 -1.146 . . . . 61.310000000000002 107.907 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.84 143.72 38.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.284 -0.635 . . . . 50.439999999999998 109.284 -177.445 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.7 tt0 -130.86 143.34 50.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-O 121.252 0.548 . . . . 73.420000000000002 110.155 -177.285 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.414 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 30.3 m-90 -126.45 121.31 32.06 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.845 -0.798 . . . . 75.340000000000003 108.845 179.089 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 105.07 13.15 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.36 0.6 . . . . 73.329999999999998 110.234 176.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 170' ' ' SER . 1.2 mm? -99.54 147.82 24.92 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.373 -0.831 . . . . 71.400000000000006 110.281 -174.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -117.68 155.45 50.59 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.984 -0.553 . . . . 63.439999999999998 112.391 -176.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.81 157.4 51.84 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.901 2.401 . . . . 61.109999999999999 110.97 178.166 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.84 -35.22 2.91 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.666 -0.778 . . . . 62.240000000000002 111.574 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 20.7 m -104.76 145.13 13.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.039 0.447 . . . . 65.030000000000001 110.232 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.2 p -101.52 144.0 13.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 107.804 -1.184 . . . . 61.039999999999999 107.804 178.041 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.473 ' HB2' HD12 ' A' ' 164' ' ' LEU . 50.0 m -149.32 153.61 37.73 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.066 0.46 . . . . 74.129999999999995 111.459 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.495 HG22 ' HG2' ' A' ' 124' ' ' ARG . 2.6 p -106.56 128.37 54.07 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.307 -0.86 . . . . 63.420000000000002 109.889 177.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 23.5 ptp -106.93 122.06 45.66 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.614 -1.624 . . . . 70.510000000000005 106.614 178.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.5 m -141.47 148.01 38.79 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.558 -1.257 . . . . 71.540000000000006 111.737 -176.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.96 136.69 18.04 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 115.234 -0.894 . . . . 70.409999999999997 108.69 -176.395 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -130.79 131.05 44.44 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 105.866 -1.901 . . . . 62.0 105.866 175.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 178' ' ' TYR . . . -157.45 160.66 38.55 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 120.876 -0.33 . . . . 74.439999999999998 110.348 -175.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.561 ' HG2' HG22 ' A' ' 118' ' ' ILE . 96.5 mtt180 -87.52 129.05 35.22 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.729 -0.841 . . . . 74.329999999999998 108.729 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 176' ' ' ALA . 99.2 m-85 -140.73 124.69 17.26 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 108.762 -0.829 . . . . 74.140000000000001 108.762 178.167 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.07 122.73 9.96 Favored 'General case' 0 N--CA 1.404 -2.739 0 O-C-N 124.795 1.309 . . . . 75.140000000000001 111.564 -177.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 106.952 -1.499 . . . . 74.310000000000002 106.952 175.444 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 108.946 -0.761 . . . . 73.310000000000002 108.946 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.17 114.01 45.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.08 -1.822 . . . . 63.200000000000003 106.08 172.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -123.75 115.66 21.75 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 120.955 0.407 . . . . 61.340000000000003 110.93 -175.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.31 108.55 17.07 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.786 -1.19 . . . . 55.240000000000002 107.786 175.302 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.3 t -114.39 115.53 27.47 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.671 -1.233 . . . . 74.400000000000006 107.671 -178.525 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.96 146.42 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.092 0.472 . . . . 71.120000000000005 109.822 -178.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 88.9 m -126.08 128.5 47.47 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.98 -0.748 . . . . 64.129999999999995 108.98 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.447 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.4 tt -114.76 114.83 47.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-O 121.622 0.725 . . . . 65.439999999999998 110.067 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -82.29 153.11 68.64 Favored Pre-proline 0 N--CA 1.423 -1.775 0 CA-C-N 115.215 -0.902 . . . . 70.420000000000002 109.564 -176.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.62 1.99 0.46 Allowed 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 123.765 2.977 . . . . 74.510000000000005 114.006 178.013 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.53 -8.27 59.62 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.387 -0.968 . . . . 71.129999999999995 108.387 174.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 72.78 29.27 1.95 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.567 1.547 . . . . 75.140000000000001 107.338 -174.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.26 126.49 51.42 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 113.55 -1.659 . . . . 73.340000000000003 107.512 178.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.33 140.1 23.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 107.871 -1.159 . . . . 75.409999999999997 107.871 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.5 p -148.47 158.97 44.46 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.318 -1.364 . . . . 61.109999999999999 107.318 -178.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.24 -167.8 39.0 Favored Glycine 0 CA--C 1.488 -1.641 0 C-N-CA 118.509 -1.805 . . . . 65.439999999999998 113.028 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -152.89 135.14 14.96 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 123.176 0.591 . . . . 75.239999999999995 110.228 -177.05 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 66.6 mt -115.53 115.89 50.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 107.838 -1.171 . . . . 61.329999999999998 107.838 177.054 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.26 116.59 52.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.726 -0.842 . . . . 62.109999999999999 108.726 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.553 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.25 108.32 16.43 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.927 -1.509 . . . . 72.099999999999994 106.927 175.379 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.47 118.98 33.68 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.324 -0.621 . . . . 35.049999999999997 109.324 -177.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.91 158.04 21.61 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 115.637 -0.71 . . . . 73.239999999999995 111.308 -174.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt . . . . . 0 N--CA 1.432 -1.356 0 N-CA-C 105.932 -1.877 . . . . 74.5 105.932 172.371 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 107.575 -1.268 . . . . 61.439999999999998 107.575 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.579 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 172.88 104.05 0.17 Allowed Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 119.807 -1.187 . . . . 44.420000000000002 113.49 174.14 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 83' ' ' SER . 45.4 Cg_exo -60.72 159.6 27.94 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.837 2.358 . . . . 72.439999999999998 110.743 173.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.2 163.14 14.23 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.902 -0.499 . . . . 40.32 110.473 178.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 83' ' ' SER . 3.6 mm? -77.72 136.28 38.15 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.111 -0.495 . . . . 62.299999999999997 109.672 177.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -110.54 95.08 5.35 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.404 0.621 . . . . 71.450000000000003 109.518 -178.673 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.62 94.01 0.1 OUTLIER Glycine 0 C--N 1.286 -2.207 0 N-CA-C 109.93 -1.268 . . . . 74.340000000000003 109.93 179.102 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.18 93.97 2.39 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.086 0.47 . . . . 65.019999999999996 111.165 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.5 m -85.79 151.95 56.0 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.439 -0.801 . . . . 73.129999999999995 109.764 178.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.06 -31.84 83.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.414 2.076 . . . . 52.439999999999998 111.707 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -96.11 38.27 1.2 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.791 -0.64 . . . . 71.319999999999993 112.095 -177.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 m -59.66 -24.48 63.92 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.563 0.579 . . . . 73.230000000000004 112.563 -178.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -70.52 -17.87 62.94 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 121.235 0.541 . . . . 74.150000000000006 110.425 -178.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -90.1 -16.63 29.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.708 -0.678 . . . . 70.019999999999996 109.731 -178.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.03 120.06 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 122.029 0.918 . . . . 71.239999999999995 112.492 -176.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.73 108.0 20.0 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.091 -0.958 . . . . 25.23 108.634 178.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 60' ' ' LEU . 67.8 t -98.08 142.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.514 -1.291 . . . . 73.209999999999994 107.514 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.7 t -157.42 172.7 18.11 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 108.742 -0.836 . . . . 72.120000000000005 108.742 -175.288 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.579 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 4.1 p-10 -86.55 146.7 26.26 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.847 -0.797 . . . . 65.310000000000002 108.847 178.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -108.2 119.1 38.5 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.592 -1.262 . . . . 65.319999999999993 107.592 175.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -138.43 99.85 3.95 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.358 -1.719 . . . . 64.010000000000005 106.358 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.7 t -174.76 159.1 2.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.858 -1.164 . . . . 72.239999999999995 107.858 -176.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 72.76 -5.43 1.88 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.874 0.869 . . . . 73.120000000000005 112.535 172.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.28 -5.28 58.94 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 109.877 -1.289 . . . . 73.409999999999997 109.877 -174.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.5 155.04 19.15 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 123.592 0.757 . . . . 73.219999999999999 109.696 -177.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.62 140.28 49.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 109.059 -0.719 . . . . 73.530000000000001 109.059 178.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -170.04 -154.83 9.63 Favored Glycine 0 N--CA 1.411 -3.001 0 C-N-CA 119.721 -1.228 . . . . 41.229999999999997 112.647 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.581 ' HB2' HD22 ' A' ' 60' ' ' LEU . 28.1 p -122.2 147.46 46.16 Favored 'General case' 0 C--N 1.278 -2.538 0 C-N-CA 123.391 0.677 . . . . 60.409999999999997 110.709 -176.107 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -137.32 143.2 41.96 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.995 0.426 . . . . 44.43 110.987 175.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.99 115.09 16.63 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.525 -1.287 . . . . 32.140000000000001 107.525 175.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.9 t -109.89 116.92 53.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.54 -0.911 . . . . 74.109999999999999 108.54 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.509 ' CD2' HD12 ' A' ' 90' ' ' LEU . 48.7 p90 -121.15 155.32 34.77 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.463 0.649 . . . . 74.030000000000001 111.832 -175.234 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 p -156.08 148.36 23.5 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.361 -0.836 . . . . 64.019999999999996 109.662 -177.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 t70 60.42 62.28 1.59 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.703 1.24 . . . . 72.530000000000001 112.175 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.509 HD12 ' CD2' ' A' ' 87' ' ' PHE . 25.6 mt -121.13 162.38 20.18 Favored 'General case' 0 N--CA 1.413 -2.301 0 CA-C-N 114.204 -1.362 . . . . 62.130000000000003 108.335 174.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -112.17 173.22 6.47 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 119.564 -0.854 . . . . 72.120000000000005 109.443 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.415 ' CE1' HD12 ' A' ' 112' ' ' LEU . 85.0 t80 -50.27 -46.71 55.25 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.272 1.029 . . . . 72.349999999999994 111.636 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.48 -25.35 68.22 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.607 -0.724 . . . . 73.109999999999999 112.337 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -85.72 -17.32 36.28 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 111.859 0.318 . . . . 72.219999999999999 111.859 -177.075 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.596 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 50.6 tp -61.96 -52.95 64.23 Favored Pre-proline 0 CA--C 1.558 1.288 0 N-CA-C 113.2 0.815 . . . . 72.230000000000004 113.2 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -62.05 -37.13 66.61 Favored 'Trans proline' 0 C--N 1.365 1.419 0 CA-C-N 120.75 1.304 . . . . 72.239999999999995 110.731 176.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.13 -36.4 84.14 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 115.067 -0.97 . . . . 74.329999999999998 111.302 -176.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -74.29 -19.51 60.45 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 120.818 0.342 . . . . 61.130000000000003 110.391 177.088 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.86 -23.27 63.25 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.201 -0.454 . . . . 70.439999999999998 110.523 -177.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -59.74 -48.45 81.61 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 109.584 -0.524 . . . . 64.019999999999996 109.584 176.371 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.419 ' HG2' ' HB3' ' A' ' 60' ' ' LEU . 17.0 ttm -56.19 -52.11 65.6 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.65 -0.704 . . . . 64.230000000000004 109.385 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -55.19 -33.36 62.96 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 114.646 -1.161 . . . . 71.430000000000007 110.901 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -65.11 -18.08 65.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 118.796 -0.621 . . . . 64.400000000000006 112.473 -174.594 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.34 -30.38 66.68 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.535 0.683 . . . . 70.420000000000002 109.823 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.67 -11.57 13.99 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.272 -0.876 . . . . 64.450000000000003 110.908 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.436 ' HB1' HG13 ' A' ' 108' ' ' VAL . . . -107.73 -48.45 3.41 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.947 1.091 . . . . 74.120000000000005 113.947 -172.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.89 18.63 79.66 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 116.289 -0.414 . . . . 70.439999999999998 112.849 -175.411 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.436 HG13 ' HB1' ' A' ' 106' ' ' ALA . 27.3 m -82.2 178.62 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.634 0.605 . . . . 71.530000000000001 112.634 -176.21 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -142.11 126.76 17.97 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.03 0.532 . . . . 73.129999999999995 109.583 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.5 mp -127.23 115.93 19.81 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.427 -0.212 . . . . 72.340000000000003 110.427 178.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.5 m -111.27 109.79 19.97 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.128 -0.693 . . . . 73.340000000000003 109.128 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.415 HD12 ' CE1' ' A' ' 92' ' ' PHE . 1.3 pt? -129.42 148.37 51.33 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.555 0.693 . . . . 53.43 111.9 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -152.65 169.96 21.41 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.465 -1.243 . . . . 74.450000000000003 110.964 -177.316 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.44 ' HG3' HG22 ' A' ' 119' ' ' VAL . 5.4 mtt85 -101.79 137.52 39.98 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 115.628 -0.714 . . . . 51.310000000000002 109.715 171.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -118.36 87.35 2.71 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.406 -1.331 . . . . 73.310000000000002 107.406 177.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.61 -98.52 0.85 Allowed Glycine 0 N--CA 1.428 -1.86 0 CA-C-N 115.044 -0.98 . . . . 52.509999999999998 111.962 -177.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -120.12 4.08 10.88 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.811 1.291 . . . . 73.099999999999994 108.563 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -118.84 149.38 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 108.325 -0.991 . . . . 73.400000000000006 108.325 -178.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 114' ' ' ARG . 78.2 t -105.4 135.38 43.76 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 110.005 -0.368 . . . . 70.209999999999994 110.005 -178.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.439 HG22 ' HG2' ' A' ' 175' ' ' GLN . 46.6 pt -113.57 131.47 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 108.733 -0.84 . . . . 71.400000000000006 108.733 177.153 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -128.61 123.61 33.74 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 115.534 -0.757 . . . . 74.099999999999994 108.979 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.71 124.86 12.89 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.722 0.772 . . . . 74.420000000000002 110.972 177.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.58 -178.68 25.68 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.891 -0.671 . . . . 52.509999999999998 111.607 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.447 ' HG2' HG22 ' A' ' 171' ' ' THR . 96.8 mtt180 -140.8 159.26 42.6 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.753 -0.462 . . . . 71.150000000000006 109.753 -176.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.46 108.52 10.61 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 106.019 -1.845 . . . . 54.420000000000002 106.019 171.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -111.86 93.51 4.49 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.505 0.669 . . . . 75.340000000000003 109.297 -178.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 166' ' ' PRO 0.334 0.0 OUTLIER -126.17 63.9 1.24 Allowed 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 123.492 1.615 . . . . 65.349999999999994 109.202 171.429 . . . . . . . . 4 4 . 1 . 023 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.432 -1.358 0 CA-C-N 112.683 -2.053 . . . . 33.310000000000002 112.489 -173.032 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 N--CA 1.441 -0.925 0 CA-C-O 120.766 0.317 . . . . 72.209999999999994 110.679 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.03 141.57 28.26 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.726 -0.39 . . . . 74.409999999999997 111.341 -177.093 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -127.48 135.45 50.41 Favored 'General case' 0 C--O 1.261 1.694 0 N-CA-C 107.009 -1.478 . . . . 65.310000000000002 107.009 172.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 55.3 t -108.7 115.14 48.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.3 -1.0 . . . . 53.299999999999997 108.3 178.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.55 120.1 40.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.968 -0.753 . . . . 72.219999999999999 108.968 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.13 111.98 21.86 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.949 -1.5 . . . . 71.120000000000005 106.949 178.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.2 m -114.15 128.51 56.4 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.435 -0.58 . . . . 75.129999999999995 109.435 -176.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 88.3 t -120.93 123.63 70.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.031 -0.729 . . . . 75.349999999999994 109.031 178.323 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.57 127.5 56.1 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.002 -0.74 . . . . 52.409999999999997 109.002 177.323 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.01 118.82 14.34 Favored Pre-proline 0 C--N 1.291 -1.949 0 N-CA-C 111.795 0.294 . . . . 71.109999999999999 111.795 178.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.37 41.42 0.36 Allowed 'Trans proline' 0 CA--C 1.555 1.561 0 C-N-CA 123.223 2.615 . . . . 71.239999999999995 112.563 175.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.08 -92.85 0.53 Allowed 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 110.148 -0.315 . . . . 63.240000000000002 110.148 178.539 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 168.24 133.68 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.522 1.129 . . . . 74.040000000000006 108.192 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.09 142.86 12.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 108.866 -0.791 . . . . 74.329999999999998 108.866 175.54 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.7 t -103.75 -33.74 8.82 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.2 -0.667 . . . . 75.219999999999999 109.2 178.153 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.0 m -158.3 132.31 7.9 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 108.833 -0.803 . . . . 74.549999999999997 108.833 175.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -139.23 159.49 42.04 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 109.559 -0.534 . . . . 61.100000000000001 109.559 174.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.564 ' HB3' ' OG ' ' A' ' 173' ' ' SER . 57.6 t30 -135.58 103.17 5.35 Favored 'General case' 0 C--O 1.274 2.365 0 N-CA-C 105.982 -1.858 . . . . 64.219999999999999 105.982 169.733 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.27 -140.75 6.06 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 107.614 -2.195 . . . . 62.219999999999999 107.614 -178.549 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.5 99.45 6.83 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 118.417 1.108 . . . . 73.239999999999995 110.041 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -75.53 131.12 39.84 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.719 -0.673 . . . . 63.119999999999997 110.64 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.9 mt -95.68 -44.51 13.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.257 -1.386 . . . . 60.140000000000001 107.257 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.96 170.37 9.22 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 105.928 -1.879 . . . . 75.510000000000005 105.928 176.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.24 -0.44 8.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.169 1.913 . . . . 53.409999999999997 111.39 177.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.611 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.8 pt-20 -128.62 5.75 5.61 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.046 -0.524 . . . . 63.149999999999999 111.207 178.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.4 t -143.22 120.8 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.799 -0.815 . . . . 72.099999999999994 108.799 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.86 147.15 33.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.364 -0.606 . . . . 52.420000000000002 109.364 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -131.01 145.35 52.02 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.147 0.499 . . . . 74.25 109.72 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.49 ' CD1' ' HA ' ' A' ' 172' ' ' MET . 30.2 m-90 -121.45 124.63 44.93 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.032 -1.099 . . . . 72.25 108.032 174.367 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -104.64 99.41 9.08 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.885 -1.154 . . . . 55.409999999999997 107.885 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 1.3 mm? -89.2 133.42 34.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.527 -0.761 . . . . 75.439999999999998 109.272 -174.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -117.58 150.59 47.03 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 116.139 -0.482 . . . . 74.219999999999999 111.854 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.426 ' HA ' HD23 ' A' ' 127' ' ' LEU . 72.2 Cg_endo -76.76 156.96 35.44 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 123.087 2.525 . . . . 64.150000000000006 111.85 177.462 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.47 -36.73 2.93 Favored Glycine 0 C--N 1.31 -0.91 0 CA-C-N 115.977 -0.556 . . . . 63.32 111.798 178.193 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.49 149.98 8.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.789 -0.819 . . . . 74.230000000000004 108.789 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -86.22 114.51 25.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.608 -0.886 . . . . 70.519999999999996 108.608 177.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.1 m -104.61 141.99 35.45 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.575 -0.528 . . . . 74.409999999999997 109.575 -177.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 124' ' ' ARG . 67.1 p -116.22 156.84 25.84 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 120.738 0.304 . . . . 75.340000000000003 110.564 -177.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.49 ' HA ' ' CD1' ' A' ' 162' ' ' TRP . 23.4 ptp -128.95 117.45 20.98 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.132 -1.062 . . . . 64.25 108.132 175.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.564 ' OG ' ' HB3' ' A' ' 151' ' ' ASN . 2.9 p -138.33 132.93 32.34 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.936 -0.706 . . . . 74.420000000000002 112.084 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.474 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.71 139.88 19.36 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 123.664 0.785 . . . . 75.450000000000003 109.341 -176.099 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.439 ' HG2' HG22 ' A' ' 120' ' ' ILE . 48.7 mt-30 -137.99 130.59 29.51 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.464 -1.31 . . . . 63.439999999999998 107.464 174.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.433 ' HB3' ' CE1' ' A' ' 178' ' ' TYR . . . -148.55 153.1 37.93 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.912 -0.315 . . . . 63.420000000000002 110.409 -177.494 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 37.5 mtp180 -89.55 126.25 35.53 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.547 -0.908 . . . . 62.130000000000003 108.547 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 176' ' ' ALA . 85.3 m-85 -124.69 152.86 43.18 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-O 120.988 0.423 . . . . 74.310000000000002 111.107 -176.706 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.2 p -78.34 94.38 4.84 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 116.138 -0.483 . . . . 70.010000000000005 111.518 177.37 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.384 0 C-N-CA 125.259 1.424 . . . . 74.140000000000001 113.773 175.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 37.4 ttm180 . . . . . 0 N--CA 1.408 -2.527 0 N-CA-C 108.992 -0.744 . . . . 74.420000000000002 108.992 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.19 113.62 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 N-CA-C 106.036 -1.838 . . . . 72.510000000000005 106.036 176.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 20.6 ttt180 -120.21 114.36 21.81 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 121.249 0.547 . . . . 72.109999999999999 109.807 -178.009 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 139' ' ' LEU . . . -104.63 108.37 19.78 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.093 -1.077 . . . . 63.119999999999997 108.093 178.5 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 140' ' ' THR . 21.2 m -119.39 115.32 23.86 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.163 -1.051 . . . . 74.430000000000007 108.163 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.9 pp -125.64 146.42 31.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.275 0.559 . . . . 73.219999999999999 109.819 -177.045 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 43.0 m -126.31 125.38 42.2 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 108.307 -0.997 . . . . 74.239999999999995 108.307 -178.403 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' OH ' ' A' ' 178' ' ' TYR . 8.4 tt -116.74 129.62 72.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.278 0.561 . . . . 74.310000000000002 110.073 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -105.34 149.63 37.98 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 116.116 -0.493 . . . . 41.399999999999999 111.514 -175.248 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.53 -7.14 0.73 Allowed 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 124.995 3.797 . . . . 64.430000000000007 116.078 -178.197 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 3.32 30.11 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.997 -0.44 . . . . 71.310000000000002 110.319 177.331 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.1 t70 71.74 34.44 1.58 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 123.993 1.854 . . . . 72.239999999999995 106.378 -175.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.17 125.05 50.52 Favored 'General case' 0 N--CA 1.392 -3.34 0 CA-C-N 113.26 -1.791 . . . . 44.329999999999998 107.459 -177.647 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.417 HG11 HD21 ' A' ' 95' ' ' LEU . 11.4 t -114.55 140.56 34.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.804 -0.813 . . . . 64.340000000000003 108.804 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.8 p -150.67 159.87 44.22 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.537 -0.912 . . . . 40.329999999999998 108.537 179.292 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.82 -173.44 43.39 Favored Glycine 0 CA--C 1.49 -1.522 0 C-N-CA 118.682 -1.723 . . . . 54.340000000000003 113.03 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.6 133.41 14.0 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.121 0.486 . . . . 54.5 110.488 -176.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 3.5 mp -116.08 115.94 50.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 106.839 -1.541 . . . . 74.230000000000004 106.839 174.422 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.02 118.74 57.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.891 -0.781 . . . . 71.299999999999997 108.891 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.1 107.37 17.18 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 106.087 -1.819 . . . . 43.229999999999997 106.087 174.186 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -125.86 133.47 51.93 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 116.184 -0.462 . . . . 62.100000000000001 111.048 -174.167 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.79 157.89 33.02 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.174 -0.921 . . . . 72.329999999999998 109.975 -177.247 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt . . . . . 0 C--N 1.312 -1.064 0 N-CA-C 107.525 -1.287 . . . . 71.510000000000005 107.525 173.391 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 61.1 m . . . . . 1 N--CA 1.378 -4.069 0 N-CA-C 108.263 -1.014 . . . . 55.340000000000003 108.263 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.44 126.89 0.91 Allowed Glycine 0 N--CA 1.422 -2.267 0 CA-C-O 118.51 -1.161 . . . . 63.299999999999997 111.611 174.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 6.9 Cg_endo -56.51 148.15 65.01 Favored 'Trans proline' 0 CA--C 1.553 1.437 0 CA-C-N 120.518 2.159 . . . . 74.540000000000006 108.839 166.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.95 128.39 54.89 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.292 0.849 . . . . 34.420000000000002 113.292 -172.534 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 90.5 mt -94.57 133.22 38.44 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.77 -0.65 . . . . 71.349999999999994 109.503 176.047 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -111.62 83.64 1.81 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.556 0.693 . . . . 73.549999999999997 111.85 176.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.6 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -88.72 87.62 1.5 Allowed Glycine 0 N--CA 1.423 -2.174 0 CA-C-N 114.677 -1.147 . . . . 53.210000000000001 111.239 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.47 104.75 16.87 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.523 0.678 . . . . 73.5 110.667 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.36 160.58 68.09 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.123 -1.066 . . . . 53.240000000000002 108.123 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.64 -8.61 23.74 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 122.52 2.146 . . . . 74.409999999999997 112.64 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -120.63 39.63 3.71 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.64 -0.709 . . . . 61.100000000000001 110.951 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.2 m -56.45 -32.97 65.44 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 116.407 -0.36 . . . . 51.229999999999997 111.867 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -68.53 -12.5 61.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.213 0.53 . . . . 65.510000000000005 111.168 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -100.64 -9.2 22.14 Favored 'General case' 0 C--O 1.26 1.628 0 CA-C-N 116.046 -0.525 . . . . 71.209999999999994 110.249 -178.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG21 ' HE1' ' A' ' 101' ' ' MET . 5.6 p -129.64 119.33 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.097 0.951 . . . . 72.319999999999993 111.209 177.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.67 110.63 21.96 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.225 -0.898 . . . . 72.019999999999996 109.815 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.01 114.42 35.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.995 -1.483 . . . . 71.430000000000007 106.995 177.245 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 m -123.78 164.38 19.29 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.776 -0.647 . . . . 72.120000000000005 109.79 -172.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -86.86 125.55 34.07 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.198 -1.408 . . . . 74.540000000000006 107.198 175.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 82.6 t80 -92.7 120.12 32.79 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.167 -0.679 . . . . 71.109999999999999 109.167 -175.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -138.52 99.21 3.77 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 106.776 -1.564 . . . . 72.219999999999999 106.776 174.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.7 t -174.36 153.35 1.92 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.024 -1.102 . . . . 74.219999999999999 108.024 -174.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.53 16.4 10.49 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.835 0.854 . . . . 65.319999999999993 111.501 174.389 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.27 85.1 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 116.065 -0.516 . . . . 54.409999999999997 112.793 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.401 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 61.6 m-85 -104.07 153.63 20.66 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.116 -0.698 . . . . 74.319999999999993 109.116 -178.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 56' ' ' THR . 27.1 m -124.33 141.51 44.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.036 -1.098 . . . . 43.439999999999998 108.036 172.449 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.469 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -177.69 -154.21 12.03 Favored Glycine 0 N--CA 1.407 -3.24 0 C-N-CA 119.981 -1.104 . . . . 65.120000000000005 111.568 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.607 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 1.7 p -130.5 150.04 51.89 Favored 'General case' 0 C--N 1.26 -3.288 0 CA-C-O 121.351 0.596 . . . . 70.420000000000002 110.971 178.114 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -138.61 138.98 38.39 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 116.15 -0.477 . . . . 54.299999999999997 110.373 -175.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.97 114.1 25.71 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.593 -1.262 . . . . 72.439999999999998 107.593 175.526 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -115.23 112.09 38.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 109.422 -0.585 . . . . 51.030000000000001 109.422 -177.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 43.1 p90 -112.47 151.85 29.43 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 110.0 -0.371 . . . . 44.350000000000001 110.0 -175.674 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 m -154.31 145.68 23.01 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 120.484 -0.487 . . . . 63.210000000000001 109.705 -175.455 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t0 60.13 62.39 1.63 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.471 1.129 . . . . 45.520000000000003 112.155 178.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.5 mt -119.23 170.97 8.63 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.675 -1.148 . . . . 50.32 108.908 175.198 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.2 t -113.59 169.12 9.2 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.825 -0.805 . . . . 55.409999999999997 108.825 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.48 -30.13 68.31 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.224 0.535 . . . . 75.200000000000003 111.077 -178.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.97 -25.56 67.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.975 -0.557 . . . . 63.420000000000002 111.433 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.475 ' OE1' HG22 ' A' ' 91' ' ' THR . 49.5 mt-10 -86.66 -16.57 36.21 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 112.468 0.544 . . . . 70.430000000000007 112.468 -176.215 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 11.6 mt -51.22 -55.19 30.6 Favored Pre-proline 0 N--CA 1.483 1.218 0 N-CA-C 115.382 1.623 . . . . 61.109999999999999 115.382 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.32 -40.66 56.69 Favored 'Trans proline' 0 C--N 1.366 1.452 0 CA-C-N 120.894 1.355 . . . . 71.150000000000006 110.954 -179.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.07 -40.0 96.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.88 -1.054 . . . . 70.239999999999995 111.511 -177.627 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -76.18 -19.89 58.02 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 120.604 -0.438 . . . . 71.120000000000005 110.586 177.621 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.09 -21.62 59.83 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.2 -0.667 . . . . 75.209999999999994 109.2 -177.534 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.03 -57.54 11.23 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.468 -0.787 . . . . 63.32 108.957 175.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.6 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 33.3 ttp -54.2 -49.09 70.17 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.764 -0.653 . . . . 55.130000000000003 110.094 178.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -53.9 -42.75 69.05 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.427 -0.806 . . . . 62.310000000000002 111.286 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.2 p -67.78 -24.92 65.38 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 120.018 -0.673 . . . . 62.0 111.603 -173.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.05 -25.14 66.11 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 120.914 0.388 . . . . 70.540000000000006 110.182 -177.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -103.4 -7.89 20.64 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.536 -0.466 . . . . 35.140000000000001 110.712 -179.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.63 -43.63 4.88 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.444 -0.503 . . . . 61.420000000000002 112.219 -173.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.92 12.72 80.81 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.694 -0.765 . . . . 64.219999999999999 111.688 -177.157 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 m -112.21 169.35 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.985 -0.746 . . . . 71.120000000000005 108.985 -178.14 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -114.07 124.76 52.9 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.854 -0.339 . . . . 64.129999999999995 110.708 -178.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.42 132.66 55.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.881 -0.785 . . . . 63.25 108.881 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.1 m -144.11 131.77 21.22 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.457 -0.571 . . . . 62.420000000000002 109.457 177.056 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 157.82 43.97 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.211 0.529 . . . . 73.540000000000006 112.405 -175.585 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -155.66 165.56 36.16 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.472 -1.24 . . . . 72.0 110.697 178.344 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.436 ' HG3' HG22 ' A' ' 119' ' ' VAL . 3.6 ttt85 -99.06 137.72 37.19 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 106.355 -1.72 . . . . 71.540000000000006 106.355 171.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -118.44 94.45 4.48 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 107.53 -1.285 . . . . 65.140000000000001 107.53 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.07 -114.44 5.25 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.406 -1.478 . . . . 71.010000000000005 109.406 -175.292 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -112.32 14.7 20.47 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.723 1.249 . . . . 73.439999999999998 108.922 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.5 pp -123.26 148.99 26.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 120.396 -1.44 . . . . 74.409999999999997 108.383 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 178' ' ' TYR . 70.8 t -99.55 135.99 32.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 O-C-N 122.18 -0.325 . . . . 73.319999999999993 110.544 -177.331 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.9 pt -118.86 130.23 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-O 121.767 0.794 . . . . 72.450000000000003 109.235 176.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 tt -126.91 131.61 51.09 Favored 'General case' 0 C--N 1.266 -3.064 0 CA-C-N 115.352 -0.84 . . . . 73.329999999999998 109.26 177.145 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -123.27 146.44 47.87 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.094 -1.076 . . . . 63.340000000000003 108.094 177.346 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.32 155.59 27.01 Favored Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 110.534 -1.026 . . . . 70.510000000000005 110.534 177.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.34 139.04 33.5 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.161 -1.051 . . . . 74.150000000000006 108.161 175.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.55 114.28 15.88 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.833 -0.622 . . . . 72.400000000000006 109.463 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -111.28 108.54 18.19 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.273 -1.01 . . . . 55.420000000000002 108.273 178.3 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.09 29.52 7.91 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.601 -0.518 . . . . 72.230000000000004 109.601 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 120.122 -0.631 . . . . 73.209999999999994 110.563 -179.059 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 113.093 0.775 . . . . 74.099999999999994 113.093 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.85 136.88 38.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.907 -1.886 . . . . 72.109999999999999 105.907 171.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.9 t70 -132.21 125.94 32.36 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 120.553 -0.459 . . . . 72.340000000000003 110.047 -172.505 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 67.5 t -116.38 127.88 73.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.54 -0.864 . . . . 74.510000000000005 109.775 -179.215 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 43.8 mt-10 -128.53 141.13 51.47 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.134 -0.691 . . . . 72.420000000000002 109.134 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 5.6 tt -132.23 122.67 25.6 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.895 -1.52 . . . . 64.340000000000003 106.895 175.354 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' SER . 2.2 m -124.86 132.52 53.31 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.994 -1.113 . . . . 72.049999999999997 107.994 -176.149 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 71.8 t -124.08 125.98 71.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 109.549 -0.537 . . . . 75.040000000000006 109.549 178.531 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -109.41 121.1 44.44 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.745 -1.206 . . . . 42.149999999999999 107.745 175.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -133.82 105.83 11.67 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 111.756 0.28 . . . . 75.150000000000006 111.756 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -67.05 34.69 0.14 Allowed 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 123.604 2.869 . . . . 71.430000000000007 113.329 178.097 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -109.26 -90.39 0.46 Allowed 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.093 -0.706 . . . . 63.030000000000001 109.093 178.338 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.12 124.0 0.01 OUTLIER 'General case' 0 C--N 1.362 1.117 0 C-N-CA 124.196 0.998 . . . . 72.540000000000006 109.682 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.406 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 7.9 p -80.02 138.46 19.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.746 -0.835 . . . . 71.340000000000003 108.746 175.183 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.8 t -104.43 -27.58 11.85 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.678 -0.409 . . . . 60.219999999999999 110.371 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.6 m -159.48 132.33 6.84 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 108.049 -1.093 . . . . 63.100000000000001 108.049 174.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.1 t -140.42 150.75 44.24 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 118.531 0.605 . . . . 44.450000000000003 111.925 174.189 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 27.6 t-20 -120.69 93.11 3.93 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 105.719 -1.956 . . . . 61.229999999999997 105.719 174.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.01 -142.73 6.41 Favored Glycine 0 C--N 1.296 -1.651 0 N-CA-C 107.347 -2.301 . . . . 65.010000000000005 107.347 -178.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -118.45 104.35 10.62 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 118.603 1.202 . . . . 71.140000000000001 109.88 177.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -84.87 113.57 21.47 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.945 -0.571 . . . . 73.319999999999993 111.094 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.5 mt -80.66 -46.62 21.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.52 -1.289 . . . . 71.230000000000004 107.52 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -134.0 160.76 67.3 Favored Pre-proline 0 C--N 1.295 -1.789 0 CA-C-N 114.317 -1.311 . . . . 75.340000000000003 107.491 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -61.5 -17.13 52.06 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.496 2.131 . . . . 65.510000000000005 111.577 173.631 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 1.4 pm0 -115.13 2.42 14.13 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 113.484 0.92 . . . . 72.25 113.484 177.054 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.79 120.44 16.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 121.621 -0.674 . . . . 74.120000000000005 109.612 178.401 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.8 t -129.36 147.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 109.304 -0.628 . . . . 74.150000000000006 109.304 -177.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -136.77 143.61 43.33 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.31 0.576 . . . . 73.209999999999994 111.049 -178.151 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.444 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.5 m-90 -119.79 123.93 44.89 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.468 -0.938 . . . . 62.140000000000001 108.468 177.686 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -101.15 110.34 22.35 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.296 0.569 . . . . 70.040000000000006 109.756 177.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.0 mm? -97.4 116.87 30.42 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 122.279 1.038 . . . . 62.310000000000002 108.723 -177.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -117.08 138.92 25.26 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 113.637 -1.619 . . . . 73.040000000000006 110.584 -169.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.06 156.63 61.68 Favored 'Trans proline' 0 C--O 1.244 0.81 0 C-N-CA 122.442 2.095 . . . . 72.340000000000003 111.351 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.55 -33.39 3.24 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 116.128 -0.487 . . . . 61.030000000000001 111.991 177.411 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 32.7 m -108.02 165.49 4.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.348 0.594 . . . . 71.099999999999994 111.656 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.42 144.14 22.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.723 -1.214 . . . . 73.319999999999993 107.723 175.144 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.9 m -139.29 142.86 37.71 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.651 -0.656 . . . . 73.239999999999995 111.549 179.078 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 13.3 p -96.25 150.36 20.63 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.337 -0.847 . . . . 72.010000000000005 108.917 177.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.455 ' HE1' HD13 ' A' ' 139' ' ' LEU . 76.2 mtp -129.65 128.75 43.23 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.863 -0.792 . . . . 75.120000000000005 108.863 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 32.7 t -143.62 142.66 31.14 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.939 -1.134 . . . . 52.109999999999999 107.939 174.646 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -155.18 116.63 4.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.879 -0.785 . . . . 73.439999999999998 108.879 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 48.3 mt-30 -125.53 130.56 51.97 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 108.022 -1.103 . . . . 72.239999999999995 108.022 176.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -143.44 158.97 43.21 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 116.533 -0.303 . . . . 54.130000000000003 110.969 -176.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -87.37 125.04 34.01 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.76 -0.376 . . . . 75.319999999999993 110.085 178.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 119' ' ' VAL . 8.0 m-85 -134.86 120.29 19.13 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 114.371 1.249 . . . . 75.510000000000005 114.371 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.2 p -61.13 105.48 0.49 Allowed 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 113.937 -1.483 . . . . 64.010000000000005 110.51 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 36.7 t70 . . . . . 0 C--N 1.3 -1.577 0 CA-C-N 113.944 -1.48 . . . . 71.329999999999998 110.646 -176.377 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.91 0 N-CA-C 110.183 -0.302 . . . . 74.230000000000004 110.183 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.401 HG23 HG13 ' A' ' 137' ' ' VAL . 27.7 m -120.22 115.5 47.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.582 0.706 . . . . 75.420000000000002 109.359 177.552 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 96.6 mtt180 -113.12 119.0 36.32 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.776 -0.647 . . . . 70.540000000000006 110.749 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.96 108.22 16.74 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.561 -1.274 . . . . 50.219999999999999 107.561 175.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 m -114.79 114.98 26.29 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.376 -1.342 . . . . 50.329999999999998 107.376 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 pp -126.83 146.18 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 109.419 -0.586 . . . . 74.219999999999999 109.419 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.6 m -126.35 137.51 53.47 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 108.566 -0.902 . . . . 62.32 108.566 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.81 125.02 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 109.032 -0.729 . . . . 73.239999999999995 109.032 -176.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 m -105.78 152.08 40.08 Favored Pre-proline 0 N--CA 1.425 -1.689 0 CA-C-N 115.762 -0.653 . . . . 74.219999999999999 110.232 -177.087 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.62 2.42 0.98 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 123.904 3.069 . . . . 64.439999999999998 114.577 -176.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -87.99 3.54 48.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.222 -1.029 . . . . 71.430000000000007 108.222 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 91' ' ' THR . 15.0 t70 72.07 28.68 2.47 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 126.298 1.839 . . . . 61.43 106.227 -175.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 tp -102.02 129.04 48.23 Favored 'General case' 0 N--CA 1.381 -3.919 0 CA-C-N 112.689 -2.05 . . . . 71.129999999999995 109.164 -176.649 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.95 132.43 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 N-CA-C 107.827 -1.175 . . . . 74.540000000000006 107.827 176.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.2 p -142.52 151.42 41.62 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.621 -1.251 . . . . 71.420000000000002 107.621 177.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.53 -176.42 47.11 Favored Glycine 0 N--CA 1.418 -2.525 0 C-N-CA 118.722 -1.704 . . . . 73.310000000000002 112.7 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.65 133.58 25.66 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.736 -0.732 . . . . 71.0 109.878 -175.677 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.8 mt -120.42 115.7 47.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.218 -1.401 . . . . 65.209999999999994 107.218 175.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.83 115.31 48.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.115 0.483 . . . . 71.430000000000007 109.98 -178.344 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.501 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -105.93 108.42 19.92 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.116 -1.809 . . . . 74.299999999999997 106.116 173.132 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -125.06 132.38 53.19 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.312 -0.555 . . . . 74.200000000000003 111.418 -175.203 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.45 129.44 41.19 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.931 -1.031 . . . . 73.310000000000002 110.866 -178.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt . . . . . 0 C--N 1.323 -0.562 0 N-CA-C 107.269 -1.382 . . . . 74.540000000000006 107.269 171.784 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.422 -1.863 0 N-CA-C 108.119 -1.067 . . . . 71.150000000000006 108.119 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.36 96.82 0.1 Allowed Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.595 -0.812 . . . . 73.019999999999996 112.845 176.048 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.77 160.57 45.93 Favored 'Trans proline' 0 C--O 1.248 1.025 0 C-N-CA 123.487 2.791 . . . . 74.340000000000003 111.932 174.547 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.83 158.49 28.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.765 0.317 . . . . 70.150000000000006 111.096 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 95.2 mt -102.25 154.99 18.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 106.62 -1.622 . . . . 74.239999999999995 106.62 173.594 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -93.03 86.35 5.38 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.227 1.013 . . . . 64.439999999999998 109.703 -177.086 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.52 ' HA2' ' SD ' ' A' ' 101' ' ' MET . . . -85.16 84.31 1.6 Allowed Glycine 0 N--CA 1.413 -2.888 0 CA-C-N 114.101 -1.408 . . . . 40.350000000000001 111.958 -178.011 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -112.05 97.6 6.77 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.986 0.422 . . . . 72.099999999999994 110.244 178.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 m -146.1 159.45 46.01 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 123.995 0.918 . . . . 52.399999999999999 108.815 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.18 -9.02 22.9 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.106 1.871 . . . . 61.200000000000003 112.05 176.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -114.79 42.05 2.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 74.329999999999998 111.994 -178.125 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.6 m -55.3 -28.32 52.83 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 111.776 0.287 . . . . 70.329999999999998 111.776 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -65.65 -20.32 66.26 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 121.276 0.56 . . . . 51.130000000000003 110.813 -178.659 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -90.85 -18.26 25.14 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.645 -0.707 . . . . 54.219999999999999 110.535 -177.097 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.98 119.59 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 121.964 0.887 . . . . 54.119999999999997 112.532 -176.25 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.67 104.79 16.11 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.273 -0.876 . . . . 54.409999999999997 109.58 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.8 p -98.95 133.04 43.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.054 -0.721 . . . . 72.040000000000006 109.054 177.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -154.74 173.46 16.39 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 123.335 0.654 . . . . 72.140000000000001 109.612 -175.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -77.72 153.62 32.82 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.495 0.664 . . . . 74.150000000000006 110.308 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 76.9 t80 -114.39 122.55 46.99 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 108.022 -1.103 . . . . 71.420000000000002 108.022 176.854 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -138.62 102.85 4.7 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.913 -1.514 . . . . 72.299999999999997 106.913 177.032 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 36.8 t -164.13 141.88 7.03 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.147 -0.686 . . . . 52.149999999999999 109.147 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 67.05 10.45 7.7 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.887 0.875 . . . . 64.150000000000006 111.996 174.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.88 -0.36 64.6 Favored Glycine 0 N--CA 1.426 -2.026 0 N-CA-C 111.238 -0.745 . . . . 70.439999999999998 111.238 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.529 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 12.6 m-85 -96.95 142.0 29.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.454 -0.943 . . . . 73.409999999999997 108.454 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 35.3 m -123.85 136.92 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 108.26 -1.015 . . . . 64.340000000000003 108.26 174.13 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.34 -155.34 9.44 Favored Glycine 0 N--CA 1.402 -3.612 0 C-N-CA 119.189 -1.482 . . . . 44.43 112.051 179.448 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 16.0 p -126.62 134.42 50.78 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 114.84 -0.68 . . . . 61.32 110.749 -177.56 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -126.74 143.12 51.34 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.06 0.457 . . . . 74.530000000000001 111.317 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -124.35 114.54 19.68 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.272 -1.381 . . . . 64.450000000000003 107.272 174.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.76 115.17 48.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 107.845 -1.169 . . . . 64.430000000000007 107.845 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.515 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.8 p90 -115.45 152.43 32.94 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.153 0.501 . . . . 72.340000000000003 110.473 -176.013 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 p -159.27 155.3 26.69 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.906 -0.588 . . . . 61.210000000000001 109.641 -176.46 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.24 31.32 6.69 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.076 0.86 . . . . 73.430000000000007 111.386 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.515 HD12 ' CD2' ' A' ' 87' ' ' PHE . 25.2 mt -91.76 156.56 17.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 116.106 -0.497 . . . . 74.549999999999997 109.785 176.585 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 40.1 p -108.0 171.9 7.14 Favored 'General case' 0 C--N 1.277 -2.556 0 O-C-N 123.801 0.688 . . . . 73.109999999999999 109.933 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -57.01 -35.95 69.85 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.998 0.519 . . . . 73.120000000000005 109.729 179.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.08 -28.5 66.57 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.859 -0.61 . . . . 72.219999999999999 111.372 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.438 ' HB3' HD22 ' A' ' 90' ' ' LEU . 41.0 mt-10 -86.33 -17.03 35.6 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.212 0.449 . . . . 55.340000000000003 112.212 -176.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.9 tt -61.36 -48.65 90.5 Favored Pre-proline 0 CA--C 1.569 1.68 0 N-CA-C 112.355 0.502 . . . . 51.109999999999999 112.355 -178.084 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.91 -37.9 82.61 Favored 'Trans proline' 0 C--N 1.376 2.009 0 CA-C-N 121.049 1.41 . . . . 74.540000000000006 110.316 176.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -63.91 -38.76 92.27 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.93 -1.032 . . . . 72.230000000000004 111.129 -177.267 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.5 pp -70.11 -23.84 63.1 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 120.669 -0.412 . . . . 72.340000000000003 110.103 177.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.4 -20.78 63.8 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.094 -0.503 . . . . 64.019999999999996 110.587 -175.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -63.27 -57.95 8.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.404 -0.591 . . . . 71.540000000000006 109.404 176.229 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.52 ' SD ' ' HA2' ' A' ' 62' ' ' GLY . 65.3 mtm -56.68 -48.97 76.46 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.436 0.636 . . . . 73.140000000000001 109.507 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -53.93 -40.57 66.86 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.264 -1.335 . . . . 73.209999999999994 111.644 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.8 p -65.22 -26.87 68.31 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 119.906 -0.717 . . . . 51.219999999999999 111.077 -172.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.04 -33.26 74.05 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 116.15 -0.477 . . . . 52.420000000000002 110.71 -176.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.41 -9.57 20.17 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.287 -0.565 . . . . 70.200000000000003 111.058 -176.383 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.96 -47.64 3.66 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.143 0.794 . . . . 53.25 113.143 -173.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.79 7.3 64.73 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.861 -0.896 . . . . 54.140000000000001 110.861 -173.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.6 m -101.51 172.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 O-C-N 122.427 -0.455 . . . . 75.209999999999994 110.493 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -138.93 141.08 38.48 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.409 -1.33 . . . . 64.540000000000006 107.409 176.065 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.87 132.29 38.37 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.744 -0.836 . . . . 75.200000000000003 108.744 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.2 m -134.76 134.12 40.61 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.343 -0.984 . . . . 73.409999999999997 108.343 178.136 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -141.85 147.91 37.96 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.328 0.585 . . . . 53.420000000000002 111.551 -178.002 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -146.02 154.87 42.36 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.402 -1.272 . . . . 75.010000000000005 110.658 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.484 ' HG2' HG22 ' A' ' 119' ' ' VAL . 51.7 mtt85 -88.61 138.68 31.21 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.627 -0.715 . . . . 72.340000000000003 109.926 171.267 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.461 ' O ' HG13 ' A' ' 118' ' ' ILE . 51.7 t30 -123.11 90.04 3.22 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 105.486 -2.042 . . . . 62.340000000000003 105.486 176.017 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.5 -118.7 8.66 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 108.857 -1.697 . . . . 42.140000000000001 108.857 -170.553 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 9.5 t30 -105.95 1.31 26.52 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.706 1.241 . . . . 71.310000000000002 108.94 178.336 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -103.9 148.98 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 118.818 -1.153 . . . . 70.340000000000003 108.19 178.486 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.484 HG22 ' HG2' ' A' ' 114' ' ' ARG . 60.5 t -112.74 140.47 32.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 121.972 -0.455 . . . . 72.25 111.45 -176.542 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.45 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.9 pp -121.41 121.52 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 115.058 -0.974 . . . . 72.239999999999995 109.161 178.585 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.33 127.8 50.25 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.127 -0.694 . . . . 74.099999999999994 109.127 179.031 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -125.97 135.71 52.15 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.36 -0.836 . . . . 73.349999999999994 109.469 177.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -145.74 158.07 27.56 Favored Glycine 0 N--CA 1.416 -2.67 0 N-CA-C 110.86 -0.896 . . . . 74.019999999999996 110.86 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.43 145.42 43.14 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.808 -0.442 . . . . 61.32 109.808 177.639 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -111.06 119.42 38.97 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.073 0.463 . . . . 72.109999999999999 111.336 -176.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -112.89 93.53 4.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.277 -0.419 . . . . 73.409999999999997 110.209 179.27 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -142.75 26.24 1.75 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.197 1.475 . . . . 75.409999999999997 108.398 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.5 p . . . . . 0 C--N 1.284 -2.257 0 CA-C-N 113.272 -1.785 . . . . 74.329999999999998 112.008 -176.849 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 112.001 0.371 . . . . 72.310000000000002 112.001 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.68 116.51 2.34 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.423 0.63 . . . . 71.329999999999998 112.569 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -118.59 126.74 52.62 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.888 -1.893 . . . . 62.43 105.888 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 42.5 t -110.97 117.07 54.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 121.136 -0.226 . . . . 63.539999999999999 110.497 -175.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 50.2 mt-10 -109.97 120.32 42.09 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.644 -0.502 . . . . 71.340000000000003 109.644 176.543 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.519 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -114.1 116.24 28.81 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.553 -2.017 . . . . 72.209999999999994 105.553 175.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 19.4 m -122.52 131.23 53.75 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.71 -0.478 . . . . 61.200000000000003 109.71 -177.639 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 94.4 t -122.68 122.83 66.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.75 -0.833 . . . . 71.430000000000007 108.75 178.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.8 126.63 55.64 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.999 0.428 . . . . 74.219999999999999 110.29 178.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.5 p90 -133.83 123.07 16.91 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.876 -0.602 . . . . 73.530000000000001 110.068 177.656 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -74.43 35.46 0.4 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.61 2.207 . . . . 70.349999999999994 113.503 -178.005 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.74 -100.47 0.43 Allowed 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 122.192 -0.318 . . . . 61.43 110.772 -177.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -177.3 128.76 0.16 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.951 -0.759 . . . . 43.32 108.951 -177.223 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.38 133.24 29.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.539 -0.755 . . . . 73.150000000000006 109.324 177.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 p -88.81 -38.92 14.26 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.376 0.607 . . . . 62.420000000000002 109.456 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 74.5 m -159.52 133.18 7.25 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 115.707 -0.679 . . . . 72.549999999999997 109.811 176.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.466 ' OG1' HG11 ' A' ' 160' ' ' VAL . 8.1 t -137.97 155.96 48.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.349 -0.611 . . . . 73.329999999999998 109.349 174.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -126.69 93.89 3.9 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 105.987 -1.857 . . . . 62.030000000000001 105.987 175.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.489 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.59 -144.51 8.2 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 108.555 -1.818 . . . . 75.030000000000001 108.555 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -114.29 99.97 7.99 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 117.653 0.726 . . . . 72.540000000000006 109.367 -178.168 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -77.51 126.93 31.66 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-N 115.752 -0.658 . . . . 65.200000000000003 109.794 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.16 -37.49 9.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.225 -1.398 . . . . 72.319999999999993 107.225 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -142.65 166.64 19.62 Favored Pre-proline 0 N--CA 1.425 -1.713 0 N-CA-C 106.451 -1.685 . . . . 73.439999999999998 106.451 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.84 0.55 6.29 Favored 'Trans proline' 0 C--O 1.21 -0.88 0 C-N-CA 122.475 2.117 . . . . 74.299999999999997 110.684 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.633 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.6 pt-20 -130.12 0.12 4.67 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.902 -0.59 . . . . 73.200000000000003 111.689 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.41 HG23 ' HG3' ' A' ' 158' ' ' GLU . 82.2 t -140.65 120.89 13.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.469 -0.937 . . . . 72.019999999999996 108.469 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.466 HG11 ' OG1' ' A' ' 150' ' ' THR . 41.6 t -125.57 147.23 30.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.345 -0.613 . . . . 71.420000000000002 109.345 -177.638 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -137.25 143.57 42.29 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.416 0.627 . . . . 64.010000000000005 110.074 -177.196 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.519 ' CE3' HD12 ' A' ' 139' ' ' LEU . 25.6 m-90 -123.67 120.2 32.04 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 108.075 -1.083 . . . . 74.329999999999998 108.075 177.082 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.0 pttt -108.95 102.47 11.47 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.352 -0.84 . . . . 63.409999999999997 109.081 -178.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 9.5 mt -101.13 138.24 38.43 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.818 -1.083 . . . . 72.25 110.166 -171.469 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -118.56 151.71 50.15 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 115.566 -0.743 . . . . 64.340000000000003 110.884 177.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.95 157.43 47.16 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.298 1.998 . . . . 75.109999999999999 111.096 178.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 86.55 -36.15 3.27 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.432 -0.89 . . . . 63.130000000000003 111.637 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.75 153.9 6.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 109.584 -0.524 . . . . 74.400000000000006 109.584 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.39 143.46 12.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.811 -0.44 . . . . 74.230000000000004 109.811 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 48.5 m -146.52 143.0 28.62 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.329 -0.989 . . . . 72.099999999999994 108.329 176.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -125.49 156.96 38.14 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.811 -0.811 . . . . 72.120000000000005 108.811 178.445 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -126.32 137.8 53.52 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.523 0.677 . . . . 75.430000000000007 112.028 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.7 t -134.48 136.92 43.51 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.141 -1.429 . . . . 75.349999999999994 107.141 173.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -148.09 116.38 6.54 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.634 -0.876 . . . . 62.539999999999999 108.634 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -127.08 131.25 50.93 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 107.216 -1.401 . . . . 73.420000000000002 107.216 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -159.44 154.13 24.44 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.445 -0.946 . . . . 72.140000000000001 108.445 -176.18 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 29.2 ptt180 -87.96 129.29 35.29 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.168 -1.013 . . . . 75.239999999999995 110.776 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.05 116.27 19.76 Favored 'General case' 0 CA--C 1.477 -1.828 0 N-CA-C 107.721 -1.214 . . . . 75.0 107.721 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.487 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 18.0 p -67.0 123.78 21.18 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.873 -1.058 . . . . 75.530000000000001 112.242 -175.106 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.321 -0.662 0 O-C-N 124.071 0.857 . . . . 70.109999999999999 108.766 172.105 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.318 0 CA-C-O 120.833 0.349 . . . . 74.239999999999995 110.83 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 57.3 t -113.86 113.4 43.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 105.564 -2.013 . . . . 71.319999999999993 105.564 173.897 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -120.73 114.61 21.9 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.026 -0.731 . . . . 75.209999999999994 109.026 -177.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -110.45 124.46 51.81 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.215 -0.902 . . . . 71.109999999999999 109.347 -178.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -124.79 115.69 21.09 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.49 -1.3 . . . . 51.119999999999997 107.49 177.507 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.6 pp -122.36 138.71 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.883 -0.784 . . . . 74.25 108.883 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 93.5 m -119.33 121.68 40.13 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 108.845 -0.798 . . . . 51.509999999999998 108.845 -179.453 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.406 HG23 ' HB3' ' A' ' 143' ' ' PHE . 7.5 tt -109.76 115.62 50.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-O 121.675 0.75 . . . . 71.510000000000005 109.729 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.8 m -80.08 148.17 67.14 Favored Pre-proline 0 N--CA 1.412 -2.349 0 N-CA-C 107.985 -1.117 . . . . 62.229999999999997 107.985 -179.072 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.85 2.87 0.85 Allowed 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 123.73 2.953 . . . . 72.109999999999999 112.972 -179.287 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -87.11 -1.82 58.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.609 -0.885 . . . . 71.129999999999995 108.609 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 12.8 t70 73.05 29.46 1.77 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.054 1.742 . . . . 63.200000000000003 108.135 -175.786 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.11 124.76 50.08 Favored 'General case' 0 N--CA 1.394 -3.24 0 CA-C-N 113.946 -1.479 . . . . 62.240000000000002 107.653 178.879 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.443 HG12 ' HE2' ' A' ' 87' ' ' PHE . 14.2 t -109.72 129.87 63.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.835 -0.802 . . . . 71.409999999999997 108.835 -178.504 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.6 p -143.79 131.55 21.38 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.286 -1.005 . . . . 72.439999999999998 108.286 179.7 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.27 -175.34 32.2 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 118.967 -1.587 . . . . 61.530000000000001 113.178 -176.473 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.39 133.3 16.02 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 123.503 0.721 . . . . 73.010000000000005 109.529 -176.724 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 60.9 mt -120.11 116.13 49.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 107.88 -1.155 . . . . 62.219999999999999 107.88 177.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.11 116.62 53.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.712 -0.477 . . . . 72.329999999999998 109.712 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.79 108.49 17.92 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.387 -1.338 . . . . 44.109999999999999 107.387 175.462 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.51 122.09 40.87 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.754 -0.461 . . . . 53.329999999999998 109.754 -177.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.92 158.07 22.49 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.76 -0.654 . . . . 71.420000000000002 111.811 -176.088 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 N--CA 1.439 -1.023 0 CA-C-N 114.579 -1.191 . . . . 62.43 109.911 175.846 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 106.034 -1.839 . . . . 74.400000000000006 106.034 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.23 98.24 0.11 Allowed Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 108.792 -1.723 . . . . 61.219999999999999 108.792 175.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -52.52 128.51 28.23 Favored 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 122.121 1.881 . . . . 61.350000000000001 110.237 177.563 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.57 157.94 16.72 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.593 0.96 . . . . 73.140000000000001 113.593 -169.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.582 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 71.1 mt -102.45 138.1 39.81 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.164 -0.925 . . . . 71.340000000000003 109.742 176.804 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.7 89.15 3.4 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.502 0.668 . . . . 75.239999999999995 111.352 178.135 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.504 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -120.47 113.87 2.52 Favored Glycine 0 N--CA 1.409 -3.108 0 CA-C-N 115.17 -0.923 . . . . 23.420000000000002 111.525 177.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -116.9 107.62 14.82 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.606 -0.887 . . . . 73.450000000000003 108.606 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.4 m -136.97 151.61 72.46 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.534 -0.913 . . . . 75.120000000000005 108.534 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -73.12 -8.82 22.67 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 122.61 2.207 . . . . 73.219999999999999 112.484 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -108.93 36.64 2.8 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.416 0.627 . . . . 73.420000000000002 109.834 176.243 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -57.71 -30.26 65.38 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.425 -0.807 . . . . 73.010000000000005 112.454 -179.411 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -69.51 -18.39 63.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.359 0.6 . . . . 74.340000000000003 110.325 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -89.55 -16.03 31.57 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.437 -0.801 . . . . 54.219999999999999 109.944 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 6.6 p -118.52 118.88 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 122.515 1.15 . . . . 73.230000000000004 111.235 179.183 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.74 104.95 16.9 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.162 -0.926 . . . . 72.030000000000001 108.864 -179.363 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 t -97.99 131.16 45.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.942 -1.503 . . . . 62.329999999999998 106.942 179.138 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.1 m -144.33 171.76 13.88 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.358 -0.979 . . . . 61.340000000000003 108.358 -176.447 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -88.63 153.87 20.77 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 118.968 -1.093 . . . . 73.120000000000005 108.259 178.122 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -112.6 123.27 49.92 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.792 -1.188 . . . . 62.109999999999999 107.792 177.803 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -139.11 99.18 3.69 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.624 0.726 . . . . 65.299999999999997 109.361 177.422 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.9 m -165.29 161.23 19.03 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.956 -1.127 . . . . 62.240000000000002 107.956 -179.514 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 70.51 3.32 4.45 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.253 1.021 . . . . 63.229999999999997 110.914 178.567 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.51 1.15 83.75 Favored Glycine 0 C--O 1.22 -0.76 0 N-CA-C 110.197 -1.161 . . . . 34.32 110.197 -172.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -104.82 150.49 24.77 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.317 0.647 . . . . 74.230000000000004 110.629 -179.405 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.11 138.18 55.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.466 0.65 . . . . 63.229999999999997 110.032 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.32 -153.36 8.15 Favored Glycine 0 C--N 1.276 -2.794 0 N-CA-C 109.946 -1.261 . . . . 52.140000000000001 109.946 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.582 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 p -131.45 159.47 37.98 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-O 121.256 0.551 . . . . 71.329999999999998 110.933 179.065 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -138.39 140.35 39.35 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.023 -0.535 . . . . 75.129999999999995 110.435 179.015 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.81 114.68 24.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.683 -1.229 . . . . 54.530000000000001 107.683 175.273 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.78 111.65 37.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.476 -0.935 . . . . 64.439999999999998 108.476 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' HE2' HG12 ' A' ' 40' ' ' VAL . 47.3 p90 -113.35 152.81 29.47 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.785 -0.366 . . . . 75.120000000000005 110.903 -174.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 p -151.65 154.35 36.2 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.215 -0.448 . . . . 73.409999999999997 111.218 -173.118 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.91 30.63 16.5 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 124.157 0.983 . . . . 72.510000000000005 112.877 173.391 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.408 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.2 mt -92.49 160.13 15.2 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 116.202 -0.454 . . . . 73.329999999999998 109.798 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.1 t -112.83 175.08 5.59 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 108.819 -0.808 . . . . 65.439999999999998 108.819 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.454 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 84.8 t80 -49.38 -44.21 44.8 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.034 0.934 . . . . 65.230000000000004 110.82 178.805 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.14 69.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.468 -0.787 . . . . 53.32 112.517 -178.18 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.35 -16.8 32.03 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.26 0.467 . . . . 53.25 112.26 -174.604 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.646 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 3.9 tt -65.91 -50.03 55.18 Favored Pre-proline 0 CA--C 1.567 1.623 0 CA-C-O 119.228 -0.415 . . . . 74.25 111.544 -178.189 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.46 -36.52 86.18 Favored 'Trans proline' 0 C--N 1.375 1.94 0 CA-C-N 121.199 1.464 . . . . 53.509999999999998 110.698 175.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -63.66 -38.8 92.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 73.109999999999999 111.523 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.0 pp -74.06 -19.94 60.45 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.782 -0.451 . . . . 74.120000000000005 109.782 177.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.09 -27.5 62.7 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.181 -0.674 . . . . 73.400000000000006 109.181 -178.093 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -61.09 -53.52 56.03 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.758 -0.83 . . . . 73.200000000000003 108.758 176.434 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.504 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 22.7 ttp -53.79 -51.85 62.16 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.518 -0.764 . . . . 63.43 110.054 176.717 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -55.41 -36.07 66.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.283 -0.871 . . . . 73.450000000000003 111.014 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.7 m -62.48 -37.61 86.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 110.182 -0.303 . . . . 63.210000000000001 110.182 -175.132 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -73.66 -13.22 60.95 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.355 0.598 . . . . 62.009999999999998 110.628 -171.552 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.43 -19.31 13.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.151 -0.62 . . . . 51.310000000000002 110.443 179.038 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.93 -44.18 4.48 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.572 0.953 . . . . 64.439999999999998 113.572 -172.497 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.04 21.43 49.86 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.135 -0.786 . . . . 50.219999999999999 111.135 -173.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.5 171.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.265 -0.643 . . . . 72.439999999999998 109.265 -178.113 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -128.64 138.28 52.1 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 117.644 0.202 . . . . 70.540000000000006 111.236 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.82 130.97 40.51 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.909 -1.145 . . . . 72.030000000000001 107.909 176.027 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.2 t -144.07 151.97 40.35 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.451 -0.944 . . . . 53.200000000000003 108.451 177.174 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.8 148.02 28.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.825 -0.806 . . . . 72.319999999999993 108.825 178.409 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -143.91 156.67 44.52 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.826 -0.625 . . . . 73.439999999999998 109.587 -176.174 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -91.22 138.09 31.86 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 121.521 0.677 . . . . 73.129999999999995 112.241 175.701 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.419 ' O ' HG13 ' A' ' 118' ' ' ILE . 30.7 t30 -127.56 91.9 3.39 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 113.978 -1.464 . . . . 71.219999999999999 107.248 177.279 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.54 -106.77 2.23 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 109.579 -1.409 . . . . 74.239999999999995 109.579 -175.737 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -123.73 10.12 8.97 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.841 1.305 . . . . 74.310000000000002 108.107 175.44 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.8 pp -112.88 149.51 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.025 -1.102 . . . . 74.219999999999999 108.025 177.139 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.3 t -107.0 133.63 51.07 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 CA-C-O 120.948 0.404 . . . . 44.149999999999999 109.996 -176.464 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.8 pt -105.68 137.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 107.627 -1.249 . . . . 74.530000000000001 107.627 176.449 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.72 127.08 45.66 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 109.048 -0.723 . . . . 64.319999999999993 109.048 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -127.71 115.31 18.52 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.347 -1.297 . . . . 72.150000000000006 108.19 -177.048 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.3 141.84 11.16 Favored Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 109.854 -1.298 . . . . 62.039999999999999 109.854 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -137.05 135.25 37.37 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.388 -0.968 . . . . 55.140000000000001 108.388 -177.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.9 110.2 19.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.909 -0.587 . . . . 32.130000000000003 111.183 -174.346 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -105.22 98.59 8.28 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.473 0.654 . . . . 73.109999999999999 110.379 177.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.7 mm? -113.26 23.95 12.76 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.602 -0.888 . . . . 73.219999999999999 108.602 178.395 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 45.5 p . . . . . 0 CA--C 1.545 0.754 0 N-CA-C 113.83 1.048 . . . . 75.310000000000002 113.83 -173.854 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 110.478 -0.193 . . . . 74.209999999999994 110.478 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.428 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -89.15 123.39 33.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.529 -0.305 . . . . 71.129999999999995 111.656 -176.356 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.77 122.63 38.55 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.182 -0.673 . . . . 75.019999999999996 109.182 173.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 61.5 t -111.53 120.88 63.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.266 -1.012 . . . . 71.299999999999997 108.266 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -121.34 126.53 49.69 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.122 -0.696 . . . . 71.299999999999997 109.122 -176.218 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -119.13 123.56 44.69 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.443 -0.947 . . . . 73.400000000000006 108.443 -178.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.7 m -123.87 134.29 53.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.047 -0.723 . . . . 75.230000000000004 109.047 179.502 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.476 HG12 ' HD2' ' A' ' 143' ' ' PHE . 90.3 t -120.68 125.64 74.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.879 -0.785 . . . . 72.239999999999995 108.879 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.83 126.27 55.26 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.829 -0.804 . . . . 32.030000000000001 108.829 177.489 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.626 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.0 p90 -134.47 119.24 14.05 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 112.044 0.387 . . . . 75.439999999999998 112.044 178.558 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -68.0 42.97 0.25 Allowed 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.166 2.577 . . . . 54.439999999999998 112.425 174.253 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.0 -106.84 0.33 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 122.732 0.413 . . . . 52.0 110.068 179.415 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -179.62 131.82 0.1 Allowed 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.401 -0.592 . . . . 72.239999999999995 109.401 -177.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -85.26 133.14 30.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.88 -0.785 . . . . 73.019999999999996 108.88 177.416 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.1 p -92.55 -34.71 13.94 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.363 -0.38 . . . . 43.130000000000003 110.432 -177.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.3 m -162.73 133.28 4.7 Favored 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 123.875 0.87 . . . . 73.219999999999999 109.216 177.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.1 t -139.01 163.92 31.13 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.489 -0.757 . . . . 72.430000000000007 111.217 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.571 ' HB3' ' OG ' ' A' ' 173' ' ' SER . 27.4 t-20 -136.41 98.38 3.81 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.23 -2.137 . . . . 73.140000000000001 105.23 171.097 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.3 -150.04 10.69 Favored Glycine 0 N--CA 1.412 -2.927 0 N-CA-C 107.157 -2.377 . . . . 65.219999999999999 107.157 -179.19 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -116.69 99.21 6.97 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.196 -1.409 . . . . 70.409999999999997 107.196 -178.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 160' ' ' VAL 0.264 6.3 ppt_? -86.34 139.34 31.06 Favored 'General case' 0 N--CA 1.414 -2.272 0 C-N-CA 119.325 -0.95 . . . . 74.040000000000006 113.28 -178.669 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 69.8 mt -94.46 -43.11 13.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.244 -1.344 . . . . 74.239999999999995 108.015 -178.103 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -137.75 172.68 6.39 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 107.54 -1.281 . . . . 53.340000000000003 107.54 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -74.22 0.61 8.26 Favored 'Trans proline' 0 C--O 1.21 -0.919 0 C-N-CA 122.197 1.932 . . . . 74.219999999999999 110.044 172.785 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 11.2 pt-20 -130.3 3.23 4.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.228 0.537 . . . . 64.420000000000002 111.867 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.3 t -142.09 121.11 9.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.487 -0.931 . . . . 63.450000000000003 108.487 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 38.2 t -127.94 147.64 32.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 109.549 -0.537 . . . . 73.319999999999993 109.549 -178.5 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -132.58 145.13 50.87 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.193 0.521 . . . . 72.5 110.259 -176.311 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.451 ' CD2' ' HG3' ' A' ' 172' ' ' MET . 27.8 m-90 -130.25 128.74 42.22 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.694 -0.484 . . . . 71.140000000000001 109.694 177.983 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -102.66 112.67 25.54 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.69 0.757 . . . . 74.120000000000005 110.019 177.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 33.2 mt -101.41 123.42 45.45 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.025 -0.989 . . . . 54.219999999999999 109.022 -176.392 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -118.07 156.38 50.4 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 115.882 -0.599 . . . . 74.109999999999999 112.052 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 127' ' ' LEU . 59.8 Cg_endo -74.41 156.47 45.69 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.79 2.327 . . . . 70.140000000000001 111.552 177.59 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.94 -30.92 2.86 Favored Glycine 0 C--N 1.317 -0.527 0 C-N-CA 121.288 -0.482 . . . . 71.409999999999997 112.4 177.538 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.82 160.96 5.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 120.902 0.382 . . . . 53.520000000000003 110.42 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.4 p -113.62 110.15 31.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 122.102 0.954 . . . . 63.530000000000001 108.787 176.641 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 32.8 t -101.09 141.5 33.88 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.597 -0.729 . . . . 72.329999999999998 109.981 -175.238 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.1 p -106.42 126.55 52.39 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.584 -0.734 . . . . 74.519999999999996 110.526 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.451 ' HG3' ' CD2' ' A' ' 162' ' ' TRP . 39.5 ttm -107.68 116.16 31.44 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.758 -1.201 . . . . 71.349999999999994 107.758 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.571 ' OG ' ' HB3' ' A' ' 151' ' ' ASN . 11.7 p -142.85 139.41 30.85 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 118.303 -1.359 . . . . 64.519999999999996 111.07 177.068 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -151.26 146.83 26.32 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 108.28 -1.007 . . . . 53.140000000000001 108.28 -176.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -138.36 130.72 28.9 Favored 'General case' 0 C--N 1.261 -3.246 0 N-CA-C 105.834 -1.913 . . . . 72.340000000000003 105.834 173.149 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.3 158.88 44.36 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.674 -0.491 . . . . 62.350000000000001 109.674 -177.212 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -91.34 135.2 33.98 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.155 -0.683 . . . . 72.109999999999999 109.155 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -143.05 123.82 14.2 Favored 'General case' 0 CA--C 1.47 -2.119 0 C-N-CA 120.119 -0.632 . . . . 75.519999999999996 109.93 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.3 p -65.14 104.05 0.85 Allowed 'General case' 0 C--N 1.284 -2.281 0 O-C-N 124.514 1.134 . . . . 72.109999999999999 111.232 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.24 0.583 0 CA-C-N 115.078 -0.964 . . . . 73.530000000000001 109.889 178.949 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 . . . . . 0 N--CA 1.439 -0.998 0 CA-C-O 120.882 0.372 . . . . 62.219999999999999 110.739 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.2 t -123.38 114.83 43.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.548 -0.908 . . . . 65.230000000000004 108.548 178.195 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -126.0 118.93 26.38 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.154 0.502 . . . . 75.329999999999998 110.203 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.52 118.65 35.04 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.647 -0.706 . . . . 75.219999999999999 109.155 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 t -117.05 114.59 23.96 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.26 -1.385 . . . . 73.129999999999995 107.26 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.5 pp -129.25 147.03 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-O 121.453 0.644 . . . . 70.450000000000003 109.723 -177.688 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.3 m -128.75 134.71 48.5 Favored 'General case' 0 C--N 1.265 -3.074 0 N-CA-C 109.481 -0.563 . . . . 45.119999999999997 109.481 -177.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.9 tt -124.72 123.14 65.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.497 0.665 . . . . 73.120000000000005 110.318 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 m -91.73 152.37 43.17 Favored Pre-proline 0 N--CA 1.42 -1.963 0 N-CA-C 108.551 -0.907 . . . . 75.329999999999998 108.551 -179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.29 2.49 0.86 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.566 2.844 . . . . 73.409999999999997 113.841 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -88.31 0.41 56.19 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.169 -0.678 . . . . 62.549999999999997 109.169 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 t70 72.64 29.72 1.96 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.778 -1.564 . . . . 71.209999999999994 106.778 -174.498 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tp -101.71 124.97 48.25 Favored 'General case' 0 N--CA 1.389 -3.484 0 CA-C-N 113.676 -1.602 . . . . 64.299999999999997 107.251 177.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.35 135.6 58.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 109.169 -0.678 . . . . 72.400000000000006 109.169 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.7 p -143.91 156.28 44.38 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.872 -1.159 . . . . 71.230000000000004 107.872 175.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.05 44.23 Favored Glycine 0 N--CA 1.425 -2.041 0 C-N-CA 119.064 -1.541 . . . . 60.539999999999999 112.265 179.043 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.75 133.38 17.78 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 109.368 -0.604 . . . . 45.030000000000001 109.368 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 58.7 mt -116.6 116.16 51.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.952 -1.129 . . . . 63.25 107.952 177.427 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.22 116.19 51.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.992 -0.373 . . . . 74.230000000000004 109.992 -177.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.18 108.1 17.66 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.377 -1.712 . . . . 54.43 106.377 173.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.82 131.34 53.72 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.252 0.549 . . . . 73.329999999999998 111.078 -174.248 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.75 158.03 37.59 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.397 -0.82 . . . . 71.209999999999994 110.445 -177.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.941 0 N-CA-C 106.522 -1.659 . . . . 74.0 106.522 170.663 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.418 -2.063 0 N-CA-C 109.871 -0.418 . . . . 74.299999999999997 109.871 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.48 102.1 0.15 Allowed Glycine 0 N--CA 1.433 -1.501 0 CA-C-O 118.267 -1.296 . . . . 72.120000000000005 111.583 178.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -54.2 128.72 31.1 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 119.961 1.88 . . . . 72.099999999999994 110.148 173.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.539 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -93.74 148.77 21.81 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 113.074 0.768 . . . . 75.420000000000002 113.074 -171.555 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.48 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 83.2 mt -100.15 160.11 14.58 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.236 -1.024 . . . . 73.340000000000003 108.236 174.111 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -90.78 86.87 6.46 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.888 -0.782 . . . . 73.219999999999999 108.888 -178.317 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' ' SD ' ' A' ' 101' ' ' MET . . . -86.35 78.27 1.94 Allowed Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 114.622 -1.172 . . . . 41.030000000000001 110.963 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -138.27 99.13 3.78 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.458 -0.371 . . . . 64.340000000000003 110.993 -176.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 m -151.51 144.65 17.14 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 124.461 1.104 . . . . 73.019999999999996 108.658 178.767 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.51 -32.72 54.43 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.326 2.684 . . . . 61.25 113.254 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -88.52 44.08 1.18 Allowed 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 111.954 0.353 . . . . 75.530000000000001 111.954 -179.676 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.8 m -53.44 -32.27 49.09 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 113.362 0.875 . . . . 72.329999999999998 113.362 -176.92 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -75.82 -12.56 60.19 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.465 -0.772 . . . . 71.120000000000005 110.616 -176.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -89.77 -18.25 26.67 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.699 -0.682 . . . . 73.120000000000005 109.462 177.54 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.54 119.26 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 122.407 1.098 . . . . 64.200000000000003 112.613 -177.258 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.81 108.99 21.82 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.859 -1.064 . . . . 63.420000000000002 108.583 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.7 t -97.62 127.89 49.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 106.709 -1.589 . . . . 72.120000000000005 106.709 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -141.39 167.48 22.08 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.26 -0.645 . . . . 60.299999999999997 109.26 -172.786 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.27 135.52 34.72 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.592 -0.892 . . . . 74.409999999999997 108.592 179.034 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 87.3 t80 -105.44 120.78 42.46 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.741 -0.837 . . . . 75.319999999999993 108.741 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -138.45 99.26 3.79 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 106.992 -1.485 . . . . 72.409999999999997 106.992 175.047 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 32.9 t -173.01 163.25 4.75 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.066 -1.457 . . . . 71.140000000000001 107.066 -176.556 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.1 t70 66.21 9.04 6.01 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.515 1.126 . . . . 75.150000000000006 110.765 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.53 -1.89 84.32 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.683 -0.69 . . . . 64.129999999999995 111.683 -177.72 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.43 157.17 17.53 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 122.509 0.323 . . . . 64.329999999999998 110.545 -178.428 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -124.65 137.18 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.775 -0.824 . . . . 44.350000000000001 108.775 174.047 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.28 -153.21 10.0 Favored Glycine 0 C--N 1.269 -3.191 0 N-CA-C 109.817 -1.313 . . . . 52.049999999999997 109.817 -177.411 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.539 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 64.3 m -133.31 154.39 50.75 Favored 'General case' 0 C--N 1.272 -2.778 0 CA-C-O 121.162 0.506 . . . . 73.310000000000002 111.383 178.423 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 10.3 pt20 -133.57 142.69 48.27 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.782 -0.645 . . . . 73.319999999999993 110.381 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.9 114.36 27.25 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.434 -1.321 . . . . 63.310000000000002 107.434 174.464 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.12 110.88 32.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.828 -1.175 . . . . 74.25 107.828 -179.229 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CD2' HD12 ' A' ' 90' ' ' LEU . 52.1 p90 -120.77 155.29 34.3 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.766 -0.373 . . . . 64.340000000000003 110.898 -174.619 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 m -160.74 160.71 31.67 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.059 -0.719 . . . . 75.409999999999997 109.059 -178.188 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 63.4 30.65 15.41 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.07 0.948 . . . . 62.219999999999999 111.628 178.237 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 87' ' ' PHE . 21.6 mt -88.31 156.98 18.89 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.72 -0.392 . . . . 61.539999999999999 110.501 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -113.64 168.02 10.12 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.998 -1.482 . . . . 72.239999999999995 106.998 177.393 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -52.76 -37.04 58.93 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 123.485 0.714 . . . . 62.310000000000002 111.812 -178.473 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.39 -26.75 64.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.192 -0.458 . . . . 74.230000000000004 112.12 -178.845 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HB3' HD22 ' A' ' 90' ' ' LEU . 54.5 mt-10 -88.15 -17.82 30.12 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.309 -0.244 . . . . 64.409999999999997 111.228 -177.457 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 98' ' ' LEU . 45.7 tp -61.45 -52.08 72.74 Favored Pre-proline 0 CA--C 1.564 1.488 0 N-CA-C 113.474 0.916 . . . . 74.420000000000002 113.474 -178.107 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.13 -32.68 74.6 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 121.255 1.303 . . . . 72.430000000000007 111.338 176.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -70.91 -31.25 67.83 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 122.264 1.031 . . . . 44.43 109.071 -175.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.425 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 25.9 tp -71.5 -30.79 66.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.376 -1.284 . . . . 55.310000000000002 109.795 173.463 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.43 -24.04 63.77 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 115.477 -0.783 . . . . 74.430000000000007 109.893 -175.611 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -56.18 -53.91 51.51 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 123.877 0.736 . . . . 64.340000000000003 110.672 179.029 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.408 ' SD ' ' HA2' ' A' ' 62' ' ' GLY . 72.2 mtm -55.63 -49.15 73.62 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.486 0.66 . . . . 70.439999999999998 109.882 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -57.27 -35.28 69.57 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.907 -1.042 . . . . 72.140000000000001 111.498 178.505 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.2 m -61.48 -32.09 72.09 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 109.696 -0.483 . . . . 64.239999999999995 109.696 -175.485 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 101' ' ' MET . 5.1 t70 -59.51 -27.97 66.64 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.351 -0.84 . . . . 73.030000000000001 111.534 -175.423 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.05 -14.25 14.26 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 120.591 -0.444 . . . . 62.109999999999999 111.344 -178.063 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.86 -48.09 3.58 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.988 1.107 . . . . 72.030000000000001 113.988 -171.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.76 28.72 41.48 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.095 -1.05 . . . . 73.340000000000003 110.88 -173.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 11.1 p -107.26 141.29 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-O 120.759 0.314 . . . . 70.299999999999997 110.335 -179.598 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.443 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 40.5 t30 -113.13 121.27 44.04 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.408 -0.96 . . . . 72.439999999999998 108.408 177.343 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.29 106.02 14.47 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.235 -0.654 . . . . 73.530000000000001 109.235 178.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.0 m -101.4 108.98 20.73 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.8 -1.185 . . . . 62.509999999999998 107.8 177.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.5 pt? -129.93 145.89 51.63 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.858 -0.61 . . . . 55.229999999999997 109.654 -176.655 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -144.37 151.9 39.95 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.553 -0.749 . . . . 65.519999999999996 111.853 -177.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.614 ' NH2' ' HA ' ' A' ' 180' ' ' ASP . 5.9 tpt180 -96.7 107.37 19.81 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 106.492 -1.669 . . . . 63.039999999999999 106.492 178.208 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.96 97.3 7.9 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.34 -0.985 . . . . 71.400000000000006 108.34 -177.255 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.13 -94.74 0.81 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 110.914 -0.874 . . . . 71.200000000000003 110.914 -177.537 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -135.55 13.62 3.46 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 123.26 1.505 . . . . 73.230000000000004 108.729 177.523 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.9 pp -121.18 149.27 24.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.908 -1.12 . . . . 75.109999999999999 109.054 177.629 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.527 HG22 ' HD3' ' A' ' 114' ' ' ARG . 95.7 t -107.12 132.79 53.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-O 120.995 0.426 . . . . 71.329999999999998 110.622 -177.232 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.0 pt -115.19 129.27 71.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.114 -1.069 . . . . 73.430000000000007 108.114 175.226 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 tt -128.95 129.76 45.86 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 115.935 -0.575 . . . . 72.329999999999998 110.675 -179.262 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -126.71 135.1 50.68 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.307 -0.997 . . . . 65.239999999999995 108.307 173.969 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -142.38 129.65 3.95 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.217 -0.992 . . . . 63.130000000000003 111.948 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.612 ' HG2' HH11 ' A' ' 124' ' ' ARG . 0.1 OUTLIER -126.13 132.57 51.83 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.354 -0.497 . . . . 73.329999999999998 110.655 176.734 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 108' ' ' VAL . . . -113.26 131.03 56.07 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.007 -0.542 . . . . 73.400000000000006 111.534 -177.253 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -96.25 92.91 6.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.968 -1.123 . . . . 73.340000000000003 107.968 175.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -133.71 17.41 3.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.234 1.016 . . . . 73.200000000000003 110.086 -177.858 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.291 -1.949 0 CA-C-N 114.748 -1.115 . . . . 75.230000000000004 109.593 175.888 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 . . . . . 0 C--O 1.243 0.729 0 N-CA-C 112.994 0.738 . . . . 74.120000000000005 112.994 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.24 115.55 28.59 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.915 1.08 . . . . 74.299999999999997 113.915 -169.691 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.5 137.76 32.47 Favored 'General case' 0 C--O 1.265 1.917 0 N-CA-C 107.64 -1.244 . . . . 55.219999999999999 107.64 170.746 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.6 t -105.89 112.15 37.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.352 -0.981 . . . . 72.310000000000002 108.352 178.389 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -102.86 121.36 42.34 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.95 -0.568 . . . . 73.099999999999994 109.564 -177.124 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.44 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -112.69 119.22 37.35 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.721 -1.585 . . . . 73.150000000000006 106.721 178.51 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.7 m -123.12 127.35 48.58 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.521 -0.548 . . . . 74.420000000000002 109.521 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.472 HG12 ' HD2' ' A' ' 143' ' ' PHE . 58.8 t -119.8 126.99 75.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.352 -0.611 . . . . 63.43 109.352 179.048 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.51 125.58 54.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.799 -0.815 . . . . 45.43 108.799 177.11 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.0 p90 -134.33 124.16 17.04 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 111.774 0.287 . . . . 74.510000000000005 111.774 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 15.6 Cg_exo -70.83 31.81 0.22 Allowed 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.972 2.448 . . . . 75.340000000000003 112.556 176.555 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -115.16 -107.37 0.38 Allowed 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.342 -0.614 . . . . 72.430000000000007 109.342 -177.209 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.66 129.87 0.08 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.597 -0.89 . . . . 60.049999999999997 108.597 -178.399 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.9 p -83.29 136.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.654 -0.869 . . . . 71.450000000000003 108.654 176.589 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.3 t -93.69 -43.3 8.72 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 119.572 -0.851 . . . . 60.140000000000001 109.21 176.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.3 m -150.24 131.14 14.23 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.062 -0.718 . . . . 63.140000000000001 109.062 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 t -140.46 154.09 46.5 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.759 -0.46 . . . . 73.310000000000002 109.759 175.484 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -123.41 98.07 5.69 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 104.839 -2.282 . . . . 72.430000000000007 104.839 170.156 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.89 -155.44 23.83 Favored Glycine 0 N--CA 1.41 -3.061 0 N-CA-C 106.521 -2.631 . . . . 62.100000000000001 106.521 -177.456 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -110.52 103.04 11.59 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 118.345 1.072 . . . . 74.430000000000007 110.23 -178.217 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -74.58 114.21 12.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.816 -0.629 . . . . 74.010000000000005 109.81 176.263 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.4 mt -79.93 -44.64 22.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.296 -1.742 . . . . 72.530000000000001 106.296 179.074 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -128.7 165.97 27.98 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 105.459 -2.052 . . . . 73.140000000000001 105.459 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.49 0.18 9.4 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 121.925 1.75 . . . . 71.209999999999994 110.422 174.406 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.1 pt-20 -132.09 5.33 4.16 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.384 -1.28 . . . . 73.420000000000002 111.049 -177.68 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -146.15 120.94 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 107.996 -1.112 . . . . 71.150000000000006 107.996 178.59 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.06 147.3 30.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.648 -0.501 . . . . 64.219999999999999 109.648 -176.902 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -135.08 143.11 46.47 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.063 0.459 . . . . 54.130000000000003 109.848 -178.371 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.445 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 26.8 m-90 -126.78 139.1 53.37 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.624 -0.88 . . . . 74.140000000000001 108.624 177.714 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -111.75 104.34 12.68 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.317 -0.994 . . . . 74.209999999999994 108.317 174.075 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.3 mp -83.02 116.32 22.23 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.147 -1.427 . . . . 73.430000000000007 107.147 177.764 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -107.34 134.75 19.82 Favored Pre-proline 0 C--N 1.278 -2.504 0 CA-C-N 114.936 -1.029 . . . . 64.299999999999997 111.021 -172.33 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.05 154.29 66.75 Favored 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 123.491 2.794 . . . . 60.310000000000002 111.745 -179.286 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.6 -37.61 2.93 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 121.082 -0.58 . . . . 74.010000000000005 111.934 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.45 160.86 5.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.167 -0.679 . . . . 75.109999999999999 109.167 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -83.5 127.87 39.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.908 -0.775 . . . . 73.439999999999998 108.908 178.474 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.8 m -120.94 128.85 53.14 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.232 -0.655 . . . . 63.109999999999999 109.232 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.522 HG22 ' HG3' ' A' ' 124' ' ' ARG . 18.1 p -121.67 154.27 37.06 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.038 -0.983 . . . . 70.230000000000004 108.576 -178.287 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.9 ptm -144.39 139.66 28.55 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.697 -0.401 . . . . 73.319999999999993 110.745 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 76.1 p -143.55 148.12 35.47 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.168 -0.613 . . . . 73.420000000000002 110.194 173.194 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.14 130.49 12.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.771 -0.825 . . . . 75.209999999999994 108.771 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -129.87 130.48 45.28 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 107.243 -1.392 . . . . 53.109999999999999 107.243 176.403 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -153.95 159.67 41.79 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.816 -0.438 . . . . 53.350000000000001 109.816 -178.223 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -90.92 130.24 36.87 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 109.091 -0.707 . . . . 73.239999999999995 109.091 -177.253 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -143.09 122.32 12.98 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 118.007 0.367 . . . . 73.209999999999994 110.871 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.71 106.77 0.43 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.247 0.967 . . . . 75.239999999999995 111.871 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.614 ' HA ' ' NH2' ' A' ' 114' ' ' ARG . 14.8 t70 . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 114.46 -1.245 . . . . 73.540000000000006 110.031 179.077 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 . . . . . 0 N--CA 1.429 -1.502 0 N-CA-C 110.081 -0.34 . . . . 73.109999999999999 110.081 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -107.6 113.86 44.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 106.531 -1.655 . . . . 75.150000000000006 106.531 175.585 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -121.31 117.77 27.83 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 109.228 -0.656 . . . . 63.549999999999997 109.228 -175.911 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.77 119.7 36.27 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.003 -0.74 . . . . 43.549999999999997 109.003 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.6 m -120.09 114.99 22.8 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.637 -1.246 . . . . 44.039999999999999 107.637 177.745 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.0 146.13 34.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.095 -0.705 . . . . 63.119999999999997 109.095 -177.409 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.6 m -129.46 122.16 28.75 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-O 121.06 0.457 . . . . 55.43 110.118 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.7 tt -107.19 119.56 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.773 0.796 . . . . 63.549999999999997 109.755 178.269 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 m -89.57 157.31 47.09 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.164 -0.926 . . . . 73.420000000000002 109.328 -177.253 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.42 2.15 1.33 Allowed 'Trans proline' 0 N--CA 1.488 1.167 0 C-N-CA 123.53 2.82 . . . . 63.240000000000002 114.279 -176.546 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.85 4.5 53.74 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.608 -0.886 . . . . 64.439999999999998 108.608 178.333 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 27.2 t70 68.48 31.21 4.97 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 123.566 1.65 . . . . 72.209999999999994 107.333 -175.968 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.06 124.1 42.4 Favored 'General case' 0 N--CA 1.39 -3.473 0 N-CA-C 106.084 -1.821 . . . . 71.0 106.084 178.578 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG12 ' HE2' ' A' ' 87' ' ' PHE . 10.0 t -112.95 134.17 56.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.318 -0.993 . . . . 75.439999999999998 108.318 -177.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.2 p -140.62 158.43 44.0 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.983 -1.488 . . . . 63.310000000000002 106.983 178.552 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.69 -174.31 42.72 Favored Glycine 0 N--CA 1.415 -2.703 0 C-N-CA 118.997 -1.573 . . . . 64.109999999999999 112.859 177.224 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -147.43 133.91 19.73 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 108.916 -0.772 . . . . 70.420000000000002 108.916 -177.568 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 52.6 mt -119.52 115.91 49.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.728 -1.212 . . . . 75.409999999999997 107.728 176.226 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.31 120.54 62.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.105 -0.702 . . . . 72.25 109.105 -177.628 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.38 107.31 16.97 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.763 -1.94 . . . . 72.510000000000005 105.763 172.616 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -118.93 132.47 56.09 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.049 0.452 . . . . 52.240000000000002 111.13 -174.314 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.17 158.25 37.59 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.54 -0.755 . . . . 74.030000000000001 110.321 -177.466 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--N 1.323 -0.577 0 C-N-CA 119.783 -0.767 . . . . 70.010000000000005 109.288 173.603 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.423 -1.823 0 N-CA-C 107.45 -1.315 . . . . 71.120000000000005 107.45 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.583 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 173.7 116.65 0.43 Allowed Glycine 0 N--CA 1.409 -3.127 0 CA-C-N 114.845 -1.07 . . . . 43.039999999999999 110.427 177.047 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 75.0 Cg_exo -52.04 134.22 48.77 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.332 2.022 . . . . 53.140000000000001 109.313 170.591 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.79 149.58 23.68 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 111.654 0.242 . . . . 73.129999999999995 111.654 -173.443 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.547 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 66.1 mt -91.77 151.03 20.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.279 -0.419 . . . . 50.039999999999999 109.969 177.311 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -109.64 102.45 11.28 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.08 -1.082 . . . . 75.219999999999999 108.08 177.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -148.84 142.61 10.06 Favored Glycine 0 C--N 1.283 -2.367 0 C-N-CA 120.58 -0.819 . . . . 71.400000000000006 112.873 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -151.35 114.27 4.71 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.543 -0.91 . . . . 72.219999999999999 108.543 176.194 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.66 159.62 71.06 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 109.925 -0.398 . . . . 64.049999999999997 109.925 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.98 -13.92 42.1 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.245 1.963 . . . . 70.150000000000006 112.532 178.089 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 51.7 p90 -113.64 28.69 8.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.62 -0.264 . . . . 54.340000000000003 111.466 -177.817 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.8 m -57.49 -26.86 61.93 Favored 'General case' 0 C--O 1.205 -1.253 0 N-CA-C 111.947 0.351 . . . . 61.210000000000001 111.947 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.512 ' HG3' ' HG3' ' A' ' 69' ' ' LYS . 29.7 pt20 -65.56 -12.26 51.37 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.395 0.617 . . . . 65.319999999999993 110.96 176.78 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HE3' HD23 ' A' ' 90' ' ' LEU . 24.6 mtpp -110.81 -7.51 14.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.636 0.774 . . . . 64.430000000000007 110.519 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 p -132.36 117.74 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 122.029 0.918 . . . . 54.130000000000003 110.409 173.688 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.32 116.31 28.83 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.687 -0.688 . . . . 75.140000000000001 109.964 -177.863 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.95 124.38 50.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 106.177 -1.786 . . . . 74.239999999999995 106.177 177.006 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.7 m -137.97 166.89 22.96 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.298 -0.41 . . . . 74.400000000000006 111.293 -172.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.583 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 57.5 t30 -80.2 140.78 36.16 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.311 -0.859 . . . . 64.409999999999997 108.799 177.067 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 77.0 t80 -119.3 121.35 39.4 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.862 -0.422 . . . . 72.400000000000006 109.862 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -138.62 114.79 10.24 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.843 -1.169 . . . . 74.140000000000001 107.843 172.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.4 t -174.51 148.09 1.17 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.903 -1.517 . . . . 73.439999999999998 106.903 -175.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 72.28 10.33 5.89 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.844 0.858 . . . . 74.239999999999995 111.027 173.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.66 5.06 82.19 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.477 -0.649 . . . . 61.020000000000003 111.477 -175.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.576 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 11.8 m-85 -104.09 149.28 25.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.617 -0.512 . . . . 65.140000000000001 109.617 179.014 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.73 136.79 58.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.987 -1.116 . . . . 73.209999999999994 107.987 174.207 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.461 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -173.5 -154.94 11.06 Favored Glycine 0 C--N 1.274 -2.873 0 N-CA-C 110.682 -0.967 . . . . 41.409999999999997 110.682 -178.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.547 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 p -129.62 153.25 48.28 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-O 121.208 0.528 . . . . 44.240000000000002 111.848 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 11.8 pt20 -134.62 141.97 46.76 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.835 -0.62 . . . . 73.120000000000005 110.791 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.88 114.2 26.61 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.645 -1.613 . . . . 71.150000000000006 106.645 173.321 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.21 115.14 48.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.658 -0.867 . . . . 74.549999999999997 108.658 -178.58 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.451 ' HE2' HG12 ' A' ' 40' ' ' VAL . 41.2 p90 -119.53 151.77 38.06 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.205 0.526 . . . . 74.420000000000002 111.085 -174.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 p -155.59 154.83 32.28 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.5 -0.773 . . . . 72.530000000000001 110.286 -177.235 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.3 t70 65.74 30.98 9.96 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.089 0.947 . . . . 62.140000000000001 110.457 175.02 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.542 HD23 ' HE3' ' A' ' 69' ' ' LYS . 18.1 mt -94.91 170.22 9.58 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.875 -0.602 . . . . 70.409999999999997 111.785 -178.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.439 HG22 ' OE1' ' A' ' 94' ' ' GLU . 12.5 t -126.61 172.79 9.97 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.059 -0.719 . . . . 73.209999999999994 109.059 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.435 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 78.1 t80 -51.92 -40.67 61.12 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.011 1.324 . . . . 71.319999999999993 112.152 -176.718 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.09 72.16 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.255 0.465 . . . . 72.540000000000006 112.255 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' OE1' HG22 ' A' ' 91' ' ' THR . 48.3 mt-10 -86.08 -18.77 31.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.003 -0.544 . . . . 72.349999999999994 111.838 -174.35 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tt -60.62 -54.59 53.28 Favored Pre-proline 0 CA--C 1.566 1.584 0 CA-C-N 116.094 -0.503 . . . . 73.319999999999993 112.22 -177.372 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.26 -34.17 36.75 Favored 'Trans proline' 0 C--N 1.367 1.518 0 CA-C-N 120.76 1.307 . . . . 65.230000000000004 111.095 178.059 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.87 -39.65 95.08 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.362 -0.835 . . . . 72.219999999999999 111.504 -176.802 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -70.67 -19.62 62.77 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.081 0.467 . . . . 75.109999999999999 111.053 177.7 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.31 -24.45 59.22 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.505 -0.478 . . . . 74.430000000000007 110.191 -176.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -59.17 -51.89 68.06 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 123.305 0.378 . . . . 71.409999999999997 110.649 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -54.29 -52.65 60.79 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-O 121.638 0.732 . . . . 75.230000000000004 110.472 -177.593 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.21 -27.28 68.95 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 115.024 -0.989 . . . . 73.25 111.28 -177.229 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -63.55 -22.9 67.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 118.622 -0.704 . . . . 61.399999999999999 112.08 -177.004 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.48 -27.64 67.73 Favored 'General case' 0 C--N 1.357 0.913 0 CA-C-O 121.215 0.531 . . . . 60.210000000000001 109.776 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.77 -12.5 13.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.721 -0.672 . . . . 74.519999999999996 111.093 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.98 -48.68 3.44 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 113.941 1.089 . . . . 52.0 113.941 -172.211 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.43 24.0 48.72 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.658 -0.782 . . . . 42.329999999999998 112.144 -174.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -87.93 147.39 5.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 O-C-N 122.332 -0.51 . . . . 52.240000000000002 110.735 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -135.28 129.05 32.97 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.846 -1.168 . . . . 65.140000000000001 107.846 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 mp -130.21 117.05 19.27 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.558 0.218 . . . . 64.040000000000006 110.544 -178.188 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.4 m -108.27 114.22 27.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.151 -1.055 . . . . 70.019999999999996 108.151 176.094 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.78 153.16 49.34 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 122.027 -0.421 . . . . 74.319999999999993 110.738 -176.569 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -148.68 154.0 39.04 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.721 -0.672 . . . . 70.109999999999999 110.199 -177.147 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.411 ' CD ' HG22 ' A' ' 119' ' ' VAL . 5.1 tpt180 -108.57 106.53 16.65 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 105.722 -1.955 . . . . 74.030000000000001 105.722 179.42 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -101.38 97.33 7.83 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.44 -0.578 . . . . 73.349999999999994 109.44 -176.378 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.19 -82.72 0.64 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.304 -0.718 . . . . 62.539999999999999 111.304 -178.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -143.52 5.35 1.41 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.714 1.245 . . . . 74.420000000000002 109.148 178.198 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.6 pp -113.58 148.87 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 O-C-N 121.339 -0.851 . . . . 73.319999999999993 108.779 -179.301 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.411 HG22 ' CD ' ' A' ' 114' ' ' ARG . 94.3 t -110.31 133.82 54.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-O 121.378 0.608 . . . . 62.210000000000001 111.04 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.5 pt -117.33 132.86 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 N-CA-C 107.945 -1.132 . . . . 71.040000000000006 107.945 173.807 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.2 tt -128.12 125.33 38.97 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 115.926 -0.579 . . . . 74.420000000000002 109.771 177.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -127.15 115.08 18.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.039 -0.982 . . . . 70.299999999999997 108.559 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.7 156.08 21.92 Favored Glycine 0 C--N 1.291 -1.942 0 C-N-CA 120.458 -0.877 . . . . 53.399999999999999 112.409 -177.477 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -139.9 125.71 19.5 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.953 -1.128 . . . . 63.200000000000003 107.953 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -101.77 111.7 24.05 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.644 -0.502 . . . . 74.219999999999999 109.644 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -104.84 93.61 4.82 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 123.031 1.396 . . . . 62.520000000000003 111.519 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 166' ' ' PRO 0.278 0.0 OUTLIER -126.75 42.86 3.23 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-O 124.21 1.957 . . . . 65.040000000000006 107.444 171.775 . . . . . . . . 4 4 . 1 . 028 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.429 -1.49 0 CA-C-N 111.419 -2.628 . . . . 73.0 110.791 179.434 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 CA--C 1.503 -0.834 0 N-CA-C 113.748 1.018 . . . . 72.439999999999998 113.748 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 166' ' ' PRO . . . -96.47 124.56 40.5 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.618 -0.433 . . . . 72.200000000000003 110.902 -175.65 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -131.94 127.87 37.29 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.731 -0.84 . . . . 61.039999999999999 108.731 178.122 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 58.2 t -121.81 128.57 75.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 119.367 -0.933 . . . . 71.400000000000006 110.104 -177.778 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.75 121.12 31.09 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.914 0.387 . . . . 62.140000000000001 110.289 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 20.5 tp -115.11 120.75 40.86 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.215 -0.448 . . . . 74.219999999999999 109.807 177.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.6 m -117.45 114.31 23.32 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.032 -0.729 . . . . 64.439999999999998 109.032 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 96.5 t -108.4 120.79 60.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.932 -0.766 . . . . 74.400000000000006 108.932 178.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -110.86 130.71 55.5 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.587 -0.523 . . . . 44.009999999999998 109.587 179.341 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.541 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.6 p90 -134.52 124.76 17.23 Favored Pre-proline 0 C--N 1.292 -1.927 0 CA-C-N 116.349 -0.387 . . . . 73.200000000000003 111.209 177.821 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.76 37.65 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.476 2.784 . . . . 73.019999999999996 112.603 176.024 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -125.9 -115.8 0.28 Allowed 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 108.522 -0.918 . . . . 74.219999999999999 108.522 -179.487 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.75 137.84 0.62 Allowed 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.71 -1.219 . . . . 73.439999999999998 107.71 -178.681 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.515 ' HA ' ' HB2' ' A' ' 176' ' ' ALA . 7.6 p -89.48 127.21 42.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.548 -0.908 . . . . 64.219999999999999 108.548 178.321 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.5 p -81.31 -38.73 26.3 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.585 0.707 . . . . 74.010000000000005 110.337 -177.497 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 49.0 m -156.56 133.1 10.09 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.08 -0.711 . . . . 52.229999999999997 109.08 178.85 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.424 ' HB ' HG21 ' A' ' 147' ' ' VAL . 9.4 t -138.45 169.72 17.29 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.669 -0.644 . . . . 63.240000000000002 111.307 177.875 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.563 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 8.0 t30 -139.0 87.17 2.19 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.751 -1.944 . . . . 44.140000000000001 105.751 175.414 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.09 -146.4 6.66 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 109.221 -1.551 . . . . 75.409999999999997 109.221 -178.819 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -118.55 99.63 6.93 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.054 -0.721 . . . . 71.209999999999994 109.054 178.674 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 39.6 ptt180 -79.03 128.72 33.62 Favored 'General case' 0 N--CA 1.422 -1.831 0 O-C-N 121.562 -0.712 . . . . 71.319999999999993 110.589 179.231 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.1 mt -87.33 -39.42 13.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.723 -1.584 . . . . 74.0 106.723 177.314 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.23 164.96 35.35 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.023 -1.843 . . . . 71.400000000000006 106.023 -179.349 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.23 -0.12 8.71 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.84 1.693 . . . . 75.230000000000004 111.128 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.3 pt-20 -129.34 4.18 5.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.566 -0.743 . . . . 75.25 111.802 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.89 120.19 8.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.028 -1.101 . . . . 74.319999999999993 108.028 178.753 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 45.5 t -125.74 143.56 38.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.924 -0.398 . . . . 72.450000000000003 109.924 -177.002 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.8 tt0 -128.14 138.28 52.44 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-O 121.304 0.573 . . . . 64.430000000000007 109.667 -177.39 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -114.87 114.86 26.07 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 115.862 -0.608 . . . . 64.420000000000002 109.405 178.21 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -98.67 98.35 9.5 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.168 -1.049 . . . . 71.409999999999997 108.168 178.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 26.2 mt -93.68 146.62 23.7 Favored 'General case' 0 C--O 1.281 2.747 0 CA-C-N 114.878 -1.056 . . . . 70.530000000000001 109.927 -172.279 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.515 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -117.02 151.25 47.28 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.245 -0.889 . . . . 74.219999999999999 111.323 -173.253 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 84.7 Cg_endo -77.94 154.93 30.03 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.874 2.383 . . . . 44.100000000000001 112.424 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.65 -28.14 2.81 Favored Glycine 0 CA--C 1.499 -0.938 0 C-N-CA 121.159 -0.543 . . . . 73.140000000000001 112.533 175.393 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.03 156.14 6.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 109.443 -0.577 . . . . 72.340000000000003 109.443 -179.176 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.3 p -92.53 109.24 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 108.106 -1.072 . . . . 72.540000000000006 108.106 177.26 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.4 m -92.85 130.27 38.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.561 -0.745 . . . . 74.109999999999999 109.678 -176.479 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 44.0 p -99.12 139.01 35.4 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.633 0.73 . . . . 71.439999999999998 111.711 -178.651 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 21.3 ttt -118.02 122.45 43.22 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.027 -1.101 . . . . 73.140000000000001 108.027 178.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.563 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 4.2 m -136.44 136.92 39.91 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.54 -1.264 . . . . 53.25 108.53 174.105 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.02 131.89 15.12 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.189 -1.041 . . . . 62.539999999999999 108.189 -179.708 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -133.33 131.49 40.19 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.474 -1.306 . . . . 65.140000000000001 107.474 177.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -162.53 154.29 18.36 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.347 -0.983 . . . . 63.100000000000001 108.347 -178.147 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 35.8 ptt180 -92.93 141.58 28.25 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.268 -0.973 . . . . 74.219999999999999 110.187 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.59 130.13 24.07 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 121.038 0.446 . . . . 75.109999999999999 110.044 -176.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.65 101.14 0.32 Allowed 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 114.721 -1.127 . . . . 73.25 112.643 -178.413 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 CA--C 1.505 -0.788 0 CA-C-N 115.425 -0.807 . . . . 65.329999999999998 111.96 172.768 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 22.8 mtp-105 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 109.682 -0.488 . . . . 74.5 109.682 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.99 116.8 53.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 115.496 -0.774 . . . . 73.5 108.957 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.4 mtp85 -106.94 114.34 28.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.228 0.537 . . . . 55.509999999999998 109.669 176.92 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.23 111.65 23.37 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.263 -1.014 . . . . 73.019999999999996 108.263 177.796 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -119.52 114.55 22.45 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.54 -1.282 . . . . 73.450000000000003 107.54 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.11 146.26 34.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.814 -0.81 . . . . 55.340000000000003 108.814 -178.728 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 85.6 m -131.36 126.41 35.17 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-O 121.067 0.46 . . . . 65.430000000000007 110.573 -178.654 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.3 tt -108.81 112.14 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 121.898 0.856 . . . . 71.230000000000004 109.428 177.592 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.9 m -76.62 158.11 81.38 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 114.74 -1.118 . . . . 61.340000000000003 110.511 -175.532 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.12 2.72 0.99 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 123.747 2.965 . . . . 75.150000000000006 112.702 177.739 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -87.57 -7.15 57.88 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.306 -0.998 . . . . 73.030000000000001 108.306 177.382 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 72.07 29.1 2.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.761 1.625 . . . . 63.420000000000002 108.004 -175.829 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -111.63 138.95 47.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.918 -1.492 . . . . 62.109999999999999 107.408 179.499 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.446 HG21 ' HG ' ' A' ' 95' ' ' LEU . 11.1 t -113.74 135.52 53.1 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.242 0.544 . . . . 64.129999999999995 109.543 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.9 p -142.77 137.75 29.95 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.566 -1.272 . . . . 70.219999999999999 107.566 177.686 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.36 -169.5 35.84 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 119.256 -1.449 . . . . 61.450000000000003 112.428 -177.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -149.84 133.6 16.84 Favored 'General case' 0 N--CA 1.418 -2.027 0 C-N-CA 123.263 0.625 . . . . 63.509999999999998 109.53 -177.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.1 mt -116.45 115.49 49.23 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 105.658 -1.979 . . . . 71.349999999999994 105.658 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.5 mt -120.37 114.27 43.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-N 116.196 -0.457 . . . . 61.119999999999997 110.005 -172.309 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.55 108.56 18.11 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.742 -0.836 . . . . 42.450000000000003 108.742 179.227 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -111.37 118.01 34.68 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 109.035 -0.728 . . . . 75.430000000000007 109.035 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.97 158.74 21.62 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-O 122.006 0.908 . . . . 71.150000000000006 112.288 -174.142 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt . . . . . 0 C--N 1.294 -1.843 0 CA-C-N 113.807 -1.542 . . . . 74.510000000000005 107.808 170.903 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.42 -1.929 0 N-CA-C 109.836 -0.431 . . . . 70.310000000000002 109.836 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.642 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 175.29 98.02 0.11 Allowed Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.146 -1.502 . . . . 61.109999999999999 113.711 178.762 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 83' ' ' SER . 38.9 Cg_exo -60.36 159.8 25.79 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 123.646 2.898 . . . . 74.140000000000001 112.639 174.315 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.68 153.25 35.87 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.619 -0.719 . . . . 53.030000000000001 109.425 177.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.0 mt -99.46 138.91 35.89 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.274 -0.421 . . . . 64.239999999999995 110.52 178.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -110.95 87.9 2.65 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.401 1.096 . . . . 75.25 110.898 176.126 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.07 78.11 0.35 Allowed Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 109.817 -1.313 . . . . 71.349999999999994 109.817 177.37 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -80.8 93.37 6.22 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.841 0.829 . . . . 75.540000000000006 109.428 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -105.54 158.38 32.41 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 114.067 -1.424 . . . . 44.43 109.841 -176.604 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.29 -20.99 71.94 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 123.114 2.543 . . . . 62.409999999999997 112.984 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -107.03 44.04 1.1 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.562 -0.745 . . . . 75.310000000000002 111.671 -178.128 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m -51.84 -39.12 58.29 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.146 0.578 . . . . 75.310000000000002 111.87 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -69.82 -15.87 63.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.94 0.4 . . . . 74.420000000000002 111.144 -175.404 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -91.1 -14.38 31.34 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.855 -0.611 . . . . 54.210000000000001 110.231 -179.06 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.66 120.05 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 119.643 -0.823 . . . . 63.340000000000003 111.788 -179.455 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.44 113.96 27.74 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.078 -0.712 . . . . 61.009999999999998 109.078 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.79 133.81 39.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.617 -0.883 . . . . 74.040000000000006 108.617 -179.128 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 m -141.73 171.94 13.37 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.15 0.5 . . . . 70.140000000000001 111.273 -177.437 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.642 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 7.2 t30 -83.39 136.95 34.14 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 124.473 1.109 . . . . 74.299999999999997 110.461 -177.532 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -116.09 119.9 37.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.822 -0.807 . . . . 63.119999999999997 108.822 177.115 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -139.2 110.44 6.93 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.349 -2.093 . . . . 62.119999999999997 105.349 177.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 75.8 m -148.13 113.21 5.5 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 110.383 -0.229 . . . . 71.040000000000006 110.383 -178.522 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 t0 68.87 9.65 7.5 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.06 1.344 . . . . 71.109999999999999 111.397 176.698 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.24 5.06 50.01 Favored Glycine 0 N--CA 1.424 -2.141 0 C-N-CA 120.166 -1.016 . . . . 64.409999999999997 112.546 -176.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.57 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 72.0 m-85 -84.71 140.78 31.05 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.161 -2.163 . . . . 75.129999999999995 105.161 166.181 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.52 135.75 62.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.481 -0.888 . . . . 73.400000000000006 109.266 174.925 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -167.77 -155.9 9.66 Favored Glycine 0 N--CA 1.403 -3.541 0 C-N-CA 120.519 -0.848 . . . . 43.420000000000002 111.468 178.739 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 9.3 p -135.88 150.41 49.35 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.084 0.469 . . . . 71.519999999999996 110.31 -177.705 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.49 127.99 40.29 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.725 -0.67 . . . . 55.149999999999999 110.95 -178.526 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.03 114.17 28.21 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.917 -1.512 . . . . 53.140000000000001 106.917 174.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.7 t -112.75 112.07 38.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.452 -1.314 . . . . 73.349999999999994 107.452 -178.623 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.474 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.9 p90 -116.09 155.17 28.64 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.286 -0.415 . . . . 74.030000000000001 111.181 -172.602 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.5 p -156.92 157.12 34.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.99 -0.55 . . . . 71.209999999999994 110.922 -176.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 t70 64.79 31.84 11.45 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.783 1.233 . . . . 74.430000000000007 111.055 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.474 HD12 ' CD2' ' A' ' 87' ' ' PHE . 27.6 mt -93.53 173.21 7.81 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.665 -0.698 . . . . 73.409999999999997 109.288 176.125 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -126.26 175.03 8.1 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 120.113 -0.635 . . . . 35.530000000000001 110.227 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.46 ' CZ ' HD13 ' A' ' 112' ' ' LEU . 86.9 t80 -54.56 -39.93 68.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.698 1.199 . . . . 75.310000000000002 112.126 -176.085 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.31 -25.76 67.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.29 0.567 . . . . 75.209999999999994 111.537 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -84.68 -16.18 42.71 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 112.471 0.545 . . . . 62.450000000000003 112.471 -174.706 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 10.3 mt -53.09 -55.69 31.27 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.671 1.36 . . . . 71.140000000000001 114.671 178.137 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.41 -37.1 51.37 Favored 'Trans proline' 0 C--N 1.36 1.148 0 CA-C-N 120.465 1.202 . . . . 73.439999999999998 110.577 177.26 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.51 -36.84 85.49 Favored 'General case' 0 N--CA 1.417 -2.082 0 C-N-CA 123.769 0.828 . . . . 70.400000000000006 111.181 -177.163 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -78.16 -20.22 52.44 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.991 -0.374 . . . . 63.219999999999999 109.991 175.898 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -69.98 -21.41 63.23 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.929 -0.578 . . . . 54.020000000000003 110.772 -177.442 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -61.21 -53.35 57.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.198 -0.667 . . . . 73.340000000000003 109.198 175.198 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 32.5 ttp -58.3 -47.27 84.21 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.48 0.657 . . . . 73.25 109.786 177.383 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 46.0 t30 -53.16 -31.06 40.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.153 -1.385 . . . . 61.109999999999999 111.149 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -56.22 -35.0 66.84 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.965 -0.541 . . . . 75.400000000000006 111.786 -174.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.52 -26.81 68.16 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.265 0.555 . . . . 62.219999999999999 111.805 -174.2 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.97 -16.16 14.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 120.401 -0.519 . . . . 52.140000000000001 110.821 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' A' ' 108' ' ' VAL . . . -106.8 -47.88 3.63 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.656 0.984 . . . . 72.239999999999995 113.656 -170.846 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.18 28.32 64.42 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.762 -0.935 . . . . 53.399999999999999 110.762 -172.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.443 HG12 ' CB ' ' A' ' 125' ' ' ALA . 13.2 m -114.62 161.45 13.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 74.510000000000005 110.989 -176.156 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -127.61 139.7 52.57 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.179 -1.415 . . . . 64.200000000000003 107.179 174.744 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -128.3 133.32 48.71 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.464 -0.569 . . . . 70.530000000000001 109.464 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.3 t -132.71 137.6 46.95 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 107.745 -1.206 . . . . 74.420000000000002 107.745 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' A' ' 113' ' ' ARG . 1.3 pp -149.24 152.14 35.46 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.782 1.03 . . . . 70.209999999999994 113.782 -176.861 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 112' ' ' LEU . 9.6 mpt_? -144.09 154.3 43.06 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.205 -1.361 . . . . 73.319999999999993 111.642 178.74 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.456 ' HD3' HG22 ' A' ' 119' ' ' VAL . 10.0 mmt-85 -90.25 137.95 31.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 107.569 -1.271 . . . . 65.420000000000002 107.569 167.91 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.446 ' O ' HG13 ' A' ' 118' ' ' ILE . 46.9 t30 -123.18 90.56 3.31 Favored 'General case' 0 C--N 1.258 -3.383 0 N-CA-C 107.134 -1.432 . . . . 74.420000000000002 107.134 173.704 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.93 -100.31 0.83 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 109.759 -1.336 . . . . 55.450000000000003 109.759 -173.594 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -121.84 -4.32 9.15 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.429 1.109 . . . . 62.329999999999998 109.0 178.517 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.6 pp -99.24 150.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.389 -0.967 . . . . 74.230000000000004 108.389 179.076 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.456 HG22 ' HD3' ' A' ' 114' ' ' ARG . 79.7 t -110.36 136.17 47.16 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 O-C-N 121.847 -0.533 . . . . 54.219999999999999 111.539 -176.767 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.3 pt -117.06 128.96 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 115.202 -0.908 . . . . 74.120000000000005 108.997 175.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -128.42 131.83 48.47 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 108.578 -0.897 . . . . 64.019999999999996 108.578 179.64 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -144.7 139.8 28.18 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.224 -0.658 . . . . 64.239999999999995 109.224 179.541 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.38 -178.12 36.83 Favored Glycine 0 C--N 1.298 -1.541 0 C-N-CA 120.398 -0.906 . . . . 45.210000000000001 111.689 179.523 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.403 ' HG2' HG22 ' A' ' 171' ' ' THR . 82.8 mtt180 -139.35 150.95 45.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 120.967 0.413 . . . . 73.230000000000004 110.904 -179.15 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.443 ' CB ' HG12 ' A' ' 108' ' ' VAL . . . -122.87 120.54 33.79 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.05 -0.977 . . . . 60.530000000000001 108.6 178.204 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.13 107.33 18.38 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.368 -0.975 . . . . 75.030000000000001 108.368 178.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.426 HD21 ' HB3' ' A' ' 164' ' ' LEU . 1.5 mm? -107.99 15.47 24.32 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.731 -0.841 . . . . 54.25 108.731 178.721 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 167' ' ' GLY . 42.3 p . . . . . 0 N--CA 1.438 -1.045 0 N-CA-C 108.096 -1.076 . . . . 54.310000000000002 108.096 179.263 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--O 1.239 0.535 0 N-CA-C 111.834 0.309 . . . . 74.430000000000007 111.834 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.547 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -98.45 116.2 30.17 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.451 -0.341 . . . . 53.549999999999997 110.644 -175.564 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 4.4 m-20 -123.6 140.54 52.9 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.557 -0.534 . . . . 74.400000000000006 109.557 179.052 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 60.4 t -124.84 131.62 72.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.795 -0.817 . . . . 63.350000000000001 108.795 178.513 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.35 122.66 44.47 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.514 -0.921 . . . . 63.310000000000002 108.514 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 46.2 tp -110.9 120.25 41.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.742 -0.836 . . . . 73.439999999999998 108.742 177.724 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.3 m -124.42 110.14 14.17 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 108.71 -0.848 . . . . 74.510000000000005 108.71 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 87.7 t -109.37 124.49 66.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.699 -0.852 . . . . 62.43 108.699 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.47 130.61 56.29 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 108.803 -0.814 . . . . 73.439999999999998 108.803 178.168 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -133.98 102.56 12.15 Favored Pre-proline 0 C--N 1.266 -3.038 0 N-CA-C 108.34 -0.985 . . . . 71.430000000000007 108.34 175.303 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.36 47.28 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 123.871 3.047 . . . . 73.120000000000005 113.379 -178.475 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 177' ' ' ARG . . . -112.82 -78.94 0.58 Allowed 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 109.47 -0.567 . . . . 64.140000000000001 109.47 178.106 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.16 118.34 0.01 OUTLIER 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.881 1.272 . . . . 74.209999999999994 108.559 179.378 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.08 134.23 29.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 109.783 -0.451 . . . . 75.420000000000002 109.783 177.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.2 p -101.11 -41.66 6.67 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.156 0.503 . . . . 45.450000000000003 109.851 178.616 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.2 m -158.25 133.36 8.59 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 109.377 -0.601 . . . . 72.010000000000005 109.377 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.421 ' OG1' HG11 ' A' ' 160' ' ' VAL . 10.0 t -138.95 157.11 46.61 Favored 'General case' 0 C--N 1.285 -2.22 0 O-C-N 121.796 -0.565 . . . . 73.409999999999997 110.172 177.755 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 43.8 t30 -124.67 88.75 2.95 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 105.524 -2.028 . . . . 73.109999999999999 105.524 174.656 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.84 -150.97 15.84 Favored Glycine 0 N--CA 1.419 -2.491 0 N-CA-C 107.275 -2.33 . . . . 71.319999999999993 107.275 -177.206 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -113.68 104.36 12.15 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 118.297 1.049 . . . . 53.210000000000001 111.587 -177.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -77.52 117.35 18.88 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.212 0.53 . . . . 75.329999999999998 110.168 176.572 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.2 mt -86.38 -48.75 15.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.611 -1.626 . . . . 74.010000000000005 106.611 177.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -123.41 162.06 42.12 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 114.245 -1.343 . . . . 62.229999999999997 107.917 -177.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.63 -4.01 11.3 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.847 2.365 . . . . 73.450000000000003 112.398 177.385 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.7 OUTLIER -132.68 5.16 3.95 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.263 0.468 . . . . 72.230000000000004 112.263 175.211 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.66 121.0 29.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 N-CA-C 109.32 -0.622 . . . . 52.32 109.32 -179.126 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.421 HG11 ' OG1' ' A' ' 150' ' ' THR . 57.3 t -124.75 143.14 39.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.507 -0.553 . . . . 70.349999999999994 109.507 -178.035 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.1 tt0 -128.67 146.07 50.98 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.17 0.509 . . . . 73.5 110.034 -177.504 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.422 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.5 m-90 -124.32 127.83 48.19 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.788 -1.19 . . . . 73.409999999999997 107.788 176.181 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.14 107.15 19.62 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.529 -0.545 . . . . 74.319999999999993 109.529 179.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.1 mm? -92.58 124.5 36.66 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.61 -0.723 . . . . 75.310000000000002 109.111 -177.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -117.09 141.69 28.83 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.869 -1.06 . . . . 71.439999999999998 110.689 -171.647 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 28.5 Cg_endo -60.79 153.13 64.85 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.879 2.386 . . . . 54.25 112.909 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 128' ' ' THR . . . 80.29 -27.21 2.82 Favored Glycine 0 C--N 1.315 -0.635 0 CA-C-N 115.813 -0.63 . . . . 63.039999999999999 113.566 175.438 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.16 162.9 4.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.715 0.769 . . . . 74.329999999999998 112.243 -179.761 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.44 131.45 66.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.012 -1.107 . . . . 73.530000000000001 108.012 176.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.4 m -119.79 145.46 46.58 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.812 0.339 . . . . 54.439999999999998 110.82 -175.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.403 HG22 ' HG2' ' A' ' 124' ' ' ARG . 22.0 p -104.92 126.35 51.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.056 -0.72 . . . . 61.409999999999997 109.056 175.912 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -110.1 131.94 54.6 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.023 -0.732 . . . . 71.310000000000002 109.023 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 13.5 m -141.53 140.59 33.49 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.975 -0.69 . . . . 64.319999999999993 109.408 175.706 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -149.09 121.65 8.56 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.106 -0.702 . . . . 74.319999999999993 109.106 -177.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -124.22 132.16 53.58 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 107.873 -1.158 . . . . 64.450000000000003 107.873 178.296 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.17 151.48 31.97 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.539 -0.541 . . . . 74.129999999999995 109.539 -175.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.405 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 7.4 ppt_? -88.92 130.15 35.48 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.221 -1.029 . . . . 73.420000000000002 108.221 -179.044 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.439 ' CD2' HG21 ' A' ' 119' ' ' VAL . 7.4 m-30 -118.2 153.64 33.53 Favored 'General case' 0 CA--C 1.465 -2.298 0 CA-C-N 118.527 0.603 . . . . 71.010000000000005 110.191 -174.692 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.6 p -96.89 91.09 5.47 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 109.247 -0.649 . . . . 73.329999999999998 109.247 173.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 110.025 -0.361 . . . . 73.209999999999994 110.025 179.978 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 . . . . . 0 N--CA 1.435 -1.204 0 N-CA-C 109.502 -0.555 . . . . 64.219999999999999 109.502 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.461 ' CG2' HG22 ' A' ' 137' ' ' VAL . 21.7 m -130.09 113.77 27.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 108.446 -0.946 . . . . 53.329999999999998 108.446 170.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -115.56 116.31 27.93 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.03 -0.986 . . . . 63.210000000000001 109.433 -177.772 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.09 108.02 16.1 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 106.458 -1.682 . . . . 73.340000000000003 106.458 172.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 140' ' ' THR . 23.1 t -125.9 115.65 20.29 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.038 -1.097 . . . . 74.340000000000003 108.038 -177.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -120.43 146.86 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 109.521 -0.548 . . . . 73.420000000000002 109.521 -177.626 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.9 m -128.91 122.63 30.69 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 109.83 -0.433 . . . . 60.439999999999998 109.83 -177.545 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -114.34 121.76 67.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.577 0.703 . . . . 72.109999999999999 110.858 -178.208 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.3 m -95.52 155.93 38.09 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 115.407 -0.815 . . . . 63.130000000000003 110.028 -177.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.14 2.34 0.47 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 124.144 3.23 . . . . 75.0 114.1 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 29.0 t70 -84.66 -4.0 58.8 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.801 -0.814 . . . . 71.430000000000007 108.801 178.385 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 72.2 29.38 2.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.895 1.678 . . . . 73.400000000000006 106.59 -174.402 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.4 OUTLIER -101.04 125.2 47.64 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 112.967 -1.924 . . . . 65.140000000000001 108.254 -178.743 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.454 HG11 HD13 ' A' ' 95' ' ' LEU . 21.7 t -113.29 133.72 58.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 N-CA-C 108.34 -0.985 . . . . 73.230000000000004 108.34 178.267 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.6 p -140.42 161.39 37.82 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.462 -1.681 . . . . 52.0 106.462 177.497 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.53 -178.12 46.44 Favored Glycine 0 CA--C 1.483 -1.929 0 C-N-CA 118.684 -1.722 . . . . 74.209999999999994 112.888 178.145 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -145.87 133.62 21.12 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 123.08 0.552 . . . . 55.340000000000003 109.53 -176.206 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.88 115.61 46.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.103 -1.443 . . . . 74.409999999999997 107.103 176.059 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.62 118.1 56.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 109.659 -0.497 . . . . 72.519999999999996 109.659 -178.402 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.468 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -114.49 108.61 17.09 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.564 -1.273 . . . . 64.519999999999996 107.564 175.764 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.81 124.12 43.41 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.507 -0.553 . . . . 64.129999999999995 109.507 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.07 158.71 23.72 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.919 -0.582 . . . . 71.319999999999993 111.905 -174.261 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.4 pttt . . . . . 0 N--CA 1.443 -0.812 0 CA-C-N 114.306 -1.316 . . . . 74.439999999999998 109.357 173.013 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.421 -1.88 0 N-CA-C 109.288 -0.634 . . . . 73.329999999999998 109.288 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.45 97.81 0.11 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 120.717 -0.754 . . . . 70.340000000000003 111.851 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 83' ' ' SER . 39.4 Cg_exo -63.35 159.5 39.6 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.753 2.302 . . . . 63.43 111.478 176.173 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.41 120.93 36.49 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.548 -0.908 . . . . 53.43 108.548 178.501 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.1 mt -72.32 126.94 31.06 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.513 0.673 . . . . 61.420000000000002 110.642 176.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.85 87.21 6.39 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.101 -1.409 . . . . 75.120000000000005 108.374 -173.009 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.494 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -165.62 82.37 0.11 Allowed Glycine 0 N--CA 1.407 -3.251 0 CA-C-N 114.78 -1.1 . . . . 72.239999999999995 112.328 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -98.14 97.5 8.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.669 -1.234 . . . . 42.409999999999997 107.669 174.021 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -110.36 158.17 36.06 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.011 -0.995 . . . . 61.100000000000001 110.522 -174.33 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.57 -23.53 71.44 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 122.762 2.308 . . . . 51.530000000000001 111.634 177.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -103.92 30.92 4.8 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.51 -0.768 . . . . 63.43 111.658 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.6 m -58.73 -23.91 60.64 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 121.152 0.501 . . . . 40.350000000000001 110.99 176.944 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -66.76 -18.87 65.6 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.806 -0.633 . . . . 74.549999999999997 110.069 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -97.62 -11.91 23.06 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.739 -0.664 . . . . 74.129999999999995 110.711 -178.388 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.62 119.27 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 122.069 0.938 . . . . 65.540000000000006 111.772 178.444 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.27 103.46 15.92 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.37 -0.832 . . . . 70.230000000000004 108.786 178.761 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 85' ' ' ALA . 7.2 p -98.13 131.21 45.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.633 -1.247 . . . . 71.209999999999994 107.633 178.684 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -146.16 171.41 14.97 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.283 -0.636 . . . . 75.530000000000001 109.283 -173.3 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -85.59 151.93 23.53 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.979 -1.119 . . . . 75.519999999999996 107.979 175.338 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 63.0 t80 -113.21 122.62 48.02 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.585 -0.895 . . . . 63.299999999999997 108.585 -179.623 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -138.67 97.9 3.45 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.096 -1.446 . . . . 71.340000000000003 107.096 176.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 48.1 m -166.24 157.22 13.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.246 -1.39 . . . . 43.020000000000003 107.246 -176.619 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.25 1.71 3.37 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.233 1.013 . . . . 75.129999999999995 112.757 173.856 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.99 -4.76 65.67 Favored Glycine 0 C--O 1.213 -1.212 0 N-CA-C 110.707 -0.957 . . . . 74.219999999999999 110.707 -174.038 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.92 156.84 16.92 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 123.61 0.764 . . . . 73.430000000000007 109.283 -176.164 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.35 137.45 56.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.335 -0.617 . . . . 61.030000000000001 109.335 173.752 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -171.2 -154.17 9.53 Favored Glycine 0 N--CA 1.416 -2.665 0 C-N-CA 119.99 -1.1 . . . . 71.239999999999995 112.373 -177.701 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 12.4 p -129.68 148.04 51.52 Favored 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 123.441 0.696 . . . . 73.319999999999993 110.195 -177.269 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -136.78 145.18 44.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.674 0.273 . . . . 72.430000000000007 110.769 178.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . . . -127.07 114.92 18.39 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.565 -1.272 . . . . 31.039999999999999 107.565 174.786 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.7 t -114.39 117.97 57.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.557 -0.905 . . . . 73.310000000000002 108.557 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.431 ' CD2' HD12 ' A' ' 90' ' ' LEU . 48.8 p90 -120.51 154.61 35.05 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 120.817 0.341 . . . . 75.140000000000001 111.076 -174.674 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.5 m -158.15 158.37 34.5 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.16 -0.473 . . . . 60.100000000000001 110.39 -179.077 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.7 t70 67.34 31.89 6.21 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.532 1.158 . . . . 75.439999999999998 111.348 176.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 90' ' ' LEU . 31.6 mt -97.4 159.91 14.64 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.633 -0.712 . . . . 72.420000000000002 111.483 178.034 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 93' ' ' ALA . 27.5 m -96.2 158.11 15.59 Favored 'General case' 0 N--CA 1.412 -2.343 0 C-N-CA 124.554 1.142 . . . . 72.129999999999995 109.23 -177.414 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.8 -38.81 70.46 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.837 0.351 . . . . 73.409999999999997 110.655 175.251 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 91' ' ' THR . . . -63.3 -25.48 68.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.964 -0.562 . . . . 73.519999999999996 111.598 178.038 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -88.14 -16.35 33.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.905 0.383 . . . . 54.130000000000003 111.318 -178.422 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 43.7 tp -56.6 -48.64 96.79 Favored Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 112.89 0.7 . . . . 72.120000000000005 112.89 179.091 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.32 -35.87 81.95 Favored 'Trans proline' 0 C--N 1.369 1.652 0 CA-C-N 120.847 1.338 . . . . 74.129999999999995 111.318 174.474 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -64.63 -39.76 94.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.283 0.563 . . . . 70.340000000000003 110.817 -177.16 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -77.09 -19.67 56.73 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.622 -0.51 . . . . 71.430000000000007 109.622 177.199 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.13 -21.62 59.8 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.197 -0.668 . . . . 54.32 109.197 -177.819 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.09 -55.77 22.59 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.26 -1.015 . . . . 75.109999999999999 108.26 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.494 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.4 ttp -53.64 -51.31 63.52 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.508 -0.769 . . . . 65.150000000000006 109.865 178.108 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -53.07 -42.62 66.0 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.015 -0.993 . . . . 64.329999999999998 109.838 179.129 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -62.08 -41.02 97.76 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.916 -0.584 . . . . 70.200000000000003 109.498 -172.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.33 -11.16 59.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.451 -0.795 . . . . 71.310000000000002 110.097 -169.393 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.86 -17.57 14.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.858 -0.61 . . . . 52.32 110.559 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.68 -43.69 4.65 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.126 0.787 . . . . 64.049999999999997 113.126 -173.532 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.97 19.44 28.82 Favored Glycine 0 C--N 1.317 -0.49 0 N-CA-C 110.03 -1.228 . . . . 71.510000000000005 110.03 -172.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -110.18 142.44 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.449 -0.574 . . . . 52.5 109.449 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -107.86 122.48 46.88 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.426 -1.324 . . . . 73.239999999999995 107.426 177.578 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.4 mt -120.55 127.67 52.37 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 121.09 -0.244 . . . . 61.140000000000001 110.356 -177.808 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -130.34 136.68 49.37 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.609 -1.256 . . . . 71.019999999999996 107.609 177.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -146.0 149.65 34.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.409 0.623 . . . . 75.310000000000002 111.013 -178.105 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -144.67 156.51 44.13 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.868 -1.06 . . . . 73.319999999999993 108.884 -179.276 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.479 ' NH1' ' HA ' ' A' ' 180' ' ' ASP . 17.0 ttm180 -114.03 130.94 56.52 Favored 'General case' 0 N--CA 1.398 -3.037 0 N-CA-C 108.196 -1.039 . . . . 74.530000000000001 108.196 172.082 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -113.06 100.76 8.86 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.899 -1.519 . . . . 73.200000000000003 106.899 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.63 -113.32 5.2 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 110.575 -1.01 . . . . 74.230000000000004 110.575 -176.2 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -109.1 1.77 20.67 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.025 0.917 . . . . 70.010000000000005 109.436 179.245 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.4 pp -110.39 146.62 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 118.217 -1.393 . . . . 71.099999999999994 109.514 179.25 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.448 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 76.3 t -110.89 143.51 20.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-O 120.972 0.415 . . . . 63.399999999999999 110.629 -177.213 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.1 pt -124.13 133.75 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 108.822 -0.807 . . . . 71.430000000000007 108.822 178.16 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.45 127.1 41.87 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.785 -0.82 . . . . 51.229999999999997 108.785 178.113 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -131.54 123.34 27.79 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.452 -1.314 . . . . 63.549999999999997 107.452 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -143.51 164.4 27.36 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.423 -0.894 . . . . 54.200000000000003 112.982 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -134.01 130.27 37.34 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.323 -0.621 . . . . 72.030000000000001 109.323 -178.767 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.19 110.46 21.69 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.766 -0.457 . . . . 74.150000000000006 109.766 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.85 93.68 5.02 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 122.03 0.919 . . . . 75.430000000000007 108.691 177.844 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.6 pt? -114.75 23.39 12.69 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-O 122.924 1.345 . . . . 65.200000000000003 109.057 177.476 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 C--N 1.311 -1.068 0 N-CA-C 106.249 -1.76 . . . . 74.010000000000005 106.249 171.596 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 112.2 0.445 . . . . 74.450000000000003 112.2 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.87 144.69 31.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.351 0.5 . . . . 73.530000000000001 112.351 -172.035 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -131.21 116.58 17.85 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 105.845 -1.909 . . . . 65.430000000000007 105.845 171.369 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 56.6 t -108.0 124.17 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 C-N-CA 120.017 -0.673 . . . . 72.230000000000004 110.463 -172.638 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.96 120.19 31.77 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.365 -0.606 . . . . 73.5 109.365 177.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.6 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.6 tm? -111.79 117.07 31.81 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.223 -1.769 . . . . 70.310000000000002 106.223 177.394 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.5 m -126.01 136.91 53.52 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 120.879 0.371 . . . . 64.099999999999994 110.263 -176.428 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.6 t -128.22 120.89 54.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.034 -1.099 . . . . 72.340000000000003 108.034 176.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.07 127.37 56.19 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.269 -0.641 . . . . 51.049999999999997 109.269 179.554 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -135.09 122.02 14.88 Favored Pre-proline 0 C--N 1.288 -2.093 0 N-CA-C 112.449 0.537 . . . . 74.120000000000005 112.449 179.186 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.88 40.81 0.44 Allowed 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 122.822 2.348 . . . . 73.120000000000005 111.527 172.293 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.52 -91.86 0.53 Allowed 'General case' 0 N--CA 1.434 -1.226 0 O-C-N 122.062 -0.399 . . . . 73.510000000000005 110.656 -178.614 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 170.31 120.29 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 124.046 0.938 . . . . 62.210000000000001 108.596 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.06 118.38 16.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 122.357 1.075 . . . . 72.409999999999997 109.999 175.242 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 176' ' ' ALA . 33.4 m -75.99 -45.81 32.75 Favored 'General case' 1 N--CA 1.367 -4.583 0 CA-C-N 113.981 -1.463 . . . . 64.549999999999997 110.498 -178.657 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.3 m -163.2 133.32 4.4 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.036 0.934 . . . . 64.120000000000005 108.949 174.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -138.58 157.53 45.97 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.467 -0.771 . . . . 73.140000000000001 111.993 177.323 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 24.1 t-20 -127.42 95.73 4.35 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 104.984 -2.228 . . . . 72.230000000000004 104.984 173.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.483 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 170.04 -148.43 11.74 Favored Glycine 0 N--CA 1.414 -2.827 0 N-CA-C 108.106 -1.998 . . . . 75.230000000000004 108.106 -178.941 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -115.59 99.25 7.2 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.864 0.84 . . . . 75.400000000000006 109.937 -176.942 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -82.88 117.06 22.47 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-N 115.526 -0.761 . . . . 61.219999999999999 111.013 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.3 -39.92 19.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.977 -1.49 . . . . 55.240000000000002 106.977 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -138.24 167.82 18.43 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 114.474 -1.239 . . . . 75.409999999999997 107.889 176.48 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -72.63 0.49 7.51 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.724 2.283 . . . . 42.219999999999999 111.086 174.529 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -127.69 -2.41 6.03 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.418 -0.81 . . . . 74.319999999999993 111.379 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.6 t -140.41 120.38 12.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.578 -0.897 . . . . 65.200000000000003 108.578 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.89 144.29 34.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.054 -0.721 . . . . 71.230000000000004 109.054 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -138.08 144.61 41.01 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.457 0.646 . . . . 74.409999999999997 109.464 -177.456 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.6 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.1 m-90 -119.05 114.57 22.71 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 108.017 -1.105 . . . . 72.120000000000005 108.017 176.345 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.53 107.37 18.08 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.04 0.924 . . . . 74.209999999999994 109.2 178.466 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.674 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 77.4 mt -101.51 127.4 48.22 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 114.493 -1.231 . . . . 53.140000000000001 110.207 -174.663 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -114.09 131.36 23.23 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 114.01 -1.45 . . . . 74.010000000000005 110.966 -173.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -54.07 151.0 29.29 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.383 2.722 . . . . 74.219999999999999 112.583 178.037 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.17 -33.47 2.92 Favored Glycine 0 C--N 1.304 -1.207 0 C-N-CA 120.98 -0.629 . . . . 74.109999999999999 112.963 176.078 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.22 155.6 6.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 120.997 0.427 . . . . 63.119999999999997 110.864 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.99 144.26 14.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.32 -0.622 . . . . 54.399999999999999 109.32 -178.266 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 m -145.19 141.12 28.41 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.611 -0.514 . . . . 61.450000000000003 109.611 177.505 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 63.1 p -105.23 135.07 47.27 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.207 -0.664 . . . . 74.120000000000005 109.207 177.121 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.4 131.79 50.2 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.72 -0.474 . . . . 73.010000000000005 109.72 177.83 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 47.4 m -137.24 139.03 40.74 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 119.659 -0.816 . . . . 74.140000000000001 109.972 174.369 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.99 133.05 15.23 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 108.62 -0.881 . . . . 55.329999999999998 108.62 -175.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -133.7 131.57 39.63 Favored 'General case' 0 C--N 1.26 -3.312 0 N-CA-C 107.353 -1.351 . . . . 74.140000000000001 107.353 176.346 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.528 ' HA ' ' OG1' ' A' ' 148' ' ' THR . . . -156.68 146.3 20.74 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.563 -0.532 . . . . 74.209999999999994 109.563 -177.23 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 19.1 ptt85 -86.22 135.25 33.64 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.999 -0.546 . . . . 75.329999999999998 110.616 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.448 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 95.3 m-85 -137.65 135.84 36.9 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 108.744 -0.836 . . . . 74.150000000000006 108.744 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.2 p -58.71 109.24 0.77 Allowed 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.066 0.854 . . . . 72.140000000000001 111.547 -178.65 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.479 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 22.3 t70 . . . . . 0 CA--C 1.489 -1.403 0 CA-C-N 115.166 -0.925 . . . . 71.219999999999999 108.69 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.129 0 N-CA-C 110.976 -0.849 . . . . 54.310000000000002 110.976 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 64.97 86.77 0.12 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.492 1.117 . . . . 70.140000000000001 112.336 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.37 172.16 7.5 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 104.773 -2.306 . . . . 72.549999999999997 104.773 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -74.57 87.26 2.12 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.23 -1.026 . . . . 75.140000000000001 108.23 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.4 mt -112.76 90.4 3.33 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.935 -0.575 . . . . 73.400000000000006 110.193 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -158.11 117.71 3.24 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.213 -1.773 . . . . 73.439999999999998 106.213 172.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -124.96 133.1 53.15 Favored 'General case' 0 C--N 1.283 -2.317 0 O-C-N 123.687 0.617 . . . . 74.409999999999997 109.629 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -81.88 159.84 23.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.882 -1.525 . . . . 60.409999999999997 106.882 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.48 -69.9 1.33 Allowed Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 119.91 -1.138 . . . . 74.209999999999994 111.318 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.635 ' HA ' ' CG ' ' A' ' 132' ' ' ASP . 82.6 m-70 65.73 96.94 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.866 0.866 . . . . 72.519999999999996 112.282 -176.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.5 ttm 71.14 71.11 0.18 Allowed 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.35 1.46 . . . . 62.420000000000002 109.088 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 pp -109.79 147.26 33.58 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 113.753 -1.567 . . . . 72.329999999999998 108.109 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -120.86 123.93 43.75 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.773 -0.825 . . . . 73.540000000000006 108.773 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.0 t -121.91 113.71 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.142 -1.429 . . . . 74.510000000000005 107.142 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -124.51 113.81 18.6 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.143 0.497 . . . . 73.519999999999996 109.71 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.09 113.75 27.14 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.407 -1.331 . . . . 74.109999999999999 107.407 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 140' ' ' THR . 37.8 m -125.18 114.51 19.09 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.931 -1.137 . . . . 75.25 107.931 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.401 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 2.1 pp -130.33 147.1 33.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.323 -0.398 . . . . 73.030000000000001 110.274 -173.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 78.3 m -125.68 123.63 39.34 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 109.27 -0.641 . . . . 74.239999999999995 109.27 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.492 ' O ' ' HD2' ' A' ' 144' ' ' PRO . 8.5 tt -114.69 131.47 66.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.944 -0.571 . . . . 74.510000000000005 111.031 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -96.55 149.95 36.44 Favored Pre-proline 0 N--CA 1.419 -1.977 0 N-CA-C 108.91 -0.774 . . . . 64.340000000000003 108.91 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.12 2.41 2.22 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.133 2.555 . . . . 70.120000000000005 112.699 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -86.74 5.82 34.44 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 123.722 0.809 . . . . 70.329999999999998 110.87 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 t70 70.83 29.48 3.11 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 123.183 1.468 . . . . 71.140000000000001 107.558 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.52 128.79 55.76 Favored 'General case' 0 N--CA 1.399 -3.018 0 CA-C-N 113.174 -1.83 . . . . 64.310000000000002 107.121 -177.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.513 HG11 HD21 ' A' ' 95' ' ' LEU . 8.1 t -124.29 144.9 32.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.095 -0.502 . . . . 51.140000000000001 110.071 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -149.21 161.26 42.36 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.791 -0.818 . . . . 65.150000000000006 108.791 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 162.26 -165.31 35.96 Favored Glycine 0 C--N 1.312 -0.786 0 C-N-CA 119.266 -1.445 . . . . 51.130000000000003 113.019 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -150.52 140.19 21.68 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.009 0.433 . . . . 72.329999999999998 109.853 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.3 mt -125.41 116.68 47.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.511 -0.922 . . . . 71.349999999999994 108.511 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.26 123.43 63.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.618 -0.512 . . . . 61.399999999999999 109.618 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.42 108.46 14.58 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.326 -1.361 . . . . 54.439999999999998 107.326 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -122.09 135.65 54.83 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.985 0.421 . . . . 72.530000000000001 111.616 -174.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.48 158.67 41.48 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.885 -0.783 . . . . 63.049999999999997 108.885 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -77.23 138.74 64.32 Favored Pre-proline 0 C--N 1.318 -0.804 0 C-N-CA 118.653 -1.219 . . . . 73.0 109.775 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.07 -58.91 1.3 Allowed 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.516 2.81 . . . . 74.120000000000005 115.742 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt 67.46 -44.34 0.47 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 115.099 1.518 . . . . 75.329999999999998 115.099 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.503 ' ND2' ' HG2' ' A' ' 54' ' ' LYS . 60.5 t30 -126.25 146.16 50.11 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.418 -0.586 . . . . 64.030000000000001 109.418 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.4 m -71.15 -12.51 61.53 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 114.002 1.112 . . . . 44.420000000000002 114.002 -172.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HG2' ' ND2' ' A' ' 52' ' ' ASN . 10.6 ptmm? -76.35 -17.91 59.16 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.052 0.453 . . . . 75.549999999999997 110.564 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.82 128.96 49.36 Favored 'General case' 0 N--CA 1.401 -2.899 0 N-CA-C 113.305 0.854 . . . . 71.420000000000002 113.305 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.493 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 4.2 t -106.08 -17.53 14.3 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.911 -1.495 . . . . 53.420000000000002 107.299 174.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.08 112.64 0.29 Allowed Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 109.875 -1.29 . . . . 72.530000000000001 109.875 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -52.36 128.91 29.39 Favored 'Trans proline' 0 C--N 1.355 0.915 0 CA-C-N 119.879 1.839 . . . . 74.099999999999994 109.089 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.63 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -95.87 151.95 18.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 114.169 1.174 . . . . 72.409999999999997 114.169 -167.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 83.4 mt -85.23 141.49 30.09 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.322 -1.308 . . . . 51.530000000000001 108.952 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -106.43 99.9 9.45 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.546 -1.279 . . . . 71.549999999999997 107.546 177.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.4 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -149.69 69.37 0.33 Allowed Glycine 0 C--N 1.287 -2.188 0 C-N-CA 120.041 -1.076 . . . . 55.039999999999999 114.023 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.65 95.51 6.59 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.18 -1.415 . . . . 74.019999999999996 107.18 172.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.31 159.28 29.98 Favored Pre-proline 0 C--N 1.293 -1.885 0 CA-C-N 115.088 -0.96 . . . . 72.549999999999997 109.823 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.56 -16.74 55.09 Favored 'Trans proline' 0 N--CA 1.481 0.741 0 C-N-CA 122.739 2.292 . . . . 61.119999999999997 113.153 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -115.79 33.37 5.53 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.058 -0.519 . . . . 73.439999999999998 110.597 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 p -57.63 -28.24 63.52 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 121.222 0.534 . . . . 74.409999999999997 112.375 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -66.94 -20.05 65.83 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.235 0.541 . . . . 73.420000000000002 110.351 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -101.03 -2.77 30.77 Favored 'General case' 0 C--O 1.257 1.492 0 CA-C-N 115.846 -0.615 . . . . 73.140000000000001 110.233 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' A' ' 87' ' ' PHE . 4.3 p -132.41 118.87 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.12 0.962 . . . . 62.240000000000002 110.817 175.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.95 106.0 17.99 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.477 -0.783 . . . . 61.509999999999998 109.209 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.21 130.93 45.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 106.784 -1.561 . . . . 71.349999999999994 106.784 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.1 t -145.67 171.77 14.24 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.89 -0.781 . . . . 33.140000000000001 108.89 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -84.53 137.9 33.06 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.14 -0.689 . . . . 74.329999999999998 109.14 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 77.0 t80 -107.38 124.96 50.6 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.473 -0.936 . . . . 73.239999999999995 108.473 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -139.0 98.84 3.62 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.553 -1.277 . . . . 74.430000000000007 107.553 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 70.3 m -160.22 148.48 16.79 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.779 -0.452 . . . . 55.32 109.779 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 67.64 8.22 6.21 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.733 1.213 . . . . 75.299999999999997 112.056 173.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.59 4.99 65.3 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.003 -0.839 . . . . 55.509999999999998 111.003 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.498 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 2.9 m-85 -104.71 142.91 33.85 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.191 -1.041 . . . . 72.010000000000005 108.191 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.8 m -124.78 139.18 51.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.547 -0.909 . . . . 65.219999999999999 108.547 175.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.26 -153.8 10.6 Favored Glycine 0 C--N 1.266 -3.353 0 N-CA-C 110.309 -1.117 . . . . 62.409999999999997 110.309 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.63 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 69.3 m -132.48 151.07 52.03 Favored 'General case' 0 C--N 1.266 -3.034 0 CA-C-O 121.289 0.566 . . . . 74.329999999999998 111.804 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -131.35 141.14 49.86 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.708 -0.678 . . . . 74.140000000000001 109.894 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.35 114.66 26.95 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.941 -1.133 . . . . 62.219999999999999 107.941 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.51 113.1 43.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.752 -1.203 . . . . 72.230000000000004 107.752 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CD2' HD12 ' A' ' 90' ' ' LEU . 40.6 p90 -120.42 156.23 31.84 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 120.745 0.307 . . . . 75.099999999999994 111.648 -173.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 p -160.7 149.54 16.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.876 -0.602 . . . . 75.519999999999996 111.089 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 67.23 32.16 6.2 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.467 1.107 . . . . 73.299999999999997 110.822 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 87' ' ' PHE . 19.6 mt -89.52 169.22 11.54 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.687 -0.688 . . . . 72.219999999999999 109.621 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.401 HG22 ' OE1' ' A' ' 94' ' ' GLU . 10.8 t -124.82 171.14 10.38 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.698 -0.482 . . . . 64.409999999999997 109.698 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -56.36 -36.37 68.72 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.856 0.862 . . . . 75.129999999999995 112.366 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.56 -25.6 63.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.15 0.5 . . . . 74.099999999999994 111.811 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' OE1' HG22 ' A' ' 91' ' ' THR . 55.7 mt-10 -81.07 -21.25 40.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 112.126 0.417 . . . . 75.140000000000001 112.126 -176.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.513 HD21 HG11 ' A' ' 40' ' ' VAL . 18.8 mt -54.53 -49.77 89.15 Favored Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 115.697 1.74 . . . . 73.030000000000001 115.697 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -54.92 -45.84 37.88 Favored 'Trans proline' 0 C--N 1.365 1.441 0 CA-C-N 120.816 1.327 . . . . 72.329999999999998 111.269 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -68.46 -32.87 73.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.948 0.88 . . . . 65.129999999999995 110.407 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.42 -40.58 89.62 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.296 -1.32 . . . . 74.299999999999997 108.829 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.75 -25.38 67.9 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.932 -1.031 . . . . 71.329999999999998 111.118 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -59.35 -55.55 33.3 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.404 0.44 . . . . 73.340000000000003 109.901 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.4 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 29.7 ttp -54.36 -48.93 70.91 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.706 0.629 . . . . 70.319999999999993 110.222 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -53.13 -41.95 65.57 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 114.964 -1.016 . . . . 61.439999999999998 111.363 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.9 m -67.23 -21.4 65.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.83 -0.623 . . . . 71.430000000000007 112.003 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.14 -28.59 70.17 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 121.38 0.61 . . . . 64.310000000000002 109.753 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -112.65 -2.55 14.51 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.823 -0.626 . . . . 72.140000000000001 110.916 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.7 -47.59 3.86 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.153 -0.619 . . . . 73.219999999999999 112.52 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.44 28.97 66.71 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.218 -0.992 . . . . 71.040000000000006 112.007 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.4 m -123.1 173.56 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.594 -0.521 . . . . 62.32 109.594 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -126.23 130.34 50.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.891 0.314 . . . . 73.209999999999994 110.912 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.05 136.16 53.42 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.06 -0.718 . . . . 63.009999999999998 109.06 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -143.34 120.21 11.27 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.933 -0.395 . . . . 63.340000000000003 109.933 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.3 145.9 36.64 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.08 -0.648 . . . . 63.549999999999997 109.262 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HE ' HD11 ' A' ' 120' ' ' ILE . 84.4 mtm-85 -147.41 151.33 36.29 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.55 -0.75 . . . . 62.219999999999999 109.571 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.416 ' CG ' HG22 ' A' ' 119' ' ' VAL . 20.3 mtt85 -97.16 137.6 35.95 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 120.126 -0.63 . . . . 61.100000000000001 111.42 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -117.77 92.26 3.79 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 106.534 -1.654 . . . . 73.430000000000007 106.534 174.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 185' ' ' SER . . . 75.94 -98.24 1.18 Allowed Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 110.694 -0.962 . . . . 62.43 110.694 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -130.64 6.28 4.74 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.809 1.29 . . . . 71.040000000000006 108.216 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.544 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.2 pp -108.51 145.06 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 106.695 -1.595 . . . . 71.209999999999994 106.695 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.416 HG22 ' CG ' ' A' ' 114' ' ' ARG . 90.9 t -105.48 136.44 39.51 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.831 0 N-CA-C 109.675 -0.491 . . . . 75.310000000000002 109.675 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.497 HG22 ' HG2' ' A' ' 175' ' ' GLN . 33.5 pt -111.69 133.57 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.318 0 N-CA-C 107.531 -1.285 . . . . 70.510000000000005 107.531 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.6 tt -115.03 123.76 49.88 Favored 'General case' 0 C--N 1.255 -3.534 0 N-CA-C 108.385 -0.968 . . . . 73.109999999999999 108.385 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -116.49 131.2 57.01 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 113.913 -1.494 . . . . 72.230000000000004 107.052 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -152.64 148.26 18.91 Favored Glycine 0 N--CA 1.413 -2.837 0 C-N-CA 119.735 -1.222 . . . . 74.129999999999995 110.301 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.58 137.47 43.77 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.103 -0.703 . . . . 71.010000000000005 109.103 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.38 109.14 13.52 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 108.633 -0.877 . . . . 64.439999999999998 108.633 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.11 98.6 7.45 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.543 -1.651 . . . . 61.409999999999997 106.543 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.13 36.99 4.49 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 123.024 1.392 . . . . 75.400000000000006 108.542 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 49.8 p -65.89 -40.46 91.57 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 113.515 -1.675 . . . . 71.439999999999998 110.538 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.2 m -84.33 16.51 3.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.002 0.921 . . . . 63.009999999999998 112.44 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 166' ' ' PRO . 8.6 p -68.98 147.46 12.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 N-CA-C 108.803 -0.814 . . . . 44.130000000000003 108.803 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.5 m -91.98 0.66 57.47 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 120.672 0.272 . . . . 74.430000000000007 111.25 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.635 ' CG ' ' HA ' ' A' ' 24' ' ' HIS . 26.2 t70 -128.85 122.74 21.61 Favored Pre-proline 0 C--N 1.308 -1.229 0 N-CA-C 112.13 0.418 . . . . 73.209999999999994 112.13 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.28 -17.83 18.64 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.886 2.39 . . . . 72.150000000000006 113.468 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -96.12 10.42 37.72 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 121.995 -0.441 . . . . 75.120000000000005 112.014 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -71.92 136.0 46.72 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.92 -0.582 . . . . 71.530000000000001 109.567 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -131.06 114.43 15.16 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.846 -0.428 . . . . 74.310000000000002 109.846 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 89.4 t -109.96 126.63 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 107.163 -1.421 . . . . 71.230000000000004 107.163 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -134.79 129.14 34.12 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 120.939 0.4 . . . . 71.450000000000003 111.206 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.9 tp -117.79 129.48 55.7 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.178 -0.464 . . . . 70.409999999999997 109.905 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' SER . 18.4 m -127.05 122.56 34.7 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.074 -1.084 . . . . 73.549999999999997 108.074 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 97.1 t -118.07 122.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.413 -0.588 . . . . 62.009999999999998 109.413 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.07 130.6 56.56 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.23 -0.655 . . . . 74.530000000000001 109.23 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.699 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.2 p90 -135.33 127.1 17.71 Favored Pre-proline 0 C--N 1.286 -2.178 0 CA-C-O 119.424 -0.322 . . . . 61.219999999999999 111.587 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 58.5 Cg_endo -75.15 36.63 0.45 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.569 2.179 . . . . 73.319999999999993 112.029 177.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.54 -103.19 0.41 Allowed 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 109.665 -0.495 . . . . 53.310000000000002 109.665 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.87 131.05 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.931 -1.137 . . . . 61.130000000000003 107.931 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.59 133.84 28.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.049 0.452 . . . . 75.219999999999999 109.969 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.3 p -89.19 -46.41 8.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.246 0.546 . . . . 72.030000000000001 109.623 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.6 m -152.05 133.88 14.85 Favored 'General case' 0 C--O 1.207 -1.178 0 CA-C-N 115.586 -0.733 . . . . 42.43 110.055 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 t -139.0 160.9 38.67 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.869 -0.519 . . . . 72.530000000000001 110.446 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 29.2 t-20 -132.26 89.56 2.68 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.723 -1.954 . . . . 75.150000000000006 105.723 174.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.35 -147.97 9.96 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 108.235 -1.946 . . . . 72.200000000000003 108.235 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -118.36 100.63 7.61 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 117.829 0.814 . . . . 64.409999999999997 110.301 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 21.0 ptt180 -83.26 123.44 29.6 Favored 'General case' 0 N--CA 1.413 -2.313 0 C-N-CA 119.884 -0.726 . . . . 73.420000000000002 111.354 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.56 -46.93 17.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.236 -1.394 . . . . 71.340000000000003 107.236 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -123.53 165.02 24.88 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 107.739 -1.208 . . . . 73.049999999999997 107.739 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -72.23 -0.16 8.22 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.429 2.086 . . . . 61.329999999999998 110.931 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.699 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.9 pt-20 -135.46 6.3 3.25 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.166 -0.925 . . . . 74.439999999999998 111.9 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.92 120.85 6.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 108.126 -1.064 . . . . 64.430000000000007 108.126 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 36.9 t -125.19 146.57 30.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 109.448 -0.575 . . . . 72.5 109.448 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -133.03 146.11 51.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 109.45 -0.574 . . . . 54.030000000000001 109.45 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 29.7 m-90 -128.19 129.35 46.34 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.639 -0.71 . . . . 72.540000000000006 109.245 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 1.0 OUTLIER -102.73 103.0 13.21 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 122.149 0.976 . . . . 74.310000000000002 111.005 176.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.5 mm? -90.73 116.22 28.42 Favored 'General case' 0 C--O 1.264 1.829 0 CA-C-O 121.827 0.822 . . . . 74.329999999999998 108.891 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 10.8 mmpt? -104.73 143.5 26.83 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 114.272 -1.331 . . . . 62.109999999999999 111.269 -172.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.46 ' CB ' HG11 ' A' ' 130' ' ' VAL . 58.5 Cg_endo -69.85 150.22 67.35 Favored 'Trans proline' 0 C--O 1.248 1.013 0 C-N-CA 123.963 3.109 . . . . 74.319999999999993 111.722 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.49 -30.64 3.06 Favored Glycine 0 C--N 1.321 -0.288 0 C-N-CA 120.913 -0.66 . . . . 41.020000000000003 112.213 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 35.3 m -105.63 165.79 3.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 110.011 -0.366 . . . . 73.230000000000004 110.011 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.69 142.26 26.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.215 -1.031 . . . . 63.310000000000002 108.215 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 63.7 m -142.34 140.89 32.26 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.204 0.526 . . . . 73.129999999999995 110.823 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 50.5 p -103.34 141.3 36.17 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.962 -1.125 . . . . 74.209999999999994 107.962 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -123.79 126.58 46.72 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.919 -0.4 . . . . 63.119999999999997 109.919 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 35.4 t -138.79 144.15 39.24 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.829 -0.434 . . . . 31.309999999999999 109.829 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.42 127.94 10.74 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.318 -0.993 . . . . 65.519999999999996 108.318 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' A' ' 120' ' ' ILE . 44.8 mt-30 -128.47 131.95 48.37 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 108.703 -0.851 . . . . 73.239999999999995 108.703 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.73 159.9 43.79 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.822 -0.436 . . . . 44.240000000000002 109.822 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.544 ' HG2' HG22 ' A' ' 118' ' ' ILE . 98.5 mtt180 -86.96 126.81 34.95 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.674 -0.491 . . . . 71.519999999999996 109.674 -177.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.401 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 74.9 m-85 -143.11 125.24 15.37 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 109.589 -0.523 . . . . 64.239999999999995 109.589 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.35 114.07 1.84 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 124.29 0.994 . . . . 73.340000000000003 111.831 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -68.61 138.04 90.88 Favored Pre-proline 0 C--O 1.213 -0.868 0 N-CA-C 108.322 -0.992 . . . . 72.030000000000001 108.322 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.39 -35.99 88.8 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.43 2.087 . . . . 44.130000000000003 113.153 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -84.61 -19.82 32.38 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.162 -1.051 . . . . 71.319999999999993 108.162 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.295 33.2 p 61.04 53.99 3.5 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 125.368 1.467 . . . . 72.219999999999999 111.713 -175.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -90.75 -177.53 5.01 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.613 -1.63 . . . . 75.349999999999994 109.437 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.558 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 70.7 m . . . . . 0 N--CA 1.417 -2.117 0 N-CA-C 107.496 -1.298 . . . . 75.329999999999998 107.496 172.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.537 0 N-CA-C 111.995 -0.442 . . . . 74.430000000000007 111.995 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.9 -4.26 42.89 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.719 0.759 . . . . 75.530000000000001 110.35 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.59 8.55 41.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.788 -0.642 . . . . 75.340000000000003 111.629 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -80.6 112.1 17.65 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 106.696 -1.594 . . . . 52.240000000000002 106.696 172.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.6 tp -69.84 99.09 1.32 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.226 0.824 . . . . 73.409999999999997 113.226 -171.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -141.64 63.99 1.41 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.049 -1.463 . . . . 75.340000000000003 107.049 170.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -149.91 -74.23 0.17 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 105.186 -2.153 . . . . 63.030000000000001 105.186 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.457 ' HA ' ' OD1' ' A' ' 134' ' ' ASP . 63.8 tt0 51.0 86.27 0.03 OUTLIER 'General case' 0 C--O 1.245 0.828 0 C-N-CA 125.57 1.548 . . . . 65.129999999999995 113.306 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.34 9.49 1.26 Allowed Glycine 0 C--N 1.292 -1.866 0 CA-C-N 115.137 -0.938 . . . . 61.329999999999998 111.318 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 51.62 32.89 9.78 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.392 1.477 . . . . 63.009999999999998 110.547 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 10.5 tpt -79.86 0.59 30.46 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.292 -1.322 . . . . 73.040000000000006 112.245 -167.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 4.3 tt -128.3 108.12 10.33 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 104.846 -2.279 . . . . 72.140000000000001 104.846 172.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -134.04 124.77 26.78 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.956 -0.757 . . . . 73.099999999999994 108.956 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.22 114.51 46.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.805 -1.183 . . . . 75.25 107.805 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -116.82 113.93 23.21 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.65 -1.159 . . . . 71.219999999999999 109.608 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.59 121.36 42.39 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 109.11 -0.7 . . . . 64.450000000000003 109.11 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.6 m -127.12 114.7 18.06 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.048 -1.093 . . . . 72.420000000000002 108.048 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -128.15 147.26 32.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.716 -0.475 . . . . 71.329999999999998 109.716 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.5 m -130.49 122.25 27.31 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 121.162 0.506 . . . . 74.239999999999995 110.221 -177.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 143' ' ' PHE . 10.7 tt -106.61 117.64 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.771 0.796 . . . . 74.540000000000006 109.51 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.8 t -77.76 150.54 78.84 Favored Pre-proline 0 N--CA 1.419 -1.987 0 CA-C-N 114.781 -1.099 . . . . 42.32 108.784 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -65.26 2.37 1.5 Allowed 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 123.555 2.837 . . . . 72.340000000000003 112.03 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -89.4 -0.31 57.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.324 1.05 . . . . 74.409999999999997 108.243 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HB2' ' HD3' ' A' ' 181' ' ' PRO . 29.3 t70 68.96 29.11 4.99 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.58 1.552 . . . . 71.120000000000005 108.523 -178.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.38 126.99 53.49 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 113.583 -1.644 . . . . 70.209999999999994 107.505 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 t -107.73 138.95 31.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 109.315 -0.624 . . . . 63.109999999999999 109.315 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.4 p -147.28 158.68 44.05 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.256 -1.387 . . . . 63.329999999999998 107.256 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.7 -172.07 41.78 Favored Glycine 0 CA--C 1.489 -1.589 0 C-N-CA 119.433 -1.365 . . . . 63.340000000000003 112.197 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.6 133.39 17.96 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.33 0.586 . . . . 24.449999999999999 109.635 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 68.2 mt -117.23 116.22 51.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.952 -1.129 . . . . 64.310000000000002 107.952 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.39 120.45 62.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.398 -0.593 . . . . 74.019999999999996 109.398 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.499 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.32 107.6 16.93 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 106.462 -1.681 . . . . 53.539999999999999 106.462 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -117.39 123.59 46.8 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.787 -0.449 . . . . 62.240000000000002 109.787 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.27 157.5 19.4 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.554 0.692 . . . . 72.219999999999999 112.22 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -64.01 146.8 97.11 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 113.404 -1.726 . . . . 70.150000000000006 110.328 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.42 44.72 0.31 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 124.055 3.17 . . . . 72.239999999999995 114.155 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -96.07 -4.17 43.41 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 123.629 0.772 . . . . 75.129999999999995 109.111 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.464 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 3.4 m120 -54.07 123.69 13.38 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.52 1.528 . . . . 74.310000000000002 110.363 -176.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.8 m -78.81 -51.45 9.73 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.259 0.552 . . . . 53.130000000000003 111.074 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -110.24 -15.4 13.99 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.245 0.461 . . . . 75.299999999999997 112.245 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 52' ' ' ASN . 38.5 m-20 -89.2 132.21 34.97 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 113.809 1.04 . . . . 73.420000000000002 113.809 -170.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.2 p -102.81 -20.72 14.21 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.247 -1.39 . . . . 61.130000000000003 107.247 172.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.625 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 174.04 97.96 0.11 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.105 -1.198 . . . . 72.530000000000001 110.105 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.535 ' O ' ' HB3' ' A' ' 83' ' ' SER . 15.7 Cg_exo -68.32 159.07 54.85 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.571 2.18 . . . . 75.409999999999997 111.672 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.62 154.48 24.82 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.196 -0.668 . . . . 50.100000000000001 109.196 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 85' ' ' ALA . 48.1 mt -74.77 152.39 39.03 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.371 0.605 . . . . 73.310000000000002 111.908 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -107.94 99.49 8.94 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.056 -0.975 . . . . 64.219999999999999 109.183 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.465 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -160.22 92.76 0.12 Allowed Glycine 0 C--N 1.29 -2.011 0 C-N-CA 120.36 -0.924 . . . . 71.129999999999995 113.525 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -86.48 112.58 21.65 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.253 -1.017 . . . . 74.409999999999997 108.253 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.09 162.08 54.36 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 116.269 -0.423 . . . . 54.200000000000003 110.499 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.18 -21.13 67.69 Favored 'Trans proline' 0 N--CA 1.478 0.593 0 C-N-CA 122.401 2.067 . . . . 71.209999999999994 112.043 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -109.87 27.99 9.03 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.632 -0.713 . . . . 52.450000000000003 111.855 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.4 m -52.19 -31.51 32.02 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.281 0.474 . . . . 71.510000000000005 112.281 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -61.65 -22.09 64.98 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.007 0.523 . . . . 75.310000000000002 111.819 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 88' ' ' SER . 32.7 mmtp -98.85 -10.08 23.4 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 122.287 -0.258 . . . . 72.340000000000003 111.134 -176.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.69 120.04 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 119.693 -0.803 . . . . 72.519999999999996 110.861 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.13 113.21 25.68 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.686 -0.688 . . . . 44.100000000000001 109.266 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.47 124.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 108.282 -1.007 . . . . 35.020000000000003 108.282 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 m -128.55 165.04 21.52 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.024 -0.989 . . . . 64.239999999999995 109.8 -172.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.625 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 5.9 t30 -77.51 136.5 38.33 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.109 -0.95 . . . . 74.549999999999997 109.132 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -110.62 119.41 39.06 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 108.64 -0.874 . . . . 70.340000000000003 108.64 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -138.86 100.01 3.94 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.528 -0.915 . . . . 43.119999999999997 108.528 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 t -163.0 143.92 9.59 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.389 -0.597 . . . . 62.409999999999997 109.389 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.92 12.05 8.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.912 0.885 . . . . 73.230000000000004 113.357 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.62 -3.61 65.7 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.33 -0.938 . . . . 53.100000000000001 111.485 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.558 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 29.8 m-85 -94.74 145.46 24.85 Favored 'General case' 0 C--O 1.254 1.316 0 N-CA-C 108.218 -1.031 . . . . 71.400000000000006 108.218 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.3 m -128.94 136.63 59.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.611 -0.885 . . . . 44.299999999999997 108.611 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.94 -155.25 9.96 Favored Glycine 0 N--CA 1.414 -2.808 0 C-N-CA 119.98 -1.105 . . . . 61.149999999999999 111.899 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 24.4 p -121.94 152.0 40.15 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.131 -0.535 . . . . 74.540000000000006 110.473 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.8 pt20 -138.73 129.4 26.23 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.571 -0.452 . . . . 62.329999999999998 110.59 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -107.3 114.49 28.56 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.011 -1.477 . . . . 63.420000000000002 107.011 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.33 116.26 51.87 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.735 -1.209 . . . . 71.099999999999994 107.735 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CD2' HD12 ' A' ' 90' ' ' LEU . 41.8 p90 -117.88 157.61 26.35 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.08 0.467 . . . . 64.120000000000005 111.286 -174.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 16.5 p -158.62 152.7 23.79 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.354 -0.839 . . . . 54.100000000000001 109.616 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 t70 62.5 47.24 5.16 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 122.959 1.361 . . . . 62.439999999999998 111.26 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.452 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.4 mt -108.06 163.32 13.25 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.572 -1.194 . . . . 74.340000000000003 110.003 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -112.15 174.03 6.08 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.367 -0.605 . . . . 64.510000000000005 109.367 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.425 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 61.9 t80 -50.53 -48.36 57.22 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.18 0.992 . . . . 74.219999999999999 111.308 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.68 -25.43 66.36 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.433 0.693 . . . . 44.350000000000001 112.193 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -86.65 -16.44 36.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 116.138 -0.483 . . . . 71.299999999999997 112.3 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 5.4 tt -64.52 -52.18 54.41 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 119.54 -0.267 . . . . 73.530000000000001 110.441 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.85 -30.89 39.85 Favored 'Trans proline' 0 C--N 1.367 1.541 0 CA-C-N 120.951 1.376 . . . . 65.0 110.529 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -67.42 -31.16 71.16 Favored 'General case' 0 N--CA 1.424 -1.744 0 O-C-N 121.957 -0.464 . . . . 75.219999999999999 110.889 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -77.84 -19.16 55.37 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.175 0.512 . . . . 73.319999999999993 109.975 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.87 -13.49 61.68 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.555 -0.748 . . . . 74.329999999999998 110.653 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -66.37 -57.89 6.47 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.241 -1.022 . . . . 74.219999999999999 108.241 172.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.465 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.8 ttp -55.85 -50.48 70.46 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.252 0.548 . . . . 73.340000000000003 110.131 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -54.54 -37.74 65.77 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 114.456 -1.247 . . . . 70.430000000000007 111.712 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.7 p -62.35 -31.73 72.42 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 119.942 -0.703 . . . . 51.420000000000002 111.248 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.37 -25.0 67.38 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.498 0.666 . . . . 70.140000000000001 111.263 -173.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.44 -13.77 15.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.22 -0.592 . . . . 42.310000000000002 111.283 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.27 -41.47 5.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.115 0.783 . . . . 75.349999999999994 113.115 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.98 19.92 58.55 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.498 -1.041 . . . . 74.099999999999994 110.498 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 m -104.36 155.44 5.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.19 0.519 . . . . 70.439999999999998 111.154 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -120.18 137.33 54.25 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.096 -1.816 . . . . 72.129999999999995 106.096 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -134.92 111.52 9.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.055 0.455 . . . . 71.25 112.143 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.8 t -119.37 122.27 41.42 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.75 -0.833 . . . . 64.319999999999993 108.75 176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -139.31 142.88 37.67 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 116.06 -0.518 . . . . 73.349999999999994 109.738 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -141.14 149.6 41.72 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.523 -1.217 . . . . 75.129999999999995 109.568 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 ttm105 -98.92 137.86 36.88 Favored 'General case' 0 N--CA 1.409 -2.492 0 N-CA-C 108.527 -0.916 . . . . 61.509999999999998 108.527 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -122.63 94.58 4.33 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.11 -1.441 . . . . 63.240000000000002 107.11 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.75 -103.87 1.36 Allowed Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.856 -0.898 . . . . 73.510000000000005 110.856 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.605 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 11.2 t30 -113.99 -8.55 13.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.227 1.013 . . . . 71.409999999999997 109.422 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -99.54 149.87 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 C-N-CA 119.36 -0.936 . . . . 74.25 109.408 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.2 t -119.02 138.86 48.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 O-C-N 121.923 -0.486 . . . . 74.030000000000001 111.195 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.6 pt -117.05 132.96 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.344 -0.844 . . . . 71.120000000000005 109.209 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.2 tt -129.22 130.93 46.92 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 115.971 -0.559 . . . . 64.150000000000006 109.717 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.32 133.23 34.69 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.971 -0.559 . . . . 73.519999999999996 110.002 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.74 171.97 32.49 Favored Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 120.161 -1.018 . . . . 71.0 112.002 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -138.53 158.11 44.88 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.417 -0.586 . . . . 75.120000000000005 109.417 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.94 113.26 18.23 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.626 -0.879 . . . . 74.310000000000002 108.626 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -111.96 93.81 4.64 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.878 0.847 . . . . 75.519999999999996 111.506 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 166' ' ' PRO . 1.1 pt? -134.98 30.92 3.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 123.88 1.8 . . . . 74.510000000000005 107.045 176.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.416 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 37.1 p -62.54 -21.08 65.28 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 111.863 -2.426 . . . . 71.349999999999994 112.596 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.5 m -72.72 -12.84 61.18 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 123.763 0.825 . . . . 75.099999999999994 111.171 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t 68.05 83.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.237 1.015 . . . . 75.109999999999999 109.976 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.5 m -72.15 -37.65 69.34 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.843 -1.072 . . . . 73.209999999999994 109.972 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -165.0 130.75 2.07 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 106.228 -1.768 . . . . 64.109999999999999 106.228 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.01 -12.88 21.52 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.747 2.298 . . . . 60.43 114.118 -176.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.457 ' OD1' ' HA ' ' A' ' 22' ' ' GLN . 38.6 t70 -104.52 2.82 31.29 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 122.043 0.925 . . . . 65.450000000000003 109.827 -176.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -92.88 140.93 28.98 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.935 -1.03 . . . . 43.43 111.831 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -132.1 141.79 49.29 Favored 'General case' 0 C--O 1.265 1.919 0 CA-C-N 115.699 -0.682 . . . . 75.310000000000002 110.124 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 60.2 t -106.4 116.23 49.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.229 -1.026 . . . . 55.340000000000003 108.229 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -115.47 120.71 40.42 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.871 -0.418 . . . . 72.010000000000005 109.871 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -118.54 115.74 25.2 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.531 -1.285 . . . . 70.400000000000006 107.531 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.5 m -120.82 128.33 52.76 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.146 -0.479 . . . . 71.420000000000002 109.732 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.4 t -120.74 127.18 75.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.353 -0.61 . . . . 64.219999999999999 109.353 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.24 124.55 52.79 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 109.503 -0.555 . . . . 74.120000000000005 109.503 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.627 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.3 p90 -134.36 112.46 11.98 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 122.909 0.484 . . . . 73.239999999999995 111.208 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -67.82 42.75 0.24 Allowed 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.484 2.789 . . . . 75.430000000000007 113.118 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.09 -92.94 0.51 Allowed 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.559 -0.534 . . . . 54.329999999999998 109.559 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.01 126.77 0.02 OUTLIER 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.939 0.896 . . . . 75.310000000000002 108.829 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.25 123.89 38.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.144 0.497 . . . . 74.040000000000006 110.07 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.7 p -86.4 -36.35 19.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.771 0.319 . . . . 65.230000000000004 111.01 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.6 m -161.99 132.92 5.08 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 107.859 -1.163 . . . . 44.109999999999999 107.859 176.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -139.03 152.29 47.48 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.903 -0.498 . . . . 72.239999999999995 110.938 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 27.8 t-20 -115.73 92.03 3.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.988 -1.856 . . . . 71.420000000000002 105.988 172.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.34 -149.77 12.07 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.139 -1.984 . . . . 75.140000000000001 108.139 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -116.54 99.76 7.38 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 117.887 0.844 . . . . 72.099999999999994 109.569 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -77.94 119.77 21.86 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 119.679 -0.809 . . . . 73.420000000000002 109.538 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.5 mm -86.81 -44.97 16.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.192 -1.411 . . . . 52.109999999999999 107.192 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -118.45 162.43 30.43 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 105.215 -2.143 . . . . 73.140000000000001 105.215 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -74.37 -0.8 10.15 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.901 1.734 . . . . 74.340000000000003 110.956 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.627 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.3 pt-20 -131.95 3.82 4.1 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.129 -0.941 . . . . 61.210000000000001 111.35 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.87 121.13 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 108.463 -0.94 . . . . 62.020000000000003 108.463 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.0 t -122.46 148.29 26.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.538 -0.541 . . . . 53.439999999999998 109.538 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -131.94 138.86 48.5 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.515 -0.55 . . . . 71.319999999999993 109.515 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.445 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.8 m-90 -119.63 130.39 55.06 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.701 -0.851 . . . . 70.200000000000003 108.701 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -109.88 104.24 13.14 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.957 0.884 . . . . 65.420000000000002 108.648 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 0.5 OUTLIER -100.98 131.19 46.97 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.818 -0.808 . . . . 72.299999999999997 108.818 -174.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 66.0 mttm -117.36 149.61 44.95 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 115.802 -0.636 . . . . 70.239999999999995 112.598 -173.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.441 ' HA ' ' HG ' ' A' ' 127' ' ' LEU . 17.0 Cg_exo -67.45 154.94 72.31 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.878 2.386 . . . . 70.25 111.743 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 84.43 -39.31 2.91 Favored Glycine 0 C--N 1.311 -0.828 0 CA-C-N 115.83 -0.623 . . . . 61.5 112.541 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.34 151.86 6.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.981 -0.378 . . . . 71.340000000000003 109.981 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.79 110.44 24.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.733 0.778 . . . . 73.400000000000006 109.15 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.405 ' HB2' HD12 ' A' ' 164' ' ' LEU . 14.9 m -101.31 131.04 47.55 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.688 -0.687 . . . . 70.209999999999994 109.689 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 37.6 p -105.41 145.2 31.14 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.109 -0.496 . . . . 63.420000000000002 109.708 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 25.1 ptp -126.66 134.05 50.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.8 -0.815 . . . . 73.430000000000007 108.8 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 9.1 m -141.69 146.94 36.69 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.236 -1.024 . . . . 64.310000000000002 108.236 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.445 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -156.31 120.59 4.49 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.787 -0.449 . . . . 61.5 109.787 -175.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -123.01 131.87 53.89 Favored 'General case' 0 C--N 1.264 -3.136 0 N-CA-C 107.391 -1.337 . . . . 72.329999999999998 107.391 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -160.31 153.06 21.18 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.978 -1.119 . . . . 72.239999999999995 107.978 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.602 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 38.5 ptt180 -92.87 131.49 37.85 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.2 -1.0 . . . . 74.510000000000005 109.685 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -126.38 118.42 24.98 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.718 -1.215 . . . . 75.140000000000001 107.718 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.605 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -53.25 109.97 0.49 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 124.905 1.378 . . . . 72.109999999999999 112.538 -177.357 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.46 ' OD1' ' HD2' ' A' ' 181' ' ' PRO . 32.6 t0 -70.11 125.13 91.86 Favored Pre-proline 0 CA--C 1.502 -0.877 0 N-CA-C 107.589 -1.263 . . . . 74.099999999999994 107.589 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 38' ' ' ASP . 18.8 Cg_endo -61.18 -43.26 30.24 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.897 2.398 . . . . 63.32 112.368 -176.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -84.49 -9.12 58.64 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 123.902 0.881 . . . . 63.310000000000002 110.991 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 60.1 p 61.46 70.19 0.61 Allowed 'General case' 0 C--O 1.248 0.987 0 N-CA-C 115.421 1.637 . . . . 74.439999999999998 115.421 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -90.06 -179.88 5.78 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.91 0.862 . . . . 73.209999999999994 113.05 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.421 -1.878 0 N-CA-C 106.18 -1.785 . . . . 74.150000000000006 106.18 175.164 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.658 0 N-CA-C 109.142 -1.583 . . . . 43.049999999999997 109.142 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -82.95 101.24 10.93 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.51 -1.293 . . . . 74.329999999999998 107.51 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -79.93 113.48 18.13 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.281 -0.872 . . . . 75.409999999999997 109.779 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -118.0 128.28 54.63 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.908 -1.145 . . . . 62.43 107.908 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.29 88.14 5.54 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.073 0.463 . . . . 55.539999999999999 111.636 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -70.13 134.22 47.93 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.805 -0.634 . . . . 72.120000000000005 109.861 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.4 t80 77.89 96.54 0.06 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.581 1.553 . . . . 70.420000000000002 112.858 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.517 ' HB3' HD21 ' A' ' 52' ' ' ASN . 0.2 OUTLIER -167.86 106.62 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 105.49 -2.041 . . . . 73.319999999999993 105.49 172.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.13 73.91 0.23 Allowed Glycine 0 N--CA 1.423 -2.181 0 N-CA-C 110.779 -0.928 . . . . 63.240000000000002 110.779 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -60.93 117.01 4.92 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.125 -0.694 . . . . 74.549999999999997 109.125 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.9 mtt 69.6 93.48 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.475 1.109 . . . . 54.130000000000003 111.468 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 4.0 pp -112.13 148.04 34.82 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.575 -0.528 . . . . 44.229999999999997 109.575 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -143.93 129.91 19.51 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.441 -0.577 . . . . 72.109999999999999 109.441 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 46' ' ' ALA . 33.1 m -125.08 129.86 73.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.964 -0.694 . . . . 75.219999999999999 109.95 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.496 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 15.5 ptt180 -139.35 122.25 16.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.52 0.676 . . . . 53.439999999999998 111.038 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.66 138.56 49.29 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.54 -0.755 . . . . 51.310000000000002 109.287 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.7 m -134.17 115.25 13.99 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.075 -1.083 . . . . 74.329999999999998 108.075 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 11.6 pt -129.04 149.1 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-O 121.359 0.599 . . . . 50.350000000000001 110.178 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 88.8 m -124.51 126.67 46.24 Favored 'General case' 0 C--N 1.264 -3.112 0 N-CA-C 108.976 -0.75 . . . . 74.200000000000003 108.976 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.482 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.8 tt -113.26 120.03 62.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.793 0.806 . . . . 52.329999999999998 109.752 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 37' ' ' ASP . 26.3 t -81.4 151.99 69.73 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 114.639 -1.164 . . . . 54.409999999999997 109.056 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.65 2.31 2.09 Favored 'Trans proline' 0 C--N 1.364 1.351 0 C-N-CA 123.291 2.66 . . . . 63.329999999999998 111.524 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 35' ' ' SER . 14.3 t70 -82.52 -7.99 59.63 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.703 1.201 . . . . 63.219999999999999 108.318 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.9 t70 72.22 29.26 2.28 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 123.444 1.592 . . . . 70.439999999999998 107.413 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.24 135.38 51.09 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 113.125 -1.852 . . . . 64.030000000000001 107.491 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.402 HG12 ' HE2' ' A' ' 87' ' ' PHE . 10.6 t -117.03 142.01 32.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.173 -0.677 . . . . 52.140000000000001 109.173 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.1 p -149.66 157.57 43.36 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.501 -1.296 . . . . 75.540000000000006 107.501 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.77 -162.84 34.88 Favored Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 118.481 -1.818 . . . . 41.109999999999999 112.949 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -150.44 133.69 16.29 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.361 0.6 . . . . 72.25 110.108 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.8 116.37 52.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.614 -1.254 . . . . 64.040000000000006 107.614 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 29' ' ' ARG . 2.0 mp -103.19 120.97 53.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 120.862 0.363 . . . . 75.040000000000006 110.258 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -119.73 108.8 14.87 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.533 -1.284 . . . . 33.509999999999998 107.533 174.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -121.6 146.52 46.89 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.448 0.642 . . . . 64.349999999999994 112.06 -173.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.83 139.28 50.15 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.438 -0.949 . . . . 65.439999999999998 108.438 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -74.31 122.2 86.99 Favored Pre-proline 0 C--N 1.31 -1.134 0 N-CA-C 107.886 -1.153 . . . . 74.420000000000002 107.886 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -36.74 -79.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 124.851 3.701 . . . . 73.310000000000002 116.862 -167.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.553 ' HE2' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 68.31 -53.99 0.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.846 1.258 . . . . 74.329999999999998 110.065 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.517 HD21 ' HB3' ' A' ' 22' ' ' GLN . 80.8 m-20 -77.36 142.12 39.5 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 123.29 0.636 . . . . 74.239999999999995 109.885 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.1 m -78.31 -17.12 57.0 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.95 -0.568 . . . . 74.230000000000004 110.841 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -87.19 -20.24 27.26 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 116.346 -0.388 . . . . 73.510000000000005 111.884 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -95.34 109.2 21.38 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 113.214 0.82 . . . . 64.340000000000003 113.214 -171.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.443 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 20.7 p -90.75 -21.83 21.37 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.616 -1.253 . . . . 71.420000000000002 107.616 172.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.08 103.62 0.17 Allowed Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 114.582 -1.19 . . . . 73.319999999999993 110.202 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.43 134.77 53.05 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.746 2.297 . . . . 51.219999999999999 110.434 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.94 148.25 25.21 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 114.802 1.408 . . . . 72.219999999999999 114.802 -168.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 92.7 mt -89.08 161.66 16.41 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 114.201 -1.363 . . . . 62.43 108.57 174.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -110.62 90.78 3.42 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.437 0.637 . . . . 74.299999999999997 109.827 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.43 51.7 1.58 Allowed Glycine 0 C--N 1.302 -1.333 0 CA-C-N 115.685 -0.689 . . . . 74.439999999999998 112.697 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -96.44 98.85 10.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.352 0.596 . . . . 73.310000000000002 110.542 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.68 171.74 7.23 Favored Pre-proline 0 C--N 1.311 -1.1 0 C-N-CA 123.569 0.748 . . . . 50.210000000000001 109.951 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.09 -19.25 34.78 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.857 1.705 . . . . 70.219999999999999 111.612 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.44 ' CE1' ' HG2' ' A' ' 97' ' ' GLN . 15.6 p90 -111.29 36.28 3.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.855 -0.612 . . . . 61.310000000000002 110.606 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.5 m -60.41 -27.7 67.67 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 122.064 -0.397 . . . . 65.120000000000005 111.814 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.4 pm0 -71.99 -9.33 58.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.487 -0.758 . . . . 62.439999999999998 110.383 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.622 ' HB3' HD21 ' A' ' 90' ' ' LEU . 14.7 mmmm -95.95 -20.09 19.01 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.895 -0.593 . . . . 75.439999999999998 109.701 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 p -130.69 117.88 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 122.157 0.98 . . . . 63.329999999999998 110.993 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.98 124.58 47.84 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.684 -0.689 . . . . 74.150000000000006 110.326 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.93 120.61 47.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.676 -1.231 . . . . 61.549999999999997 107.676 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -124.91 168.88 12.67 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.626 -0.715 . . . . 65.010000000000005 110.258 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -79.98 150.29 30.51 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.042 -0.725 . . . . 63.210000000000001 109.042 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 93.2 t80 -127.35 129.5 47.73 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.063 -0.517 . . . . 72.120000000000005 109.738 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -138.19 98.26 3.58 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.577 -1.268 . . . . 73.310000000000002 107.577 176.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 67.7 m -164.66 155.57 14.84 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.265 -0.643 . . . . 65.030000000000001 109.265 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 69.87 4.38 4.74 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.571 1.148 . . . . 73.109999999999999 110.932 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.76 -4.07 71.76 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.205 -0.758 . . . . 42.020000000000003 111.205 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.444 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 66.4 m-85 -104.44 144.05 32.19 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.527 -0.545 . . . . 75.019999999999996 109.527 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.5 m -118.2 145.53 24.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.259 -1.015 . . . . 73.420000000000002 108.259 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.19 -153.74 12.85 Favored Glycine 0 CA--C 1.459 -3.416 0 C-N-CA 118.692 -1.718 . . . . 44.119999999999997 112.14 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.617 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 4.3 p -123.72 145.06 49.28 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-O 121.721 0.772 . . . . 73.150000000000006 111.732 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -125.64 131.73 52.6 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.466 -0.788 . . . . 71.310000000000002 109.873 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.8 114.19 26.64 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.267 -1.383 . . . . 72.239999999999995 107.267 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.1 t -107.39 113.55 43.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.111 -1.07 . . . . 70.200000000000003 108.111 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CD2' HD12 ' A' ' 90' ' ' LEU . 51.7 p90 -116.03 151.45 35.48 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.846 -0.427 . . . . 73.010000000000005 109.846 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.1 m -154.06 153.96 32.82 Favored 'General case' 0 C--N 1.292 -1.891 0 C-N-CA 120.449 -0.5 . . . . 70.129999999999995 111.099 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.22 36.18 15.0 Favored 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 124.443 1.089 . . . . 72.439999999999998 111.07 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.622 HD21 ' HB3' ' A' ' 69' ' ' LYS . 37.6 mt -97.78 168.53 10.27 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 114.854 -1.067 . . . . 63.219999999999999 109.14 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -125.43 -179.92 4.83 Favored 'General case' 0 C--N 1.268 -2.968 0 N-CA-C 108.641 -0.874 . . . . 53.509999999999998 108.641 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CZ ' ' HG ' ' A' ' 112' ' ' LEU . 43.6 t80 -51.19 -48.2 62.02 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 124.766 1.227 . . . . 72.310000000000002 110.559 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.58 -25.85 66.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.892 0.701 . . . . 73.310000000000002 112.892 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.42 -17.46 27.16 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 122.069 -0.394 . . . . 64.530000000000001 111.48 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 38.0 tp -66.47 -51.8 39.92 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 113.472 0.916 . . . . 73.239999999999995 113.472 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 92' ' ' PHE . 18.3 Cg_endo -62.96 -33.88 73.03 Favored 'Trans proline' 0 C--N 1.368 1.59 0 CA-C-N 120.829 1.332 . . . . 53.399999999999999 110.389 175.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.44 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 60.1 tt0 -66.61 -36.26 82.16 Favored 'General case' 0 N--CA 1.41 -2.464 0 CA-C-N 115.226 -0.897 . . . . 74.409999999999997 110.871 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -75.69 -19.3 59.21 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.325 0.583 . . . . 64.129999999999995 110.041 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.91 -20.57 61.75 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.825 -0.625 . . . . 73.209999999999994 110.565 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -56.31 -58.05 9.63 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 123.417 0.448 . . . . 75.099999999999994 111.177 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -59.46 -46.63 88.23 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.318 0.58 . . . . 50.109999999999999 110.194 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -57.26 -34.79 68.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.376 -1.284 . . . . 73.010000000000005 110.962 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.9 m -63.32 -33.5 75.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.553 -0.459 . . . . 71.329999999999998 110.905 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.93 -20.04 63.36 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.791 0.805 . . . . 64.439999999999998 110.479 -175.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.34 -19.13 17.95 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.697 -0.683 . . . . 62.240000000000002 110.506 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.91 -47.69 3.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.591 0.96 . . . . 63.140000000000001 113.591 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.52 28.17 25.25 Favored Glycine 0 C--O 1.238 0.403 0 N-CA-C 110.436 -1.066 . . . . 73.510000000000005 110.436 -173.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.43 160.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.412 -0.394 . . . . 74.310000000000002 110.699 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -119.32 142.77 47.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.381 -1.34 . . . . 73.299999999999997 107.381 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.7 mt -139.43 144.39 38.05 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 123.355 0.409 . . . . 72.25 110.28 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 m -142.83 117.33 9.71 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.356 -0.979 . . . . 61.310000000000002 108.356 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.43 ' HG ' ' CZ ' ' A' ' 92' ' ' PHE . 52.0 tp -121.9 125.93 47.53 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.076 -0.511 . . . . 73.420000000000002 110.375 -176.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -141.7 148.52 39.21 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.197 -0.668 . . . . 72.120000000000005 109.197 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 114' ' ' ARG . 16.8 ttm180 -98.69 128.05 44.83 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 108.39 -0.967 . . . . 71.140000000000001 108.39 172.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -102.27 86.11 2.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.84 -1.171 . . . . 72.530000000000001 107.84 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.29 -98.98 0.54 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.143 -0.935 . . . . 74.329999999999998 111.709 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.541 ' HA ' ' OD1' ' A' ' 180' ' ' ASP . 3.4 t-20 -107.63 -15.19 14.65 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.307 1.051 . . . . 74.409999999999997 109.651 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.7 pp -110.0 148.62 13.46 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.758 0 O-C-N 121.115 -0.99 . . . . 73.400000000000006 108.749 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 114' ' ' ARG . 73.6 t -105.91 137.62 35.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 O-C-N 121.639 -0.663 . . . . 64.540000000000006 110.25 -177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.408 HG22 ' HG2' ' A' ' 175' ' ' GLN . 47.0 pt -117.14 130.66 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 121.84 0.828 . . . . 71.340000000000003 110.064 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.25 128.58 44.95 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 115.161 -0.927 . . . . 63.219999999999999 109.352 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -129.18 147.68 51.05 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.614 -0.884 . . . . 74.530000000000001 108.614 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.55 166.25 37.18 Favored Glycine 0 N--CA 1.407 -3.298 0 N-CA-C 111.259 -0.736 . . . . 74.310000000000002 111.259 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -136.4 145.91 45.83 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.342 -0.985 . . . . 75.349999999999994 108.342 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 164' ' ' LEU . . . -124.29 110.15 14.25 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.932 -1.136 . . . . 71.409999999999997 107.932 174.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -99.11 105.87 18.01 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.822 -0.807 . . . . 75.319999999999993 108.822 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.8 mm? -116.86 30.65 7.21 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.37 -0.974 . . . . 64.129999999999995 108.37 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 76.8 p -72.0 -8.35 54.0 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.588 0.708 . . . . 75.239999999999995 111.209 -177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.2 p -70.79 -16.12 62.72 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 125.119 1.367 . . . . 60.25 109.89 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.3 t 74.99 -65.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.029 1.732 . . . . 74.030000000000001 111.258 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.1 t 67.54 -73.9 0.08 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.165 0.986 . . . . 71.409999999999997 110.315 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -147.73 133.38 9.4 Favored Pre-proline 0 N--CA 1.434 -1.253 0 N-CA-C 106.09 -1.819 . . . . 72.239999999999995 106.09 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.22 -19.73 50.15 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 121.292 1.328 . . . . 62.439999999999998 110.696 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -86.0 3.48 42.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.07 -0.968 . . . . 74.420000000000002 111.105 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.527 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -85.79 122.29 29.66 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.979 -0.378 . . . . 54.130000000000003 109.979 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.37 139.43 53.28 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.221 -0.659 . . . . 61.32 109.221 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 84.4 t -113.4 113.06 42.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.712 -1.218 . . . . 73.200000000000003 107.712 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 38.5 mt-10 -117.52 123.49 46.4 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-O 120.97 0.414 . . . . 74.310000000000002 110.497 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tt -118.69 128.15 54.24 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.29 -1.744 . . . . 72.200000000000003 106.29 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.3 m -126.24 128.39 47.13 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.064 -0.717 . . . . 73.400000000000006 109.064 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.481 HG12 ' HD2' ' A' ' 143' ' ' PHE . 61.7 t -124.06 125.38 70.71 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.113 -0.699 . . . . 64.230000000000004 109.113 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.17 125.89 54.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.083 -1.08 . . . . 70.040000000000006 108.083 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.644 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.4 p90 -134.36 122.54 16.0 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 112.348 0.499 . . . . 75.219999999999999 112.348 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -70.4 61.19 2.07 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 122.365 2.044 . . . . 73.319999999999993 111.13 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.61 -132.46 0.08 Allowed 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.79 -1.189 . . . . 72.400000000000006 107.79 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -160.3 122.9 3.33 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.166 -1.05 . . . . 64.200000000000003 108.166 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.55 133.21 31.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 109.092 -0.707 . . . . 65.109999999999999 109.092 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.9 p -89.4 -44.43 10.19 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.997 -0.742 . . . . 62.229999999999997 108.997 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.0 m -159.01 133.47 7.9 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.097 -0.502 . . . . 71.420000000000002 109.759 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -138.24 155.25 48.82 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.098 0.475 . . . . 75.150000000000006 110.346 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.475 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 51.1 t-20 -121.6 90.92 3.4 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 104.263 -2.495 . . . . 72.120000000000005 104.263 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 171.96 -161.95 34.03 Favored Glycine 0 N--CA 1.411 -2.997 0 N-CA-C 106.702 -2.559 . . . . 55.140000000000001 106.702 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -100.08 99.75 10.52 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 118.257 1.028 . . . . 71.030000000000001 110.412 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -80.11 107.79 13.18 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-O 121.552 0.691 . . . . 72.239999999999995 110.306 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.0 mt -80.51 -49.1 19.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.533 -1.284 . . . . 64.230000000000004 107.533 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.57 164.7 34.59 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.318 -1.364 . . . . 71.230000000000004 107.318 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.61 -3.5 13.21 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.1 1.866 . . . . 71.519999999999996 111.112 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.644 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.8 pt-20 -131.86 5.87 4.27 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.017 -0.538 . . . . 72.219999999999999 112.386 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.7 t -143.18 121.41 7.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 108.772 -0.825 . . . . 70.209999999999994 108.772 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.75 148.15 32.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.665 -0.495 . . . . 32.310000000000002 109.665 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -133.75 141.12 47.37 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.716 -0.476 . . . . 74.109999999999999 109.716 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.476 ' O ' ' HA ' ' A' ' 138' ' ' GLU . 32.9 m-90 -117.92 119.78 35.87 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.941 -0.762 . . . . 72.230000000000004 108.941 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -109.54 98.32 7.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.154 -1.054 . . . . 65.049999999999997 108.154 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 14.1 mt -98.28 138.89 34.88 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 114.592 -1.185 . . . . 73.530000000000001 108.696 -172.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -117.47 162.48 28.28 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 114.702 1.371 . . . . 73.140000000000001 114.702 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 72.3 Cg_endo -76.18 156.64 37.87 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.363 2.709 . . . . 71.540000000000006 112.43 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.92 -33.54 2.86 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 111.289 -0.724 . . . . 71.140000000000001 111.289 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 166' ' ' PRO . 18.4 m -105.12 148.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 123.688 0.795 . . . . 74.349999999999994 110.131 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.76 113.78 37.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.498 -1.297 . . . . 73.310000000000002 107.498 174.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.6 p -107.62 146.48 31.91 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.909 -0.587 . . . . 74.109999999999999 111.515 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.0 p -103.13 151.68 22.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.861 -0.609 . . . . 72.340000000000003 111.334 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 70.4 mtm -123.22 119.78 31.2 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.24 -1.393 . . . . 74.099999999999994 107.24 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 11.7 t -136.92 135.61 37.91 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.781 -1.192 . . . . 75.049999999999997 107.781 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.03 118.31 5.98 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.353 -0.61 . . . . 60.310000000000002 109.353 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.408 ' HG2' HG22 ' A' ' 120' ' ' ILE . 40.6 mt-30 -122.47 130.66 53.29 Favored 'General case' 0 C--N 1.269 -2.899 0 N-CA-C 106.403 -1.703 . . . . 74.040000000000006 106.403 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.77 148.87 30.47 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.883 -0.327 . . . . 61.439999999999998 110.321 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 15.4 ptt180 -88.08 127.21 35.41 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 120.333 -0.547 . . . . 71.200000000000003 109.94 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.21 152.0 47.96 Favored 'General case' 0 CA--C 1.482 -1.638 0 C-N-CA 120.788 -0.365 . . . . 72.409999999999997 110.1 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.0 p -77.4 120.75 22.84 Favored 'General case' 0 C--N 1.262 -3.233 0 N-CA-C 109.794 -0.447 . . . . 73.540000000000006 109.794 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 117' ' ' ASN . 4.9 m-20 -72.88 123.27 89.38 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.854 -0.612 . . . . 65.420000000000002 110.522 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.76 -28.88 19.87 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 121.766 1.644 . . . . 62.25 109.87 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -84.61 -20.2 31.78 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.938 -1.028 . . . . 65.209999999999994 110.056 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.2 p 57.31 94.86 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.725 1.61 . . . . 73.349999999999994 112.307 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 185' ' ' SER . 71.1 ttt180 -115.33 158.35 22.52 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-O 121.624 0.726 . . . . 74.239999999999995 110.081 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.448 ' N ' ' HG2' ' A' ' 184' ' ' ARG . 50.8 m . . . . . 0 C--N 1.274 -2.706 0 N-CA-C 105.453 -2.055 . . . . 71.519999999999996 105.453 175.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.407 0 N-CA-C 109.633 -1.387 . . . . 65.030000000000001 109.633 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -92.04 -43.71 9.26 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.773 -0.454 . . . . 70.200000000000003 109.773 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 58.93 -79.8 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.097 1.359 . . . . 72.340000000000003 111.584 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -153.9 143.59 21.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.148 -1.056 . . . . 73.530000000000001 108.148 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -82.5 113.59 20.34 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 104.879 -2.267 . . . . 74.040000000000006 104.879 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -84.88 75.37 10.37 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.78 0.8 . . . . 73.450000000000003 112.906 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -83.28 87.71 6.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.412 1.101 . . . . 55.43 108.408 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -107.4 -170.01 1.63 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.681 -1.145 . . . . 64.239999999999995 108.706 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' O ' ' HE3' ' A' ' 51' ' ' LYS . . . -78.83 79.51 1.57 Allowed Glycine 0 C--N 1.306 -1.092 0 N-CA-C 110.872 -0.891 . . . . 73.400000000000006 110.872 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.7 151.02 51.6 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.267 -0.642 . . . . 75.040000000000006 109.267 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.1 ptm -82.11 137.96 34.88 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.228 0.537 . . . . 73.329999999999998 111.388 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' ALA . 1.6 pt? -133.3 119.15 19.39 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.477 -0.783 . . . . 74.319999999999993 109.826 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -107.42 124.36 49.74 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.259 -0.882 . . . . 74.219999999999999 109.285 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.18 114.07 43.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.743 0.782 . . . . 71.230000000000004 109.783 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 41.8 mtp85 -113.63 118.76 35.29 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.493 -0.776 . . . . 75.209999999999994 111.849 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' HB3' ' HG ' ' A' ' 139' ' ' LEU . . . -107.77 108.67 19.98 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.0 -1.111 . . . . 33.119999999999997 108.0 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 140' ' ' THR . 4.2 p -117.39 115.67 25.66 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 109.304 -0.628 . . . . 62.340000000000003 109.304 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 16.7 pt -129.4 149.05 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-O 121.336 0.589 . . . . 73.420000000000002 110.711 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 53.6 m -123.46 124.68 43.42 Favored 'General case' 0 C--N 1.272 -2.792 0 N-CA-C 108.657 -0.868 . . . . 75.510000000000005 108.657 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.2 tt -108.38 109.96 30.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 122.027 0.918 . . . . 65.200000000000003 109.414 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.7 m -76.66 152.12 82.95 Favored Pre-proline 0 N--CA 1.423 -1.796 0 CA-C-N 114.635 -1.166 . . . . 71.099999999999994 109.962 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.23 -3.32 1.18 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 124.112 3.208 . . . . 74.530000000000001 114.438 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 9.7 m-20 -85.84 -0.56 55.66 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 124.175 0.99 . . . . 62.130000000000003 109.853 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 38.2 t0 68.6 34.71 3.43 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 123.781 1.753 . . . . 63.100000000000001 107.536 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -109.82 126.1 53.44 Favored 'General case' 0 N--CA 1.397 -3.121 0 CA-C-N 112.426 -2.17 . . . . 65.340000000000003 107.701 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG11 HD23 ' A' ' 95' ' ' LEU . 10.9 t -104.87 137.22 35.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.337 -0.986 . . . . 75.109999999999999 108.337 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.1 p -143.43 149.05 37.08 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 105.946 -1.872 . . . . 71.040000000000006 105.946 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.54 -169.56 40.02 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 117.626 -2.226 . . . . 72.230000000000004 113.157 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -152.84 142.38 21.79 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.352 0.596 . . . . 73.540000000000006 111.497 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.67 116.82 53.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.869 -1.16 . . . . 72.530000000000001 107.869 174.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.55 114.92 45.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.466 -0.939 . . . . 74.319999999999993 108.466 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.51 108.0 19.12 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.32 -1.733 . . . . 55.210000000000001 106.32 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -125.75 119.92 29.22 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.645 0.736 . . . . 73.340000000000003 111.048 -174.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . . . -111.91 148.0 34.65 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.21 -0.905 . . . . 74.200000000000003 109.247 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -74.88 124.38 89.53 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 105.982 -1.859 . . . . 72.439999999999998 105.982 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -44.7 -76.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.923 3.082 . . . . 44.039999999999999 115.166 -170.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 23' ' ' GLY . 25.8 ttmm 68.65 -51.04 0.57 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.854 1.262 . . . . 63.119999999999997 111.33 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.481 ' ND2' ' HB2' ' A' ' 55' ' ' ASP . 16.8 t30 -77.94 111.94 14.32 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.431 -1.322 . . . . 72.209999999999994 107.431 172.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.3 m -48.74 -35.45 14.19 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.993 1.479 . . . . 73.310000000000002 114.993 -173.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -95.0 -5.04 45.48 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 119.327 -0.949 . . . . 74.530000000000001 112.2 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.481 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 4.0 t0 -91.55 123.89 35.3 Favored 'General case' 0 CA--C 1.492 -1.259 0 C-N-CA 118.879 -1.128 . . . . 75.420000000000002 110.187 -172.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.645 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 16.1 p -113.13 0.67 15.02 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 115.328 -0.851 . . . . 74.150000000000006 111.19 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.406 ' HA2' ' HA2' ' A' ' 82' ' ' GLY . . . 172.55 115.13 0.36 Allowed Glycine 0 N--CA 1.425 -2.048 0 C-N-CA 119.69 -1.243 . . . . 70.140000000000001 113.842 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.581 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 35.0 Cg_exo -66.76 129.37 20.83 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 CA-C-N 119.975 1.887 . . . . 74.420000000000002 108.221 168.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.73 163.22 28.2 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 113.695 0.998 . . . . 62.310000000000002 113.695 -171.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 59.2 mt -124.72 141.24 52.25 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.461 -0.94 . . . . 75.349999999999994 108.461 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -88.28 86.3 7.05 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.875 -0.787 . . . . 52.219999999999999 108.875 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.74 39.47 2.73 Favored Glycine 0 C--N 1.29 -1.986 0 CA-C-N 114.785 -1.098 . . . . 63.310000000000002 111.396 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -94.1 101.3 13.31 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.838 -1.171 . . . . 75.109999999999999 107.838 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.3 m -139.6 163.12 47.25 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 115.395 -0.821 . . . . 63.409999999999997 109.025 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.03 -24.9 51.99 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 122.435 2.09 . . . . 72.540000000000006 111.917 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -99.7 41.45 1.16 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.023 -0.535 . . . . 75.439999999999998 111.176 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p -57.47 -29.3 64.12 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.113 0.783 . . . . 72.439999999999998 113.113 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -72.5 -15.15 61.79 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-O 121.417 0.627 . . . . 75.439999999999998 109.929 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -94.89 -12.77 26.27 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.343 -0.844 . . . . 72.120000000000005 109.927 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 7.1 p -124.07 123.41 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.916 0.865 . . . . 74.530000000000001 112.296 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.43 105.77 16.83 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.212 -0.904 . . . . 72.140000000000001 108.87 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.2 t -98.06 130.16 47.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.066 -1.457 . . . . 71.310000000000002 107.066 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -148.16 172.07 14.89 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.551 -0.537 . . . . 54.119999999999997 109.551 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -87.21 153.25 21.64 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.482 -0.562 . . . . 65.219999999999999 109.482 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 71.7 t80 -123.09 129.57 51.63 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.544 0.738 . . . . 53.140000000000001 109.631 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -138.17 104.06 5.11 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.57 -1.27 . . . . 72.439999999999998 107.57 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 47.8 t -171.84 150.25 2.61 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.569 -0.9 . . . . 55.130000000000003 108.569 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 70.36 8.77 6.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.721 0.808 . . . . 72.340000000000003 111.4 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.77 -0.32 76.52 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 115.414 -0.812 . . . . 75.349999999999994 111.157 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 72.7 m-85 -104.42 146.73 28.43 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.573 -0.529 . . . . 73.299999999999997 109.573 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 56' ' ' THR . 27.4 m -124.18 138.5 53.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.239 -1.023 . . . . 72.439999999999998 108.239 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.581 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -174.91 -155.16 11.95 Favored Glycine 0 CA--C 1.464 -3.12 0 C-N-CA 119.178 -1.487 . . . . 55.350000000000001 112.47 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.402 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 46.7 m -126.03 147.55 49.53 Favored 'General case' 0 C--N 1.274 -2.681 0 CA-C-O 121.145 0.498 . . . . 74.219999999999999 110.081 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -128.5 141.18 51.47 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.918 -0.583 . . . . 71.310000000000002 109.89 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.21 114.34 23.52 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.627 -1.249 . . . . 72.230000000000004 107.627 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.7 t -109.18 111.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.827 -1.175 . . . . 72.329999999999998 107.827 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.7 p90 -113.16 157.78 21.25 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 120.924 0.392 . . . . 73.25 110.606 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 p -154.68 150.6 27.82 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.799 -0.637 . . . . 63.009999999999998 110.81 -174.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.7 t70 61.42 45.99 7.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.864 1.265 . . . . 70.340000000000003 111.819 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.492 HD12 ' CD2' ' A' ' 87' ' ' PHE . 43.3 mt -109.22 169.32 8.76 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.525 -0.761 . . . . 63.030000000000001 109.659 177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 t -128.41 -179.79 5.22 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.85 -0.74 . . . . 73.150000000000006 111.925 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.437 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 55.0 t80 -50.01 -43.87 50.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.784 2.034 . . . . 71.129999999999995 111.406 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.54 -25.59 64.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.779 -0.646 . . . . 61.210000000000001 111.747 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -89.34 -15.18 33.99 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.961 -0.563 . . . . 71.409999999999997 110.628 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.7 tm? -54.12 -56.12 29.36 Favored Pre-proline 0 CA--C 1.569 1.692 0 C-N-CA 123.802 0.841 . . . . 72.219999999999999 111.887 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.59 -35.72 57.58 Favored 'Trans proline' 0 C--N 1.372 1.785 0 CA-C-N 120.912 1.362 . . . . 72.319999999999993 111.08 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -63.03 -40.37 97.54 Favored 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 124.307 1.043 . . . . 74.530000000000001 110.398 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -76.05 -19.88 58.24 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.076 0.465 . . . . 55.100000000000001 109.783 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.1 -22.32 60.58 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.998 -0.546 . . . . 73.120000000000005 110.616 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -56.89 -48.82 77.31 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 109.68 -0.489 . . . . 72.239999999999995 109.68 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.407 ' HE1' HG21 ' A' ' 70' ' ' VAL . 24.4 ttm -53.57 -55.69 23.51 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.958 -1.019 . . . . 61.119999999999997 108.931 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -56.18 -36.58 68.53 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.299 -1.319 . . . . 72.209999999999994 111.622 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.5 m -65.59 -25.36 67.36 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 116.153 -0.476 . . . . 74.510000000000005 111.273 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.88 -27.65 66.87 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-O 121.447 0.642 . . . . 72.219999999999999 109.875 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -112.01 -13.1 13.64 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.823 -0.626 . . . . 64.319999999999993 111.305 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.477 ' HB1' HG23 ' A' ' 108' ' ' VAL . . . -107.17 -48.76 3.4 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.149 1.166 . . . . 51.200000000000003 114.149 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.61 7.0 78.75 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.144 -0.551 . . . . 62.0 112.468 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.477 HG23 ' HB1' ' A' ' 106' ' ' ALA . 61.9 t -81.2 133.96 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.475 -0.935 . . . . 62.140000000000001 108.475 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.47 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 28.7 m-80 -97.41 121.39 39.26 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.029 -1.1 . . . . 71.120000000000005 108.029 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.6 115.42 29.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.635 0.255 . . . . 62.43 110.483 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.3 m -109.49 135.89 49.78 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.656 -0.868 . . . . 65.5 108.656 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.3 tp -139.41 133.48 31.09 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 121.239 -0.184 . . . . 71.049999999999997 111.014 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -142.24 150.84 41.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.134 0.574 . . . . 73.310000000000002 110.654 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.43 HH22 ' CG ' ' A' ' 38' ' ' ASP . 39.5 ttm180 -112.02 135.8 52.2 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.389 -0.967 . . . . 75.019999999999996 108.389 174.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -127.94 93.06 3.59 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.69 -1.226 . . . . 74.349999999999994 107.69 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.408 ' HA2' ' OXT' ' A' ' 185' ' ' SER . . . 68.4 -115.76 6.98 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 115.054 -0.975 . . . . 71.109999999999999 110.808 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.31 -17.81 24.21 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.54 0.686 . . . . 63.030000000000001 109.91 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 0.7 OUTLIER -103.43 148.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 C-N-CA 118.071 -1.452 . . . . 72.420000000000002 109.652 -174.009 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.9 t -120.1 135.78 59.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 110.086 -0.338 . . . . 51.210000000000001 110.086 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 175' ' ' GLN . 44.6 pt -113.56 130.63 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-O 121.719 0.771 . . . . 70.219999999999999 109.966 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.6 tt -125.91 129.64 49.71 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 107.677 -1.231 . . . . 74.409999999999997 107.677 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.76 123.76 24.11 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.824 -0.625 . . . . 54.43 109.567 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -132.76 147.44 18.91 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 110.653 -0.979 . . . . 10.24 110.653 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.28 125.95 27.12 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.539 -0.541 . . . . 74.140000000000001 109.539 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -99.82 109.94 22.33 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.683 -0.689 . . . . 61.340000000000003 110.001 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -99.95 93.22 5.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.276 -0.639 . . . . 74.040000000000006 109.276 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.54 ' O ' HG12 ' A' ' 130' ' ' VAL . 3.6 mm? -121.0 24.28 10.25 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.541 -0.754 . . . . 63.100000000000001 109.197 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.7 p -68.21 -36.92 80.29 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.104 0.478 . . . . 61.210000000000001 111.546 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 m -101.48 20.05 16.75 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.585 -0.734 . . . . 63.229999999999997 111.622 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 127' ' ' LEU . 8.9 p -81.39 139.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.45 -0.944 . . . . 75.319999999999993 108.45 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.9 p -90.28 6.31 43.47 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.723 -0.391 . . . . 43.43 111.525 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.423 ' H ' HG22 ' A' ' 130' ' ' VAL . 45.0 m-20 -113.62 98.9 48.5 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 110.08 -0.341 . . . . 55.200000000000003 110.08 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.74 -12.9 22.13 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.491 2.127 . . . . 63.100000000000001 112.41 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -98.47 18.62 16.16 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.329 0.585 . . . . 75.450000000000003 111.189 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.26 135.52 33.41 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.46 -1.311 . . . . 65.310000000000002 107.46 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -131.62 115.19 15.75 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.596 -0.842 . . . . 74.450000000000003 109.376 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 51.2 t -106.51 122.67 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.428 -0.953 . . . . 70.5 108.428 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 31.9 tt0 -137.86 130.96 30.33 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.143 -0.688 . . . . 74.450000000000003 109.143 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' A' ' 30' ' ' ALA . 6.5 tt -128.88 135.52 49.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.307 -0.627 . . . . 55.020000000000003 109.307 -173.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 12.1 m -127.2 133.95 50.2 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.268 -0.642 . . . . 72.319999999999993 109.268 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.409 HG12 ' HD2' ' A' ' 143' ' ' PHE . 87.2 t -125.8 125.63 68.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.247 -0.649 . . . . 72.439999999999998 109.247 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -110.89 126.83 55.12 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 108.889 -0.782 . . . . 73.040000000000006 108.889 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.575 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.06 105.75 11.43 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 109.305 -0.628 . . . . 71.239999999999995 109.305 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.66 43.64 0.19 Allowed 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 123.521 2.814 . . . . 64.409999999999997 114.139 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.3 -91.25 0.56 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 123.152 0.581 . . . . 71.219999999999999 110.931 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 177.85 123.82 0.04 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.253 0.621 . . . . 41.009999999999998 110.042 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.3 p -80.89 141.81 14.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.688 -0.856 . . . . 73.120000000000005 108.688 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.9 p -99.59 -39.73 8.16 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.561 -0.533 . . . . 74.530000000000001 109.561 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.9 m -161.66 134.07 5.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.813 -0.63 . . . . 74.109999999999999 109.591 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.44 ' OG1' HG11 ' A' ' 160' ' ' VAL . 7.6 t -137.91 149.09 45.92 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.231 0.539 . . . . 72.450000000000003 111.036 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -112.5 87.53 2.6 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 106.518 -1.66 . . . . 74.310000000000002 106.518 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.71 -153.79 22.34 Favored Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 108.036 -2.026 . . . . 74.409999999999997 108.036 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -112.43 106.02 14.42 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 117.522 0.661 . . . . 73.540000000000006 110.751 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -80.05 126.34 30.94 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.736 -0.665 . . . . 75.530000000000001 109.794 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.2 mt -85.69 -42.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.885 -1.524 . . . . 62.409999999999997 106.885 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -135.28 170.02 12.24 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 113.964 -1.471 . . . . 64.239999999999995 107.387 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.98 0.05 8.36 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.295 1.997 . . . . 53.420000000000002 110.841 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.6 pt-20 -131.89 3.55 4.1 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.837 -0.62 . . . . 64.439999999999998 111.803 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.6 t -141.47 121.86 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.688 -0.856 . . . . 72.25 108.688 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.44 HG11 ' OG1' ' A' ' 150' ' ' THR . 40.5 t -127.4 149.15 32.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.739 -0.467 . . . . 71.019999999999996 109.739 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -134.15 144.0 48.27 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.599 -0.519 . . . . 64.420000000000002 109.599 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.469 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.3 m-90 -127.25 135.55 50.77 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.842 -0.617 . . . . 73.209999999999994 111.356 -178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.04 104.96 14.8 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.068 -0.969 . . . . 74.530000000000001 108.686 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 47.1 mt -101.65 119.76 39.28 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.211 -1.033 . . . . 75.209999999999994 108.211 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.488 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 74.3 mmtt -114.24 156.64 44.01 Favored Pre-proline 0 C--N 1.31 -1.149 0 N-CA-C 112.591 0.589 . . . . 73.140000000000001 112.591 -169.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.02 155.97 38.42 Favored 'Trans proline' 0 C--N 1.365 1.426 0 C-N-CA 123.025 2.483 . . . . 73.019999999999996 110.631 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.8 -32.67 2.17 Favored Glycine 0 C--N 1.312 -0.765 0 N-CA-C 112.134 -0.386 . . . . 71.120000000000005 112.134 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.488 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 21.3 m -105.72 161.4 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-O 120.94 0.4 . . . . 63.310000000000002 109.997 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.2 p -106.58 110.43 31.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.795 -1.187 . . . . 71.219999999999999 107.795 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.6 m -97.78 128.88 44.73 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.447 0.641 . . . . 61.43 110.313 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.2 p -101.63 137.87 39.38 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.352 -0.84 . . . . 71.230000000000004 109.991 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.4 ptm -131.62 133.09 44.59 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.718 -0.674 . . . . 73.150000000000006 109.586 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m -143.34 148.8 36.84 Favored 'General case' 0 C--N 1.276 -2.588 0 O-C-N 121.762 -0.586 . . . . 71.120000000000005 109.573 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -150.98 119.71 6.56 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.281 -1.007 . . . . 73.329999999999998 108.281 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.425 ' HG2' HG22 ' A' ' 120' ' ' ILE . 42.1 mt-30 -121.75 130.45 53.43 Favored 'General case' 0 C--N 1.262 -3.231 0 N-CA-C 106.292 -1.744 . . . . 71.530000000000001 106.292 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.14 160.18 41.79 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.548 -0.538 . . . . 41.219999999999999 109.548 -175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 65.0 mtp180 -88.05 125.92 34.82 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.244 -1.021 . . . . 75.319999999999993 108.244 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -123.02 127.69 49.15 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.776 -1.194 . . . . 73.310000000000002 107.776 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.5 p -63.59 107.47 1.16 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.395 -0.82 . . . . 73.5 110.216 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 184' ' ' ARG . 27.7 t70 -65.8 132.06 94.76 Favored Pre-proline 0 CA--C 1.505 -0.784 0 CA-C-N 115.893 -0.594 . . . . 50.420000000000002 110.536 -174.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 38' ' ' ASP . 41.2 Cg_endo -67.89 -46.84 2.17 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 122.68 2.253 . . . . 72.340000000000003 113.292 -177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . 0.285 0.2 OUTLIER -84.36 -7.75 59.21 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 112.842 0.682 . . . . 72.030000000000001 112.842 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 47.6 p 62.25 62.17 1.21 Allowed 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.898 1.279 . . . . 72.450000000000003 112.372 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.428 ' HG3' ' OD2' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -85.24 161.62 19.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.064 -1.425 . . . . 73.349999999999994 112.587 178.383 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.408 ' OXT' ' HA2' ' A' ' 116' ' ' GLY . 15.1 m . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 108.181 -1.044 . . . . 65.230000000000004 108.181 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.365 0 N-CA-C 109.514 -1.434 . . . . 70.109999999999999 109.514 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 61.46 70.96 0.57 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.981 0.912 . . . . 72.129999999999995 109.973 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -93.38 114.45 26.87 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.458 -0.337 . . . . 73.439999999999998 110.367 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -70.57 107.18 3.76 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 106.794 -1.558 . . . . 75.099999999999994 106.794 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.3 mt -69.92 -64.17 0.94 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.703 -0.68 . . . . 70.209999999999994 111.257 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -93.4 88.37 5.93 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.557 -1.275 . . . . 74.150000000000006 107.557 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -75.84 74.4 2.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.759 1.266 . . . . 72.129999999999995 112.839 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -81.92 122.58 27.94 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 113.972 -1.467 . . . . 70.129999999999995 108.455 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.95 73.06 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.866 0 C-N-CA 120.24 -0.981 . . . . 50.229999999999997 111.334 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -134.3 17.72 3.71 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.567 -0.901 . . . . 74.219999999999999 108.567 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -77.91 96.45 5.01 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.923 -1.035 . . . . 73.409999999999997 109.756 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 26' ' ' LEU . 2.4 pt? -113.16 125.44 54.35 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.347 0.594 . . . . 74.340000000000003 110.474 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 136' ' ' ASP . 99.3 mtt180 -114.93 124.57 52.03 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.919 -1.141 . . . . 71.25 107.919 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.13 127.57 72.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.499 0.666 . . . . 62.049999999999997 110.461 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 50.4 mtp85 -122.75 115.41 22.0 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.98 -1.009 . . . . 73.400000000000006 109.268 -178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.51 108.27 19.51 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.172 -1.048 . . . . 35.100000000000001 108.172 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.7 t -108.92 115.74 30.65 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 107.767 -1.197 . . . . 74.319999999999993 107.767 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.419 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.6 pp -129.91 146.07 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 C-N-CA 120.037 -0.665 . . . . 61.520000000000003 109.627 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 61.9 m -122.82 129.39 51.63 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.242 -1.022 . . . . 71.230000000000004 108.242 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -119.27 125.94 74.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.724 0.773 . . . . 74.209999999999994 110.511 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 46.7 m -97.56 142.72 24.99 Favored Pre-proline 0 N--CA 1.415 -2.213 0 CA-C-N 115.2 -0.909 . . . . 71.439999999999998 109.349 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 35' ' ' SER . 52.8 Cg_exo -59.45 2.7 0.24 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 124.104 3.203 . . . . 75.349999999999994 114.095 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.67 1.0 40.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 123.737 0.815 . . . . 51.439999999999998 110.027 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 91' ' ' THR . 11.5 t70 71.96 35.36 1.33 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 105.738 -1.949 . . . . 64.230000000000004 105.738 -176.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 1.7 tp -119.63 126.0 50.11 Favored 'General case' 0 N--CA 1.396 -3.164 0 CA-C-N 113.686 -1.597 . . . . 51.310000000000002 108.443 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.422 HG12 ' HE2' ' A' ' 87' ' ' PHE . 12.6 t -120.44 134.11 64.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.753 -0.832 . . . . 73.400000000000006 108.753 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.0 p -144.61 144.14 31.13 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.422 -0.955 . . . . 74.030000000000001 108.422 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 177.45 -166.68 37.28 Favored Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 119.311 -1.423 . . . . 34.100000000000001 112.065 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -151.94 135.91 16.47 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.48 0.657 . . . . 62.32 111.048 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.9 mt -111.95 116.63 53.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.107 -1.071 . . . . 74.430000000000007 108.107 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.71 114.92 48.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.331 -0.618 . . . . 64.450000000000003 109.331 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.52 108.22 19.43 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.178 -1.786 . . . . 73.409999999999997 106.178 174.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.417 ' HB1' ' CB ' ' A' ' 80' ' ' TYR . . . -122.8 128.28 50.22 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 120.023 -0.671 . . . . 73.310000000000002 112.42 -173.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . . . -116.05 157.48 24.61 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.306 -0.861 . . . . 75.430000000000007 109.509 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -70.32 151.43 95.78 Favored Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 120.353 -0.539 . . . . 74.239999999999995 110.541 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -18.84 -50.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.284 1 C-N-CA 127.378 5.385 . . . . 65.230000000000004 118.293 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER 72.57 -68.79 0.21 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.736 0.814 . . . . 75.099999999999994 110.405 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -155.25 145.07 21.47 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.291 -1.374 . . . . 62.219999999999999 107.291 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.1 m -56.59 -19.85 18.0 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.593 1.331 . . . . 73.230000000000004 114.593 -172.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -80.02 -25.01 40.4 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 122.068 -0.395 . . . . 71.230000000000004 111.885 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.544 ' N ' ' HD3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -77.27 105.05 8.13 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 122.478 1.132 . . . . 60.100000000000001 112.59 -169.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.73 -30.01 19.41 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 113.253 -1.794 . . . . 73.319999999999993 111.458 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 173.0 123.93 0.75 Allowed Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 119.523 -1.322 . . . . 74.310000000000002 113.806 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 83' ' ' SER . 22.6 Cg_exo -68.15 159.28 53.82 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.443 2.095 . . . . 73.219999999999999 109.842 170.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.02 126.32 55.03 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 122.06 -0.4 . . . . 73.030000000000001 111.735 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 90.3 mt -87.34 162.51 17.33 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.812 -0.631 . . . . 74.430000000000007 109.98 175.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -101.88 96.6 7.16 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.762 0.792 . . . . 74.400000000000006 109.197 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -108.77 45.25 1.34 Allowed Glycine 0 C--N 1.288 -2.093 0 CA-C-N 114.609 -1.178 . . . . 34.32 110.327 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -100.05 110.03 22.33 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.141 -0.53 . . . . 74.140000000000001 109.815 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -152.66 169.33 9.78 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 124.738 1.215 . . . . 72.099999999999994 109.088 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.81 -14.87 34.5 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.527 2.151 . . . . 61.140000000000001 112.343 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.41 ' HA ' HE22 ' A' ' 68' ' ' GLN . 43.8 p90 -116.09 29.4 8.0 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.965 -0.561 . . . . 74.409999999999997 111.822 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.5 m -57.86 -27.87 63.63 Favored 'General case' 0 C--O 1.209 -1.03 0 N-CA-C 113.221 0.823 . . . . 74.0 113.221 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.41 HE22 ' HA ' ' A' ' 66' ' ' PHE . 5.4 pm0 -73.12 -8.75 57.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.392 0.615 . . . . 73.230000000000004 110.542 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -99.81 -15.52 18.4 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.696 -0.684 . . . . 72.239999999999995 109.584 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.4 118.84 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 122.154 0.978 . . . . 61.039999999999999 111.951 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.52 120.16 40.63 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.525 -0.761 . . . . 71.5 110.146 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.0 139.75 20.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.96 -0.756 . . . . 54.229999999999997 108.96 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.5 m -148.01 172.19 14.62 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.488 -0.93 . . . . 73.450000000000003 108.488 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 23.0 p-10 -85.88 154.05 21.8 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.389 -0.924 . . . . 71.439999999999998 108.69 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -112.25 120.69 42.61 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.703 -0.851 . . . . 62.25 108.703 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -138.64 98.5 3.58 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.073 -1.454 . . . . 65.200000000000003 107.073 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.9 t -175.41 160.93 2.65 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.021 -1.474 . . . . 50.219999999999999 107.021 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.26 11.7 8.09 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.054 0.941 . . . . 73.439999999999998 111.851 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.97 1.11 87.04 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.967 -0.635 . . . . 72.219999999999999 111.76 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . 97.8 m-85 -104.84 167.41 9.73 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.501 -0.411 . . . . 63.049999999999997 109.988 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -134.33 136.13 53.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.524 -1.287 . . . . 73.510000000000005 107.524 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.07 -154.63 9.17 Favored Glycine 0 C--N 1.276 -2.796 0 C-N-CA 119.634 -1.27 . . . . 54.43 112.514 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.473 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 9.4 p -122.47 147.89 45.8 Favored 'General case' 0 C--N 1.273 -2.747 0 C-N-CA 123.549 0.74 . . . . 73.310000000000002 109.915 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -139.55 143.09 37.2 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.899 -0.501 . . . . 62.130000000000003 110.8 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.91 114.66 20.11 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.28 -1.378 . . . . 63.43 107.28 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.14 121.52 61.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.592 -0.892 . . . . 64.019999999999996 108.592 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.474 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.2 p90 -123.54 155.56 37.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.978 0.418 . . . . 73.299999999999997 111.52 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.0 p -156.7 157.81 35.82 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.831 -0.622 . . . . 71.310000000000002 111.357 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 64.47 31.53 12.44 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.472 1.107 . . . . 64.409999999999997 110.764 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.474 HD12 ' CD2' ' A' ' 87' ' ' PHE . 26.8 mt -93.24 163.89 13.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 121.653 -0.655 . . . . 63.310000000000002 111.026 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 45.0 p -109.46 169.64 8.57 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.397 -0.365 . . . . 75.150000000000006 110.314 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -61.73 -31.7 71.89 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.264 -0.426 . . . . 74.349999999999994 110.548 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.65 -25.7 63.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.969 0.414 . . . . 75.019999999999996 110.957 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.74 -16.79 33.24 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.208 0.447 . . . . 64.340000000000003 112.208 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.6 tt -60.82 -49.48 89.2 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 119.232 -0.413 . . . . 73.329999999999998 111.271 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.81 -35.52 88.33 Favored 'Trans proline' 0 C--N 1.376 1.989 0 CA-C-N 121.038 1.406 . . . . 25.129999999999999 110.707 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.35 -35.78 81.23 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.29 -0.868 . . . . 74.340000000000003 111.601 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -73.11 -18.96 61.24 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 120.941 0.401 . . . . 71.540000000000006 110.671 176.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.02 -19.2 62.54 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.259 -0.428 . . . . 70.230000000000004 110.354 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -65.83 -52.98 45.91 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.183 -1.043 . . . . 62.32 108.183 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.454 ' O ' ' HB3' ' A' ' 104' ' ' ASP . 14.2 mtp -54.15 -52.39 61.26 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.702 -0.681 . . . . 50.539999999999999 109.583 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -56.49 -39.45 73.27 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.11 -0.95 . . . . 74.209999999999994 112.053 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.8 p -70.96 -21.08 62.37 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 119.282 -0.967 . . . . 73.230000000000004 111.198 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 101' ' ' MET . 6.0 t70 -61.72 -27.28 68.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.761 -0.654 . . . . 63.299999999999997 110.46 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.14 -5.41 13.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 116.071 -0.513 . . . . 44.310000000000002 111.117 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.96 -46.17 3.99 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.488 0.921 . . . . 62.350000000000001 113.488 -173.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.98 22.81 58.74 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 120.495 -0.86 . . . . 75.120000000000005 111.284 -174.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -120.39 172.3 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.789 -0.819 . . . . 73.439999999999998 108.789 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.515 ' OD1' ' HB2' ' A' ' 124' ' ' ARG . 3.7 p-10 -132.82 145.41 50.95 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.854 -0.338 . . . . 74.099999999999994 110.667 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.2 112.43 17.05 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.246 -0.65 . . . . 53.329999999999998 109.246 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -115.59 112.56 22.34 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.602 -0.518 . . . . 63.549999999999997 109.602 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -137.4 148.07 45.91 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.597 0.713 . . . . 72.349999999999994 112.007 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -147.53 155.74 42.16 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.417 -1.265 . . . . 73.239999999999995 109.53 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 114' ' ' ARG . 45.3 ttm180 -106.6 131.99 53.11 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 106.891 -1.522 . . . . 72.430000000000007 106.891 172.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -118.2 103.49 9.9 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.765 -1.198 . . . . 60.43 107.765 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.91 -107.08 2.25 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 109.372 -1.491 . . . . 50.140000000000001 109.372 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -122.2 2.96 9.82 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.788 1.28 . . . . 71.400000000000006 108.505 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -107.04 142.92 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 118.74 -1.184 . . . . 62.140000000000001 108.157 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 114' ' ' ARG . 81.9 t -105.9 138.27 31.98 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 O-C-N 122.099 -0.376 . . . . 73.430000000000007 111.175 -176.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.02 131.25 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-N 115.499 -0.773 . . . . 74.340000000000003 109.012 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.4 131.62 48.49 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 115.46 -0.791 . . . . 73.099999999999994 110.296 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -139.95 115.58 10.09 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.781 0.8 . . . . 70.109999999999999 108.908 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -113.19 157.99 14.58 Favored Glycine 0 C--N 1.265 -3.364 0 N-CA-C 107.564 -2.214 . . . . 71.310000000000002 107.564 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.515 ' HB2' ' OD1' ' A' ' 109' ' ' ASN . 98.5 mtt180 -130.72 125.6 34.32 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 118.397 1.099 . . . . 55.140000000000001 109.249 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -118.68 110.33 17.17 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.919 -0.582 . . . . 72.329999999999998 110.206 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -105.57 100.04 9.62 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.154 -1.054 . . . . 65.299999999999997 108.154 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.26 17.65 21.96 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.687 -0.486 . . . . 72.310000000000002 109.687 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.0 p -63.79 -27.07 68.93 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 112.603 0.594 . . . . 50.439999999999998 112.603 -173.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.7 m -75.79 -11.2 59.94 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.02 0.378 . . . . 74.530000000000001 112.02 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.1 t 61.35 101.93 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.661 1.184 . . . . 73.299999999999997 113.907 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.5 m -71.29 -44.75 64.58 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.073 -1.084 . . . . 71.239999999999995 108.073 173.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -166.23 139.24 3.29 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 105.979 -1.86 . . . . 71.409999999999997 105.979 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.33 -23.37 71.95 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.796 2.331 . . . . 70.319999999999993 114.194 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -100.03 9.34 43.03 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 122.132 0.968 . . . . 51.32 110.163 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.45 145.33 26.32 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.92 -1.036 . . . . 74.25 109.895 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.402 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 16.4 m-20 -131.63 141.79 49.71 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.897 0.479 . . . . 74.230000000000004 110.113 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.9 t -120.86 112.79 37.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.429 -1.322 . . . . 75.230000000000004 107.429 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.405 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 38.2 mt-10 -121.41 125.29 46.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.777 -0.453 . . . . 74.549999999999997 109.777 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 tt -118.46 120.48 37.69 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.41 -1.33 . . . . 73.120000000000005 107.41 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.4 m -115.72 126.7 54.42 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.005 -0.739 . . . . 64.299999999999997 109.005 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.444 HG12 ' HD2' ' A' ' 143' ' ' PHE . 92.2 t -122.0 121.25 63.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.544 -0.539 . . . . 75.25 109.544 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.72 128.02 55.96 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.031 -0.729 . . . . 55.200000000000003 109.031 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.559 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.3 p90 -134.25 120.04 14.71 Favored Pre-proline 0 C--N 1.29 -2.005 0 C-N-CA 122.189 0.196 . . . . 72.319999999999993 111.298 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.95 55.65 2.87 Favored 'Trans proline' 0 CA--C 1.551 1.353 0 C-N-CA 122.618 2.212 . . . . 73.349999999999994 111.35 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.45 -110.53 0.15 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.719 -0.673 . . . . 23.129999999999999 110.009 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.1 128.34 0.46 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.856 -0.794 . . . . 75.530000000000001 108.856 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.76 133.85 28.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 109.377 -0.601 . . . . 65.450000000000003 109.377 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.7 p -90.45 -40.12 12.22 Favored 'General case' 0 N--CA 1.42 -1.967 0 C-N-CA 120.359 -0.537 . . . . 41.539999999999999 109.716 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 51.0 m -156.98 132.81 9.48 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 109.002 -0.74 . . . . 73.409999999999997 109.002 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.1 t -139.23 159.59 41.8 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.759 -0.46 . . . . 75.349999999999994 109.759 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 42.9 t30 -132.54 94.43 3.41 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.561 -1.644 . . . . 72.230000000000004 106.561 174.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.08 -136.67 2.92 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 108.643 -1.783 . . . . 63.509999999999998 108.643 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -119.25 99.25 6.59 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.899 -0.778 . . . . 71.430000000000007 108.899 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 154' ' ' ARG . 15.0 ptt180 -77.9 110.42 12.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.701 -0.682 . . . . 73.319999999999993 110.828 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.98 -47.54 20.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.552 -1.277 . . . . 73.200000000000003 107.552 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.37 166.59 25.7 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.185 -1.413 . . . . 70.549999999999997 107.185 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.46 0.52 7.95 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.098 1.865 . . . . 51.210000000000001 111.187 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.7 pt-20 -133.05 4.97 3.82 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 115.593 -0.73 . . . . 72.099999999999994 110.394 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.4 t -144.64 120.73 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.578 -0.897 . . . . 74.409999999999997 108.578 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.01 146.52 30.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.231 -0.655 . . . . 73.329999999999998 109.231 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -126.72 138.58 53.41 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 124.173 0.989 . . . . 73.329999999999998 109.008 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.421 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 31.8 m-90 -119.25 109.45 15.85 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.059 -1.089 . . . . 73.439999999999998 108.059 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -104.44 98.38 8.17 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 122.498 1.142 . . . . 71.439999999999998 109.112 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 19.3 mt -99.14 137.67 37.33 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.562 -1.653 . . . . 73.340000000000003 109.925 -170.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -117.73 153.74 50.79 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 114.905 -1.043 . . . . 65.019999999999996 111.422 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.34 159.11 54.71 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.515 2.143 . . . . 70.129999999999995 111.034 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.16 -34.89 3.18 Favored Glycine 0 C--N 1.303 -1.274 0 C-N-CA 120.964 -0.636 . . . . 72.299999999999997 111.564 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.6 m -105.48 159.23 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.4 0.619 . . . . 70.409999999999997 112.067 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.1 141.22 31.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.153 -1.054 . . . . 53.109999999999999 108.153 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.9 m -150.87 145.77 25.88 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.324 -0.621 . . . . 72.299999999999997 109.324 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.458 HG22 ' HG2' ' A' ' 124' ' ' ARG . 38.5 p -105.29 139.12 40.42 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.597 -0.519 . . . . 74.109999999999999 109.597 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -89.92 116.52 28.05 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.409 -1.7 . . . . 60.32 106.409 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 10.9 t -125.78 135.88 52.52 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 117.946 -1.502 . . . . 71.439999999999998 109.298 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.421 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.49 120.97 6.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.416 -0.957 . . . . 73.25 108.416 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -124.64 131.21 53.48 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.635 -1.246 . . . . 74.540000000000006 107.635 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.12 152.52 26.46 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.467 -0.568 . . . . 61.100000000000001 109.467 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 56.1 mtt180 -87.91 129.94 35.07 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.851 -0.74 . . . . 74.530000000000001 109.217 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -131.93 129.12 39.86 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 107.622 -1.251 . . . . 73.209999999999994 107.622 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.9 p -54.61 104.95 0.13 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 124.485 1.116 . . . . 74.329999999999998 111.954 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.62 141.06 97.71 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.701 -0.681 . . . . 74.530000000000001 109.554 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.06 -47.47 12.5 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.042 1.828 . . . . 73.420000000000002 113.537 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.95 -10.84 54.49 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.9 -0.5 . . . . 73.450000000000003 112.232 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 71.8 p 63.07 93.83 0.05 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.445 1.498 . . . . 70.230000000000004 113.859 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.24 161.04 20.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.916 -0.583 . . . . 54.140000000000001 109.548 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 65.3 m . . . . . 0 C--O 1.26 1.637 0 CA-C-O 117.952 -1.023 . . . . 63.32 109.293 -172.38 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.689 0 N-CA-C 111.825 -0.51 . . . . 43.049999999999997 111.825 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -64.64 113.19 3.57 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.879 0.471 . . . . 74.230000000000004 110.803 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 60.11 29.51 19.07 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.083 0.944 . . . . 74.340000000000003 109.524 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -82.54 -42.1 18.8 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.514 -0.766 . . . . 73.019999999999996 110.271 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.76 117.98 22.04 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.197 -1.038 . . . . 74.120000000000005 108.197 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -70.75 101.13 2.02 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.023 -1.102 . . . . 74.430000000000007 108.023 175.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -54.78 -62.32 1.74 Allowed 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 123.529 0.518 . . . . 73.299999999999997 110.972 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -157.93 141.39 15.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.553 -0.906 . . . . 71.439999999999998 108.553 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.03 55.05 0.71 Allowed Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 109.316 -1.514 . . . . 60.310000000000002 109.316 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.461 ' HB3' ' OD2' ' A' ' 132' ' ' ASP . 87.6 m-70 -135.94 -174.92 3.8 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 123.031 0.533 . . . . 74.219999999999999 111.053 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 62.1 mtt 67.41 92.75 0.08 Allowed 'General case' 0 C--O 1.246 0.888 0 C-N-CA 125.525 1.53 . . . . 65.519999999999996 112.439 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 2.2 pt? -136.74 164.31 28.55 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.501 -0.772 . . . . 75.209999999999994 112.228 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 136' ' ' ASP . 16.1 tpt180 -133.46 124.22 26.66 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.986 -1.857 . . . . 74.319999999999993 105.986 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.14 114.26 41.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.172 -1.047 . . . . 62.549999999999997 108.172 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -129.59 115.18 17.03 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.692 0.758 . . . . 63.329999999999998 110.99 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.51 129.75 55.72 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.692 -1.14 . . . . 63.310000000000002 108.936 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.9 m -131.16 115.2 16.06 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.083 -1.08 . . . . 75.519999999999996 108.083 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.411 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.8 pp -124.35 147.16 28.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 109.804 -0.443 . . . . 73.319999999999993 109.804 -177.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 57.2 m -127.99 124.56 37.51 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 109.11 -0.7 . . . . 62.140000000000001 109.11 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -112.77 119.67 60.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.703 0.764 . . . . 65.409999999999997 110.362 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.5 m -89.43 151.43 46.2 Favored Pre-proline 0 C--N 1.288 -2.098 0 CA-C-N 115.064 -0.971 . . . . 44.240000000000002 109.879 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.85 2.92 0.83 Allowed 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.819 3.013 . . . . 61.030000000000001 113.284 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 17.8 t70 -82.55 -2.65 54.23 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.702 -1.221 . . . . 74.400000000000006 107.702 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.1 t70 72.54 29.91 1.99 Allowed 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.458 -1.682 . . . . 72.230000000000004 106.458 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 1.0 OUTLIER -106.71 138.19 43.35 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 112.728 -2.033 . . . . 74.219999999999999 108.341 -177.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.07 140.67 46.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 109.501 -0.555 . . . . 74.430000000000007 109.501 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -147.74 160.98 42.13 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.09 -1.078 . . . . 61.109999999999999 108.09 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 166.48 -170.03 40.85 Favored Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.067 -1.54 . . . . 64.129999999999995 113.006 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.34 133.68 18.5 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.254 0.55 . . . . 72.420000000000002 109.91 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.01 116.68 52.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.872 -1.159 . . . . 61.310000000000002 107.872 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.14 116.7 53.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 110.319 -0.252 . . . . 64.230000000000004 110.319 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.76 108.03 18.24 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 106.854 -1.535 . . . . 74.340000000000003 106.854 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . . . -118.74 141.79 48.29 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.114 -0.494 . . . . 63.200000000000003 110.234 -175.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.35 158.2 31.6 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.697 -0.853 . . . . 63.109999999999999 108.697 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -74.26 137.29 75.23 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.537 -0.912 . . . . 71.299999999999997 108.537 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -60.35 123.78 13.81 Favored 'Trans proline' 0 C--O 1.251 1.127 0 C-N-CA 122.697 2.264 . . . . 54.210000000000001 111.155 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 18.5 pttm -155.73 139.04 15.72 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.325 -1.731 . . . . 75.430000000000007 106.325 -175.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 70.49 138.68 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 121.728 0.775 . . . . 74.109999999999999 112.965 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -50.6 -34.69 26.9 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 115.912 1.819 . . . . 63.329999999999998 115.912 -172.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -99.3 3.13 46.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.619 -1.232 . . . . 74.239999999999995 112.373 -175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.636 ' HB3' ' O ' ' A' ' 51' ' ' LYS . 29.7 t70 -93.09 100.6 12.98 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.85 -1.14 . . . . 61.399999999999999 113.06 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.571 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 9.2 t -121.44 -7.64 9.19 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 114.148 -1.387 . . . . 60.399999999999999 108.94 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.41 125.33 0.84 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 118.82 -0.989 . . . . 65.0 111.88 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 32.3 Cg_exo -61.4 154.26 60.09 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.069 1.846 . . . . 74.129999999999995 109.836 174.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.38 109.01 16.24 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 111.993 0.368 . . . . 64.109999999999999 111.993 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.3 mt -90.82 124.55 35.24 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.827 -0.749 . . . . 74.319999999999993 110.108 173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.46 99.41 8.19 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.406 -0.816 . . . . 73.129999999999995 110.283 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.96 75.87 0.29 Allowed Glycine 0 C--N 1.29 -2.021 0 CA-C-N 114.96 -1.018 . . . . 72.140000000000001 111.616 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.64 91.36 7.98 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 108.883 -0.784 . . . . 74.129999999999995 108.883 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.4 m -134.83 160.1 69.66 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 107.838 -1.171 . . . . 74.120000000000005 107.838 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.56 -22.74 37.89 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 121.88 1.72 . . . . 71.140000000000001 112.157 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -97.69 40.77 1.15 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.061 -0.518 . . . . 71.209999999999994 112.309 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -56.02 -35.92 67.39 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 123.052 0.541 . . . . 75.430000000000007 110.353 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -64.53 -15.18 60.49 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.55 0.74 . . . . 74.510000000000005 111.635 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -100.7 -17.66 16.87 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 116.082 -0.508 . . . . 72.530000000000001 110.828 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.83 120.09 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 122.022 0.915 . . . . 62.409999999999997 112.273 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.51 112.74 24.9 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.534 -0.757 . . . . 33.140000000000001 109.026 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.16 114.23 39.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.935 -1.135 . . . . 52.420000000000002 107.935 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 168.54 14.57 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.856 -0.794 . . . . 71.430000000000007 108.856 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -84.48 153.76 23.13 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 119.571 -0.852 . . . . 72.310000000000002 109.009 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 83.9 t80 -120.73 124.68 45.73 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 109.837 -0.431 . . . . 73.239999999999995 109.837 -177.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.17 98.14 3.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.982 -1.118 . . . . 55.140000000000001 107.982 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 49.5 m -165.28 164.27 19.96 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.3 -1.37 . . . . 63.43 107.3 -176.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 67.78 6.58 5.15 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 124.64 1.176 . . . . 74.540000000000006 111.946 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.04 5.81 85.55 Favored Glycine 0 C--N 1.314 -0.662 0 N-CA-C 110.065 -1.214 . . . . 73.140000000000001 110.065 -174.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.434 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 3.4 m-85 -105.7 163.1 12.96 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 124.767 1.227 . . . . 70.25 110.927 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 56' ' ' THR . 16.8 m -134.48 136.55 52.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.525 -0.917 . . . . 54.409999999999997 108.525 173.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -169.72 -155.13 9.77 Favored Glycine 0 N--CA 1.423 -2.22 0 C-N-CA 119.855 -1.164 . . . . 71.129999999999995 113.033 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -132.17 140.85 48.89 Favored 'General case' 0 C--N 1.289 -2.056 0 C-N-CA 124.007 0.923 . . . . 72.219999999999999 109.696 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -128.65 146.16 50.95 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 116.274 -0.421 . . . . 62.119999999999997 110.529 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.73 114.42 23.3 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.488 -1.301 . . . . 61.399999999999999 107.488 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.35 122.04 62.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.064 -1.087 . . . . 72.150000000000006 108.064 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -123.07 153.81 39.4 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.006 -0.678 . . . . 71.450000000000003 111.469 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.3 p -156.11 153.52 29.48 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.528 -0.76 . . . . 71.219999999999999 110.728 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 64.33 37.51 8.45 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.328 1.017 . . . . 73.299999999999997 112.876 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 90' ' ' LEU . 34.8 mt -101.02 176.32 5.3 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.169 -0.678 . . . . 70.340000000000003 109.169 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.447 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.8 t -121.76 171.08 9.14 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.369 -0.532 . . . . 73.540000000000006 110.398 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 114' ' ' ARG . 53.9 t80 -50.02 -44.78 51.41 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.751 1.621 . . . . 61.299999999999997 111.517 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.1 -25.63 66.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.63 0.604 . . . . 70.040000000000006 112.63 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' OE1' HG22 ' A' ' 91' ' ' THR . 49.5 mt-10 -85.76 -15.96 40.42 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.164 0.431 . . . . 62.299999999999997 112.164 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.649 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 7.0 tt -55.74 -52.48 71.85 Favored Pre-proline 0 CA--C 1.564 1.5 0 N-CA-C 111.88 0.326 . . . . 62.409999999999997 111.88 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 21.1 Cg_endo -65.1 -29.92 56.12 Favored 'Trans proline' 0 C--N 1.359 1.11 0 CA-C-N 120.6 1.25 . . . . 71.120000000000005 111.7 175.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -69.04 -35.92 77.13 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 123.279 0.631 . . . . 55.210000000000001 110.401 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -77.02 -19.28 57.42 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.351 0.596 . . . . 64.230000000000004 109.495 176.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 96' ' ' PRO . . . -73.19 -17.69 61.34 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.484 -0.78 . . . . 75.400000000000006 109.56 -177.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.04 -54.59 42.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.771 -0.65 . . . . 72.030000000000001 109.591 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 67.5 mtm -54.24 -52.31 61.74 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.82 0.819 . . . . 50.32 109.232 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -54.3 -31.6 54.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.824 -1.535 . . . . 71.120000000000005 111.694 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.8 m -58.46 -33.7 70.04 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 119.304 -0.379 . . . . 71.109999999999999 111.915 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.1 -21.94 66.88 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.438 0.533 . . . . 63.130000000000003 112.438 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.16 -4.9 13.06 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.723 -0.391 . . . . 62.140000000000001 110.629 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.48 -48.27 3.72 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.981 -0.688 . . . . 64.150000000000006 112.697 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.8 28.28 73.21 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 119.94 -1.124 . . . . 71.140000000000001 110.541 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.1 t -122.05 134.6 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 109.039 -0.726 . . . . 73.510000000000005 109.039 -176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -93.55 122.37 35.91 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.087 -0.708 . . . . 72.420000000000002 109.087 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.46 137.2 53.34 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.594 0.59 . . . . 61.240000000000002 112.594 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.4 t -138.01 142.43 40.41 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.151 -1.055 . . . . 72.540000000000006 108.151 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -148.25 127.3 12.82 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.265 -1.013 . . . . 70.129999999999995 108.265 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -144.92 149.41 35.21 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 113.615 0.969 . . . . 71.209999999999994 113.615 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.499 ' HD3' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -101.94 117.28 34.49 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.526 -1.657 . . . . 74.129999999999995 106.526 177.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -109.96 92.7 4.15 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 107.81 -1.182 . . . . 74.329999999999998 107.81 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.92 -114.16 6.19 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 108.845 -1.702 . . . . 33.200000000000003 108.845 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.499 ' OD1' ' HD2' ' A' ' 177' ' ' ARG . 29.4 t-20 -100.33 -14.73 18.27 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.441 0.639 . . . . 64.030000000000001 110.633 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.518 ' HA ' ' CB ' ' A' ' 177' ' ' ARG . 1.3 pp -96.05 146.58 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 C-N-CA 118.978 -1.089 . . . . 64.200000000000003 109.106 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.68 HG21 ' CD2' ' A' ' 178' ' ' TYR . 89.0 t -115.74 141.19 34.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.587 -0.696 . . . . 73.319999999999993 110.391 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.43 HG22 ' HG2' ' A' ' 175' ' ' GLN . 40.0 pt -122.3 140.67 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 115.328 -0.851 . . . . 61.420000000000002 109.493 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.03 127.47 47.93 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 107.636 -1.246 . . . . 74.200000000000003 107.636 172.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -127.92 118.61 23.92 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.715 -1.13 . . . . 71.129999999999995 108.497 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -144.94 133.47 5.16 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.295 -0.955 . . . . 50.409999999999997 111.169 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.48 ' HG2' HG22 ' A' ' 171' ' ' THR . 68.3 mtt85 -120.63 127.02 51.7 Favored 'General case' 0 C--N 1.28 -2.436 0 O-C-N 122.38 -0.482 . . . . 74.129999999999995 110.053 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -117.75 113.61 22.1 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.611 -0.722 . . . . 70.019999999999996 110.024 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -111.74 107.49 16.6 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.617 -1.253 . . . . 60.240000000000002 107.617 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.559 ' O ' HG12 ' A' ' 130' ' ' VAL . 2.7 mm? -111.74 27.28 9.81 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.872 -0.418 . . . . 74.120000000000005 109.872 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.4 p -71.52 -27.8 63.44 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.046 -0.662 . . . . 75.549999999999997 111.885 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.0 m -100.36 10.25 41.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.259 -0.428 . . . . 40.219999999999999 111.391 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 127' ' ' LEU . 8.4 p -73.81 140.15 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 119.62 -0.832 . . . . 70.219999999999999 108.834 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.2 m -86.8 11.92 12.12 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.953 0.406 . . . . 32.229999999999997 111.455 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.461 ' OD2' ' HB3' ' A' ' 24' ' ' HIS . 4.9 m-20 -129.76 100.65 19.16 Favored Pre-proline 0 CA--C 1.489 -1.368 0 N-CA-C 112.249 0.463 . . . . 74.349999999999994 112.249 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -74.78 -15.67 21.21 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.97 1.78 . . . . 74.219999999999999 110.003 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -83.14 -11.77 57.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.392 -1.276 . . . . 51.420000000000002 110.608 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -70.35 142.25 52.17 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.882 -0.599 . . . . 73.209999999999994 110.761 -177.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.451 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 10.1 t70 -132.03 116.31 16.93 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.042 -1.836 . . . . 70.510000000000005 106.042 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.8 t -114.35 136.51 50.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.467 -0.568 . . . . 62.5 109.467 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -133.42 131.66 40.23 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.908 -0.404 . . . . 75.340000000000003 109.908 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -122.67 118.54 28.36 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 106.817 -1.549 . . . . 74.129999999999995 106.817 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.4 m -121.62 133.36 54.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.954 -0.387 . . . . 60.009999999999998 109.954 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.37 124.04 66.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 108.697 -0.853 . . . . 73.439999999999998 108.697 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -115.16 132.51 56.58 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.577 -0.897 . . . . 72.239999999999995 108.577 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.7 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -134.43 120.37 14.69 Favored Pre-proline 0 C--N 1.28 -2.42 0 CA-C-N 116.337 -0.392 . . . . 74.430000000000007 110.147 178.391 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 31.5 Cg_exo -64.92 37.69 0.11 Allowed 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 123.928 3.085 . . . . 73.409999999999997 114.654 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.28 -97.1 0.46 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.302 -0.629 . . . . 44.340000000000003 109.302 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.44 136.81 0.06 Allowed 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.793 -1.188 . . . . 73.340000000000003 107.793 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.31 128.5 38.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.548 -0.538 . . . . 75.540000000000006 109.548 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 43.6 p -88.35 -43.85 11.21 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.686 -0.688 . . . . 75.099999999999994 110.159 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.2 m -150.64 132.51 15.09 Favored 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.4 -0.963 . . . . 71.439999999999998 108.4 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.406 ' OG1' HG11 ' A' ' 160' ' ' VAL . 10.2 t -140.28 152.31 45.8 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.889 -0.724 . . . . 72.409999999999997 111.276 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -123.79 91.16 3.41 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.369 -2.086 . . . . 64.329999999999998 105.369 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.14 -139.35 5.38 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 110.202 -1.159 . . . . 51.020000000000003 110.202 -177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 161' ' ' GLN . 24.3 t70 -115.18 99.57 7.51 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.613 0.721 . . . . 71.230000000000004 110.589 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -84.33 116.35 22.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 116.131 -0.486 . . . . 63.329999999999998 110.808 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.8 mt -93.42 -49.29 12.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.679 -0.86 . . . . 71.510000000000005 108.679 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -126.36 159.58 62.19 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.552 -1.277 . . . . 65.239999999999995 107.552 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.04 -18.61 51.63 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.568 2.179 . . . . 51.509999999999998 111.907 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.7 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.8 OUTLIER -120.22 7.65 10.79 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.842 0.682 . . . . 72.519999999999996 112.842 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.9 t -138.43 121.45 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-O 121.074 0.464 . . . . 71.430000000000007 110.812 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.406 HG11 ' OG1' ' A' ' 150' ' ' THR . 79.7 t -125.04 144.87 33.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.962 -0.563 . . . . 70.140000000000001 109.664 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' A' ' 153' ' ' ASP . 63.1 tt0 -133.57 152.03 51.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.273 -1.01 . . . . 71.040000000000006 108.273 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.533 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.0 m-90 -128.64 123.92 34.47 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 108.42 -0.956 . . . . 74.129999999999995 108.42 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 109.04 20.76 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.813 0.816 . . . . 74.409999999999997 109.983 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 66.1 mt -97.33 126.27 42.45 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.677 -1.147 . . . . 73.010000000000005 109.226 -174.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -115.22 152.19 46.54 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 115.091 -0.959 . . . . 74.319999999999993 112.266 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -68.97 158.44 57.92 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 123.192 2.595 . . . . 74.099999999999994 111.212 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 73.3 -19.82 1.33 Allowed Glycine 0 C--N 1.313 -0.746 0 N-CA-C 114.299 0.48 . . . . 63.119999999999997 114.299 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.4 m -111.63 169.25 4.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.4 0.619 . . . . 54.240000000000002 110.781 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.63 139.61 38.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.142 -1.429 . . . . 74.430000000000007 107.142 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 27.1 m -134.77 134.89 41.4 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.358 0.599 . . . . 64.519999999999996 110.55 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.48 HG22 ' HG2' ' A' ' 124' ' ' ARG . 9.7 p -103.11 126.53 50.33 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.085 -0.961 . . . . 75.219999999999999 108.727 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 56.7 mtm -108.86 126.95 53.6 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.21 -1.033 . . . . 63.509999999999998 108.21 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.9 t -141.65 138.09 32.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.339 -0.986 . . . . 73.420000000000002 108.339 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.458 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -146.03 133.39 20.68 Favored 'General case' 0 CA--C 1.469 -2.16 0 N-CA-C 108.052 -1.092 . . . . 71.310000000000002 108.052 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.43 ' HG2' HG22 ' A' ' 120' ' ' ILE . 39.5 mt-30 -126.89 131.14 51.22 Favored 'General case' 0 C--N 1.263 -3.177 0 N-CA-C 108.039 -1.097 . . . . 74.150000000000006 108.039 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 119' ' ' VAL . . . -159.79 129.45 5.35 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 106.566 -1.642 . . . . 74.209999999999994 106.566 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.518 ' CB ' ' HA ' ' A' ' 118' ' ' ILE . 17.7 ptt180 -88.05 146.86 25.25 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 118.43 -1.308 . . . . 74.319999999999993 110.117 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.68 ' CD2' HG21 ' A' ' 119' ' ' VAL . 19.6 m-30 -119.53 137.05 54.07 Favored 'General case' 0 CA--C 1.465 -2.317 0 N-CA-C 108.187 -1.042 . . . . 74.010000000000005 108.187 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.7 p -71.36 103.82 3.0 Favored 'General case' 0 N--CA 1.394 -3.236 0 CA-C-N 115.269 -0.878 . . . . 65.430000000000007 110.431 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.417 ' HB3' ' ND2' ' A' ' 182' ' ' ASN . 35.4 m-20 -54.02 134.99 58.22 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.13 -0.941 . . . . 75.109999999999999 111.145 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -69.2 -20.97 36.79 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.425 2.75 . . . . 73.400000000000006 111.716 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' ' 180' ' ' ASP . 10.9 p30 -74.19 -21.27 59.89 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 109.227 -0.657 . . . . 62.439999999999998 109.227 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.7 p 51.51 98.1 0.01 OUTLIER 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.275 1.43 . . . . 63.5 113.433 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -120.31 175.83 5.77 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.997 -1.001 . . . . 64.310000000000002 111.599 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 108.189 -1.041 . . . . 64.540000000000006 108.189 -179.027 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.64 0 N-CA-C 110.55 -1.02 . . . . 53.32 110.55 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -81.27 133.4 35.43 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 108.051 -1.092 . . . . 74.099999999999994 108.051 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -143.11 149.68 38.46 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.802 -0.759 . . . . 61.43 109.8 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.7 t30 65.13 91.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.859 1.264 . . . . 54.229999999999997 110.816 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 mp -89.51 81.05 6.59 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.571 -0.741 . . . . 73.109999999999999 110.901 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -86.75 124.64 33.23 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.908 -1.042 . . . . 72.200000000000003 110.508 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.2 t80 53.06 62.16 2.81 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 125.04 1.336 . . . . 71.530000000000001 111.419 -175.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.416 ' OE1' ' HG3' ' A' ' 51' ' ' LYS . 78.6 mm-40 -112.78 31.79 6.12 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.988 -1.486 . . . . 75.219999999999999 106.988 174.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.45 103.29 0.93 Allowed Glycine 0 N--CA 1.424 -2.127 0 CA-C-N 113.045 -1.889 . . . . 75.319999999999993 110.179 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -101.53 -154.83 0.49 Allowed 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 114.442 -0.879 . . . . 74.400000000000006 109.254 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.4 ptp -168.31 133.78 1.81 Allowed 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.598 -2.371 . . . . 72.430000000000007 104.598 172.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 135' ' ' ALA 0.301 0.0 OUTLIER -132.44 144.75 50.7 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 114.044 1.128 . . . . 63.350000000000001 114.044 -177.032 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 -113.15 124.23 52.08 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 114.236 -1.347 . . . . 72.329999999999998 107.741 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.97 114.19 43.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 106.913 -1.514 . . . . 75.150000000000006 106.913 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 22.4 ttt180 -129.32 116.94 19.85 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 121.519 0.676 . . . . 44.119999999999997 110.708 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.35 108.84 20.57 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.26 -1.385 . . . . 73.400000000000006 107.26 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.9 m -113.47 114.16 26.16 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.698 -1.593 . . . . 62.310000000000002 106.698 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.8 pp -131.76 146.07 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 C-N-CA 120.2 -0.6 . . . . 62.229999999999997 109.811 -175.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 87.3 m -126.43 122.49 35.44 Favored 'General case' 0 C--N 1.27 -2.883 0 N-CA-C 109.251 -0.648 . . . . 64.409999999999997 109.251 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 tt -110.93 118.76 58.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.652 0.739 . . . . 60.009999999999998 109.796 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.7 m -89.33 150.78 45.4 Favored Pre-proline 0 N--CA 1.411 -2.411 0 N-CA-C 108.429 -0.952 . . . . 64.319999999999993 108.429 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.03 0.9 0.36 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.792 2.995 . . . . 75.040000000000006 115.135 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 37.3 t70 -83.32 -3.25 57.3 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.783 -0.821 . . . . 72.230000000000004 108.783 176.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 t70 72.77 29.84 1.87 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 105.812 -1.921 . . . . 74.120000000000005 105.812 -173.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 2.4 tp -100.19 124.61 45.83 Favored 'General case' 0 N--CA 1.389 -3.493 0 CA-C-N 113.3 -1.773 . . . . 74.129999999999995 107.354 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG21 ' HG ' ' A' ' 95' ' ' LEU . 14.3 t -116.34 133.08 64.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 109.078 -0.712 . . . . 75.319999999999993 109.078 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.8 p -146.96 157.55 43.66 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.635 -0.876 . . . . 62.539999999999999 108.635 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.3 -165.19 38.68 Favored Glycine 0 N--CA 1.428 -1.855 0 C-N-CA 119.207 -1.473 . . . . 63.229999999999997 112.987 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.55 133.83 21.74 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 123.28 0.632 . . . . 72.329999999999998 109.873 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 102' ' ' ASN . 63.8 mt -116.94 116.01 50.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.892 -1.151 . . . . 72.400000000000006 107.892 176.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.93 126.03 65.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.046 -0.525 . . . . 74.319999999999993 109.829 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -120.72 107.93 13.37 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.282 -1.747 . . . . 70.0 106.282 171.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -120.87 127.51 51.95 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.26 -0.427 . . . . 73.310000000000002 111.003 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.77 148.88 42.35 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 116.48 -0.327 . . . . 45.420000000000002 110.244 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.82 128.88 93.44 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.433 -0.951 . . . . 64.209999999999994 108.433 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -57.95 111.94 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.161 1.907 . . . . 72.540000000000006 110.719 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG3' ' OE1' ' A' ' 22' ' ' GLN . 0.5 OUTLIER -121.51 -32.07 3.9 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.051 0.453 . . . . 75.010000000000005 110.034 -177.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -85.0 130.5 34.61 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.736 -1.209 . . . . 41.530000000000001 107.736 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.4 m -55.41 -43.4 75.24 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 124.119 0.968 . . . . 63.509999999999998 113.222 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -83.97 -7.2 59.47 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.779 0.288 . . . . 71.230000000000004 111.779 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' OD2' ' HD3' ' A' ' 58' ' ' PRO . 35.8 t70 -86.07 125.62 33.58 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 113.639 0.977 . . . . 72.439999999999998 113.639 -168.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -121.58 4.04 10.14 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.649 -1.16 . . . . 72.329999999999998 109.865 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.496 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 172.24 99.01 0.12 Allowed Glycine 0 N--CA 1.431 -1.671 0 CA-C-O 118.69 -1.061 . . . . 61.340000000000003 112.545 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.51 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 31.2 Cg_exo -59.84 128.52 27.1 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 CA-C-N 119.872 1.836 . . . . 71.400000000000006 109.052 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 83' ' ' SER . . . -89.71 151.43 21.85 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.803 0.668 . . . . 72.420000000000002 112.803 -171.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 67.3 mt -82.46 138.97 34.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.828 -0.623 . . . . 71.209999999999994 109.526 174.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -110.6 101.97 10.59 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.633 -1.618 . . . . 72.109999999999999 106.633 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.85 75.13 0.19 Allowed Glycine 0 C--N 1.29 -1.979 0 C-N-CA 120.581 -0.818 . . . . 71.409999999999997 112.857 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.01 112.2 19.55 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.56 -0.533 . . . . 73.409999999999997 109.56 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.43 HG11 ' SD ' ' A' ' 101' ' ' MET . 17.6 m -124.21 157.13 65.35 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 115.939 -0.573 . . . . 71.019999999999996 109.841 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.51 -10.09 27.56 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 122.751 2.3 . . . . 72.239999999999995 112.886 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -110.26 39.46 2.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.388 -0.369 . . . . 64.140000000000001 110.974 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 m -53.68 -32.36 51.39 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.055 0.391 . . . . 43.310000000000002 112.055 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -67.76 -11.88 59.38 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.273 0.559 . . . . 72.5 110.981 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -98.62 -20.61 16.9 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.673 -0.694 . . . . 74.349999999999994 111.071 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.22 119.79 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.731 0.777 . . . . 73.299999999999997 112.155 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 123.28 45.7 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.465 -0.789 . . . . 63.229999999999997 109.075 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.66 130.99 46.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.952 -0.758 . . . . 52.340000000000003 108.952 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 m -132.66 171.98 13.13 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.947 -0.39 . . . . 64.129999999999995 109.947 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.496 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 5.8 t30 -93.03 134.87 34.73 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.051 -1.092 . . . . 73.219999999999999 108.051 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 87.8 t80 -99.96 126.35 46.11 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.946 -0.39 . . . . 75.340000000000003 109.946 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -135.29 101.44 4.84 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.082 -1.081 . . . . 71.409999999999997 108.082 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 47.0 t -173.22 155.85 3.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.939 -1.134 . . . . 71.420000000000002 107.939 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 70.57 6.86 6.0 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.687 1.195 . . . . 73.530000000000001 110.811 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.76 6.0 87.51 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.021 -0.831 . . . . 64.430000000000007 111.021 -173.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.502 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 4.1 m-85 -104.59 148.15 26.83 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.417 0.687 . . . . 73.219999999999999 110.094 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.7 137.45 55.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.833 -0.803 . . . . 73.409999999999997 108.833 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.51 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -167.86 -154.31 8.61 Favored Glycine 0 CA--C 1.458 -3.473 0 N-CA-C 110.555 -1.018 . . . . 71.439999999999998 110.555 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.5 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . 32.7 t -134.19 149.13 50.99 Favored 'General case' 0 C--N 1.26 -3.296 0 N-CA-C 108.656 -0.868 . . . . 73.209999999999994 108.656 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -134.82 133.88 40.25 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 115.618 -0.719 . . . . 73.319999999999993 110.207 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.67 115.61 30.62 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.24 -1.022 . . . . 71.129999999999995 108.24 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.64 116.21 48.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 107.599 -1.26 . . . . 72.530000000000001 107.599 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.5 p90 -120.76 157.04 30.57 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.595 -0.442 . . . . 74.140000000000001 110.609 -175.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.2 m -159.25 157.19 30.16 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.933 -0.576 . . . . 74.430000000000007 110.06 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 64.06 32.85 12.56 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.24 0.963 . . . . 73.439999999999998 112.242 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 87' ' ' PHE . 22.9 mt -90.31 153.26 20.59 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.625 -0.716 . . . . 62.119999999999997 110.503 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.7 p -108.04 172.33 6.89 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.338 -0.846 . . . . 63.299999999999997 109.686 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -60.84 -26.55 67.44 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.183 0.516 . . . . 72.340000000000003 111.007 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.64 -29.5 66.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.534 0.683 . . . . 74.040000000000006 109.847 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HB3' HD22 ' A' ' 90' ' ' LEU . 38.9 mt-10 -93.07 -15.95 25.53 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.315 -0.857 . . . . 74.540000000000006 111.77 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.4 mt -51.98 -52.34 62.62 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 114.008 1.114 . . . . 73.420000000000002 114.008 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -64.54 -34.41 52.82 Favored 'Trans proline' 0 C--N 1.363 1.325 0 CA-C-N 120.624 1.259 . . . . 73.040000000000006 110.31 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -64.26 -38.74 92.11 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.085 -0.962 . . . . 75.129999999999995 111.385 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -70.78 -19.7 62.67 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.091 0.472 . . . . 75.519999999999996 110.601 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.27 -16.07 59.87 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.033 -0.531 . . . . 73.230000000000004 110.643 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -62.32 -57.92 9.58 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 120.8 -0.36 . . . . 74.430000000000007 110.065 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.43 ' SD ' HG11 ' A' ' 64' ' ' VAL . 3.7 mpp? -56.49 -45.74 80.84 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.133 0.492 . . . . 73.420000000000002 109.896 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB2' HD13 ' A' ' 44' ' ' ILE . 27.1 t-20 -52.95 -45.01 67.53 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 114.203 -1.362 . . . . 63.030000000000001 111.386 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.7 p -66.03 -28.3 68.76 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 120.291 -0.564 . . . . 61.539999999999999 110.937 -170.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.1 -26.04 66.51 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.16 0.505 . . . . 65.5 110.597 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.88 -9.81 17.74 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.956 -0.566 . . . . 64.329999999999998 110.594 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.26 -44.75 4.47 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.213 0.82 . . . . 61.119999999999997 113.213 -172.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.39 27.64 35.57 Favored Glycine 0 C--N 1.316 -0.548 0 N-CA-C 110.297 -1.121 . . . . 74.420000000000002 110.297 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.9 m -111.11 168.26 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.389 -0.406 . . . . 73.340000000000003 110.104 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -135.45 124.96 25.0 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.676 -0.861 . . . . 74.140000000000001 108.676 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -119.49 141.07 49.5 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 123.335 0.397 . . . . 72.310000000000002 110.283 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 49.2 m -141.56 116.39 9.79 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.534 -0.913 . . . . 52.210000000000001 108.534 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.72 146.16 51.5 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.137 -0.625 . . . . 75.349999999999994 111.337 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -139.13 154.67 48.15 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.632 -1.167 . . . . 74.340000000000003 109.034 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.451 ' HG3' HG22 ' A' ' 119' ' ' VAL . 4.7 ttt180 -100.25 137.8 38.19 Favored 'General case' 0 N--CA 1.393 -3.309 0 N-CA-C 107.661 -1.237 . . . . 73.239999999999995 107.661 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -123.26 89.36 3.09 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 106.638 -1.615 . . . . 75.510000000000005 106.638 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.71 -118.12 6.91 Favored Glycine 0 N--CA 1.423 -2.224 0 N-CA-C 110.042 -1.223 . . . . 75.109999999999999 110.042 -176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 8.1 t30 -103.96 7.31 36.66 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.086 0.946 . . . . 74.209999999999994 108.925 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 pp -119.33 149.16 21.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 120.799 -1.188 . . . . 72.140000000000001 109.079 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.451 HG22 ' HG3' ' A' ' 114' ' ' ARG . 72.9 t -107.8 137.91 36.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 O-C-N 121.845 -0.534 . . . . 62.140000000000001 110.037 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.0 pt -118.42 132.66 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 109.291 -0.633 . . . . 73.209999999999994 109.291 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 tt -124.61 129.24 50.19 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 115.549 -0.75 . . . . 54.119999999999997 109.438 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.31 124.17 29.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.526 -1.657 . . . . 74.120000000000005 106.526 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -149.58 171.9 29.63 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.392 -0.908 . . . . 74.140000000000001 112.695 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.436 ' HG2' HG22 ' A' ' 171' ' ' THR . 74.2 mtt85 -138.79 153.79 48.43 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.634 0.774 . . . . 71.25 109.365 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.07 109.04 10.2 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.475 -0.935 . . . . 54.450000000000003 108.475 174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -112.6 95.69 5.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.785 0.802 . . . . 74.299999999999997 110.742 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.88 27.97 5.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 123.393 1.568 . . . . 71.340000000000003 107.79 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.0 p -63.95 -25.7 68.26 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.562 -2.108 . . . . 72.310000000000002 112.017 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 p -69.45 -23.72 63.71 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.849 0.86 . . . . 64.099999999999994 111.361 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.9 t 71.21 86.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 125.107 1.363 . . . . 63.450000000000003 111.676 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 p -75.37 -36.39 60.93 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.77 -1.104 . . . . 74.329999999999998 109.09 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -148.77 128.55 6.5 Favored Pre-proline 0 N--CA 1.438 -1.059 0 N-CA-C 107.825 -1.176 . . . . 73.530000000000001 107.825 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.9 -12.59 21.74 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.872 2.381 . . . . 55.32 115.72 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -107.39 -11.79 15.46 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.164 -0.96 . . . . 72.420000000000002 110.186 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -61.33 138.92 58.25 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.82 -1.082 . . . . 64.109999999999999 113.863 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -131.33 130.38 42.65 Favored 'General case' 0 C--O 1.257 1.486 0 N-CA-C 107.784 -1.191 . . . . 61.240000000000002 107.784 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 47.2 t -105.9 112.72 40.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.134 -1.432 . . . . 62.039999999999999 107.134 175.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 37.0 mt-10 -108.19 120.42 42.31 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.081 -0.711 . . . . 75.25 109.081 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 3.0 tt -115.17 122.81 47.18 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 105.976 -1.861 . . . . 70.239999999999995 105.976 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.0 m -126.92 126.01 42.53 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 109.198 -0.667 . . . . 74.340000000000003 109.198 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.471 HG12 ' HD2' ' A' ' 143' ' ' PHE . 57.8 t -120.11 124.03 71.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.961 -0.755 . . . . 60.100000000000001 108.961 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.4 127.36 55.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.706 -0.85 . . . . 75.340000000000003 108.706 177.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.54 121.76 15.34 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 112.187 0.44 . . . . 74.239999999999995 112.187 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.73 46.9 1.11 Allowed 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.997 2.464 . . . . 75.030000000000001 110.809 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -128.36 -106.84 0.3 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.943 -0.571 . . . . 53.149999999999999 109.867 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.59 126.75 0.07 Allowed 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.742 -0.836 . . . . 61.030000000000001 108.742 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.91 135.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.868 -0.79 . . . . 75.540000000000006 108.868 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.4 p -90.5 -42.7 10.7 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 109.459 -0.571 . . . . 65.439999999999998 109.459 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.5 m -159.38 133.12 7.34 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.095 -0.502 . . . . 44.240000000000002 109.963 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.6 t -139.16 157.12 46.5 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 121.987 -0.445 . . . . 70.040000000000006 110.313 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -128.23 95.86 4.29 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.656 -1.979 . . . . 60.439999999999998 105.656 173.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.52 -145.21 8.14 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 107.788 -2.125 . . . . 71.040000000000006 107.788 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -110.61 99.83 8.73 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 118.294 1.047 . . . . 72.230000000000004 110.232 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -78.96 110.45 14.19 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 121.886 0.85 . . . . 63.439999999999998 109.531 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.8 mt -80.39 -38.0 17.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.149 -1.426 . . . . 61.329999999999998 107.149 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.76 163.86 38.08 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.222 -1.77 . . . . 65.450000000000003 106.222 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.09 0.23 7.56 Favored 'Trans proline' 0 N--CA 1.481 0.789 0 C-N-CA 122.588 2.192 . . . . 75.030000000000001 110.846 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.0 pt-20 -128.94 -0.42 5.3 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 114.88 -1.054 . . . . 55.310000000000002 111.297 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.7 t -142.18 120.8 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.547 -0.908 . . . . 73.530000000000001 108.547 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -127.41 143.79 39.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.532 -0.544 . . . . 75.219999999999999 109.532 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 36.1 tt0 -129.93 147.08 51.65 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.373 0.606 . . . . 71.439999999999998 110.17 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.467 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.3 m-90 -123.63 117.86 25.97 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.142 -1.059 . . . . 75.409999999999997 108.142 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -104.07 98.21 8.07 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.752 0.787 . . . . 70.230000000000004 109.407 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 18.3 mt -93.42 130.12 39.34 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.555 -1.202 . . . . 73.319999999999993 109.225 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.2 152.32 50.42 Favored Pre-proline 0 C--N 1.302 -1.468 0 CA-C-N 115.904 -0.589 . . . . 65.120000000000005 111.15 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.68 153.48 73.22 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.329 2.019 . . . . 73.150000000000006 111.06 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.09 -23.96 2.56 Favored Glycine 0 C--N 1.304 -1.201 0 C-N-CA 121.046 -0.597 . . . . 71.5 113.842 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.1 m -104.45 147.78 10.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.223 0.535 . . . . 74.109999999999999 110.698 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 82.6 t -85.38 127.9 39.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.584 -0.735 . . . . 74.099999999999994 109.504 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 10.1 p -138.44 133.07 32.31 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-O 121.424 0.63 . . . . 72.329999999999998 111.715 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 124' ' ' ARG . 21.3 p -114.83 147.38 39.93 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 108.614 -0.884 . . . . 62.299999999999997 108.614 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.405 ' SD ' HD11 ' A' ' 164' ' ' LEU . 70.2 mtm -120.5 133.31 55.42 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.645 -0.502 . . . . 73.319999999999993 109.645 -176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.9 t -143.02 137.06 29.01 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.313 -0.625 . . . . 72.409999999999997 109.313 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.467 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -148.12 118.71 7.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.943 -0.762 . . . . 72.540000000000006 108.943 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -122.75 130.97 53.55 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 106.62 -1.622 . . . . 74.5 106.62 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.44 160.93 41.89 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.035 0.21 . . . . 50.020000000000003 111.261 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.8 mtt-85 -87.39 127.29 35.21 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.862 -0.422 . . . . 72.430000000000007 109.862 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -143.5 119.54 10.7 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 117.757 0.253 . . . . 72.040000000000006 110.529 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.556 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -58.63 119.42 7.04 Favored 'General case' 0 C--N 1.288 -2.1 0 O-C-N 124.226 0.954 . . . . 75.209999999999994 112.423 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.8 136.87 70.09 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.56 -0.746 . . . . 63.200000000000003 109.894 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.3 -41.87 11.5 Favored 'Trans proline' 0 CA--C 1.555 1.575 0 C-N-CA 122.688 2.259 . . . . 71.400000000000006 114.372 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -84.89 -12.14 54.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.62 -0.675 . . . . 64.019999999999996 109.278 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.29 45.2 p 70.6 95.62 0.07 Allowed 'General case' 0 C--O 1.242 0.688 0 C-N-CA 126.535 1.934 . . . . 75.310000000000002 114.806 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -131.81 151.35 51.73 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.726 -1.124 . . . . 73.510000000000005 108.039 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.315 -0.933 0 C-N-CA 123.873 0.869 . . . . 71.040000000000006 110.326 177.839 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.665 0 N-CA-C 110.25 -1.14 . . . . 44.350000000000001 110.25 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 67.09 12.75 9.15 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.66 1.184 . . . . 62.350000000000001 112.239 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -107.56 85.17 2.08 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.638 -0.875 . . . . 71.230000000000004 108.638 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -112.27 108.21 17.34 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 107.154 -1.424 . . . . 74.25 107.154 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.2 pt? -89.39 4.61 48.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.129 0.49 . . . . 74.200000000000003 111.497 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -82.52 127.62 33.5 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.81 -1.181 . . . . 71.439999999999998 107.81 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.46 ' HB2' ' CG ' ' A' ' 134' ' ' ASP . 19.0 p90 -114.84 -176.59 2.93 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.989 -0.551 . . . . 73.25 111.021 -176.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.52 -55.46 10.12 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 120.789 -0.364 . . . . 63.350000000000001 110.494 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.55 20.09 0.03 OUTLIER Glycine 0 C--O 1.25 1.147 0 C-N-CA 118.262 -1.923 . . . . 71.540000000000006 114.842 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.644 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -146.24 -175.13 4.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.57 -0.9 . . . . 63.450000000000003 108.57 179.105 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.8 mtt -139.42 115.78 10.52 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.43 -0.952 . . . . 52.399999999999999 108.43 170.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.8 tt -106.63 107.23 18.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.145 -1.798 . . . . 72.420000000000002 106.145 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -104.66 123.24 47.24 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.348 -1.353 . . . . 71.450000000000003 107.348 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.57 114.69 39.06 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 CA-C-O 121.876 0.846 . . . . 74.140000000000001 109.436 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 61.7 mtp85 -119.22 116.69 26.81 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.549 -1.205 . . . . 73.239999999999995 110.345 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -103.66 109.52 21.24 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.769 -1.197 . . . . 62.439999999999998 107.769 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 m -114.8 115.42 26.98 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.767 -0.827 . . . . 65.150000000000006 108.767 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -129.0 141.68 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 N-CA-C 108.892 -0.781 . . . . 53.43 108.892 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.2 m -121.39 120.94 36.47 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.652 -0.87 . . . . 73.200000000000003 108.652 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.425 HG23 ' HB3' ' A' ' 143' ' ' PHE . 9.5 tt -105.44 120.79 56.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 121.657 0.741 . . . . 74.200000000000003 109.822 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.4 m -84.17 155.92 63.5 Favored Pre-proline 0 C--N 1.295 -1.782 0 CA-C-N 115.177 -0.92 . . . . 52.0 108.974 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.68 2.1 3.79 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.927 2.418 . . . . 75.129999999999995 112.531 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -89.36 2.35 54.54 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 124.635 1.174 . . . . 62.509999999999998 109.524 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.8 t70 69.21 29.4 4.64 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 123.664 1.697 . . . . 74.219999999999999 107.622 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.36 125.47 52.4 Favored 'General case' 0 N--CA 1.393 -3.299 0 CA-C-N 113.032 -1.894 . . . . 73.239999999999995 107.471 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.5 HG11 HD21 ' A' ' 95' ' ' LEU . 13.1 t -113.52 134.07 57.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 115.902 -0.59 . . . . 74.530000000000001 109.535 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.2 p -140.96 128.67 21.55 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.56 -1.274 . . . . 71.450000000000003 107.56 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.67 -171.9 30.49 Favored Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 119.487 -1.34 . . . . 61.109999999999999 112.648 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -149.21 133.67 17.57 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.173 -0.677 . . . . 64.540000000000006 109.173 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 58.4 mt -111.72 115.33 49.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 106.918 -1.512 . . . . 72.120000000000005 106.918 176.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.39 114.22 46.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.357 -0.609 . . . . 74.209999999999994 109.357 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -106.61 107.68 18.82 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.814 -1.921 . . . . 73.409999999999997 105.814 172.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.64 116.93 24.66 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.7 0.762 . . . . 51.520000000000003 110.064 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.65 139.91 50.37 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.534 -0.757 . . . . 73.329999999999998 111.304 -174.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.644 ' HD3' ' HA ' ' A' ' 24' ' ' HIS . 79.7 tttt -60.77 127.23 86.96 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 104.604 -2.369 . . . . 74.340000000000003 104.604 168.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -35.65 97.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 124.154 3.236 . . . . 63.039999999999999 114.463 -173.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -83.17 -35.11 25.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.637 -1.165 . . . . 72.129999999999995 110.164 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.49 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 48.8 t-20 -124.72 123.63 40.43 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.257 -1.757 . . . . 65.049999999999997 106.257 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.6 m -61.62 -18.64 60.28 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 114.113 1.153 . . . . 73.310000000000002 114.113 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.49 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 20.8 pttp -80.88 -16.23 54.19 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.623 -0.831 . . . . 75.439999999999998 110.151 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -96.7 113.47 25.03 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-O 121.735 0.778 . . . . 74.530000000000001 112.979 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 p -90.32 3.35 53.92 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.541 -1.209 . . . . 61.43 108.049 172.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.8 96.6 0.1 Allowed Glycine 0 N--CA 1.42 -2.38 0 CA-C-N 113.474 -1.693 . . . . 44.140000000000001 109.295 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 49.2 Cg_exo -55.88 128.95 32.39 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.563 2.175 . . . . 73.019999999999996 110.569 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.577 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -85.21 159.86 20.02 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.618 0.97 . . . . 71.010000000000005 113.618 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 80.3 mt -107.98 127.51 53.83 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 108.035 -1.098 . . . . 74.510000000000005 108.035 174.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -112.94 97.64 6.66 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.009 0.433 . . . . 75.099999999999994 111.174 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.62 136.06 8.64 Favored Glycine 0 C--N 1.284 -2.327 0 N-CA-C 110.788 -0.925 . . . . 62.25 110.788 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.57 120.54 38.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.264 0.554 . . . . 64.230000000000004 111.184 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 m -137.81 161.47 59.89 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.531 -0.759 . . . . 62.310000000000002 109.063 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.8 -22.05 24.15 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.155 1.903 . . . . 53.539999999999999 111.768 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -100.37 42.52 1.11 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.771 -0.65 . . . . 71.140000000000001 111.593 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 m -54.03 -36.56 63.17 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.475 0.71 . . . . 62.509999999999998 111.489 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -69.55 -13.68 62.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.541 0.686 . . . . 73.230000000000004 110.289 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.71 -12.77 21.96 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.431 -0.804 . . . . 74.420000000000002 110.434 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.8 119.46 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 122.303 1.049 . . . . 72.120000000000005 111.595 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.58 112.99 26.16 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.179 -0.919 . . . . 75.150000000000006 109.873 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.7 p -98.0 133.11 41.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.25 -1.018 . . . . 61.109999999999999 108.25 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.6 m -147.46 163.24 37.15 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.266 -1.013 . . . . 74.349999999999994 108.266 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -76.87 143.42 39.68 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.473 0.654 . . . . 73.439999999999998 110.808 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 73.4 t80 -108.3 123.09 48.27 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.552 -1.277 . . . . 61.030000000000001 107.552 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -138.25 99.17 3.79 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 107.659 -1.237 . . . . 74.150000000000006 107.659 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 65.2 m -162.5 149.15 13.12 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.865 -1.161 . . . . 75.420000000000002 107.865 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 69.73 4.41 4.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.876 0.87 . . . . 62.039999999999999 113.316 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.55 4.76 65.58 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.998 -0.841 . . . . 24.300000000000001 110.998 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -104.93 142.34 34.94 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.297 -1.001 . . . . 62.43 108.297 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.4 m -124.38 136.45 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 121.544 0.688 . . . . 64.129999999999995 109.481 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -173.44 -153.41 9.61 Favored Glycine 0 CA--C 1.461 -3.331 0 N-CA-C 110.088 -1.205 . . . . 75.530000000000001 110.088 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.577 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 62.9 m -134.95 149.85 50.29 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 121.506 0.67 . . . . 74.099999999999994 111.485 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 10.5 pt20 -124.58 132.14 53.45 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.873 -1.058 . . . . 75.129999999999995 109.576 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.04 113.95 27.65 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.584 -1.636 . . . . 73.109999999999999 106.584 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.69 112.74 41.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.374 -0.973 . . . . 72.340000000000003 108.374 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.532 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.5 p90 -115.71 153.68 30.92 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.978 -0.556 . . . . 72.230000000000004 110.954 -175.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -154.85 158.16 38.95 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.581 -0.736 . . . . 54.43 111.297 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 65.15 30.88 11.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 122.568 1.175 . . . . 71.450000000000003 110.824 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.532 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.4 mt -96.08 164.23 12.78 Favored 'General case' 0 N--CA 1.426 -1.628 0 O-C-N 121.275 -0.891 . . . . 71.109999999999999 111.11 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -115.22 171.34 7.75 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 116.254 -0.43 . . . . 63.039999999999999 110.686 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -57.0 -36.79 70.81 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.031 0.443 . . . . 55.109999999999999 110.181 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.05 70.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.686 -0.688 . . . . 74.409999999999997 111.019 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.87 -16.08 39.77 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 112.593 0.59 . . . . 73.400000000000006 112.593 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.5 HD21 HG11 ' A' ' 40' ' ' VAL . 17.1 mt -52.56 -53.4 54.15 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 114.322 1.23 . . . . 70.319999999999993 114.322 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.08 -42.29 44.93 Favored 'Trans proline' 0 C--N 1.369 1.607 0 CA-C-N 120.57 1.239 . . . . 72.450000000000003 110.497 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -60.08 -39.72 87.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.317 -0.856 . . . . 73.129999999999995 111.76 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -78.34 -21.86 48.89 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 120.745 -0.382 . . . . 74.549999999999997 110.728 177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.84 -26.85 61.63 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.148 -0.686 . . . . 63.039999999999999 109.148 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -57.73 -54.33 48.12 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.318 -0.855 . . . . 73.540000000000006 109.909 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.1 mtm -54.11 -49.98 67.91 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.205 0.526 . . . . 72.430000000000007 110.313 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -55.36 -37.27 67.3 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.402 -1.272 . . . . 74.340000000000003 110.117 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.7 m -60.72 -32.89 72.13 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.503 -0.317 . . . . 73.439999999999998 111.092 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -68.82 -15.63 63.55 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.531 0.682 . . . . 75.219999999999999 111.557 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.15 -11.95 12.59 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.202 -0.454 . . . . 51.409999999999997 110.607 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.52 -47.53 3.75 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.658 0.984 . . . . 72.25 113.658 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.86 22.09 77.48 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.454 -1.058 . . . . 51.100000000000001 110.454 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.3 t -111.93 143.89 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.127 0.971 . . . . 74.140000000000001 108.576 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -102.18 131.38 48.74 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.052 -0.351 . . . . 75.219999999999999 110.052 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.19 104.84 7.3 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.39 -0.967 . . . . 52.439999999999998 108.39 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.5 m -117.58 137.6 52.49 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.607 -0.886 . . . . 74.099999999999994 108.607 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -147.96 149.28 31.88 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.94 -0.704 . . . . 63.049999999999997 112.449 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -148.39 163.07 38.21 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.039 -0.982 . . . . 75.329999999999998 111.001 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.501 ' HG2' HG22 ' A' ' 119' ' ' VAL . 45.8 mtt85 -102.57 139.76 37.75 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.029 0.443 . . . . 64.530000000000001 110.315 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -121.7 83.71 2.13 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.983 -1.488 . . . . 74.219999999999999 106.983 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.95 -115.7 8.25 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.971 -1.013 . . . . 72.019999999999996 110.697 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -85.08 -20.27 30.63 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.504 0.668 . . . . 74.519999999999996 110.929 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.2 pp -102.64 148.71 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 C-N-CA 118.088 -1.445 . . . . 53.140000000000001 109.174 -175.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.501 HG22 ' HG2' ' A' ' 114' ' ' ARG . 92.8 t -116.81 140.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 O-C-N 122.008 -0.432 . . . . 72.150000000000006 110.054 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.43 HG22 ' HG2' ' A' ' 175' ' ' GLN . 44.3 pt -117.35 138.11 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 115.972 -0.558 . . . . 70.430000000000007 110.088 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 174' ' ' ALA . 7.3 tt -127.3 127.94 45.15 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.143 -1.058 . . . . 71.409999999999997 108.143 175.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -128.26 117.95 22.41 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.485 -0.932 . . . . 60.140000000000001 108.485 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.13 169.57 25.31 Favored Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 121.059 -0.591 . . . . 64.099999999999994 112.201 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -151.05 153.24 34.72 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.19 -0.67 . . . . 74.25 109.19 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -135.57 108.62 7.67 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.634 -0.876 . . . . 74.319999999999993 108.634 171.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -113.11 97.24 6.38 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.933 0.873 . . . . 74.519999999999996 110.994 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.76 34.74 4.59 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.448 -1.251 . . . . 71.409999999999997 108.193 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.4 p -66.44 -32.73 74.29 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.143 0.794 . . . . 75.450000000000003 113.143 -175.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.1 m -99.69 18.39 18.23 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.085 0.402 . . . . 52.119999999999997 112.085 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.581 HG11 ' CB ' ' A' ' 166' ' ' PRO . 5.2 p -66.61 158.09 5.43 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 N-CA-C 110.141 -0.318 . . . . 75.109999999999999 110.141 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.6 p -87.4 -47.13 9.02 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 120.775 0.322 . . . . 72.219999999999999 110.371 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -96.9 108.72 45.1 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 123.85 0.86 . . . . 74.450000000000003 112.588 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.68 -11.24 18.54 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.811 3.007 . . . . 73.150000000000006 113.315 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 24' ' ' HIS . 0.5 OUTLIER -80.19 15.32 1.58 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 115.133 1.531 . . . . 74.420000000000002 115.133 -171.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.17 135.89 40.91 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.894 -1.048 . . . . 74.430000000000007 108.714 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -131.39 130.48 42.65 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 118.089 0.404 . . . . 74.319999999999993 110.419 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 46.5 t -115.91 126.9 73.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.311 -0.626 . . . . 62.409999999999997 109.311 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 162' ' ' TRP . 50.6 mt-10 -128.65 133.06 48.14 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.962 0.41 . . . . 63.149999999999999 110.179 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 52.2 tp -114.44 121.43 43.54 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.683 -0.858 . . . . 50.350000000000001 108.683 174.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.3 m -115.8 108.82 16.81 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.988 -1.116 . . . . 73.420000000000002 107.988 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.1 t -107.92 123.59 63.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.727 -0.472 . . . . 72.230000000000004 109.727 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.16 127.07 55.83 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.318 -0.623 . . . . 62.0 109.318 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.06 120.42 15.12 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 116.38 -0.373 . . . . 71.25 111.79 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 16.1 Cg_exo -72.83 45.26 0.87 Allowed 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 122.866 2.378 . . . . 73.040000000000006 111.729 175.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -123.36 -95.59 0.47 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 119.18 -0.438 . . . . 70.329999999999998 110.869 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 173.19 123.63 0.02 OUTLIER 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.502 0.721 . . . . 51.509999999999998 109.361 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -80.28 130.58 35.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.434 -0.95 . . . . 71.319999999999993 108.434 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.3 p -88.15 -39.79 14.26 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.831 -0.433 . . . . 71.510000000000005 109.831 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.6 m -163.17 132.9 4.25 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 123.633 0.773 . . . . 73.040000000000006 109.156 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -138.38 154.37 48.93 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.983 -0.448 . . . . 73.120000000000005 110.971 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 28.9 t-20 -121.31 94.89 4.48 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.029 -1.841 . . . . 72.120000000000005 106.029 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.24 -149.75 10.08 Favored Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 107.852 -2.099 . . . . 62.109999999999999 107.852 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -117.74 99.89 7.24 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.416 -1.327 . . . . 73.019999999999996 107.416 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -81.12 132.27 35.35 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 120.113 -0.635 . . . . 73.340000000000003 110.565 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.64 -43.17 14.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.309 -1.367 . . . . 72.549999999999997 107.309 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -136.92 170.43 10.8 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.01 -1.478 . . . . 72.099999999999994 107.01 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -72.15 0.77 6.79 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.583 2.188 . . . . 45.439999999999998 110.985 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.5 pt-20 -130.33 -0.13 4.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.532 -0.758 . . . . 71.239999999999995 111.467 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 88.8 t -141.58 121.06 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.461 -0.94 . . . . 73.140000000000001 108.461 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.06 146.63 33.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 109.578 -0.526 . . . . 63.43 109.578 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 29.2 tt0 -134.01 136.74 44.29 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 121.612 0.72 . . . . 73.239999999999995 110.937 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 32.2 m-90 -112.62 125.83 54.71 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.593 -0.73 . . . . 65.109999999999999 109.953 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -104.6 99.21 8.88 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.36 -0.978 . . . . 75.040000000000006 108.36 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 1.8 mm? -95.89 121.84 38.06 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.701 -0.851 . . . . 71.549999999999997 108.701 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 59.3 mttm -116.25 151.04 46.32 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 115.394 -0.821 . . . . 73.120000000000005 110.991 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.581 ' CB ' HG11 ' A' ' 130' ' ' VAL . 7.7 Cg_exo -76.48 162.83 32.89 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.032 2.488 . . . . 70.439999999999998 109.836 173.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.45 -40.12 2.94 Favored Glycine 0 C--O 1.245 0.802 0 N-CA-C 111.145 -0.782 . . . . 62.240000000000002 111.145 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.33 158.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 123.043 0.537 . . . . 53.229999999999997 109.61 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -109.56 136.98 43.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.836 -1.172 . . . . 63.530000000000001 107.836 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.7 t -137.71 141.28 41.04 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 119.363 -0.935 . . . . 62.329999999999998 111.093 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.3 p -99.76 145.85 27.22 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.393 -1.276 . . . . 54.530000000000001 109.303 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 82.8 mtp -121.81 119.93 33.11 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.091 -1.077 . . . . 65.049999999999997 108.091 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 30.4 t -133.76 138.79 45.95 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.914 -1.143 . . . . 62.329999999999998 107.914 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.553 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.97 116.35 5.03 Favored 'General case' 0 CA--C 1.471 -2.093 0 N-CA-C 108.926 -0.768 . . . . 44.210000000000001 108.926 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.43 ' HG2' HG22 ' A' ' 120' ' ' ILE . 49.1 mt-30 -121.83 130.31 53.28 Favored 'General case' 0 C--N 1.263 -3.187 0 N-CA-C 106.916 -1.513 . . . . 62.450000000000003 106.916 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -149.45 149.84 31.43 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.145 -1.058 . . . . 72.219999999999999 108.145 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 7.3 ppt_? -93.45 145.82 24.21 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.578 -0.849 . . . . 74.310000000000002 109.237 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.418 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 96.4 m-85 -139.72 152.34 46.58 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.723 -0.843 . . . . 72.409999999999997 108.723 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.32 93.57 2.4 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 109.693 -0.484 . . . . 53.530000000000001 109.693 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.408 ' OD2' ' HG2' ' A' ' 184' ' ' ARG . 29.2 t0 -55.82 121.65 41.32 Favored Pre-proline 0 CA--C 1.5 -0.975 0 CA-C-N 114.548 -1.205 . . . . 63.240000000000002 108.961 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.94 -37.75 18.71 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.117 1.878 . . . . 71.439999999999998 112.819 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -85.34 -17.75 35.85 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.857 -0.611 . . . . 74.510000000000005 111.738 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.254 15.7 p 56.83 70.74 0.62 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 114.032 1.123 . . . . 54.350000000000001 114.032 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.408 ' HG2' ' OD2' ' A' ' 180' ' ' ASP . 14.3 ptm180 -101.87 -179.51 4.03 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.006 -0.997 . . . . 73.519999999999996 110.036 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 C--N 1.293 -1.865 0 N-CA-C 106.939 -1.504 . . . . 62.509999999999998 106.939 173.533 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.735 0 N-CA-C 110.145 -1.182 . . . . 62.210000000000001 110.145 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.534 ' HD2' ' H ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -90.27 36.64 0.88 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 117.052 0.426 . . . . 74.129999999999995 111.339 -175.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -75.32 105.34 6.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.681 -0.488 . . . . 73.5 109.681 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -121.14 75.83 1.18 Allowed 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.139 -1.43 . . . . 74.140000000000001 107.139 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.3 tp -83.95 83.11 8.06 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.541 -1.209 . . . . 74.409999999999997 109.54 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -101.08 -16.96 16.91 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.388 -1.278 . . . . 73.099999999999994 110.168 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.72 101.21 13.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.131 0.789 . . . . 73.439999999999998 113.131 -175.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -89.41 -167.53 1.89 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.607 -1.179 . . . . 75.310000000000002 107.841 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.66 36.38 9.47 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 120.128 -1.034 . . . . 62.229999999999997 110.885 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -81.85 140.22 34.26 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.521 -0.471 . . . . 72.519999999999996 111.033 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.52 98.91 4.08 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.197 -1.408 . . . . 63.420000000000002 107.197 175.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 52.4 tp -101.65 122.56 44.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.674 -1.148 . . . . 64.200000000000003 109.116 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -121.69 124.04 43.31 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 107.968 -1.123 . . . . 74.540000000000006 107.968 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 47.6 t -120.05 114.49 44.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.692 -1.225 . . . . 74.120000000000005 107.692 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -118.01 114.1 22.64 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.955 -0.757 . . . . 74.150000000000006 108.955 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.4 108.96 20.55 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 107.799 -1.186 . . . . 51.240000000000002 107.799 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 m -113.58 114.67 26.79 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.433 -1.321 . . . . 62.509999999999998 107.433 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -125.43 146.57 30.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.061 -0.718 . . . . 60.310000000000002 109.061 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 43.6 m -129.63 123.43 31.22 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-O 121.197 0.523 . . . . 60.030000000000001 109.635 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 tt -112.77 121.1 64.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.652 0.739 . . . . 74.129999999999995 110.594 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -86.69 154.04 55.75 Favored Pre-proline 0 N--CA 1.425 -1.696 0 CA-C-N 115.178 -0.919 . . . . 71.25 109.517 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.76 2.64 1.91 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.134 2.556 . . . . 73.340000000000003 113.052 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -88.74 1.94 54.28 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.93 -1.137 . . . . 72.099999999999994 107.93 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 71.43 29.73 2.65 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 123.314 1.531 . . . . 71.019999999999996 107.811 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.91 128.33 53.11 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 112.938 -1.937 . . . . 74.120000000000005 107.772 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.44 138.11 49.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.424 -0.584 . . . . 52.140000000000001 109.424 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 p -142.32 163.45 32.8 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.518 -1.29 . . . . 75.140000000000001 107.518 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.77 -171.79 43.94 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.534 -1.793 . . . . 64.040000000000006 113.407 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -148.05 133.4 18.53 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 123.855 0.862 . . . . 60.530000000000001 108.915 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.32 115.83 47.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.416 -1.327 . . . . 64.450000000000003 107.416 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 2.3 mp -115.42 114.86 47.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.61 -0.515 . . . . 73.109999999999999 109.61 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.85 108.13 17.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.874 -1.528 . . . . 73.519999999999996 106.874 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -122.56 128.6 50.94 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 120.799 -0.361 . . . . 73.420000000000002 110.899 -174.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.68 152.46 36.07 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 116.114 -0.494 . . . . 53.340000000000003 110.442 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -77.17 121.92 85.4 Favored Pre-proline 0 C--N 1.309 -1.19 0 C-N-CA 119.473 -0.891 . . . . 62.229999999999997 109.065 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.86 111.12 0.64 Allowed 'Trans proline' 0 C--O 1.252 1.181 0 C-N-CA 123.947 3.098 . . . . 31.550000000000001 114.904 -171.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -93.79 -25.76 17.25 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.795 -0.639 . . . . 73.340000000000003 109.403 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.498 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 49.6 t-20 -100.92 138.9 37.35 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.207 -1.034 . . . . 71.439999999999998 108.207 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.9 p -72.63 -27.41 62.12 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 112.38 0.511 . . . . 75.129999999999995 112.38 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 21.7 ptmt -88.02 -12.61 43.88 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.865 0.364 . . . . 70.010000000000005 110.864 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.429 ' CB ' ' HB3' ' A' ' 52' ' ' ASN . 38.8 t70 -87.42 100.43 12.74 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.244 0.831 . . . . 64.120000000000005 113.244 -167.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 t -121.31 -15.63 8.07 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.568 -1.196 . . . . 73.409999999999997 108.463 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.24 97.29 0.16 Allowed Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.56 -1.305 . . . . 44.509999999999998 113.174 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.48 159.13 32.53 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.759 2.306 . . . . 73.329999999999998 110.263 172.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.6 133.77 53.01 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.748 -0.464 . . . . 74.120000000000005 109.748 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.94 153.23 19.62 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.587 -0.523 . . . . 71.230000000000004 109.587 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -83.54 84.26 7.6 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.874 -1.158 . . . . 71.129999999999995 107.874 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.82 42.76 1.6 Allowed Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 114.904 -1.044 . . . . 62.32 111.598 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.11 88.15 7.15 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.661 -1.237 . . . . 73.349999999999994 107.661 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.431 HG11 ' SD ' ' A' ' 101' ' ' MET . 17.3 m -122.78 160.23 49.92 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-N 114.628 -1.169 . . . . 65.230000000000004 111.391 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.82 -7.87 12.24 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.489 2.793 . . . . 74.230000000000004 113.572 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.402 ' HE1' ' HG2' ' A' ' 97' ' ' GLN . 46.2 p90 -124.42 28.86 6.5 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 122.21 -0.306 . . . . 63.329999999999998 111.006 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.1 m -55.72 -27.85 52.66 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 111.971 0.36 . . . . 62.409999999999997 111.971 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -71.96 -7.97 51.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.212 0.53 . . . . 72.340000000000003 110.932 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -112.39 -6.76 14.0 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.065 -0.516 . . . . 73.409999999999997 110.15 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 p -127.58 118.53 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.892 0.854 . . . . 54.450000000000003 109.963 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.69 104.58 16.51 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.451 -0.795 . . . . 62.240000000000002 109.44 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.09 132.93 42.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.238 -1.393 . . . . 71.219999999999999 107.238 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.1 m -154.19 172.35 17.73 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.714 -0.847 . . . . 72.140000000000001 108.714 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -80.57 154.6 27.37 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.298 0.57 . . . . 75.230000000000004 110.105 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 70.7 t80 -118.23 123.39 45.34 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.957 -1.127 . . . . 73.409999999999997 107.957 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -138.22 100.35 4.11 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.04 -1.837 . . . . 75.299999999999997 106.04 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.3 t -165.23 143.78 6.35 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.768 -0.456 . . . . 45.340000000000003 109.768 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.1 t70 66.9 14.38 9.8 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.078 1.351 . . . . 70.25 109.339 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.63 -0.73 77.62 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.767 -0.73 . . . . 52.109999999999999 111.683 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.549 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 7.9 m-85 -94.0 146.04 24.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.424 -0.584 . . . . 73.540000000000006 109.424 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 m -125.56 136.96 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 108.265 -1.013 . . . . 74.420000000000002 108.265 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.69 -154.61 10.45 Favored Glycine 0 C--N 1.271 -3.037 0 N-CA-C 110.439 -1.064 . . . . 51.43 110.439 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 m -129.82 150.9 50.92 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 120.967 0.413 . . . . 73.450000000000003 110.42 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -133.64 145.26 49.82 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.083 0.468 . . . . 75.299999999999997 110.613 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.6 114.76 21.06 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.458 -1.312 . . . . 74.099999999999994 107.458 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.31 115.27 49.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.734 -0.839 . . . . 65.420000000000002 108.734 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.512 ' CD2' HD12 ' A' ' 90' ' ' LEU . 47.1 p90 -121.09 151.0 40.36 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.47 -0.492 . . . . 74.030000000000001 111.227 -174.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -153.15 156.49 38.72 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.415 -0.357 . . . . 62.020000000000003 111.202 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.4 t70 63.53 31.21 14.92 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.5 1.12 . . . . 72.530000000000001 111.046 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.512 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.4 mt -94.69 170.14 9.67 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.89 -0.595 . . . . 75.430000000000007 109.938 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t -128.08 179.72 5.44 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 120.636 -0.426 . . . . 64.420000000000002 110.617 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -54.69 -42.23 71.18 Favored 'General case' 0 C--O 1.209 -1.035 0 C-N-CA 123.794 0.837 . . . . 61.420000000000002 112.17 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.62 -29.11 69.03 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.342 0.592 . . . . 70.219999999999999 111.566 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.66 -15.97 29.44 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 115.57 -0.741 . . . . 72.019999999999996 111.285 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.9 tt -60.35 -51.46 80.0 Favored Pre-proline 0 CA--C 1.568 1.662 0 CA-C-O 119.202 -0.428 . . . . 72.310000000000002 111.205 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.52 -36.65 75.61 Favored 'Trans proline' 0 C--N 1.373 1.863 0 CA-C-N 120.976 1.384 . . . . 74.530000000000001 110.838 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.402 ' HG2' ' HE1' ' A' ' 66' ' ' PHE . 29.0 tt0 -66.44 -37.73 85.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.215 -0.902 . . . . 75.510000000000005 110.097 -175.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -78.09 -19.99 53.1 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.393 0.616 . . . . 71.310000000000002 109.736 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.34 -18.08 60.74 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.601 -0.727 . . . . 54.420000000000002 109.063 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.18 -57.22 12.29 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 116.012 -0.54 . . . . 74.140000000000001 109.737 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 64' ' ' VAL . 3.2 mpp? -55.73 -45.25 78.0 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 123.674 0.609 . . . . 72.439999999999998 109.718 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -52.88 -42.48 65.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.524 -1.217 . . . . 60.310000000000002 111.412 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.9 m -63.51 -31.76 73.01 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.179 -0.464 . . . . 65.120000000000005 110.725 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.6 -20.77 63.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.184 0.516 . . . . 73.5 110.686 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.91 -9.82 16.94 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.485 -0.486 . . . . 71.319999999999993 110.382 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.41 -47.64 3.89 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.414 0.524 . . . . 63.119999999999997 112.414 -173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.21 28.77 19.29 Favored Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 119.962 -1.114 . . . . 60.109999999999999 110.933 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.8 m -124.38 165.11 21.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 122.767 -0.255 . . . . 62.100000000000001 110.544 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.93 124.18 47.62 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.816 -1.179 . . . . 73.019999999999996 107.816 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.19 123.15 49.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.165 0.439 . . . . 73.439999999999998 111.08 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -120.93 117.56 27.64 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.346 -0.983 . . . . 71.299999999999997 108.346 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.452 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 2.2 pt? -133.35 147.43 51.82 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.223 -0.591 . . . . 74.099999999999994 111.006 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.452 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 2.1 mpt_? -142.11 155.23 45.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.968 -1.493 . . . . 75.439999999999998 106.968 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.525 ' NE ' ' HB2' ' A' ' 180' ' ' ASP . 9.4 ttt180 -108.85 137.53 46.63 Favored 'General case' 0 N--CA 1.396 -3.126 0 N-CA-C 106.69 -1.596 . . . . 74.200000000000003 106.69 173.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -127.42 99.6 5.69 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 107.98 -1.119 . . . . 71.299999999999997 107.98 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 184' ' ' ARG . . . 68.9 -115.71 6.75 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.845 -0.902 . . . . 61.0 110.845 -177.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 8.9 t30 -110.6 12.89 22.67 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.304 1.049 . . . . 51.329999999999998 109.342 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.8 pp -122.51 149.25 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 121.234 -0.916 . . . . 74.150000000000006 109.069 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.513 HG22 ' HG3' ' A' ' 114' ' ' ARG . 76.5 t -110.66 137.88 41.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 109.987 -0.375 . . . . 74.299999999999997 109.987 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 120' ' ' ILE . 42.0 pt -116.26 129.06 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 N-CA-C 108.636 -0.876 . . . . 72.430000000000007 108.636 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -128.3 125.73 39.39 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.959 -0.564 . . . . 75.430000000000007 109.653 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.48 115.96 18.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.361 0.6 . . . . 73.129999999999995 109.769 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -116.52 130.4 8.96 Favored Glycine 0 C--N 1.294 -1.789 0 N-CA-C 110.075 -1.21 . . . . 62.549999999999997 110.075 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -114.6 132.9 56.19 Favored 'General case' 0 C--N 1.282 -2.332 0 O-C-N 122.153 -0.616 . . . . 71.150000000000006 109.8 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.0 114.37 19.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.679 -0.691 . . . . 70.420000000000002 112.052 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.69 97.25 6.45 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.434 -0.95 . . . . 74.310000000000002 108.434 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.45 28.21 8.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.685 -0.857 . . . . 73.129999999999995 108.685 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 20.5 p -69.13 -9.17 51.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.254 -0.885 . . . . 45.219999999999999 112.944 -175.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.2 m -70.28 -18.85 63.13 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.845 0.355 . . . . 63.299999999999997 110.536 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.1 t 69.06 -88.12 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.786 1.235 . . . . 62.310000000000002 111.549 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.8 m 66.77 -55.54 0.42 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.001 1.32 . . . . 72.310000000000002 111.494 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 135' ' ' ALA . 1.9 p30 -136.74 104.79 9.03 Favored Pre-proline 0 C--N 1.309 -1.172 0 C-N-CA 123.691 0.797 . . . . 75.519999999999996 109.817 173.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.75 -12.52 22.07 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.637 2.225 . . . . 64.510000000000005 112.214 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -85.65 4.59 35.71 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.514 -0.766 . . . . 70.209999999999994 111.463 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -78.31 140.3 38.81 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.156 0.503 . . . . 72.109999999999999 110.808 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -131.85 110.43 10.81 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.278 -0.874 . . . . 74.430000000000007 109.29 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 77.8 t -104.89 113.66 42.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.379 -0.971 . . . . 62.420000000000002 108.379 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -108.54 121.08 44.23 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.109 -1.071 . . . . 61.109999999999999 108.109 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.524 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.9 tm? -110.81 115.7 29.99 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 105.784 -1.932 . . . . 74.019999999999996 105.784 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.9 m -123.69 127.53 48.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.501 -0.555 . . . . 53.32 109.501 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 76.9 t -124.95 126.82 71.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.182 -0.673 . . . . 72.120000000000005 109.182 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -115.95 130.93 57.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.704 -0.85 . . . . 53.439999999999998 108.704 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.713 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.2 p90 -135.06 122.84 15.39 Favored Pre-proline 0 C--N 1.283 -2.318 0 N-CA-C 112.002 0.371 . . . . 73.409999999999997 112.002 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -70.15 35.61 0.24 Allowed 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 122.57 2.18 . . . . 74.299999999999997 111.681 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -115.77 -99.31 0.44 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 123.132 0.573 . . . . 71.219999999999999 109.869 -177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.42 129.97 0.02 OUTLIER 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.304 -0.998 . . . . 54.229999999999997 108.304 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.87 138.08 20.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.704 -0.85 . . . . 75.219999999999999 108.704 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.8 p -94.09 -43.04 8.68 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 109.051 -0.722 . . . . 64.409999999999997 109.051 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.0 m -160.08 133.12 6.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.505 -0.924 . . . . 64.409999999999997 108.505 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 t -139.24 149.42 44.32 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.683 -0.635 . . . . 70.109999999999999 111.099 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -114.67 93.07 4.16 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 104.71 -2.33 . . . . 62.409999999999997 104.71 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.492 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.13 -148.86 11.57 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 107.999 -2.04 . . . . 74.409999999999997 107.999 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -114.09 100.02 8.07 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 117.587 0.693 . . . . 64.239999999999995 110.473 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -76.95 119.87 21.28 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.159 -0.616 . . . . 73.230000000000004 109.354 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.8 mt -83.98 -37.43 13.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.317 -1.364 . . . . 63.439999999999998 107.317 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.42 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . 39.3 mt-10 -145.69 161.9 38.59 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 106.766 -1.568 . . . . 65.219999999999999 106.766 -178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.31 -10.6 29.2 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.445 2.097 . . . . 72.049999999999997 112.212 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.713 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.4 OUTLIER -122.18 5.58 9.75 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 112.656 0.613 . . . . 71.310000000000002 112.656 177.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.5 t -139.84 120.95 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.56 -0.533 . . . . 64.319999999999993 109.56 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.77 148.04 31.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.482 -0.562 . . . . 71.120000000000005 109.482 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -138.55 149.58 45.46 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.298 -0.63 . . . . 61.119999999999997 109.298 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.524 ' CE3' HD12 ' A' ' 139' ' ' LEU . 28.2 m-90 -124.92 142.07 51.7 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.822 -0.807 . . . . 54.119999999999997 108.822 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -108.73 105.12 14.57 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.93 -1.507 . . . . 72.239999999999995 106.93 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 9.4 mp -100.57 119.18 38.15 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.926 0.87 . . . . 75.5 110.884 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.604 ' HD3' ' HD2' ' A' ' 166' ' ' PRO . 1.6 mmtm -118.42 140.75 28.61 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 114.231 -1.35 . . . . 63.240000000000002 108.85 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.604 ' HD2' ' HD3' ' A' ' 165' ' ' LYS . 39.1 Cg_exo -66.64 167.71 18.46 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.693 1.595 . . . . 74.439999999999998 110.729 171.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.97 -36.82 3.01 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 120.857 -0.687 . . . . 50.229999999999997 111.656 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.8 m -104.94 157.06 5.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.163 0.506 . . . . 72.319999999999993 110.093 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.6 p -114.06 127.02 71.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.914 -1.143 . . . . 74.340000000000003 107.914 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 46.6 m -145.57 143.54 29.97 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.912 -0.492 . . . . 70.150000000000006 110.863 -177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.1 p -109.23 125.91 52.75 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 115.841 -0.618 . . . . 74.420000000000002 109.651 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -101.3 134.66 44.02 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.606 -0.887 . . . . 75.439999999999998 108.606 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.0 m -143.26 140.72 30.78 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.616 -0.678 . . . . 72.420000000000002 110.907 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.507 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -143.05 132.18 23.11 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.358 -0.383 . . . . 70.200000000000003 109.982 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.1 131.32 54.19 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.82 -1.548 . . . . 72.099999999999994 106.82 170.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.84 156.24 42.05 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.21 -0.663 . . . . 74.5 109.21 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 28.4 ptt180 -87.91 134.48 33.7 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 120.362 -0.535 . . . . 71.209999999999994 109.895 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -143.72 122.72 12.81 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 109.337 -0.616 . . . . 75.450000000000003 109.337 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.572 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -58.97 109.08 0.76 Allowed 'General case' 0 C--N 1.279 -2.477 0 O-C-N 124.389 1.055 . . . . 75.099999999999994 111.536 -178.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' HB2' ' NE ' ' A' ' 114' ' ' ARG . 27.0 t70 -88.63 133.09 36.82 Favored Pre-proline 0 CA--C 1.49 -1.362 0 N-CA-C 108.888 -0.782 . . . . 71.400000000000006 108.888 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.96 -38.02 72.21 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.924 2.416 . . . . 65.25 113.092 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -86.16 -30.18 22.68 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.791 0.805 . . . . 71.219999999999999 109.777 -176.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.403 26.4 p 65.95 64.19 0.56 Allowed 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 113.603 -1.635 . . . . 71.140000000000001 110.469 -167.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.482 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 28.3 mmt180 -60.19 172.38 0.83 Allowed 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 111.413 -2.63 . . . . 72.230000000000004 113.589 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.411 -2.421 0 N-CA-C 104.389 -2.448 . . . . 74.530000000000001 104.389 179.857 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 110.294 -1.122 . . . . 61.109999999999999 110.294 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -120.38 150.77 40.24 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.054 -1.091 . . . . 72.400000000000006 108.054 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 69.4 93.8 0.08 Allowed 'General case' 0 C--O 1.239 0.54 0 O-C-N 124.262 0.976 . . . . 52.299999999999997 111.967 -176.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -72.09 129.36 38.33 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.012 -0.994 . . . . 64.549999999999997 110.206 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tt -142.89 135.49 27.71 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 105.278 -2.119 . . . . 75.109999999999999 105.278 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -86.09 -71.55 0.54 Allowed 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 120.476 -0.49 . . . . 74.540000000000006 110.11 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -149.04 137.35 20.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.458 -0.571 . . . . 63.219999999999999 109.458 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.434 HE21 ' HA ' ' A' ' 50' ' ' PRO . 60.4 tt0 -81.04 107.59 13.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.464 -0.569 . . . . 74.299999999999997 109.464 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.3 -142.83 3.55 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 109.529 -1.429 . . . . 73.010000000000005 109.529 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.434 ' HA ' ' OD2' ' A' ' 132' ' ' ASP . 83.7 m-70 69.0 95.21 0.07 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.84 1.256 . . . . 62.25 112.175 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 23.9 ttt 69.49 89.72 0.1 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.594 -1.639 . . . . 42.039999999999999 111.028 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.558 HD23 ' H ' ' A' ' 26' ' ' LEU . 2.1 pt? -112.8 136.67 52.16 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.652 -1.24 . . . . 75.349999999999994 107.652 175.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -101.52 123.97 46.43 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 106.867 -1.531 . . . . 72.340000000000003 106.867 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HB ' HG13 ' A' ' 137' ' ' VAL . 59.1 t -119.48 113.63 41.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 106.96 -1.496 . . . . 73.430000000000007 106.96 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 11.3 ttp180 -127.67 113.5 16.12 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.041 0.448 . . . . 73.140000000000001 109.958 -175.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.67 108.78 20.18 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.981 -0.748 . . . . 71.019999999999996 108.981 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.6 t -108.4 114.16 27.79 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.694 -1.595 . . . . 71.5 106.694 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.407 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.7 pp -132.98 147.17 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.379 0.609 . . . . 64.219999999999999 110.483 -174.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.3 m -129.73 128.38 42.35 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 116.024 -0.535 . . . . 71.299999999999997 109.865 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 143' ' ' PHE . 9.6 tt -113.96 125.69 71.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.299 0.571 . . . . 74.219999999999999 110.748 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.481 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 31.3 t -93.49 151.67 40.34 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.533 -0.758 . . . . 54.549999999999997 109.888 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.39 1.08 1.42 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.793 2.995 . . . . 74.209999999999994 112.922 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.71 -3.69 54.33 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.818 -1.179 . . . . 61.310000000000002 107.818 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.3 t70 72.25 29.02 2.3 Favored 'General case' 0 C--N 1.347 0.473 0 N-CA-C 106.858 -1.534 . . . . 72.450000000000003 106.858 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.3 OUTLIER -112.73 140.83 47.18 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.441 -1.254 . . . . 75.319999999999993 108.985 -178.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' A' ' 95' ' ' LEU . 17.8 t -115.63 144.71 22.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.549 -0.75 . . . . 75.109999999999999 109.126 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.2 p -149.29 158.71 44.4 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.079 -1.082 . . . . 73.030000000000001 108.079 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 161.48 -166.73 36.06 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 119.884 -1.15 . . . . 74.209999999999994 112.748 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -154.61 139.21 16.94 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.353 0.597 . . . . 73.430000000000007 111.064 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 46.6 mt -114.51 116.53 52.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.543 -0.91 . . . . 64.109999999999999 108.543 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.16 126.01 61.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.371 -0.603 . . . . 74.420000000000002 109.371 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.513 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -123.61 108.6 12.77 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.777 -1.194 . . . . 64.329999999999998 107.777 173.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.87 126.54 52.58 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.85 0.357 . . . . 63.25 111.585 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.38 158.91 30.06 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.765 -0.652 . . . . 70.150000000000006 109.755 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -72.65 130.56 85.41 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 118.974 -1.091 . . . . 74.030000000000001 109.298 175.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HA ' HE21 ' A' ' 22' ' ' GLN . 15.7 Cg_endo -56.2 -82.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.481 2.787 . . . . 63.329999999999998 115.456 -174.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt 60.6 22.72 12.51 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.899 0.88 . . . . 73.120000000000005 111.217 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -152.5 118.28 5.4 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.413 -1.267 . . . . 73.310000000000002 107.656 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.1 m -66.4 -20.59 66.11 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.998 1.111 . . . . 51.439999999999998 113.998 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' NZ ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -97.55 -11.75 23.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.189 -1.004 . . . . 74.140000000000001 112.186 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -88.51 107.44 18.88 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 119.207 -0.997 . . . . 73.340000000000003 111.025 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t -114.28 -8.85 12.88 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.249 -0.887 . . . . 71.140000000000001 108.684 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 174.15 112.04 0.28 Allowed Glycine 0 N--CA 1.425 -2.082 0 CA-C-N 115.261 -0.881 . . . . 74.209999999999994 112.046 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.04 160.33 45.02 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 123.047 2.498 . . . . 70.420000000000002 111.351 173.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.43 131.07 37.14 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.798 -0.816 . . . . 64.299999999999997 108.798 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.426 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 69.0 mt -84.87 143.66 28.9 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.423 -0.584 . . . . 71.109999999999999 109.423 176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -100.43 93.79 5.83 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.478 0.656 . . . . 72.519999999999996 109.66 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.623 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -140.6 72.59 0.41 Allowed Glycine 0 C--N 1.28 -2.56 0 CA-C-N 115.168 -0.924 . . . . 62.219999999999999 111.116 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -82.29 91.32 6.75 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.834 -0.802 . . . . 62.240000000000002 108.834 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.6 m -122.29 154.1 62.04 Favored Pre-proline 0 C--N 1.299 -1.606 0 CA-C-N 114.744 -1.117 . . . . 71.109999999999999 110.739 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.84 -21.39 70.32 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 123.595 2.863 . . . . 43.32 112.916 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -102.75 32.45 3.64 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 111.063 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 p -55.8 -34.08 64.99 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 116.29 -0.413 . . . . 64.019999999999996 111.543 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -65.29 -16.69 63.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.301 0.572 . . . . 73.420000000000002 111.47 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 88' ' ' SER . 33.3 mmtp -98.75 -16.0 19.11 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 116.157 -0.474 . . . . 72.310000000000002 110.524 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.17 118.89 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-O 122.195 0.998 . . . . 72.340000000000003 111.18 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -105.62 122.6 46.38 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.888 -1.051 . . . . 53.43 109.27 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.3 t -98.23 131.43 45.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.954 -1.128 . . . . 60.43 107.954 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 m -139.65 169.8 17.07 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.451 -0.574 . . . . 75.409999999999997 109.451 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.541 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 1.7 p-10 -83.64 142.56 30.71 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.097 0.475 . . . . 73.319999999999993 109.771 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 82.5 t80 -107.92 121.74 45.4 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.657 -1.238 . . . . 74.219999999999999 107.657 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.28 101.11 4.3 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.158 -1.053 . . . . 71.049999999999997 108.158 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 36.6 t -165.8 147.57 7.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.043 -1.095 . . . . 65.219999999999999 108.043 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 71.94 10.15 6.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.976 0.91 . . . . 64.450000000000003 111.167 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.55 1.06 83.76 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.557 -0.747 . . . . 73.0 111.967 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -104.95 147.06 28.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.454 -0.943 . . . . 63.119999999999997 108.454 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -123.85 139.0 51.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.218 -1.031 . . . . 73.200000000000003 108.218 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -167.44 -155.13 8.98 Favored Glycine 0 C--N 1.26 -3.677 0 C-N-CA 119.797 -1.192 . . . . 71.549999999999997 111.178 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.426 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 7.8 t -123.81 152.77 41.89 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 108.858 -0.793 . . . . 54.140000000000001 108.858 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 29.0 pt20 -140.67 130.71 24.72 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 120.999 0.428 . . . . 72.239999999999995 110.363 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.04 115.31 29.96 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.735 -0.839 . . . . 75.319999999999993 108.735 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.89 116.75 50.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.903 -0.777 . . . . 75.200000000000003 108.903 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.461 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.2 p90 -121.67 146.95 46.49 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 120.982 0.42 . . . . 74.109999999999999 110.944 -176.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 46.1 m -152.04 158.54 43.18 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 116.018 -0.537 . . . . 74.450000000000003 109.78 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.8 t70 60.47 38.82 18.93 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 122.31 1.052 . . . . 75.25 111.64 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.461 HD12 ' CD2' ' A' ' 87' ' ' PHE . 25.3 mt -97.47 166.53 11.48 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.238 -0.892 . . . . 74.430000000000007 109.878 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -115.08 173.72 6.35 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.875 0.307 . . . . 71.329999999999998 110.264 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -49.84 -50.49 45.26 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.223 1.409 . . . . 72.200000000000003 111.461 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.31 68.11 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.156 0.582 . . . . 74.150000000000006 112.251 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -84.3 -16.34 43.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.67 -0.241 . . . . 73.109999999999999 111.619 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.7 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.8 tt -64.52 -54.98 33.01 Favored Pre-proline 0 CA--C 1.558 1.273 0 CA-C-O 119.392 -0.337 . . . . 71.230000000000004 111.312 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.41 -33.28 88.88 Favored 'Trans proline' 0 C--N 1.367 1.54 0 CA-C-N 120.744 1.301 . . . . 65.349999999999994 111.017 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -66.57 -36.06 81.73 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.95 -0.568 . . . . 74.510000000000005 110.697 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.0 pp -75.9 -19.21 59.01 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 109.498 -0.556 . . . . 74.299999999999997 109.498 175.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.01 -15.99 62.05 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.004 -0.544 . . . . 74.549999999999997 110.342 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -63.79 -56.93 11.82 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.452 -0.944 . . . . 73.420000000000002 108.452 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.623 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 31.9 ttp -54.33 -49.67 69.18 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.664 -0.698 . . . . 73.519999999999996 109.805 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -53.33 -41.98 66.27 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.849 -1.069 . . . . 75.109999999999999 110.887 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.3 p -72.37 -20.73 61.41 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 119.421 -0.912 . . . . 74.140000000000001 112.199 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.2 -20.36 62.28 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.482 0.658 . . . . 72.230000000000004 109.703 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.91 -10.41 20.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.792 -0.64 . . . . 51.140000000000001 110.378 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.67 -48.4 3.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.667 0.618 . . . . 64.140000000000001 112.667 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.64 20.62 59.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.481 -0.648 . . . . 42.32 111.481 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.84 168.19 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 109.476 -0.565 . . . . 73.120000000000005 109.476 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -102.77 135.52 44.29 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.887 0.312 . . . . 72.540000000000006 110.407 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.25 125.65 23.42 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.38 -0.6 . . . . 70.099999999999994 109.38 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.2 p -144.34 143.12 30.81 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.756 0.313 . . . . 71.430000000000007 111.268 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.54 125.78 23.14 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.741 0.816 . . . . 60.25 108.894 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -142.01 168.33 20.0 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.302 0.241 . . . . 63.140000000000001 110.378 -174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.417 ' CG ' HG22 ' A' ' 119' ' ' VAL . 26.6 mtt85 -101.14 138.68 37.85 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 113.866 1.061 . . . . 72.140000000000001 113.866 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.434 ' O ' HG13 ' A' ' 118' ' ' ILE . 7.0 t30 -123.96 94.36 4.2 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 105.764 -1.939 . . . . 74.120000000000005 105.764 174.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.42 -114.03 4.95 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 110.106 -1.197 . . . . 72.329999999999998 110.106 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -110.7 -1.37 16.74 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.721 1.248 . . . . 73.140000000000001 108.768 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.5 pp -103.19 148.97 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 C-N-CA 118.892 -1.123 . . . . 75.239999999999995 108.323 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.417 HG22 ' CG ' ' A' ' 114' ' ' ARG . 89.1 t -108.92 136.53 44.49 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.984 0 N-CA-C 109.853 -0.425 . . . . 61.420000000000002 109.853 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.7 pt -116.01 132.14 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-O 121.921 0.867 . . . . 71.450000000000003 109.201 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 174' ' ' ALA . 5.5 tt -114.4 130.95 56.73 Favored 'General case' 0 C--N 1.255 -3.513 0 N-CA-C 105.646 -1.983 . . . . 51.310000000000002 105.646 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -140.74 130.67 24.54 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.727 -0.842 . . . . 75.430000000000007 108.727 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.92 168.05 38.26 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 111.199 -0.76 . . . . 31.25 111.199 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -140.2 141.83 35.91 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.364 -0.976 . . . . 73.0 108.364 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.69 108.78 12.37 Favored 'General case' 0 N--CA 1.413 -2.279 0 N-CA-C 108.352 -0.981 . . . . 71.120000000000005 108.352 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -112.66 111.72 22.72 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.034 -1.099 . . . . 53.140000000000001 108.034 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 0.1 OUTLIER -127.75 34.47 4.64 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.082 -1.451 . . . . 75.049999999999997 107.082 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.2 p -66.08 -12.6 56.56 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.654 0.983 . . . . 74.239999999999995 113.654 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.9 m -70.77 -12.26 61.45 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.521 0.677 . . . . 55.030000000000001 110.341 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.407 HG22 ' HA2' ' A' ' 167' ' ' GLY . 48.0 t 75.97 -70.6 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.259 1.423 . . . . 74.519999999999996 113.099 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.8 m 64.84 -76.23 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.828 0.851 . . . . 72.25 109.639 -171.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.434 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 42.5 m-20 -131.14 110.38 15.37 Favored Pre-proline 0 CA--C 1.494 -1.192 0 N-CA-C 107.576 -1.268 . . . . 73.120000000000005 107.576 176.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.9 -20.41 45.28 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 122.24 1.96 . . . . 54.100000000000001 112.59 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -96.08 11.25 34.84 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.774 -0.648 . . . . 64.519999999999996 111.872 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.2 148.15 28.6 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.987 -1.116 . . . . 70.109999999999999 107.987 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -132.68 124.58 28.5 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.888 -0.412 . . . . 71.209999999999994 109.888 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.511 ' HB ' ' HG ' ' A' ' 164' ' ' LEU . 82.6 t -117.16 121.05 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 120.161 -0.616 . . . . 73.439999999999998 110.113 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 45.3 mt-10 -115.73 138.02 51.52 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.95 -0.568 . . . . 55.399999999999999 110.686 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.407 HD13 ' SD ' ' A' ' 172' ' ' MET . 3.3 tt -127.64 125.46 40.19 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 105.237 -2.134 . . . . 70.010000000000005 105.237 170.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 13.6 m -126.57 122.94 36.53 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.144 -0.687 . . . . 75.030000000000001 109.144 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.443 HG12 ' HD2' ' A' ' 143' ' ' PHE . 94.1 t -118.24 123.5 71.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 110.131 -0.322 . . . . 63.009999999999998 110.131 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.78 127.49 55.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.074 -0.713 . . . . 41.219999999999999 109.074 176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.0 p90 -134.46 121.31 15.17 Favored Pre-proline 0 C--N 1.295 -1.779 0 C-N-CA 122.695 0.398 . . . . 73.329999999999998 112.004 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 15.0 Cg_exo -72.59 39.17 0.41 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.874 2.382 . . . . 73.219999999999999 112.108 176.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.61 -97.92 0.46 Allowed 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 119.307 -0.378 . . . . 62.420000000000002 110.482 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.59 123.8 0.03 OUTLIER 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.406 -0.59 . . . . 64.530000000000001 109.406 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.48 136.15 23.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.483 -0.932 . . . . 73.319999999999993 108.483 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.8 p -95.31 -44.97 7.34 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.204 -0.665 . . . . 63.130000000000003 109.204 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 62.5 m -158.82 133.3 7.98 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.935 -0.575 . . . . 62.549999999999997 109.536 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.2 t -138.32 159.27 42.49 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.835 -0.54 . . . . 74.319999999999993 110.113 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -126.18 94.56 4.12 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 105.343 -2.095 . . . . 71.209999999999994 105.343 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.34 -150.19 10.37 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.051 -2.02 . . . . 50.25 108.051 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.68 99.01 7.02 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.608 -0.886 . . . . 74.310000000000002 108.608 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -74.66 137.63 42.32 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.906 -0.588 . . . . 72.099999999999994 111.307 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.4 mt -100.87 -48.45 11.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.242 -1.392 . . . . 73.219999999999999 107.242 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -133.72 169.0 15.09 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 107.561 -1.274 . . . . 73.239999999999995 107.561 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.87 0.81 7.2 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.625 2.216 . . . . 72.420000000000002 111.078 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.4 pt-20 -132.75 3.7 3.83 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.946 -1.024 . . . . 73.450000000000003 110.747 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.421 HG23 ' HG3' ' A' ' 158' ' ' GLU . 59.8 t -144.6 120.82 4.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.912 -0.773 . . . . 61.520000000000003 108.912 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.97 147.83 31.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.084 -0.71 . . . . 74.340000000000003 109.084 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -130.05 143.38 50.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.111 -0.7 . . . . 64.400000000000006 109.111 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.536 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 32.6 m-90 -122.66 116.73 24.31 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 108.731 -0.841 . . . . 72.230000000000004 108.731 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.25 98.27 8.68 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.554 -0.906 . . . . 63.210000000000001 108.554 175.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.511 ' HG ' ' HB ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -96.45 131.52 42.94 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-O 122.338 1.066 . . . . 60.219999999999999 110.082 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 68.4 mttm -119.52 151.03 51.05 Favored Pre-proline 0 C--N 1.279 -2.499 0 CA-C-N 113.248 -1.796 . . . . 63.210000000000001 112.858 -170.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 20.3 Cg_exo -70.97 156.56 59.96 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.868 2.379 . . . . 71.340000000000003 110.644 174.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.407 ' HA2' HG22 ' A' ' 130' ' ' VAL . . . 84.34 -36.17 2.94 Favored Glycine 0 C--N 1.309 -0.925 0 C-N-CA 121.278 -0.487 . . . . 73.140000000000001 112.129 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.3 m -105.82 166.27 3.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 123.008 0.523 . . . . 74.349999999999994 110.223 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.0 p -113.82 142.33 26.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.348 -0.982 . . . . 64.510000000000005 108.348 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.1 m -138.53 141.95 39.32 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.937 -0.477 . . . . 72.129999999999995 109.841 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.3 p -103.43 130.01 50.68 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.871 -0.788 . . . . 74.400000000000006 108.871 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.407 ' SD ' HD13 ' A' ' 139' ' ' LEU . 44.2 ttp -104.02 116.34 32.05 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.653 -0.869 . . . . 72.030000000000001 108.653 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.1 m -140.33 139.52 35.44 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.693 -0.803 . . . . 64.329999999999998 109.305 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.536 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -149.2 120.68 7.94 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 108.507 -0.923 . . . . 40.240000000000002 108.507 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -120.7 130.74 54.21 Favored 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 106.691 -1.596 . . . . 70.340000000000003 106.691 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -155.76 150.93 26.68 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.405 -0.961 . . . . 73.219999999999999 108.405 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 5.8 ppt_? -88.2 126.41 35.13 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.81 -0.756 . . . . 74.099999999999994 110.671 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 16.5 m-30 -135.05 118.71 17.06 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 107.741 -1.207 . . . . 64.010000000000005 107.741 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.63 113.25 0.67 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 125.171 1.545 . . . . 52.409999999999997 112.274 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.26 123.35 85.9 Favored Pre-proline 0 CA--C 1.501 -0.926 0 C-N-CA 124.422 1.089 . . . . 74.239999999999995 109.082 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -73.07 -41.99 1.15 Allowed 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 121.7 1.6 . . . . 74.5 113.0 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.26 -22.05 30.9 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.825 0.45 . . . . 75.120000000000005 111.475 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 69.3 p 67.33 87.27 0.12 Allowed 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 126.322 1.849 . . . . 63.130000000000003 115.065 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -96.11 159.58 14.89 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.07 -0.514 . . . . 74.010000000000005 111.294 174.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.3 -1.547 0 N-CA-C 107.469 -1.308 . . . . 75.450000000000003 107.469 177.625 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.831 0 N-CA-C 111.262 -0.735 . . . . 43.049999999999997 111.262 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -122.98 30.4 6.4 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.693 0.758 . . . . 65.5 109.737 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -99.39 -1.27 39.16 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.377 -0.829 . . . . 72.430000000000007 110.914 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -88.42 83.06 6.87 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.086 0.946 . . . . 74.310000000000002 112.466 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.0 tp -151.04 91.38 1.7 Allowed 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 114.04 -1.436 . . . . 65.319999999999993 108.391 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -87.6 86.67 7.23 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.679 0.752 . . . . 74.230000000000004 111.407 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -83.49 -25.07 31.44 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.924 -1.035 . . . . 74.219999999999999 109.901 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -103.76 136.26 43.78 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.629 -0.714 . . . . 71.049999999999997 109.747 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.4 81.33 1.26 Allowed Glycine 0 N--CA 1.433 -1.567 0 C-N-CA 120.767 -0.73 . . . . 65.239999999999995 111.355 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -94.52 117.23 29.8 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.771 0.796 . . . . 72.010000000000005 111.814 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.496 ' HB3' ' O ' ' A' ' 134' ' ' ASP . 1.5 mpt? -116.06 -165.38 1.04 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.934 0.894 . . . . 62.520000000000003 110.395 -177.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -89.77 115.23 26.97 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.435 -1.691 . . . . 72.120000000000005 106.435 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -106.0 132.77 51.69 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.237 -0.585 . . . . 74.439999999999998 111.418 -173.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.08 114.44 41.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.729 -0.841 . . . . 64.150000000000006 108.729 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 58.6 mtp85 -119.5 119.3 33.45 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.553 -0.748 . . . . 74.349999999999994 111.961 -176.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.08 108.35 19.4 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.481 -1.303 . . . . 73.109999999999999 107.481 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 140' ' ' THR . 20.3 m -120.71 115.11 22.7 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.618 -0.512 . . . . 72.400000000000006 109.618 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.9 pp -124.45 147.47 28.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.017 0.437 . . . . 75.439999999999998 110.44 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 62.7 m -129.82 122.04 27.95 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 121.053 0.454 . . . . 63.130000000000003 110.097 -176.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -113.92 122.73 68.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 121.463 0.649 . . . . 63.439999999999998 110.439 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.1 m -86.99 151.64 52.19 Favored Pre-proline 0 N--CA 1.417 -2.112 0 CA-C-N 115.336 -0.847 . . . . 64.230000000000004 109.46 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.43 ' HG3' ' HB2' ' A' ' 145' ' ' ALA . 21.6 Cg_exo -65.96 2.13 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.312 2.675 . . . . 74.409999999999997 112.349 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 25.7 t70 -85.19 -2.22 57.79 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.139 0.975 . . . . 63.119999999999997 109.385 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.9 t70 72.76 28.96 2.01 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 123.469 1.605 . . . . 74.209999999999994 107.621 -174.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -107.51 125.84 51.78 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 113.671 -1.604 . . . . 64.129999999999995 108.25 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 t -108.97 137.12 42.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.256 -0.646 . . . . 63.149999999999999 109.256 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.2 p -146.84 165.43 29.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.722 -1.214 . . . . 74.030000000000001 107.722 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.26 -173.97 41.78 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.617 -1.278 . . . . 51.039999999999999 112.764 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 10.2 pt-20 -157.51 133.42 9.37 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.409 0.623 . . . . 75.030000000000001 110.804 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 2.0 mp -113.18 116.5 52.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.992 -1.114 . . . . 74.540000000000006 107.992 175.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mp -113.9 115.6 50.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.195 0.521 . . . . 64.230000000000004 109.698 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -108.7 125.85 52.35 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.509 -1.663 . . . . 74.409999999999997 106.509 174.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.87 116.79 14.19 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.578 0.704 . . . . 75.239999999999995 109.476 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.84 159.34 31.28 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 115.059 -0.973 . . . . 73.200000000000003 110.789 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -64.27 137.84 97.24 Favored Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 106.713 -1.588 . . . . 70.540000000000006 106.713 171.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -43.42 -41.03 10.4 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 123.994 3.13 . . . . 72.209999999999994 115.668 -172.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 62.47 76.2 0.37 Allowed 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 108.843 -0.799 . . . . 74.329999999999998 108.843 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 81.46 137.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.538 -1.665 . . . . 73.420000000000002 110.17 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.6 m -57.03 -9.98 1.0 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 126.082 1.753 . . . . 62.530000000000001 114.799 -176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -73.33 -19.28 61.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.741 0.416 . . . . 64.129999999999995 111.057 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -99.68 125.59 45.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 120.06 -0.656 . . . . 60.130000000000003 110.128 -173.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -114.72 -17.45 11.61 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.156 -0.474 . . . . 74.510000000000005 111.045 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.45 97.79 0.11 Allowed Glycine 0 N--CA 1.434 -1.47 0 C-N-CA 120.053 -1.07 . . . . 62.130000000000003 111.98 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.56 159.83 35.42 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.635 2.223 . . . . 63.109999999999999 111.454 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.96 140.47 52.3 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.452 -0.573 . . . . 72.450000000000003 109.452 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.413 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 90.8 mt -62.89 149.19 45.1 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.566 0.541 . . . . 65.209999999999994 110.208 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -82.38 85.1 6.95 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.571 -0.899 . . . . 55.43 108.571 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.531 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -122.4 120.88 4.47 Favored Glycine 0 N--CA 1.417 -2.631 0 CA-C-N 114.558 -1.201 . . . . 75.239999999999995 113.746 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -139.95 112.79 8.06 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.757 -0.831 . . . . 73.239999999999995 108.757 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.51 161.6 57.93 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.662 -0.866 . . . . 74.030000000000001 108.662 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.62 -11.86 24.36 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.047 1.831 . . . . 73.219999999999999 111.536 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -114.03 41.61 2.21 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.837 -0.619 . . . . 71.400000000000006 111.595 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.2 m -58.64 -27.23 64.53 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-N 116.211 -0.449 . . . . 65.340000000000003 111.508 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -68.84 -15.82 63.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.522 0.677 . . . . 71.420000000000002 110.405 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -95.4 -17.63 21.4 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.245 -0.889 . . . . 73.010000000000005 110.565 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 87' ' ' PHE . 7.6 p -124.55 118.97 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-O 122.246 1.022 . . . . 53.210000000000001 111.92 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.94 101.85 14.41 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.042 -0.981 . . . . 64.129999999999995 108.39 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.21 125.5 51.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.594 -1.262 . . . . 71.040000000000006 107.594 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 m -142.09 172.26 12.93 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.888 -0.782 . . . . 74.209999999999994 108.888 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -83.59 151.92 25.1 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.818 -1.178 . . . . 74.200000000000003 107.818 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -110.35 123.57 50.09 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.94 -1.504 . . . . 73.400000000000006 106.94 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -138.55 99.53 3.85 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 106.97 -1.493 . . . . 71.150000000000006 106.97 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.4 t -171.94 155.21 3.74 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.556 -1.276 . . . . 73.25 107.556 -174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 70.62 7.26 6.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.942 0.897 . . . . 73.439999999999998 111.383 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.1 -2.04 80.99 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.453 -1.059 . . . . 63.140000000000001 110.453 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -104.56 155.67 18.62 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.216 0.606 . . . . 75.319999999999993 111.288 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.64 136.69 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 108.438 -0.949 . . . . 71.140000000000001 108.438 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -163.45 -154.06 7.55 Favored Glycine 0 N--CA 1.397 -3.931 0 C-N-CA 120.056 -1.069 . . . . 62.210000000000001 111.051 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.413 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 13.0 m -131.25 143.6 50.68 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 115.462 -0.369 . . . . 61.219999999999999 110.078 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 10.1 pt20 -132.74 138.15 47.1 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.706 0.289 . . . . 63.399999999999999 110.731 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -121.03 114.4 21.44 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.295 -1.372 . . . . 74.340000000000003 107.295 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.7 113.18 43.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 108.225 -1.028 . . . . 60.399999999999999 108.225 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.449 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.8 p90 -123.41 154.68 38.69 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.186 -0.606 . . . . 73.519999999999996 111.865 -175.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -157.1 165.61 35.58 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.229 -0.896 . . . . 74.140000000000001 109.499 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 65.19 31.7 10.62 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.276 0.985 . . . . 71.510000000000005 111.767 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.449 HD12 ' CD2' ' A' ' 87' ' ' PHE . 47.9 mt -101.58 164.55 11.7 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.273 -0.422 . . . . 44.340000000000003 110.447 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -117.86 178.08 4.54 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.816 0.341 . . . . 42.539999999999999 111.082 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -54.06 -38.87 65.73 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 125.595 1.558 . . . . 64.010000000000005 111.063 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.22 -25.95 62.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.948 -0.569 . . . . 72.209999999999994 111.503 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -89.72 -17.07 29.0 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.299 -0.409 . . . . 74.140000000000001 111.564 -176.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.534 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 43.1 tp -57.84 -48.32 97.36 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 112.771 0.656 . . . . 65.540000000000006 112.771 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 40.2 Cg_exo -63.12 -37.02 54.8 Favored 'Trans proline' 0 C--N 1.367 1.53 0 CA-C-N 120.658 1.271 . . . . 74.109999999999999 110.892 174.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -68.49 -34.8 76.55 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.456 -0.793 . . . . 75.219999999999999 111.507 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -78.36 -19.44 53.39 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.501 -0.555 . . . . 74.129999999999995 109.501 176.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 96' ' ' PRO . . . -70.62 -27.15 63.85 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 115.585 -0.734 . . . . 73.140000000000001 109.933 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -57.1 -57.4 12.72 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.985 0.803 . . . . 73.519999999999996 109.675 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.531 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.6 ttp -53.58 -50.35 65.77 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.352 -0.84 . . . . 74.530000000000001 110.468 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -60.31 -33.0 71.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.227 -0.897 . . . . 73.340000000000003 111.609 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.9 m -63.99 -28.14 69.61 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 121.079 -0.249 . . . . 73.319999999999993 110.945 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.82 -26.18 68.23 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-O 121.424 0.631 . . . . 64.010000000000005 110.582 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.47 -6.64 16.05 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 116.143 -0.481 . . . . 72.450000000000003 110.669 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.52 -41.6 5.44 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.203 -0.599 . . . . 60.119999999999997 112.433 -173.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.56 26.02 68.68 Favored Glycine 0 C--O 1.242 0.638 0 C-N-CA 120.473 -0.87 . . . . 73.340000000000003 110.962 -175.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.56 160.81 9.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 121.056 0.455 . . . . 65.340000000000003 110.238 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -113.14 122.44 47.54 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.94 -1.874 . . . . 71.400000000000006 105.94 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.9 mt -119.68 123.24 43.33 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 117.82 0.282 . . . . 74.200000000000003 111.349 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.8 m -123.46 141.39 52.05 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.475 -0.565 . . . . 64.25 109.475 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.5 tp -134.92 131.85 37.77 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.259 -0.428 . . . . 75.129999999999995 110.426 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -143.03 153.68 43.2 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.406 -0.961 . . . . 71.129999999999995 108.406 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.573 ' NH1' ' HA ' ' A' ' 180' ' ' ASP . 19.8 ttm180 -112.02 132.44 54.8 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 108.763 -0.828 . . . . 75.540000000000006 108.763 171.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -110.06 89.3 2.98 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.104 -1.443 . . . . 72.340000000000003 107.104 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.26 -108.95 2.64 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.326 -1.11 . . . . 64.340000000000003 110.326 -176.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -107.63 -6.31 16.98 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.213 1.006 . . . . 53.539999999999999 109.39 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.6 pp -104.39 143.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 C-N-CA 118.202 -1.399 . . . . 75.25 109.202 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.441 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 72.8 t -105.79 138.76 29.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 O-C-N 122.003 -0.435 . . . . 63.549999999999997 110.287 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.2 pt -121.15 135.92 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-O 121.626 0.726 . . . . 74.219999999999999 109.893 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.3 tt -128.06 125.32 39.07 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 107.475 -1.306 . . . . 73.319999999999993 107.475 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -125.83 121.84 34.43 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.857 -1.534 . . . . 53.520000000000003 106.857 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.99 161.21 27.57 Favored Glycine 0 N--CA 1.407 -3.259 0 C-N-CA 120.719 -0.753 . . . . 60.549999999999997 111.567 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -139.44 138.38 36.41 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.44 -0.948 . . . . 71.129999999999995 108.44 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.23 117.19 33.47 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.532 -0.303 . . . . 64.129999999999995 111.253 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -104.16 97.42 7.38 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.013 -1.106 . . . . 75.120000000000005 108.013 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 3.1 mm? -112.21 12.83 20.42 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.451 -0.574 . . . . 71.319999999999993 109.451 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 p -66.79 -28.45 68.4 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 113.431 0.901 . . . . 62.409999999999997 113.431 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.7 m -86.99 -5.12 59.19 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.098 0.475 . . . . 73.200000000000003 110.603 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.2 t -84.24 104.38 12.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.086 -1.079 . . . . 52.509999999999998 108.086 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 12.9 m -90.26 1.89 56.02 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.897 -0.592 . . . . 73.310000000000002 110.94 -177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.1 103.33 5.5 Favored Pre-proline 0 CA--C 1.515 -0.394 0 N-CA-C 108.573 -0.899 . . . . 72.409999999999997 108.573 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 131' ' ' SER . 8.3 Cg_exo -75.04 -12.12 21.42 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.58 2.187 . . . . 74.129999999999995 111.647 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 25' ' ' MET . 4.6 m-20 -80.12 1.78 26.66 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.987 -1.006 . . . . 72.140000000000001 111.412 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.52 131.3 44.86 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.164 -0.68 . . . . 73.340000000000003 109.164 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -122.12 118.26 28.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.311 -1.366 . . . . 53.43 107.311 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 53.5 t -109.73 129.92 63.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.344 -0.542 . . . . 71.239999999999995 110.657 -173.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 44.9 mt-10 -134.53 130.71 37.01 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.861 -0.422 . . . . 74.5 109.861 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.464 HD13 ' SD ' ' A' ' 172' ' ' MET . 5.6 tt -120.15 128.98 53.93 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.307 -1.738 . . . . 73.319999999999993 106.307 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 31' ' ' SER . 29.8 m -126.98 131.65 50.99 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.548 -0.538 . . . . 74.140000000000001 109.548 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 80.2 t -121.9 125.87 73.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.513 -0.921 . . . . 73.530000000000001 108.513 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -116.63 128.69 55.61 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 108.637 -0.875 . . . . 75.019999999999996 108.637 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.683 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.12 117.78 13.81 Favored Pre-proline 0 C--N 1.281 -2.379 0 CA-C-N 116.545 -0.298 . . . . 72.109999999999999 111.072 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.8 38.25 0.18 Allowed 'Trans proline' 0 CA--C 1.554 1.521 0 C-N-CA 123.024 2.483 . . . . 70.450000000000003 112.929 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.43 ' HB2' ' HG3' ' A' ' 36' ' ' PRO . . . -122.04 -102.0 0.41 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 110.048 -0.353 . . . . 52.130000000000003 110.048 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.73 128.12 0.08 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.665 -0.865 . . . . 54.219999999999999 108.665 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.49 141.3 15.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.521 -0.918 . . . . 72.310000000000002 108.521 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.3 t -103.54 -32.79 9.28 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 120.205 -0.598 . . . . 75.0 109.643 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 54.9 m -161.12 133.37 5.94 Favored 'General case' 0 C--O 1.202 -1.405 0 N-CA-C 109.598 -0.519 . . . . 73.150000000000006 109.598 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.8 t -138.52 168.78 19.04 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.695 -0.628 . . . . 53.310000000000002 109.599 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -139.76 87.7 2.19 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.065 -2.198 . . . . 51.200000000000003 105.065 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.9 -144.39 5.94 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.264 -1.534 . . . . 52.219999999999999 109.264 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -117.94 99.65 7.05 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.545 -0.909 . . . . 72.329999999999998 108.545 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 34.8 ptt180 -82.42 133.19 35.21 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 119.298 -0.961 . . . . 74.219999999999999 110.986 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.17 -37.74 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.582 -1.266 . . . . 70.349999999999994 107.582 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -139.71 165.04 34.02 Favored Pre-proline 0 N--CA 1.427 -1.582 0 N-CA-C 106.207 -1.775 . . . . 45.509999999999998 106.207 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.78 0.17 6.05 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.5 2.133 . . . . 74.430000000000007 111.366 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.683 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.0 pt-20 -134.41 8.38 3.66 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.819 -0.628 . . . . 74.420000000000002 111.88 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 86.9 t -142.7 121.06 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 109.131 -0.692 . . . . 52.030000000000001 109.131 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 44.9 t -130.58 146.28 34.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 110.167 -0.309 . . . . 44.200000000000003 110.167 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -132.75 152.58 51.72 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 121.12 0.486 . . . . 74.239999999999995 110.359 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.417 ' CE2' ' HG3' ' A' ' 172' ' ' MET . 31.2 m-90 -125.28 119.43 28.4 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.296 -1.002 . . . . 75.230000000000004 108.296 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -98.99 106.5 18.77 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.963 0.887 . . . . 62.229999999999997 110.075 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 76.9 mt -101.44 135.51 42.82 Favored 'General case' 0 C--O 1.264 1.826 0 CA-C-N 114.907 -1.042 . . . . 74.310000000000002 111.216 -173.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 10.7 mmpt? -115.12 150.61 44.58 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 114.143 -1.39 . . . . 74.420000000000002 109.189 -175.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 11.3 Cg_exo -73.6 156.78 49.22 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.61 2.207 . . . . 54.0 111.283 176.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.79 -24.83 3.13 Favored Glycine 0 C--N 1.314 -0.688 0 O-C-N 122.318 -0.239 . . . . 74.230000000000004 112.665 176.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 31.7 m -106.05 160.83 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.264 0.554 . . . . 75.140000000000001 112.096 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.73 144.14 21.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.764 -1.198 . . . . 71.420000000000002 107.764 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 32.8 t -148.6 152.71 37.23 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.991 -0.374 . . . . 71.420000000000002 109.991 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.1 p -96.03 154.78 17.05 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.893 -0.594 . . . . 61.25 109.547 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.464 ' SD ' HD13 ' A' ' 139' ' ' LEU . 37.4 ttp -144.1 116.27 8.44 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.396 0.617 . . . . 71.329999999999998 109.408 -176.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.4 m -134.61 141.7 46.69 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.188 -0.605 . . . . 73.439999999999998 109.58 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -146.66 116.25 7.14 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.114 -1.069 . . . . 52.439999999999998 108.114 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -124.13 129.88 51.59 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.438 -1.319 . . . . 63.450000000000003 107.438 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.98 155.66 38.46 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.139 -0.689 . . . . 54.420000000000002 109.139 -175.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 16.5 ptm180 -91.85 132.75 36.23 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 120.624 -0.431 . . . . 72.310000000000002 111.078 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.441 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 63.5 m-85 -140.52 129.76 23.69 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 109.091 -0.707 . . . . 74.439999999999998 109.091 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.5 110.8 0.38 Allowed 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 125.211 1.404 . . . . 62.229999999999997 111.982 -178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.573 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 35.9 t70 -69.35 133.22 89.35 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 114.692 -1.14 . . . . 74.140000000000001 110.419 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.41 -45.19 7.51 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.619 2.212 . . . . 43.439999999999998 113.981 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.402 ' OD1' ' HG2' ' A' ' 184' ' ' ARG . 9.3 p30 -83.65 -15.98 46.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.042 0.449 . . . . 52.119999999999997 110.143 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.429 74.8 p 79.57 66.46 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.379 1.871 . . . . 71.140000000000001 115.293 173.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.402 ' HG2' ' OD1' ' A' ' 182' ' ' ASN . 15.2 mmm180 -114.22 155.7 25.65 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.886 -1.506 . . . . 72.319999999999993 109.426 171.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 C--N 1.299 -1.621 0 N-CA-C 107.581 -1.266 . . . . 52.32 107.581 177.085 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.181 0 N-CA-C 110.562 -1.015 . . . . 43.049999999999997 110.562 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -75.41 131.04 39.91 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.538 -0.542 . . . . 65.230000000000004 109.538 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -95.92 135.84 37.13 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.713 -0.676 . . . . 72.299999999999997 110.825 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 179.98 112.82 0.05 OUTLIER 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.04 -1.466 . . . . 44.420000000000002 107.04 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.2 mt -120.78 28.15 8.1 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.311 0.577 . . . . 72.25 109.561 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -86.03 -72.31 0.5 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.473 -0.785 . . . . 55.310000000000002 109.945 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -94.83 6.7 48.22 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.739 -0.664 . . . . 75.549999999999997 111.574 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -76.81 91.88 3.55 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.205 -0.665 . . . . 75.420000000000002 109.205 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.73 84.59 0.2 Allowed Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 108.748 -1.741 . . . . 70.230000000000004 108.748 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -81.34 129.48 34.64 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.77 -0.456 . . . . 75.420000000000002 109.77 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -166.2 128.09 1.87 Allowed 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.081 -0.711 . . . . 73.439999999999998 109.081 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -114.78 135.81 53.76 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.463 -0.939 . . . . 74.129999999999995 108.463 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 52.4 ttt180 -129.57 123.41 31.29 Favored 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 119.865 -0.734 . . . . 73.540000000000006 109.254 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.08 114.08 44.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 106.669 -1.604 . . . . 64.239999999999995 106.669 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.91 113.3 18.92 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.36 -1.348 . . . . 63.509999999999998 107.36 -175.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.62 136.86 52.58 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.811 -0.631 . . . . 71.109999999999999 109.905 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -138.03 115.24 11.0 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.112 -0.699 . . . . 70.340000000000003 109.112 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 14.5 pt -126.55 149.14 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 121.25 0.548 . . . . 74.310000000000002 111.038 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 69.7 m -126.51 123.68 38.33 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 108.439 -0.948 . . . . 72.319999999999993 108.439 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 tt -113.49 125.02 70.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.478 0.656 . . . . 73.549999999999997 110.642 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 43.8 t -88.74 150.96 46.99 Favored Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 115.114 -0.948 . . . . 72.230000000000004 109.243 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 35' ' ' SER . 16.8 Cg_exo -68.92 2.78 2.79 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 123.436 2.757 . . . . 71.319999999999993 111.894 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -89.08 4.53 48.1 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.058 -0.719 . . . . 75.439999999999998 109.058 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 t70 71.5 29.44 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.124 1.44 . . . . 34.25 107.144 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.42 124.93 51.83 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 113.882 -1.508 . . . . 61.310000000000002 107.938 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.479 HG11 HD13 ' A' ' 95' ' ' LEU . 20.7 t -111.58 138.81 38.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.765 -0.828 . . . . 43.229999999999997 108.765 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 p -149.64 157.92 43.69 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.626 -0.879 . . . . 64.409999999999997 108.626 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 159.28 -165.08 34.21 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 119.516 -1.326 . . . . 72.109999999999999 112.432 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.2 141.97 21.04 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.207 0.527 . . . . 74.420000000000002 110.265 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.8 mt -124.31 117.01 49.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.99 -1.115 . . . . 73.200000000000003 107.99 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.13 116.05 51.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.327 -0.62 . . . . 75.010000000000005 109.327 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.5 107.77 18.95 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.946 -1.501 . . . . 62.420000000000002 106.946 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.49 127.72 49.93 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.249 0.547 . . . . 63.340000000000003 109.884 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.82 153.02 29.83 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 109.269 -0.641 . . . . 60.229999999999997 109.269 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 80.3 tttt -79.04 128.68 75.51 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 105.837 -1.912 . . . . 73.239999999999995 105.837 175.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 52' ' ' ASN . 22.6 Cg_exo -21.63 -70.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.573 1 C-N-CA 126.03 4.487 . . . . 73.129999999999995 117.607 -171.064 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 60.6 mtpt 69.18 -31.64 0.21 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 124.669 1.188 . . . . 73.239999999999995 113.206 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 50' ' ' PRO . 45.1 m-80 -130.69 142.98 50.44 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.824 -1.547 . . . . 53.009999999999998 106.824 176.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 m -77.42 -18.64 57.07 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.062 0.458 . . . . 72.319999999999993 111.273 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.66 -17.28 54.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.395 0.617 . . . . 71.129999999999995 109.965 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.36 99.43 8.68 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 113.272 0.842 . . . . 65.219999999999999 113.272 -173.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -91.35 -13.99 31.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.935 -1.03 . . . . 70.049999999999997 108.286 171.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 173.1 104.76 0.18 Allowed Glycine 0 N--CA 1.417 -2.578 0 CA-C-O 118.472 -1.182 . . . . 74.129999999999995 111.163 176.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -52.45 132.78 46.42 Favored 'Trans proline' 0 C--O 1.243 0.771 0 CA-C-N 119.914 1.857 . . . . 74.25 110.772 173.084 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.97 155.83 39.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.055 -0.52 . . . . 60.409999999999997 111.718 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.6 tp -103.0 160.14 14.89 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.243 -1.021 . . . . 73.420000000000002 108.243 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -111.05 95.3 5.45 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.505 -0.924 . . . . 75.439999999999998 108.505 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -105.3 -106.3 3.11 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 120.726 -0.75 . . . . 64.219999999999999 112.136 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.0 t70 60.98 91.99 0.05 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 125.062 1.345 . . . . 61.219999999999999 112.028 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.68 157.72 77.24 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 114.393 -1.276 . . . . 72.439999999999998 108.136 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.82 -18.55 61.45 Favored 'Trans proline' 0 N--CA 1.479 0.634 0 C-N-CA 122.669 2.246 . . . . 70.530000000000001 112.326 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.464 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 42.1 p90 -111.16 32.35 5.38 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.559 -0.746 . . . . 73.219999999999999 112.114 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.5 m -55.92 -33.02 64.31 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 112.052 0.39 . . . . 60.409999999999997 112.052 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.39 -11.07 60.51 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.034 -0.416 . . . . 62.25 111.586 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HE3' HD23 ' A' ' 90' ' ' LEU . 24.3 mtpp -105.49 -4.45 21.27 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 109.905 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 87' ' ' PHE . 4.6 p -125.98 119.03 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 122.179 0.99 . . . . 71.120000000000005 110.377 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.02 102.37 15.02 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.593 -0.73 . . . . 52.219999999999999 109.755 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 7.4 p -98.22 128.84 49.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.734 -0.839 . . . . 70.209999999999994 108.734 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.9 m -146.48 171.8 14.5 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 116.079 -0.509 . . . . 54.149999999999999 110.297 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.465 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 7.3 t30 -82.89 139.1 33.62 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.37 -0.604 . . . . 75.349999999999994 109.37 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -110.51 123.15 49.39 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.734 -0.839 . . . . 72.299999999999997 108.734 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -138.34 99.97 3.99 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.889 -1.523 . . . . 75.519999999999996 106.889 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.4 t -172.68 154.2 2.96 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.98 -0.378 . . . . 73.019999999999996 109.98 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 70.78 7.65 6.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.282 1.033 . . . . 63.329999999999998 111.632 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.65 -9.15 64.23 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.073 -0.811 . . . . 72.530000000000001 111.073 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -104.66 149.71 25.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.048 0.451 . . . . 72.530000000000001 110.692 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.83 137.74 56.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 109.082 -0.71 . . . . 74.540000000000006 109.082 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.43 -153.81 11.04 Favored Glycine 0 C--N 1.285 -2.305 0 C-N-CA 120.209 -0.996 . . . . 74.409999999999997 111.719 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 p -126.77 149.03 49.86 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 121.268 0.556 . . . . 53.240000000000002 110.848 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 9.3 pt20 -132.44 142.37 49.23 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.489 -0.323 . . . . 71.340000000000003 110.5 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.44 114.41 22.84 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.02 -1.104 . . . . 52.219999999999999 108.02 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.19 111.92 38.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.41 -0.959 . . . . 75.340000000000003 108.41 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.45 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.7 p90 -118.47 162.41 18.38 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 112.516 0.561 . . . . 74.540000000000006 112.516 -172.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 p -164.24 160.29 20.98 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.474 -0.785 . . . . 72.319999999999993 110.345 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.0 t70 65.65 30.99 10.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 124.366 1.041 . . . . 73.010000000000005 110.699 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.507 HD23 ' HE3' ' A' ' 69' ' ' LYS . 55.8 mt -95.69 159.69 14.86 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 121.662 -0.649 . . . . 70.329999999999998 110.636 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.415 HG22 ' OE1' ' A' ' 94' ' ' GLU . 8.9 t -106.09 171.41 7.36 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.526 -0.546 . . . . 62.509999999999998 109.526 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -52.49 -40.02 61.89 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.638 0.775 . . . . 75.319999999999993 111.313 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.39 -24.9 65.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.752 -0.658 . . . . 52.219999999999999 111.92 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.415 ' OE1' HG22 ' A' ' 91' ' ' THR . 54.4 mt-10 -87.53 -16.83 33.54 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.461 -0.336 . . . . 74.140000000000001 111.634 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.596 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 49.2 tp -61.67 -51.4 76.72 Favored Pre-proline 0 CA--C 1.562 1.422 0 N-CA-C 113.174 0.805 . . . . 71.140000000000001 113.174 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.453 ' HD3' HD23 ' A' ' 112' ' ' LEU . 33.3 Cg_endo -70.32 -29.08 21.74 Favored 'Trans proline' 0 C--N 1.361 1.213 0 CA-C-N 120.887 1.353 . . . . 74.409999999999997 110.132 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -67.95 -35.52 78.55 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.404 -0.816 . . . . 62.149999999999999 110.438 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -75.62 -19.29 59.31 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 109.783 -0.451 . . . . 75.129999999999995 109.783 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.01 -20.89 63.25 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.171 -0.468 . . . . 75.109999999999999 110.159 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -58.4 -57.14 14.23 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.234 -0.654 . . . . 72.409999999999997 109.234 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.4 ttp -53.79 -51.25 64.06 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 115.633 -0.712 . . . . 74.430000000000007 110.162 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -55.67 -41.51 73.77 Favored 'General case' 0 C--O 1.251 1.178 0 CA-C-N 114.954 -1.021 . . . . 65.25 111.272 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.3 p -65.9 -25.27 67.08 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.187 -0.605 . . . . 75.25 111.675 -171.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.74 -26.59 68.72 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 121.228 0.537 . . . . 72.129999999999995 110.518 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.37 -12.58 15.3 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 120.235 -0.586 . . . . 45.030000000000001 111.185 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.0 -29.16 9.59 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 114.295 1.22 . . . . 75.400000000000006 114.295 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.61 20.88 76.02 Favored Glycine 0 C--O 1.243 0.686 0 C-N-CA 120.535 -0.841 . . . . 24.440000000000001 111.491 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 125' ' ' ALA . 34.7 m -96.68 156.41 3.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.153 -0.523 . . . . 53.329999999999998 111.547 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -132.1 122.19 25.0 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.253 -1.388 . . . . 62.200000000000003 107.253 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.08 123.36 40.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.064 0.393 . . . . 74.5 111.952 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.9 t -104.53 125.01 50.29 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 107.183 -1.414 . . . . 63.450000000000003 107.183 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.59 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 48.7 tp -128.72 123.08 32.14 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.162 -0.681 . . . . 75.420000000000002 109.162 -178.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.59 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 3.2 mpt_? -135.7 146.5 47.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.853 -0.425 . . . . 64.540000000000006 109.853 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.63 ' HG3' HG22 ' A' ' 119' ' ' VAL . 3.3 ttt180 -99.39 138.11 36.95 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 108.057 -1.09 . . . . 73.299999999999997 108.057 174.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -123.8 83.74 2.18 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.96 -1.496 . . . . 64.319999999999993 106.96 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.75 -122.61 22.69 Favored Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 114.137 -1.392 . . . . 54.200000000000003 110.97 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -75.74 -20.53 58.24 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 123.932 0.893 . . . . 72.140000000000001 110.617 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.531 HG22 ' HG2' ' A' ' 177' ' ' ARG . 0.8 OUTLIER -102.58 149.08 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 119.287 -0.965 . . . . 62.100000000000001 110.403 -172.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.63 HG22 ' HG3' ' A' ' 114' ' ' ARG . 59.4 t -117.73 139.81 43.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.784 -0.45 . . . . 74.030000000000001 109.784 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.3 pt -126.03 135.18 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 CA-C-O 121.709 0.766 . . . . 73.340000000000003 110.584 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.29 128.88 47.83 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 107.363 -1.347 . . . . 74.140000000000001 107.363 174.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.79 114.59 12.78 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 105.783 -1.932 . . . . 70.430000000000007 105.783 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.08 160.52 27.16 Favored Glycine 0 N--CA 1.41 -3.083 0 N-CA-C 110.925 -0.87 . . . . 55.350000000000001 110.925 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.469 ' HG2' HG22 ' A' ' 171' ' ' THR . 64.3 mtt180 -141.01 150.47 43.07 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.59 -1.263 . . . . 73.209999999999994 107.59 -176.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 108' ' ' VAL . . . -121.41 128.83 52.59 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.957 -0.386 . . . . 70.349999999999994 109.957 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -111.83 93.56 4.52 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 118.716 -1.194 . . . . 70.209999999999994 109.991 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.494 ' O ' HG22 ' A' ' 130' ' ' VAL . 1.9 pt? -123.26 15.52 9.78 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 113.926 -1.488 . . . . 71.420000000000002 107.482 176.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.43 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 0.2 OUTLIER -65.27 -47.43 76.71 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 113.409 -1.723 . . . . 73.219999999999999 109.01 177.575 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.9 t -87.99 14.9 8.05 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.472 -0.785 . . . . 43.310000000000002 112.589 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 127' ' ' LEU . 32.6 m -76.38 173.46 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 119.257 -0.977 . . . . 65.409999999999997 109.702 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.2 t -112.36 14.29 20.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.19 0.519 . . . . 61.329999999999998 109.622 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.55 99.17 51.49 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 116.034 -0.53 . . . . 71.510000000000005 109.955 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.37 -12.13 18.94 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.152 2.568 . . . . 61.210000000000001 113.753 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -102.25 0.43 34.37 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.545 0.688 . . . . 73.019999999999996 110.33 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.01 145.23 55.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 70.430000000000007 111.921 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 26.8 t70 -132.34 118.05 18.93 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.852 -0.613 . . . . 62.310000000000002 109.972 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 97.6 t -116.57 133.96 61.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.004 -1.11 . . . . 54.530000000000001 108.004 175.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -138.9 138.96 37.88 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.47 -0.567 . . . . 71.530000000000001 109.47 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 tt -133.42 128.23 35.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.061 -1.459 . . . . 72.129999999999995 107.061 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.0 m -126.21 134.21 51.3 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.694 -0.854 . . . . 71.140000000000001 108.694 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 57.6 t -129.02 125.22 62.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.636 -0.505 . . . . 74.129999999999995 109.636 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.08 128.39 56.48 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.008 -0.738 . . . . 75.409999999999997 109.008 177.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 3.4 p90 -134.46 129.67 19.69 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 112.917 0.71 . . . . 73.340000000000003 112.917 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 20.9 Cg_exo -71.86 49.47 1.25 Allowed 'Trans proline' 0 CA--C 1.551 1.363 0 C-N-CA 123.317 2.678 . . . . 74.140000000000001 111.286 172.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.69 -133.78 0.13 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.241 -1.392 . . . . 73.340000000000003 107.241 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -161.88 135.13 6.24 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.027 -1.472 . . . . 51.329999999999998 107.027 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.18 127.65 41.75 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.117 0.484 . . . . 64.319999999999993 110.356 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.4 t -88.08 -37.53 16.18 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.883 -0.414 . . . . 74.219999999999999 109.883 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.1 m -152.6 133.27 13.9 Favored 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 109.561 -0.533 . . . . 74.329999999999998 109.561 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -139.36 161.93 36.24 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 121.95 -0.469 . . . . 72.439999999999998 109.79 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.61 91.18 2.96 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 104.47 -2.418 . . . . 75.099999999999994 104.47 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.8 -147.47 8.76 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 109.296 -1.522 . . . . 23.420000000000002 109.296 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -119.66 99.82 6.89 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.62 -0.881 . . . . 74.239999999999995 108.62 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 12.4 ptt180 -82.11 129.49 34.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 119.513 -0.875 . . . . 73.340000000000003 111.981 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.9 mt -83.71 -42.36 17.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.351 -1.351 . . . . 73.140000000000001 107.351 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -138.71 167.2 20.37 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 106.646 -1.613 . . . . 74.140000000000001 106.646 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.54 0.14 8.51 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.095 1.864 . . . . 74.450000000000003 111.504 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -128.4 3.91 5.67 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.337 0.589 . . . . 71.140000000000001 111.008 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 65.8 t -145.13 120.59 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.377 -0.971 . . . . 74.349999999999994 108.377 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 40.9 t -123.94 149.83 28.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.432 -0.581 . . . . 74.140000000000001 109.432 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -136.23 143.64 44.44 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 109.131 -0.692 . . . . 65.25 109.131 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -122.17 130.27 53.06 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 109.65 -0.5 . . . . 71.099999999999994 109.65 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.37 111.64 24.07 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.433 -0.951 . . . . 40.399999999999999 108.433 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.7 mm? -94.81 122.33 37.32 Favored 'General case' 0 C--O 1.276 2.461 0 CA-C-N 114.726 -1.125 . . . . 54.530000000000001 107.966 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -117.08 130.94 24.25 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 114.637 -1.165 . . . . 73.329999999999998 110.293 -170.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.404 ' HA ' ' HG ' ' A' ' 127' ' ' LEU . 42.4 Cg_endo -67.57 155.37 70.46 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.328 2.685 . . . . 75.230000000000004 112.576 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 73.01 -14.6 2.72 Favored Glycine 0 N--CA 1.466 0.652 0 CA-C-N 115.805 -0.634 . . . . 64.040000000000006 113.796 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.9 m -120.81 162.83 19.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.447 -0.946 . . . . 70.329999999999998 108.447 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.1 p -99.25 128.3 51.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.32 0.581 . . . . 60.32 110.353 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.3 m -116.8 137.73 52.0 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.127 -1.064 . . . . 54.399999999999999 108.127 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 124' ' ' ARG . 20.6 p -116.09 148.03 40.68 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 110.086 -0.338 . . . . 72.129999999999995 110.086 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.432 ' SD ' HD11 ' A' ' 164' ' ' LEU . 2.7 mpp? -126.83 116.84 21.5 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.147 -0.686 . . . . 72.010000000000005 109.147 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.0 t -132.42 138.25 47.58 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.953 -1.128 . . . . 70.109999999999999 107.953 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -145.56 120.66 10.1 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.243 -1.021 . . . . 62.409999999999997 108.243 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -125.17 130.19 51.65 Favored 'General case' 0 C--N 1.272 -2.798 0 N-CA-C 107.204 -1.406 . . . . 62.450000000000003 107.204 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -155.89 153.92 30.42 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.85 -0.796 . . . . 62.439999999999998 108.85 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.531 ' HG2' HG22 ' A' ' 118' ' ' ILE . 60.1 mtt180 -88.19 132.52 34.32 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.94 -0.763 . . . . 61.399999999999999 108.94 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -135.87 129.85 32.96 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 109.282 -0.636 . . . . 74.530000000000001 109.282 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.78 104.21 0.14 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.943 0.777 . . . . 70.099999999999994 111.91 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.62 130.37 94.08 Favored Pre-proline 0 CA--C 1.503 -0.842 0 CA-C-N 114.879 -1.055 . . . . 65.450000000000003 109.238 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.64 -40.0 10.93 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.212 1.942 . . . . 61.119999999999997 112.214 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -9.19 58.84 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 123.684 0.794 . . . . 75.299999999999997 111.704 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.337 50.9 p 65.2 68.83 0.49 Allowed 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 116.612 2.079 . . . . 71.430000000000007 116.612 172.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -85.89 151.09 24.06 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.574 -1.639 . . . . 73.120000000000005 106.574 168.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 C--N 1.296 -1.752 0 N-CA-C 109.709 -0.478 . . . . 74.219999999999999 109.709 -179.235 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.713 0 N-CA-C 109.391 -1.483 . . . . 43.049999999999997 109.391 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -97.19 83.76 3.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.193 -0.669 . . . . 63.340000000000003 109.193 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.35 161.21 31.14 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.185 -0.916 . . . . 74.010000000000005 110.141 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -91.22 111.34 22.77 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.712 0.768 . . . . 60.299999999999997 109.72 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 mp -96.09 98.75 10.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.246 -1.02 . . . . 54.210000000000001 108.246 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -91.96 119.08 31.37 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.563 -0.855 . . . . 62.439999999999998 109.943 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -68.5 138.52 55.27 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.831 -0.803 . . . . 70.099999999999994 108.831 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -103.91 130.59 51.53 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.68 -0.859 . . . . 74.319999999999993 108.68 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.75 158.65 34.75 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.877 -0.602 . . . . 62.450000000000003 111.599 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -138.43 119.05 13.96 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.261 -1.385 . . . . 74.150000000000006 107.261 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 17.6 ptp -150.45 138.15 19.87 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.13 -0.628 . . . . 72.540000000000006 111.348 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 26' ' ' LEU . 2.1 pt? -118.5 109.58 16.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.089 -1.448 . . . . 75.510000000000005 107.089 171.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.01 123.83 49.75 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.42 -1.326 . . . . 63.0 107.42 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.75 122.77 47.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 C-N-CA 119.546 -0.862 . . . . 75.219999999999999 112.058 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -110.22 134.82 51.85 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.336 -0.987 . . . . 71.140000000000001 108.336 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.25 108.8 12.1 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.565 -0.902 . . . . 63.310000000000002 108.565 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 p -116.7 115.05 24.92 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.295 -1.002 . . . . 62.109999999999999 108.295 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.83 146.63 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 121.154 0.502 . . . . 71.120000000000005 109.813 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 87.4 m -126.31 127.8 46.12 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 109.678 -0.49 . . . . 75.109999999999999 109.678 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -110.47 118.26 56.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.61 -0.723 . . . . 72.310000000000002 109.852 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.2 m -84.71 155.16 62.0 Favored Pre-proline 0 C--N 1.296 -1.741 0 CA-C-N 115.446 -0.797 . . . . 75.209999999999994 109.683 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.63 0.68 4.51 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 123.225 2.616 . . . . 64.019999999999996 112.142 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.58 0.32 43.34 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 124.348 1.059 . . . . 53.119999999999997 109.831 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.9 t70 70.27 29.71 3.57 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 123.29 1.519 . . . . 74.049999999999997 107.073 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.75 138.86 52.38 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 113.02 -1.9 . . . . 74.219999999999999 107.959 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.645 HG11 HD23 ' A' ' 95' ' ' LEU . 22.7 t -120.32 140.26 44.98 Favored 'Isoleucine or valine' 0 C--O 1.259 1.564 0 CA-C-O 121.052 0.453 . . . . 63.219999999999999 109.977 -176.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.1 p -147.33 142.88 27.58 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.629 -0.878 . . . . 52.340000000000003 108.629 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.86 -169.06 40.33 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 119.33 -1.414 . . . . 71.430000000000007 112.677 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -151.11 133.8 15.66 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.125 0.488 . . . . 71.349999999999994 110.661 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -116.72 116.17 51.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.456 -1.313 . . . . 74.219999999999999 107.456 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.04 114.84 47.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.763 -0.458 . . . . 70.430000000000007 109.763 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.61 108.68 20.07 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.364 -1.347 . . . . 61.340000000000003 107.364 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.62 119.36 32.64 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.7 0.762 . . . . 74.439999999999998 110.244 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.68 145.64 37.63 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.649 -0.705 . . . . 65.400000000000006 110.164 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -80.27 114.74 49.54 Favored Pre-proline 0 N--CA 1.42 -1.948 0 N-CA-C 102.999 -2.963 . . . . 71.409999999999997 102.999 171.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -31.64 104.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 124.926 3.751 . . . . 74.019999999999996 114.615 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -84.64 -25.93 28.19 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.488 0.661 . . . . 74.200000000000003 109.983 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -104.41 129.76 52.35 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.096 -1.076 . . . . 72.239999999999995 108.096 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 m -63.8 -27.85 69.46 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 123.383 0.673 . . . . 51.329999999999998 111.756 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -87.08 -8.82 56.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.113 0.482 . . . . 72.200000000000003 110.359 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.93 120.06 30.0 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.631 0.729 . . . . 75.430000000000007 112.585 -169.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -121.85 7.34 9.88 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 114.614 -1.175 . . . . 71.099999999999994 109.818 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.14 97.69 0.11 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 119.908 -1.139 . . . . 43.240000000000002 112.936 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.68 153.3 26.27 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 123.216 2.611 . . . . 44.43 111.461 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -113.38 157.28 22.08 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.598 -0.519 . . . . 54.409999999999997 109.598 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.467 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 65.1 mt -88.81 135.76 33.36 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.857 -0.423 . . . . 42.240000000000002 109.857 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.53 87.41 3.82 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.852 -0.613 . . . . 73.230000000000004 110.059 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.488 ' HA3' ' HG3' ' A' ' 101' ' ' MET . . . -161.82 156.6 28.18 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 110.885 -0.886 . . . . 71.439999999999998 110.885 176.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -144.22 129.08 18.39 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.102 -0.703 . . . . 61.340000000000003 109.102 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.06 147.56 61.21 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.458 -0.571 . . . . 72.430000000000007 109.458 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.15 -8.99 21.88 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.203 2.602 . . . . 70.420000000000002 113.215 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -110.45 42.23 1.61 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.428 0.632 . . . . 65.319999999999993 110.286 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 m -57.97 -34.6 70.12 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.605 -0.725 . . . . 63.520000000000003 110.945 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -71.27 -9.16 57.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.266 0.555 . . . . 62.030000000000001 110.851 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.28 -17.29 17.37 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.793 -0.639 . . . . 74.340000000000003 110.019 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 p -130.39 118.1 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.912 0.863 . . . . 75.140000000000001 111.015 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.89 112.41 24.18 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.035 -0.984 . . . . 75.019999999999996 109.151 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.0 t -98.16 130.52 46.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 106.949 -1.501 . . . . 64.310000000000002 106.949 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.9 t -144.04 172.7 12.52 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.112 0.482 . . . . 65.140000000000001 110.792 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -80.19 141.74 35.36 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 124.874 1.27 . . . . 64.310000000000002 109.323 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -119.76 120.14 35.69 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.635 -0.876 . . . . 72.519999999999996 108.635 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -138.7 103.99 4.98 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.655 -0.868 . . . . 75.010000000000005 108.655 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.2 t -164.75 142.25 6.35 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.705 -0.398 . . . . 73.040000000000006 110.692 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 65.24 13.54 8.83 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.391 1.476 . . . . 70.420000000000002 112.223 174.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.41 -3.11 59.47 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.865 -0.683 . . . . 72.299999999999997 111.908 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -99.84 148.04 24.86 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.856 -0.794 . . . . 75.530000000000001 108.856 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.23 136.76 59.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.328 -0.99 . . . . 75.420000000000002 108.328 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -166.03 -154.69 8.34 Favored Glycine 0 N--CA 1.413 -2.834 0 C-N-CA 120.112 -1.042 . . . . 70.409999999999997 112.478 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.467 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 6.7 m -126.08 148.37 49.37 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.888 -0.782 . . . . 64.019999999999996 108.888 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -129.81 132.14 46.4 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 120.556 -0.457 . . . . 73.319999999999993 110.363 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.78 113.92 26.88 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.702 -1.592 . . . . 73.420000000000002 106.702 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.68 112.36 39.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.732 -0.84 . . . . 72.340000000000003 108.732 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.484 ' HE2' HG12 ' A' ' 40' ' ' VAL . 45.3 p90 -120.02 152.8 36.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.292 0.567 . . . . 61.100000000000001 111.633 -173.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.6 p -159.73 157.38 29.35 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.276 -0.874 . . . . 72.329999999999998 109.727 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 67.28 31.69 6.41 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.592 1.157 . . . . 53.340000000000003 110.295 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.459 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.1 mt -96.23 164.44 12.67 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.813 -0.631 . . . . 65.150000000000006 110.091 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m -107.79 160.22 15.89 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 109.392 -0.596 . . . . 64.209999999999994 109.392 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -49.91 -43.15 49.44 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.192 1.397 . . . . 74.129999999999995 110.628 176.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.39 -30.45 71.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.865 -0.607 . . . . 65.310000000000002 111.441 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -82.91 -15.44 51.39 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.792 -0.64 . . . . 74.239999999999995 111.589 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.645 HD23 HG11 ' A' ' 40' ' ' VAL . 2.5 tm? -54.03 -56.2 28.35 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 123.056 0.542 . . . . 75.019999999999996 111.269 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.78 -36.13 75.37 Favored 'Trans proline' 0 C--N 1.371 1.723 0 CA-C-N 120.61 1.254 . . . . 61.409999999999997 111.072 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.433 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 70.7 mt-30 -62.8 -37.41 86.59 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.691 -0.686 . . . . 72.239999999999995 111.818 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -75.54 -20.41 58.7 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.184 0.516 . . . . 61.100000000000001 110.045 177.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.49 -20.21 57.2 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.717 -0.674 . . . . 45.140000000000001 109.537 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 97' ' ' GLN . 87.7 m-20 -62.77 -55.06 29.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.85 -0.613 . . . . 75.340000000000003 110.114 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.488 ' HG3' ' HA3' ' A' ' 62' ' ' GLY . 24.3 ttp -53.97 -51.27 64.41 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.167 0.292 . . . . 72.409999999999997 110.72 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.66 -35.27 72.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.846 -0.615 . . . . 73.439999999999998 110.429 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.4 t -59.86 -39.86 86.65 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.015 -0.735 . . . . 71.310000000000002 109.015 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -63.22 -25.24 68.24 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 115.339 -0.846 . . . . 72.340000000000003 110.943 -172.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.11 -20.09 13.52 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 119.949 -0.7 . . . . 65.219999999999999 111.591 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.19 -42.1 5.17 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 114.237 1.199 . . . . 74.109999999999999 114.237 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.97 25.76 18.81 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.635 -0.986 . . . . 52.43 110.635 -172.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.2 m -109.34 157.26 9.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.68 -0.489 . . . . 73.239999999999995 109.68 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -142.66 128.26 19.13 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.803 -0.814 . . . . 74.510000000000005 108.803 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -130.03 128.98 43.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.581 0.229 . . . . 63.009999999999998 110.664 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.8 m -118.05 134.19 55.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.301 -1.0 . . . . 74.040000000000006 108.301 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.469 HD22 ' HG ' ' A' ' 95' ' ' LEU . 53.2 tp -133.13 123.4 25.61 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.188 -0.671 . . . . 52.210000000000001 109.188 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.3 mtp180 -134.23 153.02 52.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.155 0.502 . . . . 74.019999999999996 111.703 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.502 HH11 ' HB2' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -106.4 122.11 45.61 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 124.33 1.052 . . . . 71.019999999999996 108.935 179.113 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.421 ' O ' HG13 ' A' ' 118' ' ' ILE . 6.8 t30 -118.14 101.23 8.07 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.779 -1.193 . . . . 64.219999999999999 107.779 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.34 -120.06 7.52 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 108.441 -1.864 . . . . 72.439999999999998 108.441 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.28 -2.07 22.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.718 -1.216 . . . . 43.420000000000002 107.718 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -100.28 148.96 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 C-N-CA 119.37 -0.932 . . . . 63.109999999999999 109.068 -175.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.71 140.5 40.57 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-O 120.793 0.33 . . . . 73.409999999999997 111.18 -175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.3 pt -119.79 135.37 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.624 -0.717 . . . . 73.209999999999994 109.36 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.79 127.07 45.57 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.542 -0.754 . . . . 74.019999999999996 109.39 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.29 122.24 31.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.202 -0.908 . . . . 74.549999999999997 108.95 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -136.35 146.65 18.63 Favored Glycine 0 N--CA 1.422 -2.277 0 N-CA-C 110.573 -1.011 . . . . 73.219999999999999 110.573 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -139.55 144.58 37.89 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.174 -0.676 . . . . 75.310000000000002 109.174 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.48 118.82 22.72 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.046 -0.724 . . . . 73.439999999999998 109.046 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -102.35 94.04 5.49 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.768 -0.773 . . . . 62.329999999999998 111.421 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.71 16.87 13.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.984 -1.487 . . . . 72.109999999999999 106.984 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.492 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 1.3 m -60.74 -30.97 70.31 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.778 1.631 . . . . 52.130000000000003 112.733 -174.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.0 m -80.99 0.63 34.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.179 0.514 . . . . 72.120000000000005 110.073 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.5 t 65.67 75.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 125.32 1.448 . . . . 74.239999999999995 110.451 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.9 m -63.16 -42.69 99.46 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.606 -1.179 . . . . 63.32 108.701 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -150.38 132.99 8.24 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 106.045 -1.835 . . . . 74.319999999999993 106.045 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.41 -19.96 18.85 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.061 1.841 . . . . 73.150000000000006 114.613 -175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -108.22 13.02 26.14 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.614 0.721 . . . . 74.239999999999995 109.835 -173.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.45 129.49 38.92 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.741 -0.663 . . . . 75.439999999999998 110.754 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -131.73 111.65 11.84 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.695 -1.224 . . . . 73.329999999999998 107.695 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.717 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 49.2 t -111.94 127.66 68.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.956 -0.757 . . . . 62.219999999999999 108.956 -177.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -112.07 121.25 44.47 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.337 -0.616 . . . . 75.439999999999998 109.337 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.441 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.3 tm? -115.29 116.31 28.09 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.593 -1.262 . . . . 75.439999999999998 107.593 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.6 m -126.44 130.77 51.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 110.133 -0.321 . . . . 61.229999999999997 110.133 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.5 t -123.65 125.77 71.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.464 -0.569 . . . . 74.030000000000001 109.464 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.3 131.16 56.62 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.028 -0.73 . . . . 73.420000000000002 109.028 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.689 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.3 p90 -134.31 122.93 16.29 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.406 -0.361 . . . . 71.239999999999995 110.918 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -69.02 47.4 0.44 Allowed 'Trans proline' 0 CA--C 1.56 1.819 0 C-N-CA 123.008 2.472 . . . . 71.019999999999996 112.297 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -132.86 -108.13 0.24 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 122.823 0.449 . . . . 64.140000000000001 110.538 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.21 131.19 0.14 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.722 -0.844 . . . . 75.430000000000007 108.722 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.412 HG21 ' HB ' ' A' ' 150' ' ' THR . 8.4 p -85.09 128.73 38.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.14 -0.689 . . . . 73.239999999999995 109.14 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.0 t -88.62 -36.04 16.5 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.246 -0.434 . . . . 62.420000000000002 110.012 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.5 m -157.71 133.03 8.9 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 108.938 -0.764 . . . . 52.399999999999999 108.938 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.412 ' HB ' HG21 ' A' ' 147' ' ' VAL . 9.9 t -138.92 165.39 27.19 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 121.98 -0.45 . . . . 73.329999999999998 109.824 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 45.4 t30 -137.05 93.43 2.83 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 105.585 -2.006 . . . . 65.25 105.585 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.81 -147.0 10.45 Favored Glycine 0 N--CA 1.416 -2.67 0 N-CA-C 109.045 -1.622 . . . . 41.229999999999997 109.045 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -111.79 100.06 8.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.251 -0.648 . . . . 55.130000000000003 109.251 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -78.28 115.75 18.22 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.965 0.412 . . . . 71.439999999999998 110.684 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.0 mt -82.21 -48.99 17.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.217 -1.401 . . . . 73.239999999999995 107.217 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -130.92 159.74 70.0 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.095 -1.446 . . . . 74.319999999999993 107.095 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.404 ' O ' HG12 ' A' ' 147' ' ' VAL . 32.4 Cg_exo -62.74 -13.49 34.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.375 2.05 . . . . 54.229999999999997 112.187 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.689 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -122.39 8.0 9.62 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 112.816 0.673 . . . . 65.319999999999993 112.816 176.406 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.8 t -140.73 120.93 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 109.61 -0.515 . . . . 63.25 109.61 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.28 147.58 31.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.707 -0.479 . . . . 74.209999999999994 109.707 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -132.47 149.8 52.27 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.097 0.475 . . . . 55.100000000000001 109.898 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.462 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 23.8 m-90 -131.65 133.27 44.73 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.323 -1.362 . . . . 73.239999999999995 107.323 174.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -107.09 114.74 28.99 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.974 -0.75 . . . . 74.109999999999999 108.974 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.717 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.6 mp -88.9 125.57 35.0 Favored 'General case' 0 C--O 1.273 2.309 0 CA-C-N 114.212 -1.358 . . . . 75.340000000000003 110.572 -173.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 96.2 mttt -118.59 147.15 41.42 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 113.304 -1.771 . . . . 71.030000000000001 110.771 -171.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 165' ' ' LYS . 2.7 Cg_exo -76.39 159.31 36.39 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.437 2.091 . . . . 71.310000000000002 112.356 174.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 74.06 -14.72 3.62 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 123.136 0.398 . . . . 64.230000000000004 113.822 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.33 145.43 26.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.229 -1.026 . . . . 61.130000000000003 108.229 171.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.4 110.06 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 108.42 -0.956 . . . . 60.020000000000003 108.42 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.6 m -76.84 130.7 37.98 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.375 -0.83 . . . . 62.340000000000003 108.93 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.6 p -115.84 125.73 53.04 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.623 -0.717 . . . . 72.239999999999995 110.129 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -112.33 117.07 31.46 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.989 -1.115 . . . . 71.540000000000006 107.989 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 13.7 m -135.48 137.05 41.76 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.426 -1.31 . . . . 70.409999999999997 110.411 176.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -149.43 135.25 18.74 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.566 -0.901 . . . . 61.43 108.566 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -131.38 130.01 42.06 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 107.127 -1.435 . . . . 64.329999999999998 107.127 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -153.57 159.82 42.29 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.622 -0.881 . . . . 62.530000000000001 108.622 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 40.0 mtt180 -95.32 127.18 41.16 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.388 -0.925 . . . . 64.409999999999997 108.946 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -130.37 127.86 40.24 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.164 -1.05 . . . . 74.219999999999999 108.164 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.29 104.74 0.1 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 124.83 1.331 . . . . 64.150000000000006 112.675 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.11 138.87 96.0 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 114.684 -1.144 . . . . 64.5 111.728 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.59 -40.72 1.39 Allowed 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 122.801 2.334 . . . . 71.010000000000005 114.276 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.06 -13.43 53.13 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.432 0.634 . . . . 55.420000000000002 109.39 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.462 64.4 p 81.32 68.89 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 126.972 2.109 . . . . 62.43 115.294 172.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -97.15 154.77 17.16 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 113.26 -1.791 . . . . 62.229999999999997 108.464 171.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--N 1.297 -1.683 0 N-CA-C 107.589 -1.263 . . . . 41.450000000000003 107.589 178.807 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.105 0 N-CA-C 109.473 -1.451 . . . . 43.049999999999997 109.473 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 61.35 15.05 6.2 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 117.609 0.704 . . . . 74.030000000000001 112.28 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -97.94 85.92 3.62 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 122.151 0.977 . . . . 63.229999999999997 111.289 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.18 95.46 4.9 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.727 -1.212 . . . . 73.219999999999999 107.727 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -133.51 135.85 44.68 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.404 -0.816 . . . . 74.310000000000002 109.922 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -139.45 127.37 22.19 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.042 -0.725 . . . . 71.299999999999997 109.042 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.48 ' HB3' ' O ' ' A' ' 51' ' ' LYS . 73.6 m-85 -127.55 102.53 6.89 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.073 -1.084 . . . . 75.209999999999994 108.073 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -113.34 107.95 16.57 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.136 -0.484 . . . . 61.420000000000002 111.186 -173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.79 69.46 0.25 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.863 -0.684 . . . . 63.030000000000001 113.08 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.402 ' O ' ' HB3' ' A' ' 132' ' ' ASP . 87.4 m-70 -111.28 26.67 10.43 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 122.148 0.975 . . . . 73.549999999999997 110.395 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.407 ' SD ' ' HE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -107.34 103.37 12.71 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.059 -1.83 . . . . 45.340000000000003 106.059 175.576 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.2 tp -122.68 116.23 23.43 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.021 -0.733 . . . . 74.019999999999996 109.021 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -109.81 123.93 50.42 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 108.0 -1.111 . . . . 62.350000000000001 108.0 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.9 t -107.26 114.72 46.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.398 -0.964 . . . . 63.530000000000001 108.398 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -112.25 113.15 25.23 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.422 -0.955 . . . . 64.409999999999997 108.422 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.16 108.63 14.02 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.052 -1.092 . . . . 52.530000000000001 108.052 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 140' ' ' THR . 20.2 m -122.11 114.32 20.74 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.125 -0.694 . . . . 72.129999999999995 109.125 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.5 pt -126.61 148.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 O-C-N 121.891 -0.506 . . . . 75.530000000000001 109.84 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.2 m -127.92 119.93 26.6 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 116.089 -0.505 . . . . 73.319999999999993 109.783 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.598 HG23 ' OH ' ' A' ' 178' ' ' TYR . 8.7 tt -104.41 125.62 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 108.64 -0.874 . . . . 72.230000000000004 108.64 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.7 m -94.66 152.65 40.02 Favored Pre-proline 0 C--N 1.281 -2.383 0 CA-C-N 115.754 -0.657 . . . . 42.119999999999997 109.557 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.93 2.56 0.57 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 123.934 3.089 . . . . 61.240000000000002 113.475 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 33.5 t70 -82.0 -7.55 59.62 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.425 1.09 . . . . 71.430000000000007 109.582 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 73.16 28.69 1.83 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 123.374 1.559 . . . . 72.219999999999999 107.269 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -111.34 132.16 54.61 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.296 -1.774 . . . . 75.409999999999997 109.148 178.513 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.95 143.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.116 -0.698 . . . . 73.430000000000007 109.116 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 p -149.69 155.24 39.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.052 -1.462 . . . . 61.140000000000001 107.052 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.84 -174.59 44.06 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 118.287 -1.911 . . . . 73.5 114.343 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.38 133.26 36.57 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 124.327 1.051 . . . . 73.329999999999998 108.721 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.9 mt -119.89 115.54 47.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 105.663 -1.977 . . . . 73.120000000000005 105.663 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.8 mt -126.45 114.74 39.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 109.671 -0.492 . . . . 73.400000000000006 109.671 -172.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.02 109.27 19.3 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.391 -1.337 . . . . 74.120000000000005 107.391 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -119.69 126.47 51.19 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.453 -0.499 . . . . 65.340000000000003 111.53 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.9 157.35 27.83 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.531 -0.759 . . . . 60.439999999999998 109.316 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -83.44 126.35 71.72 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 106.999 -1.482 . . . . 74.510000000000005 106.999 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -33.57 111.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 124.806 3.671 . . . . 62.149999999999999 113.49 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 21' ' ' PHE . 59.7 pttt -91.26 -6.64 52.95 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.775 -0.648 . . . . 75.129999999999995 112.658 -173.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -155.84 159.63 39.54 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.329 -0.989 . . . . 72.439999999999998 108.329 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 p -57.27 -43.11 82.79 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 123.93 0.892 . . . . 35.039999999999999 111.975 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -90.56 -1.24 57.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.943 -0.571 . . . . 53.219999999999999 111.886 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.28 99.53 5.54 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.3 -0.629 . . . . 72.409999999999997 109.3 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 p -116.81 -19.44 9.89 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.304 -0.862 . . . . 52.020000000000003 112.94 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.61 98.03 0.11 Allowed Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 120.196 -1.002 . . . . 54.450000000000003 112.148 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 83' ' ' SER . 67.9 Cg_exo -54.87 159.19 9.65 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.802 2.335 . . . . 75.430000000000007 111.368 173.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.99 157.11 21.1 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.923 -0.486 . . . . 63.520000000000003 111.027 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 81.6 mt -109.9 139.12 45.35 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.82 -0.807 . . . . 71.010000000000005 108.82 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -108.27 98.78 8.27 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.097 -1.075 . . . . 64.340000000000003 108.097 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.5 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -109.63 95.96 0.92 Allowed Glycine 0 C--N 1.283 -2.386 0 CA-C-N 115.109 -0.95 . . . . 52.450000000000003 112.531 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -87.01 89.39 7.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.235 -1.024 . . . . 70.409999999999997 108.235 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.39 154.13 78.35 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 109.47 -0.567 . . . . 74.510000000000005 109.47 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.22 -28.67 18.31 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.325 2.017 . . . . 73.430000000000007 112.152 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -91.21 38.23 0.96 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.746 -0.661 . . . . 74.409999999999997 112.07 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.73 -45.07 58.43 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.523 1.129 . . . . 75.109999999999999 113.535 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -12.13 60.77 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.051 0.453 . . . . 73.040000000000006 111.099 -174.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 88' ' ' SER . 69.1 mmtt -93.35 -9.61 38.19 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 116.198 -0.455 . . . . 52.020000000000003 110.115 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -115.41 118.52 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 C-N-CA 118.518 -1.273 . . . . 74.329999999999998 110.063 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.44 102.6 14.4 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.998 -1.001 . . . . 64.239999999999995 108.871 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.7 t -98.27 135.74 31.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.462 -1.31 . . . . 71.099999999999994 107.462 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 t -155.52 171.87 19.21 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.693 -0.854 . . . . 33.539999999999999 108.693 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -83.58 142.78 30.59 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.689 -0.856 . . . . 71.439999999999998 108.689 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -99.06 122.38 42.22 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.313 -0.995 . . . . 74.340000000000003 108.313 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -138.99 99.62 3.82 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.187 -0.672 . . . . 53.439999999999998 109.187 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.2 t -172.88 149.74 1.97 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.612 -0.514 . . . . 62.549999999999997 109.612 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.91 16.2 8.83 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.393 1.077 . . . . 63.520000000000003 111.674 173.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.5 1.55 85.68 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.442 -0.663 . . . . 64.420000000000002 111.442 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.493 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 91.8 m-85 -104.29 145.51 30.12 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 109.5 -0.556 . . . . 71.420000000000002 109.5 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.2 136.67 60.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.797 -1.186 . . . . 53.329999999999998 107.797 173.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -165.47 -154.97 8.34 Favored Glycine 0 C--N 1.27 -3.115 0 C-N-CA 119.65 -1.262 . . . . 64.420000000000002 111.638 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.527 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 21.2 p -123.84 143.23 50.46 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 109.604 -0.517 . . . . 71.329999999999998 109.604 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -138.37 142.59 39.63 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 120.406 -0.518 . . . . 74.430000000000007 110.954 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.37 114.9 18.83 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.197 -1.038 . . . . 34.409999999999997 108.197 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -105.97 115.0 46.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 108.62 -0.881 . . . . 74.5 108.62 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -118.34 154.43 32.36 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 120.393 -0.523 . . . . 74.140000000000001 110.938 -175.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 80.8 p -157.53 171.35 20.51 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 109.335 -0.617 . . . . 64.209999999999994 109.335 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 62.15 30.59 17.78 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.438 1.087 . . . . 75.219999999999999 110.62 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt -101.15 164.24 11.89 Favored 'General case' 0 N--CA 1.42 -1.926 0 C-N-CA 120.165 -0.614 . . . . 62.329999999999998 111.116 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -113.04 170.79 7.95 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.235 -0.654 . . . . 73.510000000000005 109.235 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -54.57 -38.25 66.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.407 1.083 . . . . 74.409999999999997 111.746 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.51 65.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.236 -0.438 . . . . 72.439999999999998 111.876 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -86.46 -16.51 36.86 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.904 0.383 . . . . 55.32 111.665 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.7 tt -62.35 -47.71 88.8 Favored Pre-proline 0 CA--C 1.569 1.685 0 CA-C-N 116.236 -0.438 . . . . 75.349999999999994 111.378 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.55 -40.15 76.63 Favored 'Trans proline' 0 C--N 1.38 2.232 0 CA-C-N 120.831 1.333 . . . . 72.329999999999998 110.768 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -61.16 -41.8 97.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.236 -0.893 . . . . 73.519999999999996 111.534 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -72.36 -20.39 61.47 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.376 -0.375 . . . . 62.439999999999998 110.635 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.01 -26.13 60.27 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.21 -0.663 . . . . 73.030000000000001 109.21 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -62.87 -52.06 64.57 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.58 -0.896 . . . . 62.130000000000003 108.58 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.5 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 32.2 ttp -53.89 -51.59 63.2 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.478 -0.783 . . . . 72.420000000000002 109.78 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -55.22 -35.0 64.44 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.192 -0.913 . . . . 74.530000000000001 111.076 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -58.96 -32.57 69.75 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 119.234 -0.413 . . . . 72.540000000000006 111.465 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.26 -25.7 67.98 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.269 0.557 . . . . 65.099999999999994 111.233 -173.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.37 -14.48 14.43 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.809 -0.632 . . . . 74.150000000000006 111.01 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.414 ' HB1' HG13 ' A' ' 108' ' ' VAL . . . -106.3 -43.79 4.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.309 0.855 . . . . 74.329999999999998 113.309 -171.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.37 22.69 69.84 Favored Glycine 0 C--N 1.317 -0.481 0 N-CA-C 111.122 -0.791 . . . . 52.200000000000003 111.122 -173.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.414 HG13 ' HB1' ' A' ' 106' ' ' ALA . 18.3 m -103.87 161.53 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.576 -0.527 . . . . 62.219999999999999 109.576 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -123.31 121.62 36.28 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.67 -1.604 . . . . 73.109999999999999 106.67 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.0 mt -122.77 107.23 11.67 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.266 -0.642 . . . . 72.329999999999998 109.266 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.1 m -115.87 141.02 48.65 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.88 -0.785 . . . . 73.109999999999999 108.88 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -149.92 155.38 39.89 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.9 -0.32 . . . . 71.439999999999998 110.478 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -156.09 161.84 40.34 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.339 -0.985 . . . . 51.109999999999999 108.339 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -106.47 133.09 51.7 Favored 'General case' 0 N--CA 1.398 -3.031 0 N-CA-C 107.322 -1.362 . . . . 75.450000000000003 107.322 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -118.81 100.24 7.27 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 106.839 -1.541 . . . . 70.120000000000005 106.839 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.91 -113.05 4.98 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.325 -1.11 . . . . 53.240000000000002 110.325 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -114.32 12.09 17.51 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.932 1.348 . . . . 73.040000000000006 109.477 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.23 148.86 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 O-C-N 120.445 -1.41 . . . . 65.519999999999996 108.868 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 178' ' ' TYR . 82.4 t -106.41 136.0 42.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 CA-C-O 120.761 0.315 . . . . 73.430000000000007 110.398 -177.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.1 pt -116.94 134.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 108.876 -0.787 . . . . 65.439999999999998 108.876 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 tt -127.84 126.25 41.28 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.279 -1.008 . . . . 73.340000000000003 108.279 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -128.63 114.86 17.21 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.828 0.823 . . . . 73.340000000000003 109.142 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.39 139.4 14.13 Favored Glycine 0 N--CA 1.4 -3.747 0 N-CA-C 108.777 -1.729 . . . . 51.219999999999999 108.777 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -140.23 131.09 25.96 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.633 -1.618 . . . . 72.5 106.633 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -139.5 144.8 38.1 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.688 0.756 . . . . 51.32 112.871 -172.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.24 93.43 5.69 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.513 -1.221 . . . . 74.129999999999995 107.937 174.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.13 0.27 56.22 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.929 0.871 . . . . 70.129999999999995 108.827 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.5 p -65.03 -21.26 66.81 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.452 -1.249 . . . . 64.030000000000001 111.409 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.9 t -85.01 -21.72 29.34 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 116.008 -0.542 . . . . 53.219999999999999 110.613 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.6 t -68.99 113.39 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.541 -0.911 . . . . 53.310000000000002 108.541 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.8 m -101.38 9.97 41.02 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.321 0.489 . . . . 73.230000000000004 112.321 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 24' ' ' HIS . 31.2 m-20 -86.36 111.97 42.78 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.537 -0.912 . . . . 73.549999999999997 108.537 176.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -68.98 -18.91 40.5 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.61 2.207 . . . . 62.240000000000002 113.504 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -107.58 18.59 21.28 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.034 0.445 . . . . 75.340000000000003 111.236 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.02 140.37 29.81 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.42 -0.354 . . . . 75.519999999999996 111.863 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -133.06 139.67 47.29 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.492 -0.929 . . . . 72.439999999999998 108.492 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.77 113.89 44.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.126 -0.694 . . . . 75.230000000000004 109.126 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -113.29 120.13 40.11 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.21 0.529 . . . . 74.409999999999997 109.949 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 39.9 tp -112.18 120.6 42.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.306 -0.998 . . . . 74.519999999999996 108.306 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 31' ' ' SER . 17.4 m -120.89 112.62 19.01 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.566 -0.901 . . . . 41.140000000000001 108.566 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.49 120.77 61.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.508 -0.923 . . . . 61.310000000000002 108.508 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -105.73 126.92 52.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.523 -0.917 . . . . 52.200000000000003 108.523 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.443 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 0.3 OUTLIER -134.25 103.36 11.58 Favored Pre-proline 0 C--N 1.274 -2.697 0 CA-C-N 115.591 -0.731 . . . . 70.340000000000003 110.349 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.34 45.2 0.4 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 123.574 2.849 . . . . 74.530000000000001 112.277 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.53 -86.26 0.64 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.457 -0.571 . . . . 64.420000000000002 109.457 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.55 113.47 0.01 OUTLIER 'General case' 0 C--O 1.247 0.972 0 C-N-CA 123.72 0.808 . . . . 74.129999999999995 109.112 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 9.4 p -75.66 130.83 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.768 -1.197 . . . . 65.340000000000003 107.768 174.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.8 t -103.8 -28.71 11.46 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.296 -0.962 . . . . 73.040000000000006 110.852 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.7 m -159.28 132.96 7.33 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 107.406 -1.331 . . . . 74.239999999999995 107.406 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -139.75 162.14 35.85 Favored 'General case' 0 C--N 1.282 -2.331 0 O-C-N 122.104 -0.372 . . . . 70.329999999999998 110.414 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -130.04 90.55 2.98 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 104.927 -2.249 . . . . 64.109999999999999 104.927 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 172.35 -147.93 10.31 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 109.471 -1.452 . . . . 72.430000000000007 109.471 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -116.59 99.66 7.3 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 117.501 0.65 . . . . 65.109999999999999 109.481 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -72.58 131.89 43.06 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 121.287 0.565 . . . . 53.009999999999998 110.328 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.5 mm -96.07 -49.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 106.958 -1.497 . . . . 74.140000000000001 106.958 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -134.73 166.42 29.33 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 105.857 -1.905 . . . . 70.329999999999998 105.857 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.96 -2.39 11.44 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.309 2.006 . . . . 75.340000000000003 110.86 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.82 10.76 5.11 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.187 -0.915 . . . . 53.520000000000003 111.076 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.0 t -147.02 120.71 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.507 -0.923 . . . . 75.329999999999998 108.507 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.6 147.01 30.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.751 -0.833 . . . . 72.019999999999996 108.751 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 53.3 tt0 -132.92 142.44 48.9 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-O 121.595 0.712 . . . . 74.310000000000002 110.207 -174.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.451 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 29.1 m-90 -123.63 116.02 22.42 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.095 -1.076 . . . . 72.349999999999994 108.095 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.554 ' HD3' ' H ' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -112.36 98.42 7.27 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.017 0.913 . . . . 53.43 109.478 -178.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 170' ' ' SER . 0.7 OUTLIER -95.75 147.4 23.66 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.221 -1.354 . . . . 54.329999999999998 110.084 -171.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 34.1 mttp -117.11 150.19 45.66 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 115.587 -0.733 . . . . 71.519999999999996 112.105 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 165' ' ' LYS . 32.1 Cg_exo -66.06 157.48 59.32 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 123.318 2.679 . . . . 74.519999999999996 111.466 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.48 -27.26 2.51 Favored Glycine 0 C--N 1.313 -0.744 0 C-N-CA 121.54 -0.362 . . . . 31.149999999999999 112.899 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.3 m -105.85 167.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 120.723 0.297 . . . . 74.540000000000006 110.624 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.6 p -114.05 143.97 22.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.112 -0.699 . . . . 72.430000000000007 109.112 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 164' ' ' LEU . 44.5 m -153.09 150.26 28.94 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 121.992 -0.443 . . . . 74.129999999999995 110.186 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 27.7 p -120.37 126.41 50.43 Favored 'General case' 0 N--CA 1.428 -1.557 0 C-N-CA 122.94 0.496 . . . . 73.420000000000002 110.0 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -98.14 121.39 40.01 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.591 -0.522 . . . . 72.040000000000006 109.591 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.3 m -137.98 138.44 38.91 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.865 -1.147 . . . . 74.510000000000005 111.369 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.451 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -145.31 128.77 16.97 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 115.811 -0.631 . . . . 63.109999999999999 109.675 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -117.19 130.69 56.76 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 107.006 -1.479 . . . . 74.219999999999999 107.006 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -140.85 152.28 44.99 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.497 -0.557 . . . . 31.02 109.497 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -90.74 126.28 35.95 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.406 -0.961 . . . . 74.420000000000002 108.406 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.598 ' OH ' HG23 ' A' ' 34' ' ' ILE . 5.4 m-85 -126.26 126.7 44.44 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 113.059 0.763 . . . . 73.310000000000002 113.059 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 35.7 p -67.79 105.17 1.86 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.606 -1.179 . . . . 54.32 108.484 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.49 132.69 88.42 Favored Pre-proline 0 CA--C 1.506 -0.721 0 O-C-N 123.773 0.671 . . . . 55.240000000000002 110.114 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.02 -46.72 7.76 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.261 1.974 . . . . 74.340000000000003 113.673 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -84.9 -12.08 54.19 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.858 0.361 . . . . 74.420000000000002 110.522 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.272 60.1 p 72.64 47.47 0.24 Allowed 'General case' 0 C--O 1.254 1.296 0 C-N-CA 126.122 1.769 . . . . 74.319999999999993 112.685 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.49 150.93 39.63 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.161 -1.381 . . . . 72.329999999999998 109.183 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.27 -2.881 0 N-CA-C 107.527 -1.286 . . . . 71.310000000000002 107.527 -179.79 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.87 0 N-CA-C 111.324 -0.711 . . . . 43.049999999999997 111.324 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.32 101.52 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.863 0.331 . . . . 73.450000000000003 110.294 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.71 -48.9 7.87 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.213 -2.143 . . . . 74.25 105.213 171.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.3 m-20 37.8 76.07 0.06 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.491 1.916 . . . . 72.109999999999999 114.27 171.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 47.6 tp -80.42 104.01 10.67 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.666 -0.864 . . . . 55.140000000000001 108.666 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 18' ' ' ASN . 46.6 m-85 -90.22 150.46 21.96 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.757 -0.656 . . . . 71.209999999999994 111.779 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 53' ' ' SER . 97.3 m-85 -131.08 135.38 47.47 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.907 -1.145 . . . . 64.420000000000002 107.907 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -150.65 163.3 38.87 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.202 0.314 . . . . 75.519999999999996 110.347 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.98 136.94 2.17 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 110.216 -1.153 . . . . 62.310000000000002 110.216 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -98.35 -22.85 15.88 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.509 0.929 . . . . 73.340000000000003 113.509 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 134' ' ' ASP . 26.3 ptm -148.61 175.89 10.8 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.552 -0.859 . . . . 72.540000000000006 111.857 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -131.66 146.08 52.0 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.102 -1.073 . . . . 74.400000000000006 108.102 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 50.0 mtm105 -139.37 138.19 36.38 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 122.507 0.323 . . . . 74.329999999999998 110.244 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 46' ' ' ALA . 26.9 m -126.58 114.71 39.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.495 0.664 . . . . 62.100000000000001 109.559 177.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -123.8 119.08 28.68 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.413 0.625 . . . . 74.319999999999993 110.706 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -109.38 108.87 19.57 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.295 -1.002 . . . . 61.310000000000002 108.295 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 p -117.52 115.89 26.03 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.32 -0.622 . . . . 73.120000000000005 109.32 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.72 146.91 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.518 -0.549 . . . . 63.009999999999998 109.518 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.1 m -123.78 130.63 52.93 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 109.094 -0.706 . . . . 51.140000000000001 109.094 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -112.94 120.27 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 121.679 0.752 . . . . 62.229999999999997 110.553 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -92.74 158.29 38.29 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 115.054 -0.975 . . . . 51.119999999999997 110.438 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -65.53 2.39 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.997 3.131 . . . . 74.319999999999993 113.614 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 31.7 t70 -89.85 -0.32 57.49 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.973 -0.751 . . . . 52.439999999999998 108.973 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 22.0 t70 70.79 29.19 3.22 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 105.51 -2.033 . . . . 74.420000000000002 105.51 -174.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 7.0 tp -101.69 125.02 48.27 Favored 'General case' 1 N--CA 1.379 -4.023 0 CA-C-N 112.175 -2.284 . . . . 74.120000000000005 108.472 -177.247 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.6 t -115.47 130.64 69.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.629 -0.878 . . . . 71.439999999999998 108.629 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 p -145.23 151.81 38.97 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.033 -0.729 . . . . 75.230000000000004 109.033 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.51 -164.7 36.45 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 118.971 -1.585 . . . . 74.049999999999997 112.965 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.05 133.97 15.84 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.247 0.546 . . . . 71.010000000000005 110.571 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 68.0 mt -114.27 115.84 50.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.885 -1.154 . . . . 72.430000000000007 107.885 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -109.95 116.71 52.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 109.762 -0.458 . . . . 63.340000000000003 109.762 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.483 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -112.89 108.47 17.43 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.909 -1.515 . . . . 73.239999999999995 106.909 174.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -123.35 125.36 44.86 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.236 0.541 . . . . 72.400000000000006 111.672 -174.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.86 159.92 32.5 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.441 -0.8 . . . . 64.209999999999994 109.165 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 139.29 80.41 Favored Pre-proline 0 C--N 1.302 -1.494 0 C-N-CA 119.144 -1.022 . . . . 74.25 110.36 176.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -47.83 132.72 21.98 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 124.435 3.423 . . . . 72.319999999999993 114.481 -174.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -86.03 -56.64 3.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.793 -0.64 . . . . 75.319999999999993 110.462 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.402 ' H ' ' CB ' ' A' ' 55' ' ' ASP . 18.6 m120 -127.53 -176.52 3.78 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.014 -0.539 . . . . 74.299999999999997 110.575 -174.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.463 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 15.7 m -74.06 -32.26 63.22 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.069 0.461 . . . . 64.409999999999997 110.848 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -74.45 -20.23 60.1 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 121.797 0.808 . . . . 63.409999999999997 109.703 177.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.402 ' CB ' ' H ' ' A' ' 52' ' ' ASN . 13.5 t70 -81.49 96.17 7.33 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.089 -1.414 . . . . 71.329999999999998 110.955 -168.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.3 p -109.06 -1.33 18.94 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.001 -1.454 . . . . 75.099999999999994 109.103 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 172.77 99.5 0.12 Allowed Glycine 0 N--CA 1.416 -2.639 0 CA-C-O 118.289 -1.284 . . . . 63.329999999999998 111.725 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 52.2 Cg_exo -54.05 127.75 26.98 Favored 'Trans proline' 0 C--N 1.355 0.88 0 CA-C-N 120.044 1.922 . . . . 71.439999999999998 107.5 170.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.1 151.52 22.47 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 113.573 0.953 . . . . 72.200000000000003 113.573 -166.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 96.1 mt -94.35 150.48 20.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.047 -0.979 . . . . 63.329999999999998 109.301 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -107.07 93.68 4.69 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.389 -0.967 . . . . 73.420000000000002 108.389 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.38 120.01 5.87 Favored Glycine 0 N--CA 1.42 -2.39 0 CA-C-N 114.442 -1.254 . . . . 63.130000000000003 111.219 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -136.68 111.47 8.78 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.918 -0.771 . . . . 63.409999999999997 108.918 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.15 166.88 14.55 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.173 -1.047 . . . . 71.430000000000007 108.173 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -66.98 -32.67 34.55 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 121.406 1.404 . . . . 72.530000000000001 110.586 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -97.13 39.2 1.19 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.257 -0.883 . . . . 71.530000000000001 112.825 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.8 m -55.14 -27.8 48.09 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 112.784 0.661 . . . . 35.43 112.784 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -73.02 -7.89 53.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.217 0.532 . . . . 73.109999999999999 111.232 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.5 -13.13 18.8 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.117 -0.492 . . . . 65.140000000000001 110.383 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.2 p -125.31 119.99 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.882 0.849 . . . . 64.450000000000003 111.663 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.98 112.08 24.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.774 -0.825 . . . . 73.420000000000002 108.774 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.35 127.76 50.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.083 -1.081 . . . . 74.129999999999995 108.083 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 m -140.01 172.78 12.27 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.534 -0.543 . . . . 74.439999999999998 109.534 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.426 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 22.6 p-10 -86.03 149.24 25.31 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.064 -0.654 . . . . 72.120000000000005 109.539 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 79.6 t80 -101.93 120.56 40.59 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.571 -1.64 . . . . 74.430000000000007 106.571 174.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -138.49 99.13 3.75 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 108.423 -0.954 . . . . 72.400000000000006 108.423 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.3 t -174.07 153.48 2.08 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.869 -1.16 . . . . 63.43 107.869 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 66.89 15.14 10.07 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.915 0.886 . . . . 73.340000000000003 112.166 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.38 -8.25 80.25 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.575 -0.61 . . . . 64.530000000000001 111.575 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.531 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 47.9 m-85 -93.05 153.22 18.83 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.419 -0.586 . . . . 64.239999999999995 109.419 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 31.0 m -134.81 136.31 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.064 -1.088 . . . . 52.310000000000002 108.064 171.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.8 -153.85 8.86 Favored Glycine 0 C--N 1.259 -3.75 0 N-CA-C 110.505 -1.038 . . . . 73.140000000000001 110.505 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.486 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.1 p -126.43 146.76 49.96 Favored 'General case' 0 C--N 1.264 -3.141 0 CA-C-O 121.317 0.58 . . . . 64.540000000000006 111.518 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 27.1 pt20 -136.97 127.78 27.3 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.97 -0.559 . . . . 61.420000000000002 110.496 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.42 115.25 29.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.287 -1.005 . . . . 24.309999999999999 108.287 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.68 117.77 54.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.057 -1.09 . . . . 55.109999999999999 108.057 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.468 ' CD2' HD12 ' A' ' 90' ' ' LEU . 50.7 p90 -124.29 154.77 39.75 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 120.803 0.335 . . . . 72.530000000000001 110.236 -175.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.5 m -157.56 159.73 37.44 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 116.234 -0.439 . . . . 63.340000000000003 110.222 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 67.14 31.13 6.95 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.505 1.145 . . . . 71.439999999999998 110.486 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.468 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.0 mt -96.24 160.44 14.43 Favored 'General case' 0 N--CA 1.428 -1.54 0 O-C-N 121.627 -0.671 . . . . 73.519999999999996 111.304 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 m -104.78 166.53 10.32 Favored 'General case' 0 N--CA 1.401 -2.912 0 N-CA-C 109.391 -0.596 . . . . 63.130000000000003 109.391 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.493 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 60.8 t80 -50.66 -48.62 58.31 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.228 1.011 . . . . 74.239999999999995 110.674 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.07 -24.66 67.24 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.268 -0.878 . . . . 55.039999999999999 112.245 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -87.66 -16.93 33.03 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 116.272 -0.422 . . . . 72.219999999999999 111.754 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.3 tt -61.89 -52.36 68.8 Favored Pre-proline 0 CA--C 1.559 1.294 0 O-C-N 123.254 0.346 . . . . 62.509999999999998 111.228 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 35.3 Cg_exo -65.72 -32.98 45.95 Favored 'Trans proline' 0 C--N 1.369 1.654 0 CA-C-N 120.794 1.319 . . . . 65.099999999999994 110.63 176.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -64.63 -36.06 83.04 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.642 -0.708 . . . . 72.340000000000003 110.977 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -77.59 -19.84 54.95 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.871 -0.418 . . . . 64.409999999999997 109.871 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.78 -24.24 61.71 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.97 -0.559 . . . . 64.040000000000006 110.25 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -56.18 -49.75 73.14 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 109.561 -0.533 . . . . 74.409999999999997 109.561 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.5 mtm -54.37 -51.46 64.71 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.232 0.539 . . . . 73.319999999999993 110.161 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -56.58 -34.93 67.65 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.992 -1.004 . . . . 74.349999999999994 111.598 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.3 m -62.09 -30.21 70.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.269 -0.423 . . . . 54.520000000000003 110.243 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.18 -31.57 70.25 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 123.926 0.767 . . . . 73.030000000000001 110.674 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.09 -11.89 15.53 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 116.233 -0.44 . . . . 74.129999999999995 111.38 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.69 -47.86 3.65 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.646 0.98 . . . . 54.420000000000002 113.646 -172.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.07 25.81 33.11 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.814 -0.708 . . . . 72.420000000000002 111.784 -174.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 m -109.27 155.41 10.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 122.486 -0.42 . . . . 65.310000000000002 111.7 -175.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -124.28 124.79 43.17 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.088 0.555 . . . . 72.329999999999998 109.555 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.8 mp -117.56 143.66 45.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.124 0.488 . . . . 74.109999999999999 111.056 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.1 m -129.74 109.57 11.06 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.065 -0.717 . . . . 70.319999999999993 109.065 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.573 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 61.0 tp -119.87 123.84 44.59 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.526 -0.306 . . . . 70.239999999999995 110.646 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.573 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 2.8 mpt_? -137.47 147.94 45.69 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.783 0.433 . . . . 74.310000000000002 110.194 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' ' 119' ' ' VAL . 37.3 ttm180 -102.0 137.54 40.15 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 107.101 -1.444 . . . . 64.540000000000006 107.101 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -128.47 90.0 2.99 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.664 -0.865 . . . . 71.329999999999998 108.664 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.79 -113.22 4.89 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.052 -0.976 . . . . 72.530000000000001 110.874 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.29 -13.67 21.82 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.843 0.83 . . . . 62.439999999999998 109.07 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.673 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.4 pp -103.59 149.86 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 C-N-CA 119.69 -0.804 . . . . 74.0 110.009 -176.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.545 HG21 ' CD2' ' A' ' 178' ' ' TYR . 92.7 t -118.31 138.68 48.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 O-C-N 121.911 -0.493 . . . . 72.209999999999994 110.141 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.0 pt -120.05 129.43 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 122.101 0.953 . . . . 65.140000000000001 109.802 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.2 136.25 49.89 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 114.907 -1.042 . . . . 75.299999999999997 108.56 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -143.28 166.15 25.52 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 108.835 -0.802 . . . . 65.420000000000002 108.835 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.84 158.98 30.96 Favored Glycine 0 N--CA 1.405 -3.415 0 N-CA-C 109.72 -1.352 . . . . 23.300000000000001 109.72 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -134.31 125.23 27.23 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.234 -1.765 . . . . 73.109999999999999 106.234 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.15 117.51 16.63 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 120.996 0.427 . . . . 72.040000000000006 111.618 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 169' ' ' VAL . 0.0 OUTLIER -108.85 134.02 52.1 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 105.154 -2.165 . . . . 71.140000000000001 105.154 170.427 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.9 mm? -117.85 32.38 6.18 Favored 'General case' 0 C--N 1.267 -2.99 0 N-CA-C 108.754 -0.832 . . . . 65.540000000000006 108.754 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 167' ' ' GLY . 42.7 p -73.01 -23.87 60.67 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.965 -0.561 . . . . 55.539999999999999 110.487 -176.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.3 m -74.76 -12.34 60.38 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 116.051 -0.522 . . . . 61.140000000000001 111.249 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -77.41 110.82 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.138 -1.43 . . . . 75.400000000000006 107.138 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.4 t -88.45 29.5 0.98 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.116 -0.493 . . . . 73.019999999999996 111.064 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -135.1 120.02 13.77 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 109.808 -0.442 . . . . 43.530000000000001 109.808 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.86 -20.77 16.89 Favored 'Trans proline' 0 C--O 1.22 -0.419 0 C-N-CA 122.514 2.143 . . . . 74.230000000000004 112.175 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' MET . 7.0 m-20 -88.27 18.89 4.06 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.159 0.504 . . . . 71.340000000000003 111.283 -176.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.0 143.91 28.08 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.137 -0.69 . . . . 45.100000000000001 109.137 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -132.11 130.52 41.29 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.276 -1.009 . . . . 75.439999999999998 108.276 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.1 t -113.54 126.11 70.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.863 -0.421 . . . . 64.430000000000007 109.863 -175.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.35 121.99 30.45 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.866 0.365 . . . . 54.539999999999999 111.356 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.516 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -111.22 121.54 45.54 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.885 -1.894 . . . . 63.549999999999997 105.885 174.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.3 m -126.6 130.96 51.52 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.243 -0.28 . . . . 43.439999999999998 110.243 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 99.4 t -123.86 126.12 72.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 109.036 -0.728 . . . . 71.120000000000005 109.036 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.84 127.57 56.21 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.324 -0.621 . . . . 65.519999999999996 109.324 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.8 p90 -134.38 123.68 16.68 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 116.362 -0.381 . . . . 75.530000000000001 111.789 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 29.2 Cg_exo -68.27 41.07 0.24 Allowed 'Trans proline' 0 CA--C 1.557 1.635 0 C-N-CA 123.447 2.765 . . . . 64.409999999999997 113.795 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.49 -100.44 0.39 Allowed 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.985 -0.447 . . . . 73.540000000000006 110.807 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 178.92 130.75 0.08 Allowed 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.745 -0.835 . . . . 53.520000000000003 108.745 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.7 133.03 30.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.049 -0.723 . . . . 62.210000000000001 109.049 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.2 p -94.03 -43.3 8.58 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-O 121.225 0.536 . . . . 65.329999999999998 109.701 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 17.0 m -150.04 131.32 14.59 Favored 'General case' 0 C--O 1.212 -0.904 0 N-CA-C 108.407 -0.961 . . . . 71.219999999999999 108.407 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -140.91 152.32 44.94 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.39 -0.524 . . . . 73.129999999999995 111.241 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -119.5 90.97 3.44 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.162 -2.162 . . . . 52.409999999999997 105.162 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.62 -159.26 28.97 Favored Glycine 0 N--CA 1.416 -2.672 0 N-CA-C 107.345 -2.302 . . . . 74.129999999999995 107.345 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.12 102.84 11.01 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 117.846 0.823 . . . . 73.439999999999998 109.542 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 18.0 ptt180 -76.28 122.01 23.79 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-O 121.218 0.532 . . . . 74.129999999999995 109.877 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.16 -41.06 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 106.989 -1.486 . . . . 64.230000000000004 106.989 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -136.08 166.29 29.24 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.118 -1.401 . . . . 74.319999999999993 107.245 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.12 -4.75 15.53 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 122.351 2.034 . . . . 75.310000000000002 110.721 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.6 pt-20 -128.27 6.2 5.84 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.613 -0.722 . . . . 64.209999999999994 111.36 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.5 t -141.66 120.57 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.256 -1.016 . . . . 75.340000000000003 108.256 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 50.1 t -123.53 145.53 30.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.772 -0.455 . . . . 74.209999999999994 109.772 -177.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -136.09 142.72 44.34 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.362 0.601 . . . . 73.349999999999994 110.202 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.516 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.6 m-90 -118.7 113.35 21.04 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.432 -0.804 . . . . 70.450000000000003 109.106 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 163' ' ' LYS . 7.8 ptpt -95.23 99.07 11.08 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 122.316 1.055 . . . . 74.340000000000003 108.716 177.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 61.1 mt -97.68 147.48 24.3 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 113.676 -1.602 . . . . 73.129999999999995 109.428 -173.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -117.63 146.44 38.67 Favored Pre-proline 0 C--N 1.295 -1.766 0 CA-C-N 115.637 -0.711 . . . . 73.409999999999997 112.302 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.457 ' HA ' ' CB ' ' A' ' 127' ' ' LEU . 71.8 Cg_endo -71.54 160.02 49.59 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.573 2.182 . . . . 72.019999999999996 110.341 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 128' ' ' THR . . . 78.34 -26.87 2.15 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 121.096 -0.573 . . . . 73.430000000000007 113.22 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.7 170.1 3.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.008 0.432 . . . . 73.25 112.082 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 126' ' ' ASP . 8.3 p -114.07 142.94 24.92 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 CA-C-N 115.812 -0.631 . . . . 74.409999999999997 109.87 176.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.5 p -149.75 140.57 22.74 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.048 0.451 . . . . 62.310000000000002 111.975 -176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.8 p -96.67 138.11 34.73 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.201 -0.666 . . . . 64.239999999999995 109.201 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 22.4 ptm -118.63 133.1 56.11 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.944 -1.132 . . . . 70.140000000000001 107.944 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -143.55 147.93 35.19 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.613 -0.835 . . . . 73.209999999999994 111.398 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.452 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -154.89 130.29 9.75 Favored 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 123.05 0.54 . . . . 64.430000000000007 109.862 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -132.54 131.83 41.97 Favored 'General case' 0 C--N 1.264 -3.147 0 N-CA-C 106.753 -1.573 . . . . 73.040000000000006 106.753 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.18 149.83 23.3 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.832 -1.173 . . . . 44.43 107.832 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 0.8 OUTLIER -95.52 138.86 32.6 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.447 -1.686 . . . . 70.420000000000002 106.447 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.545 ' CD2' HG21 ' A' ' 119' ' ' VAL . 22.4 m-30 -121.17 151.78 39.53 Favored 'General case' 0 CA--C 1.483 -1.611 0 C-N-CA 119.926 -0.71 . . . . 74.439999999999998 109.331 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.81 86.03 3.4 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-O 121.462 0.648 . . . . 74.299999999999997 110.097 175.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -56.51 134.86 77.12 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.451 -1.249 . . . . 74.420000000000002 110.815 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.64 -27.82 21.81 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.091 1.861 . . . . 53.350000000000001 112.969 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.12 -21.1 31.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.917 -1.142 . . . . 51.210000000000001 107.917 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.344 69.7 p 68.54 49.73 0.74 Allowed 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 126.99 2.116 . . . . 54.439999999999998 112.567 -175.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -70.88 150.65 45.55 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.933 -1.485 . . . . 75.230000000000004 108.102 173.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 C--N 1.298 -1.645 0 N-CA-C 106.96 -1.496 . . . . 72.25 106.96 -177.462 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.818 0 N-CA-C 110.807 -0.917 . . . . 43.049999999999997 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.81 98.84 6.46 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.771 -1.196 . . . . 75.530000000000001 107.771 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.532 ' HG2' ' H ' ' A' ' 18' ' ' ASN . 30.6 tt0 61.0 -175.37 0.12 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.462 1.105 . . . . 64.209999999999994 110.247 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.532 ' H ' ' HG2' ' A' ' 17' ' ' GLU . 83.3 m-20 -121.42 122.1 39.04 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.662 -1.607 . . . . 71.030000000000001 106.662 176.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.64 76.74 5.71 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.967 -0.753 . . . . 74.329999999999998 108.967 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.6 t80 75.58 157.5 0.19 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.935 1.694 . . . . 62.219999999999999 109.728 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 69.28 95.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.914 1.079 . . . . 73.549999999999997 113.914 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -90.37 89.33 7.56 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.234 -1.395 . . . . 75.430000000000007 107.234 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.34 153.86 18.24 Favored Glycine 0 CA--C 1.48 -2.109 0 N-CA-C 110.189 -1.164 . . . . 73.120000000000005 110.189 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 27' ' ' ARG . 56.9 m80 71.75 33.14 1.81 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.243 1.017 . . . . 75.040000000000006 109.106 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.83 100.32 11.24 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 112.813 0.671 . . . . 73.420000000000002 112.813 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 48' ' ' ALA . 6.7 tt 75.38 100.19 0.07 Allowed 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.232 -1.349 . . . . 74.040000000000006 112.876 173.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' CZ ' ' HA ' ' A' ' 24' ' ' HIS . 3.1 mpt_? -131.72 127.99 37.99 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.102 -0.954 . . . . 61.229999999999997 108.913 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.32 117.76 56.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.45 -0.944 . . . . 61.43 108.45 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -123.05 114.06 19.87 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.342 0.591 . . . . 71.319999999999993 109.457 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.29 126.76 55.6 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.583 -0.895 . . . . 75.310000000000002 108.583 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.9 t -131.64 114.79 15.24 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.046 -1.464 . . . . 73.329999999999998 107.046 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.63 146.62 29.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.367 -0.605 . . . . 43.539999999999999 109.367 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.5 m -126.8 125.21 41.32 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.258 0.551 . . . . 75.129999999999995 109.854 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.2 tt -113.39 110.35 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-O 121.851 0.834 . . . . 54.109999999999999 110.097 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -76.99 158.55 80.06 Favored Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 114.761 -1.109 . . . . 75.120000000000005 109.747 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.5 0.81 2.55 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 123.363 2.709 . . . . 62.109999999999999 112.999 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -88.89 2.33 53.92 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 124.066 0.947 . . . . 73.400000000000006 110.156 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 91' ' ' THR . 14.5 t70 67.89 29.44 6.61 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 123.55 1.643 . . . . 74.430000000000007 106.872 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.36 124.77 50.88 Favored 'General case' 0 N--CA 1.382 -3.841 0 CA-C-N 113.904 -1.498 . . . . 65.430000000000007 107.297 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.414 HG12 ' HE2' ' A' ' 87' ' ' PHE . 3.6 t -110.78 136.29 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 108.471 -0.937 . . . . 64.430000000000007 108.471 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.8 p -144.13 154.93 43.68 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 105.966 -1.865 . . . . 62.210000000000001 105.966 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.25 -172.04 44.26 Favored Glycine 0 CA--C 1.49 -1.524 0 C-N-CA 117.913 -2.089 . . . . 64.329999999999998 113.725 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.43 134.22 28.75 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.438 0.695 . . . . 75.010000000000005 110.041 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 60.0 mt -120.75 115.7 47.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.018 -1.475 . . . . 74.439999999999998 107.018 174.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.2 114.61 46.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 120.935 0.398 . . . . 62.539999999999999 109.954 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.01 108.3 18.48 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.277 -1.749 . . . . 65.329999999999998 106.277 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -121.34 125.66 47.55 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 120.246 -0.582 . . . . 70.019999999999996 111.257 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . . . -111.64 155.73 22.93 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.934 -0.765 . . . . 64.040000000000006 108.934 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -91.68 120.51 68.08 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 104.983 -2.229 . . . . 73.519999999999996 104.983 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -31.18 106.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 125.069 3.846 . . . . 70.439999999999998 114.302 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.21 -44.27 6.31 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.877 -0.601 . . . . 65.540000000000006 110.767 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.477 ' HB2' ' CG ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER -87.12 158.14 19.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.838 -1.171 . . . . 74.540000000000006 107.838 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 m -75.02 -20.75 59.48 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.444 0.64 . . . . 75.219999999999999 109.401 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -81.99 -14.82 55.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.353 -0.839 . . . . 74.230000000000004 109.399 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.477 ' CG ' ' HB2' ' A' ' 52' ' ' ASN . 85.7 m-20 -69.45 96.76 0.92 Allowed 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.766 0.793 . . . . 71.239999999999995 112.607 -170.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -113.34 -26.76 8.21 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.311 -1.313 . . . . 74.439999999999998 108.723 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.91 98.18 0.11 Allowed Glycine 0 N--CA 1.414 -2.787 0 CA-C-N 114.824 -1.08 . . . . 65.340000000000003 112.54 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.74 159.09 53.81 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 122.673 2.248 . . . . 71.430000000000007 111.579 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.95 155.25 41.65 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.079 -0.341 . . . . 71.010000000000005 110.079 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.562 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 94.3 mt -101.15 153.47 19.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.159 -0.682 . . . . 71.219999999999999 109.159 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.92 88.07 5.6 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.878 -1.527 . . . . 74.340000000000003 106.878 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.86 50.66 0.78 Allowed Glycine 0 N--CA 1.414 -2.792 0 CA-C-N 115.077 -0.965 . . . . 54.32 112.89 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -91.6 95.46 9.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.251 -1.018 . . . . 71.150000000000006 108.251 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 m -122.37 162.21 39.16 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 114.15 -1.386 . . . . 64.209999999999994 107.609 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.86 -19.61 32.37 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.673 2.249 . . . . 54.43 112.831 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -112.52 29.58 7.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.417 -0.356 . . . . 70.319999999999993 111.659 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.9 m -56.48 -27.82 58.13 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.497 0.554 . . . . 74.239999999999995 112.497 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -70.15 -10.78 59.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.394 0.616 . . . . 73.329999999999998 110.752 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 88' ' ' SER . 68.0 mmtt -106.68 -9.83 16.36 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 111.486 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.74 118.27 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 119.382 -0.927 . . . . 75.129999999999995 111.102 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.76 103.4 15.31 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 115.051 -0.977 . . . . 52.420000000000002 108.794 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 60' ' ' LEU . 7.3 p -98.3 134.79 35.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.161 -1.052 . . . . 71.409999999999997 108.161 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.0 m -149.46 171.56 16.38 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 120.847 0.356 . . . . 75.010000000000005 111.047 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -76.85 132.09 38.97 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.125 -0.943 . . . . 63.229999999999997 109.089 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -102.62 119.92 39.66 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.287 -1.375 . . . . 75.129999999999995 107.287 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -137.6 99.61 3.99 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.513 -0.921 . . . . 74.409999999999997 108.513 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.0 t -168.42 149.1 4.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.38 -0.971 . . . . 73.120000000000005 108.38 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 69.85 13.75 8.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.979 0.911 . . . . 71.219999999999999 112.167 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.76 1.48 67.95 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.764 -0.653 . . . . 53.229999999999997 111.692 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.549 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 59.4 m-85 -102.79 151.07 22.84 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 122.506 0.322 . . . . 71.430000000000007 110.28 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.3 136.23 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 107.342 -1.355 . . . . 72.230000000000004 107.342 168.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.1 -154.95 10.51 Favored Glycine 0 C--N 1.272 -2.977 0 C-N-CA 119.965 -1.112 . . . . 34.030000000000001 111.019 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.562 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 13.0 m -126.69 145.12 50.7 Favored 'General case' 0 C--N 1.27 -2.863 0 CA-C-O 121.185 0.517 . . . . 51.030000000000001 110.39 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 9.4 pt20 -131.17 138.8 49.59 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.957 -0.565 . . . . 74.129999999999995 109.919 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.14 114.63 22.76 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.502 -1.296 . . . . 61.549999999999997 107.502 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.6 t -112.44 113.4 44.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.206 -1.035 . . . . 71.450000000000003 108.206 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.477 ' CD2' HD12 ' A' ' 90' ' ' LEU . 44.3 p90 -114.27 159.55 20.04 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.008 0.433 . . . . 74.010000000000005 111.858 -173.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 6.1 p -156.68 155.18 31.29 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.256 -0.884 . . . . 73.319999999999993 110.13 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 67.03 30.01 7.69 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 124.629 1.172 . . . . 64.129999999999995 111.945 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.477 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.2 mt -97.27 165.99 11.77 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 119.387 -0.925 . . . . 72.329999999999998 110.114 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.465 HG22 ' OE1' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -125.3 178.93 5.32 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.905 -1.146 . . . . 73.310000000000002 107.905 -178.513 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -47.54 -35.63 9.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.851 1.26 . . . . 62.310000000000002 112.452 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.451 ' H ' HG23 ' A' ' 91' ' ' THR . . . -73.1 -25.72 60.98 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.9 0.704 . . . . 75.239999999999995 112.9 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.467 ' HG2' HD22 ' A' ' 90' ' ' LEU . 14.6 mp0 -91.74 -16.97 26.1 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.797 -0.761 . . . . 74.319999999999993 112.749 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.3 tt -58.51 -50.65 86.88 Favored Pre-proline 0 CA--C 1.569 1.677 0 O-C-N 123.241 0.338 . . . . 72.409999999999997 111.456 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -68.81 -30.83 26.43 Favored 'Trans proline' 0 C--N 1.365 1.408 0 CA-C-N 120.731 1.297 . . . . 74.129999999999995 111.281 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -67.88 -33.13 74.14 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 123.534 0.734 . . . . 74.040000000000006 111.121 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.6 pp -75.54 -19.23 59.46 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.988 0.423 . . . . 70.310000000000002 110.256 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.438 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -71.63 -18.29 62.21 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.933 -0.576 . . . . 71.030000000000001 109.977 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.23 -57.24 10.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.9 -0.591 . . . . 74.230000000000004 109.85 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 14.8 ttm -54.38 -52.7 60.83 Favored 'General case' 0 C--O 1.271 2.189 0 CA-C-O 122.518 1.152 . . . . 74.340000000000003 108.428 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 6.3 t30 -52.84 -27.04 16.49 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 112.435 -2.166 . . . . 64.25 112.805 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -54.47 -45.89 73.25 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.886 -0.326 . . . . 40.219999999999999 110.557 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -69.47 -11.84 61.16 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.307 0.855 . . . . 72.510000000000005 113.307 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.38 -27.62 11.36 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.098 0.475 . . . . 54.420000000000002 110.359 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.11 -47.68 3.63 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 113.314 0.857 . . . . 72.430000000000007 113.314 -170.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.26 21.53 51.65 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.667 -0.973 . . . . 61.43 110.667 -172.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.6 m -118.97 155.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 122.306 -0.526 . . . . 51.020000000000003 110.617 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -125.71 141.4 52.03 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.91 -1.145 . . . . 74.230000000000004 107.91 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.0 mt -129.27 119.55 24.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.915 -0.772 . . . . 75.209999999999994 108.915 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -118.94 135.74 54.43 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.03 -1.1 . . . . 72.329999999999998 108.03 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.33 157.81 43.82 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 112.631 0.604 . . . . 73.219999999999999 112.631 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -145.67 150.87 37.1 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.844 -1.071 . . . . 53.520000000000003 111.267 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.544 ' NH2' ' HA ' ' A' ' 180' ' ' ASP . 3.9 tpt180 -96.49 106.56 18.83 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 106.401 -1.703 . . . . 62.520000000000003 106.401 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -96.8 89.23 4.83 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 108.097 -1.075 . . . . 63.039999999999999 108.097 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.13 -96.86 0.9 Allowed Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.086 -1.205 . . . . 65.340000000000003 110.086 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -124.42 -2.42 8.0 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.672 1.225 . . . . 70.310000000000002 109.33 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.62 148.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 O-C-N 121.087 -1.008 . . . . 70.310000000000002 108.703 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.441 HG22 ' HD3' ' A' ' 114' ' ' ARG . 96.8 t -102.89 131.77 50.44 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 O-C-N 122.06 -0.4 . . . . 64.140000000000001 110.32 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.414 HG22 ' HG2' ' A' ' 175' ' ' GLN . 44.4 pt -107.56 130.98 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 N-CA-C 106.784 -1.562 . . . . 72.209999999999994 106.784 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 tt -127.93 131.42 49.34 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 115.869 -0.605 . . . . 55.329999999999998 109.467 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -132.19 115.47 15.75 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.602 -0.888 . . . . 75.099999999999994 108.602 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -118.03 157.88 14.96 Favored Glycine 0 C--N 1.281 -2.503 0 N-CA-C 109.99 -1.244 . . . . 62.310000000000002 109.99 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.469 ' HG2' HG22 ' A' ' 171' ' ' THR . 84.0 mtt180 -139.53 127.54 22.28 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 117.542 0.671 . . . . 75.310000000000002 110.208 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -113.58 109.98 19.5 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.401 -0.592 . . . . 61.340000000000003 109.401 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -109.68 97.76 7.24 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.439 -0.948 . . . . 71.099999999999994 108.439 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.82 28.57 8.46 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.557 -0.905 . . . . 62.350000000000001 108.557 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 69.4 p -66.32 -27.7 68.11 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.883 -0.599 . . . . 75.299999999999997 112.599 -175.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.8 m -72.48 -12.07 60.93 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 111.89 0.33 . . . . 42.030000000000001 111.89 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.0 t 68.0 102.98 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.773 1.229 . . . . 72.450000000000003 113.188 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 t -68.45 -47.51 66.97 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.527 -1.286 . . . . 73.340000000000003 107.527 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -170.15 140.42 1.61 Allowed Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.013 -1.476 . . . . 73.409999999999997 107.013 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.69 -20.06 56.42 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 122.863 2.375 . . . . 71.299999999999997 115.03 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -94.54 2.86 55.67 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.071 0.939 . . . . 54.020000000000003 110.594 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -79.53 141.26 36.83 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.276 -0.875 . . . . 61.310000000000002 111.7 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 27' ' ' ARG . 11.2 m-20 -131.48 136.64 48.09 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 108.527 -0.916 . . . . 70.040000000000006 108.527 177.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.8 t -127.57 118.48 49.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.292 -0.633 . . . . 73.439999999999998 109.292 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.404 ' OE2' ' HB3' ' A' ' 136' ' ' ASP . 2.6 mp0 -109.37 123.55 49.51 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.603 -0.517 . . . . 74.310000000000002 109.603 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.407 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.5 tm? -110.94 111.83 23.23 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.949 -1.5 . . . . 64.319999999999993 106.949 176.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.6 m -117.9 133.62 55.74 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.858 0.463 . . . . 64.219999999999999 110.45 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.83 123.62 63.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.89 -0.781 . . . . 71.209999999999994 108.89 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.51 127.49 56.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.107 -0.701 . . . . 63.009999999999998 109.107 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.527 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.43 118.47 13.74 Favored Pre-proline 0 C--N 1.286 -2.179 0 CA-C-N 116.529 -0.305 . . . . 61.439999999999998 111.477 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.94 40.46 0.36 Allowed 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 122.993 2.462 . . . . 64.200000000000003 111.935 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.53 -94.09 0.5 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-O 119.288 -0.387 . . . . 63.520000000000003 110.224 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 174.03 120.77 0.02 OUTLIER 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.3 0.64 . . . . 54.409999999999997 109.873 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.472 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 7.4 p -84.03 126.22 40.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.814 -0.81 . . . . 72.230000000000004 108.814 174.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.6 t -95.35 -33.46 12.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 119.775 -0.77 . . . . 74.140000000000001 110.647 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.8 m -154.48 132.37 11.58 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 108.399 -0.963 . . . . 53.25 108.399 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 t -140.53 157.85 44.88 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 110.246 -0.279 . . . . 63.130000000000003 110.246 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 26.9 t-20 -126.95 97.89 5.13 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.193 -2.151 . . . . 62.119999999999997 105.193 170.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.19 -147.43 11.11 Favored Glycine 0 N--CA 1.417 -2.601 0 N-CA-C 108.238 -1.945 . . . . 62.310000000000002 108.238 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -114.89 99.78 7.73 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 117.835 0.817 . . . . 73.120000000000005 109.476 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -80.09 113.95 18.64 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-O 121.482 0.658 . . . . 73.040000000000006 109.66 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.15 -35.52 15.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 107.454 -1.313 . . . . 73.329999999999998 107.454 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -143.46 166.5 19.54 Favored Pre-proline 0 N--CA 1.431 -1.389 0 N-CA-C 107.446 -1.316 . . . . 73.439999999999998 107.446 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -72.59 -0.05 8.26 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.342 2.028 . . . . 64.129999999999995 111.279 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 11.5 pt-20 -129.83 5.88 5.05 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.729 -0.668 . . . . 74.219999999999999 110.864 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.413 HG23 ' HG3' ' A' ' 158' ' ' GLU . 90.6 t -144.81 121.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.44 -0.578 . . . . 71.540000000000006 109.44 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.17 145.55 33.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 109.183 -0.673 . . . . 71.25 109.183 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -134.93 146.34 49.05 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.817 -0.808 . . . . 72.329999999999998 108.817 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.407 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.6 m-90 -121.95 122.35 39.16 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.295 -1.002 . . . . 73.040000000000006 108.295 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -88.07 109.5 19.91 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.173 -1.047 . . . . 75.299999999999997 108.173 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 30.9 mt -102.07 125.1 48.68 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 121.486 0.66 . . . . 75.450000000000003 110.271 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 5.4 mmpt? -118.03 150.23 47.0 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 114.903 -1.044 . . . . 64.230000000000004 110.553 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.435 ' HD3' ' HE2' ' A' ' 165' ' ' LYS . 10.8 Cg_exo -72.07 159.46 50.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.134 1.889 . . . . 75.420000000000002 110.775 173.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.97 -35.63 2.91 Favored Glycine 0 C--N 1.312 -0.785 0 N-CA-C 111.7 -0.56 . . . . 72.329999999999998 111.7 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.28 155.06 6.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.438 -0.381 . . . . 54.549999999999997 110.139 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.6 p -113.09 116.03 51.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.055 -0.721 . . . . 54.329999999999998 109.055 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.1 m -116.3 144.47 44.2 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.01 -0.737 . . . . 74.430000000000007 109.01 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 124' ' ' ARG . 45.0 p -115.6 152.18 33.57 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-O 121.015 0.436 . . . . 73.340000000000003 110.762 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -102.3 116.79 33.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.48 -1.304 . . . . 63.310000000000002 107.48 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 18.0 t -120.27 130.2 54.38 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 107.231 -1.396 . . . . 75.420000000000002 107.231 173.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -152.53 132.14 13.08 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 109.344 -0.613 . . . . 75.310000000000002 109.344 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.414 ' HG2' HG22 ' A' ' 120' ' ' ILE . 47.3 mt-30 -133.1 129.75 38.38 Favored 'General case' 0 C--N 1.268 -2.938 0 N-CA-C 107.511 -1.292 . . . . 70.430000000000007 107.511 174.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -150.59 155.28 39.12 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.955 -0.566 . . . . 74.510000000000005 110.097 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 177' ' ' ARG . 42.3 mtt180 -87.76 125.31 34.35 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.912 -1.144 . . . . 54.020000000000003 107.912 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -132.03 123.31 27.01 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 108.986 -0.746 . . . . 70.5 108.986 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.41 113.99 2.96 Favored 'General case' 0 C--N 1.276 -2.621 0 O-C-N 124.085 0.865 . . . . 73.019999999999996 110.913 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.544 ' HA ' ' NH2' ' A' ' 114' ' ' ARG . 1.8 m-20 -54.51 146.16 35.24 Favored Pre-proline 0 C--O 1.212 -0.886 0 CA-C-N 114.953 -1.021 . . . . 73.329999999999998 110.341 176.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.21 -33.36 90.45 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 122.935 2.423 . . . . 72.340000000000003 111.401 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.432 ' OD1' ' HG2' ' A' ' 184' ' ' ARG . 27.1 p30 -83.61 -10.39 58.27 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.743 -1.117 . . . . 75.340000000000003 111.458 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 51.9 p 49.84 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.608 1.563 . . . . 71.109999999999999 114.029 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.432 ' HG2' ' OD1' ' A' ' 182' ' ' ASN . 26.6 mmt180 -121.6 149.97 42.37 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 116.006 -0.543 . . . . 75.510000000000005 111.213 -176.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 107.512 -1.292 . . . . 75.400000000000006 107.512 176.445 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.146 0 N-CA-C 110.689 -0.964 . . . . 43.049999999999997 110.689 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -81.67 100.08 9.26 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.189 -1.412 . . . . 73.109999999999999 107.189 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -138.91 111.82 7.84 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 113.211 0.819 . . . . 74.5 113.211 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -168.44 157.59 9.06 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 104.499 -2.408 . . . . 73.310000000000002 104.499 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.16 -70.85 0.16 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.727 -0.842 . . . . 52.340000000000003 108.727 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.9 t80 66.34 111.65 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.33 1.052 . . . . 65.129999999999995 110.833 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -144.44 157.06 44.43 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.069 -0.394 . . . . 60.200000000000003 110.896 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 74.58 133.28 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.477 1.511 . . . . 63.409999999999997 112.656 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.52 -12.56 1.2 Allowed Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.669 -0.777 . . . . 53.329999999999998 112.22 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 69.44 -73.11 0.09 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.564 1.546 . . . . 75.340000000000003 107.805 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.56 ' HG3' ' OD2' ' A' ' 134' ' ' ASP . 35.6 mtt -105.69 87.69 2.65 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 109.042 -0.725 . . . . 72.150000000000006 109.042 172.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 pp -104.82 122.46 45.79 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 107.856 -1.164 . . . . 73.430000000000007 107.856 173.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 55.1 mtm180 -114.0 124.29 51.78 Favored 'General case' 0 C--N 1.269 -2.916 0 N-CA-C 109.22 -0.659 . . . . 74.049999999999997 109.22 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.94 114.14 44.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.057 -1.46 . . . . 61.509999999999998 107.057 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -114.54 113.29 24.22 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.633 -0.877 . . . . 74.450000000000003 108.633 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -106.93 107.74 18.91 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.238 -1.393 . . . . 64.340000000000003 107.238 176.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 140' ' ' THR . 22.5 m -119.08 115.36 24.13 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 109.224 -0.658 . . . . 40.219999999999999 109.224 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 2.1 pp -123.41 146.47 28.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 120.39 -0.524 . . . . 51.299999999999997 110.238 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 31.5 m -123.52 121.02 34.59 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 108.468 -0.938 . . . . 63.43 108.468 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -116.06 118.63 59.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.91 0.862 . . . . 64.140000000000001 111.313 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HA ' ' HD2' ' A' ' 144' ' ' PRO . 17.9 m -87.26 148.39 44.64 Favored Pre-proline 0 N--CA 1.417 -2.12 0 CA-C-N 114.775 -1.102 . . . . 62.549999999999997 108.93 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.74 2.88 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 124.392 3.395 . . . . 71.340000000000003 113.755 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -91.02 1.61 56.95 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.226 1.01 . . . . 74.120000000000005 108.511 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 91' ' ' THR . 9.0 t70 72.48 28.73 2.21 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.015 1.726 . . . . 72.219999999999999 107.017 -176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.56 124.5 49.42 Favored 'General case' 0 N--CA 1.389 -3.501 0 CA-C-N 113.887 -1.506 . . . . 73.200000000000003 107.688 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.62 136.17 53.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.144 -1.058 . . . . 63.43 108.144 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.3 p -141.41 160.53 39.93 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 106.131 -1.803 . . . . 50.240000000000002 106.131 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.3 -165.82 39.19 Favored Glycine 0 CA--C 1.489 -1.541 0 C-N-CA 117.826 -2.13 . . . . 44.450000000000003 113.635 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HB2' HD11 ' A' ' 45' ' ' ILE . 10.5 pt-20 -157.08 133.58 9.92 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 123.51 0.724 . . . . 70.319999999999993 110.218 -175.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 3.4 mp -117.53 115.45 48.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 105.919 -1.882 . . . . 75.400000000000006 105.919 170.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 43' ' ' GLU . 5.0 mm -108.41 121.37 61.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.348 -0.982 . . . . 62.450000000000003 108.348 -175.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.493 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.98 108.86 16.77 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.33 -0.989 . . . . 61.310000000000002 108.33 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.11 122.87 38.4 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.762 0.315 . . . . 45.450000000000003 111.046 -176.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.66 158.96 28.9 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.665 -0.698 . . . . 64.310000000000002 110.913 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HG2' ' HB2' ' A' ' 25' ' ' MET . 71.7 mmtt -66.2 136.85 95.43 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 107.49 -1.3 . . . . 73.150000000000006 107.49 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.64 112.61 1.11 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.375 2.05 . . . . 52.5 111.052 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -84.24 -25.58 29.31 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.999 0.428 . . . . 64.5 110.98 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 7.7 m-20 -128.92 171.66 12.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.286 -0.259 . . . . 61.109999999999999 110.636 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -69.06 -52.58 27.09 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.424 0.63 . . . . 54.020000000000003 111.057 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -87.41 7.89 27.05 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.816 -0.629 . . . . 71.049999999999997 110.932 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 52' ' ' ASN . 13.3 t0 -73.02 108.91 6.18 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 115.551 -0.75 . . . . 72.120000000000005 109.845 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.586 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 4.1 t -90.65 -29.71 17.58 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.562 -1.199 . . . . 74.109999999999999 110.643 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.08 131.09 1.31 Allowed Glycine 0 N--CA 1.423 -2.204 0 CA-C-O 118.294 -1.281 . . . . 54.530000000000001 111.184 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -52.49 128.84 29.4 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 120.127 1.964 . . . . 73.310000000000002 109.205 169.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.04 163.39 14.92 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.903 0.705 . . . . 62.210000000000001 112.903 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 mt -121.61 124.52 44.52 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.37 -0.974 . . . . 74.420000000000002 108.37 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -112.51 90.39 3.33 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.063 0.459 . . . . 75.299999999999997 110.497 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.98 79.63 0.3 Allowed Glycine 0 C--N 1.3 -1.42 0 C-N-CA 121.021 -0.609 . . . . 14.41 111.802 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -87.88 105.18 17.25 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.685 0.755 . . . . 72.140000000000001 108.968 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.9 m -109.08 163.82 16.12 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 114.651 -1.159 . . . . 74.319999999999993 109.43 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.4 -16.91 50.25 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.744 2.296 . . . . 74.040000000000006 112.554 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -113.15 36.01 3.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.588 -0.733 . . . . 64.430000000000007 111.076 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.2 m -59.66 -29.08 67.81 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 112.463 0.542 . . . . 65.129999999999995 112.463 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -7.85 54.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.912 -0.715 . . . . 74.299999999999997 111.667 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.81 -11.5 26.76 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.797 -0.446 . . . . 70.109999999999999 109.797 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.73 120.76 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 122.135 0.969 . . . . 75.109999999999999 111.847 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.48 106.43 18.4 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.451 -0.795 . . . . 51.219999999999999 108.931 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.2 t -98.24 132.25 43.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.465 -1.309 . . . . 63.310000000000002 107.465 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.9 m -144.76 165.35 28.33 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.629 0.252 . . . . 43.25 111.538 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -87.66 128.9 35.28 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.419 -0.956 . . . . 73.439999999999998 108.419 178.798 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 60.6 t80 -92.66 125.26 37.21 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 123.88 0.872 . . . . 71.310000000000002 109.858 -177.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -140.06 98.91 3.55 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.894 -1.15 . . . . 64.209999999999994 107.894 171.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 53.2 m -163.75 153.09 14.37 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.491 -1.3 . . . . 72.230000000000004 107.491 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.72 4.03 4.54 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.885 0.874 . . . . 72.209999999999994 111.574 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.08 0.72 73.77 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.591 -1.003 . . . . 72.450000000000003 110.591 -174.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -100.79 151.29 21.86 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 109.181 -0.674 . . . . 73.230000000000004 109.181 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.7 m -127.81 138.77 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 109.074 -0.713 . . . . 72.109999999999999 109.074 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -171.72 -153.54 9.19 Favored Glycine 0 C--N 1.277 -2.721 0 N-CA-C 110.89 -0.884 . . . . 73.450000000000003 110.89 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.4 m -140.64 145.22 36.33 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 109.812 -0.44 . . . . 32.520000000000003 109.812 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.49 155.72 43.29 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 120.586 -0.446 . . . . 74.299999999999997 110.442 177.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.47 114.35 21.12 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.695 -1.224 . . . . 73.299999999999997 107.695 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.21 113.13 43.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.691 -0.855 . . . . 74.010000000000005 108.691 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.3 p90 -113.0 164.19 13.76 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.928 -0.709 . . . . 73.209999999999994 112.4 -174.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 p -157.91 155.75 30.09 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.655 -1.157 . . . . 45.420000000000002 109.931 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 67.12 30.88 7.11 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.011 1.115 . . . . 73.340000000000003 114.011 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 87' ' ' PHE . 52.1 mt -103.01 166.7 10.29 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.456 -0.498 . . . . 63.240000000000002 111.438 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 41.1 p -113.78 172.64 6.86 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.693 -0.231 . . . . 73.219999999999999 111.613 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -54.94 -37.63 66.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.626 0.77 . . . . 70.120000000000005 109.767 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.43 -25.77 62.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.094 -0.503 . . . . 74.109999999999999 111.844 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.29 -16.88 28.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.801 0.334 . . . . 63.240000000000002 111.635 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 44.0 tp -58.16 -48.11 97.63 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 113.1 0.778 . . . . 65.230000000000004 113.1 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.24 -34.96 76.76 Favored 'Trans proline' 0 C--N 1.372 1.812 0 CA-C-N 120.826 1.331 . . . . 74.230000000000004 110.794 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -64.65 -40.89 96.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.134 -0.484 . . . . 64.340000000000003 111.263 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -74.64 -19.36 60.32 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.687 -0.486 . . . . 73.030000000000001 109.687 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -69.97 -20.7 63.3 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.993 -0.549 . . . . 74.340000000000003 110.024 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -61.53 -57.93 10.14 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.257 -1.016 . . . . 62.240000000000002 108.257 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 33.6 ttp -56.38 -45.41 80.55 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.813 -0.631 . . . . 73.030000000000001 110.249 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 6.9 t30 -53.13 -44.54 67.79 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.086 -0.961 . . . . 74.519999999999996 111.046 177.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 p -68.73 -22.34 64.33 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.972 -0.691 . . . . 63.009999999999998 111.832 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.58 -25.15 67.28 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 121.192 0.52 . . . . 74.340000000000003 110.035 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.67 -11.16 16.42 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.007 -0.542 . . . . 63.549999999999997 110.432 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.55 -47.3 3.96 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.982 0.734 . . . . 73.010000000000005 112.982 -171.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.05 28.42 54.11 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.256 -0.973 . . . . 71.409999999999997 111.05 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.12 170.42 13.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 120.77 0.319 . . . . 64.510000000000005 110.682 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -118.68 126.28 51.57 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.822 -1.547 . . . . 75.010000000000005 106.822 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.71 134.23 53.74 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.985 -0.746 . . . . 71.340000000000003 108.985 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.2 m -144.13 142.37 30.54 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.739 -0.467 . . . . 73.25 109.739 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.93 146.4 30.12 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.321 -0.622 . . . . 73.25 109.321 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -138.03 148.54 45.2 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.74 -0.664 . . . . 72.349999999999994 110.613 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.427 ' CG ' HG22 ' A' ' 119' ' ' VAL . 6.6 mtt85 -90.1 137.75 32.09 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.5 -0.556 . . . . 71.439999999999998 109.5 171.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.422 ' O ' HG13 ' A' ' 118' ' ' ILE . 43.3 t30 -135.36 101.36 4.8 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.653 -0.869 . . . . 73.239999999999995 108.653 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.55 -106.97 2.03 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 109.935 -1.266 . . . . 52.049999999999997 109.935 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -115.96 -5.45 11.99 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.503 1.144 . . . . 62.509999999999998 108.864 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -105.25 149.54 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 115.513 -0.767 . . . . 74.099999999999994 109.62 -175.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.427 HG22 ' CG ' ' A' ' 114' ' ' ARG . 99.1 t -111.12 134.76 52.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 109.816 -0.439 . . . . 54.509999999999998 109.816 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.45 HG22 ' HG2' ' A' ' 175' ' ' GLN . 47.4 pt -108.47 137.7 38.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.048 -1.094 . . . . 74.030000000000001 108.048 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.08 131.44 49.07 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 108.988 -0.745 . . . . 70.310000000000002 108.988 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -135.52 122.03 20.68 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.291 -0.868 . . . . 63.020000000000003 109.655 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.68 136.73 8.65 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.451 -0.881 . . . . 73.329999999999998 111.533 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -121.34 137.61 54.62 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 118.001 0.901 . . . . 75.219999999999999 109.645 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -130.16 110.15 11.36 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.21 0.529 . . . . 74.219999999999999 111.11 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.69 107.4 17.42 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.129 -1.063 . . . . 64.439999999999998 108.129 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 130' ' ' VAL . 2.7 mm? -110.14 21.98 16.11 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.931 0.396 . . . . 74.340000000000003 109.993 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 167' ' ' GLY . 39.2 p -64.75 -25.64 68.02 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 113.05 0.759 . . . . 73.230000000000004 113.05 -177.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.1 t -84.03 -19.92 33.6 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 112.583 0.586 . . . . 62.240000000000002 112.583 -175.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 127' ' ' LEU . 11.9 p -70.82 135.32 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 119.786 -0.766 . . . . 75.549999999999997 110.438 -176.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.444 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 17.4 m -98.02 14.75 26.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.094 0.473 . . . . 74.109999999999999 111.532 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 130' ' ' VAL . 10.1 m-20 -110.62 90.7 10.9 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 107.908 -1.145 . . . . 55.039999999999999 107.908 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 131' ' ' SER . 6.7 Cg_exo -75.19 -13.51 21.01 Favored 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.024 2.483 . . . . 75.140000000000001 113.14 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.56 ' OD2' ' HG3' ' A' ' 25' ' ' MET . 27.0 t0 -99.16 18.44 17.47 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.558 1.171 . . . . 63.25 109.28 -173.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.48 154.8 17.62 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.525 -1.216 . . . . 74.409999999999997 111.097 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 8.5 m-20 -133.07 132.54 41.89 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.193 -0.317 . . . . 71.239999999999995 111.151 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 86.5 t -117.03 124.43 73.0 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 108.463 -0.94 . . . . 73.450000000000003 108.463 176.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -121.23 133.92 55.18 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.336 -0.227 . . . . 71.549999999999997 110.568 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.557 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.7 tm? -119.8 118.12 29.99 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.697 -1.964 . . . . 34.340000000000003 105.697 176.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 31' ' ' SER . 18.2 m -126.6 131.55 51.48 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.356 -0.609 . . . . 63.450000000000003 109.356 -177.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 65.8 t -124.87 126.59 71.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.467 -0.568 . . . . 65.349999999999994 109.467 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.09 126.17 54.79 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.33 -0.989 . . . . 44.020000000000003 108.33 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.597 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.8 p90 -134.1 120.91 15.34 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 112.576 0.584 . . . . 72.140000000000001 112.576 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 26.2 Cg_exo -67.83 39.64 0.2 Allowed 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 123.59 2.86 . . . . 74.409999999999997 112.798 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.62 -107.23 0.33 Allowed 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.529 -0.545 . . . . 64.420000000000002 109.529 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.81 129.18 0.11 Allowed 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.601 -0.889 . . . . 61.340000000000003 108.601 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.59 134.91 26.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.594 -0.891 . . . . 64.329999999999998 108.594 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.5 p -92.36 -38.52 11.98 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.229 0.537 . . . . 74.319999999999993 109.684 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.4 m -161.37 132.96 5.55 Favored 'General case' 0 C--O 1.208 -1.12 0 C-N-CA 123.212 0.605 . . . . 72.209999999999994 109.466 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.2 t -139.7 155.67 47.24 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.121 -0.632 . . . . 74.310000000000002 111.124 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -123.13 95.4 4.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 104.898 -2.26 . . . . 65.420000000000002 104.898 172.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.475 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.33 -155.51 24.48 Favored Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 107.508 -2.237 . . . . 42.32 107.508 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -107.01 99.85 9.38 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.131 0.965 . . . . 61.340000000000003 110.579 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -79.43 114.38 18.32 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.86 -0.609 . . . . 73.030000000000001 109.718 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.5 mt -80.85 -39.48 17.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.42 -1.326 . . . . 73.510000000000005 107.42 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -135.17 168.9 15.41 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 106.472 -1.677 . . . . 73.209999999999994 106.472 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.22 0.33 9.51 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.042 1.828 . . . . 64.349999999999994 109.822 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.5 pt-20 -134.89 10.03 3.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.2 -0.909 . . . . 72.430000000000007 112.109 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.9 t -145.87 120.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.813 -1.18 . . . . 53.020000000000003 107.813 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.99 147.4 32.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.87 -0.789 . . . . 73.150000000000006 108.87 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -137.63 146.65 44.17 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.318 -0.401 . . . . 72.519999999999996 110.019 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.557 ' CE3' HD12 ' A' ' 139' ' ' LEU . 22.8 m-90 -130.1 130.97 45.51 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.995 -1.113 . . . . 74.129999999999995 107.995 176.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -112.59 105.39 13.58 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.638 0.732 . . . . 75.400000000000006 110.632 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.3 mm? -94.03 134.5 36.38 Favored 'General case' 0 C--O 1.271 2.222 0 CA-C-N 115.64 -0.709 . . . . 73.450000000000003 110.493 -175.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 1.4 tpmt? -103.31 145.65 30.99 Favored Pre-proline 0 N--CA 1.419 -2.01 0 C-N-CA 124.063 0.945 . . . . 71.209999999999994 108.98 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -68.25 157.76 60.44 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.789 2.326 . . . . 74.129999999999995 110.813 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.524 ' O ' HG22 ' A' ' 128' ' ' THR . . . 77.61 -22.39 2.74 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 121.054 -0.593 . . . . 73.219999999999999 113.483 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 165' ' ' LYS . 5.7 m -106.07 167.8 3.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.485 0.659 . . . . 41.420000000000002 111.636 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.89 135.94 53.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.833 -1.173 . . . . 64.319999999999993 107.833 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.7 m -149.05 163.9 36.21 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.626 -0.509 . . . . 62.229999999999997 109.626 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 t -139.01 146.14 40.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.403 0.62 . . . . 71.420000000000002 111.311 175.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.2 ptp -112.88 142.91 44.99 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.389 -1.278 . . . . 74.230000000000004 108.763 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.4 m -143.14 147.09 34.39 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 120.044 -0.662 . . . . 74.340000000000003 110.027 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -154.33 147.55 24.81 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 109.1 -0.704 . . . . 73.099999999999994 109.1 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.45 ' HG2' HG22 ' A' ' 120' ' ' ILE . 42.0 mt-30 -141.15 131.52 25.15 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 107.436 -1.32 . . . . 74.219999999999999 107.436 174.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.22 149.16 26.71 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.279 -1.378 . . . . 63.340000000000003 107.279 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.593 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 16.3 ptt180 -93.27 146.65 23.55 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 118.581 -1.248 . . . . 63.119999999999997 110.925 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.402 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 98.6 m-85 -142.33 129.19 20.6 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 109.316 -0.624 . . . . 70.140000000000001 109.316 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 p -67.58 121.16 15.26 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.403 -0.817 . . . . 63.210000000000001 111.317 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.08 126.77 88.25 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 115.413 -0.812 . . . . 55.229999999999997 109.238 174.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.74 -24.44 34.74 Favored 'Trans proline' 0 C--N 1.329 -0.484 0 C-N-CA 122.678 2.252 . . . . 74.049999999999997 110.531 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -84.29 -11.25 56.73 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.453 -1.249 . . . . 73.019999999999996 109.861 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p 51.94 89.05 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.41 1.484 . . . . 75.129999999999995 112.411 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.76 158.1 17.04 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.38 0.61 . . . . 72.319999999999993 112.43 -176.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.413 -2.276 0 N-CA-C 106.712 -1.588 . . . . 63.32 106.712 176.681 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.578 0 N-CA-C 111.554 -0.618 . . . . 61.009999999999998 111.554 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.405 ' HG2' ' HG3' ' A' ' 17' ' ' GLU . 46.4 ttt180 -104.5 -63.63 1.19 Allowed 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.254 -0.647 . . . . 71.329999999999998 109.254 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 30.9 mt-10 -145.98 57.34 1.21 Allowed 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 106.062 -1.829 . . . . 64.439999999999998 106.062 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -94.07 6.45 48.49 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.452 -1.704 . . . . 64.420000000000002 109.631 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.4 mt -84.48 77.85 9.94 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.199 -1.037 . . . . 53.520000000000003 108.199 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -129.33 80.16 1.95 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.415 -0.811 . . . . 65.519999999999996 109.112 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -123.11 84.72 2.31 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-O 121.97 0.89 . . . . 73.319999999999993 110.384 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -116.91 165.64 13.1 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 114.35 -1.295 . . . . 70.200000000000003 109.318 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.45 -96.92 0.13 Allowed Glycine 0 N--CA 1.416 -2.665 0 N-CA-C 109.395 -1.482 . . . . 71.030000000000001 109.395 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.484 ' O ' ' HG3' ' A' ' 25' ' ' MET . 48.2 m-70 46.5 62.08 2.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.397 1.258 . . . . 75.409999999999997 114.397 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.588 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 34.8 mtt -174.43 102.61 0.1 Allowed 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 126.831 2.053 . . . . 65.140000000000001 107.106 176.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.4 OUTLIER -144.11 98.54 3.23 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 122.074 0.94 . . . . 74.239999999999995 110.678 177.292 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.0 mtp180 -121.57 134.32 55.02 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.126 -1.064 . . . . 75.140000000000001 108.126 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.5 t -117.09 115.02 47.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.317 -0.994 . . . . 51.149999999999999 108.317 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -115.5 120.87 40.95 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 121.074 0.464 . . . . 61.310000000000002 110.432 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -115.25 108.64 16.84 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.443 -0.947 . . . . 75.5 108.443 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 140' ' ' THR . 34.9 m -117.7 117.37 29.17 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.854 -1.165 . . . . 64.319999999999993 107.854 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -125.73 146.65 31.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 109.776 -0.453 . . . . 74.230000000000004 109.776 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.8 m -125.65 122.58 36.8 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.344 0.593 . . . . 73.340000000000003 109.908 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 143' ' ' PHE . 10.2 tt -101.98 119.01 49.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 108.714 -0.847 . . . . 72.109999999999999 108.714 176.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.5 m -87.43 160.64 47.67 Favored Pre-proline 0 N--CA 1.424 -1.757 0 CA-C-N 115.658 -0.701 . . . . 71.319999999999993 110.158 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -64.92 2.1 1.52 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 123.777 2.984 . . . . 74.549999999999997 113.595 -177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.18 -7.21 57.23 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.192 -0.669 . . . . 75.530000000000001 109.192 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.4 t70 72.54 29.12 2.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 106.86 -1.533 . . . . 74.25 106.86 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.4 146.76 37.78 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.945 -1.502 . . . . 73.540000000000006 106.945 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.516 HG11 HD13 ' A' ' 95' ' ' LEU . 21.2 t -118.39 140.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-O 121.066 0.46 . . . . 54.210000000000001 110.096 -176.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.0 p -137.22 161.82 35.15 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.624 -1.621 . . . . 52.109999999999999 106.624 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.64 -176.35 46.9 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 119.407 -1.377 . . . . 73.439999999999998 112.158 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.54 133.41 14.05 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.412 0.625 . . . . 62.200000000000003 110.273 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 65.0 mt -121.14 116.01 48.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.835 -1.172 . . . . 74.120000000000005 107.835 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.66 119.01 60.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.334 -0.617 . . . . 61.549999999999997 109.334 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.419 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -110.21 108.63 18.83 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.612 -1.625 . . . . 44.32 106.612 174.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -119.86 131.51 55.29 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 120.885 0.374 . . . . 70.400000000000006 111.088 -175.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 25' ' ' MET . . . -139.58 158.35 44.26 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.478 -0.783 . . . . 44.350000000000001 112.763 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 49.43 101.12 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 115.655 1.724 . . . . 55.210000000000001 115.655 168.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.778 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 83.7 Cg_exo -51.84 -52.23 9.44 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.14 2.56 . . . . 61.310000000000002 112.488 178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -151.64 116.65 5.22 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.6 -0.518 . . . . 60.229999999999997 109.6 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -126.22 158.22 36.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.56 -1.274 . . . . 73.230000000000004 107.56 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 p -66.31 -55.38 16.28 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 122.983 0.513 . . . . 73.109999999999999 112.256 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -105.7 -16.18 14.76 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.516 0.562 . . . . 74.340000000000003 112.516 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -96.88 101.62 13.24 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.055 -0.721 . . . . 73.349999999999994 109.055 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t -119.08 2.09 11.43 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.885 -1.052 . . . . 52.25 109.789 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.8 97.81 0.11 Allowed Glycine 0 N--CA 1.42 -2.37 0 C-N-CA 118.846 -1.645 . . . . 52.229999999999997 113.694 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 83' ' ' SER . 74.7 Cg_exo -55.55 151.36 38.6 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.391 2.06 . . . . 71.530000000000001 109.927 166.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.83 119.66 19.48 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.758 -0.46 . . . . 33.350000000000001 109.758 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 81.9 mt -69.63 137.3 52.13 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 123.54 0.525 . . . . 71.129999999999995 110.421 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -97.34 100.04 11.49 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.452 -0.944 . . . . 70.420000000000002 108.452 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.656 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -150.24 92.28 0.14 Allowed Glycine 0 C--N 1.277 -2.721 0 C-N-CA 120.156 -1.021 . . . . 72.409999999999997 113.233 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -106.15 99.67 9.24 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.048 -1.093 . . . . 74.530000000000001 108.048 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.73 155.89 48.47 Favored Pre-proline 0 C--N 1.286 -2.182 0 CA-C-N 115.501 -0.772 . . . . 70.219999999999999 108.958 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.27 -19.08 48.48 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.911 2.407 . . . . 70.549999999999997 112.941 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -107.82 32.75 4.5 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.792 -0.64 . . . . 72.340000000000003 112.212 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.4 m -56.58 -25.64 53.1 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.552 0.215 . . . . 65.040000000000006 111.406 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -64.72 -16.83 63.49 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.116 0.484 . . . . 74.140000000000001 110.599 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -103.11 -15.81 15.94 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.676 -0.693 . . . . 72.439999999999998 110.633 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 p -123.97 118.27 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-O 122.106 0.955 . . . . 55.43 111.406 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.03 109.01 21.1 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.603 -1.181 . . . . 74.439999999999998 109.319 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.5 t -97.95 114.36 35.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.812 -1.551 . . . . 53.299999999999997 106.812 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 m -125.68 171.8 10.3 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.729 -0.668 . . . . 72.340000000000003 109.796 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -88.25 151.1 22.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.397 -1.334 . . . . 73.430000000000007 107.397 174.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 67.7 t80 -115.3 125.05 52.8 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 108.299 -1.0 . . . . 71.129999999999995 108.299 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -138.69 99.61 3.85 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.566 -2.013 . . . . 60.210000000000001 105.566 174.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 42.6 t -172.51 148.04 1.95 Allowed 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.403 -0.962 . . . . 75.099999999999994 108.403 -174.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 69.32 10.04 7.59 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.998 0.919 . . . . 63.039999999999999 111.079 174.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.778 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 95.02 -3.78 67.31 Favored Glycine 0 N--CA 1.423 -2.173 0 CA-C-N 115.279 -0.873 . . . . 73.140000000000001 111.782 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.538 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 41.5 m-85 -104.2 146.28 29.0 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.374 0.587 . . . . 74.319999999999993 110.491 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.77 136.5 51.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 N-CA-C 108.308 -0.997 . . . . 73.519999999999996 108.308 172.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -167.1 -155.17 8.89 Favored Glycine 0 C--N 1.263 -3.492 0 C-N-CA 118.863 -1.637 . . . . 52.100000000000001 112.512 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' A' ' 58' ' ' PRO . 24.0 t -136.97 143.73 42.97 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 108.641 -0.874 . . . . 71.519999999999996 108.641 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -131.86 137.42 48.05 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.952 -0.567 . . . . 72.319999999999993 110.947 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.21 114.21 27.26 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.743 -1.577 . . . . 75.099999999999994 106.743 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.96 120.7 62.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.966 -1.124 . . . . 75.219999999999999 107.966 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.497 ' CD2' HD12 ' A' ' 90' ' ' LEU . 45.2 p90 -126.73 149.48 49.58 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.786 -0.765 . . . . 63.350000000000001 111.62 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.4 m -156.23 152.09 27.36 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.765 -0.652 . . . . 74.099999999999994 109.484 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.3 t70 64.46 48.75 2.62 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 122.577 1.18 . . . . 61.340000000000003 111.111 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 87' ' ' PHE . 23.2 mt -112.07 169.88 8.54 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.041 -0.982 . . . . 74.030000000000001 108.584 175.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.507 HG22 ' OE1' ' A' ' 94' ' ' GLU . 13.1 t -128.38 -178.84 4.72 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.923 -1.111 . . . . 70.150000000000006 110.955 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -50.32 -42.84 53.35 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.329 1.452 . . . . 64.140000000000001 111.146 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.37 -27.97 69.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.46 0.541 . . . . 44.530000000000001 112.46 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.507 ' OE1' HG22 ' A' ' 91' ' ' THR . 3.9 mp0 -88.48 -17.61 29.98 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 112.559 0.577 . . . . 73.310000000000002 112.559 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.516 HD13 HG11 ' A' ' 40' ' ' VAL . 40.4 tp -57.62 -47.38 99.06 Favored Pre-proline 0 CA--C 1.567 1.629 0 N-CA-C 113.807 1.04 . . . . 74.129999999999995 113.807 -177.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.64 -32.32 7.76 Favored 'Trans proline' 0 C--N 1.359 1.1 0 CA-C-N 120.72 1.293 . . . . 41.100000000000001 110.96 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -68.92 -34.68 75.78 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.992 -0.549 . . . . 75.349999999999994 111.29 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -74.16 -19.13 60.66 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.9 0.381 . . . . 73.230000000000004 110.189 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.26 -22.64 63.82 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.873 -0.603 . . . . 65.439999999999998 110.678 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -58.5 -57.87 11.02 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.638 -0.875 . . . . 65.140000000000001 108.638 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.656 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.5 ttp -54.46 -50.33 67.95 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.436 -0.802 . . . . 73.439999999999998 110.062 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -55.03 -40.07 69.81 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 114.854 -1.066 . . . . 71.310000000000002 111.367 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.9 p -69.47 -19.25 63.76 Favored 'General case' 0 N--CA 1.42 -1.967 0 C-N-CA 119.63 -0.828 . . . . 72.230000000000004 112.631 -171.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.34 -28.29 69.9 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 121.583 0.706 . . . . 62.530000000000001 110.06 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.7 -8.2 16.97 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.932 -0.577 . . . . 75.120000000000005 110.829 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.19 -34.29 7.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.557 0.947 . . . . 43.539999999999999 113.557 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.69 26.77 66.52 Favored Glycine 0 N--CA 1.46 0.264 0 N-CA-C 111.125 -0.79 . . . . 74.230000000000004 111.125 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.22 156.35 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.673 0.749 . . . . 75.099999999999994 112.376 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -117.56 121.45 40.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.964 -2.606 . . . . 70.450000000000003 103.964 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.9 mt -123.29 134.39 54.07 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 118.382 0.537 . . . . 72.340000000000003 111.185 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.7 m -126.66 128.04 46.11 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.575 -0.898 . . . . 75.420000000000002 108.575 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 tp -125.86 125.25 42.53 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.577 -0.527 . . . . 63.439999999999998 109.577 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -138.02 145.76 42.24 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.663 -0.495 . . . . 73.5 109.663 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -98.85 137.95 36.68 Favored 'General case' 0 N--CA 1.399 -3.008 0 N-CA-C 107.71 -1.219 . . . . 74.099999999999994 107.71 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.413 ' O ' HG13 ' A' ' 118' ' ' ILE . 46.8 t30 -124.77 87.08 2.65 Favored 'General case' 0 C--N 1.269 -2.897 0 N-CA-C 107.469 -1.308 . . . . 63.420000000000002 107.469 -177.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.52 -115.99 5.57 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.576 -1.41 . . . . 61.539999999999999 109.576 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -104.95 -1.88 25.27 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.106 0.955 . . . . 74.239999999999995 108.889 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.549 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -101.84 148.99 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.799 -1.186 . . . . 53.520000000000003 107.799 179.099 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.1 t -117.28 138.53 47.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 O-C-N 121.762 -0.586 . . . . 72.120000000000005 110.59 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.5 pt -120.5 135.49 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-O 121.542 0.687 . . . . 75.150000000000006 109.81 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.9 tt -128.18 127.0 42.11 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.351 -1.351 . . . . 63.229999999999997 107.351 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.99 139.58 41.55 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.671 -0.863 . . . . 74.209999999999994 108.671 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.98 -175.57 34.99 Favored Glycine 0 N--CA 1.402 -3.625 0 C-N-CA 120.345 -0.931 . . . . 61.030000000000001 111.472 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -145.47 157.3 44.03 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.117 -1.068 . . . . 65.530000000000001 108.117 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.3 109.54 11.56 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.797 -0.446 . . . . 53.520000000000003 109.797 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -112.7 93.63 4.52 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.641 -0.874 . . . . 53.25 108.641 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.348 0.0 OUTLIER -125.36 54.64 1.45 Allowed 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 124.257 1.979 . . . . 74.019999999999996 109.677 176.065 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.4 p -84.58 -30.41 25.05 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.235 -2.257 . . . . 74.409999999999997 111.499 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.6 m -71.05 -24.95 62.44 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.414 -0.357 . . . . 72.430000000000007 111.909 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.65 119.1 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 106.952 -1.499 . . . . 70.239999999999995 106.952 173.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.3 t -117.84 8.89 12.76 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.09 -0.644 . . . . 73.030000000000001 111.232 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.01 116.06 11.38 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.351 -0.611 . . . . 72.099999999999994 109.351 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.68 -12.75 37.17 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 122.92 2.413 . . . . 65.25 113.552 -173.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -97.21 14.4 26.08 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 123.568 0.747 . . . . 75.439999999999998 110.521 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -98.69 129.17 45.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 111.73 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -133.76 127.08 32.02 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.27 -1.011 . . . . 54.210000000000001 108.27 171.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 66.3 t -114.53 112.97 42.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.94 -1.133 . . . . 63.420000000000002 107.94 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -107.51 122.07 45.91 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.612 -0.514 . . . . 55.509999999999998 109.612 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.572 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.8 tm? -111.8 119.16 37.66 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.383 -1.71 . . . . 74.040000000000006 106.383 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 31' ' ' SER . 7.1 m -126.8 130.58 50.53 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.328 -0.619 . . . . 73.019999999999996 109.328 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 85.0 t -122.67 124.83 71.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.259 -0.645 . . . . 43.350000000000001 109.259 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.21 127.34 55.57 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.383 -0.599 . . . . 70.349999999999994 109.383 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.441 ' HB3' HG23 ' A' ' 34' ' ' ILE . 2.9 p90 -134.55 117.16 13.08 Favored Pre-proline 0 C--N 1.287 -2.128 0 CA-C-N 116.232 -0.44 . . . . 75.109999999999999 111.207 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.49 27.32 0.14 Allowed 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 122.846 2.364 . . . . 53.399999999999999 113.234 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -106.63 -92.34 0.4 Allowed 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.036 -0.728 . . . . 73.150000000000006 109.036 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.22 131.07 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.537 1.135 . . . . 73.200000000000003 107.987 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.92 137.95 20.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.689 -0.856 . . . . 71.239999999999995 108.689 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.7 p -91.94 -45.78 8.17 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.391 -0.596 . . . . 65.340000000000003 109.391 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.1 m -150.24 132.95 15.89 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.373 -0.83 . . . . 74.230000000000004 109.119 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.413 ' OG1' HG11 ' A' ' 160' ' ' VAL . 6.9 t -139.07 159.34 42.37 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.677 -0.64 . . . . 60.210000000000001 110.248 175.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 25.5 t-20 -131.01 97.91 4.44 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 104.723 -2.325 . . . . 60.450000000000003 104.723 172.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.69 -141.81 6.59 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.167 -1.573 . . . . 72.400000000000006 109.167 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -118.65 99.07 6.55 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 117.587 0.693 . . . . 70.409999999999997 110.129 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -75.16 130.33 39.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.853 -0.53 . . . . 71.450000000000003 111.087 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 61.1 mt -90.32 -48.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.65 -1.611 . . . . 44.219999999999999 106.65 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -136.28 171.94 7.9 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.136 -1.801 . . . . 74.239999999999995 106.136 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -75.97 -1.56 11.56 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.594 1.529 . . . . 51.119999999999997 111.082 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.27 1.96 7.8 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.707 -0.679 . . . . 71.049999999999997 111.457 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 68.1 t -143.77 120.96 5.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.576 -0.898 . . . . 64.549999999999997 108.576 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.413 HG11 ' OG1' ' A' ' 150' ' ' THR . 56.7 t -123.98 148.3 28.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.06 -0.719 . . . . 74.430000000000007 109.06 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -135.93 151.42 49.94 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.174 -0.676 . . . . 50.420000000000002 109.174 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.572 ' CE3' HD12 ' A' ' 139' ' ' LEU . 26.3 m-90 -132.47 128.68 37.94 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.222 -1.399 . . . . 64.409999999999997 107.222 175.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.17 105.29 15.2 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.919 0.866 . . . . 75.25 110.681 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.3 mp -87.8 130.56 34.82 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.478 -1.237 . . . . 72.239999999999995 109.664 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -118.15 146.89 40.33 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 115.204 -0.907 . . . . 74.019999999999996 111.144 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.93 149.86 86.04 Favored 'Trans proline' 0 N--CA 1.476 0.448 0 C-N-CA 123.389 2.726 . . . . 51.140000000000001 111.985 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.71 -27.43 2.57 Favored Glycine 0 C--N 1.308 -1.027 0 C-N-CA 121.218 -0.515 . . . . 75.239999999999995 113.169 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.5 m -105.57 154.44 6.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.198 0.523 . . . . 62.310000000000002 111.275 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 p -98.08 143.87 12.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.926 -0.768 . . . . 75.430000000000007 108.926 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 30.7 m -134.38 153.69 51.76 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.653 -0.499 . . . . 52.240000000000002 109.653 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.1 p -106.94 153.77 22.06 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.702 0.287 . . . . 75.519999999999996 111.063 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 40.1 tpp -124.95 116.87 22.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.031 -0.729 . . . . 74.319999999999993 109.031 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 8.3 t -143.57 132.5 22.8 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.022 -1.071 . . . . 74.439999999999998 109.876 172.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.83 122.94 8.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.759 -0.83 . . . . 63.329999999999998 108.759 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -127.94 132.01 49.28 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.635 -0.876 . . . . 71.450000000000003 108.635 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -156.75 158.09 36.26 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.902 -0.407 . . . . 43.030000000000001 109.902 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 118' ' ' ILE . 70.2 mtp180 -89.13 136.66 32.89 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.756 -0.461 . . . . 72.409999999999997 109.756 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -142.68 128.39 19.26 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 109.472 -0.566 . . . . 62.229999999999997 109.472 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 12.8 p -56.38 109.96 0.69 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 124.231 0.957 . . . . 63.210000000000001 112.727 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.09 130.29 79.67 Favored Pre-proline 0 CA--C 1.51 -0.592 0 O-C-N 123.951 0.782 . . . . 64.430000000000007 109.476 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.06 -46.4 10.45 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 123.034 2.49 . . . . 74.5 114.203 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.29 -17.44 39.61 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 122.337 -0.227 . . . . 72.340000000000003 110.546 -176.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.276 69.3 p 71.18 72.18 0.18 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.578 1.551 . . . . 74.329999999999998 111.549 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -45.59 144.8 1.47 Allowed 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 113.31 -1.768 . . . . 53.009999999999998 111.623 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 34.4 m . . . . . 0 C--N 1.25 -3.757 0 CA-C-N 113.385 -1.734 . . . . 74.319999999999993 108.323 -177.317 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.641 0 N-CA-C 111.405 -0.678 . . . . 71.049999999999997 111.405 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -92.04 122.59 34.69 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.52 -1.289 . . . . 71.310000000000002 107.52 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -83.17 122.78 28.83 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.211 0.529 . . . . 70.349999999999994 110.893 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -108.95 135.11 50.68 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.375 -0.972 . . . . 72.129999999999995 108.375 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.4 105.14 12.34 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.695 -0.854 . . . . 72.519999999999996 108.695 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -83.44 84.08 7.65 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.656 0.741 . . . . 74.409999999999997 110.424 -174.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -96.37 -52.35 4.01 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.127 -0.942 . . . . 73.519999999999996 108.989 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -117.83 168.21 10.69 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.674 -1.148 . . . . 60.009999999999998 108.355 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.68 95.27 1.93 Allowed Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 108.719 -1.752 . . . . 62.409999999999997 108.719 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.402 ' NE2' ' HB2' ' A' ' 51' ' ' LYS . 58.8 m80 -58.52 132.11 52.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.15 0.5 . . . . 71.319999999999993 111.542 -176.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 26.7 ttt -60.02 -39.27 85.29 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 114.45 -1.25 . . . . 65.530000000000001 109.531 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 65.2 tp 31.56 89.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.506 1.922 . . . . 71.430000000000007 114.747 173.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HD3' ' OE1' ' A' ' 138' ' ' GLU . 28.8 ttm180 -109.33 124.16 50.49 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 118.388 -1.325 . . . . 74.0 109.09 177.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 61.8 t -109.36 113.77 45.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 105.543 -2.021 . . . . 74.129999999999995 105.543 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 35.1 ttt180 -126.34 118.65 25.48 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-O 121.504 0.668 . . . . 74.239999999999995 110.369 -177.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.94 109.84 19.52 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.677 -1.147 . . . . 63.439999999999998 108.054 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.4 m -110.94 115.42 29.48 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 107.42 -1.326 . . . . 75.120000000000005 107.42 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -127.8 146.3 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 109.532 -0.544 . . . . 62.219999999999999 109.532 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.6 m -124.42 125.03 43.59 Favored 'General case' 0 C--N 1.272 -2.803 0 CA-C-N 115.928 -0.578 . . . . 64.420000000000002 109.596 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.9 tt -114.92 124.79 71.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.531 0.681 . . . . 71.340000000000003 109.62 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m -100.07 157.36 34.0 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 115.75 -0.659 . . . . 74.239999999999995 110.674 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD3' ' HG2' ' A' ' 144' ' ' PRO . 64.6 Cg_exo -58.24 -2.51 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 124.355 3.37 . . . . 64.230000000000004 113.476 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 19.5 m-20 -82.08 -0.19 43.41 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 125.278 1.431 . . . . 65.200000000000003 110.732 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.2 t70 66.86 29.81 8.14 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.855 -1.535 . . . . 71.530000000000001 106.855 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -120.92 136.95 54.82 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 112.999 -1.909 . . . . 74.120000000000005 108.602 -175.026 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 95' ' ' LEU . 22.0 t -121.35 137.19 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 115.106 -0.952 . . . . 72.120000000000005 109.3 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.3 p -138.49 149.9 45.88 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.681 -1.229 . . . . 64.120000000000005 107.681 174.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.09 -175.7 47.43 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 118.012 -2.042 . . . . 24.329999999999998 113.884 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.99 133.73 28.85 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.348 -0.926 . . . . 60.43 108.879 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.5 mt -121.19 116.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 107.776 -1.194 . . . . 70.540000000000006 107.776 176.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -120.08 115.54 47.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 120.762 0.315 . . . . 74.019999999999996 110.247 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . . . -107.92 108.21 19.26 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.444 -1.687 . . . . 52.310000000000002 106.444 174.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.474 ' HB1' ' CB ' ' A' ' 80' ' ' TYR . . . -122.82 126.22 46.96 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.309 0.576 . . . . 72.420000000000002 112.511 -172.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.98 157.81 21.97 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.573 -0.899 . . . . 52.509999999999998 108.573 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -87.28 123.9 69.12 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 106.706 -1.591 . . . . 71.120000000000005 106.706 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.45 79.71 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.557 2.838 . . . . 75.310000000000002 115.59 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 74.3 mmtt -106.66 -1.11 23.13 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.89 0.853 . . . . 53.32 109.943 173.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.506 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 49.1 t-20 -94.44 105.51 17.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.806 -2.294 . . . . 53.0 104.806 172.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.3 m -59.24 -14.51 11.23 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 114.833 1.42 . . . . 72.209999999999994 114.833 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 65.7 pttt -96.97 -19.14 18.99 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.766 -0.773 . . . . 64.120000000000005 112.73 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.38 137.31 43.4 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 118.697 -1.201 . . . . 74.040000000000006 113.068 -170.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 p -111.09 -19.84 12.59 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.39 -1.277 . . . . 73.010000000000005 110.817 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.414 ' HA3' ' CG ' ' A' ' 74' ' ' ASN . . . 172.31 97.62 0.11 Allowed Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.678 -0.772 . . . . 54.219999999999999 111.547 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.28 159.4 52.43 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.18 1.92 . . . . 73.5 110.836 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.23 154.13 33.87 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.574 -0.528 . . . . 74.129999999999995 109.574 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 83' ' ' SER . 6.6 mp -68.95 145.97 53.17 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 120.95 0.405 . . . . 73.5 111.52 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -112.52 108.88 18.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.281 -0.872 . . . . 62.140000000000001 109.187 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.9 -72.55 0.01 OUTLIER Glycine 0 C--N 1.265 -3.369 0 C-N-CA 120.194 -1.003 . . . . 54.350000000000001 112.103 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 71.17 124.54 0.03 OUTLIER 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.392 1.077 . . . . 42.530000000000001 110.519 -173.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.67 162.15 56.69 Favored Pre-proline 0 C--N 1.293 -1.877 0 CA-C-N 115.222 -0.899 . . . . 43.32 108.911 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.79 -16.25 47.77 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 122.882 2.388 . . . . 74.430000000000007 113.187 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.431 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 33.2 p90 -116.01 48.66 1.2 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.429 0.633 . . . . 72.299999999999997 111.786 -176.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m -55.85 -37.43 68.74 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.53 0.567 . . . . 75.140000000000001 112.53 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -67.56 -11.57 58.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.5 0.667 . . . . 63.43 111.426 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 66' ' ' PHE . 14.0 mmmm -95.56 -18.02 20.93 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.577 -0.738 . . . . 71.299999999999997 110.176 -177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.6 119.76 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.913 0.863 . . . . 71.019999999999996 111.66 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.62 111.48 23.81 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.545 -0.752 . . . . 75.25 109.575 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 85' ' ' ALA . 4.4 p -98.28 139.25 20.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.096 -1.075 . . . . 63.210000000000001 108.096 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -150.9 170.3 19.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.196 0.522 . . . . 64.450000000000003 110.948 -170.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.414 ' CG ' ' HA3' ' A' ' 57' ' ' GLY . 35.3 t-20 -84.16 128.98 34.91 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.122 -1.436 . . . . 71.319999999999993 107.122 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 88.3 t80 -108.83 122.05 46.37 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.61 -0.436 . . . . 72.420000000000002 110.279 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -138.77 109.49 6.65 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.913 -1.143 . . . . 72.340000000000003 107.913 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 46.6 t -168.68 147.61 4.21 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.657 -0.701 . . . . 71.400000000000006 109.329 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.87 19.28 11.66 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.644 0.979 . . . . 74.109999999999999 113.644 171.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.87 0.31 62.24 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 120.543 -0.836 . . . . 64.519999999999996 111.794 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.474 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . 49.9 m-85 -104.77 161.14 14.42 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 120.755 0.312 . . . . 65.120000000000005 110.181 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.98 136.46 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 106.049 -1.834 . . . . 75.109999999999999 106.049 163.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.82 -155.22 9.51 Favored Glycine 0 N--CA 1.408 -3.207 0 C-N-CA 119.605 -1.283 . . . . 72.109999999999999 112.957 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.484 ' HB3' HD12 ' A' ' 60' ' ' LEU . 5.3 m -118.12 141.36 48.57 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 114.531 -0.835 . . . . 42.32 109.918 -174.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.42 148.72 47.92 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.702 -0.799 . . . . 74.019999999999996 111.132 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . . . -131.81 115.1 15.52 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.427 -1.323 . . . . 40.329999999999998 107.427 175.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.1 t -108.74 117.82 54.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.386 -0.968 . . . . 72.25 108.386 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CD2' HD12 ' A' ' 90' ' ' LEU . 51.2 p90 -121.05 151.91 39.26 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.069 0.461 . . . . 71.400000000000006 110.651 -175.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -155.36 160.41 40.68 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.223 -0.444 . . . . 71.540000000000006 111.383 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 60.93 30.2 19.48 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.895 1.278 . . . . 74.549999999999997 110.867 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 87' ' ' PHE . 17.7 mt -87.79 161.08 17.76 Favored 'General case' 0 N--CA 1.413 -2.301 0 CA-C-N 115.914 -0.584 . . . . 71.340000000000003 109.62 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.407 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.7 t -122.53 177.6 5.35 Favored 'General case' 0 C--N 1.258 -3.375 0 N-CA-C 109.311 -0.626 . . . . 73.420000000000002 109.311 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -55.9 -35.42 66.52 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 123.977 0.911 . . . . 73.450000000000003 111.776 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.66 -26.29 62.48 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.27 0.557 . . . . 43.539999999999999 111.861 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' A' ' 90' ' ' LEU . 46.4 mt-10 -88.26 -20.49 25.39 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.032 0.444 . . . . 75.319999999999993 109.855 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 54.9 tp -58.91 -54.69 53.96 Favored Pre-proline 0 CA--C 1.566 1.577 0 N-CA-C 114.453 1.279 . . . . 65.010000000000005 114.453 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -74.11 -28.34 10.97 Favored 'Trans proline' 0 C--N 1.362 1.276 0 CA-C-N 121.23 1.475 . . . . 64.230000000000004 110.292 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -70.03 -29.61 66.69 Favored 'General case' 0 N--CA 1.402 -2.845 0 CA-C-N 114.932 -1.031 . . . . 72.140000000000001 110.842 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -75.82 -22.69 56.06 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 109.388 -0.597 . . . . 74.5 109.388 175.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -17.72 62.42 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.812 -0.631 . . . . 64.349999999999994 111.118 -175.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -63.61 -57.61 9.54 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.912 -0.773 . . . . 74.319999999999993 108.912 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 38.6 ttp -59.86 -47.44 85.72 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.641 -0.708 . . . . 44.200000000000003 110.386 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -57.51 -29.78 64.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.077 -0.965 . . . . 73.019999999999996 111.144 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -60.91 -37.35 81.97 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.889 -0.411 . . . . 62.43 109.889 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.5 -20.5 65.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.258 0.551 . . . . 73.140000000000001 111.073 -175.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.59 -21.27 15.33 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 120.282 -0.567 . . . . 52.100000000000001 110.826 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.42 -47.95 3.81 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.103 -0.639 . . . . 75.409999999999997 112.166 -171.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.03 12.1 60.64 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 121.014 -0.612 . . . . 72.120000000000005 111.787 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.5 m -106.64 162.65 5.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 120.81 0.338 . . . . 74.120000000000005 110.832 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -123.07 125.22 44.79 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.613 -0.884 . . . . 74.200000000000003 108.613 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 87.4 mt -125.77 111.73 15.23 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 110.007 -0.368 . . . . 73.120000000000005 110.007 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.6 t -105.45 138.29 41.88 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.076 -1.453 . . . . 71.519999999999996 107.076 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 pp -149.96 153.95 37.44 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.968 -0.693 . . . . 71.25 112.248 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -158.58 167.85 28.49 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.316 -1.311 . . . . 63.140000000000001 110.245 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HD2' HH11 ' A' ' 114' ' ' ARG . 5.4 ttt180 -112.71 138.2 49.89 Favored 'General case' 0 N--CA 1.389 -3.506 0 N-CA-C 107.645 -1.243 . . . . 71.019999999999996 107.645 172.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -115.29 89.79 3.18 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 106.625 -1.621 . . . . 70.230000000000004 106.625 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.32 -103.83 1.01 Allowed Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.661 -0.976 . . . . 60.130000000000003 110.661 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -99.79 -24.71 14.6 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.83 0.824 . . . . 73.030000000000001 110.333 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -96.13 140.11 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 C-N-CA 118.664 -1.214 . . . . 72.120000000000005 109.607 -173.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.2 t -102.27 136.29 35.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.53 0 N-CA-C 109.617 -0.512 . . . . 73.200000000000003 109.617 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.1 pt -117.7 133.36 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 121.642 0.734 . . . . 64.310000000000002 109.924 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 tt -128.22 122.33 31.54 Favored 'General case' 0 C--N 1.273 -2.747 0 N-CA-C 107.873 -1.158 . . . . 65.129999999999995 107.873 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.34 127.27 37.3 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.755 -0.831 . . . . 73.439999999999998 108.755 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.62 -178.74 23.96 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 119.56 -1.305 . . . . 43.420000000000002 112.434 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.1 mtp85 -144.23 155.58 43.94 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 123.986 0.915 . . . . 74.109999999999999 109.103 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.73 108.47 11.55 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 107.067 -1.457 . . . . 74.310000000000002 107.067 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -107.31 92.35 4.04 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.742 -1.207 . . . . 73.239999999999995 107.742 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.46 ' O ' HG22 ' A' ' 130' ' ' VAL . 70.4 mt -120.7 12.11 11.35 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.803 -1.544 . . . . 71.430000000000007 108.811 -175.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.467 ' HA ' ' CA ' ' A' ' 167' ' ' GLY . 1.3 m -62.38 -22.29 66.02 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 114.71 -1.132 . . . . 73.209999999999994 112.11 -175.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.2 m -113.68 3.34 15.57 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 112.733 0.642 . . . . 53.350000000000001 112.733 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 127' ' ' LEU . 17.5 m -80.6 164.43 3.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 C-N-CA 119.83 -0.748 . . . . 54.340000000000003 112.065 -176.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.1 m -82.74 162.79 21.64 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.28 -0.873 . . . . 72.010000000000005 111.404 -176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 71.09 99.25 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 125.123 1.369 . . . . 72.519999999999996 112.37 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.12 -26.34 10.82 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.142 2.561 . . . . 73.019999999999996 115.146 -172.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -84.68 -11.37 56.01 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.03 0.443 . . . . 64.25 110.938 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' MET . . . -52.28 145.22 11.3 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.519 1.127 . . . . 63.509999999999998 113.855 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 2.5 m-20 -125.89 120.04 29.38 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-N 115.248 -0.887 . . . . 54.520000000000003 109.088 176.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 69.3 t -106.69 113.11 42.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.96 -1.126 . . . . 70.230000000000004 107.96 174.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 44.7 mt-10 -108.37 120.73 43.24 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.268 -0.642 . . . . 44.450000000000003 109.268 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.495 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.9 tm? -111.03 118.08 35.08 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 105.302 -2.11 . . . . 61.25 105.302 175.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.2 m -123.39 125.38 44.87 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.555 -0.535 . . . . 25.43 109.555 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 98.1 t -118.46 125.21 74.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.471 -0.566 . . . . 54.130000000000003 109.471 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.99 127.68 56.29 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.658 -0.867 . . . . 63.520000000000003 108.658 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.686 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.6 p90 -134.76 120.81 14.55 Favored Pre-proline 0 C--N 1.287 -2.124 0 CA-C-N 116.589 -0.278 . . . . 74.209999999999994 111.359 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.422 ' HG2' ' HD3' ' A' ' 36' ' ' PRO . 19.7 Cg_endo -70.8 40.62 0.36 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.605 2.204 . . . . 71.519999999999996 112.523 176.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.5 -110.03 0.31 Allowed 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.86 -0.609 . . . . 40.5 109.531 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -176.32 131.51 0.22 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.578 -0.526 . . . . 61.340000000000003 109.578 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.97 144.23 10.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.304 -0.862 . . . . 63.439999999999998 109.316 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.4 t -110.22 -30.67 7.63 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.457 -0.497 . . . . 71.409999999999997 110.457 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.6 m -156.64 131.82 9.18 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.66 -0.867 . . . . 73.409999999999997 108.66 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.5 t -139.74 161.2 38.11 Favored 'General case' 0 C--N 1.285 -2.2 0 O-C-N 122.022 -0.424 . . . . 42.140000000000001 110.569 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -133.19 87.63 2.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 104.845 -2.28 . . . . 54.140000000000001 104.845 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.27 -144.54 8.05 Favored Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 108.905 -1.678 . . . . 63.329999999999998 108.905 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -118.28 107.73 14.26 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 118.112 0.956 . . . . 71.230000000000004 111.407 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -82.08 118.02 22.71 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.484 0.659 . . . . 64.219999999999999 110.307 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.89 -40.01 16.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.186 -1.412 . . . . 64.019999999999996 107.186 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 157' ' ' PRO . 51.2 mt-10 -137.18 167.15 22.1 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 106.461 -1.681 . . . . 72.409999999999997 106.461 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 156' ' ' GLU . 55.8 Cg_endo -73.07 -0.21 8.76 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.896 1.731 . . . . 72.140000000000001 110.947 177.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.686 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 7.8 pt-20 -130.73 3.72 4.53 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.006 -0.997 . . . . 73.349999999999994 111.329 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.42 121.39 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.132 -0.692 . . . . 64.099999999999994 109.132 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.32 143.66 39.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.226 -0.657 . . . . 75.120000000000005 109.226 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.96 151.46 52.06 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.363 -0.606 . . . . 70.439999999999998 109.363 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.495 ' CE3' HD12 ' A' ' 139' ' ' LEU . 28.0 m-90 -132.68 128.62 37.4 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.24 -0.652 . . . . 74.340000000000003 109.24 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -100.14 113.66 26.47 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.372 0.606 . . . . 74.120000000000005 109.796 171.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 22.4 mt -102.09 133.18 47.35 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.468 -0.938 . . . . 74.420000000000002 108.468 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -117.93 145.45 36.76 Favored Pre-proline 0 C--N 1.309 -1.168 0 CA-C-N 115.935 -0.575 . . . . 65.129999999999995 112.117 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.24 161.44 44.61 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.574 2.183 . . . . 73.340000000000003 110.705 173.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 128' ' ' THR . . . 68.79 -9.93 1.74 Allowed Glycine 0 N--CA 1.472 1.072 0 N-CA-C 114.381 0.512 . . . . 65.120000000000005 114.381 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.66 171.09 9.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.484 -0.561 . . . . 62.240000000000002 109.484 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.88 142.02 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.624 -0.88 . . . . 65.140000000000001 108.624 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 40.9 m -140.81 143.74 35.0 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.91 -0.494 . . . . 61.329999999999998 110.905 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.8 p -108.12 141.14 40.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.368 -0.604 . . . . 74.150000000000006 109.368 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 80.4 mtp -123.66 130.03 52.02 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.276 -0.639 . . . . 74.519999999999996 109.276 -175.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.5 m -143.74 140.18 29.83 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.902 -0.719 . . . . 72.409999999999997 110.806 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.467 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -147.64 120.44 8.68 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.044 -1.095 . . . . 74.239999999999995 108.044 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -127.73 130.15 48.3 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 107.632 -1.247 . . . . 74.109999999999999 107.632 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.33 153.69 38.97 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.733 -0.469 . . . . 71.5 109.733 -175.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 48.9 mtm180 -96.66 126.26 41.7 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.983 -0.747 . . . . 75.010000000000005 108.983 -176.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -134.01 150.03 51.22 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.34 -0.985 . . . . 73.510000000000005 108.34 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.99 108.57 1.24 Allowed 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 120.971 0.415 . . . . 75.239999999999995 110.931 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.586 ' OD2' ' HA ' ' A' ' 183' ' ' THR . 19.2 p-10 -82.09 122.5 79.68 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 113.564 0.95 . . . . 73.420000000000002 113.564 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.04 -20.02 19.73 Favored 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 123.278 2.652 . . . . 72.340000000000003 110.414 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -81.39 -25.58 36.15 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.373 -1.285 . . . . 72.519999999999996 110.353 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.586 ' HA ' ' OD2' ' A' ' 180' ' ' ASP 0.317 26.4 p 47.95 76.12 0.12 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 114.646 1.35 . . . . 63.219999999999999 114.646 -178.675 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -121.65 164.04 17.99 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.751 -1.113 . . . . 45.329999999999998 109.917 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 108.611 -0.885 . . . . 43.329999999999998 108.611 -179.821 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.183 0 N-CA-C 110.2 -1.16 . . . . 74.310000000000002 110.2 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -84.5 83.3 8.05 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.21 1.005 . . . . 74.310000000000002 109.268 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.45 83.26 2.14 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.791 -1.559 . . . . 74.439999999999998 106.791 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -82.58 94.8 7.58 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.107 -0.951 . . . . 70.439999999999998 110.11 -175.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.4 mt -111.3 22.28 15.35 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.716 -1.129 . . . . 53.25 108.382 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -77.0 90.19 3.57 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.826 -1.079 . . . . 70.109999999999999 111.334 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -96.29 156.42 16.35 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.085 -0.962 . . . . 74.329999999999998 108.564 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -84.31 95.48 8.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.278 -0.638 . . . . 75.109999999999999 109.278 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.76 103.9 2.37 Favored Glycine 0 N--CA 1.427 -1.952 0 N-CA-C 108.672 -1.771 . . . . 73.109999999999999 108.672 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -70.21 150.09 46.82 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 123.662 0.272 . . . . 71.519999999999996 111.33 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 62.9 mtt 70.93 83.1 0.15 Allowed 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 125.111 1.507 . . . . 73.409999999999997 108.996 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -132.99 128.21 35.86 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.64 -1.164 . . . . 63.039999999999999 108.083 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 16.6 ptp180 -132.32 125.9 32.06 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 115.757 -0.656 . . . . 65.409999999999997 110.44 -176.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.09 114.66 47.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.42 -0.809 . . . . 73.530000000000001 108.906 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -115.58 114.18 24.6 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.441 -0.799 . . . . 73.150000000000006 109.475 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' HB3' HD22 ' A' ' 139' ' ' LEU . . . -110.54 108.77 18.84 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 107.66 -1.237 . . . . 52.229999999999997 107.66 176.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.3 t -119.71 115.36 23.75 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.989 -1.115 . . . . 65.329999999999998 107.989 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -127.98 147.17 32.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.157 0.503 . . . . 62.340000000000003 110.089 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.8 m -129.29 132.73 47.21 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 109.742 -0.466 . . . . 53.030000000000001 109.742 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.546 ' O ' ' HD2' ' A' ' 144' ' ' PRO . 10.8 tt -118.61 111.12 32.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.952 0.882 . . . . 74.519999999999996 111.023 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.2 m -76.62 163.97 62.5 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 114.177 -1.374 . . . . 70.510000000000005 111.214 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.67 0.61 5.32 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.865 2.377 . . . . 73.120000000000005 113.323 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 13.8 t70 -91.46 -0.49 57.63 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.026 -1.102 . . . . 60.409999999999997 108.026 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 91' ' ' THR . 25.6 t70 67.79 33.45 4.83 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.612 -1.625 . . . . 73.200000000000003 106.612 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -97.73 124.65 42.16 Favored 'General case' 0 N--CA 1.391 -3.411 0 CA-C-N 113.082 -1.872 . . . . 74.430000000000007 106.541 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.449 HG11 HD13 ' A' ' 95' ' ' LEU . 12.0 t -110.34 129.7 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 108.549 -0.908 . . . . 62.340000000000003 108.549 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.1 p -139.92 144.21 37.01 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 107.443 -1.317 . . . . 45.039999999999999 107.443 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.07 -174.77 41.18 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 118.861 -1.638 . . . . 72.140000000000001 112.412 -177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -145.27 133.37 21.49 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.011 -0.594 . . . . 70.519999999999996 109.879 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.0 mt -118.86 115.69 48.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 106.977 -1.49 . . . . 53.210000000000001 106.977 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.31 116.05 51.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.723 -0.473 . . . . 64.040000000000006 109.723 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.492 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -108.22 108.32 19.31 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.689 -1.597 . . . . 73.239999999999995 106.689 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -120.24 129.46 54.07 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.692 0.282 . . . . 70.329999999999998 111.024 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.84 144.02 49.48 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.519 -0.919 . . . . 73.329999999999998 108.519 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -81.54 120.75 78.81 Favored Pre-proline 0 C--N 1.292 -1.93 0 N-CA-C 107.746 -1.205 . . . . 73.549999999999997 107.746 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -33.79 -63.28 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 125.284 3.989 . . . . 74.019999999999996 116.422 -168.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.9 tttt 67.01 -54.26 0.45 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.463 1.105 . . . . 73.010000000000005 112.58 -176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.405 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 23.6 t-20 -108.14 145.69 33.78 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.411 -0.588 . . . . 55.329999999999998 109.411 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -59.08 -16.77 20.9 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.322 1.449 . . . . 63.310000000000002 113.815 -175.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 12.2 ptmm? -75.85 -20.69 57.91 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.781 0.324 . . . . 60.439999999999998 111.765 -174.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.9 110.19 22.46 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 115.22 1.563 . . . . 73.219999999999999 115.22 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 t -121.34 -16.48 7.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.52 -1.218 . . . . 74.439999999999998 109.863 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.64 97.11 0.11 Allowed Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.778 -0.725 . . . . 62.420000000000002 113.081 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -73.13 160.55 45.22 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.355 2.703 . . . . 74.549999999999997 110.844 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -131.24 133.93 45.93 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.863 -0.421 . . . . 64.030000000000001 109.863 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' O ' HG11 ' A' ' 72' ' ' VAL . 94.6 mt -75.82 140.87 42.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.754 -0.461 . . . . 72.340000000000003 109.754 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -111.63 99.86 8.51 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.226 0.536 . . . . 34.020000000000003 109.557 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.67 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -115.01 94.77 0.68 Allowed Glycine 0 C--N 1.274 -2.914 0 N-CA-C 110.952 -0.859 . . . . 65.129999999999995 110.952 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.54 96.55 10.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.956 -0.757 . . . . 74.209999999999994 108.956 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.91 161.61 45.76 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.203 -0.908 . . . . 65.319999999999993 109.145 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.68 -26.68 82.91 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.443 2.095 . . . . 63.350000000000001 111.313 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.429 ' HB2' ' CG ' ' A' ' 69' ' ' LYS . 31.6 p90 -107.73 41.96 1.43 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.419 -0.809 . . . . 71.219999999999999 111.905 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.1 m -59.5 -28.09 66.73 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 111.72 0.267 . . . . 74.329999999999998 111.72 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -66.58 -18.6 65.45 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.421 0.629 . . . . 71.400000000000006 110.824 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' CG ' ' HB2' ' A' ' 66' ' ' PHE . 32.7 mmtp -89.64 -19.81 24.43 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.61 -0.723 . . . . 62.439999999999998 109.993 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.67 121.19 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.855 0.835 . . . . 60.409999999999997 112.552 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.14 114.48 28.81 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.08 -0.963 . . . . 71.219999999999999 108.843 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 60' ' ' LEU . 58.1 t -98.27 141.52 16.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.004 -1.11 . . . . 75.319999999999993 108.004 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 m -148.51 167.93 24.07 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.275 -0.639 . . . . 71.140000000000001 109.275 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -82.76 154.12 24.92 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.446 -1.316 . . . . 71.010000000000005 107.446 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 75.2 t80 -116.65 124.55 50.01 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 109.281 -0.637 . . . . 73.219999999999999 109.281 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -138.62 99.6 3.86 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.013 -1.106 . . . . 73.140000000000001 108.013 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.2 m -156.59 137.9 13.83 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.238 -0.437 . . . . 71.010000000000005 110.014 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.03 0.41 2.38 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.182 1.393 . . . . 74.439999999999998 112.893 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.34 9.83 43.36 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.876 -1.154 . . . . 44.43 111.23 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.479 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 74.2 m-85 -105.04 142.5 34.72 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.368 -0.975 . . . . 73.140000000000001 108.368 171.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 33.8 m -124.09 136.79 59.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.315 -0.994 . . . . 61.420000000000002 108.315 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -165.6 -155.14 8.47 Favored Glycine 0 C--N 1.262 -3.583 0 C-N-CA 119.077 -1.535 . . . . 43.219999999999999 111.791 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.429 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 13.0 p -128.75 137.4 51.54 Favored 'General case' 0 C--N 1.267 -3.011 0 O-C-N 124.43 0.723 . . . . 73.010000000000005 110.354 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.12 146.09 50.81 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 120.815 0.34 . . . . 73.140000000000001 110.897 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -124.41 115.03 20.29 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.55 -1.278 . . . . 54.240000000000002 107.55 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.0 t -108.03 119.39 57.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 107.712 -1.218 . . . . 72.310000000000002 107.712 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.539 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.1 p90 -118.2 155.98 29.57 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.689 -0.404 . . . . 73.430000000000007 111.137 -175.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.4 p -156.53 157.63 35.74 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.791 -0.64 . . . . 63.149999999999999 110.488 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 63.98 35.12 10.93 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.59 1.186 . . . . 63.229999999999997 111.319 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.539 HD12 ' CD2' ' A' ' 87' ' ' PHE . 52.7 mt -96.9 167.11 11.29 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.728 -0.669 . . . . 73.319999999999993 110.34 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 4.9 t -126.3 169.99 12.35 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.521 -1.659 . . . . 54.310000000000002 106.521 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -57.14 -33.53 67.49 Favored 'General case' 0 C--O 1.205 -1.279 0 CA-C-N 118.928 0.786 . . . . 73.129999999999995 112.443 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.57 -29.67 70.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.707 0.765 . . . . 63.509999999999998 111.304 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.03 -16.82 34.5 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.536 -0.756 . . . . 64.420000000000002 110.318 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.658 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 51.5 tp -62.31 -54.84 45.53 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 114.053 1.131 . . . . 61.240000000000002 114.053 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.32 -33.59 69.99 Favored 'Trans proline' 0 C--N 1.368 1.6 0 CA-C-N 121.357 1.52 . . . . 70.450000000000003 110.598 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -67.68 -35.08 78.18 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-N 114.882 -1.054 . . . . 74.310000000000002 110.755 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.7 pp -78.24 -20.13 52.33 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.909 -0.774 . . . . 74.310000000000002 108.909 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.64 -21.24 62.64 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.636 -0.711 . . . . 53.200000000000003 110.691 -174.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -58.87 -57.11 14.5 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 108.468 -0.938 . . . . 75.319999999999993 108.468 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.67 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 35.4 ttp -55.44 -47.25 76.29 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.2 -0.909 . . . . 65.030000000000001 110.508 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -54.75 -39.25 68.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.354 -0.839 . . . . 62.509999999999998 110.671 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 m -66.79 -27.64 67.75 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.311 -0.404 . . . . 72.310000000000002 111.355 -174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -70.66 -17.46 62.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.369 0.604 . . . . 73.239999999999995 110.42 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.28 -9.72 16.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.97 -0.559 . . . . 72.319999999999993 110.46 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.71 -44.82 4.56 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.512 0.56 . . . . 61.530000000000001 112.512 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.93 27.2 42.15 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 110.492 -1.043 . . . . 51.020000000000003 110.492 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.75 155.64 20.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.479 -0.934 . . . . 62.119999999999997 108.479 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.436 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 39.5 t30 -103.99 121.5 43.29 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.865 -1.161 . . . . 61.439999999999998 107.865 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -108.87 137.65 46.46 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 123.304 0.377 . . . . 63.240000000000002 110.689 -177.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -144.24 116.94 8.69 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.414 -0.958 . . . . 63.149999999999999 108.414 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -144.57 149.94 36.67 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.806 -0.559 . . . . 74.129999999999995 110.785 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -151.19 157.99 43.37 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 124.47 1.106 . . . . 73.209999999999994 111.065 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HD3' HG22 ' A' ' 119' ' ' VAL . 2.0 tpp180 -94.33 109.07 20.93 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.438 -1.319 . . . . 73.200000000000003 107.438 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -93.03 92.21 7.72 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.133 -1.062 . . . . 75.329999999999998 108.133 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.57 -115.48 5.64 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.601 -1.4 . . . . 73.109999999999999 109.601 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -108.64 3.27 22.66 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.707 1.241 . . . . 60.140000000000001 109.223 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 pp -112.05 149.54 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 121.066 -1.021 . . . . 62.140000000000001 108.675 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 178' ' ' TYR . 76.5 t -106.89 139.34 28.74 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 O-C-N 121.76 -0.588 . . . . 64.040000000000006 111.407 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.431 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.8 pp -119.45 119.34 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 107.186 -1.413 . . . . 54.240000000000002 107.186 174.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 tt -125.34 130.0 51.08 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.862 -0.421 . . . . 72.310000000000002 109.862 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -131.84 151.87 51.39 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.548 0.69 . . . . 64.230000000000004 110.376 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -151.07 129.93 3.03 Favored Glycine 0 N--CA 1.407 -3.268 0 N-CA-C 108.712 -1.755 . . . . 65.430000000000007 108.712 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.5 mtt180 -116.25 125.41 52.18 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.33 -0.989 . . . . 60.399999999999999 108.33 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -108.51 123.26 48.63 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.449 -0.796 . . . . 72.019999999999996 112.331 -171.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -96.13 93.7 7.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.158 -1.423 . . . . 63.149999999999999 107.158 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 1.0 OUTLIER -101.69 2.1 38.26 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.102 -0.703 . . . . 72.129999999999995 109.102 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 167' ' ' GLY . 23.4 p -78.17 -16.84 57.53 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 116.235 -0.438 . . . . 74.230000000000004 111.074 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.9 m -72.47 -24.63 61.21 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.319 -0.401 . . . . 44.25 111.5 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.44 124.4 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.304 -0.999 . . . . 55.5 108.304 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 31.2 m -111.07 9.88 22.04 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 115.05 1.5 . . . . 75.439999999999998 115.05 -170.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -95.08 150.49 37.78 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 118.593 -1.243 . . . . 71.230000000000004 108.946 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.17 -11.8 19.36 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.903 2.402 . . . . 65.530000000000001 113.862 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -88.46 -12.11 44.01 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 113.346 0.869 . . . . 74.519999999999996 113.346 -169.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.44 135.9 42.32 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.416 0.15 . . . . 63.520000000000003 110.664 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.1 t70 -131.93 125.0 30.57 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.445 -0.576 . . . . 73.409999999999997 109.445 176.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 86.9 t -114.62 119.82 62.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 107.943 -1.132 . . . . 71.430000000000007 107.943 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -129.75 121.32 26.64 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.055 0.455 . . . . 74.099999999999994 110.501 -174.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.611 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.1 tm? -116.99 121.3 40.97 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.84 -1.541 . . . . 74.040000000000006 106.84 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.3 m -126.63 130.34 50.28 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.474 -0.565 . . . . 71.099999999999994 109.474 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.3 t -129.01 128.87 67.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 109.567 -0.531 . . . . 72.049999999999997 109.567 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -119.17 124.72 47.5 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.251 -0.648 . . . . 74.329999999999998 109.251 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.564 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.5 p90 -134.42 113.35 12.12 Favored Pre-proline 0 C--N 1.288 -2.108 0 CA-C-N 116.219 -0.446 . . . . 64.040000000000006 110.178 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 58.0 Cg_endo -68.67 30.79 0.16 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.086 2.524 . . . . 50.32 114.039 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.55 -95.18 0.36 Allowed 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.92 -0.77 . . . . 64.150000000000006 108.92 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 178.68 126.06 0.06 Allowed 'General case' 0 C--O 1.249 1.076 0 N-CA-C 109.542 -0.54 . . . . 53.310000000000002 109.542 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.37 139.15 18.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.465 -1.309 . . . . 74.239999999999995 107.465 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.0 t -104.47 -30.16 10.23 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.33 -0.948 . . . . 63.329999999999998 110.016 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.0 m -157.49 132.3 8.67 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.138 -1.06 . . . . 75.030000000000001 108.138 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -139.94 151.63 45.71 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.662 -0.649 . . . . 62.130000000000003 112.292 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 27.5 t-20 -118.67 85.81 2.43 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 105.7 -1.963 . . . . 64.420000000000002 105.7 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.478 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 173.88 -151.11 12.56 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 108.458 -1.857 . . . . 61.25 108.458 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -114.59 106.28 14.07 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 118.352 1.076 . . . . 72.420000000000002 109.596 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -80.43 123.76 28.32 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.099 -0.955 . . . . 62.149999999999999 110.534 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 67.5 mt -88.49 -47.74 15.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.232 -1.396 . . . . 74.129999999999995 107.232 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -134.63 169.75 13.03 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 106.992 -1.485 . . . . 72.049999999999997 106.992 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -73.34 -0.19 8.86 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.981 1.787 . . . . 63.149999999999999 111.322 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.2 pt-20 -130.27 3.52 4.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.456 0.646 . . . . 72.230000000000004 111.401 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.09 121.09 14.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 108.735 -0.839 . . . . 63.329999999999998 108.735 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.0 144.4 38.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.865 -0.791 . . . . 75.140000000000001 108.865 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -138.15 144.88 40.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.592 -0.522 . . . . 74.340000000000003 109.592 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.611 ' CE3' HD12 ' A' ' 139' ' ' LEU . 28.0 m-90 -122.85 124.98 44.51 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.238 -0.652 . . . . 73.340000000000003 109.238 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -105.83 107.2 18.07 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.059 0.933 . . . . 74.239999999999995 109.413 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.608 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.7 mm? -101.37 120.5 40.36 Favored 'General case' 0 C--O 1.26 1.642 0 CA-C-N 114.803 -1.09 . . . . 72.540000000000006 110.14 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -103.65 146.2 32.05 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 115.633 -0.712 . . . . 73.420000000000002 110.986 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 68.9 Cg_endo -72.06 155.26 57.27 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 123.035 2.49 . . . . 74.519999999999996 111.599 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 128' ' ' THR . . . 81.27 -30.9 2.67 Favored Glycine 0 C--N 1.302 -1.345 0 C-N-CA 121.365 -0.445 . . . . 72.319999999999993 112.355 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 35.4 m -105.34 164.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 110.05 -0.352 . . . . 31.510000000000002 110.05 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.2 p -113.79 143.8 22.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.975 -0.38 . . . . 61.399999999999999 109.975 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 45.3 m -154.82 144.4 21.41 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.828 -0.434 . . . . 72.310000000000002 109.828 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.0 p -97.57 153.82 17.93 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 123.971 0.908 . . . . 64.109999999999999 109.75 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.0 ptp -125.17 125.21 43.32 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.989 -1.486 . . . . 54.43 106.989 174.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 35.2 m -143.39 145.66 32.84 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.37 -0.831 . . . . 74.329999999999998 110.107 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.61 125.94 9.37 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.312 -0.995 . . . . 74.109999999999999 108.312 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -124.61 130.16 51.91 Favored 'General case' 0 C--N 1.262 -3.21 0 N-CA-C 106.439 -1.689 . . . . 54.439999999999998 106.439 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.77 160.19 43.67 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.869 -0.419 . . . . 73.230000000000004 109.869 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -96.62 128.61 43.72 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.676 -1.231 . . . . 75.109999999999999 107.676 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.569 ' CD2' HG21 ' A' ' 119' ' ' VAL . 17.0 m-30 -121.58 152.15 39.57 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 118.388 0.54 . . . . 72.310000000000002 109.874 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 21.0 p -87.84 100.33 12.79 Favored 'General case' 0 C--N 1.261 -3.264 0 N-CA-C 109.475 -0.565 . . . . 70.140000000000001 109.475 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -61.61 138.15 95.06 Favored Pre-proline 0 C--O 1.218 -0.586 0 N-CA-C 107.506 -1.294 . . . . 62.450000000000003 107.506 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -52.78 -46.02 36.53 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 123.125 2.55 . . . . 73.099999999999994 112.724 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -84.8 -10.64 56.99 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.064 -1.425 . . . . 75.439999999999998 110.756 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.1 p 59.4 81.46 0.17 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.498 1.519 . . . . 61.420000000000002 111.944 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -90.31 151.8 21.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.619 -0.719 . . . . 74.109999999999999 110.534 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 72.3 m . . . . . 0 C--N 1.295 -1.787 0 C-N-CA 128.1 2.56 . . . . 70.239999999999995 105.207 178.99 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.324 0 N-CA-C 109.574 -1.41 . . . . 53.409999999999997 109.574 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -132.27 58.14 1.76 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.665 0.745 . . . . 74.25 111.89 179.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.94 104.38 16.8 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.444 -0.798 . . . . 74.129999999999995 109.974 176.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.22 147.39 27.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.628 -1.619 . . . . 63.020000000000003 106.628 175.159 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.1 mt -76.63 111.73 12.43 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.316 0.579 . . . . 73.010000000000005 109.751 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -63.2 136.73 57.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.43 -1.259 . . . . 64.319999999999993 112.813 -173.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 65.23 94.82 0.06 Allowed 'General case' 0 C--O 1.25 1.084 0 C-N-CA 125.329 1.452 . . . . 70.540000000000006 111.602 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.462 ' HA ' ' HG2' ' A' ' 51' ' ' LYS . 16.7 tt0 -79.08 92.07 4.97 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.28 -0.873 . . . . 72.329999999999998 109.068 -178.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.21 147.54 5.04 Favored Glycine 0 N--CA 1.415 -2.75 0 C-N-CA 120.075 -1.06 . . . . 75.129999999999995 112.255 177.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -153.83 -41.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 124.617 1.167 . . . . 74.109999999999999 109.724 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 92.5 mtp -156.74 144.58 19.31 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.586 -0.894 . . . . 71.120000000000005 108.586 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 99.0 mt -125.55 137.09 53.92 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.097 -1.075 . . . . 74.400000000000006 108.097 173.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 46.1 ttm-85 -136.8 124.51 22.44 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.63 -0.878 . . . . 71.239999999999995 108.63 172.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.508 ' HB ' HG13 ' A' ' 137' ' ' VAL . 62.9 t -117.37 118.96 60.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.998 -0.741 . . . . 74.510000000000005 108.998 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -108.35 113.17 26.03 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.527 -1.286 . . . . 73.209999999999994 107.527 178.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.05 120.15 36.36 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.509 -1.293 . . . . 73.209999999999994 107.509 177.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 140' ' ' THR . 21.9 m -137.19 115.09 11.42 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 109.192 -0.67 . . . . 74.129999999999995 109.192 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.42 HG13 HG22 ' A' ' 141' ' ' VAL . 1.8 pp -127.82 147.11 32.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.635 -0.506 . . . . 63.200000000000003 109.635 -175.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.8 m -125.64 128.37 47.75 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 120.974 0.416 . . . . 71.239999999999995 109.919 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.0 tt -113.39 119.51 60.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.526 0.679 . . . . 72.030000000000001 109.579 179.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -84.42 160.97 55.67 Favored Pre-proline 0 C--N 1.296 -1.761 0 CA-C-N 115.389 -0.823 . . . . 61.240000000000002 109.913 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.82 2.06 2.82 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 123.367 2.711 . . . . 41.020000000000003 112.166 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.55 -8.0 59.62 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.398 1.079 . . . . 74.519999999999996 108.403 177.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.3 t70 71.96 28.48 2.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.338 1.455 . . . . 74.409999999999997 107.131 -175.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.2 139.84 44.95 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.769 -1.559 . . . . 71.329999999999998 107.6 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.416 HG11 HD21 ' A' ' 95' ' ' LEU . 13.7 t -117.26 140.45 40.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.239 -0.652 . . . . 74.040000000000006 109.239 -177.251 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.7 p -146.94 142.74 27.88 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.623 -1.251 . . . . 74.319999999999993 107.623 176.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.9 -171.53 41.4 Favored Glycine 0 N--CA 1.422 -2.273 0 C-N-CA 119.125 -1.512 . . . . 70.430000000000007 113.079 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -145.74 133.87 21.58 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.03 -0.73 . . . . 73.019999999999996 109.03 -175.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.0 mt -123.66 115.81 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.994 -1.113 . . . . 62.310000000000002 107.994 175.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.36 114.95 48.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.494 -0.558 . . . . 75.209999999999994 109.494 -178.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.66 108.52 19.42 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.285 -1.376 . . . . 74.319999999999993 107.285 175.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . . . -113.85 135.81 53.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.169 0.509 . . . . 55.119999999999997 111.592 -175.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.49 156.33 29.26 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.238 -0.892 . . . . 52.32 109.76 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -77.46 111.28 16.2 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 105.875 -1.898 . . . . 64.340000000000003 105.875 175.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 80' ' ' TYR . 52.9 Cg_exo -30.52 -71.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.021 1 C-N-CA 125.737 4.292 . . . . 74.109999999999999 116.195 -171.068 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.462 ' HG2' ' HA ' ' A' ' 22' ' ' GLN . 56.6 tptt 66.96 -65.92 0.2 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.781 1.232 . . . . 71.340000000000003 111.168 -178.357 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.531 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 49.9 t-20 -69.65 133.24 47.33 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.967 0.907 . . . . 54.149999999999999 108.759 -178.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 t -73.12 -21.82 60.66 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.507 -0.315 . . . . 54.450000000000003 111.793 -176.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.531 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 22.4 ptmt -102.62 -0.06 32.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.248 -0.581 . . . . 64.439999999999998 111.68 -177.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.41 103.19 15.9 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.104 -0.638 . . . . 75.310000000000002 111.054 -175.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 p -93.59 -20.49 20.16 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.196 -0.911 . . . . 44.229999999999997 110.502 179.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . 174.02 119.85 0.56 Allowed Glycine 0 N--CA 1.424 -2.157 0 CA-C-O 118.669 -1.073 . . . . 75.430000000000007 111.122 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' HB3' ' A' ' 83' ' ' SER . 4.5 Cg_endo -52.74 138.81 59.52 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.839 2.359 . . . . 65.239999999999995 111.771 174.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.01 125.6 35.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.27 -0.423 . . . . 34.229999999999997 110.256 -178.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.2 mt -88.55 129.94 35.36 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.873 -0.417 . . . . 63.43 109.873 176.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.86 84.62 6.65 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.875 0.845 . . . . 65.219999999999999 108.866 178.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -141.1 59.2 0.56 Allowed Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.867 -1.061 . . . . 64.329999999999998 113.059 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -90.26 93.47 9.36 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.676 -0.861 . . . . 63.119999999999997 108.676 176.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.88 161.41 22.92 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 115.191 -0.913 . . . . 74.230000000000004 111.36 -176.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.42 -9.62 26.69 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.117 2.545 . . . . 75.230000000000004 112.93 -177.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -110.62 30.76 6.52 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.881 -0.599 . . . . 73.510000000000005 109.735 176.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 p -57.31 -29.71 64.14 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.391 -0.822 . . . . 70.340000000000003 112.643 -178.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -67.98 -14.86 63.3 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.301 0.572 . . . . 71.140000000000001 110.276 -178.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -98.09 -20.4 17.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 116.058 -0.519 . . . . 72.540000000000006 110.676 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.13 118.1 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.85 0.833 . . . . 73.109999999999999 110.896 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.34 114.64 28.31 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.448 -0.796 . . . . 73.299999999999997 109.564 -177.245 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.72 137.02 27.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.699 -1.223 . . . . 61.219999999999999 107.699 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.6 m -151.28 172.02 16.53 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 122.054 -0.404 . . . . 75.120000000000005 109.984 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.59 151.31 23.57 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.028 -1.101 . . . . 73.239999999999995 108.028 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 89.4 t80 -116.75 129.02 55.86 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.261 -0.644 . . . . 74.120000000000005 109.261 -178.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.38 98.83 3.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.42 -0.955 . . . . 72.299999999999997 108.42 176.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 74.6 m -166.94 158.91 12.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.309 1.044 . . . . 72.340000000000003 108.895 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 68.72 9.25 7.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.711 1.205 . . . . 62.43 111.492 173.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.05 0.13 85.66 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.242 -0.743 . . . . 71.400000000000006 111.242 -175.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 99.2 m-85 -105.37 158.75 16.42 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 123.232 0.613 . . . . 73.209999999999994 110.432 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.88 140.53 48.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.351 -1.352 . . . . 70.209999999999994 107.351 174.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -162.68 -160.91 11.56 Favored Glycine 0 N--CA 1.411 -2.999 0 C-N-CA 118.871 -1.633 . . . . 74.340000000000003 113.241 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.548 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 33.6 p -123.11 140.64 52.82 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 108.719 -0.845 . . . . 70.409999999999997 108.719 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -131.41 141.15 49.79 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 120.553 -0.459 . . . . 71.420000000000002 111.125 178.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.22 115.07 22.32 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.217 -1.401 . . . . 60.450000000000003 107.217 175.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -111.55 120.2 61.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.677 -0.86 . . . . 65.439999999999998 108.677 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.473 ' CD2' HD12 ' A' ' 90' ' ' LEU . 41.4 p90 -124.37 150.41 45.58 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.042 0.449 . . . . 73.219999999999999 110.91 -174.049 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 m -154.79 156.85 37.03 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.509 -0.552 . . . . 74.219999999999999 109.509 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.0 t70 66.68 31.13 7.82 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 122.311 1.053 . . . . 74.209999999999994 110.683 175.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.473 HD12 ' CD2' ' A' ' 87' ' ' PHE . 34.8 mt -98.52 171.38 8.19 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.402 -0.817 . . . . 75.200000000000003 109.518 177.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 p -121.59 172.65 7.95 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 122.833 0.083 . . . . 73.420000000000002 111.166 -178.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.578 ' CZ ' HD13 ' A' ' 112' ' ' LEU . 86.7 t80 -57.25 -35.66 69.99 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.415 0.447 . . . . 71.409999999999997 110.447 175.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.6 -27.12 68.73 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.39 0.614 . . . . 74.420000000000002 110.521 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -88.32 -15.5 35.54 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.769 -0.65 . . . . 60.439999999999998 112.596 -177.351 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.416 HD21 HG11 ' A' ' 40' ' ' VAL . 22.8 mt -50.49 -52.19 57.67 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 113.522 0.934 . . . . 74.530000000000001 113.522 175.356 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -56.45 -45.56 36.51 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 121.312 1.341 . . . . 53.130000000000003 110.24 175.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -58.87 -44.19 91.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.905 -1.043 . . . . 73.340000000000003 111.76 -176.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.406 HD21 HD23 ' A' ' 95' ' ' LEU . 4.4 pp -75.72 -19.96 58.71 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.059 0.457 . . . . 72.400000000000006 111.011 178.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.38 -14.04 60.1 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.08 -0.509 . . . . 53.149999999999999 110.615 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -65.27 -57.34 8.71 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.185 -0.606 . . . . 62.020000000000003 109.96 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -56.31 -49.17 75.06 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.667 0.604 . . . . 75.219999999999999 110.221 -176.202 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -57.08 -37.5 71.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.007 -0.997 . . . . 73.439999999999998 111.528 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.6 t -65.33 -30.67 71.53 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 116.294 -0.412 . . . . 43.130000000000003 110.077 -172.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.38 -15.37 63.29 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 121.225 0.536 . . . . 64.519999999999996 111.216 -174.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.46 -12.1 11.73 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.228 -0.589 . . . . 75.310000000000002 110.875 177.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.93 -48.47 3.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.277 0.843 . . . . 64.200000000000003 113.277 -172.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.56 28.43 19.34 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.245 -0.979 . . . . 35.420000000000002 110.802 -172.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.1 m -97.44 151.56 4.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.42 -0.39 . . . . 73.109999999999999 109.949 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -129.1 121.89 28.74 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.408 -1.33 . . . . 74.319999999999993 107.408 176.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.426 HD23 ' HA3' ' A' ' 123' ' ' GLY . 91.7 mt -121.24 139.89 52.78 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.709 0.29 . . . . 61.340000000000003 110.275 -177.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -136.31 121.85 19.55 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.899 -1.519 . . . . 63.200000000000003 106.899 177.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.578 HD13 ' CZ ' ' A' ' 92' ' ' PHE . 2.7 pp -135.51 155.51 50.39 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-O 121.037 0.446 . . . . 65.549999999999997 111.679 -177.15 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -150.62 155.71 39.93 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.096 -0.956 . . . . 64.150000000000006 112.521 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -94.51 128.87 41.38 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.512 -1.222 . . . . 72.349999999999994 108.597 173.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -122.49 82.85 2.03 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.533 -1.654 . . . . 63.25 106.533 175.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 57.72 -130.25 50.73 Favored Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 114.372 -1.285 . . . . 42.340000000000003 110.502 -173.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.589 ' HA ' ' OD1' ' A' ' 180' ' ' ASP . 23.7 t-20 -71.14 -13.4 61.93 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.642 0.734 . . . . 61.32 111.581 -178.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.671 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -110.63 146.32 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 C-N-CA 117.831 -1.548 . . . . 71.120000000000005 110.756 -176.747 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.2 t -107.18 133.56 51.49 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.726 0 CA-C-N 115.348 -0.842 . . . . 74.299999999999997 110.016 -178.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.1 pt -116.29 131.38 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 121.49 0.662 . . . . 64.319999999999993 109.685 175.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 tt -128.45 131.53 48.41 Favored 'General case' 0 C--N 1.278 -2.541 0 CA-C-N 115.276 -0.875 . . . . 70.439999999999998 110.148 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -129.2 146.2 51.17 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.126 -1.065 . . . . 50.210000000000001 108.126 174.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.426 ' HA3' HD23 ' A' ' 110' ' ' LEU . . . -164.13 160.39 33.34 Favored Glycine 0 N--CA 1.407 -3.297 0 N-CA-C 111.402 -0.679 . . . . 23.25 111.402 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -137.49 133.44 34.59 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.881 -0.785 . . . . 74.209999999999994 108.881 177.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -103.92 110.07 22.07 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.31 -0.996 . . . . 42.140000000000001 108.31 178.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -103.2 93.75 5.16 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 122.365 1.079 . . . . 72.400000000000006 110.703 -177.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 127' ' ' LEU . 2.0 pt? -124.29 21.39 8.75 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.138 -1.392 . . . . 73.230000000000004 107.512 177.601 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.432 ' HA ' ' C ' ' A' ' 167' ' ' GLY . 2.6 m -63.7 -14.12 49.31 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.039 -1.891 . . . . 63.109999999999999 110.248 177.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.6 p -74.69 -4.59 38.25 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.455 1.102 . . . . 44.43 110.057 177.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.7 t 81.67 -64.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 126.208 1.803 . . . . 70.099999999999994 112.146 176.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.1 m 67.63 -62.96 0.32 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.215 1.006 . . . . 73.319999999999993 111.336 -177.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 11.5 t70 -143.0 115.34 5.98 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 106.569 -1.641 . . . . 73.209999999999994 106.569 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.53 -26.29 63.11 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.272 2.648 . . . . 64.329999999999998 116.12 -174.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -107.71 8.82 29.14 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.857 -0.737 . . . . 62.130000000000003 111.224 -175.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -61.41 138.99 58.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.485 -0.779 . . . . 62.439999999999998 111.658 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 28.3 t70 -131.5 121.96 25.36 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.571 -0.529 . . . . 74.209999999999994 109.571 177.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 90.1 t -119.71 126.98 75.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.855 -0.424 . . . . 75.310000000000002 109.855 -178.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.45 123.47 41.37 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.227 -0.657 . . . . 72.319999999999993 109.227 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 tt -113.94 118.29 33.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.003 -1.48 . . . . 53.520000000000003 107.003 176.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 31' ' ' SER . 6.7 m -117.48 128.44 54.98 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.213 -0.662 . . . . 73.519999999999996 109.213 -175.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.42 HG22 HG13 ' A' ' 32' ' ' ILE . 84.1 t -122.33 127.87 75.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.625 -0.509 . . . . 74.239999999999995 109.625 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -116.74 132.47 56.68 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.071 -0.714 . . . . 65.049999999999997 109.071 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.593 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.2 p90 -134.93 127.63 18.36 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 116.412 -0.358 . . . . 75.120000000000005 111.785 177.46 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -70.15 51.27 1.0 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 123.24 2.627 . . . . 65.439999999999998 110.879 172.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.11 -128.57 0.09 Allowed 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.3 -1.37 . . . . 74.120000000000005 107.3 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -167.21 134.75 2.44 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.645 -1.613 . . . . 61.409999999999997 106.645 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.527 ' HB ' ' CZ ' ' A' ' 143' ' ' PHE . 7.7 p -85.93 123.43 39.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 108.577 -0.897 . . . . 64.239999999999995 108.577 177.592 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.7 t -81.73 -33.02 31.31 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.22 -0.592 . . . . 72.530000000000001 111.358 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 64.0 m -152.84 133.01 13.5 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 109.672 -0.492 . . . . 72.340000000000003 109.672 175.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.435 ' HB ' HG21 ' A' ' 147' ' ' VAL . 6.7 t -138.77 158.87 43.43 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.946 -0.471 . . . . 74.549999999999997 111.339 177.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 2.9 t-20 -127.61 89.8 3.01 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.018 -1.845 . . . . 75.299999999999997 106.018 175.291 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 174.44 -140.35 5.36 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 109.582 -1.407 . . . . 73.430000000000007 109.582 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.82 99.98 7.29 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 117.235 0.517 . . . . 75.129999999999995 109.702 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -82.13 115.92 21.46 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.534 0.683 . . . . 73.420000000000002 110.31 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.4 mt -81.57 -47.56 19.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.151 -1.426 . . . . 70.25 107.151 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.83 160.48 67.28 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 107.119 -1.437 . . . . 73.329999999999998 107.119 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.52 -19.63 65.42 Favored 'Trans proline' 0 C--N 1.328 -0.539 0 C-N-CA 122.054 1.836 . . . . 73.150000000000006 111.948 175.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.593 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -114.55 4.09 15.07 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.381 0.882 . . . . 71.109999999999999 113.381 178.75 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.2 t -140.34 120.28 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.995 -0.742 . . . . 54.439999999999998 108.995 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.93 149.33 31.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.049 -0.723 . . . . 73.409999999999997 109.049 -177.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -133.68 146.9 51.27 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.62 -0.882 . . . . 75.319999999999993 108.62 -178.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -119.62 122.37 41.39 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 109.446 -0.576 . . . . 62.229999999999997 109.446 177.206 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -89.32 114.0 25.35 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.896 0.855 . . . . 43.049999999999997 110.01 177.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 10.2 mp -101.49 118.64 37.37 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.957 -1.02 . . . . 73.120000000000005 109.493 178.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 75.5 mmtt -117.45 143.51 32.25 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 114.447 -1.251 . . . . 60.329999999999998 108.978 -176.3 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.43 150.46 64.16 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.377 2.052 . . . . 74.409999999999997 111.355 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.432 ' C ' ' HA ' ' A' ' 128' ' ' THR . . . 73.42 -11.88 4.95 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 116.495 -0.321 . . . . 71.209999999999994 113.864 176.111 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 33.2 m -117.01 145.46 22.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 109.344 -0.613 . . . . 74.230000000000004 109.344 171.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.76 129.07 40.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.085 -0.709 . . . . 71.420000000000002 109.085 178.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.7 t -111.45 136.93 49.92 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 120.048 -0.661 . . . . 73.109999999999999 109.552 -178.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.6 p -100.1 138.76 36.73 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.505 -0.77 . . . . 64.319999999999993 110.626 -179.413 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 23.0 ttt -125.68 117.48 23.58 Favored 'General case' 0 C--O 1.193 -1.899 0 CA-C-N 115.756 -0.656 . . . . 54.409999999999997 109.681 -177.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 24.7 t -142.92 144.83 32.56 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.542 -0.911 . . . . 71.209999999999994 108.542 174.3 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -154.53 128.12 8.62 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.073 -1.084 . . . . 73.5 108.073 -177.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -129.04 130.27 46.36 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.028 -1.101 . . . . 64.030000000000001 108.028 176.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -152.78 158.21 41.92 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 120.803 -0.359 . . . . 62.5 110.084 -178.286 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.671 ' HG2' HG22 ' A' ' 118' ' ' ILE . 96.1 mtt180 -87.3 136.3 32.99 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.633 -0.877 . . . . 71.200000000000003 108.633 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -143.25 147.2 34.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.991 -0.744 . . . . 61.420000000000002 108.991 176.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.47 112.07 5.07 Favored 'General case' 0 N--CA 1.414 -2.248 0 C-N-CA 122.849 0.459 . . . . 64.519999999999996 110.507 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 117' ' ' ASN . 2.6 m-20 -56.47 132.77 76.91 Favored Pre-proline 0 C--N 1.308 -1.221 0 C-N-CA 124.714 1.206 . . . . 63.43 112.23 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.43 -26.5 14.2 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.541 1.494 . . . . 72.420000000000002 108.925 169.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -84.9 -12.3 53.73 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 125.659 1.584 . . . . 74.519999999999996 110.772 -179.079 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' A' ' 180' ' ' ASP . 53.2 p 55.63 83.1 0.09 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.674 1.589 . . . . 72.219999999999999 114.934 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -132.06 169.88 15.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.027 0.531 . . . . 73.310000000000002 110.011 178.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.435 -1.197 0 N-CA-C 106.544 -1.65 . . . . 74.349999999999994 106.544 179.807 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.523 ' N ' ' HG ' ' A' ' 53' ' ' SER . . . . . . . . 0 C--O 1.249 1.032 0 N-CA-C 111.238 -0.745 . . . . 43.049999999999997 111.238 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -131.18 127.94 39.01 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 122.795 -0.238 . . . . 75.430000000000007 110.563 -177.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 71.82 -52.64 0.69 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.884 1.273 . . . . 72.299999999999997 114.379 174.041 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 73.15 -179.72 0.21 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.634 1.174 . . . . 65.329999999999998 110.971 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.8 tp 60.28 50.57 6.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.903 1.281 . . . . 62.420000000000002 111.809 174.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -82.02 -56.44 3.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.459 0.647 . . . . 62.409999999999997 109.812 177.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -134.57 15.05 3.71 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.964 -1.016 . . . . 72.430000000000007 108.643 -179.027 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.433 ' HA ' ' OE1' ' A' ' 22' ' ' GLN . 5.9 tp60 67.12 -88.38 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.808 -1.542 . . . . 73.040000000000006 112.296 -177.218 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.92 -87.14 0.28 Allowed Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 119.858 -1.163 . . . . 40.409999999999997 114.737 -175.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 175.0 -45.61 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.802 -1.185 . . . . 61.520000000000003 107.802 -171.065 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.563 ' HB3' ' OH ' ' A' ' 80' ' ' TYR . 18.8 ttt -172.68 -64.71 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.728 0 CA-C-N 113.897 -1.501 . . . . 73.439999999999998 108.304 -176.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 mt 74.7 115.39 0.06 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.856 1.262 . . . . 75.040000000000006 108.233 -175.547 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -119.53 126.22 50.73 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.517 -0.549 . . . . 62.549999999999997 109.517 -176.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 p -124.77 123.42 65.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 120.267 -0.573 . . . . 75.140000000000001 110.02 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -125.1 126.61 45.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.942 -0.572 . . . . 74.209999999999994 109.474 -176.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.77 108.35 16.97 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 106.366 -1.716 . . . . 72.230000000000004 106.366 172.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -117.6 114.65 23.72 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.63 -1.618 . . . . 62.329999999999998 106.63 -178.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -129.64 146.68 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-O 121.255 0.55 . . . . 53.420000000000002 109.869 -174.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.5 m -127.8 119.55 25.93 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-O 121.366 0.603 . . . . 42.039999999999999 109.749 -177.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.436 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.0 tt -105.96 124.36 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.417 -0.811 . . . . 34.439999999999998 109.674 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 m -98.88 150.37 36.63 Favored Pre-proline 0 C--N 1.288 -2.07 0 CA-C-N 115.44 -0.8 . . . . 75.239999999999995 109.703 -176.051 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.99 1.96 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 124.038 3.159 . . . . 54.530000000000001 114.975 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 30.3 t70 -83.85 -2.66 56.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.15 -0.685 . . . . 61.420000000000002 109.15 177.089 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.7 t70 72.72 29.29 1.98 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 106.125 -1.806 . . . . 73.340000000000003 106.125 -173.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 2.1 tp -104.09 125.58 50.53 Favored 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 112.682 -2.054 . . . . 71.120000000000005 109.006 -178.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.583 HG11 HD23 ' A' ' 95' ' ' LEU . 21.8 t -112.36 135.76 50.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.675 -0.861 . . . . 74.219999999999999 108.675 177.516 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 p -147.47 152.81 38.67 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.119 -1.067 . . . . 74.400000000000006 108.119 178.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.09 -171.24 44.31 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 118.74 -1.695 . . . . 54.240000000000002 113.782 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.66 133.69 30.95 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.672 0.789 . . . . 75.310000000000002 109.646 -176.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 102' ' ' ASN . 58.9 mt -121.0 116.09 48.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.918 -1.142 . . . . 74.310000000000002 107.918 176.071 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.71 121.3 66.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 123.135 0.574 . . . . 71.319999999999993 110.016 -176.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.91 108.46 16.3 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.255 -1.387 . . . . 75.430000000000007 107.255 175.147 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -117.79 132.82 56.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.403 0.621 . . . . 73.340000000000003 112.602 -174.529 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.29 158.43 35.8 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.405 -0.961 . . . . 40.149999999999999 108.405 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.75 153.81 83.26 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 104.551 -2.389 . . . . 61.5 104.551 173.174 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.42 103.67 0.06 OUTLIER 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 122.299 1.999 . . . . 63.310000000000002 111.766 -179.227 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -77.6 -36.9 51.34 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.867 0.692 . . . . 73.219999999999999 112.867 -169.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.499 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 45.3 t30 -151.8 167.72 27.34 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.878 -0.786 . . . . 65.150000000000006 108.878 -176.174 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.523 ' HG ' ' N ' ' A' ' 15' ' ' GLY . 4.2 m -58.87 -28.1 65.81 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.92 1.288 . . . . 73.439999999999998 112.683 -175.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -90.8 -6.11 54.74 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.868 -0.52 . . . . 62.43 110.017 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.499 ' HB3' ' H ' ' A' ' 52' ' ' ASN . 33.5 t70 -99.45 96.76 7.91 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.609 0.719 . . . . 75.310000000000002 111.103 -172.635 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t -122.25 -11.05 8.45 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.698 -1.137 . . . . 70.349999999999994 109.623 175.16 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.26 96.47 0.1 Allowed Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.829 -0.909 . . . . 71.209999999999994 110.829 176.479 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.43 ' O ' ' HB3' ' A' ' 83' ' ' SER . 26.1 Cg_endo -68.52 159.6 52.83 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.931 2.42 . . . . 71.099999999999994 113.046 177.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.25 140.39 50.33 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.593 -0.892 . . . . 32.450000000000003 108.593 176.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 90.2 mt -79.92 140.78 36.56 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.703 0.287 . . . . 45.020000000000003 111.337 -178.383 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.16 96.61 6.77 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.263 1.03 . . . . 72.409999999999997 108.473 177.448 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -113.45 -71.01 0.55 Allowed Glycine 0 C--N 1.292 -1.872 0 CA-C-N 114.415 -1.266 . . . . 72.120000000000005 113.117 -177.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 58.59 86.02 0.09 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.23 1.014 . . . . 74.010000000000005 112.404 -176.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 m -115.81 158.63 41.66 Favored Pre-proline 0 C--N 1.29 -1.993 0 CA-C-N 114.652 -1.158 . . . . 73.319999999999993 108.686 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.57 -16.84 50.6 Favored 'Trans proline' 0 N--CA 1.483 0.884 0 C-N-CA 122.747 2.298 . . . . 72.5 112.354 179.285 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -113.45 25.22 11.47 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.543 -0.753 . . . . 73.329999999999998 112.037 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.8 m -56.36 -24.01 41.35 Favored 'General case' 0 C--O 1.21 -1.004 0 N-CA-C 111.753 0.279 . . . . 61.240000000000002 111.753 177.459 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -62.57 -23.17 66.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.18 0.514 . . . . 55.039999999999999 110.456 178.117 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 88' ' ' SER . 33.4 mmtp -95.51 -14.44 23.67 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.246 0.546 . . . . 55.240000000000002 110.104 -178.23 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 49.8 t -108.19 121.05 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 116.081 -0.509 . . . . 74.439999999999998 110.407 -177.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 110.67 22.69 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.171 -0.677 . . . . 73.239999999999995 109.171 177.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.96 137.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.98 -1.119 . . . . 64.140000000000001 107.98 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 t -148.2 172.22 14.68 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.803 -0.814 . . . . 74.230000000000004 108.803 -174.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -92.02 141.23 28.84 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.132 -1.062 . . . . 70.329999999999998 108.132 177.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 93.0 t80 -102.24 127.36 49.24 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.374 -0.602 . . . . 65.409999999999997 109.374 -178.408 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.56 99.63 4.12 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.568 -0.901 . . . . 71.340000000000003 108.568 176.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 30.9 t -170.0 155.76 5.75 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.276 -1.009 . . . . 63.329999999999998 108.276 -179.067 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 71.06 6.72 5.95 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.803 1.241 . . . . 74.340000000000003 111.604 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.91 4.51 84.63 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.659 -1.376 . . . . 73.439999999999998 109.659 -173.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.563 ' OH ' ' HB3' ' A' ' 25' ' ' MET . 6.2 m-85 -104.31 149.34 25.44 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 124.164 0.986 . . . . 72.019999999999996 110.049 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -125.5 136.06 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 108.015 -1.106 . . . . 70.120000000000005 108.015 174.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -163.12 -155.42 8.1 Favored Glycine 0 C--N 1.27 -3.09 0 C-N-CA 119.4 -1.381 . . . . 62.530000000000001 112.19 -178.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 13.4 p -124.1 140.95 52.47 Favored 'General case' 0 C--N 1.274 -2.715 0 CA-C-N 115.096 -0.552 . . . . 72.219999999999999 109.729 -178.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -135.53 141.68 45.28 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 120.816 0.341 . . . . 72.140000000000001 110.649 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.35 115.56 21.86 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.027 -0.731 . . . . 75.510000000000005 109.027 178.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.4 t -106.01 112.53 39.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.165 -1.05 . . . . 63.420000000000002 108.165 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 50.7 p90 -112.87 153.96 27.08 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 120.708 -0.397 . . . . 72.430000000000007 110.746 -174.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 42.4 m -153.61 161.49 42.14 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.822 -0.351 . . . . 71.420000000000002 110.932 -177.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.1 t70 59.68 37.82 22.14 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.471 1.129 . . . . 74.420000000000002 111.574 173.563 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.424 HD12 ' CD2' ' A' ' 87' ' ' PHE . 35.8 mt -103.29 164.76 11.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.33 -0.85 . . . . 71.310000000000002 110.922 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -114.21 174.02 6.16 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.052 0.453 . . . . 74.510000000000005 110.742 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -56.49 -34.28 66.8 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 125.58 1.552 . . . . 72.209999999999994 111.021 -178.426 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.4 -25.26 61.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.98 -0.555 . . . . 43.119999999999997 111.185 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -88.77 -16.45 32.12 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 116.107 -0.497 . . . . 75.310000000000002 111.648 -176.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.6 tm? -52.73 -56.44 23.12 Favored Pre-proline 0 CA--C 1.569 1.696 0 C-N-CA 123.442 0.697 . . . . 70.120000000000005 111.756 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.18 -37.14 33.38 Favored 'Trans proline' 0 C--N 1.372 1.795 0 CA-C-N 120.741 1.3 . . . . 73.010000000000005 111.232 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -65.55 -34.67 78.79 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 124.437 1.095 . . . . 72.129999999999995 110.857 -176.389 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -78.38 -23.01 47.02 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.384 0.611 . . . . 74.219999999999999 109.543 175.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.34 -22.95 59.0 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 115.577 -0.738 . . . . 44.229999999999997 109.842 -175.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -62.06 -46.79 87.56 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.445 -0.798 . . . . 60.229999999999997 109.659 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.6 mtm -55.95 -49.67 72.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.282 0.563 . . . . 75.400000000000006 109.711 177.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' HB2' HD13 ' A' ' 44' ' ' ILE . 34.2 t30 -54.49 -35.63 63.29 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 114.726 -1.124 . . . . 75.030000000000001 110.96 178.121 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.4 m -60.65 -29.21 69.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.786 -0.643 . . . . 64.310000000000002 110.86 -173.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.81 -30.29 69.98 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 123.558 0.536 . . . . 71.120000000000005 111.345 -175.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.87 -10.86 15.47 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.085 -0.507 . . . . 75.450000000000003 110.89 -177.258 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.69 -47.8 3.67 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 113.44 0.904 . . . . 31.399999999999999 113.44 -172.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.42 24.9 41.38 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.428 -1.069 . . . . 73.209999999999994 110.428 -173.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 m -106.42 163.09 5.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.393 -0.404 . . . . 74.519999999999996 110.319 -178.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -128.56 122.2 30.5 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.597 -1.26 . . . . 74.530000000000001 107.597 176.295 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.1 mt -119.09 122.48 42.2 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.957 0.408 . . . . 74.450000000000003 111.209 -178.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 p -137.22 139.5 41.07 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.984 -0.553 . . . . 72.420000000000002 109.736 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.87 150.67 32.27 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 122.075 -0.391 . . . . 63.210000000000001 110.042 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -143.51 155.04 44.22 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.109 -0.496 . . . . 74.519999999999996 110.683 -176.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.431 ' HG2' HG22 ' A' ' 119' ' ' VAL . 40.6 mtt85 -92.31 138.53 31.45 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 121.587 0.708 . . . . 74.409999999999997 111.333 173.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.44 ' O ' HG13 ' A' ' 118' ' ' ILE . 6.8 t30 -123.9 88.02 2.84 Favored 'General case' 0 C--N 1.269 -2.908 0 N-CA-C 105.665 -1.976 . . . . 70.120000000000005 105.665 175.355 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 185' ' ' SER . . . 73.71 -120.23 6.81 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 109.646 -1.381 . . . . 74.230000000000004 109.646 -175.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -104.54 12.45 33.14 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.509 1.147 . . . . 71.010000000000005 108.635 178.513 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.561 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.2 pp -119.26 149.46 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 O-C-N 120.951 -1.093 . . . . 63.340000000000003 109.041 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.431 HG22 ' HG2' ' A' ' 114' ' ' ARG . 86.5 t -110.27 138.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 CA-C-O 120.951 0.405 . . . . 62.549999999999997 110.352 -178.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.9 pt -110.6 129.29 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.361 0 N-CA-C 107.132 -1.433 . . . . 74.099999999999994 107.132 172.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.24 129.53 50.93 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 109.391 -0.596 . . . . 73.239999999999995 109.391 -178.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -134.8 119.23 17.91 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.913 0.863 . . . . 72.120000000000005 111.27 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.38 148.36 17.85 Favored Glycine 0 N--CA 1.418 -2.527 0 N-CA-C 110.834 -0.906 . . . . 74.340000000000003 110.834 178.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.495 ' HG2' HG22 ' A' ' 171' ' ' THR . 75.7 mtt180 -123.63 140.21 53.22 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 109.256 -0.646 . . . . 71.549999999999997 109.256 179.012 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.92 109.24 14.86 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 109.293 -0.632 . . . . 72.430000000000007 109.293 178.476 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -112.64 94.39 4.89 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.06 -1.089 . . . . 73.530000000000001 108.06 176.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -122.96 37.01 4.52 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 122.937 1.351 . . . . 62.340000000000003 108.313 177.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 75.6 p -69.96 -8.74 51.44 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.385 -1.734 . . . . 64.340000000000003 110.59 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.5 p -73.7 -24.63 59.96 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 125.231 1.413 . . . . 63.210000000000001 110.461 178.267 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.8 t 66.28 93.23 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.544 1.137 . . . . 75.239999999999995 112.083 178.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 m -63.27 -49.57 73.56 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 108.555 -0.905 . . . . 73.200000000000003 108.555 176.043 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -148.52 140.61 14.6 Favored Pre-proline 0 CA--C 1.495 -1.139 0 N-CA-C 104.55 -2.389 . . . . 72.310000000000002 104.55 174.098 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -49.63 -32.05 26.9 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.121 2.548 . . . . 75.030000000000001 115.146 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 25' ' ' MET . 9.2 t70 -107.96 18.97 20.63 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.258 -0.977 . . . . 70.129999999999995 112.733 -173.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.82 48.48 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.687 0.995 . . . . 73.209999999999994 113.687 -177.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -132.9 136.45 46.18 Favored 'General case' 0 C--O 1.26 1.614 0 CA-C-N 115.69 -0.686 . . . . 61.329999999999998 109.684 171.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.2 t -114.82 114.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.979 -1.119 . . . . 74.439999999999998 107.979 176.275 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.32 124.42 52.19 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 120.694 -0.402 . . . . 73.340000000000003 111.444 -178.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 50.7 tp -111.08 124.52 52.35 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.697 -1.223 . . . . 73.549999999999997 107.697 170.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.5 m -126.05 112.55 16.0 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.898 -0.778 . . . . 62.229999999999997 108.898 178.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.462 HG12 ' HD1' ' A' ' 143' ' ' PHE . 82.1 t -107.51 120.81 59.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 109.33 -0.618 . . . . 75.409999999999997 109.33 179.264 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.33 127.81 55.76 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.207 -0.664 . . . . 51.520000000000003 109.207 178.468 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.647 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.5 p90 -135.1 122.2 14.98 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 112.266 0.469 . . . . 55.32 112.266 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -67.78 42.32 0.23 Allowed 'Trans proline' 0 CA--C 1.566 2.113 0 C-N-CA 123.162 2.575 . . . . 72.340000000000003 112.443 173.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.41 -108.68 0.31 Allowed 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 122.977 0.511 . . . . 54.509999999999998 109.806 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.85 133.96 0.13 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.966 -0.753 . . . . 62.200000000000003 108.966 -177.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.3 p -88.38 141.11 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 109.235 -0.654 . . . . 75.230000000000004 109.235 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 39.5 p -102.15 -38.14 7.83 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.027 0.441 . . . . 54.409999999999997 110.411 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.9 m -155.75 132.39 10.41 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 108.625 -0.879 . . . . 43.32 108.625 178.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.2 t -139.97 152.83 46.62 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 120.144 -0.622 . . . . 75.430000000000007 112.103 176.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -118.98 88.15 2.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.325 -2.102 . . . . 75.549999999999997 105.325 175.095 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.414 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.09 -145.03 8.62 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 108.644 -1.782 . . . . 75.400000000000006 108.644 -177.015 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -118.27 99.99 7.21 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 118.129 0.964 . . . . 62.5 110.8 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.26 109.23 13.41 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.537 0.684 . . . . 74.209999999999994 109.449 176.085 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 61.9 mt -80.12 -46.96 21.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.096 -1.446 . . . . 64.530000000000001 107.096 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 159' ' ' VAL . 13.1 mm-40 -121.63 163.42 30.97 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 106.802 -1.555 . . . . 74.010000000000005 106.802 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.93 -1.18 10.09 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.164 1.909 . . . . 72.219999999999999 111.376 178.485 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.5 pt-20 -137.07 9.66 3.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.439 -0.8 . . . . 63.350000000000001 111.66 -177.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 156' ' ' GLU . 54.7 t -145.07 120.7 3.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.907 -1.146 . . . . 61.310000000000002 107.907 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.84 143.72 38.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.284 -0.635 . . . . 50.439999999999998 109.284 -177.445 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.7 tt0 -130.86 143.34 50.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-O 121.252 0.548 . . . . 73.420000000000002 110.155 -177.285 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.414 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 30.3 m-90 -126.45 121.31 32.06 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.845 -0.798 . . . . 75.340000000000003 108.845 179.089 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 105.07 13.15 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.36 0.6 . . . . 73.329999999999998 110.234 176.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 170' ' ' SER . 1.2 mm? -99.54 147.82 24.92 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.373 -0.831 . . . . 71.400000000000006 110.281 -174.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -117.68 155.45 50.59 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.984 -0.553 . . . . 63.439999999999998 112.391 -176.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.81 157.4 51.84 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.901 2.401 . . . . 61.109999999999999 110.97 178.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.84 -35.22 2.91 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.666 -0.778 . . . . 62.240000000000002 111.574 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 20.7 m -104.76 145.13 13.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.039 0.447 . . . . 65.030000000000001 110.232 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.2 p -101.52 144.0 13.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 107.804 -1.184 . . . . 61.039999999999999 107.804 178.041 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.473 ' HB2' HD12 ' A' ' 164' ' ' LEU . 50.0 m -149.32 153.61 37.73 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.066 0.46 . . . . 74.129999999999995 111.459 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.495 HG22 ' HG2' ' A' ' 124' ' ' ARG . 2.6 p -106.56 128.37 54.07 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.307 -0.86 . . . . 63.420000000000002 109.889 177.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 23.5 ptp -106.93 122.06 45.66 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.614 -1.624 . . . . 70.510000000000005 106.614 178.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.5 m -141.47 148.01 38.79 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.558 -1.257 . . . . 71.540000000000006 111.737 -176.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.96 136.69 18.04 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 115.234 -0.894 . . . . 70.409999999999997 108.69 -176.395 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -130.79 131.05 44.44 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 105.866 -1.901 . . . . 62.0 105.866 175.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 178' ' ' TYR . . . -157.45 160.66 38.55 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 120.876 -0.33 . . . . 74.439999999999998 110.348 -175.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.561 ' HG2' HG22 ' A' ' 118' ' ' ILE . 96.5 mtt180 -87.52 129.05 35.22 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.729 -0.841 . . . . 74.329999999999998 108.729 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 176' ' ' ALA . 99.2 m-85 -140.73 124.69 17.26 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 108.762 -0.829 . . . . 74.140000000000001 108.762 178.167 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.07 122.73 9.96 Favored 'General case' 0 N--CA 1.404 -2.739 0 O-C-N 124.795 1.309 . . . . 75.140000000000001 111.564 -177.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -75.65 135.07 71.89 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 106.952 -1.499 . . . . 74.310000000000002 106.952 175.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.69 -39.21 75.82 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 122.176 1.917 . . . . 61.340000000000003 112.527 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -84.51 -19.23 33.57 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 123.689 0.796 . . . . 73.409999999999997 108.961 -175.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 65.4 p 65.38 31.97 10.02 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.817 1.647 . . . . 62.43 111.423 -177.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -100.43 156.71 17.11 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.643 -1.162 . . . . 63.200000000000003 110.304 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.468 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 48.3 m . . . . . 0 N--CA 1.42 -1.943 0 N-CA-C 107.144 -1.428 . . . . 71.030000000000001 107.144 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.583 0 N-CA-C 111.27 -0.732 . . . . 60.439999999999998 111.27 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -150.44 126.64 10.62 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.752 -1.573 . . . . 73.349999999999994 106.752 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.98 160.37 18.68 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.396 -0.521 . . . . 75.219999999999999 110.243 178.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -116.37 128.8 55.84 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.848 -1.168 . . . . 75.409999999999997 107.848 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.44 131.46 36.19 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.923 -0.58 . . . . 71.230000000000004 109.751 -175.254 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -92.34 133.91 35.41 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.106 -0.497 . . . . 71.400000000000006 110.78 -174.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -98.62 141.34 31.57 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.909 -0.404 . . . . 52.350000000000001 109.909 178.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -114.45 -75.23 0.59 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 114.818 1.414 . . . . 72.349999999999994 114.818 -170.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.08 26.47 2.47 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 116.479 1.352 . . . . 51.420000000000002 116.479 -168.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.492 ' HB2' ' OH ' ' A' ' 80' ' ' TYR . 51.0 m80 -142.7 -56.16 0.43 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.287 -1.005 . . . . 70.530000000000001 108.287 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.4 mmt 71.56 -171.27 0.15 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 114.703 -1.135 . . . . 74.549999999999997 111.022 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.9 pt? -75.29 127.41 33.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.038 0.447 . . . . 70.129999999999995 109.962 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -113.47 124.34 52.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.946 -0.761 . . . . 73.310000000000002 108.946 -175.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.17 114.01 45.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.08 -1.822 . . . . 63.200000000000003 106.08 172.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -123.75 115.66 21.75 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 120.955 0.407 . . . . 61.340000000000003 110.93 -175.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.31 108.55 17.07 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.786 -1.19 . . . . 55.240000000000002 107.786 175.302 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.3 t -114.39 115.53 27.47 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.671 -1.233 . . . . 74.400000000000006 107.671 -178.525 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.96 146.42 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.092 0.472 . . . . 71.120000000000005 109.822 -178.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 88.9 m -126.08 128.5 47.47 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.98 -0.748 . . . . 64.129999999999995 108.98 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.447 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.4 tt -114.76 114.83 47.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-O 121.622 0.725 . . . . 65.439999999999998 110.067 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -82.29 153.11 68.64 Favored Pre-proline 0 N--CA 1.423 -1.775 0 CA-C-N 115.215 -0.902 . . . . 70.420000000000002 109.564 -176.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.62 1.99 0.46 Allowed 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 123.765 2.977 . . . . 74.510000000000005 114.006 178.013 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.53 -8.27 59.62 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.387 -0.968 . . . . 71.129999999999995 108.387 174.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 72.78 29.27 1.95 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.567 1.547 . . . . 75.140000000000001 107.338 -174.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.26 126.49 51.42 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 113.55 -1.659 . . . . 73.340000000000003 107.512 178.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.33 140.1 23.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 107.871 -1.159 . . . . 75.409999999999997 107.871 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.5 p -148.47 158.97 44.46 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.318 -1.364 . . . . 61.109999999999999 107.318 -178.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.24 -167.8 39.0 Favored Glycine 0 CA--C 1.488 -1.641 0 C-N-CA 118.509 -1.805 . . . . 65.439999999999998 113.028 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -152.89 135.14 14.96 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 123.176 0.591 . . . . 75.239999999999995 110.228 -177.05 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 66.6 mt -115.53 115.89 50.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 107.838 -1.171 . . . . 61.329999999999998 107.838 177.054 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.26 116.59 52.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.726 -0.842 . . . . 62.109999999999999 108.726 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.553 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.25 108.32 16.43 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.927 -1.509 . . . . 72.099999999999994 106.927 175.379 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.47 118.98 33.68 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.324 -0.621 . . . . 35.049999999999997 109.324 -177.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HA ' ' CB ' ' A' ' 26' ' ' LEU . . . -113.91 158.04 21.61 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 115.637 -0.71 . . . . 73.239999999999995 111.308 -174.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -65.71 127.99 93.47 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 105.932 -1.877 . . . . 74.5 105.932 172.371 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -65.78 90.7 0.24 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.691 1.594 . . . . 65.349999999999994 112.343 -178.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -71.69 -54.21 11.06 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 106.232 -1.766 . . . . 74.310000000000002 106.232 172.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -82.86 97.57 8.72 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 106.245 -1.761 . . . . 62.130000000000003 106.245 174.456 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.5 t -64.42 -12.24 41.21 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 123.327 0.651 . . . . 74.549999999999997 112.609 -175.346 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -76.73 -18.08 58.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.971 0.415 . . . . 74.439999999999998 110.342 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -86.95 130.23 34.55 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 112.52 0.563 . . . . 63.109999999999999 112.52 -174.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -104.01 -23.21 13.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.575 -1.268 . . . . 61.439999999999998 107.575 172.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.579 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 172.88 104.05 0.17 Allowed Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 119.807 -1.187 . . . . 44.420000000000002 113.49 174.14 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 83' ' ' SER . 45.4 Cg_exo -60.72 159.6 27.94 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.837 2.358 . . . . 72.439999999999998 110.743 173.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.2 163.14 14.23 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.902 -0.499 . . . . 40.32 110.473 178.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 83' ' ' SER . 3.6 mm? -77.72 136.28 38.15 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.111 -0.495 . . . . 62.299999999999997 109.672 177.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -110.54 95.08 5.35 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.404 0.621 . . . . 71.450000000000003 109.518 -178.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.62 94.01 0.1 OUTLIER Glycine 0 C--N 1.286 -2.207 0 N-CA-C 109.93 -1.268 . . . . 74.340000000000003 109.93 179.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.18 93.97 2.39 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.086 0.47 . . . . 65.019999999999996 111.165 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.5 m -85.79 151.95 56.0 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.439 -0.801 . . . . 73.129999999999995 109.764 178.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.06 -31.84 83.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.414 2.076 . . . . 52.439999999999998 111.707 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -96.11 38.27 1.2 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.791 -0.64 . . . . 71.319999999999993 112.095 -177.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 m -59.66 -24.48 63.92 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.563 0.579 . . . . 73.230000000000004 112.563 -178.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -70.52 -17.87 62.94 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 121.235 0.541 . . . . 74.150000000000006 110.425 -178.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -90.1 -16.63 29.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.708 -0.678 . . . . 70.019999999999996 109.731 -178.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.03 120.06 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 122.029 0.918 . . . . 71.239999999999995 112.492 -176.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.73 108.0 20.0 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.091 -0.958 . . . . 25.23 108.634 178.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 60' ' ' LEU . 67.8 t -98.08 142.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.514 -1.291 . . . . 73.209999999999994 107.514 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.7 t -157.42 172.7 18.11 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 108.742 -0.836 . . . . 72.120000000000005 108.742 -175.288 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.579 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 4.1 p-10 -86.55 146.7 26.26 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.847 -0.797 . . . . 65.310000000000002 108.847 178.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -108.2 119.1 38.5 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.592 -1.262 . . . . 65.319999999999993 107.592 175.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -138.43 99.85 3.95 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.358 -1.719 . . . . 64.010000000000005 106.358 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.7 t -174.76 159.1 2.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.858 -1.164 . . . . 72.239999999999995 107.858 -176.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 72.76 -5.43 1.88 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.874 0.869 . . . . 73.120000000000005 112.535 172.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.28 -5.28 58.94 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 109.877 -1.289 . . . . 73.409999999999997 109.877 -174.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.492 ' OH ' ' HB2' ' A' ' 24' ' ' HIS . 89.3 m-85 -104.5 155.04 19.15 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 123.592 0.757 . . . . 73.219999999999999 109.696 -177.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.62 140.28 49.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 109.059 -0.719 . . . . 73.530000000000001 109.059 178.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -170.04 -154.83 9.63 Favored Glycine 0 N--CA 1.411 -3.001 0 C-N-CA 119.721 -1.228 . . . . 41.229999999999997 112.647 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.581 ' HB2' HD22 ' A' ' 60' ' ' LEU . 28.1 p -122.2 147.46 46.16 Favored 'General case' 0 C--N 1.278 -2.538 0 C-N-CA 123.391 0.677 . . . . 60.409999999999997 110.709 -176.107 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -137.32 143.2 41.96 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.995 0.426 . . . . 44.43 110.987 175.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.99 115.09 16.63 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.525 -1.287 . . . . 32.140000000000001 107.525 175.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.9 t -109.89 116.92 53.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.54 -0.911 . . . . 74.109999999999999 108.54 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.509 ' CD2' HD12 ' A' ' 90' ' ' LEU . 48.7 p90 -121.15 155.32 34.77 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.463 0.649 . . . . 74.030000000000001 111.832 -175.234 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 p -156.08 148.36 23.5 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.361 -0.836 . . . . 64.019999999999996 109.662 -177.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 t70 60.42 62.28 1.59 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.703 1.24 . . . . 72.530000000000001 112.175 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.509 HD12 ' CD2' ' A' ' 87' ' ' PHE . 25.6 mt -121.13 162.38 20.18 Favored 'General case' 0 N--CA 1.413 -2.301 0 CA-C-N 114.204 -1.362 . . . . 62.130000000000003 108.335 174.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -112.17 173.22 6.47 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 119.564 -0.854 . . . . 72.120000000000005 109.443 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.415 ' CE1' HD12 ' A' ' 112' ' ' LEU . 85.0 t80 -50.27 -46.71 55.25 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.272 1.029 . . . . 72.349999999999994 111.636 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.48 -25.35 68.22 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.607 -0.724 . . . . 73.109999999999999 112.337 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -85.72 -17.32 36.28 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 111.859 0.318 . . . . 72.219999999999999 111.859 -177.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.596 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 50.6 tp -61.96 -52.95 64.23 Favored Pre-proline 0 CA--C 1.558 1.288 0 N-CA-C 113.2 0.815 . . . . 72.230000000000004 113.2 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -62.05 -37.13 66.61 Favored 'Trans proline' 0 C--N 1.365 1.419 0 CA-C-N 120.75 1.304 . . . . 72.239999999999995 110.731 176.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.13 -36.4 84.14 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 115.067 -0.97 . . . . 74.329999999999998 111.302 -176.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -74.29 -19.51 60.45 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 120.818 0.342 . . . . 61.130000000000003 110.391 177.088 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.86 -23.27 63.25 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.201 -0.454 . . . . 70.439999999999998 110.523 -177.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -59.74 -48.45 81.61 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 109.584 -0.524 . . . . 64.019999999999996 109.584 176.371 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.419 ' HG2' ' HB3' ' A' ' 60' ' ' LEU . 17.0 ttm -56.19 -52.11 65.6 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.65 -0.704 . . . . 64.230000000000004 109.385 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -55.19 -33.36 62.96 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 114.646 -1.161 . . . . 71.430000000000007 110.901 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -65.11 -18.08 65.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 118.796 -0.621 . . . . 64.400000000000006 112.473 -174.594 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.34 -30.38 66.68 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.535 0.683 . . . . 70.420000000000002 109.823 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.67 -11.57 13.99 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.272 -0.876 . . . . 64.450000000000003 110.908 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.436 ' HB1' HG13 ' A' ' 108' ' ' VAL . . . -107.73 -48.45 3.41 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.947 1.091 . . . . 74.120000000000005 113.947 -172.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.89 18.63 79.66 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 116.289 -0.414 . . . . 70.439999999999998 112.849 -175.411 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.436 HG13 ' HB1' ' A' ' 106' ' ' ALA . 27.3 m -82.2 178.62 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.634 0.605 . . . . 71.530000000000001 112.634 -176.21 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -142.11 126.76 17.97 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.03 0.532 . . . . 73.129999999999995 109.583 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.5 mp -127.23 115.93 19.81 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.427 -0.212 . . . . 72.340000000000003 110.427 178.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.5 m -111.27 109.79 19.97 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.128 -0.693 . . . . 73.340000000000003 109.128 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.415 HD12 ' CE1' ' A' ' 92' ' ' PHE . 1.3 pt? -129.42 148.37 51.33 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.555 0.693 . . . . 53.43 111.9 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -152.65 169.96 21.41 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.465 -1.243 . . . . 74.450000000000003 110.964 -177.316 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.44 ' HG3' HG22 ' A' ' 119' ' ' VAL . 5.4 mtt85 -101.79 137.52 39.98 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 115.628 -0.714 . . . . 51.310000000000002 109.715 171.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -118.36 87.35 2.71 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.406 -1.331 . . . . 73.310000000000002 107.406 177.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 185' ' ' SER . . . 72.61 -98.52 0.85 Allowed Glycine 0 N--CA 1.428 -1.86 0 CA-C-N 115.044 -0.98 . . . . 52.509999999999998 111.962 -177.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -120.12 4.08 10.88 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.811 1.291 . . . . 73.099999999999994 108.563 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -118.84 149.38 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 108.325 -0.991 . . . . 73.400000000000006 108.325 -178.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 114' ' ' ARG . 78.2 t -105.4 135.38 43.76 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 110.005 -0.368 . . . . 70.209999999999994 110.005 -178.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.439 HG22 ' HG2' ' A' ' 175' ' ' GLN . 46.6 pt -113.57 131.47 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 108.733 -0.84 . . . . 71.400000000000006 108.733 177.153 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -128.61 123.61 33.74 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 115.534 -0.757 . . . . 74.099999999999994 108.979 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.71 124.86 12.89 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.722 0.772 . . . . 74.420000000000002 110.972 177.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.58 -178.68 25.68 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.891 -0.671 . . . . 52.509999999999998 111.607 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.447 ' HG2' HG22 ' A' ' 171' ' ' THR . 96.8 mtt180 -140.8 159.26 42.6 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.753 -0.462 . . . . 71.150000000000006 109.753 -176.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.46 108.52 10.61 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 106.019 -1.845 . . . . 54.420000000000002 106.019 171.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -111.86 93.51 4.49 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.505 0.669 . . . . 75.340000000000003 109.297 -178.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 166' ' ' PRO 0.334 0.0 OUTLIER -126.17 63.9 1.24 Allowed 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 123.492 1.615 . . . . 65.349999999999994 109.202 171.429 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.3 p -83.62 -21.9 32.38 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 112.683 -2.053 . . . . 33.310000000000002 112.489 -173.032 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.7 m -78.43 -17.53 56.24 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.861 -0.422 . . . . 74.239999999999995 109.861 178.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.2 t 72.49 111.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 124.621 1.168 . . . . 73.140000000000001 113.172 174.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.3 m -91.6 -49.68 6.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.285 -1.376 . . . . 61.100000000000001 107.285 172.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -130.65 117.93 17.68 Favored Pre-proline 0 CA--C 1.488 -1.412 0 CA-C-N 115.19 -0.914 . . . . 73.219999999999999 108.578 175.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.58 -12.28 22.42 Favored 'Trans proline' 0 C--N 1.327 -0.59 0 C-N-CA 122.24 1.96 . . . . 73.450000000000003 111.463 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -101.81 3.57 39.5 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.351 -0.841 . . . . 72.209999999999994 110.679 -177.151 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.03 141.57 28.26 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.726 -0.39 . . . . 74.409999999999997 111.341 -177.093 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -127.48 135.45 50.41 Favored 'General case' 0 C--O 1.261 1.694 0 N-CA-C 107.009 -1.478 . . . . 65.310000000000002 107.009 172.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 55.3 t -108.7 115.14 48.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.3 -1.0 . . . . 53.299999999999997 108.3 178.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.55 120.1 40.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.968 -0.753 . . . . 72.219999999999999 108.968 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.13 111.98 21.86 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.949 -1.5 . . . . 71.120000000000005 106.949 178.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.2 m -114.15 128.51 56.4 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.435 -0.58 . . . . 75.129999999999995 109.435 -176.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 88.3 t -120.93 123.63 70.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.031 -0.729 . . . . 75.349999999999994 109.031 178.323 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.57 127.5 56.1 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.002 -0.74 . . . . 52.409999999999997 109.002 177.323 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.01 118.82 14.34 Favored Pre-proline 0 C--N 1.291 -1.949 0 N-CA-C 111.795 0.294 . . . . 71.109999999999999 111.795 178.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.37 41.42 0.36 Allowed 'Trans proline' 0 CA--C 1.555 1.561 0 C-N-CA 123.223 2.615 . . . . 71.239999999999995 112.563 175.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.08 -92.85 0.53 Allowed 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 110.148 -0.315 . . . . 63.240000000000002 110.148 178.539 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 168.24 133.68 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.522 1.129 . . . . 74.040000000000006 108.192 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.09 142.86 12.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 108.866 -0.791 . . . . 74.329999999999998 108.866 175.54 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.7 t -103.75 -33.74 8.82 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.2 -0.667 . . . . 75.219999999999999 109.2 178.153 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.0 m -158.3 132.31 7.9 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 108.833 -0.803 . . . . 74.549999999999997 108.833 175.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -139.23 159.49 42.04 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 109.559 -0.534 . . . . 61.100000000000001 109.559 174.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.564 ' HB3' ' OG ' ' A' ' 173' ' ' SER . 57.6 t30 -135.58 103.17 5.35 Favored 'General case' 0 C--O 1.274 2.365 0 N-CA-C 105.982 -1.858 . . . . 64.219999999999999 105.982 169.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.27 -140.75 6.06 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 107.614 -2.195 . . . . 62.219999999999999 107.614 -178.549 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.5 99.45 6.83 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 118.417 1.108 . . . . 73.239999999999995 110.041 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -75.53 131.12 39.84 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.719 -0.673 . . . . 63.119999999999997 110.64 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.9 mt -95.68 -44.51 13.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.257 -1.386 . . . . 60.140000000000001 107.257 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.96 170.37 9.22 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 105.928 -1.879 . . . . 75.510000000000005 105.928 176.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.24 -0.44 8.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.169 1.913 . . . . 53.409999999999997 111.39 177.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.611 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.8 pt-20 -128.62 5.75 5.61 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.046 -0.524 . . . . 63.149999999999999 111.207 178.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.4 t -143.22 120.8 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.799 -0.815 . . . . 72.099999999999994 108.799 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.86 147.15 33.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.364 -0.606 . . . . 52.420000000000002 109.364 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -131.01 145.35 52.02 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.147 0.499 . . . . 74.25 109.72 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.49 ' CD1' ' HA ' ' A' ' 172' ' ' MET . 30.2 m-90 -121.45 124.63 44.93 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.032 -1.099 . . . . 72.25 108.032 174.367 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -104.64 99.41 9.08 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.885 -1.154 . . . . 55.409999999999997 107.885 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 1.3 mm? -89.2 133.42 34.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.527 -0.761 . . . . 75.439999999999998 109.272 -174.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -117.58 150.59 47.03 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 116.139 -0.482 . . . . 74.219999999999999 111.854 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.426 ' HA ' HD23 ' A' ' 127' ' ' LEU . 72.2 Cg_endo -76.76 156.96 35.44 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 123.087 2.525 . . . . 64.150000000000006 111.85 177.462 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.47 -36.73 2.93 Favored Glycine 0 C--N 1.31 -0.91 0 CA-C-N 115.977 -0.556 . . . . 63.32 111.798 178.193 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.49 149.98 8.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.789 -0.819 . . . . 74.230000000000004 108.789 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -86.22 114.51 25.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.608 -0.886 . . . . 70.519999999999996 108.608 177.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.1 m -104.61 141.99 35.45 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.575 -0.528 . . . . 74.409999999999997 109.575 -177.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 124' ' ' ARG . 67.1 p -116.22 156.84 25.84 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 120.738 0.304 . . . . 75.340000000000003 110.564 -177.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.49 ' HA ' ' CD1' ' A' ' 162' ' ' TRP . 23.4 ptp -128.95 117.45 20.98 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.132 -1.062 . . . . 64.25 108.132 175.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.564 ' OG ' ' HB3' ' A' ' 151' ' ' ASN . 2.9 p -138.33 132.93 32.34 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.936 -0.706 . . . . 74.420000000000002 112.084 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.474 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.71 139.88 19.36 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 123.664 0.785 . . . . 75.450000000000003 109.341 -176.099 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.439 ' HG2' HG22 ' A' ' 120' ' ' ILE . 48.7 mt-30 -137.99 130.59 29.51 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.464 -1.31 . . . . 63.439999999999998 107.464 174.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.433 ' HB3' ' CE1' ' A' ' 178' ' ' TYR . . . -148.55 153.1 37.93 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.912 -0.315 . . . . 63.420000000000002 110.409 -177.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 37.5 mtp180 -89.55 126.25 35.53 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.547 -0.908 . . . . 62.130000000000003 108.547 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 176' ' ' ALA . 85.3 m-85 -124.69 152.86 43.18 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-O 120.988 0.423 . . . . 74.310000000000002 111.107 -176.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.2 p -78.34 94.38 4.84 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 116.138 -0.483 . . . . 70.010000000000005 111.518 177.37 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.519 ' HB3' ' H ' ' A' ' 183' ' ' THR . 0.5 OUTLIER -55.88 110.84 2.55 Favored Pre-proline 0 N--CA 1.467 0.384 0 C-N-CA 125.259 1.424 . . . . 74.140000000000001 113.773 175.483 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -75.71 -34.02 3.53 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.645 1.563 . . . . 64.030000000000001 109.496 168.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -80.02 -23.7 41.3 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.215 -1.357 . . . . 74.239999999999995 110.965 -177.162 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.519 ' H ' ' HB3' ' A' ' 180' ' ' ASP . 36.5 p 54.88 88.37 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.156 1.382 . . . . 50.140000000000001 114.186 177.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.61 ' HA ' ' NE ' ' A' ' 184' ' ' ARG . 3.1 mmp_? -108.26 176.31 5.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.308 -0.406 . . . . 73.209999999999994 111.567 176.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.407 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 50.7 m . . . . . 0 C--N 1.31 -1.111 0 N-CA-C 108.995 -0.743 . . . . 72.319999999999993 108.995 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.719 0 N-CA-C 110.263 -1.135 . . . . 43.049999999999997 110.263 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -96.79 -65.73 0.95 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.384 0.611 . . . . 73.299999999999997 111.005 178.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -126.83 107.76 10.41 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.997 -1.001 . . . . 74.120000000000005 110.571 -170.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -80.44 103.56 10.38 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.574 -0.898 . . . . 54.43 108.574 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 19' ' ' LEU . 2.3 pt? -101.36 87.33 3.18 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.467 1.284 . . . . 72.120000000000005 114.467 -173.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.26 45.98 2.71 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 104.297 -2.483 . . . . 61.549999999999997 104.297 169.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -77.46 165.4 24.43 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.082 -1.872 . . . . 63.149999999999999 110.674 -172.298 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -52.66 123.38 11.07 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 113.052 0.76 . . . . 64.5 113.052 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.15 77.01 2.14 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 114.937 -1.029 . . . . 74.150000000000006 112.44 -177.248 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -74.41 125.08 27.76 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.552 -1.277 . . . . 73.540000000000006 107.552 177.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.531 ' SD ' ' HE3' ' A' ' 49' ' ' LYS . 33.9 mtt 60.38 27.21 16.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.358 0.663 . . . . 60.210000000000001 112.225 -171.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.85 100.53 2.43 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.294 0.569 . . . . 74.329999999999998 110.189 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 37.4 ttm180 -103.47 123.96 47.85 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.992 -0.744 . . . . 74.420000000000002 108.992 175.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.19 113.62 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 N-CA-C 106.036 -1.838 . . . . 72.510000000000005 106.036 176.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 20.6 ttt180 -120.21 114.36 21.81 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 121.249 0.547 . . . . 72.109999999999999 109.807 -178.009 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 139' ' ' LEU . . . -104.63 108.37 19.78 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.093 -1.077 . . . . 63.119999999999997 108.093 178.5 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 140' ' ' THR . 21.2 m -119.39 115.32 23.86 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.163 -1.051 . . . . 74.430000000000007 108.163 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.9 pp -125.64 146.42 31.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.275 0.559 . . . . 73.219999999999999 109.819 -177.045 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 43.0 m -126.31 125.38 42.2 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 108.307 -0.997 . . . . 74.239999999999995 108.307 -178.403 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' OH ' ' A' ' 178' ' ' TYR . 8.4 tt -116.74 129.62 72.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.278 0.561 . . . . 74.310000000000002 110.073 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -105.34 149.63 37.98 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 116.116 -0.493 . . . . 41.399999999999999 111.514 -175.248 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.53 -7.14 0.73 Allowed 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 124.995 3.797 . . . . 64.430000000000007 116.078 -178.197 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 3.32 30.11 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.997 -0.44 . . . . 71.310000000000002 110.319 177.331 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.1 t70 71.74 34.44 1.58 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 123.993 1.854 . . . . 72.239999999999995 106.378 -175.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.17 125.05 50.52 Favored 'General case' 0 N--CA 1.392 -3.34 0 CA-C-N 113.26 -1.791 . . . . 44.329999999999998 107.459 -177.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.417 HG11 HD21 ' A' ' 95' ' ' LEU . 11.4 t -114.55 140.56 34.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.804 -0.813 . . . . 64.340000000000003 108.804 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.8 p -150.67 159.87 44.22 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.537 -0.912 . . . . 40.329999999999998 108.537 179.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.82 -173.44 43.39 Favored Glycine 0 CA--C 1.49 -1.522 0 C-N-CA 118.682 -1.723 . . . . 54.340000000000003 113.03 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.6 133.41 14.0 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.121 0.486 . . . . 54.5 110.488 -176.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 3.5 mp -116.08 115.94 50.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 106.839 -1.541 . . . . 74.230000000000004 106.839 174.422 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.02 118.74 57.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.891 -0.781 . . . . 71.299999999999997 108.891 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.1 107.37 17.18 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 106.087 -1.819 . . . . 43.229999999999997 106.087 174.186 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -125.86 133.47 51.93 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 116.184 -0.462 . . . . 62.100000000000001 111.048 -174.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.79 157.89 33.02 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.174 -0.921 . . . . 72.329999999999998 109.975 -177.247 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.531 ' HE3' ' SD ' ' A' ' 25' ' ' MET . 36.8 ttmt -74.55 126.93 88.21 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 107.525 -1.287 . . . . 71.510000000000005 107.525 173.391 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -48.75 111.37 0.46 Allowed 'Trans proline' 0 C--N 1.363 1.315 0 C-N-CA 122.957 2.438 . . . . 74.109999999999999 110.63 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -109.78 -20.41 12.8 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.592 0.71 . . . . 73.150000000000006 109.768 -173.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 37.2 m-80 -97.92 161.32 13.79 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.81 -0.811 . . . . 74.530000000000001 108.81 178.197 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 m -74.72 -34.76 62.63 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.635 0.731 . . . . 43.130000000000003 109.867 -177.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -94.87 9.68 38.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.381 -0.827 . . . . 73.030000000000001 109.744 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 2.3 t0 -63.68 98.77 0.2 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.703 -0.681 . . . . 71.349999999999994 111.759 -171.343 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 61.1 m -103.98 -31.74 9.58 Favored 'General case' 1 N--CA 1.378 -4.069 0 N-CA-C 108.263 -1.014 . . . . 55.340000000000003 108.263 177.574 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.44 126.89 0.91 Allowed Glycine 0 N--CA 1.422 -2.267 0 CA-C-O 118.51 -1.161 . . . . 63.299999999999997 111.611 174.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 6.9 Cg_endo -56.51 148.15 65.01 Favored 'Trans proline' 0 CA--C 1.553 1.437 0 CA-C-N 120.518 2.159 . . . . 74.540000000000006 108.839 166.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.95 128.39 54.89 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.292 0.849 . . . . 34.420000000000002 113.292 -172.534 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 90.5 mt -94.57 133.22 38.44 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.77 -0.65 . . . . 71.349999999999994 109.503 176.047 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -111.62 83.64 1.81 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.556 0.693 . . . . 73.549999999999997 111.85 176.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.6 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -88.72 87.62 1.5 Allowed Glycine 0 N--CA 1.423 -2.174 0 CA-C-N 114.677 -1.147 . . . . 53.210000000000001 111.239 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.47 104.75 16.87 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.523 0.678 . . . . 73.5 110.667 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.36 160.58 68.09 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.123 -1.066 . . . . 53.240000000000002 108.123 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.64 -8.61 23.74 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 122.52 2.146 . . . . 74.409999999999997 112.64 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -120.63 39.63 3.71 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.64 -0.709 . . . . 61.100000000000001 110.951 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.2 m -56.45 -32.97 65.44 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 116.407 -0.36 . . . . 51.229999999999997 111.867 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -68.53 -12.5 61.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.213 0.53 . . . . 65.510000000000005 111.168 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -100.64 -9.2 22.14 Favored 'General case' 0 C--O 1.26 1.628 0 CA-C-N 116.046 -0.525 . . . . 71.209999999999994 110.249 -178.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG21 ' HE1' ' A' ' 101' ' ' MET . 5.6 p -129.64 119.33 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.097 0.951 . . . . 72.319999999999993 111.209 177.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.67 110.63 21.96 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.225 -0.898 . . . . 72.019999999999996 109.815 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.01 114.42 35.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.995 -1.483 . . . . 71.430000000000007 106.995 177.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 m -123.78 164.38 19.29 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.776 -0.647 . . . . 72.120000000000005 109.79 -172.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -86.86 125.55 34.07 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.198 -1.408 . . . . 74.540000000000006 107.198 175.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 82.6 t80 -92.7 120.12 32.79 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.167 -0.679 . . . . 71.109999999999999 109.167 -175.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -138.52 99.21 3.77 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 106.776 -1.564 . . . . 72.219999999999999 106.776 174.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.7 t -174.36 153.35 1.92 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.024 -1.102 . . . . 74.219999999999999 108.024 -174.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.53 16.4 10.49 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.835 0.854 . . . . 65.319999999999993 111.501 174.389 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.27 85.1 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 116.065 -0.516 . . . . 54.409999999999997 112.793 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.401 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 61.6 m-85 -104.07 153.63 20.66 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.116 -0.698 . . . . 74.319999999999993 109.116 -178.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 56' ' ' THR . 27.1 m -124.33 141.51 44.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.036 -1.098 . . . . 43.439999999999998 108.036 172.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.469 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -177.69 -154.21 12.03 Favored Glycine 0 N--CA 1.407 -3.24 0 C-N-CA 119.981 -1.104 . . . . 65.120000000000005 111.568 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.607 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 1.7 p -130.5 150.04 51.89 Favored 'General case' 0 C--N 1.26 -3.288 0 CA-C-O 121.351 0.596 . . . . 70.420000000000002 110.971 178.114 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -138.61 138.98 38.39 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 116.15 -0.477 . . . . 54.299999999999997 110.373 -175.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.97 114.1 25.71 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.593 -1.262 . . . . 72.439999999999998 107.593 175.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -115.23 112.09 38.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 109.422 -0.585 . . . . 51.030000000000001 109.422 -177.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 43.1 p90 -112.47 151.85 29.43 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 110.0 -0.371 . . . . 44.350000000000001 110.0 -175.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 m -154.31 145.68 23.01 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 120.484 -0.487 . . . . 63.210000000000001 109.705 -175.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t0 60.13 62.39 1.63 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.471 1.129 . . . . 45.520000000000003 112.155 178.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.5 mt -119.23 170.97 8.63 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.675 -1.148 . . . . 50.32 108.908 175.198 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.2 t -113.59 169.12 9.2 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.825 -0.805 . . . . 55.409999999999997 108.825 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.48 -30.13 68.31 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.224 0.535 . . . . 75.200000000000003 111.077 -178.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.97 -25.56 67.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.975 -0.557 . . . . 63.420000000000002 111.433 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.475 ' OE1' HG22 ' A' ' 91' ' ' THR . 49.5 mt-10 -86.66 -16.57 36.21 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 112.468 0.544 . . . . 70.430000000000007 112.468 -176.215 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 11.6 mt -51.22 -55.19 30.6 Favored Pre-proline 0 N--CA 1.483 1.218 0 N-CA-C 115.382 1.623 . . . . 61.109999999999999 115.382 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.32 -40.66 56.69 Favored 'Trans proline' 0 C--N 1.366 1.452 0 CA-C-N 120.894 1.355 . . . . 71.150000000000006 110.954 -179.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.07 -40.0 96.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.88 -1.054 . . . . 70.239999999999995 111.511 -177.627 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -76.18 -19.89 58.02 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 120.604 -0.438 . . . . 71.120000000000005 110.586 177.621 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.09 -21.62 59.83 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.2 -0.667 . . . . 75.209999999999994 109.2 -177.534 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.03 -57.54 11.23 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.468 -0.787 . . . . 63.32 108.957 175.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.6 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 33.3 ttp -54.2 -49.09 70.17 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.764 -0.653 . . . . 55.130000000000003 110.094 178.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -53.9 -42.75 69.05 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.427 -0.806 . . . . 62.310000000000002 111.286 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.2 p -67.78 -24.92 65.38 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 120.018 -0.673 . . . . 62.0 111.603 -173.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.05 -25.14 66.11 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 120.914 0.388 . . . . 70.540000000000006 110.182 -177.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -103.4 -7.89 20.64 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.536 -0.466 . . . . 35.140000000000001 110.712 -179.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.63 -43.63 4.88 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.444 -0.503 . . . . 61.420000000000002 112.219 -173.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.92 12.72 80.81 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.694 -0.765 . . . . 64.219999999999999 111.688 -177.157 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 m -112.21 169.35 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.985 -0.746 . . . . 71.120000000000005 108.985 -178.14 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -114.07 124.76 52.9 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.854 -0.339 . . . . 64.129999999999995 110.708 -178.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.42 132.66 55.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.881 -0.785 . . . . 63.25 108.881 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.1 m -144.11 131.77 21.22 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.457 -0.571 . . . . 62.420000000000002 109.457 177.056 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 157.82 43.97 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.211 0.529 . . . . 73.540000000000006 112.405 -175.585 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -155.66 165.56 36.16 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.472 -1.24 . . . . 72.0 110.697 178.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.436 ' HG3' HG22 ' A' ' 119' ' ' VAL . 3.6 ttt85 -99.06 137.72 37.19 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 106.355 -1.72 . . . . 71.540000000000006 106.355 171.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -118.44 94.45 4.48 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 107.53 -1.285 . . . . 65.140000000000001 107.53 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.07 -114.44 5.25 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.406 -1.478 . . . . 71.010000000000005 109.406 -175.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -112.32 14.7 20.47 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.723 1.249 . . . . 73.439999999999998 108.922 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.5 pp -123.26 148.99 26.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 120.396 -1.44 . . . . 74.409999999999997 108.383 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 178' ' ' TYR . 70.8 t -99.55 135.99 32.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 O-C-N 122.18 -0.325 . . . . 73.319999999999993 110.544 -177.331 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.9 pt -118.86 130.23 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-O 121.767 0.794 . . . . 72.450000000000003 109.235 176.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 tt -126.91 131.61 51.09 Favored 'General case' 0 C--N 1.266 -3.064 0 CA-C-N 115.352 -0.84 . . . . 73.329999999999998 109.26 177.145 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -123.27 146.44 47.87 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.094 -1.076 . . . . 63.340000000000003 108.094 177.346 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.32 155.59 27.01 Favored Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 110.534 -1.026 . . . . 70.510000000000005 110.534 177.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.34 139.04 33.5 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.161 -1.051 . . . . 74.150000000000006 108.161 175.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.55 114.28 15.88 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.833 -0.622 . . . . 72.400000000000006 109.463 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -111.28 108.54 18.19 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.273 -1.01 . . . . 55.420000000000002 108.273 178.3 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.09 29.52 7.91 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.601 -0.518 . . . . 72.230000000000004 109.601 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.7 p -74.3 -13.92 60.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.122 -0.631 . . . . 73.209999999999994 110.563 -179.059 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.4 m -73.01 -9.84 59.16 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.46 -0.791 . . . . 72.299999999999997 109.491 174.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . 0.36 14.9 p 59.05 -59.16 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 128.127 2.571 . . . . 54.340000000000003 116.32 177.122 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.2 t 69.12 -66.24 0.26 Allowed 'General case' 0 C--O 1.251 1.164 0 C-N-CA 124.504 1.122 . . . . 74.150000000000006 110.593 -176.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -146.25 122.62 5.78 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 107.441 -1.318 . . . . 50.130000000000003 107.441 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -48.77 -43.03 35.86 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 123.845 3.03 . . . . 72.010000000000005 115.091 -176.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -99.52 17.47 20.29 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.093 0.775 . . . . 74.099999999999994 113.093 -174.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.85 136.88 38.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.907 -1.886 . . . . 72.109999999999999 105.907 171.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.9 t70 -132.21 125.94 32.36 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 120.553 -0.459 . . . . 72.340000000000003 110.047 -172.505 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 67.5 t -116.38 127.88 73.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.54 -0.864 . . . . 74.510000000000005 109.775 -179.215 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 43.8 mt-10 -128.53 141.13 51.47 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.134 -0.691 . . . . 72.420000000000002 109.134 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 5.6 tt -132.23 122.67 25.6 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.895 -1.52 . . . . 64.340000000000003 106.895 175.354 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' SER . 2.2 m -124.86 132.52 53.31 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.994 -1.113 . . . . 72.049999999999997 107.994 -176.149 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 71.8 t -124.08 125.98 71.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 109.549 -0.537 . . . . 75.040000000000006 109.549 178.531 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -109.41 121.1 44.44 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.745 -1.206 . . . . 42.149999999999999 107.745 175.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -133.82 105.83 11.67 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 111.756 0.28 . . . . 75.150000000000006 111.756 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -67.05 34.69 0.14 Allowed 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 123.604 2.869 . . . . 71.430000000000007 113.329 178.097 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -109.26 -90.39 0.46 Allowed 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.093 -0.706 . . . . 63.030000000000001 109.093 178.338 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.12 124.0 0.01 OUTLIER 'General case' 0 C--N 1.362 1.117 0 C-N-CA 124.196 0.998 . . . . 72.540000000000006 109.682 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.406 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 7.9 p -80.02 138.46 19.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.746 -0.835 . . . . 71.340000000000003 108.746 175.183 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.8 t -104.43 -27.58 11.85 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.678 -0.409 . . . . 60.219999999999999 110.371 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.6 m -159.48 132.33 6.84 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 108.049 -1.093 . . . . 63.100000000000001 108.049 174.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.1 t -140.42 150.75 44.24 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 118.531 0.605 . . . . 44.450000000000003 111.925 174.189 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 27.6 t-20 -120.69 93.11 3.93 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 105.719 -1.956 . . . . 61.229999999999997 105.719 174.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.01 -142.73 6.41 Favored Glycine 0 C--N 1.296 -1.651 0 N-CA-C 107.347 -2.301 . . . . 65.010000000000005 107.347 -178.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -118.45 104.35 10.62 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 118.603 1.202 . . . . 71.140000000000001 109.88 177.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -84.87 113.57 21.47 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.945 -0.571 . . . . 73.319999999999993 111.094 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.5 mt -80.66 -46.62 21.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.52 -1.289 . . . . 71.230000000000004 107.52 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -134.0 160.76 67.3 Favored Pre-proline 0 C--N 1.295 -1.789 0 CA-C-N 114.317 -1.311 . . . . 75.340000000000003 107.491 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -61.5 -17.13 52.06 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.496 2.131 . . . . 65.510000000000005 111.577 173.631 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 1.4 pm0 -115.13 2.42 14.13 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 113.484 0.92 . . . . 72.25 113.484 177.054 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.79 120.44 16.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 121.621 -0.674 . . . . 74.120000000000005 109.612 178.401 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.8 t -129.36 147.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 109.304 -0.628 . . . . 74.150000000000006 109.304 -177.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -136.77 143.61 43.33 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.31 0.576 . . . . 73.209999999999994 111.049 -178.151 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.444 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.5 m-90 -119.79 123.93 44.89 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.468 -0.938 . . . . 62.140000000000001 108.468 177.686 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -101.15 110.34 22.35 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.296 0.569 . . . . 70.040000000000006 109.756 177.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.0 mm? -97.4 116.87 30.42 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 122.279 1.038 . . . . 62.310000000000002 108.723 -177.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -117.08 138.92 25.26 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 113.637 -1.619 . . . . 73.040000000000006 110.584 -169.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.06 156.63 61.68 Favored 'Trans proline' 0 C--O 1.244 0.81 0 C-N-CA 122.442 2.095 . . . . 72.340000000000003 111.351 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.55 -33.39 3.24 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 116.128 -0.487 . . . . 61.030000000000001 111.991 177.411 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 32.7 m -108.02 165.49 4.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.348 0.594 . . . . 71.099999999999994 111.656 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.42 144.14 22.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.723 -1.214 . . . . 73.319999999999993 107.723 175.144 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.9 m -139.29 142.86 37.71 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.651 -0.656 . . . . 73.239999999999995 111.549 179.078 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 13.3 p -96.25 150.36 20.63 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.337 -0.847 . . . . 72.010000000000005 108.917 177.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.455 ' HE1' HD13 ' A' ' 139' ' ' LEU . 76.2 mtp -129.65 128.75 43.23 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.863 -0.792 . . . . 75.120000000000005 108.863 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 32.7 t -143.62 142.66 31.14 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.939 -1.134 . . . . 52.109999999999999 107.939 174.646 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -155.18 116.63 4.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.879 -0.785 . . . . 73.439999999999998 108.879 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 48.3 mt-30 -125.53 130.56 51.97 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 108.022 -1.103 . . . . 72.239999999999995 108.022 176.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -143.44 158.97 43.21 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 116.533 -0.303 . . . . 54.130000000000003 110.969 -176.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -87.37 125.04 34.01 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.76 -0.376 . . . . 75.319999999999993 110.085 178.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 119' ' ' VAL . 8.0 m-85 -134.86 120.29 19.13 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 114.371 1.249 . . . . 75.510000000000005 114.371 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.2 p -61.13 105.48 0.49 Allowed 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 113.937 -1.483 . . . . 64.010000000000005 110.51 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.55 139.76 94.32 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 113.944 -1.48 . . . . 71.329999999999998 110.646 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.55 -46.81 8.54 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.229 1.953 . . . . 65.129999999999995 113.33 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . 0.319 0.2 OUTLIER -84.21 -7.67 59.28 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 112.883 0.698 . . . . 74.140000000000001 112.883 -179.046 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.356 70.6 p 72.37 68.41 0.13 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 126.519 1.928 . . . . 72.420000000000002 115.158 172.355 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -84.11 155.64 22.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.92 -1.491 . . . . 73.099999999999994 108.637 174.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.297 -1.688 0 N-CA-C 108.15 -1.056 . . . . 62.530000000000001 108.15 179.128 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.533 0 N-CA-C 111.704 -0.558 . . . . 53.109999999999999 111.704 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -117.84 115.55 25.18 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.394 -0.965 . . . . 64.219999999999999 108.394 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -76.14 110.97 11.07 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.34 -0.615 . . . . 72.230000000000004 109.34 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -65.54 144.3 57.09 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.541 -0.754 . . . . 75.030000000000001 109.676 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mp -78.57 71.11 5.02 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.592 0.711 . . . . 74.109999999999999 111.794 -179.067 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -89.31 109.99 20.82 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.395 -0.965 . . . . 74.120000000000005 108.395 176.021 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -127.58 156.27 42.52 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.411 -0.589 . . . . 63.219999999999999 109.411 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.75 119.94 23.99 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.474 -0.936 . . . . 71.340000000000003 108.474 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.634 ' HA2' ' OD1' ' A' ' 134' ' ' ASP . . . -72.7 56.58 1.7 Allowed Glycine 0 C--N 1.32 -0.323 0 N-CA-C 116.296 1.278 . . . . 41.240000000000002 116.296 -171.229 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.495 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 39.8 m-70 -146.1 26.97 1.19 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 123.777 0.831 . . . . 73.409999999999997 109.325 178.124 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 48.6 ttm -86.93 -57.2 3.06 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.816 -0.353 . . . . 74.25 111.626 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.74 148.59 34.32 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.257 0.466 . . . . 73.409999999999997 112.257 -178.283 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.495 ' NH2' ' HA ' ' A' ' 24' ' ' HIS . 0.0 OUTLIER -158.78 155.64 28.29 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.049 -0.523 . . . . 74.230000000000004 110.183 179.575 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.401 HG23 HG13 ' A' ' 137' ' ' VAL . 27.7 m -120.22 115.5 47.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.582 0.706 . . . . 75.420000000000002 109.359 177.552 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 96.6 mtt180 -113.12 119.0 36.32 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.776 -0.647 . . . . 70.540000000000006 110.749 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.96 108.22 16.74 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.561 -1.274 . . . . 50.219999999999999 107.561 175.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 m -114.79 114.98 26.29 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.376 -1.342 . . . . 50.329999999999998 107.376 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 pp -126.83 146.18 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 109.419 -0.586 . . . . 74.219999999999999 109.419 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.6 m -126.35 137.51 53.47 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 108.566 -0.902 . . . . 62.32 108.566 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.81 125.02 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 109.032 -0.729 . . . . 73.239999999999995 109.032 -176.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 m -105.78 152.08 40.08 Favored Pre-proline 0 N--CA 1.425 -1.689 0 CA-C-N 115.762 -0.653 . . . . 74.219999999999999 110.232 -177.087 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.62 2.42 0.98 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 123.904 3.069 . . . . 64.439999999999998 114.577 -176.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -87.99 3.54 48.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.222 -1.029 . . . . 71.430000000000007 108.222 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 91' ' ' THR . 15.0 t70 72.07 28.68 2.47 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 126.298 1.839 . . . . 61.43 106.227 -175.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 tp -102.02 129.04 48.23 Favored 'General case' 0 N--CA 1.381 -3.919 0 CA-C-N 112.689 -2.05 . . . . 71.129999999999995 109.164 -176.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.95 132.43 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 N-CA-C 107.827 -1.175 . . . . 74.540000000000006 107.827 176.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.2 p -142.52 151.42 41.62 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.621 -1.251 . . . . 71.420000000000002 107.621 177.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.53 -176.42 47.11 Favored Glycine 0 N--CA 1.418 -2.525 0 C-N-CA 118.722 -1.704 . . . . 73.310000000000002 112.7 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.65 133.58 25.66 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.736 -0.732 . . . . 71.0 109.878 -175.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.8 mt -120.42 115.7 47.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.218 -1.401 . . . . 65.209999999999994 107.218 175.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.83 115.31 48.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.115 0.483 . . . . 71.430000000000007 109.98 -178.344 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.501 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -105.93 108.42 19.92 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.116 -1.809 . . . . 74.299999999999997 106.116 173.132 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -125.06 132.38 53.19 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.312 -0.555 . . . . 74.200000000000003 111.418 -175.203 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.45 129.44 41.19 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.931 -1.031 . . . . 73.310000000000002 110.866 -178.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 24' ' ' HIS . 54.3 mtmt -68.45 121.14 79.53 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 107.269 -1.382 . . . . 74.540000000000006 107.269 171.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -20.84 88.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 1 C-N-CA 126.418 4.745 . . . . 71.349999999999994 117.716 -168.017 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -82.69 -28.45 30.57 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.499 -0.773 . . . . 53.409999999999997 108.98 175.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -105.97 127.22 53.01 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.685 -1.143 . . . . 72.030000000000001 108.094 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.4 t -63.88 -25.63 68.24 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 124.003 0.921 . . . . 51.439999999999998 112.19 -173.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -103.03 6.14 38.57 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.992 0.738 . . . . 74.310000000000002 112.992 -177.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.38 116.13 28.7 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 114.633 1.346 . . . . 60.229999999999997 114.633 -175.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -110.4 -7.92 14.74 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.529 -1.214 . . . . 71.150000000000006 108.119 173.118 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.36 96.82 0.1 Allowed Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.595 -0.812 . . . . 73.019999999999996 112.845 176.048 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.77 160.57 45.93 Favored 'Trans proline' 0 C--O 1.248 1.025 0 C-N-CA 123.487 2.791 . . . . 74.340000000000003 111.932 174.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.83 158.49 28.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.765 0.317 . . . . 70.150000000000006 111.096 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 95.2 mt -102.25 154.99 18.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 106.62 -1.622 . . . . 74.239999999999995 106.62 173.594 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -93.03 86.35 5.38 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.227 1.013 . . . . 64.439999999999998 109.703 -177.086 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.52 ' HA2' ' SD ' ' A' ' 101' ' ' MET . . . -85.16 84.31 1.6 Allowed Glycine 0 N--CA 1.413 -2.888 0 CA-C-N 114.101 -1.408 . . . . 40.350000000000001 111.958 -178.011 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -112.05 97.6 6.77 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.986 0.422 . . . . 72.099999999999994 110.244 178.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 m -146.1 159.45 46.01 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 123.995 0.918 . . . . 52.399999999999999 108.815 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.18 -9.02 22.9 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.106 1.871 . . . . 61.200000000000003 112.05 176.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -114.79 42.05 2.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 74.329999999999998 111.994 -178.125 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.6 m -55.3 -28.32 52.83 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 111.776 0.287 . . . . 70.329999999999998 111.776 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -65.65 -20.32 66.26 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 121.276 0.56 . . . . 51.130000000000003 110.813 -178.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -90.85 -18.26 25.14 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.645 -0.707 . . . . 54.219999999999999 110.535 -177.097 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.98 119.59 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 121.964 0.887 . . . . 54.119999999999997 112.532 -176.25 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.67 104.79 16.11 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.273 -0.876 . . . . 54.409999999999997 109.58 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.8 p -98.95 133.04 43.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.054 -0.721 . . . . 72.040000000000006 109.054 177.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -154.74 173.46 16.39 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 123.335 0.654 . . . . 72.140000000000001 109.612 -175.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -77.72 153.62 32.82 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.495 0.664 . . . . 74.150000000000006 110.308 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 76.9 t80 -114.39 122.55 46.99 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 108.022 -1.103 . . . . 71.420000000000002 108.022 176.854 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -138.62 102.85 4.7 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.913 -1.514 . . . . 72.299999999999997 106.913 177.032 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 36.8 t -164.13 141.88 7.03 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.147 -0.686 . . . . 52.149999999999999 109.147 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 67.05 10.45 7.7 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.887 0.875 . . . . 64.150000000000006 111.996 174.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.88 -0.36 64.6 Favored Glycine 0 N--CA 1.426 -2.026 0 N-CA-C 111.238 -0.745 . . . . 70.439999999999998 111.238 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.529 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 12.6 m-85 -96.95 142.0 29.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.454 -0.943 . . . . 73.409999999999997 108.454 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 35.3 m -123.85 136.92 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 108.26 -1.015 . . . . 64.340000000000003 108.26 174.13 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.34 -155.34 9.44 Favored Glycine 0 N--CA 1.402 -3.612 0 C-N-CA 119.189 -1.482 . . . . 44.43 112.051 179.448 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 16.0 p -126.62 134.42 50.78 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 114.84 -0.68 . . . . 61.32 110.749 -177.56 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -126.74 143.12 51.34 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.06 0.457 . . . . 74.530000000000001 111.317 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -124.35 114.54 19.68 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.272 -1.381 . . . . 64.450000000000003 107.272 174.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.76 115.17 48.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 107.845 -1.169 . . . . 64.430000000000007 107.845 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.515 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.8 p90 -115.45 152.43 32.94 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.153 0.501 . . . . 72.340000000000003 110.473 -176.013 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 p -159.27 155.3 26.69 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.906 -0.588 . . . . 61.210000000000001 109.641 -176.46 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.24 31.32 6.69 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.076 0.86 . . . . 73.430000000000007 111.386 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.515 HD12 ' CD2' ' A' ' 87' ' ' PHE . 25.2 mt -91.76 156.56 17.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 116.106 -0.497 . . . . 74.549999999999997 109.785 176.585 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 40.1 p -108.0 171.9 7.14 Favored 'General case' 0 C--N 1.277 -2.556 0 O-C-N 123.801 0.688 . . . . 73.109999999999999 109.933 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -57.01 -35.95 69.85 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.998 0.519 . . . . 73.120000000000005 109.729 179.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.08 -28.5 66.57 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.859 -0.61 . . . . 72.219999999999999 111.372 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.438 ' HB3' HD22 ' A' ' 90' ' ' LEU . 41.0 mt-10 -86.33 -17.03 35.6 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.212 0.449 . . . . 55.340000000000003 112.212 -176.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.9 tt -61.36 -48.65 90.5 Favored Pre-proline 0 CA--C 1.569 1.68 0 N-CA-C 112.355 0.502 . . . . 51.109999999999999 112.355 -178.084 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.91 -37.9 82.61 Favored 'Trans proline' 0 C--N 1.376 2.009 0 CA-C-N 121.049 1.41 . . . . 74.540000000000006 110.316 176.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -63.91 -38.76 92.27 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.93 -1.032 . . . . 72.230000000000004 111.129 -177.267 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.5 pp -70.11 -23.84 63.1 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 120.669 -0.412 . . . . 72.340000000000003 110.103 177.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.4 -20.78 63.8 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.094 -0.503 . . . . 64.019999999999996 110.587 -175.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -63.27 -57.95 8.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.404 -0.591 . . . . 71.540000000000006 109.404 176.229 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.52 ' SD ' ' HA2' ' A' ' 62' ' ' GLY . 65.3 mtm -56.68 -48.97 76.46 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.436 0.636 . . . . 73.140000000000001 109.507 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -53.93 -40.57 66.86 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.264 -1.335 . . . . 73.209999999999994 111.644 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.8 p -65.22 -26.87 68.31 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 119.906 -0.717 . . . . 51.219999999999999 111.077 -172.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.04 -33.26 74.05 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 116.15 -0.477 . . . . 52.420000000000002 110.71 -176.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.41 -9.57 20.17 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.287 -0.565 . . . . 70.200000000000003 111.058 -176.383 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.96 -47.64 3.66 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.143 0.794 . . . . 53.25 113.143 -173.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.79 7.3 64.73 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.861 -0.896 . . . . 54.140000000000001 110.861 -173.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.6 m -101.51 172.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 O-C-N 122.427 -0.455 . . . . 75.209999999999994 110.493 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -138.93 141.08 38.48 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.409 -1.33 . . . . 64.540000000000006 107.409 176.065 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.87 132.29 38.37 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.744 -0.836 . . . . 75.200000000000003 108.744 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.2 m -134.76 134.12 40.61 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.343 -0.984 . . . . 73.409999999999997 108.343 178.136 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -141.85 147.91 37.96 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.328 0.585 . . . . 53.420000000000002 111.551 -178.002 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -146.02 154.87 42.36 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.402 -1.272 . . . . 75.010000000000005 110.658 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.484 ' HG2' HG22 ' A' ' 119' ' ' VAL . 51.7 mtt85 -88.61 138.68 31.21 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.627 -0.715 . . . . 72.340000000000003 109.926 171.267 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.461 ' O ' HG13 ' A' ' 118' ' ' ILE . 51.7 t30 -123.11 90.04 3.22 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 105.486 -2.042 . . . . 62.340000000000003 105.486 176.017 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.5 -118.7 8.66 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 108.857 -1.697 . . . . 42.140000000000001 108.857 -170.553 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 9.5 t30 -105.95 1.31 26.52 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.706 1.241 . . . . 71.310000000000002 108.94 178.336 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -103.9 148.98 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 118.818 -1.153 . . . . 70.340000000000003 108.19 178.486 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.484 HG22 ' HG2' ' A' ' 114' ' ' ARG . 60.5 t -112.74 140.47 32.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 121.972 -0.455 . . . . 72.25 111.45 -176.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.45 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.9 pp -121.41 121.52 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 115.058 -0.974 . . . . 72.239999999999995 109.161 178.585 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.33 127.8 50.25 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.127 -0.694 . . . . 74.099999999999994 109.127 179.031 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -125.97 135.71 52.15 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.36 -0.836 . . . . 73.349999999999994 109.469 177.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -145.74 158.07 27.56 Favored Glycine 0 N--CA 1.416 -2.67 0 N-CA-C 110.86 -0.896 . . . . 74.019999999999996 110.86 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.43 145.42 43.14 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.808 -0.442 . . . . 61.32 109.808 177.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -111.06 119.42 38.97 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.073 0.463 . . . . 72.109999999999999 111.336 -176.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -112.89 93.53 4.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.277 -0.419 . . . . 73.409999999999997 110.209 179.27 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -142.75 26.24 1.75 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.197 1.475 . . . . 75.409999999999997 108.398 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.5 p -68.64 -25.85 65.04 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 113.272 -1.785 . . . . 74.329999999999998 112.008 -176.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.1 m -82.97 5.58 21.58 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.343 0.592 . . . . 64.530000000000001 110.874 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.9 t 65.75 96.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.31 0 C-N-CA 124.823 1.249 . . . . 61.409999999999997 111.998 177.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.4 m -69.31 -44.36 71.88 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.575 0.702 . . . . 71.420000000000002 109.442 177.318 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 8.4 t70 -155.2 141.6 13.16 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 107.139 -1.43 . . . . 74.109999999999999 107.139 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.25 -26.97 79.0 Favored 'Trans proline' 0 CA--C 1.552 1.399 0 C-N-CA 123.322 2.681 . . . . 72.219999999999999 115.454 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.634 ' OD1' ' HA2' ' A' ' 23' ' ' GLY . 36.8 t70 -107.11 -11.23 15.68 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.522 0.601 . . . . 72.310000000000002 112.001 -176.066 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 132' ' ' ASP . . . -52.68 116.51 2.34 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.423 0.63 . . . . 71.329999999999998 112.569 -176.252 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -118.59 126.74 52.62 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.888 -1.893 . . . . 62.43 105.888 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 42.5 t -110.97 117.07 54.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 121.136 -0.226 . . . . 63.539999999999999 110.497 -175.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 50.2 mt-10 -109.97 120.32 42.09 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.644 -0.502 . . . . 71.340000000000003 109.644 176.543 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.519 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -114.1 116.24 28.81 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.553 -2.017 . . . . 72.209999999999994 105.553 175.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 19.4 m -122.52 131.23 53.75 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.71 -0.478 . . . . 61.200000000000003 109.71 -177.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 94.4 t -122.68 122.83 66.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.75 -0.833 . . . . 71.430000000000007 108.75 178.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.8 126.63 55.64 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.999 0.428 . . . . 74.219999999999999 110.29 178.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.5 p90 -133.83 123.07 16.91 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.876 -0.602 . . . . 73.530000000000001 110.068 177.656 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -74.43 35.46 0.4 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.61 2.207 . . . . 70.349999999999994 113.503 -178.005 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.74 -100.47 0.43 Allowed 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 122.192 -0.318 . . . . 61.43 110.772 -177.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -177.3 128.76 0.16 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.951 -0.759 . . . . 43.32 108.951 -177.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.38 133.24 29.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.539 -0.755 . . . . 73.150000000000006 109.324 177.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 p -88.81 -38.92 14.26 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.376 0.607 . . . . 62.420000000000002 109.456 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 74.5 m -159.52 133.18 7.25 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 115.707 -0.679 . . . . 72.549999999999997 109.811 176.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.466 ' OG1' HG11 ' A' ' 160' ' ' VAL . 8.1 t -137.97 155.96 48.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.349 -0.611 . . . . 73.329999999999998 109.349 174.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -126.69 93.89 3.9 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 105.987 -1.857 . . . . 62.030000000000001 105.987 175.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.489 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.59 -144.51 8.2 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 108.555 -1.818 . . . . 75.030000000000001 108.555 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -114.29 99.97 7.99 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 117.653 0.726 . . . . 72.540000000000006 109.367 -178.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -77.51 126.93 31.66 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-N 115.752 -0.658 . . . . 65.200000000000003 109.794 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.16 -37.49 9.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.225 -1.398 . . . . 72.319999999999993 107.225 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -142.65 166.64 19.62 Favored Pre-proline 0 N--CA 1.425 -1.713 0 N-CA-C 106.451 -1.685 . . . . 73.439999999999998 106.451 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.84 0.55 6.29 Favored 'Trans proline' 0 C--O 1.21 -0.88 0 C-N-CA 122.475 2.117 . . . . 74.299999999999997 110.684 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.633 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.6 pt-20 -130.12 0.12 4.67 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.902 -0.59 . . . . 73.200000000000003 111.689 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.41 HG23 ' HG3' ' A' ' 158' ' ' GLU . 82.2 t -140.65 120.89 13.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.469 -0.937 . . . . 72.019999999999996 108.469 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.466 HG11 ' OG1' ' A' ' 150' ' ' THR . 41.6 t -125.57 147.23 30.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.345 -0.613 . . . . 71.420000000000002 109.345 -177.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -137.25 143.57 42.29 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.416 0.627 . . . . 64.010000000000005 110.074 -177.196 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.519 ' CE3' HD12 ' A' ' 139' ' ' LEU . 25.6 m-90 -123.67 120.2 32.04 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 108.075 -1.083 . . . . 74.329999999999998 108.075 177.082 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.0 pttt -108.95 102.47 11.47 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.352 -0.84 . . . . 63.409999999999997 109.081 -178.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 9.5 mt -101.13 138.24 38.43 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.818 -1.083 . . . . 72.25 110.166 -171.469 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -118.56 151.71 50.15 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 115.566 -0.743 . . . . 64.340000000000003 110.884 177.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.95 157.43 47.16 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.298 1.998 . . . . 75.109999999999999 111.096 178.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 86.55 -36.15 3.27 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.432 -0.89 . . . . 63.130000000000003 111.637 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.75 153.9 6.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 109.584 -0.524 . . . . 74.400000000000006 109.584 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.39 143.46 12.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.811 -0.44 . . . . 74.230000000000004 109.811 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 48.5 m -146.52 143.0 28.62 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.329 -0.989 . . . . 72.099999999999994 108.329 176.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -125.49 156.96 38.14 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.811 -0.811 . . . . 72.120000000000005 108.811 178.445 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -126.32 137.8 53.52 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.523 0.677 . . . . 75.430000000000007 112.028 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.7 t -134.48 136.92 43.51 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.141 -1.429 . . . . 75.349999999999994 107.141 173.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -148.09 116.38 6.54 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.634 -0.876 . . . . 62.539999999999999 108.634 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -127.08 131.25 50.93 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 107.216 -1.401 . . . . 73.420000000000002 107.216 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -159.44 154.13 24.44 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.445 -0.946 . . . . 72.140000000000001 108.445 -176.18 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 29.2 ptt180 -87.96 129.29 35.29 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.168 -1.013 . . . . 75.239999999999995 110.776 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.05 116.27 19.76 Favored 'General case' 0 CA--C 1.477 -1.828 0 N-CA-C 107.721 -1.214 . . . . 75.0 107.721 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.487 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 18.0 p -67.0 123.78 21.18 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.873 -1.058 . . . . 75.530000000000001 112.242 -175.106 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.47 124.2 60.56 Favored Pre-proline 0 C--N 1.321 -0.662 0 O-C-N 124.071 0.857 . . . . 70.109999999999999 108.766 172.105 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.406 ' HG3' ' HB2' ' A' ' 38' ' ' ASP . 30.6 Cg_endo -67.32 -24.81 43.01 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 122.325 2.017 . . . . 74.420000000000002 110.81 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.04 -12.09 55.71 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.135 -1.393 . . . . 73.319999999999993 110.334 178.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.2 p 63.47 111.39 0.03 OUTLIER 'General case' 0 C--O 1.246 0.87 0 C-N-CA 126.252 1.821 . . . . 71.109999999999999 113.239 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -123.71 175.99 6.52 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.005 0.907 . . . . 74.329999999999998 112.609 -177.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.424 -1.754 0 CA-C-N 113.889 -1.505 . . . . 64.319999999999993 107.73 172.558 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.388 0 N-CA-C 109.949 -1.26 . . . . 43.310000000000002 109.949 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.0 ptt85 -108.27 -26.63 10.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.632 0.604 . . . . 70.420000000000002 112.632 -177.046 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -74.48 -46.83 37.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.98 0.419 . . . . 64.0 111.262 -175.514 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -128.12 101.13 6.14 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.32 0.581 . . . . 60.420000000000002 109.725 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.8 tp -141.73 102.28 4.14 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.926 -1.139 . . . . 71.319999999999993 107.926 178.337 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.4 t80 71.88 108.47 0.07 Allowed 'General case' 0 C--O 1.245 0.849 0 O-C-N 124.876 1.36 . . . . 72.299999999999997 110.046 -176.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -59.45 119.9 8.35 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.048 -0.978 . . . . 74.019999999999996 111.039 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -84.28 -53.85 5.2 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.213 -1.032 . . . . 73.430000000000007 108.213 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.04 108.47 3.18 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 109.221 -1.552 . . . . 50.329999999999998 109.221 -177.316 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -79.66 -62.41 1.69 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.402 0.519 . . . . 62.030000000000001 112.402 -174.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 23.7 ptm -145.86 -174.95 4.55 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 116.21 -0.45 . . . . 65.510000000000005 110.198 -171.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 48' ' ' ALA . 4.6 pp -133.65 141.86 47.8 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.873 -1.528 . . . . 72.230000000000004 106.873 175.022 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 141.4 39.91 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 119.056 -1.058 . . . . 74.239999999999995 110.83 -176.767 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 57.3 t -113.86 113.4 43.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 105.564 -2.013 . . . . 71.319999999999993 105.564 173.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -120.73 114.61 21.9 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.026 -0.731 . . . . 75.209999999999994 109.026 -177.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -110.45 124.46 51.81 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.215 -0.902 . . . . 71.109999999999999 109.347 -178.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -124.79 115.69 21.09 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.49 -1.3 . . . . 51.119999999999997 107.49 177.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.6 pp -122.36 138.71 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.883 -0.784 . . . . 74.25 108.883 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 93.5 m -119.33 121.68 40.13 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 108.845 -0.798 . . . . 51.509999999999998 108.845 -179.453 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.406 HG23 ' HB3' ' A' ' 143' ' ' PHE . 7.5 tt -109.76 115.62 50.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-O 121.675 0.75 . . . . 71.510000000000005 109.729 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.8 m -80.08 148.17 67.14 Favored Pre-proline 0 N--CA 1.412 -2.349 0 N-CA-C 107.985 -1.117 . . . . 62.229999999999997 107.985 -179.072 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.85 2.87 0.85 Allowed 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 123.73 2.953 . . . . 72.109999999999999 112.972 -179.287 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -87.11 -1.82 58.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.609 -0.885 . . . . 71.129999999999995 108.609 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 12.8 t70 73.05 29.46 1.77 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.054 1.742 . . . . 63.200000000000003 108.135 -175.786 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.11 124.76 50.08 Favored 'General case' 0 N--CA 1.394 -3.24 0 CA-C-N 113.946 -1.479 . . . . 62.240000000000002 107.653 178.879 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.443 HG12 ' HE2' ' A' ' 87' ' ' PHE . 14.2 t -109.72 129.87 63.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.835 -0.802 . . . . 71.409999999999997 108.835 -178.504 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.6 p -143.79 131.55 21.38 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.286 -1.005 . . . . 72.439999999999998 108.286 179.7 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.27 -175.34 32.2 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 118.967 -1.587 . . . . 61.530000000000001 113.178 -176.473 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.39 133.3 16.02 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 123.503 0.721 . . . . 73.010000000000005 109.529 -176.724 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 60.9 mt -120.11 116.13 49.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 107.88 -1.155 . . . . 62.219999999999999 107.88 177.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.11 116.62 53.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.712 -0.477 . . . . 72.329999999999998 109.712 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.79 108.49 17.92 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.387 -1.338 . . . . 44.109999999999999 107.387 175.462 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.51 122.09 40.87 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.754 -0.461 . . . . 53.329999999999998 109.754 -177.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HA ' ' CB ' ' A' ' 26' ' ' LEU . . . -114.92 158.07 22.49 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.76 -0.654 . . . . 71.420000000000002 111.811 -176.088 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -69.01 123.32 87.9 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 114.579 -1.191 . . . . 62.43 109.911 175.846 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.63 132.3 24.89 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.592 2.195 . . . . 75.430000000000007 114.23 -174.525 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 10.8 tmtt? -91.23 -5.82 54.25 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 104.331 -2.47 . . . . 74.439999999999998 104.331 171.045 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 71.3 -63.22 0.43 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.006 2.122 . . . . 63.25 112.7 173.64 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.1 t -55.3 -37.74 67.76 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.589 0.756 . . . . 74.239999999999995 112.948 -173.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -103.35 -14.02 16.45 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.994 0.426 . . . . 63.119999999999997 110.489 178.201 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' HB3' HG21 ' A' ' 81' ' ' VAL . 74.3 m-20 -102.99 96.94 7.13 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 114.473 1.286 . . . . 75.519999999999996 114.473 -166.915 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -96.9 -29.67 13.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.034 -1.839 . . . . 74.400000000000006 106.034 166.44 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.23 98.24 0.11 Allowed Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 108.792 -1.723 . . . . 61.219999999999999 108.792 175.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -52.52 128.51 28.23 Favored 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 122.121 1.881 . . . . 61.350000000000001 110.237 177.563 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.57 157.94 16.72 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.593 0.96 . . . . 73.140000000000001 113.593 -169.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.582 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 71.1 mt -102.45 138.1 39.81 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.164 -0.925 . . . . 71.340000000000003 109.742 176.804 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.7 89.15 3.4 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.502 0.668 . . . . 75.239999999999995 111.352 178.135 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.504 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -120.47 113.87 2.52 Favored Glycine 0 N--CA 1.409 -3.108 0 CA-C-N 115.17 -0.923 . . . . 23.420000000000002 111.525 177.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -116.9 107.62 14.82 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.606 -0.887 . . . . 73.450000000000003 108.606 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.4 m -136.97 151.61 72.46 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.534 -0.913 . . . . 75.120000000000005 108.534 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -73.12 -8.82 22.67 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 122.61 2.207 . . . . 73.219999999999999 112.484 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -108.93 36.64 2.8 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.416 0.627 . . . . 73.420000000000002 109.834 176.243 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -57.71 -30.26 65.38 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.425 -0.807 . . . . 73.010000000000005 112.454 -179.411 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -69.51 -18.39 63.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.359 0.6 . . . . 74.340000000000003 110.325 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -89.55 -16.03 31.57 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.437 -0.801 . . . . 54.219999999999999 109.944 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 6.6 p -118.52 118.88 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 122.515 1.15 . . . . 73.230000000000004 111.235 179.183 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.74 104.95 16.9 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.162 -0.926 . . . . 72.030000000000001 108.864 -179.363 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 t -97.99 131.16 45.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.942 -1.503 . . . . 62.329999999999998 106.942 179.138 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.1 m -144.33 171.76 13.88 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.358 -0.979 . . . . 61.340000000000003 108.358 -176.447 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -88.63 153.87 20.77 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 118.968 -1.093 . . . . 73.120000000000005 108.259 178.122 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -112.6 123.27 49.92 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.792 -1.188 . . . . 62.109999999999999 107.792 177.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -139.11 99.18 3.69 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.624 0.726 . . . . 65.299999999999997 109.361 177.422 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.9 m -165.29 161.23 19.03 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.956 -1.127 . . . . 62.240000000000002 107.956 -179.514 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 70.51 3.32 4.45 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.253 1.021 . . . . 63.229999999999997 110.914 178.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.51 1.15 83.75 Favored Glycine 0 C--O 1.22 -0.76 0 N-CA-C 110.197 -1.161 . . . . 34.32 110.197 -172.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -104.82 150.49 24.77 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.317 0.647 . . . . 74.230000000000004 110.629 -179.405 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 55' ' ' ASP . 19.3 m -129.11 138.18 55.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.466 0.65 . . . . 63.229999999999997 110.032 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.32 -153.36 8.15 Favored Glycine 0 C--N 1.276 -2.794 0 N-CA-C 109.946 -1.261 . . . . 52.140000000000001 109.946 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.582 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 p -131.45 159.47 37.98 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-O 121.256 0.551 . . . . 71.329999999999998 110.933 179.065 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -138.39 140.35 39.35 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.023 -0.535 . . . . 75.129999999999995 110.435 179.015 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.81 114.68 24.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.683 -1.229 . . . . 54.530000000000001 107.683 175.273 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.78 111.65 37.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.476 -0.935 . . . . 64.439999999999998 108.476 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' HE2' HG12 ' A' ' 40' ' ' VAL . 47.3 p90 -113.35 152.81 29.47 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.785 -0.366 . . . . 75.120000000000005 110.903 -174.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 p -151.65 154.35 36.2 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.215 -0.448 . . . . 73.409999999999997 111.218 -173.118 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.91 30.63 16.5 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 124.157 0.983 . . . . 72.510000000000005 112.877 173.391 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.408 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.2 mt -92.49 160.13 15.2 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 116.202 -0.454 . . . . 73.329999999999998 109.798 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.1 t -112.83 175.08 5.59 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 108.819 -0.808 . . . . 65.439999999999998 108.819 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.454 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 84.8 t80 -49.38 -44.21 44.8 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.034 0.934 . . . . 65.230000000000004 110.82 178.805 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.14 69.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.468 -0.787 . . . . 53.32 112.517 -178.18 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.35 -16.8 32.03 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.26 0.467 . . . . 53.25 112.26 -174.604 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.646 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 3.9 tt -65.91 -50.03 55.18 Favored Pre-proline 0 CA--C 1.567 1.623 0 CA-C-O 119.228 -0.415 . . . . 74.25 111.544 -178.189 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.46 -36.52 86.18 Favored 'Trans proline' 0 C--N 1.375 1.94 0 CA-C-N 121.199 1.464 . . . . 53.509999999999998 110.698 175.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -63.66 -38.8 92.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 73.109999999999999 111.523 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.0 pp -74.06 -19.94 60.45 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.782 -0.451 . . . . 74.120000000000005 109.782 177.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.09 -27.5 62.7 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.181 -0.674 . . . . 73.400000000000006 109.181 -178.093 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -61.09 -53.52 56.03 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.758 -0.83 . . . . 73.200000000000003 108.758 176.434 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.504 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 22.7 ttp -53.79 -51.85 62.16 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.518 -0.764 . . . . 63.43 110.054 176.717 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -55.41 -36.07 66.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.283 -0.871 . . . . 73.450000000000003 111.014 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.7 m -62.48 -37.61 86.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 110.182 -0.303 . . . . 63.210000000000001 110.182 -175.132 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -73.66 -13.22 60.95 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.355 0.598 . . . . 62.009999999999998 110.628 -171.552 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.43 -19.31 13.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.151 -0.62 . . . . 51.310000000000002 110.443 179.038 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.93 -44.18 4.48 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.572 0.953 . . . . 64.439999999999998 113.572 -172.497 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.04 21.43 49.86 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.135 -0.786 . . . . 50.219999999999999 111.135 -173.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.5 171.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.265 -0.643 . . . . 72.439999999999998 109.265 -178.113 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -128.64 138.28 52.1 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 117.644 0.202 . . . . 70.540000000000006 111.236 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.82 130.97 40.51 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.909 -1.145 . . . . 72.030000000000001 107.909 176.027 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.2 t -144.07 151.97 40.35 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.451 -0.944 . . . . 53.200000000000003 108.451 177.174 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.8 148.02 28.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.825 -0.806 . . . . 72.319999999999993 108.825 178.409 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -143.91 156.67 44.52 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.826 -0.625 . . . . 73.439999999999998 109.587 -176.174 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -91.22 138.09 31.86 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 121.521 0.677 . . . . 73.129999999999995 112.241 175.701 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.419 ' O ' HG13 ' A' ' 118' ' ' ILE . 30.7 t30 -127.56 91.9 3.39 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 113.978 -1.464 . . . . 71.219999999999999 107.248 177.279 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 185' ' ' SER . . . 76.54 -106.77 2.23 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 109.579 -1.409 . . . . 74.239999999999995 109.579 -175.737 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -123.73 10.12 8.97 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.841 1.305 . . . . 74.310000000000002 108.107 175.44 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.8 pp -112.88 149.51 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.025 -1.102 . . . . 74.219999999999999 108.025 177.139 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.3 t -107.0 133.63 51.07 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 CA-C-O 120.948 0.404 . . . . 44.149999999999999 109.996 -176.464 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.8 pt -105.68 137.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 107.627 -1.249 . . . . 74.530000000000001 107.627 176.449 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.72 127.08 45.66 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 109.048 -0.723 . . . . 64.319999999999993 109.048 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -127.71 115.31 18.52 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.347 -1.297 . . . . 72.150000000000006 108.19 -177.048 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.3 141.84 11.16 Favored Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 109.854 -1.298 . . . . 62.039999999999999 109.854 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -137.05 135.25 37.37 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.388 -0.968 . . . . 55.140000000000001 108.388 -177.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.9 110.2 19.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.909 -0.587 . . . . 32.130000000000003 111.183 -174.346 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -105.22 98.59 8.28 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.473 0.654 . . . . 73.109999999999999 110.379 177.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.7 mm? -113.26 23.95 12.76 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.602 -0.888 . . . . 73.219999999999999 108.602 178.395 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 45.5 p -65.58 -19.11 65.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.83 1.048 . . . . 75.310000000000002 113.83 -173.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.1 m -72.95 -24.65 60.82 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.272 -0.268 . . . . 43.420000000000002 111.42 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.9 t 62.43 86.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.49 1.116 . . . . 75.299999999999997 111.788 179.753 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.7 m -79.2 -49.32 12.71 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.308 -0.997 . . . . 55.240000000000002 108.308 177.629 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.24 125.63 18.97 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.218 -1.03 . . . . 75.439999999999998 108.218 176.884 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.3 -15.6 31.47 Favored 'Trans proline' 0 C--O 1.22 -0.393 0 C-N-CA 121.958 1.772 . . . . 73.150000000000006 111.289 178.279 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.53 11.54 38.89 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.454 -0.794 . . . . 74.209999999999994 110.478 -178.365 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.428 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -89.15 123.39 33.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.529 -0.305 . . . . 71.129999999999995 111.656 -176.356 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.77 122.63 38.55 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.182 -0.673 . . . . 75.019999999999996 109.182 173.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 61.5 t -111.53 120.88 63.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.266 -1.012 . . . . 71.299999999999997 108.266 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -121.34 126.53 49.69 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.122 -0.696 . . . . 71.299999999999997 109.122 -176.218 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -119.13 123.56 44.69 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.443 -0.947 . . . . 73.400000000000006 108.443 -178.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.7 m -123.87 134.29 53.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.047 -0.723 . . . . 75.230000000000004 109.047 179.502 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.476 HG12 ' HD2' ' A' ' 143' ' ' PHE . 90.3 t -120.68 125.64 74.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.879 -0.785 . . . . 72.239999999999995 108.879 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.83 126.27 55.26 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.829 -0.804 . . . . 32.030000000000001 108.829 177.489 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.626 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.0 p90 -134.47 119.24 14.05 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 112.044 0.387 . . . . 75.439999999999998 112.044 178.558 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -68.0 42.97 0.25 Allowed 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.166 2.577 . . . . 54.439999999999998 112.425 174.253 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.0 -106.84 0.33 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 122.732 0.413 . . . . 52.0 110.068 179.415 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -179.62 131.82 0.1 Allowed 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.401 -0.592 . . . . 72.239999999999995 109.401 -177.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -85.26 133.14 30.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.88 -0.785 . . . . 73.019999999999996 108.88 177.416 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.1 p -92.55 -34.71 13.94 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.363 -0.38 . . . . 43.130000000000003 110.432 -177.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.3 m -162.73 133.28 4.7 Favored 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 123.875 0.87 . . . . 73.219999999999999 109.216 177.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.1 t -139.01 163.92 31.13 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.489 -0.757 . . . . 72.430000000000007 111.217 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.571 ' HB3' ' OG ' ' A' ' 173' ' ' SER . 27.4 t-20 -136.41 98.38 3.81 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.23 -2.137 . . . . 73.140000000000001 105.23 171.097 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.3 -150.04 10.69 Favored Glycine 0 N--CA 1.412 -2.927 0 N-CA-C 107.157 -2.377 . . . . 65.219999999999999 107.157 -179.19 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -116.69 99.21 6.97 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.196 -1.409 . . . . 70.409999999999997 107.196 -178.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 160' ' ' VAL 0.264 6.3 ppt_? -86.34 139.34 31.06 Favored 'General case' 0 N--CA 1.414 -2.272 0 C-N-CA 119.325 -0.95 . . . . 74.040000000000006 113.28 -178.669 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 69.8 mt -94.46 -43.11 13.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.244 -1.344 . . . . 74.239999999999995 108.015 -178.103 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -137.75 172.68 6.39 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 107.54 -1.281 . . . . 53.340000000000003 107.54 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -74.22 0.61 8.26 Favored 'Trans proline' 0 C--O 1.21 -0.919 0 C-N-CA 122.197 1.932 . . . . 74.219999999999999 110.044 172.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 11.2 pt-20 -130.3 3.23 4.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.228 0.537 . . . . 64.420000000000002 111.867 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.3 t -142.09 121.11 9.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.487 -0.931 . . . . 63.450000000000003 108.487 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 38.2 t -127.94 147.64 32.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 109.549 -0.537 . . . . 73.319999999999993 109.549 -178.5 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -132.58 145.13 50.87 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.193 0.521 . . . . 72.5 110.259 -176.311 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.451 ' CD2' ' HG3' ' A' ' 172' ' ' MET . 27.8 m-90 -130.25 128.74 42.22 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.694 -0.484 . . . . 71.140000000000001 109.694 177.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -102.66 112.67 25.54 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.69 0.757 . . . . 74.120000000000005 110.019 177.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 33.2 mt -101.41 123.42 45.45 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.025 -0.989 . . . . 54.219999999999999 109.022 -176.392 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -118.07 156.38 50.4 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 115.882 -0.599 . . . . 74.109999999999999 112.052 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 127' ' ' LEU . 59.8 Cg_endo -74.41 156.47 45.69 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.79 2.327 . . . . 70.140000000000001 111.552 177.59 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.94 -30.92 2.86 Favored Glycine 0 C--N 1.317 -0.527 0 C-N-CA 121.288 -0.482 . . . . 71.409999999999997 112.4 177.538 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.82 160.96 5.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 120.902 0.382 . . . . 53.520000000000003 110.42 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.4 p -113.62 110.15 31.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 122.102 0.954 . . . . 63.530000000000001 108.787 176.641 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 32.8 t -101.09 141.5 33.88 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.597 -0.729 . . . . 72.329999999999998 109.981 -175.238 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.1 p -106.42 126.55 52.39 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.584 -0.734 . . . . 74.519999999999996 110.526 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.451 ' HG3' ' CD2' ' A' ' 162' ' ' TRP . 39.5 ttm -107.68 116.16 31.44 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.758 -1.201 . . . . 71.349999999999994 107.758 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.571 ' OG ' ' HB3' ' A' ' 151' ' ' ASN . 11.7 p -142.85 139.41 30.85 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 118.303 -1.359 . . . . 64.519999999999996 111.07 177.068 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -151.26 146.83 26.32 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 108.28 -1.007 . . . . 53.140000000000001 108.28 -176.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -138.36 130.72 28.9 Favored 'General case' 0 C--N 1.261 -3.246 0 N-CA-C 105.834 -1.913 . . . . 72.340000000000003 105.834 173.149 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.3 158.88 44.36 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.674 -0.491 . . . . 62.350000000000001 109.674 -177.212 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -91.34 135.2 33.98 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.155 -0.683 . . . . 72.109999999999999 109.155 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -143.05 123.82 14.2 Favored 'General case' 0 CA--C 1.47 -2.119 0 C-N-CA 120.119 -0.632 . . . . 75.519999999999996 109.93 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.3 p -65.14 104.05 0.85 Allowed 'General case' 0 C--N 1.284 -2.281 0 O-C-N 124.514 1.134 . . . . 72.109999999999999 111.232 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.434 ' OD2' ' HG2' ' A' ' 184' ' ' ARG . 13.7 t70 -57.41 134.25 81.68 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 115.078 -0.964 . . . . 73.530000000000001 109.889 178.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 38' ' ' ASP . 68.3 Cg_endo -73.78 -38.99 2.04 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.64 2.227 . . . . 72.430000000000007 112.644 -178.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.88 -10.16 58.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.396 0.617 . . . . 71.420000000000002 110.454 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.304 51.1 p 68.23 72.15 0.3 Allowed 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 126.9 2.08 . . . . 73.129999999999995 114.075 172.765 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.434 ' HG2' ' OD2' ' A' ' 180' ' ' ASP . 7.9 ptm180 -99.95 168.74 9.67 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.772 -1.104 . . . . 71.109999999999999 109.587 175.462 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.525 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 49.5 m . . . . . 0 C--N 1.292 -1.905 0 N-CA-C 106.663 -1.606 . . . . 74.219999999999999 106.663 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.959 0 N-CA-C 109.714 -1.354 . . . . 43.049999999999997 109.714 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 70.43 -41.42 0.5 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.506 1.522 . . . . 65.420000000000002 111.894 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.87 106.16 4.09 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 105.95 -1.87 . . . . 73.430000000000007 105.95 172.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 68.22 85.41 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 124.427 1.08 . . . . 73.040000000000006 108.977 -170.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 tt -82.66 101.14 10.63 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.61 -1.626 . . . . 72.140000000000001 106.61 178.336 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -94.0 116.85 29.33 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.036 -0.983 . . . . 73.099999999999994 109.136 -174.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -97.03 107.44 19.97 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.387 -1.338 . . . . 72.140000000000001 107.387 176.103 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -95.28 162.96 13.47 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.65 -1.241 . . . . 62.530000000000001 107.65 -177.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.34 23.45 54.32 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 107.553 -2.219 . . . . 53.119999999999997 107.553 -171.331 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -131.79 145.45 51.59 Favored 'General case' 0 N--CA 1.418 -2.062 0 C-N-CA 126.364 1.866 . . . . 73.510000000000005 106.148 -175.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 66.8 mtt 80.15 -41.43 0.21 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.025 1.33 . . . . 75.549999999999997 110.318 -175.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tt -147.56 131.92 17.57 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 104.658 -2.349 . . . . 73.109999999999999 104.658 172.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -146.2 137.44 24.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.882 0.372 . . . . 62.219999999999999 110.739 -176.627 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.2 t -123.38 114.83 43.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.548 -0.908 . . . . 65.230000000000004 108.548 178.195 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -126.0 118.93 26.38 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.154 0.502 . . . . 75.329999999999998 110.203 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.52 118.65 35.04 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.647 -0.706 . . . . 75.219999999999999 109.155 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 t -117.05 114.59 23.96 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.26 -1.385 . . . . 73.129999999999995 107.26 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.5 pp -129.25 147.03 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-O 121.453 0.644 . . . . 70.450000000000003 109.723 -177.688 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.3 m -128.75 134.71 48.5 Favored 'General case' 0 C--N 1.265 -3.074 0 N-CA-C 109.481 -0.563 . . . . 45.119999999999997 109.481 -177.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.9 tt -124.72 123.14 65.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.497 0.665 . . . . 73.120000000000005 110.318 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 m -91.73 152.37 43.17 Favored Pre-proline 0 N--CA 1.42 -1.963 0 N-CA-C 108.551 -0.907 . . . . 75.329999999999998 108.551 -179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.29 2.49 0.86 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.566 2.844 . . . . 73.409999999999997 113.841 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -88.31 0.41 56.19 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.169 -0.678 . . . . 62.549999999999997 109.169 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 t70 72.64 29.72 1.96 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.778 -1.564 . . . . 71.209999999999994 106.778 -174.498 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tp -101.71 124.97 48.25 Favored 'General case' 0 N--CA 1.389 -3.484 0 CA-C-N 113.676 -1.602 . . . . 64.299999999999997 107.251 177.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.35 135.6 58.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 109.169 -0.678 . . . . 72.400000000000006 109.169 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.7 p -143.91 156.28 44.38 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.872 -1.159 . . . . 71.230000000000004 107.872 175.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.05 44.23 Favored Glycine 0 N--CA 1.425 -2.041 0 C-N-CA 119.064 -1.541 . . . . 60.539999999999999 112.265 179.043 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.75 133.38 17.78 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 109.368 -0.604 . . . . 45.030000000000001 109.368 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 58.7 mt -116.6 116.16 51.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.952 -1.129 . . . . 63.25 107.952 177.427 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.22 116.19 51.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.992 -0.373 . . . . 74.230000000000004 109.992 -177.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.18 108.1 17.66 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.377 -1.712 . . . . 54.43 106.377 173.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.82 131.34 53.72 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.252 0.549 . . . . 73.329999999999998 111.078 -174.248 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.75 158.03 37.59 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.397 -0.82 . . . . 71.209999999999994 110.445 -177.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.14 144.65 92.82 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 106.522 -1.659 . . . . 74.0 106.522 170.663 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.05 114.92 0.74 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.711 2.274 . . . . 65.349999999999994 111.576 -178.093 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -61.16 -35.07 76.12 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 124.453 1.101 . . . . 74.409999999999997 112.837 -173.324 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.445 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 23.7 t-20 -158.73 172.95 17.32 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.995 -1.483 . . . . 62.5 106.995 -174.429 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.0 m -60.86 -27.57 68.21 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.282 0.563 . . . . 54.310000000000002 110.443 178.444 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -88.58 -2.54 58.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.59 . . . . 74.349999999999994 111.664 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 52' ' ' ASN . 26.8 t70 -90.15 125.3 35.41 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.41 0.624 . . . . 71.030000000000001 111.816 -174.241 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -119.23 -13.3 9.34 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 114.745 -1.116 . . . . 74.299999999999997 109.871 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.48 102.1 0.15 Allowed Glycine 0 N--CA 1.433 -1.501 0 CA-C-O 118.267 -1.296 . . . . 72.120000000000005 111.583 178.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -54.2 128.72 31.1 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 119.961 1.88 . . . . 72.099999999999994 110.148 173.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.539 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -93.74 148.77 21.81 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 113.074 0.768 . . . . 75.420000000000002 113.074 -171.555 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.48 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 83.2 mt -100.15 160.11 14.58 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.236 -1.024 . . . . 73.340000000000003 108.236 174.111 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -90.78 86.87 6.46 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.888 -0.782 . . . . 73.219999999999999 108.888 -178.317 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' ' SD ' ' A' ' 101' ' ' MET . . . -86.35 78.27 1.94 Allowed Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 114.622 -1.172 . . . . 41.030000000000001 110.963 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -138.27 99.13 3.78 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.458 -0.371 . . . . 64.340000000000003 110.993 -176.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 m -151.51 144.65 17.14 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 124.461 1.104 . . . . 73.019999999999996 108.658 178.767 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.51 -32.72 54.43 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.326 2.684 . . . . 61.25 113.254 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -88.52 44.08 1.18 Allowed 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 111.954 0.353 . . . . 75.530000000000001 111.954 -179.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.8 m -53.44 -32.27 49.09 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 113.362 0.875 . . . . 72.329999999999998 113.362 -176.92 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -75.82 -12.56 60.19 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.465 -0.772 . . . . 71.120000000000005 110.616 -176.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -89.77 -18.25 26.67 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.699 -0.682 . . . . 73.120000000000005 109.462 177.54 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.54 119.26 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 122.407 1.098 . . . . 64.200000000000003 112.613 -177.258 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.81 108.99 21.82 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.859 -1.064 . . . . 63.420000000000002 108.583 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.7 t -97.62 127.89 49.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 106.709 -1.589 . . . . 72.120000000000005 106.709 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -141.39 167.48 22.08 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.26 -0.645 . . . . 60.299999999999997 109.26 -172.786 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.27 135.52 34.72 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.592 -0.892 . . . . 74.409999999999997 108.592 179.034 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 87.3 t80 -105.44 120.78 42.46 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.741 -0.837 . . . . 75.319999999999993 108.741 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -138.45 99.26 3.79 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 106.992 -1.485 . . . . 72.409999999999997 106.992 175.047 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 32.9 t -173.01 163.25 4.75 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.066 -1.457 . . . . 71.140000000000001 107.066 -176.556 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.1 t70 66.21 9.04 6.01 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.515 1.126 . . . . 75.150000000000006 110.765 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.53 -1.89 84.32 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.683 -0.69 . . . . 64.129999999999995 111.683 -177.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.43 157.17 17.53 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 122.509 0.323 . . . . 64.329999999999998 110.545 -178.428 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -124.65 137.18 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.775 -0.824 . . . . 44.350000000000001 108.775 174.047 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.28 -153.21 10.0 Favored Glycine 0 C--N 1.269 -3.191 0 N-CA-C 109.817 -1.313 . . . . 52.049999999999997 109.817 -177.411 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.539 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 64.3 m -133.31 154.39 50.75 Favored 'General case' 0 C--N 1.272 -2.778 0 CA-C-O 121.162 0.506 . . . . 73.310000000000002 111.383 178.423 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 10.3 pt20 -133.57 142.69 48.27 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.782 -0.645 . . . . 73.319999999999993 110.381 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.9 114.36 27.25 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.434 -1.321 . . . . 63.310000000000002 107.434 174.464 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.12 110.88 32.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.828 -1.175 . . . . 74.25 107.828 -179.229 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CD2' HD12 ' A' ' 90' ' ' LEU . 52.1 p90 -120.77 155.29 34.3 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.766 -0.373 . . . . 64.340000000000003 110.898 -174.619 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 m -160.74 160.71 31.67 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.059 -0.719 . . . . 75.409999999999997 109.059 -178.188 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 63.4 30.65 15.41 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.07 0.948 . . . . 62.219999999999999 111.628 178.237 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 87' ' ' PHE . 21.6 mt -88.31 156.98 18.89 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.72 -0.392 . . . . 61.539999999999999 110.501 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -113.64 168.02 10.12 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.998 -1.482 . . . . 72.239999999999995 106.998 177.393 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -52.76 -37.04 58.93 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 123.485 0.714 . . . . 62.310000000000002 111.812 -178.473 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.39 -26.75 64.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.192 -0.458 . . . . 74.230000000000004 112.12 -178.845 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HB3' HD22 ' A' ' 90' ' ' LEU . 54.5 mt-10 -88.15 -17.82 30.12 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.309 -0.244 . . . . 64.409999999999997 111.228 -177.457 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 98' ' ' LEU . 45.7 tp -61.45 -52.08 72.74 Favored Pre-proline 0 CA--C 1.564 1.488 0 N-CA-C 113.474 0.916 . . . . 74.420000000000002 113.474 -178.107 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.13 -32.68 74.6 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 121.255 1.303 . . . . 72.430000000000007 111.338 176.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -70.91 -31.25 67.83 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 122.264 1.031 . . . . 44.43 109.071 -175.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.425 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 25.9 tp -71.5 -30.79 66.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.376 -1.284 . . . . 55.310000000000002 109.795 173.463 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.43 -24.04 63.77 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 115.477 -0.783 . . . . 74.430000000000007 109.893 -175.611 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -56.18 -53.91 51.51 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 123.877 0.736 . . . . 64.340000000000003 110.672 179.029 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.408 ' SD ' ' HA2' ' A' ' 62' ' ' GLY . 72.2 mtm -55.63 -49.15 73.62 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.486 0.66 . . . . 70.439999999999998 109.882 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -57.27 -35.28 69.57 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.907 -1.042 . . . . 72.140000000000001 111.498 178.505 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.2 m -61.48 -32.09 72.09 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 109.696 -0.483 . . . . 64.239999999999995 109.696 -175.485 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 101' ' ' MET . 5.1 t70 -59.51 -27.97 66.64 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.351 -0.84 . . . . 73.030000000000001 111.534 -175.423 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.05 -14.25 14.26 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 120.591 -0.444 . . . . 62.109999999999999 111.344 -178.063 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.86 -48.09 3.58 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.988 1.107 . . . . 72.030000000000001 113.988 -171.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.76 28.72 41.48 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.095 -1.05 . . . . 73.340000000000003 110.88 -173.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 11.1 p -107.26 141.29 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-O 120.759 0.314 . . . . 70.299999999999997 110.335 -179.598 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.443 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 40.5 t30 -113.13 121.27 44.04 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.408 -0.96 . . . . 72.439999999999998 108.408 177.343 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.29 106.02 14.47 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.235 -0.654 . . . . 73.530000000000001 109.235 178.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.0 m -101.4 108.98 20.73 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.8 -1.185 . . . . 62.509999999999998 107.8 177.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.5 pt? -129.93 145.89 51.63 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.858 -0.61 . . . . 55.229999999999997 109.654 -176.655 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -144.37 151.9 39.95 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.553 -0.749 . . . . 65.519999999999996 111.853 -177.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.614 ' NH2' ' HA ' ' A' ' 180' ' ' ASP . 5.9 tpt180 -96.7 107.37 19.81 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 106.492 -1.669 . . . . 63.039999999999999 106.492 178.208 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.96 97.3 7.9 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.34 -0.985 . . . . 71.400000000000006 108.34 -177.255 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.13 -94.74 0.81 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 110.914 -0.874 . . . . 71.200000000000003 110.914 -177.537 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -135.55 13.62 3.46 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 123.26 1.505 . . . . 73.230000000000004 108.729 177.523 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.9 pp -121.18 149.27 24.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.908 -1.12 . . . . 75.109999999999999 109.054 177.629 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.527 HG22 ' HD3' ' A' ' 114' ' ' ARG . 95.7 t -107.12 132.79 53.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-O 120.995 0.426 . . . . 71.329999999999998 110.622 -177.232 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.0 pt -115.19 129.27 71.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.114 -1.069 . . . . 73.430000000000007 108.114 175.226 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 tt -128.95 129.76 45.86 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 115.935 -0.575 . . . . 72.329999999999998 110.675 -179.262 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -126.71 135.1 50.68 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.307 -0.997 . . . . 65.239999999999995 108.307 173.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -142.38 129.65 3.95 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.217 -0.992 . . . . 63.130000000000003 111.948 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.612 ' HG2' HH11 ' A' ' 124' ' ' ARG . 0.1 OUTLIER -126.13 132.57 51.83 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.354 -0.497 . . . . 73.329999999999998 110.655 176.734 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 108' ' ' VAL . . . -113.26 131.03 56.07 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.007 -0.542 . . . . 73.400000000000006 111.534 -177.253 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -96.25 92.91 6.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.968 -1.123 . . . . 73.340000000000003 107.968 175.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -133.71 17.41 3.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.234 1.016 . . . . 73.200000000000003 110.086 -177.858 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 p -67.25 -51.8 48.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.748 -1.115 . . . . 75.230000000000004 109.593 175.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.0 m -90.85 20.83 4.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.721 -1.127 . . . . 72.420000000000002 111.343 -179.41 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.27 154.98 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 C-N-CA 123.319 0.648 . . . . 62.32 111.49 -176.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.5 m -82.0 -29.33 32.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.417 0.525 . . . . 74.230000000000004 112.417 -179.185 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -112.02 103.91 55.63 Favored Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.147 -0.346 . . . . 75.109999999999999 110.791 -178.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.88 -12.21 21.75 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.251 2.634 . . . . 73.230000000000004 115.134 -176.321 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -87.82 -6.82 57.93 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.994 0.738 . . . . 74.120000000000005 112.994 -175.724 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.24 115.55 28.59 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.915 1.08 . . . . 74.299999999999997 113.915 -169.691 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.5 137.76 32.47 Favored 'General case' 0 C--O 1.265 1.917 0 N-CA-C 107.64 -1.244 . . . . 55.219999999999999 107.64 170.746 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.6 t -105.89 112.15 37.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.352 -0.981 . . . . 72.310000000000002 108.352 178.389 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -102.86 121.36 42.34 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.95 -0.568 . . . . 73.099999999999994 109.564 -177.124 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.44 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -112.69 119.22 37.35 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.721 -1.585 . . . . 73.150000000000006 106.721 178.51 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.7 m -123.12 127.35 48.58 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.521 -0.548 . . . . 74.420000000000002 109.521 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.472 HG12 ' HD2' ' A' ' 143' ' ' PHE . 58.8 t -119.8 126.99 75.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.352 -0.611 . . . . 63.43 109.352 179.048 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.51 125.58 54.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.799 -0.815 . . . . 45.43 108.799 177.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.0 p90 -134.33 124.16 17.04 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 111.774 0.287 . . . . 74.510000000000005 111.774 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 15.6 Cg_exo -70.83 31.81 0.22 Allowed 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.972 2.448 . . . . 75.340000000000003 112.556 176.555 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -115.16 -107.37 0.38 Allowed 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.342 -0.614 . . . . 72.430000000000007 109.342 -177.209 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.66 129.87 0.08 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.597 -0.89 . . . . 60.049999999999997 108.597 -178.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.9 p -83.29 136.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.654 -0.869 . . . . 71.450000000000003 108.654 176.589 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.3 t -93.69 -43.3 8.72 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 119.572 -0.851 . . . . 60.140000000000001 109.21 176.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.3 m -150.24 131.14 14.23 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.062 -0.718 . . . . 63.140000000000001 109.062 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 t -140.46 154.09 46.5 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.759 -0.46 . . . . 73.310000000000002 109.759 175.484 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -123.41 98.07 5.69 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 104.839 -2.282 . . . . 72.430000000000007 104.839 170.156 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.89 -155.44 23.83 Favored Glycine 0 N--CA 1.41 -3.061 0 N-CA-C 106.521 -2.631 . . . . 62.100000000000001 106.521 -177.456 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -110.52 103.04 11.59 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 118.345 1.072 . . . . 74.430000000000007 110.23 -178.217 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -74.58 114.21 12.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.816 -0.629 . . . . 74.010000000000005 109.81 176.263 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.4 mt -79.93 -44.64 22.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.296 -1.742 . . . . 72.530000000000001 106.296 179.074 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -128.7 165.97 27.98 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 105.459 -2.052 . . . . 73.140000000000001 105.459 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.49 0.18 9.4 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 121.925 1.75 . . . . 71.209999999999994 110.422 174.406 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.1 pt-20 -132.09 5.33 4.16 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.384 -1.28 . . . . 73.420000000000002 111.049 -177.68 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -146.15 120.94 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 107.996 -1.112 . . . . 71.150000000000006 107.996 178.59 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.06 147.3 30.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.648 -0.501 . . . . 64.219999999999999 109.648 -176.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -135.08 143.11 46.47 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.063 0.459 . . . . 54.130000000000003 109.848 -178.371 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.445 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 26.8 m-90 -126.78 139.1 53.37 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.624 -0.88 . . . . 74.140000000000001 108.624 177.714 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -111.75 104.34 12.68 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.317 -0.994 . . . . 74.209999999999994 108.317 174.075 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.3 mp -83.02 116.32 22.23 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.147 -1.427 . . . . 73.430000000000007 107.147 177.764 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -107.34 134.75 19.82 Favored Pre-proline 0 C--N 1.278 -2.504 0 CA-C-N 114.936 -1.029 . . . . 64.299999999999997 111.021 -172.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.05 154.29 66.75 Favored 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 123.491 2.794 . . . . 60.310000000000002 111.745 -179.286 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.6 -37.61 2.93 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 121.082 -0.58 . . . . 74.010000000000005 111.934 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.45 160.86 5.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.167 -0.679 . . . . 75.109999999999999 109.167 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -83.5 127.87 39.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.908 -0.775 . . . . 73.439999999999998 108.908 178.474 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.8 m -120.94 128.85 53.14 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.232 -0.655 . . . . 63.109999999999999 109.232 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.522 HG22 ' HG3' ' A' ' 124' ' ' ARG . 18.1 p -121.67 154.27 37.06 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.038 -0.983 . . . . 70.230000000000004 108.576 -178.287 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.9 ptm -144.39 139.66 28.55 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.697 -0.401 . . . . 73.319999999999993 110.745 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 76.1 p -143.55 148.12 35.47 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.168 -0.613 . . . . 73.420000000000002 110.194 173.194 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.14 130.49 12.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.771 -0.825 . . . . 75.209999999999994 108.771 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -129.87 130.48 45.28 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 107.243 -1.392 . . . . 53.109999999999999 107.243 176.403 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -153.95 159.67 41.79 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.816 -0.438 . . . . 53.350000000000001 109.816 -178.223 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -90.92 130.24 36.87 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 109.091 -0.707 . . . . 73.239999999999995 109.091 -177.253 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -143.09 122.32 12.98 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 118.007 0.367 . . . . 73.209999999999994 110.871 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.71 106.77 0.43 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.247 0.967 . . . . 75.239999999999995 111.871 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.614 ' HA ' ' NH2' ' A' ' 114' ' ' ARG . 14.8 t70 -61.9 140.22 95.63 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 114.46 -1.245 . . . . 73.540000000000006 110.031 179.077 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.77 -47.3 13.62 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.112 1.875 . . . . 60.219999999999999 112.911 -179.261 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.401 ' ND2' ' OD1' ' A' ' 180' ' ' ASP 0.306 0.2 OUTLIER -86.23 -26.06 25.25 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 113.187 0.81 . . . . 75.120000000000005 113.187 176.894 . . . . . . . . 4 4 . 1 . 027 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.275 4.8 t 36.52 83.44 0.02 OUTLIER 'General case' 0 C--O 1.244 0.811 0 C-N-CA 126.603 1.961 . . . . 73.409999999999997 113.578 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -109.66 161.98 14.87 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.802 -1.09 . . . . 72.340000000000003 111.747 -173.643 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.418 -2.069 0 N-CA-C 107.139 -1.43 . . . . 74.430000000000007 107.139 177.85 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.616 0 N-CA-C 110.065 -1.214 . . . . 44.219999999999999 110.065 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -106.52 -11.91 15.77 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 117.356 0.578 . . . . 63.149999999999999 110.337 178.138 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -106.41 115.86 30.94 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.94 0.4 . . . . 50.43 111.462 -175.118 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -165.08 152.15 10.78 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.106 -1.442 . . . . 64.340000000000003 107.106 175.478 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -122.63 153.27 39.56 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 112.09 0.404 . . . . 73.140000000000001 112.09 -174.828 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -158.92 -27.21 0.07 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.521 -0.763 . . . . 74.120000000000005 110.343 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -87.24 75.06 9.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.222 0.534 . . . . 75.219999999999999 110.157 -177.255 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -176.89 165.44 2.43 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.979 -1.489 . . . . 63.25 106.979 -177.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 49' ' ' LYS . . . 110.93 -75.06 0.21 Allowed Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.182 -1.008 . . . . 70.430000000000007 113.79 173.142 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 71.96 151.94 0.11 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.094 0.957 . . . . 74.310000000000002 111.348 -172.221 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.503 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 20.9 ttt 44.69 37.29 2.14 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.406 1.483 . . . . 74.239999999999995 110.556 -171.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.498 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.15 143.05 43.46 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.288 -0.869 . . . . 73.439999999999998 110.23 -178.153 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -130.14 125.45 35.09 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.704 -0.68 . . . . 73.109999999999999 110.081 -175.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -107.6 113.86 44.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 106.531 -1.655 . . . . 75.150000000000006 106.531 175.585 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -121.31 117.77 27.83 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 109.228 -0.656 . . . . 63.549999999999997 109.228 -175.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.77 119.7 36.27 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.003 -0.74 . . . . 43.549999999999997 109.003 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.6 m -120.09 114.99 22.8 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.637 -1.246 . . . . 44.039999999999999 107.637 177.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.0 146.13 34.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.095 -0.705 . . . . 63.119999999999997 109.095 -177.409 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.6 m -129.46 122.16 28.75 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-O 121.06 0.457 . . . . 55.43 110.118 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.7 tt -107.19 119.56 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.773 0.796 . . . . 63.549999999999997 109.755 178.269 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 m -89.57 157.31 47.09 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.164 -0.926 . . . . 73.420000000000002 109.328 -177.253 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.42 2.15 1.33 Allowed 'Trans proline' 0 N--CA 1.488 1.167 0 C-N-CA 123.53 2.82 . . . . 63.240000000000002 114.279 -176.546 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.85 4.5 53.74 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.608 -0.886 . . . . 64.439999999999998 108.608 178.333 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 27.2 t70 68.48 31.21 4.97 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 123.566 1.65 . . . . 72.209999999999994 107.333 -175.968 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.06 124.1 42.4 Favored 'General case' 0 N--CA 1.39 -3.473 0 N-CA-C 106.084 -1.821 . . . . 71.0 106.084 178.578 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG12 ' HE2' ' A' ' 87' ' ' PHE . 10.0 t -112.95 134.17 56.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.318 -0.993 . . . . 75.439999999999998 108.318 -177.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.2 p -140.62 158.43 44.0 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.983 -1.488 . . . . 63.310000000000002 106.983 178.552 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.69 -174.31 42.72 Favored Glycine 0 N--CA 1.415 -2.703 0 C-N-CA 118.997 -1.573 . . . . 64.109999999999999 112.859 177.224 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -147.43 133.91 19.73 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 108.916 -0.772 . . . . 70.420000000000002 108.916 -177.568 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 52.6 mt -119.52 115.91 49.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.728 -1.212 . . . . 75.409999999999997 107.728 176.226 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.31 120.54 62.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.105 -0.702 . . . . 72.25 109.105 -177.628 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.38 107.31 16.97 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.763 -1.94 . . . . 72.510000000000005 105.763 172.616 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -118.93 132.47 56.09 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.049 0.452 . . . . 52.240000000000002 111.13 -174.314 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.17 158.25 37.59 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.54 -0.755 . . . . 74.030000000000001 110.321 -177.466 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' O ' ' HA2' ' A' ' 23' ' ' GLY . 98.4 mttt -72.4 137.85 81.03 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 119.783 -0.767 . . . . 70.010000000000005 109.288 173.603 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.97 -63.61 0.23 Allowed 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 123.348 2.699 . . . . 71.549999999999997 114.925 -174.547 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 67.98 -49.6 0.53 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.676 1.191 . . . . 54.039999999999999 113.097 -177.347 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.643 ' OD1' ' HG3' ' A' ' 54' ' ' LYS . 24.0 t-20 -105.54 152.98 22.37 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 122.428 0.291 . . . . 71.530000000000001 110.226 -176.822 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.0 m -78.55 -22.1 47.74 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.261 1.208 . . . . 61.43 114.261 -175.447 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.643 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -83.51 -24.39 31.72 Favored 'General case' 0 CA--C 1.471 -2.058 0 C-N-CA 118.806 -1.158 . . . . 71.120000000000005 110.409 177.879 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.508 ' N ' ' HD3' ' A' ' 54' ' ' LYS . 31.5 m-20 -68.48 95.05 0.6 Allowed 'General case' 0 N--CA 1.401 -2.889 0 CA-C-O 123.046 1.403 . . . . 74.230000000000004 112.374 -179.24 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -90.29 -22.54 21.52 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-N 112.498 -2.137 . . . . 71.120000000000005 107.45 174.084 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.583 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 173.7 116.65 0.43 Allowed Glycine 0 N--CA 1.409 -3.127 0 CA-C-N 114.845 -1.07 . . . . 43.039999999999999 110.427 177.047 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 75.0 Cg_exo -52.04 134.22 48.77 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.332 2.022 . . . . 53.140000000000001 109.313 170.591 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.79 149.58 23.68 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 111.654 0.242 . . . . 73.129999999999995 111.654 -173.443 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.547 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 66.1 mt -91.77 151.03 20.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.279 -0.419 . . . . 50.039999999999999 109.969 177.311 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -109.64 102.45 11.28 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.08 -1.082 . . . . 75.219999999999999 108.08 177.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -148.84 142.61 10.06 Favored Glycine 0 C--N 1.283 -2.367 0 C-N-CA 120.58 -0.819 . . . . 71.400000000000006 112.873 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -151.35 114.27 4.71 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.543 -0.91 . . . . 72.219999999999999 108.543 176.194 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.66 159.62 71.06 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 109.925 -0.398 . . . . 64.049999999999997 109.925 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.98 -13.92 42.1 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.245 1.963 . . . . 70.150000000000006 112.532 178.089 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 51.7 p90 -113.64 28.69 8.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.62 -0.264 . . . . 54.340000000000003 111.466 -177.817 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.8 m -57.49 -26.86 61.93 Favored 'General case' 0 C--O 1.205 -1.253 0 N-CA-C 111.947 0.351 . . . . 61.210000000000001 111.947 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.512 ' HG3' ' HG3' ' A' ' 69' ' ' LYS . 29.7 pt20 -65.56 -12.26 51.37 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.395 0.617 . . . . 65.319999999999993 110.96 176.78 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HE3' HD23 ' A' ' 90' ' ' LEU . 24.6 mtpp -110.81 -7.51 14.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.636 0.774 . . . . 64.430000000000007 110.519 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 p -132.36 117.74 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 122.029 0.918 . . . . 54.130000000000003 110.409 173.688 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.32 116.31 28.83 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.687 -0.688 . . . . 75.140000000000001 109.964 -177.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.95 124.38 50.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 106.177 -1.786 . . . . 74.239999999999995 106.177 177.006 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.7 m -137.97 166.89 22.96 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.298 -0.41 . . . . 74.400000000000006 111.293 -172.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.583 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 57.5 t30 -80.2 140.78 36.16 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.311 -0.859 . . . . 64.409999999999997 108.799 177.067 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 77.0 t80 -119.3 121.35 39.4 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.862 -0.422 . . . . 72.400000000000006 109.862 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -138.62 114.79 10.24 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.843 -1.169 . . . . 74.140000000000001 107.843 172.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.4 t -174.51 148.09 1.17 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.903 -1.517 . . . . 73.439999999999998 106.903 -175.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 72.28 10.33 5.89 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.844 0.858 . . . . 74.239999999999995 111.027 173.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.66 5.06 82.19 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.477 -0.649 . . . . 61.020000000000003 111.477 -175.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.576 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 11.8 m-85 -104.09 149.28 25.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.617 -0.512 . . . . 65.140000000000001 109.617 179.014 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.73 136.79 58.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.987 -1.116 . . . . 73.209999999999994 107.987 174.207 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.461 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -173.5 -154.94 11.06 Favored Glycine 0 C--N 1.274 -2.873 0 N-CA-C 110.682 -0.967 . . . . 41.409999999999997 110.682 -178.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.547 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 p -129.62 153.25 48.28 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-O 121.208 0.528 . . . . 44.240000000000002 111.848 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 11.8 pt20 -134.62 141.97 46.76 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.835 -0.62 . . . . 73.120000000000005 110.791 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.88 114.2 26.61 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.645 -1.613 . . . . 71.150000000000006 106.645 173.321 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.21 115.14 48.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.658 -0.867 . . . . 74.549999999999997 108.658 -178.58 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.451 ' HE2' HG12 ' A' ' 40' ' ' VAL . 41.2 p90 -119.53 151.77 38.06 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.205 0.526 . . . . 74.420000000000002 111.085 -174.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 p -155.59 154.83 32.28 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.5 -0.773 . . . . 72.530000000000001 110.286 -177.235 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.3 t70 65.74 30.98 9.96 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.089 0.947 . . . . 62.140000000000001 110.457 175.02 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.542 HD23 ' HE3' ' A' ' 69' ' ' LYS . 18.1 mt -94.91 170.22 9.58 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.875 -0.602 . . . . 70.409999999999997 111.785 -178.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.439 HG22 ' OE1' ' A' ' 94' ' ' GLU . 12.5 t -126.61 172.79 9.97 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.059 -0.719 . . . . 73.209999999999994 109.059 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.435 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 78.1 t80 -51.92 -40.67 61.12 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.011 1.324 . . . . 71.319999999999993 112.152 -176.718 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.09 72.16 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.255 0.465 . . . . 72.540000000000006 112.255 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' OE1' HG22 ' A' ' 91' ' ' THR . 48.3 mt-10 -86.08 -18.77 31.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.003 -0.544 . . . . 72.349999999999994 111.838 -174.35 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tt -60.62 -54.59 53.28 Favored Pre-proline 0 CA--C 1.566 1.584 0 CA-C-N 116.094 -0.503 . . . . 73.319999999999993 112.22 -177.372 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.26 -34.17 36.75 Favored 'Trans proline' 0 C--N 1.367 1.518 0 CA-C-N 120.76 1.307 . . . . 65.230000000000004 111.095 178.059 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.87 -39.65 95.08 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.362 -0.835 . . . . 72.219999999999999 111.504 -176.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -70.67 -19.62 62.77 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.081 0.467 . . . . 75.109999999999999 111.053 177.7 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.31 -24.45 59.22 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.505 -0.478 . . . . 74.430000000000007 110.191 -176.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -59.17 -51.89 68.06 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 123.305 0.378 . . . . 71.409999999999997 110.649 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -54.29 -52.65 60.79 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-O 121.638 0.732 . . . . 75.230000000000004 110.472 -177.593 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.21 -27.28 68.95 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 115.024 -0.989 . . . . 73.25 111.28 -177.229 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -63.55 -22.9 67.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 118.622 -0.704 . . . . 61.399999999999999 112.08 -177.004 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.48 -27.64 67.73 Favored 'General case' 0 C--N 1.357 0.913 0 CA-C-O 121.215 0.531 . . . . 60.210000000000001 109.776 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.77 -12.5 13.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.721 -0.672 . . . . 74.519999999999996 111.093 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.98 -48.68 3.44 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 113.941 1.089 . . . . 52.0 113.941 -172.211 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.43 24.0 48.72 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.658 -0.782 . . . . 42.329999999999998 112.144 -174.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -87.93 147.39 5.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 O-C-N 122.332 -0.51 . . . . 52.240000000000002 110.735 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -135.28 129.05 32.97 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.846 -1.168 . . . . 65.140000000000001 107.846 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 mp -130.21 117.05 19.27 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.558 0.218 . . . . 64.040000000000006 110.544 -178.188 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.4 m -108.27 114.22 27.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.151 -1.055 . . . . 70.019999999999996 108.151 176.094 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.78 153.16 49.34 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 122.027 -0.421 . . . . 74.319999999999993 110.738 -176.569 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -148.68 154.0 39.04 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.721 -0.672 . . . . 70.109999999999999 110.199 -177.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.411 ' CD ' HG22 ' A' ' 119' ' ' VAL . 5.1 tpt180 -108.57 106.53 16.65 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 105.722 -1.955 . . . . 74.030000000000001 105.722 179.42 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -101.38 97.33 7.83 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.44 -0.578 . . . . 73.349999999999994 109.44 -176.378 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.19 -82.72 0.64 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.304 -0.718 . . . . 62.539999999999999 111.304 -178.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -143.52 5.35 1.41 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.714 1.245 . . . . 74.420000000000002 109.148 178.198 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.6 pp -113.58 148.87 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 O-C-N 121.339 -0.851 . . . . 73.319999999999993 108.779 -179.301 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.411 HG22 ' CD ' ' A' ' 114' ' ' ARG . 94.3 t -110.31 133.82 54.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-O 121.378 0.608 . . . . 62.210000000000001 111.04 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.5 pt -117.33 132.86 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 N-CA-C 107.945 -1.132 . . . . 71.040000000000006 107.945 173.807 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.2 tt -128.12 125.33 38.97 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 115.926 -0.579 . . . . 74.420000000000002 109.771 177.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -127.15 115.08 18.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.039 -0.982 . . . . 70.299999999999997 108.559 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.7 156.08 21.92 Favored Glycine 0 C--N 1.291 -1.942 0 C-N-CA 120.458 -0.877 . . . . 53.399999999999999 112.409 -177.477 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -139.9 125.71 19.5 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.953 -1.128 . . . . 63.200000000000003 107.953 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -101.77 111.7 24.05 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.644 -0.502 . . . . 74.219999999999999 109.644 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -104.84 93.61 4.82 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 123.031 1.396 . . . . 62.520000000000003 111.519 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 166' ' ' PRO 0.278 0.0 OUTLIER -126.75 42.86 3.23 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-O 124.21 1.957 . . . . 65.040000000000006 107.444 171.775 . . . . . . . . 4 4 . 1 . 028 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.4 p -68.2 -19.6 64.78 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 111.419 -2.628 . . . . 73.0 110.791 179.434 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.8 p -73.79 -19.53 60.74 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.449 -0.796 . . . . 64.319999999999993 110.512 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.3 t -83.01 93.41 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 108.34 -0.985 . . . . 50.100000000000001 108.34 178.174 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.2 t -92.12 14.51 15.82 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.02 0.914 . . . . 75.140000000000001 109.138 -178.045 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 29.8 m-20 -103.42 131.27 22.23 Favored Pre-proline 0 N--CA 1.432 -1.36 0 CA-C-N 115.766 -0.652 . . . . 73.310000000000002 110.094 -179.084 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 132' ' ' ASP . 23.4 Cg_exo -63.09 -9.68 17.96 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 124.129 3.219 . . . . 74.439999999999998 113.907 -178.273 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.503 ' HB3' ' H ' ' A' ' 25' ' ' MET . 5.0 m-20 -75.89 -11.89 60.05 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 113.748 1.018 . . . . 72.439999999999998 113.748 -170.844 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 166' ' ' PRO . . . -96.47 124.56 40.5 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.618 -0.433 . . . . 72.200000000000003 110.902 -175.65 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -131.94 127.87 37.29 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.731 -0.84 . . . . 61.039999999999999 108.731 178.122 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 58.2 t -121.81 128.57 75.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 119.367 -0.933 . . . . 71.400000000000006 110.104 -177.778 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.75 121.12 31.09 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.914 0.387 . . . . 62.140000000000001 110.289 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 20.5 tp -115.11 120.75 40.86 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.215 -0.448 . . . . 74.219999999999999 109.807 177.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.6 m -117.45 114.31 23.32 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.032 -0.729 . . . . 64.439999999999998 109.032 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 96.5 t -108.4 120.79 60.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.932 -0.766 . . . . 74.400000000000006 108.932 178.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -110.86 130.71 55.5 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.587 -0.523 . . . . 44.009999999999998 109.587 179.341 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.541 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.6 p90 -134.52 124.76 17.23 Favored Pre-proline 0 C--N 1.292 -1.927 0 CA-C-N 116.349 -0.387 . . . . 73.200000000000003 111.209 177.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.76 37.65 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.476 2.784 . . . . 73.019999999999996 112.603 176.024 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -125.9 -115.8 0.28 Allowed 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 108.522 -0.918 . . . . 74.219999999999999 108.522 -179.487 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.75 137.84 0.62 Allowed 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.71 -1.219 . . . . 73.439999999999998 107.71 -178.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.515 ' HA ' ' HB2' ' A' ' 176' ' ' ALA . 7.6 p -89.48 127.21 42.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.548 -0.908 . . . . 64.219999999999999 108.548 178.321 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.5 p -81.31 -38.73 26.3 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.585 0.707 . . . . 74.010000000000005 110.337 -177.497 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 49.0 m -156.56 133.1 10.09 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.08 -0.711 . . . . 52.229999999999997 109.08 178.85 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.424 ' HB ' HG21 ' A' ' 147' ' ' VAL . 9.4 t -138.45 169.72 17.29 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.669 -0.644 . . . . 63.240000000000002 111.307 177.875 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.563 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 8.0 t30 -139.0 87.17 2.19 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.751 -1.944 . . . . 44.140000000000001 105.751 175.414 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.09 -146.4 6.66 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 109.221 -1.551 . . . . 75.409999999999997 109.221 -178.819 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -118.55 99.63 6.93 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.054 -0.721 . . . . 71.209999999999994 109.054 178.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 39.6 ptt180 -79.03 128.72 33.62 Favored 'General case' 0 N--CA 1.422 -1.831 0 O-C-N 121.562 -0.712 . . . . 71.319999999999993 110.589 179.231 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.1 mt -87.33 -39.42 13.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.723 -1.584 . . . . 74.0 106.723 177.314 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.23 164.96 35.35 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.023 -1.843 . . . . 71.400000000000006 106.023 -179.349 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.23 -0.12 8.71 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.84 1.693 . . . . 75.230000000000004 111.128 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.3 pt-20 -129.34 4.18 5.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.566 -0.743 . . . . 75.25 111.802 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.89 120.19 8.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.028 -1.101 . . . . 74.319999999999993 108.028 178.753 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 45.5 t -125.74 143.56 38.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.924 -0.398 . . . . 72.450000000000003 109.924 -177.002 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.8 tt0 -128.14 138.28 52.44 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-O 121.304 0.573 . . . . 64.430000000000007 109.667 -177.39 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -114.87 114.86 26.07 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 115.862 -0.608 . . . . 64.420000000000002 109.405 178.21 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -98.67 98.35 9.5 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.168 -1.049 . . . . 71.409999999999997 108.168 178.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 26.2 mt -93.68 146.62 23.7 Favored 'General case' 0 C--O 1.281 2.747 0 CA-C-N 114.878 -1.056 . . . . 70.530000000000001 109.927 -172.279 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.515 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -117.02 151.25 47.28 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.245 -0.889 . . . . 74.219999999999999 111.323 -173.253 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 84.7 Cg_endo -77.94 154.93 30.03 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.874 2.383 . . . . 44.100000000000001 112.424 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.65 -28.14 2.81 Favored Glycine 0 CA--C 1.499 -0.938 0 C-N-CA 121.159 -0.543 . . . . 73.140000000000001 112.533 175.393 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.03 156.14 6.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 109.443 -0.577 . . . . 72.340000000000003 109.443 -179.176 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.3 p -92.53 109.24 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 108.106 -1.072 . . . . 72.540000000000006 108.106 177.26 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.4 m -92.85 130.27 38.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.561 -0.745 . . . . 74.109999999999999 109.678 -176.479 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 44.0 p -99.12 139.01 35.4 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.633 0.73 . . . . 71.439999999999998 111.711 -178.651 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 21.3 ttt -118.02 122.45 43.22 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.027 -1.101 . . . . 73.140000000000001 108.027 178.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.563 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 4.2 m -136.44 136.92 39.91 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.54 -1.264 . . . . 53.25 108.53 174.105 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.02 131.89 15.12 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.189 -1.041 . . . . 62.539999999999999 108.189 -179.708 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -133.33 131.49 40.19 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.474 -1.306 . . . . 65.140000000000001 107.474 177.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -162.53 154.29 18.36 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.347 -0.983 . . . . 63.100000000000001 108.347 -178.147 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 35.8 ptt180 -92.93 141.58 28.25 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.268 -0.973 . . . . 74.219999999999999 110.187 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.59 130.13 24.07 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 121.038 0.446 . . . . 75.109999999999999 110.044 -176.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.65 101.14 0.32 Allowed 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 114.721 -1.127 . . . . 73.25 112.643 -178.413 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.45 129.89 69.67 Favored Pre-proline 0 CA--C 1.505 -0.788 0 CA-C-N 115.425 -0.807 . . . . 65.329999999999998 111.96 172.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 38' ' ' ASP . 30.4 Cg_endo -71.26 -24.37 23.19 Favored 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 122.926 2.417 . . . . 63.030000000000001 109.997 175.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -84.07 -12.95 54.29 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.038 -1.437 . . . . 43.020000000000003 109.608 177.678 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.311 3.9 t 42.64 87.7 0.01 OUTLIER 'General case' 0 C--N 1.349 0.587 0 C-N-CA 127.231 2.213 . . . . 73.040000000000006 116.024 172.683 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -100.2 151.42 21.46 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.227 -1.351 . . . . 75.420000000000002 108.108 177.161 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 C--N 1.295 -1.761 0 N-CA-C 108.385 -0.969 . . . . 64.329999999999998 108.385 177.746 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.024 0 N-CA-C 109.705 -1.358 . . . . 73.439999999999998 109.705 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -100.71 -15.96 17.53 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.423 0.527 . . . . 63.520000000000003 112.423 178.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -87.91 83.6 7.07 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.203 -1.406 . . . . 71.120000000000005 107.203 173.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -77.75 102.61 7.24 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.171 1.175 . . . . 60.420000000000002 114.171 -171.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.6 tp -116.85 100.95 8.13 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.784 -1.932 . . . . 72.239999999999995 105.784 171.229 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -79.19 -53.88 6.53 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.396 -0.366 . . . . 73.109999999999999 111.706 -174.661 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -144.61 125.35 14.2 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.035 -0.728 . . . . 74.430000000000007 109.035 -175.665 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.07 128.45 35.5 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.511 -1.292 . . . . 71.319999999999993 107.511 174.616 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.29 -90.74 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 115.165 0.826 . . . . 73.010000000000005 115.165 -173.417 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' A' ' 49' ' ' LYS . 87.5 m-70 -141.69 -162.45 1.39 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.285 0.564 . . . . 71.439999999999998 111.81 -170.69 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.466 ' HG2' ' OD2' ' A' ' 134' ' ' ASP . 77.3 mtp -89.31 -172.64 3.7 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.693 -1.139 . . . . 73.049999999999997 108.325 173.558 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.6 pt? -132.22 111.73 11.65 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.624 -0.88 . . . . 74.140000000000001 108.624 175.227 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 22.8 mtp-105 -127.19 133.85 50.22 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.094 -0.503 . . . . 74.5 109.682 -175.624 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.99 116.8 53.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 115.496 -0.774 . . . . 73.5 108.957 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.4 mtp85 -106.94 114.34 28.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.228 0.537 . . . . 55.509999999999998 109.669 176.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.23 111.65 23.37 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.263 -1.014 . . . . 73.019999999999996 108.263 177.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -119.52 114.55 22.45 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.54 -1.282 . . . . 73.450000000000003 107.54 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.11 146.26 34.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.814 -0.81 . . . . 55.340000000000003 108.814 -178.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 85.6 m -131.36 126.41 35.17 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-O 121.067 0.46 . . . . 65.430000000000007 110.573 -178.654 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.3 tt -108.81 112.14 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 121.898 0.856 . . . . 71.230000000000004 109.428 177.592 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.9 m -76.62 158.11 81.38 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 114.74 -1.118 . . . . 61.340000000000003 110.511 -175.532 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.12 2.72 0.99 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 123.747 2.965 . . . . 75.150000000000006 112.702 177.739 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -87.57 -7.15 57.88 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.306 -0.998 . . . . 73.030000000000001 108.306 177.382 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 72.07 29.1 2.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.761 1.625 . . . . 63.420000000000002 108.004 -175.829 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -111.63 138.95 47.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.918 -1.492 . . . . 62.109999999999999 107.408 179.499 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.446 HG21 ' HG ' ' A' ' 95' ' ' LEU . 11.1 t -113.74 135.52 53.1 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.242 0.544 . . . . 64.129999999999995 109.543 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.9 p -142.77 137.75 29.95 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.566 -1.272 . . . . 70.219999999999999 107.566 177.686 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.36 -169.5 35.84 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 119.256 -1.449 . . . . 61.450000000000003 112.428 -177.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -149.84 133.6 16.84 Favored 'General case' 0 N--CA 1.418 -2.027 0 C-N-CA 123.263 0.625 . . . . 63.509999999999998 109.53 -177.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.1 mt -116.45 115.49 49.23 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 105.658 -1.979 . . . . 71.349999999999994 105.658 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.5 mt -120.37 114.27 43.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-N 116.196 -0.457 . . . . 61.119999999999997 110.005 -172.309 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.55 108.56 18.11 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.742 -0.836 . . . . 42.450000000000003 108.742 179.227 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -111.37 118.01 34.68 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 109.035 -0.728 . . . . 75.430000000000007 109.035 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.97 158.74 21.62 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-O 122.006 0.908 . . . . 71.150000000000006 112.288 -174.142 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 24' ' ' HIS . 18.8 ptmt -62.94 135.05 95.95 Favored Pre-proline 0 C--N 1.294 -1.843 0 CA-C-N 113.807 -1.542 . . . . 74.510000000000005 107.808 170.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.17 101.05 0.09 OUTLIER 'Trans proline' 0 C--O 1.244 0.808 0 C-N-CA 121.978 1.785 . . . . 74.409999999999997 110.376 177.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -98.47 -16.7 19.11 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.734 0.778 . . . . 62.530000000000001 110.346 -174.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 37.6 t-20 -123.28 117.5 25.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.076 -1.824 . . . . 54.439999999999998 106.076 176.609 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.3 m -56.96 -33.31 66.92 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.951 1.463 . . . . 71.340000000000003 114.951 -171.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -88.59 -15.94 33.79 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.621 -0.831 . . . . 72.230000000000004 109.611 -179.084 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 52' ' ' ASN . 35.1 t70 -81.58 114.67 20.44 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.248 -0.887 . . . . 74.140000000000001 112.138 -172.172 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.5 t -110.81 11.87 22.45 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.754 -1.112 . . . . 70.310000000000002 109.836 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.642 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 175.29 98.02 0.11 Allowed Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.146 -1.502 . . . . 61.109999999999999 113.711 178.762 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 83' ' ' SER . 38.9 Cg_exo -60.36 159.8 25.79 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 123.646 2.898 . . . . 74.140000000000001 112.639 174.315 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.68 153.25 35.87 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.619 -0.719 . . . . 53.030000000000001 109.425 177.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.0 mt -99.46 138.91 35.89 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.274 -0.421 . . . . 64.239999999999995 110.52 178.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -110.95 87.9 2.65 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.401 1.096 . . . . 75.25 110.898 176.126 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.07 78.11 0.35 Allowed Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 109.817 -1.313 . . . . 71.349999999999994 109.817 177.37 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -80.8 93.37 6.22 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.841 0.829 . . . . 75.540000000000006 109.428 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -105.54 158.38 32.41 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 114.067 -1.424 . . . . 44.43 109.841 -176.604 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.29 -20.99 71.94 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 123.114 2.543 . . . . 62.409999999999997 112.984 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -107.03 44.04 1.1 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.562 -0.745 . . . . 75.310000000000002 111.671 -178.128 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m -51.84 -39.12 58.29 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.146 0.578 . . . . 75.310000000000002 111.87 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -69.82 -15.87 63.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.94 0.4 . . . . 74.420000000000002 111.144 -175.404 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -91.1 -14.38 31.34 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.855 -0.611 . . . . 54.210000000000001 110.231 -179.06 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.66 120.05 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 119.643 -0.823 . . . . 63.340000000000003 111.788 -179.455 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.44 113.96 27.74 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.078 -0.712 . . . . 61.009999999999998 109.078 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.79 133.81 39.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.617 -0.883 . . . . 74.040000000000006 108.617 -179.128 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 m -141.73 171.94 13.37 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.15 0.5 . . . . 70.140000000000001 111.273 -177.437 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.642 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 7.2 t30 -83.39 136.95 34.14 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 124.473 1.109 . . . . 74.299999999999997 110.461 -177.532 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -116.09 119.9 37.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.822 -0.807 . . . . 63.119999999999997 108.822 177.115 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -139.2 110.44 6.93 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.349 -2.093 . . . . 62.119999999999997 105.349 177.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 75.8 m -148.13 113.21 5.5 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 110.383 -0.229 . . . . 71.040000000000006 110.383 -178.522 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 t0 68.87 9.65 7.5 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.06 1.344 . . . . 71.109999999999999 111.397 176.698 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.24 5.06 50.01 Favored Glycine 0 N--CA 1.424 -2.141 0 C-N-CA 120.166 -1.016 . . . . 64.409999999999997 112.546 -176.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.57 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 72.0 m-85 -84.71 140.78 31.05 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.161 -2.163 . . . . 75.129999999999995 105.161 166.181 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.52 135.75 62.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.481 -0.888 . . . . 73.400000000000006 109.266 174.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -167.77 -155.9 9.66 Favored Glycine 0 N--CA 1.403 -3.541 0 C-N-CA 120.519 -0.848 . . . . 43.420000000000002 111.468 178.739 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 9.3 p -135.88 150.41 49.35 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.084 0.469 . . . . 71.519999999999996 110.31 -177.705 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.49 127.99 40.29 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.725 -0.67 . . . . 55.149999999999999 110.95 -178.526 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.03 114.17 28.21 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.917 -1.512 . . . . 53.140000000000001 106.917 174.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.7 t -112.75 112.07 38.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.452 -1.314 . . . . 73.349999999999994 107.452 -178.623 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.474 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.9 p90 -116.09 155.17 28.64 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.286 -0.415 . . . . 74.030000000000001 111.181 -172.602 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.5 p -156.92 157.12 34.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.99 -0.55 . . . . 71.209999999999994 110.922 -176.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 t70 64.79 31.84 11.45 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.783 1.233 . . . . 74.430000000000007 111.055 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.474 HD12 ' CD2' ' A' ' 87' ' ' PHE . 27.6 mt -93.53 173.21 7.81 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.665 -0.698 . . . . 73.409999999999997 109.288 176.125 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -126.26 175.03 8.1 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 120.113 -0.635 . . . . 35.530000000000001 110.227 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.46 ' CZ ' HD13 ' A' ' 112' ' ' LEU . 86.9 t80 -54.56 -39.93 68.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.698 1.199 . . . . 75.310000000000002 112.126 -176.085 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.31 -25.76 67.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.29 0.567 . . . . 75.209999999999994 111.537 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -84.68 -16.18 42.71 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 112.471 0.545 . . . . 62.450000000000003 112.471 -174.706 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 10.3 mt -53.09 -55.69 31.27 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.671 1.36 . . . . 71.140000000000001 114.671 178.137 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.41 -37.1 51.37 Favored 'Trans proline' 0 C--N 1.36 1.148 0 CA-C-N 120.465 1.202 . . . . 73.439999999999998 110.577 177.26 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -64.51 -36.84 85.49 Favored 'General case' 0 N--CA 1.417 -2.082 0 C-N-CA 123.769 0.828 . . . . 70.400000000000006 111.181 -177.163 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -78.16 -20.22 52.44 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.991 -0.374 . . . . 63.219999999999999 109.991 175.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -69.98 -21.41 63.23 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.929 -0.578 . . . . 54.020000000000003 110.772 -177.442 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -61.21 -53.35 57.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.198 -0.667 . . . . 73.340000000000003 109.198 175.198 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 32.5 ttp -58.3 -47.27 84.21 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.48 0.657 . . . . 73.25 109.786 177.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 46.0 t30 -53.16 -31.06 40.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.153 -1.385 . . . . 61.109999999999999 111.149 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -56.22 -35.0 66.84 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.965 -0.541 . . . . 75.400000000000006 111.786 -174.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.52 -26.81 68.16 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.265 0.555 . . . . 62.219999999999999 111.805 -174.2 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.97 -16.16 14.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 120.401 -0.519 . . . . 52.140000000000001 110.821 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' A' ' 108' ' ' VAL . . . -106.8 -47.88 3.63 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.656 0.984 . . . . 72.239999999999995 113.656 -170.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.18 28.32 64.42 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.762 -0.935 . . . . 53.399999999999999 110.762 -172.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.443 HG12 ' CB ' ' A' ' 125' ' ' ALA . 13.2 m -114.62 161.45 13.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 74.510000000000005 110.989 -176.156 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -127.61 139.7 52.57 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.179 -1.415 . . . . 64.200000000000003 107.179 174.744 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -128.3 133.32 48.71 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.464 -0.569 . . . . 70.530000000000001 109.464 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.3 t -132.71 137.6 46.95 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 107.745 -1.206 . . . . 74.420000000000002 107.745 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' A' ' 113' ' ' ARG . 1.3 pp -149.24 152.14 35.46 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.782 1.03 . . . . 70.209999999999994 113.782 -176.861 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 112' ' ' LEU . 9.6 mpt_? -144.09 154.3 43.06 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.205 -1.361 . . . . 73.319999999999993 111.642 178.74 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.456 ' HD3' HG22 ' A' ' 119' ' ' VAL . 10.0 mmt-85 -90.25 137.95 31.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 107.569 -1.271 . . . . 65.420000000000002 107.569 167.91 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.446 ' O ' HG13 ' A' ' 118' ' ' ILE . 46.9 t30 -123.18 90.56 3.31 Favored 'General case' 0 C--N 1.258 -3.383 0 N-CA-C 107.134 -1.432 . . . . 74.420000000000002 107.134 173.704 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.93 -100.31 0.83 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 109.759 -1.336 . . . . 55.450000000000003 109.759 -173.594 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -121.84 -4.32 9.15 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.429 1.109 . . . . 62.329999999999998 109.0 178.517 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.6 pp -99.24 150.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.389 -0.967 . . . . 74.230000000000004 108.389 179.076 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.456 HG22 ' HD3' ' A' ' 114' ' ' ARG . 79.7 t -110.36 136.17 47.16 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 O-C-N 121.847 -0.533 . . . . 54.219999999999999 111.539 -176.767 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.3 pt -117.06 128.96 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 115.202 -0.908 . . . . 74.120000000000005 108.997 175.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -128.42 131.83 48.47 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 108.578 -0.897 . . . . 64.019999999999996 108.578 179.64 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -144.7 139.8 28.18 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.224 -0.658 . . . . 64.239999999999995 109.224 179.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.38 -178.12 36.83 Favored Glycine 0 C--N 1.298 -1.541 0 C-N-CA 120.398 -0.906 . . . . 45.210000000000001 111.689 179.523 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.403 ' HG2' HG22 ' A' ' 171' ' ' THR . 82.8 mtt180 -139.35 150.95 45.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 120.967 0.413 . . . . 73.230000000000004 110.904 -179.15 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.443 ' CB ' HG12 ' A' ' 108' ' ' VAL . . . -122.87 120.54 33.79 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.05 -0.977 . . . . 60.530000000000001 108.6 178.204 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.13 107.33 18.38 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.368 -0.975 . . . . 75.030000000000001 108.368 178.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.426 HD21 ' HB3' ' A' ' 164' ' ' LEU . 1.5 mm? -107.99 15.47 24.32 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.731 -0.841 . . . . 54.25 108.731 178.721 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 167' ' ' GLY . 42.3 p -81.22 -21.05 39.81 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.096 -1.076 . . . . 54.310000000000002 108.096 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.3 m -92.95 17.53 10.53 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.555 -1.202 . . . . 73.109999999999999 111.58 -178.016 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.64 141.42 16.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 120.077 -0.649 . . . . 65.299999999999997 110.826 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.5 m -83.43 -21.28 32.99 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.022 -0.535 . . . . 63.450000000000003 111.208 -178.564 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.437 ' HB3' HD21 ' A' ' 26' ' ' LEU . 11.8 t70 -134.1 137.66 28.74 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 109.089 -0.708 . . . . 55.450000000000003 109.089 -175.652 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.18 -17.41 45.25 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.344 2.696 . . . . 73.129999999999995 113.83 -178.461 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 25' ' ' MET . 2.7 m-20 -90.93 20.9 4.48 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.892 0.477 . . . . 74.430000000000007 111.834 -178.303 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -98.45 116.2 30.17 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.451 -0.341 . . . . 53.549999999999997 110.644 -175.564 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 4.4 m-20 -123.6 140.54 52.9 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.557 -0.534 . . . . 74.400000000000006 109.557 179.052 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 60.4 t -124.84 131.62 72.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.795 -0.817 . . . . 63.350000000000001 108.795 178.513 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.35 122.66 44.47 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.514 -0.921 . . . . 63.310000000000002 108.514 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 46.2 tp -110.9 120.25 41.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.742 -0.836 . . . . 73.439999999999998 108.742 177.724 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.3 m -124.42 110.14 14.17 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 108.71 -0.848 . . . . 74.510000000000005 108.71 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 87.7 t -109.37 124.49 66.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.699 -0.852 . . . . 62.43 108.699 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.47 130.61 56.29 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 108.803 -0.814 . . . . 73.439999999999998 108.803 178.168 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -133.98 102.56 12.15 Favored Pre-proline 0 C--N 1.266 -3.038 0 N-CA-C 108.34 -0.985 . . . . 71.430000000000007 108.34 175.303 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.36 47.28 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 123.871 3.047 . . . . 73.120000000000005 113.379 -178.475 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 177' ' ' ARG . . . -112.82 -78.94 0.58 Allowed 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 109.47 -0.567 . . . . 64.140000000000001 109.47 178.106 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.16 118.34 0.01 OUTLIER 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.881 1.272 . . . . 74.209999999999994 108.559 179.378 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.08 134.23 29.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 109.783 -0.451 . . . . 75.420000000000002 109.783 177.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.2 p -101.11 -41.66 6.67 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.156 0.503 . . . . 45.450000000000003 109.851 178.616 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.2 m -158.25 133.36 8.59 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 109.377 -0.601 . . . . 72.010000000000005 109.377 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.421 ' OG1' HG11 ' A' ' 160' ' ' VAL . 10.0 t -138.95 157.11 46.61 Favored 'General case' 0 C--N 1.285 -2.22 0 O-C-N 121.796 -0.565 . . . . 73.409999999999997 110.172 177.755 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 43.8 t30 -124.67 88.75 2.95 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 105.524 -2.028 . . . . 73.109999999999999 105.524 174.656 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.84 -150.97 15.84 Favored Glycine 0 N--CA 1.419 -2.491 0 N-CA-C 107.275 -2.33 . . . . 71.319999999999993 107.275 -177.206 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -113.68 104.36 12.15 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 118.297 1.049 . . . . 53.210000000000001 111.587 -177.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -77.52 117.35 18.88 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.212 0.53 . . . . 75.329999999999998 110.168 176.572 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.2 mt -86.38 -48.75 15.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.611 -1.626 . . . . 74.010000000000005 106.611 177.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -123.41 162.06 42.12 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 114.245 -1.343 . . . . 62.229999999999997 107.917 -177.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.63 -4.01 11.3 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.847 2.365 . . . . 73.450000000000003 112.398 177.385 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.7 OUTLIER -132.68 5.16 3.95 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.263 0.468 . . . . 72.230000000000004 112.263 175.211 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.66 121.0 29.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 N-CA-C 109.32 -0.622 . . . . 52.32 109.32 -179.126 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.421 HG11 ' OG1' ' A' ' 150' ' ' THR . 57.3 t -124.75 143.14 39.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.507 -0.553 . . . . 70.349999999999994 109.507 -178.035 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.1 tt0 -128.67 146.07 50.98 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.17 0.509 . . . . 73.5 110.034 -177.504 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.422 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.5 m-90 -124.32 127.83 48.19 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.788 -1.19 . . . . 73.409999999999997 107.788 176.181 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.14 107.15 19.62 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.529 -0.545 . . . . 74.319999999999993 109.529 179.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.1 mm? -92.58 124.5 36.66 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.61 -0.723 . . . . 75.310000000000002 109.111 -177.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -117.09 141.69 28.83 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.869 -1.06 . . . . 71.439999999999998 110.689 -171.647 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 28.5 Cg_endo -60.79 153.13 64.85 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.879 2.386 . . . . 54.25 112.909 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 128' ' ' THR . . . 80.29 -27.21 2.82 Favored Glycine 0 C--N 1.315 -0.635 0 CA-C-N 115.813 -0.63 . . . . 63.039999999999999 113.566 175.438 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.16 162.9 4.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.715 0.769 . . . . 74.329999999999998 112.243 -179.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.44 131.45 66.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.012 -1.107 . . . . 73.530000000000001 108.012 176.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.4 m -119.79 145.46 46.58 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.812 0.339 . . . . 54.439999999999998 110.82 -175.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.403 HG22 ' HG2' ' A' ' 124' ' ' ARG . 22.0 p -104.92 126.35 51.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.056 -0.72 . . . . 61.409999999999997 109.056 175.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -110.1 131.94 54.6 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.023 -0.732 . . . . 71.310000000000002 109.023 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 13.5 m -141.53 140.59 33.49 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.975 -0.69 . . . . 64.319999999999993 109.408 175.706 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -149.09 121.65 8.56 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.106 -0.702 . . . . 74.319999999999993 109.106 -177.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -124.22 132.16 53.58 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 107.873 -1.158 . . . . 64.450000000000003 107.873 178.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.17 151.48 31.97 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.539 -0.541 . . . . 74.129999999999995 109.539 -175.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.405 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 7.4 ppt_? -88.92 130.15 35.48 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.221 -1.029 . . . . 73.420000000000002 108.221 -179.044 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.439 ' CD2' HG21 ' A' ' 119' ' ' VAL . 7.4 m-30 -118.2 153.64 33.53 Favored 'General case' 0 CA--C 1.465 -2.298 0 CA-C-N 118.527 0.603 . . . . 71.010000000000005 110.191 -174.692 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.6 p -96.89 91.09 5.47 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 109.247 -0.649 . . . . 73.329999999999998 109.247 173.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -55.68 132.28 72.02 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 110.025 -0.361 . . . . 73.209999999999994 110.025 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.21 -33.77 70.64 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.724 2.283 . . . . 62.549999999999997 112.771 -179.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -84.0 -16.93 42.19 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.242 -1.022 . . . . 75.319999999999993 108.242 -178.233 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 66.5 p 60.9 29.42 19.0 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.565 1.546 . . . . 74.120000000000005 111.217 -178.342 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -84.06 139.52 32.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.005 -1.452 . . . . 74.230000000000004 110.28 179.259 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 C--N 1.277 -2.586 0 N-CA-C 107.019 -1.474 . . . . 53.43 107.019 179.533 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.062 0 N-CA-C 109.993 -1.243 . . . . 72.420000000000002 109.993 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -98.82 106.69 18.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.651 -1.24 . . . . 74.040000000000006 107.651 177.72 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.72 160.09 17.49 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.892 -0.323 . . . . 75.540000000000006 111.833 -176.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 56.19 68.35 0.87 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.54 1.311 . . . . 73.209999999999994 114.54 174.751 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.6 tp -100.77 99.82 10.4 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.621 -1.252 . . . . 64.209999999999994 107.621 174.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -108.9 103.53 12.6 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.418 -0.586 . . . . 72.400000000000006 109.418 -178.226 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -72.27 135.58 46.04 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.048 -1.094 . . . . 75.420000000000002 108.048 177.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.11 -71.25 0.77 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.493 -0.558 . . . . 71.5 109.493 -177.85 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.25 -112.55 5.01 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.556 -0.618 . . . . 62.549999999999997 111.556 -178.657 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.431 ' CG ' ' HB2' ' A' ' 136' ' ' ASP . 21.7 m-70 -137.35 123.97 21.02 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.435 -1.32 . . . . 71.510000000000005 107.435 177.724 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 14.6 tpt -83.92 8.64 14.41 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.781 0.8 . . . . 63.530000000000001 112.184 -173.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 tt -137.19 118.81 14.93 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.403 -1.702 . . . . 73.409999999999997 106.403 174.184 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -121.5 136.91 54.92 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 109.502 -0.555 . . . . 64.219999999999999 109.502 -176.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.461 ' CG2' HG22 ' A' ' 137' ' ' VAL . 21.7 m -130.09 113.77 27.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 108.446 -0.946 . . . . 53.329999999999998 108.446 170.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -115.56 116.31 27.93 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.03 -0.986 . . . . 63.210000000000001 109.433 -177.772 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.09 108.02 16.1 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 106.458 -1.682 . . . . 73.340000000000003 106.458 172.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 140' ' ' THR . 23.1 t -125.9 115.65 20.29 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.038 -1.097 . . . . 74.340000000000003 108.038 -177.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -120.43 146.86 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 109.521 -0.548 . . . . 73.420000000000002 109.521 -177.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.9 m -128.91 122.63 30.69 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 109.83 -0.433 . . . . 60.439999999999998 109.83 -177.545 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -114.34 121.76 67.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.577 0.703 . . . . 72.109999999999999 110.858 -178.208 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.3 m -95.52 155.93 38.09 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 115.407 -0.815 . . . . 63.130000000000003 110.028 -177.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.14 2.34 0.47 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 124.144 3.23 . . . . 75.0 114.1 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 29.0 t70 -84.66 -4.0 58.8 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.801 -0.814 . . . . 71.430000000000007 108.801 178.385 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 72.2 29.38 2.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.895 1.678 . . . . 73.400000000000006 106.59 -174.402 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.4 OUTLIER -101.04 125.2 47.64 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 112.967 -1.924 . . . . 65.140000000000001 108.254 -178.743 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.454 HG11 HD13 ' A' ' 95' ' ' LEU . 21.7 t -113.29 133.72 58.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 N-CA-C 108.34 -0.985 . . . . 73.230000000000004 108.34 178.267 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.6 p -140.42 161.39 37.82 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.462 -1.681 . . . . 52.0 106.462 177.497 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.53 -178.12 46.44 Favored Glycine 0 CA--C 1.483 -1.929 0 C-N-CA 118.684 -1.722 . . . . 74.209999999999994 112.888 178.145 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -145.87 133.62 21.12 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 123.08 0.552 . . . . 55.340000000000003 109.53 -176.206 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.88 115.61 46.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.103 -1.443 . . . . 74.409999999999997 107.103 176.059 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.62 118.1 56.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 109.659 -0.497 . . . . 72.519999999999996 109.659 -178.402 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.468 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -114.49 108.61 17.09 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.564 -1.273 . . . . 64.519999999999996 107.564 175.764 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.81 124.12 43.41 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.507 -0.553 . . . . 64.129999999999995 109.507 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.07 158.71 23.72 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.919 -0.582 . . . . 71.319999999999993 111.905 -174.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -53.53 130.96 54.5 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 114.306 -1.316 . . . . 74.439999999999998 109.357 173.013 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.44 87.89 0.11 Allowed 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 122.59 2.193 . . . . 44.049999999999997 111.94 177.414 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -134.06 152.62 51.92 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 104.058 -2.571 . . . . 64.310000000000002 104.058 178.652 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 73.25 101.17 0.07 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 106.19 -1.781 . . . . 71.400000000000006 106.19 -168.38 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.2 m -56.71 -31.33 64.39 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 114.138 1.162 . . . . 63.409999999999997 114.138 -173.767 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -84.99 -8.09 58.88 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.725 -0.39 . . . . 75.219999999999999 111.752 -179.071 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -104.65 109.49 21.42 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.835 0.826 . . . . 75.129999999999995 112.625 -171.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 t -121.81 7.57 9.92 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.271 -1.331 . . . . 73.329999999999998 109.288 175.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.45 97.81 0.11 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 120.717 -0.754 . . . . 70.340000000000003 111.851 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 83' ' ' SER . 39.4 Cg_exo -63.35 159.5 39.6 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.753 2.302 . . . . 63.43 111.478 176.173 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.41 120.93 36.49 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.548 -0.908 . . . . 53.43 108.548 178.501 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.1 mt -72.32 126.94 31.06 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.513 0.673 . . . . 61.420000000000002 110.642 176.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.85 87.21 6.39 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.101 -1.409 . . . . 75.120000000000005 108.374 -173.009 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.494 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -165.62 82.37 0.11 Allowed Glycine 0 N--CA 1.407 -3.251 0 CA-C-N 114.78 -1.1 . . . . 72.239999999999995 112.328 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -98.14 97.5 8.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.669 -1.234 . . . . 42.409999999999997 107.669 174.021 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -110.36 158.17 36.06 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.011 -0.995 . . . . 61.100000000000001 110.522 -174.33 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.57 -23.53 71.44 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 122.762 2.308 . . . . 51.530000000000001 111.634 177.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -103.92 30.92 4.8 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.51 -0.768 . . . . 63.43 111.658 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.6 m -58.73 -23.91 60.64 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 121.152 0.501 . . . . 40.350000000000001 110.99 176.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -66.76 -18.87 65.6 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.806 -0.633 . . . . 74.549999999999997 110.069 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -97.62 -11.91 23.06 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.739 -0.664 . . . . 74.129999999999995 110.711 -178.388 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.62 119.27 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 122.069 0.938 . . . . 65.540000000000006 111.772 178.444 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.27 103.46 15.92 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.37 -0.832 . . . . 70.230000000000004 108.786 178.761 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 85' ' ' ALA . 7.2 p -98.13 131.21 45.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.633 -1.247 . . . . 71.209999999999994 107.633 178.684 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -146.16 171.41 14.97 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.283 -0.636 . . . . 75.530000000000001 109.283 -173.3 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -85.59 151.93 23.53 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.979 -1.119 . . . . 75.519999999999996 107.979 175.338 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 63.0 t80 -113.21 122.62 48.02 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.585 -0.895 . . . . 63.299999999999997 108.585 -179.623 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -138.67 97.9 3.45 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.096 -1.446 . . . . 71.340000000000003 107.096 176.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 48.1 m -166.24 157.22 13.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.246 -1.39 . . . . 43.020000000000003 107.246 -176.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.25 1.71 3.37 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.233 1.013 . . . . 75.129999999999995 112.757 173.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.99 -4.76 65.67 Favored Glycine 0 C--O 1.213 -1.212 0 N-CA-C 110.707 -0.957 . . . . 74.219999999999999 110.707 -174.038 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.92 156.84 16.92 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 123.61 0.764 . . . . 73.430000000000007 109.283 -176.164 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.35 137.45 56.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.335 -0.617 . . . . 61.030000000000001 109.335 173.752 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -171.2 -154.17 9.53 Favored Glycine 0 N--CA 1.416 -2.665 0 C-N-CA 119.99 -1.1 . . . . 71.239999999999995 112.373 -177.701 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 12.4 p -129.68 148.04 51.52 Favored 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 123.441 0.696 . . . . 73.319999999999993 110.195 -177.269 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -136.78 145.18 44.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.674 0.273 . . . . 72.430000000000007 110.769 178.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . . . -127.07 114.92 18.39 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.565 -1.272 . . . . 31.039999999999999 107.565 174.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.7 t -114.39 117.97 57.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.557 -0.905 . . . . 73.310000000000002 108.557 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.431 ' CD2' HD12 ' A' ' 90' ' ' LEU . 48.8 p90 -120.51 154.61 35.05 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 120.817 0.341 . . . . 75.140000000000001 111.076 -174.674 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.5 m -158.15 158.37 34.5 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.16 -0.473 . . . . 60.100000000000001 110.39 -179.077 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.7 t70 67.34 31.89 6.21 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.532 1.158 . . . . 75.439999999999998 111.348 176.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 90' ' ' LEU . 31.6 mt -97.4 159.91 14.64 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.633 -0.712 . . . . 72.420000000000002 111.483 178.034 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 93' ' ' ALA . 27.5 m -96.2 158.11 15.59 Favored 'General case' 0 N--CA 1.412 -2.343 0 C-N-CA 124.554 1.142 . . . . 72.129999999999995 109.23 -177.414 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.8 -38.81 70.46 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.837 0.351 . . . . 73.409999999999997 110.655 175.251 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 91' ' ' THR . . . -63.3 -25.48 68.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.964 -0.562 . . . . 73.519999999999996 111.598 178.038 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -88.14 -16.35 33.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.905 0.383 . . . . 54.130000000000003 111.318 -178.422 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 43.7 tp -56.6 -48.64 96.79 Favored Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 112.89 0.7 . . . . 72.120000000000005 112.89 179.091 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.32 -35.87 81.95 Favored 'Trans proline' 0 C--N 1.369 1.652 0 CA-C-N 120.847 1.338 . . . . 74.129999999999995 111.318 174.474 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -64.63 -39.76 94.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.283 0.563 . . . . 70.340000000000003 110.817 -177.16 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -77.09 -19.67 56.73 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.622 -0.51 . . . . 71.430000000000007 109.622 177.199 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.13 -21.62 59.8 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.197 -0.668 . . . . 54.32 109.197 -177.819 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.09 -55.77 22.59 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.26 -1.015 . . . . 75.109999999999999 108.26 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.494 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.4 ttp -53.64 -51.31 63.52 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.508 -0.769 . . . . 65.150000000000006 109.865 178.108 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -53.07 -42.62 66.0 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.015 -0.993 . . . . 64.329999999999998 109.838 179.129 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -62.08 -41.02 97.76 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.916 -0.584 . . . . 70.200000000000003 109.498 -172.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.33 -11.16 59.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.451 -0.795 . . . . 71.310000000000002 110.097 -169.393 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.86 -17.57 14.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.858 -0.61 . . . . 52.32 110.559 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.68 -43.69 4.65 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.126 0.787 . . . . 64.049999999999997 113.126 -173.532 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.97 19.44 28.82 Favored Glycine 0 C--N 1.317 -0.49 0 N-CA-C 110.03 -1.228 . . . . 71.510000000000005 110.03 -172.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -110.18 142.44 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.449 -0.574 . . . . 52.5 109.449 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -107.86 122.48 46.88 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.426 -1.324 . . . . 73.239999999999995 107.426 177.578 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.4 mt -120.55 127.67 52.37 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 121.09 -0.244 . . . . 61.140000000000001 110.356 -177.808 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -130.34 136.68 49.37 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.609 -1.256 . . . . 71.019999999999996 107.609 177.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -146.0 149.65 34.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.409 0.623 . . . . 75.310000000000002 111.013 -178.105 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -144.67 156.51 44.13 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.868 -1.06 . . . . 73.319999999999993 108.884 -179.276 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.479 ' NH1' ' HA ' ' A' ' 180' ' ' ASP . 17.0 ttm180 -114.03 130.94 56.52 Favored 'General case' 0 N--CA 1.398 -3.037 0 N-CA-C 108.196 -1.039 . . . . 74.530000000000001 108.196 172.082 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -113.06 100.76 8.86 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.899 -1.519 . . . . 73.200000000000003 106.899 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.63 -113.32 5.2 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 110.575 -1.01 . . . . 74.230000000000004 110.575 -176.2 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -109.1 1.77 20.67 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.025 0.917 . . . . 70.010000000000005 109.436 179.245 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.4 pp -110.39 146.62 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 118.217 -1.393 . . . . 71.099999999999994 109.514 179.25 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.448 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 76.3 t -110.89 143.51 20.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-O 120.972 0.415 . . . . 63.399999999999999 110.629 -177.213 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.1 pt -124.13 133.75 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 108.822 -0.807 . . . . 71.430000000000007 108.822 178.16 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.45 127.1 41.87 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.785 -0.82 . . . . 51.229999999999997 108.785 178.113 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -131.54 123.34 27.79 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.452 -1.314 . . . . 63.549999999999997 107.452 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -143.51 164.4 27.36 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.423 -0.894 . . . . 54.200000000000003 112.982 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -134.01 130.27 37.34 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.323 -0.621 . . . . 72.030000000000001 109.323 -178.767 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.19 110.46 21.69 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.766 -0.457 . . . . 74.150000000000006 109.766 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.85 93.68 5.02 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 122.03 0.919 . . . . 75.430000000000007 108.691 177.844 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.6 pt? -114.75 23.39 12.69 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-O 122.924 1.345 . . . . 65.200000000000003 109.057 177.476 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.3 p -77.04 -26.02 53.15 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.249 -1.76 . . . . 74.010000000000005 106.249 171.596 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.9 m -93.07 18.07 9.84 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.651 -1.613 . . . . 65.450000000000003 111.541 -177.592 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 166' ' ' PRO . 8.8 p -81.65 132.44 31.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 N-CA-C 109.525 -0.546 . . . . 74.019999999999996 109.525 -179.423 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.9 t -81.99 -42.97 18.63 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.1 -0.5 . . . . 74.099999999999994 110.413 -177.07 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.82 113.9 55.48 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-O 120.944 0.402 . . . . 65.109999999999999 110.406 179.106 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.27 -11.78 21.0 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.115 2.543 . . . . 71.400000000000006 113.26 -176.365 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.44 3.61 12.95 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.034 0.934 . . . . 74.450000000000003 112.2 -175.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.87 144.69 31.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.351 0.5 . . . . 73.530000000000001 112.351 -172.035 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 24' ' ' HIS . 21.9 t0 -131.21 116.58 17.85 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 105.845 -1.909 . . . . 65.430000000000007 105.845 171.369 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 56.6 t -108.0 124.17 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 C-N-CA 120.017 -0.673 . . . . 72.230000000000004 110.463 -172.638 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.96 120.19 31.77 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.365 -0.606 . . . . 73.5 109.365 177.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.6 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.6 tm? -111.79 117.07 31.81 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.223 -1.769 . . . . 70.310000000000002 106.223 177.394 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.5 m -126.01 136.91 53.52 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 120.879 0.371 . . . . 64.099999999999994 110.263 -176.428 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.6 t -128.22 120.89 54.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.034 -1.099 . . . . 72.340000000000003 108.034 176.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.07 127.37 56.19 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.269 -0.641 . . . . 51.049999999999997 109.269 179.554 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -135.09 122.02 14.88 Favored Pre-proline 0 C--N 1.288 -2.093 0 N-CA-C 112.449 0.537 . . . . 74.120000000000005 112.449 179.186 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.88 40.81 0.44 Allowed 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 122.822 2.348 . . . . 73.120000000000005 111.527 172.293 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.52 -91.86 0.53 Allowed 'General case' 0 N--CA 1.434 -1.226 0 O-C-N 122.062 -0.399 . . . . 73.510000000000005 110.656 -178.614 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 170.31 120.29 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 124.046 0.938 . . . . 62.210000000000001 108.596 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.06 118.38 16.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 122.357 1.075 . . . . 72.409999999999997 109.999 175.242 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 176' ' ' ALA . 33.4 m -75.99 -45.81 32.75 Favored 'General case' 1 N--CA 1.367 -4.583 0 CA-C-N 113.981 -1.463 . . . . 64.549999999999997 110.498 -178.657 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.3 m -163.2 133.32 4.4 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.036 0.934 . . . . 64.120000000000005 108.949 174.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -138.58 157.53 45.97 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.467 -0.771 . . . . 73.140000000000001 111.993 177.323 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 24.1 t-20 -127.42 95.73 4.35 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 104.984 -2.228 . . . . 72.230000000000004 104.984 173.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.483 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 170.04 -148.43 11.74 Favored Glycine 0 N--CA 1.414 -2.827 0 N-CA-C 108.106 -1.998 . . . . 75.230000000000004 108.106 -178.941 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -115.59 99.25 7.2 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.864 0.84 . . . . 75.400000000000006 109.937 -176.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -82.88 117.06 22.47 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-N 115.526 -0.761 . . . . 61.219999999999999 111.013 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.3 -39.92 19.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.977 -1.49 . . . . 55.240000000000002 106.977 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -138.24 167.82 18.43 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 114.474 -1.239 . . . . 75.409999999999997 107.889 176.48 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -72.63 0.49 7.51 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.724 2.283 . . . . 42.219999999999999 111.086 174.529 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -127.69 -2.41 6.03 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.418 -0.81 . . . . 74.319999999999993 111.379 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.6 t -140.41 120.38 12.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.578 -0.897 . . . . 65.200000000000003 108.578 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.89 144.29 34.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.054 -0.721 . . . . 71.230000000000004 109.054 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -138.08 144.61 41.01 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.457 0.646 . . . . 74.409999999999997 109.464 -177.456 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.6 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.1 m-90 -119.05 114.57 22.71 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 108.017 -1.105 . . . . 72.120000000000005 108.017 176.345 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.53 107.37 18.08 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.04 0.924 . . . . 74.209999999999994 109.2 178.466 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.674 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 77.4 mt -101.51 127.4 48.22 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 114.493 -1.231 . . . . 53.140000000000001 110.207 -174.663 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -114.09 131.36 23.23 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 114.01 -1.45 . . . . 74.010000000000005 110.966 -173.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.416 ' HB3' HG11 ' A' ' 130' ' ' VAL . 97.0 Cg_exo -54.07 151.0 29.29 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.383 2.722 . . . . 74.219999999999999 112.583 178.037 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.17 -33.47 2.92 Favored Glycine 0 C--N 1.304 -1.207 0 C-N-CA 120.98 -0.629 . . . . 74.109999999999999 112.963 176.078 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.22 155.6 6.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 120.997 0.427 . . . . 63.119999999999997 110.864 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.99 144.26 14.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.32 -0.622 . . . . 54.399999999999999 109.32 -178.266 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 m -145.19 141.12 28.41 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.611 -0.514 . . . . 61.450000000000003 109.611 177.505 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 63.1 p -105.23 135.07 47.27 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.207 -0.664 . . . . 74.120000000000005 109.207 177.121 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.4 131.79 50.2 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.72 -0.474 . . . . 73.010000000000005 109.72 177.83 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 47.4 m -137.24 139.03 40.74 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 119.659 -0.816 . . . . 74.140000000000001 109.972 174.369 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.99 133.05 15.23 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 108.62 -0.881 . . . . 55.329999999999998 108.62 -175.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -133.7 131.57 39.63 Favored 'General case' 0 C--N 1.26 -3.312 0 N-CA-C 107.353 -1.351 . . . . 74.140000000000001 107.353 176.346 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.528 ' HA ' ' OG1' ' A' ' 148' ' ' THR . . . -156.68 146.3 20.74 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.563 -0.532 . . . . 74.209999999999994 109.563 -177.23 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 19.1 ptt85 -86.22 135.25 33.64 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.999 -0.546 . . . . 75.329999999999998 110.616 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.448 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 95.3 m-85 -137.65 135.84 36.9 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 108.744 -0.836 . . . . 74.150000000000006 108.744 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.2 p -58.71 109.24 0.77 Allowed 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.066 0.854 . . . . 72.140000000000001 111.547 -178.65 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.479 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 22.3 t70 -65.02 120.26 65.39 Favored Pre-proline 0 CA--C 1.489 -1.403 0 CA-C-N 115.166 -0.925 . . . . 71.219999999999999 108.69 -179.168 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.53 -45.13 12.13 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 122.14 1.893 . . . . 54.240000000000002 112.765 -175.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -84.69 -12.7 53.32 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.83 -1.077 . . . . 64.040000000000006 111.723 -176.715 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 75.8 p 60.26 56.62 3.19 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.862 1.265 . . . . 75.530000000000001 112.833 176.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -85.02 161.01 19.9 Favored 'General case' 0 N--CA 1.404 -2.734 0 CA-C-N 114.244 -1.344 . . . . 65.129999999999995 110.573 -178.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.27 -2.863 0 N-CA-C 106.247 -1.761 . . . . 73.439999999999998 106.247 176.741 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 N--CA 1.434 -1.274 0 N-CA-C 108.773 -0.825 . . . . 73.540000000000006 108.773 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.0 t -121.91 113.71 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.142 -1.429 . . . . 74.510000000000005 107.142 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -124.51 113.81 18.6 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.143 0.497 . . . . 73.519999999999996 109.71 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.09 113.75 27.14 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.407 -1.331 . . . . 74.109999999999999 107.407 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 140' ' ' THR . 37.8 m -125.18 114.51 19.09 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.931 -1.137 . . . . 75.25 107.931 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.401 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 2.1 pp -130.33 147.1 33.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.323 -0.398 . . . . 73.030000000000001 110.274 -173.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 78.3 m -125.68 123.63 39.34 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 109.27 -0.641 . . . . 74.239999999999995 109.27 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.492 ' O ' ' HD2' ' A' ' 144' ' ' PRO . 8.5 tt -114.69 131.47 66.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.944 -0.571 . . . . 74.510000000000005 111.031 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -96.55 149.95 36.44 Favored Pre-proline 0 N--CA 1.419 -1.977 0 N-CA-C 108.91 -0.774 . . . . 64.340000000000003 108.91 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.12 2.41 2.22 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.133 2.555 . . . . 70.120000000000005 112.699 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -86.74 5.82 34.44 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 123.722 0.809 . . . . 70.329999999999998 110.87 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 t70 70.83 29.48 3.11 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 123.183 1.468 . . . . 71.140000000000001 107.558 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.52 128.79 55.76 Favored 'General case' 0 N--CA 1.399 -3.018 0 CA-C-N 113.174 -1.83 . . . . 64.310000000000002 107.121 -177.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.513 HG11 HD21 ' A' ' 95' ' ' LEU . 8.1 t -124.29 144.9 32.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.095 -0.502 . . . . 51.140000000000001 110.071 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -149.21 161.26 42.36 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.791 -0.818 . . . . 65.150000000000006 108.791 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 162.26 -165.31 35.96 Favored Glycine 0 C--N 1.312 -0.786 0 C-N-CA 119.266 -1.445 . . . . 51.130000000000003 113.019 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -150.52 140.19 21.68 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.009 0.433 . . . . 72.329999999999998 109.853 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.3 mt -125.41 116.68 47.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.511 -0.922 . . . . 71.349999999999994 108.511 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.26 123.43 63.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.618 -0.512 . . . . 61.399999999999999 109.618 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.42 108.46 14.58 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.326 -1.361 . . . . 54.439999999999998 107.326 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -122.09 135.65 54.83 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.985 0.421 . . . . 72.530000000000001 111.616 -174.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.48 158.67 41.48 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.885 -0.783 . . . . 63.049999999999997 108.885 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 pttt . . . . . 0 C--N 1.318 -0.804 0 C-N-CA 118.653 -1.219 . . . . 73.0 109.775 177.18 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.493 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 4.2 t . . . . . 0 N--CA 1.431 -1.411 0 N-CA-C 107.299 -1.371 . . . . 53.420000000000002 107.299 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.08 112.64 0.29 Allowed Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 109.875 -1.29 . . . . 72.530000000000001 109.875 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -52.36 128.91 29.39 Favored 'Trans proline' 0 C--N 1.355 0.915 0 CA-C-N 119.879 1.839 . . . . 74.099999999999994 109.089 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.63 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -95.87 151.95 18.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 114.169 1.174 . . . . 72.409999999999997 114.169 -167.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 83.4 mt -85.23 141.49 30.09 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.322 -1.308 . . . . 51.530000000000001 108.952 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -106.43 99.9 9.45 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.546 -1.279 . . . . 71.549999999999997 107.546 177.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.4 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -149.69 69.37 0.33 Allowed Glycine 0 C--N 1.287 -2.188 0 C-N-CA 120.041 -1.076 . . . . 55.039999999999999 114.023 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.65 95.51 6.59 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.18 -1.415 . . . . 74.019999999999996 107.18 172.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.31 159.28 29.98 Favored Pre-proline 0 C--N 1.293 -1.885 0 CA-C-N 115.088 -0.96 . . . . 72.549999999999997 109.823 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.56 -16.74 55.09 Favored 'Trans proline' 0 N--CA 1.481 0.741 0 C-N-CA 122.739 2.292 . . . . 61.119999999999997 113.153 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -115.79 33.37 5.53 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.058 -0.519 . . . . 73.439999999999998 110.597 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 p -57.63 -28.24 63.52 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 121.222 0.534 . . . . 74.409999999999997 112.375 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -66.94 -20.05 65.83 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.235 0.541 . . . . 73.420000000000002 110.351 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -101.03 -2.77 30.77 Favored 'General case' 0 C--O 1.257 1.492 0 CA-C-N 115.846 -0.615 . . . . 73.140000000000001 110.233 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' A' ' 87' ' ' PHE . 4.3 p -132.41 118.87 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.12 0.962 . . . . 62.240000000000002 110.817 175.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.95 106.0 17.99 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.477 -0.783 . . . . 61.509999999999998 109.209 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.21 130.93 45.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 106.784 -1.561 . . . . 71.349999999999994 106.784 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.1 t -145.67 171.77 14.24 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.89 -0.781 . . . . 33.140000000000001 108.89 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -84.53 137.9 33.06 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.14 -0.689 . . . . 74.329999999999998 109.14 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 77.0 t80 -107.38 124.96 50.6 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.473 -0.936 . . . . 73.239999999999995 108.473 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -139.0 98.84 3.62 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.553 -1.277 . . . . 74.430000000000007 107.553 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 70.3 m -160.22 148.48 16.79 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.779 -0.452 . . . . 55.32 109.779 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 67.64 8.22 6.21 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.733 1.213 . . . . 75.299999999999997 112.056 173.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.59 4.99 65.3 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.003 -0.839 . . . . 55.509999999999998 111.003 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.498 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 2.9 m-85 -104.71 142.91 33.85 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.191 -1.041 . . . . 72.010000000000005 108.191 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.8 m -124.78 139.18 51.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.547 -0.909 . . . . 65.219999999999999 108.547 175.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.26 -153.8 10.6 Favored Glycine 0 C--N 1.266 -3.353 0 N-CA-C 110.309 -1.117 . . . . 62.409999999999997 110.309 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.63 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 69.3 m -132.48 151.07 52.03 Favored 'General case' 0 C--N 1.266 -3.034 0 CA-C-O 121.289 0.566 . . . . 74.329999999999998 111.804 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -131.35 141.14 49.86 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.708 -0.678 . . . . 74.140000000000001 109.894 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.35 114.66 26.95 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.941 -1.133 . . . . 62.219999999999999 107.941 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.51 113.1 43.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.752 -1.203 . . . . 72.230000000000004 107.752 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CD2' HD12 ' A' ' 90' ' ' LEU . 40.6 p90 -120.42 156.23 31.84 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 120.745 0.307 . . . . 75.099999999999994 111.648 -173.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 p -160.7 149.54 16.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.876 -0.602 . . . . 75.519999999999996 111.089 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 67.23 32.16 6.2 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.467 1.107 . . . . 73.299999999999997 110.822 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 87' ' ' PHE . 19.6 mt -89.52 169.22 11.54 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.687 -0.688 . . . . 72.219999999999999 109.621 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.401 HG22 ' OE1' ' A' ' 94' ' ' GLU . 10.8 t -124.82 171.14 10.38 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.698 -0.482 . . . . 64.409999999999997 109.698 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -56.36 -36.37 68.72 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.856 0.862 . . . . 75.129999999999995 112.366 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.56 -25.6 63.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.15 0.5 . . . . 74.099999999999994 111.811 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' OE1' HG22 ' A' ' 91' ' ' THR . 55.7 mt-10 -81.07 -21.25 40.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 112.126 0.417 . . . . 75.140000000000001 112.126 -176.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.513 HD21 HG11 ' A' ' 40' ' ' VAL . 18.8 mt -54.53 -49.77 89.15 Favored Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 115.697 1.74 . . . . 73.030000000000001 115.697 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -54.92 -45.84 37.88 Favored 'Trans proline' 0 C--N 1.365 1.441 0 CA-C-N 120.816 1.327 . . . . 72.329999999999998 111.269 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.526 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 22.0 mt-30 -68.46 -32.87 73.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.948 0.88 . . . . 65.129999999999995 110.407 -174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.42 -40.58 89.62 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.296 -1.32 . . . . 74.299999999999997 108.829 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.75 -25.38 67.9 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.932 -1.031 . . . . 71.329999999999998 111.118 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' ' 97' ' ' GLN . 84.2 m-20 -59.35 -55.55 33.3 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.404 0.44 . . . . 73.340000000000003 109.901 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.4 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 29.7 ttp -54.36 -48.93 70.91 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.706 0.629 . . . . 70.319999999999993 110.222 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -53.13 -41.95 65.57 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 114.964 -1.016 . . . . 61.439999999999998 111.363 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.9 m -67.23 -21.4 65.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.83 -0.623 . . . . 71.430000000000007 112.003 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.14 -28.59 70.17 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 121.38 0.61 . . . . 64.310000000000002 109.753 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -112.65 -2.55 14.51 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.823 -0.626 . . . . 72.140000000000001 110.916 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.7 -47.59 3.86 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.153 -0.619 . . . . 73.219999999999999 112.52 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.44 28.97 66.71 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.218 -0.992 . . . . 71.040000000000006 112.007 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.4 m -123.1 173.56 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.594 -0.521 . . . . 62.32 109.594 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -126.23 130.34 50.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.891 0.314 . . . . 73.209999999999994 110.912 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.05 136.16 53.42 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.06 -0.718 . . . . 63.009999999999998 109.06 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -143.34 120.21 11.27 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.933 -0.395 . . . . 63.340000000000003 109.933 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.3 145.9 36.64 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.08 -0.648 . . . . 63.549999999999997 109.262 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HE ' HD11 ' A' ' 120' ' ' ILE . 84.4 mtm-85 -147.41 151.33 36.29 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.55 -0.75 . . . . 62.219999999999999 109.571 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.416 ' CG ' HG22 ' A' ' 119' ' ' VAL . 20.3 mtt85 -97.16 137.6 35.95 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 120.126 -0.63 . . . . 61.100000000000001 111.42 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -117.77 92.26 3.79 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 106.534 -1.654 . . . . 73.430000000000007 106.534 174.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.94 -98.24 1.18 Allowed Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 110.694 -0.962 . . . . 62.43 110.694 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -130.64 6.28 4.74 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.809 1.29 . . . . 71.040000000000006 108.216 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.544 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.2 pp -108.51 145.06 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 106.695 -1.595 . . . . 71.209999999999994 106.695 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.416 HG22 ' CG ' ' A' ' 114' ' ' ARG . 90.9 t -105.48 136.44 39.51 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.831 0 N-CA-C 109.675 -0.491 . . . . 75.310000000000002 109.675 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.497 HG22 ' HG2' ' A' ' 175' ' ' GLN . 33.5 pt -111.69 133.57 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.318 0 N-CA-C 107.531 -1.285 . . . . 70.510000000000005 107.531 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.6 tt -115.03 123.76 49.88 Favored 'General case' 0 C--N 1.255 -3.534 0 N-CA-C 108.385 -0.968 . . . . 73.109999999999999 108.385 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -116.49 131.2 57.01 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 113.913 -1.494 . . . . 72.230000000000004 107.052 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -152.64 148.26 18.91 Favored Glycine 0 N--CA 1.413 -2.837 0 C-N-CA 119.735 -1.222 . . . . 74.129999999999995 110.301 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.58 137.47 43.77 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.103 -0.703 . . . . 71.010000000000005 109.103 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.38 109.14 13.52 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 108.633 -0.877 . . . . 64.439999999999998 108.633 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.11 98.6 7.45 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.543 -1.651 . . . . 61.409999999999997 106.543 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.13 36.99 4.49 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 123.024 1.392 . . . . 75.400000000000006 108.542 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 49.8 p . . . . . 0 C--N 1.288 -2.093 0 CA-C-N 113.515 -1.675 . . . . 71.439999999999998 110.538 178.574 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 . . . . . 0 C--O 1.243 0.728 0 N-CA-C 112.014 0.376 . . . . 75.120000000000005 112.014 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -71.92 136.0 46.72 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.92 -0.582 . . . . 71.530000000000001 109.567 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -131.06 114.43 15.16 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.846 -0.428 . . . . 74.310000000000002 109.846 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 89.4 t -109.96 126.63 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 107.163 -1.421 . . . . 71.230000000000004 107.163 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -134.79 129.14 34.12 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 120.939 0.4 . . . . 71.450000000000003 111.206 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.9 tp -117.79 129.48 55.7 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.178 -0.464 . . . . 70.409999999999997 109.905 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' SER . 18.4 m -127.05 122.56 34.7 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.074 -1.084 . . . . 73.549999999999997 108.074 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 97.1 t -118.07 122.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.413 -0.588 . . . . 62.009999999999998 109.413 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.07 130.6 56.56 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.23 -0.655 . . . . 74.530000000000001 109.23 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.699 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.2 p90 -135.33 127.1 17.71 Favored Pre-proline 0 C--N 1.286 -2.178 0 CA-C-O 119.424 -0.322 . . . . 61.219999999999999 111.587 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 58.5 Cg_endo -75.15 36.63 0.45 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.569 2.179 . . . . 73.319999999999993 112.029 177.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.54 -103.19 0.41 Allowed 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 109.665 -0.495 . . . . 53.310000000000002 109.665 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.87 131.05 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.931 -1.137 . . . . 61.130000000000003 107.931 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.59 133.84 28.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.049 0.452 . . . . 75.219999999999999 109.969 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.3 p -89.19 -46.41 8.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.246 0.546 . . . . 72.030000000000001 109.623 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.6 m -152.05 133.88 14.85 Favored 'General case' 0 C--O 1.207 -1.178 0 CA-C-N 115.586 -0.733 . . . . 42.43 110.055 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 t -139.0 160.9 38.67 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.869 -0.519 . . . . 72.530000000000001 110.446 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 29.2 t-20 -132.26 89.56 2.68 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.723 -1.954 . . . . 75.150000000000006 105.723 174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.35 -147.97 9.96 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 108.235 -1.946 . . . . 72.200000000000003 108.235 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -118.36 100.63 7.61 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 117.829 0.814 . . . . 64.409999999999997 110.301 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 21.0 ptt180 -83.26 123.44 29.6 Favored 'General case' 0 N--CA 1.413 -2.313 0 C-N-CA 119.884 -0.726 . . . . 73.420000000000002 111.354 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.56 -46.93 17.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.236 -1.394 . . . . 71.340000000000003 107.236 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -123.53 165.02 24.88 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 107.739 -1.208 . . . . 73.049999999999997 107.739 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -72.23 -0.16 8.22 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.429 2.086 . . . . 61.329999999999998 110.931 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.699 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.9 pt-20 -135.46 6.3 3.25 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.166 -0.925 . . . . 74.439999999999998 111.9 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.92 120.85 6.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 108.126 -1.064 . . . . 64.430000000000007 108.126 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 36.9 t -125.19 146.57 30.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 109.448 -0.575 . . . . 72.5 109.448 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -133.03 146.11 51.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 109.45 -0.574 . . . . 54.030000000000001 109.45 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 29.7 m-90 -128.19 129.35 46.34 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.639 -0.71 . . . . 72.540000000000006 109.245 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 1.0 OUTLIER -102.73 103.0 13.21 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 122.149 0.976 . . . . 74.310000000000002 111.005 176.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.5 mm? -90.73 116.22 28.42 Favored 'General case' 0 C--O 1.264 1.829 0 CA-C-O 121.827 0.822 . . . . 74.329999999999998 108.891 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 10.8 mmpt? -104.73 143.5 26.83 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 114.272 -1.331 . . . . 62.109999999999999 111.269 -172.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 58.5 Cg_endo -69.85 150.22 67.35 Favored 'Trans proline' 0 C--O 1.248 1.013 0 C-N-CA 123.963 3.109 . . . . 74.319999999999993 111.722 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.49 -30.64 3.06 Favored Glycine 0 C--N 1.321 -0.288 0 C-N-CA 120.913 -0.66 . . . . 41.020000000000003 112.213 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 35.3 m -105.63 165.79 3.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 110.011 -0.366 . . . . 73.230000000000004 110.011 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.69 142.26 26.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.215 -1.031 . . . . 63.310000000000002 108.215 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 63.7 m -142.34 140.89 32.26 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.204 0.526 . . . . 73.129999999999995 110.823 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 50.5 p -103.34 141.3 36.17 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.962 -1.125 . . . . 74.209999999999994 107.962 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -123.79 126.58 46.72 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.919 -0.4 . . . . 63.119999999999997 109.919 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 35.4 t -138.79 144.15 39.24 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.829 -0.434 . . . . 31.309999999999999 109.829 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.42 127.94 10.74 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.318 -0.993 . . . . 65.519999999999996 108.318 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' A' ' 120' ' ' ILE . 44.8 mt-30 -128.47 131.95 48.37 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 108.703 -0.851 . . . . 73.239999999999995 108.703 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.73 159.9 43.79 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.822 -0.436 . . . . 44.240000000000002 109.822 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.544 ' HG2' HG22 ' A' ' 118' ' ' ILE . 98.5 mtt180 -86.96 126.81 34.95 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.674 -0.491 . . . . 71.519999999999996 109.674 -177.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.401 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 74.9 m-85 -143.11 125.24 15.37 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 109.589 -0.523 . . . . 64.239999999999995 109.589 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.35 114.07 1.84 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 124.29 0.994 . . . . 73.340000000000003 111.831 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.2 t70 . . . . . 0 C--O 1.213 -0.868 0 N-CA-C 108.322 -0.992 . . . . 72.030000000000001 108.322 177.495 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 . . . . . 0 N--CA 1.417 -2.086 0 N-CA-C 108.956 -0.757 . . . . 73.099999999999994 108.956 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.22 114.51 46.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.805 -1.183 . . . . 75.25 107.805 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -116.82 113.93 23.21 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.65 -1.159 . . . . 71.219999999999999 109.608 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.59 121.36 42.39 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 109.11 -0.7 . . . . 64.450000000000003 109.11 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.6 m -127.12 114.7 18.06 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.048 -1.093 . . . . 72.420000000000002 108.048 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -128.15 147.26 32.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.716 -0.475 . . . . 71.329999999999998 109.716 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.5 m -130.49 122.25 27.31 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 121.162 0.506 . . . . 74.239999999999995 110.221 -177.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 143' ' ' PHE . 10.7 tt -106.61 117.64 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.771 0.796 . . . . 74.540000000000006 109.51 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.8 t -77.76 150.54 78.84 Favored Pre-proline 0 N--CA 1.419 -1.987 0 CA-C-N 114.781 -1.099 . . . . 42.32 108.784 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -65.26 2.37 1.5 Allowed 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 123.555 2.837 . . . . 72.340000000000003 112.03 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -89.4 -0.31 57.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.324 1.05 . . . . 74.409999999999997 108.243 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 29.3 t70 68.96 29.11 4.99 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.58 1.552 . . . . 71.120000000000005 108.523 -178.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.38 126.99 53.49 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 113.583 -1.644 . . . . 70.209999999999994 107.505 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 t -107.73 138.95 31.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 109.315 -0.624 . . . . 63.109999999999999 109.315 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.4 p -147.28 158.68 44.05 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.256 -1.387 . . . . 63.329999999999998 107.256 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.7 -172.07 41.78 Favored Glycine 0 CA--C 1.489 -1.589 0 C-N-CA 119.433 -1.365 . . . . 63.340000000000003 112.197 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.6 133.39 17.96 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.33 0.586 . . . . 24.449999999999999 109.635 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 68.2 mt -117.23 116.22 51.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.952 -1.129 . . . . 64.310000000000002 107.952 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.39 120.45 62.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.398 -0.593 . . . . 74.019999999999996 109.398 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.499 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.32 107.6 16.93 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 106.462 -1.681 . . . . 53.539999999999999 106.462 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -117.39 123.59 46.8 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.787 -0.449 . . . . 62.240000000000002 109.787 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.27 157.5 19.4 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.554 0.692 . . . . 72.219999999999999 112.22 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 N--CA 1.441 -0.907 0 CA-C-N 113.404 -1.726 . . . . 70.150000000000006 110.328 179.685 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 N--CA 1.429 -1.493 0 N-CA-C 107.247 -1.39 . . . . 61.130000000000003 107.247 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.625 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 174.04 97.96 0.11 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.105 -1.198 . . . . 72.530000000000001 110.105 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.535 ' O ' ' HB3' ' A' ' 83' ' ' SER . 15.7 Cg_exo -68.32 159.07 54.85 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.571 2.18 . . . . 75.409999999999997 111.672 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.62 154.48 24.82 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.196 -0.668 . . . . 50.100000000000001 109.196 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 85' ' ' ALA . 48.1 mt -74.77 152.39 39.03 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.371 0.605 . . . . 73.310000000000002 111.908 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -107.94 99.49 8.94 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.056 -0.975 . . . . 64.219999999999999 109.183 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.465 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -160.22 92.76 0.12 Allowed Glycine 0 C--N 1.29 -2.011 0 C-N-CA 120.36 -0.924 . . . . 71.129999999999995 113.525 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -86.48 112.58 21.65 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.253 -1.017 . . . . 74.409999999999997 108.253 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.09 162.08 54.36 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 116.269 -0.423 . . . . 54.200000000000003 110.499 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.18 -21.13 67.69 Favored 'Trans proline' 0 N--CA 1.478 0.593 0 C-N-CA 122.401 2.067 . . . . 71.209999999999994 112.043 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -109.87 27.99 9.03 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.632 -0.713 . . . . 52.450000000000003 111.855 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.4 m -52.19 -31.51 32.02 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.281 0.474 . . . . 71.510000000000005 112.281 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -61.65 -22.09 64.98 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.007 0.523 . . . . 75.310000000000002 111.819 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 88' ' ' SER . 32.7 mmtp -98.85 -10.08 23.4 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 122.287 -0.258 . . . . 72.340000000000003 111.134 -176.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.69 120.04 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 119.693 -0.803 . . . . 72.519999999999996 110.861 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.13 113.21 25.68 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.686 -0.688 . . . . 44.100000000000001 109.266 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.47 124.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 108.282 -1.007 . . . . 35.020000000000003 108.282 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 m -128.55 165.04 21.52 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.024 -0.989 . . . . 64.239999999999995 109.8 -172.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.625 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 5.9 t30 -77.51 136.5 38.33 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.109 -0.95 . . . . 74.549999999999997 109.132 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -110.62 119.41 39.06 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 108.64 -0.874 . . . . 70.340000000000003 108.64 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -138.86 100.01 3.94 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.528 -0.915 . . . . 43.119999999999997 108.528 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 t -163.0 143.92 9.59 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.389 -0.597 . . . . 62.409999999999997 109.389 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.92 12.05 8.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.912 0.885 . . . . 73.230000000000004 113.357 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.62 -3.61 65.7 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.33 -0.938 . . . . 53.100000000000001 111.485 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.558 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 29.8 m-85 -94.74 145.46 24.85 Favored 'General case' 0 C--O 1.254 1.316 0 N-CA-C 108.218 -1.031 . . . . 71.400000000000006 108.218 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.3 m -128.94 136.63 59.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.611 -0.885 . . . . 44.299999999999997 108.611 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.94 -155.25 9.96 Favored Glycine 0 N--CA 1.414 -2.808 0 C-N-CA 119.98 -1.105 . . . . 61.149999999999999 111.899 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 24.4 p -121.94 152.0 40.15 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.131 -0.535 . . . . 74.540000000000006 110.473 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.8 pt20 -138.73 129.4 26.23 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.571 -0.452 . . . . 62.329999999999998 110.59 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -107.3 114.49 28.56 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.011 -1.477 . . . . 63.420000000000002 107.011 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.33 116.26 51.87 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.735 -1.209 . . . . 71.099999999999994 107.735 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CD2' HD12 ' A' ' 90' ' ' LEU . 41.8 p90 -117.88 157.61 26.35 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.08 0.467 . . . . 64.120000000000005 111.286 -174.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 16.5 p -158.62 152.7 23.79 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.354 -0.839 . . . . 54.100000000000001 109.616 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 t70 62.5 47.24 5.16 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 122.959 1.361 . . . . 62.439999999999998 111.26 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.452 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.4 mt -108.06 163.32 13.25 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.572 -1.194 . . . . 74.340000000000003 110.003 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -112.15 174.03 6.08 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.367 -0.605 . . . . 64.510000000000005 109.367 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.425 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 61.9 t80 -50.53 -48.36 57.22 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.18 0.992 . . . . 74.219999999999999 111.308 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.68 -25.43 66.36 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.433 0.693 . . . . 44.350000000000001 112.193 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -86.65 -16.44 36.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 116.138 -0.483 . . . . 71.299999999999997 112.3 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 5.4 tt -64.52 -52.18 54.41 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 119.54 -0.267 . . . . 73.530000000000001 110.441 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.85 -30.89 39.85 Favored 'Trans proline' 0 C--N 1.367 1.541 0 CA-C-N 120.951 1.376 . . . . 65.0 110.529 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -67.42 -31.16 71.16 Favored 'General case' 0 N--CA 1.424 -1.744 0 O-C-N 121.957 -0.464 . . . . 75.219999999999999 110.889 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -77.84 -19.16 55.37 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.175 0.512 . . . . 73.319999999999993 109.975 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.87 -13.49 61.68 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.555 -0.748 . . . . 74.329999999999998 110.653 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -66.37 -57.89 6.47 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.241 -1.022 . . . . 74.219999999999999 108.241 172.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.465 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.8 ttp -55.85 -50.48 70.46 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.252 0.548 . . . . 73.340000000000003 110.131 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.54 -37.74 65.77 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 114.456 -1.247 . . . . 70.430000000000007 111.712 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.7 p -62.35 -31.73 72.42 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 119.942 -0.703 . . . . 51.420000000000002 111.248 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.37 -25.0 67.38 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.498 0.666 . . . . 70.140000000000001 111.263 -173.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.44 -13.77 15.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.22 -0.592 . . . . 42.310000000000002 111.283 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.27 -41.47 5.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.115 0.783 . . . . 75.349999999999994 113.115 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.98 19.92 58.55 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.498 -1.041 . . . . 74.099999999999994 110.498 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 m -104.36 155.44 5.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.19 0.519 . . . . 70.439999999999998 111.154 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.18 137.33 54.25 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.096 -1.816 . . . . 72.129999999999995 106.096 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -134.92 111.52 9.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.055 0.455 . . . . 71.25 112.143 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.8 t -119.37 122.27 41.42 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.75 -0.833 . . . . 64.319999999999993 108.75 176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -139.31 142.88 37.67 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 116.06 -0.518 . . . . 73.349999999999994 109.738 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -141.14 149.6 41.72 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.523 -1.217 . . . . 75.129999999999995 109.568 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 ttm105 -98.92 137.86 36.88 Favored 'General case' 0 N--CA 1.409 -2.492 0 N-CA-C 108.527 -0.916 . . . . 61.509999999999998 108.527 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -122.63 94.58 4.33 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.11 -1.441 . . . . 63.240000000000002 107.11 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.75 -103.87 1.36 Allowed Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.856 -0.898 . . . . 73.510000000000005 110.856 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.605 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 11.2 t30 -113.99 -8.55 13.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.227 1.013 . . . . 71.409999999999997 109.422 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -99.54 149.87 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 C-N-CA 119.36 -0.936 . . . . 74.25 109.408 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.2 t -119.02 138.86 48.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 O-C-N 121.923 -0.486 . . . . 74.030000000000001 111.195 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.6 pt -117.05 132.96 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.344 -0.844 . . . . 71.120000000000005 109.209 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.2 tt -129.22 130.93 46.92 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 115.971 -0.559 . . . . 64.150000000000006 109.717 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.32 133.23 34.69 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.971 -0.559 . . . . 73.519999999999996 110.002 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.74 171.97 32.49 Favored Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 120.161 -1.018 . . . . 71.0 112.002 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -138.53 158.11 44.88 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.417 -0.586 . . . . 75.120000000000005 109.417 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.94 113.26 18.23 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.626 -0.879 . . . . 74.310000000000002 108.626 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -111.96 93.81 4.64 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.878 0.847 . . . . 75.519999999999996 111.506 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 166' ' ' PRO . 1.1 pt? -134.98 30.92 3.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 123.88 1.8 . . . . 74.510000000000005 107.045 176.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.416 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 37.1 p . . . . . 0 C--N 1.296 -1.72 0 CA-C-N 111.863 -2.426 . . . . 71.349999999999994 112.596 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 C--O 1.237 0.395 0 CA-C-O 122.043 0.925 . . . . 65.450000000000003 109.827 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.88 140.93 28.98 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.935 -1.03 . . . . 43.43 111.831 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -132.1 141.79 49.29 Favored 'General case' 0 C--O 1.265 1.919 0 CA-C-N 115.699 -0.682 . . . . 75.310000000000002 110.124 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 60.2 t -106.4 116.23 49.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.229 -1.026 . . . . 55.340000000000003 108.229 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -115.47 120.71 40.42 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.871 -0.418 . . . . 72.010000000000005 109.871 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -118.54 115.74 25.2 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.531 -1.285 . . . . 70.400000000000006 107.531 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.5 m -120.82 128.33 52.76 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.146 -0.479 . . . . 71.420000000000002 109.732 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.4 t -120.74 127.18 75.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.353 -0.61 . . . . 64.219999999999999 109.353 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.24 124.55 52.79 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 109.503 -0.555 . . . . 74.120000000000005 109.503 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.627 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.3 p90 -134.36 112.46 11.98 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 122.909 0.484 . . . . 73.239999999999995 111.208 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -67.82 42.75 0.24 Allowed 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.484 2.789 . . . . 75.430000000000007 113.118 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.09 -92.94 0.51 Allowed 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.559 -0.534 . . . . 54.329999999999998 109.559 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.01 126.77 0.02 OUTLIER 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.939 0.896 . . . . 75.310000000000002 108.829 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.25 123.89 38.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.144 0.497 . . . . 74.040000000000006 110.07 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.7 p -86.4 -36.35 19.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.771 0.319 . . . . 65.230000000000004 111.01 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.6 m -161.99 132.92 5.08 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 107.859 -1.163 . . . . 44.109999999999999 107.859 176.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -139.03 152.29 47.48 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.903 -0.498 . . . . 72.239999999999995 110.938 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 27.8 t-20 -115.73 92.03 3.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.988 -1.856 . . . . 71.420000000000002 105.988 172.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.34 -149.77 12.07 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.139 -1.984 . . . . 75.140000000000001 108.139 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -116.54 99.76 7.38 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 117.887 0.844 . . . . 72.099999999999994 109.569 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -77.94 119.77 21.86 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 119.679 -0.809 . . . . 73.420000000000002 109.538 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.5 mm -86.81 -44.97 16.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.192 -1.411 . . . . 52.109999999999999 107.192 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -118.45 162.43 30.43 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 105.215 -2.143 . . . . 73.140000000000001 105.215 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -74.37 -0.8 10.15 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.901 1.734 . . . . 74.340000000000003 110.956 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.627 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.3 pt-20 -131.95 3.82 4.1 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.129 -0.941 . . . . 61.210000000000001 111.35 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.87 121.13 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 108.463 -0.94 . . . . 62.020000000000003 108.463 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.0 t -122.46 148.29 26.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.538 -0.541 . . . . 53.439999999999998 109.538 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -131.94 138.86 48.5 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.515 -0.55 . . . . 71.319999999999993 109.515 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.445 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.8 m-90 -119.63 130.39 55.06 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.701 -0.851 . . . . 70.200000000000003 108.701 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -109.88 104.24 13.14 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.957 0.884 . . . . 65.420000000000002 108.648 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 0.5 OUTLIER -100.98 131.19 46.97 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.818 -0.808 . . . . 72.299999999999997 108.818 -174.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 66.0 mttm -117.36 149.61 44.95 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 115.802 -0.636 . . . . 70.239999999999995 112.598 -173.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.441 ' HA ' ' HG ' ' A' ' 127' ' ' LEU . 17.0 Cg_exo -67.45 154.94 72.31 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.878 2.386 . . . . 70.25 111.743 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 84.43 -39.31 2.91 Favored Glycine 0 C--N 1.311 -0.828 0 CA-C-N 115.83 -0.623 . . . . 61.5 112.541 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.34 151.86 6.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.981 -0.378 . . . . 71.340000000000003 109.981 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.79 110.44 24.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.733 0.778 . . . . 73.400000000000006 109.15 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.405 ' HB2' HD12 ' A' ' 164' ' ' LEU . 14.9 m -101.31 131.04 47.55 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.688 -0.687 . . . . 70.209999999999994 109.689 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 37.6 p -105.41 145.2 31.14 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.109 -0.496 . . . . 63.420000000000002 109.708 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 25.1 ptp -126.66 134.05 50.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.8 -0.815 . . . . 73.430000000000007 108.8 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 9.1 m -141.69 146.94 36.69 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.236 -1.024 . . . . 64.310000000000002 108.236 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.445 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -156.31 120.59 4.49 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.787 -0.449 . . . . 61.5 109.787 -175.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -123.01 131.87 53.89 Favored 'General case' 0 C--N 1.264 -3.136 0 N-CA-C 107.391 -1.337 . . . . 72.329999999999998 107.391 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -160.31 153.06 21.18 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.978 -1.119 . . . . 72.239999999999995 107.978 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.602 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 38.5 ptt180 -92.87 131.49 37.85 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.2 -1.0 . . . . 74.510000000000005 109.685 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -126.38 118.42 24.98 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.718 -1.215 . . . . 75.140000000000001 107.718 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.605 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -53.25 109.97 0.49 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 124.905 1.378 . . . . 72.109999999999999 112.538 -177.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.6 t0 . . . . . 0 CA--C 1.502 -0.877 0 N-CA-C 107.589 -1.263 . . . . 74.099999999999994 107.589 -179.523 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 109.441 -0.577 . . . . 72.109999999999999 109.441 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 46' ' ' ALA . 33.1 m -125.08 129.86 73.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.964 -0.694 . . . . 75.219999999999999 109.95 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.496 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 15.5 ptt180 -139.35 122.25 16.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.52 0.676 . . . . 53.439999999999998 111.038 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.66 138.56 49.29 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.54 -0.755 . . . . 51.310000000000002 109.287 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.7 m -134.17 115.25 13.99 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.075 -1.083 . . . . 74.329999999999998 108.075 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 11.6 pt -129.04 149.1 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-O 121.359 0.599 . . . . 50.350000000000001 110.178 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 88.8 m -124.51 126.67 46.24 Favored 'General case' 0 C--N 1.264 -3.112 0 N-CA-C 108.976 -0.75 . . . . 74.200000000000003 108.976 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.482 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.8 tt -113.26 120.03 62.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.793 0.806 . . . . 52.329999999999998 109.752 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 37' ' ' ASP . 26.3 t -81.4 151.99 69.73 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 114.639 -1.164 . . . . 54.409999999999997 109.056 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.65 2.31 2.09 Favored 'Trans proline' 0 C--N 1.364 1.351 0 C-N-CA 123.291 2.66 . . . . 63.329999999999998 111.524 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 35' ' ' SER . 14.3 t70 -82.52 -7.99 59.63 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.703 1.201 . . . . 63.219999999999999 108.318 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.9 t70 72.22 29.26 2.28 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 123.444 1.592 . . . . 70.439999999999998 107.413 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.24 135.38 51.09 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 113.125 -1.852 . . . . 64.030000000000001 107.491 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.402 HG12 ' HE2' ' A' ' 87' ' ' PHE . 10.6 t -117.03 142.01 32.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.173 -0.677 . . . . 52.140000000000001 109.173 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.1 p -149.66 157.57 43.36 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.501 -1.296 . . . . 75.540000000000006 107.501 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.77 -162.84 34.88 Favored Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 118.481 -1.818 . . . . 41.109999999999999 112.949 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -150.44 133.69 16.29 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.361 0.6 . . . . 72.25 110.108 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.8 116.37 52.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.614 -1.254 . . . . 64.040000000000006 107.614 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 29' ' ' ARG . 2.0 mp -103.19 120.97 53.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 120.862 0.363 . . . . 75.040000000000006 110.258 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -119.73 108.8 14.87 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.533 -1.284 . . . . 33.509999999999998 107.533 174.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -121.6 146.52 46.89 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.448 0.642 . . . . 64.349999999999994 112.06 -173.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.83 139.28 50.15 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.438 -0.949 . . . . 65.439999999999998 108.438 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 tttm . . . . . 0 C--N 1.31 -1.134 0 N-CA-C 107.886 -1.153 . . . . 74.420000000000002 107.886 179.244 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.443 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 20.7 p . . . . . 0 N--CA 1.427 -1.604 0 N-CA-C 107.616 -1.253 . . . . 71.420000000000002 107.616 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.08 103.62 0.17 Allowed Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 114.582 -1.19 . . . . 73.319999999999993 110.202 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.43 134.77 53.05 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.746 2.297 . . . . 51.219999999999999 110.434 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.94 148.25 25.21 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 114.802 1.408 . . . . 72.219999999999999 114.802 -168.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 92.7 mt -89.08 161.66 16.41 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 114.201 -1.363 . . . . 62.43 108.57 174.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -110.62 90.78 3.42 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.437 0.637 . . . . 74.299999999999997 109.827 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.43 51.7 1.58 Allowed Glycine 0 C--N 1.302 -1.333 0 CA-C-N 115.685 -0.689 . . . . 74.439999999999998 112.697 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -96.44 98.85 10.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.352 0.596 . . . . 73.310000000000002 110.542 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.68 171.74 7.23 Favored Pre-proline 0 C--N 1.311 -1.1 0 C-N-CA 123.569 0.748 . . . . 50.210000000000001 109.951 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.09 -19.25 34.78 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.857 1.705 . . . . 70.219999999999999 111.612 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.44 ' CE1' ' HG2' ' A' ' 97' ' ' GLN . 15.6 p90 -111.29 36.28 3.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.855 -0.612 . . . . 61.310000000000002 110.606 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.5 m -60.41 -27.7 67.67 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 122.064 -0.397 . . . . 65.120000000000005 111.814 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.4 pm0 -71.99 -9.33 58.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.487 -0.758 . . . . 62.439999999999998 110.383 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.622 ' HB3' HD21 ' A' ' 90' ' ' LEU . 14.7 mmmm -95.95 -20.09 19.01 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.895 -0.593 . . . . 75.439999999999998 109.701 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 p -130.69 117.88 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 122.157 0.98 . . . . 63.329999999999998 110.993 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.98 124.58 47.84 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.684 -0.689 . . . . 74.150000000000006 110.326 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.93 120.61 47.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.676 -1.231 . . . . 61.549999999999997 107.676 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -124.91 168.88 12.67 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.626 -0.715 . . . . 65.010000000000005 110.258 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -79.98 150.29 30.51 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.042 -0.725 . . . . 63.210000000000001 109.042 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 93.2 t80 -127.35 129.5 47.73 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.063 -0.517 . . . . 72.120000000000005 109.738 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -138.19 98.26 3.58 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.577 -1.268 . . . . 73.310000000000002 107.577 176.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 67.7 m -164.66 155.57 14.84 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.265 -0.643 . . . . 65.030000000000001 109.265 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 69.87 4.38 4.74 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.571 1.148 . . . . 73.109999999999999 110.932 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.76 -4.07 71.76 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.205 -0.758 . . . . 42.020000000000003 111.205 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.444 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 66.4 m-85 -104.44 144.05 32.19 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.527 -0.545 . . . . 75.019999999999996 109.527 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.5 m -118.2 145.53 24.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.259 -1.015 . . . . 73.420000000000002 108.259 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.19 -153.74 12.85 Favored Glycine 0 CA--C 1.459 -3.416 0 C-N-CA 118.692 -1.718 . . . . 44.119999999999997 112.14 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.617 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 4.3 p -123.72 145.06 49.28 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-O 121.721 0.772 . . . . 73.150000000000006 111.732 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -125.64 131.73 52.6 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.466 -0.788 . . . . 71.310000000000002 109.873 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.8 114.19 26.64 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.267 -1.383 . . . . 72.239999999999995 107.267 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.1 t -107.39 113.55 43.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.111 -1.07 . . . . 70.200000000000003 108.111 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CD2' HD12 ' A' ' 90' ' ' LEU . 51.7 p90 -116.03 151.45 35.48 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.846 -0.427 . . . . 73.010000000000005 109.846 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.1 m -154.06 153.96 32.82 Favored 'General case' 0 C--N 1.292 -1.891 0 C-N-CA 120.449 -0.5 . . . . 70.129999999999995 111.099 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.22 36.18 15.0 Favored 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 124.443 1.089 . . . . 72.439999999999998 111.07 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.622 HD21 ' HB3' ' A' ' 69' ' ' LYS . 37.6 mt -97.78 168.53 10.27 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 114.854 -1.067 . . . . 63.219999999999999 109.14 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -125.43 -179.92 4.83 Favored 'General case' 0 C--N 1.268 -2.968 0 N-CA-C 108.641 -0.874 . . . . 53.509999999999998 108.641 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CZ ' ' HG ' ' A' ' 112' ' ' LEU . 43.6 t80 -51.19 -48.2 62.02 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 124.766 1.227 . . . . 72.310000000000002 110.559 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.58 -25.85 66.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.892 0.701 . . . . 73.310000000000002 112.892 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.42 -17.46 27.16 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 122.069 -0.394 . . . . 64.530000000000001 111.48 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 38.0 tp -66.47 -51.8 39.92 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 113.472 0.916 . . . . 73.239999999999995 113.472 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 92' ' ' PHE . 18.3 Cg_endo -62.96 -33.88 73.03 Favored 'Trans proline' 0 C--N 1.368 1.59 0 CA-C-N 120.829 1.332 . . . . 53.399999999999999 110.389 175.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.44 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 9.4 tt0 -66.61 -36.26 82.16 Favored 'General case' 0 N--CA 1.41 -2.464 0 CA-C-N 115.226 -0.897 . . . . 74.409999999999997 110.871 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -75.69 -19.3 59.21 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.325 0.583 . . . . 64.129999999999995 110.041 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.91 -20.57 61.75 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.825 -0.625 . . . . 73.209999999999994 110.565 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -56.31 -58.05 9.63 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 123.417 0.448 . . . . 75.099999999999994 111.177 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -59.46 -46.63 88.23 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.318 0.58 . . . . 50.109999999999999 110.194 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -57.26 -34.79 68.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.376 -1.284 . . . . 73.010000000000005 110.962 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.9 m -63.32 -33.5 75.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.553 -0.459 . . . . 71.329999999999998 110.905 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.93 -20.04 63.36 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.791 0.805 . . . . 64.439999999999998 110.479 -175.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.34 -19.13 17.95 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.697 -0.683 . . . . 62.240000000000002 110.506 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.91 -47.69 3.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.591 0.96 . . . . 63.140000000000001 113.591 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.52 28.17 25.25 Favored Glycine 0 C--O 1.238 0.403 0 N-CA-C 110.436 -1.066 . . . . 73.510000000000005 110.436 -173.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.43 160.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.412 -0.394 . . . . 74.310000000000002 110.699 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -119.32 142.77 47.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.381 -1.34 . . . . 73.299999999999997 107.381 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.7 mt -139.43 144.39 38.05 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 123.355 0.409 . . . . 72.25 110.28 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 m -142.83 117.33 9.71 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.356 -0.979 . . . . 61.310000000000002 108.356 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.43 ' HG ' ' CZ ' ' A' ' 92' ' ' PHE . 52.0 tp -121.9 125.93 47.53 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.076 -0.511 . . . . 73.420000000000002 110.375 -176.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -141.7 148.52 39.21 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.197 -0.668 . . . . 72.120000000000005 109.197 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 114' ' ' ARG . 16.8 ttm180 -98.69 128.05 44.83 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 108.39 -0.967 . . . . 71.140000000000001 108.39 172.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -102.27 86.11 2.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.84 -1.171 . . . . 72.530000000000001 107.84 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.29 -98.98 0.54 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.143 -0.935 . . . . 74.329999999999998 111.709 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.541 ' HA ' ' OD1' ' A' ' 180' ' ' ASP . 3.4 t-20 -107.63 -15.19 14.65 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.307 1.051 . . . . 74.409999999999997 109.651 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.7 pp -110.0 148.62 13.46 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.758 0 O-C-N 121.115 -0.99 . . . . 73.400000000000006 108.749 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 114' ' ' ARG . 73.6 t -105.91 137.62 35.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 O-C-N 121.639 -0.663 . . . . 64.540000000000006 110.25 -177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.408 HG22 ' HG2' ' A' ' 175' ' ' GLN . 47.0 pt -117.14 130.66 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 121.84 0.828 . . . . 71.340000000000003 110.064 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.25 128.58 44.95 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 115.161 -0.927 . . . . 63.219999999999999 109.352 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -129.18 147.68 51.05 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.614 -0.884 . . . . 74.530000000000001 108.614 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.55 166.25 37.18 Favored Glycine 0 N--CA 1.407 -3.298 0 N-CA-C 111.259 -0.736 . . . . 74.310000000000002 111.259 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -136.4 145.91 45.83 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.342 -0.985 . . . . 75.349999999999994 108.342 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 164' ' ' LEU . . . -124.29 110.15 14.25 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.932 -1.136 . . . . 71.409999999999997 107.932 174.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -99.11 105.87 18.01 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.822 -0.807 . . . . 75.319999999999993 108.822 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.8 mm? -116.86 30.65 7.21 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.37 -0.974 . . . . 64.129999999999995 108.37 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 121.588 0.708 . . . . 75.239999999999995 111.209 -177.077 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 CA--C 1.516 -0.33 0 CA-C-O 120.792 0.33 . . . . 74.420000000000002 111.105 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.527 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -85.79 122.29 29.66 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.979 -0.378 . . . . 54.130000000000003 109.979 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.37 139.43 53.28 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.221 -0.659 . . . . 61.32 109.221 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 84.4 t -113.4 113.06 42.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.712 -1.218 . . . . 73.200000000000003 107.712 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 38.5 mt-10 -117.52 123.49 46.4 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-O 120.97 0.414 . . . . 74.310000000000002 110.497 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tt -118.69 128.15 54.24 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.29 -1.744 . . . . 72.200000000000003 106.29 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.3 m -126.24 128.39 47.13 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.064 -0.717 . . . . 73.400000000000006 109.064 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.481 HG12 ' HD2' ' A' ' 143' ' ' PHE . 61.7 t -124.06 125.38 70.71 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.113 -0.699 . . . . 64.230000000000004 109.113 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.17 125.89 54.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.083 -1.08 . . . . 70.040000000000006 108.083 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.644 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.4 p90 -134.36 122.54 16.0 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 112.348 0.499 . . . . 75.219999999999999 112.348 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -70.4 61.19 2.07 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 122.365 2.044 . . . . 73.319999999999993 111.13 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.61 -132.46 0.08 Allowed 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.79 -1.189 . . . . 72.400000000000006 107.79 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -160.3 122.9 3.33 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.166 -1.05 . . . . 64.200000000000003 108.166 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.55 133.21 31.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 109.092 -0.707 . . . . 65.109999999999999 109.092 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.9 p -89.4 -44.43 10.19 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.997 -0.742 . . . . 62.229999999999997 108.997 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.0 m -159.01 133.47 7.9 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.097 -0.502 . . . . 71.420000000000002 109.759 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -138.24 155.25 48.82 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.098 0.475 . . . . 75.150000000000006 110.346 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.475 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 51.1 t-20 -121.6 90.92 3.4 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 104.263 -2.495 . . . . 72.120000000000005 104.263 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 171.96 -161.95 34.03 Favored Glycine 0 N--CA 1.411 -2.997 0 N-CA-C 106.702 -2.559 . . . . 55.140000000000001 106.702 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -100.08 99.75 10.52 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 118.257 1.028 . . . . 71.030000000000001 110.412 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -80.11 107.79 13.18 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-O 121.552 0.691 . . . . 72.239999999999995 110.306 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.0 mt -80.51 -49.1 19.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.533 -1.284 . . . . 64.230000000000004 107.533 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.57 164.7 34.59 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.318 -1.364 . . . . 71.230000000000004 107.318 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.61 -3.5 13.21 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.1 1.866 . . . . 71.519999999999996 111.112 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.644 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.8 pt-20 -131.86 5.87 4.27 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.017 -0.538 . . . . 72.219999999999999 112.386 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.7 t -143.18 121.41 7.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 108.772 -0.825 . . . . 70.209999999999994 108.772 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.75 148.15 32.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.665 -0.495 . . . . 32.310000000000002 109.665 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -133.75 141.12 47.37 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.716 -0.476 . . . . 74.109999999999999 109.716 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.476 ' O ' ' HA ' ' A' ' 138' ' ' GLU . 32.9 m-90 -117.92 119.78 35.87 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.941 -0.762 . . . . 72.230000000000004 108.941 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -109.54 98.32 7.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.154 -1.054 . . . . 65.049999999999997 108.154 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 14.1 mt -98.28 138.89 34.88 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 114.592 -1.185 . . . . 73.530000000000001 108.696 -172.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -117.47 162.48 28.28 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 114.702 1.371 . . . . 73.140000000000001 114.702 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 72.3 Cg_endo -76.18 156.64 37.87 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.363 2.709 . . . . 71.540000000000006 112.43 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.92 -33.54 2.86 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 111.289 -0.724 . . . . 71.140000000000001 111.289 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 166' ' ' PRO . 18.4 m -105.12 148.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 123.688 0.795 . . . . 74.349999999999994 110.131 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.76 113.78 37.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.498 -1.297 . . . . 73.310000000000002 107.498 174.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.6 p -107.62 146.48 31.91 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.909 -0.587 . . . . 74.109999999999999 111.515 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.0 p -103.13 151.68 22.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.861 -0.609 . . . . 72.340000000000003 111.334 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 70.4 mtm -123.22 119.78 31.2 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.24 -1.393 . . . . 74.099999999999994 107.24 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 11.7 t -136.92 135.61 37.91 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.781 -1.192 . . . . 75.049999999999997 107.781 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.03 118.31 5.98 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.353 -0.61 . . . . 60.310000000000002 109.353 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.408 ' HG2' HG22 ' A' ' 120' ' ' ILE . 40.6 mt-30 -122.47 130.66 53.29 Favored 'General case' 0 C--N 1.269 -2.899 0 N-CA-C 106.403 -1.703 . . . . 74.040000000000006 106.403 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.77 148.87 30.47 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.883 -0.327 . . . . 61.439999999999998 110.321 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 15.4 ptt180 -88.08 127.21 35.41 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 120.333 -0.547 . . . . 71.200000000000003 109.94 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.21 152.0 47.96 Favored 'General case' 0 CA--C 1.482 -1.638 0 C-N-CA 120.788 -0.365 . . . . 72.409999999999997 110.1 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.0 p -77.4 120.75 22.84 Favored 'General case' 0 C--N 1.262 -3.233 0 N-CA-C 109.794 -0.447 . . . . 73.540000000000006 109.794 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 117' ' ' ASN . 4.9 m-20 . . . . . 0 C--N 1.313 -0.997 0 CA-C-N 115.854 -0.612 . . . . 65.420000000000002 110.522 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 . . . . . 0 N--CA 1.43 -1.463 0 N-CA-C 109.285 -0.635 . . . . 74.219999999999999 109.285 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.18 114.07 43.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.743 0.782 . . . . 71.230000000000004 109.783 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 41.8 mtp85 -113.63 118.76 35.29 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.493 -0.776 . . . . 75.209999999999994 111.849 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.419 ' HB3' ' HG ' ' A' ' 139' ' ' LEU . . . -107.77 108.67 19.98 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.0 -1.111 . . . . 33.119999999999997 108.0 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 140' ' ' THR . 4.2 p -117.39 115.67 25.66 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 109.304 -0.628 . . . . 62.340000000000003 109.304 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 16.7 pt -129.4 149.05 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-O 121.336 0.589 . . . . 73.420000000000002 110.711 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 53.6 m -123.46 124.68 43.42 Favored 'General case' 0 C--N 1.272 -2.792 0 N-CA-C 108.657 -0.868 . . . . 75.510000000000005 108.657 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.2 tt -108.38 109.96 30.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 122.027 0.918 . . . . 65.200000000000003 109.414 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.7 m -76.66 152.12 82.95 Favored Pre-proline 0 N--CA 1.423 -1.796 0 CA-C-N 114.635 -1.166 . . . . 71.099999999999994 109.962 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.23 -3.32 1.18 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 124.112 3.208 . . . . 74.530000000000001 114.438 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 9.7 m-20 -85.84 -0.56 55.66 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 124.175 0.99 . . . . 62.130000000000003 109.853 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 38.2 t0 68.6 34.71 3.43 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 123.781 1.753 . . . . 63.100000000000001 107.536 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -109.82 126.1 53.44 Favored 'General case' 0 N--CA 1.397 -3.121 0 CA-C-N 112.426 -2.17 . . . . 65.340000000000003 107.701 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG11 HD23 ' A' ' 95' ' ' LEU . 10.9 t -104.87 137.22 35.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.337 -0.986 . . . . 75.109999999999999 108.337 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.1 p -143.43 149.05 37.08 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 105.946 -1.872 . . . . 71.040000000000006 105.946 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.54 -169.56 40.02 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 117.626 -2.226 . . . . 72.230000000000004 113.157 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -152.84 142.38 21.79 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.352 0.596 . . . . 73.540000000000006 111.497 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.67 116.82 53.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.869 -1.16 . . . . 72.530000000000001 107.869 174.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.55 114.92 45.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.466 -0.939 . . . . 74.319999999999993 108.466 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.51 108.0 19.12 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.32 -1.733 . . . . 55.210000000000001 106.32 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -125.75 119.92 29.22 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.645 0.736 . . . . 73.340000000000003 111.048 -174.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.91 148.0 34.65 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.21 -0.905 . . . . 74.200000000000003 109.247 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.2 tttp . . . . . 0 C--N 1.306 -1.283 0 N-CA-C 105.982 -1.859 . . . . 72.439999999999998 105.982 175.438 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.645 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 16.1 p . . . . . 0 N--CA 1.42 -1.967 0 CA-C-O 120.566 0.222 . . . . 74.150000000000006 111.19 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.406 ' HA2' ' HA2' ' A' ' 82' ' ' GLY . . . 172.55 115.13 0.36 Allowed Glycine 0 N--CA 1.425 -2.048 0 C-N-CA 119.69 -1.243 . . . . 70.140000000000001 113.842 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.581 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 35.0 Cg_exo -66.76 129.37 20.83 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 CA-C-N 119.975 1.887 . . . . 74.420000000000002 108.221 168.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.73 163.22 28.2 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 113.695 0.998 . . . . 62.310000000000002 113.695 -171.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 59.2 mt -124.72 141.24 52.25 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.461 -0.94 . . . . 75.349999999999994 108.461 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -88.28 86.3 7.05 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.875 -0.787 . . . . 52.219999999999999 108.875 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.74 39.47 2.73 Favored Glycine 0 C--N 1.29 -1.986 0 CA-C-N 114.785 -1.098 . . . . 63.310000000000002 111.396 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -94.1 101.3 13.31 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.838 -1.171 . . . . 75.109999999999999 107.838 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.3 m -139.6 163.12 47.25 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 115.395 -0.821 . . . . 63.409999999999997 109.025 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.03 -24.9 51.99 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 122.435 2.09 . . . . 72.540000000000006 111.917 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -99.7 41.45 1.16 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.023 -0.535 . . . . 75.439999999999998 111.176 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p -57.47 -29.3 64.12 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.113 0.783 . . . . 72.439999999999998 113.113 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -72.5 -15.15 61.79 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-O 121.417 0.627 . . . . 75.439999999999998 109.929 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -94.89 -12.77 26.27 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.343 -0.844 . . . . 72.120000000000005 109.927 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 7.1 p -124.07 123.41 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.916 0.865 . . . . 74.530000000000001 112.296 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.43 105.77 16.83 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.212 -0.904 . . . . 72.140000000000001 108.87 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.2 t -98.06 130.16 47.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.066 -1.457 . . . . 71.310000000000002 107.066 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -148.16 172.07 14.89 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.551 -0.537 . . . . 54.119999999999997 109.551 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -87.21 153.25 21.64 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.482 -0.562 . . . . 65.219999999999999 109.482 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 71.7 t80 -123.09 129.57 51.63 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.544 0.738 . . . . 53.140000000000001 109.631 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -138.17 104.06 5.11 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.57 -1.27 . . . . 72.439999999999998 107.57 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 47.8 t -171.84 150.25 2.61 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.569 -0.9 . . . . 55.130000000000003 108.569 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 70.36 8.77 6.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.721 0.808 . . . . 72.340000000000003 111.4 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.77 -0.32 76.52 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 115.414 -0.812 . . . . 75.349999999999994 111.157 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 72.7 m-85 -104.42 146.73 28.43 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.573 -0.529 . . . . 73.299999999999997 109.573 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 56' ' ' THR . 27.4 m -124.18 138.5 53.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.239 -1.023 . . . . 72.439999999999998 108.239 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.581 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -174.91 -155.16 11.95 Favored Glycine 0 CA--C 1.464 -3.12 0 C-N-CA 119.178 -1.487 . . . . 55.350000000000001 112.47 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.402 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 46.7 m -126.03 147.55 49.53 Favored 'General case' 0 C--N 1.274 -2.681 0 CA-C-O 121.145 0.498 . . . . 74.219999999999999 110.081 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.5 141.18 51.47 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.918 -0.583 . . . . 71.310000000000002 109.89 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.21 114.34 23.52 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.627 -1.249 . . . . 72.230000000000004 107.627 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.7 t -109.18 111.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.827 -1.175 . . . . 72.329999999999998 107.827 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.7 p90 -113.16 157.78 21.25 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 120.924 0.392 . . . . 73.25 110.606 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 p -154.68 150.6 27.82 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.799 -0.637 . . . . 63.009999999999998 110.81 -174.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.7 t70 61.42 45.99 7.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.864 1.265 . . . . 70.340000000000003 111.819 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.492 HD12 ' CD2' ' A' ' 87' ' ' PHE . 43.3 mt -109.22 169.32 8.76 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.525 -0.761 . . . . 63.030000000000001 109.659 177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 t -128.41 -179.79 5.22 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.85 -0.74 . . . . 73.150000000000006 111.925 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.437 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 55.0 t80 -50.01 -43.87 50.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.784 2.034 . . . . 71.129999999999995 111.406 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.54 -25.59 64.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.779 -0.646 . . . . 61.210000000000001 111.747 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -89.34 -15.18 33.99 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.961 -0.563 . . . . 71.409999999999997 110.628 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.7 tm? -54.12 -56.12 29.36 Favored Pre-proline 0 CA--C 1.569 1.692 0 C-N-CA 123.802 0.841 . . . . 72.219999999999999 111.887 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.59 -35.72 57.58 Favored 'Trans proline' 0 C--N 1.372 1.785 0 CA-C-N 120.912 1.362 . . . . 72.319999999999993 111.08 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -63.03 -40.37 97.54 Favored 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 124.307 1.043 . . . . 74.530000000000001 110.398 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -76.05 -19.88 58.24 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.076 0.465 . . . . 55.100000000000001 109.783 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.1 -22.32 60.58 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.998 -0.546 . . . . 73.120000000000005 110.616 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -56.89 -48.82 77.31 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 109.68 -0.489 . . . . 72.239999999999995 109.68 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.407 ' HE1' HG21 ' A' ' 70' ' ' VAL . 24.4 ttm -53.57 -55.69 23.51 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.958 -1.019 . . . . 61.119999999999997 108.931 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -56.18 -36.58 68.53 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.299 -1.319 . . . . 72.209999999999994 111.622 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.5 m -65.59 -25.36 67.36 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 116.153 -0.476 . . . . 74.510000000000005 111.273 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.88 -27.65 66.87 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-O 121.447 0.642 . . . . 72.219999999999999 109.875 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -112.01 -13.1 13.64 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.823 -0.626 . . . . 64.319999999999993 111.305 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.477 ' HB1' HG23 ' A' ' 108' ' ' VAL . . . -107.17 -48.76 3.4 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.149 1.166 . . . . 51.200000000000003 114.149 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.61 7.0 78.75 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.144 -0.551 . . . . 62.0 112.468 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.477 HG23 ' HB1' ' A' ' 106' ' ' ALA . 61.9 t -81.2 133.96 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.475 -0.935 . . . . 62.140000000000001 108.475 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.47 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 28.7 m-80 -97.41 121.39 39.26 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.029 -1.1 . . . . 71.120000000000005 108.029 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.6 115.42 29.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.635 0.255 . . . . 62.43 110.483 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.3 m -109.49 135.89 49.78 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.656 -0.868 . . . . 65.5 108.656 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.3 tp -139.41 133.48 31.09 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 121.239 -0.184 . . . . 71.049999999999997 111.014 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -142.24 150.84 41.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.134 0.574 . . . . 73.310000000000002 110.654 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.43 HH22 ' CG ' ' A' ' 38' ' ' ASP . 39.5 ttm180 -112.02 135.8 52.2 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.389 -0.967 . . . . 75.019999999999996 108.389 174.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -127.94 93.06 3.59 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.69 -1.226 . . . . 74.349999999999994 107.69 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.4 -115.76 6.98 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 115.054 -0.975 . . . . 71.109999999999999 110.808 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.31 -17.81 24.21 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.54 0.686 . . . . 63.030000000000001 109.91 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 0.7 OUTLIER -103.43 148.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 C-N-CA 118.071 -1.452 . . . . 72.420000000000002 109.652 -174.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.9 t -120.1 135.78 59.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 110.086 -0.338 . . . . 51.210000000000001 110.086 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 175' ' ' GLN . 44.6 pt -113.56 130.63 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-O 121.719 0.771 . . . . 70.219999999999999 109.966 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.6 tt -125.91 129.64 49.71 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 107.677 -1.231 . . . . 74.409999999999997 107.677 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.76 123.76 24.11 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.824 -0.625 . . . . 54.43 109.567 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -132.76 147.44 18.91 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 110.653 -0.979 . . . . 10.24 110.653 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.28 125.95 27.12 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.539 -0.541 . . . . 74.140000000000001 109.539 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -99.82 109.94 22.33 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.683 -0.689 . . . . 61.340000000000003 110.001 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -99.95 93.22 5.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.276 -0.639 . . . . 74.040000000000006 109.276 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.0 24.28 10.25 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.541 -0.754 . . . . 63.100000000000001 109.197 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.7 p . . . . . 0 C--N 1.304 -1.375 0 CA-C-O 121.104 0.478 . . . . 61.210000000000001 111.546 -177.262 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 121.329 0.585 . . . . 75.450000000000003 111.189 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.26 135.52 33.41 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.46 -1.311 . . . . 65.310000000000002 107.46 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -131.62 115.19 15.75 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.596 -0.842 . . . . 74.450000000000003 109.376 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 51.2 t -106.51 122.67 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.428 -0.953 . . . . 70.5 108.428 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 31.9 tt0 -137.86 130.96 30.33 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.143 -0.688 . . . . 74.450000000000003 109.143 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' A' ' 30' ' ' ALA . 6.5 tt -128.88 135.52 49.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.307 -0.627 . . . . 55.020000000000003 109.307 -173.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 12.1 m -127.2 133.95 50.2 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.268 -0.642 . . . . 72.319999999999993 109.268 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.409 HG12 ' HD2' ' A' ' 143' ' ' PHE . 87.2 t -125.8 125.63 68.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.247 -0.649 . . . . 72.439999999999998 109.247 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -110.89 126.83 55.12 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 108.889 -0.782 . . . . 73.040000000000006 108.889 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.575 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.06 105.75 11.43 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 109.305 -0.628 . . . . 71.239999999999995 109.305 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.66 43.64 0.19 Allowed 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 123.521 2.814 . . . . 64.409999999999997 114.139 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.3 -91.25 0.56 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 123.152 0.581 . . . . 71.219999999999999 110.931 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 177.85 123.82 0.04 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.253 0.621 . . . . 41.009999999999998 110.042 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.3 p -80.89 141.81 14.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.688 -0.856 . . . . 73.120000000000005 108.688 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.9 p -99.59 -39.73 8.16 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.561 -0.533 . . . . 74.530000000000001 109.561 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.9 m -161.66 134.07 5.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.813 -0.63 . . . . 74.109999999999999 109.591 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.44 ' OG1' HG11 ' A' ' 160' ' ' VAL . 7.6 t -137.91 149.09 45.92 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.231 0.539 . . . . 72.450000000000003 111.036 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -112.5 87.53 2.6 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 106.518 -1.66 . . . . 74.310000000000002 106.518 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.71 -153.79 22.34 Favored Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 108.036 -2.026 . . . . 74.409999999999997 108.036 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -112.43 106.02 14.42 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 117.522 0.661 . . . . 73.540000000000006 110.751 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -80.05 126.34 30.94 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.736 -0.665 . . . . 75.530000000000001 109.794 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.2 mt -85.69 -42.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.885 -1.524 . . . . 62.409999999999997 106.885 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -135.28 170.02 12.24 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 113.964 -1.471 . . . . 64.239999999999995 107.387 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.98 0.05 8.36 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.295 1.997 . . . . 53.420000000000002 110.841 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.6 pt-20 -131.89 3.55 4.1 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.837 -0.62 . . . . 64.439999999999998 111.803 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.6 t -141.47 121.86 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.688 -0.856 . . . . 72.25 108.688 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.44 HG11 ' OG1' ' A' ' 150' ' ' THR . 40.5 t -127.4 149.15 32.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.739 -0.467 . . . . 71.019999999999996 109.739 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -134.15 144.0 48.27 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.599 -0.519 . . . . 64.420000000000002 109.599 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.469 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.3 m-90 -127.25 135.55 50.77 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.842 -0.617 . . . . 73.209999999999994 111.356 -178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.04 104.96 14.8 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.068 -0.969 . . . . 74.530000000000001 108.686 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 47.1 mt -101.65 119.76 39.28 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.211 -1.033 . . . . 75.209999999999994 108.211 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.488 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 74.3 mmtt -114.24 156.64 44.01 Favored Pre-proline 0 C--N 1.31 -1.149 0 N-CA-C 112.591 0.589 . . . . 73.140000000000001 112.591 -169.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.02 155.97 38.42 Favored 'Trans proline' 0 C--N 1.365 1.426 0 C-N-CA 123.025 2.483 . . . . 73.019999999999996 110.631 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.8 -32.67 2.17 Favored Glycine 0 C--N 1.312 -0.765 0 N-CA-C 112.134 -0.386 . . . . 71.120000000000005 112.134 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.488 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 21.3 m -105.72 161.4 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-O 120.94 0.4 . . . . 63.310000000000002 109.997 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.2 p -106.58 110.43 31.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.795 -1.187 . . . . 71.219999999999999 107.795 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.6 m -97.78 128.88 44.73 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.447 0.641 . . . . 61.43 110.313 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.2 p -101.63 137.87 39.38 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.352 -0.84 . . . . 71.230000000000004 109.991 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.4 ptm -131.62 133.09 44.59 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.718 -0.674 . . . . 73.150000000000006 109.586 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m -143.34 148.8 36.84 Favored 'General case' 0 C--N 1.276 -2.588 0 O-C-N 121.762 -0.586 . . . . 71.120000000000005 109.573 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -150.98 119.71 6.56 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.281 -1.007 . . . . 73.329999999999998 108.281 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.425 ' HG2' HG22 ' A' ' 120' ' ' ILE . 42.1 mt-30 -121.75 130.45 53.43 Favored 'General case' 0 C--N 1.262 -3.231 0 N-CA-C 106.292 -1.744 . . . . 71.530000000000001 106.292 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.14 160.18 41.79 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.548 -0.538 . . . . 41.219999999999999 109.548 -175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 65.0 mtp180 -88.05 125.92 34.82 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.244 -1.021 . . . . 75.319999999999993 108.244 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -123.02 127.69 49.15 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.776 -1.194 . . . . 73.310000000000002 107.776 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.5 p -63.59 107.47 1.16 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.395 -0.82 . . . . 73.5 110.216 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 CA--C 1.505 -0.784 0 CA-C-N 115.893 -0.594 . . . . 50.420000000000002 110.536 -174.911 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 136' ' ' ASP . 99.3 mtt180 . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 107.919 -1.141 . . . . 71.25 107.919 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.13 127.57 72.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.499 0.666 . . . . 62.049999999999997 110.461 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 50.4 mtp85 -122.75 115.41 22.0 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.98 -1.009 . . . . 73.400000000000006 109.268 -178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.51 108.27 19.51 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.172 -1.048 . . . . 35.100000000000001 108.172 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.7 t -108.92 115.74 30.65 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 107.767 -1.197 . . . . 74.319999999999993 107.767 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.419 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.6 pp -129.91 146.07 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 C-N-CA 120.037 -0.665 . . . . 61.520000000000003 109.627 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 61.9 m -122.82 129.39 51.63 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.242 -1.022 . . . . 71.230000000000004 108.242 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -119.27 125.94 74.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.724 0.773 . . . . 74.209999999999994 110.511 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 46.7 m -97.56 142.72 24.99 Favored Pre-proline 0 N--CA 1.415 -2.213 0 CA-C-N 115.2 -0.909 . . . . 71.439999999999998 109.349 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 35' ' ' SER . 52.8 Cg_exo -59.45 2.7 0.24 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 124.104 3.203 . . . . 75.349999999999994 114.095 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.67 1.0 40.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 123.737 0.815 . . . . 51.439999999999998 110.027 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 91' ' ' THR . 11.5 t70 71.96 35.36 1.33 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 105.738 -1.949 . . . . 64.230000000000004 105.738 -176.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 1.7 tp -119.63 126.0 50.11 Favored 'General case' 0 N--CA 1.396 -3.164 0 CA-C-N 113.686 -1.597 . . . . 51.310000000000002 108.443 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.422 HG12 ' HE2' ' A' ' 87' ' ' PHE . 12.6 t -120.44 134.11 64.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.753 -0.832 . . . . 73.400000000000006 108.753 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.0 p -144.61 144.14 31.13 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.422 -0.955 . . . . 74.030000000000001 108.422 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 177.45 -166.68 37.28 Favored Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 119.311 -1.423 . . . . 34.100000000000001 112.065 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -151.94 135.91 16.47 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.48 0.657 . . . . 62.32 111.048 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.9 mt -111.95 116.63 53.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.107 -1.071 . . . . 74.430000000000007 108.107 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.71 114.92 48.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.331 -0.618 . . . . 64.450000000000003 109.331 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.52 108.22 19.43 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.178 -1.786 . . . . 73.409999999999997 106.178 174.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.417 ' HB1' ' CB ' ' A' ' 80' ' ' TYR . . . -122.8 128.28 50.22 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 120.023 -0.671 . . . . 73.310000000000002 112.42 -173.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.05 157.48 24.61 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.306 -0.861 . . . . 75.430000000000007 109.509 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttm . . . . . 0 C--N 1.301 -1.514 0 C-N-CA 120.353 -0.539 . . . . 74.239999999999995 110.541 175.008 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.405 -2.689 0 N-CA-C 111.458 0.17 . . . . 73.319999999999993 111.458 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 173.0 123.93 0.75 Allowed Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 119.523 -1.322 . . . . 74.310000000000002 113.806 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 83' ' ' SER . 22.6 Cg_exo -68.15 159.28 53.82 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.443 2.095 . . . . 73.219999999999999 109.842 170.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.02 126.32 55.03 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 122.06 -0.4 . . . . 73.030000000000001 111.735 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 90.3 mt -87.34 162.51 17.33 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.812 -0.631 . . . . 74.430000000000007 109.98 175.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -101.88 96.6 7.16 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.762 0.792 . . . . 74.400000000000006 109.197 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -108.77 45.25 1.34 Allowed Glycine 0 C--N 1.288 -2.093 0 CA-C-N 114.609 -1.178 . . . . 34.32 110.327 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -100.05 110.03 22.33 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.141 -0.53 . . . . 74.140000000000001 109.815 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -152.66 169.33 9.78 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 124.738 1.215 . . . . 72.099999999999994 109.088 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.81 -14.87 34.5 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.527 2.151 . . . . 61.140000000000001 112.343 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.41 ' HA ' HE22 ' A' ' 68' ' ' GLN . 43.8 p90 -116.09 29.4 8.0 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.965 -0.561 . . . . 74.409999999999997 111.822 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.5 m -57.86 -27.87 63.63 Favored 'General case' 0 C--O 1.209 -1.03 0 N-CA-C 113.221 0.823 . . . . 74.0 113.221 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.41 HE22 ' HA ' ' A' ' 66' ' ' PHE . 5.4 pm0 -73.12 -8.75 57.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.392 0.615 . . . . 73.230000000000004 110.542 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -99.81 -15.52 18.4 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.696 -0.684 . . . . 72.239999999999995 109.584 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.4 118.84 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 122.154 0.978 . . . . 61.039999999999999 111.951 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.52 120.16 40.63 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.525 -0.761 . . . . 71.5 110.146 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.0 139.75 20.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.96 -0.756 . . . . 54.229999999999997 108.96 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.5 m -148.01 172.19 14.62 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.488 -0.93 . . . . 73.450000000000003 108.488 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 23.0 p-10 -85.88 154.05 21.8 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.389 -0.924 . . . . 71.439999999999998 108.69 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -112.25 120.69 42.61 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.703 -0.851 . . . . 62.25 108.703 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -138.64 98.5 3.58 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.073 -1.454 . . . . 65.200000000000003 107.073 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.9 t -175.41 160.93 2.65 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.021 -1.474 . . . . 50.219999999999999 107.021 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.26 11.7 8.09 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.054 0.941 . . . . 73.439999999999998 111.851 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.97 1.11 87.04 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.967 -0.635 . . . . 72.219999999999999 111.76 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . 97.8 m-85 -104.84 167.41 9.73 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.501 -0.411 . . . . 63.049999999999997 109.988 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -134.33 136.13 53.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.524 -1.287 . . . . 73.510000000000005 107.524 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.07 -154.63 9.17 Favored Glycine 0 C--N 1.276 -2.796 0 C-N-CA 119.634 -1.27 . . . . 54.43 112.514 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.473 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 9.4 p -122.47 147.89 45.8 Favored 'General case' 0 C--N 1.273 -2.747 0 C-N-CA 123.549 0.74 . . . . 73.310000000000002 109.915 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -139.55 143.09 37.2 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.899 -0.501 . . . . 62.130000000000003 110.8 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.91 114.66 20.11 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.28 -1.378 . . . . 63.43 107.28 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.14 121.52 61.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.592 -0.892 . . . . 64.019999999999996 108.592 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.474 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.2 p90 -123.54 155.56 37.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.978 0.418 . . . . 73.299999999999997 111.52 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.0 p -156.7 157.81 35.82 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.831 -0.622 . . . . 71.310000000000002 111.357 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 64.47 31.53 12.44 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.472 1.107 . . . . 64.409999999999997 110.764 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.474 HD12 ' CD2' ' A' ' 87' ' ' PHE . 26.8 mt -93.24 163.89 13.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 121.653 -0.655 . . . . 63.310000000000002 111.026 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 45.0 p -109.46 169.64 8.57 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.397 -0.365 . . . . 75.150000000000006 110.314 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -61.73 -31.7 71.89 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.264 -0.426 . . . . 74.349999999999994 110.548 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.65 -25.7 63.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.969 0.414 . . . . 75.019999999999996 110.957 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.74 -16.79 33.24 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.208 0.447 . . . . 64.340000000000003 112.208 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.6 tt -60.82 -49.48 89.2 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 119.232 -0.413 . . . . 73.329999999999998 111.271 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.81 -35.52 88.33 Favored 'Trans proline' 0 C--N 1.376 1.989 0 CA-C-N 121.038 1.406 . . . . 25.129999999999999 110.707 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.35 -35.78 81.23 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.29 -0.868 . . . . 74.340000000000003 111.601 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -73.11 -18.96 61.24 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 120.941 0.401 . . . . 71.540000000000006 110.671 176.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.02 -19.2 62.54 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.259 -0.428 . . . . 70.230000000000004 110.354 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -65.83 -52.98 45.91 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.183 -1.043 . . . . 62.32 108.183 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.454 ' O ' ' HB3' ' A' ' 104' ' ' ASP . 14.2 mtp -54.15 -52.39 61.26 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.702 -0.681 . . . . 50.539999999999999 109.583 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -56.49 -39.45 73.27 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.11 -0.95 . . . . 74.209999999999994 112.053 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.8 p -70.96 -21.08 62.37 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 119.282 -0.967 . . . . 73.230000000000004 111.198 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 101' ' ' MET . 6.0 t70 -61.72 -27.28 68.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.761 -0.654 . . . . 63.299999999999997 110.46 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.14 -5.41 13.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 116.071 -0.513 . . . . 44.310000000000002 111.117 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.96 -46.17 3.99 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.488 0.921 . . . . 62.350000000000001 113.488 -173.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.98 22.81 58.74 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 120.495 -0.86 . . . . 75.120000000000005 111.284 -174.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -120.39 172.3 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.789 -0.819 . . . . 73.439999999999998 108.789 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.515 ' OD1' ' HB2' ' A' ' 124' ' ' ARG . 3.7 p-10 -132.82 145.41 50.95 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.854 -0.338 . . . . 74.099999999999994 110.667 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.2 112.43 17.05 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.246 -0.65 . . . . 53.329999999999998 109.246 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -115.59 112.56 22.34 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.602 -0.518 . . . . 63.549999999999997 109.602 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -137.4 148.07 45.91 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.597 0.713 . . . . 72.349999999999994 112.007 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -147.53 155.74 42.16 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.417 -1.265 . . . . 73.239999999999995 109.53 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 114' ' ' ARG . 45.3 ttm180 -106.6 131.99 53.11 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 106.891 -1.522 . . . . 72.430000000000007 106.891 172.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -118.2 103.49 9.9 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.765 -1.198 . . . . 60.43 107.765 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.91 -107.08 2.25 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 109.372 -1.491 . . . . 50.140000000000001 109.372 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -122.2 2.96 9.82 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.788 1.28 . . . . 71.400000000000006 108.505 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -107.04 142.92 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 118.74 -1.184 . . . . 62.140000000000001 108.157 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 114' ' ' ARG . 81.9 t -105.9 138.27 31.98 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 O-C-N 122.099 -0.376 . . . . 73.430000000000007 111.175 -176.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.02 131.25 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-N 115.499 -0.773 . . . . 74.340000000000003 109.012 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.4 131.62 48.49 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 115.46 -0.791 . . . . 73.099999999999994 110.296 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -139.95 115.58 10.09 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.781 0.8 . . . . 70.109999999999999 108.908 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -113.19 157.99 14.58 Favored Glycine 0 C--N 1.265 -3.364 0 N-CA-C 107.564 -2.214 . . . . 71.310000000000002 107.564 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.515 ' HB2' ' OD1' ' A' ' 109' ' ' ASN . 98.5 mtt180 -130.72 125.6 34.32 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 118.397 1.099 . . . . 55.140000000000001 109.249 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -118.68 110.33 17.17 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.919 -0.582 . . . . 72.329999999999998 110.206 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -105.57 100.04 9.62 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.154 -1.054 . . . . 65.299999999999997 108.154 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.26 17.65 21.96 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.687 -0.486 . . . . 72.310000000000002 109.687 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.0 p . . . . . 0 C--O 1.215 -0.737 0 N-CA-C 112.603 0.594 . . . . 50.439999999999998 112.603 -173.43 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 C--O 1.242 0.71 0 CA-C-O 122.132 0.968 . . . . 51.32 110.163 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.45 145.33 26.32 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.92 -1.036 . . . . 74.25 109.895 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.402 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 16.4 m-20 -131.63 141.79 49.71 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.897 0.479 . . . . 74.230000000000004 110.113 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.9 t -120.86 112.79 37.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.429 -1.322 . . . . 75.230000000000004 107.429 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.405 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 38.2 mt-10 -121.41 125.29 46.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.777 -0.453 . . . . 74.549999999999997 109.777 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 tt -118.46 120.48 37.69 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.41 -1.33 . . . . 73.120000000000005 107.41 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.4 m -115.72 126.7 54.42 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.005 -0.739 . . . . 64.299999999999997 109.005 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.444 HG12 ' HD2' ' A' ' 143' ' ' PHE . 92.2 t -122.0 121.25 63.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.544 -0.539 . . . . 75.25 109.544 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.72 128.02 55.96 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.031 -0.729 . . . . 55.200000000000003 109.031 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.559 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.3 p90 -134.25 120.04 14.71 Favored Pre-proline 0 C--N 1.29 -2.005 0 C-N-CA 122.189 0.196 . . . . 72.319999999999993 111.298 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.95 55.65 2.87 Favored 'Trans proline' 0 CA--C 1.551 1.353 0 C-N-CA 122.618 2.212 . . . . 73.349999999999994 111.35 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.45 -110.53 0.15 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.719 -0.673 . . . . 23.129999999999999 110.009 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.1 128.34 0.46 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.856 -0.794 . . . . 75.530000000000001 108.856 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.76 133.85 28.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 109.377 -0.601 . . . . 65.450000000000003 109.377 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.7 p -90.45 -40.12 12.22 Favored 'General case' 0 N--CA 1.42 -1.967 0 C-N-CA 120.359 -0.537 . . . . 41.539999999999999 109.716 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 51.0 m -156.98 132.81 9.48 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 109.002 -0.74 . . . . 73.409999999999997 109.002 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.1 t -139.23 159.59 41.8 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.759 -0.46 . . . . 75.349999999999994 109.759 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 42.9 t30 -132.54 94.43 3.41 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.561 -1.644 . . . . 72.230000000000004 106.561 174.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.08 -136.67 2.92 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 108.643 -1.783 . . . . 63.509999999999998 108.643 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -119.25 99.25 6.59 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.899 -0.778 . . . . 71.430000000000007 108.899 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 154' ' ' ARG . 15.0 ptt180 -77.9 110.42 12.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.701 -0.682 . . . . 73.319999999999993 110.828 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.98 -47.54 20.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.552 -1.277 . . . . 73.200000000000003 107.552 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.37 166.59 25.7 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.185 -1.413 . . . . 70.549999999999997 107.185 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.46 0.52 7.95 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.098 1.865 . . . . 51.210000000000001 111.187 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.7 pt-20 -133.05 4.97 3.82 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 115.593 -0.73 . . . . 72.099999999999994 110.394 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.4 t -144.64 120.73 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.578 -0.897 . . . . 74.409999999999997 108.578 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.01 146.52 30.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.231 -0.655 . . . . 73.329999999999998 109.231 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -126.72 138.58 53.41 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 124.173 0.989 . . . . 73.329999999999998 109.008 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.421 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 31.8 m-90 -119.25 109.45 15.85 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.059 -1.089 . . . . 73.439999999999998 108.059 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -104.44 98.38 8.17 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 122.498 1.142 . . . . 71.439999999999998 109.112 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 19.3 mt -99.14 137.67 37.33 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.562 -1.653 . . . . 73.340000000000003 109.925 -170.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -117.73 153.74 50.79 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 114.905 -1.043 . . . . 65.019999999999996 111.422 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.34 159.11 54.71 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.515 2.143 . . . . 70.129999999999995 111.034 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.16 -34.89 3.18 Favored Glycine 0 C--N 1.303 -1.274 0 C-N-CA 120.964 -0.636 . . . . 72.299999999999997 111.564 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.6 m -105.48 159.23 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.4 0.619 . . . . 70.409999999999997 112.067 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.1 141.22 31.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.153 -1.054 . . . . 53.109999999999999 108.153 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.9 m -150.87 145.77 25.88 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.324 -0.621 . . . . 72.299999999999997 109.324 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.458 HG22 ' HG2' ' A' ' 124' ' ' ARG . 38.5 p -105.29 139.12 40.42 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.597 -0.519 . . . . 74.109999999999999 109.597 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -89.92 116.52 28.05 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.409 -1.7 . . . . 60.32 106.409 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 10.9 t -125.78 135.88 52.52 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 117.946 -1.502 . . . . 71.439999999999998 109.298 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.421 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.49 120.97 6.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.416 -0.957 . . . . 73.25 108.416 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -124.64 131.21 53.48 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.635 -1.246 . . . . 74.540000000000006 107.635 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.12 152.52 26.46 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.467 -0.568 . . . . 61.100000000000001 109.467 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 56.1 mtt180 -87.91 129.94 35.07 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.851 -0.74 . . . . 74.530000000000001 109.217 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -131.93 129.12 39.86 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 107.622 -1.251 . . . . 73.209999999999994 107.622 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.9 p -54.61 104.95 0.13 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 124.485 1.116 . . . . 74.329999999999998 111.954 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.701 -0.681 . . . . 74.530000000000001 109.554 -178.698 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 136' ' ' ASP . 16.1 tpt180 . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 105.986 -1.857 . . . . 74.319999999999993 105.986 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.14 114.26 41.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.172 -1.047 . . . . 62.549999999999997 108.172 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -129.59 115.18 17.03 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.692 0.758 . . . . 63.329999999999998 110.99 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.51 129.75 55.72 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.692 -1.14 . . . . 63.310000000000002 108.936 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.9 m -131.16 115.2 16.06 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.083 -1.08 . . . . 75.519999999999996 108.083 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.411 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.8 pp -124.35 147.16 28.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 109.804 -0.443 . . . . 73.319999999999993 109.804 -177.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 57.2 m -127.99 124.56 37.51 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 109.11 -0.7 . . . . 62.140000000000001 109.11 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -112.77 119.67 60.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.703 0.764 . . . . 65.409999999999997 110.362 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.5 m -89.43 151.43 46.2 Favored Pre-proline 0 C--N 1.288 -2.098 0 CA-C-N 115.064 -0.971 . . . . 44.240000000000002 109.879 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.85 2.92 0.83 Allowed 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.819 3.013 . . . . 61.030000000000001 113.284 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 17.8 t70 -82.55 -2.65 54.23 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.702 -1.221 . . . . 74.400000000000006 107.702 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.1 t70 72.54 29.91 1.99 Allowed 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.458 -1.682 . . . . 72.230000000000004 106.458 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 1.0 OUTLIER -106.71 138.19 43.35 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 112.728 -2.033 . . . . 74.219999999999999 108.341 -177.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.07 140.67 46.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 109.501 -0.555 . . . . 74.430000000000007 109.501 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -147.74 160.98 42.13 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.09 -1.078 . . . . 61.109999999999999 108.09 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 166.48 -170.03 40.85 Favored Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.067 -1.54 . . . . 64.129999999999995 113.006 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.34 133.68 18.5 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.254 0.55 . . . . 72.420000000000002 109.91 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.01 116.68 52.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.872 -1.159 . . . . 61.310000000000002 107.872 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.14 116.7 53.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 110.319 -0.252 . . . . 64.230000000000004 110.319 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.76 108.03 18.24 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 106.854 -1.535 . . . . 74.340000000000003 106.854 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . . . -118.74 141.79 48.29 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.114 -0.494 . . . . 63.200000000000003 110.234 -175.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.35 158.2 31.6 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.697 -0.853 . . . . 63.109999999999999 108.697 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.3 mttt . . . . . 0 C--N 1.3 -1.55 0 N-CA-C 108.537 -0.912 . . . . 71.299999999999997 108.537 175.932 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.571 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 9.2 t . . . . . 0 N--CA 1.423 -1.79 0 N-CA-C 108.94 -0.763 . . . . 60.399999999999999 108.94 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.41 125.33 0.84 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 118.82 -0.989 . . . . 65.0 111.88 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 32.3 Cg_exo -61.4 154.26 60.09 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.069 1.846 . . . . 74.129999999999995 109.836 174.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.38 109.01 16.24 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 111.993 0.368 . . . . 64.109999999999999 111.993 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.3 mt -90.82 124.55 35.24 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.827 -0.749 . . . . 74.319999999999993 110.108 173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.46 99.41 8.19 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.406 -0.816 . . . . 73.129999999999995 110.283 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.96 75.87 0.29 Allowed Glycine 0 C--N 1.29 -2.021 0 CA-C-N 114.96 -1.018 . . . . 72.140000000000001 111.616 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.64 91.36 7.98 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 108.883 -0.784 . . . . 74.129999999999995 108.883 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.4 m -134.83 160.1 69.66 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 107.838 -1.171 . . . . 74.120000000000005 107.838 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.56 -22.74 37.89 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 121.88 1.72 . . . . 71.140000000000001 112.157 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -97.69 40.77 1.15 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.061 -0.518 . . . . 71.209999999999994 112.309 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -56.02 -35.92 67.39 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 123.052 0.541 . . . . 75.430000000000007 110.353 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -64.53 -15.18 60.49 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.55 0.74 . . . . 74.510000000000005 111.635 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -100.7 -17.66 16.87 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 116.082 -0.508 . . . . 72.530000000000001 110.828 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.83 120.09 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 122.022 0.915 . . . . 62.409999999999997 112.273 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.51 112.74 24.9 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.534 -0.757 . . . . 33.140000000000001 109.026 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.16 114.23 39.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.935 -1.135 . . . . 52.420000000000002 107.935 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 168.54 14.57 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.856 -0.794 . . . . 71.430000000000007 108.856 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -84.48 153.76 23.13 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 119.571 -0.852 . . . . 72.310000000000002 109.009 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 83.9 t80 -120.73 124.68 45.73 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 109.837 -0.431 . . . . 73.239999999999995 109.837 -177.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.17 98.14 3.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.982 -1.118 . . . . 55.140000000000001 107.982 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 49.5 m -165.28 164.27 19.96 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.3 -1.37 . . . . 63.43 107.3 -176.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 67.78 6.58 5.15 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 124.64 1.176 . . . . 74.540000000000006 111.946 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.04 5.81 85.55 Favored Glycine 0 C--N 1.314 -0.662 0 N-CA-C 110.065 -1.214 . . . . 73.140000000000001 110.065 -174.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.434 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 3.4 m-85 -105.7 163.1 12.96 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 124.767 1.227 . . . . 70.25 110.927 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 56' ' ' THR . 16.8 m -134.48 136.55 52.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.525 -0.917 . . . . 54.409999999999997 108.525 173.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -169.72 -155.13 9.77 Favored Glycine 0 N--CA 1.423 -2.22 0 C-N-CA 119.855 -1.164 . . . . 71.129999999999995 113.033 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -132.17 140.85 48.89 Favored 'General case' 0 C--N 1.289 -2.056 0 C-N-CA 124.007 0.923 . . . . 72.219999999999999 109.696 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -128.65 146.16 50.95 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 116.274 -0.421 . . . . 62.119999999999997 110.529 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.73 114.42 23.3 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.488 -1.301 . . . . 61.399999999999999 107.488 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.35 122.04 62.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.064 -1.087 . . . . 72.150000000000006 108.064 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -123.07 153.81 39.4 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.006 -0.678 . . . . 71.450000000000003 111.469 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.3 p -156.11 153.52 29.48 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.528 -0.76 . . . . 71.219999999999999 110.728 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 64.33 37.51 8.45 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.328 1.017 . . . . 73.299999999999997 112.876 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 90' ' ' LEU . 34.8 mt -101.02 176.32 5.3 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.169 -0.678 . . . . 70.340000000000003 109.169 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.447 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.8 t -121.76 171.08 9.14 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.369 -0.532 . . . . 73.540000000000006 110.398 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 114' ' ' ARG . 53.9 t80 -50.02 -44.78 51.41 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.751 1.621 . . . . 61.299999999999997 111.517 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.1 -25.63 66.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.63 0.604 . . . . 70.040000000000006 112.63 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.447 ' OE1' HG22 ' A' ' 91' ' ' THR . 49.5 mt-10 -85.76 -15.96 40.42 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.164 0.431 . . . . 62.299999999999997 112.164 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.649 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 7.0 tt -55.74 -52.48 71.85 Favored Pre-proline 0 CA--C 1.564 1.5 0 N-CA-C 111.88 0.326 . . . . 62.409999999999997 111.88 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 21.1 Cg_endo -65.1 -29.92 56.12 Favored 'Trans proline' 0 C--N 1.359 1.11 0 CA-C-N 120.6 1.25 . . . . 71.120000000000005 111.7 175.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -69.04 -35.92 77.13 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 123.279 0.631 . . . . 55.210000000000001 110.401 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -77.02 -19.28 57.42 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.351 0.596 . . . . 64.230000000000004 109.495 176.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 96' ' ' PRO . . . -73.19 -17.69 61.34 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.484 -0.78 . . . . 75.400000000000006 109.56 -177.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.04 -54.59 42.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.771 -0.65 . . . . 72.030000000000001 109.591 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 67.5 mtm -54.24 -52.31 61.74 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.82 0.819 . . . . 50.32 109.232 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -54.3 -31.6 54.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.824 -1.535 . . . . 71.120000000000005 111.694 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.8 m -58.46 -33.7 70.04 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 119.304 -0.379 . . . . 71.109999999999999 111.915 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.1 -21.94 66.88 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.438 0.533 . . . . 63.130000000000003 112.438 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.16 -4.9 13.06 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.723 -0.391 . . . . 62.140000000000001 110.629 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.48 -48.27 3.72 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.981 -0.688 . . . . 64.150000000000006 112.697 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.8 28.28 73.21 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 119.94 -1.124 . . . . 71.140000000000001 110.541 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.1 t -122.05 134.6 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 109.039 -0.726 . . . . 73.510000000000005 109.039 -176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -93.55 122.37 35.91 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.087 -0.708 . . . . 72.420000000000002 109.087 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.46 137.2 53.34 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.594 0.59 . . . . 61.240000000000002 112.594 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.4 t -138.01 142.43 40.41 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.151 -1.055 . . . . 72.540000000000006 108.151 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -148.25 127.3 12.82 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.265 -1.013 . . . . 70.129999999999995 108.265 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -144.92 149.41 35.21 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 113.615 0.969 . . . . 71.209999999999994 113.615 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.499 ' HD3' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -101.94 117.28 34.49 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.526 -1.657 . . . . 74.129999999999995 106.526 177.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -109.96 92.7 4.15 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 107.81 -1.182 . . . . 74.329999999999998 107.81 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.92 -114.16 6.19 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 108.845 -1.702 . . . . 33.200000000000003 108.845 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.499 ' OD1' ' HD2' ' A' ' 177' ' ' ARG . 29.4 t-20 -100.33 -14.73 18.27 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.441 0.639 . . . . 64.030000000000001 110.633 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.518 ' HA ' ' CB ' ' A' ' 177' ' ' ARG . 1.3 pp -96.05 146.58 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 C-N-CA 118.978 -1.089 . . . . 64.200000000000003 109.106 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.68 HG21 ' CD2' ' A' ' 178' ' ' TYR . 89.0 t -115.74 141.19 34.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.587 -0.696 . . . . 73.319999999999993 110.391 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.43 HG22 ' HG2' ' A' ' 175' ' ' GLN . 40.0 pt -122.3 140.67 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 115.328 -0.851 . . . . 61.420000000000002 109.493 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.03 127.47 47.93 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 107.636 -1.246 . . . . 74.200000000000003 107.636 172.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -127.92 118.61 23.92 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.715 -1.13 . . . . 71.129999999999995 108.497 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -144.94 133.47 5.16 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.295 -0.955 . . . . 50.409999999999997 111.169 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.48 ' HG2' HG22 ' A' ' 171' ' ' THR . 68.3 mtt85 -120.63 127.02 51.7 Favored 'General case' 0 C--N 1.28 -2.436 0 O-C-N 122.38 -0.482 . . . . 74.129999999999995 110.053 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -117.75 113.61 22.1 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.611 -0.722 . . . . 70.019999999999996 110.024 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -111.74 107.49 16.6 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.617 -1.253 . . . . 60.240000000000002 107.617 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.74 27.28 9.81 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.872 -0.418 . . . . 74.120000000000005 109.872 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.4 p . . . . . 0 C--N 1.313 -0.984 0 C-N-CA 120.046 -0.662 . . . . 75.549999999999997 111.885 -176.755 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--O 1.238 0.458 0 CA-C-O 121.187 0.518 . . . . 51.420000000000002 110.608 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.35 142.25 52.17 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.882 -0.599 . . . . 73.209999999999994 110.761 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.451 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 10.1 t70 -132.03 116.31 16.93 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.042 -1.836 . . . . 70.510000000000005 106.042 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.8 t -114.35 136.51 50.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.467 -0.568 . . . . 62.5 109.467 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -133.42 131.66 40.23 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.908 -0.404 . . . . 75.340000000000003 109.908 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -122.67 118.54 28.36 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 106.817 -1.549 . . . . 74.129999999999995 106.817 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.4 m -121.62 133.36 54.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.954 -0.387 . . . . 60.009999999999998 109.954 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.37 124.04 66.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 108.697 -0.853 . . . . 73.439999999999998 108.697 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -115.16 132.51 56.58 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.577 -0.897 . . . . 72.239999999999995 108.577 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.7 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -134.43 120.37 14.69 Favored Pre-proline 0 C--N 1.28 -2.42 0 CA-C-N 116.337 -0.392 . . . . 74.430000000000007 110.147 178.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 31.5 Cg_exo -64.92 37.69 0.11 Allowed 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 123.928 3.085 . . . . 73.409999999999997 114.654 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.28 -97.1 0.46 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.302 -0.629 . . . . 44.340000000000003 109.302 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.44 136.81 0.06 Allowed 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.793 -1.188 . . . . 73.340000000000003 107.793 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.31 128.5 38.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.548 -0.538 . . . . 75.540000000000006 109.548 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 43.6 p -88.35 -43.85 11.21 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.686 -0.688 . . . . 75.099999999999994 110.159 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.2 m -150.64 132.51 15.09 Favored 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.4 -0.963 . . . . 71.439999999999998 108.4 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.406 ' OG1' HG11 ' A' ' 160' ' ' VAL . 10.2 t -140.28 152.31 45.8 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.889 -0.724 . . . . 72.409999999999997 111.276 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -123.79 91.16 3.41 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.369 -2.086 . . . . 64.329999999999998 105.369 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.14 -139.35 5.38 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 110.202 -1.159 . . . . 51.020000000000003 110.202 -177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 161' ' ' GLN . 24.3 t70 -115.18 99.57 7.51 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.613 0.721 . . . . 71.230000000000004 110.589 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -84.33 116.35 22.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 116.131 -0.486 . . . . 63.329999999999998 110.808 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.485 HD11 ' NE2' ' A' ' 161' ' ' GLN . 54.8 mt -93.42 -49.29 12.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.679 -0.86 . . . . 71.510000000000005 108.679 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -126.36 159.58 62.19 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.552 -1.277 . . . . 65.239999999999995 107.552 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.04 -18.61 51.63 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.568 2.179 . . . . 51.509999999999998 111.907 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.7 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.8 OUTLIER -120.22 7.65 10.79 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.842 0.682 . . . . 72.519999999999996 112.842 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.9 t -138.43 121.45 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-O 121.074 0.464 . . . . 71.430000000000007 110.812 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.406 HG11 ' OG1' ' A' ' 150' ' ' THR . 79.7 t -125.04 144.87 33.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.962 -0.563 . . . . 70.140000000000001 109.664 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.485 ' NE2' HD11 ' A' ' 155' ' ' ILE . 9.2 tt0 -133.57 152.03 51.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.273 -1.01 . . . . 71.040000000000006 108.273 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.533 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.0 m-90 -128.64 123.92 34.47 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 108.42 -0.956 . . . . 74.129999999999995 108.42 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 109.04 20.76 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.813 0.816 . . . . 74.409999999999997 109.983 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 66.1 mt -97.33 126.27 42.45 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.677 -1.147 . . . . 73.010000000000005 109.226 -174.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -115.22 152.19 46.54 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 115.091 -0.959 . . . . 74.319999999999993 112.266 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -68.97 158.44 57.92 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 123.192 2.595 . . . . 74.099999999999994 111.212 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 73.3 -19.82 1.33 Allowed Glycine 0 C--N 1.313 -0.746 0 N-CA-C 114.299 0.48 . . . . 63.119999999999997 114.299 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.4 m -111.63 169.25 4.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.4 0.619 . . . . 54.240000000000002 110.781 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.63 139.61 38.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.142 -1.429 . . . . 74.430000000000007 107.142 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 27.1 m -134.77 134.89 41.4 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.358 0.599 . . . . 64.519999999999996 110.55 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.48 HG22 ' HG2' ' A' ' 124' ' ' ARG . 9.7 p -103.11 126.53 50.33 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.085 -0.961 . . . . 75.219999999999999 108.727 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 56.7 mtm -108.86 126.95 53.6 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.21 -1.033 . . . . 63.509999999999998 108.21 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.9 t -141.65 138.09 32.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.339 -0.986 . . . . 73.420000000000002 108.339 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.458 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -146.03 133.39 20.68 Favored 'General case' 0 CA--C 1.469 -2.16 0 N-CA-C 108.052 -1.092 . . . . 71.310000000000002 108.052 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.43 ' HG2' HG22 ' A' ' 120' ' ' ILE . 39.5 mt-30 -126.89 131.14 51.22 Favored 'General case' 0 C--N 1.263 -3.177 0 N-CA-C 108.039 -1.097 . . . . 74.150000000000006 108.039 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 119' ' ' VAL . . . -159.79 129.45 5.35 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 106.566 -1.642 . . . . 74.209999999999994 106.566 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.518 ' CB ' ' HA ' ' A' ' 118' ' ' ILE . 17.7 ptt180 -88.05 146.86 25.25 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 118.43 -1.308 . . . . 74.319999999999993 110.117 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.68 ' CD2' HG21 ' A' ' 119' ' ' VAL . 19.6 m-30 -119.53 137.05 54.07 Favored 'General case' 0 CA--C 1.465 -2.317 0 N-CA-C 108.187 -1.042 . . . . 74.010000000000005 108.187 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.7 p -71.36 103.82 3.0 Favored 'General case' 0 N--CA 1.394 -3.236 0 CA-C-N 115.269 -0.878 . . . . 65.430000000000007 110.431 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 . . . . . 0 N--CA 1.446 -0.643 0 CA-C-N 115.13 -0.941 . . . . 75.109999999999999 111.145 176.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 . . . . . 0 N--CA 1.416 -2.132 0 N-CA-C 107.741 -1.207 . . . . 72.329999999999998 107.741 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.97 114.19 43.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 106.913 -1.514 . . . . 75.150000000000006 106.913 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 22.4 ttt180 -129.32 116.94 19.85 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 121.519 0.676 . . . . 44.119999999999997 110.708 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.35 108.84 20.57 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.26 -1.385 . . . . 73.400000000000006 107.26 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.9 m -113.47 114.16 26.16 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.698 -1.593 . . . . 62.310000000000002 106.698 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.8 pp -131.76 146.07 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 C-N-CA 120.2 -0.6 . . . . 62.229999999999997 109.811 -175.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 87.3 m -126.43 122.49 35.44 Favored 'General case' 0 C--N 1.27 -2.883 0 N-CA-C 109.251 -0.648 . . . . 64.409999999999997 109.251 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 tt -110.93 118.76 58.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.652 0.739 . . . . 60.009999999999998 109.796 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.7 m -89.33 150.78 45.4 Favored Pre-proline 0 N--CA 1.411 -2.411 0 N-CA-C 108.429 -0.952 . . . . 64.319999999999993 108.429 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.03 0.9 0.36 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.792 2.995 . . . . 75.040000000000006 115.135 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 37.3 t70 -83.32 -3.25 57.3 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.783 -0.821 . . . . 72.230000000000004 108.783 176.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 t70 72.77 29.84 1.87 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 105.812 -1.921 . . . . 74.120000000000005 105.812 -173.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 2.4 tp -100.19 124.61 45.83 Favored 'General case' 0 N--CA 1.389 -3.493 0 CA-C-N 113.3 -1.773 . . . . 74.129999999999995 107.354 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG21 ' HG ' ' A' ' 95' ' ' LEU . 14.3 t -116.34 133.08 64.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 109.078 -0.712 . . . . 75.319999999999993 109.078 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.8 p -146.96 157.55 43.66 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.635 -0.876 . . . . 62.539999999999999 108.635 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.3 -165.19 38.68 Favored Glycine 0 N--CA 1.428 -1.855 0 C-N-CA 119.207 -1.473 . . . . 63.229999999999997 112.987 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.55 133.83 21.74 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 123.28 0.632 . . . . 72.329999999999998 109.873 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 102' ' ' ASN . 63.8 mt -116.94 116.01 50.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.892 -1.151 . . . . 72.400000000000006 107.892 176.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.93 126.03 65.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.046 -0.525 . . . . 74.319999999999993 109.829 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -120.72 107.93 13.37 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.282 -1.747 . . . . 70.0 106.282 171.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -120.87 127.51 51.95 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.26 -0.427 . . . . 73.310000000000002 111.003 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.77 148.88 42.35 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 116.48 -0.327 . . . . 45.420000000000002 110.244 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.31 -1.14 0 N-CA-C 108.433 -0.951 . . . . 64.209999999999994 108.433 173.535 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.427 -1.59 0 N-CA-C 109.865 -0.42 . . . . 72.329999999999998 109.865 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.496 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 172.24 99.01 0.12 Allowed Glycine 0 N--CA 1.431 -1.671 0 CA-C-O 118.69 -1.061 . . . . 61.340000000000003 112.545 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.51 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 31.2 Cg_exo -59.84 128.52 27.1 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 CA-C-N 119.872 1.836 . . . . 71.400000000000006 109.052 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 83' ' ' SER . . . -89.71 151.43 21.85 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.803 0.668 . . . . 72.420000000000002 112.803 -171.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 67.3 mt -82.46 138.97 34.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.828 -0.623 . . . . 71.209999999999994 109.526 174.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -110.6 101.97 10.59 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.633 -1.618 . . . . 72.109999999999999 106.633 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.85 75.13 0.19 Allowed Glycine 0 C--N 1.29 -1.979 0 C-N-CA 120.581 -0.818 . . . . 71.409999999999997 112.857 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.01 112.2 19.55 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.56 -0.533 . . . . 73.409999999999997 109.56 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG11 ' SD ' ' A' ' 101' ' ' MET . 17.6 m -124.21 157.13 65.35 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 115.939 -0.573 . . . . 71.019999999999996 109.841 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.51 -10.09 27.56 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 122.751 2.3 . . . . 72.239999999999995 112.886 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -110.26 39.46 2.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.388 -0.369 . . . . 64.140000000000001 110.974 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 m -53.68 -32.36 51.39 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.055 0.391 . . . . 43.310000000000002 112.055 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -67.76 -11.88 59.38 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.273 0.559 . . . . 72.5 110.981 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -98.62 -20.61 16.9 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.673 -0.694 . . . . 74.349999999999994 111.071 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.22 119.79 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.731 0.777 . . . . 73.299999999999997 112.155 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 123.28 45.7 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.465 -0.789 . . . . 63.229999999999997 109.075 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.66 130.99 46.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.952 -0.758 . . . . 52.340000000000003 108.952 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 m -132.66 171.98 13.13 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.947 -0.39 . . . . 64.129999999999995 109.947 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.496 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 5.8 t30 -93.03 134.87 34.73 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.051 -1.092 . . . . 73.219999999999999 108.051 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 87.8 t80 -99.96 126.35 46.11 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.946 -0.39 . . . . 75.340000000000003 109.946 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -135.29 101.44 4.84 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.082 -1.081 . . . . 71.409999999999997 108.082 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 47.0 t -173.22 155.85 3.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.939 -1.134 . . . . 71.420000000000002 107.939 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 70.57 6.86 6.0 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.687 1.195 . . . . 73.530000000000001 110.811 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.76 6.0 87.51 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.021 -0.831 . . . . 64.430000000000007 111.021 -173.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.502 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 4.1 m-85 -104.59 148.15 26.83 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.417 0.687 . . . . 73.219999999999999 110.094 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.7 137.45 55.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.833 -0.803 . . . . 73.409999999999997 108.833 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.51 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -167.86 -154.31 8.61 Favored Glycine 0 CA--C 1.458 -3.473 0 N-CA-C 110.555 -1.018 . . . . 71.439999999999998 110.555 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.5 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . 32.7 t -134.19 149.13 50.99 Favored 'General case' 0 C--N 1.26 -3.296 0 N-CA-C 108.656 -0.868 . . . . 73.209999999999994 108.656 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -134.82 133.88 40.25 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 115.618 -0.719 . . . . 73.319999999999993 110.207 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.67 115.61 30.62 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.24 -1.022 . . . . 71.129999999999995 108.24 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.64 116.21 48.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 107.599 -1.26 . . . . 72.530000000000001 107.599 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.5 p90 -120.76 157.04 30.57 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.595 -0.442 . . . . 74.140000000000001 110.609 -175.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.2 m -159.25 157.19 30.16 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.933 -0.576 . . . . 74.430000000000007 110.06 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 64.06 32.85 12.56 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.24 0.963 . . . . 73.439999999999998 112.242 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 87' ' ' PHE . 22.9 mt -90.31 153.26 20.59 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.625 -0.716 . . . . 62.119999999999997 110.503 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.7 p -108.04 172.33 6.89 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.338 -0.846 . . . . 63.299999999999997 109.686 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -60.84 -26.55 67.44 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.183 0.516 . . . . 72.340000000000003 111.007 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.64 -29.5 66.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.534 0.683 . . . . 74.040000000000006 109.847 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HB3' HD22 ' A' ' 90' ' ' LEU . 38.9 mt-10 -93.07 -15.95 25.53 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.315 -0.857 . . . . 74.540000000000006 111.77 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.4 mt -51.98 -52.34 62.62 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 114.008 1.114 . . . . 73.420000000000002 114.008 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -64.54 -34.41 52.82 Favored 'Trans proline' 0 C--N 1.363 1.325 0 CA-C-N 120.624 1.259 . . . . 73.040000000000006 110.31 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -64.26 -38.74 92.11 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.085 -0.962 . . . . 75.129999999999995 111.385 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -70.78 -19.7 62.67 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.091 0.472 . . . . 75.519999999999996 110.601 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.27 -16.07 59.87 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.033 -0.531 . . . . 73.230000000000004 110.643 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -62.32 -57.92 9.58 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 120.8 -0.36 . . . . 74.430000000000007 110.065 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.43 ' SD ' HG11 ' A' ' 64' ' ' VAL . 3.7 mpp? -56.49 -45.74 80.84 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.133 0.492 . . . . 73.420000000000002 109.896 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB2' HD13 ' A' ' 44' ' ' ILE . 27.1 t-20 -52.95 -45.01 67.53 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 114.203 -1.362 . . . . 63.030000000000001 111.386 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.7 p -66.03 -28.3 68.76 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 120.291 -0.564 . . . . 61.539999999999999 110.937 -170.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.1 -26.04 66.51 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.16 0.505 . . . . 65.5 110.597 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.88 -9.81 17.74 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.956 -0.566 . . . . 64.329999999999998 110.594 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.26 -44.75 4.47 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.213 0.82 . . . . 61.119999999999997 113.213 -172.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.39 27.64 35.57 Favored Glycine 0 C--N 1.316 -0.548 0 N-CA-C 110.297 -1.121 . . . . 74.420000000000002 110.297 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.9 m -111.11 168.26 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.389 -0.406 . . . . 73.340000000000003 110.104 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -135.45 124.96 25.0 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.676 -0.861 . . . . 74.140000000000001 108.676 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -119.49 141.07 49.5 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 123.335 0.397 . . . . 72.310000000000002 110.283 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 49.2 m -141.56 116.39 9.79 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.534 -0.913 . . . . 52.210000000000001 108.534 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.72 146.16 51.5 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.137 -0.625 . . . . 75.349999999999994 111.337 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -139.13 154.67 48.15 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.632 -1.167 . . . . 74.340000000000003 109.034 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.451 ' HG3' HG22 ' A' ' 119' ' ' VAL . 4.7 ttt180 -100.25 137.8 38.19 Favored 'General case' 0 N--CA 1.393 -3.309 0 N-CA-C 107.661 -1.237 . . . . 73.239999999999995 107.661 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -123.26 89.36 3.09 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 106.638 -1.615 . . . . 75.510000000000005 106.638 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.71 -118.12 6.91 Favored Glycine 0 N--CA 1.423 -2.224 0 N-CA-C 110.042 -1.223 . . . . 75.109999999999999 110.042 -176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 8.1 t30 -103.96 7.31 36.66 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.086 0.946 . . . . 74.209999999999994 108.925 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 pp -119.33 149.16 21.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 120.799 -1.188 . . . . 72.140000000000001 109.079 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.451 HG22 ' HG3' ' A' ' 114' ' ' ARG . 72.9 t -107.8 137.91 36.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 O-C-N 121.845 -0.534 . . . . 62.140000000000001 110.037 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.0 pt -118.42 132.66 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 109.291 -0.633 . . . . 73.209999999999994 109.291 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 tt -124.61 129.24 50.19 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 115.549 -0.75 . . . . 54.119999999999997 109.438 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.31 124.17 29.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.526 -1.657 . . . . 74.120000000000005 106.526 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -149.58 171.9 29.63 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.392 -0.908 . . . . 74.140000000000001 112.695 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.436 ' HG2' HG22 ' A' ' 171' ' ' THR . 74.2 mtt85 -138.79 153.79 48.43 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.634 0.774 . . . . 71.25 109.365 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.07 109.04 10.2 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.475 -0.935 . . . . 54.450000000000003 108.475 174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -112.6 95.69 5.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.785 0.802 . . . . 74.299999999999997 110.742 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.88 27.97 5.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 123.393 1.568 . . . . 71.340000000000003 107.79 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 C--N 1.304 -1.388 0 CA-C-N 112.562 -2.108 . . . . 72.310000000000002 112.017 -179.483 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 121.495 0.664 . . . . 72.420000000000002 110.186 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.33 138.92 58.25 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.82 -1.082 . . . . 64.109999999999999 113.863 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -131.33 130.38 42.65 Favored 'General case' 0 C--O 1.257 1.486 0 N-CA-C 107.784 -1.191 . . . . 61.240000000000002 107.784 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 47.2 t -105.9 112.72 40.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.134 -1.432 . . . . 62.039999999999999 107.134 175.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 37.0 mt-10 -108.19 120.42 42.31 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.081 -0.711 . . . . 75.25 109.081 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 3.0 tt -115.17 122.81 47.18 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 105.976 -1.861 . . . . 70.239999999999995 105.976 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.0 m -126.92 126.01 42.53 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 109.198 -0.667 . . . . 74.340000000000003 109.198 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.471 HG12 ' HD2' ' A' ' 143' ' ' PHE . 57.8 t -120.11 124.03 71.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.961 -0.755 . . . . 60.100000000000001 108.961 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.4 127.36 55.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.706 -0.85 . . . . 75.340000000000003 108.706 177.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.54 121.76 15.34 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 112.187 0.44 . . . . 74.239999999999995 112.187 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.73 46.9 1.11 Allowed 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.997 2.464 . . . . 75.030000000000001 110.809 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -128.36 -106.84 0.3 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.943 -0.571 . . . . 53.149999999999999 109.867 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.59 126.75 0.07 Allowed 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.742 -0.836 . . . . 61.030000000000001 108.742 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.91 135.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.868 -0.79 . . . . 75.540000000000006 108.868 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.4 p -90.5 -42.7 10.7 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 109.459 -0.571 . . . . 65.439999999999998 109.459 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.5 m -159.38 133.12 7.34 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.095 -0.502 . . . . 44.240000000000002 109.963 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.6 t -139.16 157.12 46.5 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 121.987 -0.445 . . . . 70.040000000000006 110.313 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -128.23 95.86 4.29 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.656 -1.979 . . . . 60.439999999999998 105.656 173.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.52 -145.21 8.14 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 107.788 -2.125 . . . . 71.040000000000006 107.788 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -110.61 99.83 8.73 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 118.294 1.047 . . . . 72.230000000000004 110.232 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -78.96 110.45 14.19 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 121.886 0.85 . . . . 63.439999999999998 109.531 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.8 mt -80.39 -38.0 17.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.149 -1.426 . . . . 61.329999999999998 107.149 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.76 163.86 38.08 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.222 -1.77 . . . . 65.450000000000003 106.222 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.09 0.23 7.56 Favored 'Trans proline' 0 N--CA 1.481 0.789 0 C-N-CA 122.588 2.192 . . . . 75.030000000000001 110.846 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.0 pt-20 -128.94 -0.42 5.3 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 114.88 -1.054 . . . . 55.310000000000002 111.297 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.7 t -142.18 120.8 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.547 -0.908 . . . . 73.530000000000001 108.547 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -127.41 143.79 39.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.532 -0.544 . . . . 75.219999999999999 109.532 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 36.1 tt0 -129.93 147.08 51.65 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.373 0.606 . . . . 71.439999999999998 110.17 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.467 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.3 m-90 -123.63 117.86 25.97 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.142 -1.059 . . . . 75.409999999999997 108.142 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -104.07 98.21 8.07 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.752 0.787 . . . . 70.230000000000004 109.407 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 18.3 mt -93.42 130.12 39.34 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.555 -1.202 . . . . 73.319999999999993 109.225 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.2 152.32 50.42 Favored Pre-proline 0 C--N 1.302 -1.468 0 CA-C-N 115.904 -0.589 . . . . 65.120000000000005 111.15 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.68 153.48 73.22 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.329 2.019 . . . . 73.150000000000006 111.06 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.09 -23.96 2.56 Favored Glycine 0 C--N 1.304 -1.201 0 C-N-CA 121.046 -0.597 . . . . 71.5 113.842 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.1 m -104.45 147.78 10.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.223 0.535 . . . . 74.109999999999999 110.698 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 82.6 t -85.38 127.9 39.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.584 -0.735 . . . . 74.099999999999994 109.504 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 10.1 p -138.44 133.07 32.31 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-O 121.424 0.63 . . . . 72.329999999999998 111.715 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 124' ' ' ARG . 21.3 p -114.83 147.38 39.93 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 108.614 -0.884 . . . . 62.299999999999997 108.614 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.405 ' SD ' HD11 ' A' ' 164' ' ' LEU . 70.2 mtm -120.5 133.31 55.42 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.645 -0.502 . . . . 73.319999999999993 109.645 -176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.9 t -143.02 137.06 29.01 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.313 -0.625 . . . . 72.409999999999997 109.313 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.467 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -148.12 118.71 7.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.943 -0.762 . . . . 72.540000000000006 108.943 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -122.75 130.97 53.55 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 106.62 -1.622 . . . . 74.5 106.62 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.44 160.93 41.89 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.035 0.21 . . . . 50.020000000000003 111.261 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.8 mtt-85 -87.39 127.29 35.21 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.862 -0.422 . . . . 72.430000000000007 109.862 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -143.5 119.54 10.7 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 117.757 0.253 . . . . 72.040000000000006 110.529 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.556 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -58.63 119.42 7.04 Favored 'General case' 0 C--N 1.288 -2.1 0 O-C-N 124.226 0.954 . . . . 75.209999999999994 112.423 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.56 -0.746 . . . . 63.200000000000003 109.894 -179.133 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 N--CA 1.423 -1.821 0 N-CA-C 107.348 -1.353 . . . . 71.450000000000003 107.348 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.57 114.69 39.06 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 CA-C-O 121.876 0.846 . . . . 74.140000000000001 109.436 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 61.7 mtp85 -119.22 116.69 26.81 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.549 -1.205 . . . . 73.239999999999995 110.345 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -103.66 109.52 21.24 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.769 -1.197 . . . . 62.439999999999998 107.769 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 m -114.8 115.42 26.98 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.767 -0.827 . . . . 65.150000000000006 108.767 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -129.0 141.68 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 N-CA-C 108.892 -0.781 . . . . 53.43 108.892 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.2 m -121.39 120.94 36.47 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.652 -0.87 . . . . 73.200000000000003 108.652 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.425 HG23 ' HB3' ' A' ' 143' ' ' PHE . 9.5 tt -105.44 120.79 56.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 121.657 0.741 . . . . 74.200000000000003 109.822 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.4 m -84.17 155.92 63.5 Favored Pre-proline 0 C--N 1.295 -1.782 0 CA-C-N 115.177 -0.92 . . . . 52.0 108.974 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.68 2.1 3.79 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.927 2.418 . . . . 75.129999999999995 112.531 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -89.36 2.35 54.54 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 124.635 1.174 . . . . 62.509999999999998 109.524 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.8 t70 69.21 29.4 4.64 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 123.664 1.697 . . . . 74.219999999999999 107.622 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.36 125.47 52.4 Favored 'General case' 0 N--CA 1.393 -3.299 0 CA-C-N 113.032 -1.894 . . . . 73.239999999999995 107.471 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.5 HG11 HD21 ' A' ' 95' ' ' LEU . 13.1 t -113.52 134.07 57.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 115.902 -0.59 . . . . 74.530000000000001 109.535 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.2 p -140.96 128.67 21.55 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.56 -1.274 . . . . 71.450000000000003 107.56 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.67 -171.9 30.49 Favored Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 119.487 -1.34 . . . . 61.109999999999999 112.648 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -149.21 133.67 17.57 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.173 -0.677 . . . . 64.540000000000006 109.173 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 58.4 mt -111.72 115.33 49.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 106.918 -1.512 . . . . 72.120000000000005 106.918 176.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.39 114.22 46.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.357 -0.609 . . . . 74.209999999999994 109.357 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -106.61 107.68 18.82 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.814 -1.921 . . . . 73.409999999999997 105.814 172.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.64 116.93 24.66 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.7 0.762 . . . . 51.520000000000003 110.064 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.65 139.91 50.37 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.534 -0.757 . . . . 73.329999999999998 111.304 -174.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.7 tttt . . . . . 0 C--N 1.316 -0.881 0 N-CA-C 104.604 -2.369 . . . . 74.340000000000003 104.604 168.326 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.439 -1.005 0 N-CA-C 108.049 -1.093 . . . . 61.43 108.049 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.8 96.6 0.1 Allowed Glycine 0 N--CA 1.42 -2.38 0 CA-C-N 113.474 -1.693 . . . . 44.140000000000001 109.295 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 49.2 Cg_exo -55.88 128.95 32.39 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.563 2.175 . . . . 73.019999999999996 110.569 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.577 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -85.21 159.86 20.02 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.618 0.97 . . . . 71.010000000000005 113.618 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 80.3 mt -107.98 127.51 53.83 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 108.035 -1.098 . . . . 74.510000000000005 108.035 174.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -112.94 97.64 6.66 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.009 0.433 . . . . 75.099999999999994 111.174 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.62 136.06 8.64 Favored Glycine 0 C--N 1.284 -2.327 0 N-CA-C 110.788 -0.925 . . . . 62.25 110.788 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.57 120.54 38.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.264 0.554 . . . . 64.230000000000004 111.184 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 m -137.81 161.47 59.89 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.531 -0.759 . . . . 62.310000000000002 109.063 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.8 -22.05 24.15 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.155 1.903 . . . . 53.539999999999999 111.768 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -100.37 42.52 1.11 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.771 -0.65 . . . . 71.140000000000001 111.593 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 m -54.03 -36.56 63.17 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.475 0.71 . . . . 62.509999999999998 111.489 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -69.55 -13.68 62.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.541 0.686 . . . . 73.230000000000004 110.289 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.71 -12.77 21.96 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.431 -0.804 . . . . 74.420000000000002 110.434 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.8 119.46 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 122.303 1.049 . . . . 72.120000000000005 111.595 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.58 112.99 26.16 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.179 -0.919 . . . . 75.150000000000006 109.873 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.7 p -98.0 133.11 41.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.25 -1.018 . . . . 61.109999999999999 108.25 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.6 m -147.46 163.24 37.15 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.266 -1.013 . . . . 74.349999999999994 108.266 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -76.87 143.42 39.68 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.473 0.654 . . . . 73.439999999999998 110.808 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 73.4 t80 -108.3 123.09 48.27 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.552 -1.277 . . . . 61.030000000000001 107.552 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -138.25 99.17 3.79 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 107.659 -1.237 . . . . 74.150000000000006 107.659 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 65.2 m -162.5 149.15 13.12 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.865 -1.161 . . . . 75.420000000000002 107.865 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 69.73 4.41 4.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.876 0.87 . . . . 62.039999999999999 113.316 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.55 4.76 65.58 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.998 -0.841 . . . . 24.300000000000001 110.998 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -104.93 142.34 34.94 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.297 -1.001 . . . . 62.43 108.297 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.4 m -124.38 136.45 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 121.544 0.688 . . . . 64.129999999999995 109.481 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -173.44 -153.41 9.61 Favored Glycine 0 CA--C 1.461 -3.331 0 N-CA-C 110.088 -1.205 . . . . 75.530000000000001 110.088 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.577 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 62.9 m -134.95 149.85 50.29 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 121.506 0.67 . . . . 74.099999999999994 111.485 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.9 pt20 -124.58 132.14 53.45 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.873 -1.058 . . . . 75.129999999999995 109.576 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.04 113.95 27.65 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.584 -1.636 . . . . 73.109999999999999 106.584 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.69 112.74 41.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.374 -0.973 . . . . 72.340000000000003 108.374 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.532 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.5 p90 -115.71 153.68 30.92 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.978 -0.556 . . . . 72.230000000000004 110.954 -175.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -154.85 158.16 38.95 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.581 -0.736 . . . . 54.43 111.297 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 65.15 30.88 11.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 122.568 1.175 . . . . 71.450000000000003 110.824 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.532 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.4 mt -96.08 164.23 12.78 Favored 'General case' 0 N--CA 1.426 -1.628 0 O-C-N 121.275 -0.891 . . . . 71.109999999999999 111.11 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -115.22 171.34 7.75 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 116.254 -0.43 . . . . 63.039999999999999 110.686 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -57.0 -36.79 70.81 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.031 0.443 . . . . 55.109999999999999 110.181 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.05 70.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.686 -0.688 . . . . 74.409999999999997 111.019 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.87 -16.08 39.77 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 112.593 0.59 . . . . 73.400000000000006 112.593 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.5 HD21 HG11 ' A' ' 40' ' ' VAL . 17.1 mt -52.56 -53.4 54.15 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 114.322 1.23 . . . . 70.319999999999993 114.322 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.08 -42.29 44.93 Favored 'Trans proline' 0 C--N 1.369 1.607 0 CA-C-N 120.57 1.239 . . . . 72.450000000000003 110.497 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -60.08 -39.72 87.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.317 -0.856 . . . . 73.129999999999995 111.76 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -78.34 -21.86 48.89 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 120.745 -0.382 . . . . 74.549999999999997 110.728 177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.84 -26.85 61.63 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.148 -0.686 . . . . 63.039999999999999 109.148 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -57.73 -54.33 48.12 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.318 -0.855 . . . . 73.540000000000006 109.909 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.1 mtm -54.11 -49.98 67.91 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.205 0.526 . . . . 72.430000000000007 110.313 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -55.36 -37.27 67.3 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.402 -1.272 . . . . 74.340000000000003 110.117 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.7 m -60.72 -32.89 72.13 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.503 -0.317 . . . . 73.439999999999998 111.092 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -68.82 -15.63 63.55 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.531 0.682 . . . . 75.219999999999999 111.557 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.15 -11.95 12.59 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.202 -0.454 . . . . 51.409999999999997 110.607 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.52 -47.53 3.75 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.658 0.984 . . . . 72.25 113.658 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.86 22.09 77.48 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.454 -1.058 . . . . 51.100000000000001 110.454 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.3 t -111.93 143.89 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.127 0.971 . . . . 74.140000000000001 108.576 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -102.18 131.38 48.74 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.052 -0.351 . . . . 75.219999999999999 110.052 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.19 104.84 7.3 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.39 -0.967 . . . . 52.439999999999998 108.39 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.5 m -117.58 137.6 52.49 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.607 -0.886 . . . . 74.099999999999994 108.607 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -147.96 149.28 31.88 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.94 -0.704 . . . . 63.049999999999997 112.449 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -148.39 163.07 38.21 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.039 -0.982 . . . . 75.329999999999998 111.001 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.501 ' HG2' HG22 ' A' ' 119' ' ' VAL . 45.8 mtt85 -102.57 139.76 37.75 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.029 0.443 . . . . 64.530000000000001 110.315 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -121.7 83.71 2.13 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.983 -1.488 . . . . 74.219999999999999 106.983 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.95 -115.7 8.25 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.971 -1.013 . . . . 72.019999999999996 110.697 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -85.08 -20.27 30.63 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.504 0.668 . . . . 74.519999999999996 110.929 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.2 pp -102.64 148.71 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 C-N-CA 118.088 -1.445 . . . . 53.140000000000001 109.174 -175.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.501 HG22 ' HG2' ' A' ' 114' ' ' ARG . 92.8 t -116.81 140.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 O-C-N 122.008 -0.432 . . . . 72.150000000000006 110.054 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.43 HG22 ' HG2' ' A' ' 175' ' ' GLN . 44.3 pt -117.35 138.11 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 115.972 -0.558 . . . . 70.430000000000007 110.088 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 174' ' ' ALA . 7.3 tt -127.3 127.94 45.15 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.143 -1.058 . . . . 71.409999999999997 108.143 175.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -128.26 117.95 22.41 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.485 -0.932 . . . . 60.140000000000001 108.485 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.13 169.57 25.31 Favored Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 121.059 -0.591 . . . . 64.099999999999994 112.201 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -151.05 153.24 34.72 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.19 -0.67 . . . . 74.25 109.19 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -135.57 108.62 7.67 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.634 -0.876 . . . . 74.319999999999993 108.634 171.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -113.11 97.24 6.38 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.933 0.873 . . . . 74.519999999999996 110.994 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.76 34.74 4.59 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.448 -1.251 . . . . 71.409999999999997 108.193 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 C--N 1.314 -0.943 0 N-CA-C 113.143 0.794 . . . . 75.450000000000003 113.143 -175.599 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.241 0.646 0 N-CA-C 115.133 1.531 . . . . 74.420000000000002 115.133 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.17 135.89 40.91 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.894 -1.048 . . . . 74.430000000000007 108.714 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -131.39 130.48 42.65 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 118.089 0.404 . . . . 74.319999999999993 110.419 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 46.5 t -115.91 126.9 73.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.311 -0.626 . . . . 62.409999999999997 109.311 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 162' ' ' TRP . 50.6 mt-10 -128.65 133.06 48.14 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.962 0.41 . . . . 63.149999999999999 110.179 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 52.2 tp -114.44 121.43 43.54 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.683 -0.858 . . . . 50.350000000000001 108.683 174.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.3 m -115.8 108.82 16.81 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.988 -1.116 . . . . 73.420000000000002 107.988 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.1 t -107.92 123.59 63.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.727 -0.472 . . . . 72.230000000000004 109.727 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.16 127.07 55.83 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.318 -0.623 . . . . 62.0 109.318 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.06 120.42 15.12 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 116.38 -0.373 . . . . 71.25 111.79 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 16.1 Cg_exo -72.83 45.26 0.87 Allowed 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 122.866 2.378 . . . . 73.040000000000006 111.729 175.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -123.36 -95.59 0.47 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 119.18 -0.438 . . . . 70.329999999999998 110.869 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 173.19 123.63 0.02 OUTLIER 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.502 0.721 . . . . 51.509999999999998 109.361 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -80.28 130.58 35.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.434 -0.95 . . . . 71.319999999999993 108.434 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.3 p -88.15 -39.79 14.26 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.831 -0.433 . . . . 71.510000000000005 109.831 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.6 m -163.17 132.9 4.25 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 123.633 0.773 . . . . 73.040000000000006 109.156 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -138.38 154.37 48.93 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.983 -0.448 . . . . 73.120000000000005 110.971 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 28.9 t-20 -121.31 94.89 4.48 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.029 -1.841 . . . . 72.120000000000005 106.029 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.24 -149.75 10.08 Favored Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 107.852 -2.099 . . . . 62.109999999999999 107.852 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -117.74 99.89 7.24 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.416 -1.327 . . . . 73.019999999999996 107.416 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -81.12 132.27 35.35 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 120.113 -0.635 . . . . 73.340000000000003 110.565 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.64 -43.17 14.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.309 -1.367 . . . . 72.549999999999997 107.309 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -136.92 170.43 10.8 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.01 -1.478 . . . . 72.099999999999994 107.01 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -72.15 0.77 6.79 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.583 2.188 . . . . 45.439999999999998 110.985 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.5 pt-20 -130.33 -0.13 4.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.532 -0.758 . . . . 71.239999999999995 111.467 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 88.8 t -141.58 121.06 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.461 -0.94 . . . . 73.140000000000001 108.461 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.06 146.63 33.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 109.578 -0.526 . . . . 63.43 109.578 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 29.2 tt0 -134.01 136.74 44.29 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 121.612 0.72 . . . . 73.239999999999995 110.937 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 32.2 m-90 -112.62 125.83 54.71 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.593 -0.73 . . . . 65.109999999999999 109.953 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -104.6 99.21 8.88 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.36 -0.978 . . . . 75.040000000000006 108.36 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 1.8 mm? -95.89 121.84 38.06 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.701 -0.851 . . . . 71.549999999999997 108.701 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 59.3 mttm -116.25 151.04 46.32 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 115.394 -0.821 . . . . 73.120000000000005 110.991 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 165' ' ' LYS . 7.7 Cg_exo -76.48 162.83 32.89 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.032 2.488 . . . . 70.439999999999998 109.836 173.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.45 -40.12 2.94 Favored Glycine 0 C--O 1.245 0.802 0 N-CA-C 111.145 -0.782 . . . . 62.240000000000002 111.145 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.33 158.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 123.043 0.537 . . . . 53.229999999999997 109.61 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -109.56 136.98 43.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.836 -1.172 . . . . 63.530000000000001 107.836 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.7 t -137.71 141.28 41.04 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 119.363 -0.935 . . . . 62.329999999999998 111.093 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.3 p -99.76 145.85 27.22 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.393 -1.276 . . . . 54.530000000000001 109.303 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 82.8 mtp -121.81 119.93 33.11 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.091 -1.077 . . . . 65.049999999999997 108.091 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 30.4 t -133.76 138.79 45.95 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.914 -1.143 . . . . 62.329999999999998 107.914 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.553 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.97 116.35 5.03 Favored 'General case' 0 CA--C 1.471 -2.093 0 N-CA-C 108.926 -0.768 . . . . 44.210000000000001 108.926 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.43 ' HG2' HG22 ' A' ' 120' ' ' ILE . 49.1 mt-30 -121.83 130.31 53.28 Favored 'General case' 0 C--N 1.263 -3.187 0 N-CA-C 106.916 -1.513 . . . . 62.450000000000003 106.916 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -149.45 149.84 31.43 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.145 -1.058 . . . . 72.219999999999999 108.145 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 7.3 ppt_? -93.45 145.82 24.21 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.578 -0.849 . . . . 74.310000000000002 109.237 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.418 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 96.4 m-85 -139.72 152.34 46.58 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.723 -0.843 . . . . 72.409999999999997 108.723 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.32 93.57 2.4 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 109.693 -0.484 . . . . 53.530000000000001 109.693 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.2 t0 . . . . . 0 CA--C 1.5 -0.975 0 CA-C-N 114.548 -1.205 . . . . 63.240000000000002 108.961 -179.15 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 . . . . . 0 N--CA 1.41 -2.468 0 N-CA-C 107.968 -1.123 . . . . 74.540000000000006 107.968 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 47.6 t -120.05 114.49 44.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.692 -1.225 . . . . 74.120000000000005 107.692 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -118.01 114.1 22.64 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.955 -0.757 . . . . 74.150000000000006 108.955 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.4 108.96 20.55 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 107.799 -1.186 . . . . 51.240000000000002 107.799 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 m -113.58 114.67 26.79 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.433 -1.321 . . . . 62.509999999999998 107.433 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -125.43 146.57 30.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.061 -0.718 . . . . 60.310000000000002 109.061 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 43.6 m -129.63 123.43 31.22 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-O 121.197 0.523 . . . . 60.030000000000001 109.635 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 tt -112.77 121.1 64.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.652 0.739 . . . . 74.129999999999995 110.594 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -86.69 154.04 55.75 Favored Pre-proline 0 N--CA 1.425 -1.696 0 CA-C-N 115.178 -0.919 . . . . 71.25 109.517 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.76 2.64 1.91 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.134 2.556 . . . . 73.340000000000003 113.052 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -88.74 1.94 54.28 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.93 -1.137 . . . . 72.099999999999994 107.93 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 71.43 29.73 2.65 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 123.314 1.531 . . . . 71.019999999999996 107.811 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.91 128.33 53.11 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 112.938 -1.937 . . . . 74.120000000000005 107.772 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.44 138.11 49.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.424 -0.584 . . . . 52.140000000000001 109.424 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 p -142.32 163.45 32.8 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.518 -1.29 . . . . 75.140000000000001 107.518 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.77 -171.79 43.94 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.534 -1.793 . . . . 64.040000000000006 113.407 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -148.05 133.4 18.53 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 123.855 0.862 . . . . 60.530000000000001 108.915 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.32 115.83 47.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.416 -1.327 . . . . 64.450000000000003 107.416 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 2.3 mp -115.42 114.86 47.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.61 -0.515 . . . . 73.109999999999999 109.61 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.85 108.13 17.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.874 -1.528 . . . . 73.519999999999996 106.874 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -122.56 128.6 50.94 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 120.799 -0.361 . . . . 73.420000000000002 110.899 -174.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.68 152.46 36.07 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 116.114 -0.494 . . . . 53.340000000000003 110.442 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--N 1.309 -1.19 0 C-N-CA 119.473 -0.891 . . . . 62.229999999999997 109.065 171.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.436 -1.156 0 N-CA-C 108.463 -0.94 . . . . 73.409999999999997 108.463 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.24 97.29 0.16 Allowed Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.56 -1.305 . . . . 44.509999999999998 113.174 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.48 159.13 32.53 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.759 2.306 . . . . 73.329999999999998 110.263 172.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.6 133.77 53.01 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.748 -0.464 . . . . 74.120000000000005 109.748 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.94 153.23 19.62 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.587 -0.523 . . . . 71.230000000000004 109.587 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -83.54 84.26 7.6 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.874 -1.158 . . . . 71.129999999999995 107.874 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.82 42.76 1.6 Allowed Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 114.904 -1.044 . . . . 62.32 111.598 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.11 88.15 7.15 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.661 -1.237 . . . . 73.349999999999994 107.661 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.431 HG11 ' SD ' ' A' ' 101' ' ' MET . 17.3 m -122.78 160.23 49.92 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-N 114.628 -1.169 . . . . 65.230000000000004 111.391 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.82 -7.87 12.24 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.489 2.793 . . . . 74.230000000000004 113.572 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.402 ' HE1' ' HG2' ' A' ' 97' ' ' GLN . 46.2 p90 -124.42 28.86 6.5 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 122.21 -0.306 . . . . 63.329999999999998 111.006 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.1 m -55.72 -27.85 52.66 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 111.971 0.36 . . . . 62.409999999999997 111.971 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -71.96 -7.97 51.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.212 0.53 . . . . 72.340000000000003 110.932 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -112.39 -6.76 14.0 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.065 -0.516 . . . . 73.409999999999997 110.15 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 p -127.58 118.53 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.892 0.854 . . . . 54.450000000000003 109.963 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.69 104.58 16.51 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.451 -0.795 . . . . 62.240000000000002 109.44 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.09 132.93 42.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.238 -1.393 . . . . 71.219999999999999 107.238 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.1 m -154.19 172.35 17.73 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.714 -0.847 . . . . 72.140000000000001 108.714 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -80.57 154.6 27.37 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.298 0.57 . . . . 75.230000000000004 110.105 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 70.7 t80 -118.23 123.39 45.34 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.957 -1.127 . . . . 73.409999999999997 107.957 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -138.22 100.35 4.11 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.04 -1.837 . . . . 75.299999999999997 106.04 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.3 t -165.23 143.78 6.35 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.768 -0.456 . . . . 45.340000000000003 109.768 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.1 t70 66.9 14.38 9.8 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.078 1.351 . . . . 70.25 109.339 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.63 -0.73 77.62 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.767 -0.73 . . . . 52.109999999999999 111.683 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.549 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 7.9 m-85 -94.0 146.04 24.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.424 -0.584 . . . . 73.540000000000006 109.424 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 m -125.56 136.96 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 108.265 -1.013 . . . . 74.420000000000002 108.265 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.69 -154.61 10.45 Favored Glycine 0 C--N 1.271 -3.037 0 N-CA-C 110.439 -1.064 . . . . 51.43 110.439 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 m -129.82 150.9 50.92 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 120.967 0.413 . . . . 73.450000000000003 110.42 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -133.64 145.26 49.82 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.083 0.468 . . . . 75.299999999999997 110.613 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.6 114.76 21.06 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.458 -1.312 . . . . 74.099999999999994 107.458 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.31 115.27 49.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.734 -0.839 . . . . 65.420000000000002 108.734 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.512 ' CD2' HD12 ' A' ' 90' ' ' LEU . 47.1 p90 -121.09 151.0 40.36 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.47 -0.492 . . . . 74.030000000000001 111.227 -174.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -153.15 156.49 38.72 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.415 -0.357 . . . . 62.020000000000003 111.202 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.4 t70 63.53 31.21 14.92 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.5 1.12 . . . . 72.530000000000001 111.046 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.512 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.4 mt -94.69 170.14 9.67 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.89 -0.595 . . . . 75.430000000000007 109.938 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t -128.08 179.72 5.44 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 120.636 -0.426 . . . . 64.420000000000002 110.617 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -54.69 -42.23 71.18 Favored 'General case' 0 C--O 1.209 -1.035 0 C-N-CA 123.794 0.837 . . . . 61.420000000000002 112.17 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.62 -29.11 69.03 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.342 0.592 . . . . 70.219999999999999 111.566 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.66 -15.97 29.44 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 115.57 -0.741 . . . . 72.019999999999996 111.285 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.9 tt -60.35 -51.46 80.0 Favored Pre-proline 0 CA--C 1.568 1.662 0 CA-C-O 119.202 -0.428 . . . . 72.310000000000002 111.205 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.52 -36.65 75.61 Favored 'Trans proline' 0 C--N 1.373 1.863 0 CA-C-N 120.976 1.384 . . . . 74.530000000000001 110.838 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.402 ' HG2' ' HE1' ' A' ' 66' ' ' PHE . 5.3 tt0 -66.44 -37.73 85.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.215 -0.902 . . . . 75.510000000000005 110.097 -175.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -78.09 -19.99 53.1 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.393 0.616 . . . . 71.310000000000002 109.736 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.34 -18.08 60.74 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.601 -0.727 . . . . 54.420000000000002 109.063 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.18 -57.22 12.29 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 116.012 -0.54 . . . . 74.140000000000001 109.737 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 64' ' ' VAL . 3.2 mpp? -55.73 -45.25 78.0 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 123.674 0.609 . . . . 72.439999999999998 109.718 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -52.88 -42.48 65.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.524 -1.217 . . . . 60.310000000000002 111.412 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.9 m -63.51 -31.76 73.01 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.179 -0.464 . . . . 65.120000000000005 110.725 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.6 -20.77 63.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.184 0.516 . . . . 73.5 110.686 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.91 -9.82 16.94 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.485 -0.486 . . . . 71.319999999999993 110.382 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.41 -47.64 3.89 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.414 0.524 . . . . 63.119999999999997 112.414 -173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.21 28.77 19.29 Favored Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 119.962 -1.114 . . . . 60.109999999999999 110.933 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.8 m -124.38 165.11 21.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 122.767 -0.255 . . . . 62.100000000000001 110.544 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.93 124.18 47.62 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.816 -1.179 . . . . 73.019999999999996 107.816 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.19 123.15 49.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.165 0.439 . . . . 73.439999999999998 111.08 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -120.93 117.56 27.64 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.346 -0.983 . . . . 71.299999999999997 108.346 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.452 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 2.2 pt? -133.35 147.43 51.82 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.223 -0.591 . . . . 74.099999999999994 111.006 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.452 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 2.1 mpt_? -142.11 155.23 45.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.968 -1.493 . . . . 75.439999999999998 106.968 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.525 ' NE ' ' HB2' ' A' ' 180' ' ' ASP . 9.4 ttt180 -108.85 137.53 46.63 Favored 'General case' 0 N--CA 1.396 -3.126 0 N-CA-C 106.69 -1.596 . . . . 74.200000000000003 106.69 173.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -127.42 99.6 5.69 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 107.98 -1.119 . . . . 71.299999999999997 107.98 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.9 -115.71 6.75 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.845 -0.902 . . . . 61.0 110.845 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 8.9 t30 -110.6 12.89 22.67 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.304 1.049 . . . . 51.329999999999998 109.342 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.8 pp -122.51 149.25 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 121.234 -0.916 . . . . 74.150000000000006 109.069 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.513 HG22 ' HG3' ' A' ' 114' ' ' ARG . 76.5 t -110.66 137.88 41.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 109.987 -0.375 . . . . 74.299999999999997 109.987 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 120' ' ' ILE . 42.0 pt -116.26 129.06 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 N-CA-C 108.636 -0.876 . . . . 72.430000000000007 108.636 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -128.3 125.73 39.39 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.959 -0.564 . . . . 75.430000000000007 109.653 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.48 115.96 18.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.361 0.6 . . . . 73.129999999999995 109.769 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -116.52 130.4 8.96 Favored Glycine 0 C--N 1.294 -1.789 0 N-CA-C 110.075 -1.21 . . . . 62.549999999999997 110.075 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -114.6 132.9 56.19 Favored 'General case' 0 C--N 1.282 -2.332 0 O-C-N 122.153 -0.616 . . . . 71.150000000000006 109.8 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.0 114.37 19.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.679 -0.691 . . . . 70.420000000000002 112.052 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.69 97.25 6.45 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.434 -0.95 . . . . 74.310000000000002 108.434 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.45 28.21 8.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.685 -0.857 . . . . 73.129999999999995 108.685 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 20.5 p . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.254 -0.885 . . . . 45.219999999999999 112.944 -175.741 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 . . . . . 0 CA--C 1.501 -0.92 0 CA-C-O 120.561 0.219 . . . . 70.209999999999994 111.463 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.31 140.3 38.81 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.156 0.503 . . . . 72.109999999999999 110.808 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -131.85 110.43 10.81 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.278 -0.874 . . . . 74.430000000000007 109.29 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 77.8 t -104.89 113.66 42.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.379 -0.971 . . . . 62.420000000000002 108.379 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -108.54 121.08 44.23 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.109 -1.071 . . . . 61.109999999999999 108.109 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.524 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.9 tm? -110.81 115.7 29.99 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 105.784 -1.932 . . . . 74.019999999999996 105.784 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.9 m -123.69 127.53 48.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.501 -0.555 . . . . 53.32 109.501 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 76.9 t -124.95 126.82 71.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.182 -0.673 . . . . 72.120000000000005 109.182 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -115.95 130.93 57.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.704 -0.85 . . . . 53.439999999999998 108.704 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.713 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.2 p90 -135.06 122.84 15.39 Favored Pre-proline 0 C--N 1.283 -2.318 0 N-CA-C 112.002 0.371 . . . . 73.409999999999997 112.002 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -70.15 35.61 0.24 Allowed 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 122.57 2.18 . . . . 74.299999999999997 111.681 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -115.77 -99.31 0.44 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 123.132 0.573 . . . . 71.219999999999999 109.869 -177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.42 129.97 0.02 OUTLIER 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.304 -0.998 . . . . 54.229999999999997 108.304 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.87 138.08 20.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.704 -0.85 . . . . 75.219999999999999 108.704 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.8 p -94.09 -43.04 8.68 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 109.051 -0.722 . . . . 64.409999999999997 109.051 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.0 m -160.08 133.12 6.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.505 -0.924 . . . . 64.409999999999997 108.505 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 t -139.24 149.42 44.32 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.683 -0.635 . . . . 70.109999999999999 111.099 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -114.67 93.07 4.16 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 104.71 -2.33 . . . . 62.409999999999997 104.71 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.492 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.13 -148.86 11.57 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 107.999 -2.04 . . . . 74.409999999999997 107.999 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -114.09 100.02 8.07 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 117.587 0.693 . . . . 64.239999999999995 110.473 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -76.95 119.87 21.28 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.159 -0.616 . . . . 73.230000000000004 109.354 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.8 mt -83.98 -37.43 13.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.317 -1.364 . . . . 63.439999999999998 107.317 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.42 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . 39.3 mt-10 -145.69 161.9 38.59 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 106.766 -1.568 . . . . 65.219999999999999 106.766 -178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.31 -10.6 29.2 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.445 2.097 . . . . 72.049999999999997 112.212 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.713 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.4 OUTLIER -122.18 5.58 9.75 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 112.656 0.613 . . . . 71.310000000000002 112.656 177.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.5 t -139.84 120.95 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.56 -0.533 . . . . 64.319999999999993 109.56 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.77 148.04 31.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.482 -0.562 . . . . 71.120000000000005 109.482 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -138.55 149.58 45.46 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.298 -0.63 . . . . 61.119999999999997 109.298 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.524 ' CE3' HD12 ' A' ' 139' ' ' LEU . 28.2 m-90 -124.92 142.07 51.7 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.822 -0.807 . . . . 54.119999999999997 108.822 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -108.73 105.12 14.57 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.93 -1.507 . . . . 72.239999999999995 106.93 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 9.4 mp -100.57 119.18 38.15 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.926 0.87 . . . . 75.5 110.884 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.604 ' HD3' ' HD2' ' A' ' 166' ' ' PRO . 1.6 mmtm -118.42 140.75 28.61 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 114.231 -1.35 . . . . 63.240000000000002 108.85 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.604 ' HD2' ' HD3' ' A' ' 165' ' ' LYS . 39.1 Cg_exo -66.64 167.71 18.46 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.693 1.595 . . . . 74.439999999999998 110.729 171.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.97 -36.82 3.01 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 120.857 -0.687 . . . . 50.229999999999997 111.656 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.8 m -104.94 157.06 5.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.163 0.506 . . . . 72.319999999999993 110.093 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.6 p -114.06 127.02 71.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.914 -1.143 . . . . 74.340000000000003 107.914 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 46.6 m -145.57 143.54 29.97 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.912 -0.492 . . . . 70.150000000000006 110.863 -177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.1 p -109.23 125.91 52.75 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 115.841 -0.618 . . . . 74.420000000000002 109.651 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -101.3 134.66 44.02 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.606 -0.887 . . . . 75.439999999999998 108.606 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.0 m -143.26 140.72 30.78 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.616 -0.678 . . . . 72.420000000000002 110.907 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.507 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -143.05 132.18 23.11 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.358 -0.383 . . . . 70.200000000000003 109.982 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.1 131.32 54.19 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.82 -1.548 . . . . 72.099999999999994 106.82 170.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.84 156.24 42.05 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.21 -0.663 . . . . 74.5 109.21 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 28.4 ptt180 -87.91 134.48 33.7 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 120.362 -0.535 . . . . 71.209999999999994 109.895 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -143.72 122.72 12.81 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 109.337 -0.616 . . . . 75.450000000000003 109.337 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.572 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -58.97 109.08 0.76 Allowed 'General case' 0 C--N 1.279 -2.477 0 O-C-N 124.389 1.055 . . . . 75.099999999999994 111.536 -178.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' HB2' ' NE ' ' A' ' 114' ' ' ARG . 27.0 t70 . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 108.888 -0.782 . . . . 71.400000000000006 108.888 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 . . . . . 0 N--CA 1.424 -1.743 0 N-CA-C 106.867 -1.531 . . . . 72.340000000000003 106.867 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HB ' HG13 ' A' ' 137' ' ' VAL . 59.1 t -119.48 113.63 41.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 106.96 -1.496 . . . . 73.430000000000007 106.96 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 11.3 ttp180 -127.67 113.5 16.12 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.041 0.448 . . . . 73.140000000000001 109.958 -175.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.67 108.78 20.18 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.981 -0.748 . . . . 71.019999999999996 108.981 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.6 t -108.4 114.16 27.79 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.694 -1.595 . . . . 71.5 106.694 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.407 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.7 pp -132.98 147.17 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.379 0.609 . . . . 64.219999999999999 110.483 -174.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.3 m -129.73 128.38 42.35 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 116.024 -0.535 . . . . 71.299999999999997 109.865 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 143' ' ' PHE . 9.6 tt -113.96 125.69 71.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.299 0.571 . . . . 74.219999999999999 110.748 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.481 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 31.3 t -93.49 151.67 40.34 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.533 -0.758 . . . . 54.549999999999997 109.888 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.39 1.08 1.42 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.793 2.995 . . . . 74.209999999999994 112.922 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.71 -3.69 54.33 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.818 -1.179 . . . . 61.310000000000002 107.818 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.3 t70 72.25 29.02 2.3 Favored 'General case' 0 C--N 1.347 0.473 0 N-CA-C 106.858 -1.534 . . . . 72.450000000000003 106.858 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.3 OUTLIER -112.73 140.83 47.18 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.441 -1.254 . . . . 75.319999999999993 108.985 -178.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' A' ' 95' ' ' LEU . 17.8 t -115.63 144.71 22.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.549 -0.75 . . . . 75.109999999999999 109.126 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.2 p -149.29 158.71 44.4 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.079 -1.082 . . . . 73.030000000000001 108.079 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 161.48 -166.73 36.06 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 119.884 -1.15 . . . . 74.209999999999994 112.748 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -154.61 139.21 16.94 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.353 0.597 . . . . 73.430000000000007 111.064 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 46.6 mt -114.51 116.53 52.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.543 -0.91 . . . . 64.109999999999999 108.543 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.16 126.01 61.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.371 -0.603 . . . . 74.420000000000002 109.371 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.513 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -123.61 108.6 12.77 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.777 -1.194 . . . . 64.329999999999998 107.777 173.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.87 126.54 52.58 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.85 0.357 . . . . 63.25 111.585 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.38 158.91 30.06 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.765 -0.652 . . . . 70.150000000000006 109.755 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 118.974 -1.091 . . . . 74.030000000000001 109.298 175.263 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.427 -1.598 0 N-CA-C 108.684 -0.858 . . . . 71.140000000000001 108.684 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 174.15 112.04 0.28 Allowed Glycine 0 N--CA 1.425 -2.082 0 CA-C-N 115.261 -0.881 . . . . 74.209999999999994 112.046 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.04 160.33 45.02 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 123.047 2.498 . . . . 70.420000000000002 111.351 173.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.43 131.07 37.14 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.798 -0.816 . . . . 64.299999999999997 108.798 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.426 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 69.0 mt -84.87 143.66 28.9 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.423 -0.584 . . . . 71.109999999999999 109.423 176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -100.43 93.79 5.83 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.478 0.656 . . . . 72.519999999999996 109.66 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.623 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -140.6 72.59 0.41 Allowed Glycine 0 C--N 1.28 -2.56 0 CA-C-N 115.168 -0.924 . . . . 62.219999999999999 111.116 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -82.29 91.32 6.75 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.834 -0.802 . . . . 62.240000000000002 108.834 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.6 m -122.29 154.1 62.04 Favored Pre-proline 0 C--N 1.299 -1.606 0 CA-C-N 114.744 -1.117 . . . . 71.109999999999999 110.739 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.84 -21.39 70.32 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 123.595 2.863 . . . . 43.32 112.916 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -102.75 32.45 3.64 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 111.063 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 p -55.8 -34.08 64.99 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 116.29 -0.413 . . . . 64.019999999999996 111.543 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -65.29 -16.69 63.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.301 0.572 . . . . 73.420000000000002 111.47 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 88' ' ' SER . 33.3 mmtp -98.75 -16.0 19.11 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 116.157 -0.474 . . . . 72.310000000000002 110.524 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.17 118.89 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-O 122.195 0.998 . . . . 72.340000000000003 111.18 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -105.62 122.6 46.38 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.888 -1.051 . . . . 53.43 109.27 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.3 t -98.23 131.43 45.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.954 -1.128 . . . . 60.43 107.954 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 m -139.65 169.8 17.07 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.451 -0.574 . . . . 75.409999999999997 109.451 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.541 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 1.7 p-10 -83.64 142.56 30.71 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.097 0.475 . . . . 73.319999999999993 109.771 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 82.5 t80 -107.92 121.74 45.4 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.657 -1.238 . . . . 74.219999999999999 107.657 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.28 101.11 4.3 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.158 -1.053 . . . . 71.049999999999997 108.158 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 36.6 t -165.8 147.57 7.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.043 -1.095 . . . . 65.219999999999999 108.043 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 71.94 10.15 6.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.976 0.91 . . . . 64.450000000000003 111.167 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.55 1.06 83.76 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.557 -0.747 . . . . 73.0 111.967 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -104.95 147.06 28.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.454 -0.943 . . . . 63.119999999999997 108.454 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -123.85 139.0 51.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.218 -1.031 . . . . 73.200000000000003 108.218 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -167.44 -155.13 8.98 Favored Glycine 0 C--N 1.26 -3.677 0 C-N-CA 119.797 -1.192 . . . . 71.549999999999997 111.178 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.426 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 7.8 t -123.81 152.77 41.89 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 108.858 -0.793 . . . . 54.140000000000001 108.858 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.8 pt20 -140.67 130.71 24.72 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 120.999 0.428 . . . . 72.239999999999995 110.363 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.04 115.31 29.96 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.735 -0.839 . . . . 75.319999999999993 108.735 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.89 116.75 50.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.903 -0.777 . . . . 75.200000000000003 108.903 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.461 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.2 p90 -121.67 146.95 46.49 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 120.982 0.42 . . . . 74.109999999999999 110.944 -176.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 46.1 m -152.04 158.54 43.18 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 116.018 -0.537 . . . . 74.450000000000003 109.78 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.8 t70 60.47 38.82 18.93 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 122.31 1.052 . . . . 75.25 111.64 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.461 HD12 ' CD2' ' A' ' 87' ' ' PHE . 25.3 mt -97.47 166.53 11.48 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.238 -0.892 . . . . 74.430000000000007 109.878 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -115.08 173.72 6.35 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.875 0.307 . . . . 71.329999999999998 110.264 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -49.84 -50.49 45.26 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.223 1.409 . . . . 72.200000000000003 111.461 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.31 68.11 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.156 0.582 . . . . 74.150000000000006 112.251 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -84.3 -16.34 43.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.67 -0.241 . . . . 73.109999999999999 111.619 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.7 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.8 tt -64.52 -54.98 33.01 Favored Pre-proline 0 CA--C 1.558 1.273 0 CA-C-O 119.392 -0.337 . . . . 71.230000000000004 111.312 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.41 -33.28 88.88 Favored 'Trans proline' 0 C--N 1.367 1.54 0 CA-C-N 120.744 1.301 . . . . 65.349999999999994 111.017 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -66.57 -36.06 81.73 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.95 -0.568 . . . . 74.510000000000005 110.697 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.0 pp -75.9 -19.21 59.01 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 109.498 -0.556 . . . . 74.299999999999997 109.498 175.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.01 -15.99 62.05 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.004 -0.544 . . . . 74.549999999999997 110.342 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -63.79 -56.93 11.82 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.452 -0.944 . . . . 73.420000000000002 108.452 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.623 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 31.9 ttp -54.33 -49.67 69.18 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.664 -0.698 . . . . 73.519999999999996 109.805 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -53.33 -41.98 66.27 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.849 -1.069 . . . . 75.109999999999999 110.887 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.3 p -72.37 -20.73 61.41 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 119.421 -0.912 . . . . 74.140000000000001 112.199 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.2 -20.36 62.28 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.482 0.658 . . . . 72.230000000000004 109.703 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.91 -10.41 20.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.792 -0.64 . . . . 51.140000000000001 110.378 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.67 -48.4 3.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.667 0.618 . . . . 64.140000000000001 112.667 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.64 20.62 59.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.481 -0.648 . . . . 42.32 111.481 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.84 168.19 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 109.476 -0.565 . . . . 73.120000000000005 109.476 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -102.77 135.52 44.29 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.887 0.312 . . . . 72.540000000000006 110.407 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.25 125.65 23.42 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.38 -0.6 . . . . 70.099999999999994 109.38 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.2 p -144.34 143.12 30.81 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.756 0.313 . . . . 71.430000000000007 111.268 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.54 125.78 23.14 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.741 0.816 . . . . 60.25 108.894 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -142.01 168.33 20.0 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.302 0.241 . . . . 63.140000000000001 110.378 -174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.417 ' CG ' HG22 ' A' ' 119' ' ' VAL . 26.6 mtt85 -101.14 138.68 37.85 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 113.866 1.061 . . . . 72.140000000000001 113.866 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.434 ' O ' HG13 ' A' ' 118' ' ' ILE . 7.0 t30 -123.96 94.36 4.2 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 105.764 -1.939 . . . . 74.120000000000005 105.764 174.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.42 -114.03 4.95 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 110.106 -1.197 . . . . 72.329999999999998 110.106 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -110.7 -1.37 16.74 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.721 1.248 . . . . 73.140000000000001 108.768 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.5 pp -103.19 148.97 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 C-N-CA 118.892 -1.123 . . . . 75.239999999999995 108.323 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.417 HG22 ' CG ' ' A' ' 114' ' ' ARG . 89.1 t -108.92 136.53 44.49 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.984 0 N-CA-C 109.853 -0.425 . . . . 61.420000000000002 109.853 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.7 pt -116.01 132.14 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-O 121.921 0.867 . . . . 71.450000000000003 109.201 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 174' ' ' ALA . 5.5 tt -114.4 130.95 56.73 Favored 'General case' 0 C--N 1.255 -3.513 0 N-CA-C 105.646 -1.983 . . . . 51.310000000000002 105.646 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -140.74 130.67 24.54 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.727 -0.842 . . . . 75.430000000000007 108.727 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.92 168.05 38.26 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 111.199 -0.76 . . . . 31.25 111.199 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -140.2 141.83 35.91 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.364 -0.976 . . . . 73.0 108.364 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.69 108.78 12.37 Favored 'General case' 0 N--CA 1.413 -2.279 0 N-CA-C 108.352 -0.981 . . . . 71.120000000000005 108.352 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -112.66 111.72 22.72 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.034 -1.099 . . . . 53.140000000000001 108.034 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 0.1 OUTLIER -127.75 34.47 4.64 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.082 -1.451 . . . . 75.049999999999997 107.082 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 113.654 0.983 . . . . 74.239999999999995 113.654 -175.151 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 121.23 0.538 . . . . 64.519999999999996 111.872 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.2 148.15 28.6 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.987 -1.116 . . . . 70.109999999999999 107.987 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -132.68 124.58 28.5 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.888 -0.412 . . . . 71.209999999999994 109.888 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.511 ' HB ' ' HG ' ' A' ' 164' ' ' LEU . 82.6 t -117.16 121.05 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 120.161 -0.616 . . . . 73.439999999999998 110.113 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 45.3 mt-10 -115.73 138.02 51.52 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.95 -0.568 . . . . 55.399999999999999 110.686 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.407 HD13 ' SD ' ' A' ' 172' ' ' MET . 3.3 tt -127.64 125.46 40.19 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 105.237 -2.134 . . . . 70.010000000000005 105.237 170.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 13.6 m -126.57 122.94 36.53 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.144 -0.687 . . . . 75.030000000000001 109.144 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.443 HG12 ' HD2' ' A' ' 143' ' ' PHE . 94.1 t -118.24 123.5 71.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 110.131 -0.322 . . . . 63.009999999999998 110.131 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.78 127.49 55.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.074 -0.713 . . . . 41.219999999999999 109.074 176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.0 p90 -134.46 121.31 15.17 Favored Pre-proline 0 C--N 1.295 -1.779 0 C-N-CA 122.695 0.398 . . . . 73.329999999999998 112.004 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 15.0 Cg_exo -72.59 39.17 0.41 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.874 2.382 . . . . 73.219999999999999 112.108 176.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.61 -97.92 0.46 Allowed 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 119.307 -0.378 . . . . 62.420000000000002 110.482 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.59 123.8 0.03 OUTLIER 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.406 -0.59 . . . . 64.530000000000001 109.406 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.48 136.15 23.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.483 -0.932 . . . . 73.319999999999993 108.483 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.8 p -95.31 -44.97 7.34 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.204 -0.665 . . . . 63.130000000000003 109.204 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 62.5 m -158.82 133.3 7.98 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.935 -0.575 . . . . 62.549999999999997 109.536 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.2 t -138.32 159.27 42.49 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.835 -0.54 . . . . 74.319999999999993 110.113 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -126.18 94.56 4.12 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 105.343 -2.095 . . . . 71.209999999999994 105.343 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.34 -150.19 10.37 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.051 -2.02 . . . . 50.25 108.051 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.68 99.01 7.02 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.608 -0.886 . . . . 74.310000000000002 108.608 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -74.66 137.63 42.32 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.906 -0.588 . . . . 72.099999999999994 111.307 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.4 mt -100.87 -48.45 11.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.242 -1.392 . . . . 73.219999999999999 107.242 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -133.72 169.0 15.09 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 107.561 -1.274 . . . . 73.239999999999995 107.561 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.87 0.81 7.2 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.625 2.216 . . . . 72.420000000000002 111.078 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.4 pt-20 -132.75 3.7 3.83 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.946 -1.024 . . . . 73.450000000000003 110.747 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.421 HG23 ' HG3' ' A' ' 158' ' ' GLU . 59.8 t -144.6 120.82 4.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.912 -0.773 . . . . 61.520000000000003 108.912 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.97 147.83 31.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.084 -0.71 . . . . 74.340000000000003 109.084 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -130.05 143.38 50.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.111 -0.7 . . . . 64.400000000000006 109.111 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.536 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 32.6 m-90 -122.66 116.73 24.31 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 108.731 -0.841 . . . . 72.230000000000004 108.731 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.25 98.27 8.68 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.554 -0.906 . . . . 63.210000000000001 108.554 175.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.511 ' HG ' ' HB ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -96.45 131.52 42.94 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-O 122.338 1.066 . . . . 60.219999999999999 110.082 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 68.4 mttm -119.52 151.03 51.05 Favored Pre-proline 0 C--N 1.279 -2.499 0 CA-C-N 113.248 -1.796 . . . . 63.210000000000001 112.858 -170.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 20.3 Cg_exo -70.97 156.56 59.96 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.868 2.379 . . . . 71.340000000000003 110.644 174.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.34 -36.17 2.94 Favored Glycine 0 C--N 1.309 -0.925 0 C-N-CA 121.278 -0.487 . . . . 73.140000000000001 112.129 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.3 m -105.82 166.27 3.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 123.008 0.523 . . . . 74.349999999999994 110.223 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.0 p -113.82 142.33 26.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.348 -0.982 . . . . 64.510000000000005 108.348 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.1 m -138.53 141.95 39.32 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.937 -0.477 . . . . 72.129999999999995 109.841 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.3 p -103.43 130.01 50.68 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.871 -0.788 . . . . 74.400000000000006 108.871 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.407 ' SD ' HD13 ' A' ' 139' ' ' LEU . 44.2 ttp -104.02 116.34 32.05 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.653 -0.869 . . . . 72.030000000000001 108.653 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.1 m -140.33 139.52 35.44 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.693 -0.803 . . . . 64.329999999999998 109.305 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.536 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -149.2 120.68 7.94 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 108.507 -0.923 . . . . 40.240000000000002 108.507 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -120.7 130.74 54.21 Favored 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 106.691 -1.596 . . . . 70.340000000000003 106.691 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -155.76 150.93 26.68 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.405 -0.961 . . . . 73.219999999999999 108.405 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 5.8 ppt_? -88.2 126.41 35.13 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.81 -0.756 . . . . 74.099999999999994 110.671 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 16.5 m-30 -135.05 118.71 17.06 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 107.741 -1.207 . . . . 64.010000000000005 107.741 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.63 113.25 0.67 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 125.171 1.545 . . . . 52.409999999999997 112.274 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.5 t0 . . . . . 0 CA--C 1.501 -0.926 0 C-N-CA 124.422 1.089 . . . . 74.239999999999995 109.082 -176.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 . . . . . 0 N--CA 1.44 -0.929 0 CA-C-O 121.121 0.486 . . . . 74.439999999999998 111.418 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.08 114.44 41.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.729 -0.841 . . . . 64.150000000000006 108.729 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 58.6 mtp85 -119.5 119.3 33.45 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.553 -0.748 . . . . 74.349999999999994 111.961 -176.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.08 108.35 19.4 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.481 -1.303 . . . . 73.109999999999999 107.481 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 140' ' ' THR . 20.3 m -120.71 115.11 22.7 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.618 -0.512 . . . . 72.400000000000006 109.618 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.9 pp -124.45 147.47 28.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.017 0.437 . . . . 75.439999999999998 110.44 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 62.7 m -129.82 122.04 27.95 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 121.053 0.454 . . . . 63.130000000000003 110.097 -176.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -113.92 122.73 68.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 121.463 0.649 . . . . 63.439999999999998 110.439 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.1 m -86.99 151.64 52.19 Favored Pre-proline 0 N--CA 1.417 -2.112 0 CA-C-N 115.336 -0.847 . . . . 64.230000000000004 109.46 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.43 ' HG3' ' HB2' ' A' ' 145' ' ' ALA . 21.6 Cg_exo -65.96 2.13 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.312 2.675 . . . . 74.409999999999997 112.349 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 25.7 t70 -85.19 -2.22 57.79 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.139 0.975 . . . . 63.119999999999997 109.385 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.9 t70 72.76 28.96 2.01 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 123.469 1.605 . . . . 74.209999999999994 107.621 -174.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -107.51 125.84 51.78 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 113.671 -1.604 . . . . 64.129999999999995 108.25 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 t -108.97 137.12 42.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.256 -0.646 . . . . 63.149999999999999 109.256 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.2 p -146.84 165.43 29.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.722 -1.214 . . . . 74.030000000000001 107.722 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.26 -173.97 41.78 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.617 -1.278 . . . . 51.039999999999999 112.764 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 10.2 pt-20 -157.51 133.42 9.37 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.409 0.623 . . . . 75.030000000000001 110.804 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 2.0 mp -113.18 116.5 52.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.992 -1.114 . . . . 74.540000000000006 107.992 175.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mp -113.9 115.6 50.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.195 0.521 . . . . 64.230000000000004 109.698 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -108.7 125.85 52.35 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.509 -1.663 . . . . 74.409999999999997 106.509 174.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.87 116.79 14.19 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.578 0.704 . . . . 75.239999999999995 109.476 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.84 159.34 31.28 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 115.059 -0.973 . . . . 73.200000000000003 110.789 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 mttp . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 106.713 -1.588 . . . . 70.540000000000006 106.713 171.29 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.443 -0.799 0 CA-C-O 120.563 0.22 . . . . 74.510000000000005 111.045 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.45 97.79 0.11 Allowed Glycine 0 N--CA 1.434 -1.47 0 C-N-CA 120.053 -1.07 . . . . 62.130000000000003 111.98 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.56 159.83 35.42 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.635 2.223 . . . . 63.109999999999999 111.454 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.96 140.47 52.3 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.452 -0.573 . . . . 72.450000000000003 109.452 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.413 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 90.8 mt -62.89 149.19 45.1 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.566 0.541 . . . . 65.209999999999994 110.208 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -82.38 85.1 6.95 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.571 -0.899 . . . . 55.43 108.571 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.531 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -122.4 120.88 4.47 Favored Glycine 0 N--CA 1.417 -2.631 0 CA-C-N 114.558 -1.201 . . . . 75.239999999999995 113.746 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -139.95 112.79 8.06 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.757 -0.831 . . . . 73.239999999999995 108.757 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.51 161.6 57.93 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.662 -0.866 . . . . 74.030000000000001 108.662 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.62 -11.86 24.36 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.047 1.831 . . . . 73.219999999999999 111.536 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -114.03 41.61 2.21 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.837 -0.619 . . . . 71.400000000000006 111.595 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.2 m -58.64 -27.23 64.53 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-N 116.211 -0.449 . . . . 65.340000000000003 111.508 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -68.84 -15.82 63.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.522 0.677 . . . . 71.420000000000002 110.405 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -95.4 -17.63 21.4 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.245 -0.889 . . . . 73.010000000000005 110.565 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 87' ' ' PHE . 7.6 p -124.55 118.97 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-O 122.246 1.022 . . . . 53.210000000000001 111.92 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.94 101.85 14.41 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.042 -0.981 . . . . 64.129999999999995 108.39 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.21 125.5 51.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.594 -1.262 . . . . 71.040000000000006 107.594 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 m -142.09 172.26 12.93 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.888 -0.782 . . . . 74.209999999999994 108.888 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -83.59 151.92 25.1 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.818 -1.178 . . . . 74.200000000000003 107.818 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -110.35 123.57 50.09 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.94 -1.504 . . . . 73.400000000000006 106.94 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -138.55 99.53 3.85 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 106.97 -1.493 . . . . 71.150000000000006 106.97 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.4 t -171.94 155.21 3.74 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.556 -1.276 . . . . 73.25 107.556 -174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 70.62 7.26 6.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.942 0.897 . . . . 73.439999999999998 111.383 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.1 -2.04 80.99 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.453 -1.059 . . . . 63.140000000000001 110.453 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -104.56 155.67 18.62 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.216 0.606 . . . . 75.319999999999993 111.288 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.64 136.69 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 108.438 -0.949 . . . . 71.140000000000001 108.438 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -163.45 -154.06 7.55 Favored Glycine 0 N--CA 1.397 -3.931 0 C-N-CA 120.056 -1.069 . . . . 62.210000000000001 111.051 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.413 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 13.0 m -131.25 143.6 50.68 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 115.462 -0.369 . . . . 61.219999999999999 110.078 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.9 pt20 -132.74 138.15 47.1 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.706 0.289 . . . . 63.399999999999999 110.731 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -121.03 114.4 21.44 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.295 -1.372 . . . . 74.340000000000003 107.295 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.7 113.18 43.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 108.225 -1.028 . . . . 60.399999999999999 108.225 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.449 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.8 p90 -123.41 154.68 38.69 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.186 -0.606 . . . . 73.519999999999996 111.865 -175.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -157.1 165.61 35.58 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.229 -0.896 . . . . 74.140000000000001 109.499 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 65.19 31.7 10.62 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.276 0.985 . . . . 71.510000000000005 111.767 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.449 HD12 ' CD2' ' A' ' 87' ' ' PHE . 47.9 mt -101.58 164.55 11.7 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.273 -0.422 . . . . 44.340000000000003 110.447 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -117.86 178.08 4.54 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.816 0.341 . . . . 42.539999999999999 111.082 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -54.06 -38.87 65.73 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 125.595 1.558 . . . . 64.010000000000005 111.063 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.22 -25.95 62.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.948 -0.569 . . . . 72.209999999999994 111.503 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -89.72 -17.07 29.0 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.299 -0.409 . . . . 74.140000000000001 111.564 -176.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.534 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 43.1 tp -57.84 -48.32 97.36 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 112.771 0.656 . . . . 65.540000000000006 112.771 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 40.2 Cg_exo -63.12 -37.02 54.8 Favored 'Trans proline' 0 C--N 1.367 1.53 0 CA-C-N 120.658 1.271 . . . . 74.109999999999999 110.892 174.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -68.49 -34.8 76.55 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.456 -0.793 . . . . 75.219999999999999 111.507 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -78.36 -19.44 53.39 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.501 -0.555 . . . . 74.129999999999995 109.501 176.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 96' ' ' PRO . . . -70.62 -27.15 63.85 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 115.585 -0.734 . . . . 73.140000000000001 109.933 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -57.1 -57.4 12.72 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.985 0.803 . . . . 73.519999999999996 109.675 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.531 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.6 ttp -53.58 -50.35 65.77 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.352 -0.84 . . . . 74.530000000000001 110.468 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -60.31 -33.0 71.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.227 -0.897 . . . . 73.340000000000003 111.609 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.9 m -63.99 -28.14 69.61 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 121.079 -0.249 . . . . 73.319999999999993 110.945 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.82 -26.18 68.23 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-O 121.424 0.631 . . . . 64.010000000000005 110.582 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.47 -6.64 16.05 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 116.143 -0.481 . . . . 72.450000000000003 110.669 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.52 -41.6 5.44 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.203 -0.599 . . . . 60.119999999999997 112.433 -173.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.56 26.02 68.68 Favored Glycine 0 C--O 1.242 0.638 0 C-N-CA 120.473 -0.87 . . . . 73.340000000000003 110.962 -175.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.56 160.81 9.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 121.056 0.455 . . . . 65.340000000000003 110.238 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -113.14 122.44 47.54 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.94 -1.874 . . . . 71.400000000000006 105.94 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.9 mt -119.68 123.24 43.33 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 117.82 0.282 . . . . 74.200000000000003 111.349 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.8 m -123.46 141.39 52.05 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.475 -0.565 . . . . 64.25 109.475 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.5 tp -134.92 131.85 37.77 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.259 -0.428 . . . . 75.129999999999995 110.426 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -143.03 153.68 43.2 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.406 -0.961 . . . . 71.129999999999995 108.406 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.573 ' NH1' ' HA ' ' A' ' 180' ' ' ASP . 19.8 ttm180 -112.02 132.44 54.8 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 108.763 -0.828 . . . . 75.540000000000006 108.763 171.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -110.06 89.3 2.98 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.104 -1.443 . . . . 72.340000000000003 107.104 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.26 -108.95 2.64 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.326 -1.11 . . . . 64.340000000000003 110.326 -176.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -107.63 -6.31 16.98 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.213 1.006 . . . . 53.539999999999999 109.39 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.6 pp -104.39 143.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 C-N-CA 118.202 -1.399 . . . . 75.25 109.202 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.441 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 72.8 t -105.79 138.76 29.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 O-C-N 122.003 -0.435 . . . . 63.549999999999997 110.287 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.2 pt -121.15 135.92 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-O 121.626 0.726 . . . . 74.219999999999999 109.893 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.3 tt -128.06 125.32 39.07 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 107.475 -1.306 . . . . 73.319999999999993 107.475 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -125.83 121.84 34.43 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.857 -1.534 . . . . 53.520000000000003 106.857 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.99 161.21 27.57 Favored Glycine 0 N--CA 1.407 -3.259 0 C-N-CA 120.719 -0.753 . . . . 60.549999999999997 111.567 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -139.44 138.38 36.41 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.44 -0.948 . . . . 71.129999999999995 108.44 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.23 117.19 33.47 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.532 -0.303 . . . . 64.129999999999995 111.253 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -104.16 97.42 7.38 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.013 -1.106 . . . . 75.120000000000005 108.013 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 3.1 mm? -112.21 12.83 20.42 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.451 -0.574 . . . . 71.319999999999993 109.451 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 p . . . . . 0 C--N 1.309 -1.191 0 N-CA-C 113.431 0.901 . . . . 62.409999999999997 113.431 -175.241 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 120.57 0.224 . . . . 72.140000000000001 111.412 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.52 131.3 44.86 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.164 -0.68 . . . . 73.340000000000003 109.164 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -122.12 118.26 28.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.311 -1.366 . . . . 53.43 107.311 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 53.5 t -109.73 129.92 63.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.344 -0.542 . . . . 71.239999999999995 110.657 -173.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 44.9 mt-10 -134.53 130.71 37.01 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.861 -0.422 . . . . 74.5 109.861 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.464 HD13 ' SD ' ' A' ' 172' ' ' MET . 5.6 tt -120.15 128.98 53.93 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.307 -1.738 . . . . 73.319999999999993 106.307 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 31' ' ' SER . 29.8 m -126.98 131.65 50.99 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.548 -0.538 . . . . 74.140000000000001 109.548 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 80.2 t -121.9 125.87 73.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.513 -0.921 . . . . 73.530000000000001 108.513 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -116.63 128.69 55.61 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 108.637 -0.875 . . . . 75.019999999999996 108.637 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.683 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.12 117.78 13.81 Favored Pre-proline 0 C--N 1.281 -2.379 0 CA-C-N 116.545 -0.298 . . . . 72.109999999999999 111.072 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.8 38.25 0.18 Allowed 'Trans proline' 0 CA--C 1.554 1.521 0 C-N-CA 123.024 2.483 . . . . 70.450000000000003 112.929 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.43 ' HB2' ' HG3' ' A' ' 36' ' ' PRO . . . -122.04 -102.0 0.41 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 110.048 -0.353 . . . . 52.130000000000003 110.048 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.73 128.12 0.08 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.665 -0.865 . . . . 54.219999999999999 108.665 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.49 141.3 15.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.521 -0.918 . . . . 72.310000000000002 108.521 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.3 t -103.54 -32.79 9.28 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 120.205 -0.598 . . . . 75.0 109.643 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 54.9 m -161.12 133.37 5.94 Favored 'General case' 0 C--O 1.202 -1.405 0 N-CA-C 109.598 -0.519 . . . . 73.150000000000006 109.598 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.8 t -138.52 168.78 19.04 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.695 -0.628 . . . . 53.310000000000002 109.599 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -139.76 87.7 2.19 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.065 -2.198 . . . . 51.200000000000003 105.065 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.9 -144.39 5.94 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.264 -1.534 . . . . 52.219999999999999 109.264 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -117.94 99.65 7.05 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.545 -0.909 . . . . 72.329999999999998 108.545 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 34.8 ptt180 -82.42 133.19 35.21 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 119.298 -0.961 . . . . 74.219999999999999 110.986 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.17 -37.74 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.582 -1.266 . . . . 70.349999999999994 107.582 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -139.71 165.04 34.02 Favored Pre-proline 0 N--CA 1.427 -1.582 0 N-CA-C 106.207 -1.775 . . . . 45.509999999999998 106.207 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.78 0.17 6.05 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.5 2.133 . . . . 74.430000000000007 111.366 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.683 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.0 pt-20 -134.41 8.38 3.66 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.819 -0.628 . . . . 74.420000000000002 111.88 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 86.9 t -142.7 121.06 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 109.131 -0.692 . . . . 52.030000000000001 109.131 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 44.9 t -130.58 146.28 34.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 110.167 -0.309 . . . . 44.200000000000003 110.167 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -132.75 152.58 51.72 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 121.12 0.486 . . . . 74.239999999999995 110.359 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.417 ' CE2' ' HG3' ' A' ' 172' ' ' MET . 31.2 m-90 -125.28 119.43 28.4 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.296 -1.002 . . . . 75.230000000000004 108.296 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -98.99 106.5 18.77 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.963 0.887 . . . . 62.229999999999997 110.075 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 76.9 mt -101.44 135.51 42.82 Favored 'General case' 0 C--O 1.264 1.826 0 CA-C-N 114.907 -1.042 . . . . 74.310000000000002 111.216 -173.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 10.7 mmpt? -115.12 150.61 44.58 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 114.143 -1.39 . . . . 74.420000000000002 109.189 -175.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 11.3 Cg_exo -73.6 156.78 49.22 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.61 2.207 . . . . 54.0 111.283 176.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.79 -24.83 3.13 Favored Glycine 0 C--N 1.314 -0.688 0 O-C-N 122.318 -0.239 . . . . 74.230000000000004 112.665 176.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 31.7 m -106.05 160.83 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.264 0.554 . . . . 75.140000000000001 112.096 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.73 144.14 21.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.764 -1.198 . . . . 71.420000000000002 107.764 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 32.8 t -148.6 152.71 37.23 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.991 -0.374 . . . . 71.420000000000002 109.991 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.1 p -96.03 154.78 17.05 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.893 -0.594 . . . . 61.25 109.547 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.464 ' SD ' HD13 ' A' ' 139' ' ' LEU . 37.4 ttp -144.1 116.27 8.44 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.396 0.617 . . . . 71.329999999999998 109.408 -176.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.4 m -134.61 141.7 46.69 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.188 -0.605 . . . . 73.439999999999998 109.58 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -146.66 116.25 7.14 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.114 -1.069 . . . . 52.439999999999998 108.114 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -124.13 129.88 51.59 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.438 -1.319 . . . . 63.450000000000003 107.438 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.98 155.66 38.46 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.139 -0.689 . . . . 54.420000000000002 109.139 -175.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 16.5 ptm180 -91.85 132.75 36.23 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 120.624 -0.431 . . . . 72.310000000000002 111.078 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.441 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 63.5 m-85 -140.52 129.76 23.69 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 109.091 -0.707 . . . . 74.439999999999998 109.091 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.5 110.8 0.38 Allowed 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 125.211 1.404 . . . . 62.229999999999997 111.982 -178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.573 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 35.9 t70 . . . . . 0 C--N 1.311 -1.089 0 CA-C-N 114.692 -1.14 . . . . 74.140000000000001 110.419 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 52.4 ttt180 . . . . . 0 N--CA 1.423 -1.811 0 N-CA-C 109.254 -0.647 . . . . 73.540000000000006 109.254 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.08 114.08 44.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 106.669 -1.604 . . . . 64.239999999999995 106.669 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.91 113.3 18.92 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.36 -1.348 . . . . 63.509999999999998 107.36 -175.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.62 136.86 52.58 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.811 -0.631 . . . . 71.109999999999999 109.905 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -138.03 115.24 11.0 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.112 -0.699 . . . . 70.340000000000003 109.112 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 14.5 pt -126.55 149.14 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 121.25 0.548 . . . . 74.310000000000002 111.038 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 69.7 m -126.51 123.68 38.33 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 108.439 -0.948 . . . . 72.319999999999993 108.439 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 tt -113.49 125.02 70.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.478 0.656 . . . . 73.549999999999997 110.642 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 43.8 t -88.74 150.96 46.99 Favored Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 115.114 -0.948 . . . . 72.230000000000004 109.243 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 35' ' ' SER . 16.8 Cg_exo -68.92 2.78 2.79 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 123.436 2.757 . . . . 71.319999999999993 111.894 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -89.08 4.53 48.1 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.058 -0.719 . . . . 75.439999999999998 109.058 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 t70 71.5 29.44 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.124 1.44 . . . . 34.25 107.144 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.42 124.93 51.83 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 113.882 -1.508 . . . . 61.310000000000002 107.938 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.479 HG11 HD13 ' A' ' 95' ' ' LEU . 20.7 t -111.58 138.81 38.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.765 -0.828 . . . . 43.229999999999997 108.765 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 p -149.64 157.92 43.69 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.626 -0.879 . . . . 64.409999999999997 108.626 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 159.28 -165.08 34.21 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 119.516 -1.326 . . . . 72.109999999999999 112.432 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.2 141.97 21.04 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.207 0.527 . . . . 74.420000000000002 110.265 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.8 mt -124.31 117.01 49.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.99 -1.115 . . . . 73.200000000000003 107.99 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.13 116.05 51.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.327 -0.62 . . . . 75.010000000000005 109.327 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.5 107.77 18.95 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.946 -1.501 . . . . 62.420000000000002 106.946 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.49 127.72 49.93 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.249 0.547 . . . . 63.340000000000003 109.884 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.82 153.02 29.83 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 109.269 -0.641 . . . . 60.229999999999997 109.269 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.3 tttt . . . . . 0 C--N 1.287 -2.139 0 N-CA-C 105.837 -1.912 . . . . 73.239999999999995 105.837 175.238 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 108.286 -1.005 . . . . 70.049999999999997 108.286 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 173.1 104.76 0.18 Allowed Glycine 0 N--CA 1.417 -2.578 0 CA-C-O 118.472 -1.182 . . . . 74.129999999999995 111.163 176.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -52.45 132.78 46.42 Favored 'Trans proline' 0 C--O 1.243 0.771 0 CA-C-N 119.914 1.857 . . . . 74.25 110.772 173.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.97 155.83 39.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.055 -0.52 . . . . 60.409999999999997 111.718 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.6 tp -103.0 160.14 14.89 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.243 -1.021 . . . . 73.420000000000002 108.243 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -111.05 95.3 5.45 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.505 -0.924 . . . . 75.439999999999998 108.505 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -105.3 -106.3 3.11 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 120.726 -0.75 . . . . 64.219999999999999 112.136 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.0 t70 60.98 91.99 0.05 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 125.062 1.345 . . . . 61.219999999999999 112.028 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.68 157.72 77.24 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 114.393 -1.276 . . . . 72.439999999999998 108.136 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.82 -18.55 61.45 Favored 'Trans proline' 0 N--CA 1.479 0.634 0 C-N-CA 122.669 2.246 . . . . 70.530000000000001 112.326 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.464 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 42.1 p90 -111.16 32.35 5.38 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.559 -0.746 . . . . 73.219999999999999 112.114 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.5 m -55.92 -33.02 64.31 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 112.052 0.39 . . . . 60.409999999999997 112.052 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.39 -11.07 60.51 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.034 -0.416 . . . . 62.25 111.586 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HE3' HD23 ' A' ' 90' ' ' LEU . 24.3 mtpp -105.49 -4.45 21.27 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 109.905 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 87' ' ' PHE . 4.6 p -125.98 119.03 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 122.179 0.99 . . . . 71.120000000000005 110.377 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.02 102.37 15.02 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.593 -0.73 . . . . 52.219999999999999 109.755 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 7.4 p -98.22 128.84 49.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.734 -0.839 . . . . 70.209999999999994 108.734 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.9 m -146.48 171.8 14.5 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 116.079 -0.509 . . . . 54.149999999999999 110.297 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.465 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 7.3 t30 -82.89 139.1 33.62 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.37 -0.604 . . . . 75.349999999999994 109.37 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -110.51 123.15 49.39 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.734 -0.839 . . . . 72.299999999999997 108.734 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -138.34 99.97 3.99 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.889 -1.523 . . . . 75.519999999999996 106.889 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.4 t -172.68 154.2 2.96 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.98 -0.378 . . . . 73.019999999999996 109.98 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 70.78 7.65 6.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.282 1.033 . . . . 63.329999999999998 111.632 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.65 -9.15 64.23 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.073 -0.811 . . . . 72.530000000000001 111.073 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -104.66 149.71 25.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.048 0.451 . . . . 72.530000000000001 110.692 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.83 137.74 56.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 109.082 -0.71 . . . . 74.540000000000006 109.082 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.43 -153.81 11.04 Favored Glycine 0 C--N 1.285 -2.305 0 C-N-CA 120.209 -0.996 . . . . 74.409999999999997 111.719 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 p -126.77 149.03 49.86 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 121.268 0.556 . . . . 53.240000000000002 110.848 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 3.7 pt20 -132.44 142.37 49.23 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.489 -0.323 . . . . 71.340000000000003 110.5 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.44 114.41 22.84 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.02 -1.104 . . . . 52.219999999999999 108.02 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.19 111.92 38.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.41 -0.959 . . . . 75.340000000000003 108.41 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.45 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.7 p90 -118.47 162.41 18.38 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 112.516 0.561 . . . . 74.540000000000006 112.516 -172.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 p -164.24 160.29 20.98 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.474 -0.785 . . . . 72.319999999999993 110.345 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.0 t70 65.65 30.99 10.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 124.366 1.041 . . . . 73.010000000000005 110.699 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.507 HD23 ' HE3' ' A' ' 69' ' ' LYS . 55.8 mt -95.69 159.69 14.86 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 121.662 -0.649 . . . . 70.329999999999998 110.636 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.415 HG22 ' OE1' ' A' ' 94' ' ' GLU . 8.9 t -106.09 171.41 7.36 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.526 -0.546 . . . . 62.509999999999998 109.526 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -52.49 -40.02 61.89 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.638 0.775 . . . . 75.319999999999993 111.313 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.39 -24.9 65.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.752 -0.658 . . . . 52.219999999999999 111.92 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.415 ' OE1' HG22 ' A' ' 91' ' ' THR . 54.4 mt-10 -87.53 -16.83 33.54 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.461 -0.336 . . . . 74.140000000000001 111.634 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.596 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 49.2 tp -61.67 -51.4 76.72 Favored Pre-proline 0 CA--C 1.562 1.422 0 N-CA-C 113.174 0.805 . . . . 71.140000000000001 113.174 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.453 ' HD3' HD23 ' A' ' 112' ' ' LEU . 33.3 Cg_endo -70.32 -29.08 21.74 Favored 'Trans proline' 0 C--N 1.361 1.213 0 CA-C-N 120.887 1.353 . . . . 74.409999999999997 110.132 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -67.95 -35.52 78.55 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.404 -0.816 . . . . 62.149999999999999 110.438 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -75.62 -19.29 59.31 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 109.783 -0.451 . . . . 75.129999999999995 109.783 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.01 -20.89 63.25 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.171 -0.468 . . . . 75.109999999999999 110.159 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -58.4 -57.14 14.23 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.234 -0.654 . . . . 72.409999999999997 109.234 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.4 ttp -53.79 -51.25 64.06 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 115.633 -0.712 . . . . 74.430000000000007 110.162 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -55.67 -41.51 73.77 Favored 'General case' 0 C--O 1.251 1.178 0 CA-C-N 114.954 -1.021 . . . . 65.25 111.272 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.3 p -65.9 -25.27 67.08 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.187 -0.605 . . . . 75.25 111.675 -171.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.74 -26.59 68.72 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 121.228 0.537 . . . . 72.129999999999995 110.518 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.37 -12.58 15.3 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 120.235 -0.586 . . . . 45.030000000000001 111.185 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.0 -29.16 9.59 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 114.295 1.22 . . . . 75.400000000000006 114.295 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.61 20.88 76.02 Favored Glycine 0 C--O 1.243 0.686 0 C-N-CA 120.535 -0.841 . . . . 24.440000000000001 111.491 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 125' ' ' ALA . 34.7 m -96.68 156.41 3.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.153 -0.523 . . . . 53.329999999999998 111.547 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -132.1 122.19 25.0 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.253 -1.388 . . . . 62.200000000000003 107.253 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.08 123.36 40.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.064 0.393 . . . . 74.5 111.952 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.9 t -104.53 125.01 50.29 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 107.183 -1.414 . . . . 63.450000000000003 107.183 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.59 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 48.7 tp -128.72 123.08 32.14 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.162 -0.681 . . . . 75.420000000000002 109.162 -178.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.59 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 3.2 mpt_? -135.7 146.5 47.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.853 -0.425 . . . . 64.540000000000006 109.853 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.63 ' HG3' HG22 ' A' ' 119' ' ' VAL . 3.3 ttt180 -99.39 138.11 36.95 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 108.057 -1.09 . . . . 73.299999999999997 108.057 174.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -123.8 83.74 2.18 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.96 -1.496 . . . . 64.319999999999993 106.96 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.75 -122.61 22.69 Favored Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 114.137 -1.392 . . . . 54.200000000000003 110.97 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -75.74 -20.53 58.24 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 123.932 0.893 . . . . 72.140000000000001 110.617 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.531 HG22 ' HG2' ' A' ' 177' ' ' ARG . 0.8 OUTLIER -102.58 149.08 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 119.287 -0.965 . . . . 62.100000000000001 110.403 -172.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.63 HG22 ' HG3' ' A' ' 114' ' ' ARG . 59.4 t -117.73 139.81 43.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.784 -0.45 . . . . 74.030000000000001 109.784 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.3 pt -126.03 135.18 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 CA-C-O 121.709 0.766 . . . . 73.340000000000003 110.584 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.29 128.88 47.83 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 107.363 -1.347 . . . . 74.140000000000001 107.363 174.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.79 114.59 12.78 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 105.783 -1.932 . . . . 70.430000000000007 105.783 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.08 160.52 27.16 Favored Glycine 0 N--CA 1.41 -3.083 0 N-CA-C 110.925 -0.87 . . . . 55.350000000000001 110.925 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.469 ' HG2' HG22 ' A' ' 171' ' ' THR . 64.3 mtt180 -141.01 150.47 43.07 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.59 -1.263 . . . . 73.209999999999994 107.59 -176.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 108' ' ' VAL . . . -121.41 128.83 52.59 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.957 -0.386 . . . . 70.349999999999994 109.957 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -111.83 93.56 4.52 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 118.716 -1.194 . . . . 70.209999999999994 109.991 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.9 pt? -123.26 15.52 9.78 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 113.926 -1.488 . . . . 71.420000000000002 107.482 176.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.43 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.423 -1.779 0 CA-C-N 113.409 -1.723 . . . . 73.219999999999999 109.01 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t0 . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 121.545 0.688 . . . . 73.019999999999996 110.33 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.01 145.23 55.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 70.430000000000007 111.921 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 26.8 t70 -132.34 118.05 18.93 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.852 -0.613 . . . . 62.310000000000002 109.972 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 97.6 t -116.57 133.96 61.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.004 -1.11 . . . . 54.530000000000001 108.004 175.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -138.9 138.96 37.88 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.47 -0.567 . . . . 71.530000000000001 109.47 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 tt -133.42 128.23 35.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.061 -1.459 . . . . 72.129999999999995 107.061 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.0 m -126.21 134.21 51.3 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.694 -0.854 . . . . 71.140000000000001 108.694 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 57.6 t -129.02 125.22 62.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.636 -0.505 . . . . 74.129999999999995 109.636 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.08 128.39 56.48 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.008 -0.738 . . . . 75.409999999999997 109.008 177.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 3.4 p90 -134.46 129.67 19.69 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 112.917 0.71 . . . . 73.340000000000003 112.917 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 20.9 Cg_exo -71.86 49.47 1.25 Allowed 'Trans proline' 0 CA--C 1.551 1.363 0 C-N-CA 123.317 2.678 . . . . 74.140000000000001 111.286 172.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.69 -133.78 0.13 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.241 -1.392 . . . . 73.340000000000003 107.241 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -161.88 135.13 6.24 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.027 -1.472 . . . . 51.329999999999998 107.027 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.18 127.65 41.75 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.117 0.484 . . . . 64.319999999999993 110.356 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.4 t -88.08 -37.53 16.18 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.883 -0.414 . . . . 74.219999999999999 109.883 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.1 m -152.6 133.27 13.9 Favored 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 109.561 -0.533 . . . . 74.329999999999998 109.561 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -139.36 161.93 36.24 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 121.95 -0.469 . . . . 72.439999999999998 109.79 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.61 91.18 2.96 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 104.47 -2.418 . . . . 75.099999999999994 104.47 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.8 -147.47 8.76 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 109.296 -1.522 . . . . 23.420000000000002 109.296 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -119.66 99.82 6.89 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.62 -0.881 . . . . 74.239999999999995 108.62 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 12.4 ptt180 -82.11 129.49 34.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 119.513 -0.875 . . . . 73.340000000000003 111.981 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.9 mt -83.71 -42.36 17.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.351 -1.351 . . . . 73.140000000000001 107.351 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -138.71 167.2 20.37 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 106.646 -1.613 . . . . 74.140000000000001 106.646 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.54 0.14 8.51 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.095 1.864 . . . . 74.450000000000003 111.504 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -128.4 3.91 5.67 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.337 0.589 . . . . 71.140000000000001 111.008 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 65.8 t -145.13 120.59 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.377 -0.971 . . . . 74.349999999999994 108.377 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 40.9 t -123.94 149.83 28.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.432 -0.581 . . . . 74.140000000000001 109.432 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -136.23 143.64 44.44 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 109.131 -0.692 . . . . 65.25 109.131 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -122.17 130.27 53.06 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 109.65 -0.5 . . . . 71.099999999999994 109.65 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.37 111.64 24.07 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.433 -0.951 . . . . 40.399999999999999 108.433 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.7 mm? -94.81 122.33 37.32 Favored 'General case' 0 C--O 1.276 2.461 0 CA-C-N 114.726 -1.125 . . . . 54.530000000000001 107.966 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -117.08 130.94 24.25 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 114.637 -1.165 . . . . 73.329999999999998 110.293 -170.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.404 ' HA ' ' HG ' ' A' ' 127' ' ' LEU . 42.4 Cg_endo -67.57 155.37 70.46 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.328 2.685 . . . . 75.230000000000004 112.576 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 73.01 -14.6 2.72 Favored Glycine 0 N--CA 1.466 0.652 0 CA-C-N 115.805 -0.634 . . . . 64.040000000000006 113.796 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.9 m -120.81 162.83 19.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.447 -0.946 . . . . 70.329999999999998 108.447 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.1 p -99.25 128.3 51.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.32 0.581 . . . . 60.32 110.353 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.3 m -116.8 137.73 52.0 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.127 -1.064 . . . . 54.399999999999999 108.127 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 124' ' ' ARG . 20.6 p -116.09 148.03 40.68 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 110.086 -0.338 . . . . 72.129999999999995 110.086 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.432 ' SD ' HD11 ' A' ' 164' ' ' LEU . 2.7 mpp? -126.83 116.84 21.5 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.147 -0.686 . . . . 72.010000000000005 109.147 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.0 t -132.42 138.25 47.58 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.953 -1.128 . . . . 70.109999999999999 107.953 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -145.56 120.66 10.1 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.243 -1.021 . . . . 62.409999999999997 108.243 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -125.17 130.19 51.65 Favored 'General case' 0 C--N 1.272 -2.798 0 N-CA-C 107.204 -1.406 . . . . 62.450000000000003 107.204 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -155.89 153.92 30.42 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.85 -0.796 . . . . 62.439999999999998 108.85 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.531 ' HG2' HG22 ' A' ' 118' ' ' ILE . 60.1 mtt180 -88.19 132.52 34.32 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.94 -0.763 . . . . 61.399999999999999 108.94 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -135.87 129.85 32.96 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 109.282 -0.636 . . . . 74.530000000000001 109.282 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.78 104.21 0.14 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.943 0.777 . . . . 70.099999999999994 111.91 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 CA--C 1.503 -0.842 0 CA-C-N 114.879 -1.055 . . . . 65.450000000000003 109.238 178.728 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.927 0 N-CA-C 107.42 -1.326 . . . . 63.0 107.42 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.75 122.77 47.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 C-N-CA 119.546 -0.862 . . . . 75.219999999999999 112.058 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -110.22 134.82 51.85 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.336 -0.987 . . . . 71.140000000000001 108.336 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.25 108.8 12.1 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.565 -0.902 . . . . 63.310000000000002 108.565 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 p -116.7 115.05 24.92 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.295 -1.002 . . . . 62.109999999999999 108.295 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.83 146.63 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 121.154 0.502 . . . . 71.120000000000005 109.813 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 87.4 m -126.31 127.8 46.12 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 109.678 -0.49 . . . . 75.109999999999999 109.678 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -110.47 118.26 56.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.61 -0.723 . . . . 72.310000000000002 109.852 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.2 m -84.71 155.16 62.0 Favored Pre-proline 0 C--N 1.296 -1.741 0 CA-C-N 115.446 -0.797 . . . . 75.209999999999994 109.683 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.63 0.68 4.51 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 123.225 2.616 . . . . 64.019999999999996 112.142 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.58 0.32 43.34 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 124.348 1.059 . . . . 53.119999999999997 109.831 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.9 t70 70.27 29.71 3.57 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 123.29 1.519 . . . . 74.049999999999997 107.073 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.75 138.86 52.38 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 113.02 -1.9 . . . . 74.219999999999999 107.959 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.645 HG11 HD23 ' A' ' 95' ' ' LEU . 22.7 t -120.32 140.26 44.98 Favored 'Isoleucine or valine' 0 C--O 1.259 1.564 0 CA-C-O 121.052 0.453 . . . . 63.219999999999999 109.977 -176.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.1 p -147.33 142.88 27.58 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.629 -0.878 . . . . 52.340000000000003 108.629 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.86 -169.06 40.33 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 119.33 -1.414 . . . . 71.430000000000007 112.677 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -151.11 133.8 15.66 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.125 0.488 . . . . 71.349999999999994 110.661 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -116.72 116.17 51.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.456 -1.313 . . . . 74.219999999999999 107.456 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.04 114.84 47.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.763 -0.458 . . . . 70.430000000000007 109.763 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.61 108.68 20.07 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.364 -1.347 . . . . 61.340000000000003 107.364 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.62 119.36 32.64 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.7 0.762 . . . . 74.439999999999998 110.244 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.68 145.64 37.63 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.649 -0.705 . . . . 65.400000000000006 110.164 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.0 tttt . . . . . 0 N--CA 1.42 -1.948 0 N-CA-C 102.999 -2.963 . . . . 71.409999999999997 102.999 171.667 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.415 -2.197 0 N-CA-C 109.818 -0.438 . . . . 71.099999999999994 109.818 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.14 97.69 0.11 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 119.908 -1.139 . . . . 43.240000000000002 112.936 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.68 153.3 26.27 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 123.216 2.611 . . . . 44.43 111.461 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -113.38 157.28 22.08 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.598 -0.519 . . . . 54.409999999999997 109.598 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.467 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 65.1 mt -88.81 135.76 33.36 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.857 -0.423 . . . . 42.240000000000002 109.857 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.53 87.41 3.82 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.852 -0.613 . . . . 73.230000000000004 110.059 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.488 ' HA3' ' HG3' ' A' ' 101' ' ' MET . . . -161.82 156.6 28.18 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 110.885 -0.886 . . . . 71.439999999999998 110.885 176.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -144.22 129.08 18.39 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.102 -0.703 . . . . 61.340000000000003 109.102 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.06 147.56 61.21 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.458 -0.571 . . . . 72.430000000000007 109.458 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.15 -8.99 21.88 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.203 2.602 . . . . 70.420000000000002 113.215 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -110.45 42.23 1.61 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.428 0.632 . . . . 65.319999999999993 110.286 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 m -57.97 -34.6 70.12 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.605 -0.725 . . . . 63.520000000000003 110.945 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -71.27 -9.16 57.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.266 0.555 . . . . 62.030000000000001 110.851 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.28 -17.29 17.37 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.793 -0.639 . . . . 74.340000000000003 110.019 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 p -130.39 118.1 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.912 0.863 . . . . 75.140000000000001 111.015 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.89 112.41 24.18 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.035 -0.984 . . . . 75.019999999999996 109.151 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.0 t -98.16 130.52 46.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 106.949 -1.501 . . . . 64.310000000000002 106.949 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.9 t -144.04 172.7 12.52 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.112 0.482 . . . . 65.140000000000001 110.792 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -80.19 141.74 35.36 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 124.874 1.27 . . . . 64.310000000000002 109.323 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -119.76 120.14 35.69 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.635 -0.876 . . . . 72.519999999999996 108.635 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -138.7 103.99 4.98 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.655 -0.868 . . . . 75.010000000000005 108.655 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.2 t -164.75 142.25 6.35 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.705 -0.398 . . . . 73.040000000000006 110.692 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 65.24 13.54 8.83 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.391 1.476 . . . . 70.420000000000002 112.223 174.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.41 -3.11 59.47 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.865 -0.683 . . . . 72.299999999999997 111.908 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -99.84 148.04 24.86 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.856 -0.794 . . . . 75.530000000000001 108.856 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.23 136.76 59.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.328 -0.99 . . . . 75.420000000000002 108.328 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -166.03 -154.69 8.34 Favored Glycine 0 N--CA 1.413 -2.834 0 C-N-CA 120.112 -1.042 . . . . 70.409999999999997 112.478 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.467 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 6.7 m -126.08 148.37 49.37 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.888 -0.782 . . . . 64.019999999999996 108.888 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -129.81 132.14 46.4 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 120.556 -0.457 . . . . 73.319999999999993 110.363 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.78 113.92 26.88 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.702 -1.592 . . . . 73.420000000000002 106.702 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.68 112.36 39.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.732 -0.84 . . . . 72.340000000000003 108.732 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.484 ' HE2' HG12 ' A' ' 40' ' ' VAL . 45.3 p90 -120.02 152.8 36.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.292 0.567 . . . . 61.100000000000001 111.633 -173.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.6 p -159.73 157.38 29.35 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.276 -0.874 . . . . 72.329999999999998 109.727 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 67.28 31.69 6.41 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.592 1.157 . . . . 53.340000000000003 110.295 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.459 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.1 mt -96.23 164.44 12.67 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.813 -0.631 . . . . 65.150000000000006 110.091 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m -107.79 160.22 15.89 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 109.392 -0.596 . . . . 64.209999999999994 109.392 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -49.91 -43.15 49.44 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.192 1.397 . . . . 74.129999999999995 110.628 176.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.39 -30.45 71.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.865 -0.607 . . . . 65.310000000000002 111.441 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -82.91 -15.44 51.39 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.792 -0.64 . . . . 74.239999999999995 111.589 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.645 HD23 HG11 ' A' ' 40' ' ' VAL . 2.5 tm? -54.03 -56.2 28.35 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 123.056 0.542 . . . . 75.019999999999996 111.269 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.78 -36.13 75.37 Favored 'Trans proline' 0 C--N 1.371 1.723 0 CA-C-N 120.61 1.254 . . . . 61.409999999999997 111.072 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.433 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 23.6 mt-30 -62.8 -37.41 86.59 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.691 -0.686 . . . . 72.239999999999995 111.818 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -75.54 -20.41 58.7 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.184 0.516 . . . . 61.100000000000001 110.045 177.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.49 -20.21 57.2 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.717 -0.674 . . . . 45.140000000000001 109.537 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 97' ' ' GLN . 87.7 m-20 -62.77 -55.06 29.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.85 -0.613 . . . . 75.340000000000003 110.114 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.488 ' HG3' ' HA3' ' A' ' 62' ' ' GLY . 24.3 ttp -53.97 -51.27 64.41 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.167 0.292 . . . . 72.409999999999997 110.72 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.66 -35.27 72.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.846 -0.615 . . . . 73.439999999999998 110.429 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.4 t -59.86 -39.86 86.65 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.015 -0.735 . . . . 71.310000000000002 109.015 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -63.22 -25.24 68.24 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 115.339 -0.846 . . . . 72.340000000000003 110.943 -172.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.11 -20.09 13.52 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 119.949 -0.7 . . . . 65.219999999999999 111.591 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.19 -42.1 5.17 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 114.237 1.199 . . . . 74.109999999999999 114.237 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.97 25.76 18.81 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.635 -0.986 . . . . 52.43 110.635 -172.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.2 m -109.34 157.26 9.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.68 -0.489 . . . . 73.239999999999995 109.68 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -142.66 128.26 19.13 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.803 -0.814 . . . . 74.510000000000005 108.803 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -130.03 128.98 43.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.581 0.229 . . . . 63.009999999999998 110.664 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.8 m -118.05 134.19 55.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.301 -1.0 . . . . 74.040000000000006 108.301 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.469 HD22 ' HG ' ' A' ' 95' ' ' LEU . 53.2 tp -133.13 123.4 25.61 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.188 -0.671 . . . . 52.210000000000001 109.188 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.3 mtp180 -134.23 153.02 52.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.155 0.502 . . . . 74.019999999999996 111.703 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.502 HH11 ' HB2' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -106.4 122.11 45.61 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 124.33 1.052 . . . . 71.019999999999996 108.935 179.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.421 ' O ' HG13 ' A' ' 118' ' ' ILE . 6.8 t30 -118.14 101.23 8.07 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.779 -1.193 . . . . 64.219999999999999 107.779 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.34 -120.06 7.52 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 108.441 -1.864 . . . . 72.439999999999998 108.441 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.28 -2.07 22.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.718 -1.216 . . . . 43.420000000000002 107.718 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -100.28 148.96 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 C-N-CA 119.37 -0.932 . . . . 63.109999999999999 109.068 -175.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.71 140.5 40.57 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-O 120.793 0.33 . . . . 73.409999999999997 111.18 -175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.3 pt -119.79 135.37 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.624 -0.717 . . . . 73.209999999999994 109.36 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.79 127.07 45.57 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.542 -0.754 . . . . 74.019999999999996 109.39 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.29 122.24 31.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.202 -0.908 . . . . 74.549999999999997 108.95 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -136.35 146.65 18.63 Favored Glycine 0 N--CA 1.422 -2.277 0 N-CA-C 110.573 -1.011 . . . . 73.219999999999999 110.573 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -139.55 144.58 37.89 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.174 -0.676 . . . . 75.310000000000002 109.174 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.48 118.82 22.72 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.046 -0.724 . . . . 73.439999999999998 109.046 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -102.35 94.04 5.49 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.768 -0.773 . . . . 62.329999999999998 111.421 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.71 16.87 13.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.984 -1.487 . . . . 72.109999999999999 106.984 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.492 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 1.3 m . . . . . 0 C--N 1.319 -0.745 0 C-N-CA 125.778 1.631 . . . . 52.130000000000003 112.733 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.614 0.721 . . . . 74.239999999999995 109.835 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.45 129.49 38.92 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.741 -0.663 . . . . 75.439999999999998 110.754 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -131.73 111.65 11.84 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.695 -1.224 . . . . 73.329999999999998 107.695 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.717 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 49.2 t -111.94 127.66 68.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.956 -0.757 . . . . 62.219999999999999 108.956 -177.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -112.07 121.25 44.47 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.337 -0.616 . . . . 75.439999999999998 109.337 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.441 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.3 tm? -115.29 116.31 28.09 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.593 -1.262 . . . . 75.439999999999998 107.593 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.6 m -126.44 130.77 51.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 110.133 -0.321 . . . . 61.229999999999997 110.133 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.5 t -123.65 125.77 71.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.464 -0.569 . . . . 74.030000000000001 109.464 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.3 131.16 56.62 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.028 -0.73 . . . . 73.420000000000002 109.028 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.689 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.3 p90 -134.31 122.93 16.29 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.406 -0.361 . . . . 71.239999999999995 110.918 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -69.02 47.4 0.44 Allowed 'Trans proline' 0 CA--C 1.56 1.819 0 C-N-CA 123.008 2.472 . . . . 71.019999999999996 112.297 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -132.86 -108.13 0.24 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 122.823 0.449 . . . . 64.140000000000001 110.538 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.21 131.19 0.14 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.722 -0.844 . . . . 75.430000000000007 108.722 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.412 HG21 ' HB ' ' A' ' 150' ' ' THR . 8.4 p -85.09 128.73 38.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.14 -0.689 . . . . 73.239999999999995 109.14 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.0 t -88.62 -36.04 16.5 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.246 -0.434 . . . . 62.420000000000002 110.012 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.5 m -157.71 133.03 8.9 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 108.938 -0.764 . . . . 52.399999999999999 108.938 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.412 ' HB ' HG21 ' A' ' 147' ' ' VAL . 9.9 t -138.92 165.39 27.19 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 121.98 -0.45 . . . . 73.329999999999998 109.824 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 45.4 t30 -137.05 93.43 2.83 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 105.585 -2.006 . . . . 65.25 105.585 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.81 -147.0 10.45 Favored Glycine 0 N--CA 1.416 -2.67 0 N-CA-C 109.045 -1.622 . . . . 41.229999999999997 109.045 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -111.79 100.06 8.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.251 -0.648 . . . . 55.130000000000003 109.251 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -78.28 115.75 18.22 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.965 0.412 . . . . 71.439999999999998 110.684 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.0 mt -82.21 -48.99 17.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.217 -1.401 . . . . 73.239999999999995 107.217 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -130.92 159.74 70.0 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.095 -1.446 . . . . 74.319999999999993 107.095 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.404 ' O ' HG12 ' A' ' 147' ' ' VAL . 32.4 Cg_exo -62.74 -13.49 34.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.375 2.05 . . . . 54.229999999999997 112.187 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.689 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -122.39 8.0 9.62 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 112.816 0.673 . . . . 65.319999999999993 112.816 176.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.8 t -140.73 120.93 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 109.61 -0.515 . . . . 63.25 109.61 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.28 147.58 31.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.707 -0.479 . . . . 74.209999999999994 109.707 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -132.47 149.8 52.27 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.097 0.475 . . . . 55.100000000000001 109.898 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.462 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 23.8 m-90 -131.65 133.27 44.73 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.323 -1.362 . . . . 73.239999999999995 107.323 174.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -107.09 114.74 28.99 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.974 -0.75 . . . . 74.109999999999999 108.974 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.717 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.6 mp -88.9 125.57 35.0 Favored 'General case' 0 C--O 1.273 2.309 0 CA-C-N 114.212 -1.358 . . . . 75.340000000000003 110.572 -173.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 96.2 mttt -118.59 147.15 41.42 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 113.304 -1.771 . . . . 71.030000000000001 110.771 -171.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 165' ' ' LYS . 2.7 Cg_exo -76.39 159.31 36.39 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.437 2.091 . . . . 71.310000000000002 112.356 174.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 74.06 -14.72 3.62 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 123.136 0.398 . . . . 64.230000000000004 113.822 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.33 145.43 26.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.229 -1.026 . . . . 61.130000000000003 108.229 171.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.4 110.06 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 108.42 -0.956 . . . . 60.020000000000003 108.42 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.6 m -76.84 130.7 37.98 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.375 -0.83 . . . . 62.340000000000003 108.93 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.6 p -115.84 125.73 53.04 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.623 -0.717 . . . . 72.239999999999995 110.129 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -112.33 117.07 31.46 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.989 -1.115 . . . . 71.540000000000006 107.989 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 13.7 m -135.48 137.05 41.76 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.426 -1.31 . . . . 70.409999999999997 110.411 176.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -149.43 135.25 18.74 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.566 -0.901 . . . . 61.43 108.566 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -131.38 130.01 42.06 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 107.127 -1.435 . . . . 64.329999999999998 107.127 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -153.57 159.82 42.29 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.622 -0.881 . . . . 62.530000000000001 108.622 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 40.0 mtt180 -95.32 127.18 41.16 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.388 -0.925 . . . . 64.409999999999997 108.946 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -130.37 127.86 40.24 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.164 -1.05 . . . . 74.219999999999999 108.164 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.29 104.74 0.1 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 124.83 1.331 . . . . 64.150000000000006 112.675 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 N--CA 1.482 1.127 0 CA-C-N 114.684 -1.144 . . . . 64.5 111.728 -177.325 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 . . . . . 0 N--CA 1.416 -2.169 0 N-CA-C 108.0 -1.111 . . . . 62.350000000000001 108.0 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.9 t -107.26 114.72 46.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.398 -0.964 . . . . 63.530000000000001 108.398 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -112.25 113.15 25.23 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.422 -0.955 . . . . 64.409999999999997 108.422 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.16 108.63 14.02 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.052 -1.092 . . . . 52.530000000000001 108.052 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 140' ' ' THR . 20.2 m -122.11 114.32 20.74 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.125 -0.694 . . . . 72.129999999999995 109.125 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.5 pt -126.61 148.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 O-C-N 121.891 -0.506 . . . . 75.530000000000001 109.84 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.2 m -127.92 119.93 26.6 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 116.089 -0.505 . . . . 73.319999999999993 109.783 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.598 HG23 ' OH ' ' A' ' 178' ' ' TYR . 8.7 tt -104.41 125.62 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 108.64 -0.874 . . . . 72.230000000000004 108.64 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.7 m -94.66 152.65 40.02 Favored Pre-proline 0 C--N 1.281 -2.383 0 CA-C-N 115.754 -0.657 . . . . 42.119999999999997 109.557 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.93 2.56 0.57 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 123.934 3.089 . . . . 61.240000000000002 113.475 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 33.5 t70 -82.0 -7.55 59.62 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.425 1.09 . . . . 71.430000000000007 109.582 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 73.16 28.69 1.83 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 123.374 1.559 . . . . 72.219999999999999 107.269 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -111.34 132.16 54.61 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.296 -1.774 . . . . 75.409999999999997 109.148 178.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.95 143.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.116 -0.698 . . . . 73.430000000000007 109.116 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 p -149.69 155.24 39.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.052 -1.462 . . . . 61.140000000000001 107.052 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.84 -174.59 44.06 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 118.287 -1.911 . . . . 73.5 114.343 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.38 133.26 36.57 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 124.327 1.051 . . . . 73.329999999999998 108.721 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.9 mt -119.89 115.54 47.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 105.663 -1.977 . . . . 73.120000000000005 105.663 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.8 mt -126.45 114.74 39.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 109.671 -0.492 . . . . 73.400000000000006 109.671 -172.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.526 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.02 109.27 19.3 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.391 -1.337 . . . . 74.120000000000005 107.391 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -119.69 126.47 51.19 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.453 -0.499 . . . . 65.340000000000003 111.53 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.9 157.35 27.83 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.531 -0.759 . . . . 60.439999999999998 109.316 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 C--N 1.288 -2.095 0 N-CA-C 106.999 -1.482 . . . . 74.510000000000005 106.999 172.182 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.435 -1.189 0 N-CA-C 112.94 0.719 . . . . 52.020000000000003 112.94 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.61 98.03 0.11 Allowed Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 120.196 -1.002 . . . . 54.450000000000003 112.148 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 83' ' ' SER . 67.9 Cg_exo -54.87 159.19 9.65 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.802 2.335 . . . . 75.430000000000007 111.368 173.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.99 157.11 21.1 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.923 -0.486 . . . . 63.520000000000003 111.027 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 81.6 mt -109.9 139.12 45.35 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.82 -0.807 . . . . 71.010000000000005 108.82 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -108.27 98.78 8.27 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.097 -1.075 . . . . 64.340000000000003 108.097 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.5 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -109.63 95.96 0.92 Allowed Glycine 0 C--N 1.283 -2.386 0 CA-C-N 115.109 -0.95 . . . . 52.450000000000003 112.531 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -87.01 89.39 7.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.235 -1.024 . . . . 70.409999999999997 108.235 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.39 154.13 78.35 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 109.47 -0.567 . . . . 74.510000000000005 109.47 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.22 -28.67 18.31 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.325 2.017 . . . . 73.430000000000007 112.152 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -91.21 38.23 0.96 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.746 -0.661 . . . . 74.409999999999997 112.07 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.73 -45.07 58.43 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.523 1.129 . . . . 75.109999999999999 113.535 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -12.13 60.77 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.051 0.453 . . . . 73.040000000000006 111.099 -174.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 88' ' ' SER . 69.1 mmtt -93.35 -9.61 38.19 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 116.198 -0.455 . . . . 52.020000000000003 110.115 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -115.41 118.52 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 C-N-CA 118.518 -1.273 . . . . 74.329999999999998 110.063 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.44 102.6 14.4 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.998 -1.001 . . . . 64.239999999999995 108.871 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.7 t -98.27 135.74 31.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.462 -1.31 . . . . 71.099999999999994 107.462 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 t -155.52 171.87 19.21 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.693 -0.854 . . . . 33.539999999999999 108.693 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -83.58 142.78 30.59 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.689 -0.856 . . . . 71.439999999999998 108.689 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -99.06 122.38 42.22 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.313 -0.995 . . . . 74.340000000000003 108.313 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -138.99 99.62 3.82 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.187 -0.672 . . . . 53.439999999999998 109.187 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.2 t -172.88 149.74 1.97 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.612 -0.514 . . . . 62.549999999999997 109.612 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.91 16.2 8.83 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.393 1.077 . . . . 63.520000000000003 111.674 173.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.5 1.55 85.68 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.442 -0.663 . . . . 64.420000000000002 111.442 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.493 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 91.8 m-85 -104.29 145.51 30.12 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 109.5 -0.556 . . . . 71.420000000000002 109.5 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.2 136.67 60.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.797 -1.186 . . . . 53.329999999999998 107.797 173.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -165.47 -154.97 8.34 Favored Glycine 0 C--N 1.27 -3.115 0 C-N-CA 119.65 -1.262 . . . . 64.420000000000002 111.638 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.527 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 21.2 p -123.84 143.23 50.46 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 109.604 -0.517 . . . . 71.329999999999998 109.604 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -138.37 142.59 39.63 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 120.406 -0.518 . . . . 74.430000000000007 110.954 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.37 114.9 18.83 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.197 -1.038 . . . . 34.409999999999997 108.197 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -105.97 115.0 46.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 108.62 -0.881 . . . . 74.5 108.62 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -118.34 154.43 32.36 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 120.393 -0.523 . . . . 74.140000000000001 110.938 -175.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 80.8 p -157.53 171.35 20.51 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 109.335 -0.617 . . . . 64.209999999999994 109.335 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 62.15 30.59 17.78 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.438 1.087 . . . . 75.219999999999999 110.62 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt -101.15 164.24 11.89 Favored 'General case' 0 N--CA 1.42 -1.926 0 C-N-CA 120.165 -0.614 . . . . 62.329999999999998 111.116 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -113.04 170.79 7.95 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.235 -0.654 . . . . 73.510000000000005 109.235 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -54.57 -38.25 66.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.407 1.083 . . . . 74.409999999999997 111.746 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.51 65.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.236 -0.438 . . . . 72.439999999999998 111.876 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -86.46 -16.51 36.86 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.904 0.383 . . . . 55.32 111.665 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.7 tt -62.35 -47.71 88.8 Favored Pre-proline 0 CA--C 1.569 1.685 0 CA-C-N 116.236 -0.438 . . . . 75.349999999999994 111.378 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.55 -40.15 76.63 Favored 'Trans proline' 0 C--N 1.38 2.232 0 CA-C-N 120.831 1.333 . . . . 72.329999999999998 110.768 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -61.16 -41.8 97.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.236 -0.893 . . . . 73.519999999999996 111.534 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -72.36 -20.39 61.47 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.376 -0.375 . . . . 62.439999999999998 110.635 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.01 -26.13 60.27 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.21 -0.663 . . . . 73.030000000000001 109.21 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -62.87 -52.06 64.57 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.58 -0.896 . . . . 62.130000000000003 108.58 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.5 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 32.2 ttp -53.89 -51.59 63.2 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.478 -0.783 . . . . 72.420000000000002 109.78 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -55.22 -35.0 64.44 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.192 -0.913 . . . . 74.530000000000001 111.076 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -58.96 -32.57 69.75 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 119.234 -0.413 . . . . 72.540000000000006 111.465 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.26 -25.7 67.98 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.269 0.557 . . . . 65.099999999999994 111.233 -173.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.37 -14.48 14.43 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.809 -0.632 . . . . 74.150000000000006 111.01 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.414 ' HB1' HG13 ' A' ' 108' ' ' VAL . . . -106.3 -43.79 4.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.309 0.855 . . . . 74.329999999999998 113.309 -171.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.37 22.69 69.84 Favored Glycine 0 C--N 1.317 -0.481 0 N-CA-C 111.122 -0.791 . . . . 52.200000000000003 111.122 -173.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.414 HG13 ' HB1' ' A' ' 106' ' ' ALA . 18.3 m -103.87 161.53 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.576 -0.527 . . . . 62.219999999999999 109.576 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -123.31 121.62 36.28 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.67 -1.604 . . . . 73.109999999999999 106.67 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.0 mt -122.77 107.23 11.67 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.266 -0.642 . . . . 72.329999999999998 109.266 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.1 m -115.87 141.02 48.65 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.88 -0.785 . . . . 73.109999999999999 108.88 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -149.92 155.38 39.89 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.9 -0.32 . . . . 71.439999999999998 110.478 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -156.09 161.84 40.34 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.339 -0.985 . . . . 51.109999999999999 108.339 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -106.47 133.09 51.7 Favored 'General case' 0 N--CA 1.398 -3.031 0 N-CA-C 107.322 -1.362 . . . . 75.450000000000003 107.322 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -118.81 100.24 7.27 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 106.839 -1.541 . . . . 70.120000000000005 106.839 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.91 -113.05 4.98 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.325 -1.11 . . . . 53.240000000000002 110.325 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -114.32 12.09 17.51 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.932 1.348 . . . . 73.040000000000006 109.477 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.23 148.86 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 O-C-N 120.445 -1.41 . . . . 65.519999999999996 108.868 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 178' ' ' TYR . 82.4 t -106.41 136.0 42.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 CA-C-O 120.761 0.315 . . . . 73.430000000000007 110.398 -177.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.1 pt -116.94 134.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 108.876 -0.787 . . . . 65.439999999999998 108.876 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 tt -127.84 126.25 41.28 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.279 -1.008 . . . . 73.340000000000003 108.279 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -128.63 114.86 17.21 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.828 0.823 . . . . 73.340000000000003 109.142 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.39 139.4 14.13 Favored Glycine 0 N--CA 1.4 -3.747 0 N-CA-C 108.777 -1.729 . . . . 51.219999999999999 108.777 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -140.23 131.09 25.96 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.633 -1.618 . . . . 72.5 106.633 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -139.5 144.8 38.1 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.688 0.756 . . . . 51.32 112.871 -172.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.24 93.43 5.69 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.513 -1.221 . . . . 74.129999999999995 107.937 174.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.13 0.27 56.22 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.929 0.871 . . . . 70.129999999999995 108.827 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.431 -1.378 0 CA-C-N 114.452 -1.249 . . . . 64.030000000000001 111.409 -179.464 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 . . . . . 0 N--CA 1.44 -0.95 0 CA-C-O 121.034 0.445 . . . . 75.340000000000003 111.236 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.02 140.37 29.81 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.42 -0.354 . . . . 75.519999999999996 111.863 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -133.06 139.67 47.29 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.492 -0.929 . . . . 72.439999999999998 108.492 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.77 113.89 44.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.126 -0.694 . . . . 75.230000000000004 109.126 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -113.29 120.13 40.11 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.21 0.529 . . . . 74.409999999999997 109.949 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 39.9 tp -112.18 120.6 42.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.306 -0.998 . . . . 74.519999999999996 108.306 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 31' ' ' SER . 17.4 m -120.89 112.62 19.01 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.566 -0.901 . . . . 41.140000000000001 108.566 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.49 120.77 61.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.508 -0.923 . . . . 61.310000000000002 108.508 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -105.73 126.92 52.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.523 -0.917 . . . . 52.200000000000003 108.523 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.443 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 0.3 OUTLIER -134.25 103.36 11.58 Favored Pre-proline 0 C--N 1.274 -2.697 0 CA-C-N 115.591 -0.731 . . . . 70.340000000000003 110.349 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.34 45.2 0.4 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 123.574 2.849 . . . . 74.530000000000001 112.277 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.53 -86.26 0.64 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.457 -0.571 . . . . 64.420000000000002 109.457 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.55 113.47 0.01 OUTLIER 'General case' 0 C--O 1.247 0.972 0 C-N-CA 123.72 0.808 . . . . 74.129999999999995 109.112 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 9.4 p -75.66 130.83 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.768 -1.197 . . . . 65.340000000000003 107.768 174.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.8 t -103.8 -28.71 11.46 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.296 -0.962 . . . . 73.040000000000006 110.852 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.7 m -159.28 132.96 7.33 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 107.406 -1.331 . . . . 74.239999999999995 107.406 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -139.75 162.14 35.85 Favored 'General case' 0 C--N 1.282 -2.331 0 O-C-N 122.104 -0.372 . . . . 70.329999999999998 110.414 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -130.04 90.55 2.98 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 104.927 -2.249 . . . . 64.109999999999999 104.927 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 172.35 -147.93 10.31 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 109.471 -1.452 . . . . 72.430000000000007 109.471 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -116.59 99.66 7.3 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 117.501 0.65 . . . . 65.109999999999999 109.481 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -72.58 131.89 43.06 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 121.287 0.565 . . . . 53.009999999999998 110.328 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.5 mm -96.07 -49.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 106.958 -1.497 . . . . 74.140000000000001 106.958 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -134.73 166.42 29.33 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 105.857 -1.905 . . . . 70.329999999999998 105.857 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.96 -2.39 11.44 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.309 2.006 . . . . 75.340000000000003 110.86 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.82 10.76 5.11 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.187 -0.915 . . . . 53.520000000000003 111.076 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.0 t -147.02 120.71 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.507 -0.923 . . . . 75.329999999999998 108.507 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.6 147.01 30.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.751 -0.833 . . . . 72.019999999999996 108.751 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 8.5 tt0 -132.92 142.44 48.9 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-O 121.595 0.712 . . . . 74.310000000000002 110.207 -174.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.451 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 29.1 m-90 -123.63 116.02 22.42 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.095 -1.076 . . . . 72.349999999999994 108.095 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.554 ' HD3' ' H ' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -112.36 98.42 7.27 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.017 0.913 . . . . 53.43 109.478 -178.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 170' ' ' SER . 0.7 OUTLIER -95.75 147.4 23.66 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.221 -1.354 . . . . 54.329999999999998 110.084 -171.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 34.1 mttp -117.11 150.19 45.66 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 115.587 -0.733 . . . . 71.519999999999996 112.105 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 165' ' ' LYS . 32.1 Cg_exo -66.06 157.48 59.32 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 123.318 2.679 . . . . 74.519999999999996 111.466 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.48 -27.26 2.51 Favored Glycine 0 C--N 1.313 -0.744 0 C-N-CA 121.54 -0.362 . . . . 31.149999999999999 112.899 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.3 m -105.85 167.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 120.723 0.297 . . . . 74.540000000000006 110.624 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.6 p -114.05 143.97 22.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.112 -0.699 . . . . 72.430000000000007 109.112 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 164' ' ' LEU . 44.5 m -153.09 150.26 28.94 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 121.992 -0.443 . . . . 74.129999999999995 110.186 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 27.7 p -120.37 126.41 50.43 Favored 'General case' 0 N--CA 1.428 -1.557 0 C-N-CA 122.94 0.496 . . . . 73.420000000000002 110.0 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -98.14 121.39 40.01 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.591 -0.522 . . . . 72.040000000000006 109.591 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.3 m -137.98 138.44 38.91 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.865 -1.147 . . . . 74.510000000000005 111.369 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.451 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -145.31 128.77 16.97 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 115.811 -0.631 . . . . 63.109999999999999 109.675 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -117.19 130.69 56.76 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 107.006 -1.479 . . . . 74.219999999999999 107.006 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -140.85 152.28 44.99 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.497 -0.557 . . . . 31.02 109.497 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -90.74 126.28 35.95 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.406 -0.961 . . . . 74.420000000000002 108.406 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.598 ' OH ' HG23 ' A' ' 34' ' ' ILE . 5.4 m-85 -126.26 126.7 44.44 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 113.059 0.763 . . . . 73.310000000000002 113.059 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 35.7 p -67.79 105.17 1.86 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.606 -1.179 . . . . 54.32 108.484 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 CA--C 1.506 -0.721 0 O-C-N 123.773 0.671 . . . . 55.240000000000002 110.114 -178.127 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 50.0 mtm105 . . . . . 0 CA--C 1.507 -0.692 0 N-CA-C 110.244 -0.28 . . . . 74.329999999999998 110.244 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 46' ' ' ALA . 26.9 m -126.58 114.71 39.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.495 0.664 . . . . 62.100000000000001 109.559 177.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -123.8 119.08 28.68 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.413 0.625 . . . . 74.319999999999993 110.706 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -109.38 108.87 19.57 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.295 -1.002 . . . . 61.310000000000002 108.295 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 p -117.52 115.89 26.03 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.32 -0.622 . . . . 73.120000000000005 109.32 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.72 146.91 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.518 -0.549 . . . . 63.009999999999998 109.518 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.1 m -123.78 130.63 52.93 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 109.094 -0.706 . . . . 51.140000000000001 109.094 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -112.94 120.27 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 121.679 0.752 . . . . 62.229999999999997 110.553 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -92.74 158.29 38.29 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 115.054 -0.975 . . . . 51.119999999999997 110.438 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -65.53 2.39 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.997 3.131 . . . . 74.319999999999993 113.614 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 31.7 t70 -89.85 -0.32 57.49 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.973 -0.751 . . . . 52.439999999999998 108.973 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 22.0 t70 70.79 29.19 3.22 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 105.51 -2.033 . . . . 74.420000000000002 105.51 -174.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 7.0 tp -101.69 125.02 48.27 Favored 'General case' 1 N--CA 1.379 -4.023 0 CA-C-N 112.175 -2.284 . . . . 74.120000000000005 108.472 -177.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.6 t -115.47 130.64 69.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.629 -0.878 . . . . 71.439999999999998 108.629 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 p -145.23 151.81 38.97 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.033 -0.729 . . . . 75.230000000000004 109.033 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.51 -164.7 36.45 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 118.971 -1.585 . . . . 74.049999999999997 112.965 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.05 133.97 15.84 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.247 0.546 . . . . 71.010000000000005 110.571 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 68.0 mt -114.27 115.84 50.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.885 -1.154 . . . . 72.430000000000007 107.885 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -109.95 116.71 52.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 109.762 -0.458 . . . . 63.340000000000003 109.762 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.483 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -112.89 108.47 17.43 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.909 -1.515 . . . . 73.239999999999995 106.909 174.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -123.35 125.36 44.86 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.236 0.541 . . . . 72.400000000000006 111.672 -174.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.86 159.92 32.5 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.441 -0.8 . . . . 64.209999999999994 109.165 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.494 0 C-N-CA 119.144 -1.022 . . . . 74.25 110.36 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.432 -1.366 0 CA-C-O 121.7 0.762 . . . . 75.099999999999994 109.103 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 172.77 99.5 0.12 Allowed Glycine 0 N--CA 1.416 -2.639 0 CA-C-O 118.289 -1.284 . . . . 63.329999999999998 111.725 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 52.2 Cg_exo -54.05 127.75 26.98 Favored 'Trans proline' 0 C--N 1.355 0.88 0 CA-C-N 120.044 1.922 . . . . 71.439999999999998 107.5 170.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.1 151.52 22.47 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 113.573 0.953 . . . . 72.200000000000003 113.573 -166.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 96.1 mt -94.35 150.48 20.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.047 -0.979 . . . . 63.329999999999998 109.301 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -107.07 93.68 4.69 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.389 -0.967 . . . . 73.420000000000002 108.389 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.38 120.01 5.87 Favored Glycine 0 N--CA 1.42 -2.39 0 CA-C-N 114.442 -1.254 . . . . 63.130000000000003 111.219 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -136.68 111.47 8.78 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.918 -0.771 . . . . 63.409999999999997 108.918 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.15 166.88 14.55 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.173 -1.047 . . . . 71.430000000000007 108.173 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -66.98 -32.67 34.55 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 121.406 1.404 . . . . 72.530000000000001 110.586 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -97.13 39.2 1.19 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.257 -0.883 . . . . 71.530000000000001 112.825 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.8 m -55.14 -27.8 48.09 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 112.784 0.661 . . . . 35.43 112.784 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -73.02 -7.89 53.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.217 0.532 . . . . 73.109999999999999 111.232 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.5 -13.13 18.8 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.117 -0.492 . . . . 65.140000000000001 110.383 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.2 p -125.31 119.99 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.882 0.849 . . . . 64.450000000000003 111.663 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.98 112.08 24.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.774 -0.825 . . . . 73.420000000000002 108.774 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.35 127.76 50.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.083 -1.081 . . . . 74.129999999999995 108.083 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 m -140.01 172.78 12.27 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.534 -0.543 . . . . 74.439999999999998 109.534 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.426 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 22.6 p-10 -86.03 149.24 25.31 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.064 -0.654 . . . . 72.120000000000005 109.539 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 79.6 t80 -101.93 120.56 40.59 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.571 -1.64 . . . . 74.430000000000007 106.571 174.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -138.49 99.13 3.75 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 108.423 -0.954 . . . . 72.400000000000006 108.423 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.3 t -174.07 153.48 2.08 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.869 -1.16 . . . . 63.43 107.869 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 66.89 15.14 10.07 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.915 0.886 . . . . 73.340000000000003 112.166 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.38 -8.25 80.25 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.575 -0.61 . . . . 64.530000000000001 111.575 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.531 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 47.9 m-85 -93.05 153.22 18.83 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.419 -0.586 . . . . 64.239999999999995 109.419 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 31.0 m -134.81 136.31 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.064 -1.088 . . . . 52.310000000000002 108.064 171.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.8 -153.85 8.86 Favored Glycine 0 C--N 1.259 -3.75 0 N-CA-C 110.505 -1.038 . . . . 73.140000000000001 110.505 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.486 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.1 p -126.43 146.76 49.96 Favored 'General case' 0 C--N 1.264 -3.141 0 CA-C-O 121.317 0.58 . . . . 64.540000000000006 111.518 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 4.4 pt20 -136.97 127.78 27.3 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.97 -0.559 . . . . 61.420000000000002 110.496 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.42 115.25 29.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.287 -1.005 . . . . 24.309999999999999 108.287 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.68 117.77 54.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.057 -1.09 . . . . 55.109999999999999 108.057 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.468 ' CD2' HD12 ' A' ' 90' ' ' LEU . 50.7 p90 -124.29 154.77 39.75 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 120.803 0.335 . . . . 72.530000000000001 110.236 -175.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.5 m -157.56 159.73 37.44 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 116.234 -0.439 . . . . 63.340000000000003 110.222 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 67.14 31.13 6.95 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.505 1.145 . . . . 71.439999999999998 110.486 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.468 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.0 mt -96.24 160.44 14.43 Favored 'General case' 0 N--CA 1.428 -1.54 0 O-C-N 121.627 -0.671 . . . . 73.519999999999996 111.304 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 m -104.78 166.53 10.32 Favored 'General case' 0 N--CA 1.401 -2.912 0 N-CA-C 109.391 -0.596 . . . . 63.130000000000003 109.391 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.493 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 60.8 t80 -50.66 -48.62 58.31 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.228 1.011 . . . . 74.239999999999995 110.674 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.07 -24.66 67.24 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.268 -0.878 . . . . 55.039999999999999 112.245 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -87.66 -16.93 33.03 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 116.272 -0.422 . . . . 72.219999999999999 111.754 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.3 tt -61.89 -52.36 68.8 Favored Pre-proline 0 CA--C 1.559 1.294 0 O-C-N 123.254 0.346 . . . . 62.509999999999998 111.228 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 35.3 Cg_exo -65.72 -32.98 45.95 Favored 'Trans proline' 0 C--N 1.369 1.654 0 CA-C-N 120.794 1.319 . . . . 65.099999999999994 110.63 176.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.63 -36.06 83.04 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.642 -0.708 . . . . 72.340000000000003 110.977 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -77.59 -19.84 54.95 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.871 -0.418 . . . . 64.409999999999997 109.871 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.78 -24.24 61.71 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.97 -0.559 . . . . 64.040000000000006 110.25 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -56.18 -49.75 73.14 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 109.561 -0.533 . . . . 74.409999999999997 109.561 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.5 mtm -54.37 -51.46 64.71 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.232 0.539 . . . . 73.319999999999993 110.161 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -56.58 -34.93 67.65 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.992 -1.004 . . . . 74.349999999999994 111.598 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.3 m -62.09 -30.21 70.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.269 -0.423 . . . . 54.520000000000003 110.243 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.18 -31.57 70.25 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 123.926 0.767 . . . . 73.030000000000001 110.674 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.09 -11.89 15.53 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 116.233 -0.44 . . . . 74.129999999999995 111.38 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.69 -47.86 3.65 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.646 0.98 . . . . 54.420000000000002 113.646 -172.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.07 25.81 33.11 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.814 -0.708 . . . . 72.420000000000002 111.784 -174.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 m -109.27 155.41 10.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 122.486 -0.42 . . . . 65.310000000000002 111.7 -175.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -124.28 124.79 43.17 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.088 0.555 . . . . 72.329999999999998 109.555 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.8 mp -117.56 143.66 45.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.124 0.488 . . . . 74.109999999999999 111.056 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.1 m -129.74 109.57 11.06 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.065 -0.717 . . . . 70.319999999999993 109.065 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.573 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 61.0 tp -119.87 123.84 44.59 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.526 -0.306 . . . . 70.239999999999995 110.646 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.573 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 2.8 mpt_? -137.47 147.94 45.69 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.783 0.433 . . . . 74.310000000000002 110.194 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' ' 119' ' ' VAL . 37.3 ttm180 -102.0 137.54 40.15 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 107.101 -1.444 . . . . 64.540000000000006 107.101 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -128.47 90.0 2.99 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.664 -0.865 . . . . 71.329999999999998 108.664 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.79 -113.22 4.89 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.052 -0.976 . . . . 72.530000000000001 110.874 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.29 -13.67 21.82 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.843 0.83 . . . . 62.439999999999998 109.07 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.673 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.4 pp -103.59 149.86 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 C-N-CA 119.69 -0.804 . . . . 74.0 110.009 -176.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.545 HG21 ' CD2' ' A' ' 178' ' ' TYR . 92.7 t -118.31 138.68 48.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 O-C-N 121.911 -0.493 . . . . 72.209999999999994 110.141 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.0 pt -120.05 129.43 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 122.101 0.953 . . . . 65.140000000000001 109.802 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.2 136.25 49.89 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 114.907 -1.042 . . . . 75.299999999999997 108.56 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -143.28 166.15 25.52 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 108.835 -0.802 . . . . 65.420000000000002 108.835 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.84 158.98 30.96 Favored Glycine 0 N--CA 1.405 -3.415 0 N-CA-C 109.72 -1.352 . . . . 23.300000000000001 109.72 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -134.31 125.23 27.23 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.234 -1.765 . . . . 73.109999999999999 106.234 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.15 117.51 16.63 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 120.996 0.427 . . . . 72.040000000000006 111.618 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 169' ' ' VAL . 0.0 OUTLIER -108.85 134.02 52.1 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 105.154 -2.165 . . . . 71.140000000000001 105.154 170.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.9 mm? -117.85 32.38 6.18 Favored 'General case' 0 C--N 1.267 -2.99 0 N-CA-C 108.754 -0.832 . . . . 65.540000000000006 108.754 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 167' ' ' GLY . 42.7 p . . . . . 0 N--CA 1.446 -0.638 0 CA-C-N 115.965 -0.561 . . . . 55.539999999999999 110.487 -176.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 121.159 0.504 . . . . 71.340000000000003 111.283 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.0 143.91 28.08 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.137 -0.69 . . . . 45.100000000000001 109.137 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -132.11 130.52 41.29 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.276 -1.009 . . . . 75.439999999999998 108.276 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.1 t -113.54 126.11 70.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.863 -0.421 . . . . 64.430000000000007 109.863 -175.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.35 121.99 30.45 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.866 0.365 . . . . 54.539999999999999 111.356 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.516 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -111.22 121.54 45.54 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.885 -1.894 . . . . 63.549999999999997 105.885 174.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.3 m -126.6 130.96 51.52 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.243 -0.28 . . . . 43.439999999999998 110.243 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 99.4 t -123.86 126.12 72.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 109.036 -0.728 . . . . 71.120000000000005 109.036 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.84 127.57 56.21 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.324 -0.621 . . . . 65.519999999999996 109.324 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.8 p90 -134.38 123.68 16.68 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 116.362 -0.381 . . . . 75.530000000000001 111.789 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 29.2 Cg_exo -68.27 41.07 0.24 Allowed 'Trans proline' 0 CA--C 1.557 1.635 0 C-N-CA 123.447 2.765 . . . . 64.409999999999997 113.795 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.49 -100.44 0.39 Allowed 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.985 -0.447 . . . . 73.540000000000006 110.807 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 178.92 130.75 0.08 Allowed 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.745 -0.835 . . . . 53.520000000000003 108.745 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.7 133.03 30.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.049 -0.723 . . . . 62.210000000000001 109.049 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.2 p -94.03 -43.3 8.58 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-O 121.225 0.536 . . . . 65.329999999999998 109.701 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 17.0 m -150.04 131.32 14.59 Favored 'General case' 0 C--O 1.212 -0.904 0 N-CA-C 108.407 -0.961 . . . . 71.219999999999999 108.407 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -140.91 152.32 44.94 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.39 -0.524 . . . . 73.129999999999995 111.241 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -119.5 90.97 3.44 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.162 -2.162 . . . . 52.409999999999997 105.162 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.62 -159.26 28.97 Favored Glycine 0 N--CA 1.416 -2.672 0 N-CA-C 107.345 -2.302 . . . . 74.129999999999995 107.345 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.12 102.84 11.01 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 117.846 0.823 . . . . 73.439999999999998 109.542 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 18.0 ptt180 -76.28 122.01 23.79 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-O 121.218 0.532 . . . . 74.129999999999995 109.877 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.16 -41.06 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 106.989 -1.486 . . . . 64.230000000000004 106.989 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -136.08 166.29 29.24 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.118 -1.401 . . . . 74.319999999999993 107.245 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.12 -4.75 15.53 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 122.351 2.034 . . . . 75.310000000000002 110.721 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.6 pt-20 -128.27 6.2 5.84 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.613 -0.722 . . . . 64.209999999999994 111.36 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.5 t -141.66 120.57 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.256 -1.016 . . . . 75.340000000000003 108.256 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 50.1 t -123.53 145.53 30.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.772 -0.455 . . . . 74.209999999999994 109.772 -177.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -136.09 142.72 44.34 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.362 0.601 . . . . 73.349999999999994 110.202 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.516 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.6 m-90 -118.7 113.35 21.04 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.432 -0.804 . . . . 70.450000000000003 109.106 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 163' ' ' LYS . 7.8 ptpt -95.23 99.07 11.08 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 122.316 1.055 . . . . 74.340000000000003 108.716 177.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 61.1 mt -97.68 147.48 24.3 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 113.676 -1.602 . . . . 73.129999999999995 109.428 -173.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -117.63 146.44 38.67 Favored Pre-proline 0 C--N 1.295 -1.766 0 CA-C-N 115.637 -0.711 . . . . 73.409999999999997 112.302 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.457 ' HA ' ' CB ' ' A' ' 127' ' ' LEU . 71.8 Cg_endo -71.54 160.02 49.59 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.573 2.182 . . . . 72.019999999999996 110.341 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 128' ' ' THR . . . 78.34 -26.87 2.15 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 121.096 -0.573 . . . . 73.430000000000007 113.22 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.7 170.1 3.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.008 0.432 . . . . 73.25 112.082 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 126' ' ' ASP . 8.3 p -114.07 142.94 24.92 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 CA-C-N 115.812 -0.631 . . . . 74.409999999999997 109.87 176.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.5 p -149.75 140.57 22.74 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.048 0.451 . . . . 62.310000000000002 111.975 -176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.8 p -96.67 138.11 34.73 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.201 -0.666 . . . . 64.239999999999995 109.201 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 22.4 ptm -118.63 133.1 56.11 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.944 -1.132 . . . . 70.140000000000001 107.944 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -143.55 147.93 35.19 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.613 -0.835 . . . . 73.209999999999994 111.398 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.452 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -154.89 130.29 9.75 Favored 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 123.05 0.54 . . . . 64.430000000000007 109.862 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -132.54 131.83 41.97 Favored 'General case' 0 C--N 1.264 -3.147 0 N-CA-C 106.753 -1.573 . . . . 73.040000000000006 106.753 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.18 149.83 23.3 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.832 -1.173 . . . . 44.43 107.832 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 0.8 OUTLIER -95.52 138.86 32.6 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.447 -1.686 . . . . 70.420000000000002 106.447 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.545 ' CD2' HG21 ' A' ' 119' ' ' VAL . 22.4 m-30 -121.17 151.78 39.53 Favored 'General case' 0 CA--C 1.483 -1.611 0 C-N-CA 119.926 -0.71 . . . . 74.439999999999998 109.331 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.81 86.03 3.4 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-O 121.462 0.648 . . . . 74.299999999999997 110.097 175.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.5 t70 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 114.451 -1.249 . . . . 74.420000000000002 110.815 179.505 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.407 ' HG3' ' HB2' ' A' ' 136' ' ' ASP . 3.1 mpt_? . . . . . 0 N--CA 1.434 -1.245 0 N-CA-C 108.913 -0.773 . . . . 61.229999999999997 108.913 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.32 117.76 56.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.45 -0.944 . . . . 61.43 108.45 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -123.05 114.06 19.87 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.342 0.591 . . . . 71.319999999999993 109.457 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.29 126.76 55.6 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.583 -0.895 . . . . 75.310000000000002 108.583 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.9 t -131.64 114.79 15.24 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.046 -1.464 . . . . 73.329999999999998 107.046 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.63 146.62 29.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.367 -0.605 . . . . 43.539999999999999 109.367 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.5 m -126.8 125.21 41.32 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.258 0.551 . . . . 75.129999999999995 109.854 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.2 tt -113.39 110.35 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-O 121.851 0.834 . . . . 54.109999999999999 110.097 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -76.99 158.55 80.06 Favored Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 114.761 -1.109 . . . . 75.120000000000005 109.747 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.5 0.81 2.55 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 123.363 2.709 . . . . 62.109999999999999 112.999 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -88.89 2.33 53.92 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 124.066 0.947 . . . . 73.400000000000006 110.156 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 91' ' ' THR . 14.5 t70 67.89 29.44 6.61 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 123.55 1.643 . . . . 74.430000000000007 106.872 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.36 124.77 50.88 Favored 'General case' 0 N--CA 1.382 -3.841 0 CA-C-N 113.904 -1.498 . . . . 65.430000000000007 107.297 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.414 HG12 ' HE2' ' A' ' 87' ' ' PHE . 3.6 t -110.78 136.29 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 108.471 -0.937 . . . . 64.430000000000007 108.471 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.8 p -144.13 154.93 43.68 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 105.966 -1.865 . . . . 62.210000000000001 105.966 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.25 -172.04 44.26 Favored Glycine 0 CA--C 1.49 -1.524 0 C-N-CA 117.913 -2.089 . . . . 64.329999999999998 113.725 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.43 134.22 28.75 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.438 0.695 . . . . 75.010000000000005 110.041 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 60.0 mt -120.75 115.7 47.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.018 -1.475 . . . . 74.439999999999998 107.018 174.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.2 114.61 46.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 120.935 0.398 . . . . 62.539999999999999 109.954 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.01 108.3 18.48 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.277 -1.749 . . . . 65.329999999999998 106.277 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -121.34 125.66 47.55 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 120.246 -0.582 . . . . 70.019999999999996 111.257 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.64 155.73 22.93 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.934 -0.765 . . . . 64.040000000000006 108.934 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.6 tttm . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 104.983 -2.229 . . . . 73.519999999999996 104.983 176.131 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.427 -1.575 0 N-CA-C 108.723 -0.843 . . . . 74.439999999999998 108.723 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.91 98.18 0.11 Allowed Glycine 0 N--CA 1.414 -2.787 0 CA-C-N 114.824 -1.08 . . . . 65.340000000000003 112.54 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.74 159.09 53.81 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 122.673 2.248 . . . . 71.430000000000007 111.579 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.95 155.25 41.65 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.079 -0.341 . . . . 71.010000000000005 110.079 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.562 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 94.3 mt -101.15 153.47 19.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.159 -0.682 . . . . 71.219999999999999 109.159 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.92 88.07 5.6 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.878 -1.527 . . . . 74.340000000000003 106.878 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.86 50.66 0.78 Allowed Glycine 0 N--CA 1.414 -2.792 0 CA-C-N 115.077 -0.965 . . . . 54.32 112.89 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -91.6 95.46 9.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.251 -1.018 . . . . 71.150000000000006 108.251 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 m -122.37 162.21 39.16 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 114.15 -1.386 . . . . 64.209999999999994 107.609 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.86 -19.61 32.37 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.673 2.249 . . . . 54.43 112.831 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -112.52 29.58 7.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.417 -0.356 . . . . 70.319999999999993 111.659 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.9 m -56.48 -27.82 58.13 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.497 0.554 . . . . 74.239999999999995 112.497 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -70.15 -10.78 59.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.394 0.616 . . . . 73.329999999999998 110.752 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 88' ' ' SER . 68.0 mmtt -106.68 -9.83 16.36 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 111.486 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.74 118.27 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 119.382 -0.927 . . . . 75.129999999999995 111.102 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.76 103.4 15.31 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 115.051 -0.977 . . . . 52.420000000000002 108.794 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 60' ' ' LEU . 7.3 p -98.3 134.79 35.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.161 -1.052 . . . . 71.409999999999997 108.161 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.0 m -149.46 171.56 16.38 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 120.847 0.356 . . . . 75.010000000000005 111.047 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -76.85 132.09 38.97 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.125 -0.943 . . . . 63.229999999999997 109.089 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -102.62 119.92 39.66 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.287 -1.375 . . . . 75.129999999999995 107.287 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -137.6 99.61 3.99 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.513 -0.921 . . . . 74.409999999999997 108.513 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.0 t -168.42 149.1 4.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.38 -0.971 . . . . 73.120000000000005 108.38 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 69.85 13.75 8.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.979 0.911 . . . . 71.219999999999999 112.167 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.76 1.48 67.95 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.764 -0.653 . . . . 53.229999999999997 111.692 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.549 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 59.4 m-85 -102.79 151.07 22.84 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 122.506 0.322 . . . . 71.430000000000007 110.28 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.3 136.23 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 107.342 -1.355 . . . . 72.230000000000004 107.342 168.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.1 -154.95 10.51 Favored Glycine 0 C--N 1.272 -2.977 0 C-N-CA 119.965 -1.112 . . . . 34.030000000000001 111.019 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.562 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 13.0 m -126.69 145.12 50.7 Favored 'General case' 0 C--N 1.27 -2.863 0 CA-C-O 121.185 0.517 . . . . 51.030000000000001 110.39 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -131.17 138.8 49.59 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.957 -0.565 . . . . 74.129999999999995 109.919 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.14 114.63 22.76 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.502 -1.296 . . . . 61.549999999999997 107.502 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.6 t -112.44 113.4 44.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.206 -1.035 . . . . 71.450000000000003 108.206 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.477 ' CD2' HD12 ' A' ' 90' ' ' LEU . 44.3 p90 -114.27 159.55 20.04 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.008 0.433 . . . . 74.010000000000005 111.858 -173.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 6.1 p -156.68 155.18 31.29 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.256 -0.884 . . . . 73.319999999999993 110.13 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 67.03 30.01 7.69 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 124.629 1.172 . . . . 64.129999999999995 111.945 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.477 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.2 mt -97.27 165.99 11.77 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 119.387 -0.925 . . . . 72.329999999999998 110.114 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.465 HG22 ' OE1' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -125.3 178.93 5.32 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.905 -1.146 . . . . 73.310000000000002 107.905 -178.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -47.54 -35.63 9.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.851 1.26 . . . . 62.310000000000002 112.452 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.451 ' H ' HG23 ' A' ' 91' ' ' THR . . . -73.1 -25.72 60.98 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.9 0.704 . . . . 75.239999999999995 112.9 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.467 ' HG2' HD22 ' A' ' 90' ' ' LEU . 14.6 mp0 -91.74 -16.97 26.1 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.797 -0.761 . . . . 74.319999999999993 112.749 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.3 tt -58.51 -50.65 86.88 Favored Pre-proline 0 CA--C 1.569 1.677 0 O-C-N 123.241 0.338 . . . . 72.409999999999997 111.456 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -68.81 -30.83 26.43 Favored 'Trans proline' 0 C--N 1.365 1.408 0 CA-C-N 120.731 1.297 . . . . 74.129999999999995 111.281 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -67.88 -33.13 74.14 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 123.534 0.734 . . . . 74.040000000000006 111.121 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.6 pp -75.54 -19.23 59.46 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.988 0.423 . . . . 70.310000000000002 110.256 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.438 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -71.63 -18.29 62.21 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.933 -0.576 . . . . 71.030000000000001 109.977 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.23 -57.24 10.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.9 -0.591 . . . . 74.230000000000004 109.85 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 14.8 ttm -54.38 -52.7 60.83 Favored 'General case' 0 C--O 1.271 2.189 0 CA-C-O 122.518 1.152 . . . . 74.340000000000003 108.428 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 6.3 t30 -52.84 -27.04 16.49 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 112.435 -2.166 . . . . 64.25 112.805 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -54.47 -45.89 73.25 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.886 -0.326 . . . . 40.219999999999999 110.557 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -69.47 -11.84 61.16 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.307 0.855 . . . . 72.510000000000005 113.307 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.38 -27.62 11.36 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.098 0.475 . . . . 54.420000000000002 110.359 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.11 -47.68 3.63 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 113.314 0.857 . . . . 72.430000000000007 113.314 -170.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.26 21.53 51.65 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.667 -0.973 . . . . 61.43 110.667 -172.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.6 m -118.97 155.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 122.306 -0.526 . . . . 51.020000000000003 110.617 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -125.71 141.4 52.03 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.91 -1.145 . . . . 74.230000000000004 107.91 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.0 mt -129.27 119.55 24.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.915 -0.772 . . . . 75.209999999999994 108.915 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -118.94 135.74 54.43 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.03 -1.1 . . . . 72.329999999999998 108.03 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.33 157.81 43.82 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 112.631 0.604 . . . . 73.219999999999999 112.631 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -145.67 150.87 37.1 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.844 -1.071 . . . . 53.520000000000003 111.267 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.544 ' NH2' ' HA ' ' A' ' 180' ' ' ASP . 3.9 tpt180 -96.49 106.56 18.83 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 106.401 -1.703 . . . . 62.520000000000003 106.401 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -96.8 89.23 4.83 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 108.097 -1.075 . . . . 63.039999999999999 108.097 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.13 -96.86 0.9 Allowed Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.086 -1.205 . . . . 65.340000000000003 110.086 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 179' ' ' THR . 2.9 t-20 -124.42 -2.42 8.0 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.672 1.225 . . . . 70.310000000000002 109.33 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.62 148.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 O-C-N 121.087 -1.008 . . . . 70.310000000000002 108.703 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.441 HG22 ' HD3' ' A' ' 114' ' ' ARG . 96.8 t -102.89 131.77 50.44 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 O-C-N 122.06 -0.4 . . . . 64.140000000000001 110.32 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.414 HG22 ' HG2' ' A' ' 175' ' ' GLN . 44.4 pt -107.56 130.98 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 N-CA-C 106.784 -1.562 . . . . 72.209999999999994 106.784 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 tt -127.93 131.42 49.34 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 115.869 -0.605 . . . . 55.329999999999998 109.467 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -132.19 115.47 15.75 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.602 -0.888 . . . . 75.099999999999994 108.602 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -118.03 157.88 14.96 Favored Glycine 0 C--N 1.281 -2.503 0 N-CA-C 109.99 -1.244 . . . . 62.310000000000002 109.99 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.469 ' HG2' HG22 ' A' ' 171' ' ' THR . 84.0 mtt180 -139.53 127.54 22.28 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 117.542 0.671 . . . . 75.310000000000002 110.208 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -113.58 109.98 19.5 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.401 -0.592 . . . . 61.340000000000003 109.401 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -109.68 97.76 7.24 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.439 -0.948 . . . . 71.099999999999994 108.439 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.82 28.57 8.46 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.557 -0.905 . . . . 62.350000000000001 108.557 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 69.4 p . . . . . 0 N--CA 1.447 -0.619 0 CA-C-N 115.883 -0.599 . . . . 75.299999999999997 112.599 -175.238 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.8 t70 . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 122.071 0.939 . . . . 54.020000000000003 110.594 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.53 141.26 36.83 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.276 -0.875 . . . . 61.310000000000002 111.7 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 27' ' ' ARG . 11.2 m-20 -131.48 136.64 48.09 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 108.527 -0.916 . . . . 70.040000000000006 108.527 177.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.8 t -127.57 118.48 49.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.292 -0.633 . . . . 73.439999999999998 109.292 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.404 ' OE2' ' HB3' ' A' ' 136' ' ' ASP . 2.6 mp0 -109.37 123.55 49.51 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.603 -0.517 . . . . 74.310000000000002 109.603 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.407 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.5 tm? -110.94 111.83 23.23 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.949 -1.5 . . . . 64.319999999999993 106.949 176.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.6 m -117.9 133.62 55.74 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.858 0.463 . . . . 64.219999999999999 110.45 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.83 123.62 63.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.89 -0.781 . . . . 71.209999999999994 108.89 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.51 127.49 56.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.107 -0.701 . . . . 63.009999999999998 109.107 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.527 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.43 118.47 13.74 Favored Pre-proline 0 C--N 1.286 -2.179 0 CA-C-N 116.529 -0.305 . . . . 61.439999999999998 111.477 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.94 40.46 0.36 Allowed 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 122.993 2.462 . . . . 64.200000000000003 111.935 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.53 -94.09 0.5 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-O 119.288 -0.387 . . . . 63.520000000000003 110.224 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 174.03 120.77 0.02 OUTLIER 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.3 0.64 . . . . 54.409999999999997 109.873 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.472 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 7.4 p -84.03 126.22 40.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.814 -0.81 . . . . 72.230000000000004 108.814 174.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.6 t -95.35 -33.46 12.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 119.775 -0.77 . . . . 74.140000000000001 110.647 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.8 m -154.48 132.37 11.58 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 108.399 -0.963 . . . . 53.25 108.399 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 t -140.53 157.85 44.88 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 110.246 -0.279 . . . . 63.130000000000003 110.246 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 26.9 t-20 -126.95 97.89 5.13 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.193 -2.151 . . . . 62.119999999999997 105.193 170.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.19 -147.43 11.11 Favored Glycine 0 N--CA 1.417 -2.601 0 N-CA-C 108.238 -1.945 . . . . 62.310000000000002 108.238 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -114.89 99.78 7.73 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 117.835 0.817 . . . . 73.120000000000005 109.476 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -80.09 113.95 18.64 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-O 121.482 0.658 . . . . 73.040000000000006 109.66 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.15 -35.52 15.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 107.454 -1.313 . . . . 73.329999999999998 107.454 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -143.46 166.5 19.54 Favored Pre-proline 0 N--CA 1.431 -1.389 0 N-CA-C 107.446 -1.316 . . . . 73.439999999999998 107.446 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -72.59 -0.05 8.26 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.342 2.028 . . . . 64.129999999999995 111.279 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 11.5 pt-20 -129.83 5.88 5.05 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.729 -0.668 . . . . 74.219999999999999 110.864 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.413 HG23 ' HG3' ' A' ' 158' ' ' GLU . 90.6 t -144.81 121.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.44 -0.578 . . . . 71.540000000000006 109.44 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.17 145.55 33.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 109.183 -0.673 . . . . 71.25 109.183 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -134.93 146.34 49.05 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.817 -0.808 . . . . 72.329999999999998 108.817 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.407 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.6 m-90 -121.95 122.35 39.16 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.295 -1.002 . . . . 73.040000000000006 108.295 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -88.07 109.5 19.91 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.173 -1.047 . . . . 75.299999999999997 108.173 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 30.9 mt -102.07 125.1 48.68 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 121.486 0.66 . . . . 75.450000000000003 110.271 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 5.4 mmpt? -118.03 150.23 47.0 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 114.903 -1.044 . . . . 64.230000000000004 110.553 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.435 ' HD3' ' HE2' ' A' ' 165' ' ' LYS . 10.8 Cg_exo -72.07 159.46 50.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.134 1.889 . . . . 75.420000000000002 110.775 173.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.97 -35.63 2.91 Favored Glycine 0 C--N 1.312 -0.785 0 N-CA-C 111.7 -0.56 . . . . 72.329999999999998 111.7 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.28 155.06 6.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.438 -0.381 . . . . 54.549999999999997 110.139 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.6 p -113.09 116.03 51.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.055 -0.721 . . . . 54.329999999999998 109.055 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.1 m -116.3 144.47 44.2 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.01 -0.737 . . . . 74.430000000000007 109.01 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 124' ' ' ARG . 45.0 p -115.6 152.18 33.57 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-O 121.015 0.436 . . . . 73.340000000000003 110.762 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -102.3 116.79 33.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.48 -1.304 . . . . 63.310000000000002 107.48 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 18.0 t -120.27 130.2 54.38 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 107.231 -1.396 . . . . 75.420000000000002 107.231 173.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -152.53 132.14 13.08 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 109.344 -0.613 . . . . 75.310000000000002 109.344 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.414 ' HG2' HG22 ' A' ' 120' ' ' ILE . 47.3 mt-30 -133.1 129.75 38.38 Favored 'General case' 0 C--N 1.268 -2.938 0 N-CA-C 107.511 -1.292 . . . . 70.430000000000007 107.511 174.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -150.59 155.28 39.12 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.955 -0.566 . . . . 74.510000000000005 110.097 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 177' ' ' ARG . 42.3 mtt180 -87.76 125.31 34.35 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.912 -1.144 . . . . 54.020000000000003 107.912 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -132.03 123.31 27.01 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 108.986 -0.746 . . . . 70.5 108.986 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.41 ' HA ' HD21 ' A' ' 117' ' ' ASN . 0.8 OUTLIER -61.41 113.99 2.96 Favored 'General case' 0 C--N 1.276 -2.621 0 O-C-N 124.085 0.865 . . . . 73.019999999999996 110.913 178.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.544 ' HA ' ' NH2' ' A' ' 114' ' ' ARG . 1.8 m-20 . . . . . 0 C--O 1.212 -0.886 0 CA-C-N 114.953 -1.021 . . . . 73.329999999999998 110.341 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 55.1 mtm180 . . . . . 0 N--CA 1.413 -2.316 0 N-CA-C 109.22 -0.659 . . . . 74.049999999999997 109.22 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.94 114.14 44.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.057 -1.46 . . . . 61.509999999999998 107.057 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -114.54 113.29 24.22 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.633 -0.877 . . . . 74.450000000000003 108.633 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -106.93 107.74 18.91 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.238 -1.393 . . . . 64.340000000000003 107.238 176.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 140' ' ' THR . 22.5 m -119.08 115.36 24.13 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 109.224 -0.658 . . . . 40.219999999999999 109.224 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 2.1 pp -123.41 146.47 28.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 120.39 -0.524 . . . . 51.299999999999997 110.238 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 31.5 m -123.52 121.02 34.59 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 108.468 -0.938 . . . . 63.43 108.468 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -116.06 118.63 59.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.91 0.862 . . . . 64.140000000000001 111.313 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HA ' ' HD2' ' A' ' 144' ' ' PRO . 17.9 m -87.26 148.39 44.64 Favored Pre-proline 0 N--CA 1.417 -2.12 0 CA-C-N 114.775 -1.102 . . . . 62.549999999999997 108.93 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.74 2.88 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 124.392 3.395 . . . . 71.340000000000003 113.755 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -91.02 1.61 56.95 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.226 1.01 . . . . 74.120000000000005 108.511 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 91' ' ' THR . 9.0 t70 72.48 28.73 2.21 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.015 1.726 . . . . 72.219999999999999 107.017 -176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.56 124.5 49.42 Favored 'General case' 0 N--CA 1.389 -3.501 0 CA-C-N 113.887 -1.506 . . . . 73.200000000000003 107.688 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.62 136.17 53.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.144 -1.058 . . . . 63.43 108.144 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.3 p -141.41 160.53 39.93 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 106.131 -1.803 . . . . 50.240000000000002 106.131 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.3 -165.82 39.19 Favored Glycine 0 CA--C 1.489 -1.541 0 C-N-CA 117.826 -2.13 . . . . 44.450000000000003 113.635 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HB2' HD11 ' A' ' 45' ' ' ILE . 10.5 pt-20 -157.08 133.58 9.92 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 123.51 0.724 . . . . 70.319999999999993 110.218 -175.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 3.4 mp -117.53 115.45 48.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 105.919 -1.882 . . . . 75.400000000000006 105.919 170.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 43' ' ' GLU . 5.0 mm -108.41 121.37 61.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.348 -0.982 . . . . 62.450000000000003 108.348 -175.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.493 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.98 108.86 16.77 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.33 -0.989 . . . . 61.310000000000002 108.33 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.11 122.87 38.4 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.762 0.315 . . . . 45.450000000000003 111.046 -176.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.66 158.96 28.9 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.665 -0.698 . . . . 64.310000000000002 110.913 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--N 1.319 -0.748 0 N-CA-C 107.49 -1.3 . . . . 73.150000000000006 107.49 171.53 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.586 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 4.1 t . . . . . 0 N--CA 1.422 -1.847 0 CA-C-O 120.396 0.141 . . . . 74.109999999999999 110.643 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.08 131.09 1.31 Allowed Glycine 0 N--CA 1.423 -2.204 0 CA-C-O 118.294 -1.281 . . . . 54.530000000000001 111.184 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -52.49 128.84 29.4 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 120.127 1.964 . . . . 73.310000000000002 109.205 169.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.04 163.39 14.92 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.903 0.705 . . . . 62.210000000000001 112.903 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 mt -121.61 124.52 44.52 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.37 -0.974 . . . . 74.420000000000002 108.37 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -112.51 90.39 3.33 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.063 0.459 . . . . 75.299999999999997 110.497 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.98 79.63 0.3 Allowed Glycine 0 C--N 1.3 -1.42 0 C-N-CA 121.021 -0.609 . . . . 14.41 111.802 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -87.88 105.18 17.25 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.685 0.755 . . . . 72.140000000000001 108.968 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.9 m -109.08 163.82 16.12 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 114.651 -1.159 . . . . 74.319999999999993 109.43 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.4 -16.91 50.25 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.744 2.296 . . . . 74.040000000000006 112.554 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -113.15 36.01 3.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.588 -0.733 . . . . 64.430000000000007 111.076 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.2 m -59.66 -29.08 67.81 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 112.463 0.542 . . . . 65.129999999999995 112.463 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.478 ' H ' ' NE2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -74.46 -7.85 54.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.912 -0.715 . . . . 74.299999999999997 111.667 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.81 -11.5 26.76 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.797 -0.446 . . . . 70.109999999999999 109.797 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.73 120.76 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 122.135 0.969 . . . . 75.109999999999999 111.847 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.48 106.43 18.4 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.451 -0.795 . . . . 51.219999999999999 108.931 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.2 t -98.24 132.25 43.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.465 -1.309 . . . . 63.310000000000002 107.465 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.9 m -144.76 165.35 28.33 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.629 0.252 . . . . 43.25 111.538 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -87.66 128.9 35.28 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.419 -0.956 . . . . 73.439999999999998 108.419 178.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 60.6 t80 -92.66 125.26 37.21 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 123.88 0.872 . . . . 71.310000000000002 109.858 -177.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -140.06 98.91 3.55 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.894 -1.15 . . . . 64.209999999999994 107.894 171.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 53.2 m -163.75 153.09 14.37 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.491 -1.3 . . . . 72.230000000000004 107.491 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.72 4.03 4.54 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.885 0.874 . . . . 72.209999999999994 111.574 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.08 0.72 73.77 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.591 -1.003 . . . . 72.450000000000003 110.591 -174.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -100.79 151.29 21.86 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 109.181 -0.674 . . . . 73.230000000000004 109.181 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.7 m -127.81 138.77 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 109.074 -0.713 . . . . 72.109999999999999 109.074 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -171.72 -153.54 9.19 Favored Glycine 0 C--N 1.277 -2.721 0 N-CA-C 110.89 -0.884 . . . . 73.450000000000003 110.89 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.4 m -140.64 145.22 36.33 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 109.812 -0.44 . . . . 32.520000000000003 109.812 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.49 155.72 43.29 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 120.586 -0.446 . . . . 74.299999999999997 110.442 177.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.47 114.35 21.12 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.695 -1.224 . . . . 73.299999999999997 107.695 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.21 113.13 43.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.691 -0.855 . . . . 74.010000000000005 108.691 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.3 p90 -113.0 164.19 13.76 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.928 -0.709 . . . . 73.209999999999994 112.4 -174.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 p -157.91 155.75 30.09 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.655 -1.157 . . . . 45.420000000000002 109.931 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 67.12 30.88 7.11 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.011 1.115 . . . . 73.340000000000003 114.011 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 87' ' ' PHE . 52.1 mt -103.01 166.7 10.29 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.456 -0.498 . . . . 63.240000000000002 111.438 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 41.1 p -113.78 172.64 6.86 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.693 -0.231 . . . . 73.219999999999999 111.613 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -54.94 -37.63 66.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.626 0.77 . . . . 70.120000000000005 109.767 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.43 -25.77 62.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.094 -0.503 . . . . 74.109999999999999 111.844 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.29 -16.88 28.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.801 0.334 . . . . 63.240000000000002 111.635 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 44.0 tp -58.16 -48.11 97.63 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 113.1 0.778 . . . . 65.230000000000004 113.1 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.24 -34.96 76.76 Favored 'Trans proline' 0 C--N 1.372 1.812 0 CA-C-N 120.826 1.331 . . . . 74.230000000000004 110.794 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -64.65 -40.89 96.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.134 -0.484 . . . . 64.340000000000003 111.263 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -74.64 -19.36 60.32 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.687 -0.486 . . . . 73.030000000000001 109.687 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -69.97 -20.7 63.3 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.993 -0.549 . . . . 74.340000000000003 110.024 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -61.53 -57.93 10.14 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.257 -1.016 . . . . 62.240000000000002 108.257 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 33.6 ttp -56.38 -45.41 80.55 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.813 -0.631 . . . . 73.030000000000001 110.249 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 6.9 t30 -53.13 -44.54 67.79 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.086 -0.961 . . . . 74.519999999999996 111.046 177.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 p -68.73 -22.34 64.33 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.972 -0.691 . . . . 63.009999999999998 111.832 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.58 -25.15 67.28 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 121.192 0.52 . . . . 74.340000000000003 110.035 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.67 -11.16 16.42 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.007 -0.542 . . . . 63.549999999999997 110.432 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.55 -47.3 3.96 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.982 0.734 . . . . 73.010000000000005 112.982 -171.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.05 28.42 54.11 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.256 -0.973 . . . . 71.409999999999997 111.05 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.12 170.42 13.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 120.77 0.319 . . . . 64.510000000000005 110.682 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.44 HD22 ' N ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -118.68 126.28 51.57 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.822 -1.547 . . . . 75.010000000000005 106.822 177.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 109' ' ' ASN . 93.5 mt -123.71 134.23 53.74 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.985 -0.746 . . . . 71.340000000000003 108.985 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.2 m -144.13 142.37 30.54 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.739 -0.467 . . . . 73.25 109.739 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.93 146.4 30.12 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.321 -0.622 . . . . 73.25 109.321 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -138.03 148.54 45.2 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.74 -0.664 . . . . 72.349999999999994 110.613 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.427 ' CG ' HG22 ' A' ' 119' ' ' VAL . 6.6 mtt85 -90.1 137.75 32.09 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.5 -0.556 . . . . 71.439999999999998 109.5 171.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.422 ' O ' HG13 ' A' ' 118' ' ' ILE . 43.3 t30 -135.36 101.36 4.8 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.653 -0.869 . . . . 73.239999999999995 108.653 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.55 -106.97 2.03 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 109.935 -1.266 . . . . 52.049999999999997 109.935 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.441 HD21 ' HA ' ' A' ' 179' ' ' THR . 3.0 t-20 -115.96 -5.45 11.99 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.503 1.144 . . . . 62.509999999999998 108.864 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -105.25 149.54 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 115.513 -0.767 . . . . 74.099999999999994 109.62 -175.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.427 HG22 ' CG ' ' A' ' 114' ' ' ARG . 99.1 t -111.12 134.76 52.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 109.816 -0.439 . . . . 54.509999999999998 109.816 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.45 HG22 ' HG2' ' A' ' 175' ' ' GLN . 47.4 pt -108.47 137.7 38.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.048 -1.094 . . . . 74.030000000000001 108.048 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.08 131.44 49.07 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 108.988 -0.745 . . . . 70.310000000000002 108.988 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -135.52 122.03 20.68 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.291 -0.868 . . . . 63.020000000000003 109.655 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.68 136.73 8.65 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.451 -0.881 . . . . 73.329999999999998 111.533 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -121.34 137.61 54.62 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 118.001 0.901 . . . . 75.219999999999999 109.645 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -130.16 110.15 11.36 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.21 0.529 . . . . 74.219999999999999 111.11 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.69 107.4 17.42 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.129 -1.063 . . . . 64.439999999999998 108.129 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.14 21.98 16.11 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.931 0.396 . . . . 74.340000000000003 109.993 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 167' ' ' GLY . 39.2 p . . . . . 0 C--N 1.31 -1.128 0 N-CA-C 113.05 0.759 . . . . 73.230000000000004 113.05 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.0 t0 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 122.558 1.171 . . . . 63.25 109.28 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.48 154.8 17.62 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.525 -1.216 . . . . 74.409999999999997 111.097 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 8.5 m-20 -133.07 132.54 41.89 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.193 -0.317 . . . . 71.239999999999995 111.151 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 86.5 t -117.03 124.43 73.0 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 108.463 -0.94 . . . . 73.450000000000003 108.463 176.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -121.23 133.92 55.18 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.336 -0.227 . . . . 71.549999999999997 110.568 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.557 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.7 tm? -119.8 118.12 29.99 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.697 -1.964 . . . . 34.340000000000003 105.697 176.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 31' ' ' SER . 18.2 m -126.6 131.55 51.48 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.356 -0.609 . . . . 63.450000000000003 109.356 -177.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 65.8 t -124.87 126.59 71.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.467 -0.568 . . . . 65.349999999999994 109.467 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.09 126.17 54.79 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.33 -0.989 . . . . 44.020000000000003 108.33 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.597 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.8 p90 -134.1 120.91 15.34 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 112.576 0.584 . . . . 72.140000000000001 112.576 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 26.2 Cg_exo -67.83 39.64 0.2 Allowed 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 123.59 2.86 . . . . 74.409999999999997 112.798 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.62 -107.23 0.33 Allowed 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.529 -0.545 . . . . 64.420000000000002 109.529 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.81 129.18 0.11 Allowed 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.601 -0.889 . . . . 61.340000000000003 108.601 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.59 134.91 26.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.594 -0.891 . . . . 64.329999999999998 108.594 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.5 p -92.36 -38.52 11.98 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.229 0.537 . . . . 74.319999999999993 109.684 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.4 m -161.37 132.96 5.55 Favored 'General case' 0 C--O 1.208 -1.12 0 C-N-CA 123.212 0.605 . . . . 72.209999999999994 109.466 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.2 t -139.7 155.67 47.24 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.121 -0.632 . . . . 74.310000000000002 111.124 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -123.13 95.4 4.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 104.898 -2.26 . . . . 65.420000000000002 104.898 172.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.475 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.33 -155.51 24.48 Favored Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 107.508 -2.237 . . . . 42.32 107.508 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -107.01 99.85 9.38 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.131 0.965 . . . . 61.340000000000003 110.579 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -79.43 114.38 18.32 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.86 -0.609 . . . . 73.030000000000001 109.718 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.5 mt -80.85 -39.48 17.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.42 -1.326 . . . . 73.510000000000005 107.42 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -135.17 168.9 15.41 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 106.472 -1.677 . . . . 73.209999999999994 106.472 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.22 0.33 9.51 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.042 1.828 . . . . 64.349999999999994 109.822 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.5 pt-20 -134.89 10.03 3.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.2 -0.909 . . . . 72.430000000000007 112.109 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.9 t -145.87 120.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.813 -1.18 . . . . 53.020000000000003 107.813 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.99 147.4 32.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.87 -0.789 . . . . 73.150000000000006 108.87 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -137.63 146.65 44.17 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.318 -0.401 . . . . 72.519999999999996 110.019 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.557 ' CE3' HD12 ' A' ' 139' ' ' LEU . 22.8 m-90 -130.1 130.97 45.51 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.995 -1.113 . . . . 74.129999999999995 107.995 176.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -112.59 105.39 13.58 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.638 0.732 . . . . 75.400000000000006 110.632 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.3 mm? -94.03 134.5 36.38 Favored 'General case' 0 C--O 1.271 2.222 0 CA-C-N 115.64 -0.709 . . . . 73.450000000000003 110.493 -175.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 1.4 tpmt? -103.31 145.65 30.99 Favored Pre-proline 0 N--CA 1.419 -2.01 0 C-N-CA 124.063 0.945 . . . . 71.209999999999994 108.98 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -68.25 157.76 60.44 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.789 2.326 . . . . 74.129999999999995 110.813 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.524 ' O ' HG22 ' A' ' 128' ' ' THR . . . 77.61 -22.39 2.74 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 121.054 -0.593 . . . . 73.219999999999999 113.483 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 165' ' ' LYS . 5.7 m -106.07 167.8 3.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.485 0.659 . . . . 41.420000000000002 111.636 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.89 135.94 53.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.833 -1.173 . . . . 64.319999999999993 107.833 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.7 m -149.05 163.9 36.21 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.626 -0.509 . . . . 62.229999999999997 109.626 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 t -139.01 146.14 40.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.403 0.62 . . . . 71.420000000000002 111.311 175.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.2 ptp -112.88 142.91 44.99 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.389 -1.278 . . . . 74.230000000000004 108.763 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.4 m -143.14 147.09 34.39 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 120.044 -0.662 . . . . 74.340000000000003 110.027 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -154.33 147.55 24.81 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 109.1 -0.704 . . . . 73.099999999999994 109.1 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.45 ' HG2' HG22 ' A' ' 120' ' ' ILE . 42.0 mt-30 -141.15 131.52 25.15 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 107.436 -1.32 . . . . 74.219999999999999 107.436 174.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.22 149.16 26.71 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.279 -1.378 . . . . 63.340000000000003 107.279 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.593 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 16.3 ptt180 -93.27 146.65 23.55 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 118.581 -1.248 . . . . 63.119999999999997 110.925 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.402 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 98.6 m-85 -142.33 129.19 20.6 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 109.316 -0.624 . . . . 70.140000000000001 109.316 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.441 ' HA ' HD21 ' A' ' 117' ' ' ASN . 5.4 p -67.58 121.16 15.26 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.403 -0.817 . . . . 63.210000000000001 111.317 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.31 -1.129 0 CA-C-N 115.413 -0.812 . . . . 55.229999999999997 109.238 174.174 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.0 mtp180 . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 108.126 -1.064 . . . . 75.140000000000001 108.126 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.5 t -117.09 115.02 47.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.317 -0.994 . . . . 51.149999999999999 108.317 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -115.5 120.87 40.95 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 121.074 0.464 . . . . 61.310000000000002 110.432 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -115.25 108.64 16.84 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.443 -0.947 . . . . 75.5 108.443 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 140' ' ' THR . 34.9 m -117.7 117.37 29.17 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.854 -1.165 . . . . 64.319999999999993 107.854 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -125.73 146.65 31.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 109.776 -0.453 . . . . 74.230000000000004 109.776 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.8 m -125.65 122.58 36.8 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.344 0.593 . . . . 73.340000000000003 109.908 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 143' ' ' PHE . 10.2 tt -101.98 119.01 49.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 108.714 -0.847 . . . . 72.109999999999999 108.714 176.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.5 m -87.43 160.64 47.67 Favored Pre-proline 0 N--CA 1.424 -1.757 0 CA-C-N 115.658 -0.701 . . . . 71.319999999999993 110.158 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -64.92 2.1 1.52 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 123.777 2.984 . . . . 74.549999999999997 113.595 -177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.18 -7.21 57.23 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.192 -0.669 . . . . 75.530000000000001 109.192 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.4 t70 72.54 29.12 2.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 106.86 -1.533 . . . . 74.25 106.86 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.4 146.76 37.78 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.945 -1.502 . . . . 73.540000000000006 106.945 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.516 HG11 HD13 ' A' ' 95' ' ' LEU . 21.2 t -118.39 140.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-O 121.066 0.46 . . . . 54.210000000000001 110.096 -176.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.0 p -137.22 161.82 35.15 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.624 -1.621 . . . . 52.109999999999999 106.624 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.64 -176.35 46.9 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 119.407 -1.377 . . . . 73.439999999999998 112.158 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.54 133.41 14.05 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.412 0.625 . . . . 62.200000000000003 110.273 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 65.0 mt -121.14 116.01 48.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.835 -1.172 . . . . 74.120000000000005 107.835 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.66 119.01 60.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.334 -0.617 . . . . 61.549999999999997 109.334 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.419 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -110.21 108.63 18.83 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.612 -1.625 . . . . 44.32 106.612 174.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -119.86 131.51 55.29 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 120.885 0.374 . . . . 70.400000000000006 111.088 -175.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.58 158.35 44.26 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.478 -0.783 . . . . 44.350000000000001 112.763 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.6 mttt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 115.655 1.724 . . . . 55.210000000000001 115.655 168.302 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.421 -1.882 0 N-CA-C 109.789 -0.449 . . . . 52.25 109.789 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.8 97.81 0.11 Allowed Glycine 0 N--CA 1.42 -2.37 0 C-N-CA 118.846 -1.645 . . . . 52.229999999999997 113.694 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 83' ' ' SER . 74.7 Cg_exo -55.55 151.36 38.6 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.391 2.06 . . . . 71.530000000000001 109.927 166.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.83 119.66 19.48 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.758 -0.46 . . . . 33.350000000000001 109.758 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 81.9 mt -69.63 137.3 52.13 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 123.54 0.525 . . . . 71.129999999999995 110.421 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -97.34 100.04 11.49 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.452 -0.944 . . . . 70.420000000000002 108.452 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.656 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -150.24 92.28 0.14 Allowed Glycine 0 C--N 1.277 -2.721 0 C-N-CA 120.156 -1.021 . . . . 72.409999999999997 113.233 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -106.15 99.67 9.24 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.048 -1.093 . . . . 74.530000000000001 108.048 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.73 155.89 48.47 Favored Pre-proline 0 C--N 1.286 -2.182 0 CA-C-N 115.501 -0.772 . . . . 70.219999999999999 108.958 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.27 -19.08 48.48 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.911 2.407 . . . . 70.549999999999997 112.941 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -107.82 32.75 4.5 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.792 -0.64 . . . . 72.340000000000003 112.212 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.4 m -56.58 -25.64 53.1 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.552 0.215 . . . . 65.040000000000006 111.406 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -64.72 -16.83 63.49 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.116 0.484 . . . . 74.140000000000001 110.599 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -103.11 -15.81 15.94 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.676 -0.693 . . . . 72.439999999999998 110.633 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 p -123.97 118.27 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-O 122.106 0.955 . . . . 55.43 111.406 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.03 109.01 21.1 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.603 -1.181 . . . . 74.439999999999998 109.319 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.5 t -97.95 114.36 35.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.812 -1.551 . . . . 53.299999999999997 106.812 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 m -125.68 171.8 10.3 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.729 -0.668 . . . . 72.340000000000003 109.796 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -88.25 151.1 22.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.397 -1.334 . . . . 73.430000000000007 107.397 174.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 67.7 t80 -115.3 125.05 52.8 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 108.299 -1.0 . . . . 71.129999999999995 108.299 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -138.69 99.61 3.85 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.566 -2.013 . . . . 60.210000000000001 105.566 174.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 42.6 t -172.51 148.04 1.95 Allowed 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.403 -0.962 . . . . 75.099999999999994 108.403 -174.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 69.32 10.04 7.59 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.998 0.919 . . . . 63.039999999999999 111.079 174.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.02 -3.78 67.31 Favored Glycine 0 N--CA 1.423 -2.173 0 CA-C-N 115.279 -0.873 . . . . 73.140000000000001 111.782 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.538 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 41.5 m-85 -104.2 146.28 29.0 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.374 0.587 . . . . 74.319999999999993 110.491 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.77 136.5 51.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 N-CA-C 108.308 -0.997 . . . . 73.519999999999996 108.308 172.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.478 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -167.1 -155.17 8.89 Favored Glycine 0 C--N 1.263 -3.492 0 C-N-CA 118.863 -1.637 . . . . 52.100000000000001 112.512 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' A' ' 58' ' ' PRO . 24.0 t -136.97 143.73 42.97 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 108.641 -0.874 . . . . 71.519999999999996 108.641 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -131.86 137.42 48.05 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.952 -0.567 . . . . 72.319999999999993 110.947 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.21 114.21 27.26 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.743 -1.577 . . . . 75.099999999999994 106.743 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.96 120.7 62.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.966 -1.124 . . . . 75.219999999999999 107.966 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.497 ' CD2' HD12 ' A' ' 90' ' ' LEU . 45.2 p90 -126.73 149.48 49.58 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.786 -0.765 . . . . 63.350000000000001 111.62 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.4 m -156.23 152.09 27.36 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.765 -0.652 . . . . 74.099999999999994 109.484 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.3 t70 64.46 48.75 2.62 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 122.577 1.18 . . . . 61.340000000000003 111.111 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 87' ' ' PHE . 23.2 mt -112.07 169.88 8.54 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.041 -0.982 . . . . 74.030000000000001 108.584 175.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.507 HG22 ' OE1' ' A' ' 94' ' ' GLU . 13.1 t -128.38 -178.84 4.72 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.923 -1.111 . . . . 70.150000000000006 110.955 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -50.32 -42.84 53.35 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.329 1.452 . . . . 64.140000000000001 111.146 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.37 -27.97 69.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.46 0.541 . . . . 44.530000000000001 112.46 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.507 ' OE1' HG22 ' A' ' 91' ' ' THR . 3.9 mp0 -88.48 -17.61 29.98 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 112.559 0.577 . . . . 73.310000000000002 112.559 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.516 HD13 HG11 ' A' ' 40' ' ' VAL . 40.4 tp -57.62 -47.38 99.06 Favored Pre-proline 0 CA--C 1.567 1.629 0 N-CA-C 113.807 1.04 . . . . 74.129999999999995 113.807 -177.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.64 -32.32 7.76 Favored 'Trans proline' 0 C--N 1.359 1.1 0 CA-C-N 120.72 1.293 . . . . 41.100000000000001 110.96 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -68.92 -34.68 75.78 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.992 -0.549 . . . . 75.349999999999994 111.29 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -74.16 -19.13 60.66 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.9 0.381 . . . . 73.230000000000004 110.189 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.26 -22.64 63.82 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.873 -0.603 . . . . 65.439999999999998 110.678 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -58.5 -57.87 11.02 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.638 -0.875 . . . . 65.140000000000001 108.638 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.656 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.5 ttp -54.46 -50.33 67.95 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.436 -0.802 . . . . 73.439999999999998 110.062 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -55.03 -40.07 69.81 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 114.854 -1.066 . . . . 71.310000000000002 111.367 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.9 p -69.47 -19.25 63.76 Favored 'General case' 0 N--CA 1.42 -1.967 0 C-N-CA 119.63 -0.828 . . . . 72.230000000000004 112.631 -171.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.34 -28.29 69.9 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 121.583 0.706 . . . . 62.530000000000001 110.06 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.7 -8.2 16.97 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.932 -0.577 . . . . 75.120000000000005 110.829 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.19 -34.29 7.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.557 0.947 . . . . 43.539999999999999 113.557 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.69 26.77 66.52 Favored Glycine 0 N--CA 1.46 0.264 0 N-CA-C 111.125 -0.79 . . . . 74.230000000000004 111.125 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.22 156.35 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.673 0.749 . . . . 75.099999999999994 112.376 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.44 HD22 ' N ' ' A' ' 109' ' ' ASN . 0.7 OUTLIER -117.56 121.45 40.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.964 -2.606 . . . . 70.450000000000003 103.964 171.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.9 mt -123.29 134.39 54.07 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 118.382 0.537 . . . . 72.340000000000003 111.185 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.7 m -126.66 128.04 46.11 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.575 -0.898 . . . . 75.420000000000002 108.575 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 tp -125.86 125.25 42.53 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.577 -0.527 . . . . 63.439999999999998 109.577 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -138.02 145.76 42.24 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.663 -0.495 . . . . 73.5 109.663 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -98.85 137.95 36.68 Favored 'General case' 0 N--CA 1.399 -3.008 0 N-CA-C 107.71 -1.219 . . . . 74.099999999999994 107.71 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.413 ' O ' HG13 ' A' ' 118' ' ' ILE . 46.8 t30 -124.77 87.08 2.65 Favored 'General case' 0 C--N 1.269 -2.897 0 N-CA-C 107.469 -1.308 . . . . 63.420000000000002 107.469 -177.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.52 -115.99 5.57 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.576 -1.41 . . . . 61.539999999999999 109.576 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -104.95 -1.88 25.27 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.106 0.955 . . . . 74.239999999999995 108.889 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.549 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -101.84 148.99 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.799 -1.186 . . . . 53.520000000000003 107.799 179.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.1 t -117.28 138.53 47.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 O-C-N 121.762 -0.586 . . . . 72.120000000000005 110.59 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.5 pt -120.5 135.49 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-O 121.542 0.687 . . . . 75.150000000000006 109.81 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.9 tt -128.18 127.0 42.11 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.351 -1.351 . . . . 63.229999999999997 107.351 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.99 139.58 41.55 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.671 -0.863 . . . . 74.209999999999994 108.671 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.98 -175.57 34.99 Favored Glycine 0 N--CA 1.402 -3.625 0 C-N-CA 120.345 -0.931 . . . . 61.030000000000001 111.472 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -145.47 157.3 44.03 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.117 -1.068 . . . . 65.530000000000001 108.117 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.3 109.54 11.56 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.797 -0.446 . . . . 53.520000000000003 109.797 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -112.7 93.63 4.52 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.641 -0.874 . . . . 53.25 108.641 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.348 0.0 OUTLIER -125.36 54.64 1.45 Allowed 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 124.257 1.979 . . . . 74.019999999999996 109.677 176.065 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 N--CA 1.427 -1.599 0 CA-C-N 112.235 -2.257 . . . . 74.409999999999997 111.499 -175.474 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 120.929 0.395 . . . . 75.439999999999998 110.521 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.69 129.17 45.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 111.73 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -133.76 127.08 32.02 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.27 -1.011 . . . . 54.210000000000001 108.27 171.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 66.3 t -114.53 112.97 42.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.94 -1.133 . . . . 63.420000000000002 107.94 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -107.51 122.07 45.91 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.612 -0.514 . . . . 55.509999999999998 109.612 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.572 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.8 tm? -111.8 119.16 37.66 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.383 -1.71 . . . . 74.040000000000006 106.383 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 31' ' ' SER . 7.1 m -126.8 130.58 50.53 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.328 -0.619 . . . . 73.019999999999996 109.328 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 85.0 t -122.67 124.83 71.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.259 -0.645 . . . . 43.350000000000001 109.259 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.21 127.34 55.57 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.383 -0.599 . . . . 70.349999999999994 109.383 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.441 ' HB3' HG23 ' A' ' 34' ' ' ILE . 2.9 p90 -134.55 117.16 13.08 Favored Pre-proline 0 C--N 1.287 -2.128 0 CA-C-N 116.232 -0.44 . . . . 75.109999999999999 111.207 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.49 27.32 0.14 Allowed 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 122.846 2.364 . . . . 53.399999999999999 113.234 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -106.63 -92.34 0.4 Allowed 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.036 -0.728 . . . . 73.150000000000006 109.036 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.22 131.07 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.537 1.135 . . . . 73.200000000000003 107.987 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.92 137.95 20.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.689 -0.856 . . . . 71.239999999999995 108.689 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.7 p -91.94 -45.78 8.17 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.391 -0.596 . . . . 65.340000000000003 109.391 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.1 m -150.24 132.95 15.89 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.373 -0.83 . . . . 74.230000000000004 109.119 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.413 ' OG1' HG11 ' A' ' 160' ' ' VAL . 6.9 t -139.07 159.34 42.37 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.677 -0.64 . . . . 60.210000000000001 110.248 175.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 25.5 t-20 -131.01 97.91 4.44 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 104.723 -2.325 . . . . 60.450000000000003 104.723 172.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.69 -141.81 6.59 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.167 -1.573 . . . . 72.400000000000006 109.167 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -118.65 99.07 6.55 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 117.587 0.693 . . . . 70.409999999999997 110.129 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -75.16 130.33 39.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.853 -0.53 . . . . 71.450000000000003 111.087 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 61.1 mt -90.32 -48.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.65 -1.611 . . . . 44.219999999999999 106.65 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -136.28 171.94 7.9 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.136 -1.801 . . . . 74.239999999999995 106.136 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -75.97 -1.56 11.56 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.594 1.529 . . . . 51.119999999999997 111.082 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.27 1.96 7.8 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.707 -0.679 . . . . 71.049999999999997 111.457 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 68.1 t -143.77 120.96 5.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.576 -0.898 . . . . 64.549999999999997 108.576 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.413 HG11 ' OG1' ' A' ' 150' ' ' THR . 56.7 t -123.98 148.3 28.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.06 -0.719 . . . . 74.430000000000007 109.06 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -135.93 151.42 49.94 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.174 -0.676 . . . . 50.420000000000002 109.174 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.572 ' CE3' HD12 ' A' ' 139' ' ' LEU . 26.3 m-90 -132.47 128.68 37.94 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.222 -1.399 . . . . 64.409999999999997 107.222 175.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.17 105.29 15.2 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.919 0.866 . . . . 75.25 110.681 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.3 mp -87.8 130.56 34.82 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.478 -1.237 . . . . 72.239999999999995 109.664 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -118.15 146.89 40.33 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 115.204 -0.907 . . . . 74.019999999999996 111.144 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.93 149.86 86.04 Favored 'Trans proline' 0 N--CA 1.476 0.448 0 C-N-CA 123.389 2.726 . . . . 51.140000000000001 111.985 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.71 -27.43 2.57 Favored Glycine 0 C--N 1.308 -1.027 0 C-N-CA 121.218 -0.515 . . . . 75.239999999999995 113.169 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.5 m -105.57 154.44 6.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.198 0.523 . . . . 62.310000000000002 111.275 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 p -98.08 143.87 12.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.926 -0.768 . . . . 75.430000000000007 108.926 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 30.7 m -134.38 153.69 51.76 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.653 -0.499 . . . . 52.240000000000002 109.653 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.1 p -106.94 153.77 22.06 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.702 0.287 . . . . 75.519999999999996 111.063 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 40.1 tpp -124.95 116.87 22.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.031 -0.729 . . . . 74.319999999999993 109.031 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 8.3 t -143.57 132.5 22.8 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.022 -1.071 . . . . 74.439999999999998 109.876 172.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.83 122.94 8.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.759 -0.83 . . . . 63.329999999999998 108.759 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -127.94 132.01 49.28 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.635 -0.876 . . . . 71.450000000000003 108.635 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -156.75 158.09 36.26 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.902 -0.407 . . . . 43.030000000000001 109.902 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 118' ' ' ILE . 70.2 mtp180 -89.13 136.66 32.89 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.756 -0.461 . . . . 72.409999999999997 109.756 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -142.68 128.39 19.26 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 109.472 -0.566 . . . . 62.229999999999997 109.472 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 12.8 p -56.38 109.96 0.69 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 124.231 0.957 . . . . 63.210000000000001 112.727 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 CA--C 1.51 -0.592 0 O-C-N 123.951 0.782 . . . . 64.430000000000007 109.476 177.363 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HD3' ' OE1' ' A' ' 138' ' ' GLU . 28.8 ttm180 . . . . . 0 N--CA 1.412 -2.334 0 N-CA-C 109.09 -0.707 . . . . 74.0 109.09 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 61.8 t -109.36 113.77 45.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 105.543 -2.021 . . . . 74.129999999999995 105.543 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 35.1 ttt180 -126.34 118.65 25.48 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-O 121.504 0.668 . . . . 74.239999999999995 110.369 -177.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.94 109.84 19.52 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.677 -1.147 . . . . 63.439999999999998 108.054 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.4 m -110.94 115.42 29.48 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 107.42 -1.326 . . . . 75.120000000000005 107.42 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -127.8 146.3 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 109.532 -0.544 . . . . 62.219999999999999 109.532 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.6 m -124.42 125.03 43.59 Favored 'General case' 0 C--N 1.272 -2.803 0 CA-C-N 115.928 -0.578 . . . . 64.420000000000002 109.596 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.9 tt -114.92 124.79 71.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.531 0.681 . . . . 71.340000000000003 109.62 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m -100.07 157.36 34.0 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 115.75 -0.659 . . . . 74.239999999999995 110.674 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD3' ' HG2' ' A' ' 144' ' ' PRO . 64.6 Cg_exo -58.24 -2.51 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 124.355 3.37 . . . . 64.230000000000004 113.476 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 19.5 m-20 -82.08 -0.19 43.41 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 125.278 1.431 . . . . 65.200000000000003 110.732 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.2 t70 66.86 29.81 8.14 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.855 -1.535 . . . . 71.530000000000001 106.855 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -120.92 136.95 54.82 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 112.999 -1.909 . . . . 74.120000000000005 108.602 -175.026 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 95' ' ' LEU . 22.0 t -121.35 137.19 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 115.106 -0.952 . . . . 72.120000000000005 109.3 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.3 p -138.49 149.9 45.88 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.681 -1.229 . . . . 64.120000000000005 107.681 174.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.09 -175.7 47.43 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 118.012 -2.042 . . . . 24.329999999999998 113.884 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.99 133.73 28.85 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.348 -0.926 . . . . 60.43 108.879 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.5 mt -121.19 116.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 107.776 -1.194 . . . . 70.540000000000006 107.776 176.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -120.08 115.54 47.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 120.762 0.315 . . . . 74.019999999999996 110.247 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . . . -107.92 108.21 19.26 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.444 -1.687 . . . . 52.310000000000002 106.444 174.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.474 ' HB1' ' CB ' ' A' ' 80' ' ' TYR . . . -122.82 126.22 46.96 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.309 0.576 . . . . 72.420000000000002 112.511 -172.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.98 157.81 21.97 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.573 -0.899 . . . . 52.509999999999998 108.573 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 tttp . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 106.706 -1.591 . . . . 71.120000000000005 106.706 178.266 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.44 -0.929 0 CA-C-O 121.162 0.506 . . . . 73.010000000000005 110.817 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.532 ' HA3' ' ND2' ' A' ' 74' ' ' ASN . . . 172.31 97.62 0.11 Allowed Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.678 -0.772 . . . . 54.219999999999999 111.547 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.28 159.4 52.43 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.18 1.92 . . . . 73.5 110.836 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.23 154.13 33.87 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.574 -0.528 . . . . 74.129999999999995 109.574 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 83' ' ' SER . 6.6 mp -68.95 145.97 53.17 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 120.95 0.405 . . . . 73.5 111.52 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -112.52 108.88 18.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.281 -0.872 . . . . 62.140000000000001 109.187 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.9 -72.55 0.01 OUTLIER Glycine 0 C--N 1.265 -3.369 0 C-N-CA 120.194 -1.003 . . . . 54.350000000000001 112.103 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 71.17 124.54 0.03 OUTLIER 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.392 1.077 . . . . 42.530000000000001 110.519 -173.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.67 162.15 56.69 Favored Pre-proline 0 C--N 1.293 -1.877 0 CA-C-N 115.222 -0.899 . . . . 43.32 108.911 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.79 -16.25 47.77 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 122.882 2.388 . . . . 74.430000000000007 113.187 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.431 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 33.2 p90 -116.01 48.66 1.2 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.429 0.633 . . . . 72.299999999999997 111.786 -176.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m -55.85 -37.43 68.74 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.53 0.567 . . . . 75.140000000000001 112.53 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -67.56 -11.57 58.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.5 0.667 . . . . 63.43 111.426 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 66' ' ' PHE . 14.0 mmmm -95.56 -18.02 20.93 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.577 -0.738 . . . . 71.299999999999997 110.176 -177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.6 119.76 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.913 0.863 . . . . 71.019999999999996 111.66 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.62 111.48 23.81 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.545 -0.752 . . . . 75.25 109.575 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 85' ' ' ALA . 4.4 p -98.28 139.25 20.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.096 -1.075 . . . . 63.210000000000001 108.096 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -150.9 170.3 19.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.196 0.522 . . . . 64.450000000000003 110.948 -170.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.532 ' ND2' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -84.16 128.98 34.91 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.122 -1.436 . . . . 71.319999999999993 107.122 178.384 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 88.3 t80 -108.83 122.05 46.37 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.61 -0.436 . . . . 72.420000000000002 110.279 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -138.77 109.49 6.65 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.913 -1.143 . . . . 72.340000000000003 107.913 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 46.6 t -168.68 147.61 4.21 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.657 -0.701 . . . . 71.400000000000006 109.329 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.87 19.28 11.66 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.644 0.979 . . . . 74.109999999999999 113.644 171.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.87 0.31 62.24 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 120.543 -0.836 . . . . 64.519999999999996 111.794 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.474 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . 49.9 m-85 -104.77 161.14 14.42 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 120.755 0.312 . . . . 65.120000000000005 110.181 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.98 136.46 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 106.049 -1.834 . . . . 75.109999999999999 106.049 163.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.82 -155.22 9.51 Favored Glycine 0 N--CA 1.408 -3.207 0 C-N-CA 119.605 -1.283 . . . . 72.109999999999999 112.957 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.484 ' HB3' HD12 ' A' ' 60' ' ' LEU . 5.3 m -118.12 141.36 48.57 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 114.531 -0.835 . . . . 42.32 109.918 -174.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.42 148.72 47.92 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.702 -0.799 . . . . 74.019999999999996 111.132 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . . . -131.81 115.1 15.52 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.427 -1.323 . . . . 40.329999999999998 107.427 175.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.1 t -108.74 117.82 54.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.386 -0.968 . . . . 72.25 108.386 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CD2' HD12 ' A' ' 90' ' ' LEU . 51.2 p90 -121.05 151.91 39.26 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.069 0.461 . . . . 71.400000000000006 110.651 -175.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -155.36 160.41 40.68 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.223 -0.444 . . . . 71.540000000000006 111.383 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 60.93 30.2 19.48 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.895 1.278 . . . . 74.549999999999997 110.867 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 87' ' ' PHE . 17.7 mt -87.79 161.08 17.76 Favored 'General case' 0 N--CA 1.413 -2.301 0 CA-C-N 115.914 -0.584 . . . . 71.340000000000003 109.62 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.407 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.7 t -122.53 177.6 5.35 Favored 'General case' 0 C--N 1.258 -3.375 0 N-CA-C 109.311 -0.626 . . . . 73.420000000000002 109.311 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -55.9 -35.42 66.52 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 123.977 0.911 . . . . 73.450000000000003 111.776 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.66 -26.29 62.48 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.27 0.557 . . . . 43.539999999999999 111.861 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' A' ' 90' ' ' LEU . 46.4 mt-10 -88.26 -20.49 25.39 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.032 0.444 . . . . 75.319999999999993 109.855 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 54.9 tp -58.91 -54.69 53.96 Favored Pre-proline 0 CA--C 1.566 1.577 0 N-CA-C 114.453 1.279 . . . . 65.010000000000005 114.453 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -74.11 -28.34 10.97 Favored 'Trans proline' 0 C--N 1.362 1.276 0 CA-C-N 121.23 1.475 . . . . 64.230000000000004 110.292 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -70.03 -29.61 66.69 Favored 'General case' 0 N--CA 1.402 -2.845 0 CA-C-N 114.932 -1.031 . . . . 72.140000000000001 110.842 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -75.82 -22.69 56.06 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 109.388 -0.597 . . . . 74.5 109.388 175.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -17.72 62.42 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.812 -0.631 . . . . 64.349999999999994 111.118 -175.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -63.61 -57.61 9.54 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.912 -0.773 . . . . 74.319999999999993 108.912 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 38.6 ttp -59.86 -47.44 85.72 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.641 -0.708 . . . . 44.200000000000003 110.386 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -57.51 -29.78 64.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.077 -0.965 . . . . 73.019999999999996 111.144 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -60.91 -37.35 81.97 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.889 -0.411 . . . . 62.43 109.889 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.5 -20.5 65.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.258 0.551 . . . . 73.140000000000001 111.073 -175.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.59 -21.27 15.33 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 120.282 -0.567 . . . . 52.100000000000001 110.826 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.42 -47.95 3.81 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.103 -0.639 . . . . 75.409999999999997 112.166 -171.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.03 12.1 60.64 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 121.014 -0.612 . . . . 72.120000000000005 111.787 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.5 m -106.64 162.65 5.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 120.81 0.338 . . . . 74.120000000000005 110.832 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -123.07 125.22 44.79 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.613 -0.884 . . . . 74.200000000000003 108.613 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 87.4 mt -125.77 111.73 15.23 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 110.007 -0.368 . . . . 73.120000000000005 110.007 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.6 t -105.45 138.29 41.88 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.076 -1.453 . . . . 71.519999999999996 107.076 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 pp -149.96 153.95 37.44 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.968 -0.693 . . . . 71.25 112.248 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -158.58 167.85 28.49 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.316 -1.311 . . . . 63.140000000000001 110.245 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HD2' HH11 ' A' ' 114' ' ' ARG . 5.4 ttt180 -112.71 138.2 49.89 Favored 'General case' 0 N--CA 1.389 -3.506 0 N-CA-C 107.645 -1.243 . . . . 71.019999999999996 107.645 172.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -115.29 89.79 3.18 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 106.625 -1.621 . . . . 70.230000000000004 106.625 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.32 -103.83 1.01 Allowed Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.661 -0.976 . . . . 60.130000000000003 110.661 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -99.79 -24.71 14.6 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.83 0.824 . . . . 73.030000000000001 110.333 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -96.13 140.11 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 C-N-CA 118.664 -1.214 . . . . 72.120000000000005 109.607 -173.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.2 t -102.27 136.29 35.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.53 0 N-CA-C 109.617 -0.512 . . . . 73.200000000000003 109.617 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.1 pt -117.7 133.36 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 121.642 0.734 . . . . 64.310000000000002 109.924 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 tt -128.22 122.33 31.54 Favored 'General case' 0 C--N 1.273 -2.747 0 N-CA-C 107.873 -1.158 . . . . 65.129999999999995 107.873 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.34 127.27 37.3 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.755 -0.831 . . . . 73.439999999999998 108.755 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.62 -178.74 23.96 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 119.56 -1.305 . . . . 43.420000000000002 112.434 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.1 mtp85 -144.23 155.58 43.94 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 123.986 0.915 . . . . 74.109999999999999 109.103 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.73 108.47 11.55 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 107.067 -1.457 . . . . 74.310000000000002 107.067 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -107.31 92.35 4.04 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.742 -1.207 . . . . 73.239999999999995 107.742 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.4 mt -120.7 12.11 11.35 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.803 -1.544 . . . . 71.430000000000007 108.811 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.467 ' HA ' ' CA ' ' A' ' 167' ' ' GLY . 1.3 m . . . . . 0 C--N 1.291 -1.969 0 CA-C-N 114.71 -1.132 . . . . 73.209999999999994 112.11 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 121.03 0.443 . . . . 64.25 110.938 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.28 145.22 11.3 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.519 1.127 . . . . 63.509999999999998 113.855 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 2.5 m-20 -125.89 120.04 29.38 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-N 115.248 -0.887 . . . . 54.520000000000003 109.088 176.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 69.3 t -106.69 113.11 42.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.96 -1.126 . . . . 70.230000000000004 107.96 174.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 44.7 mt-10 -108.37 120.73 43.24 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.268 -0.642 . . . . 44.450000000000003 109.268 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.495 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.9 tm? -111.03 118.08 35.08 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 105.302 -2.11 . . . . 61.25 105.302 175.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.2 m -123.39 125.38 44.87 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.555 -0.535 . . . . 25.43 109.555 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 98.1 t -118.46 125.21 74.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.471 -0.566 . . . . 54.130000000000003 109.471 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.99 127.68 56.29 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.658 -0.867 . . . . 63.520000000000003 108.658 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.686 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.6 p90 -134.76 120.81 14.55 Favored Pre-proline 0 C--N 1.287 -2.124 0 CA-C-N 116.589 -0.278 . . . . 74.209999999999994 111.359 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.422 ' HG2' ' HD3' ' A' ' 36' ' ' PRO . 19.7 Cg_endo -70.8 40.62 0.36 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.605 2.204 . . . . 71.519999999999996 112.523 176.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.5 -110.03 0.31 Allowed 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.86 -0.609 . . . . 40.5 109.531 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -176.32 131.51 0.22 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.578 -0.526 . . . . 61.340000000000003 109.578 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.97 144.23 10.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.304 -0.862 . . . . 63.439999999999998 109.316 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.4 t -110.22 -30.67 7.63 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.457 -0.497 . . . . 71.409999999999997 110.457 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.6 m -156.64 131.82 9.18 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.66 -0.867 . . . . 73.409999999999997 108.66 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.5 t -139.74 161.2 38.11 Favored 'General case' 0 C--N 1.285 -2.2 0 O-C-N 122.022 -0.424 . . . . 42.140000000000001 110.569 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -133.19 87.63 2.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 104.845 -2.28 . . . . 54.140000000000001 104.845 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.27 -144.54 8.05 Favored Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 108.905 -1.678 . . . . 63.329999999999998 108.905 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -118.28 107.73 14.26 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 118.112 0.956 . . . . 71.230000000000004 111.407 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -82.08 118.02 22.71 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.484 0.659 . . . . 64.219999999999999 110.307 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.89 -40.01 16.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.186 -1.412 . . . . 64.019999999999996 107.186 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 157' ' ' PRO . 51.2 mt-10 -137.18 167.15 22.1 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 106.461 -1.681 . . . . 72.409999999999997 106.461 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 156' ' ' GLU . 55.8 Cg_endo -73.07 -0.21 8.76 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.896 1.731 . . . . 72.140000000000001 110.947 177.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.686 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 7.8 pt-20 -130.73 3.72 4.53 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.006 -0.997 . . . . 73.349999999999994 111.329 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.42 121.39 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.132 -0.692 . . . . 64.099999999999994 109.132 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.32 143.66 39.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.226 -0.657 . . . . 75.120000000000005 109.226 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.96 151.46 52.06 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.363 -0.606 . . . . 70.439999999999998 109.363 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.495 ' CE3' HD12 ' A' ' 139' ' ' LEU . 28.0 m-90 -132.68 128.62 37.4 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.24 -0.652 . . . . 74.340000000000003 109.24 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -100.14 113.66 26.47 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.372 0.606 . . . . 74.120000000000005 109.796 171.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 22.4 mt -102.09 133.18 47.35 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.468 -0.938 . . . . 74.420000000000002 108.468 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -117.93 145.45 36.76 Favored Pre-proline 0 C--N 1.309 -1.168 0 CA-C-N 115.935 -0.575 . . . . 65.129999999999995 112.117 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.24 161.44 44.61 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.574 2.183 . . . . 73.340000000000003 110.705 173.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 128' ' ' THR . . . 68.79 -9.93 1.74 Allowed Glycine 0 N--CA 1.472 1.072 0 N-CA-C 114.381 0.512 . . . . 65.120000000000005 114.381 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.66 171.09 9.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.484 -0.561 . . . . 62.240000000000002 109.484 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.88 142.02 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.624 -0.88 . . . . 65.140000000000001 108.624 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 40.9 m -140.81 143.74 35.0 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.91 -0.494 . . . . 61.329999999999998 110.905 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.8 p -108.12 141.14 40.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.368 -0.604 . . . . 74.150000000000006 109.368 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 80.4 mtp -123.66 130.03 52.02 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.276 -0.639 . . . . 74.519999999999996 109.276 -175.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.5 m -143.74 140.18 29.83 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.902 -0.719 . . . . 72.409999999999997 110.806 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.467 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -147.64 120.44 8.68 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.044 -1.095 . . . . 74.239999999999995 108.044 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -127.73 130.15 48.3 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 107.632 -1.247 . . . . 74.109999999999999 107.632 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.33 153.69 38.97 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.733 -0.469 . . . . 71.5 109.733 -175.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 48.9 mtm180 -96.66 126.26 41.7 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.983 -0.747 . . . . 75.010000000000005 108.983 -176.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -134.01 150.03 51.22 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.34 -0.985 . . . . 73.510000000000005 108.34 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.99 108.57 1.24 Allowed 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 120.971 0.415 . . . . 75.239999999999995 110.931 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 . . . . . 0 N--CA 1.434 -1.273 0 N-CA-C 113.564 0.95 . . . . 73.420000000000002 113.564 -177.417 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 16.6 ptp180 . . . . . 0 N--CA 1.418 -2.071 0 CA-C-O 121.245 0.545 . . . . 65.409999999999997 110.44 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.09 114.66 47.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.42 -0.809 . . . . 73.530000000000001 108.906 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -115.58 114.18 24.6 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.441 -0.799 . . . . 73.150000000000006 109.475 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' HB3' HD22 ' A' ' 139' ' ' LEU . . . -110.54 108.77 18.84 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 107.66 -1.237 . . . . 52.229999999999997 107.66 176.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.3 t -119.71 115.36 23.75 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.989 -1.115 . . . . 65.329999999999998 107.989 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -127.98 147.17 32.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.157 0.503 . . . . 62.340000000000003 110.089 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.8 m -129.29 132.73 47.21 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 109.742 -0.466 . . . . 53.030000000000001 109.742 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.546 ' O ' ' HD2' ' A' ' 144' ' ' PRO . 10.8 tt -118.61 111.12 32.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.952 0.882 . . . . 74.519999999999996 111.023 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.2 m -76.62 163.97 62.5 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 114.177 -1.374 . . . . 70.510000000000005 111.214 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.67 0.61 5.32 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.865 2.377 . . . . 73.120000000000005 113.323 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 13.8 t70 -91.46 -0.49 57.63 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.026 -1.102 . . . . 60.409999999999997 108.026 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 91' ' ' THR . 25.6 t70 67.79 33.45 4.83 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.612 -1.625 . . . . 73.200000000000003 106.612 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -97.73 124.65 42.16 Favored 'General case' 0 N--CA 1.391 -3.411 0 CA-C-N 113.082 -1.872 . . . . 74.430000000000007 106.541 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.449 HG11 HD13 ' A' ' 95' ' ' LEU . 12.0 t -110.34 129.7 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 108.549 -0.908 . . . . 62.340000000000003 108.549 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.1 p -139.92 144.21 37.01 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 107.443 -1.317 . . . . 45.039999999999999 107.443 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.07 -174.77 41.18 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 118.861 -1.638 . . . . 72.140000000000001 112.412 -177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -145.27 133.37 21.49 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.011 -0.594 . . . . 70.519999999999996 109.879 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.0 mt -118.86 115.69 48.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 106.977 -1.49 . . . . 53.210000000000001 106.977 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.31 116.05 51.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.723 -0.473 . . . . 64.040000000000006 109.723 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.492 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -108.22 108.32 19.31 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.689 -1.597 . . . . 73.239999999999995 106.689 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -120.24 129.46 54.07 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.692 0.282 . . . . 70.329999999999998 111.024 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.84 144.02 49.48 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.519 -0.919 . . . . 73.329999999999998 108.519 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 tttp . . . . . 0 C--N 1.292 -1.93 0 N-CA-C 107.746 -1.205 . . . . 73.549999999999997 107.746 177.4 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.43 -1.449 0 CA-C-O 121.019 0.438 . . . . 74.439999999999998 109.863 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.64 97.11 0.11 Allowed Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.778 -0.725 . . . . 62.420000000000002 113.081 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -73.13 160.55 45.22 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.355 2.703 . . . . 74.549999999999997 110.844 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -131.24 133.93 45.93 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.863 -0.421 . . . . 64.030000000000001 109.863 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' O ' HG11 ' A' ' 72' ' ' VAL . 94.6 mt -75.82 140.87 42.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.754 -0.461 . . . . 72.340000000000003 109.754 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -111.63 99.86 8.51 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.226 0.536 . . . . 34.020000000000003 109.557 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.67 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -115.01 94.77 0.68 Allowed Glycine 0 C--N 1.274 -2.914 0 N-CA-C 110.952 -0.859 . . . . 65.129999999999995 110.952 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.54 96.55 10.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.956 -0.757 . . . . 74.209999999999994 108.956 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.91 161.61 45.76 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.203 -0.908 . . . . 65.319999999999993 109.145 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.68 -26.68 82.91 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.443 2.095 . . . . 63.350000000000001 111.313 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.429 ' HB2' ' CG ' ' A' ' 69' ' ' LYS . 31.6 p90 -107.73 41.96 1.43 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.419 -0.809 . . . . 71.219999999999999 111.905 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.1 m -59.5 -28.09 66.73 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 111.72 0.267 . . . . 74.329999999999998 111.72 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -66.58 -18.6 65.45 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.421 0.629 . . . . 71.400000000000006 110.824 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' CG ' ' HB2' ' A' ' 66' ' ' PHE . 32.7 mmtp -89.64 -19.81 24.43 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.61 -0.723 . . . . 62.439999999999998 109.993 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.67 121.19 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.855 0.835 . . . . 60.409999999999997 112.552 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.14 114.48 28.81 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.08 -0.963 . . . . 71.219999999999999 108.843 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 60' ' ' LEU . 58.1 t -98.27 141.52 16.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.004 -1.11 . . . . 75.319999999999993 108.004 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 m -148.51 167.93 24.07 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.275 -0.639 . . . . 71.140000000000001 109.275 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -82.76 154.12 24.92 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.446 -1.316 . . . . 71.010000000000005 107.446 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 75.2 t80 -116.65 124.55 50.01 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 109.281 -0.637 . . . . 73.219999999999999 109.281 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -138.62 99.6 3.86 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.013 -1.106 . . . . 73.140000000000001 108.013 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.2 m -156.59 137.9 13.83 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.238 -0.437 . . . . 71.010000000000005 110.014 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.03 0.41 2.38 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.182 1.393 . . . . 74.439999999999998 112.893 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.34 9.83 43.36 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.876 -1.154 . . . . 44.43 111.23 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.479 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 74.2 m-85 -105.04 142.5 34.72 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.368 -0.975 . . . . 73.140000000000001 108.368 171.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 33.8 m -124.09 136.79 59.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.315 -0.994 . . . . 61.420000000000002 108.315 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -165.6 -155.14 8.47 Favored Glycine 0 C--N 1.262 -3.583 0 C-N-CA 119.077 -1.535 . . . . 43.219999999999999 111.791 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.429 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 13.0 p -128.75 137.4 51.54 Favored 'General case' 0 C--N 1.267 -3.011 0 O-C-N 124.43 0.723 . . . . 73.010000000000005 110.354 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.12 146.09 50.81 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 120.815 0.34 . . . . 73.140000000000001 110.897 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -124.41 115.03 20.29 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.55 -1.278 . . . . 54.240000000000002 107.55 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.0 t -108.03 119.39 57.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 107.712 -1.218 . . . . 72.310000000000002 107.712 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.539 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.1 p90 -118.2 155.98 29.57 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.689 -0.404 . . . . 73.430000000000007 111.137 -175.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.4 p -156.53 157.63 35.74 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.791 -0.64 . . . . 63.149999999999999 110.488 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 63.98 35.12 10.93 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.59 1.186 . . . . 63.229999999999997 111.319 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.539 HD12 ' CD2' ' A' ' 87' ' ' PHE . 52.7 mt -96.9 167.11 11.29 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.728 -0.669 . . . . 73.319999999999993 110.34 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 4.9 t -126.3 169.99 12.35 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.521 -1.659 . . . . 54.310000000000002 106.521 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -57.14 -33.53 67.49 Favored 'General case' 0 C--O 1.205 -1.279 0 CA-C-N 118.928 0.786 . . . . 73.129999999999995 112.443 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.57 -29.67 70.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.707 0.765 . . . . 63.509999999999998 111.304 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.03 -16.82 34.5 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.536 -0.756 . . . . 64.420000000000002 110.318 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.658 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 51.5 tp -62.31 -54.84 45.53 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 114.053 1.131 . . . . 61.240000000000002 114.053 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.32 -33.59 69.99 Favored 'Trans proline' 0 C--N 1.368 1.6 0 CA-C-N 121.357 1.52 . . . . 70.450000000000003 110.598 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.68 -35.08 78.18 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-N 114.882 -1.054 . . . . 74.310000000000002 110.755 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.7 pp -78.24 -20.13 52.33 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.909 -0.774 . . . . 74.310000000000002 108.909 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.64 -21.24 62.64 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.636 -0.711 . . . . 53.200000000000003 110.691 -174.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -58.87 -57.11 14.5 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 108.468 -0.938 . . . . 75.319999999999993 108.468 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.67 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 35.4 ttp -55.44 -47.25 76.29 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.2 -0.909 . . . . 65.030000000000001 110.508 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -54.75 -39.25 68.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.354 -0.839 . . . . 62.509999999999998 110.671 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 m -66.79 -27.64 67.75 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.311 -0.404 . . . . 72.310000000000002 111.355 -174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -70.66 -17.46 62.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.369 0.604 . . . . 73.239999999999995 110.42 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.28 -9.72 16.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.97 -0.559 . . . . 72.319999999999993 110.46 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.71 -44.82 4.56 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.512 0.56 . . . . 61.530000000000001 112.512 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.93 27.2 42.15 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 110.492 -1.043 . . . . 51.020000000000003 110.492 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.75 155.64 20.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.479 -0.934 . . . . 62.119999999999997 108.479 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.436 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 39.5 t30 -103.99 121.5 43.29 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.865 -1.161 . . . . 61.439999999999998 107.865 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -108.87 137.65 46.46 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 123.304 0.377 . . . . 63.240000000000002 110.689 -177.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -144.24 116.94 8.69 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.414 -0.958 . . . . 63.149999999999999 108.414 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -144.57 149.94 36.67 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.806 -0.559 . . . . 74.129999999999995 110.785 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -151.19 157.99 43.37 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 124.47 1.106 . . . . 73.209999999999994 111.065 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HD3' HG22 ' A' ' 119' ' ' VAL . 2.0 tpp180 -94.33 109.07 20.93 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.438 -1.319 . . . . 73.200000000000003 107.438 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -93.03 92.21 7.72 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.133 -1.062 . . . . 75.329999999999998 108.133 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.57 -115.48 5.64 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.601 -1.4 . . . . 73.109999999999999 109.601 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -108.64 3.27 22.66 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.707 1.241 . . . . 60.140000000000001 109.223 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 pp -112.05 149.54 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 121.066 -1.021 . . . . 62.140000000000001 108.675 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 178' ' ' TYR . 76.5 t -106.89 139.34 28.74 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 O-C-N 121.76 -0.588 . . . . 64.040000000000006 111.407 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.431 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.8 pp -119.45 119.34 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 107.186 -1.413 . . . . 54.240000000000002 107.186 174.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 tt -125.34 130.0 51.08 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.862 -0.421 . . . . 72.310000000000002 109.862 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -131.84 151.87 51.39 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.548 0.69 . . . . 64.230000000000004 110.376 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -151.07 129.93 3.03 Favored Glycine 0 N--CA 1.407 -3.268 0 N-CA-C 108.712 -1.755 . . . . 65.430000000000007 108.712 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.5 mtt180 -116.25 125.41 52.18 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.33 -0.989 . . . . 60.399999999999999 108.33 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -108.51 123.26 48.63 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.449 -0.796 . . . . 72.019999999999996 112.331 -171.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -96.13 93.7 7.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.158 -1.423 . . . . 63.149999999999999 107.158 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 1.0 OUTLIER -101.69 2.1 38.26 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.102 -0.703 . . . . 72.129999999999995 109.102 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 167' ' ' GLY . 23.4 p . . . . . 0 N--CA 1.426 -1.671 0 CA-C-N 116.235 -0.438 . . . . 74.230000000000004 111.074 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 . . . . . 0 C--O 1.242 0.696 0 N-CA-C 113.346 0.869 . . . . 74.519999999999996 113.346 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.44 135.9 42.32 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.416 0.15 . . . . 63.520000000000003 110.664 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.1 t70 -131.93 125.0 30.57 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.445 -0.576 . . . . 73.409999999999997 109.445 176.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 86.9 t -114.62 119.82 62.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 107.943 -1.132 . . . . 71.430000000000007 107.943 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -129.75 121.32 26.64 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.055 0.455 . . . . 74.099999999999994 110.501 -174.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.611 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.1 tm? -116.99 121.3 40.97 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.84 -1.541 . . . . 74.040000000000006 106.84 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.3 m -126.63 130.34 50.28 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.474 -0.565 . . . . 71.099999999999994 109.474 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.3 t -129.01 128.87 67.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 109.567 -0.531 . . . . 72.049999999999997 109.567 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -119.17 124.72 47.5 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.251 -0.648 . . . . 74.329999999999998 109.251 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.564 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.5 p90 -134.42 113.35 12.12 Favored Pre-proline 0 C--N 1.288 -2.108 0 CA-C-N 116.219 -0.446 . . . . 64.040000000000006 110.178 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 58.0 Cg_endo -68.67 30.79 0.16 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.086 2.524 . . . . 50.32 114.039 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.55 -95.18 0.36 Allowed 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.92 -0.77 . . . . 64.150000000000006 108.92 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 178.68 126.06 0.06 Allowed 'General case' 0 C--O 1.249 1.076 0 N-CA-C 109.542 -0.54 . . . . 53.310000000000002 109.542 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.37 139.15 18.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.465 -1.309 . . . . 74.239999999999995 107.465 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.0 t -104.47 -30.16 10.23 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.33 -0.948 . . . . 63.329999999999998 110.016 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.0 m -157.49 132.3 8.67 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.138 -1.06 . . . . 75.030000000000001 108.138 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -139.94 151.63 45.71 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.662 -0.649 . . . . 62.130000000000003 112.292 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 27.5 t-20 -118.67 85.81 2.43 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 105.7 -1.963 . . . . 64.420000000000002 105.7 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.478 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 173.88 -151.11 12.56 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 108.458 -1.857 . . . . 61.25 108.458 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -114.59 106.28 14.07 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 118.352 1.076 . . . . 72.420000000000002 109.596 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -80.43 123.76 28.32 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.099 -0.955 . . . . 62.149999999999999 110.534 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 67.5 mt -88.49 -47.74 15.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.232 -1.396 . . . . 74.129999999999995 107.232 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -134.63 169.75 13.03 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 106.992 -1.485 . . . . 72.049999999999997 106.992 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -73.34 -0.19 8.86 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.981 1.787 . . . . 63.149999999999999 111.322 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.2 pt-20 -130.27 3.52 4.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.456 0.646 . . . . 72.230000000000004 111.401 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.09 121.09 14.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 108.735 -0.839 . . . . 63.329999999999998 108.735 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.0 144.4 38.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.865 -0.791 . . . . 75.140000000000001 108.865 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -138.15 144.88 40.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.592 -0.522 . . . . 74.340000000000003 109.592 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.611 ' CE3' HD12 ' A' ' 139' ' ' LEU . 28.0 m-90 -122.85 124.98 44.51 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.238 -0.652 . . . . 73.340000000000003 109.238 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -105.83 107.2 18.07 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.059 0.933 . . . . 74.239999999999995 109.413 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.608 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.7 mm? -101.37 120.5 40.36 Favored 'General case' 0 C--O 1.26 1.642 0 CA-C-N 114.803 -1.09 . . . . 72.540000000000006 110.14 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -103.65 146.2 32.05 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 115.633 -0.712 . . . . 73.420000000000002 110.986 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 68.9 Cg_endo -72.06 155.26 57.27 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 123.035 2.49 . . . . 74.519999999999996 111.599 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 128' ' ' THR . . . 81.27 -30.9 2.67 Favored Glycine 0 C--N 1.302 -1.345 0 C-N-CA 121.365 -0.445 . . . . 72.319999999999993 112.355 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 35.4 m -105.34 164.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 110.05 -0.352 . . . . 31.510000000000002 110.05 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.2 p -113.79 143.8 22.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.975 -0.38 . . . . 61.399999999999999 109.975 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 45.3 m -154.82 144.4 21.41 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.828 -0.434 . . . . 72.310000000000002 109.828 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.0 p -97.57 153.82 17.93 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 123.971 0.908 . . . . 64.109999999999999 109.75 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.0 ptp -125.17 125.21 43.32 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.989 -1.486 . . . . 54.43 106.989 174.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 35.2 m -143.39 145.66 32.84 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.37 -0.831 . . . . 74.329999999999998 110.107 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.61 125.94 9.37 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.312 -0.995 . . . . 74.109999999999999 108.312 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -124.61 130.16 51.91 Favored 'General case' 0 C--N 1.262 -3.21 0 N-CA-C 106.439 -1.689 . . . . 54.439999999999998 106.439 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.77 160.19 43.67 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.869 -0.419 . . . . 73.230000000000004 109.869 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -96.62 128.61 43.72 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.676 -1.231 . . . . 75.109999999999999 107.676 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.569 ' CD2' HG21 ' A' ' 119' ' ' VAL . 17.0 m-30 -121.58 152.15 39.57 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 118.388 0.54 . . . . 72.310000000000002 109.874 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 21.0 p -87.84 100.33 12.79 Favored 'General case' 0 C--N 1.261 -3.264 0 N-CA-C 109.475 -0.565 . . . . 70.140000000000001 109.475 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.3 t0 . . . . . 0 C--O 1.218 -0.586 0 N-CA-C 107.506 -1.294 . . . . 62.450000000000003 107.506 178.552 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 46.1 ttm-85 . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 108.63 -0.878 . . . . 71.239999999999995 108.63 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.508 ' HB ' HG13 ' A' ' 137' ' ' VAL . 62.9 t -117.37 118.96 60.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.998 -0.741 . . . . 74.510000000000005 108.998 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -108.35 113.17 26.03 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.527 -1.286 . . . . 73.209999999999994 107.527 178.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.05 120.15 36.36 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.509 -1.293 . . . . 73.209999999999994 107.509 177.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 140' ' ' THR . 21.9 m -137.19 115.09 11.42 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 109.192 -0.67 . . . . 74.129999999999995 109.192 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.42 HG13 HG22 ' A' ' 141' ' ' VAL . 1.8 pp -127.82 147.11 32.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.635 -0.506 . . . . 63.200000000000003 109.635 -175.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.8 m -125.64 128.37 47.75 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 120.974 0.416 . . . . 71.239999999999995 109.919 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.0 tt -113.39 119.51 60.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.526 0.679 . . . . 72.030000000000001 109.579 179.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -84.42 160.97 55.67 Favored Pre-proline 0 C--N 1.296 -1.761 0 CA-C-N 115.389 -0.823 . . . . 61.240000000000002 109.913 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.82 2.06 2.82 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 123.367 2.711 . . . . 41.020000000000003 112.166 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.55 -8.0 59.62 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.398 1.079 . . . . 74.519999999999996 108.403 177.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.3 t70 71.96 28.48 2.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.338 1.455 . . . . 74.409999999999997 107.131 -175.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.2 139.84 44.95 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.769 -1.559 . . . . 71.329999999999998 107.6 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.416 HG11 HD21 ' A' ' 95' ' ' LEU . 13.7 t -117.26 140.45 40.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.239 -0.652 . . . . 74.040000000000006 109.239 -177.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.7 p -146.94 142.74 27.88 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.623 -1.251 . . . . 74.319999999999993 107.623 176.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.9 -171.53 41.4 Favored Glycine 0 N--CA 1.422 -2.273 0 C-N-CA 119.125 -1.512 . . . . 70.430000000000007 113.079 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -145.74 133.87 21.58 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.03 -0.73 . . . . 73.019999999999996 109.03 -175.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.0 mt -123.66 115.81 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.994 -1.113 . . . . 62.310000000000002 107.994 175.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.36 114.95 48.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.494 -0.558 . . . . 75.209999999999994 109.494 -178.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.66 108.52 19.42 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.285 -1.376 . . . . 74.319999999999993 107.285 175.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . . . -113.85 135.81 53.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.169 0.509 . . . . 55.119999999999997 111.592 -175.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.49 156.33 29.26 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.238 -0.892 . . . . 52.32 109.76 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? . . . . . 0 C--N 1.308 -1.214 0 N-CA-C 105.875 -1.898 . . . . 64.340000000000003 105.875 175.954 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.434 -1.238 0 CA-C-O 121.601 0.715 . . . . 44.229999999999997 110.502 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . 174.02 119.85 0.56 Allowed Glycine 0 N--CA 1.424 -2.157 0 CA-C-O 118.669 -1.073 . . . . 75.430000000000007 111.122 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' HB3' ' A' ' 83' ' ' SER . 4.5 Cg_endo -52.74 138.81 59.52 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.839 2.359 . . . . 65.239999999999995 111.771 174.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.01 125.6 35.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.27 -0.423 . . . . 34.229999999999997 110.256 -178.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.2 mt -88.55 129.94 35.36 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.873 -0.417 . . . . 63.43 109.873 176.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.86 84.62 6.65 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.875 0.845 . . . . 65.219999999999999 108.866 178.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -141.1 59.2 0.56 Allowed Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.867 -1.061 . . . . 64.329999999999998 113.059 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -90.26 93.47 9.36 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.676 -0.861 . . . . 63.119999999999997 108.676 176.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.88 161.41 22.92 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 115.191 -0.913 . . . . 74.230000000000004 111.36 -176.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.42 -9.62 26.69 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.117 2.545 . . . . 75.230000000000004 112.93 -177.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -110.62 30.76 6.52 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.881 -0.599 . . . . 73.510000000000005 109.735 176.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 p -57.31 -29.71 64.14 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.391 -0.822 . . . . 70.340000000000003 112.643 -178.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -67.98 -14.86 63.3 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.301 0.572 . . . . 71.140000000000001 110.276 -178.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -98.09 -20.4 17.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 116.058 -0.519 . . . . 72.540000000000006 110.676 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.13 118.1 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.85 0.833 . . . . 73.109999999999999 110.896 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.34 114.64 28.31 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.448 -0.796 . . . . 73.299999999999997 109.564 -177.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.72 137.02 27.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.699 -1.223 . . . . 61.219999999999999 107.699 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.6 m -151.28 172.02 16.53 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 122.054 -0.404 . . . . 75.120000000000005 109.984 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.59 151.31 23.57 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.028 -1.101 . . . . 73.239999999999995 108.028 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 89.4 t80 -116.75 129.02 55.86 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.261 -0.644 . . . . 74.120000000000005 109.261 -178.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.38 98.83 3.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.42 -0.955 . . . . 72.299999999999997 108.42 176.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 74.6 m -166.94 158.91 12.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.309 1.044 . . . . 72.340000000000003 108.895 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 68.72 9.25 7.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.711 1.205 . . . . 62.43 111.492 173.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.05 0.13 85.66 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.242 -0.743 . . . . 71.400000000000006 111.242 -175.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -105.37 158.75 16.42 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 123.232 0.613 . . . . 73.209999999999994 110.432 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.88 140.53 48.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.351 -1.352 . . . . 70.209999999999994 107.351 174.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -162.68 -160.91 11.56 Favored Glycine 0 N--CA 1.411 -2.999 0 C-N-CA 118.871 -1.633 . . . . 74.340000000000003 113.241 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.548 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 33.6 p -123.11 140.64 52.82 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 108.719 -0.845 . . . . 70.409999999999997 108.719 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -131.41 141.15 49.79 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 120.553 -0.459 . . . . 71.420000000000002 111.125 178.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.22 115.07 22.32 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.217 -1.401 . . . . 60.450000000000003 107.217 175.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -111.55 120.2 61.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.677 -0.86 . . . . 65.439999999999998 108.677 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.473 ' CD2' HD12 ' A' ' 90' ' ' LEU . 41.4 p90 -124.37 150.41 45.58 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.042 0.449 . . . . 73.219999999999999 110.91 -174.049 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 m -154.79 156.85 37.03 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.509 -0.552 . . . . 74.219999999999999 109.509 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.0 t70 66.68 31.13 7.82 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 122.311 1.053 . . . . 74.209999999999994 110.683 175.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.473 HD12 ' CD2' ' A' ' 87' ' ' PHE . 34.8 mt -98.52 171.38 8.19 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.402 -0.817 . . . . 75.200000000000003 109.518 177.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 p -121.59 172.65 7.95 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 122.833 0.083 . . . . 73.420000000000002 111.166 -178.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.578 ' CZ ' HD13 ' A' ' 112' ' ' LEU . 86.7 t80 -57.25 -35.66 69.99 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.415 0.447 . . . . 71.409999999999997 110.447 175.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.6 -27.12 68.73 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.39 0.614 . . . . 74.420000000000002 110.521 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG2' ' NE2' ' A' ' 97' ' ' GLN . 43.5 mt-10 -88.32 -15.5 35.54 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.769 -0.65 . . . . 60.439999999999998 112.596 -177.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.416 HD21 HG11 ' A' ' 40' ' ' VAL . 22.8 mt -50.49 -52.19 57.67 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 113.522 0.934 . . . . 74.530000000000001 113.522 175.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -56.45 -45.56 36.51 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 121.312 1.341 . . . . 53.130000000000003 110.24 175.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.453 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 24.3 mt-30 -58.87 -44.19 91.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.905 -1.043 . . . . 73.340000000000003 111.76 -176.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.406 HD21 HD23 ' A' ' 95' ' ' LEU . 4.4 pp -75.72 -19.96 58.71 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.059 0.457 . . . . 72.400000000000006 111.011 178.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.38 -14.04 60.1 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.08 -0.509 . . . . 53.149999999999999 110.615 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -65.27 -57.34 8.71 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.185 -0.606 . . . . 62.020000000000003 109.96 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -56.31 -49.17 75.06 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.667 0.604 . . . . 75.219999999999999 110.221 -176.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.08 -37.5 71.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.007 -0.997 . . . . 73.439999999999998 111.528 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.6 t -65.33 -30.67 71.53 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 116.294 -0.412 . . . . 43.130000000000003 110.077 -172.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.38 -15.37 63.29 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 121.225 0.536 . . . . 64.519999999999996 111.216 -174.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.46 -12.1 11.73 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.228 -0.589 . . . . 75.310000000000002 110.875 177.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.93 -48.47 3.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.277 0.843 . . . . 64.200000000000003 113.277 -172.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.56 28.43 19.34 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.245 -0.979 . . . . 35.420000000000002 110.802 -172.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.1 m -97.44 151.56 4.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.42 -0.39 . . . . 73.109999999999999 109.949 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -129.1 121.89 28.74 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.408 -1.33 . . . . 74.319999999999993 107.408 176.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.426 HD23 ' HA3' ' A' ' 123' ' ' GLY . 91.7 mt -121.24 139.89 52.78 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.709 0.29 . . . . 61.340000000000003 110.275 -177.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -136.31 121.85 19.55 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.899 -1.519 . . . . 63.200000000000003 106.899 177.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.578 HD13 ' CZ ' ' A' ' 92' ' ' PHE . 2.7 pp -135.51 155.51 50.39 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-O 121.037 0.446 . . . . 65.549999999999997 111.679 -177.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -150.62 155.71 39.93 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.096 -0.956 . . . . 64.150000000000006 112.521 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -94.51 128.87 41.38 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.512 -1.222 . . . . 72.349999999999994 108.597 173.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -122.49 82.85 2.03 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.533 -1.654 . . . . 63.25 106.533 175.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 57.72 -130.25 50.73 Favored Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 114.372 -1.285 . . . . 42.340000000000003 110.502 -173.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.589 ' HA ' ' OD1' ' A' ' 180' ' ' ASP . 23.7 t-20 -71.14 -13.4 61.93 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.642 0.734 . . . . 61.32 111.581 -178.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.671 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -110.63 146.32 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 C-N-CA 117.831 -1.548 . . . . 71.120000000000005 110.756 -176.747 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.2 t -107.18 133.56 51.49 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.726 0 CA-C-N 115.348 -0.842 . . . . 74.299999999999997 110.016 -178.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.1 pt -116.29 131.38 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 121.49 0.662 . . . . 64.319999999999993 109.685 175.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 tt -128.45 131.53 48.41 Favored 'General case' 0 C--N 1.278 -2.541 0 CA-C-N 115.276 -0.875 . . . . 70.439999999999998 110.148 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -129.2 146.2 51.17 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.126 -1.065 . . . . 50.210000000000001 108.126 174.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.426 ' HA3' HD23 ' A' ' 110' ' ' LEU . . . -164.13 160.39 33.34 Favored Glycine 0 N--CA 1.407 -3.297 0 N-CA-C 111.402 -0.679 . . . . 23.25 111.402 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -137.49 133.44 34.59 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.881 -0.785 . . . . 74.209999999999994 108.881 177.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -103.92 110.07 22.07 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.31 -0.996 . . . . 42.140000000000001 108.31 178.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -103.2 93.75 5.16 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 122.365 1.079 . . . . 72.400000000000006 110.703 -177.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 127' ' ' LEU . 2.0 pt? -124.29 21.39 8.75 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.138 -1.392 . . . . 73.230000000000004 107.512 177.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.432 ' HA ' ' C ' ' A' ' 167' ' ' GLY . 2.6 m . . . . . 0 CA--C 1.552 1.037 0 CA-C-N 113.039 -1.891 . . . . 63.109999999999999 110.248 177.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 C--O 1.237 0.438 0 CA-C-O 121.422 0.63 . . . . 62.130000000000003 111.224 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.41 138.99 58.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.485 -0.779 . . . . 62.439999999999998 111.658 179.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 28.3 t70 -131.5 121.96 25.36 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.571 -0.529 . . . . 74.209999999999994 109.571 177.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 90.1 t -119.71 126.98 75.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.855 -0.424 . . . . 75.310000000000002 109.855 -178.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.45 123.47 41.37 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.227 -0.657 . . . . 72.319999999999993 109.227 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 tt -113.94 118.29 33.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.003 -1.48 . . . . 53.520000000000003 107.003 176.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 31' ' ' SER . 6.7 m -117.48 128.44 54.98 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.213 -0.662 . . . . 73.519999999999996 109.213 -175.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.42 HG22 HG13 ' A' ' 32' ' ' ILE . 84.1 t -122.33 127.87 75.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.625 -0.509 . . . . 74.239999999999995 109.625 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -116.74 132.47 56.68 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.071 -0.714 . . . . 65.049999999999997 109.071 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.593 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.2 p90 -134.93 127.63 18.36 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 116.412 -0.358 . . . . 75.120000000000005 111.785 177.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -70.15 51.27 1.0 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 123.24 2.627 . . . . 65.439999999999998 110.879 172.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.11 -128.57 0.09 Allowed 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.3 -1.37 . . . . 74.120000000000005 107.3 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -167.21 134.75 2.44 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.645 -1.613 . . . . 61.409999999999997 106.645 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.527 ' HB ' ' CZ ' ' A' ' 143' ' ' PHE . 7.7 p -85.93 123.43 39.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 108.577 -0.897 . . . . 64.239999999999995 108.577 177.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.7 t -81.73 -33.02 31.31 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.22 -0.592 . . . . 72.530000000000001 111.358 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 64.0 m -152.84 133.01 13.5 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 109.672 -0.492 . . . . 72.340000000000003 109.672 175.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.435 ' HB ' HG21 ' A' ' 147' ' ' VAL . 6.7 t -138.77 158.87 43.43 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.946 -0.471 . . . . 74.549999999999997 111.339 177.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 2.9 t-20 -127.61 89.8 3.01 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.018 -1.845 . . . . 75.299999999999997 106.018 175.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 174.44 -140.35 5.36 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 109.582 -1.407 . . . . 73.430000000000007 109.582 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.82 99.98 7.29 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 117.235 0.517 . . . . 75.129999999999995 109.702 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -82.13 115.92 21.46 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.534 0.683 . . . . 73.420000000000002 110.31 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.4 mt -81.57 -47.56 19.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.151 -1.426 . . . . 70.25 107.151 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.83 160.48 67.28 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 107.119 -1.437 . . . . 73.329999999999998 107.119 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.52 -19.63 65.42 Favored 'Trans proline' 0 C--N 1.328 -0.539 0 C-N-CA 122.054 1.836 . . . . 73.150000000000006 111.948 175.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.593 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -114.55 4.09 15.07 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.381 0.882 . . . . 71.109999999999999 113.381 178.75 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.2 t -140.34 120.28 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.995 -0.742 . . . . 54.439999999999998 108.995 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.93 149.33 31.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.049 -0.723 . . . . 73.409999999999997 109.049 -177.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -133.68 146.9 51.27 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.62 -0.882 . . . . 75.319999999999993 108.62 -178.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -119.62 122.37 41.39 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 109.446 -0.576 . . . . 62.229999999999997 109.446 177.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -89.32 114.0 25.35 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.896 0.855 . . . . 43.049999999999997 110.01 177.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 10.2 mp -101.49 118.64 37.37 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.957 -1.02 . . . . 73.120000000000005 109.493 178.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 75.5 mmtt -117.45 143.51 32.25 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 114.447 -1.251 . . . . 60.329999999999998 108.978 -176.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.43 150.46 64.16 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.377 2.052 . . . . 74.409999999999997 111.355 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.432 ' C ' ' HA ' ' A' ' 128' ' ' THR . . . 73.42 -11.88 4.95 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 116.495 -0.321 . . . . 71.209999999999994 113.864 176.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 33.2 m -117.01 145.46 22.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 109.344 -0.613 . . . . 74.230000000000004 109.344 171.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.76 129.07 40.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.085 -0.709 . . . . 71.420000000000002 109.085 178.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.7 t -111.45 136.93 49.92 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 120.048 -0.661 . . . . 73.109999999999999 109.552 -178.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.6 p -100.1 138.76 36.73 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.505 -0.77 . . . . 64.319999999999993 110.626 -179.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 23.0 ttt -125.68 117.48 23.58 Favored 'General case' 0 C--O 1.193 -1.899 0 CA-C-N 115.756 -0.656 . . . . 54.409999999999997 109.681 -177.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 24.7 t -142.92 144.83 32.56 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.542 -0.911 . . . . 71.209999999999994 108.542 174.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -154.53 128.12 8.62 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.073 -1.084 . . . . 73.5 108.073 -177.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -129.04 130.27 46.36 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.028 -1.101 . . . . 64.030000000000001 108.028 176.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -152.78 158.21 41.92 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 120.803 -0.359 . . . . 62.5 110.084 -178.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.671 ' HG2' HG22 ' A' ' 118' ' ' ILE . 96.1 mtt180 -87.3 136.3 32.99 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.633 -0.877 . . . . 71.200000000000003 108.633 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -143.25 147.2 34.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.991 -0.744 . . . . 61.420000000000002 108.991 176.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.47 112.07 5.07 Favored 'General case' 0 N--CA 1.414 -2.248 0 C-N-CA 122.849 0.459 . . . . 64.519999999999996 110.507 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 117' ' ' ASN . 2.6 m-20 . . . . . 0 C--N 1.308 -1.221 0 C-N-CA 124.714 1.206 . . . . 63.43 112.23 178.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 . . . . . 0 N--CA 1.441 -0.908 0 N-CA-C 109.517 -0.549 . . . . 62.549999999999997 109.517 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 p -124.77 123.42 65.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 120.267 -0.573 . . . . 75.140000000000001 110.02 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -125.1 126.61 45.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.942 -0.572 . . . . 74.209999999999994 109.474 -176.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.77 108.35 16.97 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 106.366 -1.716 . . . . 72.230000000000004 106.366 172.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -117.6 114.65 23.72 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.63 -1.618 . . . . 62.329999999999998 106.63 -178.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -129.64 146.68 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-O 121.255 0.55 . . . . 53.420000000000002 109.869 -174.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.5 m -127.8 119.55 25.93 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-O 121.366 0.603 . . . . 42.039999999999999 109.749 -177.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.436 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.0 tt -105.96 124.36 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.417 -0.811 . . . . 34.439999999999998 109.674 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 m -98.88 150.37 36.63 Favored Pre-proline 0 C--N 1.288 -2.07 0 CA-C-N 115.44 -0.8 . . . . 75.239999999999995 109.703 -176.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.99 1.96 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 124.038 3.159 . . . . 54.530000000000001 114.975 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 30.3 t70 -83.85 -2.66 56.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.15 -0.685 . . . . 61.420000000000002 109.15 177.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.7 t70 72.72 29.29 1.98 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 106.125 -1.806 . . . . 73.340000000000003 106.125 -173.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 2.1 tp -104.09 125.58 50.53 Favored 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 112.682 -2.054 . . . . 71.120000000000005 109.006 -178.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.583 HG11 HD23 ' A' ' 95' ' ' LEU . 21.8 t -112.36 135.76 50.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.675 -0.861 . . . . 74.219999999999999 108.675 177.516 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 p -147.47 152.81 38.67 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.119 -1.067 . . . . 74.400000000000006 108.119 178.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.09 -171.24 44.31 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 118.74 -1.695 . . . . 54.240000000000002 113.782 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.66 133.69 30.95 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.672 0.789 . . . . 75.310000000000002 109.646 -176.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 102' ' ' ASN . 58.9 mt -121.0 116.09 48.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.918 -1.142 . . . . 74.310000000000002 107.918 176.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.71 121.3 66.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 123.135 0.574 . . . . 71.319999999999993 110.016 -176.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.91 108.46 16.3 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.255 -1.387 . . . . 75.430000000000007 107.255 175.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -117.79 132.82 56.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.403 0.621 . . . . 73.340000000000003 112.602 -174.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.29 158.43 35.8 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.405 -0.961 . . . . 40.149999999999999 108.405 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.553 0 N-CA-C 104.551 -2.389 . . . . 61.5 104.551 173.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 109.623 -0.51 . . . . 70.349999999999994 109.623 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.26 96.47 0.1 Allowed Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.829 -0.909 . . . . 71.209999999999994 110.829 176.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.43 ' O ' ' HB3' ' A' ' 83' ' ' SER . 26.1 Cg_endo -68.52 159.6 52.83 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.931 2.42 . . . . 71.099999999999994 113.046 177.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.25 140.39 50.33 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.593 -0.892 . . . . 32.450000000000003 108.593 176.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 90.2 mt -79.92 140.78 36.56 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.703 0.287 . . . . 45.020000000000003 111.337 -178.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.16 96.61 6.77 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.263 1.03 . . . . 72.409999999999997 108.473 177.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -113.45 -71.01 0.55 Allowed Glycine 0 C--N 1.292 -1.872 0 CA-C-N 114.415 -1.266 . . . . 72.120000000000005 113.117 -177.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 58.59 86.02 0.09 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.23 1.014 . . . . 74.010000000000005 112.404 -176.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 m -115.81 158.63 41.66 Favored Pre-proline 0 C--N 1.29 -1.993 0 CA-C-N 114.652 -1.158 . . . . 73.319999999999993 108.686 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.57 -16.84 50.6 Favored 'Trans proline' 0 N--CA 1.483 0.884 0 C-N-CA 122.747 2.298 . . . . 72.5 112.354 179.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -113.45 25.22 11.47 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.543 -0.753 . . . . 73.329999999999998 112.037 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.8 m -56.36 -24.01 41.35 Favored 'General case' 0 C--O 1.21 -1.004 0 N-CA-C 111.753 0.279 . . . . 61.240000000000002 111.753 177.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -62.57 -23.17 66.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.18 0.514 . . . . 55.039999999999999 110.456 178.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 88' ' ' SER . 33.4 mmtp -95.51 -14.44 23.67 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.246 0.546 . . . . 55.240000000000002 110.104 -178.23 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 49.8 t -108.19 121.05 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 116.081 -0.509 . . . . 74.439999999999998 110.407 -177.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 110.67 22.69 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.171 -0.677 . . . . 73.239999999999995 109.171 177.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.96 137.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.98 -1.119 . . . . 64.140000000000001 107.98 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 t -148.2 172.22 14.68 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.803 -0.814 . . . . 74.230000000000004 108.803 -174.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -92.02 141.23 28.84 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.132 -1.062 . . . . 70.329999999999998 108.132 177.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 93.0 t80 -102.24 127.36 49.24 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.374 -0.602 . . . . 65.409999999999997 109.374 -178.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.56 99.63 4.12 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.568 -0.901 . . . . 71.340000000000003 108.568 176.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 30.9 t -170.0 155.76 5.75 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.276 -1.009 . . . . 63.329999999999998 108.276 -179.067 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 71.06 6.72 5.95 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.803 1.241 . . . . 74.340000000000003 111.604 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.91 4.51 84.63 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.659 -1.376 . . . . 73.439999999999998 109.659 -173.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.456 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 6.2 m-85 -104.31 149.34 25.44 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 124.164 0.986 . . . . 72.019999999999996 110.049 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -125.5 136.06 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 108.015 -1.106 . . . . 70.120000000000005 108.015 174.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -163.12 -155.42 8.1 Favored Glycine 0 C--N 1.27 -3.09 0 C-N-CA 119.4 -1.381 . . . . 62.530000000000001 112.19 -178.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 13.4 p -124.1 140.95 52.47 Favored 'General case' 0 C--N 1.274 -2.715 0 CA-C-N 115.096 -0.552 . . . . 72.219999999999999 109.729 -178.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.53 141.68 45.28 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 120.816 0.341 . . . . 72.140000000000001 110.649 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.35 115.56 21.86 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.027 -0.731 . . . . 75.510000000000005 109.027 178.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.4 t -106.01 112.53 39.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.165 -1.05 . . . . 63.420000000000002 108.165 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 50.7 p90 -112.87 153.96 27.08 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 120.708 -0.397 . . . . 72.430000000000007 110.746 -174.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 42.4 m -153.61 161.49 42.14 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.822 -0.351 . . . . 71.420000000000002 110.932 -177.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.1 t70 59.68 37.82 22.14 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.471 1.129 . . . . 74.420000000000002 111.574 173.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.424 HD12 ' CD2' ' A' ' 87' ' ' PHE . 35.8 mt -103.29 164.76 11.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.33 -0.85 . . . . 71.310000000000002 110.922 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -114.21 174.02 6.16 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.052 0.453 . . . . 74.510000000000005 110.742 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -56.49 -34.28 66.8 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 125.58 1.552 . . . . 72.209999999999994 111.021 -178.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.4 -25.26 61.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.98 -0.555 . . . . 43.119999999999997 111.185 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -88.77 -16.45 32.12 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 116.107 -0.497 . . . . 75.310000000000002 111.648 -176.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.6 tm? -52.73 -56.44 23.12 Favored Pre-proline 0 CA--C 1.569 1.696 0 C-N-CA 123.442 0.697 . . . . 70.120000000000005 111.756 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.18 -37.14 33.38 Favored 'Trans proline' 0 C--N 1.372 1.795 0 CA-C-N 120.741 1.3 . . . . 73.010000000000005 111.232 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.55 -34.67 78.79 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 124.437 1.095 . . . . 72.129999999999995 110.857 -176.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -78.38 -23.01 47.02 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.384 0.611 . . . . 74.219999999999999 109.543 175.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.34 -22.95 59.0 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 115.577 -0.738 . . . . 44.229999999999997 109.842 -175.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -62.06 -46.79 87.56 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.445 -0.798 . . . . 60.229999999999997 109.659 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.6 mtm -55.95 -49.67 72.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.282 0.563 . . . . 75.400000000000006 109.711 177.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' HB2' HD13 ' A' ' 44' ' ' ILE . 34.2 t30 -54.49 -35.63 63.29 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 114.726 -1.124 . . . . 75.030000000000001 110.96 178.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.4 m -60.65 -29.21 69.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.786 -0.643 . . . . 64.310000000000002 110.86 -173.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.81 -30.29 69.98 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 123.558 0.536 . . . . 71.120000000000005 111.345 -175.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.87 -10.86 15.47 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.085 -0.507 . . . . 75.450000000000003 110.89 -177.258 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.69 -47.8 3.67 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 113.44 0.904 . . . . 31.399999999999999 113.44 -172.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.42 24.9 41.38 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.428 -1.069 . . . . 73.209999999999994 110.428 -173.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 m -106.42 163.09 5.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.393 -0.404 . . . . 74.519999999999996 110.319 -178.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -128.56 122.2 30.5 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.597 -1.26 . . . . 74.530000000000001 107.597 176.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.1 mt -119.09 122.48 42.2 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.957 0.408 . . . . 74.450000000000003 111.209 -178.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 p -137.22 139.5 41.07 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.984 -0.553 . . . . 72.420000000000002 109.736 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.87 150.67 32.27 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 122.075 -0.391 . . . . 63.210000000000001 110.042 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -143.51 155.04 44.22 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.109 -0.496 . . . . 74.519999999999996 110.683 -176.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.431 ' HG2' HG22 ' A' ' 119' ' ' VAL . 40.6 mtt85 -92.31 138.53 31.45 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 121.587 0.708 . . . . 74.409999999999997 111.333 173.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.44 ' O ' HG13 ' A' ' 118' ' ' ILE . 6.8 t30 -123.9 88.02 2.84 Favored 'General case' 0 C--N 1.269 -2.908 0 N-CA-C 105.665 -1.976 . . . . 70.120000000000005 105.665 175.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.71 -120.23 6.81 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 109.646 -1.381 . . . . 74.230000000000004 109.646 -175.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -104.54 12.45 33.14 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.509 1.147 . . . . 71.010000000000005 108.635 178.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.561 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.2 pp -119.26 149.46 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 O-C-N 120.951 -1.093 . . . . 63.340000000000003 109.041 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.431 HG22 ' HG2' ' A' ' 114' ' ' ARG . 86.5 t -110.27 138.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 CA-C-O 120.951 0.405 . . . . 62.549999999999997 110.352 -178.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.9 pt -110.6 129.29 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.361 0 N-CA-C 107.132 -1.433 . . . . 74.099999999999994 107.132 172.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.24 129.53 50.93 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 109.391 -0.596 . . . . 73.239999999999995 109.391 -178.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -134.8 119.23 17.91 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.913 0.863 . . . . 72.120000000000005 111.27 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.38 148.36 17.85 Favored Glycine 0 N--CA 1.418 -2.527 0 N-CA-C 110.834 -0.906 . . . . 74.340000000000003 110.834 178.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.495 ' HG2' HG22 ' A' ' 171' ' ' THR . 75.7 mtt180 -123.63 140.21 53.22 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 109.256 -0.646 . . . . 71.549999999999997 109.256 179.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.92 109.24 14.86 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 109.293 -0.632 . . . . 72.430000000000007 109.293 178.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -112.64 94.39 4.89 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.06 -1.089 . . . . 73.530000000000001 108.06 176.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -122.96 37.01 4.52 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 122.937 1.351 . . . . 62.340000000000003 108.313 177.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 75.6 p . . . . . 0 C--N 1.31 -1.148 0 CA-C-N 113.385 -1.734 . . . . 64.340000000000003 110.59 179.436 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 112.733 0.642 . . . . 70.129999999999995 112.733 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.82 48.48 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.687 0.995 . . . . 73.209999999999994 113.687 -177.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -132.9 136.45 46.18 Favored 'General case' 0 C--O 1.26 1.614 0 CA-C-N 115.69 -0.686 . . . . 61.329999999999998 109.684 171.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.2 t -114.82 114.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.979 -1.119 . . . . 74.439999999999998 107.979 176.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.32 124.42 52.19 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 120.694 -0.402 . . . . 73.340000000000003 111.444 -178.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 50.7 tp -111.08 124.52 52.35 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.697 -1.223 . . . . 73.549999999999997 107.697 170.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.5 m -126.05 112.55 16.0 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.898 -0.778 . . . . 62.229999999999997 108.898 178.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.462 HG12 ' HD1' ' A' ' 143' ' ' PHE . 82.1 t -107.51 120.81 59.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 109.33 -0.618 . . . . 75.409999999999997 109.33 179.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.33 127.81 55.76 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.207 -0.664 . . . . 51.520000000000003 109.207 178.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.647 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.5 p90 -135.1 122.2 14.98 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 112.266 0.469 . . . . 55.32 112.266 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -67.78 42.32 0.23 Allowed 'Trans proline' 0 CA--C 1.566 2.113 0 C-N-CA 123.162 2.575 . . . . 72.340000000000003 112.443 173.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.41 -108.68 0.31 Allowed 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 122.977 0.511 . . . . 54.509999999999998 109.806 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.85 133.96 0.13 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.966 -0.753 . . . . 62.200000000000003 108.966 -177.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.3 p -88.38 141.11 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 109.235 -0.654 . . . . 75.230000000000004 109.235 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 39.5 p -102.15 -38.14 7.83 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.027 0.441 . . . . 54.409999999999997 110.411 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.9 m -155.75 132.39 10.41 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 108.625 -0.879 . . . . 43.32 108.625 178.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.2 t -139.97 152.83 46.62 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 120.144 -0.622 . . . . 75.430000000000007 112.103 176.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -118.98 88.15 2.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.325 -2.102 . . . . 75.549999999999997 105.325 175.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.414 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.09 -145.03 8.62 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 108.644 -1.782 . . . . 75.400000000000006 108.644 -177.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -118.27 99.99 7.21 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 118.129 0.964 . . . . 62.5 110.8 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.26 109.23 13.41 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.537 0.684 . . . . 74.209999999999994 109.449 176.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 61.9 mt -80.12 -46.96 21.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.096 -1.446 . . . . 64.530000000000001 107.096 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 159' ' ' VAL . 13.1 mm-40 -121.63 163.42 30.97 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 106.802 -1.555 . . . . 74.010000000000005 106.802 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.93 -1.18 10.09 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.164 1.909 . . . . 72.219999999999999 111.376 178.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.5 pt-20 -137.07 9.66 3.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.439 -0.8 . . . . 63.350000000000001 111.66 -177.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 156' ' ' GLU . 54.7 t -145.07 120.7 3.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.907 -1.146 . . . . 61.310000000000002 107.907 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.84 143.72 38.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.284 -0.635 . . . . 50.439999999999998 109.284 -177.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.7 tt0 -130.86 143.34 50.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-O 121.252 0.548 . . . . 73.420000000000002 110.155 -177.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.414 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 30.3 m-90 -126.45 121.31 32.06 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.845 -0.798 . . . . 75.340000000000003 108.845 179.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 105.07 13.15 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.36 0.6 . . . . 73.329999999999998 110.234 176.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 170' ' ' SER . 1.2 mm? -99.54 147.82 24.92 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.373 -0.831 . . . . 71.400000000000006 110.281 -174.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -117.68 155.45 50.59 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.984 -0.553 . . . . 63.439999999999998 112.391 -176.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.81 157.4 51.84 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.901 2.401 . . . . 61.109999999999999 110.97 178.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.84 -35.22 2.91 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.666 -0.778 . . . . 62.240000000000002 111.574 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 20.7 m -104.76 145.13 13.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.039 0.447 . . . . 65.030000000000001 110.232 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.2 p -101.52 144.0 13.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 107.804 -1.184 . . . . 61.039999999999999 107.804 178.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.473 ' HB2' HD12 ' A' ' 164' ' ' LEU . 50.0 m -149.32 153.61 37.73 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.066 0.46 . . . . 74.129999999999995 111.459 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.495 HG22 ' HG2' ' A' ' 124' ' ' ARG . 2.6 p -106.56 128.37 54.07 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.307 -0.86 . . . . 63.420000000000002 109.889 177.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 23.5 ptp -106.93 122.06 45.66 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.614 -1.624 . . . . 70.510000000000005 106.614 178.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.5 m -141.47 148.01 38.79 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.558 -1.257 . . . . 71.540000000000006 111.737 -176.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.96 136.69 18.04 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 115.234 -0.894 . . . . 70.409999999999997 108.69 -176.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -130.79 131.05 44.44 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 105.866 -1.901 . . . . 62.0 105.866 175.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 178' ' ' TYR . . . -157.45 160.66 38.55 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 120.876 -0.33 . . . . 74.439999999999998 110.348 -175.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.561 ' HG2' HG22 ' A' ' 118' ' ' ILE . 96.5 mtt180 -87.52 129.05 35.22 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.729 -0.841 . . . . 74.329999999999998 108.729 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 176' ' ' ALA . 99.2 m-85 -140.73 124.69 17.26 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 108.762 -0.829 . . . . 74.140000000000001 108.762 178.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.07 122.73 9.96 Favored 'General case' 0 N--CA 1.404 -2.739 0 O-C-N 124.795 1.309 . . . . 75.140000000000001 111.564 -177.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 106.952 -1.499 . . . . 74.310000000000002 106.952 175.444 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 108.946 -0.761 . . . . 73.310000000000002 108.946 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.17 114.01 45.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.08 -1.822 . . . . 63.200000000000003 106.08 172.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -123.75 115.66 21.75 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 120.955 0.407 . . . . 61.340000000000003 110.93 -175.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.31 108.55 17.07 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.786 -1.19 . . . . 55.240000000000002 107.786 175.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.3 t -114.39 115.53 27.47 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.671 -1.233 . . . . 74.400000000000006 107.671 -178.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.96 146.42 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.092 0.472 . . . . 71.120000000000005 109.822 -178.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 88.9 m -126.08 128.5 47.47 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.98 -0.748 . . . . 64.129999999999995 108.98 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.447 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.4 tt -114.76 114.83 47.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-O 121.622 0.725 . . . . 65.439999999999998 110.067 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -82.29 153.11 68.64 Favored Pre-proline 0 N--CA 1.423 -1.775 0 CA-C-N 115.215 -0.902 . . . . 70.420000000000002 109.564 -176.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.62 1.99 0.46 Allowed 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 123.765 2.977 . . . . 74.510000000000005 114.006 178.013 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.53 -8.27 59.62 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.387 -0.968 . . . . 71.129999999999995 108.387 174.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 72.78 29.27 1.95 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.567 1.547 . . . . 75.140000000000001 107.338 -174.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.26 126.49 51.42 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 113.55 -1.659 . . . . 73.340000000000003 107.512 178.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.33 140.1 23.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 107.871 -1.159 . . . . 75.409999999999997 107.871 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.5 p -148.47 158.97 44.46 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.318 -1.364 . . . . 61.109999999999999 107.318 -178.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.24 -167.8 39.0 Favored Glycine 0 CA--C 1.488 -1.641 0 C-N-CA 118.509 -1.805 . . . . 65.439999999999998 113.028 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -152.89 135.14 14.96 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 123.176 0.591 . . . . 75.239999999999995 110.228 -177.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 66.6 mt -115.53 115.89 50.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 107.838 -1.171 . . . . 61.329999999999998 107.838 177.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.26 116.59 52.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.726 -0.842 . . . . 62.109999999999999 108.726 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.553 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.25 108.32 16.43 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.927 -1.509 . . . . 72.099999999999994 106.927 175.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.47 118.98 33.68 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.324 -0.621 . . . . 35.049999999999997 109.324 -177.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.91 158.04 21.61 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 115.637 -0.71 . . . . 73.239999999999995 111.308 -174.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt . . . . . 0 N--CA 1.432 -1.356 0 N-CA-C 105.932 -1.877 . . . . 74.5 105.932 172.371 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 107.575 -1.268 . . . . 61.439999999999998 107.575 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.579 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 172.88 104.05 0.17 Allowed Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 119.807 -1.187 . . . . 44.420000000000002 113.49 174.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 83' ' ' SER . 45.4 Cg_exo -60.72 159.6 27.94 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.837 2.358 . . . . 72.439999999999998 110.743 173.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.2 163.14 14.23 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.902 -0.499 . . . . 40.32 110.473 178.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 83' ' ' SER . 3.6 mm? -77.72 136.28 38.15 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.111 -0.495 . . . . 62.299999999999997 109.672 177.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -110.54 95.08 5.35 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.404 0.621 . . . . 71.450000000000003 109.518 -178.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.62 94.01 0.1 OUTLIER Glycine 0 C--N 1.286 -2.207 0 N-CA-C 109.93 -1.268 . . . . 74.340000000000003 109.93 179.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.18 93.97 2.39 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.086 0.47 . . . . 65.019999999999996 111.165 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.5 m -85.79 151.95 56.0 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.439 -0.801 . . . . 73.129999999999995 109.764 178.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.06 -31.84 83.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.414 2.076 . . . . 52.439999999999998 111.707 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -96.11 38.27 1.2 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.791 -0.64 . . . . 71.319999999999993 112.095 -177.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 m -59.66 -24.48 63.92 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.563 0.579 . . . . 73.230000000000004 112.563 -178.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -70.52 -17.87 62.94 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 121.235 0.541 . . . . 74.150000000000006 110.425 -178.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -90.1 -16.63 29.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.708 -0.678 . . . . 70.019999999999996 109.731 -178.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.03 120.06 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 122.029 0.918 . . . . 71.239999999999995 112.492 -176.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.73 108.0 20.0 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.091 -0.958 . . . . 25.23 108.634 178.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 60' ' ' LEU . 67.8 t -98.08 142.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.514 -1.291 . . . . 73.209999999999994 107.514 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.7 t -157.42 172.7 18.11 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 108.742 -0.836 . . . . 72.120000000000005 108.742 -175.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.579 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 4.1 p-10 -86.55 146.7 26.26 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.847 -0.797 . . . . 65.310000000000002 108.847 178.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -108.2 119.1 38.5 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.592 -1.262 . . . . 65.319999999999993 107.592 175.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -138.43 99.85 3.95 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.358 -1.719 . . . . 64.010000000000005 106.358 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.7 t -174.76 159.1 2.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.858 -1.164 . . . . 72.239999999999995 107.858 -176.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 72.76 -5.43 1.88 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.874 0.869 . . . . 73.120000000000005 112.535 172.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.28 -5.28 58.94 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 109.877 -1.289 . . . . 73.409999999999997 109.877 -174.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.5 155.04 19.15 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 123.592 0.757 . . . . 73.219999999999999 109.696 -177.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.62 140.28 49.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 109.059 -0.719 . . . . 73.530000000000001 109.059 178.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -170.04 -154.83 9.63 Favored Glycine 0 N--CA 1.411 -3.001 0 C-N-CA 119.721 -1.228 . . . . 41.229999999999997 112.647 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.581 ' HB2' HD22 ' A' ' 60' ' ' LEU . 28.1 p -122.2 147.46 46.16 Favored 'General case' 0 C--N 1.278 -2.538 0 C-N-CA 123.391 0.677 . . . . 60.409999999999997 110.709 -176.107 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -137.32 143.2 41.96 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.995 0.426 . . . . 44.43 110.987 175.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.99 115.09 16.63 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.525 -1.287 . . . . 32.140000000000001 107.525 175.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.9 t -109.89 116.92 53.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.54 -0.911 . . . . 74.109999999999999 108.54 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.509 ' CD2' HD12 ' A' ' 90' ' ' LEU . 48.7 p90 -121.15 155.32 34.77 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.463 0.649 . . . . 74.030000000000001 111.832 -175.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 p -156.08 148.36 23.5 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.361 -0.836 . . . . 64.019999999999996 109.662 -177.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 t70 60.42 62.28 1.59 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.703 1.24 . . . . 72.530000000000001 112.175 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.509 HD12 ' CD2' ' A' ' 87' ' ' PHE . 25.6 mt -121.13 162.38 20.18 Favored 'General case' 0 N--CA 1.413 -2.301 0 CA-C-N 114.204 -1.362 . . . . 62.130000000000003 108.335 174.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -112.17 173.22 6.47 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 119.564 -0.854 . . . . 72.120000000000005 109.443 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.415 ' CE1' HD12 ' A' ' 112' ' ' LEU . 85.0 t80 -50.27 -46.71 55.25 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.272 1.029 . . . . 72.349999999999994 111.636 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.48 -25.35 68.22 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.607 -0.724 . . . . 73.109999999999999 112.337 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -85.72 -17.32 36.28 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 111.859 0.318 . . . . 72.219999999999999 111.859 -177.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.596 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 50.6 tp -61.96 -52.95 64.23 Favored Pre-proline 0 CA--C 1.558 1.288 0 N-CA-C 113.2 0.815 . . . . 72.230000000000004 113.2 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -62.05 -37.13 66.61 Favored 'Trans proline' 0 C--N 1.365 1.419 0 CA-C-N 120.75 1.304 . . . . 72.239999999999995 110.731 176.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.13 -36.4 84.14 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 115.067 -0.97 . . . . 74.329999999999998 111.302 -176.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -74.29 -19.51 60.45 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 120.818 0.342 . . . . 61.130000000000003 110.391 177.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.86 -23.27 63.25 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.201 -0.454 . . . . 70.439999999999998 110.523 -177.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -59.74 -48.45 81.61 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 109.584 -0.524 . . . . 64.019999999999996 109.584 176.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.419 ' HG2' ' HB3' ' A' ' 60' ' ' LEU . 17.0 ttm -56.19 -52.11 65.6 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.65 -0.704 . . . . 64.230000000000004 109.385 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -55.19 -33.36 62.96 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 114.646 -1.161 . . . . 71.430000000000007 110.901 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -65.11 -18.08 65.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 118.796 -0.621 . . . . 64.400000000000006 112.473 -174.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.34 -30.38 66.68 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.535 0.683 . . . . 70.420000000000002 109.823 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.67 -11.57 13.99 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.272 -0.876 . . . . 64.450000000000003 110.908 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.436 ' HB1' HG13 ' A' ' 108' ' ' VAL . . . -107.73 -48.45 3.41 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.947 1.091 . . . . 74.120000000000005 113.947 -172.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.89 18.63 79.66 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 116.289 -0.414 . . . . 70.439999999999998 112.849 -175.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.436 HG13 ' HB1' ' A' ' 106' ' ' ALA . 27.3 m -82.2 178.62 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.634 0.605 . . . . 71.530000000000001 112.634 -176.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -142.11 126.76 17.97 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.03 0.532 . . . . 73.129999999999995 109.583 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.5 mp -127.23 115.93 19.81 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.427 -0.212 . . . . 72.340000000000003 110.427 178.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.5 m -111.27 109.79 19.97 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.128 -0.693 . . . . 73.340000000000003 109.128 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.415 HD12 ' CE1' ' A' ' 92' ' ' PHE . 1.3 pt? -129.42 148.37 51.33 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.555 0.693 . . . . 53.43 111.9 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -152.65 169.96 21.41 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.465 -1.243 . . . . 74.450000000000003 110.964 -177.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.44 ' HG3' HG22 ' A' ' 119' ' ' VAL . 5.4 mtt85 -101.79 137.52 39.98 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 115.628 -0.714 . . . . 51.310000000000002 109.715 171.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -118.36 87.35 2.71 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.406 -1.331 . . . . 73.310000000000002 107.406 177.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.61 -98.52 0.85 Allowed Glycine 0 N--CA 1.428 -1.86 0 CA-C-N 115.044 -0.98 . . . . 52.509999999999998 111.962 -177.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -120.12 4.08 10.88 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.811 1.291 . . . . 73.099999999999994 108.563 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -118.84 149.38 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 108.325 -0.991 . . . . 73.400000000000006 108.325 -178.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 114' ' ' ARG . 78.2 t -105.4 135.38 43.76 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 110.005 -0.368 . . . . 70.209999999999994 110.005 -178.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.439 HG22 ' HG2' ' A' ' 175' ' ' GLN . 46.6 pt -113.57 131.47 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 108.733 -0.84 . . . . 71.400000000000006 108.733 177.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -128.61 123.61 33.74 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 115.534 -0.757 . . . . 74.099999999999994 108.979 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.71 124.86 12.89 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.722 0.772 . . . . 74.420000000000002 110.972 177.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.58 -178.68 25.68 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.891 -0.671 . . . . 52.509999999999998 111.607 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.447 ' HG2' HG22 ' A' ' 171' ' ' THR . 96.8 mtt180 -140.8 159.26 42.6 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.753 -0.462 . . . . 71.150000000000006 109.753 -176.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.46 108.52 10.61 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 106.019 -1.845 . . . . 54.420000000000002 106.019 171.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -111.86 93.51 4.49 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.505 0.669 . . . . 75.340000000000003 109.297 -178.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 166' ' ' PRO 0.334 0.0 OUTLIER -126.17 63.9 1.24 Allowed 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 123.492 1.615 . . . . 65.349999999999994 109.202 171.429 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.432 -1.358 0 CA-C-N 112.683 -2.053 . . . . 33.310000000000002 112.489 -173.032 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 N--CA 1.441 -0.925 0 CA-C-O 120.766 0.317 . . . . 72.209999999999994 110.679 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.03 141.57 28.26 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.726 -0.39 . . . . 74.409999999999997 111.341 -177.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -127.48 135.45 50.41 Favored 'General case' 0 C--O 1.261 1.694 0 N-CA-C 107.009 -1.478 . . . . 65.310000000000002 107.009 172.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 55.3 t -108.7 115.14 48.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.3 -1.0 . . . . 53.299999999999997 108.3 178.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.55 120.1 40.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.968 -0.753 . . . . 72.219999999999999 108.968 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.13 111.98 21.86 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.949 -1.5 . . . . 71.120000000000005 106.949 178.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.2 m -114.15 128.51 56.4 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.435 -0.58 . . . . 75.129999999999995 109.435 -176.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 88.3 t -120.93 123.63 70.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.031 -0.729 . . . . 75.349999999999994 109.031 178.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.57 127.5 56.1 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.002 -0.74 . . . . 52.409999999999997 109.002 177.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.01 118.82 14.34 Favored Pre-proline 0 C--N 1.291 -1.949 0 N-CA-C 111.795 0.294 . . . . 71.109999999999999 111.795 178.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.37 41.42 0.36 Allowed 'Trans proline' 0 CA--C 1.555 1.561 0 C-N-CA 123.223 2.615 . . . . 71.239999999999995 112.563 175.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.08 -92.85 0.53 Allowed 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 110.148 -0.315 . . . . 63.240000000000002 110.148 178.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 168.24 133.68 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.522 1.129 . . . . 74.040000000000006 108.192 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.09 142.86 12.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 108.866 -0.791 . . . . 74.329999999999998 108.866 175.54 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.7 t -103.75 -33.74 8.82 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.2 -0.667 . . . . 75.219999999999999 109.2 178.153 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.0 m -158.3 132.31 7.9 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 108.833 -0.803 . . . . 74.549999999999997 108.833 175.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -139.23 159.49 42.04 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 109.559 -0.534 . . . . 61.100000000000001 109.559 174.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.564 ' HB3' ' OG ' ' A' ' 173' ' ' SER . 57.6 t30 -135.58 103.17 5.35 Favored 'General case' 0 C--O 1.274 2.365 0 N-CA-C 105.982 -1.858 . . . . 64.219999999999999 105.982 169.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.27 -140.75 6.06 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 107.614 -2.195 . . . . 62.219999999999999 107.614 -178.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.5 99.45 6.83 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 118.417 1.108 . . . . 73.239999999999995 110.041 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -75.53 131.12 39.84 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.719 -0.673 . . . . 63.119999999999997 110.64 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.9 mt -95.68 -44.51 13.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.257 -1.386 . . . . 60.140000000000001 107.257 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.96 170.37 9.22 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 105.928 -1.879 . . . . 75.510000000000005 105.928 176.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.24 -0.44 8.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.169 1.913 . . . . 53.409999999999997 111.39 177.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.611 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.8 pt-20 -128.62 5.75 5.61 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.046 -0.524 . . . . 63.149999999999999 111.207 178.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.4 t -143.22 120.8 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.799 -0.815 . . . . 72.099999999999994 108.799 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.86 147.15 33.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.364 -0.606 . . . . 52.420000000000002 109.364 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -131.01 145.35 52.02 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.147 0.499 . . . . 74.25 109.72 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.49 ' CD1' ' HA ' ' A' ' 172' ' ' MET . 30.2 m-90 -121.45 124.63 44.93 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.032 -1.099 . . . . 72.25 108.032 174.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -104.64 99.41 9.08 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.885 -1.154 . . . . 55.409999999999997 107.885 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 1.3 mm? -89.2 133.42 34.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.527 -0.761 . . . . 75.439999999999998 109.272 -174.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -117.58 150.59 47.03 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 116.139 -0.482 . . . . 74.219999999999999 111.854 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.426 ' HA ' HD23 ' A' ' 127' ' ' LEU . 72.2 Cg_endo -76.76 156.96 35.44 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 123.087 2.525 . . . . 64.150000000000006 111.85 177.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.47 -36.73 2.93 Favored Glycine 0 C--N 1.31 -0.91 0 CA-C-N 115.977 -0.556 . . . . 63.32 111.798 178.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.49 149.98 8.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.789 -0.819 . . . . 74.230000000000004 108.789 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -86.22 114.51 25.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.608 -0.886 . . . . 70.519999999999996 108.608 177.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.1 m -104.61 141.99 35.45 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.575 -0.528 . . . . 74.409999999999997 109.575 -177.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 124' ' ' ARG . 67.1 p -116.22 156.84 25.84 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 120.738 0.304 . . . . 75.340000000000003 110.564 -177.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.49 ' HA ' ' CD1' ' A' ' 162' ' ' TRP . 23.4 ptp -128.95 117.45 20.98 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.132 -1.062 . . . . 64.25 108.132 175.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.564 ' OG ' ' HB3' ' A' ' 151' ' ' ASN . 2.9 p -138.33 132.93 32.34 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.936 -0.706 . . . . 74.420000000000002 112.084 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.474 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.71 139.88 19.36 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 123.664 0.785 . . . . 75.450000000000003 109.341 -176.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.439 ' HG2' HG22 ' A' ' 120' ' ' ILE . 48.7 mt-30 -137.99 130.59 29.51 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.464 -1.31 . . . . 63.439999999999998 107.464 174.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.433 ' HB3' ' CE1' ' A' ' 178' ' ' TYR . . . -148.55 153.1 37.93 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.912 -0.315 . . . . 63.420000000000002 110.409 -177.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 37.5 mtp180 -89.55 126.25 35.53 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.547 -0.908 . . . . 62.130000000000003 108.547 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 176' ' ' ALA . 85.3 m-85 -124.69 152.86 43.18 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-O 120.988 0.423 . . . . 74.310000000000002 111.107 -176.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.2 p -78.34 94.38 4.84 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 116.138 -0.483 . . . . 70.010000000000005 111.518 177.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.384 0 C-N-CA 125.259 1.424 . . . . 74.140000000000001 113.773 175.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 37.4 ttm180 . . . . . 0 N--CA 1.408 -2.527 0 N-CA-C 108.992 -0.744 . . . . 74.420000000000002 108.992 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.19 113.62 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 N-CA-C 106.036 -1.838 . . . . 72.510000000000005 106.036 176.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 20.6 ttt180 -120.21 114.36 21.81 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 121.249 0.547 . . . . 72.109999999999999 109.807 -178.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 139' ' ' LEU . . . -104.63 108.37 19.78 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.093 -1.077 . . . . 63.119999999999997 108.093 178.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 140' ' ' THR . 21.2 m -119.39 115.32 23.86 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.163 -1.051 . . . . 74.430000000000007 108.163 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.9 pp -125.64 146.42 31.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.275 0.559 . . . . 73.219999999999999 109.819 -177.045 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 43.0 m -126.31 125.38 42.2 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 108.307 -0.997 . . . . 74.239999999999995 108.307 -178.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' OH ' ' A' ' 178' ' ' TYR . 8.4 tt -116.74 129.62 72.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.278 0.561 . . . . 74.310000000000002 110.073 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -105.34 149.63 37.98 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 116.116 -0.493 . . . . 41.399999999999999 111.514 -175.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.53 -7.14 0.73 Allowed 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 124.995 3.797 . . . . 64.430000000000007 116.078 -178.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 3.32 30.11 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.997 -0.44 . . . . 71.310000000000002 110.319 177.331 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.1 t70 71.74 34.44 1.58 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 123.993 1.854 . . . . 72.239999999999995 106.378 -175.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.17 125.05 50.52 Favored 'General case' 0 N--CA 1.392 -3.34 0 CA-C-N 113.26 -1.791 . . . . 44.329999999999998 107.459 -177.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.417 HG11 HD21 ' A' ' 95' ' ' LEU . 11.4 t -114.55 140.56 34.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.804 -0.813 . . . . 64.340000000000003 108.804 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.8 p -150.67 159.87 44.22 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.537 -0.912 . . . . 40.329999999999998 108.537 179.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.82 -173.44 43.39 Favored Glycine 0 CA--C 1.49 -1.522 0 C-N-CA 118.682 -1.723 . . . . 54.340000000000003 113.03 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.6 133.41 14.0 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.121 0.486 . . . . 54.5 110.488 -176.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 3.5 mp -116.08 115.94 50.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 106.839 -1.541 . . . . 74.230000000000004 106.839 174.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.02 118.74 57.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.891 -0.781 . . . . 71.299999999999997 108.891 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.1 107.37 17.18 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 106.087 -1.819 . . . . 43.229999999999997 106.087 174.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -125.86 133.47 51.93 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 116.184 -0.462 . . . . 62.100000000000001 111.048 -174.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.79 157.89 33.02 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.174 -0.921 . . . . 72.329999999999998 109.975 -177.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt . . . . . 0 C--N 1.312 -1.064 0 N-CA-C 107.525 -1.287 . . . . 71.510000000000005 107.525 173.391 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 61.1 m . . . . . 1 N--CA 1.378 -4.069 0 N-CA-C 108.263 -1.014 . . . . 55.340000000000003 108.263 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.44 126.89 0.91 Allowed Glycine 0 N--CA 1.422 -2.267 0 CA-C-O 118.51 -1.161 . . . . 63.299999999999997 111.611 174.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 6.9 Cg_endo -56.51 148.15 65.01 Favored 'Trans proline' 0 CA--C 1.553 1.437 0 CA-C-N 120.518 2.159 . . . . 74.540000000000006 108.839 166.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.95 128.39 54.89 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.292 0.849 . . . . 34.420000000000002 113.292 -172.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 90.5 mt -94.57 133.22 38.44 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.77 -0.65 . . . . 71.349999999999994 109.503 176.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -111.62 83.64 1.81 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.556 0.693 . . . . 73.549999999999997 111.85 176.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.6 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -88.72 87.62 1.5 Allowed Glycine 0 N--CA 1.423 -2.174 0 CA-C-N 114.677 -1.147 . . . . 53.210000000000001 111.239 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.47 104.75 16.87 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.523 0.678 . . . . 73.5 110.667 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.36 160.58 68.09 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.123 -1.066 . . . . 53.240000000000002 108.123 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.64 -8.61 23.74 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 122.52 2.146 . . . . 74.409999999999997 112.64 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -120.63 39.63 3.71 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.64 -0.709 . . . . 61.100000000000001 110.951 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.2 m -56.45 -32.97 65.44 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 116.407 -0.36 . . . . 51.229999999999997 111.867 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -68.53 -12.5 61.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.213 0.53 . . . . 65.510000000000005 111.168 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -100.64 -9.2 22.14 Favored 'General case' 0 C--O 1.26 1.628 0 CA-C-N 116.046 -0.525 . . . . 71.209999999999994 110.249 -178.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG21 ' HE1' ' A' ' 101' ' ' MET . 5.6 p -129.64 119.33 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.097 0.951 . . . . 72.319999999999993 111.209 177.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.67 110.63 21.96 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.225 -0.898 . . . . 72.019999999999996 109.815 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.01 114.42 35.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.995 -1.483 . . . . 71.430000000000007 106.995 177.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 m -123.78 164.38 19.29 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.776 -0.647 . . . . 72.120000000000005 109.79 -172.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -86.86 125.55 34.07 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.198 -1.408 . . . . 74.540000000000006 107.198 175.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 82.6 t80 -92.7 120.12 32.79 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.167 -0.679 . . . . 71.109999999999999 109.167 -175.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -138.52 99.21 3.77 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 106.776 -1.564 . . . . 72.219999999999999 106.776 174.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.7 t -174.36 153.35 1.92 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.024 -1.102 . . . . 74.219999999999999 108.024 -174.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.53 16.4 10.49 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.835 0.854 . . . . 65.319999999999993 111.501 174.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.27 85.1 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 116.065 -0.516 . . . . 54.409999999999997 112.793 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.401 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 61.6 m-85 -104.07 153.63 20.66 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.116 -0.698 . . . . 74.319999999999993 109.116 -178.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 56' ' ' THR . 27.1 m -124.33 141.51 44.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.036 -1.098 . . . . 43.439999999999998 108.036 172.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.469 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -177.69 -154.21 12.03 Favored Glycine 0 N--CA 1.407 -3.24 0 C-N-CA 119.981 -1.104 . . . . 65.120000000000005 111.568 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.607 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 1.7 p -130.5 150.04 51.89 Favored 'General case' 0 C--N 1.26 -3.288 0 CA-C-O 121.351 0.596 . . . . 70.420000000000002 110.971 178.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -138.61 138.98 38.39 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 116.15 -0.477 . . . . 54.299999999999997 110.373 -175.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.97 114.1 25.71 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.593 -1.262 . . . . 72.439999999999998 107.593 175.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -115.23 112.09 38.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 109.422 -0.585 . . . . 51.030000000000001 109.422 -177.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 43.1 p90 -112.47 151.85 29.43 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 110.0 -0.371 . . . . 44.350000000000001 110.0 -175.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 m -154.31 145.68 23.01 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 120.484 -0.487 . . . . 63.210000000000001 109.705 -175.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t0 60.13 62.39 1.63 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.471 1.129 . . . . 45.520000000000003 112.155 178.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.5 mt -119.23 170.97 8.63 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.675 -1.148 . . . . 50.32 108.908 175.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.2 t -113.59 169.12 9.2 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.825 -0.805 . . . . 55.409999999999997 108.825 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.48 -30.13 68.31 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.224 0.535 . . . . 75.200000000000003 111.077 -178.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.97 -25.56 67.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.975 -0.557 . . . . 63.420000000000002 111.433 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.475 ' OE1' HG22 ' A' ' 91' ' ' THR . 49.5 mt-10 -86.66 -16.57 36.21 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 112.468 0.544 . . . . 70.430000000000007 112.468 -176.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 11.6 mt -51.22 -55.19 30.6 Favored Pre-proline 0 N--CA 1.483 1.218 0 N-CA-C 115.382 1.623 . . . . 61.109999999999999 115.382 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.32 -40.66 56.69 Favored 'Trans proline' 0 C--N 1.366 1.452 0 CA-C-N 120.894 1.355 . . . . 71.150000000000006 110.954 -179.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -63.07 -40.0 96.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.88 -1.054 . . . . 70.239999999999995 111.511 -177.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -76.18 -19.89 58.02 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 120.604 -0.438 . . . . 71.120000000000005 110.586 177.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.09 -21.62 59.83 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.2 -0.667 . . . . 75.209999999999994 109.2 -177.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.03 -57.54 11.23 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.468 -0.787 . . . . 63.32 108.957 175.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.6 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 33.3 ttp -54.2 -49.09 70.17 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.764 -0.653 . . . . 55.130000000000003 110.094 178.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -53.9 -42.75 69.05 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.427 -0.806 . . . . 62.310000000000002 111.286 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.2 p -67.78 -24.92 65.38 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 120.018 -0.673 . . . . 62.0 111.603 -173.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.05 -25.14 66.11 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 120.914 0.388 . . . . 70.540000000000006 110.182 -177.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -103.4 -7.89 20.64 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.536 -0.466 . . . . 35.140000000000001 110.712 -179.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.63 -43.63 4.88 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.444 -0.503 . . . . 61.420000000000002 112.219 -173.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.92 12.72 80.81 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.694 -0.765 . . . . 64.219999999999999 111.688 -177.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 m -112.21 169.35 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.985 -0.746 . . . . 71.120000000000005 108.985 -178.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -114.07 124.76 52.9 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.854 -0.339 . . . . 64.129999999999995 110.708 -178.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.42 132.66 55.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.881 -0.785 . . . . 63.25 108.881 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.1 m -144.11 131.77 21.22 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.457 -0.571 . . . . 62.420000000000002 109.457 177.056 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 157.82 43.97 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.211 0.529 . . . . 73.540000000000006 112.405 -175.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -155.66 165.56 36.16 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.472 -1.24 . . . . 72.0 110.697 178.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.436 ' HG3' HG22 ' A' ' 119' ' ' VAL . 3.6 ttt85 -99.06 137.72 37.19 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 106.355 -1.72 . . . . 71.540000000000006 106.355 171.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -118.44 94.45 4.48 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 107.53 -1.285 . . . . 65.140000000000001 107.53 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.07 -114.44 5.25 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.406 -1.478 . . . . 71.010000000000005 109.406 -175.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -112.32 14.7 20.47 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.723 1.249 . . . . 73.439999999999998 108.922 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.5 pp -123.26 148.99 26.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 120.396 -1.44 . . . . 74.409999999999997 108.383 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 178' ' ' TYR . 70.8 t -99.55 135.99 32.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 O-C-N 122.18 -0.325 . . . . 73.319999999999993 110.544 -177.331 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.9 pt -118.86 130.23 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-O 121.767 0.794 . . . . 72.450000000000003 109.235 176.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 tt -126.91 131.61 51.09 Favored 'General case' 0 C--N 1.266 -3.064 0 CA-C-N 115.352 -0.84 . . . . 73.329999999999998 109.26 177.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -123.27 146.44 47.87 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.094 -1.076 . . . . 63.340000000000003 108.094 177.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.32 155.59 27.01 Favored Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 110.534 -1.026 . . . . 70.510000000000005 110.534 177.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.34 139.04 33.5 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.161 -1.051 . . . . 74.150000000000006 108.161 175.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.55 114.28 15.88 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.833 -0.622 . . . . 72.400000000000006 109.463 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -111.28 108.54 18.19 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.273 -1.01 . . . . 55.420000000000002 108.273 178.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.09 29.52 7.91 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.601 -0.518 . . . . 72.230000000000004 109.601 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 120.122 -0.631 . . . . 73.209999999999994 110.563 -179.059 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 113.093 0.775 . . . . 74.099999999999994 113.093 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.85 136.88 38.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.907 -1.886 . . . . 72.109999999999999 105.907 171.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.9 t70 -132.21 125.94 32.36 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 120.553 -0.459 . . . . 72.340000000000003 110.047 -172.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 67.5 t -116.38 127.88 73.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.54 -0.864 . . . . 74.510000000000005 109.775 -179.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 43.8 mt-10 -128.53 141.13 51.47 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.134 -0.691 . . . . 72.420000000000002 109.134 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 5.6 tt -132.23 122.67 25.6 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.895 -1.52 . . . . 64.340000000000003 106.895 175.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' SER . 2.2 m -124.86 132.52 53.31 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.994 -1.113 . . . . 72.049999999999997 107.994 -176.149 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 71.8 t -124.08 125.98 71.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 109.549 -0.537 . . . . 75.040000000000006 109.549 178.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -109.41 121.1 44.44 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.745 -1.206 . . . . 42.149999999999999 107.745 175.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -133.82 105.83 11.67 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 111.756 0.28 . . . . 75.150000000000006 111.756 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -67.05 34.69 0.14 Allowed 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 123.604 2.869 . . . . 71.430000000000007 113.329 178.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -109.26 -90.39 0.46 Allowed 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.093 -0.706 . . . . 63.030000000000001 109.093 178.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.12 124.0 0.01 OUTLIER 'General case' 0 C--N 1.362 1.117 0 C-N-CA 124.196 0.998 . . . . 72.540000000000006 109.682 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.406 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 7.9 p -80.02 138.46 19.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.746 -0.835 . . . . 71.340000000000003 108.746 175.183 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.8 t -104.43 -27.58 11.85 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.678 -0.409 . . . . 60.219999999999999 110.371 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.6 m -159.48 132.33 6.84 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 108.049 -1.093 . . . . 63.100000000000001 108.049 174.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.1 t -140.42 150.75 44.24 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 118.531 0.605 . . . . 44.450000000000003 111.925 174.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 27.6 t-20 -120.69 93.11 3.93 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 105.719 -1.956 . . . . 61.229999999999997 105.719 174.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.01 -142.73 6.41 Favored Glycine 0 C--N 1.296 -1.651 0 N-CA-C 107.347 -2.301 . . . . 65.010000000000005 107.347 -178.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -118.45 104.35 10.62 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 118.603 1.202 . . . . 71.140000000000001 109.88 177.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -84.87 113.57 21.47 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.945 -0.571 . . . . 73.319999999999993 111.094 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.5 mt -80.66 -46.62 21.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.52 -1.289 . . . . 71.230000000000004 107.52 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -134.0 160.76 67.3 Favored Pre-proline 0 C--N 1.295 -1.789 0 CA-C-N 114.317 -1.311 . . . . 75.340000000000003 107.491 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -61.5 -17.13 52.06 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.496 2.131 . . . . 65.510000000000005 111.577 173.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 1.4 pm0 -115.13 2.42 14.13 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 113.484 0.92 . . . . 72.25 113.484 177.054 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.79 120.44 16.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 121.621 -0.674 . . . . 74.120000000000005 109.612 178.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.8 t -129.36 147.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 109.304 -0.628 . . . . 74.150000000000006 109.304 -177.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -136.77 143.61 43.33 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.31 0.576 . . . . 73.209999999999994 111.049 -178.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.444 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.5 m-90 -119.79 123.93 44.89 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.468 -0.938 . . . . 62.140000000000001 108.468 177.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -101.15 110.34 22.35 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.296 0.569 . . . . 70.040000000000006 109.756 177.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.0 mm? -97.4 116.87 30.42 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 122.279 1.038 . . . . 62.310000000000002 108.723 -177.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -117.08 138.92 25.26 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 113.637 -1.619 . . . . 73.040000000000006 110.584 -169.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.06 156.63 61.68 Favored 'Trans proline' 0 C--O 1.244 0.81 0 C-N-CA 122.442 2.095 . . . . 72.340000000000003 111.351 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.55 -33.39 3.24 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 116.128 -0.487 . . . . 61.030000000000001 111.991 177.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 32.7 m -108.02 165.49 4.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.348 0.594 . . . . 71.099999999999994 111.656 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.42 144.14 22.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.723 -1.214 . . . . 73.319999999999993 107.723 175.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.9 m -139.29 142.86 37.71 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.651 -0.656 . . . . 73.239999999999995 111.549 179.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 13.3 p -96.25 150.36 20.63 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.337 -0.847 . . . . 72.010000000000005 108.917 177.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.455 ' HE1' HD13 ' A' ' 139' ' ' LEU . 76.2 mtp -129.65 128.75 43.23 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.863 -0.792 . . . . 75.120000000000005 108.863 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 32.7 t -143.62 142.66 31.14 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.939 -1.134 . . . . 52.109999999999999 107.939 174.646 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -155.18 116.63 4.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.879 -0.785 . . . . 73.439999999999998 108.879 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 48.3 mt-30 -125.53 130.56 51.97 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 108.022 -1.103 . . . . 72.239999999999995 108.022 176.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -143.44 158.97 43.21 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 116.533 -0.303 . . . . 54.130000000000003 110.969 -176.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -87.37 125.04 34.01 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.76 -0.376 . . . . 75.319999999999993 110.085 178.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 119' ' ' VAL . 8.0 m-85 -134.86 120.29 19.13 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 114.371 1.249 . . . . 75.510000000000005 114.371 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.2 p -61.13 105.48 0.49 Allowed 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 113.937 -1.483 . . . . 64.010000000000005 110.51 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 36.7 t70 . . . . . 0 C--N 1.3 -1.577 0 CA-C-N 113.944 -1.48 . . . . 71.329999999999998 110.646 -176.377 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.91 0 N-CA-C 110.183 -0.302 . . . . 74.230000000000004 110.183 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.401 HG23 HG13 ' A' ' 137' ' ' VAL . 27.7 m -120.22 115.5 47.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.582 0.706 . . . . 75.420000000000002 109.359 177.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 96.6 mtt180 -113.12 119.0 36.32 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.776 -0.647 . . . . 70.540000000000006 110.749 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.96 108.22 16.74 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.561 -1.274 . . . . 50.219999999999999 107.561 175.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 m -114.79 114.98 26.29 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.376 -1.342 . . . . 50.329999999999998 107.376 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 pp -126.83 146.18 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 109.419 -0.586 . . . . 74.219999999999999 109.419 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.6 m -126.35 137.51 53.47 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 108.566 -0.902 . . . . 62.32 108.566 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.81 125.02 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 109.032 -0.729 . . . . 73.239999999999995 109.032 -176.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 m -105.78 152.08 40.08 Favored Pre-proline 0 N--CA 1.425 -1.689 0 CA-C-N 115.762 -0.653 . . . . 74.219999999999999 110.232 -177.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.62 2.42 0.98 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 123.904 3.069 . . . . 64.439999999999998 114.577 -176.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -87.99 3.54 48.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.222 -1.029 . . . . 71.430000000000007 108.222 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 91' ' ' THR . 15.0 t70 72.07 28.68 2.47 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 126.298 1.839 . . . . 61.43 106.227 -175.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 tp -102.02 129.04 48.23 Favored 'General case' 0 N--CA 1.381 -3.919 0 CA-C-N 112.689 -2.05 . . . . 71.129999999999995 109.164 -176.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.95 132.43 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 N-CA-C 107.827 -1.175 . . . . 74.540000000000006 107.827 176.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.2 p -142.52 151.42 41.62 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.621 -1.251 . . . . 71.420000000000002 107.621 177.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.53 -176.42 47.11 Favored Glycine 0 N--CA 1.418 -2.525 0 C-N-CA 118.722 -1.704 . . . . 73.310000000000002 112.7 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.65 133.58 25.66 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.736 -0.732 . . . . 71.0 109.878 -175.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.8 mt -120.42 115.7 47.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.218 -1.401 . . . . 65.209999999999994 107.218 175.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.83 115.31 48.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.115 0.483 . . . . 71.430000000000007 109.98 -178.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.501 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -105.93 108.42 19.92 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.116 -1.809 . . . . 74.299999999999997 106.116 173.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -125.06 132.38 53.19 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.312 -0.555 . . . . 74.200000000000003 111.418 -175.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.45 129.44 41.19 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.931 -1.031 . . . . 73.310000000000002 110.866 -178.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt . . . . . 0 C--N 1.323 -0.562 0 N-CA-C 107.269 -1.382 . . . . 74.540000000000006 107.269 171.784 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.422 -1.863 0 N-CA-C 108.119 -1.067 . . . . 71.150000000000006 108.119 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.36 96.82 0.1 Allowed Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.595 -0.812 . . . . 73.019999999999996 112.845 176.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.77 160.57 45.93 Favored 'Trans proline' 0 C--O 1.248 1.025 0 C-N-CA 123.487 2.791 . . . . 74.340000000000003 111.932 174.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.83 158.49 28.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.765 0.317 . . . . 70.150000000000006 111.096 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 95.2 mt -102.25 154.99 18.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 106.62 -1.622 . . . . 74.239999999999995 106.62 173.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -93.03 86.35 5.38 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.227 1.013 . . . . 64.439999999999998 109.703 -177.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.52 ' HA2' ' SD ' ' A' ' 101' ' ' MET . . . -85.16 84.31 1.6 Allowed Glycine 0 N--CA 1.413 -2.888 0 CA-C-N 114.101 -1.408 . . . . 40.350000000000001 111.958 -178.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -112.05 97.6 6.77 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.986 0.422 . . . . 72.099999999999994 110.244 178.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 m -146.1 159.45 46.01 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 123.995 0.918 . . . . 52.399999999999999 108.815 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.18 -9.02 22.9 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.106 1.871 . . . . 61.200000000000003 112.05 176.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -114.79 42.05 2.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 74.329999999999998 111.994 -178.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.6 m -55.3 -28.32 52.83 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 111.776 0.287 . . . . 70.329999999999998 111.776 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -65.65 -20.32 66.26 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 121.276 0.56 . . . . 51.130000000000003 110.813 -178.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -90.85 -18.26 25.14 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.645 -0.707 . . . . 54.219999999999999 110.535 -177.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.98 119.59 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 121.964 0.887 . . . . 54.119999999999997 112.532 -176.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.67 104.79 16.11 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.273 -0.876 . . . . 54.409999999999997 109.58 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.8 p -98.95 133.04 43.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.054 -0.721 . . . . 72.040000000000006 109.054 177.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -154.74 173.46 16.39 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 123.335 0.654 . . . . 72.140000000000001 109.612 -175.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -77.72 153.62 32.82 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.495 0.664 . . . . 74.150000000000006 110.308 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 76.9 t80 -114.39 122.55 46.99 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 108.022 -1.103 . . . . 71.420000000000002 108.022 176.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -138.62 102.85 4.7 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.913 -1.514 . . . . 72.299999999999997 106.913 177.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 36.8 t -164.13 141.88 7.03 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.147 -0.686 . . . . 52.149999999999999 109.147 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 67.05 10.45 7.7 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.887 0.875 . . . . 64.150000000000006 111.996 174.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.88 -0.36 64.6 Favored Glycine 0 N--CA 1.426 -2.026 0 N-CA-C 111.238 -0.745 . . . . 70.439999999999998 111.238 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.529 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 12.6 m-85 -96.95 142.0 29.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.454 -0.943 . . . . 73.409999999999997 108.454 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 35.3 m -123.85 136.92 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 108.26 -1.015 . . . . 64.340000000000003 108.26 174.13 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.34 -155.34 9.44 Favored Glycine 0 N--CA 1.402 -3.612 0 C-N-CA 119.189 -1.482 . . . . 44.43 112.051 179.448 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 16.0 p -126.62 134.42 50.78 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 114.84 -0.68 . . . . 61.32 110.749 -177.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.413 ' NE2' ' HD1' ' A' ' 75' ' ' TYR . 3.7 pt20 -126.74 143.12 51.34 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.06 0.457 . . . . 74.530000000000001 111.317 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -124.35 114.54 19.68 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.272 -1.381 . . . . 64.450000000000003 107.272 174.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.76 115.17 48.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 107.845 -1.169 . . . . 64.430000000000007 107.845 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.515 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.8 p90 -115.45 152.43 32.94 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.153 0.501 . . . . 72.340000000000003 110.473 -176.013 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 p -159.27 155.3 26.69 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.906 -0.588 . . . . 61.210000000000001 109.641 -176.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.24 31.32 6.69 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.076 0.86 . . . . 73.430000000000007 111.386 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.515 HD12 ' CD2' ' A' ' 87' ' ' PHE . 25.2 mt -91.76 156.56 17.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 116.106 -0.497 . . . . 74.549999999999997 109.785 176.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 40.1 p -108.0 171.9 7.14 Favored 'General case' 0 C--N 1.277 -2.556 0 O-C-N 123.801 0.688 . . . . 73.109999999999999 109.933 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -57.01 -35.95 69.85 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.998 0.519 . . . . 73.120000000000005 109.729 179.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.08 -28.5 66.57 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.859 -0.61 . . . . 72.219999999999999 111.372 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.438 ' HB3' HD22 ' A' ' 90' ' ' LEU . 41.0 mt-10 -86.33 -17.03 35.6 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.212 0.449 . . . . 55.340000000000003 112.212 -176.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.9 tt -61.36 -48.65 90.5 Favored Pre-proline 0 CA--C 1.569 1.68 0 N-CA-C 112.355 0.502 . . . . 51.109999999999999 112.355 -178.084 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.91 -37.9 82.61 Favored 'Trans proline' 0 C--N 1.376 2.009 0 CA-C-N 121.049 1.41 . . . . 74.540000000000006 110.316 176.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' A' ' 94' ' ' GLU . 20.7 mt-30 -63.91 -38.76 92.27 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.93 -1.032 . . . . 72.230000000000004 111.129 -177.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.5 pp -70.11 -23.84 63.1 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 120.669 -0.412 . . . . 72.340000000000003 110.103 177.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.4 -20.78 63.8 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.094 -0.503 . . . . 64.019999999999996 110.587 -175.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -63.27 -57.95 8.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.404 -0.591 . . . . 71.540000000000006 109.404 176.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.52 ' SD ' ' HA2' ' A' ' 62' ' ' GLY . 65.3 mtm -56.68 -48.97 76.46 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.436 0.636 . . . . 73.140000000000001 109.507 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -53.93 -40.57 66.86 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.264 -1.335 . . . . 73.209999999999994 111.644 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.8 p -65.22 -26.87 68.31 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 119.906 -0.717 . . . . 51.219999999999999 111.077 -172.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.04 -33.26 74.05 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 116.15 -0.477 . . . . 52.420000000000002 110.71 -176.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.41 -9.57 20.17 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.287 -0.565 . . . . 70.200000000000003 111.058 -176.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.96 -47.64 3.66 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.143 0.794 . . . . 53.25 113.143 -173.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.79 7.3 64.73 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.861 -0.896 . . . . 54.140000000000001 110.861 -173.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.6 m -101.51 172.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 O-C-N 122.427 -0.455 . . . . 75.209999999999994 110.493 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -138.93 141.08 38.48 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.409 -1.33 . . . . 64.540000000000006 107.409 176.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.87 132.29 38.37 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.744 -0.836 . . . . 75.200000000000003 108.744 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.2 m -134.76 134.12 40.61 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.343 -0.984 . . . . 73.409999999999997 108.343 178.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -141.85 147.91 37.96 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.328 0.585 . . . . 53.420000000000002 111.551 -178.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -146.02 154.87 42.36 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.402 -1.272 . . . . 75.010000000000005 110.658 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.484 ' HG2' HG22 ' A' ' 119' ' ' VAL . 51.7 mtt85 -88.61 138.68 31.21 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.627 -0.715 . . . . 72.340000000000003 109.926 171.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.461 ' O ' HG13 ' A' ' 118' ' ' ILE . 51.7 t30 -123.11 90.04 3.22 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 105.486 -2.042 . . . . 62.340000000000003 105.486 176.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.5 -118.7 8.66 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 108.857 -1.697 . . . . 42.140000000000001 108.857 -170.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 9.5 t30 -105.95 1.31 26.52 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.706 1.241 . . . . 71.310000000000002 108.94 178.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -103.9 148.98 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 118.818 -1.153 . . . . 70.340000000000003 108.19 178.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.484 HG22 ' HG2' ' A' ' 114' ' ' ARG . 60.5 t -112.74 140.47 32.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 121.972 -0.455 . . . . 72.25 111.45 -176.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.45 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.9 pp -121.41 121.52 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 115.058 -0.974 . . . . 72.239999999999995 109.161 178.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.33 127.8 50.25 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.127 -0.694 . . . . 74.099999999999994 109.127 179.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -125.97 135.71 52.15 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.36 -0.836 . . . . 73.349999999999994 109.469 177.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -145.74 158.07 27.56 Favored Glycine 0 N--CA 1.416 -2.67 0 N-CA-C 110.86 -0.896 . . . . 74.019999999999996 110.86 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.43 145.42 43.14 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.808 -0.442 . . . . 61.32 109.808 177.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -111.06 119.42 38.97 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.073 0.463 . . . . 72.109999999999999 111.336 -176.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -112.89 93.53 4.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.277 -0.419 . . . . 73.409999999999997 110.209 179.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -142.75 26.24 1.75 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.197 1.475 . . . . 75.409999999999997 108.398 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.5 p . . . . . 0 C--N 1.284 -2.257 0 CA-C-N 113.272 -1.785 . . . . 74.329999999999998 112.008 -176.849 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 112.001 0.371 . . . . 72.310000000000002 112.001 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.68 116.51 2.34 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.423 0.63 . . . . 71.329999999999998 112.569 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -118.59 126.74 52.62 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.888 -1.893 . . . . 62.43 105.888 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 42.5 t -110.97 117.07 54.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 121.136 -0.226 . . . . 63.539999999999999 110.497 -175.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 50.2 mt-10 -109.97 120.32 42.09 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.644 -0.502 . . . . 71.340000000000003 109.644 176.543 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.519 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -114.1 116.24 28.81 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.553 -2.017 . . . . 72.209999999999994 105.553 175.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 19.4 m -122.52 131.23 53.75 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.71 -0.478 . . . . 61.200000000000003 109.71 -177.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 94.4 t -122.68 122.83 66.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.75 -0.833 . . . . 71.430000000000007 108.75 178.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.8 126.63 55.64 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.999 0.428 . . . . 74.219999999999999 110.29 178.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.5 p90 -133.83 123.07 16.91 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.876 -0.602 . . . . 73.530000000000001 110.068 177.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -74.43 35.46 0.4 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.61 2.207 . . . . 70.349999999999994 113.503 -178.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.74 -100.47 0.43 Allowed 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 122.192 -0.318 . . . . 61.43 110.772 -177.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -177.3 128.76 0.16 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.951 -0.759 . . . . 43.32 108.951 -177.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.38 133.24 29.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.539 -0.755 . . . . 73.150000000000006 109.324 177.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 p -88.81 -38.92 14.26 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.376 0.607 . . . . 62.420000000000002 109.456 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 74.5 m -159.52 133.18 7.25 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 115.707 -0.679 . . . . 72.549999999999997 109.811 176.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.466 ' OG1' HG11 ' A' ' 160' ' ' VAL . 8.1 t -137.97 155.96 48.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.349 -0.611 . . . . 73.329999999999998 109.349 174.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -126.69 93.89 3.9 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 105.987 -1.857 . . . . 62.030000000000001 105.987 175.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.489 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.59 -144.51 8.2 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 108.555 -1.818 . . . . 75.030000000000001 108.555 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -114.29 99.97 7.99 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 117.653 0.726 . . . . 72.540000000000006 109.367 -178.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -77.51 126.93 31.66 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-N 115.752 -0.658 . . . . 65.200000000000003 109.794 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.16 -37.49 9.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.225 -1.398 . . . . 72.319999999999993 107.225 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -142.65 166.64 19.62 Favored Pre-proline 0 N--CA 1.425 -1.713 0 N-CA-C 106.451 -1.685 . . . . 73.439999999999998 106.451 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.84 0.55 6.29 Favored 'Trans proline' 0 C--O 1.21 -0.88 0 C-N-CA 122.475 2.117 . . . . 74.299999999999997 110.684 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.633 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.6 pt-20 -130.12 0.12 4.67 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.902 -0.59 . . . . 73.200000000000003 111.689 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.41 HG23 ' HG3' ' A' ' 158' ' ' GLU . 82.2 t -140.65 120.89 13.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.469 -0.937 . . . . 72.019999999999996 108.469 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.466 HG11 ' OG1' ' A' ' 150' ' ' THR . 41.6 t -125.57 147.23 30.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.345 -0.613 . . . . 71.420000000000002 109.345 -177.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -137.25 143.57 42.29 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.416 0.627 . . . . 64.010000000000005 110.074 -177.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.519 ' CE3' HD12 ' A' ' 139' ' ' LEU . 25.6 m-90 -123.67 120.2 32.04 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 108.075 -1.083 . . . . 74.329999999999998 108.075 177.082 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.0 pttt -108.95 102.47 11.47 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.352 -0.84 . . . . 63.409999999999997 109.081 -178.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 9.5 mt -101.13 138.24 38.43 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.818 -1.083 . . . . 72.25 110.166 -171.469 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -118.56 151.71 50.15 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 115.566 -0.743 . . . . 64.340000000000003 110.884 177.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.95 157.43 47.16 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.298 1.998 . . . . 75.109999999999999 111.096 178.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 86.55 -36.15 3.27 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.432 -0.89 . . . . 63.130000000000003 111.637 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.75 153.9 6.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 109.584 -0.524 . . . . 74.400000000000006 109.584 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.39 143.46 12.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.811 -0.44 . . . . 74.230000000000004 109.811 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 48.5 m -146.52 143.0 28.62 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.329 -0.989 . . . . 72.099999999999994 108.329 176.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -125.49 156.96 38.14 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.811 -0.811 . . . . 72.120000000000005 108.811 178.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -126.32 137.8 53.52 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.523 0.677 . . . . 75.430000000000007 112.028 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.7 t -134.48 136.92 43.51 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.141 -1.429 . . . . 75.349999999999994 107.141 173.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -148.09 116.38 6.54 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.634 -0.876 . . . . 62.539999999999999 108.634 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -127.08 131.25 50.93 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 107.216 -1.401 . . . . 73.420000000000002 107.216 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -159.44 154.13 24.44 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.445 -0.946 . . . . 72.140000000000001 108.445 -176.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 29.2 ptt180 -87.96 129.29 35.29 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.168 -1.013 . . . . 75.239999999999995 110.776 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.05 116.27 19.76 Favored 'General case' 0 CA--C 1.477 -1.828 0 N-CA-C 107.721 -1.214 . . . . 75.0 107.721 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.487 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 18.0 p -67.0 123.78 21.18 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.873 -1.058 . . . . 75.530000000000001 112.242 -175.106 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.321 -0.662 0 O-C-N 124.071 0.857 . . . . 70.109999999999999 108.766 172.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.433 -1.318 0 CA-C-O 120.833 0.349 . . . . 74.239999999999995 110.83 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 57.3 t -113.86 113.4 43.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 105.564 -2.013 . . . . 71.319999999999993 105.564 173.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -120.73 114.61 21.9 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.026 -0.731 . . . . 75.209999999999994 109.026 -177.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -110.45 124.46 51.81 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.215 -0.902 . . . . 71.109999999999999 109.347 -178.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -124.79 115.69 21.09 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.49 -1.3 . . . . 51.119999999999997 107.49 177.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.6 pp -122.36 138.71 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.883 -0.784 . . . . 74.25 108.883 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 93.5 m -119.33 121.68 40.13 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 108.845 -0.798 . . . . 51.509999999999998 108.845 -179.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.406 HG23 ' HB3' ' A' ' 143' ' ' PHE . 7.5 tt -109.76 115.62 50.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-O 121.675 0.75 . . . . 71.510000000000005 109.729 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.8 m -80.08 148.17 67.14 Favored Pre-proline 0 N--CA 1.412 -2.349 0 N-CA-C 107.985 -1.117 . . . . 62.229999999999997 107.985 -179.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.85 2.87 0.85 Allowed 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 123.73 2.953 . . . . 72.109999999999999 112.972 -179.287 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -87.11 -1.82 58.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.609 -0.885 . . . . 71.129999999999995 108.609 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 12.8 t70 73.05 29.46 1.77 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.054 1.742 . . . . 63.200000000000003 108.135 -175.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.11 124.76 50.08 Favored 'General case' 0 N--CA 1.394 -3.24 0 CA-C-N 113.946 -1.479 . . . . 62.240000000000002 107.653 178.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.443 HG12 ' HE2' ' A' ' 87' ' ' PHE . 14.2 t -109.72 129.87 63.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.835 -0.802 . . . . 71.409999999999997 108.835 -178.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.6 p -143.79 131.55 21.38 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.286 -1.005 . . . . 72.439999999999998 108.286 179.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.27 -175.34 32.2 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 118.967 -1.587 . . . . 61.530000000000001 113.178 -176.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.39 133.3 16.02 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 123.503 0.721 . . . . 73.010000000000005 109.529 -176.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 60.9 mt -120.11 116.13 49.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 107.88 -1.155 . . . . 62.219999999999999 107.88 177.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.11 116.62 53.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.712 -0.477 . . . . 72.329999999999998 109.712 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.79 108.49 17.92 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.387 -1.338 . . . . 44.109999999999999 107.387 175.462 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.51 122.09 40.87 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.754 -0.461 . . . . 53.329999999999998 109.754 -177.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.92 158.07 22.49 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.76 -0.654 . . . . 71.420000000000002 111.811 -176.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 N--CA 1.439 -1.023 0 CA-C-N 114.579 -1.191 . . . . 62.43 109.911 175.846 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 106.034 -1.839 . . . . 74.400000000000006 106.034 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.23 98.24 0.11 Allowed Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 108.792 -1.723 . . . . 61.219999999999999 108.792 175.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -52.52 128.51 28.23 Favored 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 122.121 1.881 . . . . 61.350000000000001 110.237 177.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.57 157.94 16.72 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.593 0.96 . . . . 73.140000000000001 113.593 -169.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.582 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 71.1 mt -102.45 138.1 39.81 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.164 -0.925 . . . . 71.340000000000003 109.742 176.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.7 89.15 3.4 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.502 0.668 . . . . 75.239999999999995 111.352 178.135 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.504 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -120.47 113.87 2.52 Favored Glycine 0 N--CA 1.409 -3.108 0 CA-C-N 115.17 -0.923 . . . . 23.420000000000002 111.525 177.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -116.9 107.62 14.82 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.606 -0.887 . . . . 73.450000000000003 108.606 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.4 m -136.97 151.61 72.46 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.534 -0.913 . . . . 75.120000000000005 108.534 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -73.12 -8.82 22.67 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 122.61 2.207 . . . . 73.219999999999999 112.484 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -108.93 36.64 2.8 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.416 0.627 . . . . 73.420000000000002 109.834 176.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -57.71 -30.26 65.38 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.425 -0.807 . . . . 73.010000000000005 112.454 -179.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -69.51 -18.39 63.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.359 0.6 . . . . 74.340000000000003 110.325 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -89.55 -16.03 31.57 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.437 -0.801 . . . . 54.219999999999999 109.944 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 6.6 p -118.52 118.88 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 122.515 1.15 . . . . 73.230000000000004 111.235 179.183 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.74 104.95 16.9 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.162 -0.926 . . . . 72.030000000000001 108.864 -179.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 t -97.99 131.16 45.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.942 -1.503 . . . . 62.329999999999998 106.942 179.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.1 m -144.33 171.76 13.88 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.358 -0.979 . . . . 61.340000000000003 108.358 -176.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -88.63 153.87 20.77 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 118.968 -1.093 . . . . 73.120000000000005 108.259 178.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -112.6 123.27 49.92 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.792 -1.188 . . . . 62.109999999999999 107.792 177.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -139.11 99.18 3.69 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.624 0.726 . . . . 65.299999999999997 109.361 177.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.9 m -165.29 161.23 19.03 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.956 -1.127 . . . . 62.240000000000002 107.956 -179.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 70.51 3.32 4.45 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.253 1.021 . . . . 63.229999999999997 110.914 178.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.51 1.15 83.75 Favored Glycine 0 C--O 1.22 -0.76 0 N-CA-C 110.197 -1.161 . . . . 34.32 110.197 -172.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -104.82 150.49 24.77 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.317 0.647 . . . . 74.230000000000004 110.629 -179.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.11 138.18 55.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.466 0.65 . . . . 63.229999999999997 110.032 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.32 -153.36 8.15 Favored Glycine 0 C--N 1.276 -2.794 0 N-CA-C 109.946 -1.261 . . . . 52.140000000000001 109.946 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.582 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 p -131.45 159.47 37.98 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-O 121.256 0.551 . . . . 71.329999999999998 110.933 179.065 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -138.39 140.35 39.35 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.023 -0.535 . . . . 75.129999999999995 110.435 179.015 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.81 114.68 24.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.683 -1.229 . . . . 54.530000000000001 107.683 175.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.78 111.65 37.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.476 -0.935 . . . . 64.439999999999998 108.476 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' HE2' HG12 ' A' ' 40' ' ' VAL . 47.3 p90 -113.35 152.81 29.47 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.785 -0.366 . . . . 75.120000000000005 110.903 -174.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 p -151.65 154.35 36.2 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.215 -0.448 . . . . 73.409999999999997 111.218 -173.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.91 30.63 16.5 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 124.157 0.983 . . . . 72.510000000000005 112.877 173.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.408 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.2 mt -92.49 160.13 15.2 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 116.202 -0.454 . . . . 73.329999999999998 109.798 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.1 t -112.83 175.08 5.59 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 108.819 -0.808 . . . . 65.439999999999998 108.819 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.454 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 84.8 t80 -49.38 -44.21 44.8 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.034 0.934 . . . . 65.230000000000004 110.82 178.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.14 69.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.468 -0.787 . . . . 53.32 112.517 -178.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.35 -16.8 32.03 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.26 0.467 . . . . 53.25 112.26 -174.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.646 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 3.9 tt -65.91 -50.03 55.18 Favored Pre-proline 0 CA--C 1.567 1.623 0 CA-C-O 119.228 -0.415 . . . . 74.25 111.544 -178.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.46 -36.52 86.18 Favored 'Trans proline' 0 C--N 1.375 1.94 0 CA-C-N 121.199 1.464 . . . . 53.509999999999998 110.698 175.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -63.66 -38.8 92.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 73.109999999999999 111.523 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.0 pp -74.06 -19.94 60.45 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.782 -0.451 . . . . 74.120000000000005 109.782 177.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.09 -27.5 62.7 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.181 -0.674 . . . . 73.400000000000006 109.181 -178.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -61.09 -53.52 56.03 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.758 -0.83 . . . . 73.200000000000003 108.758 176.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.504 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 22.7 ttp -53.79 -51.85 62.16 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.518 -0.764 . . . . 63.43 110.054 176.717 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -55.41 -36.07 66.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.283 -0.871 . . . . 73.450000000000003 111.014 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.7 m -62.48 -37.61 86.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 110.182 -0.303 . . . . 63.210000000000001 110.182 -175.132 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -73.66 -13.22 60.95 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.355 0.598 . . . . 62.009999999999998 110.628 -171.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.43 -19.31 13.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.151 -0.62 . . . . 51.310000000000002 110.443 179.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.93 -44.18 4.48 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.572 0.953 . . . . 64.439999999999998 113.572 -172.497 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.04 21.43 49.86 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.135 -0.786 . . . . 50.219999999999999 111.135 -173.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.5 171.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.265 -0.643 . . . . 72.439999999999998 109.265 -178.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -128.64 138.28 52.1 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 117.644 0.202 . . . . 70.540000000000006 111.236 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.82 130.97 40.51 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.909 -1.145 . . . . 72.030000000000001 107.909 176.027 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.2 t -144.07 151.97 40.35 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.451 -0.944 . . . . 53.200000000000003 108.451 177.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.8 148.02 28.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.825 -0.806 . . . . 72.319999999999993 108.825 178.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -143.91 156.67 44.52 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.826 -0.625 . . . . 73.439999999999998 109.587 -176.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -91.22 138.09 31.86 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 121.521 0.677 . . . . 73.129999999999995 112.241 175.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.419 ' O ' HG13 ' A' ' 118' ' ' ILE . 30.7 t30 -127.56 91.9 3.39 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 113.978 -1.464 . . . . 71.219999999999999 107.248 177.279 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.54 -106.77 2.23 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 109.579 -1.409 . . . . 74.239999999999995 109.579 -175.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -123.73 10.12 8.97 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.841 1.305 . . . . 74.310000000000002 108.107 175.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.8 pp -112.88 149.51 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.025 -1.102 . . . . 74.219999999999999 108.025 177.139 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.3 t -107.0 133.63 51.07 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 CA-C-O 120.948 0.404 . . . . 44.149999999999999 109.996 -176.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.8 pt -105.68 137.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 107.627 -1.249 . . . . 74.530000000000001 107.627 176.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.72 127.08 45.66 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 109.048 -0.723 . . . . 64.319999999999993 109.048 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -127.71 115.31 18.52 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.347 -1.297 . . . . 72.150000000000006 108.19 -177.048 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.3 141.84 11.16 Favored Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 109.854 -1.298 . . . . 62.039999999999999 109.854 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -137.05 135.25 37.37 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.388 -0.968 . . . . 55.140000000000001 108.388 -177.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.9 110.2 19.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.909 -0.587 . . . . 32.130000000000003 111.183 -174.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -105.22 98.59 8.28 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.473 0.654 . . . . 73.109999999999999 110.379 177.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.7 mm? -113.26 23.95 12.76 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.602 -0.888 . . . . 73.219999999999999 108.602 178.395 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 45.5 p . . . . . 0 CA--C 1.545 0.754 0 N-CA-C 113.83 1.048 . . . . 75.310000000000002 113.83 -173.854 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 110.478 -0.193 . . . . 74.209999999999994 110.478 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.428 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -89.15 123.39 33.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.529 -0.305 . . . . 71.129999999999995 111.656 -176.356 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.77 122.63 38.55 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.182 -0.673 . . . . 75.019999999999996 109.182 173.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 61.5 t -111.53 120.88 63.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.266 -1.012 . . . . 71.299999999999997 108.266 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -121.34 126.53 49.69 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.122 -0.696 . . . . 71.299999999999997 109.122 -176.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -119.13 123.56 44.69 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.443 -0.947 . . . . 73.400000000000006 108.443 -178.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.7 m -123.87 134.29 53.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.047 -0.723 . . . . 75.230000000000004 109.047 179.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.476 HG12 ' HD2' ' A' ' 143' ' ' PHE . 90.3 t -120.68 125.64 74.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.879 -0.785 . . . . 72.239999999999995 108.879 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.83 126.27 55.26 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.829 -0.804 . . . . 32.030000000000001 108.829 177.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.626 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.0 p90 -134.47 119.24 14.05 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 112.044 0.387 . . . . 75.439999999999998 112.044 178.558 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -68.0 42.97 0.25 Allowed 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.166 2.577 . . . . 54.439999999999998 112.425 174.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.0 -106.84 0.33 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 122.732 0.413 . . . . 52.0 110.068 179.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -179.62 131.82 0.1 Allowed 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.401 -0.592 . . . . 72.239999999999995 109.401 -177.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -85.26 133.14 30.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.88 -0.785 . . . . 73.019999999999996 108.88 177.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.1 p -92.55 -34.71 13.94 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.363 -0.38 . . . . 43.130000000000003 110.432 -177.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.3 m -162.73 133.28 4.7 Favored 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 123.875 0.87 . . . . 73.219999999999999 109.216 177.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.1 t -139.01 163.92 31.13 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.489 -0.757 . . . . 72.430000000000007 111.217 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.571 ' HB3' ' OG ' ' A' ' 173' ' ' SER . 27.4 t-20 -136.41 98.38 3.81 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.23 -2.137 . . . . 73.140000000000001 105.23 171.097 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.3 -150.04 10.69 Favored Glycine 0 N--CA 1.412 -2.927 0 N-CA-C 107.157 -2.377 . . . . 65.219999999999999 107.157 -179.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -116.69 99.21 6.97 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.196 -1.409 . . . . 70.409999999999997 107.196 -178.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 160' ' ' VAL 0.264 6.3 ppt_? -86.34 139.34 31.06 Favored 'General case' 0 N--CA 1.414 -2.272 0 C-N-CA 119.325 -0.95 . . . . 74.040000000000006 113.28 -178.669 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 69.8 mt -94.46 -43.11 13.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.244 -1.344 . . . . 74.239999999999995 108.015 -178.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -137.75 172.68 6.39 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 107.54 -1.281 . . . . 53.340000000000003 107.54 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -74.22 0.61 8.26 Favored 'Trans proline' 0 C--O 1.21 -0.919 0 C-N-CA 122.197 1.932 . . . . 74.219999999999999 110.044 172.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 11.2 pt-20 -130.3 3.23 4.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.228 0.537 . . . . 64.420000000000002 111.867 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.3 t -142.09 121.11 9.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.487 -0.931 . . . . 63.450000000000003 108.487 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 38.2 t -127.94 147.64 32.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 109.549 -0.537 . . . . 73.319999999999993 109.549 -178.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -132.58 145.13 50.87 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.193 0.521 . . . . 72.5 110.259 -176.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.451 ' CD2' ' HG3' ' A' ' 172' ' ' MET . 27.8 m-90 -130.25 128.74 42.22 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.694 -0.484 . . . . 71.140000000000001 109.694 177.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -102.66 112.67 25.54 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.69 0.757 . . . . 74.120000000000005 110.019 177.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 33.2 mt -101.41 123.42 45.45 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.025 -0.989 . . . . 54.219999999999999 109.022 -176.392 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -118.07 156.38 50.4 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 115.882 -0.599 . . . . 74.109999999999999 112.052 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 127' ' ' LEU . 59.8 Cg_endo -74.41 156.47 45.69 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.79 2.327 . . . . 70.140000000000001 111.552 177.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.94 -30.92 2.86 Favored Glycine 0 C--N 1.317 -0.527 0 C-N-CA 121.288 -0.482 . . . . 71.409999999999997 112.4 177.538 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.82 160.96 5.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 120.902 0.382 . . . . 53.520000000000003 110.42 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.4 p -113.62 110.15 31.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 122.102 0.954 . . . . 63.530000000000001 108.787 176.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 32.8 t -101.09 141.5 33.88 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.597 -0.729 . . . . 72.329999999999998 109.981 -175.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.1 p -106.42 126.55 52.39 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.584 -0.734 . . . . 74.519999999999996 110.526 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.451 ' HG3' ' CD2' ' A' ' 162' ' ' TRP . 39.5 ttm -107.68 116.16 31.44 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.758 -1.201 . . . . 71.349999999999994 107.758 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.571 ' OG ' ' HB3' ' A' ' 151' ' ' ASN . 11.7 p -142.85 139.41 30.85 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 118.303 -1.359 . . . . 64.519999999999996 111.07 177.068 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -151.26 146.83 26.32 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 108.28 -1.007 . . . . 53.140000000000001 108.28 -176.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -138.36 130.72 28.9 Favored 'General case' 0 C--N 1.261 -3.246 0 N-CA-C 105.834 -1.913 . . . . 72.340000000000003 105.834 173.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.3 158.88 44.36 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.674 -0.491 . . . . 62.350000000000001 109.674 -177.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -91.34 135.2 33.98 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.155 -0.683 . . . . 72.109999999999999 109.155 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -143.05 123.82 14.2 Favored 'General case' 0 CA--C 1.47 -2.119 0 C-N-CA 120.119 -0.632 . . . . 75.519999999999996 109.93 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.3 p -65.14 104.05 0.85 Allowed 'General case' 0 C--N 1.284 -2.281 0 O-C-N 124.514 1.134 . . . . 72.109999999999999 111.232 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.24 0.583 0 CA-C-N 115.078 -0.964 . . . . 73.530000000000001 109.889 178.949 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 . . . . . 0 N--CA 1.439 -0.998 0 CA-C-O 120.882 0.372 . . . . 62.219999999999999 110.739 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.2 t -123.38 114.83 43.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.548 -0.908 . . . . 65.230000000000004 108.548 178.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -126.0 118.93 26.38 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.154 0.502 . . . . 75.329999999999998 110.203 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.52 118.65 35.04 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.647 -0.706 . . . . 75.219999999999999 109.155 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 t -117.05 114.59 23.96 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.26 -1.385 . . . . 73.129999999999995 107.26 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.5 pp -129.25 147.03 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-O 121.453 0.644 . . . . 70.450000000000003 109.723 -177.688 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.3 m -128.75 134.71 48.5 Favored 'General case' 0 C--N 1.265 -3.074 0 N-CA-C 109.481 -0.563 . . . . 45.119999999999997 109.481 -177.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.9 tt -124.72 123.14 65.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.497 0.665 . . . . 73.120000000000005 110.318 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 m -91.73 152.37 43.17 Favored Pre-proline 0 N--CA 1.42 -1.963 0 N-CA-C 108.551 -0.907 . . . . 75.329999999999998 108.551 -179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.29 2.49 0.86 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.566 2.844 . . . . 73.409999999999997 113.841 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -88.31 0.41 56.19 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.169 -0.678 . . . . 62.549999999999997 109.169 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 t70 72.64 29.72 1.96 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.778 -1.564 . . . . 71.209999999999994 106.778 -174.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tp -101.71 124.97 48.25 Favored 'General case' 0 N--CA 1.389 -3.484 0 CA-C-N 113.676 -1.602 . . . . 64.299999999999997 107.251 177.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.35 135.6 58.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 109.169 -0.678 . . . . 72.400000000000006 109.169 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.7 p -143.91 156.28 44.38 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.872 -1.159 . . . . 71.230000000000004 107.872 175.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.05 44.23 Favored Glycine 0 N--CA 1.425 -2.041 0 C-N-CA 119.064 -1.541 . . . . 60.539999999999999 112.265 179.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.75 133.38 17.78 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 109.368 -0.604 . . . . 45.030000000000001 109.368 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 58.7 mt -116.6 116.16 51.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.952 -1.129 . . . . 63.25 107.952 177.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.22 116.19 51.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.992 -0.373 . . . . 74.230000000000004 109.992 -177.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.18 108.1 17.66 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.377 -1.712 . . . . 54.43 106.377 173.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.82 131.34 53.72 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.252 0.549 . . . . 73.329999999999998 111.078 -174.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.75 158.03 37.59 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.397 -0.82 . . . . 71.209999999999994 110.445 -177.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.941 0 N-CA-C 106.522 -1.659 . . . . 74.0 106.522 170.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.418 -2.063 0 N-CA-C 109.871 -0.418 . . . . 74.299999999999997 109.871 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.48 102.1 0.15 Allowed Glycine 0 N--CA 1.433 -1.501 0 CA-C-O 118.267 -1.296 . . . . 72.120000000000005 111.583 178.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -54.2 128.72 31.1 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 119.961 1.88 . . . . 72.099999999999994 110.148 173.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.539 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -93.74 148.77 21.81 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 113.074 0.768 . . . . 75.420000000000002 113.074 -171.555 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.48 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 83.2 mt -100.15 160.11 14.58 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.236 -1.024 . . . . 73.340000000000003 108.236 174.111 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -90.78 86.87 6.46 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.888 -0.782 . . . . 73.219999999999999 108.888 -178.317 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' ' SD ' ' A' ' 101' ' ' MET . . . -86.35 78.27 1.94 Allowed Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 114.622 -1.172 . . . . 41.030000000000001 110.963 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -138.27 99.13 3.78 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.458 -0.371 . . . . 64.340000000000003 110.993 -176.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 m -151.51 144.65 17.14 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 124.461 1.104 . . . . 73.019999999999996 108.658 178.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.51 -32.72 54.43 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.326 2.684 . . . . 61.25 113.254 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -88.52 44.08 1.18 Allowed 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 111.954 0.353 . . . . 75.530000000000001 111.954 -179.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.8 m -53.44 -32.27 49.09 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 113.362 0.875 . . . . 72.329999999999998 113.362 -176.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -75.82 -12.56 60.19 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.465 -0.772 . . . . 71.120000000000005 110.616 -176.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -89.77 -18.25 26.67 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.699 -0.682 . . . . 73.120000000000005 109.462 177.54 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.54 119.26 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 122.407 1.098 . . . . 64.200000000000003 112.613 -177.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.81 108.99 21.82 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.859 -1.064 . . . . 63.420000000000002 108.583 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.7 t -97.62 127.89 49.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 106.709 -1.589 . . . . 72.120000000000005 106.709 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -141.39 167.48 22.08 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.26 -0.645 . . . . 60.299999999999997 109.26 -172.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.27 135.52 34.72 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.592 -0.892 . . . . 74.409999999999997 108.592 179.034 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 87.3 t80 -105.44 120.78 42.46 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.741 -0.837 . . . . 75.319999999999993 108.741 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -138.45 99.26 3.79 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 106.992 -1.485 . . . . 72.409999999999997 106.992 175.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 32.9 t -173.01 163.25 4.75 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.066 -1.457 . . . . 71.140000000000001 107.066 -176.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.1 t70 66.21 9.04 6.01 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.515 1.126 . . . . 75.150000000000006 110.765 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.53 -1.89 84.32 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.683 -0.69 . . . . 64.129999999999995 111.683 -177.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.43 157.17 17.53 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 122.509 0.323 . . . . 64.329999999999998 110.545 -178.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -124.65 137.18 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.775 -0.824 . . . . 44.350000000000001 108.775 174.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.28 -153.21 10.0 Favored Glycine 0 C--N 1.269 -3.191 0 N-CA-C 109.817 -1.313 . . . . 52.049999999999997 109.817 -177.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.539 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 64.3 m -133.31 154.39 50.75 Favored 'General case' 0 C--N 1.272 -2.778 0 CA-C-O 121.162 0.506 . . . . 73.310000000000002 111.383 178.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.9 pt20 -133.57 142.69 48.27 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.782 -0.645 . . . . 73.319999999999993 110.381 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.9 114.36 27.25 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.434 -1.321 . . . . 63.310000000000002 107.434 174.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.12 110.88 32.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.828 -1.175 . . . . 74.25 107.828 -179.229 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CD2' HD12 ' A' ' 90' ' ' LEU . 52.1 p90 -120.77 155.29 34.3 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.766 -0.373 . . . . 64.340000000000003 110.898 -174.619 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 m -160.74 160.71 31.67 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.059 -0.719 . . . . 75.409999999999997 109.059 -178.188 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 63.4 30.65 15.41 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.07 0.948 . . . . 62.219999999999999 111.628 178.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 87' ' ' PHE . 21.6 mt -88.31 156.98 18.89 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.72 -0.392 . . . . 61.539999999999999 110.501 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -113.64 168.02 10.12 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.998 -1.482 . . . . 72.239999999999995 106.998 177.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -52.76 -37.04 58.93 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 123.485 0.714 . . . . 62.310000000000002 111.812 -178.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.39 -26.75 64.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.192 -0.458 . . . . 74.230000000000004 112.12 -178.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HB3' HD22 ' A' ' 90' ' ' LEU . 54.5 mt-10 -88.15 -17.82 30.12 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.309 -0.244 . . . . 64.409999999999997 111.228 -177.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 98' ' ' LEU . 45.7 tp -61.45 -52.08 72.74 Favored Pre-proline 0 CA--C 1.564 1.488 0 N-CA-C 113.474 0.916 . . . . 74.420000000000002 113.474 -178.107 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.13 -32.68 74.6 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 121.255 1.303 . . . . 72.430000000000007 111.338 176.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.91 -31.25 67.83 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 122.264 1.031 . . . . 44.43 109.071 -175.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.425 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 25.9 tp -71.5 -30.79 66.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.376 -1.284 . . . . 55.310000000000002 109.795 173.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.43 -24.04 63.77 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 115.477 -0.783 . . . . 74.430000000000007 109.893 -175.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -56.18 -53.91 51.51 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 123.877 0.736 . . . . 64.340000000000003 110.672 179.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.408 ' SD ' ' HA2' ' A' ' 62' ' ' GLY . 72.2 mtm -55.63 -49.15 73.62 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.486 0.66 . . . . 70.439999999999998 109.882 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -57.27 -35.28 69.57 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.907 -1.042 . . . . 72.140000000000001 111.498 178.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.2 m -61.48 -32.09 72.09 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 109.696 -0.483 . . . . 64.239999999999995 109.696 -175.485 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 101' ' ' MET . 5.1 t70 -59.51 -27.97 66.64 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.351 -0.84 . . . . 73.030000000000001 111.534 -175.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.05 -14.25 14.26 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 120.591 -0.444 . . . . 62.109999999999999 111.344 -178.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.86 -48.09 3.58 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.988 1.107 . . . . 72.030000000000001 113.988 -171.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.76 28.72 41.48 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.095 -1.05 . . . . 73.340000000000003 110.88 -173.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 11.1 p -107.26 141.29 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-O 120.759 0.314 . . . . 70.299999999999997 110.335 -179.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.443 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 40.5 t30 -113.13 121.27 44.04 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.408 -0.96 . . . . 72.439999999999998 108.408 177.343 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.29 106.02 14.47 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.235 -0.654 . . . . 73.530000000000001 109.235 178.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.0 m -101.4 108.98 20.73 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.8 -1.185 . . . . 62.509999999999998 107.8 177.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.5 pt? -129.93 145.89 51.63 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.858 -0.61 . . . . 55.229999999999997 109.654 -176.655 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -144.37 151.9 39.95 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.553 -0.749 . . . . 65.519999999999996 111.853 -177.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.614 ' NH2' ' HA ' ' A' ' 180' ' ' ASP . 5.9 tpt180 -96.7 107.37 19.81 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 106.492 -1.669 . . . . 63.039999999999999 106.492 178.208 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.96 97.3 7.9 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.34 -0.985 . . . . 71.400000000000006 108.34 -177.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.13 -94.74 0.81 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 110.914 -0.874 . . . . 71.200000000000003 110.914 -177.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -135.55 13.62 3.46 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 123.26 1.505 . . . . 73.230000000000004 108.729 177.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.9 pp -121.18 149.27 24.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.908 -1.12 . . . . 75.109999999999999 109.054 177.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.527 HG22 ' HD3' ' A' ' 114' ' ' ARG . 95.7 t -107.12 132.79 53.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-O 120.995 0.426 . . . . 71.329999999999998 110.622 -177.232 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.0 pt -115.19 129.27 71.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.114 -1.069 . . . . 73.430000000000007 108.114 175.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 tt -128.95 129.76 45.86 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 115.935 -0.575 . . . . 72.329999999999998 110.675 -179.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -126.71 135.1 50.68 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.307 -0.997 . . . . 65.239999999999995 108.307 173.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -142.38 129.65 3.95 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.217 -0.992 . . . . 63.130000000000003 111.948 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.612 ' HG2' HH11 ' A' ' 124' ' ' ARG . 0.1 OUTLIER -126.13 132.57 51.83 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.354 -0.497 . . . . 73.329999999999998 110.655 176.734 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 108' ' ' VAL . . . -113.26 131.03 56.07 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.007 -0.542 . . . . 73.400000000000006 111.534 -177.253 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -96.25 92.91 6.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.968 -1.123 . . . . 73.340000000000003 107.968 175.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -133.71 17.41 3.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.234 1.016 . . . . 73.200000000000003 110.086 -177.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.291 -1.949 0 CA-C-N 114.748 -1.115 . . . . 75.230000000000004 109.593 175.888 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 . . . . . 0 C--O 1.243 0.729 0 N-CA-C 112.994 0.738 . . . . 74.120000000000005 112.994 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.24 115.55 28.59 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.915 1.08 . . . . 74.299999999999997 113.915 -169.691 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.5 137.76 32.47 Favored 'General case' 0 C--O 1.265 1.917 0 N-CA-C 107.64 -1.244 . . . . 55.219999999999999 107.64 170.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.6 t -105.89 112.15 37.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.352 -0.981 . . . . 72.310000000000002 108.352 178.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -102.86 121.36 42.34 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.95 -0.568 . . . . 73.099999999999994 109.564 -177.124 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.44 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -112.69 119.22 37.35 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.721 -1.585 . . . . 73.150000000000006 106.721 178.51 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.7 m -123.12 127.35 48.58 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.521 -0.548 . . . . 74.420000000000002 109.521 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.472 HG12 ' HD2' ' A' ' 143' ' ' PHE . 58.8 t -119.8 126.99 75.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.352 -0.611 . . . . 63.43 109.352 179.048 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.51 125.58 54.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.799 -0.815 . . . . 45.43 108.799 177.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.0 p90 -134.33 124.16 17.04 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 111.774 0.287 . . . . 74.510000000000005 111.774 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 15.6 Cg_exo -70.83 31.81 0.22 Allowed 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.972 2.448 . . . . 75.340000000000003 112.556 176.555 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -115.16 -107.37 0.38 Allowed 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.342 -0.614 . . . . 72.430000000000007 109.342 -177.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.66 129.87 0.08 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.597 -0.89 . . . . 60.049999999999997 108.597 -178.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.9 p -83.29 136.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.654 -0.869 . . . . 71.450000000000003 108.654 176.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.3 t -93.69 -43.3 8.72 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 119.572 -0.851 . . . . 60.140000000000001 109.21 176.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.3 m -150.24 131.14 14.23 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.062 -0.718 . . . . 63.140000000000001 109.062 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 t -140.46 154.09 46.5 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.759 -0.46 . . . . 73.310000000000002 109.759 175.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -123.41 98.07 5.69 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 104.839 -2.282 . . . . 72.430000000000007 104.839 170.156 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.89 -155.44 23.83 Favored Glycine 0 N--CA 1.41 -3.061 0 N-CA-C 106.521 -2.631 . . . . 62.100000000000001 106.521 -177.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -110.52 103.04 11.59 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 118.345 1.072 . . . . 74.430000000000007 110.23 -178.217 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -74.58 114.21 12.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.816 -0.629 . . . . 74.010000000000005 109.81 176.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.4 mt -79.93 -44.64 22.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.296 -1.742 . . . . 72.530000000000001 106.296 179.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -128.7 165.97 27.98 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 105.459 -2.052 . . . . 73.140000000000001 105.459 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.49 0.18 9.4 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 121.925 1.75 . . . . 71.209999999999994 110.422 174.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.1 pt-20 -132.09 5.33 4.16 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.384 -1.28 . . . . 73.420000000000002 111.049 -177.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -146.15 120.94 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 107.996 -1.112 . . . . 71.150000000000006 107.996 178.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.06 147.3 30.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.648 -0.501 . . . . 64.219999999999999 109.648 -176.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -135.08 143.11 46.47 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.063 0.459 . . . . 54.130000000000003 109.848 -178.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.445 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 26.8 m-90 -126.78 139.1 53.37 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.624 -0.88 . . . . 74.140000000000001 108.624 177.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -111.75 104.34 12.68 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.317 -0.994 . . . . 74.209999999999994 108.317 174.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.3 mp -83.02 116.32 22.23 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.147 -1.427 . . . . 73.430000000000007 107.147 177.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -107.34 134.75 19.82 Favored Pre-proline 0 C--N 1.278 -2.504 0 CA-C-N 114.936 -1.029 . . . . 64.299999999999997 111.021 -172.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.05 154.29 66.75 Favored 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 123.491 2.794 . . . . 60.310000000000002 111.745 -179.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.6 -37.61 2.93 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 121.082 -0.58 . . . . 74.010000000000005 111.934 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.45 160.86 5.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.167 -0.679 . . . . 75.109999999999999 109.167 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -83.5 127.87 39.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.908 -0.775 . . . . 73.439999999999998 108.908 178.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.8 m -120.94 128.85 53.14 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.232 -0.655 . . . . 63.109999999999999 109.232 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.522 HG22 ' HG3' ' A' ' 124' ' ' ARG . 18.1 p -121.67 154.27 37.06 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.038 -0.983 . . . . 70.230000000000004 108.576 -178.287 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.9 ptm -144.39 139.66 28.55 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.697 -0.401 . . . . 73.319999999999993 110.745 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 76.1 p -143.55 148.12 35.47 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.168 -0.613 . . . . 73.420000000000002 110.194 173.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.14 130.49 12.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.771 -0.825 . . . . 75.209999999999994 108.771 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -129.87 130.48 45.28 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 107.243 -1.392 . . . . 53.109999999999999 107.243 176.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -153.95 159.67 41.79 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.816 -0.438 . . . . 53.350000000000001 109.816 -178.223 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -90.92 130.24 36.87 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 109.091 -0.707 . . . . 73.239999999999995 109.091 -177.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -143.09 122.32 12.98 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 118.007 0.367 . . . . 73.209999999999994 110.871 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.71 106.77 0.43 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.247 0.967 . . . . 75.239999999999995 111.871 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.614 ' HA ' ' NH2' ' A' ' 114' ' ' ARG . 14.8 t70 . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 114.46 -1.245 . . . . 73.540000000000006 110.031 179.077 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 . . . . . 0 N--CA 1.429 -1.502 0 N-CA-C 110.081 -0.34 . . . . 73.109999999999999 110.081 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -107.6 113.86 44.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 106.531 -1.655 . . . . 75.150000000000006 106.531 175.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -121.31 117.77 27.83 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 109.228 -0.656 . . . . 63.549999999999997 109.228 -175.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.77 119.7 36.27 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.003 -0.74 . . . . 43.549999999999997 109.003 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.6 m -120.09 114.99 22.8 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.637 -1.246 . . . . 44.039999999999999 107.637 177.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.0 146.13 34.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.095 -0.705 . . . . 63.119999999999997 109.095 -177.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.6 m -129.46 122.16 28.75 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-O 121.06 0.457 . . . . 55.43 110.118 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.7 tt -107.19 119.56 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.773 0.796 . . . . 63.549999999999997 109.755 178.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 m -89.57 157.31 47.09 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.164 -0.926 . . . . 73.420000000000002 109.328 -177.253 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.42 2.15 1.33 Allowed 'Trans proline' 0 N--CA 1.488 1.167 0 C-N-CA 123.53 2.82 . . . . 63.240000000000002 114.279 -176.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.85 4.5 53.74 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.608 -0.886 . . . . 64.439999999999998 108.608 178.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 27.2 t70 68.48 31.21 4.97 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 123.566 1.65 . . . . 72.209999999999994 107.333 -175.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.06 124.1 42.4 Favored 'General case' 0 N--CA 1.39 -3.473 0 N-CA-C 106.084 -1.821 . . . . 71.0 106.084 178.578 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG12 ' HE2' ' A' ' 87' ' ' PHE . 10.0 t -112.95 134.17 56.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.318 -0.993 . . . . 75.439999999999998 108.318 -177.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.2 p -140.62 158.43 44.0 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.983 -1.488 . . . . 63.310000000000002 106.983 178.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.69 -174.31 42.72 Favored Glycine 0 N--CA 1.415 -2.703 0 C-N-CA 118.997 -1.573 . . . . 64.109999999999999 112.859 177.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -147.43 133.91 19.73 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 108.916 -0.772 . . . . 70.420000000000002 108.916 -177.568 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 52.6 mt -119.52 115.91 49.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.728 -1.212 . . . . 75.409999999999997 107.728 176.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.31 120.54 62.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.105 -0.702 . . . . 72.25 109.105 -177.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.38 107.31 16.97 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.763 -1.94 . . . . 72.510000000000005 105.763 172.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -118.93 132.47 56.09 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.049 0.452 . . . . 52.240000000000002 111.13 -174.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.17 158.25 37.59 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.54 -0.755 . . . . 74.030000000000001 110.321 -177.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--N 1.323 -0.577 0 C-N-CA 119.783 -0.767 . . . . 70.010000000000005 109.288 173.603 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.423 -1.823 0 N-CA-C 107.45 -1.315 . . . . 71.120000000000005 107.45 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.583 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 173.7 116.65 0.43 Allowed Glycine 0 N--CA 1.409 -3.127 0 CA-C-N 114.845 -1.07 . . . . 43.039999999999999 110.427 177.047 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 75.0 Cg_exo -52.04 134.22 48.77 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.332 2.022 . . . . 53.140000000000001 109.313 170.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.79 149.58 23.68 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 111.654 0.242 . . . . 73.129999999999995 111.654 -173.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.547 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 66.1 mt -91.77 151.03 20.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.279 -0.419 . . . . 50.039999999999999 109.969 177.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -109.64 102.45 11.28 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.08 -1.082 . . . . 75.219999999999999 108.08 177.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -148.84 142.61 10.06 Favored Glycine 0 C--N 1.283 -2.367 0 C-N-CA 120.58 -0.819 . . . . 71.400000000000006 112.873 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -151.35 114.27 4.71 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.543 -0.91 . . . . 72.219999999999999 108.543 176.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.66 159.62 71.06 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 109.925 -0.398 . . . . 64.049999999999997 109.925 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.98 -13.92 42.1 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.245 1.963 . . . . 70.150000000000006 112.532 178.089 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 51.7 p90 -113.64 28.69 8.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.62 -0.264 . . . . 54.340000000000003 111.466 -177.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.8 m -57.49 -26.86 61.93 Favored 'General case' 0 C--O 1.205 -1.253 0 N-CA-C 111.947 0.351 . . . . 61.210000000000001 111.947 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.512 ' HG3' ' HG3' ' A' ' 69' ' ' LYS . 29.7 pt20 -65.56 -12.26 51.37 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.395 0.617 . . . . 65.319999999999993 110.96 176.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HE3' HD23 ' A' ' 90' ' ' LEU . 24.6 mtpp -110.81 -7.51 14.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.636 0.774 . . . . 64.430000000000007 110.519 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 p -132.36 117.74 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 122.029 0.918 . . . . 54.130000000000003 110.409 173.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.32 116.31 28.83 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.687 -0.688 . . . . 75.140000000000001 109.964 -177.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.95 124.38 50.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 106.177 -1.786 . . . . 74.239999999999995 106.177 177.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.7 m -137.97 166.89 22.96 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.298 -0.41 . . . . 74.400000000000006 111.293 -172.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.583 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 57.5 t30 -80.2 140.78 36.16 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.311 -0.859 . . . . 64.409999999999997 108.799 177.067 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 77.0 t80 -119.3 121.35 39.4 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.862 -0.422 . . . . 72.400000000000006 109.862 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -138.62 114.79 10.24 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.843 -1.169 . . . . 74.140000000000001 107.843 172.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.4 t -174.51 148.09 1.17 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.903 -1.517 . . . . 73.439999999999998 106.903 -175.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 72.28 10.33 5.89 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.844 0.858 . . . . 74.239999999999995 111.027 173.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.66 5.06 82.19 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.477 -0.649 . . . . 61.020000000000003 111.477 -175.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.576 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 11.8 m-85 -104.09 149.28 25.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.617 -0.512 . . . . 65.140000000000001 109.617 179.014 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.73 136.79 58.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.987 -1.116 . . . . 73.209999999999994 107.987 174.207 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.461 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -173.5 -154.94 11.06 Favored Glycine 0 C--N 1.274 -2.873 0 N-CA-C 110.682 -0.967 . . . . 41.409999999999997 110.682 -178.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.547 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 p -129.62 153.25 48.28 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-O 121.208 0.528 . . . . 44.240000000000002 111.848 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 4.1 pt20 -134.62 141.97 46.76 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.835 -0.62 . . . . 73.120000000000005 110.791 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.88 114.2 26.61 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.645 -1.613 . . . . 71.150000000000006 106.645 173.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.21 115.14 48.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.658 -0.867 . . . . 74.549999999999997 108.658 -178.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.451 ' HE2' HG12 ' A' ' 40' ' ' VAL . 41.2 p90 -119.53 151.77 38.06 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.205 0.526 . . . . 74.420000000000002 111.085 -174.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 p -155.59 154.83 32.28 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.5 -0.773 . . . . 72.530000000000001 110.286 -177.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.3 t70 65.74 30.98 9.96 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.089 0.947 . . . . 62.140000000000001 110.457 175.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.542 HD23 ' HE3' ' A' ' 69' ' ' LYS . 18.1 mt -94.91 170.22 9.58 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.875 -0.602 . . . . 70.409999999999997 111.785 -178.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.439 HG22 ' OE1' ' A' ' 94' ' ' GLU . 12.5 t -126.61 172.79 9.97 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.059 -0.719 . . . . 73.209999999999994 109.059 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.435 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 78.1 t80 -51.92 -40.67 61.12 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.011 1.324 . . . . 71.319999999999993 112.152 -176.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.09 72.16 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.255 0.465 . . . . 72.540000000000006 112.255 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' OE1' HG22 ' A' ' 91' ' ' THR . 48.3 mt-10 -86.08 -18.77 31.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.003 -0.544 . . . . 72.349999999999994 111.838 -174.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tt -60.62 -54.59 53.28 Favored Pre-proline 0 CA--C 1.566 1.584 0 CA-C-N 116.094 -0.503 . . . . 73.319999999999993 112.22 -177.372 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.26 -34.17 36.75 Favored 'Trans proline' 0 C--N 1.367 1.518 0 CA-C-N 120.76 1.307 . . . . 65.230000000000004 111.095 178.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -62.87 -39.65 95.08 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.362 -0.835 . . . . 72.219999999999999 111.504 -176.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -70.67 -19.62 62.77 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.081 0.467 . . . . 75.109999999999999 111.053 177.7 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.31 -24.45 59.22 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.505 -0.478 . . . . 74.430000000000007 110.191 -176.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -59.17 -51.89 68.06 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 123.305 0.378 . . . . 71.409999999999997 110.649 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -54.29 -52.65 60.79 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-O 121.638 0.732 . . . . 75.230000000000004 110.472 -177.593 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.21 -27.28 68.95 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 115.024 -0.989 . . . . 73.25 111.28 -177.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -63.55 -22.9 67.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 118.622 -0.704 . . . . 61.399999999999999 112.08 -177.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.48 -27.64 67.73 Favored 'General case' 0 C--N 1.357 0.913 0 CA-C-O 121.215 0.531 . . . . 60.210000000000001 109.776 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.77 -12.5 13.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.721 -0.672 . . . . 74.519999999999996 111.093 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.98 -48.68 3.44 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 113.941 1.089 . . . . 52.0 113.941 -172.211 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.43 24.0 48.72 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.658 -0.782 . . . . 42.329999999999998 112.144 -174.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -87.93 147.39 5.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 O-C-N 122.332 -0.51 . . . . 52.240000000000002 110.735 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -135.28 129.05 32.97 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.846 -1.168 . . . . 65.140000000000001 107.846 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 mp -130.21 117.05 19.27 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.558 0.218 . . . . 64.040000000000006 110.544 -178.188 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.4 m -108.27 114.22 27.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.151 -1.055 . . . . 70.019999999999996 108.151 176.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.78 153.16 49.34 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 122.027 -0.421 . . . . 74.319999999999993 110.738 -176.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -148.68 154.0 39.04 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.721 -0.672 . . . . 70.109999999999999 110.199 -177.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.411 ' CD ' HG22 ' A' ' 119' ' ' VAL . 5.1 tpt180 -108.57 106.53 16.65 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 105.722 -1.955 . . . . 74.030000000000001 105.722 179.42 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -101.38 97.33 7.83 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.44 -0.578 . . . . 73.349999999999994 109.44 -176.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.19 -82.72 0.64 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.304 -0.718 . . . . 62.539999999999999 111.304 -178.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.426 HD21 ' HA ' ' A' ' 179' ' ' THR . 2.5 t-20 -143.52 5.35 1.41 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.714 1.245 . . . . 74.420000000000002 109.148 178.198 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.6 pp -113.58 148.87 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 O-C-N 121.339 -0.851 . . . . 73.319999999999993 108.779 -179.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.411 HG22 ' CD ' ' A' ' 114' ' ' ARG . 94.3 t -110.31 133.82 54.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-O 121.378 0.608 . . . . 62.210000000000001 111.04 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.5 pt -117.33 132.86 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 N-CA-C 107.945 -1.132 . . . . 71.040000000000006 107.945 173.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.2 tt -128.12 125.33 38.97 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 115.926 -0.579 . . . . 74.420000000000002 109.771 177.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -127.15 115.08 18.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.039 -0.982 . . . . 70.299999999999997 108.559 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.7 156.08 21.92 Favored Glycine 0 C--N 1.291 -1.942 0 C-N-CA 120.458 -0.877 . . . . 53.399999999999999 112.409 -177.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -139.9 125.71 19.5 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.953 -1.128 . . . . 63.200000000000003 107.953 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -101.77 111.7 24.05 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.644 -0.502 . . . . 74.219999999999999 109.644 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -104.84 93.61 4.82 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 123.031 1.396 . . . . 62.520000000000003 111.519 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 166' ' ' PRO 0.278 0.0 OUTLIER -126.75 42.86 3.23 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-O 124.21 1.957 . . . . 65.040000000000006 107.444 171.775 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.429 -1.49 0 CA-C-N 111.419 -2.628 . . . . 73.0 110.791 179.434 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 CA--C 1.503 -0.834 0 N-CA-C 113.748 1.018 . . . . 72.439999999999998 113.748 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 166' ' ' PRO . . . -96.47 124.56 40.5 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.618 -0.433 . . . . 72.200000000000003 110.902 -175.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -131.94 127.87 37.29 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.731 -0.84 . . . . 61.039999999999999 108.731 178.122 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 58.2 t -121.81 128.57 75.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 119.367 -0.933 . . . . 71.400000000000006 110.104 -177.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.75 121.12 31.09 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.914 0.387 . . . . 62.140000000000001 110.289 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 20.5 tp -115.11 120.75 40.86 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.215 -0.448 . . . . 74.219999999999999 109.807 177.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.6 m -117.45 114.31 23.32 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.032 -0.729 . . . . 64.439999999999998 109.032 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 96.5 t -108.4 120.79 60.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.932 -0.766 . . . . 74.400000000000006 108.932 178.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -110.86 130.71 55.5 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.587 -0.523 . . . . 44.009999999999998 109.587 179.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.541 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.6 p90 -134.52 124.76 17.23 Favored Pre-proline 0 C--N 1.292 -1.927 0 CA-C-N 116.349 -0.387 . . . . 73.200000000000003 111.209 177.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.76 37.65 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.476 2.784 . . . . 73.019999999999996 112.603 176.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -125.9 -115.8 0.28 Allowed 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 108.522 -0.918 . . . . 74.219999999999999 108.522 -179.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.75 137.84 0.62 Allowed 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.71 -1.219 . . . . 73.439999999999998 107.71 -178.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.515 ' HA ' ' HB2' ' A' ' 176' ' ' ALA . 7.6 p -89.48 127.21 42.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.548 -0.908 . . . . 64.219999999999999 108.548 178.321 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.5 p -81.31 -38.73 26.3 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.585 0.707 . . . . 74.010000000000005 110.337 -177.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 49.0 m -156.56 133.1 10.09 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.08 -0.711 . . . . 52.229999999999997 109.08 178.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.424 ' HB ' HG21 ' A' ' 147' ' ' VAL . 9.4 t -138.45 169.72 17.29 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.669 -0.644 . . . . 63.240000000000002 111.307 177.875 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.563 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 8.0 t30 -139.0 87.17 2.19 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.751 -1.944 . . . . 44.140000000000001 105.751 175.414 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.09 -146.4 6.66 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 109.221 -1.551 . . . . 75.409999999999997 109.221 -178.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -118.55 99.63 6.93 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.054 -0.721 . . . . 71.209999999999994 109.054 178.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 39.6 ptt180 -79.03 128.72 33.62 Favored 'General case' 0 N--CA 1.422 -1.831 0 O-C-N 121.562 -0.712 . . . . 71.319999999999993 110.589 179.231 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.1 mt -87.33 -39.42 13.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.723 -1.584 . . . . 74.0 106.723 177.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.23 164.96 35.35 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.023 -1.843 . . . . 71.400000000000006 106.023 -179.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.23 -0.12 8.71 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.84 1.693 . . . . 75.230000000000004 111.128 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.3 pt-20 -129.34 4.18 5.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.566 -0.743 . . . . 75.25 111.802 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.89 120.19 8.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.028 -1.101 . . . . 74.319999999999993 108.028 178.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 45.5 t -125.74 143.56 38.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.924 -0.398 . . . . 72.450000000000003 109.924 -177.002 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.8 tt0 -128.14 138.28 52.44 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-O 121.304 0.573 . . . . 64.430000000000007 109.667 -177.39 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -114.87 114.86 26.07 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 115.862 -0.608 . . . . 64.420000000000002 109.405 178.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -98.67 98.35 9.5 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.168 -1.049 . . . . 71.409999999999997 108.168 178.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 26.2 mt -93.68 146.62 23.7 Favored 'General case' 0 C--O 1.281 2.747 0 CA-C-N 114.878 -1.056 . . . . 70.530000000000001 109.927 -172.279 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.515 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -117.02 151.25 47.28 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.245 -0.889 . . . . 74.219999999999999 111.323 -173.253 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 84.7 Cg_endo -77.94 154.93 30.03 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.874 2.383 . . . . 44.100000000000001 112.424 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.65 -28.14 2.81 Favored Glycine 0 CA--C 1.499 -0.938 0 C-N-CA 121.159 -0.543 . . . . 73.140000000000001 112.533 175.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.03 156.14 6.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 109.443 -0.577 . . . . 72.340000000000003 109.443 -179.176 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.3 p -92.53 109.24 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 108.106 -1.072 . . . . 72.540000000000006 108.106 177.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.4 m -92.85 130.27 38.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.561 -0.745 . . . . 74.109999999999999 109.678 -176.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 44.0 p -99.12 139.01 35.4 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.633 0.73 . . . . 71.439999999999998 111.711 -178.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 21.3 ttt -118.02 122.45 43.22 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.027 -1.101 . . . . 73.140000000000001 108.027 178.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.563 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 4.2 m -136.44 136.92 39.91 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.54 -1.264 . . . . 53.25 108.53 174.105 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.02 131.89 15.12 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.189 -1.041 . . . . 62.539999999999999 108.189 -179.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -133.33 131.49 40.19 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.474 -1.306 . . . . 65.140000000000001 107.474 177.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -162.53 154.29 18.36 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.347 -0.983 . . . . 63.100000000000001 108.347 -178.147 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 35.8 ptt180 -92.93 141.58 28.25 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.268 -0.973 . . . . 74.219999999999999 110.187 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.59 130.13 24.07 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 121.038 0.446 . . . . 75.109999999999999 110.044 -176.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.426 ' HA ' HD21 ' A' ' 117' ' ' ASN . 0.8 OUTLIER -63.65 101.14 0.32 Allowed 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 114.721 -1.127 . . . . 73.25 112.643 -178.413 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.414 ' H ' ' ND2' ' A' ' 117' ' ' ASN . 1.7 m-20 . . . . . 0 CA--C 1.505 -0.788 0 CA-C-N 115.425 -0.807 . . . . 65.329999999999998 111.96 172.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 22.8 mtp-105 . . . . . 0 N--CA 1.426 -1.629 0 N-CA-C 109.682 -0.488 . . . . 74.5 109.682 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.99 116.8 53.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 115.496 -0.774 . . . . 73.5 108.957 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.4 mtp85 -106.94 114.34 28.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.228 0.537 . . . . 55.509999999999998 109.669 176.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.23 111.65 23.37 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.263 -1.014 . . . . 73.019999999999996 108.263 177.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -119.52 114.55 22.45 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.54 -1.282 . . . . 73.450000000000003 107.54 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.11 146.26 34.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.814 -0.81 . . . . 55.340000000000003 108.814 -178.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 85.6 m -131.36 126.41 35.17 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-O 121.067 0.46 . . . . 65.430000000000007 110.573 -178.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.3 tt -108.81 112.14 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 121.898 0.856 . . . . 71.230000000000004 109.428 177.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.9 m -76.62 158.11 81.38 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 114.74 -1.118 . . . . 61.340000000000003 110.511 -175.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.12 2.72 0.99 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 123.747 2.965 . . . . 75.150000000000006 112.702 177.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -87.57 -7.15 57.88 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.306 -0.998 . . . . 73.030000000000001 108.306 177.382 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 72.07 29.1 2.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.761 1.625 . . . . 63.420000000000002 108.004 -175.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -111.63 138.95 47.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.918 -1.492 . . . . 62.109999999999999 107.408 179.499 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.446 HG21 ' HG ' ' A' ' 95' ' ' LEU . 11.1 t -113.74 135.52 53.1 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.242 0.544 . . . . 64.129999999999995 109.543 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.9 p -142.77 137.75 29.95 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.566 -1.272 . . . . 70.219999999999999 107.566 177.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.36 -169.5 35.84 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 119.256 -1.449 . . . . 61.450000000000003 112.428 -177.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -149.84 133.6 16.84 Favored 'General case' 0 N--CA 1.418 -2.027 0 C-N-CA 123.263 0.625 . . . . 63.509999999999998 109.53 -177.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.1 mt -116.45 115.49 49.23 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 105.658 -1.979 . . . . 71.349999999999994 105.658 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.5 mt -120.37 114.27 43.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-N 116.196 -0.457 . . . . 61.119999999999997 110.005 -172.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.55 108.56 18.11 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.742 -0.836 . . . . 42.450000000000003 108.742 179.227 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -111.37 118.01 34.68 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 109.035 -0.728 . . . . 75.430000000000007 109.035 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.97 158.74 21.62 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-O 122.006 0.908 . . . . 71.150000000000006 112.288 -174.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt . . . . . 0 C--N 1.294 -1.843 0 CA-C-N 113.807 -1.542 . . . . 74.510000000000005 107.808 170.903 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.42 -1.929 0 N-CA-C 109.836 -0.431 . . . . 70.310000000000002 109.836 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.642 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 175.29 98.02 0.11 Allowed Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.146 -1.502 . . . . 61.109999999999999 113.711 178.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 83' ' ' SER . 38.9 Cg_exo -60.36 159.8 25.79 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 123.646 2.898 . . . . 74.140000000000001 112.639 174.315 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.68 153.25 35.87 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.619 -0.719 . . . . 53.030000000000001 109.425 177.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.0 mt -99.46 138.91 35.89 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.274 -0.421 . . . . 64.239999999999995 110.52 178.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -110.95 87.9 2.65 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.401 1.096 . . . . 75.25 110.898 176.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.07 78.11 0.35 Allowed Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 109.817 -1.313 . . . . 71.349999999999994 109.817 177.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -80.8 93.37 6.22 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.841 0.829 . . . . 75.540000000000006 109.428 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -105.54 158.38 32.41 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 114.067 -1.424 . . . . 44.43 109.841 -176.604 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.29 -20.99 71.94 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 123.114 2.543 . . . . 62.409999999999997 112.984 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -107.03 44.04 1.1 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.562 -0.745 . . . . 75.310000000000002 111.671 -178.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m -51.84 -39.12 58.29 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.146 0.578 . . . . 75.310000000000002 111.87 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -69.82 -15.87 63.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.94 0.4 . . . . 74.420000000000002 111.144 -175.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -91.1 -14.38 31.34 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.855 -0.611 . . . . 54.210000000000001 110.231 -179.06 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.66 120.05 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 119.643 -0.823 . . . . 63.340000000000003 111.788 -179.455 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.44 113.96 27.74 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.078 -0.712 . . . . 61.009999999999998 109.078 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.79 133.81 39.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.617 -0.883 . . . . 74.040000000000006 108.617 -179.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 m -141.73 171.94 13.37 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.15 0.5 . . . . 70.140000000000001 111.273 -177.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.642 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 7.2 t30 -83.39 136.95 34.14 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 124.473 1.109 . . . . 74.299999999999997 110.461 -177.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -116.09 119.9 37.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.822 -0.807 . . . . 63.119999999999997 108.822 177.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -139.2 110.44 6.93 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.349 -2.093 . . . . 62.119999999999997 105.349 177.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 75.8 m -148.13 113.21 5.5 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 110.383 -0.229 . . . . 71.040000000000006 110.383 -178.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.8 t0 68.87 9.65 7.5 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.06 1.344 . . . . 71.109999999999999 111.397 176.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.24 5.06 50.01 Favored Glycine 0 N--CA 1.424 -2.141 0 C-N-CA 120.166 -1.016 . . . . 64.409999999999997 112.546 -176.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.57 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 72.0 m-85 -84.71 140.78 31.05 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.161 -2.163 . . . . 75.129999999999995 105.161 166.181 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.52 135.75 62.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.481 -0.888 . . . . 73.400000000000006 109.266 174.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -167.77 -155.9 9.66 Favored Glycine 0 N--CA 1.403 -3.541 0 C-N-CA 120.519 -0.848 . . . . 43.420000000000002 111.468 178.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 9.3 p -135.88 150.41 49.35 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.084 0.469 . . . . 71.519999999999996 110.31 -177.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.49 127.99 40.29 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.725 -0.67 . . . . 55.149999999999999 110.95 -178.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.03 114.17 28.21 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.917 -1.512 . . . . 53.140000000000001 106.917 174.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.7 t -112.75 112.07 38.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.452 -1.314 . . . . 73.349999999999994 107.452 -178.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.474 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.9 p90 -116.09 155.17 28.64 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.286 -0.415 . . . . 74.030000000000001 111.181 -172.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.5 p -156.92 157.12 34.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.99 -0.55 . . . . 71.209999999999994 110.922 -176.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 t70 64.79 31.84 11.45 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.783 1.233 . . . . 74.430000000000007 111.055 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.474 HD12 ' CD2' ' A' ' 87' ' ' PHE . 27.6 mt -93.53 173.21 7.81 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.665 -0.698 . . . . 73.409999999999997 109.288 176.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -126.26 175.03 8.1 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 120.113 -0.635 . . . . 35.530000000000001 110.227 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.46 ' CZ ' HD13 ' A' ' 112' ' ' LEU . 86.9 t80 -54.56 -39.93 68.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.698 1.199 . . . . 75.310000000000002 112.126 -176.085 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.31 -25.76 67.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.29 0.567 . . . . 75.209999999999994 111.537 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -84.68 -16.18 42.71 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 112.471 0.545 . . . . 62.450000000000003 112.471 -174.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 10.3 mt -53.09 -55.69 31.27 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.671 1.36 . . . . 71.140000000000001 114.671 178.137 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.41 -37.1 51.37 Favored 'Trans proline' 0 C--N 1.36 1.148 0 CA-C-N 120.465 1.202 . . . . 73.439999999999998 110.577 177.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.51 -36.84 85.49 Favored 'General case' 0 N--CA 1.417 -2.082 0 C-N-CA 123.769 0.828 . . . . 70.400000000000006 111.181 -177.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -78.16 -20.22 52.44 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.991 -0.374 . . . . 63.219999999999999 109.991 175.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -69.98 -21.41 63.23 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.929 -0.578 . . . . 54.020000000000003 110.772 -177.442 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -61.21 -53.35 57.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.198 -0.667 . . . . 73.340000000000003 109.198 175.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 32.5 ttp -58.3 -47.27 84.21 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.48 0.657 . . . . 73.25 109.786 177.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 46.0 t30 -53.16 -31.06 40.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.153 -1.385 . . . . 61.109999999999999 111.149 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -56.22 -35.0 66.84 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.965 -0.541 . . . . 75.400000000000006 111.786 -174.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.52 -26.81 68.16 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.265 0.555 . . . . 62.219999999999999 111.805 -174.2 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.97 -16.16 14.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 120.401 -0.519 . . . . 52.140000000000001 110.821 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' A' ' 108' ' ' VAL . . . -106.8 -47.88 3.63 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.656 0.984 . . . . 72.239999999999995 113.656 -170.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.18 28.32 64.42 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.762 -0.935 . . . . 53.399999999999999 110.762 -172.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.443 HG12 ' CB ' ' A' ' 125' ' ' ALA . 13.2 m -114.62 161.45 13.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 74.510000000000005 110.989 -176.156 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -127.61 139.7 52.57 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.179 -1.415 . . . . 64.200000000000003 107.179 174.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -128.3 133.32 48.71 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.464 -0.569 . . . . 70.530000000000001 109.464 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.3 t -132.71 137.6 46.95 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 107.745 -1.206 . . . . 74.420000000000002 107.745 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' A' ' 113' ' ' ARG . 1.3 pp -149.24 152.14 35.46 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.782 1.03 . . . . 70.209999999999994 113.782 -176.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 112' ' ' LEU . 9.6 mpt_? -144.09 154.3 43.06 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.205 -1.361 . . . . 73.319999999999993 111.642 178.74 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.456 ' HD3' HG22 ' A' ' 119' ' ' VAL . 10.0 mmt-85 -90.25 137.95 31.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 107.569 -1.271 . . . . 65.420000000000002 107.569 167.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.446 ' O ' HG13 ' A' ' 118' ' ' ILE . 46.9 t30 -123.18 90.56 3.31 Favored 'General case' 0 C--N 1.258 -3.383 0 N-CA-C 107.134 -1.432 . . . . 74.420000000000002 107.134 173.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.93 -100.31 0.83 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 109.759 -1.336 . . . . 55.450000000000003 109.759 -173.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -121.84 -4.32 9.15 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.429 1.109 . . . . 62.329999999999998 109.0 178.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.6 pp -99.24 150.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.389 -0.967 . . . . 74.230000000000004 108.389 179.076 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.456 HG22 ' HD3' ' A' ' 114' ' ' ARG . 79.7 t -110.36 136.17 47.16 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 O-C-N 121.847 -0.533 . . . . 54.219999999999999 111.539 -176.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.3 pt -117.06 128.96 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 115.202 -0.908 . . . . 74.120000000000005 108.997 175.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -128.42 131.83 48.47 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 108.578 -0.897 . . . . 64.019999999999996 108.578 179.64 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -144.7 139.8 28.18 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.224 -0.658 . . . . 64.239999999999995 109.224 179.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.38 -178.12 36.83 Favored Glycine 0 C--N 1.298 -1.541 0 C-N-CA 120.398 -0.906 . . . . 45.210000000000001 111.689 179.523 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.403 ' HG2' HG22 ' A' ' 171' ' ' THR . 82.8 mtt180 -139.35 150.95 45.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 120.967 0.413 . . . . 73.230000000000004 110.904 -179.15 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.443 ' CB ' HG12 ' A' ' 108' ' ' VAL . . . -122.87 120.54 33.79 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.05 -0.977 . . . . 60.530000000000001 108.6 178.204 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.13 107.33 18.38 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.368 -0.975 . . . . 75.030000000000001 108.368 178.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.426 HD21 ' HB3' ' A' ' 164' ' ' LEU . 1.5 mm? -107.99 15.47 24.32 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.731 -0.841 . . . . 54.25 108.731 178.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 167' ' ' GLY . 42.3 p . . . . . 0 N--CA 1.438 -1.045 0 N-CA-C 108.096 -1.076 . . . . 54.310000000000002 108.096 179.263 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--O 1.239 0.535 0 N-CA-C 111.834 0.309 . . . . 74.430000000000007 111.834 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.547 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -98.45 116.2 30.17 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.451 -0.341 . . . . 53.549999999999997 110.644 -175.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 4.4 m-20 -123.6 140.54 52.9 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.557 -0.534 . . . . 74.400000000000006 109.557 179.052 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 60.4 t -124.84 131.62 72.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.795 -0.817 . . . . 63.350000000000001 108.795 178.513 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.35 122.66 44.47 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.514 -0.921 . . . . 63.310000000000002 108.514 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 46.2 tp -110.9 120.25 41.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.742 -0.836 . . . . 73.439999999999998 108.742 177.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.3 m -124.42 110.14 14.17 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 108.71 -0.848 . . . . 74.510000000000005 108.71 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 87.7 t -109.37 124.49 66.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.699 -0.852 . . . . 62.43 108.699 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.47 130.61 56.29 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 108.803 -0.814 . . . . 73.439999999999998 108.803 178.168 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -133.98 102.56 12.15 Favored Pre-proline 0 C--N 1.266 -3.038 0 N-CA-C 108.34 -0.985 . . . . 71.430000000000007 108.34 175.303 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.36 47.28 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 123.871 3.047 . . . . 73.120000000000005 113.379 -178.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 177' ' ' ARG . . . -112.82 -78.94 0.58 Allowed 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 109.47 -0.567 . . . . 64.140000000000001 109.47 178.106 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.16 118.34 0.01 OUTLIER 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.881 1.272 . . . . 74.209999999999994 108.559 179.378 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.08 134.23 29.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 109.783 -0.451 . . . . 75.420000000000002 109.783 177.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.2 p -101.11 -41.66 6.67 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.156 0.503 . . . . 45.450000000000003 109.851 178.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.2 m -158.25 133.36 8.59 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 109.377 -0.601 . . . . 72.010000000000005 109.377 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.421 ' OG1' HG11 ' A' ' 160' ' ' VAL . 10.0 t -138.95 157.11 46.61 Favored 'General case' 0 C--N 1.285 -2.22 0 O-C-N 121.796 -0.565 . . . . 73.409999999999997 110.172 177.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 43.8 t30 -124.67 88.75 2.95 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 105.524 -2.028 . . . . 73.109999999999999 105.524 174.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.84 -150.97 15.84 Favored Glycine 0 N--CA 1.419 -2.491 0 N-CA-C 107.275 -2.33 . . . . 71.319999999999993 107.275 -177.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -113.68 104.36 12.15 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 118.297 1.049 . . . . 53.210000000000001 111.587 -177.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -77.52 117.35 18.88 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.212 0.53 . . . . 75.329999999999998 110.168 176.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.2 mt -86.38 -48.75 15.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.611 -1.626 . . . . 74.010000000000005 106.611 177.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -123.41 162.06 42.12 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 114.245 -1.343 . . . . 62.229999999999997 107.917 -177.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.63 -4.01 11.3 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.847 2.365 . . . . 73.450000000000003 112.398 177.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.7 OUTLIER -132.68 5.16 3.95 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.263 0.468 . . . . 72.230000000000004 112.263 175.211 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.66 121.0 29.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 N-CA-C 109.32 -0.622 . . . . 52.32 109.32 -179.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.421 HG11 ' OG1' ' A' ' 150' ' ' THR . 57.3 t -124.75 143.14 39.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.507 -0.553 . . . . 70.349999999999994 109.507 -178.035 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.1 tt0 -128.67 146.07 50.98 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.17 0.509 . . . . 73.5 110.034 -177.504 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.422 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.5 m-90 -124.32 127.83 48.19 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.788 -1.19 . . . . 73.409999999999997 107.788 176.181 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.14 107.15 19.62 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.529 -0.545 . . . . 74.319999999999993 109.529 179.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.1 mm? -92.58 124.5 36.66 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.61 -0.723 . . . . 75.310000000000002 109.111 -177.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -117.09 141.69 28.83 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.869 -1.06 . . . . 71.439999999999998 110.689 -171.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 28.5 Cg_endo -60.79 153.13 64.85 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.879 2.386 . . . . 54.25 112.909 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 128' ' ' THR . . . 80.29 -27.21 2.82 Favored Glycine 0 C--N 1.315 -0.635 0 CA-C-N 115.813 -0.63 . . . . 63.039999999999999 113.566 175.438 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.16 162.9 4.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.715 0.769 . . . . 74.329999999999998 112.243 -179.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.44 131.45 66.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.012 -1.107 . . . . 73.530000000000001 108.012 176.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.4 m -119.79 145.46 46.58 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.812 0.339 . . . . 54.439999999999998 110.82 -175.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.403 HG22 ' HG2' ' A' ' 124' ' ' ARG . 22.0 p -104.92 126.35 51.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.056 -0.72 . . . . 61.409999999999997 109.056 175.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -110.1 131.94 54.6 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.023 -0.732 . . . . 71.310000000000002 109.023 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 13.5 m -141.53 140.59 33.49 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.975 -0.69 . . . . 64.319999999999993 109.408 175.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -149.09 121.65 8.56 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.106 -0.702 . . . . 74.319999999999993 109.106 -177.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -124.22 132.16 53.58 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 107.873 -1.158 . . . . 64.450000000000003 107.873 178.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.17 151.48 31.97 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.539 -0.541 . . . . 74.129999999999995 109.539 -175.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.405 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 7.4 ppt_? -88.92 130.15 35.48 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.221 -1.029 . . . . 73.420000000000002 108.221 -179.044 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.439 ' CD2' HG21 ' A' ' 119' ' ' VAL . 7.4 m-30 -118.2 153.64 33.53 Favored 'General case' 0 CA--C 1.465 -2.298 0 CA-C-N 118.527 0.603 . . . . 71.010000000000005 110.191 -174.692 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.6 p -96.89 91.09 5.47 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 109.247 -0.649 . . . . 73.329999999999998 109.247 173.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.2 t70 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 110.025 -0.361 . . . . 73.209999999999994 110.025 179.978 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 . . . . . 0 N--CA 1.435 -1.204 0 N-CA-C 109.502 -0.555 . . . . 64.219999999999999 109.502 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.461 ' CG2' HG22 ' A' ' 137' ' ' VAL . 21.7 m -130.09 113.77 27.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 108.446 -0.946 . . . . 53.329999999999998 108.446 170.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -115.56 116.31 27.93 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.03 -0.986 . . . . 63.210000000000001 109.433 -177.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.09 108.02 16.1 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 106.458 -1.682 . . . . 73.340000000000003 106.458 172.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 140' ' ' THR . 23.1 t -125.9 115.65 20.29 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.038 -1.097 . . . . 74.340000000000003 108.038 -177.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -120.43 146.86 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 109.521 -0.548 . . . . 73.420000000000002 109.521 -177.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.9 m -128.91 122.63 30.69 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 109.83 -0.433 . . . . 60.439999999999998 109.83 -177.545 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -114.34 121.76 67.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.577 0.703 . . . . 72.109999999999999 110.858 -178.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.3 m -95.52 155.93 38.09 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 115.407 -0.815 . . . . 63.130000000000003 110.028 -177.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.14 2.34 0.47 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 124.144 3.23 . . . . 75.0 114.1 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 29.0 t70 -84.66 -4.0 58.8 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.801 -0.814 . . . . 71.430000000000007 108.801 178.385 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 72.2 29.38 2.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.895 1.678 . . . . 73.400000000000006 106.59 -174.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.4 OUTLIER -101.04 125.2 47.64 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 112.967 -1.924 . . . . 65.140000000000001 108.254 -178.743 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.454 HG11 HD13 ' A' ' 95' ' ' LEU . 21.7 t -113.29 133.72 58.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 N-CA-C 108.34 -0.985 . . . . 73.230000000000004 108.34 178.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.6 p -140.42 161.39 37.82 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.462 -1.681 . . . . 52.0 106.462 177.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.53 -178.12 46.44 Favored Glycine 0 CA--C 1.483 -1.929 0 C-N-CA 118.684 -1.722 . . . . 74.209999999999994 112.888 178.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -145.87 133.62 21.12 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 123.08 0.552 . . . . 55.340000000000003 109.53 -176.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.88 115.61 46.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.103 -1.443 . . . . 74.409999999999997 107.103 176.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.62 118.1 56.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 109.659 -0.497 . . . . 72.519999999999996 109.659 -178.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.468 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -114.49 108.61 17.09 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.564 -1.273 . . . . 64.519999999999996 107.564 175.764 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.81 124.12 43.41 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.507 -0.553 . . . . 64.129999999999995 109.507 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.07 158.71 23.72 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.919 -0.582 . . . . 71.319999999999993 111.905 -174.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.4 pttt . . . . . 0 N--CA 1.443 -0.812 0 CA-C-N 114.306 -1.316 . . . . 74.439999999999998 109.357 173.013 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.421 -1.88 0 N-CA-C 109.288 -0.634 . . . . 73.329999999999998 109.288 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.45 97.81 0.11 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 120.717 -0.754 . . . . 70.340000000000003 111.851 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 83' ' ' SER . 39.4 Cg_exo -63.35 159.5 39.6 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.753 2.302 . . . . 63.43 111.478 176.173 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.41 120.93 36.49 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.548 -0.908 . . . . 53.43 108.548 178.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.1 mt -72.32 126.94 31.06 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.513 0.673 . . . . 61.420000000000002 110.642 176.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.85 87.21 6.39 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.101 -1.409 . . . . 75.120000000000005 108.374 -173.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.494 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -165.62 82.37 0.11 Allowed Glycine 0 N--CA 1.407 -3.251 0 CA-C-N 114.78 -1.1 . . . . 72.239999999999995 112.328 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -98.14 97.5 8.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.669 -1.234 . . . . 42.409999999999997 107.669 174.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -110.36 158.17 36.06 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.011 -0.995 . . . . 61.100000000000001 110.522 -174.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.57 -23.53 71.44 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 122.762 2.308 . . . . 51.530000000000001 111.634 177.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -103.92 30.92 4.8 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.51 -0.768 . . . . 63.43 111.658 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.6 m -58.73 -23.91 60.64 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 121.152 0.501 . . . . 40.350000000000001 110.99 176.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -66.76 -18.87 65.6 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.806 -0.633 . . . . 74.549999999999997 110.069 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -97.62 -11.91 23.06 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.739 -0.664 . . . . 74.129999999999995 110.711 -178.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.62 119.27 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 122.069 0.938 . . . . 65.540000000000006 111.772 178.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.27 103.46 15.92 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.37 -0.832 . . . . 70.230000000000004 108.786 178.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 85' ' ' ALA . 7.2 p -98.13 131.21 45.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.633 -1.247 . . . . 71.209999999999994 107.633 178.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -146.16 171.41 14.97 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.283 -0.636 . . . . 75.530000000000001 109.283 -173.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -85.59 151.93 23.53 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.979 -1.119 . . . . 75.519999999999996 107.979 175.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 63.0 t80 -113.21 122.62 48.02 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.585 -0.895 . . . . 63.299999999999997 108.585 -179.623 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -138.67 97.9 3.45 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.096 -1.446 . . . . 71.340000000000003 107.096 176.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 48.1 m -166.24 157.22 13.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.246 -1.39 . . . . 43.020000000000003 107.246 -176.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.25 1.71 3.37 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.233 1.013 . . . . 75.129999999999995 112.757 173.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.99 -4.76 65.67 Favored Glycine 0 C--O 1.213 -1.212 0 N-CA-C 110.707 -0.957 . . . . 74.219999999999999 110.707 -174.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.92 156.84 16.92 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 123.61 0.764 . . . . 73.430000000000007 109.283 -176.164 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.35 137.45 56.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.335 -0.617 . . . . 61.030000000000001 109.335 173.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -171.2 -154.17 9.53 Favored Glycine 0 N--CA 1.416 -2.665 0 C-N-CA 119.99 -1.1 . . . . 71.239999999999995 112.373 -177.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 12.4 p -129.68 148.04 51.52 Favored 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 123.441 0.696 . . . . 73.319999999999993 110.195 -177.269 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.78 145.18 44.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.674 0.273 . . . . 72.430000000000007 110.769 178.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . . . -127.07 114.92 18.39 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.565 -1.272 . . . . 31.039999999999999 107.565 174.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.7 t -114.39 117.97 57.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.557 -0.905 . . . . 73.310000000000002 108.557 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.431 ' CD2' HD12 ' A' ' 90' ' ' LEU . 48.8 p90 -120.51 154.61 35.05 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 120.817 0.341 . . . . 75.140000000000001 111.076 -174.674 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.5 m -158.15 158.37 34.5 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.16 -0.473 . . . . 60.100000000000001 110.39 -179.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.7 t70 67.34 31.89 6.21 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.532 1.158 . . . . 75.439999999999998 111.348 176.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 90' ' ' LEU . 31.6 mt -97.4 159.91 14.64 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.633 -0.712 . . . . 72.420000000000002 111.483 178.034 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 93' ' ' ALA . 27.5 m -96.2 158.11 15.59 Favored 'General case' 0 N--CA 1.412 -2.343 0 C-N-CA 124.554 1.142 . . . . 72.129999999999995 109.23 -177.414 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.8 -38.81 70.46 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.837 0.351 . . . . 73.409999999999997 110.655 175.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 91' ' ' THR . . . -63.3 -25.48 68.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.964 -0.562 . . . . 73.519999999999996 111.598 178.038 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -88.14 -16.35 33.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.905 0.383 . . . . 54.130000000000003 111.318 -178.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 43.7 tp -56.6 -48.64 96.79 Favored Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 112.89 0.7 . . . . 72.120000000000005 112.89 179.091 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.32 -35.87 81.95 Favored 'Trans proline' 0 C--N 1.369 1.652 0 CA-C-N 120.847 1.338 . . . . 74.129999999999995 111.318 174.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -64.63 -39.76 94.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.283 0.563 . . . . 70.340000000000003 110.817 -177.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -77.09 -19.67 56.73 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.622 -0.51 . . . . 71.430000000000007 109.622 177.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.13 -21.62 59.8 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.197 -0.668 . . . . 54.32 109.197 -177.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.09 -55.77 22.59 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.26 -1.015 . . . . 75.109999999999999 108.26 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.494 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.4 ttp -53.64 -51.31 63.52 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.508 -0.769 . . . . 65.150000000000006 109.865 178.108 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -53.07 -42.62 66.0 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.015 -0.993 . . . . 64.329999999999998 109.838 179.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -62.08 -41.02 97.76 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.916 -0.584 . . . . 70.200000000000003 109.498 -172.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.33 -11.16 59.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.451 -0.795 . . . . 71.310000000000002 110.097 -169.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.86 -17.57 14.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.858 -0.61 . . . . 52.32 110.559 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.68 -43.69 4.65 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.126 0.787 . . . . 64.049999999999997 113.126 -173.532 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.97 19.44 28.82 Favored Glycine 0 C--N 1.317 -0.49 0 N-CA-C 110.03 -1.228 . . . . 71.510000000000005 110.03 -172.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -110.18 142.44 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.449 -0.574 . . . . 52.5 109.449 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -107.86 122.48 46.88 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.426 -1.324 . . . . 73.239999999999995 107.426 177.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.4 mt -120.55 127.67 52.37 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 121.09 -0.244 . . . . 61.140000000000001 110.356 -177.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -130.34 136.68 49.37 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.609 -1.256 . . . . 71.019999999999996 107.609 177.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -146.0 149.65 34.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.409 0.623 . . . . 75.310000000000002 111.013 -178.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -144.67 156.51 44.13 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.868 -1.06 . . . . 73.319999999999993 108.884 -179.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.479 ' NH1' ' HA ' ' A' ' 180' ' ' ASP . 17.0 ttm180 -114.03 130.94 56.52 Favored 'General case' 0 N--CA 1.398 -3.037 0 N-CA-C 108.196 -1.039 . . . . 74.530000000000001 108.196 172.082 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -113.06 100.76 8.86 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.899 -1.519 . . . . 73.200000000000003 106.899 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.63 -113.32 5.2 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 110.575 -1.01 . . . . 74.230000000000004 110.575 -176.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -109.1 1.77 20.67 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.025 0.917 . . . . 70.010000000000005 109.436 179.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.4 pp -110.39 146.62 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 118.217 -1.393 . . . . 71.099999999999994 109.514 179.25 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.448 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 76.3 t -110.89 143.51 20.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-O 120.972 0.415 . . . . 63.399999999999999 110.629 -177.213 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.1 pt -124.13 133.75 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 108.822 -0.807 . . . . 71.430000000000007 108.822 178.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.45 127.1 41.87 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.785 -0.82 . . . . 51.229999999999997 108.785 178.113 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -131.54 123.34 27.79 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.452 -1.314 . . . . 63.549999999999997 107.452 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -143.51 164.4 27.36 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.423 -0.894 . . . . 54.200000000000003 112.982 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -134.01 130.27 37.34 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.323 -0.621 . . . . 72.030000000000001 109.323 -178.767 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.19 110.46 21.69 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.766 -0.457 . . . . 74.150000000000006 109.766 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.85 93.68 5.02 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 122.03 0.919 . . . . 75.430000000000007 108.691 177.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.6 pt? -114.75 23.39 12.69 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-O 122.924 1.345 . . . . 65.200000000000003 109.057 177.476 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 C--N 1.311 -1.068 0 N-CA-C 106.249 -1.76 . . . . 74.010000000000005 106.249 171.596 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 112.2 0.445 . . . . 74.450000000000003 112.2 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.87 144.69 31.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.351 0.5 . . . . 73.530000000000001 112.351 -172.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -131.21 116.58 17.85 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 105.845 -1.909 . . . . 65.430000000000007 105.845 171.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 56.6 t -108.0 124.17 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 C-N-CA 120.017 -0.673 . . . . 72.230000000000004 110.463 -172.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.96 120.19 31.77 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.365 -0.606 . . . . 73.5 109.365 177.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.6 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.6 tm? -111.79 117.07 31.81 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.223 -1.769 . . . . 70.310000000000002 106.223 177.394 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.5 m -126.01 136.91 53.52 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 120.879 0.371 . . . . 64.099999999999994 110.263 -176.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.6 t -128.22 120.89 54.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.034 -1.099 . . . . 72.340000000000003 108.034 176.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.07 127.37 56.19 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.269 -0.641 . . . . 51.049999999999997 109.269 179.554 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -135.09 122.02 14.88 Favored Pre-proline 0 C--N 1.288 -2.093 0 N-CA-C 112.449 0.537 . . . . 74.120000000000005 112.449 179.186 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.88 40.81 0.44 Allowed 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 122.822 2.348 . . . . 73.120000000000005 111.527 172.293 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.52 -91.86 0.53 Allowed 'General case' 0 N--CA 1.434 -1.226 0 O-C-N 122.062 -0.399 . . . . 73.510000000000005 110.656 -178.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 170.31 120.29 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 124.046 0.938 . . . . 62.210000000000001 108.596 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.06 118.38 16.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 122.357 1.075 . . . . 72.409999999999997 109.999 175.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 176' ' ' ALA . 33.4 m -75.99 -45.81 32.75 Favored 'General case' 1 N--CA 1.367 -4.583 0 CA-C-N 113.981 -1.463 . . . . 64.549999999999997 110.498 -178.657 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.3 m -163.2 133.32 4.4 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.036 0.934 . . . . 64.120000000000005 108.949 174.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -138.58 157.53 45.97 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.467 -0.771 . . . . 73.140000000000001 111.993 177.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 24.1 t-20 -127.42 95.73 4.35 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 104.984 -2.228 . . . . 72.230000000000004 104.984 173.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.483 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 170.04 -148.43 11.74 Favored Glycine 0 N--CA 1.414 -2.827 0 N-CA-C 108.106 -1.998 . . . . 75.230000000000004 108.106 -178.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -115.59 99.25 7.2 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.864 0.84 . . . . 75.400000000000006 109.937 -176.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -82.88 117.06 22.47 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-N 115.526 -0.761 . . . . 61.219999999999999 111.013 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.3 -39.92 19.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.977 -1.49 . . . . 55.240000000000002 106.977 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -138.24 167.82 18.43 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 114.474 -1.239 . . . . 75.409999999999997 107.889 176.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -72.63 0.49 7.51 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.724 2.283 . . . . 42.219999999999999 111.086 174.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -127.69 -2.41 6.03 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.418 -0.81 . . . . 74.319999999999993 111.379 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.6 t -140.41 120.38 12.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.578 -0.897 . . . . 65.200000000000003 108.578 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.89 144.29 34.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.054 -0.721 . . . . 71.230000000000004 109.054 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -138.08 144.61 41.01 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.457 0.646 . . . . 74.409999999999997 109.464 -177.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.6 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.1 m-90 -119.05 114.57 22.71 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 108.017 -1.105 . . . . 72.120000000000005 108.017 176.345 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.53 107.37 18.08 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.04 0.924 . . . . 74.209999999999994 109.2 178.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.674 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 77.4 mt -101.51 127.4 48.22 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 114.493 -1.231 . . . . 53.140000000000001 110.207 -174.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -114.09 131.36 23.23 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 114.01 -1.45 . . . . 74.010000000000005 110.966 -173.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -54.07 151.0 29.29 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.383 2.722 . . . . 74.219999999999999 112.583 178.037 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.17 -33.47 2.92 Favored Glycine 0 C--N 1.304 -1.207 0 C-N-CA 120.98 -0.629 . . . . 74.109999999999999 112.963 176.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.22 155.6 6.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 120.997 0.427 . . . . 63.119999999999997 110.864 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.99 144.26 14.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.32 -0.622 . . . . 54.399999999999999 109.32 -178.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 m -145.19 141.12 28.41 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.611 -0.514 . . . . 61.450000000000003 109.611 177.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 63.1 p -105.23 135.07 47.27 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.207 -0.664 . . . . 74.120000000000005 109.207 177.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.4 131.79 50.2 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.72 -0.474 . . . . 73.010000000000005 109.72 177.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 47.4 m -137.24 139.03 40.74 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 119.659 -0.816 . . . . 74.140000000000001 109.972 174.369 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.99 133.05 15.23 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 108.62 -0.881 . . . . 55.329999999999998 108.62 -175.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -133.7 131.57 39.63 Favored 'General case' 0 C--N 1.26 -3.312 0 N-CA-C 107.353 -1.351 . . . . 74.140000000000001 107.353 176.346 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.528 ' HA ' ' OG1' ' A' ' 148' ' ' THR . . . -156.68 146.3 20.74 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.563 -0.532 . . . . 74.209999999999994 109.563 -177.23 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 19.1 ptt85 -86.22 135.25 33.64 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.999 -0.546 . . . . 75.329999999999998 110.616 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.448 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 95.3 m-85 -137.65 135.84 36.9 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 108.744 -0.836 . . . . 74.150000000000006 108.744 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.2 p -58.71 109.24 0.77 Allowed 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.066 0.854 . . . . 72.140000000000001 111.547 -178.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.479 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 22.3 t70 . . . . . 0 CA--C 1.489 -1.403 0 CA-C-N 115.166 -0.925 . . . . 71.219999999999999 108.69 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.129 0 N-CA-C 110.976 -0.849 . . . . 54.310000000000002 110.976 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 64.97 86.77 0.12 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.492 1.117 . . . . 70.140000000000001 112.336 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.37 172.16 7.5 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 104.773 -2.306 . . . . 72.549999999999997 104.773 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -74.57 87.26 2.12 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 108.23 -1.026 . . . . 75.140000000000001 108.23 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.4 mt -112.76 90.4 3.33 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.935 -0.575 . . . . 73.400000000000006 110.193 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -158.11 117.71 3.24 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.213 -1.773 . . . . 73.439999999999998 106.213 172.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -124.96 133.1 53.15 Favored 'General case' 0 C--N 1.283 -2.317 0 O-C-N 123.687 0.617 . . . . 74.409999999999997 109.629 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -81.88 159.84 23.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.882 -1.525 . . . . 60.409999999999997 106.882 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.48 -69.9 1.33 Allowed Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 119.91 -1.138 . . . . 74.209999999999994 111.318 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.635 ' HA ' ' CG ' ' A' ' 132' ' ' ASP . 82.6 m-70 65.73 96.94 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 123.866 0.866 . . . . 72.519999999999996 112.282 -176.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.5 ttm 71.14 71.11 0.18 Allowed 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.35 1.46 . . . . 62.420000000000002 109.088 -174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 pp -109.79 147.26 33.58 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 113.753 -1.567 . . . . 72.329999999999998 108.109 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -120.86 123.93 43.75 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 108.773 -0.825 . . . . 73.540000000000006 108.773 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.0 t -121.91 113.71 40.0 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 107.142 -1.429 . . . . 74.510000000000005 107.142 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -124.51 113.81 18.6 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.143 0.497 . . . . 73.519999999999996 109.71 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.09 113.75 27.14 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.407 -1.331 . . . . 74.109999999999999 107.407 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 140' ' ' THR . 37.8 m -125.18 114.51 19.09 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.931 -1.137 . . . . 75.25 107.931 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.401 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 2.1 pp -130.33 147.1 33.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.323 -0.398 . . . . 73.030000000000001 110.274 -173.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 78.3 m -125.68 123.63 39.34 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 109.27 -0.641 . . . . 74.239999999999995 109.27 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.492 ' O ' ' HD2' ' A' ' 144' ' ' PRO . 8.5 tt -114.69 131.47 66.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.944 -0.571 . . . . 74.510000000000005 111.031 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -96.55 149.95 36.44 Favored Pre-proline 0 N--CA 1.419 -1.977 0 N-CA-C 108.91 -0.774 . . . . 64.340000000000003 108.91 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.12 2.41 2.22 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.133 2.555 . . . . 70.120000000000005 112.699 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -86.74 5.82 34.44 Favored 'General case' 0 N--CA 1.414 -2.241 0 C-N-CA 123.722 0.809 . . . . 70.329999999999998 110.87 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 t70 70.83 29.48 3.11 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 123.183 1.468 . . . . 71.140000000000001 107.558 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.52 128.79 55.76 Favored 'General case' 0 N--CA 1.399 -3.018 0 CA-C-N 113.174 -1.83 . . . . 64.310000000000002 107.121 -177.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.513 HG11 HD21 ' A' ' 95' ' ' LEU . 8.1 t -124.29 144.9 32.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.095 -0.502 . . . . 51.140000000000001 110.071 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -149.21 161.26 42.36 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.791 -0.818 . . . . 65.150000000000006 108.791 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 162.26 -165.31 35.96 Favored Glycine 0 C--N 1.312 -0.786 0 C-N-CA 119.266 -1.445 . . . . 51.130000000000003 113.019 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -150.52 140.19 21.68 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.009 0.433 . . . . 72.329999999999998 109.853 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.3 mt -125.41 116.68 47.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.511 -0.922 . . . . 71.349999999999994 108.511 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.26 123.43 63.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.618 -0.512 . . . . 61.399999999999999 109.618 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.42 108.46 14.58 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.326 -1.361 . . . . 54.439999999999998 107.326 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -122.09 135.65 54.83 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.985 0.421 . . . . 72.530000000000001 111.616 -174.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.48 158.67 41.48 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.885 -0.783 . . . . 63.049999999999997 108.885 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -77.23 138.74 64.32 Favored Pre-proline 0 C--N 1.318 -0.804 0 C-N-CA 118.653 -1.219 . . . . 73.0 109.775 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.07 -58.91 1.3 Allowed 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.516 2.81 . . . . 74.120000000000005 115.742 -173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt 67.46 -44.34 0.47 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 115.099 1.518 . . . . 75.329999999999998 115.099 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.503 ' ND2' ' HG2' ' A' ' 54' ' ' LYS . 60.5 t30 -126.25 146.16 50.11 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.418 -0.586 . . . . 64.030000000000001 109.418 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.4 m -71.15 -12.51 61.53 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 114.002 1.112 . . . . 44.420000000000002 114.002 -172.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HG2' ' ND2' ' A' ' 52' ' ' ASN . 10.6 ptmm? -76.35 -17.91 59.16 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.052 0.453 . . . . 75.549999999999997 110.564 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.82 128.96 49.36 Favored 'General case' 0 N--CA 1.401 -2.899 0 N-CA-C 113.305 0.854 . . . . 71.420000000000002 113.305 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.493 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 4.2 t -106.08 -17.53 14.3 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.911 -1.495 . . . . 53.420000000000002 107.299 174.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.08 112.64 0.29 Allowed Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 109.875 -1.29 . . . . 72.530000000000001 109.875 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -52.36 128.91 29.39 Favored 'Trans proline' 0 C--N 1.355 0.915 0 CA-C-N 119.879 1.839 . . . . 74.099999999999994 109.089 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.63 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -95.87 151.95 18.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 114.169 1.174 . . . . 72.409999999999997 114.169 -167.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 83.4 mt -85.23 141.49 30.09 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.322 -1.308 . . . . 51.530000000000001 108.952 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -106.43 99.9 9.45 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.546 -1.279 . . . . 71.549999999999997 107.546 177.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.4 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -149.69 69.37 0.33 Allowed Glycine 0 C--N 1.287 -2.188 0 C-N-CA 120.041 -1.076 . . . . 55.039999999999999 114.023 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.65 95.51 6.59 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.18 -1.415 . . . . 74.019999999999996 107.18 172.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.31 159.28 29.98 Favored Pre-proline 0 C--N 1.293 -1.885 0 CA-C-N 115.088 -0.96 . . . . 72.549999999999997 109.823 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.56 -16.74 55.09 Favored 'Trans proline' 0 N--CA 1.481 0.741 0 C-N-CA 122.739 2.292 . . . . 61.119999999999997 113.153 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -115.79 33.37 5.53 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.058 -0.519 . . . . 73.439999999999998 110.597 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 p -57.63 -28.24 63.52 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 121.222 0.534 . . . . 74.409999999999997 112.375 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -66.94 -20.05 65.83 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.235 0.541 . . . . 73.420000000000002 110.351 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -101.03 -2.77 30.77 Favored 'General case' 0 C--O 1.257 1.492 0 CA-C-N 115.846 -0.615 . . . . 73.140000000000001 110.233 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' A' ' 87' ' ' PHE . 4.3 p -132.41 118.87 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 122.12 0.962 . . . . 62.240000000000002 110.817 175.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.95 106.0 17.99 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 115.477 -0.783 . . . . 61.509999999999998 109.209 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.21 130.93 45.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 106.784 -1.561 . . . . 71.349999999999994 106.784 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.1 t -145.67 171.77 14.24 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.89 -0.781 . . . . 33.140000000000001 108.89 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -84.53 137.9 33.06 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.14 -0.689 . . . . 74.329999999999998 109.14 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 77.0 t80 -107.38 124.96 50.6 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.473 -0.936 . . . . 73.239999999999995 108.473 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -139.0 98.84 3.62 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.553 -1.277 . . . . 74.430000000000007 107.553 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 70.3 m -160.22 148.48 16.79 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.779 -0.452 . . . . 55.32 109.779 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 67.64 8.22 6.21 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.733 1.213 . . . . 75.299999999999997 112.056 173.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.59 4.99 65.3 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.003 -0.839 . . . . 55.509999999999998 111.003 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.498 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 2.9 m-85 -104.71 142.91 33.85 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.191 -1.041 . . . . 72.010000000000005 108.191 178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.8 m -124.78 139.18 51.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.547 -0.909 . . . . 65.219999999999999 108.547 175.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.26 -153.8 10.6 Favored Glycine 0 C--N 1.266 -3.353 0 N-CA-C 110.309 -1.117 . . . . 62.409999999999997 110.309 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.63 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 69.3 m -132.48 151.07 52.03 Favored 'General case' 0 C--N 1.266 -3.034 0 CA-C-O 121.289 0.566 . . . . 74.329999999999998 111.804 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -131.35 141.14 49.86 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.708 -0.678 . . . . 74.140000000000001 109.894 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.35 114.66 26.95 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.941 -1.133 . . . . 62.219999999999999 107.941 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -110.51 113.1 43.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.752 -1.203 . . . . 72.230000000000004 107.752 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CD2' HD12 ' A' ' 90' ' ' LEU . 40.6 p90 -120.42 156.23 31.84 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 120.745 0.307 . . . . 75.099999999999994 111.648 -173.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 p -160.7 149.54 16.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.876 -0.602 . . . . 75.519999999999996 111.089 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 67.23 32.16 6.2 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.467 1.107 . . . . 73.299999999999997 110.822 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 87' ' ' PHE . 19.6 mt -89.52 169.22 11.54 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.687 -0.688 . . . . 72.219999999999999 109.621 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.401 HG22 ' OE1' ' A' ' 94' ' ' GLU . 10.8 t -124.82 171.14 10.38 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.698 -0.482 . . . . 64.409999999999997 109.698 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -56.36 -36.37 68.72 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.856 0.862 . . . . 75.129999999999995 112.366 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.56 -25.6 63.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.15 0.5 . . . . 74.099999999999994 111.811 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' OE1' HG22 ' A' ' 91' ' ' THR . 55.7 mt-10 -81.07 -21.25 40.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 112.126 0.417 . . . . 75.140000000000001 112.126 -176.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.513 HD21 HG11 ' A' ' 40' ' ' VAL . 18.8 mt -54.53 -49.77 89.15 Favored Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 115.697 1.74 . . . . 73.030000000000001 115.697 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -54.92 -45.84 37.88 Favored 'Trans proline' 0 C--N 1.365 1.441 0 CA-C-N 120.816 1.327 . . . . 72.329999999999998 111.269 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.526 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 22.0 mt-30 -68.46 -32.87 73.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.948 0.88 . . . . 65.129999999999995 110.407 -174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.42 -40.58 89.62 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.296 -1.32 . . . . 74.299999999999997 108.829 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.75 -25.38 67.9 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.932 -1.031 . . . . 71.329999999999998 111.118 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' ' 97' ' ' GLN . 84.2 m-20 -59.35 -55.55 33.3 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.404 0.44 . . . . 73.340000000000003 109.901 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.4 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 29.7 ttp -54.36 -48.93 70.91 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 123.706 0.629 . . . . 70.319999999999993 110.222 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -53.13 -41.95 65.57 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 114.964 -1.016 . . . . 61.439999999999998 111.363 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.9 m -67.23 -21.4 65.75 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.83 -0.623 . . . . 71.430000000000007 112.003 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.14 -28.59 70.17 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 121.38 0.61 . . . . 64.310000000000002 109.753 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -112.65 -2.55 14.51 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.823 -0.626 . . . . 72.140000000000001 110.916 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.7 -47.59 3.86 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.153 -0.619 . . . . 73.219999999999999 112.52 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.44 28.97 66.71 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.218 -0.992 . . . . 71.040000000000006 112.007 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.4 m -123.1 173.56 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.594 -0.521 . . . . 62.32 109.594 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -126.23 130.34 50.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 117.891 0.314 . . . . 73.209999999999994 110.912 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.05 136.16 53.42 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.06 -0.718 . . . . 63.009999999999998 109.06 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -143.34 120.21 11.27 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.933 -0.395 . . . . 63.340000000000003 109.933 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.3 145.9 36.64 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.08 -0.648 . . . . 63.549999999999997 109.262 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HE ' HD11 ' A' ' 120' ' ' ILE . 84.4 mtm-85 -147.41 151.33 36.29 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.55 -0.75 . . . . 62.219999999999999 109.571 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.416 ' CG ' HG22 ' A' ' 119' ' ' VAL . 20.3 mtt85 -97.16 137.6 35.95 Favored 'General case' 0 CA--C 1.484 -1.559 0 C-N-CA 120.126 -0.63 . . . . 61.100000000000001 111.42 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -117.77 92.26 3.79 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 106.534 -1.654 . . . . 73.430000000000007 106.534 174.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' A' ' 185' ' ' SER . . . 75.94 -98.24 1.18 Allowed Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 110.694 -0.962 . . . . 62.43 110.694 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -130.64 6.28 4.74 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.809 1.29 . . . . 71.040000000000006 108.216 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.544 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.2 pp -108.51 145.06 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 106.695 -1.595 . . . . 71.209999999999994 106.695 177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.416 HG22 ' CG ' ' A' ' 114' ' ' ARG . 90.9 t -105.48 136.44 39.51 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.831 0 N-CA-C 109.675 -0.491 . . . . 75.310000000000002 109.675 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.497 HG22 ' HG2' ' A' ' 175' ' ' GLN . 33.5 pt -111.69 133.57 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.318 0 N-CA-C 107.531 -1.285 . . . . 70.510000000000005 107.531 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.6 tt -115.03 123.76 49.88 Favored 'General case' 0 C--N 1.255 -3.534 0 N-CA-C 108.385 -0.968 . . . . 73.109999999999999 108.385 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -116.49 131.2 57.01 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 113.913 -1.494 . . . . 72.230000000000004 107.052 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -152.64 148.26 18.91 Favored Glycine 0 N--CA 1.413 -2.837 0 C-N-CA 119.735 -1.222 . . . . 74.129999999999995 110.301 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.58 137.47 43.77 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.103 -0.703 . . . . 71.010000000000005 109.103 176.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.38 109.14 13.52 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 108.633 -0.877 . . . . 64.439999999999998 108.633 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.11 98.6 7.45 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.543 -1.651 . . . . 61.409999999999997 106.543 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -122.13 36.99 4.49 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 123.024 1.392 . . . . 75.400000000000006 108.542 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 49.8 p -65.89 -40.46 91.57 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 113.515 -1.675 . . . . 71.439999999999998 110.538 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.2 m -84.33 16.51 3.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.002 0.921 . . . . 63.009999999999998 112.44 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 166' ' ' PRO . 8.6 p -68.98 147.46 12.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.011 0 N-CA-C 108.803 -0.814 . . . . 44.130000000000003 108.803 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.5 m -91.98 0.66 57.47 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 120.672 0.272 . . . . 74.430000000000007 111.25 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.635 ' CG ' ' HA ' ' A' ' 24' ' ' HIS . 26.2 t70 -128.85 122.74 21.61 Favored Pre-proline 0 C--N 1.308 -1.229 0 N-CA-C 112.13 0.418 . . . . 73.209999999999994 112.13 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.28 -17.83 18.64 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.886 2.39 . . . . 72.150000000000006 113.468 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -96.12 10.42 37.72 Favored 'General case' 0 C--O 1.243 0.728 0 O-C-N 121.995 -0.441 . . . . 75.120000000000005 112.014 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -71.92 136.0 46.72 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.92 -0.582 . . . . 71.530000000000001 109.567 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -131.06 114.43 15.16 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.846 -0.428 . . . . 74.310000000000002 109.846 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 89.4 t -109.96 126.63 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 107.163 -1.421 . . . . 71.230000000000004 107.163 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -134.79 129.14 34.12 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-O 120.939 0.4 . . . . 71.450000000000003 111.206 -171.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.9 tp -117.79 129.48 55.7 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.178 -0.464 . . . . 70.409999999999997 109.905 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' SER . 18.4 m -127.05 122.56 34.7 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.074 -1.084 . . . . 73.549999999999997 108.074 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 97.1 t -118.07 122.62 70.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.413 -0.588 . . . . 62.009999999999998 109.413 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.07 130.6 56.56 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.23 -0.655 . . . . 74.530000000000001 109.23 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.699 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.2 p90 -135.33 127.1 17.71 Favored Pre-proline 0 C--N 1.286 -2.178 0 CA-C-O 119.424 -0.322 . . . . 61.219999999999999 111.587 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 58.5 Cg_endo -75.15 36.63 0.45 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.569 2.179 . . . . 73.319999999999993 112.029 177.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.54 -103.19 0.41 Allowed 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 109.665 -0.495 . . . . 53.310000000000002 109.665 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.87 131.05 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.931 -1.137 . . . . 61.130000000000003 107.931 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.59 133.84 28.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.049 0.452 . . . . 75.219999999999999 109.969 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.3 p -89.19 -46.41 8.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.246 0.546 . . . . 72.030000000000001 109.623 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 68.6 m -152.05 133.88 14.85 Favored 'General case' 0 C--O 1.207 -1.178 0 CA-C-N 115.586 -0.733 . . . . 42.43 110.055 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 t -139.0 160.9 38.67 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.869 -0.519 . . . . 72.530000000000001 110.446 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 29.2 t-20 -132.26 89.56 2.68 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.723 -1.954 . . . . 75.150000000000006 105.723 174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.35 -147.97 9.96 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 108.235 -1.946 . . . . 72.200000000000003 108.235 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -118.36 100.63 7.61 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 117.829 0.814 . . . . 64.409999999999997 110.301 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 21.0 ptt180 -83.26 123.44 29.6 Favored 'General case' 0 N--CA 1.413 -2.313 0 C-N-CA 119.884 -0.726 . . . . 73.420000000000002 111.354 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.56 -46.93 17.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.236 -1.394 . . . . 71.340000000000003 107.236 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -123.53 165.02 24.88 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 107.739 -1.208 . . . . 73.049999999999997 107.739 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -72.23 -0.16 8.22 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.429 2.086 . . . . 61.329999999999998 110.931 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.699 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.9 pt-20 -135.46 6.3 3.25 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.166 -0.925 . . . . 74.439999999999998 111.9 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.92 120.85 6.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 108.126 -1.064 . . . . 64.430000000000007 108.126 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 36.9 t -125.19 146.57 30.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 109.448 -0.575 . . . . 72.5 109.448 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -133.03 146.11 51.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 109.45 -0.574 . . . . 54.030000000000001 109.45 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 29.7 m-90 -128.19 129.35 46.34 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.639 -0.71 . . . . 72.540000000000006 109.245 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 1.0 OUTLIER -102.73 103.0 13.21 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 122.149 0.976 . . . . 74.310000000000002 111.005 176.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.5 mm? -90.73 116.22 28.42 Favored 'General case' 0 C--O 1.264 1.829 0 CA-C-O 121.827 0.822 . . . . 74.329999999999998 108.891 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 10.8 mmpt? -104.73 143.5 26.83 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 114.272 -1.331 . . . . 62.109999999999999 111.269 -172.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.46 ' CB ' HG11 ' A' ' 130' ' ' VAL . 58.5 Cg_endo -69.85 150.22 67.35 Favored 'Trans proline' 0 C--O 1.248 1.013 0 C-N-CA 123.963 3.109 . . . . 74.319999999999993 111.722 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.49 -30.64 3.06 Favored Glycine 0 C--N 1.321 -0.288 0 C-N-CA 120.913 -0.66 . . . . 41.020000000000003 112.213 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 35.3 m -105.63 165.79 3.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 110.011 -0.366 . . . . 73.230000000000004 110.011 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.69 142.26 26.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.215 -1.031 . . . . 63.310000000000002 108.215 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 63.7 m -142.34 140.89 32.26 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.204 0.526 . . . . 73.129999999999995 110.823 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 50.5 p -103.34 141.3 36.17 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 107.962 -1.125 . . . . 74.209999999999994 107.962 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -123.79 126.58 46.72 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 109.919 -0.4 . . . . 63.119999999999997 109.919 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 35.4 t -138.79 144.15 39.24 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.829 -0.434 . . . . 31.309999999999999 109.829 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.42 127.94 10.74 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.318 -0.993 . . . . 65.519999999999996 108.318 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' A' ' 120' ' ' ILE . 44.8 mt-30 -128.47 131.95 48.37 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 108.703 -0.851 . . . . 73.239999999999995 108.703 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.73 159.9 43.79 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.822 -0.436 . . . . 44.240000000000002 109.822 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.544 ' HG2' HG22 ' A' ' 118' ' ' ILE . 98.5 mtt180 -86.96 126.81 34.95 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.674 -0.491 . . . . 71.519999999999996 109.674 -177.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.401 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 74.9 m-85 -143.11 125.24 15.37 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 109.589 -0.523 . . . . 64.239999999999995 109.589 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.35 114.07 1.84 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 124.29 0.994 . . . . 73.340000000000003 111.831 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -68.61 138.04 90.88 Favored Pre-proline 0 C--O 1.213 -0.868 0 N-CA-C 108.322 -0.992 . . . . 72.030000000000001 108.322 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.39 -35.99 88.8 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.43 2.087 . . . . 44.130000000000003 113.153 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -84.61 -19.82 32.38 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.162 -1.051 . . . . 71.319999999999993 108.162 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.295 33.2 p 61.04 53.99 3.5 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 125.368 1.467 . . . . 72.219999999999999 111.713 -175.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -90.75 -177.53 5.01 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.613 -1.63 . . . . 75.349999999999994 109.437 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.558 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 70.7 m . . . . . 0 N--CA 1.417 -2.117 0 N-CA-C 107.496 -1.298 . . . . 75.329999999999998 107.496 172.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.537 0 N-CA-C 111.995 -0.442 . . . . 74.430000000000007 111.995 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.9 -4.26 42.89 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.719 0.759 . . . . 75.530000000000001 110.35 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.59 8.55 41.92 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.788 -0.642 . . . . 75.340000000000003 111.629 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -80.6 112.1 17.65 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 106.696 -1.594 . . . . 52.240000000000002 106.696 172.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.6 tp -69.84 99.09 1.32 Allowed 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.226 0.824 . . . . 73.409999999999997 113.226 -171.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -141.64 63.99 1.41 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.049 -1.463 . . . . 75.340000000000003 107.049 170.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -149.91 -74.23 0.17 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 105.186 -2.153 . . . . 63.030000000000001 105.186 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.457 ' HA ' ' OD1' ' A' ' 134' ' ' ASP . 63.8 tt0 51.0 86.27 0.03 OUTLIER 'General case' 0 C--O 1.245 0.828 0 C-N-CA 125.57 1.548 . . . . 65.129999999999995 113.306 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.34 9.49 1.26 Allowed Glycine 0 C--N 1.292 -1.866 0 CA-C-N 115.137 -0.938 . . . . 61.329999999999998 111.318 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 51.62 32.89 9.78 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.392 1.477 . . . . 63.009999999999998 110.547 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 10.5 tpt -79.86 0.59 30.46 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.292 -1.322 . . . . 73.040000000000006 112.245 -167.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 4.3 tt -128.3 108.12 10.33 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 104.846 -2.279 . . . . 72.140000000000001 104.846 172.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -134.04 124.77 26.78 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.956 -0.757 . . . . 73.099999999999994 108.956 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -108.22 114.51 46.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.805 -1.183 . . . . 75.25 107.805 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -116.82 113.93 23.21 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.65 -1.159 . . . . 71.219999999999999 109.608 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.59 121.36 42.39 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 109.11 -0.7 . . . . 64.450000000000003 109.11 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.6 m -127.12 114.7 18.06 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.048 -1.093 . . . . 72.420000000000002 108.048 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -128.15 147.26 32.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.716 -0.475 . . . . 71.329999999999998 109.716 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.5 m -130.49 122.25 27.31 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 121.162 0.506 . . . . 74.239999999999995 110.221 -177.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 143' ' ' PHE . 10.7 tt -106.61 117.64 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-O 121.771 0.796 . . . . 74.540000000000006 109.51 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.8 t -77.76 150.54 78.84 Favored Pre-proline 0 N--CA 1.419 -1.987 0 CA-C-N 114.781 -1.099 . . . . 42.32 108.784 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -65.26 2.37 1.5 Allowed 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 123.555 2.837 . . . . 72.340000000000003 112.03 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -89.4 -0.31 57.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.324 1.05 . . . . 74.409999999999997 108.243 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HB2' ' HD3' ' A' ' 181' ' ' PRO . 29.3 t70 68.96 29.11 4.99 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.58 1.552 . . . . 71.120000000000005 108.523 -178.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.38 126.99 53.49 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 113.583 -1.644 . . . . 70.209999999999994 107.505 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 t -107.73 138.95 31.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 109.315 -0.624 . . . . 63.109999999999999 109.315 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.4 p -147.28 158.68 44.05 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.256 -1.387 . . . . 63.329999999999998 107.256 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.7 -172.07 41.78 Favored Glycine 0 CA--C 1.489 -1.589 0 C-N-CA 119.433 -1.365 . . . . 63.340000000000003 112.197 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.6 133.39 17.96 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.33 0.586 . . . . 24.449999999999999 109.635 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 68.2 mt -117.23 116.22 51.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.952 -1.129 . . . . 64.310000000000002 107.952 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.39 120.45 62.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.398 -0.593 . . . . 74.019999999999996 109.398 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.499 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.32 107.6 16.93 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 106.462 -1.681 . . . . 53.539999999999999 106.462 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -117.39 123.59 46.8 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.787 -0.449 . . . . 62.240000000000002 109.787 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.27 157.5 19.4 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.554 0.692 . . . . 72.219999999999999 112.22 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -64.01 146.8 97.11 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 113.404 -1.726 . . . . 70.150000000000006 110.328 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.42 44.72 0.31 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 124.055 3.17 . . . . 72.239999999999995 114.155 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -96.07 -4.17 43.41 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 123.629 0.772 . . . . 75.129999999999995 109.111 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.464 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 3.4 m120 -54.07 123.69 13.38 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.52 1.528 . . . . 74.310000000000002 110.363 -176.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.8 m -78.81 -51.45 9.73 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.259 0.552 . . . . 53.130000000000003 111.074 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -110.24 -15.4 13.99 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.245 0.461 . . . . 75.299999999999997 112.245 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 52' ' ' ASN . 38.5 m-20 -89.2 132.21 34.97 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 113.809 1.04 . . . . 73.420000000000002 113.809 -170.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.2 p -102.81 -20.72 14.21 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.247 -1.39 . . . . 61.130000000000003 107.247 172.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.625 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 174.04 97.96 0.11 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.105 -1.198 . . . . 72.530000000000001 110.105 176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.535 ' O ' ' HB3' ' A' ' 83' ' ' SER . 15.7 Cg_exo -68.32 159.07 54.85 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.571 2.18 . . . . 75.409999999999997 111.672 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.62 154.48 24.82 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.196 -0.668 . . . . 50.100000000000001 109.196 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 85' ' ' ALA . 48.1 mt -74.77 152.39 39.03 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.371 0.605 . . . . 73.310000000000002 111.908 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -107.94 99.49 8.94 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.056 -0.975 . . . . 64.219999999999999 109.183 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.465 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -160.22 92.76 0.12 Allowed Glycine 0 C--N 1.29 -2.011 0 C-N-CA 120.36 -0.924 . . . . 71.129999999999995 113.525 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -86.48 112.58 21.65 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.253 -1.017 . . . . 74.409999999999997 108.253 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.09 162.08 54.36 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 116.269 -0.423 . . . . 54.200000000000003 110.499 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.18 -21.13 67.69 Favored 'Trans proline' 0 N--CA 1.478 0.593 0 C-N-CA 122.401 2.067 . . . . 71.209999999999994 112.043 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -109.87 27.99 9.03 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.632 -0.713 . . . . 52.450000000000003 111.855 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.4 m -52.19 -31.51 32.02 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.281 0.474 . . . . 71.510000000000005 112.281 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -61.65 -22.09 64.98 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 123.007 0.523 . . . . 75.310000000000002 111.819 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 88' ' ' SER . 32.7 mmtp -98.85 -10.08 23.4 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 122.287 -0.258 . . . . 72.340000000000003 111.134 -176.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.69 120.04 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 119.693 -0.803 . . . . 72.519999999999996 110.861 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.13 113.21 25.68 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.686 -0.688 . . . . 44.100000000000001 109.266 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.47 124.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 108.282 -1.007 . . . . 35.020000000000003 108.282 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 m -128.55 165.04 21.52 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.024 -0.989 . . . . 64.239999999999995 109.8 -172.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.625 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 5.9 t30 -77.51 136.5 38.33 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.109 -0.95 . . . . 74.549999999999997 109.132 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -110.62 119.41 39.06 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 108.64 -0.874 . . . . 70.340000000000003 108.64 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -138.86 100.01 3.94 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.528 -0.915 . . . . 43.119999999999997 108.528 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 t -163.0 143.92 9.59 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.389 -0.597 . . . . 62.409999999999997 109.389 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.92 12.05 8.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.912 0.885 . . . . 73.230000000000004 113.357 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.62 -3.61 65.7 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.33 -0.938 . . . . 53.100000000000001 111.485 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.558 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 29.8 m-85 -94.74 145.46 24.85 Favored 'General case' 0 C--O 1.254 1.316 0 N-CA-C 108.218 -1.031 . . . . 71.400000000000006 108.218 178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.3 m -128.94 136.63 59.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.611 -0.885 . . . . 44.299999999999997 108.611 170.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.94 -155.25 9.96 Favored Glycine 0 N--CA 1.414 -2.808 0 C-N-CA 119.98 -1.105 . . . . 61.149999999999999 111.899 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 24.4 p -121.94 152.0 40.15 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.131 -0.535 . . . . 74.540000000000006 110.473 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.8 pt20 -138.73 129.4 26.23 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.571 -0.452 . . . . 62.329999999999998 110.59 174.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -107.3 114.49 28.56 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.011 -1.477 . . . . 63.420000000000002 107.011 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.33 116.26 51.87 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 N-CA-C 107.735 -1.209 . . . . 71.099999999999994 107.735 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CD2' HD12 ' A' ' 90' ' ' LEU . 41.8 p90 -117.88 157.61 26.35 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.08 0.467 . . . . 64.120000000000005 111.286 -174.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 16.5 p -158.62 152.7 23.79 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.354 -0.839 . . . . 54.100000000000001 109.616 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 t70 62.5 47.24 5.16 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 122.959 1.361 . . . . 62.439999999999998 111.26 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.452 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.4 mt -108.06 163.32 13.25 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.572 -1.194 . . . . 74.340000000000003 110.003 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -112.15 174.03 6.08 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.367 -0.605 . . . . 64.510000000000005 109.367 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.425 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 61.9 t80 -50.53 -48.36 57.22 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.18 0.992 . . . . 74.219999999999999 111.308 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.68 -25.43 66.36 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.433 0.693 . . . . 44.350000000000001 112.193 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -86.65 -16.44 36.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 116.138 -0.483 . . . . 71.299999999999997 112.3 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 5.4 tt -64.52 -52.18 54.41 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 119.54 -0.267 . . . . 73.530000000000001 110.441 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.85 -30.89 39.85 Favored 'Trans proline' 0 C--N 1.367 1.541 0 CA-C-N 120.951 1.376 . . . . 65.0 110.529 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -67.42 -31.16 71.16 Favored 'General case' 0 N--CA 1.424 -1.744 0 O-C-N 121.957 -0.464 . . . . 75.219999999999999 110.889 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -77.84 -19.16 55.37 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.175 0.512 . . . . 73.319999999999993 109.975 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.87 -13.49 61.68 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.555 -0.748 . . . . 74.329999999999998 110.653 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -66.37 -57.89 6.47 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.241 -1.022 . . . . 74.219999999999999 108.241 172.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.465 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.8 ttp -55.85 -50.48 70.46 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 121.252 0.548 . . . . 73.340000000000003 110.131 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.54 -37.74 65.77 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 114.456 -1.247 . . . . 70.430000000000007 111.712 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.7 p -62.35 -31.73 72.42 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 119.942 -0.703 . . . . 51.420000000000002 111.248 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.37 -25.0 67.38 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.498 0.666 . . . . 70.140000000000001 111.263 -173.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.44 -13.77 15.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.22 -0.592 . . . . 42.310000000000002 111.283 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.27 -41.47 5.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.115 0.783 . . . . 75.349999999999994 113.115 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.98 19.92 58.55 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.498 -1.041 . . . . 74.099999999999994 110.498 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 m -104.36 155.44 5.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.19 0.519 . . . . 70.439999999999998 111.154 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.18 137.33 54.25 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.096 -1.816 . . . . 72.129999999999995 106.096 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -134.92 111.52 9.91 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.055 0.455 . . . . 71.25 112.143 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.8 t -119.37 122.27 41.42 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.75 -0.833 . . . . 64.319999999999993 108.75 176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -139.31 142.88 37.67 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 116.06 -0.518 . . . . 73.349999999999994 109.738 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -141.14 149.6 41.72 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.523 -1.217 . . . . 75.129999999999995 109.568 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.9 ttm105 -98.92 137.86 36.88 Favored 'General case' 0 N--CA 1.409 -2.492 0 N-CA-C 108.527 -0.916 . . . . 61.509999999999998 108.527 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -122.63 94.58 4.33 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.11 -1.441 . . . . 63.240000000000002 107.11 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.75 -103.87 1.36 Allowed Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.856 -0.898 . . . . 73.510000000000005 110.856 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.605 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 11.2 t30 -113.99 -8.55 13.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 122.227 1.013 . . . . 71.409999999999997 109.422 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -99.54 149.87 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 C-N-CA 119.36 -0.936 . . . . 74.25 109.408 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.2 t -119.02 138.86 48.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 O-C-N 121.923 -0.486 . . . . 74.030000000000001 111.195 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.6 pt -117.05 132.96 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.344 -0.844 . . . . 71.120000000000005 109.209 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.2 tt -129.22 130.93 46.92 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 115.971 -0.559 . . . . 64.150000000000006 109.717 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.32 133.23 34.69 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.971 -0.559 . . . . 73.519999999999996 110.002 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.74 171.97 32.49 Favored Glycine 0 N--CA 1.432 -1.576 0 C-N-CA 120.161 -1.018 . . . . 71.0 112.002 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -138.53 158.11 44.88 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.417 -0.586 . . . . 75.120000000000005 109.417 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.94 113.26 18.23 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.626 -0.879 . . . . 74.310000000000002 108.626 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -111.96 93.81 4.64 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.878 0.847 . . . . 75.519999999999996 111.506 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 166' ' ' PRO . 1.1 pt? -134.98 30.92 3.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 123.88 1.8 . . . . 74.510000000000005 107.045 176.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.416 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 37.1 p -62.54 -21.08 65.28 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 111.863 -2.426 . . . . 71.349999999999994 112.596 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.5 m -72.72 -12.84 61.18 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 123.763 0.825 . . . . 75.099999999999994 111.171 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t 68.05 83.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.237 1.015 . . . . 75.109999999999999 109.976 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.5 m -72.15 -37.65 69.34 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.843 -1.072 . . . . 73.209999999999994 109.972 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -165.0 130.75 2.07 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 106.228 -1.768 . . . . 64.109999999999999 106.228 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.01 -12.88 21.52 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.747 2.298 . . . . 60.43 114.118 -176.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.457 ' OD1' ' HA ' ' A' ' 22' ' ' GLN . 38.6 t70 -104.52 2.82 31.29 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 122.043 0.925 . . . . 65.450000000000003 109.827 -176.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -92.88 140.93 28.98 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.935 -1.03 . . . . 43.43 111.831 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -132.1 141.79 49.29 Favored 'General case' 0 C--O 1.265 1.919 0 CA-C-N 115.699 -0.682 . . . . 75.310000000000002 110.124 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 60.2 t -106.4 116.23 49.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.229 -1.026 . . . . 55.340000000000003 108.229 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -115.47 120.71 40.42 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.871 -0.418 . . . . 72.010000000000005 109.871 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -118.54 115.74 25.2 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.531 -1.285 . . . . 70.400000000000006 107.531 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.5 m -120.82 128.33 52.76 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.146 -0.479 . . . . 71.420000000000002 109.732 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.4 t -120.74 127.18 75.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.353 -0.61 . . . . 64.219999999999999 109.353 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.24 124.55 52.79 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 109.503 -0.555 . . . . 74.120000000000005 109.503 177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.627 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.3 p90 -134.36 112.46 11.98 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 122.909 0.484 . . . . 73.239999999999995 111.208 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -67.82 42.75 0.24 Allowed 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.484 2.789 . . . . 75.430000000000007 113.118 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.09 -92.94 0.51 Allowed 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.559 -0.534 . . . . 54.329999999999998 109.559 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.01 126.77 0.02 OUTLIER 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.939 0.896 . . . . 75.310000000000002 108.829 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.25 123.89 38.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 121.144 0.497 . . . . 74.040000000000006 110.07 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.7 p -86.4 -36.35 19.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.771 0.319 . . . . 65.230000000000004 111.01 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 36.6 m -161.99 132.92 5.08 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 107.859 -1.163 . . . . 44.109999999999999 107.859 176.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -139.03 152.29 47.48 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.903 -0.498 . . . . 72.239999999999995 110.938 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 27.8 t-20 -115.73 92.03 3.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.988 -1.856 . . . . 71.420000000000002 105.988 172.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.34 -149.77 12.07 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.139 -1.984 . . . . 75.140000000000001 108.139 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -116.54 99.76 7.38 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 117.887 0.844 . . . . 72.099999999999994 109.569 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -77.94 119.77 21.86 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 119.679 -0.809 . . . . 73.420000000000002 109.538 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.5 mm -86.81 -44.97 16.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.192 -1.411 . . . . 52.109999999999999 107.192 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -118.45 162.43 30.43 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 105.215 -2.143 . . . . 73.140000000000001 105.215 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -74.37 -0.8 10.15 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.901 1.734 . . . . 74.340000000000003 110.956 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.627 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.3 pt-20 -131.95 3.82 4.1 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.129 -0.941 . . . . 61.210000000000001 111.35 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.87 121.13 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 108.463 -0.94 . . . . 62.020000000000003 108.463 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.0 t -122.46 148.29 26.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.538 -0.541 . . . . 53.439999999999998 109.538 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -131.94 138.86 48.5 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.515 -0.55 . . . . 71.319999999999993 109.515 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.445 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.8 m-90 -119.63 130.39 55.06 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.701 -0.851 . . . . 70.200000000000003 108.701 177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -109.88 104.24 13.14 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.957 0.884 . . . . 65.420000000000002 108.648 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 0.5 OUTLIER -100.98 131.19 46.97 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.818 -0.808 . . . . 72.299999999999997 108.818 -174.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 66.0 mttm -117.36 149.61 44.95 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 115.802 -0.636 . . . . 70.239999999999995 112.598 -173.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.441 ' HA ' ' HG ' ' A' ' 127' ' ' LEU . 17.0 Cg_exo -67.45 154.94 72.31 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.878 2.386 . . . . 70.25 111.743 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 84.43 -39.31 2.91 Favored Glycine 0 C--N 1.311 -0.828 0 CA-C-N 115.83 -0.623 . . . . 61.5 112.541 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.5 m -104.34 151.86 6.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.981 -0.378 . . . . 71.340000000000003 109.981 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.79 110.44 24.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.733 0.778 . . . . 73.400000000000006 109.15 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.405 ' HB2' HD12 ' A' ' 164' ' ' LEU . 14.9 m -101.31 131.04 47.55 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.688 -0.687 . . . . 70.209999999999994 109.689 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 37.6 p -105.41 145.2 31.14 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.109 -0.496 . . . . 63.420000000000002 109.708 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 25.1 ptp -126.66 134.05 50.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.8 -0.815 . . . . 73.430000000000007 108.8 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 9.1 m -141.69 146.94 36.69 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.236 -1.024 . . . . 64.310000000000002 108.236 177.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.445 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -156.31 120.59 4.49 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.787 -0.449 . . . . 61.5 109.787 -175.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -123.01 131.87 53.89 Favored 'General case' 0 C--N 1.264 -3.136 0 N-CA-C 107.391 -1.337 . . . . 72.329999999999998 107.391 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -160.31 153.06 21.18 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.978 -1.119 . . . . 72.239999999999995 107.978 -176.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.602 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 38.5 ptt180 -92.87 131.49 37.85 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.2 -1.0 . . . . 74.510000000000005 109.685 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -126.38 118.42 24.98 Favored 'General case' 0 CA--C 1.476 -1.88 0 N-CA-C 107.718 -1.215 . . . . 75.140000000000001 107.718 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.605 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -53.25 109.97 0.49 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 124.905 1.378 . . . . 72.109999999999999 112.538 -177.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.46 ' OD1' ' HD2' ' A' ' 181' ' ' PRO . 32.6 t0 -70.11 125.13 91.86 Favored Pre-proline 0 CA--C 1.502 -0.877 0 N-CA-C 107.589 -1.263 . . . . 74.099999999999994 107.589 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 38' ' ' ASP . 18.8 Cg_endo -61.18 -43.26 30.24 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.897 2.398 . . . . 63.32 112.368 -176.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -84.49 -9.12 58.64 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 123.902 0.881 . . . . 63.310000000000002 110.991 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 60.1 p 61.46 70.19 0.61 Allowed 'General case' 0 C--O 1.248 0.987 0 N-CA-C 115.421 1.637 . . . . 74.439999999999998 115.421 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -90.06 -179.88 5.78 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.91 0.862 . . . . 73.209999999999994 113.05 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.421 -1.878 0 N-CA-C 106.18 -1.785 . . . . 74.150000000000006 106.18 175.164 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.658 0 N-CA-C 109.142 -1.583 . . . . 43.049999999999997 109.142 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -82.95 101.24 10.93 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 107.51 -1.293 . . . . 74.329999999999998 107.51 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -79.93 113.48 18.13 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.281 -0.872 . . . . 75.409999999999997 109.779 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -118.0 128.28 54.63 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.908 -1.145 . . . . 62.43 107.908 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.29 88.14 5.54 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.073 0.463 . . . . 55.539999999999999 111.636 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -70.13 134.22 47.93 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.805 -0.634 . . . . 72.120000000000005 109.861 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.4 t80 77.89 96.54 0.06 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.581 1.553 . . . . 70.420000000000002 112.858 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.517 ' HB3' HD21 ' A' ' 52' ' ' ASN . 0.2 OUTLIER -167.86 106.62 0.53 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 105.49 -2.041 . . . . 73.319999999999993 105.49 172.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.13 73.91 0.23 Allowed Glycine 0 N--CA 1.423 -2.181 0 N-CA-C 110.779 -0.928 . . . . 63.240000000000002 110.779 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -60.93 117.01 4.92 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.125 -0.694 . . . . 74.549999999999997 109.125 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 63.9 mtt 69.6 93.48 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.475 1.109 . . . . 54.130000000000003 111.468 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 4.0 pp -112.13 148.04 34.82 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.575 -0.528 . . . . 44.229999999999997 109.575 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -143.93 129.91 19.51 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.441 -0.577 . . . . 72.109999999999999 109.441 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 46' ' ' ALA . 33.1 m -125.08 129.86 73.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.964 -0.694 . . . . 75.219999999999999 109.95 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.496 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 15.5 ptt180 -139.35 122.25 16.62 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.52 0.676 . . . . 53.439999999999998 111.038 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.66 138.56 49.29 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.54 -0.755 . . . . 51.310000000000002 109.287 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.7 m -134.17 115.25 13.99 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.075 -1.083 . . . . 74.329999999999998 108.075 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 11.6 pt -129.04 149.1 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-O 121.359 0.599 . . . . 50.350000000000001 110.178 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 88.8 m -124.51 126.67 46.24 Favored 'General case' 0 C--N 1.264 -3.112 0 N-CA-C 108.976 -0.75 . . . . 74.200000000000003 108.976 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.482 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.8 tt -113.26 120.03 62.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.793 0.806 . . . . 52.329999999999998 109.752 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 37' ' ' ASP . 26.3 t -81.4 151.99 69.73 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 114.639 -1.164 . . . . 54.409999999999997 109.056 -175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.65 2.31 2.09 Favored 'Trans proline' 0 C--N 1.364 1.351 0 C-N-CA 123.291 2.66 . . . . 63.329999999999998 111.524 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 35' ' ' SER . 14.3 t70 -82.52 -7.99 59.63 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 124.703 1.201 . . . . 63.219999999999999 108.318 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.9 t70 72.22 29.26 2.28 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 123.444 1.592 . . . . 70.439999999999998 107.413 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.24 135.38 51.09 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 113.125 -1.852 . . . . 64.030000000000001 107.491 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.402 HG12 ' HE2' ' A' ' 87' ' ' PHE . 10.6 t -117.03 142.01 32.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 109.173 -0.677 . . . . 52.140000000000001 109.173 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.1 p -149.66 157.57 43.36 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.501 -1.296 . . . . 75.540000000000006 107.501 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.77 -162.84 34.88 Favored Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 118.481 -1.818 . . . . 41.109999999999999 112.949 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -150.44 133.69 16.29 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.361 0.6 . . . . 72.25 110.108 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.5 mt -112.8 116.37 52.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.614 -1.254 . . . . 64.040000000000006 107.614 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 29' ' ' ARG . 2.0 mp -103.19 120.97 53.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 120.862 0.363 . . . . 75.040000000000006 110.258 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -119.73 108.8 14.87 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.533 -1.284 . . . . 33.509999999999998 107.533 174.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -121.6 146.52 46.89 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-O 121.448 0.642 . . . . 64.349999999999994 112.06 -173.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.83 139.28 50.15 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.438 -0.949 . . . . 65.439999999999998 108.438 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -74.31 122.2 86.99 Favored Pre-proline 0 C--N 1.31 -1.134 0 N-CA-C 107.886 -1.153 . . . . 74.420000000000002 107.886 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -36.74 -79.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 124.851 3.701 . . . . 73.310000000000002 116.862 -167.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.553 ' HE2' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 68.31 -53.99 0.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.846 1.258 . . . . 74.329999999999998 110.065 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.517 HD21 ' HB3' ' A' ' 22' ' ' GLN . 80.8 m-20 -77.36 142.12 39.5 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 123.29 0.636 . . . . 74.239999999999995 109.885 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.1 m -78.31 -17.12 57.0 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.95 -0.568 . . . . 74.230000000000004 110.841 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -87.19 -20.24 27.26 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 116.346 -0.388 . . . . 73.510000000000005 111.884 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -95.34 109.2 21.38 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 113.214 0.82 . . . . 64.340000000000003 113.214 -171.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.443 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 20.7 p -90.75 -21.83 21.37 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 107.616 -1.253 . . . . 71.420000000000002 107.616 172.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.08 103.62 0.17 Allowed Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 114.582 -1.19 . . . . 73.319999999999993 110.202 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.43 134.77 53.05 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.746 2.297 . . . . 51.219999999999999 110.434 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.94 148.25 25.21 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 114.802 1.408 . . . . 72.219999999999999 114.802 -168.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 92.7 mt -89.08 161.66 16.41 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 114.201 -1.363 . . . . 62.43 108.57 174.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -110.62 90.78 3.42 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.437 0.637 . . . . 74.299999999999997 109.827 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.43 51.7 1.58 Allowed Glycine 0 C--N 1.302 -1.333 0 CA-C-N 115.685 -0.689 . . . . 74.439999999999998 112.697 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -96.44 98.85 10.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.352 0.596 . . . . 73.310000000000002 110.542 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.68 171.74 7.23 Favored Pre-proline 0 C--N 1.311 -1.1 0 C-N-CA 123.569 0.748 . . . . 50.210000000000001 109.951 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.09 -19.25 34.78 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.857 1.705 . . . . 70.219999999999999 111.612 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.44 ' CE1' ' HG2' ' A' ' 97' ' ' GLN . 15.6 p90 -111.29 36.28 3.26 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.855 -0.612 . . . . 61.310000000000002 110.606 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.5 m -60.41 -27.7 67.67 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 122.064 -0.397 . . . . 65.120000000000005 111.814 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.4 pm0 -71.99 -9.33 58.22 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.487 -0.758 . . . . 62.439999999999998 110.383 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.622 ' HB3' HD21 ' A' ' 90' ' ' LEU . 14.7 mmmm -95.95 -20.09 19.01 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.895 -0.593 . . . . 75.439999999999998 109.701 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 p -130.69 117.88 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 122.157 0.98 . . . . 63.329999999999998 110.993 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.98 124.58 47.84 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.684 -0.689 . . . . 74.150000000000006 110.326 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.93 120.61 47.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.676 -1.231 . . . . 61.549999999999997 107.676 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -124.91 168.88 12.67 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.626 -0.715 . . . . 65.010000000000005 110.258 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -79.98 150.29 30.51 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.042 -0.725 . . . . 63.210000000000001 109.042 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 93.2 t80 -127.35 129.5 47.73 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.063 -0.517 . . . . 72.120000000000005 109.738 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -138.19 98.26 3.58 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.577 -1.268 . . . . 73.310000000000002 107.577 176.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 67.7 m -164.66 155.57 14.84 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.265 -0.643 . . . . 65.030000000000001 109.265 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 69.87 4.38 4.74 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.571 1.148 . . . . 73.109999999999999 110.932 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.76 -4.07 71.76 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.205 -0.758 . . . . 42.020000000000003 111.205 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.444 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 66.4 m-85 -104.44 144.05 32.19 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.527 -0.545 . . . . 75.019999999999996 109.527 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.5 m -118.2 145.53 24.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.259 -1.015 . . . . 73.420000000000002 108.259 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.19 -153.74 12.85 Favored Glycine 0 CA--C 1.459 -3.416 0 C-N-CA 118.692 -1.718 . . . . 44.119999999999997 112.14 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.617 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 4.3 p -123.72 145.06 49.28 Favored 'General case' 0 C--N 1.27 -2.854 0 CA-C-O 121.721 0.772 . . . . 73.150000000000006 111.732 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -125.64 131.73 52.6 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.466 -0.788 . . . . 71.310000000000002 109.873 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.8 114.19 26.64 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.267 -1.383 . . . . 72.239999999999995 107.267 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.1 t -107.39 113.55 43.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.111 -1.07 . . . . 70.200000000000003 108.111 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CD2' HD12 ' A' ' 90' ' ' LEU . 51.7 p90 -116.03 151.45 35.48 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.846 -0.427 . . . . 73.010000000000005 109.846 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.1 m -154.06 153.96 32.82 Favored 'General case' 0 C--N 1.292 -1.891 0 C-N-CA 120.449 -0.5 . . . . 70.129999999999995 111.099 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.22 36.18 15.0 Favored 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 124.443 1.089 . . . . 72.439999999999998 111.07 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.622 HD21 ' HB3' ' A' ' 69' ' ' LYS . 37.6 mt -97.78 168.53 10.27 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 114.854 -1.067 . . . . 63.219999999999999 109.14 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -125.43 -179.92 4.83 Favored 'General case' 0 C--N 1.268 -2.968 0 N-CA-C 108.641 -0.874 . . . . 53.509999999999998 108.641 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CZ ' ' HG ' ' A' ' 112' ' ' LEU . 43.6 t80 -51.19 -48.2 62.02 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 124.766 1.227 . . . . 72.310000000000002 110.559 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.58 -25.85 66.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.892 0.701 . . . . 73.310000000000002 112.892 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.42 -17.46 27.16 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 122.069 -0.394 . . . . 64.530000000000001 111.48 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 38.0 tp -66.47 -51.8 39.92 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 113.472 0.916 . . . . 73.239999999999995 113.472 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 92' ' ' PHE . 18.3 Cg_endo -62.96 -33.88 73.03 Favored 'Trans proline' 0 C--N 1.368 1.59 0 CA-C-N 120.829 1.332 . . . . 53.399999999999999 110.389 175.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.44 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 9.4 tt0 -66.61 -36.26 82.16 Favored 'General case' 0 N--CA 1.41 -2.464 0 CA-C-N 115.226 -0.897 . . . . 74.409999999999997 110.871 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -75.69 -19.3 59.21 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.325 0.583 . . . . 64.129999999999995 110.041 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.91 -20.57 61.75 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.825 -0.625 . . . . 73.209999999999994 110.565 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -56.31 -58.05 9.63 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 123.417 0.448 . . . . 75.099999999999994 111.177 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -59.46 -46.63 88.23 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.318 0.58 . . . . 50.109999999999999 110.194 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -57.26 -34.79 68.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.376 -1.284 . . . . 73.010000000000005 110.962 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.9 m -63.32 -33.5 75.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.553 -0.459 . . . . 71.329999999999998 110.905 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.93 -20.04 63.36 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.791 0.805 . . . . 64.439999999999998 110.479 -175.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.34 -19.13 17.95 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.697 -0.683 . . . . 62.240000000000002 110.506 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.91 -47.69 3.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.591 0.96 . . . . 63.140000000000001 113.591 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.52 28.17 25.25 Favored Glycine 0 C--O 1.238 0.403 0 N-CA-C 110.436 -1.066 . . . . 73.510000000000005 110.436 -173.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -108.43 160.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.412 -0.394 . . . . 74.310000000000002 110.699 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -119.32 142.77 47.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.381 -1.34 . . . . 73.299999999999997 107.381 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.7 mt -139.43 144.39 38.05 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 123.355 0.409 . . . . 72.25 110.28 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 m -142.83 117.33 9.71 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.356 -0.979 . . . . 61.310000000000002 108.356 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.43 ' HG ' ' CZ ' ' A' ' 92' ' ' PHE . 52.0 tp -121.9 125.93 47.53 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.076 -0.511 . . . . 73.420000000000002 110.375 -176.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -141.7 148.52 39.21 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.197 -0.668 . . . . 72.120000000000005 109.197 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 114' ' ' ARG . 16.8 ttm180 -98.69 128.05 44.83 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 108.39 -0.967 . . . . 71.140000000000001 108.39 172.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -102.27 86.11 2.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.84 -1.171 . . . . 72.530000000000001 107.84 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.29 -98.98 0.54 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.143 -0.935 . . . . 74.329999999999998 111.709 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.541 ' HA ' ' OD1' ' A' ' 180' ' ' ASP . 3.4 t-20 -107.63 -15.19 14.65 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.307 1.051 . . . . 74.409999999999997 109.651 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.7 pp -110.0 148.62 13.46 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.758 0 O-C-N 121.115 -0.99 . . . . 73.400000000000006 108.749 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 114' ' ' ARG . 73.6 t -105.91 137.62 35.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 O-C-N 121.639 -0.663 . . . . 64.540000000000006 110.25 -177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.408 HG22 ' HG2' ' A' ' 175' ' ' GLN . 47.0 pt -117.14 130.66 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 121.84 0.828 . . . . 71.340000000000003 110.064 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.25 128.58 44.95 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 115.161 -0.927 . . . . 63.219999999999999 109.352 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -129.18 147.68 51.05 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.614 -0.884 . . . . 74.530000000000001 108.614 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.55 166.25 37.18 Favored Glycine 0 N--CA 1.407 -3.298 0 N-CA-C 111.259 -0.736 . . . . 74.310000000000002 111.259 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -136.4 145.91 45.83 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.342 -0.985 . . . . 75.349999999999994 108.342 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 164' ' ' LEU . . . -124.29 110.15 14.25 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.932 -1.136 . . . . 71.409999999999997 107.932 174.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -99.11 105.87 18.01 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.822 -0.807 . . . . 75.319999999999993 108.822 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.8 mm? -116.86 30.65 7.21 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.37 -0.974 . . . . 64.129999999999995 108.37 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 76.8 p -72.0 -8.35 54.0 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.588 0.708 . . . . 75.239999999999995 111.209 -177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.2 p -70.79 -16.12 62.72 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 125.119 1.367 . . . . 60.25 109.89 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.3 t 74.99 -65.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.029 1.732 . . . . 74.030000000000001 111.258 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.1 t 67.54 -73.9 0.08 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.165 0.986 . . . . 71.409999999999997 110.315 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -147.73 133.38 9.4 Favored Pre-proline 0 N--CA 1.434 -1.253 0 N-CA-C 106.09 -1.819 . . . . 72.239999999999995 106.09 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.22 -19.73 50.15 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 121.292 1.328 . . . . 62.439999999999998 110.696 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -86.0 3.48 42.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.07 -0.968 . . . . 74.420000000000002 111.105 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.527 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -85.79 122.29 29.66 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.979 -0.378 . . . . 54.130000000000003 109.979 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.37 139.43 53.28 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.221 -0.659 . . . . 61.32 109.221 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 84.4 t -113.4 113.06 42.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.712 -1.218 . . . . 73.200000000000003 107.712 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 38.5 mt-10 -117.52 123.49 46.4 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-O 120.97 0.414 . . . . 74.310000000000002 110.497 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tt -118.69 128.15 54.24 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.29 -1.744 . . . . 72.200000000000003 106.29 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.3 m -126.24 128.39 47.13 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.064 -0.717 . . . . 73.400000000000006 109.064 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.481 HG12 ' HD2' ' A' ' 143' ' ' PHE . 61.7 t -124.06 125.38 70.71 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.113 -0.699 . . . . 64.230000000000004 109.113 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.17 125.89 54.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.083 -1.08 . . . . 70.040000000000006 108.083 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.644 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.4 p90 -134.36 122.54 16.0 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 112.348 0.499 . . . . 75.219999999999999 112.348 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -70.4 61.19 2.07 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 122.365 2.044 . . . . 73.319999999999993 111.13 172.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.61 -132.46 0.08 Allowed 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.79 -1.189 . . . . 72.400000000000006 107.79 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -160.3 122.9 3.33 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 108.166 -1.05 . . . . 64.200000000000003 108.166 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.55 133.21 31.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 109.092 -0.707 . . . . 65.109999999999999 109.092 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.9 p -89.4 -44.43 10.19 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.997 -0.742 . . . . 62.229999999999997 108.997 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.0 m -159.01 133.47 7.9 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.097 -0.502 . . . . 71.420000000000002 109.759 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -138.24 155.25 48.82 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.098 0.475 . . . . 75.150000000000006 110.346 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.475 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 51.1 t-20 -121.6 90.92 3.4 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 104.263 -2.495 . . . . 72.120000000000005 104.263 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 171.96 -161.95 34.03 Favored Glycine 0 N--CA 1.411 -2.997 0 N-CA-C 106.702 -2.559 . . . . 55.140000000000001 106.702 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -100.08 99.75 10.52 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 118.257 1.028 . . . . 71.030000000000001 110.412 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -80.11 107.79 13.18 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-O 121.552 0.691 . . . . 72.239999999999995 110.306 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.0 mt -80.51 -49.1 19.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.533 -1.284 . . . . 64.230000000000004 107.533 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.57 164.7 34.59 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.318 -1.364 . . . . 71.230000000000004 107.318 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.61 -3.5 13.21 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.1 1.866 . . . . 71.519999999999996 111.112 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.644 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.8 pt-20 -131.86 5.87 4.27 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.017 -0.538 . . . . 72.219999999999999 112.386 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.7 t -143.18 121.41 7.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 N-CA-C 108.772 -0.825 . . . . 70.209999999999994 108.772 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.75 148.15 32.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.665 -0.495 . . . . 32.310000000000002 109.665 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -133.75 141.12 47.37 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.716 -0.476 . . . . 74.109999999999999 109.716 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.476 ' O ' ' HA ' ' A' ' 138' ' ' GLU . 32.9 m-90 -117.92 119.78 35.87 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.941 -0.762 . . . . 72.230000000000004 108.941 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -109.54 98.32 7.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.154 -1.054 . . . . 65.049999999999997 108.154 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 14.1 mt -98.28 138.89 34.88 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 114.592 -1.185 . . . . 73.530000000000001 108.696 -172.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -117.47 162.48 28.28 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 114.702 1.371 . . . . 73.140000000000001 114.702 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 72.3 Cg_endo -76.18 156.64 37.87 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.363 2.709 . . . . 71.540000000000006 112.43 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 82.92 -33.54 2.86 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 111.289 -0.724 . . . . 71.140000000000001 111.289 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 166' ' ' PRO . 18.4 m -105.12 148.74 9.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 123.688 0.795 . . . . 74.349999999999994 110.131 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.76 113.78 37.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.498 -1.297 . . . . 73.310000000000002 107.498 174.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.6 p -107.62 146.48 31.91 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.909 -0.587 . . . . 74.109999999999999 111.515 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.0 p -103.13 151.68 22.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.861 -0.609 . . . . 72.340000000000003 111.334 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 70.4 mtm -123.22 119.78 31.2 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.24 -1.393 . . . . 74.099999999999994 107.24 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 11.7 t -136.92 135.61 37.91 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.781 -1.192 . . . . 75.049999999999997 107.781 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.03 118.31 5.98 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.353 -0.61 . . . . 60.310000000000002 109.353 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.408 ' HG2' HG22 ' A' ' 120' ' ' ILE . 40.6 mt-30 -122.47 130.66 53.29 Favored 'General case' 0 C--N 1.269 -2.899 0 N-CA-C 106.403 -1.703 . . . . 74.040000000000006 106.403 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.77 148.87 30.47 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.883 -0.327 . . . . 61.439999999999998 110.321 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 15.4 ptt180 -88.08 127.21 35.41 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 120.333 -0.547 . . . . 71.200000000000003 109.94 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -127.21 152.0 47.96 Favored 'General case' 0 CA--C 1.482 -1.638 0 C-N-CA 120.788 -0.365 . . . . 72.409999999999997 110.1 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.0 p -77.4 120.75 22.84 Favored 'General case' 0 C--N 1.262 -3.233 0 N-CA-C 109.794 -0.447 . . . . 73.540000000000006 109.794 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 117' ' ' ASN . 4.9 m-20 -72.88 123.27 89.38 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.854 -0.612 . . . . 65.420000000000002 110.522 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.76 -28.88 19.87 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 121.766 1.644 . . . . 62.25 109.87 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -84.61 -20.2 31.78 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.938 -1.028 . . . . 65.209999999999994 110.056 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.2 p 57.31 94.86 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.725 1.61 . . . . 73.349999999999994 112.307 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 185' ' ' SER . 71.1 ttt180 -115.33 158.35 22.52 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-O 121.624 0.726 . . . . 74.239999999999995 110.081 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.448 ' N ' ' HG2' ' A' ' 184' ' ' ARG . 50.8 m . . . . . 0 C--N 1.274 -2.706 0 N-CA-C 105.453 -2.055 . . . . 71.519999999999996 105.453 175.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.407 0 N-CA-C 109.633 -1.387 . . . . 65.030000000000001 109.633 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -92.04 -43.71 9.26 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.773 -0.454 . . . . 70.200000000000003 109.773 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 58.93 -79.8 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.097 1.359 . . . . 72.340000000000003 111.584 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -153.9 143.59 21.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.148 -1.056 . . . . 73.530000000000001 108.148 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -82.5 113.59 20.34 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 104.879 -2.267 . . . . 74.040000000000006 104.879 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -84.88 75.37 10.37 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.78 0.8 . . . . 73.450000000000003 112.906 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -83.28 87.71 6.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.412 1.101 . . . . 55.43 108.408 174.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -107.4 -170.01 1.63 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.681 -1.145 . . . . 64.239999999999995 108.706 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' O ' ' HE3' ' A' ' 51' ' ' LYS . . . -78.83 79.51 1.57 Allowed Glycine 0 C--N 1.306 -1.092 0 N-CA-C 110.872 -0.891 . . . . 73.400000000000006 110.872 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.7 151.02 51.6 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.267 -0.642 . . . . 75.040000000000006 109.267 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.1 ptm -82.11 137.96 34.88 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.228 0.537 . . . . 73.329999999999998 111.388 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 48' ' ' ALA . 1.6 pt? -133.3 119.15 19.39 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.477 -0.783 . . . . 74.319999999999993 109.826 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -107.42 124.36 49.74 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.259 -0.882 . . . . 74.219999999999999 109.285 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.18 114.07 43.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.743 0.782 . . . . 71.230000000000004 109.783 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 41.8 mtp85 -113.63 118.76 35.29 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.493 -0.776 . . . . 75.209999999999994 111.849 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' HB3' ' HG ' ' A' ' 139' ' ' LEU . . . -107.77 108.67 19.98 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.0 -1.111 . . . . 33.119999999999997 108.0 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 140' ' ' THR . 4.2 p -117.39 115.67 25.66 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 109.304 -0.628 . . . . 62.340000000000003 109.304 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 16.7 pt -129.4 149.05 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-O 121.336 0.589 . . . . 73.420000000000002 110.711 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 53.6 m -123.46 124.68 43.42 Favored 'General case' 0 C--N 1.272 -2.792 0 N-CA-C 108.657 -0.868 . . . . 75.510000000000005 108.657 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.2 tt -108.38 109.96 30.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 122.027 0.918 . . . . 65.200000000000003 109.414 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.7 m -76.66 152.12 82.95 Favored Pre-proline 0 N--CA 1.423 -1.796 0 CA-C-N 114.635 -1.166 . . . . 71.099999999999994 109.962 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.23 -3.32 1.18 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 124.112 3.208 . . . . 74.530000000000001 114.438 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 9.7 m-20 -85.84 -0.56 55.66 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 124.175 0.99 . . . . 62.130000000000003 109.853 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 38.2 t0 68.6 34.71 3.43 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 123.781 1.753 . . . . 63.100000000000001 107.536 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -109.82 126.1 53.44 Favored 'General case' 0 N--CA 1.397 -3.121 0 CA-C-N 112.426 -2.17 . . . . 65.340000000000003 107.701 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG11 HD23 ' A' ' 95' ' ' LEU . 10.9 t -104.87 137.22 35.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.337 -0.986 . . . . 75.109999999999999 108.337 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.1 p -143.43 149.05 37.08 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 105.946 -1.872 . . . . 71.040000000000006 105.946 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.54 -169.56 40.02 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 117.626 -2.226 . . . . 72.230000000000004 113.157 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -152.84 142.38 21.79 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 121.352 0.596 . . . . 73.540000000000006 111.497 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.67 116.82 53.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.869 -1.16 . . . . 72.530000000000001 107.869 174.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.55 114.92 45.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.466 -0.939 . . . . 74.319999999999993 108.466 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.51 108.0 19.12 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 106.32 -1.733 . . . . 55.210000000000001 106.32 174.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -125.75 119.92 29.22 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.645 0.736 . . . . 73.340000000000003 111.048 -174.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . . . -111.91 148.0 34.65 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.21 -0.905 . . . . 74.200000000000003 109.247 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -74.88 124.38 89.53 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 105.982 -1.859 . . . . 72.439999999999998 105.982 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -44.7 -76.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.923 3.082 . . . . 44.039999999999999 115.166 -170.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 23' ' ' GLY . 25.8 ttmm 68.65 -51.04 0.57 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.854 1.262 . . . . 63.119999999999997 111.33 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.481 ' ND2' ' HB2' ' A' ' 55' ' ' ASP . 16.8 t30 -77.94 111.94 14.32 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.431 -1.322 . . . . 72.209999999999994 107.431 172.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.3 m -48.74 -35.45 14.19 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.993 1.479 . . . . 73.310000000000002 114.993 -173.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -95.0 -5.04 45.48 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 119.327 -0.949 . . . . 74.530000000000001 112.2 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.481 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 4.0 t0 -91.55 123.89 35.3 Favored 'General case' 0 CA--C 1.492 -1.259 0 C-N-CA 118.879 -1.128 . . . . 75.420000000000002 110.187 -172.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.645 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 16.1 p -113.13 0.67 15.02 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 115.328 -0.851 . . . . 74.150000000000006 111.19 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.406 ' HA2' ' HA2' ' A' ' 82' ' ' GLY . . . 172.55 115.13 0.36 Allowed Glycine 0 N--CA 1.425 -2.048 0 C-N-CA 119.69 -1.243 . . . . 70.140000000000001 113.842 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.581 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 35.0 Cg_exo -66.76 129.37 20.83 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 CA-C-N 119.975 1.887 . . . . 74.420000000000002 108.221 168.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.73 163.22 28.2 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 113.695 0.998 . . . . 62.310000000000002 113.695 -171.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 59.2 mt -124.72 141.24 52.25 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.461 -0.94 . . . . 75.349999999999994 108.461 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -88.28 86.3 7.05 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.875 -0.787 . . . . 52.219999999999999 108.875 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.74 39.47 2.73 Favored Glycine 0 C--N 1.29 -1.986 0 CA-C-N 114.785 -1.098 . . . . 63.310000000000002 111.396 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -94.1 101.3 13.31 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.838 -1.171 . . . . 75.109999999999999 107.838 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.3 m -139.6 163.12 47.25 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 115.395 -0.821 . . . . 63.409999999999997 109.025 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.03 -24.9 51.99 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 122.435 2.09 . . . . 72.540000000000006 111.917 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -99.7 41.45 1.16 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.023 -0.535 . . . . 75.439999999999998 111.176 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p -57.47 -29.3 64.12 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.113 0.783 . . . . 72.439999999999998 113.113 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -72.5 -15.15 61.79 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-O 121.417 0.627 . . . . 75.439999999999998 109.929 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -94.89 -12.77 26.27 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 115.343 -0.844 . . . . 72.120000000000005 109.927 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 7.1 p -124.07 123.41 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.916 0.865 . . . . 74.530000000000001 112.296 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.43 105.77 16.83 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.212 -0.904 . . . . 72.140000000000001 108.87 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.2 t -98.06 130.16 47.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.066 -1.457 . . . . 71.310000000000002 107.066 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -148.16 172.07 14.89 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.551 -0.537 . . . . 54.119999999999997 109.551 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -87.21 153.25 21.64 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.482 -0.562 . . . . 65.219999999999999 109.482 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 71.7 t80 -123.09 129.57 51.63 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.544 0.738 . . . . 53.140000000000001 109.631 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -138.17 104.06 5.11 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.57 -1.27 . . . . 72.439999999999998 107.57 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 47.8 t -171.84 150.25 2.61 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.569 -0.9 . . . . 55.130000000000003 108.569 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 70.36 8.77 6.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.721 0.808 . . . . 72.340000000000003 111.4 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.77 -0.32 76.52 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 115.414 -0.812 . . . . 75.349999999999994 111.157 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 72.7 m-85 -104.42 146.73 28.43 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.573 -0.529 . . . . 73.299999999999997 109.573 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 56' ' ' THR . 27.4 m -124.18 138.5 53.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 108.239 -1.023 . . . . 72.439999999999998 108.239 177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.581 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -174.91 -155.16 11.95 Favored Glycine 0 CA--C 1.464 -3.12 0 C-N-CA 119.178 -1.487 . . . . 55.350000000000001 112.47 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.402 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 46.7 m -126.03 147.55 49.53 Favored 'General case' 0 C--N 1.274 -2.681 0 CA-C-O 121.145 0.498 . . . . 74.219999999999999 110.081 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.5 141.18 51.47 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.918 -0.583 . . . . 71.310000000000002 109.89 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.21 114.34 23.52 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.627 -1.249 . . . . 72.230000000000004 107.627 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.7 t -109.18 111.84 37.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.827 -1.175 . . . . 72.329999999999998 107.827 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.7 p90 -113.16 157.78 21.25 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 120.924 0.392 . . . . 73.25 110.606 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 p -154.68 150.6 27.82 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.799 -0.637 . . . . 63.009999999999998 110.81 -174.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.7 t70 61.42 45.99 7.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.864 1.265 . . . . 70.340000000000003 111.819 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.492 HD12 ' CD2' ' A' ' 87' ' ' PHE . 43.3 mt -109.22 169.32 8.76 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.525 -0.761 . . . . 63.030000000000001 109.659 177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 t -128.41 -179.79 5.22 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.85 -0.74 . . . . 73.150000000000006 111.925 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.437 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 55.0 t80 -50.01 -43.87 50.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.784 2.034 . . . . 71.129999999999995 111.406 -176.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.54 -25.59 64.09 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.779 -0.646 . . . . 61.210000000000001 111.747 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -89.34 -15.18 33.99 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.961 -0.563 . . . . 71.409999999999997 110.628 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 2.7 tm? -54.12 -56.12 29.36 Favored Pre-proline 0 CA--C 1.569 1.692 0 C-N-CA 123.802 0.841 . . . . 72.219999999999999 111.887 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.59 -35.72 57.58 Favored 'Trans proline' 0 C--N 1.372 1.785 0 CA-C-N 120.912 1.362 . . . . 72.319999999999993 111.08 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -63.03 -40.37 97.54 Favored 'General case' 0 N--CA 1.424 -1.765 0 C-N-CA 124.307 1.043 . . . . 74.530000000000001 110.398 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -76.05 -19.88 58.24 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.076 0.465 . . . . 55.100000000000001 109.783 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.1 -22.32 60.58 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.998 -0.546 . . . . 73.120000000000005 110.616 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -56.89 -48.82 77.31 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 109.68 -0.489 . . . . 72.239999999999995 109.68 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.407 ' HE1' HG21 ' A' ' 70' ' ' VAL . 24.4 ttm -53.57 -55.69 23.51 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.958 -1.019 . . . . 61.119999999999997 108.931 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -56.18 -36.58 68.53 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.299 -1.319 . . . . 72.209999999999994 111.622 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.5 m -65.59 -25.36 67.36 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 116.153 -0.476 . . . . 74.510000000000005 111.273 -173.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -59.88 -27.65 66.87 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-O 121.447 0.642 . . . . 72.219999999999999 109.875 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -112.01 -13.1 13.64 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.823 -0.626 . . . . 64.319999999999993 111.305 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.477 ' HB1' HG23 ' A' ' 108' ' ' VAL . . . -107.17 -48.76 3.4 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.149 1.166 . . . . 51.200000000000003 114.149 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.61 7.0 78.75 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.144 -0.551 . . . . 62.0 112.468 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.477 HG23 ' HB1' ' A' ' 106' ' ' ALA . 61.9 t -81.2 133.96 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.475 -0.935 . . . . 62.140000000000001 108.475 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.47 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 28.7 m-80 -97.41 121.39 39.26 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.029 -1.1 . . . . 71.120000000000005 108.029 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.6 115.42 29.13 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.635 0.255 . . . . 62.43 110.483 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.3 m -109.49 135.89 49.78 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.656 -0.868 . . . . 65.5 108.656 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.3 tp -139.41 133.48 31.09 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 121.239 -0.184 . . . . 71.049999999999997 111.014 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -142.24 150.84 41.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.134 0.574 . . . . 73.310000000000002 110.654 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.43 HH22 ' CG ' ' A' ' 38' ' ' ASP . 39.5 ttm180 -112.02 135.8 52.2 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.389 -0.967 . . . . 75.019999999999996 108.389 174.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -127.94 93.06 3.59 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.69 -1.226 . . . . 74.349999999999994 107.69 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.408 ' HA2' ' OXT' ' A' ' 185' ' ' SER . . . 68.4 -115.76 6.98 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 115.054 -0.975 . . . . 71.109999999999999 110.808 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.31 -17.81 24.21 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.54 0.686 . . . . 63.030000000000001 109.91 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 0.7 OUTLIER -103.43 148.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 C-N-CA 118.071 -1.452 . . . . 72.420000000000002 109.652 -174.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.9 t -120.1 135.78 59.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 110.086 -0.338 . . . . 51.210000000000001 110.086 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 175' ' ' GLN . 44.6 pt -113.56 130.63 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-O 121.719 0.771 . . . . 70.219999999999999 109.966 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.6 tt -125.91 129.64 49.71 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 107.677 -1.231 . . . . 74.409999999999997 107.677 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.76 123.76 24.11 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.824 -0.625 . . . . 54.43 109.567 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -132.76 147.44 18.91 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 110.653 -0.979 . . . . 10.24 110.653 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.28 125.95 27.12 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 109.539 -0.541 . . . . 74.140000000000001 109.539 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -99.82 109.94 22.33 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.683 -0.689 . . . . 61.340000000000003 110.001 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -99.95 93.22 5.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.276 -0.639 . . . . 74.040000000000006 109.276 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.54 ' O ' HG12 ' A' ' 130' ' ' VAL . 3.6 mm? -121.0 24.28 10.25 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.541 -0.754 . . . . 63.100000000000001 109.197 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.7 p -68.21 -36.92 80.29 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.104 0.478 . . . . 61.210000000000001 111.546 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 m -101.48 20.05 16.75 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.585 -0.734 . . . . 63.229999999999997 111.622 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 127' ' ' LEU . 8.9 p -81.39 139.59 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.45 -0.944 . . . . 75.319999999999993 108.45 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.9 p -90.28 6.31 43.47 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.723 -0.391 . . . . 43.43 111.525 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.423 ' H ' HG22 ' A' ' 130' ' ' VAL . 45.0 m-20 -113.62 98.9 48.5 Favored Pre-proline 0 C--N 1.311 -1.068 0 N-CA-C 110.08 -0.341 . . . . 55.200000000000003 110.08 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.74 -12.9 22.13 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.491 2.127 . . . . 63.100000000000001 112.41 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -98.47 18.62 16.16 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.329 0.585 . . . . 75.450000000000003 111.189 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.26 135.52 33.41 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.46 -1.311 . . . . 65.310000000000002 107.46 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -131.62 115.19 15.75 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.596 -0.842 . . . . 74.450000000000003 109.376 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 51.2 t -106.51 122.67 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 108.428 -0.953 . . . . 70.5 108.428 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 31.9 tt0 -137.86 130.96 30.33 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.143 -0.688 . . . . 74.450000000000003 109.143 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' A' ' 30' ' ' ALA . 6.5 tt -128.88 135.52 49.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.307 -0.627 . . . . 55.020000000000003 109.307 -173.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 12.1 m -127.2 133.95 50.2 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.268 -0.642 . . . . 72.319999999999993 109.268 178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.409 HG12 ' HD2' ' A' ' 143' ' ' PHE . 87.2 t -125.8 125.63 68.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.247 -0.649 . . . . 72.439999999999998 109.247 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -110.89 126.83 55.12 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 108.889 -0.782 . . . . 73.040000000000006 108.889 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.575 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.06 105.75 11.43 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 109.305 -0.628 . . . . 71.239999999999995 109.305 176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.66 43.64 0.19 Allowed 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 123.521 2.814 . . . . 64.409999999999997 114.139 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.3 -91.25 0.56 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 123.152 0.581 . . . . 71.219999999999999 110.931 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 177.85 123.82 0.04 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.253 0.621 . . . . 41.009999999999998 110.042 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.3 p -80.89 141.81 14.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.688 -0.856 . . . . 73.120000000000005 108.688 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.9 p -99.59 -39.73 8.16 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.561 -0.533 . . . . 74.530000000000001 109.561 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.9 m -161.66 134.07 5.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.813 -0.63 . . . . 74.109999999999999 109.591 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.44 ' OG1' HG11 ' A' ' 160' ' ' VAL . 7.6 t -137.91 149.09 45.92 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.231 0.539 . . . . 72.450000000000003 111.036 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -112.5 87.53 2.6 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 106.518 -1.66 . . . . 74.310000000000002 106.518 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.71 -153.79 22.34 Favored Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 108.036 -2.026 . . . . 74.409999999999997 108.036 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -112.43 106.02 14.42 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 117.522 0.661 . . . . 73.540000000000006 110.751 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -80.05 126.34 30.94 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.736 -0.665 . . . . 75.530000000000001 109.794 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.2 mt -85.69 -42.94 16.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.885 -1.524 . . . . 62.409999999999997 106.885 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -135.28 170.02 12.24 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 113.964 -1.471 . . . . 64.239999999999995 107.387 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.98 0.05 8.36 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.295 1.997 . . . . 53.420000000000002 110.841 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.575 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.6 pt-20 -131.89 3.55 4.1 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.837 -0.62 . . . . 64.439999999999998 111.803 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.6 t -141.47 121.86 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.688 -0.856 . . . . 72.25 108.688 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.44 HG11 ' OG1' ' A' ' 150' ' ' THR . 40.5 t -127.4 149.15 32.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.739 -0.467 . . . . 71.019999999999996 109.739 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -134.15 144.0 48.27 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.599 -0.519 . . . . 64.420000000000002 109.599 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.469 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.3 m-90 -127.25 135.55 50.77 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.842 -0.617 . . . . 73.209999999999994 111.356 -178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.04 104.96 14.8 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.068 -0.969 . . . . 74.530000000000001 108.686 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 47.1 mt -101.65 119.76 39.28 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.211 -1.033 . . . . 75.209999999999994 108.211 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.488 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 74.3 mmtt -114.24 156.64 44.01 Favored Pre-proline 0 C--N 1.31 -1.149 0 N-CA-C 112.591 0.589 . . . . 73.140000000000001 112.591 -169.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.02 155.97 38.42 Favored 'Trans proline' 0 C--N 1.365 1.426 0 C-N-CA 123.025 2.483 . . . . 73.019999999999996 110.631 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.8 -32.67 2.17 Favored Glycine 0 C--N 1.312 -0.765 0 N-CA-C 112.134 -0.386 . . . . 71.120000000000005 112.134 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.488 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 21.3 m -105.72 161.4 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.62 0 CA-C-O 120.94 0.4 . . . . 63.310000000000002 109.997 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.2 p -106.58 110.43 31.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.795 -1.187 . . . . 71.219999999999999 107.795 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.6 m -97.78 128.88 44.73 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.447 0.641 . . . . 61.43 110.313 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.2 p -101.63 137.87 39.38 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.352 -0.84 . . . . 71.230000000000004 109.991 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.4 ptm -131.62 133.09 44.59 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.718 -0.674 . . . . 73.150000000000006 109.586 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m -143.34 148.8 36.84 Favored 'General case' 0 C--N 1.276 -2.588 0 O-C-N 121.762 -0.586 . . . . 71.120000000000005 109.573 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -150.98 119.71 6.56 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.281 -1.007 . . . . 73.329999999999998 108.281 -177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.425 ' HG2' HG22 ' A' ' 120' ' ' ILE . 42.1 mt-30 -121.75 130.45 53.43 Favored 'General case' 0 C--N 1.262 -3.231 0 N-CA-C 106.292 -1.744 . . . . 71.530000000000001 106.292 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.14 160.18 41.79 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.548 -0.538 . . . . 41.219999999999999 109.548 -175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 65.0 mtp180 -88.05 125.92 34.82 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.244 -1.021 . . . . 75.319999999999993 108.244 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -123.02 127.69 49.15 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.776 -1.194 . . . . 73.310000000000002 107.776 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.5 p -63.59 107.47 1.16 Allowed 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.395 -0.82 . . . . 73.5 110.216 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 184' ' ' ARG . 27.7 t70 -65.8 132.06 94.76 Favored Pre-proline 0 CA--C 1.505 -0.784 0 CA-C-N 115.893 -0.594 . . . . 50.420000000000002 110.536 -174.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 38' ' ' ASP . 41.2 Cg_endo -67.89 -46.84 2.17 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 122.68 2.253 . . . . 72.340000000000003 113.292 -177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . 0.285 0.2 OUTLIER -84.36 -7.75 59.21 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 112.842 0.682 . . . . 72.030000000000001 112.842 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 47.6 p 62.25 62.17 1.21 Allowed 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.898 1.279 . . . . 72.450000000000003 112.372 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.428 ' HG3' ' OD2' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -85.24 161.62 19.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.064 -1.425 . . . . 73.349999999999994 112.587 178.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.408 ' OXT' ' HA2' ' A' ' 116' ' ' GLY . 15.1 m . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 108.181 -1.044 . . . . 65.230000000000004 108.181 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.365 0 N-CA-C 109.514 -1.434 . . . . 70.109999999999999 109.514 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 61.46 70.96 0.57 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.981 0.912 . . . . 72.129999999999995 109.973 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -93.38 114.45 26.87 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.458 -0.337 . . . . 73.439999999999998 110.367 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -70.57 107.18 3.76 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 106.794 -1.558 . . . . 75.099999999999994 106.794 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.3 mt -69.92 -64.17 0.94 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.703 -0.68 . . . . 70.209999999999994 111.257 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -93.4 88.37 5.93 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.557 -1.275 . . . . 74.150000000000006 107.557 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -75.84 74.4 2.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.759 1.266 . . . . 72.129999999999995 112.839 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -81.92 122.58 27.94 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 113.972 -1.467 . . . . 70.129999999999995 108.455 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.95 73.06 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.866 0 C-N-CA 120.24 -0.981 . . . . 50.229999999999997 111.334 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -134.3 17.72 3.71 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.567 -0.901 . . . . 74.219999999999999 108.567 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -77.91 96.45 5.01 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.923 -1.035 . . . . 73.409999999999997 109.756 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 26' ' ' LEU . 2.4 pt? -113.16 125.44 54.35 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.347 0.594 . . . . 74.340000000000003 110.474 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 136' ' ' ASP . 99.3 mtt180 -114.93 124.57 52.03 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.919 -1.141 . . . . 71.25 107.919 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.13 127.57 72.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.499 0.666 . . . . 62.049999999999997 110.461 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 50.4 mtp85 -122.75 115.41 22.0 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 114.98 -1.009 . . . . 73.400000000000006 109.268 -178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.51 108.27 19.51 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.172 -1.048 . . . . 35.100000000000001 108.172 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.7 t -108.92 115.74 30.65 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 107.767 -1.197 . . . . 74.319999999999993 107.767 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.419 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.6 pp -129.91 146.07 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 C-N-CA 120.037 -0.665 . . . . 61.520000000000003 109.627 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 61.9 m -122.82 129.39 51.63 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.242 -1.022 . . . . 71.230000000000004 108.242 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -119.27 125.94 74.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.724 0.773 . . . . 74.209999999999994 110.511 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 46.7 m -97.56 142.72 24.99 Favored Pre-proline 0 N--CA 1.415 -2.213 0 CA-C-N 115.2 -0.909 . . . . 71.439999999999998 109.349 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 35' ' ' SER . 52.8 Cg_exo -59.45 2.7 0.24 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 124.104 3.203 . . . . 75.349999999999994 114.095 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.67 1.0 40.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 123.737 0.815 . . . . 51.439999999999998 110.027 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 91' ' ' THR . 11.5 t70 71.96 35.36 1.33 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 105.738 -1.949 . . . . 64.230000000000004 105.738 -176.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 1.7 tp -119.63 126.0 50.11 Favored 'General case' 0 N--CA 1.396 -3.164 0 CA-C-N 113.686 -1.597 . . . . 51.310000000000002 108.443 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.422 HG12 ' HE2' ' A' ' 87' ' ' PHE . 12.6 t -120.44 134.11 64.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.753 -0.832 . . . . 73.400000000000006 108.753 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.0 p -144.61 144.14 31.13 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.422 -0.955 . . . . 74.030000000000001 108.422 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 177.45 -166.68 37.28 Favored Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 119.311 -1.423 . . . . 34.100000000000001 112.065 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -151.94 135.91 16.47 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.48 0.657 . . . . 62.32 111.048 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.9 mt -111.95 116.63 53.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.107 -1.071 . . . . 74.430000000000007 108.107 177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.71 114.92 48.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.331 -0.618 . . . . 64.450000000000003 109.331 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.52 108.22 19.43 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.178 -1.786 . . . . 73.409999999999997 106.178 174.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.417 ' HB1' ' CB ' ' A' ' 80' ' ' TYR . . . -122.8 128.28 50.22 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 120.023 -0.671 . . . . 73.310000000000002 112.42 -173.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . . . -116.05 157.48 24.61 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.306 -0.861 . . . . 75.430000000000007 109.509 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -70.32 151.43 95.78 Favored Pre-proline 0 C--N 1.301 -1.514 0 C-N-CA 120.353 -0.539 . . . . 74.239999999999995 110.541 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -18.84 -50.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.284 1 C-N-CA 127.378 5.385 . . . . 65.230000000000004 118.293 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER 72.57 -68.79 0.21 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.736 0.814 . . . . 75.099999999999994 110.405 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -155.25 145.07 21.47 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.291 -1.374 . . . . 62.219999999999999 107.291 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.1 m -56.59 -19.85 18.0 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 114.593 1.331 . . . . 73.230000000000004 114.593 -172.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -80.02 -25.01 40.4 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 122.068 -0.395 . . . . 71.230000000000004 111.885 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.544 ' N ' ' HD3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -77.27 105.05 8.13 Favored 'General case' 0 CA--C 1.479 -1.757 0 CA-C-O 122.478 1.132 . . . . 60.100000000000001 112.59 -169.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.73 -30.01 19.41 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 113.253 -1.794 . . . . 73.319999999999993 111.458 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 173.0 123.93 0.75 Allowed Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 119.523 -1.322 . . . . 74.310000000000002 113.806 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 83' ' ' SER . 22.6 Cg_exo -68.15 159.28 53.82 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.443 2.095 . . . . 73.219999999999999 109.842 170.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.02 126.32 55.03 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 122.06 -0.4 . . . . 73.030000000000001 111.735 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 90.3 mt -87.34 162.51 17.33 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.812 -0.631 . . . . 74.430000000000007 109.98 175.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -101.88 96.6 7.16 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.762 0.792 . . . . 74.400000000000006 109.197 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -108.77 45.25 1.34 Allowed Glycine 0 C--N 1.288 -2.093 0 CA-C-N 114.609 -1.178 . . . . 34.32 110.327 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -100.05 110.03 22.33 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.141 -0.53 . . . . 74.140000000000001 109.815 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -152.66 169.33 9.78 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 124.738 1.215 . . . . 72.099999999999994 109.088 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.81 -14.87 34.5 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.527 2.151 . . . . 61.140000000000001 112.343 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.41 ' HA ' HE22 ' A' ' 68' ' ' GLN . 43.8 p90 -116.09 29.4 8.0 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.965 -0.561 . . . . 74.409999999999997 111.822 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.5 m -57.86 -27.87 63.63 Favored 'General case' 0 C--O 1.209 -1.03 0 N-CA-C 113.221 0.823 . . . . 74.0 113.221 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.41 HE22 ' HA ' ' A' ' 66' ' ' PHE . 5.4 pm0 -73.12 -8.75 57.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.392 0.615 . . . . 73.230000000000004 110.542 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -99.81 -15.52 18.4 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.696 -0.684 . . . . 72.239999999999995 109.584 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.4 118.84 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 122.154 0.978 . . . . 61.039999999999999 111.951 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.52 120.16 40.63 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.525 -0.761 . . . . 71.5 110.146 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.0 139.75 20.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.96 -0.756 . . . . 54.229999999999997 108.96 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.5 m -148.01 172.19 14.62 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.488 -0.93 . . . . 73.450000000000003 108.488 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 23.0 p-10 -85.88 154.05 21.8 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.389 -0.924 . . . . 71.439999999999998 108.69 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -112.25 120.69 42.61 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.703 -0.851 . . . . 62.25 108.703 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -138.64 98.5 3.58 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.073 -1.454 . . . . 65.200000000000003 107.073 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.9 t -175.41 160.93 2.65 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.021 -1.474 . . . . 50.219999999999999 107.021 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.26 11.7 8.09 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.054 0.941 . . . . 73.439999999999998 111.851 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.97 1.11 87.04 Favored Glycine 0 N--CA 1.441 -1.024 0 C-N-CA 120.967 -0.635 . . . . 72.219999999999999 111.76 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . 97.8 m-85 -104.84 167.41 9.73 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 122.501 -0.411 . . . . 63.049999999999997 109.988 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -134.33 136.13 53.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.524 -1.287 . . . . 73.510000000000005 107.524 169.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.07 -154.63 9.17 Favored Glycine 0 C--N 1.276 -2.796 0 C-N-CA 119.634 -1.27 . . . . 54.43 112.514 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.473 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 9.4 p -122.47 147.89 45.8 Favored 'General case' 0 C--N 1.273 -2.747 0 C-N-CA 123.549 0.74 . . . . 73.310000000000002 109.915 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -139.55 143.09 37.2 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.899 -0.501 . . . . 62.130000000000003 110.8 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.91 114.66 20.11 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.28 -1.378 . . . . 63.43 107.28 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.14 121.52 61.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.592 -0.892 . . . . 64.019999999999996 108.592 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.474 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.2 p90 -123.54 155.56 37.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.978 0.418 . . . . 73.299999999999997 111.52 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.0 p -156.7 157.81 35.82 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.831 -0.622 . . . . 71.310000000000002 111.357 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 64.47 31.53 12.44 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.472 1.107 . . . . 64.409999999999997 110.764 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.474 HD12 ' CD2' ' A' ' 87' ' ' PHE . 26.8 mt -93.24 163.89 13.45 Favored 'General case' 0 N--CA 1.438 -1.048 0 O-C-N 121.653 -0.655 . . . . 63.310000000000002 111.026 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 45.0 p -109.46 169.64 8.57 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 116.397 -0.365 . . . . 75.150000000000006 110.314 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -61.73 -31.7 71.89 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.264 -0.426 . . . . 74.349999999999994 110.548 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.65 -25.7 63.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.969 0.414 . . . . 75.019999999999996 110.957 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.74 -16.79 33.24 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.208 0.447 . . . . 64.340000000000003 112.208 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.6 tt -60.82 -49.48 89.2 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-O 119.232 -0.413 . . . . 73.329999999999998 111.271 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.81 -35.52 88.33 Favored 'Trans proline' 0 C--N 1.376 1.989 0 CA-C-N 121.038 1.406 . . . . 25.129999999999999 110.707 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.35 -35.78 81.23 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.29 -0.868 . . . . 74.340000000000003 111.601 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -73.11 -18.96 61.24 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 120.941 0.401 . . . . 71.540000000000006 110.671 176.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.02 -19.2 62.54 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.259 -0.428 . . . . 70.230000000000004 110.354 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -65.83 -52.98 45.91 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.183 -1.043 . . . . 62.32 108.183 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.454 ' O ' ' HB3' ' A' ' 104' ' ' ASP . 14.2 mtp -54.15 -52.39 61.26 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 115.702 -0.681 . . . . 50.539999999999999 109.583 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -56.49 -39.45 73.27 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.11 -0.95 . . . . 74.209999999999994 112.053 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.8 p -70.96 -21.08 62.37 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 119.282 -0.967 . . . . 73.230000000000004 111.198 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 101' ' ' MET . 6.0 t70 -61.72 -27.28 68.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.761 -0.654 . . . . 63.299999999999997 110.46 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.14 -5.41 13.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 116.071 -0.513 . . . . 44.310000000000002 111.117 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.96 -46.17 3.99 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.488 0.921 . . . . 62.350000000000001 113.488 -173.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.98 22.81 58.74 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 120.495 -0.86 . . . . 75.120000000000005 111.284 -174.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -120.39 172.3 7.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.789 -0.819 . . . . 73.439999999999998 108.789 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.515 ' OD1' ' HB2' ' A' ' 124' ' ' ARG . 3.7 p-10 -132.82 145.41 50.95 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.854 -0.338 . . . . 74.099999999999994 110.667 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.2 112.43 17.05 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.246 -0.65 . . . . 53.329999999999998 109.246 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -115.59 112.56 22.34 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.602 -0.518 . . . . 63.549999999999997 109.602 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -137.4 148.07 45.91 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.597 0.713 . . . . 72.349999999999994 112.007 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -147.53 155.74 42.16 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.417 -1.265 . . . . 73.239999999999995 109.53 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 114' ' ' ARG . 45.3 ttm180 -106.6 131.99 53.11 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 106.891 -1.522 . . . . 72.430000000000007 106.891 172.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -118.2 103.49 9.9 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.765 -1.198 . . . . 60.43 107.765 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.91 -107.08 2.25 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 109.372 -1.491 . . . . 50.140000000000001 109.372 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -122.2 2.96 9.82 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.788 1.28 . . . . 71.400000000000006 108.505 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -107.04 142.92 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 118.74 -1.184 . . . . 62.140000000000001 108.157 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 114' ' ' ARG . 81.9 t -105.9 138.27 31.98 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 O-C-N 122.099 -0.376 . . . . 73.430000000000007 111.175 -176.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.02 131.25 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 CA-C-N 115.499 -0.773 . . . . 74.340000000000003 109.012 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.4 131.62 48.49 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 115.46 -0.791 . . . . 73.099999999999994 110.296 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -139.95 115.58 10.09 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.781 0.8 . . . . 70.109999999999999 108.908 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -113.19 157.99 14.58 Favored Glycine 0 C--N 1.265 -3.364 0 N-CA-C 107.564 -2.214 . . . . 71.310000000000002 107.564 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.515 ' HB2' ' OD1' ' A' ' 109' ' ' ASN . 98.5 mtt180 -130.72 125.6 34.32 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 118.397 1.099 . . . . 55.140000000000001 109.249 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -118.68 110.33 17.17 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.919 -0.582 . . . . 72.329999999999998 110.206 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -105.57 100.04 9.62 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.154 -1.054 . . . . 65.299999999999997 108.154 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.26 17.65 21.96 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.687 -0.486 . . . . 72.310000000000002 109.687 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.0 p -63.79 -27.07 68.93 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 112.603 0.594 . . . . 50.439999999999998 112.603 -173.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.7 m -75.79 -11.2 59.94 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.02 0.378 . . . . 74.530000000000001 112.02 -178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.1 t 61.35 101.93 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.661 1.184 . . . . 73.299999999999997 113.907 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.5 m -71.29 -44.75 64.58 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.073 -1.084 . . . . 71.239999999999995 108.073 173.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -166.23 139.24 3.29 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 105.979 -1.86 . . . . 71.409999999999997 105.979 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.33 -23.37 71.95 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.796 2.331 . . . . 70.319999999999993 114.194 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -100.03 9.34 43.03 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 122.132 0.968 . . . . 51.32 110.163 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -87.45 145.33 26.32 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.92 -1.036 . . . . 74.25 109.895 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.402 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 16.4 m-20 -131.63 141.79 49.71 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 122.897 0.479 . . . . 74.230000000000004 110.113 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.9 t -120.86 112.79 37.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.429 -1.322 . . . . 75.230000000000004 107.429 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.405 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 38.2 mt-10 -121.41 125.29 46.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.777 -0.453 . . . . 74.549999999999997 109.777 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 tt -118.46 120.48 37.69 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.41 -1.33 . . . . 73.120000000000005 107.41 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.4 m -115.72 126.7 54.42 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.005 -0.739 . . . . 64.299999999999997 109.005 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.444 HG12 ' HD2' ' A' ' 143' ' ' PHE . 92.2 t -122.0 121.25 63.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.544 -0.539 . . . . 75.25 109.544 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.72 128.02 55.96 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.031 -0.729 . . . . 55.200000000000003 109.031 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.559 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.3 p90 -134.25 120.04 14.71 Favored Pre-proline 0 C--N 1.29 -2.005 0 C-N-CA 122.189 0.196 . . . . 72.319999999999993 111.298 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.95 55.65 2.87 Favored 'Trans proline' 0 CA--C 1.551 1.353 0 C-N-CA 122.618 2.212 . . . . 73.349999999999994 111.35 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.45 -110.53 0.15 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.719 -0.673 . . . . 23.129999999999999 110.009 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.1 128.34 0.46 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.856 -0.794 . . . . 75.530000000000001 108.856 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.76 133.85 28.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 109.377 -0.601 . . . . 65.450000000000003 109.377 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.7 p -90.45 -40.12 12.22 Favored 'General case' 0 N--CA 1.42 -1.967 0 C-N-CA 120.359 -0.537 . . . . 41.539999999999999 109.716 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 51.0 m -156.98 132.81 9.48 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 109.002 -0.74 . . . . 73.409999999999997 109.002 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.1 t -139.23 159.59 41.8 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.759 -0.46 . . . . 75.349999999999994 109.759 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 42.9 t30 -132.54 94.43 3.41 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.561 -1.644 . . . . 72.230000000000004 106.561 174.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.08 -136.67 2.92 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 108.643 -1.783 . . . . 63.509999999999998 108.643 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -119.25 99.25 6.59 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.899 -0.778 . . . . 71.430000000000007 108.899 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 154' ' ' ARG . 15.0 ptt180 -77.9 110.42 12.79 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.701 -0.682 . . . . 73.319999999999993 110.828 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.98 -47.54 20.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.552 -1.277 . . . . 73.200000000000003 107.552 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.37 166.59 25.7 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 107.185 -1.413 . . . . 70.549999999999997 107.185 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.46 0.52 7.95 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.098 1.865 . . . . 51.210000000000001 111.187 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.7 pt-20 -133.05 4.97 3.82 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 115.593 -0.73 . . . . 72.099999999999994 110.394 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.4 t -144.64 120.73 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.578 -0.897 . . . . 74.409999999999997 108.578 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.01 146.52 30.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.231 -0.655 . . . . 73.329999999999998 109.231 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -126.72 138.58 53.41 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 124.173 0.989 . . . . 73.329999999999998 109.008 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.421 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 31.8 m-90 -119.25 109.45 15.85 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.059 -1.089 . . . . 73.439999999999998 108.059 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -104.44 98.38 8.17 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 122.498 1.142 . . . . 71.439999999999998 109.112 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 19.3 mt -99.14 137.67 37.33 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.562 -1.653 . . . . 73.340000000000003 109.925 -170.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -117.73 153.74 50.79 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 114.905 -1.043 . . . . 65.019999999999996 111.422 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.34 159.11 54.71 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.515 2.143 . . . . 70.129999999999995 111.034 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 85.16 -34.89 3.18 Favored Glycine 0 C--N 1.303 -1.274 0 C-N-CA 120.964 -0.636 . . . . 72.299999999999997 111.564 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.6 m -105.48 159.23 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.4 0.619 . . . . 70.409999999999997 112.067 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.1 141.22 31.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.153 -1.054 . . . . 53.109999999999999 108.153 176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.9 m -150.87 145.77 25.88 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.324 -0.621 . . . . 72.299999999999997 109.324 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.458 HG22 ' HG2' ' A' ' 124' ' ' ARG . 38.5 p -105.29 139.12 40.42 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.597 -0.519 . . . . 74.109999999999999 109.597 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -89.92 116.52 28.05 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.409 -1.7 . . . . 60.32 106.409 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 10.9 t -125.78 135.88 52.52 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 117.946 -1.502 . . . . 71.439999999999998 109.298 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.421 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.49 120.97 6.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.416 -0.957 . . . . 73.25 108.416 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -124.64 131.21 53.48 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.635 -1.246 . . . . 74.540000000000006 107.635 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.12 152.52 26.46 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.467 -0.568 . . . . 61.100000000000001 109.467 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 56.1 mtt180 -87.91 129.94 35.07 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.851 -0.74 . . . . 74.530000000000001 109.217 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -131.93 129.12 39.86 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 107.622 -1.251 . . . . 73.209999999999994 107.622 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.9 p -54.61 104.95 0.13 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 124.485 1.116 . . . . 74.329999999999998 111.954 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.62 141.06 97.71 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.701 -0.681 . . . . 74.530000000000001 109.554 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.06 -47.47 12.5 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.042 1.828 . . . . 73.420000000000002 113.537 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.95 -10.84 54.49 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 121.9 -0.5 . . . . 73.450000000000003 112.232 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 71.8 p 63.07 93.83 0.05 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.445 1.498 . . . . 70.230000000000004 113.859 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.24 161.04 20.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 115.916 -0.583 . . . . 54.140000000000001 109.548 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 65.3 m . . . . . 0 C--O 1.26 1.637 0 CA-C-O 117.952 -1.023 . . . . 63.32 109.293 -172.38 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.689 0 N-CA-C 111.825 -0.51 . . . . 43.049999999999997 111.825 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -64.64 113.19 3.57 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.879 0.471 . . . . 74.230000000000004 110.803 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 60.11 29.51 19.07 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 122.083 0.944 . . . . 74.340000000000003 109.524 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.54 -42.1 18.8 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.514 -0.766 . . . . 73.019999999999996 110.271 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.76 117.98 22.04 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.197 -1.038 . . . . 74.120000000000005 108.197 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -70.75 101.13 2.02 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.023 -1.102 . . . . 74.430000000000007 108.023 175.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -54.78 -62.32 1.74 Allowed 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 123.529 0.518 . . . . 73.299999999999997 110.972 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -157.93 141.39 15.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.553 -0.906 . . . . 71.439999999999998 108.553 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.03 55.05 0.71 Allowed Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 109.316 -1.514 . . . . 60.310000000000002 109.316 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.461 ' HB3' ' OD2' ' A' ' 132' ' ' ASP . 87.6 m-70 -135.94 -174.92 3.8 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 123.031 0.533 . . . . 74.219999999999999 111.053 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 62.1 mtt 67.41 92.75 0.08 Allowed 'General case' 0 C--O 1.246 0.888 0 C-N-CA 125.525 1.53 . . . . 65.519999999999996 112.439 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 2.2 pt? -136.74 164.31 28.55 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.501 -0.772 . . . . 75.209999999999994 112.228 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 136' ' ' ASP . 16.1 tpt180 -133.46 124.22 26.66 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 105.986 -1.857 . . . . 74.319999999999993 105.986 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.14 114.26 41.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.172 -1.047 . . . . 62.549999999999997 108.172 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -129.59 115.18 17.03 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.692 0.758 . . . . 63.329999999999998 110.99 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.51 129.75 55.72 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.692 -1.14 . . . . 63.310000000000002 108.936 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.9 m -131.16 115.2 16.06 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.083 -1.08 . . . . 75.519999999999996 108.083 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.411 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.8 pp -124.35 147.16 28.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 109.804 -0.443 . . . . 73.319999999999993 109.804 -177.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 57.2 m -127.99 124.56 37.51 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 109.11 -0.7 . . . . 62.140000000000001 109.11 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.5 tt -112.77 119.67 60.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.703 0.764 . . . . 65.409999999999997 110.362 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.5 m -89.43 151.43 46.2 Favored Pre-proline 0 C--N 1.288 -2.098 0 CA-C-N 115.064 -0.971 . . . . 44.240000000000002 109.879 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.85 2.92 0.83 Allowed 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.819 3.013 . . . . 61.030000000000001 113.284 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 17.8 t70 -82.55 -2.65 54.23 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.702 -1.221 . . . . 74.400000000000006 107.702 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.1 t70 72.54 29.91 1.99 Allowed 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.458 -1.682 . . . . 72.230000000000004 106.458 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 1.0 OUTLIER -106.71 138.19 43.35 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 112.728 -2.033 . . . . 74.219999999999999 108.341 -177.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.07 140.67 46.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 109.501 -0.555 . . . . 74.430000000000007 109.501 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -147.74 160.98 42.13 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.09 -1.078 . . . . 61.109999999999999 108.09 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 166.48 -170.03 40.85 Favored Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.067 -1.54 . . . . 64.129999999999995 113.006 177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.34 133.68 18.5 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.254 0.55 . . . . 72.420000000000002 109.91 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.01 116.68 52.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 107.872 -1.159 . . . . 61.310000000000002 107.872 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.14 116.7 53.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 110.319 -0.252 . . . . 64.230000000000004 110.319 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.76 108.03 18.24 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 106.854 -1.535 . . . . 74.340000000000003 106.854 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . . . -118.74 141.79 48.29 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.114 -0.494 . . . . 63.200000000000003 110.234 -175.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.35 158.2 31.6 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.697 -0.853 . . . . 63.109999999999999 108.697 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -74.26 137.29 75.23 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.537 -0.912 . . . . 71.299999999999997 108.537 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -60.35 123.78 13.81 Favored 'Trans proline' 0 C--O 1.251 1.127 0 C-N-CA 122.697 2.264 . . . . 54.210000000000001 111.155 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 18.5 pttm -155.73 139.04 15.72 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.325 -1.731 . . . . 75.430000000000007 106.325 -175.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.616 HD21 ' HG2' ' A' ' 54' ' ' LYS . 6.2 t30 70.49 138.68 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 121.728 0.775 . . . . 74.109999999999999 112.965 177.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -50.6 -34.69 26.9 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 115.912 1.819 . . . . 63.329999999999998 115.912 -172.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.616 ' HG2' HD21 ' A' ' 52' ' ' ASN . 19.8 ptmt -99.3 3.13 46.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.619 -1.232 . . . . 74.239999999999995 112.373 -175.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.636 ' HB3' ' O ' ' A' ' 51' ' ' LYS . 29.7 t70 -93.09 100.6 12.98 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.85 -1.14 . . . . 61.399999999999999 113.06 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.571 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 9.2 t -121.44 -7.64 9.19 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 114.148 -1.387 . . . . 60.399999999999999 108.94 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.41 125.33 0.84 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 118.82 -0.989 . . . . 65.0 111.88 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 32.3 Cg_exo -61.4 154.26 60.09 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.069 1.846 . . . . 74.129999999999995 109.836 174.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.38 109.01 16.24 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 111.993 0.368 . . . . 64.109999999999999 111.993 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.3 mt -90.82 124.55 35.24 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.827 -0.749 . . . . 74.319999999999993 110.108 173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.46 99.41 8.19 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.406 -0.816 . . . . 73.129999999999995 110.283 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.96 75.87 0.29 Allowed Glycine 0 C--N 1.29 -2.021 0 CA-C-N 114.96 -1.018 . . . . 72.140000000000001 111.616 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.64 91.36 7.98 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 108.883 -0.784 . . . . 74.129999999999995 108.883 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.4 m -134.83 160.1 69.66 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 107.838 -1.171 . . . . 74.120000000000005 107.838 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -68.56 -22.74 37.89 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 121.88 1.72 . . . . 71.140000000000001 112.157 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -97.69 40.77 1.15 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.061 -0.518 . . . . 71.209999999999994 112.309 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 m -56.02 -35.92 67.39 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 123.052 0.541 . . . . 75.430000000000007 110.353 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -64.53 -15.18 60.49 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 123.55 0.74 . . . . 74.510000000000005 111.635 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -100.7 -17.66 16.87 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 116.082 -0.508 . . . . 72.530000000000001 110.828 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.83 120.09 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 122.022 0.915 . . . . 62.409999999999997 112.273 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.51 112.74 24.9 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.534 -0.757 . . . . 33.140000000000001 109.026 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.16 114.23 39.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.935 -1.135 . . . . 52.420000000000002 107.935 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 168.54 14.57 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.856 -0.794 . . . . 71.430000000000007 108.856 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -84.48 153.76 23.13 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 119.571 -0.852 . . . . 72.310000000000002 109.009 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 83.9 t80 -120.73 124.68 45.73 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 109.837 -0.431 . . . . 73.239999999999995 109.837 -177.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.17 98.14 3.55 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.982 -1.118 . . . . 55.140000000000001 107.982 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 49.5 m -165.28 164.27 19.96 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.3 -1.37 . . . . 63.43 107.3 -176.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 67.78 6.58 5.15 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 124.64 1.176 . . . . 74.540000000000006 111.946 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.04 5.81 85.55 Favored Glycine 0 C--N 1.314 -0.662 0 N-CA-C 110.065 -1.214 . . . . 73.140000000000001 110.065 -174.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.434 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 3.4 m-85 -105.7 163.1 12.96 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 124.767 1.227 . . . . 70.25 110.927 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 56' ' ' THR . 16.8 m -134.48 136.55 52.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.525 -0.917 . . . . 54.409999999999997 108.525 173.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -169.72 -155.13 9.77 Favored Glycine 0 N--CA 1.423 -2.22 0 C-N-CA 119.855 -1.164 . . . . 71.129999999999995 113.033 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -132.17 140.85 48.89 Favored 'General case' 0 C--N 1.289 -2.056 0 C-N-CA 124.007 0.923 . . . . 72.219999999999999 109.696 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -128.65 146.16 50.95 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 116.274 -0.421 . . . . 62.119999999999997 110.529 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.73 114.42 23.3 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.488 -1.301 . . . . 61.399999999999999 107.488 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.35 122.04 62.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.064 -1.087 . . . . 72.150000000000006 108.064 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -123.07 153.81 39.4 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.006 -0.678 . . . . 71.450000000000003 111.469 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.3 p -156.11 153.52 29.48 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.528 -0.76 . . . . 71.219999999999999 110.728 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 64.33 37.51 8.45 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.328 1.017 . . . . 73.299999999999997 112.876 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 90' ' ' LEU . 34.8 mt -101.02 176.32 5.3 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.169 -0.678 . . . . 70.340000000000003 109.169 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.447 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.8 t -121.76 171.08 9.14 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.369 -0.532 . . . . 73.540000000000006 110.398 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 114' ' ' ARG . 53.9 t80 -50.02 -44.78 51.41 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.751 1.621 . . . . 61.299999999999997 111.517 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.1 -25.63 66.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.63 0.604 . . . . 70.040000000000006 112.63 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' OE1' HG22 ' A' ' 91' ' ' THR . 49.5 mt-10 -85.76 -15.96 40.42 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.164 0.431 . . . . 62.299999999999997 112.164 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.649 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 7.0 tt -55.74 -52.48 71.85 Favored Pre-proline 0 CA--C 1.564 1.5 0 N-CA-C 111.88 0.326 . . . . 62.409999999999997 111.88 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 21.1 Cg_endo -65.1 -29.92 56.12 Favored 'Trans proline' 0 C--N 1.359 1.11 0 CA-C-N 120.6 1.25 . . . . 71.120000000000005 111.7 175.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -69.04 -35.92 77.13 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 123.279 0.631 . . . . 55.210000000000001 110.401 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -77.02 -19.28 57.42 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.351 0.596 . . . . 64.230000000000004 109.495 176.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 96' ' ' PRO . . . -73.19 -17.69 61.34 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.484 -0.78 . . . . 75.400000000000006 109.56 -177.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.04 -54.59 42.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.771 -0.65 . . . . 72.030000000000001 109.591 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 67.5 mtm -54.24 -52.31 61.74 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.82 0.819 . . . . 50.32 109.232 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -54.3 -31.6 54.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.824 -1.535 . . . . 71.120000000000005 111.694 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.8 m -58.46 -33.7 70.04 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 119.304 -0.379 . . . . 71.109999999999999 111.915 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.1 -21.94 66.88 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.438 0.533 . . . . 63.130000000000003 112.438 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.16 -4.9 13.06 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.723 -0.391 . . . . 62.140000000000001 110.629 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.48 -48.27 3.72 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.981 -0.688 . . . . 64.150000000000006 112.697 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.8 28.28 73.21 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 119.94 -1.124 . . . . 71.140000000000001 110.541 -173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.1 t -122.05 134.6 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 109.039 -0.726 . . . . 73.510000000000005 109.039 -176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -93.55 122.37 35.91 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.087 -0.708 . . . . 72.420000000000002 109.087 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.46 137.2 53.34 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.594 0.59 . . . . 61.240000000000002 112.594 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.4 t -138.01 142.43 40.41 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.151 -1.055 . . . . 72.540000000000006 108.151 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -148.25 127.3 12.82 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.265 -1.013 . . . . 70.129999999999995 108.265 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -144.92 149.41 35.21 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 113.615 0.969 . . . . 71.209999999999994 113.615 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.499 ' HD3' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -101.94 117.28 34.49 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.526 -1.657 . . . . 74.129999999999995 106.526 177.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -109.96 92.7 4.15 Favored 'General case' 0 CA--C 1.474 -1.944 0 N-CA-C 107.81 -1.182 . . . . 74.329999999999998 107.81 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.92 -114.16 6.19 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 108.845 -1.702 . . . . 33.200000000000003 108.845 -172.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.499 ' OD1' ' HD2' ' A' ' 177' ' ' ARG . 29.4 t-20 -100.33 -14.73 18.27 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.441 0.639 . . . . 64.030000000000001 110.633 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.518 ' HA ' ' CB ' ' A' ' 177' ' ' ARG . 1.3 pp -96.05 146.58 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 C-N-CA 118.978 -1.089 . . . . 64.200000000000003 109.106 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.68 HG21 ' CD2' ' A' ' 178' ' ' TYR . 89.0 t -115.74 141.19 34.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.587 -0.696 . . . . 73.319999999999993 110.391 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.43 HG22 ' HG2' ' A' ' 175' ' ' GLN . 40.0 pt -122.3 140.67 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 115.328 -0.851 . . . . 61.420000000000002 109.493 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.03 127.47 47.93 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 107.636 -1.246 . . . . 74.200000000000003 107.636 172.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -127.92 118.61 23.92 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 114.715 -1.13 . . . . 71.129999999999995 108.497 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -144.94 133.47 5.16 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.295 -0.955 . . . . 50.409999999999997 111.169 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.48 ' HG2' HG22 ' A' ' 171' ' ' THR . 68.3 mtt85 -120.63 127.02 51.7 Favored 'General case' 0 C--N 1.28 -2.436 0 O-C-N 122.38 -0.482 . . . . 74.129999999999995 110.053 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -117.75 113.61 22.1 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.611 -0.722 . . . . 70.019999999999996 110.024 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -111.74 107.49 16.6 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.617 -1.253 . . . . 60.240000000000002 107.617 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.559 ' O ' HG12 ' A' ' 130' ' ' VAL . 2.7 mm? -111.74 27.28 9.81 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.872 -0.418 . . . . 74.120000000000005 109.872 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.4 p -71.52 -27.8 63.44 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.046 -0.662 . . . . 75.549999999999997 111.885 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.0 m -100.36 10.25 41.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.259 -0.428 . . . . 40.219999999999999 111.391 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 127' ' ' LEU . 8.4 p -73.81 140.15 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 119.62 -0.832 . . . . 70.219999999999999 108.834 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.2 m -86.8 11.92 12.12 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.953 0.406 . . . . 32.229999999999997 111.455 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.461 ' OD2' ' HB3' ' A' ' 24' ' ' HIS . 4.9 m-20 -129.76 100.65 19.16 Favored Pre-proline 0 CA--C 1.489 -1.368 0 N-CA-C 112.249 0.463 . . . . 74.349999999999994 112.249 -176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -74.78 -15.67 21.21 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.97 1.78 . . . . 74.219999999999999 110.003 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -83.14 -11.77 57.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.392 -1.276 . . . . 51.420000000000002 110.608 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -70.35 142.25 52.17 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.882 -0.599 . . . . 73.209999999999994 110.761 -177.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.451 ' O ' ' HD2' ' A' ' 27' ' ' ARG . 10.1 t70 -132.03 116.31 16.93 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.042 -1.836 . . . . 70.510000000000005 106.042 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.8 t -114.35 136.51 50.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.467 -0.568 . . . . 62.5 109.467 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -133.42 131.66 40.23 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.908 -0.404 . . . . 75.340000000000003 109.908 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -122.67 118.54 28.36 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 106.817 -1.549 . . . . 74.129999999999995 106.817 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.4 m -121.62 133.36 54.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.954 -0.387 . . . . 60.009999999999998 109.954 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.9 t -125.37 124.04 66.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 108.697 -0.853 . . . . 73.439999999999998 108.697 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -115.16 132.51 56.58 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.577 -0.897 . . . . 72.239999999999995 108.577 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.7 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -134.43 120.37 14.69 Favored Pre-proline 0 C--N 1.28 -2.42 0 CA-C-N 116.337 -0.392 . . . . 74.430000000000007 110.147 178.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 31.5 Cg_exo -64.92 37.69 0.11 Allowed 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 123.928 3.085 . . . . 73.409999999999997 114.654 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.28 -97.1 0.46 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.302 -0.629 . . . . 44.340000000000003 109.302 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.44 136.81 0.06 Allowed 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.793 -1.188 . . . . 73.340000000000003 107.793 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -84.31 128.5 38.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.548 -0.538 . . . . 75.540000000000006 109.548 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 43.6 p -88.35 -43.85 11.21 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.686 -0.688 . . . . 75.099999999999994 110.159 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.2 m -150.64 132.51 15.09 Favored 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.4 -0.963 . . . . 71.439999999999998 108.4 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.406 ' OG1' HG11 ' A' ' 160' ' ' VAL . 10.2 t -140.28 152.31 45.8 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.889 -0.724 . . . . 72.409999999999997 111.276 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -123.79 91.16 3.41 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.369 -2.086 . . . . 64.329999999999998 105.369 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.14 -139.35 5.38 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 110.202 -1.159 . . . . 51.020000000000003 110.202 -177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 161' ' ' GLN . 24.3 t70 -115.18 99.57 7.51 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.613 0.721 . . . . 71.230000000000004 110.589 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -84.33 116.35 22.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 116.131 -0.486 . . . . 63.329999999999998 110.808 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.485 HD11 ' NE2' ' A' ' 161' ' ' GLN . 54.8 mt -93.42 -49.29 12.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.679 -0.86 . . . . 71.510000000000005 108.679 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -126.36 159.58 62.19 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.552 -1.277 . . . . 65.239999999999995 107.552 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.04 -18.61 51.63 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.568 2.179 . . . . 51.509999999999998 111.907 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.7 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.8 OUTLIER -120.22 7.65 10.79 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.842 0.682 . . . . 72.519999999999996 112.842 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.9 t -138.43 121.45 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-O 121.074 0.464 . . . . 71.430000000000007 110.812 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.406 HG11 ' OG1' ' A' ' 150' ' ' THR . 79.7 t -125.04 144.87 33.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.962 -0.563 . . . . 70.140000000000001 109.664 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.485 ' NE2' HD11 ' A' ' 155' ' ' ILE . 9.2 tt0 -133.57 152.03 51.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.273 -1.01 . . . . 71.040000000000006 108.273 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.533 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.0 m-90 -128.64 123.92 34.47 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 108.42 -0.956 . . . . 74.129999999999995 108.42 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 109.04 20.76 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.813 0.816 . . . . 74.409999999999997 109.983 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 66.1 mt -97.33 126.27 42.45 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.677 -1.147 . . . . 73.010000000000005 109.226 -174.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -115.22 152.19 46.54 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 115.091 -0.959 . . . . 74.319999999999993 112.266 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -68.97 158.44 57.92 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 123.192 2.595 . . . . 74.099999999999994 111.212 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 73.3 -19.82 1.33 Allowed Glycine 0 C--N 1.313 -0.746 0 N-CA-C 114.299 0.48 . . . . 63.119999999999997 114.299 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.4 m -111.63 169.25 4.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.4 0.619 . . . . 54.240000000000002 110.781 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.63 139.61 38.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.142 -1.429 . . . . 74.430000000000007 107.142 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 27.1 m -134.77 134.89 41.4 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.358 0.599 . . . . 64.519999999999996 110.55 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.48 HG22 ' HG2' ' A' ' 124' ' ' ARG . 9.7 p -103.11 126.53 50.33 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.085 -0.961 . . . . 75.219999999999999 108.727 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 56.7 mtm -108.86 126.95 53.6 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.21 -1.033 . . . . 63.509999999999998 108.21 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.9 t -141.65 138.09 32.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.339 -0.986 . . . . 73.420000000000002 108.339 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.458 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -146.03 133.39 20.68 Favored 'General case' 0 CA--C 1.469 -2.16 0 N-CA-C 108.052 -1.092 . . . . 71.310000000000002 108.052 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.43 ' HG2' HG22 ' A' ' 120' ' ' ILE . 39.5 mt-30 -126.89 131.14 51.22 Favored 'General case' 0 C--N 1.263 -3.177 0 N-CA-C 108.039 -1.097 . . . . 74.150000000000006 108.039 175.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 119' ' ' VAL . . . -159.79 129.45 5.35 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 106.566 -1.642 . . . . 74.209999999999994 106.566 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.518 ' CB ' ' HA ' ' A' ' 118' ' ' ILE . 17.7 ptt180 -88.05 146.86 25.25 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 118.43 -1.308 . . . . 74.319999999999993 110.117 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.68 ' CD2' HG21 ' A' ' 119' ' ' VAL . 19.6 m-30 -119.53 137.05 54.07 Favored 'General case' 0 CA--C 1.465 -2.317 0 N-CA-C 108.187 -1.042 . . . . 74.010000000000005 108.187 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.7 p -71.36 103.82 3.0 Favored 'General case' 0 N--CA 1.394 -3.236 0 CA-C-N 115.269 -0.878 . . . . 65.430000000000007 110.431 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.417 ' HB3' ' ND2' ' A' ' 182' ' ' ASN . 35.4 m-20 -54.02 134.99 58.22 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.13 -0.941 . . . . 75.109999999999999 111.145 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -69.2 -20.97 36.79 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.425 2.75 . . . . 73.400000000000006 111.716 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' ' 180' ' ' ASP . 10.9 p30 -74.19 -21.27 59.89 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 109.227 -0.657 . . . . 62.439999999999998 109.227 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.7 p 51.51 98.1 0.01 OUTLIER 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.275 1.43 . . . . 63.5 113.433 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -120.31 175.83 5.77 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.997 -1.001 . . . . 64.310000000000002 111.599 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 108.189 -1.041 . . . . 64.540000000000006 108.189 -179.027 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.64 0 N-CA-C 110.55 -1.02 . . . . 53.32 110.55 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -81.27 133.4 35.43 Favored 'General case' 0 C--O 1.252 1.201 0 N-CA-C 108.051 -1.092 . . . . 74.099999999999994 108.051 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -143.11 149.68 38.46 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.802 -0.759 . . . . 61.43 109.8 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.7 t30 65.13 91.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.859 1.264 . . . . 54.229999999999997 110.816 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 mp -89.51 81.05 6.59 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.571 -0.741 . . . . 73.109999999999999 110.901 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -86.75 124.64 33.23 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.908 -1.042 . . . . 72.200000000000003 110.508 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.2 t80 53.06 62.16 2.81 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 125.04 1.336 . . . . 71.530000000000001 111.419 -175.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.416 ' OE1' ' HG3' ' A' ' 51' ' ' LYS . 78.6 mm-40 -112.78 31.79 6.12 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.988 -1.486 . . . . 75.219999999999999 106.988 174.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.45 103.29 0.93 Allowed Glycine 0 N--CA 1.424 -2.127 0 CA-C-N 113.045 -1.889 . . . . 75.319999999999993 110.179 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -101.53 -154.83 0.49 Allowed 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 114.442 -0.879 . . . . 74.400000000000006 109.254 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.4 ptp -168.31 133.78 1.81 Allowed 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.598 -2.371 . . . . 72.430000000000007 104.598 172.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 135' ' ' ALA 0.301 0.0 OUTLIER -132.44 144.75 50.7 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 114.044 1.128 . . . . 63.350000000000001 114.044 -177.032 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 -113.15 124.23 52.08 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 114.236 -1.347 . . . . 72.329999999999998 107.741 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.97 114.19 43.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 106.913 -1.514 . . . . 75.150000000000006 106.913 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 22.4 ttt180 -129.32 116.94 19.85 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 121.519 0.676 . . . . 44.119999999999997 110.708 -178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.35 108.84 20.57 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.26 -1.385 . . . . 73.400000000000006 107.26 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.9 m -113.47 114.16 26.16 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.698 -1.593 . . . . 62.310000000000002 106.698 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.8 pp -131.76 146.07 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 C-N-CA 120.2 -0.6 . . . . 62.229999999999997 109.811 -175.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 87.3 m -126.43 122.49 35.44 Favored 'General case' 0 C--N 1.27 -2.883 0 N-CA-C 109.251 -0.648 . . . . 64.409999999999997 109.251 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 tt -110.93 118.76 58.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.652 0.739 . . . . 60.009999999999998 109.796 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.7 m -89.33 150.78 45.4 Favored Pre-proline 0 N--CA 1.411 -2.411 0 N-CA-C 108.429 -0.952 . . . . 64.319999999999993 108.429 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.03 0.9 0.36 Allowed 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.792 2.995 . . . . 75.040000000000006 115.135 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 37.3 t70 -83.32 -3.25 57.3 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.783 -0.821 . . . . 72.230000000000004 108.783 176.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 t70 72.77 29.84 1.87 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 105.812 -1.921 . . . . 74.120000000000005 105.812 -173.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 2.4 tp -100.19 124.61 45.83 Favored 'General case' 0 N--CA 1.389 -3.493 0 CA-C-N 113.3 -1.773 . . . . 74.129999999999995 107.354 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG21 ' HG ' ' A' ' 95' ' ' LEU . 14.3 t -116.34 133.08 64.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 109.078 -0.712 . . . . 75.319999999999993 109.078 -177.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.8 p -146.96 157.55 43.66 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.635 -0.876 . . . . 62.539999999999999 108.635 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.3 -165.19 38.68 Favored Glycine 0 N--CA 1.428 -1.855 0 C-N-CA 119.207 -1.473 . . . . 63.229999999999997 112.987 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.55 133.83 21.74 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 123.28 0.632 . . . . 72.329999999999998 109.873 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 102' ' ' ASN . 63.8 mt -116.94 116.01 50.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.892 -1.151 . . . . 72.400000000000006 107.892 176.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.93 126.03 65.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.046 -0.525 . . . . 74.319999999999993 109.829 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -120.72 107.93 13.37 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.282 -1.747 . . . . 70.0 106.282 171.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -120.87 127.51 51.95 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 116.26 -0.427 . . . . 73.310000000000002 111.003 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.77 148.88 42.35 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 116.48 -0.327 . . . . 45.420000000000002 110.244 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.82 128.88 93.44 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 108.433 -0.951 . . . . 64.209999999999994 108.433 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -57.95 111.94 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.161 1.907 . . . . 72.540000000000006 110.719 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG3' ' OE1' ' A' ' 22' ' ' GLN . 0.5 OUTLIER -121.51 -32.07 3.9 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.051 0.453 . . . . 75.010000000000005 110.034 -177.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -85.0 130.5 34.61 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.736 -1.209 . . . . 41.530000000000001 107.736 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.4 m -55.41 -43.4 75.24 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 124.119 0.968 . . . . 63.509999999999998 113.222 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -83.97 -7.2 59.47 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.779 0.288 . . . . 71.230000000000004 111.779 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' OD2' ' HD3' ' A' ' 58' ' ' PRO . 35.8 t70 -86.07 125.62 33.58 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 113.639 0.977 . . . . 72.439999999999998 113.639 -168.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 t -121.58 4.04 10.14 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.649 -1.16 . . . . 72.329999999999998 109.865 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.496 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 172.24 99.01 0.12 Allowed Glycine 0 N--CA 1.431 -1.671 0 CA-C-O 118.69 -1.061 . . . . 61.340000000000003 112.545 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.51 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 31.2 Cg_exo -59.84 128.52 27.1 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 CA-C-N 119.872 1.836 . . . . 71.400000000000006 109.052 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 83' ' ' SER . . . -89.71 151.43 21.85 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.803 0.668 . . . . 72.420000000000002 112.803 -171.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 67.3 mt -82.46 138.97 34.22 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.828 -0.623 . . . . 71.209999999999994 109.526 174.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -110.6 101.97 10.59 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.633 -1.618 . . . . 72.109999999999999 106.633 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -160.85 75.13 0.19 Allowed Glycine 0 C--N 1.29 -1.979 0 C-N-CA 120.581 -0.818 . . . . 71.409999999999997 112.857 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.01 112.2 19.55 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.56 -0.533 . . . . 73.409999999999997 109.56 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.43 HG11 ' SD ' ' A' ' 101' ' ' MET . 17.6 m -124.21 157.13 65.35 Favored Pre-proline 0 C--N 1.293 -1.891 0 CA-C-N 115.939 -0.573 . . . . 71.019999999999996 109.841 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.51 -10.09 27.56 Favored 'Trans proline' 0 N--CA 1.48 0.71 0 C-N-CA 122.751 2.3 . . . . 72.239999999999995 112.886 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -110.26 39.46 2.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.388 -0.369 . . . . 64.140000000000001 110.974 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 m -53.68 -32.36 51.39 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.055 0.391 . . . . 43.310000000000002 112.055 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -67.76 -11.88 59.38 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.273 0.559 . . . . 72.5 110.981 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -98.62 -20.61 16.9 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.673 -0.694 . . . . 74.349999999999994 111.071 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.22 119.79 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.731 0.777 . . . . 73.299999999999997 112.155 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 123.28 45.7 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.465 -0.789 . . . . 63.229999999999997 109.075 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.66 130.99 46.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.952 -0.758 . . . . 52.340000000000003 108.952 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 m -132.66 171.98 13.13 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.947 -0.39 . . . . 64.129999999999995 109.947 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.496 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 5.8 t30 -93.03 134.87 34.73 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.051 -1.092 . . . . 73.219999999999999 108.051 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 87.8 t80 -99.96 126.35 46.11 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.946 -0.39 . . . . 75.340000000000003 109.946 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -135.29 101.44 4.84 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.082 -1.081 . . . . 71.409999999999997 108.082 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 47.0 t -173.22 155.85 3.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.939 -1.134 . . . . 71.420000000000002 107.939 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 70.57 6.86 6.0 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.687 1.195 . . . . 73.530000000000001 110.811 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.76 6.0 87.51 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.021 -0.831 . . . . 64.430000000000007 111.021 -173.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.502 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 4.1 m-85 -104.59 148.15 26.83 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 123.417 0.687 . . . . 73.219999999999999 110.094 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.7 137.45 55.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.833 -0.803 . . . . 73.409999999999997 108.833 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.51 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -167.86 -154.31 8.61 Favored Glycine 0 CA--C 1.458 -3.473 0 N-CA-C 110.555 -1.018 . . . . 71.439999999999998 110.555 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.5 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . 32.7 t -134.19 149.13 50.99 Favored 'General case' 0 C--N 1.26 -3.296 0 N-CA-C 108.656 -0.868 . . . . 73.209999999999994 108.656 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -134.82 133.88 40.25 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 115.618 -0.719 . . . . 73.319999999999993 110.207 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.67 115.61 30.62 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.24 -1.022 . . . . 71.129999999999995 108.24 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.64 116.21 48.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 107.599 -1.26 . . . . 72.530000000000001 107.599 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.5 p90 -120.76 157.04 30.57 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 120.595 -0.442 . . . . 74.140000000000001 110.609 -175.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.2 m -159.25 157.19 30.16 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.933 -0.576 . . . . 74.430000000000007 110.06 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 64.06 32.85 12.56 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.24 0.963 . . . . 73.439999999999998 112.242 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 87' ' ' PHE . 22.9 mt -90.31 153.26 20.59 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.625 -0.716 . . . . 62.119999999999997 110.503 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.7 p -108.04 172.33 6.89 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.338 -0.846 . . . . 63.299999999999997 109.686 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -60.84 -26.55 67.44 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.183 0.516 . . . . 72.340000000000003 111.007 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.64 -29.5 66.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.534 0.683 . . . . 74.040000000000006 109.847 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HB3' HD22 ' A' ' 90' ' ' LEU . 38.9 mt-10 -93.07 -15.95 25.53 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.315 -0.857 . . . . 74.540000000000006 111.77 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.4 mt -51.98 -52.34 62.62 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 114.008 1.114 . . . . 73.420000000000002 114.008 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -64.54 -34.41 52.82 Favored 'Trans proline' 0 C--N 1.363 1.325 0 CA-C-N 120.624 1.259 . . . . 73.040000000000006 110.31 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -64.26 -38.74 92.11 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.085 -0.962 . . . . 75.129999999999995 111.385 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -70.78 -19.7 62.67 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.091 0.472 . . . . 75.519999999999996 110.601 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.27 -16.07 59.87 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.033 -0.531 . . . . 73.230000000000004 110.643 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -62.32 -57.92 9.58 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 120.8 -0.36 . . . . 74.430000000000007 110.065 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.43 ' SD ' HG11 ' A' ' 64' ' ' VAL . 3.7 mpp? -56.49 -45.74 80.84 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.133 0.492 . . . . 73.420000000000002 109.896 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB2' HD13 ' A' ' 44' ' ' ILE . 27.1 t-20 -52.95 -45.01 67.53 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 114.203 -1.362 . . . . 63.030000000000001 111.386 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.7 p -66.03 -28.3 68.76 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 120.291 -0.564 . . . . 61.539999999999999 110.937 -170.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.1 -26.04 66.51 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.16 0.505 . . . . 65.5 110.597 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.88 -9.81 17.74 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.956 -0.566 . . . . 64.329999999999998 110.594 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.26 -44.75 4.47 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.213 0.82 . . . . 61.119999999999997 113.213 -172.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.39 27.64 35.57 Favored Glycine 0 C--N 1.316 -0.548 0 N-CA-C 110.297 -1.121 . . . . 74.420000000000002 110.297 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.9 m -111.11 168.26 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.389 -0.406 . . . . 73.340000000000003 110.104 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -135.45 124.96 25.0 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.676 -0.861 . . . . 74.140000000000001 108.676 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -119.49 141.07 49.5 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 123.335 0.397 . . . . 72.310000000000002 110.283 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 49.2 m -141.56 116.39 9.79 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.534 -0.913 . . . . 52.210000000000001 108.534 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -129.72 146.16 51.5 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.137 -0.625 . . . . 75.349999999999994 111.337 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -139.13 154.67 48.15 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.632 -1.167 . . . . 74.340000000000003 109.034 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.451 ' HG3' HG22 ' A' ' 119' ' ' VAL . 4.7 ttt180 -100.25 137.8 38.19 Favored 'General case' 0 N--CA 1.393 -3.309 0 N-CA-C 107.661 -1.237 . . . . 73.239999999999995 107.661 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -123.26 89.36 3.09 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 106.638 -1.615 . . . . 75.510000000000005 106.638 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.71 -118.12 6.91 Favored Glycine 0 N--CA 1.423 -2.224 0 N-CA-C 110.042 -1.223 . . . . 75.109999999999999 110.042 -176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 8.1 t30 -103.96 7.31 36.66 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.086 0.946 . . . . 74.209999999999994 108.925 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 pp -119.33 149.16 21.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 120.799 -1.188 . . . . 72.140000000000001 109.079 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.451 HG22 ' HG3' ' A' ' 114' ' ' ARG . 72.9 t -107.8 137.91 36.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 O-C-N 121.845 -0.534 . . . . 62.140000000000001 110.037 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.0 pt -118.42 132.66 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 109.291 -0.633 . . . . 73.209999999999994 109.291 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 tt -124.61 129.24 50.19 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 115.549 -0.75 . . . . 54.119999999999997 109.438 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.31 124.17 29.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.526 -1.657 . . . . 74.120000000000005 106.526 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -149.58 171.9 29.63 Favored Glycine 0 N--CA 1.426 -2.027 0 C-N-CA 120.392 -0.908 . . . . 74.140000000000001 112.695 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.436 ' HG2' HG22 ' A' ' 171' ' ' THR . 74.2 mtt85 -138.79 153.79 48.43 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.634 0.774 . . . . 71.25 109.365 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -131.07 109.04 10.2 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.475 -0.935 . . . . 54.450000000000003 108.475 174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -112.6 95.69 5.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.785 0.802 . . . . 74.299999999999997 110.742 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.88 27.97 5.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 123.393 1.568 . . . . 71.340000000000003 107.79 177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.0 p -63.95 -25.7 68.26 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 112.562 -2.108 . . . . 72.310000000000002 112.017 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 p -69.45 -23.72 63.71 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.849 0.86 . . . . 64.099999999999994 111.361 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.9 t 71.21 86.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 125.107 1.363 . . . . 63.450000000000003 111.676 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 p -75.37 -36.39 60.93 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.77 -1.104 . . . . 74.329999999999998 109.09 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -148.77 128.55 6.5 Favored Pre-proline 0 N--CA 1.438 -1.059 0 N-CA-C 107.825 -1.176 . . . . 73.530000000000001 107.825 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.9 -12.59 21.74 Favored 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 122.872 2.381 . . . . 55.32 115.72 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -107.39 -11.79 15.46 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.164 -0.96 . . . . 72.420000000000002 110.186 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -61.33 138.92 58.25 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.82 -1.082 . . . . 64.109999999999999 113.863 -175.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -131.33 130.38 42.65 Favored 'General case' 0 C--O 1.257 1.486 0 N-CA-C 107.784 -1.191 . . . . 61.240000000000002 107.784 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 47.2 t -105.9 112.72 40.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.134 -1.432 . . . . 62.039999999999999 107.134 175.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 37.0 mt-10 -108.19 120.42 42.31 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.081 -0.711 . . . . 75.25 109.081 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 3.0 tt -115.17 122.81 47.18 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 105.976 -1.861 . . . . 70.239999999999995 105.976 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.0 m -126.92 126.01 42.53 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 109.198 -0.667 . . . . 74.340000000000003 109.198 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.471 HG12 ' HD2' ' A' ' 143' ' ' PHE . 57.8 t -120.11 124.03 71.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 108.961 -0.755 . . . . 60.100000000000001 108.961 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.4 127.36 55.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.706 -0.85 . . . . 75.340000000000003 108.706 177.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.54 121.76 15.34 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 112.187 0.44 . . . . 74.239999999999995 112.187 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.73 46.9 1.11 Allowed 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.997 2.464 . . . . 75.030000000000001 110.809 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -128.36 -106.84 0.3 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.943 -0.571 . . . . 53.149999999999999 109.867 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.59 126.75 0.07 Allowed 'General case' 0 C--O 1.245 0.834 0 N-CA-C 108.742 -0.836 . . . . 61.030000000000001 108.742 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.1 p -79.91 135.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 108.868 -0.79 . . . . 75.540000000000006 108.868 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.4 p -90.5 -42.7 10.7 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 109.459 -0.571 . . . . 65.439999999999998 109.459 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.5 m -159.38 133.12 7.34 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.095 -0.502 . . . . 44.240000000000002 109.963 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.6 t -139.16 157.12 46.5 Favored 'General case' 0 C--N 1.286 -2.193 0 O-C-N 121.987 -0.445 . . . . 70.040000000000006 110.313 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -128.23 95.86 4.29 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.656 -1.979 . . . . 60.439999999999998 105.656 173.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.52 -145.21 8.14 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 107.788 -2.125 . . . . 71.040000000000006 107.788 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -110.61 99.83 8.73 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 118.294 1.047 . . . . 72.230000000000004 110.232 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -78.96 110.45 14.19 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 121.886 0.85 . . . . 63.439999999999998 109.531 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.8 mt -80.39 -38.0 17.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.149 -1.426 . . . . 61.329999999999998 107.149 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.76 163.86 38.08 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.222 -1.77 . . . . 65.450000000000003 106.222 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.09 0.23 7.56 Favored 'Trans proline' 0 N--CA 1.481 0.789 0 C-N-CA 122.588 2.192 . . . . 75.030000000000001 110.846 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 12.0 pt-20 -128.94 -0.42 5.3 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 114.88 -1.054 . . . . 55.310000000000002 111.297 -178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.7 t -142.18 120.8 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.547 -0.908 . . . . 73.530000000000001 108.547 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -127.41 143.79 39.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.532 -0.544 . . . . 75.219999999999999 109.532 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 36.1 tt0 -129.93 147.08 51.65 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.373 0.606 . . . . 71.439999999999998 110.17 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.467 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.3 m-90 -123.63 117.86 25.97 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 108.142 -1.059 . . . . 75.409999999999997 108.142 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -104.07 98.21 8.07 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.752 0.787 . . . . 70.230000000000004 109.407 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 18.3 mt -93.42 130.12 39.34 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.555 -1.202 . . . . 73.319999999999993 109.225 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.2 152.32 50.42 Favored Pre-proline 0 C--N 1.302 -1.468 0 CA-C-N 115.904 -0.589 . . . . 65.120000000000005 111.15 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.68 153.48 73.22 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.329 2.019 . . . . 73.150000000000006 111.06 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 78.09 -23.96 2.56 Favored Glycine 0 C--N 1.304 -1.201 0 C-N-CA 121.046 -0.597 . . . . 71.5 113.842 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.1 m -104.45 147.78 10.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.223 0.535 . . . . 74.109999999999999 110.698 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 82.6 t -85.38 127.9 39.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.584 -0.735 . . . . 74.099999999999994 109.504 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 10.1 p -138.44 133.07 32.31 Favored 'General case' 0 N--CA 1.424 -1.744 0 CA-C-O 121.424 0.63 . . . . 72.329999999999998 111.715 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 124' ' ' ARG . 21.3 p -114.83 147.38 39.93 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 108.614 -0.884 . . . . 62.299999999999997 108.614 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.405 ' SD ' HD11 ' A' ' 164' ' ' LEU . 70.2 mtm -120.5 133.31 55.42 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.645 -0.502 . . . . 73.319999999999993 109.645 -176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.9 t -143.02 137.06 29.01 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.313 -0.625 . . . . 72.409999999999997 109.313 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.467 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -148.12 118.71 7.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.943 -0.762 . . . . 72.540000000000006 108.943 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -122.75 130.97 53.55 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 106.62 -1.622 . . . . 74.5 106.62 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.44 160.93 41.89 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.035 0.21 . . . . 50.020000000000003 111.261 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.8 mtt-85 -87.39 127.29 35.21 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.862 -0.422 . . . . 72.430000000000007 109.862 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -143.5 119.54 10.7 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 117.757 0.253 . . . . 72.040000000000006 110.529 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.556 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -58.63 119.42 7.04 Favored 'General case' 0 C--N 1.288 -2.1 0 O-C-N 124.226 0.954 . . . . 75.209999999999994 112.423 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.8 136.87 70.09 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.56 -0.746 . . . . 63.200000000000003 109.894 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.3 -41.87 11.5 Favored 'Trans proline' 0 CA--C 1.555 1.575 0 C-N-CA 122.688 2.259 . . . . 71.400000000000006 114.372 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -84.89 -12.14 54.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.62 -0.675 . . . . 64.019999999999996 109.278 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.29 45.2 p 70.6 95.62 0.07 Allowed 'General case' 0 C--O 1.242 0.688 0 C-N-CA 126.535 1.934 . . . . 75.310000000000002 114.806 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -131.81 151.35 51.73 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.726 -1.124 . . . . 73.510000000000005 108.039 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.315 -0.933 0 C-N-CA 123.873 0.869 . . . . 71.040000000000006 110.326 177.839 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.665 0 N-CA-C 110.25 -1.14 . . . . 44.350000000000001 110.25 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 67.09 12.75 9.15 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.66 1.184 . . . . 62.350000000000001 112.239 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -107.56 85.17 2.08 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.638 -0.875 . . . . 71.230000000000004 108.638 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -112.27 108.21 17.34 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 107.154 -1.424 . . . . 74.25 107.154 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.2 pt? -89.39 4.61 48.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.129 0.49 . . . . 74.200000000000003 111.497 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -82.52 127.62 33.5 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.81 -1.181 . . . . 71.439999999999998 107.81 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.46 ' HB2' ' CG ' ' A' ' 134' ' ' ASP . 19.0 p90 -114.84 -176.59 2.93 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.989 -0.551 . . . . 73.25 111.021 -176.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.52 -55.46 10.12 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 120.789 -0.364 . . . . 63.350000000000001 110.494 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.55 20.09 0.03 OUTLIER Glycine 0 C--O 1.25 1.147 0 C-N-CA 118.262 -1.923 . . . . 71.540000000000006 114.842 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.644 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -146.24 -175.13 4.64 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.57 -0.9 . . . . 63.450000000000003 108.57 179.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 57.8 mtt -139.42 115.78 10.52 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.43 -0.952 . . . . 52.399999999999999 108.43 170.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.8 tt -106.63 107.23 18.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.145 -1.798 . . . . 72.420000000000002 106.145 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -104.66 123.24 47.24 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.348 -1.353 . . . . 71.450000000000003 107.348 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.57 114.69 39.06 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 CA-C-O 121.876 0.846 . . . . 74.140000000000001 109.436 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 61.7 mtp85 -119.22 116.69 26.81 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.549 -1.205 . . . . 73.239999999999995 110.345 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -103.66 109.52 21.24 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 107.769 -1.197 . . . . 62.439999999999998 107.769 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 m -114.8 115.42 26.98 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.767 -0.827 . . . . 65.150000000000006 108.767 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -129.0 141.68 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 N-CA-C 108.892 -0.781 . . . . 53.43 108.892 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.2 m -121.39 120.94 36.47 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.652 -0.87 . . . . 73.200000000000003 108.652 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.425 HG23 ' HB3' ' A' ' 143' ' ' PHE . 9.5 tt -105.44 120.79 56.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 121.657 0.741 . . . . 74.200000000000003 109.822 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.4 m -84.17 155.92 63.5 Favored Pre-proline 0 C--N 1.295 -1.782 0 CA-C-N 115.177 -0.92 . . . . 52.0 108.974 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.68 2.1 3.79 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.927 2.418 . . . . 75.129999999999995 112.531 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -89.36 2.35 54.54 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 124.635 1.174 . . . . 62.509999999999998 109.524 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.8 t70 69.21 29.4 4.64 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 123.664 1.697 . . . . 74.219999999999999 107.622 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.36 125.47 52.4 Favored 'General case' 0 N--CA 1.393 -3.299 0 CA-C-N 113.032 -1.894 . . . . 73.239999999999995 107.471 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.5 HG11 HD21 ' A' ' 95' ' ' LEU . 13.1 t -113.52 134.07 57.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 115.902 -0.59 . . . . 74.530000000000001 109.535 -177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.2 p -140.96 128.67 21.55 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.56 -1.274 . . . . 71.450000000000003 107.56 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.67 -171.9 30.49 Favored Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 119.487 -1.34 . . . . 61.109999999999999 112.648 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -149.21 133.67 17.57 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.173 -0.677 . . . . 64.540000000000006 109.173 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 58.4 mt -111.72 115.33 49.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 106.918 -1.512 . . . . 72.120000000000005 106.918 176.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.39 114.22 46.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.357 -0.609 . . . . 74.209999999999994 109.357 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -106.61 107.68 18.82 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.814 -1.921 . . . . 73.409999999999997 105.814 172.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.64 116.93 24.66 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-O 121.7 0.762 . . . . 51.520000000000003 110.064 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.65 139.91 50.37 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.534 -0.757 . . . . 73.329999999999998 111.304 -174.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.644 ' HD3' ' HA ' ' A' ' 24' ' ' HIS . 79.7 tttt -60.77 127.23 86.96 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 104.604 -2.369 . . . . 74.340000000000003 104.604 168.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -35.65 97.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 124.154 3.236 . . . . 63.039999999999999 114.463 -173.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -83.17 -35.11 25.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.637 -1.165 . . . . 72.129999999999995 110.164 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.49 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 48.8 t-20 -124.72 123.63 40.43 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.257 -1.757 . . . . 65.049999999999997 106.257 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.6 m -61.62 -18.64 60.28 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 114.113 1.153 . . . . 73.310000000000002 114.113 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.49 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 20.8 pttp -80.88 -16.23 54.19 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.623 -0.831 . . . . 75.439999999999998 110.151 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -96.7 113.47 25.03 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-O 121.735 0.778 . . . . 74.530000000000001 112.979 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 p -90.32 3.35 53.92 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.541 -1.209 . . . . 61.43 108.049 172.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.8 96.6 0.1 Allowed Glycine 0 N--CA 1.42 -2.38 0 CA-C-N 113.474 -1.693 . . . . 44.140000000000001 109.295 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 49.2 Cg_exo -55.88 128.95 32.39 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 122.563 2.175 . . . . 73.019999999999996 110.569 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.577 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -85.21 159.86 20.02 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 113.618 0.97 . . . . 71.010000000000005 113.618 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 80.3 mt -107.98 127.51 53.83 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 108.035 -1.098 . . . . 74.510000000000005 108.035 174.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -112.94 97.64 6.66 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.009 0.433 . . . . 75.099999999999994 111.174 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.62 136.06 8.64 Favored Glycine 0 C--N 1.284 -2.327 0 N-CA-C 110.788 -0.925 . . . . 62.25 110.788 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.57 120.54 38.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.264 0.554 . . . . 64.230000000000004 111.184 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.9 m -137.81 161.47 59.89 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.531 -0.759 . . . . 62.310000000000002 109.063 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.8 -22.05 24.15 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.155 1.903 . . . . 53.539999999999999 111.768 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -100.37 42.52 1.11 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.771 -0.65 . . . . 71.140000000000001 111.593 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 m -54.03 -36.56 63.17 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.475 0.71 . . . . 62.509999999999998 111.489 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -69.55 -13.68 62.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.541 0.686 . . . . 73.230000000000004 110.289 -176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.71 -12.77 21.96 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.431 -0.804 . . . . 74.420000000000002 110.434 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.8 119.46 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 122.303 1.049 . . . . 72.120000000000005 111.595 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.58 112.99 26.16 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.179 -0.919 . . . . 75.150000000000006 109.873 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.7 p -98.0 133.11 41.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.25 -1.018 . . . . 61.109999999999999 108.25 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.6 m -147.46 163.24 37.15 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.266 -1.013 . . . . 74.349999999999994 108.266 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -76.87 143.42 39.68 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.473 0.654 . . . . 73.439999999999998 110.808 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 73.4 t80 -108.3 123.09 48.27 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.552 -1.277 . . . . 61.030000000000001 107.552 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -138.25 99.17 3.79 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 107.659 -1.237 . . . . 74.150000000000006 107.659 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 65.2 m -162.5 149.15 13.12 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.865 -1.161 . . . . 75.420000000000002 107.865 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 69.73 4.41 4.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.876 0.87 . . . . 62.039999999999999 113.316 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.55 4.76 65.58 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.998 -0.841 . . . . 24.300000000000001 110.998 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -104.93 142.34 34.94 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.297 -1.001 . . . . 62.43 108.297 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.4 m -124.38 136.45 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 121.544 0.688 . . . . 64.129999999999995 109.481 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -173.44 -153.41 9.61 Favored Glycine 0 CA--C 1.461 -3.331 0 N-CA-C 110.088 -1.205 . . . . 75.530000000000001 110.088 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.577 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 62.9 m -134.95 149.85 50.29 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 121.506 0.67 . . . . 74.099999999999994 111.485 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.9 pt20 -124.58 132.14 53.45 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.873 -1.058 . . . . 75.129999999999995 109.576 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.04 113.95 27.65 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.584 -1.636 . . . . 73.109999999999999 106.584 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -108.69 112.74 41.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.374 -0.973 . . . . 72.340000000000003 108.374 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.532 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.5 p90 -115.71 153.68 30.92 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.978 -0.556 . . . . 72.230000000000004 110.954 -175.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -154.85 158.16 38.95 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.581 -0.736 . . . . 54.43 111.297 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 65.15 30.88 11.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 122.568 1.175 . . . . 71.450000000000003 110.824 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.532 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.4 mt -96.08 164.23 12.78 Favored 'General case' 0 N--CA 1.426 -1.628 0 O-C-N 121.275 -0.891 . . . . 71.109999999999999 111.11 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.1 p -115.22 171.34 7.75 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 116.254 -0.43 . . . . 63.039999999999999 110.686 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -57.0 -36.79 70.81 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.031 0.443 . . . . 55.109999999999999 110.181 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.05 70.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.686 -0.688 . . . . 74.409999999999997 111.019 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.87 -16.08 39.77 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 112.593 0.59 . . . . 73.400000000000006 112.593 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.5 HD21 HG11 ' A' ' 40' ' ' VAL . 17.1 mt -52.56 -53.4 54.15 Favored Pre-proline 0 N--CA 1.472 0.646 0 N-CA-C 114.322 1.23 . . . . 70.319999999999993 114.322 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.08 -42.29 44.93 Favored 'Trans proline' 0 C--N 1.369 1.607 0 CA-C-N 120.57 1.239 . . . . 72.450000000000003 110.497 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -60.08 -39.72 87.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.317 -0.856 . . . . 73.129999999999995 111.76 -177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -78.34 -21.86 48.89 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 120.745 -0.382 . . . . 74.549999999999997 110.728 177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.84 -26.85 61.63 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 109.148 -0.686 . . . . 63.039999999999999 109.148 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -57.73 -54.33 48.12 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.318 -0.855 . . . . 73.540000000000006 109.909 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.1 mtm -54.11 -49.98 67.91 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.205 0.526 . . . . 72.430000000000007 110.313 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -55.36 -37.27 67.3 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.402 -1.272 . . . . 74.340000000000003 110.117 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.7 m -60.72 -32.89 72.13 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.503 -0.317 . . . . 73.439999999999998 111.092 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -68.82 -15.63 63.55 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.531 0.682 . . . . 75.219999999999999 111.557 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -114.15 -11.95 12.59 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.202 -0.454 . . . . 51.409999999999997 110.607 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.52 -47.53 3.75 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.658 0.984 . . . . 72.25 113.658 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.86 22.09 77.48 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.454 -1.058 . . . . 51.100000000000001 110.454 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.3 t -111.93 143.89 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.127 0.971 . . . . 74.140000000000001 108.576 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -102.18 131.38 48.74 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.052 -0.351 . . . . 75.219999999999999 110.052 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.19 104.84 7.3 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.39 -0.967 . . . . 52.439999999999998 108.39 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.5 m -117.58 137.6 52.49 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.607 -0.886 . . . . 74.099999999999994 108.607 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -147.96 149.28 31.88 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.94 -0.704 . . . . 63.049999999999997 112.449 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -148.39 163.07 38.21 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.039 -0.982 . . . . 75.329999999999998 111.001 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.501 ' HG2' HG22 ' A' ' 119' ' ' VAL . 45.8 mtt85 -102.57 139.76 37.75 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.029 0.443 . . . . 64.530000000000001 110.315 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -121.7 83.71 2.13 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.983 -1.488 . . . . 74.219999999999999 106.983 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.95 -115.7 8.25 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.971 -1.013 . . . . 72.019999999999996 110.697 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -85.08 -20.27 30.63 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.504 0.668 . . . . 74.519999999999996 110.929 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.2 pp -102.64 148.71 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 C-N-CA 118.088 -1.445 . . . . 53.140000000000001 109.174 -175.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.501 HG22 ' HG2' ' A' ' 114' ' ' ARG . 92.8 t -116.81 140.31 39.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 O-C-N 122.008 -0.432 . . . . 72.150000000000006 110.054 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.43 HG22 ' HG2' ' A' ' 175' ' ' GLN . 44.3 pt -117.35 138.11 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 115.972 -0.558 . . . . 70.430000000000007 110.088 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 174' ' ' ALA . 7.3 tt -127.3 127.94 45.15 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.143 -1.058 . . . . 71.409999999999997 108.143 175.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -128.26 117.95 22.41 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.485 -0.932 . . . . 60.140000000000001 108.485 -176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.13 169.57 25.31 Favored Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 121.059 -0.591 . . . . 64.099999999999994 112.201 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -151.05 153.24 34.72 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.19 -0.67 . . . . 74.25 109.19 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -135.57 108.62 7.67 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.634 -0.876 . . . . 74.319999999999993 108.634 171.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -113.11 97.24 6.38 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.933 0.873 . . . . 74.519999999999996 110.994 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.76 34.74 4.59 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.448 -1.251 . . . . 71.409999999999997 108.193 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.4 p -66.44 -32.73 74.29 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.143 0.794 . . . . 75.450000000000003 113.143 -175.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.1 m -99.69 18.39 18.23 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.085 0.402 . . . . 52.119999999999997 112.085 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.581 HG11 ' CB ' ' A' ' 166' ' ' PRO . 5.2 p -66.61 158.09 5.43 Favored 'Isoleucine or valine' 0 C--O 1.252 1.224 0 N-CA-C 110.141 -0.318 . . . . 75.109999999999999 110.141 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.6 p -87.4 -47.13 9.02 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 120.775 0.322 . . . . 72.219999999999999 110.371 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -96.9 108.72 45.1 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 123.85 0.86 . . . . 74.450000000000003 112.588 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.68 -11.24 18.54 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.811 3.007 . . . . 73.150000000000006 113.315 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 24' ' ' HIS . 0.5 OUTLIER -80.19 15.32 1.58 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 115.133 1.531 . . . . 74.420000000000002 115.133 -171.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.17 135.89 40.91 Favored 'General case' 0 C--N 1.274 -2.674 0 CA-C-N 114.894 -1.048 . . . . 74.430000000000007 108.714 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -131.39 130.48 42.65 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 118.089 0.404 . . . . 74.319999999999993 110.419 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 46.5 t -115.91 126.9 73.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 109.311 -0.626 . . . . 62.409999999999997 109.311 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 162' ' ' TRP . 50.6 mt-10 -128.65 133.06 48.14 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.962 0.41 . . . . 63.149999999999999 110.179 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 52.2 tp -114.44 121.43 43.54 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.683 -0.858 . . . . 50.350000000000001 108.683 174.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.3 m -115.8 108.82 16.81 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.988 -1.116 . . . . 73.420000000000002 107.988 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.1 t -107.92 123.59 63.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.727 -0.472 . . . . 72.230000000000004 109.727 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.16 127.07 55.83 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.318 -0.623 . . . . 62.0 109.318 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.06 120.42 15.12 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 116.38 -0.373 . . . . 71.25 111.79 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 16.1 Cg_exo -72.83 45.26 0.87 Allowed 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 122.866 2.378 . . . . 73.040000000000006 111.729 175.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -123.36 -95.59 0.47 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 119.18 -0.438 . . . . 70.329999999999998 110.869 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 173.19 123.63 0.02 OUTLIER 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.502 0.721 . . . . 51.509999999999998 109.361 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -80.28 130.58 35.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.434 -0.95 . . . . 71.319999999999993 108.434 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 27.3 p -88.15 -39.79 14.26 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.831 -0.433 . . . . 71.510000000000005 109.831 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 67.6 m -163.17 132.9 4.25 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 123.633 0.773 . . . . 73.040000000000006 109.156 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -138.38 154.37 48.93 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.983 -0.448 . . . . 73.120000000000005 110.971 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 28.9 t-20 -121.31 94.89 4.48 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.029 -1.841 . . . . 72.120000000000005 106.029 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.24 -149.75 10.08 Favored Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 107.852 -2.099 . . . . 62.109999999999999 107.852 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -117.74 99.89 7.24 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.416 -1.327 . . . . 73.019999999999996 107.416 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -81.12 132.27 35.35 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 120.113 -0.635 . . . . 73.340000000000003 110.565 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.64 -43.17 14.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.309 -1.367 . . . . 72.549999999999997 107.309 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -136.92 170.43 10.8 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.01 -1.478 . . . . 72.099999999999994 107.01 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -72.15 0.77 6.79 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.583 2.188 . . . . 45.439999999999998 110.985 174.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.5 pt-20 -130.33 -0.13 4.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.532 -0.758 . . . . 71.239999999999995 111.467 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 88.8 t -141.58 121.06 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.461 -0.94 . . . . 73.140000000000001 108.461 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.06 146.63 33.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 109.578 -0.526 . . . . 63.43 109.578 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 29.2 tt0 -134.01 136.74 44.29 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 121.612 0.72 . . . . 73.239999999999995 110.937 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 32.2 m-90 -112.62 125.83 54.71 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.593 -0.73 . . . . 65.109999999999999 109.953 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -104.6 99.21 8.88 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.36 -0.978 . . . . 75.040000000000006 108.36 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 1.8 mm? -95.89 121.84 38.06 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.701 -0.851 . . . . 71.549999999999997 108.701 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 59.3 mttm -116.25 151.04 46.32 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 115.394 -0.821 . . . . 73.120000000000005 110.991 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.581 ' CB ' HG11 ' A' ' 130' ' ' VAL . 7.7 Cg_exo -76.48 162.83 32.89 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.032 2.488 . . . . 70.439999999999998 109.836 173.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.45 -40.12 2.94 Favored Glycine 0 C--O 1.245 0.802 0 N-CA-C 111.145 -0.782 . . . . 62.240000000000002 111.145 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.33 158.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 123.043 0.537 . . . . 53.229999999999997 109.61 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.5 p -109.56 136.98 43.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.836 -1.172 . . . . 63.530000000000001 107.836 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.7 t -137.71 141.28 41.04 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 119.363 -0.935 . . . . 62.329999999999998 111.093 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.3 p -99.76 145.85 27.22 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 114.393 -1.276 . . . . 54.530000000000001 109.303 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 82.8 mtp -121.81 119.93 33.11 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.091 -1.077 . . . . 65.049999999999997 108.091 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 30.4 t -133.76 138.79 45.95 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.914 -1.143 . . . . 62.329999999999998 107.914 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.553 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.97 116.35 5.03 Favored 'General case' 0 CA--C 1.471 -2.093 0 N-CA-C 108.926 -0.768 . . . . 44.210000000000001 108.926 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.43 ' HG2' HG22 ' A' ' 120' ' ' ILE . 49.1 mt-30 -121.83 130.31 53.28 Favored 'General case' 0 C--N 1.263 -3.187 0 N-CA-C 106.916 -1.513 . . . . 62.450000000000003 106.916 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -149.45 149.84 31.43 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.145 -1.058 . . . . 72.219999999999999 108.145 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 7.3 ppt_? -93.45 145.82 24.21 Favored 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 119.578 -0.849 . . . . 74.310000000000002 109.237 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.418 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 96.4 m-85 -139.72 152.34 46.58 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.723 -0.843 . . . . 72.409999999999997 108.723 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.32 93.57 2.4 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 109.693 -0.484 . . . . 53.530000000000001 109.693 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.408 ' OD2' ' HG2' ' A' ' 184' ' ' ARG . 29.2 t0 -55.82 121.65 41.32 Favored Pre-proline 0 CA--C 1.5 -0.975 0 CA-C-N 114.548 -1.205 . . . . 63.240000000000002 108.961 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.94 -37.75 18.71 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.117 1.878 . . . . 71.439999999999998 112.819 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -85.34 -17.75 35.85 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.857 -0.611 . . . . 74.510000000000005 111.738 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.254 15.7 p 56.83 70.74 0.62 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 114.032 1.123 . . . . 54.350000000000001 114.032 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.408 ' HG2' ' OD2' ' A' ' 180' ' ' ASP . 14.3 ptm180 -101.87 -179.51 4.03 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.006 -0.997 . . . . 73.519999999999996 110.036 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 C--N 1.293 -1.865 0 N-CA-C 106.939 -1.504 . . . . 62.509999999999998 106.939 173.533 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.735 0 N-CA-C 110.145 -1.182 . . . . 62.210000000000001 110.145 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.534 ' HD2' ' H ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -90.27 36.64 0.88 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 117.052 0.426 . . . . 74.129999999999995 111.339 -175.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -75.32 105.34 6.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.681 -0.488 . . . . 73.5 109.681 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -121.14 75.83 1.18 Allowed 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.139 -1.43 . . . . 74.140000000000001 107.139 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.3 tp -83.95 83.11 8.06 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.541 -1.209 . . . . 74.409999999999997 109.54 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -101.08 -16.96 16.91 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.388 -1.278 . . . . 73.099999999999994 110.168 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.72 101.21 13.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.131 0.789 . . . . 73.439999999999998 113.131 -175.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -89.41 -167.53 1.89 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.607 -1.179 . . . . 75.310000000000002 107.841 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.66 36.38 9.47 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 120.128 -1.034 . . . . 62.229999999999997 110.885 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -81.85 140.22 34.26 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.521 -0.471 . . . . 72.519999999999996 111.033 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -75.52 98.91 4.08 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.197 -1.408 . . . . 63.420000000000002 107.197 175.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 52.4 tp -101.65 122.56 44.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.674 -1.148 . . . . 64.200000000000003 109.116 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -121.69 124.04 43.31 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 107.968 -1.123 . . . . 74.540000000000006 107.968 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 47.6 t -120.05 114.49 44.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.692 -1.225 . . . . 74.120000000000005 107.692 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -118.01 114.1 22.64 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.955 -0.757 . . . . 74.150000000000006 108.955 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.4 108.96 20.55 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 107.799 -1.186 . . . . 51.240000000000002 107.799 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 m -113.58 114.67 26.79 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.433 -1.321 . . . . 62.509999999999998 107.433 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -125.43 146.57 30.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 109.061 -0.718 . . . . 60.310000000000002 109.061 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 43.6 m -129.63 123.43 31.22 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-O 121.197 0.523 . . . . 60.030000000000001 109.635 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 tt -112.77 121.1 64.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.652 0.739 . . . . 74.129999999999995 110.594 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -86.69 154.04 55.75 Favored Pre-proline 0 N--CA 1.425 -1.696 0 CA-C-N 115.178 -0.919 . . . . 71.25 109.517 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.76 2.64 1.91 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.134 2.556 . . . . 73.340000000000003 113.052 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -88.74 1.94 54.28 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.93 -1.137 . . . . 72.099999999999994 107.93 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 71.43 29.73 2.65 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 123.314 1.531 . . . . 71.019999999999996 107.811 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.91 128.33 53.11 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 112.938 -1.937 . . . . 74.120000000000005 107.772 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.44 138.11 49.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.424 -0.584 . . . . 52.140000000000001 109.424 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 p -142.32 163.45 32.8 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.518 -1.29 . . . . 75.140000000000001 107.518 175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.77 -171.79 43.94 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.534 -1.793 . . . . 64.040000000000006 113.407 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -148.05 133.4 18.53 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 123.855 0.862 . . . . 60.530000000000001 108.915 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.32 115.83 47.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.416 -1.327 . . . . 64.450000000000003 107.416 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 2.3 mp -115.42 114.86 47.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.61 -0.515 . . . . 73.109999999999999 109.61 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.85 108.13 17.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.874 -1.528 . . . . 73.519999999999996 106.874 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -122.56 128.6 50.94 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 120.799 -0.361 . . . . 73.420000000000002 110.899 -174.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.68 152.46 36.07 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 116.114 -0.494 . . . . 53.340000000000003 110.442 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -77.17 121.92 85.4 Favored Pre-proline 0 C--N 1.309 -1.19 0 C-N-CA 119.473 -0.891 . . . . 62.229999999999997 109.065 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.86 111.12 0.64 Allowed 'Trans proline' 0 C--O 1.252 1.181 0 C-N-CA 123.947 3.098 . . . . 31.550000000000001 114.904 -171.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -93.79 -25.76 17.25 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.795 -0.639 . . . . 73.340000000000003 109.403 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.498 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 49.6 t-20 -100.92 138.9 37.35 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.207 -1.034 . . . . 71.439999999999998 108.207 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.9 p -72.63 -27.41 62.12 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 112.38 0.511 . . . . 75.129999999999995 112.38 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 21.7 ptmt -88.02 -12.61 43.88 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.865 0.364 . . . . 70.010000000000005 110.864 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.429 ' CB ' ' HB3' ' A' ' 52' ' ' ASN . 38.8 t70 -87.42 100.43 12.74 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.244 0.831 . . . . 64.120000000000005 113.244 -167.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 t -121.31 -15.63 8.07 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 114.568 -1.196 . . . . 73.409999999999997 108.463 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.24 97.29 0.16 Allowed Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.56 -1.305 . . . . 44.509999999999998 113.174 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.48 159.13 32.53 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.759 2.306 . . . . 73.329999999999998 110.263 172.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.6 133.77 53.01 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.748 -0.464 . . . . 74.120000000000005 109.748 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.94 153.23 19.62 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.587 -0.523 . . . . 71.230000000000004 109.587 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -83.54 84.26 7.6 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.874 -1.158 . . . . 71.129999999999995 107.874 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.82 42.76 1.6 Allowed Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 114.904 -1.044 . . . . 62.32 111.598 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.11 88.15 7.15 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.661 -1.237 . . . . 73.349999999999994 107.661 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.431 HG11 ' SD ' ' A' ' 101' ' ' MET . 17.3 m -122.78 160.23 49.92 Favored Pre-proline 0 C--N 1.307 -1.26 0 CA-C-N 114.628 -1.169 . . . . 65.230000000000004 111.391 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.82 -7.87 12.24 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.489 2.793 . . . . 74.230000000000004 113.572 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.402 ' HE1' ' HG2' ' A' ' 97' ' ' GLN . 46.2 p90 -124.42 28.86 6.5 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 122.21 -0.306 . . . . 63.329999999999998 111.006 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.1 m -55.72 -27.85 52.66 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 111.971 0.36 . . . . 62.409999999999997 111.971 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -71.96 -7.97 51.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.212 0.53 . . . . 72.340000000000003 110.932 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -112.39 -6.76 14.0 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.065 -0.516 . . . . 73.409999999999997 110.15 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 p -127.58 118.53 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 CA-C-O 121.892 0.854 . . . . 54.450000000000003 109.963 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.69 104.58 16.51 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.451 -0.795 . . . . 62.240000000000002 109.44 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.09 132.93 42.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 107.238 -1.393 . . . . 71.219999999999999 107.238 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.1 m -154.19 172.35 17.73 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.714 -0.847 . . . . 72.140000000000001 108.714 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -80.57 154.6 27.37 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.298 0.57 . . . . 75.230000000000004 110.105 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 70.7 t80 -118.23 123.39 45.34 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.957 -1.127 . . . . 73.409999999999997 107.957 177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -138.22 100.35 4.11 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.04 -1.837 . . . . 75.299999999999997 106.04 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.3 t -165.23 143.78 6.35 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.768 -0.456 . . . . 45.340000000000003 109.768 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.1 t70 66.9 14.38 9.8 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.078 1.351 . . . . 70.25 109.339 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.63 -0.73 77.62 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.767 -0.73 . . . . 52.109999999999999 111.683 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.549 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 7.9 m-85 -94.0 146.04 24.22 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.424 -0.584 . . . . 73.540000000000006 109.424 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 m -125.56 136.96 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 108.265 -1.013 . . . . 74.420000000000002 108.265 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.69 -154.61 10.45 Favored Glycine 0 C--N 1.271 -3.037 0 N-CA-C 110.439 -1.064 . . . . 51.43 110.439 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 m -129.82 150.9 50.92 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-O 120.967 0.413 . . . . 73.450000000000003 110.42 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -133.64 145.26 49.82 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.083 0.468 . . . . 75.299999999999997 110.613 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -122.6 114.76 21.06 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.458 -1.312 . . . . 74.099999999999994 107.458 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.31 115.27 49.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 108.734 -0.839 . . . . 65.420000000000002 108.734 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.512 ' CD2' HD12 ' A' ' 90' ' ' LEU . 47.1 p90 -121.09 151.0 40.36 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 120.47 -0.492 . . . . 74.030000000000001 111.227 -174.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -153.15 156.49 38.72 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.415 -0.357 . . . . 62.020000000000003 111.202 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.4 t70 63.53 31.21 14.92 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.5 1.12 . . . . 72.530000000000001 111.046 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.512 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.4 mt -94.69 170.14 9.67 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.89 -0.595 . . . . 75.430000000000007 109.938 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.0 t -128.08 179.72 5.44 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 120.636 -0.426 . . . . 64.420000000000002 110.617 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -54.69 -42.23 71.18 Favored 'General case' 0 C--O 1.209 -1.035 0 C-N-CA 123.794 0.837 . . . . 61.420000000000002 112.17 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.62 -29.11 69.03 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.342 0.592 . . . . 70.219999999999999 111.566 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.66 -15.97 29.44 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 115.57 -0.741 . . . . 72.019999999999996 111.285 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.9 tt -60.35 -51.46 80.0 Favored Pre-proline 0 CA--C 1.568 1.662 0 CA-C-O 119.202 -0.428 . . . . 72.310000000000002 111.205 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.52 -36.65 75.61 Favored 'Trans proline' 0 C--N 1.373 1.863 0 CA-C-N 120.976 1.384 . . . . 74.530000000000001 110.838 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.402 ' HG2' ' HE1' ' A' ' 66' ' ' PHE . 5.3 tt0 -66.44 -37.73 85.82 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 115.215 -0.902 . . . . 75.510000000000005 110.097 -175.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -78.09 -19.99 53.1 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.393 0.616 . . . . 71.310000000000002 109.736 176.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.34 -18.08 60.74 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.601 -0.727 . . . . 54.420000000000002 109.063 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.18 -57.22 12.29 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 116.012 -0.54 . . . . 74.140000000000001 109.737 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 64' ' ' VAL . 3.2 mpp? -55.73 -45.25 78.0 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 123.674 0.609 . . . . 72.439999999999998 109.718 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -52.88 -42.48 65.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.524 -1.217 . . . . 60.310000000000002 111.412 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.9 m -63.51 -31.76 73.01 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.179 -0.464 . . . . 65.120000000000005 110.725 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.6 -20.77 63.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.184 0.516 . . . . 73.5 110.686 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.91 -9.82 16.94 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.485 -0.486 . . . . 71.319999999999993 110.382 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.41 -47.64 3.89 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.414 0.524 . . . . 63.119999999999997 112.414 -173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.21 28.77 19.29 Favored Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 119.962 -1.114 . . . . 60.109999999999999 110.933 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.8 m -124.38 165.11 21.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 122.767 -0.255 . . . . 62.100000000000001 110.544 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.93 124.18 47.62 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.816 -1.179 . . . . 73.019999999999996 107.816 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.19 123.15 49.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 118.165 0.439 . . . . 73.439999999999998 111.08 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -120.93 117.56 27.64 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.346 -0.983 . . . . 71.299999999999997 108.346 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.452 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 2.2 pt? -133.35 147.43 51.82 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.223 -0.591 . . . . 74.099999999999994 111.006 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.452 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 2.1 mpt_? -142.11 155.23 45.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.968 -1.493 . . . . 75.439999999999998 106.968 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.525 ' NE ' ' HB2' ' A' ' 180' ' ' ASP . 9.4 ttt180 -108.85 137.53 46.63 Favored 'General case' 0 N--CA 1.396 -3.126 0 N-CA-C 106.69 -1.596 . . . . 74.200000000000003 106.69 173.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -127.42 99.6 5.69 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 107.98 -1.119 . . . . 71.299999999999997 107.98 -177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 184' ' ' ARG . . . 68.9 -115.71 6.75 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 110.845 -0.902 . . . . 61.0 110.845 -177.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 8.9 t30 -110.6 12.89 22.67 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 122.304 1.049 . . . . 51.329999999999998 109.342 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.8 pp -122.51 149.25 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 121.234 -0.916 . . . . 74.150000000000006 109.069 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.513 HG22 ' HG3' ' A' ' 114' ' ' ARG . 76.5 t -110.66 137.88 41.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 109.987 -0.375 . . . . 74.299999999999997 109.987 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 120' ' ' ILE . 42.0 pt -116.26 129.06 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 N-CA-C 108.636 -0.876 . . . . 72.430000000000007 108.636 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -128.3 125.73 39.39 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.959 -0.564 . . . . 75.430000000000007 109.653 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -128.48 115.96 18.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.361 0.6 . . . . 73.129999999999995 109.769 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -116.52 130.4 8.96 Favored Glycine 0 C--N 1.294 -1.789 0 N-CA-C 110.075 -1.21 . . . . 62.549999999999997 110.075 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -114.6 132.9 56.19 Favored 'General case' 0 C--N 1.282 -2.332 0 O-C-N 122.153 -0.616 . . . . 71.150000000000006 109.8 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.0 114.37 19.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.679 -0.691 . . . . 70.420000000000002 112.052 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -112.69 97.25 6.45 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.434 -0.95 . . . . 74.310000000000002 108.434 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.45 28.21 8.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.685 -0.857 . . . . 73.129999999999995 108.685 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 20.5 p -69.13 -9.17 51.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.254 -0.885 . . . . 45.219999999999999 112.944 -175.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.2 m -70.28 -18.85 63.13 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.845 0.355 . . . . 63.299999999999997 110.536 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.1 t 69.06 -88.12 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.786 1.235 . . . . 62.310000000000002 111.549 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.8 m 66.77 -55.54 0.42 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.001 1.32 . . . . 72.310000000000002 111.494 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 135' ' ' ALA . 1.9 p30 -136.74 104.79 9.03 Favored Pre-proline 0 C--N 1.309 -1.172 0 C-N-CA 123.691 0.797 . . . . 75.519999999999996 109.817 173.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.75 -12.52 22.07 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.637 2.225 . . . . 64.510000000000005 112.214 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -85.65 4.59 35.71 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.514 -0.766 . . . . 70.209999999999994 111.463 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -78.31 140.3 38.81 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.156 0.503 . . . . 72.109999999999999 110.808 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -131.85 110.43 10.81 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.278 -0.874 . . . . 74.430000000000007 109.29 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 77.8 t -104.89 113.66 42.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.379 -0.971 . . . . 62.420000000000002 108.379 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -108.54 121.08 44.23 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.109 -1.071 . . . . 61.109999999999999 108.109 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.524 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.9 tm? -110.81 115.7 29.99 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 105.784 -1.932 . . . . 74.019999999999996 105.784 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.9 m -123.69 127.53 48.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.501 -0.555 . . . . 53.32 109.501 -174.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 76.9 t -124.95 126.82 71.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.182 -0.673 . . . . 72.120000000000005 109.182 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -115.95 130.93 57.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.704 -0.85 . . . . 53.439999999999998 108.704 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.713 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.2 p90 -135.06 122.84 15.39 Favored Pre-proline 0 C--N 1.283 -2.318 0 N-CA-C 112.002 0.371 . . . . 73.409999999999997 112.002 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -70.15 35.61 0.24 Allowed 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 122.57 2.18 . . . . 74.299999999999997 111.681 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -115.77 -99.31 0.44 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 123.132 0.573 . . . . 71.219999999999999 109.869 -177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.42 129.97 0.02 OUTLIER 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.304 -0.998 . . . . 54.229999999999997 108.304 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.87 138.08 20.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.704 -0.85 . . . . 75.219999999999999 108.704 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.8 p -94.09 -43.04 8.68 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 109.051 -0.722 . . . . 64.409999999999997 109.051 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.0 m -160.08 133.12 6.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.505 -0.924 . . . . 64.409999999999997 108.505 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.4 t -139.24 149.42 44.32 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.683 -0.635 . . . . 70.109999999999999 111.099 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -114.67 93.07 4.16 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 104.71 -2.33 . . . . 62.409999999999997 104.71 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.492 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.13 -148.86 11.57 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 107.999 -2.04 . . . . 74.409999999999997 107.999 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -114.09 100.02 8.07 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 117.587 0.693 . . . . 64.239999999999995 110.473 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -76.95 119.87 21.28 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 120.159 -0.616 . . . . 73.230000000000004 109.354 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.8 mt -83.98 -37.43 13.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.317 -1.364 . . . . 63.439999999999998 107.317 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.42 ' HB3' ' OE2' ' A' ' 158' ' ' GLU . 39.3 mt-10 -145.69 161.9 38.59 Favored Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 106.766 -1.568 . . . . 65.219999999999999 106.766 -178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.31 -10.6 29.2 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.445 2.097 . . . . 72.049999999999997 112.212 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.713 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.4 OUTLIER -122.18 5.58 9.75 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 112.656 0.613 . . . . 71.310000000000002 112.656 177.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.5 t -139.84 120.95 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.56 -0.533 . . . . 64.319999999999993 109.56 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.77 148.04 31.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 109.482 -0.562 . . . . 71.120000000000005 109.482 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -138.55 149.58 45.46 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.298 -0.63 . . . . 61.119999999999997 109.298 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.524 ' CE3' HD12 ' A' ' 139' ' ' LEU . 28.2 m-90 -124.92 142.07 51.7 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.822 -0.807 . . . . 54.119999999999997 108.822 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -108.73 105.12 14.57 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.93 -1.507 . . . . 72.239999999999995 106.93 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 9.4 mp -100.57 119.18 38.15 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.926 0.87 . . . . 75.5 110.884 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.604 ' HD3' ' HD2' ' A' ' 166' ' ' PRO . 1.6 mmtm -118.42 140.75 28.61 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 114.231 -1.35 . . . . 63.240000000000002 108.85 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.604 ' HD2' ' HD3' ' A' ' 165' ' ' LYS . 39.1 Cg_exo -66.64 167.71 18.46 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.693 1.595 . . . . 74.439999999999998 110.729 171.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.97 -36.82 3.01 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 120.857 -0.687 . . . . 50.229999999999997 111.656 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.8 m -104.94 157.06 5.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.163 0.506 . . . . 72.319999999999993 110.093 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.6 p -114.06 127.02 71.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 107.914 -1.143 . . . . 74.340000000000003 107.914 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 46.6 m -145.57 143.54 29.97 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.912 -0.492 . . . . 70.150000000000006 110.863 -177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.1 p -109.23 125.91 52.75 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 115.841 -0.618 . . . . 74.420000000000002 109.651 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -101.3 134.66 44.02 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.606 -0.887 . . . . 75.439999999999998 108.606 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.0 m -143.26 140.72 30.78 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.616 -0.678 . . . . 72.420000000000002 110.907 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.507 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -143.05 132.18 23.11 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.358 -0.383 . . . . 70.200000000000003 109.982 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.1 131.32 54.19 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.82 -1.548 . . . . 72.099999999999994 106.82 170.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.84 156.24 42.05 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.21 -0.663 . . . . 74.5 109.21 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 28.4 ptt180 -87.91 134.48 33.7 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 120.362 -0.535 . . . . 71.209999999999994 109.895 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -143.72 122.72 12.81 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 109.337 -0.616 . . . . 75.450000000000003 109.337 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.572 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -58.97 109.08 0.76 Allowed 'General case' 0 C--N 1.279 -2.477 0 O-C-N 124.389 1.055 . . . . 75.099999999999994 111.536 -178.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' HB2' ' NE ' ' A' ' 114' ' ' ARG . 27.0 t70 -88.63 133.09 36.82 Favored Pre-proline 0 CA--C 1.49 -1.362 0 N-CA-C 108.888 -0.782 . . . . 71.400000000000006 108.888 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.96 -38.02 72.21 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.924 2.416 . . . . 65.25 113.092 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -86.16 -30.18 22.68 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.791 0.805 . . . . 71.219999999999999 109.777 -176.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.403 26.4 p 65.95 64.19 0.56 Allowed 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 113.603 -1.635 . . . . 71.140000000000001 110.469 -167.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.482 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 28.3 mmt180 -60.19 172.38 0.83 Allowed 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 111.413 -2.63 . . . . 72.230000000000004 113.589 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.411 -2.421 0 N-CA-C 104.389 -2.448 . . . . 74.530000000000001 104.389 179.857 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 110.294 -1.122 . . . . 61.109999999999999 110.294 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -120.38 150.77 40.24 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.054 -1.091 . . . . 72.400000000000006 108.054 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 69.4 93.8 0.08 Allowed 'General case' 0 C--O 1.239 0.54 0 O-C-N 124.262 0.976 . . . . 52.299999999999997 111.967 -176.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -72.09 129.36 38.33 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.012 -0.994 . . . . 64.549999999999997 110.206 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 tt -142.89 135.49 27.71 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 105.278 -2.119 . . . . 75.109999999999999 105.278 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -86.09 -71.55 0.54 Allowed 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 120.476 -0.49 . . . . 74.540000000000006 110.11 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -149.04 137.35 20.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.458 -0.571 . . . . 63.219999999999999 109.458 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.434 HE21 ' HA ' ' A' ' 50' ' ' PRO . 60.4 tt0 -81.04 107.59 13.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.464 -0.569 . . . . 74.299999999999997 109.464 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -166.3 -142.83 3.55 Favored Glycine 0 N--CA 1.418 -2.514 0 N-CA-C 109.529 -1.429 . . . . 73.010000000000005 109.529 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.434 ' HA ' ' OD2' ' A' ' 132' ' ' ASP . 83.7 m-70 69.0 95.21 0.07 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.84 1.256 . . . . 62.25 112.175 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 23.9 ttt 69.49 89.72 0.1 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.594 -1.639 . . . . 42.039999999999999 111.028 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.558 HD23 ' H ' ' A' ' 26' ' ' LEU . 2.1 pt? -112.8 136.67 52.16 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.652 -1.24 . . . . 75.349999999999994 107.652 175.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -101.52 123.97 46.43 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 106.867 -1.531 . . . . 72.340000000000003 106.867 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HB ' HG13 ' A' ' 137' ' ' VAL . 59.1 t -119.48 113.63 41.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 106.96 -1.496 . . . . 73.430000000000007 106.96 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 11.3 ttp180 -127.67 113.5 16.12 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.041 0.448 . . . . 73.140000000000001 109.958 -175.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -107.67 108.78 20.18 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.981 -0.748 . . . . 71.019999999999996 108.981 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.6 t -108.4 114.16 27.79 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.694 -1.595 . . . . 71.5 106.694 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.407 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.7 pp -132.98 147.17 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.379 0.609 . . . . 64.219999999999999 110.483 -174.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.3 m -129.73 128.38 42.35 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 116.024 -0.535 . . . . 71.299999999999997 109.865 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 143' ' ' PHE . 9.6 tt -113.96 125.69 71.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.299 0.571 . . . . 74.219999999999999 110.748 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.481 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 31.3 t -93.49 151.67 40.34 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.533 -0.758 . . . . 54.549999999999997 109.888 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.39 1.08 1.42 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.793 2.995 . . . . 74.209999999999994 112.922 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.71 -3.69 54.33 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.818 -1.179 . . . . 61.310000000000002 107.818 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.3 t70 72.25 29.02 2.3 Favored 'General case' 0 C--N 1.347 0.473 0 N-CA-C 106.858 -1.534 . . . . 72.450000000000003 106.858 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 35' ' ' SER . 0.3 OUTLIER -112.73 140.83 47.18 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.441 -1.254 . . . . 75.319999999999993 108.985 -178.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' A' ' 95' ' ' LEU . 17.8 t -115.63 144.71 22.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.549 -0.75 . . . . 75.109999999999999 109.126 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.2 p -149.29 158.71 44.4 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.079 -1.082 . . . . 73.030000000000001 108.079 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 161.48 -166.73 36.06 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 119.884 -1.15 . . . . 74.209999999999994 112.748 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -154.61 139.21 16.94 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.353 0.597 . . . . 73.430000000000007 111.064 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 46.6 mt -114.51 116.53 52.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.543 -0.91 . . . . 64.109999999999999 108.543 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.16 126.01 61.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.371 -0.603 . . . . 74.420000000000002 109.371 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.513 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -123.61 108.6 12.77 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.777 -1.194 . . . . 64.329999999999998 107.777 173.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.87 126.54 52.58 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.85 0.357 . . . . 63.25 111.585 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.38 158.91 30.06 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.765 -0.652 . . . . 70.150000000000006 109.755 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -72.65 130.56 85.41 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 118.974 -1.091 . . . . 74.030000000000001 109.298 175.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HA ' HE21 ' A' ' 22' ' ' GLN . 15.7 Cg_endo -56.2 -82.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.481 2.787 . . . . 63.329999999999998 115.456 -174.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt 60.6 22.72 12.51 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.899 0.88 . . . . 73.120000000000005 111.217 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -152.5 118.28 5.4 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.413 -1.267 . . . . 73.310000000000002 107.656 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.1 m -66.4 -20.59 66.11 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.998 1.111 . . . . 51.439999999999998 113.998 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' NZ ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -97.55 -11.75 23.35 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.189 -1.004 . . . . 74.140000000000001 112.186 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -88.51 107.44 18.88 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 119.207 -0.997 . . . . 73.340000000000003 111.025 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t -114.28 -8.85 12.88 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.249 -0.887 . . . . 71.140000000000001 108.684 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 174.15 112.04 0.28 Allowed Glycine 0 N--CA 1.425 -2.082 0 CA-C-N 115.261 -0.881 . . . . 74.209999999999994 112.046 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.04 160.33 45.02 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 123.047 2.498 . . . . 70.420000000000002 111.351 173.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.43 131.07 37.14 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.798 -0.816 . . . . 64.299999999999997 108.798 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.426 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 69.0 mt -84.87 143.66 28.9 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.423 -0.584 . . . . 71.109999999999999 109.423 176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -100.43 93.79 5.83 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.478 0.656 . . . . 72.519999999999996 109.66 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.623 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -140.6 72.59 0.41 Allowed Glycine 0 C--N 1.28 -2.56 0 CA-C-N 115.168 -0.924 . . . . 62.219999999999999 111.116 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -82.29 91.32 6.75 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.834 -0.802 . . . . 62.240000000000002 108.834 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.6 m -122.29 154.1 62.04 Favored Pre-proline 0 C--N 1.299 -1.606 0 CA-C-N 114.744 -1.117 . . . . 71.109999999999999 110.739 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.84 -21.39 70.32 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 123.595 2.863 . . . . 43.32 112.916 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -102.75 32.45 3.64 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 111.063 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 p -55.8 -34.08 64.99 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 116.29 -0.413 . . . . 64.019999999999996 111.543 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -65.29 -16.69 63.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.301 0.572 . . . . 73.420000000000002 111.47 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 88' ' ' SER . 33.3 mmtp -98.75 -16.0 19.11 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 116.157 -0.474 . . . . 72.310000000000002 110.524 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.17 118.89 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-O 122.195 0.998 . . . . 72.340000000000003 111.18 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -105.62 122.6 46.38 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.888 -1.051 . . . . 53.43 109.27 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.3 t -98.23 131.43 45.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.954 -1.128 . . . . 60.43 107.954 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 m -139.65 169.8 17.07 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.451 -0.574 . . . . 75.409999999999997 109.451 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.541 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 1.7 p-10 -83.64 142.56 30.71 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.097 0.475 . . . . 73.319999999999993 109.771 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 82.5 t80 -107.92 121.74 45.4 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.657 -1.238 . . . . 74.219999999999999 107.657 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -138.28 101.11 4.3 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.158 -1.053 . . . . 71.049999999999997 108.158 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 36.6 t -165.8 147.57 7.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.043 -1.095 . . . . 65.219999999999999 108.043 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 71.94 10.15 6.15 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.976 0.91 . . . . 64.450000000000003 111.167 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.55 1.06 83.76 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.557 -0.747 . . . . 73.0 111.967 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -104.95 147.06 28.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.454 -0.943 . . . . 63.119999999999997 108.454 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 36.0 m -123.85 139.0 51.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.218 -1.031 . . . . 73.200000000000003 108.218 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -167.44 -155.13 8.98 Favored Glycine 0 C--N 1.26 -3.677 0 C-N-CA 119.797 -1.192 . . . . 71.549999999999997 111.178 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.426 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 7.8 t -123.81 152.77 41.89 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 108.858 -0.793 . . . . 54.140000000000001 108.858 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.8 pt20 -140.67 130.71 24.72 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 120.999 0.428 . . . . 72.239999999999995 110.363 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.04 115.31 29.96 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.735 -0.839 . . . . 75.319999999999993 108.735 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.89 116.75 50.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.903 -0.777 . . . . 75.200000000000003 108.903 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.461 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.2 p90 -121.67 146.95 46.49 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 120.982 0.42 . . . . 74.109999999999999 110.944 -176.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 46.1 m -152.04 158.54 43.18 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 116.018 -0.537 . . . . 74.450000000000003 109.78 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.8 t70 60.47 38.82 18.93 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 122.31 1.052 . . . . 75.25 111.64 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.461 HD12 ' CD2' ' A' ' 87' ' ' PHE . 25.3 mt -97.47 166.53 11.48 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.238 -0.892 . . . . 74.430000000000007 109.878 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -115.08 173.72 6.35 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 117.875 0.307 . . . . 71.329999999999998 110.264 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -49.84 -50.49 45.26 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.223 1.409 . . . . 72.200000000000003 111.461 -177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.31 68.11 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.156 0.582 . . . . 74.150000000000006 112.251 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -84.3 -16.34 43.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.67 -0.241 . . . . 73.109999999999999 111.619 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.7 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.8 tt -64.52 -54.98 33.01 Favored Pre-proline 0 CA--C 1.558 1.273 0 CA-C-O 119.392 -0.337 . . . . 71.230000000000004 111.312 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.41 -33.28 88.88 Favored 'Trans proline' 0 C--N 1.367 1.54 0 CA-C-N 120.744 1.301 . . . . 65.349999999999994 111.017 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -66.57 -36.06 81.73 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.95 -0.568 . . . . 74.510000000000005 110.697 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.0 pp -75.9 -19.21 59.01 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 109.498 -0.556 . . . . 74.299999999999997 109.498 175.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.01 -15.99 62.05 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.004 -0.544 . . . . 74.549999999999997 110.342 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -63.79 -56.93 11.82 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.452 -0.944 . . . . 73.420000000000002 108.452 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.623 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 31.9 ttp -54.33 -49.67 69.18 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.664 -0.698 . . . . 73.519999999999996 109.805 178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -53.33 -41.98 66.27 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.849 -1.069 . . . . 75.109999999999999 110.887 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.3 p -72.37 -20.73 61.41 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 119.421 -0.912 . . . . 74.140000000000001 112.199 -172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.2 -20.36 62.28 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.482 0.658 . . . . 72.230000000000004 109.703 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.91 -10.41 20.67 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.792 -0.64 . . . . 51.140000000000001 110.378 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.67 -48.4 3.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.667 0.618 . . . . 64.140000000000001 112.667 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.64 20.62 59.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.481 -0.648 . . . . 42.32 111.481 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.84 168.19 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 109.476 -0.565 . . . . 73.120000000000005 109.476 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -102.77 135.52 44.29 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.887 0.312 . . . . 72.540000000000006 110.407 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.25 125.65 23.42 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.38 -0.6 . . . . 70.099999999999994 109.38 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.2 p -144.34 143.12 30.81 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.756 0.313 . . . . 71.430000000000007 111.268 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.8 tt -137.54 125.78 23.14 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.741 0.816 . . . . 60.25 108.894 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -142.01 168.33 20.0 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.302 0.241 . . . . 63.140000000000001 110.378 -174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.417 ' CG ' HG22 ' A' ' 119' ' ' VAL . 26.6 mtt85 -101.14 138.68 37.85 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 113.866 1.061 . . . . 72.140000000000001 113.866 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.434 ' O ' HG13 ' A' ' 118' ' ' ILE . 7.0 t30 -123.96 94.36 4.2 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 105.764 -1.939 . . . . 74.120000000000005 105.764 174.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.42 -114.03 4.95 Favored Glycine 0 N--CA 1.428 -1.852 0 N-CA-C 110.106 -1.197 . . . . 72.329999999999998 110.106 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -110.7 -1.37 16.74 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.721 1.248 . . . . 73.140000000000001 108.768 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.5 pp -103.19 148.97 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 C-N-CA 118.892 -1.123 . . . . 75.239999999999995 108.323 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.417 HG22 ' CG ' ' A' ' 114' ' ' ARG . 89.1 t -108.92 136.53 44.49 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.984 0 N-CA-C 109.853 -0.425 . . . . 61.420000000000002 109.853 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.7 pt -116.01 132.14 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-O 121.921 0.867 . . . . 71.450000000000003 109.201 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 174' ' ' ALA . 5.5 tt -114.4 130.95 56.73 Favored 'General case' 0 C--N 1.255 -3.513 0 N-CA-C 105.646 -1.983 . . . . 51.310000000000002 105.646 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -140.74 130.67 24.54 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.727 -0.842 . . . . 75.430000000000007 108.727 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.92 168.05 38.26 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 111.199 -0.76 . . . . 31.25 111.199 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -140.2 141.83 35.91 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.364 -0.976 . . . . 73.0 108.364 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -124.69 108.78 12.37 Favored 'General case' 0 N--CA 1.413 -2.279 0 N-CA-C 108.352 -0.981 . . . . 71.120000000000005 108.352 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -112.66 111.72 22.72 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.034 -1.099 . . . . 53.140000000000001 108.034 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.572 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 0.1 OUTLIER -127.75 34.47 4.64 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.082 -1.451 . . . . 75.049999999999997 107.082 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.2 p -66.08 -12.6 56.56 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.654 0.983 . . . . 74.239999999999995 113.654 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.9 m -70.77 -12.26 61.45 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.521 0.677 . . . . 55.030000000000001 110.341 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.407 HG22 ' HA2' ' A' ' 167' ' ' GLY . 48.0 t 75.97 -70.6 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.259 1.423 . . . . 74.519999999999996 113.099 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.8 m 64.84 -76.23 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.828 0.851 . . . . 72.25 109.639 -171.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.434 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 42.5 m-20 -131.14 110.38 15.37 Favored Pre-proline 0 CA--C 1.494 -1.192 0 N-CA-C 107.576 -1.268 . . . . 73.120000000000005 107.576 176.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.9 -20.41 45.28 Favored 'Trans proline' 0 N--CA 1.476 0.445 0 C-N-CA 122.24 1.96 . . . . 54.100000000000001 112.59 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -96.08 11.25 34.84 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.774 -0.648 . . . . 64.519999999999996 111.872 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.2 148.15 28.6 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.987 -1.116 . . . . 70.109999999999999 107.987 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -132.68 124.58 28.5 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.888 -0.412 . . . . 71.209999999999994 109.888 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.511 ' HB ' ' HG ' ' A' ' 164' ' ' LEU . 82.6 t -117.16 121.05 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 120.161 -0.616 . . . . 73.439999999999998 110.113 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 45.3 mt-10 -115.73 138.02 51.52 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.95 -0.568 . . . . 55.399999999999999 110.686 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.407 HD13 ' SD ' ' A' ' 172' ' ' MET . 3.3 tt -127.64 125.46 40.19 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 105.237 -2.134 . . . . 70.010000000000005 105.237 170.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 13.6 m -126.57 122.94 36.53 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.144 -0.687 . . . . 75.030000000000001 109.144 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.443 HG12 ' HD2' ' A' ' 143' ' ' PHE . 94.1 t -118.24 123.5 71.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 110.131 -0.322 . . . . 63.009999999999998 110.131 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.78 127.49 55.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.074 -0.713 . . . . 41.219999999999999 109.074 176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.0 p90 -134.46 121.31 15.17 Favored Pre-proline 0 C--N 1.295 -1.779 0 C-N-CA 122.695 0.398 . . . . 73.329999999999998 112.004 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 15.0 Cg_exo -72.59 39.17 0.41 Allowed 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 122.874 2.382 . . . . 73.219999999999999 112.108 176.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.61 -97.92 0.46 Allowed 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 119.307 -0.378 . . . . 62.420000000000002 110.482 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 176.59 123.8 0.03 OUTLIER 'General case' 0 C--O 1.242 0.703 0 N-CA-C 109.406 -0.59 . . . . 64.530000000000001 109.406 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.48 136.15 23.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.483 -0.932 . . . . 73.319999999999993 108.483 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.8 p -95.31 -44.97 7.34 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 109.204 -0.665 . . . . 63.130000000000003 109.204 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 62.5 m -158.82 133.3 7.98 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.935 -0.575 . . . . 62.549999999999997 109.536 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.2 t -138.32 159.27 42.49 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.835 -0.54 . . . . 74.319999999999993 110.113 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -126.18 94.56 4.12 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 105.343 -2.095 . . . . 71.209999999999994 105.343 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.34 -150.19 10.37 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.051 -2.02 . . . . 50.25 108.051 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.68 99.01 7.02 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.608 -0.886 . . . . 74.310000000000002 108.608 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -74.66 137.63 42.32 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.906 -0.588 . . . . 72.099999999999994 111.307 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.4 mt -100.87 -48.45 11.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.242 -1.392 . . . . 73.219999999999999 107.242 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -133.72 169.0 15.09 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 107.561 -1.274 . . . . 73.239999999999995 107.561 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -72.87 0.81 7.2 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.625 2.216 . . . . 72.420000000000002 111.078 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.4 pt-20 -132.75 3.7 3.83 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.946 -1.024 . . . . 73.450000000000003 110.747 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.421 HG23 ' HG3' ' A' ' 158' ' ' GLU . 59.8 t -144.6 120.82 4.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 108.912 -0.773 . . . . 61.520000000000003 108.912 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.97 147.83 31.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 109.084 -0.71 . . . . 74.340000000000003 109.084 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -130.05 143.38 50.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.111 -0.7 . . . . 64.400000000000006 109.111 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.536 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 32.6 m-90 -122.66 116.73 24.31 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 108.731 -0.841 . . . . 72.230000000000004 108.731 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.25 98.27 8.68 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.554 -0.906 . . . . 63.210000000000001 108.554 175.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.511 ' HG ' ' HB ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -96.45 131.52 42.94 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-O 122.338 1.066 . . . . 60.219999999999999 110.082 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 68.4 mttm -119.52 151.03 51.05 Favored Pre-proline 0 C--N 1.279 -2.499 0 CA-C-N 113.248 -1.796 . . . . 63.210000000000001 112.858 -170.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 20.3 Cg_exo -70.97 156.56 59.96 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.868 2.379 . . . . 71.340000000000003 110.644 174.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.407 ' HA2' HG22 ' A' ' 130' ' ' VAL . . . 84.34 -36.17 2.94 Favored Glycine 0 C--N 1.309 -0.925 0 C-N-CA 121.278 -0.487 . . . . 73.140000000000001 112.129 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.3 m -105.82 166.27 3.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 123.008 0.523 . . . . 74.349999999999994 110.223 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.0 p -113.82 142.33 26.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.348 -0.982 . . . . 64.510000000000005 108.348 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.1 m -138.53 141.95 39.32 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.937 -0.477 . . . . 72.129999999999995 109.841 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.3 p -103.43 130.01 50.68 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.871 -0.788 . . . . 74.400000000000006 108.871 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.407 ' SD ' HD13 ' A' ' 139' ' ' LEU . 44.2 ttp -104.02 116.34 32.05 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.653 -0.869 . . . . 72.030000000000001 108.653 -177.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.1 m -140.33 139.52 35.44 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.693 -0.803 . . . . 64.329999999999998 109.305 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.536 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -149.2 120.68 7.94 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 108.507 -0.923 . . . . 40.240000000000002 108.507 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -120.7 130.74 54.21 Favored 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 106.691 -1.596 . . . . 70.340000000000003 106.691 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -155.76 150.93 26.68 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.405 -0.961 . . . . 73.219999999999999 108.405 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 5.8 ppt_? -88.2 126.41 35.13 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.81 -0.756 . . . . 74.099999999999994 110.671 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 16.5 m-30 -135.05 118.71 17.06 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 107.741 -1.207 . . . . 64.010000000000005 107.741 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.63 113.25 0.67 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 125.171 1.545 . . . . 52.409999999999997 112.274 -176.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.26 123.35 85.9 Favored Pre-proline 0 CA--C 1.501 -0.926 0 C-N-CA 124.422 1.089 . . . . 74.239999999999995 109.082 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -73.07 -41.99 1.15 Allowed 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 121.7 1.6 . . . . 74.5 113.0 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.26 -22.05 30.9 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.825 0.45 . . . . 75.120000000000005 111.475 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 69.3 p 67.33 87.27 0.12 Allowed 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 126.322 1.849 . . . . 63.130000000000003 115.065 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -96.11 159.58 14.89 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.07 -0.514 . . . . 74.010000000000005 111.294 174.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.3 -1.547 0 N-CA-C 107.469 -1.308 . . . . 75.450000000000003 107.469 177.625 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.831 0 N-CA-C 111.262 -0.735 . . . . 43.049999999999997 111.262 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -122.98 30.4 6.4 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.693 0.758 . . . . 65.5 109.737 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.6 mp0 -99.39 -1.27 39.16 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.377 -0.829 . . . . 72.430000000000007 110.914 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -88.42 83.06 6.87 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.086 0.946 . . . . 74.310000000000002 112.466 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.0 tp -151.04 91.38 1.7 Allowed 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 114.04 -1.436 . . . . 65.319999999999993 108.391 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -87.6 86.67 7.23 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.679 0.752 . . . . 74.230000000000004 111.407 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -83.49 -25.07 31.44 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.924 -1.035 . . . . 74.219999999999999 109.901 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -103.76 136.26 43.78 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.629 -0.714 . . . . 71.049999999999997 109.747 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.4 81.33 1.26 Allowed Glycine 0 N--CA 1.433 -1.567 0 C-N-CA 120.767 -0.73 . . . . 65.239999999999995 111.355 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -94.52 117.23 29.8 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.771 0.796 . . . . 72.010000000000005 111.814 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.496 ' HB3' ' O ' ' A' ' 134' ' ' ASP . 1.5 mpt? -116.06 -165.38 1.04 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.934 0.894 . . . . 62.520000000000003 110.395 -177.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -89.77 115.23 26.97 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.435 -1.691 . . . . 72.120000000000005 106.435 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -106.0 132.77 51.69 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.237 -0.585 . . . . 74.439999999999998 111.418 -173.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.08 114.44 41.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.729 -0.841 . . . . 64.150000000000006 108.729 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 58.6 mtp85 -119.5 119.3 33.45 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.553 -0.748 . . . . 74.349999999999994 111.961 -176.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.08 108.35 19.4 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.481 -1.303 . . . . 73.109999999999999 107.481 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 140' ' ' THR . 20.3 m -120.71 115.11 22.7 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.618 -0.512 . . . . 72.400000000000006 109.618 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.9 pp -124.45 147.47 28.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.017 0.437 . . . . 75.439999999999998 110.44 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 62.7 m -129.82 122.04 27.95 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-O 121.053 0.454 . . . . 63.130000000000003 110.097 -176.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -113.92 122.73 68.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-O 121.463 0.649 . . . . 63.439999999999998 110.439 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.1 m -86.99 151.64 52.19 Favored Pre-proline 0 N--CA 1.417 -2.112 0 CA-C-N 115.336 -0.847 . . . . 64.230000000000004 109.46 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.43 ' HG3' ' HB2' ' A' ' 145' ' ' ALA . 21.6 Cg_exo -65.96 2.13 1.93 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.312 2.675 . . . . 74.409999999999997 112.349 178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 25.7 t70 -85.19 -2.22 57.79 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.139 0.975 . . . . 63.119999999999997 109.385 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.9 t70 72.76 28.96 2.01 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 123.469 1.605 . . . . 74.209999999999994 107.621 -174.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -107.51 125.84 51.78 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 113.671 -1.604 . . . . 64.129999999999995 108.25 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 t -108.97 137.12 42.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.256 -0.646 . . . . 63.149999999999999 109.256 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.2 p -146.84 165.43 29.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.722 -1.214 . . . . 74.030000000000001 107.722 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.26 -173.97 41.78 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.617 -1.278 . . . . 51.039999999999999 112.764 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 10.2 pt-20 -157.51 133.42 9.37 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.409 0.623 . . . . 75.030000000000001 110.804 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 2.0 mp -113.18 116.5 52.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.992 -1.114 . . . . 74.540000000000006 107.992 175.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mp -113.9 115.6 50.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 121.195 0.521 . . . . 64.230000000000004 109.698 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -108.7 125.85 52.35 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.509 -1.663 . . . . 74.409999999999997 106.509 174.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.87 116.79 14.19 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.578 0.704 . . . . 75.239999999999995 109.476 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.84 159.34 31.28 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 115.059 -0.973 . . . . 73.200000000000003 110.789 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -64.27 137.84 97.24 Favored Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 106.713 -1.588 . . . . 70.540000000000006 106.713 171.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -43.42 -41.03 10.4 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 123.994 3.13 . . . . 72.209999999999994 115.668 -172.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 62.47 76.2 0.37 Allowed 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 108.843 -0.799 . . . . 74.329999999999998 108.843 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 81.46 137.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 113.538 -1.665 . . . . 73.420000000000002 110.17 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.6 m -57.03 -9.98 1.0 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 126.082 1.753 . . . . 62.530000000000001 114.799 -176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -73.33 -19.28 61.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.741 0.416 . . . . 64.129999999999995 111.057 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -99.68 125.59 45.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 120.06 -0.656 . . . . 60.130000000000003 110.128 -173.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -114.72 -17.45 11.61 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.156 -0.474 . . . . 74.510000000000005 111.045 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.45 97.79 0.11 Allowed Glycine 0 N--CA 1.434 -1.47 0 C-N-CA 120.053 -1.07 . . . . 62.130000000000003 111.98 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.56 159.83 35.42 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 122.635 2.223 . . . . 63.109999999999999 111.454 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.96 140.47 52.3 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.452 -0.573 . . . . 72.450000000000003 109.452 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.413 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 90.8 mt -62.89 149.19 45.1 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.566 0.541 . . . . 65.209999999999994 110.208 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -82.38 85.1 6.95 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.571 -0.899 . . . . 55.43 108.571 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.531 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -122.4 120.88 4.47 Favored Glycine 0 N--CA 1.417 -2.631 0 CA-C-N 114.558 -1.201 . . . . 75.239999999999995 113.746 -176.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -139.95 112.79 8.06 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.757 -0.831 . . . . 73.239999999999995 108.757 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.51 161.6 57.93 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.662 -0.866 . . . . 74.030000000000001 108.662 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.62 -11.86 24.36 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.047 1.831 . . . . 73.219999999999999 111.536 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -114.03 41.61 2.21 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.837 -0.619 . . . . 71.400000000000006 111.595 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.2 m -58.64 -27.23 64.53 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-N 116.211 -0.449 . . . . 65.340000000000003 111.508 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -68.84 -15.82 63.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.522 0.677 . . . . 71.420000000000002 110.405 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -95.4 -17.63 21.4 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.245 -0.889 . . . . 73.010000000000005 110.565 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 87' ' ' PHE . 7.6 p -124.55 118.97 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-O 122.246 1.022 . . . . 53.210000000000001 111.92 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.94 101.85 14.41 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.042 -0.981 . . . . 64.129999999999995 108.39 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.21 125.5 51.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.594 -1.262 . . . . 71.040000000000006 107.594 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 m -142.09 172.26 12.93 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.888 -0.782 . . . . 74.209999999999994 108.888 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -83.59 151.92 25.1 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.818 -1.178 . . . . 74.200000000000003 107.818 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -110.35 123.57 50.09 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.94 -1.504 . . . . 73.400000000000006 106.94 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -138.55 99.53 3.85 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 106.97 -1.493 . . . . 71.150000000000006 106.97 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.4 t -171.94 155.21 3.74 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.556 -1.276 . . . . 73.25 107.556 -174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 70.62 7.26 6.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.942 0.897 . . . . 73.439999999999998 111.383 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.1 -2.04 80.99 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.453 -1.059 . . . . 63.140000000000001 110.453 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -104.56 155.67 18.62 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.216 0.606 . . . . 75.319999999999993 111.288 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.64 136.69 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 N-CA-C 108.438 -0.949 . . . . 71.140000000000001 108.438 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -163.45 -154.06 7.55 Favored Glycine 0 N--CA 1.397 -3.931 0 C-N-CA 120.056 -1.069 . . . . 62.210000000000001 111.051 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.413 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 13.0 m -131.25 143.6 50.68 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 115.462 -0.369 . . . . 61.219999999999999 110.078 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.9 pt20 -132.74 138.15 47.1 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.706 0.289 . . . . 63.399999999999999 110.731 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -121.03 114.4 21.44 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.295 -1.372 . . . . 74.340000000000003 107.295 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.7 113.18 43.53 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 108.225 -1.028 . . . . 60.399999999999999 108.225 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.449 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.8 p90 -123.41 154.68 38.69 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.186 -0.606 . . . . 73.519999999999996 111.865 -175.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -157.1 165.61 35.58 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.229 -0.896 . . . . 74.140000000000001 109.499 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 65.19 31.7 10.62 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.276 0.985 . . . . 71.510000000000005 111.767 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.449 HD12 ' CD2' ' A' ' 87' ' ' PHE . 47.9 mt -101.58 164.55 11.7 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.273 -0.422 . . . . 44.340000000000003 110.447 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -117.86 178.08 4.54 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.816 0.341 . . . . 42.539999999999999 111.082 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -54.06 -38.87 65.73 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 125.595 1.558 . . . . 64.010000000000005 111.063 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.22 -25.95 62.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.948 -0.569 . . . . 72.209999999999994 111.503 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -89.72 -17.07 29.0 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.299 -0.409 . . . . 74.140000000000001 111.564 -176.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.534 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 43.1 tp -57.84 -48.32 97.36 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 112.771 0.656 . . . . 65.540000000000006 112.771 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 40.2 Cg_exo -63.12 -37.02 54.8 Favored 'Trans proline' 0 C--N 1.367 1.53 0 CA-C-N 120.658 1.271 . . . . 74.109999999999999 110.892 174.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -68.49 -34.8 76.55 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.456 -0.793 . . . . 75.219999999999999 111.507 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -78.36 -19.44 53.39 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.501 -0.555 . . . . 74.129999999999995 109.501 176.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 96' ' ' PRO . . . -70.62 -27.15 63.85 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-N 115.585 -0.734 . . . . 73.140000000000001 109.933 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -57.1 -57.4 12.72 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.985 0.803 . . . . 73.519999999999996 109.675 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.531 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.6 ttp -53.58 -50.35 65.77 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.352 -0.84 . . . . 74.530000000000001 110.468 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -60.31 -33.0 71.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.227 -0.897 . . . . 73.340000000000003 111.609 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.9 m -63.99 -28.14 69.61 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 121.079 -0.249 . . . . 73.319999999999993 110.945 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.82 -26.18 68.23 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-O 121.424 0.631 . . . . 64.010000000000005 110.582 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.47 -6.64 16.05 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 116.143 -0.481 . . . . 72.450000000000003 110.669 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.52 -41.6 5.44 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.203 -0.599 . . . . 60.119999999999997 112.433 -173.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.56 26.02 68.68 Favored Glycine 0 C--O 1.242 0.638 0 C-N-CA 120.473 -0.87 . . . . 73.340000000000003 110.962 -175.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.56 160.81 9.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 121.056 0.455 . . . . 65.340000000000003 110.238 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -113.14 122.44 47.54 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 105.94 -1.874 . . . . 71.400000000000006 105.94 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.9 mt -119.68 123.24 43.33 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 117.82 0.282 . . . . 74.200000000000003 111.349 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.8 m -123.46 141.39 52.05 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.475 -0.565 . . . . 64.25 109.475 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.5 tp -134.92 131.85 37.77 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.259 -0.428 . . . . 75.129999999999995 110.426 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -143.03 153.68 43.2 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.406 -0.961 . . . . 71.129999999999995 108.406 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.573 ' NH1' ' HA ' ' A' ' 180' ' ' ASP . 19.8 ttm180 -112.02 132.44 54.8 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 108.763 -0.828 . . . . 75.540000000000006 108.763 171.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -110.06 89.3 2.98 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.104 -1.443 . . . . 72.340000000000003 107.104 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.26 -108.95 2.64 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.326 -1.11 . . . . 64.340000000000003 110.326 -176.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -107.63 -6.31 16.98 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 122.213 1.006 . . . . 53.539999999999999 109.39 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.6 pp -104.39 143.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 C-N-CA 118.202 -1.399 . . . . 75.25 109.202 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.441 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 72.8 t -105.79 138.76 29.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 O-C-N 122.003 -0.435 . . . . 63.549999999999997 110.287 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.2 pt -121.15 135.92 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-O 121.626 0.726 . . . . 74.219999999999999 109.893 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.3 tt -128.06 125.32 39.07 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 107.475 -1.306 . . . . 73.319999999999993 107.475 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -125.83 121.84 34.43 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.857 -1.534 . . . . 53.520000000000003 106.857 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.99 161.21 27.57 Favored Glycine 0 N--CA 1.407 -3.259 0 C-N-CA 120.719 -0.753 . . . . 60.549999999999997 111.567 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -139.44 138.38 36.41 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.44 -0.948 . . . . 71.129999999999995 108.44 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.23 117.19 33.47 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.532 -0.303 . . . . 64.129999999999995 111.253 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -104.16 97.42 7.38 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.013 -1.106 . . . . 75.120000000000005 108.013 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 3.1 mm? -112.21 12.83 20.42 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.451 -0.574 . . . . 71.319999999999993 109.451 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 p -66.79 -28.45 68.4 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 113.431 0.901 . . . . 62.409999999999997 113.431 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.7 m -86.99 -5.12 59.19 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.098 0.475 . . . . 73.200000000000003 110.603 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.2 t -84.24 104.38 12.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.086 -1.079 . . . . 52.509999999999998 108.086 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 12.9 m -90.26 1.89 56.02 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.897 -0.592 . . . . 73.310000000000002 110.94 -177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.1 103.33 5.5 Favored Pre-proline 0 CA--C 1.515 -0.394 0 N-CA-C 108.573 -0.899 . . . . 72.409999999999997 108.573 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 131' ' ' SER . 8.3 Cg_exo -75.04 -12.12 21.42 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.58 2.187 . . . . 74.129999999999995 111.647 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 25' ' ' MET . 4.6 m-20 -80.12 1.78 26.66 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.987 -1.006 . . . . 72.140000000000001 111.412 -175.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.52 131.3 44.86 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.164 -0.68 . . . . 73.340000000000003 109.164 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -122.12 118.26 28.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.311 -1.366 . . . . 53.43 107.311 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 53.5 t -109.73 129.92 63.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.344 -0.542 . . . . 71.239999999999995 110.657 -173.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 44.9 mt-10 -134.53 130.71 37.01 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.861 -0.422 . . . . 74.5 109.861 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.464 HD13 ' SD ' ' A' ' 172' ' ' MET . 5.6 tt -120.15 128.98 53.93 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.307 -1.738 . . . . 73.319999999999993 106.307 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 31' ' ' SER . 29.8 m -126.98 131.65 50.99 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.548 -0.538 . . . . 74.140000000000001 109.548 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 80.2 t -121.9 125.87 73.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.513 -0.921 . . . . 73.530000000000001 108.513 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -116.63 128.69 55.61 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 108.637 -0.875 . . . . 75.019999999999996 108.637 178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.683 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.8 p90 -134.12 117.78 13.81 Favored Pre-proline 0 C--N 1.281 -2.379 0 CA-C-N 116.545 -0.298 . . . . 72.109999999999999 111.072 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.8 38.25 0.18 Allowed 'Trans proline' 0 CA--C 1.554 1.521 0 C-N-CA 123.024 2.483 . . . . 70.450000000000003 112.929 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.43 ' HB2' ' HG3' ' A' ' 36' ' ' PRO . . . -122.04 -102.0 0.41 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 110.048 -0.353 . . . . 52.130000000000003 110.048 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.73 128.12 0.08 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.665 -0.865 . . . . 54.219999999999999 108.665 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.49 141.3 15.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 108.521 -0.918 . . . . 72.310000000000002 108.521 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.3 t -103.54 -32.79 9.28 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 120.205 -0.598 . . . . 75.0 109.643 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 54.9 m -161.12 133.37 5.94 Favored 'General case' 0 C--O 1.202 -1.405 0 N-CA-C 109.598 -0.519 . . . . 73.150000000000006 109.598 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.8 t -138.52 168.78 19.04 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.695 -0.628 . . . . 53.310000000000002 109.599 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -139.76 87.7 2.19 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.065 -2.198 . . . . 51.200000000000003 105.065 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.9 -144.39 5.94 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.264 -1.534 . . . . 52.219999999999999 109.264 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -117.94 99.65 7.05 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.545 -0.909 . . . . 72.329999999999998 108.545 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 34.8 ptt180 -82.42 133.19 35.21 Favored 'General case' 0 N--CA 1.413 -2.275 0 C-N-CA 119.298 -0.961 . . . . 74.219999999999999 110.986 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.17 -37.74 8.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.582 -1.266 . . . . 70.349999999999994 107.582 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -139.71 165.04 34.02 Favored Pre-proline 0 N--CA 1.427 -1.582 0 N-CA-C 106.207 -1.775 . . . . 45.509999999999998 106.207 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.78 0.17 6.05 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.5 2.133 . . . . 74.430000000000007 111.366 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.683 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.0 pt-20 -134.41 8.38 3.66 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.819 -0.628 . . . . 74.420000000000002 111.88 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 86.9 t -142.7 121.06 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 109.131 -0.692 . . . . 52.030000000000001 109.131 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 44.9 t -130.58 146.28 34.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 110.167 -0.309 . . . . 44.200000000000003 110.167 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -132.75 152.58 51.72 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-O 121.12 0.486 . . . . 74.239999999999995 110.359 177.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.417 ' CE2' ' HG3' ' A' ' 172' ' ' MET . 31.2 m-90 -125.28 119.43 28.4 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 108.296 -1.002 . . . . 75.230000000000004 108.296 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -98.99 106.5 18.77 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.963 0.887 . . . . 62.229999999999997 110.075 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 76.9 mt -101.44 135.51 42.82 Favored 'General case' 0 C--O 1.264 1.826 0 CA-C-N 114.907 -1.042 . . . . 74.310000000000002 111.216 -173.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 10.7 mmpt? -115.12 150.61 44.58 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 114.143 -1.39 . . . . 74.420000000000002 109.189 -175.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 11.3 Cg_exo -73.6 156.78 49.22 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.61 2.207 . . . . 54.0 111.283 176.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.79 -24.83 3.13 Favored Glycine 0 C--N 1.314 -0.688 0 O-C-N 122.318 -0.239 . . . . 74.230000000000004 112.665 176.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 31.7 m -106.05 160.83 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 121.264 0.554 . . . . 75.140000000000001 112.096 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.73 144.14 21.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.764 -1.198 . . . . 71.420000000000002 107.764 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 32.8 t -148.6 152.71 37.23 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.991 -0.374 . . . . 71.420000000000002 109.991 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.1 p -96.03 154.78 17.05 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.893 -0.594 . . . . 61.25 109.547 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.464 ' SD ' HD13 ' A' ' 139' ' ' LEU . 37.4 ttp -144.1 116.27 8.44 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.396 0.617 . . . . 71.329999999999998 109.408 -176.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.4 m -134.61 141.7 46.69 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 120.188 -0.605 . . . . 73.439999999999998 109.58 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -146.66 116.25 7.14 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.114 -1.069 . . . . 52.439999999999998 108.114 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -124.13 129.88 51.59 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.438 -1.319 . . . . 63.450000000000003 107.438 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.98 155.66 38.46 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.139 -0.689 . . . . 54.420000000000002 109.139 -175.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 16.5 ptm180 -91.85 132.75 36.23 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 120.624 -0.431 . . . . 72.310000000000002 111.078 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.441 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 63.5 m-85 -140.52 129.76 23.69 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 109.091 -0.707 . . . . 74.439999999999998 109.091 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.5 110.8 0.38 Allowed 'General case' 0 N--CA 1.421 -1.885 0 C-N-CA 125.211 1.404 . . . . 62.229999999999997 111.982 -178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.573 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 35.9 t70 -69.35 133.22 89.35 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 114.692 -1.14 . . . . 74.140000000000001 110.419 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.41 -45.19 7.51 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.619 2.212 . . . . 43.439999999999998 113.981 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.402 ' OD1' ' HG2' ' A' ' 184' ' ' ARG . 9.3 p30 -83.65 -15.98 46.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.042 0.449 . . . . 52.119999999999997 110.143 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.429 74.8 p 79.57 66.46 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.379 1.871 . . . . 71.140000000000001 115.293 173.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.402 ' HG2' ' OD1' ' A' ' 182' ' ' ASN . 15.2 mmm180 -114.22 155.7 25.65 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.886 -1.506 . . . . 72.319999999999993 109.426 171.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 C--N 1.299 -1.621 0 N-CA-C 107.581 -1.266 . . . . 52.32 107.581 177.085 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.181 0 N-CA-C 110.562 -1.015 . . . . 43.049999999999997 110.562 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -75.41 131.04 39.91 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.538 -0.542 . . . . 65.230000000000004 109.538 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -95.92 135.84 37.13 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.713 -0.676 . . . . 72.299999999999997 110.825 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 179.98 112.82 0.05 OUTLIER 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 107.04 -1.466 . . . . 44.420000000000002 107.04 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.2 mt -120.78 28.15 8.1 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.311 0.577 . . . . 72.25 109.561 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -86.03 -72.31 0.5 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.473 -0.785 . . . . 55.310000000000002 109.945 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -94.83 6.7 48.22 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.739 -0.664 . . . . 75.549999999999997 111.574 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -76.81 91.88 3.55 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.205 -0.665 . . . . 75.420000000000002 109.205 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.73 84.59 0.2 Allowed Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 108.748 -1.741 . . . . 70.230000000000004 108.748 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -81.34 129.48 34.64 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.77 -0.456 . . . . 75.420000000000002 109.77 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -166.2 128.09 1.87 Allowed 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.081 -0.711 . . . . 73.439999999999998 109.081 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -114.78 135.81 53.76 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.463 -0.939 . . . . 74.129999999999995 108.463 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 52.4 ttt180 -129.57 123.41 31.29 Favored 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 119.865 -0.734 . . . . 73.540000000000006 109.254 174.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.08 114.08 44.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 106.669 -1.604 . . . . 64.239999999999995 106.669 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.91 113.3 18.92 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.36 -1.348 . . . . 63.509999999999998 107.36 -175.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.62 136.86 52.58 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.811 -0.631 . . . . 71.109999999999999 109.905 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -138.03 115.24 11.0 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.112 -0.699 . . . . 70.340000000000003 109.112 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 14.5 pt -126.55 149.14 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-O 121.25 0.548 . . . . 74.310000000000002 111.038 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 69.7 m -126.51 123.68 38.33 Favored 'General case' 0 C--N 1.271 -2.841 0 N-CA-C 108.439 -0.948 . . . . 72.319999999999993 108.439 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.4 tt -113.49 125.02 70.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.478 0.656 . . . . 73.549999999999997 110.642 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 43.8 t -88.74 150.96 46.99 Favored Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 115.114 -0.948 . . . . 72.230000000000004 109.243 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 35' ' ' SER . 16.8 Cg_exo -68.92 2.78 2.79 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 123.436 2.757 . . . . 71.319999999999993 111.894 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -89.08 4.53 48.1 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.058 -0.719 . . . . 75.439999999999998 109.058 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 t70 71.5 29.44 2.67 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.124 1.44 . . . . 34.25 107.144 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.42 124.93 51.83 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 113.882 -1.508 . . . . 61.310000000000002 107.938 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.479 HG11 HD13 ' A' ' 95' ' ' LEU . 20.7 t -111.58 138.81 38.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.765 -0.828 . . . . 43.229999999999997 108.765 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 p -149.64 157.92 43.69 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.626 -0.879 . . . . 64.409999999999997 108.626 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 32' ' ' ILE . . . 159.28 -165.08 34.21 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 119.516 -1.326 . . . . 72.109999999999999 112.432 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.2 141.97 21.04 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.207 0.527 . . . . 74.420000000000002 110.265 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.8 mt -124.31 117.01 49.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.99 -1.115 . . . . 73.200000000000003 107.99 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.13 116.05 51.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 109.327 -0.62 . . . . 75.010000000000005 109.327 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.5 107.77 18.95 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.946 -1.501 . . . . 62.420000000000002 106.946 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.49 127.72 49.93 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.249 0.547 . . . . 63.340000000000003 109.884 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.82 153.02 29.83 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 109.269 -0.641 . . . . 60.229999999999997 109.269 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 80.3 tttt -79.04 128.68 75.51 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 105.837 -1.912 . . . . 73.239999999999995 105.837 175.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 52' ' ' ASN . 22.6 Cg_exo -21.63 -70.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.573 1 C-N-CA 126.03 4.487 . . . . 73.129999999999995 117.607 -171.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 60.6 mtpt 69.18 -31.64 0.21 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 124.669 1.188 . . . . 73.239999999999995 113.206 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 50' ' ' PRO . 45.1 m-80 -130.69 142.98 50.44 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.824 -1.547 . . . . 53.009999999999998 106.824 176.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 m -77.42 -18.64 57.07 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.062 0.458 . . . . 72.319999999999993 111.273 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.66 -17.28 54.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.395 0.617 . . . . 71.129999999999995 109.965 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.36 99.43 8.68 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 113.272 0.842 . . . . 65.219999999999999 113.272 -173.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -91.35 -13.99 31.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.935 -1.03 . . . . 70.049999999999997 108.286 171.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.465 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 173.1 104.76 0.18 Allowed Glycine 0 N--CA 1.417 -2.578 0 CA-C-O 118.472 -1.182 . . . . 74.129999999999995 111.163 176.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -52.45 132.78 46.42 Favored 'Trans proline' 0 C--O 1.243 0.771 0 CA-C-N 119.914 1.857 . . . . 74.25 110.772 173.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.97 155.83 39.91 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.055 -0.52 . . . . 60.409999999999997 111.718 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.6 tp -103.0 160.14 14.89 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.243 -1.021 . . . . 73.420000000000002 108.243 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -111.05 95.3 5.45 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.505 -0.924 . . . . 75.439999999999998 108.505 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -105.3 -106.3 3.11 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 120.726 -0.75 . . . . 64.219999999999999 112.136 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.0 t70 60.98 91.99 0.05 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 125.062 1.345 . . . . 61.219999999999999 112.028 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.68 157.72 77.24 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 114.393 -1.276 . . . . 72.439999999999998 108.136 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.82 -18.55 61.45 Favored 'Trans proline' 0 N--CA 1.479 0.634 0 C-N-CA 122.669 2.246 . . . . 70.530000000000001 112.326 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.464 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 42.1 p90 -111.16 32.35 5.38 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.559 -0.746 . . . . 73.219999999999999 112.114 -178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.5 m -55.92 -33.02 64.31 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 112.052 0.39 . . . . 60.409999999999997 112.052 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.39 -11.07 60.51 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.034 -0.416 . . . . 62.25 111.586 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HE3' HD23 ' A' ' 90' ' ' LEU . 24.3 mtpp -105.49 -4.45 21.27 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 109.905 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 87' ' ' PHE . 4.6 p -125.98 119.03 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 122.179 0.99 . . . . 71.120000000000005 110.377 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.02 102.37 15.02 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.593 -0.73 . . . . 52.219999999999999 109.755 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 84' ' ' GLN . 7.4 p -98.22 128.84 49.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.734 -0.839 . . . . 70.209999999999994 108.734 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.9 m -146.48 171.8 14.5 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 116.079 -0.509 . . . . 54.149999999999999 110.297 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.465 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 7.3 t30 -82.89 139.1 33.62 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.37 -0.604 . . . . 75.349999999999994 109.37 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -110.51 123.15 49.39 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.734 -0.839 . . . . 72.299999999999997 108.734 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -138.34 99.97 3.99 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.889 -1.523 . . . . 75.519999999999996 106.889 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.4 t -172.68 154.2 2.96 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.98 -0.378 . . . . 73.019999999999996 109.98 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 70.78 7.65 6.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.282 1.033 . . . . 63.329999999999998 111.632 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.65 -9.15 64.23 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.073 -0.811 . . . . 72.530000000000001 111.073 -177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -104.66 149.71 25.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.048 0.451 . . . . 72.530000000000001 110.692 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.83 137.74 56.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 109.082 -0.71 . . . . 74.540000000000006 109.082 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.43 -153.81 11.04 Favored Glycine 0 C--N 1.285 -2.305 0 C-N-CA 120.209 -0.996 . . . . 74.409999999999997 111.719 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 p -126.77 149.03 49.86 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 121.268 0.556 . . . . 53.240000000000002 110.848 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 3.7 pt20 -132.44 142.37 49.23 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.489 -0.323 . . . . 71.340000000000003 110.5 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -118.44 114.41 22.84 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.02 -1.104 . . . . 52.219999999999999 108.02 175.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.19 111.92 38.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.41 -0.959 . . . . 75.340000000000003 108.41 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.45 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.7 p90 -118.47 162.41 18.38 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 112.516 0.561 . . . . 74.540000000000006 112.516 -172.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 p -164.24 160.29 20.98 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.474 -0.785 . . . . 72.319999999999993 110.345 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.0 t70 65.65 30.99 10.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 124.366 1.041 . . . . 73.010000000000005 110.699 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.507 HD23 ' HE3' ' A' ' 69' ' ' LYS . 55.8 mt -95.69 159.69 14.86 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 121.662 -0.649 . . . . 70.329999999999998 110.636 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.415 HG22 ' OE1' ' A' ' 94' ' ' GLU . 8.9 t -106.09 171.41 7.36 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.526 -0.546 . . . . 62.509999999999998 109.526 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -52.49 -40.02 61.89 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.638 0.775 . . . . 75.319999999999993 111.313 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.39 -24.9 65.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.752 -0.658 . . . . 52.219999999999999 111.92 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.415 ' OE1' HG22 ' A' ' 91' ' ' THR . 54.4 mt-10 -87.53 -16.83 33.54 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.461 -0.336 . . . . 74.140000000000001 111.634 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.596 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 49.2 tp -61.67 -51.4 76.72 Favored Pre-proline 0 CA--C 1.562 1.422 0 N-CA-C 113.174 0.805 . . . . 71.140000000000001 113.174 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.453 ' HD3' HD23 ' A' ' 112' ' ' LEU . 33.3 Cg_endo -70.32 -29.08 21.74 Favored 'Trans proline' 0 C--N 1.361 1.213 0 CA-C-N 120.887 1.353 . . . . 74.409999999999997 110.132 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -67.95 -35.52 78.55 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.404 -0.816 . . . . 62.149999999999999 110.438 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -75.62 -19.29 59.31 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 109.783 -0.451 . . . . 75.129999999999995 109.783 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.01 -20.89 63.25 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 116.171 -0.468 . . . . 75.109999999999999 110.159 -177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -58.4 -57.14 14.23 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.234 -0.654 . . . . 72.409999999999997 109.234 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.4 ttp -53.79 -51.25 64.06 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 115.633 -0.712 . . . . 74.430000000000007 110.162 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -55.67 -41.51 73.77 Favored 'General case' 0 C--O 1.251 1.178 0 CA-C-N 114.954 -1.021 . . . . 65.25 111.272 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.3 p -65.9 -25.27 67.08 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.187 -0.605 . . . . 75.25 111.675 -171.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.74 -26.59 68.72 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 121.228 0.537 . . . . 72.129999999999995 110.518 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.37 -12.58 15.3 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 120.235 -0.586 . . . . 45.030000000000001 111.185 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.0 -29.16 9.59 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 114.295 1.22 . . . . 75.400000000000006 114.295 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.61 20.88 76.02 Favored Glycine 0 C--O 1.243 0.686 0 C-N-CA 120.535 -0.841 . . . . 24.440000000000001 111.491 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 125' ' ' ALA . 34.7 m -96.68 156.41 3.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.153 -0.523 . . . . 53.329999999999998 111.547 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -132.1 122.19 25.0 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.253 -1.388 . . . . 62.200000000000003 107.253 176.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -124.08 123.36 40.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.064 0.393 . . . . 74.5 111.952 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.9 t -104.53 125.01 50.29 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 107.183 -1.414 . . . . 63.450000000000003 107.183 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.59 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 48.7 tp -128.72 123.08 32.14 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.162 -0.681 . . . . 75.420000000000002 109.162 -178.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.59 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 3.2 mpt_? -135.7 146.5 47.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.853 -0.425 . . . . 64.540000000000006 109.853 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.63 ' HG3' HG22 ' A' ' 119' ' ' VAL . 3.3 ttt180 -99.39 138.11 36.95 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 108.057 -1.09 . . . . 73.299999999999997 108.057 174.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -123.8 83.74 2.18 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.96 -1.496 . . . . 64.319999999999993 106.96 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.75 -122.61 22.69 Favored Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 114.137 -1.392 . . . . 54.200000000000003 110.97 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -75.74 -20.53 58.24 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 123.932 0.893 . . . . 72.140000000000001 110.617 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.531 HG22 ' HG2' ' A' ' 177' ' ' ARG . 0.8 OUTLIER -102.58 149.08 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 119.287 -0.965 . . . . 62.100000000000001 110.403 -172.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.63 HG22 ' HG3' ' A' ' 114' ' ' ARG . 59.4 t -117.73 139.81 43.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.784 -0.45 . . . . 74.030000000000001 109.784 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.3 pt -126.03 135.18 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 CA-C-O 121.709 0.766 . . . . 73.340000000000003 110.584 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.29 128.88 47.83 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 107.363 -1.347 . . . . 74.140000000000001 107.363 174.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.79 114.59 12.78 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 105.783 -1.932 . . . . 70.430000000000007 105.783 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.08 160.52 27.16 Favored Glycine 0 N--CA 1.41 -3.083 0 N-CA-C 110.925 -0.87 . . . . 55.350000000000001 110.925 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.469 ' HG2' HG22 ' A' ' 171' ' ' THR . 64.3 mtt180 -141.01 150.47 43.07 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.59 -1.263 . . . . 73.209999999999994 107.59 -176.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 108' ' ' VAL . . . -121.41 128.83 52.59 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.957 -0.386 . . . . 70.349999999999994 109.957 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -111.83 93.56 4.52 Favored 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 118.716 -1.194 . . . . 70.209999999999994 109.991 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.494 ' O ' HG22 ' A' ' 130' ' ' VAL . 1.9 pt? -123.26 15.52 9.78 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 113.926 -1.488 . . . . 71.420000000000002 107.482 176.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.43 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 0.2 OUTLIER -65.27 -47.43 76.71 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 113.409 -1.723 . . . . 73.219999999999999 109.01 177.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.9 t -87.99 14.9 8.05 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.472 -0.785 . . . . 43.310000000000002 112.589 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 127' ' ' LEU . 32.6 m -76.38 173.46 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 119.257 -0.977 . . . . 65.409999999999997 109.702 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.2 t -112.36 14.29 20.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.19 0.519 . . . . 61.329999999999998 109.622 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -118.55 99.17 51.49 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 116.034 -0.53 . . . . 71.510000000000005 109.955 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -76.37 -12.13 18.94 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.152 2.568 . . . . 61.210000000000001 113.753 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -102.25 0.43 34.37 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.545 0.688 . . . . 73.019999999999996 110.33 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.01 145.23 55.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 70.430000000000007 111.921 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 26.8 t70 -132.34 118.05 18.93 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.852 -0.613 . . . . 62.310000000000002 109.972 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 97.6 t -116.57 133.96 61.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.004 -1.11 . . . . 54.530000000000001 108.004 175.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -138.9 138.96 37.88 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.47 -0.567 . . . . 71.530000000000001 109.47 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 tt -133.42 128.23 35.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.061 -1.459 . . . . 72.129999999999995 107.061 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.0 m -126.21 134.21 51.3 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.694 -0.854 . . . . 71.140000000000001 108.694 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 57.6 t -129.02 125.22 62.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.636 -0.505 . . . . 74.129999999999995 109.636 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.08 128.39 56.48 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.008 -0.738 . . . . 75.409999999999997 109.008 177.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 3.4 p90 -134.46 129.67 19.69 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 112.917 0.71 . . . . 73.340000000000003 112.917 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 20.9 Cg_exo -71.86 49.47 1.25 Allowed 'Trans proline' 0 CA--C 1.551 1.363 0 C-N-CA 123.317 2.678 . . . . 74.140000000000001 111.286 172.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.69 -133.78 0.13 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.241 -1.392 . . . . 73.340000000000003 107.241 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -161.88 135.13 6.24 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.027 -1.472 . . . . 51.329999999999998 107.027 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.18 127.65 41.75 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.117 0.484 . . . . 64.319999999999993 110.356 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.4 t -88.08 -37.53 16.18 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.883 -0.414 . . . . 74.219999999999999 109.883 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.1 m -152.6 133.27 13.9 Favored 'General case' 0 C--O 1.203 -1.345 0 N-CA-C 109.561 -0.533 . . . . 74.329999999999998 109.561 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -139.36 161.93 36.24 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 121.95 -0.469 . . . . 72.439999999999998 109.79 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.61 91.18 2.96 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 104.47 -2.418 . . . . 75.099999999999994 104.47 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.8 -147.47 8.76 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 109.296 -1.522 . . . . 23.420000000000002 109.296 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -119.66 99.82 6.89 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.62 -0.881 . . . . 74.239999999999995 108.62 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 12.4 ptt180 -82.11 129.49 34.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 119.513 -0.875 . . . . 73.340000000000003 111.981 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.9 mt -83.71 -42.36 17.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.351 -1.351 . . . . 73.140000000000001 107.351 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -138.71 167.2 20.37 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 106.646 -1.613 . . . . 74.140000000000001 106.646 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.54 0.14 8.51 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.095 1.864 . . . . 74.450000000000003 111.504 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -128.4 3.91 5.67 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.337 0.589 . . . . 71.140000000000001 111.008 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 65.8 t -145.13 120.59 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.377 -0.971 . . . . 74.349999999999994 108.377 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 40.9 t -123.94 149.83 28.18 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.432 -0.581 . . . . 74.140000000000001 109.432 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -136.23 143.64 44.44 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 109.131 -0.692 . . . . 65.25 109.131 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -122.17 130.27 53.06 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 109.65 -0.5 . . . . 71.099999999999994 109.65 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.37 111.64 24.07 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.433 -0.951 . . . . 40.399999999999999 108.433 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.7 mm? -94.81 122.33 37.32 Favored 'General case' 0 C--O 1.276 2.461 0 CA-C-N 114.726 -1.125 . . . . 54.530000000000001 107.966 -177.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -117.08 130.94 24.25 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 114.637 -1.165 . . . . 73.329999999999998 110.293 -170.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.404 ' HA ' ' HG ' ' A' ' 127' ' ' LEU . 42.4 Cg_endo -67.57 155.37 70.46 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.328 2.685 . . . . 75.230000000000004 112.576 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 73.01 -14.6 2.72 Favored Glycine 0 N--CA 1.466 0.652 0 CA-C-N 115.805 -0.634 . . . . 64.040000000000006 113.796 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.9 m -120.81 162.83 19.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.447 -0.946 . . . . 70.329999999999998 108.447 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.1 p -99.25 128.3 51.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.32 0.581 . . . . 60.32 110.353 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 14.3 m -116.8 137.73 52.0 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.127 -1.064 . . . . 54.399999999999999 108.127 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 124' ' ' ARG . 20.6 p -116.09 148.03 40.68 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 110.086 -0.338 . . . . 72.129999999999995 110.086 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.432 ' SD ' HD11 ' A' ' 164' ' ' LEU . 2.7 mpp? -126.83 116.84 21.5 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.147 -0.686 . . . . 72.010000000000005 109.147 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.0 t -132.42 138.25 47.58 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.953 -1.128 . . . . 70.109999999999999 107.953 175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -145.56 120.66 10.1 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.243 -1.021 . . . . 62.409999999999997 108.243 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -125.17 130.19 51.65 Favored 'General case' 0 C--N 1.272 -2.798 0 N-CA-C 107.204 -1.406 . . . . 62.450000000000003 107.204 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -155.89 153.92 30.42 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.85 -0.796 . . . . 62.439999999999998 108.85 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.531 ' HG2' HG22 ' A' ' 118' ' ' ILE . 60.1 mtt180 -88.19 132.52 34.32 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.94 -0.763 . . . . 61.399999999999999 108.94 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -135.87 129.85 32.96 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 109.282 -0.636 . . . . 74.530000000000001 109.282 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.78 104.21 0.14 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.943 0.777 . . . . 70.099999999999994 111.91 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -66.62 130.37 94.08 Favored Pre-proline 0 CA--C 1.503 -0.842 0 CA-C-N 114.879 -1.055 . . . . 65.450000000000003 109.238 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.64 -40.0 10.93 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.212 1.942 . . . . 61.119999999999997 112.214 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -9.19 58.84 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 123.684 0.794 . . . . 75.299999999999997 111.704 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.337 50.9 p 65.2 68.83 0.49 Allowed 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 116.612 2.079 . . . . 71.430000000000007 116.612 172.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -85.89 151.09 24.06 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.574 -1.639 . . . . 73.120000000000005 106.574 168.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 C--N 1.296 -1.752 0 N-CA-C 109.709 -0.478 . . . . 74.219999999999999 109.709 -179.235 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.713 0 N-CA-C 109.391 -1.483 . . . . 43.049999999999997 109.391 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -97.19 83.76 3.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.193 -0.669 . . . . 63.340000000000003 109.193 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.35 161.21 31.14 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.185 -0.916 . . . . 74.010000000000005 110.141 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -91.22 111.34 22.77 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.712 0.768 . . . . 60.299999999999997 109.72 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 mp -96.09 98.75 10.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.246 -1.02 . . . . 54.210000000000001 108.246 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -91.96 119.08 31.37 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.563 -0.855 . . . . 62.439999999999998 109.943 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -68.5 138.52 55.27 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.831 -0.803 . . . . 70.099999999999994 108.831 176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -103.91 130.59 51.53 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.68 -0.859 . . . . 74.319999999999993 108.68 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.75 158.65 34.75 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.877 -0.602 . . . . 62.450000000000003 111.599 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -138.43 119.05 13.96 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.261 -1.385 . . . . 74.150000000000006 107.261 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 17.6 ptp -150.45 138.15 19.87 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.13 -0.628 . . . . 72.540000000000006 111.348 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 26' ' ' LEU . 2.1 pt? -118.5 109.58 16.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.089 -1.448 . . . . 75.510000000000005 107.089 171.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.01 123.83 49.75 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.42 -1.326 . . . . 63.0 107.42 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.75 122.77 47.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 C-N-CA 119.546 -0.862 . . . . 75.219999999999999 112.058 -175.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -110.22 134.82 51.85 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.336 -0.987 . . . . 71.140000000000001 108.336 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.25 108.8 12.1 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.565 -0.902 . . . . 63.310000000000002 108.565 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.8 p -116.7 115.05 24.92 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.295 -1.002 . . . . 62.109999999999999 108.295 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.83 146.63 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 121.154 0.502 . . . . 71.120000000000005 109.813 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 87.4 m -126.31 127.8 46.12 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 109.678 -0.49 . . . . 75.109999999999999 109.678 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -110.47 118.26 56.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.61 -0.723 . . . . 72.310000000000002 109.852 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.2 m -84.71 155.16 62.0 Favored Pre-proline 0 C--N 1.296 -1.741 0 CA-C-N 115.446 -0.797 . . . . 75.209999999999994 109.683 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.63 0.68 4.51 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 123.225 2.616 . . . . 64.019999999999996 112.142 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.58 0.32 43.34 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 124.348 1.059 . . . . 53.119999999999997 109.831 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.9 t70 70.27 29.71 3.57 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 123.29 1.519 . . . . 74.049999999999997 107.073 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.75 138.86 52.38 Favored 'General case' 0 N--CA 1.407 -2.595 0 CA-C-N 113.02 -1.9 . . . . 74.219999999999999 107.959 -174.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.645 HG11 HD23 ' A' ' 95' ' ' LEU . 22.7 t -120.32 140.26 44.98 Favored 'Isoleucine or valine' 0 C--O 1.259 1.564 0 CA-C-O 121.052 0.453 . . . . 63.219999999999999 109.977 -176.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.1 p -147.33 142.88 27.58 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.629 -0.878 . . . . 52.340000000000003 108.629 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.86 -169.06 40.33 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 119.33 -1.414 . . . . 71.430000000000007 112.677 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -151.11 133.8 15.66 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.125 0.488 . . . . 71.349999999999994 110.661 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.3 mt -116.72 116.17 51.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.456 -1.313 . . . . 74.219999999999999 107.456 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.04 114.84 47.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.763 -0.458 . . . . 70.430000000000007 109.763 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -107.61 108.68 20.07 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.364 -1.347 . . . . 61.340000000000003 107.364 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.62 119.36 32.64 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.7 0.762 . . . . 74.439999999999998 110.244 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.68 145.64 37.63 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.649 -0.705 . . . . 65.400000000000006 110.164 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -80.27 114.74 49.54 Favored Pre-proline 0 N--CA 1.42 -1.948 0 N-CA-C 102.999 -2.963 . . . . 71.409999999999997 102.999 171.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -31.64 104.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 124.926 3.751 . . . . 74.019999999999996 114.615 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -84.64 -25.93 28.19 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.488 0.661 . . . . 74.200000000000003 109.983 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -104.41 129.76 52.35 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.096 -1.076 . . . . 72.239999999999995 108.096 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 m -63.8 -27.85 69.46 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 123.383 0.673 . . . . 51.329999999999998 111.756 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -87.08 -8.82 56.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.113 0.482 . . . . 72.200000000000003 110.359 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -88.93 120.06 30.0 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.631 0.729 . . . . 75.430000000000007 112.585 -169.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -121.85 7.34 9.88 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 114.614 -1.175 . . . . 71.099999999999994 109.818 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.14 97.69 0.11 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 119.908 -1.139 . . . . 43.240000000000002 112.936 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.68 153.3 26.27 Favored 'Trans proline' 0 C--O 1.241 0.646 0 C-N-CA 123.216 2.611 . . . . 44.43 111.461 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -113.38 157.28 22.08 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.598 -0.519 . . . . 54.409999999999997 109.598 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.467 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 65.1 mt -88.81 135.76 33.36 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.857 -0.423 . . . . 42.240000000000002 109.857 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.53 87.41 3.82 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.852 -0.613 . . . . 73.230000000000004 110.059 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.488 ' HA3' ' HG3' ' A' ' 101' ' ' MET . . . -161.82 156.6 28.18 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 110.885 -0.886 . . . . 71.439999999999998 110.885 176.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -144.22 129.08 18.39 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.102 -0.703 . . . . 61.340000000000003 109.102 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.06 147.56 61.21 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.458 -0.571 . . . . 72.430000000000007 109.458 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.15 -8.99 21.88 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.203 2.602 . . . . 70.420000000000002 113.215 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -110.45 42.23 1.61 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.428 0.632 . . . . 65.319999999999993 110.286 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 m -57.97 -34.6 70.12 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.605 -0.725 . . . . 63.520000000000003 110.945 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -71.27 -9.16 57.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.266 0.555 . . . . 62.030000000000001 110.851 -177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.28 -17.29 17.37 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.793 -0.639 . . . . 74.340000000000003 110.019 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 p -130.39 118.1 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.912 0.863 . . . . 75.140000000000001 111.015 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.89 112.41 24.18 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.035 -0.984 . . . . 75.019999999999996 109.151 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.0 t -98.16 130.52 46.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 106.949 -1.501 . . . . 64.310000000000002 106.949 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.9 t -144.04 172.7 12.52 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.112 0.482 . . . . 65.140000000000001 110.792 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -80.19 141.74 35.36 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 124.874 1.27 . . . . 64.310000000000002 109.323 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -119.76 120.14 35.69 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.635 -0.876 . . . . 72.519999999999996 108.635 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -138.7 103.99 4.98 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.655 -0.868 . . . . 75.010000000000005 108.655 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.2 t -164.75 142.25 6.35 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.705 -0.398 . . . . 73.040000000000006 110.692 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 65.24 13.54 8.83 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.391 1.476 . . . . 70.420000000000002 112.223 174.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.41 -3.11 59.47 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.865 -0.683 . . . . 72.299999999999997 111.908 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -99.84 148.04 24.86 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.856 -0.794 . . . . 75.530000000000001 108.856 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.23 136.76 59.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.328 -0.99 . . . . 75.420000000000002 108.328 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -166.03 -154.69 8.34 Favored Glycine 0 N--CA 1.413 -2.834 0 C-N-CA 120.112 -1.042 . . . . 70.409999999999997 112.478 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.467 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 6.7 m -126.08 148.37 49.37 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.888 -0.782 . . . . 64.019999999999996 108.888 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -129.81 132.14 46.4 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 120.556 -0.457 . . . . 73.319999999999993 110.363 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -110.78 113.92 26.88 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.702 -1.592 . . . . 73.420000000000002 106.702 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.68 112.36 39.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.732 -0.84 . . . . 72.340000000000003 108.732 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.484 ' HE2' HG12 ' A' ' 40' ' ' VAL . 45.3 p90 -120.02 152.8 36.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.292 0.567 . . . . 61.100000000000001 111.633 -173.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.6 p -159.73 157.38 29.35 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.276 -0.874 . . . . 72.329999999999998 109.727 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 67.28 31.69 6.41 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.592 1.157 . . . . 53.340000000000003 110.295 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.459 HD12 ' CD2' ' A' ' 87' ' ' PHE . 30.1 mt -96.23 164.44 12.67 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.813 -0.631 . . . . 65.150000000000006 110.091 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.2 m -107.79 160.22 15.89 Favored 'General case' 0 N--CA 1.389 -3.519 0 N-CA-C 109.392 -0.596 . . . . 64.209999999999994 109.392 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -49.91 -43.15 49.44 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.192 1.397 . . . . 74.129999999999995 110.628 176.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.39 -30.45 71.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.865 -0.607 . . . . 65.310000000000002 111.441 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -82.91 -15.44 51.39 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.792 -0.64 . . . . 74.239999999999995 111.589 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.645 HD23 HG11 ' A' ' 40' ' ' VAL . 2.5 tm? -54.03 -56.2 28.35 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 123.056 0.542 . . . . 75.019999999999996 111.269 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.78 -36.13 75.37 Favored 'Trans proline' 0 C--N 1.371 1.723 0 CA-C-N 120.61 1.254 . . . . 61.409999999999997 111.072 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.433 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 23.6 mt-30 -62.8 -37.41 86.59 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.691 -0.686 . . . . 72.239999999999995 111.818 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -75.54 -20.41 58.7 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.184 0.516 . . . . 61.100000000000001 110.045 177.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.49 -20.21 57.2 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.717 -0.674 . . . . 45.140000000000001 109.537 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 97' ' ' GLN . 87.7 m-20 -62.77 -55.06 29.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.85 -0.613 . . . . 75.340000000000003 110.114 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.488 ' HG3' ' HA3' ' A' ' 62' ' ' GLY . 24.3 ttp -53.97 -51.27 64.41 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.167 0.292 . . . . 72.409999999999997 110.72 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -58.66 -35.27 72.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.846 -0.615 . . . . 73.439999999999998 110.429 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.4 t -59.86 -39.86 86.65 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.015 -0.735 . . . . 71.310000000000002 109.015 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -63.22 -25.24 68.24 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 115.339 -0.846 . . . . 72.340000000000003 110.943 -172.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.11 -20.09 13.52 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 119.949 -0.7 . . . . 65.219999999999999 111.591 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.19 -42.1 5.17 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 114.237 1.199 . . . . 74.109999999999999 114.237 -169.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.97 25.76 18.81 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.635 -0.986 . . . . 52.43 110.635 -172.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.2 m -109.34 157.26 9.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.68 -0.489 . . . . 73.239999999999995 109.68 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -142.66 128.26 19.13 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.803 -0.814 . . . . 74.510000000000005 108.803 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -130.03 128.98 43.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.581 0.229 . . . . 63.009999999999998 110.664 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.8 m -118.05 134.19 55.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.301 -1.0 . . . . 74.040000000000006 108.301 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.469 HD22 ' HG ' ' A' ' 95' ' ' LEU . 53.2 tp -133.13 123.4 25.61 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.188 -0.671 . . . . 52.210000000000001 109.188 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.3 mtp180 -134.23 153.02 52.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.155 0.502 . . . . 74.019999999999996 111.703 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.502 HH11 ' HB2' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -106.4 122.11 45.61 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 124.33 1.052 . . . . 71.019999999999996 108.935 179.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.421 ' O ' HG13 ' A' ' 118' ' ' ILE . 6.8 t30 -118.14 101.23 8.07 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.779 -1.193 . . . . 64.219999999999999 107.779 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.34 -120.06 7.52 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 108.441 -1.864 . . . . 72.439999999999998 108.441 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.28 -2.07 22.76 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.718 -1.216 . . . . 43.420000000000002 107.718 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -100.28 148.96 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 C-N-CA 119.37 -0.932 . . . . 63.109999999999999 109.068 -175.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.71 140.5 40.57 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-O 120.793 0.33 . . . . 73.409999999999997 111.18 -175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.3 pt -119.79 135.37 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.624 -0.717 . . . . 73.209999999999994 109.36 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.79 127.07 45.57 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.542 -0.754 . . . . 74.019999999999996 109.39 177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.29 122.24 31.15 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.202 -0.908 . . . . 74.549999999999997 108.95 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -136.35 146.65 18.63 Favored Glycine 0 N--CA 1.422 -2.277 0 N-CA-C 110.573 -1.011 . . . . 73.219999999999999 110.573 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -139.55 144.58 37.89 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.174 -0.676 . . . . 75.310000000000002 109.174 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.48 118.82 22.72 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.046 -0.724 . . . . 73.439999999999998 109.046 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -102.35 94.04 5.49 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.768 -0.773 . . . . 62.329999999999998 111.421 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.71 16.87 13.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.984 -1.487 . . . . 72.109999999999999 106.984 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.492 ' O ' ' HA2' ' A' ' 167' ' ' GLY . 1.3 m -60.74 -30.97 70.31 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.778 1.631 . . . . 52.130000000000003 112.733 -174.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.0 m -80.99 0.63 34.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.179 0.514 . . . . 72.120000000000005 110.073 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.5 t 65.67 75.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 125.32 1.448 . . . . 74.239999999999995 110.451 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.9 m -63.16 -42.69 99.46 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.606 -1.179 . . . . 63.32 108.701 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -150.38 132.99 8.24 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 106.045 -1.835 . . . . 74.319999999999993 106.045 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.41 -19.96 18.85 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.061 1.841 . . . . 73.150000000000006 114.613 -175.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -108.22 13.02 26.14 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.614 0.721 . . . . 74.239999999999995 109.835 -173.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.45 129.49 38.92 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.741 -0.663 . . . . 75.439999999999998 110.754 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -131.73 111.65 11.84 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.695 -1.224 . . . . 73.329999999999998 107.695 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.717 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 49.2 t -111.94 127.66 68.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.956 -0.757 . . . . 62.219999999999999 108.956 -177.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -112.07 121.25 44.47 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.337 -0.616 . . . . 75.439999999999998 109.337 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.441 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.3 tm? -115.29 116.31 28.09 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.593 -1.262 . . . . 75.439999999999998 107.593 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.6 m -126.44 130.77 51.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 110.133 -0.321 . . . . 61.229999999999997 110.133 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.5 t -123.65 125.77 71.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.464 -0.569 . . . . 74.030000000000001 109.464 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.3 131.16 56.62 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.028 -0.73 . . . . 73.420000000000002 109.028 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.689 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.3 p90 -134.31 122.93 16.29 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.406 -0.361 . . . . 71.239999999999995 110.918 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -69.02 47.4 0.44 Allowed 'Trans proline' 0 CA--C 1.56 1.819 0 C-N-CA 123.008 2.472 . . . . 71.019999999999996 112.297 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -132.86 -108.13 0.24 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 122.823 0.449 . . . . 64.140000000000001 110.538 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.21 131.19 0.14 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.722 -0.844 . . . . 75.430000000000007 108.722 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.412 HG21 ' HB ' ' A' ' 150' ' ' THR . 8.4 p -85.09 128.73 38.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.14 -0.689 . . . . 73.239999999999995 109.14 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.0 t -88.62 -36.04 16.5 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.246 -0.434 . . . . 62.420000000000002 110.012 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.5 m -157.71 133.03 8.9 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 108.938 -0.764 . . . . 52.399999999999999 108.938 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.412 ' HB ' HG21 ' A' ' 147' ' ' VAL . 9.9 t -138.92 165.39 27.19 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 121.98 -0.45 . . . . 73.329999999999998 109.824 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 45.4 t30 -137.05 93.43 2.83 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 105.585 -2.006 . . . . 65.25 105.585 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.81 -147.0 10.45 Favored Glycine 0 N--CA 1.416 -2.67 0 N-CA-C 109.045 -1.622 . . . . 41.229999999999997 109.045 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -111.79 100.06 8.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.251 -0.648 . . . . 55.130000000000003 109.251 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -78.28 115.75 18.22 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.965 0.412 . . . . 71.439999999999998 110.684 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.0 mt -82.21 -48.99 17.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.217 -1.401 . . . . 73.239999999999995 107.217 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -130.92 159.74 70.0 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 107.095 -1.446 . . . . 74.319999999999993 107.095 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.404 ' O ' HG12 ' A' ' 147' ' ' VAL . 32.4 Cg_exo -62.74 -13.49 34.54 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.375 2.05 . . . . 54.229999999999997 112.187 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.689 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -122.39 8.0 9.62 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 112.816 0.673 . . . . 65.319999999999993 112.816 176.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.8 t -140.73 120.93 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 109.61 -0.515 . . . . 63.25 109.61 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.28 147.58 31.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.707 -0.479 . . . . 74.209999999999994 109.707 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -132.47 149.8 52.27 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.097 0.475 . . . . 55.100000000000001 109.898 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.462 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 23.8 m-90 -131.65 133.27 44.73 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.323 -1.362 . . . . 73.239999999999995 107.323 174.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -107.09 114.74 28.99 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.974 -0.75 . . . . 74.109999999999999 108.974 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.717 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.6 mp -88.9 125.57 35.0 Favored 'General case' 0 C--O 1.273 2.309 0 CA-C-N 114.212 -1.358 . . . . 75.340000000000003 110.572 -173.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 96.2 mttt -118.59 147.15 41.42 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 113.304 -1.771 . . . . 71.030000000000001 110.771 -171.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 165' ' ' LYS . 2.7 Cg_exo -76.39 159.31 36.39 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.437 2.091 . . . . 71.310000000000002 112.356 174.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 128' ' ' THR . . . 74.06 -14.72 3.62 Favored Glycine 0 N--CA 1.477 1.385 0 C-N-CA 123.136 0.398 . . . . 64.230000000000004 113.822 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.33 145.43 26.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.229 -1.026 . . . . 61.130000000000003 108.229 171.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.4 110.06 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 108.42 -0.956 . . . . 60.020000000000003 108.42 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.6 m -76.84 130.7 37.98 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.375 -0.83 . . . . 62.340000000000003 108.93 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.6 p -115.84 125.73 53.04 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 115.623 -0.717 . . . . 72.239999999999995 110.129 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -112.33 117.07 31.46 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.989 -1.115 . . . . 71.540000000000006 107.989 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 13.7 m -135.48 137.05 41.76 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.426 -1.31 . . . . 70.409999999999997 110.411 176.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -149.43 135.25 18.74 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.566 -0.901 . . . . 61.43 108.566 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -131.38 130.01 42.06 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 107.127 -1.435 . . . . 64.329999999999998 107.127 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -153.57 159.82 42.29 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.622 -0.881 . . . . 62.530000000000001 108.622 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 40.0 mtt180 -95.32 127.18 41.16 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.388 -0.925 . . . . 64.409999999999997 108.946 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -130.37 127.86 40.24 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.164 -1.05 . . . . 74.219999999999999 108.164 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.29 104.74 0.1 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 124.83 1.331 . . . . 64.150000000000006 112.675 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.11 138.87 96.0 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 114.684 -1.144 . . . . 64.5 111.728 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.59 -40.72 1.39 Allowed 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 122.801 2.334 . . . . 71.010000000000005 114.276 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.06 -13.43 53.13 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.432 0.634 . . . . 55.420000000000002 109.39 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.462 64.4 p 81.32 68.89 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 126.972 2.109 . . . . 62.43 115.294 172.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -97.15 154.77 17.16 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 113.26 -1.791 . . . . 62.229999999999997 108.464 171.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--N 1.297 -1.683 0 N-CA-C 107.589 -1.263 . . . . 41.450000000000003 107.589 178.807 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.105 0 N-CA-C 109.473 -1.451 . . . . 43.049999999999997 109.473 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 61.35 15.05 6.2 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 117.609 0.704 . . . . 74.030000000000001 112.28 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -97.94 85.92 3.62 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 122.151 0.977 . . . . 63.229999999999997 111.289 -172.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -118.18 95.46 4.9 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.727 -1.212 . . . . 73.219999999999999 107.727 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -133.51 135.85 44.68 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.404 -0.816 . . . . 74.310000000000002 109.922 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -139.45 127.37 22.19 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.042 -0.725 . . . . 71.299999999999997 109.042 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.48 ' HB3' ' O ' ' A' ' 51' ' ' LYS . 73.6 m-85 -127.55 102.53 6.89 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.073 -1.084 . . . . 75.209999999999994 108.073 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -113.34 107.95 16.57 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.136 -0.484 . . . . 61.420000000000002 111.186 -173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.79 69.46 0.25 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.863 -0.684 . . . . 63.030000000000001 113.08 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.402 ' O ' ' HB3' ' A' ' 132' ' ' ASP . 87.4 m-70 -111.28 26.67 10.43 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 122.148 0.975 . . . . 73.549999999999997 110.395 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.407 ' SD ' ' HE2' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -107.34 103.37 12.71 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.059 -1.83 . . . . 45.340000000000003 106.059 175.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.2 tp -122.68 116.23 23.43 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.021 -0.733 . . . . 74.019999999999996 109.021 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -109.81 123.93 50.42 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 108.0 -1.111 . . . . 62.350000000000001 108.0 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.9 t -107.26 114.72 46.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.398 -0.964 . . . . 63.530000000000001 108.398 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -112.25 113.15 25.23 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.422 -0.955 . . . . 64.409999999999997 108.422 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.16 108.63 14.02 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.052 -1.092 . . . . 52.530000000000001 108.052 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 140' ' ' THR . 20.2 m -122.11 114.32 20.74 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.125 -0.694 . . . . 72.129999999999995 109.125 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.5 pt -126.61 148.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 O-C-N 121.891 -0.506 . . . . 75.530000000000001 109.84 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.2 m -127.92 119.93 26.6 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 116.089 -0.505 . . . . 73.319999999999993 109.783 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.598 HG23 ' OH ' ' A' ' 178' ' ' TYR . 8.7 tt -104.41 125.62 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 108.64 -0.874 . . . . 72.230000000000004 108.64 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.7 m -94.66 152.65 40.02 Favored Pre-proline 0 C--N 1.281 -2.383 0 CA-C-N 115.754 -0.657 . . . . 42.119999999999997 109.557 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.93 2.56 0.57 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 123.934 3.089 . . . . 61.240000000000002 113.475 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 33.5 t70 -82.0 -7.55 59.62 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.425 1.09 . . . . 71.430000000000007 109.582 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.0 t70 73.16 28.69 1.83 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 123.374 1.559 . . . . 72.219999999999999 107.269 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -111.34 132.16 54.61 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.296 -1.774 . . . . 75.409999999999997 109.148 178.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.95 143.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.116 -0.698 . . . . 73.430000000000007 109.116 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 p -149.69 155.24 39.88 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.052 -1.462 . . . . 61.140000000000001 107.052 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.84 -174.59 44.06 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 118.287 -1.911 . . . . 73.5 114.343 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.38 133.26 36.57 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 124.327 1.051 . . . . 73.329999999999998 108.721 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.9 mt -119.89 115.54 47.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 105.663 -1.977 . . . . 73.120000000000005 105.663 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.8 mt -126.45 114.74 39.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 109.671 -0.492 . . . . 73.400000000000006 109.671 -172.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.02 109.27 19.3 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.391 -1.337 . . . . 74.120000000000005 107.391 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -119.69 126.47 51.19 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 120.453 -0.499 . . . . 65.340000000000003 111.53 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.9 157.35 27.83 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.531 -0.759 . . . . 60.439999999999998 109.316 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -83.44 126.35 71.72 Favored Pre-proline 0 C--N 1.288 -2.095 0 N-CA-C 106.999 -1.482 . . . . 74.510000000000005 106.999 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -33.57 111.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 124.806 3.671 . . . . 62.149999999999999 113.49 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 21' ' ' PHE . 59.7 pttt -91.26 -6.64 52.95 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.775 -0.648 . . . . 75.129999999999995 112.658 -173.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -155.84 159.63 39.54 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.329 -0.989 . . . . 72.439999999999998 108.329 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.6 p -57.27 -43.11 82.79 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 123.93 0.892 . . . . 35.039999999999999 111.975 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -90.56 -1.24 57.88 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.943 -0.571 . . . . 53.219999999999999 111.886 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.28 99.53 5.54 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.3 -0.629 . . . . 72.409999999999997 109.3 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 p -116.81 -19.44 9.89 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.304 -0.862 . . . . 52.020000000000003 112.94 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.61 98.03 0.11 Allowed Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 120.196 -1.002 . . . . 54.450000000000003 112.148 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 83' ' ' SER . 67.9 Cg_exo -54.87 159.19 9.65 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.802 2.335 . . . . 75.430000000000007 111.368 173.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.99 157.11 21.1 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.923 -0.486 . . . . 63.520000000000003 111.027 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 81.6 mt -109.9 139.12 45.35 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.82 -0.807 . . . . 71.010000000000005 108.82 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -108.27 98.78 8.27 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.097 -1.075 . . . . 64.340000000000003 108.097 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.5 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -109.63 95.96 0.92 Allowed Glycine 0 C--N 1.283 -2.386 0 CA-C-N 115.109 -0.95 . . . . 52.450000000000003 112.531 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -87.01 89.39 7.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.235 -1.024 . . . . 70.409999999999997 108.235 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.39 154.13 78.35 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 109.47 -0.567 . . . . 74.510000000000005 109.47 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.22 -28.67 18.31 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.325 2.017 . . . . 73.430000000000007 112.152 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -91.21 38.23 0.96 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.746 -0.661 . . . . 74.409999999999997 112.07 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.73 -45.07 58.43 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 124.523 1.129 . . . . 75.109999999999999 113.535 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -12.13 60.77 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 121.051 0.453 . . . . 73.040000000000006 111.099 -174.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 88' ' ' SER . 69.1 mmtt -93.35 -9.61 38.19 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-N 116.198 -0.455 . . . . 52.020000000000003 110.115 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -115.41 118.52 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 C-N-CA 118.518 -1.273 . . . . 74.329999999999998 110.063 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.44 102.6 14.4 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.998 -1.001 . . . . 64.239999999999995 108.871 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.7 t -98.27 135.74 31.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.462 -1.31 . . . . 71.099999999999994 107.462 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 t -155.52 171.87 19.21 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.693 -0.854 . . . . 33.539999999999999 108.693 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -83.58 142.78 30.59 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.689 -0.856 . . . . 71.439999999999998 108.689 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -99.06 122.38 42.22 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.313 -0.995 . . . . 74.340000000000003 108.313 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -138.99 99.62 3.82 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.187 -0.672 . . . . 53.439999999999998 109.187 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.2 t -172.88 149.74 1.97 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.612 -0.514 . . . . 62.549999999999997 109.612 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.91 16.2 8.83 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.393 1.077 . . . . 63.520000000000003 111.674 173.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.5 1.55 85.68 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.442 -0.663 . . . . 64.420000000000002 111.442 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.493 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 91.8 m-85 -104.29 145.51 30.12 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 109.5 -0.556 . . . . 71.420000000000002 109.5 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.2 136.67 60.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.797 -1.186 . . . . 53.329999999999998 107.797 173.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -165.47 -154.97 8.34 Favored Glycine 0 C--N 1.27 -3.115 0 C-N-CA 119.65 -1.262 . . . . 64.420000000000002 111.638 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.527 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 21.2 p -123.84 143.23 50.46 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 109.604 -0.517 . . . . 71.329999999999998 109.604 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -138.37 142.59 39.63 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 120.406 -0.518 . . . . 74.430000000000007 110.954 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.37 114.9 18.83 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.197 -1.038 . . . . 34.409999999999997 108.197 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -105.97 115.0 46.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 108.62 -0.881 . . . . 74.5 108.62 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -118.34 154.43 32.36 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 120.393 -0.523 . . . . 74.140000000000001 110.938 -175.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 80.8 p -157.53 171.35 20.51 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 109.335 -0.617 . . . . 64.209999999999994 109.335 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 62.15 30.59 17.78 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.438 1.087 . . . . 75.219999999999999 110.62 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt -101.15 164.24 11.89 Favored 'General case' 0 N--CA 1.42 -1.926 0 C-N-CA 120.165 -0.614 . . . . 62.329999999999998 111.116 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -113.04 170.79 7.95 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 109.235 -0.654 . . . . 73.510000000000005 109.235 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -54.57 -38.25 66.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.407 1.083 . . . . 74.409999999999997 111.746 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.51 65.46 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.236 -0.438 . . . . 72.439999999999998 111.876 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -86.46 -16.51 36.86 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.904 0.383 . . . . 55.32 111.665 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.7 tt -62.35 -47.71 88.8 Favored Pre-proline 0 CA--C 1.569 1.685 0 CA-C-N 116.236 -0.438 . . . . 75.349999999999994 111.378 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.55 -40.15 76.63 Favored 'Trans proline' 0 C--N 1.38 2.232 0 CA-C-N 120.831 1.333 . . . . 72.329999999999998 110.768 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -61.16 -41.8 97.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.236 -0.893 . . . . 73.519999999999996 111.534 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -72.36 -20.39 61.47 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.376 -0.375 . . . . 62.439999999999998 110.635 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.01 -26.13 60.27 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.21 -0.663 . . . . 73.030000000000001 109.21 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -62.87 -52.06 64.57 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.58 -0.896 . . . . 62.130000000000003 108.58 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.5 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 32.2 ttp -53.89 -51.59 63.2 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-N 115.478 -0.783 . . . . 72.420000000000002 109.78 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -55.22 -35.0 64.44 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.192 -0.913 . . . . 74.530000000000001 111.076 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -58.96 -32.57 69.75 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 119.234 -0.413 . . . . 72.540000000000006 111.465 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.26 -25.7 67.98 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-O 121.269 0.557 . . . . 65.099999999999994 111.233 -173.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.37 -14.48 14.43 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.809 -0.632 . . . . 74.150000000000006 111.01 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.414 ' HB1' HG13 ' A' ' 108' ' ' VAL . . . -106.3 -43.79 4.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.309 0.855 . . . . 74.329999999999998 113.309 -171.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.37 22.69 69.84 Favored Glycine 0 C--N 1.317 -0.481 0 N-CA-C 111.122 -0.791 . . . . 52.200000000000003 111.122 -173.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.414 HG13 ' HB1' ' A' ' 106' ' ' ALA . 18.3 m -103.87 161.53 4.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.576 -0.527 . . . . 62.219999999999999 109.576 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -123.31 121.62 36.28 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.67 -1.604 . . . . 73.109999999999999 106.67 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.0 mt -122.77 107.23 11.67 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.266 -0.642 . . . . 72.329999999999998 109.266 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.1 m -115.87 141.02 48.65 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.88 -0.785 . . . . 73.109999999999999 108.88 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -149.92 155.38 39.89 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 120.9 -0.32 . . . . 71.439999999999998 110.478 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -156.09 161.84 40.34 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.339 -0.985 . . . . 51.109999999999999 108.339 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -106.47 133.09 51.7 Favored 'General case' 0 N--CA 1.398 -3.031 0 N-CA-C 107.322 -1.362 . . . . 75.450000000000003 107.322 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -118.81 100.24 7.27 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 106.839 -1.541 . . . . 70.120000000000005 106.839 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.91 -113.05 4.98 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.325 -1.11 . . . . 53.240000000000002 110.325 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -114.32 12.09 17.51 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.932 1.348 . . . . 73.040000000000006 109.477 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.23 148.86 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 O-C-N 120.445 -1.41 . . . . 65.519999999999996 108.868 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 178' ' ' TYR . 82.4 t -106.41 136.0 42.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 CA-C-O 120.761 0.315 . . . . 73.430000000000007 110.398 -177.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.1 pt -116.94 134.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 N-CA-C 108.876 -0.787 . . . . 65.439999999999998 108.876 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 tt -127.84 126.25 41.28 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.279 -1.008 . . . . 73.340000000000003 108.279 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -128.63 114.86 17.21 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.828 0.823 . . . . 73.340000000000003 109.142 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -119.39 139.4 14.13 Favored Glycine 0 N--CA 1.4 -3.747 0 N-CA-C 108.777 -1.729 . . . . 51.219999999999999 108.777 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -140.23 131.09 25.96 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 106.633 -1.618 . . . . 72.5 106.633 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -139.5 144.8 38.1 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.688 0.756 . . . . 51.32 112.871 -172.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.24 93.43 5.69 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.513 -1.221 . . . . 74.129999999999995 107.937 174.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.13 0.27 56.22 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.929 0.871 . . . . 70.129999999999995 108.827 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.5 p -65.03 -21.26 66.81 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.452 -1.249 . . . . 64.030000000000001 111.409 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.9 t -85.01 -21.72 29.34 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 116.008 -0.542 . . . . 53.219999999999999 110.613 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.6 t -68.99 113.39 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.541 -0.911 . . . . 53.310000000000002 108.541 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.8 m -101.38 9.97 41.02 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.321 0.489 . . . . 73.230000000000004 112.321 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 24' ' ' HIS . 31.2 m-20 -86.36 111.97 42.78 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.537 -0.912 . . . . 73.549999999999997 108.537 176.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -68.98 -18.91 40.5 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.61 2.207 . . . . 62.240000000000002 113.504 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -107.58 18.59 21.28 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.034 0.445 . . . . 75.340000000000003 111.236 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.02 140.37 29.81 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.42 -0.354 . . . . 75.519999999999996 111.863 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -133.06 139.67 47.29 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.492 -0.929 . . . . 72.439999999999998 108.492 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.77 113.89 44.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.126 -0.694 . . . . 75.230000000000004 109.126 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -113.29 120.13 40.11 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.21 0.529 . . . . 74.409999999999997 109.949 -178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 39.9 tp -112.18 120.6 42.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.306 -0.998 . . . . 74.519999999999996 108.306 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 31' ' ' SER . 17.4 m -120.89 112.62 19.01 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.566 -0.901 . . . . 41.140000000000001 108.566 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.49 120.77 61.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.508 -0.923 . . . . 61.310000000000002 108.508 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -105.73 126.92 52.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.523 -0.917 . . . . 52.200000000000003 108.523 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.443 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 0.3 OUTLIER -134.25 103.36 11.58 Favored Pre-proline 0 C--N 1.274 -2.697 0 CA-C-N 115.591 -0.731 . . . . 70.340000000000003 110.349 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.34 45.2 0.4 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 123.574 2.849 . . . . 74.530000000000001 112.277 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.53 -86.26 0.64 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.457 -0.571 . . . . 64.420000000000002 109.457 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 172.55 113.47 0.01 OUTLIER 'General case' 0 C--O 1.247 0.972 0 C-N-CA 123.72 0.808 . . . . 74.129999999999995 109.112 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 9.4 p -75.66 130.83 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 107.768 -1.197 . . . . 65.340000000000003 107.768 174.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.8 t -103.8 -28.71 11.46 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.296 -0.962 . . . . 73.040000000000006 110.852 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.7 m -159.28 132.96 7.33 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 107.406 -1.331 . . . . 74.239999999999995 107.406 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -139.75 162.14 35.85 Favored 'General case' 0 C--N 1.282 -2.331 0 O-C-N 122.104 -0.372 . . . . 70.329999999999998 110.414 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -130.04 90.55 2.98 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 104.927 -2.249 . . . . 64.109999999999999 104.927 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 172.35 -147.93 10.31 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 109.471 -1.452 . . . . 72.430000000000007 109.471 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -116.59 99.66 7.3 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 117.501 0.65 . . . . 65.109999999999999 109.481 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -72.58 131.89 43.06 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 121.287 0.565 . . . . 53.009999999999998 110.328 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.5 mm -96.07 -49.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 106.958 -1.497 . . . . 74.140000000000001 106.958 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -134.73 166.42 29.33 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 105.857 -1.905 . . . . 70.329999999999998 105.857 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.96 -2.39 11.44 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.309 2.006 . . . . 75.340000000000003 110.86 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.82 10.76 5.11 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.187 -0.915 . . . . 53.520000000000003 111.076 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.0 t -147.02 120.71 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.507 -0.923 . . . . 75.329999999999998 108.507 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.6 147.01 30.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.751 -0.833 . . . . 72.019999999999996 108.751 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 8.5 tt0 -132.92 142.44 48.9 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-O 121.595 0.712 . . . . 74.310000000000002 110.207 -174.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.451 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 29.1 m-90 -123.63 116.02 22.42 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.095 -1.076 . . . . 72.349999999999994 108.095 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.554 ' HD3' ' H ' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -112.36 98.42 7.27 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 122.017 0.913 . . . . 53.43 109.478 -178.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 170' ' ' SER . 0.7 OUTLIER -95.75 147.4 23.66 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.221 -1.354 . . . . 54.329999999999998 110.084 -171.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 166' ' ' PRO . 34.1 mttp -117.11 150.19 45.66 Favored Pre-proline 0 C--N 1.298 -1.667 0 CA-C-N 115.587 -0.733 . . . . 71.519999999999996 112.105 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 165' ' ' LYS . 32.1 Cg_exo -66.06 157.48 59.32 Favored 'Trans proline' 0 C--O 1.238 0.482 0 C-N-CA 123.318 2.679 . . . . 74.519999999999996 111.466 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.48 -27.26 2.51 Favored Glycine 0 C--N 1.313 -0.744 0 C-N-CA 121.54 -0.362 . . . . 31.149999999999999 112.899 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.3 m -105.85 167.29 3.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 120.723 0.297 . . . . 74.540000000000006 110.624 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.6 p -114.05 143.97 22.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.112 -0.699 . . . . 72.430000000000007 109.112 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.43 ' HB2' HD12 ' A' ' 164' ' ' LEU . 44.5 m -153.09 150.26 28.94 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 121.992 -0.443 . . . . 74.129999999999995 110.186 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 27.7 p -120.37 126.41 50.43 Favored 'General case' 0 N--CA 1.428 -1.557 0 C-N-CA 122.94 0.496 . . . . 73.420000000000002 110.0 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -98.14 121.39 40.01 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.591 -0.522 . . . . 72.040000000000006 109.591 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.3 m -137.98 138.44 38.91 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.865 -1.147 . . . . 74.510000000000005 111.369 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.451 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -145.31 128.77 16.97 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 115.811 -0.631 . . . . 63.109999999999999 109.675 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -117.19 130.69 56.76 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 107.006 -1.479 . . . . 74.219999999999999 107.006 172.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -140.85 152.28 44.99 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.497 -0.557 . . . . 31.02 109.497 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -90.74 126.28 35.95 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.406 -0.961 . . . . 74.420000000000002 108.406 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.598 ' OH ' HG23 ' A' ' 34' ' ' ILE . 5.4 m-85 -126.26 126.7 44.44 Favored 'General case' 0 CA--C 1.47 -2.132 0 N-CA-C 113.059 0.763 . . . . 73.310000000000002 113.059 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 35.7 p -67.79 105.17 1.86 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.606 -1.179 . . . . 54.32 108.484 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.49 132.69 88.42 Favored Pre-proline 0 CA--C 1.506 -0.721 0 O-C-N 123.773 0.671 . . . . 55.240000000000002 110.114 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.02 -46.72 7.76 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.261 1.974 . . . . 74.340000000000003 113.673 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -84.9 -12.08 54.19 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.858 0.361 . . . . 74.420000000000002 110.522 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.272 60.1 p 72.64 47.47 0.24 Allowed 'General case' 0 C--O 1.254 1.296 0 C-N-CA 126.122 1.769 . . . . 74.319999999999993 112.685 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.49 150.93 39.63 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.161 -1.381 . . . . 72.329999999999998 109.183 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.27 -2.881 0 N-CA-C 107.527 -1.286 . . . . 71.310000000000002 107.527 -179.79 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.87 0 N-CA-C 111.324 -0.711 . . . . 43.049999999999997 111.324 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -80.32 101.52 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.863 0.331 . . . . 73.450000000000003 110.294 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.71 -48.9 7.87 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.213 -2.143 . . . . 74.25 105.213 171.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 2.3 m-20 37.8 76.07 0.06 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.491 1.916 . . . . 72.109999999999999 114.27 171.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 47.6 tp -80.42 104.01 10.67 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.666 -0.864 . . . . 55.140000000000001 108.666 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 18' ' ' ASN . 46.6 m-85 -90.22 150.46 21.96 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.757 -0.656 . . . . 71.209999999999994 111.779 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 53' ' ' SER . 97.3 m-85 -131.08 135.38 47.47 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.907 -1.145 . . . . 64.420000000000002 107.907 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -150.65 163.3 38.87 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.202 0.314 . . . . 75.519999999999996 110.347 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.98 136.94 2.17 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 110.216 -1.153 . . . . 62.310000000000002 110.216 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -98.35 -22.85 15.88 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.509 0.929 . . . . 73.340000000000003 113.509 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 134' ' ' ASP . 26.3 ptm -148.61 175.89 10.8 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.552 -0.859 . . . . 72.540000000000006 111.857 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -131.66 146.08 52.0 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.102 -1.073 . . . . 74.400000000000006 108.102 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 50.0 mtm105 -139.37 138.19 36.38 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 122.507 0.323 . . . . 74.329999999999998 110.244 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 46' ' ' ALA . 26.9 m -126.58 114.71 39.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.495 0.664 . . . . 62.100000000000001 109.559 177.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -123.8 119.08 28.68 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.413 0.625 . . . . 74.319999999999993 110.706 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -109.38 108.87 19.57 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.295 -1.002 . . . . 61.310000000000002 108.295 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 p -117.52 115.89 26.03 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.32 -0.622 . . . . 73.120000000000005 109.32 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.72 146.91 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.518 -0.549 . . . . 63.009999999999998 109.518 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.1 m -123.78 130.63 52.93 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 109.094 -0.706 . . . . 51.140000000000001 109.094 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -112.94 120.27 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 121.679 0.752 . . . . 62.229999999999997 110.553 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -92.74 158.29 38.29 Favored Pre-proline 0 C--N 1.295 -1.776 0 CA-C-N 115.054 -0.975 . . . . 51.119999999999997 110.438 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -65.53 2.39 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.997 3.131 . . . . 74.319999999999993 113.614 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 31.7 t70 -89.85 -0.32 57.49 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.973 -0.751 . . . . 52.439999999999998 108.973 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 22.0 t70 70.79 29.19 3.22 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 105.51 -2.033 . . . . 74.420000000000002 105.51 -174.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 7.0 tp -101.69 125.02 48.27 Favored 'General case' 1 N--CA 1.379 -4.023 0 CA-C-N 112.175 -2.284 . . . . 74.120000000000005 108.472 -177.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.6 t -115.47 130.64 69.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.629 -0.878 . . . . 71.439999999999998 108.629 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 p -145.23 151.81 38.97 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.033 -0.729 . . . . 75.230000000000004 109.033 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.51 -164.7 36.45 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 118.971 -1.585 . . . . 74.049999999999997 112.965 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.05 133.97 15.84 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.247 0.546 . . . . 71.010000000000005 110.571 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 68.0 mt -114.27 115.84 50.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.885 -1.154 . . . . 72.430000000000007 107.885 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -109.95 116.71 52.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 109.762 -0.458 . . . . 63.340000000000003 109.762 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.483 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -112.89 108.47 17.43 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.909 -1.515 . . . . 73.239999999999995 106.909 174.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -123.35 125.36 44.86 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.236 0.541 . . . . 72.400000000000006 111.672 -174.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.86 159.92 32.5 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.441 -0.8 . . . . 64.209999999999994 109.165 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 139.29 80.41 Favored Pre-proline 0 C--N 1.302 -1.494 0 C-N-CA 119.144 -1.022 . . . . 74.25 110.36 176.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -47.83 132.72 21.98 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 124.435 3.423 . . . . 72.319999999999993 114.481 -174.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -86.03 -56.64 3.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.793 -0.64 . . . . 75.319999999999993 110.462 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.402 ' H ' ' CB ' ' A' ' 55' ' ' ASP . 18.6 m120 -127.53 -176.52 3.78 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.014 -0.539 . . . . 74.299999999999997 110.575 -174.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.463 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 15.7 m -74.06 -32.26 63.22 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.069 0.461 . . . . 64.409999999999997 110.848 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -74.45 -20.23 60.1 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 121.797 0.808 . . . . 63.409999999999997 109.703 177.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.402 ' CB ' ' H ' ' A' ' 52' ' ' ASN . 13.5 t70 -81.49 96.17 7.33 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.089 -1.414 . . . . 71.329999999999998 110.955 -168.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.3 p -109.06 -1.33 18.94 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.001 -1.454 . . . . 75.099999999999994 109.103 177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 172.77 99.5 0.12 Allowed Glycine 0 N--CA 1.416 -2.639 0 CA-C-O 118.289 -1.284 . . . . 63.329999999999998 111.725 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 52.2 Cg_exo -54.05 127.75 26.98 Favored 'Trans proline' 0 C--N 1.355 0.88 0 CA-C-N 120.044 1.922 . . . . 71.439999999999998 107.5 170.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.1 151.52 22.47 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 113.573 0.953 . . . . 72.200000000000003 113.573 -166.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 96.1 mt -94.35 150.48 20.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.047 -0.979 . . . . 63.329999999999998 109.301 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -107.07 93.68 4.69 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.389 -0.967 . . . . 73.420000000000002 108.389 175.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.38 120.01 5.87 Favored Glycine 0 N--CA 1.42 -2.39 0 CA-C-N 114.442 -1.254 . . . . 63.130000000000003 111.219 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -136.68 111.47 8.78 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.918 -0.771 . . . . 63.409999999999997 108.918 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.15 166.88 14.55 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 108.173 -1.047 . . . . 71.430000000000007 108.173 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -66.98 -32.67 34.55 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 121.406 1.404 . . . . 72.530000000000001 110.586 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -97.13 39.2 1.19 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.257 -0.883 . . . . 71.530000000000001 112.825 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.8 m -55.14 -27.8 48.09 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 112.784 0.661 . . . . 35.43 112.784 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -73.02 -7.89 53.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.217 0.532 . . . . 73.109999999999999 111.232 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.5 -13.13 18.8 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.117 -0.492 . . . . 65.140000000000001 110.383 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.2 p -125.31 119.99 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.882 0.849 . . . . 64.450000000000003 111.663 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.98 112.08 24.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.774 -0.825 . . . . 73.420000000000002 108.774 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.35 127.76 50.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.083 -1.081 . . . . 74.129999999999995 108.083 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 m -140.01 172.78 12.27 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.534 -0.543 . . . . 74.439999999999998 109.534 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.426 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 22.6 p-10 -86.03 149.24 25.31 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.064 -0.654 . . . . 72.120000000000005 109.539 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 79.6 t80 -101.93 120.56 40.59 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.571 -1.64 . . . . 74.430000000000007 106.571 174.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -138.49 99.13 3.75 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 108.423 -0.954 . . . . 72.400000000000006 108.423 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.3 t -174.07 153.48 2.08 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.869 -1.16 . . . . 63.43 107.869 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 66.89 15.14 10.07 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.915 0.886 . . . . 73.340000000000003 112.166 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.38 -8.25 80.25 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.575 -0.61 . . . . 64.530000000000001 111.575 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.531 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 47.9 m-85 -93.05 153.22 18.83 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.419 -0.586 . . . . 64.239999999999995 109.419 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 31.0 m -134.81 136.31 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.064 -1.088 . . . . 52.310000000000002 108.064 171.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -169.8 -153.85 8.86 Favored Glycine 0 C--N 1.259 -3.75 0 N-CA-C 110.505 -1.038 . . . . 73.140000000000001 110.505 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.486 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.1 p -126.43 146.76 49.96 Favored 'General case' 0 C--N 1.264 -3.141 0 CA-C-O 121.317 0.58 . . . . 64.540000000000006 111.518 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 4.4 pt20 -136.97 127.78 27.3 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.97 -0.559 . . . . 61.420000000000002 110.496 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.42 115.25 29.93 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.287 -1.005 . . . . 24.309999999999999 108.287 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.68 117.77 54.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.057 -1.09 . . . . 55.109999999999999 108.057 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.468 ' CD2' HD12 ' A' ' 90' ' ' LEU . 50.7 p90 -124.29 154.77 39.75 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 120.803 0.335 . . . . 72.530000000000001 110.236 -175.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.5 m -157.56 159.73 37.44 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 116.234 -0.439 . . . . 63.340000000000003 110.222 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 67.14 31.13 6.95 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.505 1.145 . . . . 71.439999999999998 110.486 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.468 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.0 mt -96.24 160.44 14.43 Favored 'General case' 0 N--CA 1.428 -1.54 0 O-C-N 121.627 -0.671 . . . . 73.519999999999996 111.304 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 m -104.78 166.53 10.32 Favored 'General case' 0 N--CA 1.401 -2.912 0 N-CA-C 109.391 -0.596 . . . . 63.130000000000003 109.391 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.493 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 60.8 t80 -50.66 -48.62 58.31 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.228 1.011 . . . . 74.239999999999995 110.674 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.07 -24.66 67.24 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.268 -0.878 . . . . 55.039999999999999 112.245 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -87.66 -16.93 33.03 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 116.272 -0.422 . . . . 72.219999999999999 111.754 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.3 tt -61.89 -52.36 68.8 Favored Pre-proline 0 CA--C 1.559 1.294 0 O-C-N 123.254 0.346 . . . . 62.509999999999998 111.228 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 35.3 Cg_exo -65.72 -32.98 45.95 Favored 'Trans proline' 0 C--N 1.369 1.654 0 CA-C-N 120.794 1.319 . . . . 65.099999999999994 110.63 176.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.63 -36.06 83.04 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.642 -0.708 . . . . 72.340000000000003 110.977 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.1 pp -77.59 -19.84 54.95 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.871 -0.418 . . . . 64.409999999999997 109.871 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.78 -24.24 61.71 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.97 -0.559 . . . . 64.040000000000006 110.25 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -56.18 -49.75 73.14 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 109.561 -0.533 . . . . 74.409999999999997 109.561 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.5 mtm -54.37 -51.46 64.71 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.232 0.539 . . . . 73.319999999999993 110.161 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -56.58 -34.93 67.65 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.992 -1.004 . . . . 74.349999999999994 111.598 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.3 m -62.09 -30.21 70.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.269 -0.423 . . . . 54.520000000000003 110.243 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.18 -31.57 70.25 Favored 'General case' 0 CA--C 1.504 -0.815 0 O-C-N 123.926 0.767 . . . . 73.030000000000001 110.674 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.09 -11.89 15.53 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 116.233 -0.44 . . . . 74.129999999999995 111.38 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.69 -47.86 3.65 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.646 0.98 . . . . 54.420000000000002 113.646 -172.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.07 25.81 33.11 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.814 -0.708 . . . . 72.420000000000002 111.784 -174.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 m -109.27 155.41 10.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 O-C-N 122.486 -0.42 . . . . 65.310000000000002 111.7 -175.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -124.28 124.79 43.17 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.088 0.555 . . . . 72.329999999999998 109.555 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.8 mp -117.56 143.66 45.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.124 0.488 . . . . 74.109999999999999 111.056 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.1 m -129.74 109.57 11.06 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.065 -0.717 . . . . 70.319999999999993 109.065 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.573 ' C ' ' HD2' ' A' ' 113' ' ' ARG . 61.0 tp -119.87 123.84 44.59 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.526 -0.306 . . . . 70.239999999999995 110.646 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.573 ' HD2' ' C ' ' A' ' 112' ' ' LEU . 2.8 mpt_? -137.47 147.94 45.69 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.783 0.433 . . . . 74.310000000000002 110.194 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' ' 119' ' ' VAL . 37.3 ttm180 -102.0 137.54 40.15 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 107.101 -1.444 . . . . 64.540000000000006 107.101 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -128.47 90.0 2.99 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.664 -0.865 . . . . 71.329999999999998 108.664 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.79 -113.22 4.89 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 115.052 -0.976 . . . . 72.530000000000001 110.874 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.29 -13.67 21.82 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.843 0.83 . . . . 62.439999999999998 109.07 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.673 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.4 pp -103.59 149.86 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 C-N-CA 119.69 -0.804 . . . . 74.0 110.009 -176.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.545 HG21 ' CD2' ' A' ' 178' ' ' TYR . 92.7 t -118.31 138.68 48.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 O-C-N 121.911 -0.493 . . . . 72.209999999999994 110.141 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.0 pt -120.05 129.43 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 122.101 0.953 . . . . 65.140000000000001 109.802 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.2 136.25 49.89 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 114.907 -1.042 . . . . 75.299999999999997 108.56 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -143.28 166.15 25.52 Favored 'General case' 0 C--N 1.277 -2.581 0 N-CA-C 108.835 -0.802 . . . . 65.420000000000002 108.835 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.84 158.98 30.96 Favored Glycine 0 N--CA 1.405 -3.415 0 N-CA-C 109.72 -1.352 . . . . 23.300000000000001 109.72 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -134.31 125.23 27.23 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.234 -1.765 . . . . 73.109999999999999 106.234 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.15 117.51 16.63 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 120.996 0.427 . . . . 72.040000000000006 111.618 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 169' ' ' VAL . 0.0 OUTLIER -108.85 134.02 52.1 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 105.154 -2.165 . . . . 71.140000000000001 105.154 170.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.9 mm? -117.85 32.38 6.18 Favored 'General case' 0 C--N 1.267 -2.99 0 N-CA-C 108.754 -0.832 . . . . 65.540000000000006 108.754 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 167' ' ' GLY . 42.7 p -73.01 -23.87 60.67 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.965 -0.561 . . . . 55.539999999999999 110.487 -176.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.3 m -74.76 -12.34 60.38 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 116.051 -0.522 . . . . 61.140000000000001 111.249 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -77.41 110.82 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.138 -1.43 . . . . 75.400000000000006 107.138 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.4 t -88.45 29.5 0.98 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.116 -0.493 . . . . 73.019999999999996 111.064 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -135.1 120.02 13.77 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 109.808 -0.442 . . . . 43.530000000000001 109.808 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.86 -20.77 16.89 Favored 'Trans proline' 0 C--O 1.22 -0.419 0 C-N-CA 122.514 2.143 . . . . 74.230000000000004 112.175 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' MET . 7.0 m-20 -88.27 18.89 4.06 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.159 0.504 . . . . 71.340000000000003 111.283 -176.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.0 143.91 28.08 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.137 -0.69 . . . . 45.100000000000001 109.137 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -132.11 130.52 41.29 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.276 -1.009 . . . . 75.439999999999998 108.276 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.1 t -113.54 126.11 70.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.863 -0.421 . . . . 64.430000000000007 109.863 -175.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -128.35 121.99 30.45 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.866 0.365 . . . . 54.539999999999999 111.356 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.516 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -111.22 121.54 45.54 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.885 -1.894 . . . . 63.549999999999997 105.885 174.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.3 m -126.6 130.96 51.52 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.243 -0.28 . . . . 43.439999999999998 110.243 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 99.4 t -123.86 126.12 72.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 109.036 -0.728 . . . . 71.120000000000005 109.036 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.84 127.57 56.21 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.324 -0.621 . . . . 65.519999999999996 109.324 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 2.8 p90 -134.38 123.68 16.68 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 116.362 -0.381 . . . . 75.530000000000001 111.789 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 29.2 Cg_exo -68.27 41.07 0.24 Allowed 'Trans proline' 0 CA--C 1.557 1.635 0 C-N-CA 123.447 2.765 . . . . 64.409999999999997 113.795 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.49 -100.44 0.39 Allowed 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.985 -0.447 . . . . 73.540000000000006 110.807 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 178.92 130.75 0.08 Allowed 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.745 -0.835 . . . . 53.520000000000003 108.745 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.7 133.03 30.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.049 -0.723 . . . . 62.210000000000001 109.049 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.2 p -94.03 -43.3 8.58 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-O 121.225 0.536 . . . . 65.329999999999998 109.701 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 17.0 m -150.04 131.32 14.59 Favored 'General case' 0 C--O 1.212 -0.904 0 N-CA-C 108.407 -0.961 . . . . 71.219999999999999 108.407 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -140.91 152.32 44.94 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 120.39 -0.524 . . . . 73.129999999999995 111.241 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -119.5 90.97 3.44 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.162 -2.162 . . . . 52.409999999999997 105.162 171.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.62 -159.26 28.97 Favored Glycine 0 N--CA 1.416 -2.672 0 N-CA-C 107.345 -2.302 . . . . 74.129999999999995 107.345 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -112.12 102.84 11.01 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 117.846 0.823 . . . . 73.439999999999998 109.542 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 18.0 ptt180 -76.28 122.01 23.79 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-O 121.218 0.532 . . . . 74.129999999999995 109.877 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.16 -41.06 18.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 106.989 -1.486 . . . . 64.230000000000004 106.989 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -136.08 166.29 29.24 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.118 -1.401 . . . . 74.319999999999993 107.245 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -71.12 -4.75 15.53 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 122.351 2.034 . . . . 75.310000000000002 110.721 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.6 pt-20 -128.27 6.2 5.84 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.613 -0.722 . . . . 64.209999999999994 111.36 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.5 t -141.66 120.57 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.256 -1.016 . . . . 75.340000000000003 108.256 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 50.1 t -123.53 145.53 30.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.772 -0.455 . . . . 74.209999999999994 109.772 -177.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -136.09 142.72 44.34 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.362 0.601 . . . . 73.349999999999994 110.202 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.516 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.6 m-90 -118.7 113.35 21.04 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.432 -0.804 . . . . 70.450000000000003 109.106 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 163' ' ' LYS . 7.8 ptpt -95.23 99.07 11.08 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 122.316 1.055 . . . . 74.340000000000003 108.716 177.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 61.1 mt -97.68 147.48 24.3 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 113.676 -1.602 . . . . 73.129999999999995 109.428 -173.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -117.63 146.44 38.67 Favored Pre-proline 0 C--N 1.295 -1.766 0 CA-C-N 115.637 -0.711 . . . . 73.409999999999997 112.302 -174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.457 ' HA ' ' CB ' ' A' ' 127' ' ' LEU . 71.8 Cg_endo -71.54 160.02 49.59 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.573 2.182 . . . . 72.019999999999996 110.341 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 128' ' ' THR . . . 78.34 -26.87 2.15 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 121.096 -0.573 . . . . 73.430000000000007 113.22 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.7 170.1 3.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.008 0.432 . . . . 73.25 112.082 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 126' ' ' ASP . 8.3 p -114.07 142.94 24.92 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 CA-C-N 115.812 -0.631 . . . . 74.409999999999997 109.87 176.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.5 p -149.75 140.57 22.74 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.048 0.451 . . . . 62.310000000000002 111.975 -176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.8 p -96.67 138.11 34.73 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.201 -0.666 . . . . 64.239999999999995 109.201 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 22.4 ptm -118.63 133.1 56.11 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.944 -1.132 . . . . 70.140000000000001 107.944 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -143.55 147.93 35.19 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.613 -0.835 . . . . 73.209999999999994 111.398 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.452 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -154.89 130.29 9.75 Favored 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 123.05 0.54 . . . . 64.430000000000007 109.862 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -132.54 131.83 41.97 Favored 'General case' 0 C--N 1.264 -3.147 0 N-CA-C 106.753 -1.573 . . . . 73.040000000000006 106.753 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -157.18 149.83 23.3 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.832 -1.173 . . . . 44.43 107.832 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 0.8 OUTLIER -95.52 138.86 32.6 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.447 -1.686 . . . . 70.420000000000002 106.447 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.545 ' CD2' HG21 ' A' ' 119' ' ' VAL . 22.4 m-30 -121.17 151.78 39.53 Favored 'General case' 0 CA--C 1.483 -1.611 0 C-N-CA 119.926 -0.71 . . . . 74.439999999999998 109.331 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.81 86.03 3.4 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-O 121.462 0.648 . . . . 74.299999999999997 110.097 175.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -56.51 134.86 77.12 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.451 -1.249 . . . . 74.420000000000002 110.815 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.64 -27.82 21.81 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.091 1.861 . . . . 53.350000000000001 112.969 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -84.12 -21.1 31.54 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.917 -1.142 . . . . 51.210000000000001 107.917 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.344 69.7 p 68.54 49.73 0.74 Allowed 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 126.99 2.116 . . . . 54.439999999999998 112.567 -175.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -70.88 150.65 45.55 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.933 -1.485 . . . . 75.230000000000004 108.102 173.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 C--N 1.298 -1.645 0 N-CA-C 106.96 -1.496 . . . . 72.25 106.96 -177.462 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.818 0 N-CA-C 110.807 -0.917 . . . . 43.049999999999997 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.81 98.84 6.46 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.771 -1.196 . . . . 75.530000000000001 107.771 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.532 ' HG2' ' H ' ' A' ' 18' ' ' ASN . 30.6 tt0 61.0 -175.37 0.12 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.462 1.105 . . . . 64.209999999999994 110.247 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.532 ' H ' ' HG2' ' A' ' 17' ' ' GLU . 83.3 m-20 -121.42 122.1 39.04 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 106.662 -1.607 . . . . 71.030000000000001 106.662 176.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.64 76.74 5.71 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.967 -0.753 . . . . 74.329999999999998 108.967 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.6 t80 75.58 157.5 0.19 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.935 1.694 . . . . 62.219999999999999 109.728 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 69.28 95.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.914 1.079 . . . . 73.549999999999997 113.914 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -90.37 89.33 7.56 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.234 -1.395 . . . . 75.430000000000007 107.234 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.34 153.86 18.24 Favored Glycine 0 CA--C 1.48 -2.109 0 N-CA-C 110.189 -1.164 . . . . 73.120000000000005 110.189 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 27' ' ' ARG . 56.9 m80 71.75 33.14 1.81 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.243 1.017 . . . . 75.040000000000006 109.106 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.83 100.32 11.24 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 112.813 0.671 . . . . 73.420000000000002 112.813 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 48' ' ' ALA . 6.7 tt 75.38 100.19 0.07 Allowed 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.232 -1.349 . . . . 74.040000000000006 112.876 173.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' CZ ' ' HA ' ' A' ' 24' ' ' HIS . 3.1 mpt_? -131.72 127.99 37.99 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.102 -0.954 . . . . 61.229999999999997 108.913 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.32 117.76 56.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.45 -0.944 . . . . 61.43 108.45 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -123.05 114.06 19.87 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.342 0.591 . . . . 71.319999999999993 109.457 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.29 126.76 55.6 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.583 -0.895 . . . . 75.310000000000002 108.583 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.9 t -131.64 114.79 15.24 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.046 -1.464 . . . . 73.329999999999998 107.046 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.63 146.62 29.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 109.367 -0.605 . . . . 43.539999999999999 109.367 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.5 m -126.8 125.21 41.32 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.258 0.551 . . . . 75.129999999999995 109.854 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.2 tt -113.39 110.35 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.606 0 CA-C-O 121.851 0.834 . . . . 54.109999999999999 110.097 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -76.99 158.55 80.06 Favored Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 114.761 -1.109 . . . . 75.120000000000005 109.747 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.5 0.81 2.55 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 123.363 2.709 . . . . 62.109999999999999 112.999 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -88.89 2.33 53.92 Favored 'General case' 0 N--CA 1.427 -1.617 0 C-N-CA 124.066 0.947 . . . . 73.400000000000006 110.156 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 91' ' ' THR . 14.5 t70 67.89 29.44 6.61 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 123.55 1.643 . . . . 74.430000000000007 106.872 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.36 124.77 50.88 Favored 'General case' 0 N--CA 1.382 -3.841 0 CA-C-N 113.904 -1.498 . . . . 65.430000000000007 107.297 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.414 HG12 ' HE2' ' A' ' 87' ' ' PHE . 3.6 t -110.78 136.29 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 108.471 -0.937 . . . . 64.430000000000007 108.471 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.8 p -144.13 154.93 43.68 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 105.966 -1.865 . . . . 62.210000000000001 105.966 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.25 -172.04 44.26 Favored Glycine 0 CA--C 1.49 -1.524 0 C-N-CA 117.913 -2.089 . . . . 64.329999999999998 113.725 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.43 134.22 28.75 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.438 0.695 . . . . 75.010000000000005 110.041 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 60.0 mt -120.75 115.7 47.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.018 -1.475 . . . . 74.439999999999998 107.018 174.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.2 114.61 46.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 120.935 0.398 . . . . 62.539999999999999 109.954 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.01 108.3 18.48 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 106.277 -1.749 . . . . 65.329999999999998 106.277 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -121.34 125.66 47.55 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 120.246 -0.582 . . . . 70.019999999999996 111.257 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 26' ' ' LEU . . . -111.64 155.73 22.93 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.934 -0.765 . . . . 64.040000000000006 108.934 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -91.68 120.51 68.08 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 104.983 -2.229 . . . . 73.519999999999996 104.983 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -31.18 106.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 125.069 3.846 . . . . 70.439999999999998 114.302 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.21 -44.27 6.31 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.877 -0.601 . . . . 65.540000000000006 110.767 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.477 ' HB2' ' CG ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER -87.12 158.14 19.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.838 -1.171 . . . . 74.540000000000006 107.838 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 m -75.02 -20.75 59.48 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.444 0.64 . . . . 75.219999999999999 109.401 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -81.99 -14.82 55.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.353 -0.839 . . . . 74.230000000000004 109.399 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.477 ' CG ' ' HB2' ' A' ' 52' ' ' ASN . 85.7 m-20 -69.45 96.76 0.92 Allowed 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.766 0.793 . . . . 71.239999999999995 112.607 -170.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.1 p -113.34 -26.76 8.21 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.311 -1.313 . . . . 74.439999999999998 108.723 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.91 98.18 0.11 Allowed Glycine 0 N--CA 1.414 -2.787 0 CA-C-N 114.824 -1.08 . . . . 65.340000000000003 112.54 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.74 159.09 53.81 Favored 'Trans proline' 0 C--O 1.247 0.945 0 C-N-CA 122.673 2.248 . . . . 71.430000000000007 111.579 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.95 155.25 41.65 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.079 -0.341 . . . . 71.010000000000005 110.079 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.562 ' HG ' ' CB ' ' A' ' 83' ' ' SER . 94.3 mt -101.15 153.47 19.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.159 -0.682 . . . . 71.219999999999999 109.159 177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.92 88.07 5.6 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.878 -1.527 . . . . 74.340000000000003 106.878 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.86 50.66 0.78 Allowed Glycine 0 N--CA 1.414 -2.792 0 CA-C-N 115.077 -0.965 . . . . 54.32 112.89 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -91.6 95.46 9.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.251 -1.018 . . . . 71.150000000000006 108.251 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 m -122.37 162.21 39.16 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 114.15 -1.386 . . . . 64.209999999999994 107.609 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.86 -19.61 32.37 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.673 2.249 . . . . 54.43 112.831 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -112.52 29.58 7.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.417 -0.356 . . . . 70.319999999999993 111.659 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.9 m -56.48 -27.82 58.13 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.497 0.554 . . . . 74.239999999999995 112.497 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -70.15 -10.78 59.89 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.394 0.616 . . . . 73.329999999999998 110.752 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 88' ' ' SER . 68.0 mmtt -106.68 -9.83 16.36 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 111.486 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.74 118.27 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 119.382 -0.927 . . . . 75.129999999999995 111.102 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.76 103.4 15.31 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 115.051 -0.977 . . . . 52.420000000000002 108.794 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 60' ' ' LEU . 7.3 p -98.3 134.79 35.48 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.161 -1.052 . . . . 71.409999999999997 108.161 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.0 m -149.46 171.56 16.38 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 120.847 0.356 . . . . 75.010000000000005 111.047 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -76.85 132.09 38.97 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.125 -0.943 . . . . 63.229999999999997 109.089 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -102.62 119.92 39.66 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.287 -1.375 . . . . 75.129999999999995 107.287 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -137.6 99.61 3.99 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.513 -0.921 . . . . 74.409999999999997 108.513 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.0 t -168.42 149.1 4.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.38 -0.971 . . . . 73.120000000000005 108.38 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 69.85 13.75 8.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.979 0.911 . . . . 71.219999999999999 112.167 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.76 1.48 67.95 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.764 -0.653 . . . . 53.229999999999997 111.692 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.549 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 59.4 m-85 -102.79 151.07 22.84 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 122.506 0.322 . . . . 71.430000000000007 110.28 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.3 136.23 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 107.342 -1.355 . . . . 72.230000000000004 107.342 168.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.1 -154.95 10.51 Favored Glycine 0 C--N 1.272 -2.977 0 C-N-CA 119.965 -1.112 . . . . 34.030000000000001 111.019 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.562 ' CB ' ' HG ' ' A' ' 60' ' ' LEU . 13.0 m -126.69 145.12 50.7 Favored 'General case' 0 C--N 1.27 -2.863 0 CA-C-O 121.185 0.517 . . . . 51.030000000000001 110.39 -176.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -131.17 138.8 49.59 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.957 -0.565 . . . . 74.129999999999995 109.919 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -119.14 114.63 22.76 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.502 -1.296 . . . . 61.549999999999997 107.502 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.6 t -112.44 113.4 44.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.206 -1.035 . . . . 71.450000000000003 108.206 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.477 ' CD2' HD12 ' A' ' 90' ' ' LEU . 44.3 p90 -114.27 159.55 20.04 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.008 0.433 . . . . 74.010000000000005 111.858 -173.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 6.1 p -156.68 155.18 31.29 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.256 -0.884 . . . . 73.319999999999993 110.13 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 67.03 30.01 7.69 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 124.629 1.172 . . . . 64.129999999999995 111.945 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.477 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.2 mt -97.27 165.99 11.77 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 119.387 -0.925 . . . . 72.329999999999998 110.114 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.465 HG22 ' OE1' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -125.3 178.93 5.32 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.905 -1.146 . . . . 73.310000000000002 107.905 -178.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -47.54 -35.63 9.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.851 1.26 . . . . 62.310000000000002 112.452 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.451 ' H ' HG23 ' A' ' 91' ' ' THR . . . -73.1 -25.72 60.98 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.9 0.704 . . . . 75.239999999999995 112.9 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.467 ' HG2' HD22 ' A' ' 90' ' ' LEU . 14.6 mp0 -91.74 -16.97 26.1 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.797 -0.761 . . . . 74.319999999999993 112.749 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.3 tt -58.51 -50.65 86.88 Favored Pre-proline 0 CA--C 1.569 1.677 0 O-C-N 123.241 0.338 . . . . 72.409999999999997 111.456 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -68.81 -30.83 26.43 Favored 'Trans proline' 0 C--N 1.365 1.408 0 CA-C-N 120.731 1.297 . . . . 74.129999999999995 111.281 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -67.88 -33.13 74.14 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 123.534 0.734 . . . . 74.040000000000006 111.121 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.6 pp -75.54 -19.23 59.46 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.988 0.423 . . . . 70.310000000000002 110.256 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.438 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -71.63 -18.29 62.21 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.933 -0.576 . . . . 71.030000000000001 109.977 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.23 -57.24 10.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.9 -0.591 . . . . 74.230000000000004 109.85 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 14.8 ttm -54.38 -52.7 60.83 Favored 'General case' 0 C--O 1.271 2.189 0 CA-C-O 122.518 1.152 . . . . 74.340000000000003 108.428 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 6.3 t30 -52.84 -27.04 16.49 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 112.435 -2.166 . . . . 64.25 112.805 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -54.47 -45.89 73.25 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.886 -0.326 . . . . 40.219999999999999 110.557 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -69.47 -11.84 61.16 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.307 0.855 . . . . 72.510000000000005 113.307 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.38 -27.62 11.36 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.098 0.475 . . . . 54.420000000000002 110.359 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.11 -47.68 3.63 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 113.314 0.857 . . . . 72.430000000000007 113.314 -170.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.26 21.53 51.65 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.667 -0.973 . . . . 61.43 110.667 -172.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.6 m -118.97 155.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 122.306 -0.526 . . . . 51.020000000000003 110.617 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -125.71 141.4 52.03 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.91 -1.145 . . . . 74.230000000000004 107.91 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.0 mt -129.27 119.55 24.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.915 -0.772 . . . . 75.209999999999994 108.915 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.3 m -118.94 135.74 54.43 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.03 -1.1 . . . . 72.329999999999998 108.03 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.33 157.81 43.82 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 112.631 0.604 . . . . 73.219999999999999 112.631 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -145.67 150.87 37.1 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.844 -1.071 . . . . 53.520000000000003 111.267 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.544 ' NH2' ' HA ' ' A' ' 180' ' ' ASP . 3.9 tpt180 -96.49 106.56 18.83 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 106.401 -1.703 . . . . 62.520000000000003 106.401 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -96.8 89.23 4.83 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 108.097 -1.075 . . . . 63.039999999999999 108.097 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.13 -96.86 0.9 Allowed Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.086 -1.205 . . . . 65.340000000000003 110.086 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 179' ' ' THR . 2.9 t-20 -124.42 -2.42 8.0 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.672 1.225 . . . . 70.310000000000002 109.33 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.62 148.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 O-C-N 121.087 -1.008 . . . . 70.310000000000002 108.703 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.441 HG22 ' HD3' ' A' ' 114' ' ' ARG . 96.8 t -102.89 131.77 50.44 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 O-C-N 122.06 -0.4 . . . . 64.140000000000001 110.32 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.414 HG22 ' HG2' ' A' ' 175' ' ' GLN . 44.4 pt -107.56 130.98 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 N-CA-C 106.784 -1.562 . . . . 72.209999999999994 106.784 174.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 tt -127.93 131.42 49.34 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 115.869 -0.605 . . . . 55.329999999999998 109.467 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -132.19 115.47 15.75 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.602 -0.888 . . . . 75.099999999999994 108.602 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -118.03 157.88 14.96 Favored Glycine 0 C--N 1.281 -2.503 0 N-CA-C 109.99 -1.244 . . . . 62.310000000000002 109.99 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.469 ' HG2' HG22 ' A' ' 171' ' ' THR . 84.0 mtt180 -139.53 127.54 22.28 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 117.542 0.671 . . . . 75.310000000000002 110.208 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -113.58 109.98 19.5 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.401 -0.592 . . . . 61.340000000000003 109.401 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -109.68 97.76 7.24 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.439 -0.948 . . . . 71.099999999999994 108.439 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.82 28.57 8.46 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.557 -0.905 . . . . 62.350000000000001 108.557 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 69.4 p -66.32 -27.7 68.11 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.883 -0.599 . . . . 75.299999999999997 112.599 -175.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.8 m -72.48 -12.07 60.93 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 111.89 0.33 . . . . 42.030000000000001 111.89 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.0 t 68.0 102.98 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.773 1.229 . . . . 72.450000000000003 113.188 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.6 t -68.45 -47.51 66.97 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.527 -1.286 . . . . 73.340000000000003 107.527 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -170.15 140.42 1.61 Allowed Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.013 -1.476 . . . . 73.409999999999997 107.013 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.69 -20.06 56.42 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 122.863 2.375 . . . . 71.299999999999997 115.03 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -94.54 2.86 55.67 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.071 0.939 . . . . 54.020000000000003 110.594 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -79.53 141.26 36.83 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.276 -0.875 . . . . 61.310000000000002 111.7 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 27' ' ' ARG . 11.2 m-20 -131.48 136.64 48.09 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 108.527 -0.916 . . . . 70.040000000000006 108.527 177.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 64.8 t -127.57 118.48 49.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.292 -0.633 . . . . 73.439999999999998 109.292 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.404 ' OE2' ' HB3' ' A' ' 136' ' ' ASP . 2.6 mp0 -109.37 123.55 49.51 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.603 -0.517 . . . . 74.310000000000002 109.603 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.407 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.5 tm? -110.94 111.83 23.23 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 106.949 -1.5 . . . . 64.319999999999993 106.949 176.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.6 m -117.9 133.62 55.74 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.858 0.463 . . . . 64.219999999999999 110.45 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.83 123.62 63.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.89 -0.781 . . . . 71.209999999999994 108.89 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.51 127.49 56.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.107 -0.701 . . . . 63.009999999999998 109.107 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.527 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.43 118.47 13.74 Favored Pre-proline 0 C--N 1.286 -2.179 0 CA-C-N 116.529 -0.305 . . . . 61.439999999999998 111.477 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.94 40.46 0.36 Allowed 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 122.993 2.462 . . . . 64.200000000000003 111.935 176.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.53 -94.09 0.5 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-O 119.288 -0.387 . . . . 63.520000000000003 110.224 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 174.03 120.77 0.02 OUTLIER 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.3 0.64 . . . . 54.409999999999997 109.873 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.472 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 7.4 p -84.03 126.22 40.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.814 -0.81 . . . . 72.230000000000004 108.814 174.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.6 t -95.35 -33.46 12.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 119.775 -0.77 . . . . 74.140000000000001 110.647 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.8 m -154.48 132.37 11.58 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 108.399 -0.963 . . . . 53.25 108.399 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 t -140.53 157.85 44.88 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 110.246 -0.279 . . . . 63.130000000000003 110.246 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 26.9 t-20 -126.95 97.89 5.13 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.193 -2.151 . . . . 62.119999999999997 105.193 170.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.19 -147.43 11.11 Favored Glycine 0 N--CA 1.417 -2.601 0 N-CA-C 108.238 -1.945 . . . . 62.310000000000002 108.238 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -114.89 99.78 7.73 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 117.835 0.817 . . . . 73.120000000000005 109.476 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -80.09 113.95 18.64 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-O 121.482 0.658 . . . . 73.040000000000006 109.66 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.15 -35.52 15.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 107.454 -1.313 . . . . 73.329999999999998 107.454 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -143.46 166.5 19.54 Favored Pre-proline 0 N--CA 1.431 -1.389 0 N-CA-C 107.446 -1.316 . . . . 73.439999999999998 107.446 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -72.59 -0.05 8.26 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.342 2.028 . . . . 64.129999999999995 111.279 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 11.5 pt-20 -129.83 5.88 5.05 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.729 -0.668 . . . . 74.219999999999999 110.864 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.413 HG23 ' HG3' ' A' ' 158' ' ' GLU . 90.6 t -144.81 121.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.44 -0.578 . . . . 71.540000000000006 109.44 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.17 145.55 33.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 109.183 -0.673 . . . . 71.25 109.183 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -134.93 146.34 49.05 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.817 -0.808 . . . . 72.329999999999998 108.817 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.407 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.6 m-90 -121.95 122.35 39.16 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.295 -1.002 . . . . 73.040000000000006 108.295 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -88.07 109.5 19.91 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.173 -1.047 . . . . 75.299999999999997 108.173 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 30.9 mt -102.07 125.1 48.68 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 121.486 0.66 . . . . 75.450000000000003 110.271 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 165' ' ' LYS . 5.4 mmpt? -118.03 150.23 47.0 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 114.903 -1.044 . . . . 64.230000000000004 110.553 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.435 ' HD3' ' HE2' ' A' ' 165' ' ' LYS . 10.8 Cg_exo -72.07 159.46 50.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.134 1.889 . . . . 75.420000000000002 110.775 173.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.97 -35.63 2.91 Favored Glycine 0 C--N 1.312 -0.785 0 N-CA-C 111.7 -0.56 . . . . 72.329999999999998 111.7 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.28 155.06 6.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.438 -0.381 . . . . 54.549999999999997 110.139 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.6 p -113.09 116.03 51.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 109.055 -0.721 . . . . 54.329999999999998 109.055 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.1 m -116.3 144.47 44.2 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.01 -0.737 . . . . 74.430000000000007 109.01 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 124' ' ' ARG . 45.0 p -115.6 152.18 33.57 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-O 121.015 0.436 . . . . 73.340000000000003 110.762 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -102.3 116.79 33.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.48 -1.304 . . . . 63.310000000000002 107.48 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.641 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 18.0 t -120.27 130.2 54.38 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 107.231 -1.396 . . . . 75.420000000000002 107.231 173.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -152.53 132.14 13.08 Favored 'General case' 0 CA--C 1.473 -1.982 0 N-CA-C 109.344 -0.613 . . . . 75.310000000000002 109.344 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.414 ' HG2' HG22 ' A' ' 120' ' ' ILE . 47.3 mt-30 -133.1 129.75 38.38 Favored 'General case' 0 C--N 1.268 -2.938 0 N-CA-C 107.511 -1.292 . . . . 70.430000000000007 107.511 174.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -150.59 155.28 39.12 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.955 -0.566 . . . . 74.510000000000005 110.097 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 177' ' ' ARG . 42.3 mtt180 -87.76 125.31 34.35 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.912 -1.144 . . . . 54.020000000000003 107.912 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -132.03 123.31 27.01 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 108.986 -0.746 . . . . 70.5 108.986 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.41 ' HA ' HD21 ' A' ' 117' ' ' ASN . 0.8 OUTLIER -61.41 113.99 2.96 Favored 'General case' 0 C--N 1.276 -2.621 0 O-C-N 124.085 0.865 . . . . 73.019999999999996 110.913 178.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.544 ' HA ' ' NH2' ' A' ' 114' ' ' ARG . 1.8 m-20 -54.51 146.16 35.24 Favored Pre-proline 0 C--O 1.212 -0.886 0 CA-C-N 114.953 -1.021 . . . . 73.329999999999998 110.341 176.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.21 -33.36 90.45 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 122.935 2.423 . . . . 72.340000000000003 111.401 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.58 ' ND2' ' HG2' ' A' ' 184' ' ' ARG . 0.2 OUTLIER -83.61 -10.39 58.27 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.743 -1.117 . . . . 75.340000000000003 111.458 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.508 ' N ' HD22 ' A' ' 182' ' ' ASN . 51.9 p 49.84 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.608 1.563 . . . . 71.109999999999999 114.029 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.58 ' HG2' ' ND2' ' A' ' 182' ' ' ASN . 26.6 mmt180 -121.6 149.97 42.37 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 116.006 -0.543 . . . . 75.510000000000005 111.213 -176.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 107.512 -1.292 . . . . 75.400000000000006 107.512 176.445 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.146 0 N-CA-C 110.689 -0.964 . . . . 43.049999999999997 110.689 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -81.67 100.08 9.26 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.189 -1.412 . . . . 73.109999999999999 107.189 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -138.91 111.82 7.84 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 113.211 0.819 . . . . 74.5 113.211 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -168.44 157.59 9.06 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 104.499 -2.408 . . . . 73.310000000000002 104.499 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.16 -70.85 0.16 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.727 -0.842 . . . . 52.340000000000003 108.727 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.9 t80 66.34 111.65 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.33 1.052 . . . . 65.129999999999995 110.833 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -144.44 157.06 44.43 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 122.069 -0.394 . . . . 60.200000000000003 110.896 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 74.58 133.28 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.477 1.511 . . . . 63.409999999999997 112.656 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.52 -12.56 1.2 Allowed Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.669 -0.777 . . . . 53.329999999999998 112.22 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 69.44 -73.11 0.09 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.564 1.546 . . . . 75.340000000000003 107.805 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.56 ' HG3' ' OD2' ' A' ' 134' ' ' ASP . 35.6 mtt -105.69 87.69 2.65 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 109.042 -0.725 . . . . 72.150000000000006 109.042 172.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 pp -104.82 122.46 45.79 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 107.856 -1.164 . . . . 73.430000000000007 107.856 173.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 55.1 mtm180 -114.0 124.29 51.78 Favored 'General case' 0 C--N 1.269 -2.916 0 N-CA-C 109.22 -0.659 . . . . 74.049999999999997 109.22 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.94 114.14 44.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.057 -1.46 . . . . 61.509999999999998 107.057 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -114.54 113.29 24.22 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.633 -0.877 . . . . 74.450000000000003 108.633 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -106.93 107.74 18.91 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.238 -1.393 . . . . 64.340000000000003 107.238 176.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 140' ' ' THR . 22.5 m -119.08 115.36 24.13 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 109.224 -0.658 . . . . 40.219999999999999 109.224 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 2.1 pp -123.41 146.47 28.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 120.39 -0.524 . . . . 51.299999999999997 110.238 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 31.5 m -123.52 121.02 34.59 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 108.468 -0.938 . . . . 63.43 108.468 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 tt -116.06 118.63 59.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.91 0.862 . . . . 64.140000000000001 111.313 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HA ' ' HD2' ' A' ' 144' ' ' PRO . 17.9 m -87.26 148.39 44.64 Favored Pre-proline 0 N--CA 1.417 -2.12 0 CA-C-N 114.775 -1.102 . . . . 62.549999999999997 108.93 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.74 2.88 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 124.392 3.395 . . . . 71.340000000000003 113.755 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -91.02 1.61 56.95 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.226 1.01 . . . . 74.120000000000005 108.511 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 91' ' ' THR . 9.0 t70 72.48 28.73 2.21 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.015 1.726 . . . . 72.219999999999999 107.017 -176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.56 124.5 49.42 Favored 'General case' 0 N--CA 1.389 -3.501 0 CA-C-N 113.887 -1.506 . . . . 73.200000000000003 107.688 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.62 136.17 53.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.144 -1.058 . . . . 63.43 108.144 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.3 p -141.41 160.53 39.93 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 106.131 -1.803 . . . . 50.240000000000002 106.131 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.3 -165.82 39.19 Favored Glycine 0 CA--C 1.489 -1.541 0 C-N-CA 117.826 -2.13 . . . . 44.450000000000003 113.635 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HB2' HD11 ' A' ' 45' ' ' ILE . 10.5 pt-20 -157.08 133.58 9.92 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 123.51 0.724 . . . . 70.319999999999993 110.218 -175.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 3.4 mp -117.53 115.45 48.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 105.919 -1.882 . . . . 75.400000000000006 105.919 170.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 43' ' ' GLU . 5.0 mm -108.41 121.37 61.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.348 -0.982 . . . . 62.450000000000003 108.348 -175.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.493 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.98 108.86 16.77 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.33 -0.989 . . . . 61.310000000000002 108.33 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.11 122.87 38.4 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.762 0.315 . . . . 45.450000000000003 111.046 -176.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.66 158.96 28.9 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.665 -0.698 . . . . 64.310000000000002 110.913 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HG2' ' HB2' ' A' ' 25' ' ' MET . 71.7 mmtt -66.2 136.85 95.43 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 107.49 -1.3 . . . . 73.150000000000006 107.49 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.64 112.61 1.11 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.375 2.05 . . . . 52.5 111.052 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.41 ' C ' HD22 ' A' ' 52' ' ' ASN . 27.4 tptp -84.24 -25.58 29.31 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.999 0.428 . . . . 64.5 110.98 -173.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -128.92 171.66 12.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.286 -0.259 . . . . 61.109999999999999 110.636 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 p -69.06 -52.58 27.09 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.424 0.63 . . . . 54.020000000000003 111.057 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -87.41 7.89 27.05 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.816 -0.629 . . . . 71.049999999999997 110.932 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 52' ' ' ASN . 13.3 t0 -73.02 108.91 6.18 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 115.551 -0.75 . . . . 72.120000000000005 109.845 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.586 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 4.1 t -90.65 -29.71 17.58 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.562 -1.199 . . . . 74.109999999999999 110.643 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.08 131.09 1.31 Allowed Glycine 0 N--CA 1.423 -2.204 0 CA-C-O 118.294 -1.281 . . . . 54.530000000000001 111.184 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -52.49 128.84 29.4 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 120.127 1.964 . . . . 73.310000000000002 109.205 169.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.04 163.39 14.92 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.903 0.705 . . . . 62.210000000000001 112.903 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 mt -121.61 124.52 44.52 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.37 -0.974 . . . . 74.420000000000002 108.37 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -112.51 90.39 3.33 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.063 0.459 . . . . 75.299999999999997 110.497 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.98 79.63 0.3 Allowed Glycine 0 C--N 1.3 -1.42 0 C-N-CA 121.021 -0.609 . . . . 14.41 111.802 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -87.88 105.18 17.25 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.685 0.755 . . . . 72.140000000000001 108.968 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.9 m -109.08 163.82 16.12 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 114.651 -1.159 . . . . 74.319999999999993 109.43 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.4 -16.91 50.25 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.744 2.296 . . . . 74.040000000000006 112.554 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -113.15 36.01 3.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.588 -0.733 . . . . 64.430000000000007 111.076 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.2 m -59.66 -29.08 67.81 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 112.463 0.542 . . . . 65.129999999999995 112.463 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.478 ' H ' ' NE2' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -74.46 -7.85 54.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.912 -0.715 . . . . 74.299999999999997 111.667 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.81 -11.5 26.76 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.797 -0.446 . . . . 70.109999999999999 109.797 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.73 120.76 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 122.135 0.969 . . . . 75.109999999999999 111.847 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.48 106.43 18.4 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.451 -0.795 . . . . 51.219999999999999 108.931 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.2 t -98.24 132.25 43.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.465 -1.309 . . . . 63.310000000000002 107.465 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.9 m -144.76 165.35 28.33 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.629 0.252 . . . . 43.25 111.538 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -87.66 128.9 35.28 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.419 -0.956 . . . . 73.439999999999998 108.419 178.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 60.6 t80 -92.66 125.26 37.21 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 123.88 0.872 . . . . 71.310000000000002 109.858 -177.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -140.06 98.91 3.55 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.894 -1.15 . . . . 64.209999999999994 107.894 171.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 53.2 m -163.75 153.09 14.37 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.491 -1.3 . . . . 72.230000000000004 107.491 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.72 4.03 4.54 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.885 0.874 . . . . 72.209999999999994 111.574 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.08 0.72 73.77 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.591 -1.003 . . . . 72.450000000000003 110.591 -174.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -100.79 151.29 21.86 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 109.181 -0.674 . . . . 73.230000000000004 109.181 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 56' ' ' THR . 34.7 m -127.81 138.77 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 109.074 -0.713 . . . . 72.109999999999999 109.074 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -171.72 -153.54 9.19 Favored Glycine 0 C--N 1.277 -2.721 0 N-CA-C 110.89 -0.884 . . . . 73.450000000000003 110.89 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.4 m -140.64 145.22 36.33 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 109.812 -0.44 . . . . 32.520000000000003 109.812 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.49 155.72 43.29 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 120.586 -0.446 . . . . 74.299999999999997 110.442 177.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.47 114.35 21.12 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.695 -1.224 . . . . 73.299999999999997 107.695 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.21 113.13 43.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.691 -0.855 . . . . 74.010000000000005 108.691 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CD2' HD12 ' A' ' 90' ' ' LEU . 54.3 p90 -113.0 164.19 13.76 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.928 -0.709 . . . . 73.209999999999994 112.4 -174.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 p -157.91 155.75 30.09 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.655 -1.157 . . . . 45.420000000000002 109.931 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 67.12 30.88 7.11 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.011 1.115 . . . . 73.340000000000003 114.011 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 87' ' ' PHE . 52.1 mt -103.01 166.7 10.29 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.456 -0.498 . . . . 63.240000000000002 111.438 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 41.1 p -113.78 172.64 6.86 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.693 -0.231 . . . . 73.219999999999999 111.613 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -54.94 -37.63 66.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.626 0.77 . . . . 70.120000000000005 109.767 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.43 -25.77 62.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.094 -0.503 . . . . 74.109999999999999 111.844 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.29 -16.88 28.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.801 0.334 . . . . 63.240000000000002 111.635 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 44.0 tp -58.16 -48.11 97.63 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 113.1 0.778 . . . . 65.230000000000004 113.1 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.24 -34.96 76.76 Favored 'Trans proline' 0 C--N 1.372 1.812 0 CA-C-N 120.826 1.331 . . . . 74.230000000000004 110.794 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -64.65 -40.89 96.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.134 -0.484 . . . . 64.340000000000003 111.263 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -74.64 -19.36 60.32 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.687 -0.486 . . . . 73.030000000000001 109.687 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -69.97 -20.7 63.3 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.993 -0.549 . . . . 74.340000000000003 110.024 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -61.53 -57.93 10.14 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.257 -1.016 . . . . 62.240000000000002 108.257 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 33.6 ttp -56.38 -45.41 80.55 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.813 -0.631 . . . . 73.030000000000001 110.249 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 6.9 t30 -53.13 -44.54 67.79 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.086 -0.961 . . . . 74.519999999999996 111.046 177.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 p -68.73 -22.34 64.33 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.972 -0.691 . . . . 63.009999999999998 111.832 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.58 -25.15 67.28 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-O 121.192 0.52 . . . . 74.340000000000003 110.035 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -105.67 -11.16 16.42 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.007 -0.542 . . . . 63.549999999999997 110.432 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.55 -47.3 3.96 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.982 0.734 . . . . 73.010000000000005 112.982 -171.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.05 28.42 54.11 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.256 -0.973 . . . . 71.409999999999997 111.05 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.12 170.42 13.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 120.77 0.319 . . . . 64.510000000000005 110.682 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.44 HD22 ' N ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -118.68 126.28 51.57 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.822 -1.547 . . . . 75.010000000000005 106.822 177.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 109' ' ' ASN . 93.5 mt -123.71 134.23 53.74 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.985 -0.746 . . . . 71.340000000000003 108.985 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.2 m -144.13 142.37 30.54 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.739 -0.467 . . . . 73.25 109.739 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.93 146.4 30.12 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.321 -0.622 . . . . 73.25 109.321 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -138.03 148.54 45.2 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.74 -0.664 . . . . 72.349999999999994 110.613 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.427 ' CG ' HG22 ' A' ' 119' ' ' VAL . 6.6 mtt85 -90.1 137.75 32.09 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.5 -0.556 . . . . 71.439999999999998 109.5 171.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.422 ' O ' HG13 ' A' ' 118' ' ' ILE . 43.3 t30 -135.36 101.36 4.8 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.653 -0.869 . . . . 73.239999999999995 108.653 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.55 -106.97 2.03 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 109.935 -1.266 . . . . 52.049999999999997 109.935 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.441 HD21 ' HA ' ' A' ' 179' ' ' THR . 3.0 t-20 -115.96 -5.45 11.99 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.503 1.144 . . . . 62.509999999999998 108.864 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -105.25 149.54 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 115.513 -0.767 . . . . 74.099999999999994 109.62 -175.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.427 HG22 ' CG ' ' A' ' 114' ' ' ARG . 99.1 t -111.12 134.76 52.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 109.816 -0.439 . . . . 54.509999999999998 109.816 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.45 HG22 ' HG2' ' A' ' 175' ' ' GLN . 47.4 pt -108.47 137.7 38.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.048 -1.094 . . . . 74.030000000000001 108.048 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -128.08 131.44 49.07 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 108.988 -0.745 . . . . 70.310000000000002 108.988 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -135.52 122.03 20.68 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.291 -0.868 . . . . 63.020000000000003 109.655 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.68 136.73 8.65 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.451 -0.881 . . . . 73.329999999999998 111.533 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -121.34 137.61 54.62 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 118.001 0.901 . . . . 75.219999999999999 109.645 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -130.16 110.15 11.36 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.21 0.529 . . . . 74.219999999999999 111.11 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.69 107.4 17.42 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 108.129 -1.063 . . . . 64.439999999999998 108.129 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 130' ' ' VAL . 2.7 mm? -110.14 21.98 16.11 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.931 0.396 . . . . 74.340000000000003 109.993 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 167' ' ' GLY . 39.2 p -64.75 -25.64 68.02 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 113.05 0.759 . . . . 73.230000000000004 113.05 -177.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.1 t -84.03 -19.92 33.6 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 112.583 0.586 . . . . 62.240000000000002 112.583 -175.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 127' ' ' LEU . 11.9 p -70.82 135.32 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 119.786 -0.766 . . . . 75.549999999999997 110.438 -176.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.444 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 17.4 m -98.02 14.75 26.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.094 0.473 . . . . 74.109999999999999 111.532 -176.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 130' ' ' VAL . 10.1 m-20 -110.62 90.7 10.9 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 107.908 -1.145 . . . . 55.039999999999999 107.908 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 131' ' ' SER . 6.7 Cg_exo -75.19 -13.51 21.01 Favored 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.024 2.483 . . . . 75.140000000000001 113.14 -175.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.56 ' OD2' ' HG3' ' A' ' 25' ' ' MET . 27.0 t0 -99.16 18.44 17.47 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.558 1.171 . . . . 63.25 109.28 -173.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.48 154.8 17.62 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.525 -1.216 . . . . 74.409999999999997 111.097 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 8.5 m-20 -133.07 132.54 41.89 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.193 -0.317 . . . . 71.239999999999995 111.151 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 86.5 t -117.03 124.43 73.0 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 N-CA-C 108.463 -0.94 . . . . 73.450000000000003 108.463 176.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -121.23 133.92 55.18 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 122.336 -0.227 . . . . 71.549999999999997 110.568 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.557 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.7 tm? -119.8 118.12 29.99 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.697 -1.964 . . . . 34.340000000000003 105.697 176.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 31' ' ' SER . 18.2 m -126.6 131.55 51.48 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.356 -0.609 . . . . 63.450000000000003 109.356 -177.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 65.8 t -124.87 126.59 71.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.467 -0.568 . . . . 65.349999999999994 109.467 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -114.09 126.17 54.79 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.33 -0.989 . . . . 44.020000000000003 108.33 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.597 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.8 p90 -134.1 120.91 15.34 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 112.576 0.584 . . . . 72.140000000000001 112.576 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 26.2 Cg_exo -67.83 39.64 0.2 Allowed 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 123.59 2.86 . . . . 74.409999999999997 112.798 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.62 -107.23 0.33 Allowed 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.529 -0.545 . . . . 64.420000000000002 109.529 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.81 129.18 0.11 Allowed 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.601 -0.889 . . . . 61.340000000000003 108.601 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.59 134.91 26.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.594 -0.891 . . . . 64.329999999999998 108.594 177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.5 p -92.36 -38.52 11.98 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.229 0.537 . . . . 74.319999999999993 109.684 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.4 m -161.37 132.96 5.55 Favored 'General case' 0 C--O 1.208 -1.12 0 C-N-CA 123.212 0.605 . . . . 72.209999999999994 109.466 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.2 t -139.7 155.67 47.24 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.121 -0.632 . . . . 74.310000000000002 111.124 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -123.13 95.4 4.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 104.898 -2.26 . . . . 65.420000000000002 104.898 172.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.475 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.33 -155.51 24.48 Favored Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 107.508 -2.237 . . . . 42.32 107.508 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -107.01 99.85 9.38 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.131 0.965 . . . . 61.340000000000003 110.579 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -79.43 114.38 18.32 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.86 -0.609 . . . . 73.030000000000001 109.718 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.5 mt -80.85 -39.48 17.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.42 -1.326 . . . . 73.510000000000005 107.42 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -135.17 168.9 15.41 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 106.472 -1.677 . . . . 73.209999999999994 106.472 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.22 0.33 9.51 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.042 1.828 . . . . 64.349999999999994 109.822 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.5 pt-20 -134.89 10.03 3.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.2 -0.909 . . . . 72.430000000000007 112.109 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.9 t -145.87 120.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.813 -1.18 . . . . 53.020000000000003 107.813 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.99 147.4 32.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.87 -0.789 . . . . 73.150000000000006 108.87 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -137.63 146.65 44.17 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.318 -0.401 . . . . 72.519999999999996 110.019 -176.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.557 ' CE3' HD12 ' A' ' 139' ' ' LEU . 22.8 m-90 -130.1 130.97 45.51 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.995 -1.113 . . . . 74.129999999999995 107.995 176.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -112.59 105.39 13.58 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.638 0.732 . . . . 75.400000000000006 110.632 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.3 mm? -94.03 134.5 36.38 Favored 'General case' 0 C--O 1.271 2.222 0 CA-C-N 115.64 -0.709 . . . . 73.450000000000003 110.493 -175.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 168' ' ' VAL . 1.4 tpmt? -103.31 145.65 30.99 Favored Pre-proline 0 N--CA 1.419 -2.01 0 C-N-CA 124.063 0.945 . . . . 71.209999999999994 108.98 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -68.25 157.76 60.44 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 122.789 2.326 . . . . 74.129999999999995 110.813 173.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.524 ' O ' HG22 ' A' ' 128' ' ' THR . . . 77.61 -22.39 2.74 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 121.054 -0.593 . . . . 73.219999999999999 113.483 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 165' ' ' LYS . 5.7 m -106.07 167.8 3.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 121.485 0.659 . . . . 41.420000000000002 111.636 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.89 135.94 53.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.833 -1.173 . . . . 64.319999999999993 107.833 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 36.7 m -149.05 163.9 36.21 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.626 -0.509 . . . . 62.229999999999997 109.626 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 t -139.01 146.14 40.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.403 0.62 . . . . 71.420000000000002 111.311 175.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.2 ptp -112.88 142.91 44.99 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.389 -1.278 . . . . 74.230000000000004 108.763 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.4 m -143.14 147.09 34.39 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 120.044 -0.662 . . . . 74.340000000000003 110.027 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -154.33 147.55 24.81 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 109.1 -0.704 . . . . 73.099999999999994 109.1 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.45 ' HG2' HG22 ' A' ' 120' ' ' ILE . 42.0 mt-30 -141.15 131.52 25.15 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 107.436 -1.32 . . . . 74.219999999999999 107.436 174.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -154.22 149.16 26.71 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.279 -1.378 . . . . 63.340000000000003 107.279 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.593 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 16.3 ptt180 -93.27 146.65 23.55 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 118.581 -1.248 . . . . 63.119999999999997 110.925 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.402 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 98.6 m-85 -142.33 129.19 20.6 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 109.316 -0.624 . . . . 70.140000000000001 109.316 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.441 ' HA ' HD21 ' A' ' 117' ' ' ASN . 5.4 p -67.58 121.16 15.26 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.403 -0.817 . . . . 63.210000000000001 111.317 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.08 126.77 88.25 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 115.413 -0.812 . . . . 55.229999999999997 109.238 174.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.74 -24.44 34.74 Favored 'Trans proline' 0 C--N 1.329 -0.484 0 C-N-CA 122.678 2.252 . . . . 74.049999999999997 110.531 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -84.29 -11.25 56.73 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.453 -1.249 . . . . 73.019999999999996 109.861 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p 51.94 89.05 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.41 1.484 . . . . 75.129999999999995 112.411 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.76 158.1 17.04 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.38 0.61 . . . . 72.319999999999993 112.43 -176.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.413 -2.276 0 N-CA-C 106.712 -1.588 . . . . 63.32 106.712 176.681 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.578 0 N-CA-C 111.554 -0.618 . . . . 61.009999999999998 111.554 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.405 ' HG2' ' HG3' ' A' ' 17' ' ' GLU . 46.4 ttt180 -104.5 -63.63 1.19 Allowed 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.254 -0.647 . . . . 71.329999999999998 109.254 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 30.9 mt-10 -145.98 57.34 1.21 Allowed 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 106.062 -1.829 . . . . 64.439999999999998 106.062 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -94.07 6.45 48.49 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.452 -1.704 . . . . 64.420000000000002 109.631 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.4 mt -84.48 77.85 9.94 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.199 -1.037 . . . . 53.520000000000003 108.199 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -129.33 80.16 1.95 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.415 -0.811 . . . . 65.519999999999996 109.112 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -123.11 84.72 2.31 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-O 121.97 0.89 . . . . 73.319999999999993 110.384 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -116.91 165.64 13.1 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 114.35 -1.295 . . . . 70.200000000000003 109.318 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.45 -96.92 0.13 Allowed Glycine 0 N--CA 1.416 -2.665 0 N-CA-C 109.395 -1.482 . . . . 71.030000000000001 109.395 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.484 ' O ' ' HG3' ' A' ' 25' ' ' MET . 48.2 m-70 46.5 62.08 2.48 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 114.397 1.258 . . . . 75.409999999999997 114.397 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.588 ' O ' ' HA ' ' A' ' 48' ' ' ALA . 34.8 mtt -174.43 102.61 0.1 Allowed 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 126.831 2.053 . . . . 65.140000000000001 107.106 176.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.4 OUTLIER -144.11 98.54 3.23 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 122.074 0.94 . . . . 74.239999999999995 110.678 177.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.0 mtp180 -121.57 134.32 55.02 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.126 -1.064 . . . . 75.140000000000001 108.126 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.5 t -117.09 115.02 47.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.317 -0.994 . . . . 51.149999999999999 108.317 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -115.5 120.87 40.95 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 121.074 0.464 . . . . 61.310000000000002 110.432 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -115.25 108.64 16.84 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.443 -0.947 . . . . 75.5 108.443 178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 140' ' ' THR . 34.9 m -117.7 117.37 29.17 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.854 -1.165 . . . . 64.319999999999993 107.854 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -125.73 146.65 31.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 109.776 -0.453 . . . . 74.230000000000004 109.776 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.8 m -125.65 122.58 36.8 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.344 0.593 . . . . 73.340000000000003 109.908 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 143' ' ' PHE . 10.2 tt -101.98 119.01 49.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 108.714 -0.847 . . . . 72.109999999999999 108.714 176.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.5 m -87.43 160.64 47.67 Favored Pre-proline 0 N--CA 1.424 -1.757 0 CA-C-N 115.658 -0.701 . . . . 71.319999999999993 110.158 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -64.92 2.1 1.52 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 123.777 2.984 . . . . 74.549999999999997 113.595 -177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.18 -7.21 57.23 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.192 -0.669 . . . . 75.530000000000001 109.192 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.4 t70 72.54 29.12 2.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 106.86 -1.533 . . . . 74.25 106.86 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.4 146.76 37.78 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.945 -1.502 . . . . 73.540000000000006 106.945 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.516 HG11 HD13 ' A' ' 95' ' ' LEU . 21.2 t -118.39 140.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-O 121.066 0.46 . . . . 54.210000000000001 110.096 -176.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.0 p -137.22 161.82 35.15 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.624 -1.621 . . . . 52.109999999999999 106.624 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.64 -176.35 46.9 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 119.407 -1.377 . . . . 73.439999999999998 112.158 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.54 133.41 14.05 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.412 0.625 . . . . 62.200000000000003 110.273 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 65.0 mt -121.14 116.01 48.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.835 -1.172 . . . . 74.120000000000005 107.835 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.66 119.01 60.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.334 -0.617 . . . . 61.549999999999997 109.334 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.419 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -110.21 108.63 18.83 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.612 -1.625 . . . . 44.32 106.612 174.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -119.86 131.51 55.29 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 120.885 0.374 . . . . 70.400000000000006 111.088 -175.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 25' ' ' MET . . . -139.58 158.35 44.26 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.478 -0.783 . . . . 44.350000000000001 112.763 -173.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 49.43 101.12 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 115.655 1.724 . . . . 55.210000000000001 115.655 168.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.778 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 83.7 Cg_exo -51.84 -52.23 9.44 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.14 2.56 . . . . 61.310000000000002 112.488 178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -151.64 116.65 5.22 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.6 -0.518 . . . . 60.229999999999997 109.6 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -126.22 158.22 36.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.56 -1.274 . . . . 73.230000000000004 107.56 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 p -66.31 -55.38 16.28 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 122.983 0.513 . . . . 73.109999999999999 112.256 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -105.7 -16.18 14.76 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.516 0.562 . . . . 74.340000000000003 112.516 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -96.88 101.62 13.24 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.055 -0.721 . . . . 73.349999999999994 109.055 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t -119.08 2.09 11.43 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.885 -1.052 . . . . 52.25 109.789 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.8 97.81 0.11 Allowed Glycine 0 N--CA 1.42 -2.37 0 C-N-CA 118.846 -1.645 . . . . 52.229999999999997 113.694 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 83' ' ' SER . 74.7 Cg_exo -55.55 151.36 38.6 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.391 2.06 . . . . 71.530000000000001 109.927 166.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.83 119.66 19.48 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.758 -0.46 . . . . 33.350000000000001 109.758 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 81.9 mt -69.63 137.3 52.13 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 123.54 0.525 . . . . 71.129999999999995 110.421 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -97.34 100.04 11.49 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.452 -0.944 . . . . 70.420000000000002 108.452 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.656 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -150.24 92.28 0.14 Allowed Glycine 0 C--N 1.277 -2.721 0 C-N-CA 120.156 -1.021 . . . . 72.409999999999997 113.233 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -106.15 99.67 9.24 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.048 -1.093 . . . . 74.530000000000001 108.048 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.73 155.89 48.47 Favored Pre-proline 0 C--N 1.286 -2.182 0 CA-C-N 115.501 -0.772 . . . . 70.219999999999999 108.958 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.27 -19.08 48.48 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.911 2.407 . . . . 70.549999999999997 112.941 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -107.82 32.75 4.5 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.792 -0.64 . . . . 72.340000000000003 112.212 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.4 m -56.58 -25.64 53.1 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.552 0.215 . . . . 65.040000000000006 111.406 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -64.72 -16.83 63.49 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.116 0.484 . . . . 74.140000000000001 110.599 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -103.11 -15.81 15.94 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.676 -0.693 . . . . 72.439999999999998 110.633 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.7 p -123.97 118.27 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 CA-C-O 122.106 0.955 . . . . 55.43 111.406 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.03 109.01 21.1 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.603 -1.181 . . . . 74.439999999999998 109.319 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.5 t -97.95 114.36 35.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 106.812 -1.551 . . . . 53.299999999999997 106.812 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 m -125.68 171.8 10.3 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.729 -0.668 . . . . 72.340000000000003 109.796 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -88.25 151.1 22.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.397 -1.334 . . . . 73.430000000000007 107.397 174.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 67.7 t80 -115.3 125.05 52.8 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 108.299 -1.0 . . . . 71.129999999999995 108.299 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -138.69 99.61 3.85 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.566 -2.013 . . . . 60.210000000000001 105.566 174.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 42.6 t -172.51 148.04 1.95 Allowed 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.403 -0.962 . . . . 75.099999999999994 108.403 -174.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 69.32 10.04 7.59 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.998 0.919 . . . . 63.039999999999999 111.079 174.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.778 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 95.02 -3.78 67.31 Favored Glycine 0 N--CA 1.423 -2.173 0 CA-C-N 115.279 -0.873 . . . . 73.140000000000001 111.782 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.538 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 41.5 m-85 -104.2 146.28 29.0 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 117.374 0.587 . . . . 74.319999999999993 110.491 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.77 136.5 51.23 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.105 0 N-CA-C 108.308 -0.997 . . . . 73.519999999999996 108.308 172.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.478 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -167.1 -155.17 8.89 Favored Glycine 0 C--N 1.263 -3.492 0 C-N-CA 118.863 -1.637 . . . . 52.100000000000001 112.512 -177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' A' ' 58' ' ' PRO . 24.0 t -136.97 143.73 42.97 Favored 'General case' 0 C--N 1.267 -2.995 0 N-CA-C 108.641 -0.874 . . . . 71.519999999999996 108.641 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -131.86 137.42 48.05 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 115.952 -0.567 . . . . 72.319999999999993 110.947 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.21 114.21 27.26 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.743 -1.577 . . . . 75.099999999999994 106.743 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.96 120.7 62.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.966 -1.124 . . . . 75.219999999999999 107.966 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.497 ' CD2' HD12 ' A' ' 90' ' ' LEU . 45.2 p90 -126.73 149.48 49.58 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.786 -0.765 . . . . 63.350000000000001 111.62 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.4 m -156.23 152.09 27.36 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.765 -0.652 . . . . 74.099999999999994 109.484 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.3 t70 64.46 48.75 2.62 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 122.577 1.18 . . . . 61.340000000000003 111.111 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 87' ' ' PHE . 23.2 mt -112.07 169.88 8.54 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.041 -0.982 . . . . 74.030000000000001 108.584 175.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.507 HG22 ' OE1' ' A' ' 94' ' ' GLU . 13.1 t -128.38 -178.84 4.72 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.923 -1.111 . . . . 70.150000000000006 110.955 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -50.32 -42.84 53.35 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.329 1.452 . . . . 64.140000000000001 111.146 -177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.37 -27.97 69.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.46 0.541 . . . . 44.530000000000001 112.46 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.507 ' OE1' HG22 ' A' ' 91' ' ' THR . 3.9 mp0 -88.48 -17.61 29.98 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 112.559 0.577 . . . . 73.310000000000002 112.559 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.516 HD13 HG11 ' A' ' 40' ' ' VAL . 40.4 tp -57.62 -47.38 99.06 Favored Pre-proline 0 CA--C 1.567 1.629 0 N-CA-C 113.807 1.04 . . . . 74.129999999999995 113.807 -177.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.64 -32.32 7.76 Favored 'Trans proline' 0 C--N 1.359 1.1 0 CA-C-N 120.72 1.293 . . . . 41.100000000000001 110.96 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -68.92 -34.68 75.78 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.992 -0.549 . . . . 75.349999999999994 111.29 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -74.16 -19.13 60.66 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.9 0.381 . . . . 73.230000000000004 110.189 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.26 -22.64 63.82 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.873 -0.603 . . . . 65.439999999999998 110.678 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -58.5 -57.87 11.02 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.638 -0.875 . . . . 65.140000000000001 108.638 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.656 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.5 ttp -54.46 -50.33 67.95 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.436 -0.802 . . . . 73.439999999999998 110.062 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -55.03 -40.07 69.81 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 114.854 -1.066 . . . . 71.310000000000002 111.367 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.9 p -69.47 -19.25 63.76 Favored 'General case' 0 N--CA 1.42 -1.967 0 C-N-CA 119.63 -0.828 . . . . 72.230000000000004 112.631 -171.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.34 -28.29 69.9 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 121.583 0.706 . . . . 62.530000000000001 110.06 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.7 -8.2 16.97 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.932 -0.577 . . . . 75.120000000000005 110.829 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -107.19 -34.29 7.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.557 0.947 . . . . 43.539999999999999 113.557 -174.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.69 26.77 66.52 Favored Glycine 0 N--CA 1.46 0.264 0 N-CA-C 111.125 -0.79 . . . . 74.230000000000004 111.125 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -103.22 156.35 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.673 0.749 . . . . 75.099999999999994 112.376 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.44 HD22 ' N ' ' A' ' 109' ' ' ASN . 0.7 OUTLIER -117.56 121.45 40.98 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.964 -2.606 . . . . 70.450000000000003 103.964 171.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 98.9 mt -123.29 134.39 54.07 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 118.382 0.537 . . . . 72.340000000000003 111.185 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.7 m -126.66 128.04 46.11 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.575 -0.898 . . . . 75.420000000000002 108.575 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 tp -125.86 125.25 42.53 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.577 -0.527 . . . . 63.439999999999998 109.577 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -138.02 145.76 42.24 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.663 -0.495 . . . . 73.5 109.663 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -98.85 137.95 36.68 Favored 'General case' 0 N--CA 1.399 -3.008 0 N-CA-C 107.71 -1.219 . . . . 74.099999999999994 107.71 175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.413 ' O ' HG13 ' A' ' 118' ' ' ILE . 46.8 t30 -124.77 87.08 2.65 Favored 'General case' 0 C--N 1.269 -2.897 0 N-CA-C 107.469 -1.308 . . . . 63.420000000000002 107.469 -177.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.52 -115.99 5.57 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 109.576 -1.41 . . . . 61.539999999999999 109.576 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -104.95 -1.88 25.27 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.106 0.955 . . . . 74.239999999999995 108.889 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.549 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -101.84 148.99 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.799 -1.186 . . . . 53.520000000000003 107.799 179.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.1 t -117.28 138.53 47.64 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 O-C-N 121.762 -0.586 . . . . 72.120000000000005 110.59 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.5 pt -120.5 135.49 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-O 121.542 0.687 . . . . 75.150000000000006 109.81 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.9 tt -128.18 127.0 42.11 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 107.351 -1.351 . . . . 63.229999999999997 107.351 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.99 139.58 41.55 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.671 -0.863 . . . . 74.209999999999994 108.671 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.98 -175.57 34.99 Favored Glycine 0 N--CA 1.402 -3.625 0 C-N-CA 120.345 -0.931 . . . . 61.030000000000001 111.472 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -145.47 157.3 44.03 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.117 -1.068 . . . . 65.530000000000001 108.117 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.3 109.54 11.56 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.797 -0.446 . . . . 53.520000000000003 109.797 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -112.7 93.63 4.52 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.641 -0.874 . . . . 53.25 108.641 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.348 0.0 OUTLIER -125.36 54.64 1.45 Allowed 'General case' 0 C--N 1.288 -2.079 0 CA-C-O 124.257 1.979 . . . . 74.019999999999996 109.677 176.065 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 34.4 p -84.58 -30.41 25.05 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.235 -2.257 . . . . 74.409999999999997 111.499 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.6 m -71.05 -24.95 62.44 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.414 -0.357 . . . . 72.430000000000007 111.909 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.65 119.1 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 106.952 -1.499 . . . . 70.239999999999995 106.952 173.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.3 t -117.84 8.89 12.76 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.09 -0.644 . . . . 73.030000000000001 111.232 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.01 116.06 11.38 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.351 -0.611 . . . . 72.099999999999994 109.351 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.68 -12.75 37.17 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 122.92 2.413 . . . . 65.25 113.552 -173.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -97.21 14.4 26.08 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 123.568 0.747 . . . . 75.439999999999998 110.521 -177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -98.69 129.17 45.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 111.73 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -133.76 127.08 32.02 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.27 -1.011 . . . . 54.210000000000001 108.27 171.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 66.3 t -114.53 112.97 42.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 107.94 -1.133 . . . . 63.420000000000002 107.94 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -107.51 122.07 45.91 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.612 -0.514 . . . . 55.509999999999998 109.612 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.572 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.8 tm? -111.8 119.16 37.66 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.383 -1.71 . . . . 74.040000000000006 106.383 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 31' ' ' SER . 7.1 m -126.8 130.58 50.53 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.328 -0.619 . . . . 73.019999999999996 109.328 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 85.0 t -122.67 124.83 71.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 109.259 -0.645 . . . . 43.350000000000001 109.259 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.21 127.34 55.57 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.383 -0.599 . . . . 70.349999999999994 109.383 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.441 ' HB3' HG23 ' A' ' 34' ' ' ILE . 2.9 p90 -134.55 117.16 13.08 Favored Pre-proline 0 C--N 1.287 -2.128 0 CA-C-N 116.232 -0.44 . . . . 75.109999999999999 111.207 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.49 27.32 0.14 Allowed 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 122.846 2.364 . . . . 53.399999999999999 113.234 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -106.63 -92.34 0.4 Allowed 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.036 -0.728 . . . . 73.150000000000006 109.036 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.22 131.07 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 124.537 1.135 . . . . 73.200000000000003 107.987 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.92 137.95 20.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.689 -0.856 . . . . 71.239999999999995 108.689 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.7 p -91.94 -45.78 8.17 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 109.391 -0.596 . . . . 65.340000000000003 109.391 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.1 m -150.24 132.95 15.89 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.373 -0.83 . . . . 74.230000000000004 109.119 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.413 ' OG1' HG11 ' A' ' 160' ' ' VAL . 6.9 t -139.07 159.34 42.37 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.677 -0.64 . . . . 60.210000000000001 110.248 175.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 25.5 t-20 -131.01 97.91 4.44 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 104.723 -2.325 . . . . 60.450000000000003 104.723 172.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.69 -141.81 6.59 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.167 -1.573 . . . . 72.400000000000006 109.167 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -118.65 99.07 6.55 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 117.587 0.693 . . . . 70.409999999999997 110.129 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -75.16 130.33 39.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.853 -0.53 . . . . 71.450000000000003 111.087 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 61.1 mt -90.32 -48.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.65 -1.611 . . . . 44.219999999999999 106.65 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -136.28 171.94 7.9 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.136 -1.801 . . . . 74.239999999999995 106.136 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -75.97 -1.56 11.56 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.594 1.529 . . . . 51.119999999999997 111.082 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.27 1.96 7.8 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.707 -0.679 . . . . 71.049999999999997 111.457 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 68.1 t -143.77 120.96 5.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.576 -0.898 . . . . 64.549999999999997 108.576 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.413 HG11 ' OG1' ' A' ' 150' ' ' THR . 56.7 t -123.98 148.3 28.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.06 -0.719 . . . . 74.430000000000007 109.06 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -135.93 151.42 49.94 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.174 -0.676 . . . . 50.420000000000002 109.174 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.572 ' CE3' HD12 ' A' ' 139' ' ' LEU . 26.3 m-90 -132.47 128.68 37.94 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.222 -1.399 . . . . 64.409999999999997 107.222 175.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.17 105.29 15.2 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.919 0.866 . . . . 75.25 110.681 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.3 mp -87.8 130.56 34.82 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.478 -1.237 . . . . 72.239999999999995 109.664 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -118.15 146.89 40.33 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 115.204 -0.907 . . . . 74.019999999999996 111.144 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.93 149.86 86.04 Favored 'Trans proline' 0 N--CA 1.476 0.448 0 C-N-CA 123.389 2.726 . . . . 51.140000000000001 111.985 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 79.71 -27.43 2.57 Favored Glycine 0 C--N 1.308 -1.027 0 C-N-CA 121.218 -0.515 . . . . 75.239999999999995 113.169 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.5 m -105.57 154.44 6.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.198 0.523 . . . . 62.310000000000002 111.275 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 p -98.08 143.87 12.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.926 -0.768 . . . . 75.430000000000007 108.926 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 30.7 m -134.38 153.69 51.76 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.653 -0.499 . . . . 52.240000000000002 109.653 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.1 p -106.94 153.77 22.06 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.702 0.287 . . . . 75.519999999999996 111.063 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 40.1 tpp -124.95 116.87 22.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.031 -0.729 . . . . 74.319999999999993 109.031 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 8.3 t -143.57 132.5 22.8 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.022 -1.071 . . . . 74.439999999999998 109.876 172.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.83 122.94 8.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.759 -0.83 . . . . 63.329999999999998 108.759 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -127.94 132.01 49.28 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.635 -0.876 . . . . 71.450000000000003 108.635 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -156.75 158.09 36.26 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 109.902 -0.407 . . . . 43.030000000000001 109.902 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 118' ' ' ILE . 70.2 mtp180 -89.13 136.66 32.89 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.756 -0.461 . . . . 72.409999999999997 109.756 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -142.68 128.39 19.26 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 109.472 -0.566 . . . . 62.229999999999997 109.472 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 12.8 p -56.38 109.96 0.69 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 124.231 0.957 . . . . 63.210000000000001 112.727 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -57.09 130.29 79.67 Favored Pre-proline 0 CA--C 1.51 -0.592 0 O-C-N 123.951 0.782 . . . . 64.430000000000007 109.476 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.06 -46.4 10.45 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 123.034 2.49 . . . . 74.5 114.203 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.29 -17.44 39.61 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 122.337 -0.227 . . . . 72.340000000000003 110.546 -176.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.276 69.3 p 71.18 72.18 0.18 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.578 1.551 . . . . 74.329999999999998 111.549 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -45.59 144.8 1.47 Allowed 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 113.31 -1.768 . . . . 53.009999999999998 111.623 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 34.4 m . . . . . 0 C--N 1.25 -3.757 0 CA-C-N 113.385 -1.734 . . . . 74.319999999999993 108.323 -177.317 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.641 0 N-CA-C 111.405 -0.678 . . . . 71.049999999999997 111.405 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -92.04 122.59 34.69 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.52 -1.289 . . . . 71.310000000000002 107.52 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -83.17 122.78 28.83 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.211 0.529 . . . . 70.349999999999994 110.893 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -108.95 135.11 50.68 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.375 -0.972 . . . . 72.129999999999995 108.375 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.4 105.14 12.34 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.695 -0.854 . . . . 72.519999999999996 108.695 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -83.44 84.08 7.65 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.656 0.741 . . . . 74.409999999999997 110.424 -174.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -96.37 -52.35 4.01 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.127 -0.942 . . . . 73.519999999999996 108.989 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -117.83 168.21 10.69 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.674 -1.148 . . . . 60.009999999999998 108.355 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.68 95.27 1.93 Allowed Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 108.719 -1.752 . . . . 62.409999999999997 108.719 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.402 ' NE2' ' HB2' ' A' ' 51' ' ' LYS . 58.8 m80 -58.52 132.11 52.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.15 0.5 . . . . 71.319999999999993 111.542 -176.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 26.7 ttt -60.02 -39.27 85.29 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 114.45 -1.25 . . . . 65.530000000000001 109.531 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 65.2 tp 31.56 89.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.506 1.922 . . . . 71.430000000000007 114.747 173.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HD3' ' OE1' ' A' ' 138' ' ' GLU . 28.8 ttm180 -109.33 124.16 50.49 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 118.388 -1.325 . . . . 74.0 109.09 177.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 61.8 t -109.36 113.77 45.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 105.543 -2.021 . . . . 74.129999999999995 105.543 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 35.1 ttt180 -126.34 118.65 25.48 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-O 121.504 0.668 . . . . 74.239999999999995 110.369 -177.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.94 109.84 19.52 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 114.677 -1.147 . . . . 63.439999999999998 108.054 178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.4 m -110.94 115.42 29.48 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 107.42 -1.326 . . . . 75.120000000000005 107.42 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.7 pp -127.8 146.3 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 109.532 -0.544 . . . . 62.219999999999999 109.532 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.6 m -124.42 125.03 43.59 Favored 'General case' 0 C--N 1.272 -2.803 0 CA-C-N 115.928 -0.578 . . . . 64.420000000000002 109.596 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.9 tt -114.92 124.79 71.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 121.531 0.681 . . . . 71.340000000000003 109.62 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m -100.07 157.36 34.0 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 115.75 -0.659 . . . . 74.239999999999995 110.674 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD3' ' HG2' ' A' ' 144' ' ' PRO . 64.6 Cg_exo -58.24 -2.51 0.93 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 124.355 3.37 . . . . 64.230000000000004 113.476 176.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 39' ' ' LEU . 19.5 m-20 -82.08 -0.19 43.41 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 125.278 1.431 . . . . 65.200000000000003 110.732 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.2 t70 66.86 29.81 8.14 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.855 -1.535 . . . . 71.530000000000001 106.855 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -120.92 136.95 54.82 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 112.999 -1.909 . . . . 74.120000000000005 108.602 -175.026 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 95' ' ' LEU . 22.0 t -121.35 137.19 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 115.106 -0.952 . . . . 72.120000000000005 109.3 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.3 p -138.49 149.9 45.88 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.681 -1.229 . . . . 64.120000000000005 107.681 174.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.09 -175.7 47.43 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 118.012 -2.042 . . . . 24.329999999999998 113.884 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.99 133.73 28.85 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.348 -0.926 . . . . 60.43 108.879 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.5 mt -121.19 116.27 49.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 107.776 -1.194 . . . . 70.540000000000006 107.776 176.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -120.08 115.54 47.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 120.762 0.315 . . . . 74.019999999999996 110.247 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . . . -107.92 108.21 19.26 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 106.444 -1.687 . . . . 52.310000000000002 106.444 174.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.474 ' HB1' ' CB ' ' A' ' 80' ' ' TYR . . . -122.82 126.22 46.96 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.309 0.576 . . . . 72.420000000000002 112.511 -172.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.98 157.81 21.97 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.573 -0.899 . . . . 52.509999999999998 108.573 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -87.28 123.9 69.12 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 106.706 -1.591 . . . . 71.120000000000005 106.706 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.45 79.71 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.557 2.838 . . . . 75.310000000000002 115.59 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 74.3 mmtt -106.66 -1.11 23.13 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.89 0.853 . . . . 53.32 109.943 173.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.506 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 49.1 t-20 -94.44 105.51 17.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.806 -2.294 . . . . 53.0 104.806 172.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.3 m -59.24 -14.51 11.23 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 114.833 1.42 . . . . 72.209999999999994 114.833 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 65.7 pttt -96.97 -19.14 18.99 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.766 -0.773 . . . . 64.120000000000005 112.73 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.38 137.31 43.4 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 118.697 -1.201 . . . . 74.040000000000006 113.068 -170.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 p -111.09 -19.84 12.59 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.39 -1.277 . . . . 73.010000000000005 110.817 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.532 ' HA3' ' ND2' ' A' ' 74' ' ' ASN . . . 172.31 97.62 0.11 Allowed Glycine 0 N--CA 1.426 -1.97 0 C-N-CA 120.678 -0.772 . . . . 54.219999999999999 111.547 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.28 159.4 52.43 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.18 1.92 . . . . 73.5 110.836 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.23 154.13 33.87 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.574 -0.528 . . . . 74.129999999999995 109.574 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 83' ' ' SER . 6.6 mp -68.95 145.97 53.17 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 120.95 0.405 . . . . 73.5 111.52 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -112.52 108.88 18.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.281 -0.872 . . . . 62.140000000000001 109.187 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.9 -72.55 0.01 OUTLIER Glycine 0 C--N 1.265 -3.369 0 C-N-CA 120.194 -1.003 . . . . 54.350000000000001 112.103 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 71.17 124.54 0.03 OUTLIER 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.392 1.077 . . . . 42.530000000000001 110.519 -173.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -130.67 162.15 56.69 Favored Pre-proline 0 C--N 1.293 -1.877 0 CA-C-N 115.222 -0.899 . . . . 43.32 108.911 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.79 -16.25 47.77 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 122.882 2.388 . . . . 74.430000000000007 113.187 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.431 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 33.2 p90 -116.01 48.66 1.2 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.429 0.633 . . . . 72.299999999999997 111.786 -176.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m -55.85 -37.43 68.74 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.53 0.567 . . . . 75.140000000000001 112.53 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -67.56 -11.57 58.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.5 0.667 . . . . 63.43 111.426 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 66' ' ' PHE . 14.0 mmmm -95.56 -18.02 20.93 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.577 -0.738 . . . . 71.299999999999997 110.176 -177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.6 119.76 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.913 0.863 . . . . 71.019999999999996 111.66 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.62 111.48 23.81 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.545 -0.752 . . . . 75.25 109.575 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 85' ' ' ALA . 4.4 p -98.28 139.25 20.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.096 -1.075 . . . . 63.210000000000001 108.096 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -150.9 170.3 19.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.196 0.522 . . . . 64.450000000000003 110.948 -170.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.532 ' ND2' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -84.16 128.98 34.91 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.122 -1.436 . . . . 71.319999999999993 107.122 178.384 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 88.3 t80 -108.83 122.05 46.37 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.61 -0.436 . . . . 72.420000000000002 110.279 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -138.77 109.49 6.65 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.913 -1.143 . . . . 72.340000000000003 107.913 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 46.6 t -168.68 147.61 4.21 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.657 -0.701 . . . . 71.400000000000006 109.329 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.87 19.28 11.66 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.644 0.979 . . . . 74.109999999999999 113.644 171.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.87 0.31 62.24 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 120.543 -0.836 . . . . 64.519999999999996 111.794 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.474 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . 49.9 m-85 -104.77 161.14 14.42 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 120.755 0.312 . . . . 65.120000000000005 110.181 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.98 136.46 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 106.049 -1.834 . . . . 75.109999999999999 106.049 163.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.82 -155.22 9.51 Favored Glycine 0 N--CA 1.408 -3.207 0 C-N-CA 119.605 -1.283 . . . . 72.109999999999999 112.957 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.484 ' HB3' HD12 ' A' ' 60' ' ' LEU . 5.3 m -118.12 141.36 48.57 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 114.531 -0.835 . . . . 42.32 109.918 -174.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.42 148.72 47.92 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.702 -0.799 . . . . 74.019999999999996 111.132 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . . . -131.81 115.1 15.52 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.427 -1.323 . . . . 40.329999999999998 107.427 175.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.1 t -108.74 117.82 54.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.386 -0.968 . . . . 72.25 108.386 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CD2' HD12 ' A' ' 90' ' ' LEU . 51.2 p90 -121.05 151.91 39.26 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.069 0.461 . . . . 71.400000000000006 110.651 -175.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -155.36 160.41 40.68 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 116.223 -0.444 . . . . 71.540000000000006 111.383 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 60.93 30.2 19.48 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.895 1.278 . . . . 74.549999999999997 110.867 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 87' ' ' PHE . 17.7 mt -87.79 161.08 17.76 Favored 'General case' 0 N--CA 1.413 -2.301 0 CA-C-N 115.914 -0.584 . . . . 71.340000000000003 109.62 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.407 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.7 t -122.53 177.6 5.35 Favored 'General case' 0 C--N 1.258 -3.375 0 N-CA-C 109.311 -0.626 . . . . 73.420000000000002 109.311 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -55.9 -35.42 66.52 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 123.977 0.911 . . . . 73.450000000000003 111.776 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.66 -26.29 62.48 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.27 0.557 . . . . 43.539999999999999 111.861 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' A' ' 90' ' ' LEU . 46.4 mt-10 -88.26 -20.49 25.39 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.032 0.444 . . . . 75.319999999999993 109.855 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 54.9 tp -58.91 -54.69 53.96 Favored Pre-proline 0 CA--C 1.566 1.577 0 N-CA-C 114.453 1.279 . . . . 65.010000000000005 114.453 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -74.11 -28.34 10.97 Favored 'Trans proline' 0 C--N 1.362 1.276 0 CA-C-N 121.23 1.475 . . . . 64.230000000000004 110.292 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -70.03 -29.61 66.69 Favored 'General case' 0 N--CA 1.402 -2.845 0 CA-C-N 114.932 -1.031 . . . . 72.140000000000001 110.842 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -75.82 -22.69 56.06 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 109.388 -0.597 . . . . 74.5 109.388 175.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -17.72 62.42 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.812 -0.631 . . . . 64.349999999999994 111.118 -175.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -63.61 -57.61 9.54 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.912 -0.773 . . . . 74.319999999999993 108.912 176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 38.6 ttp -59.86 -47.44 85.72 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.641 -0.708 . . . . 44.200000000000003 110.386 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -57.51 -29.78 64.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.077 -0.965 . . . . 73.019999999999996 111.144 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -60.91 -37.35 81.97 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.889 -0.411 . . . . 62.43 109.889 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.5 -20.5 65.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.258 0.551 . . . . 73.140000000000001 111.073 -175.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.59 -21.27 15.33 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 120.282 -0.567 . . . . 52.100000000000001 110.826 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.42 -47.95 3.81 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.103 -0.639 . . . . 75.409999999999997 112.166 -171.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.03 12.1 60.64 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 121.014 -0.612 . . . . 72.120000000000005 111.787 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.5 m -106.64 162.65 5.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 120.81 0.338 . . . . 74.120000000000005 110.832 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -123.07 125.22 44.79 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.613 -0.884 . . . . 74.200000000000003 108.613 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 87.4 mt -125.77 111.73 15.23 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 110.007 -0.368 . . . . 73.120000000000005 110.007 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.6 t -105.45 138.29 41.88 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.076 -1.453 . . . . 71.519999999999996 107.076 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 pp -149.96 153.95 37.44 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.968 -0.693 . . . . 71.25 112.248 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -158.58 167.85 28.49 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.316 -1.311 . . . . 63.140000000000001 110.245 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HD2' HH11 ' A' ' 114' ' ' ARG . 5.4 ttt180 -112.71 138.2 49.89 Favored 'General case' 0 N--CA 1.389 -3.506 0 N-CA-C 107.645 -1.243 . . . . 71.019999999999996 107.645 172.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -115.29 89.79 3.18 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 106.625 -1.621 . . . . 70.230000000000004 106.625 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.32 -103.83 1.01 Allowed Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.661 -0.976 . . . . 60.130000000000003 110.661 -175.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -99.79 -24.71 14.6 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.83 0.824 . . . . 73.030000000000001 110.333 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -96.13 140.11 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 C-N-CA 118.664 -1.214 . . . . 72.120000000000005 109.607 -173.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.2 t -102.27 136.29 35.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.53 0 N-CA-C 109.617 -0.512 . . . . 73.200000000000003 109.617 -177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.1 pt -117.7 133.36 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-O 121.642 0.734 . . . . 64.310000000000002 109.924 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 tt -128.22 122.33 31.54 Favored 'General case' 0 C--N 1.273 -2.747 0 N-CA-C 107.873 -1.158 . . . . 65.129999999999995 107.873 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.34 127.27 37.3 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.755 -0.831 . . . . 73.439999999999998 108.755 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.62 -178.74 23.96 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 119.56 -1.305 . . . . 43.420000000000002 112.434 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.1 mtp85 -144.23 155.58 43.94 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 123.986 0.915 . . . . 74.109999999999999 109.103 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -125.73 108.47 11.55 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 107.067 -1.457 . . . . 74.310000000000002 107.067 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -107.31 92.35 4.04 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.742 -1.207 . . . . 73.239999999999995 107.742 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.46 ' O ' HG22 ' A' ' 130' ' ' VAL . 70.4 mt -120.7 12.11 11.35 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.803 -1.544 . . . . 71.430000000000007 108.811 -175.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.467 ' HA ' ' CA ' ' A' ' 167' ' ' GLY . 1.3 m -62.38 -22.29 66.02 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 114.71 -1.132 . . . . 73.209999999999994 112.11 -175.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.2 m -113.68 3.34 15.57 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 112.733 0.642 . . . . 53.350000000000001 112.733 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 127' ' ' LEU . 17.5 m -80.6 164.43 3.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 C-N-CA 119.83 -0.748 . . . . 54.340000000000003 112.065 -176.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.1 m -82.74 162.79 21.64 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.28 -0.873 . . . . 72.010000000000005 111.404 -176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 71.09 99.25 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 125.123 1.369 . . . . 72.519999999999996 112.37 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.12 -26.34 10.82 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.142 2.561 . . . . 73.019999999999996 115.146 -172.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -84.68 -11.37 56.01 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.03 0.443 . . . . 64.25 110.938 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' MET . . . -52.28 145.22 11.3 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.519 1.127 . . . . 63.509999999999998 113.855 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 2.5 m-20 -125.89 120.04 29.38 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-N 115.248 -0.887 . . . . 54.520000000000003 109.088 176.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 69.3 t -106.69 113.11 42.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.96 -1.126 . . . . 70.230000000000004 107.96 174.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 44.7 mt-10 -108.37 120.73 43.24 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.268 -0.642 . . . . 44.450000000000003 109.268 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.495 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.9 tm? -111.03 118.08 35.08 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 105.302 -2.11 . . . . 61.25 105.302 175.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.2 m -123.39 125.38 44.87 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.555 -0.535 . . . . 25.43 109.555 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 98.1 t -118.46 125.21 74.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.471 -0.566 . . . . 54.130000000000003 109.471 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.99 127.68 56.29 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.658 -0.867 . . . . 63.520000000000003 108.658 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.686 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 5.6 p90 -134.76 120.81 14.55 Favored Pre-proline 0 C--N 1.287 -2.124 0 CA-C-N 116.589 -0.278 . . . . 74.209999999999994 111.359 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.422 ' HG2' ' HD3' ' A' ' 36' ' ' PRO . 19.7 Cg_endo -70.8 40.62 0.36 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.605 2.204 . . . . 71.519999999999996 112.523 176.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -125.5 -110.03 0.31 Allowed 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.86 -0.609 . . . . 40.5 109.531 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -176.32 131.51 0.22 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.578 -0.526 . . . . 61.340000000000003 109.578 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.97 144.23 10.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.304 -0.862 . . . . 63.439999999999998 109.316 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.4 t -110.22 -30.67 7.63 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.457 -0.497 . . . . 71.409999999999997 110.457 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.6 m -156.64 131.82 9.18 Favored 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.66 -0.867 . . . . 73.409999999999997 108.66 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.5 t -139.74 161.2 38.11 Favored 'General case' 0 C--N 1.285 -2.2 0 O-C-N 122.022 -0.424 . . . . 42.140000000000001 110.569 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -133.19 87.63 2.41 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 104.845 -2.28 . . . . 54.140000000000001 104.845 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.27 -144.54 8.05 Favored Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 108.905 -1.678 . . . . 63.329999999999998 108.905 -177.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -118.28 107.73 14.26 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 118.112 0.956 . . . . 71.230000000000004 111.407 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -82.08 118.02 22.71 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.484 0.659 . . . . 64.219999999999999 110.307 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.89 -40.01 16.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.186 -1.412 . . . . 64.019999999999996 107.186 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 157' ' ' PRO . 51.2 mt-10 -137.18 167.15 22.1 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 106.461 -1.681 . . . . 72.409999999999997 106.461 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 156' ' ' GLU . 55.8 Cg_endo -73.07 -0.21 8.76 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.896 1.731 . . . . 72.140000000000001 110.947 177.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.686 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 7.8 pt-20 -130.73 3.72 4.53 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.006 -0.997 . . . . 73.349999999999994 111.329 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.42 121.39 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.132 -0.692 . . . . 64.099999999999994 109.132 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.32 143.66 39.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.226 -0.657 . . . . 75.120000000000005 109.226 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -132.96 151.46 52.06 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.363 -0.606 . . . . 70.439999999999998 109.363 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.495 ' CE3' HD12 ' A' ' 139' ' ' LEU . 28.0 m-90 -132.68 128.62 37.4 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.24 -0.652 . . . . 74.340000000000003 109.24 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -100.14 113.66 26.47 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.372 0.606 . . . . 74.120000000000005 109.796 171.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 22.4 mt -102.09 133.18 47.35 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.468 -0.938 . . . . 74.420000000000002 108.468 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -117.93 145.45 36.76 Favored Pre-proline 0 C--N 1.309 -1.168 0 CA-C-N 115.935 -0.575 . . . . 65.129999999999995 112.117 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.24 161.44 44.61 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.574 2.183 . . . . 73.340000000000003 110.705 173.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 128' ' ' THR . . . 68.79 -9.93 1.74 Allowed Glycine 0 N--CA 1.472 1.072 0 N-CA-C 114.381 0.512 . . . . 65.120000000000005 114.381 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.66 171.09 9.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.484 -0.561 . . . . 62.240000000000002 109.484 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.4 p -114.88 142.02 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.624 -0.88 . . . . 65.140000000000001 108.624 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 40.9 m -140.81 143.74 35.0 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.91 -0.494 . . . . 61.329999999999998 110.905 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.8 p -108.12 141.14 40.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.368 -0.604 . . . . 74.150000000000006 109.368 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 80.4 mtp -123.66 130.03 52.02 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.276 -0.639 . . . . 74.519999999999996 109.276 -175.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.5 m -143.74 140.18 29.83 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.902 -0.719 . . . . 72.409999999999997 110.806 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.467 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -147.64 120.44 8.68 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.044 -1.095 . . . . 74.239999999999995 108.044 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -127.73 130.15 48.3 Favored 'General case' 0 C--N 1.27 -2.854 0 N-CA-C 107.632 -1.247 . . . . 74.109999999999999 107.632 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.33 153.69 38.97 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.733 -0.469 . . . . 71.5 109.733 -175.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 48.9 mtm180 -96.66 126.26 41.7 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.983 -0.747 . . . . 75.010000000000005 108.983 -176.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -134.01 150.03 51.22 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 108.34 -0.985 . . . . 73.510000000000005 108.34 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.99 108.57 1.24 Allowed 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 120.971 0.415 . . . . 75.239999999999995 110.931 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.586 ' OD2' ' HA ' ' A' ' 183' ' ' THR . 19.2 p-10 -82.09 122.5 79.68 Favored Pre-proline 0 N--CA 1.434 -1.273 0 N-CA-C 113.564 0.95 . . . . 73.420000000000002 113.564 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.04 -20.02 19.73 Favored 'Trans proline' 0 N--CA 1.475 0.393 0 C-N-CA 123.278 2.652 . . . . 72.340000000000003 110.414 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.401 ' ND2' ' HB2' ' A' ' 180' ' ' ASP . 1.4 p-10 -81.39 -25.58 36.15 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 114.373 -1.285 . . . . 72.519999999999996 110.353 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.586 ' HA ' ' OD2' ' A' ' 180' ' ' ASP 0.317 26.4 p 47.95 76.12 0.12 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 114.646 1.35 . . . . 63.219999999999999 114.646 -178.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -121.65 164.04 17.99 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.751 -1.113 . . . . 45.329999999999998 109.917 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 108.611 -0.885 . . . . 43.329999999999998 108.611 -179.821 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.183 0 N-CA-C 110.2 -1.16 . . . . 74.310000000000002 110.2 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -84.5 83.3 8.05 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.21 1.005 . . . . 74.310000000000002 109.268 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.45 83.26 2.14 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 106.791 -1.559 . . . . 74.439999999999998 106.791 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -82.58 94.8 7.58 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.107 -0.951 . . . . 70.439999999999998 110.11 -175.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.4 mt -111.3 22.28 15.35 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.716 -1.129 . . . . 53.25 108.382 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -77.0 90.19 3.57 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.826 -1.079 . . . . 70.109999999999999 111.334 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -96.29 156.42 16.35 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.085 -0.962 . . . . 74.329999999999998 108.564 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -84.31 95.48 8.73 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.278 -0.638 . . . . 75.109999999999999 109.278 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.76 103.9 2.37 Favored Glycine 0 N--CA 1.427 -1.952 0 N-CA-C 108.672 -1.771 . . . . 73.109999999999999 108.672 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -70.21 150.09 46.82 Favored 'General case' 0 CA--C 1.489 -1.391 0 O-C-N 123.662 0.272 . . . . 71.519999999999996 111.33 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 62.9 mtt 70.93 83.1 0.15 Allowed 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 125.111 1.507 . . . . 73.409999999999997 108.996 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -132.99 128.21 35.86 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.64 -1.164 . . . . 63.039999999999999 108.083 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 16.6 ptp180 -132.32 125.9 32.06 Favored 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 115.757 -0.656 . . . . 65.409999999999997 110.44 -176.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.09 114.66 47.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.42 -0.809 . . . . 73.530000000000001 108.906 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -115.58 114.18 24.6 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.441 -0.799 . . . . 73.150000000000006 109.475 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' HB3' HD22 ' A' ' 139' ' ' LEU . . . -110.54 108.77 18.84 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 107.66 -1.237 . . . . 52.229999999999997 107.66 176.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.3 t -119.71 115.36 23.75 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.989 -1.115 . . . . 65.329999999999998 107.989 -177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -127.98 147.17 32.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.157 0.503 . . . . 62.340000000000003 110.089 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.8 m -129.29 132.73 47.21 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 109.742 -0.466 . . . . 53.030000000000001 109.742 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.546 ' O ' ' HD2' ' A' ' 144' ' ' PRO . 10.8 tt -118.61 111.12 32.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.952 0.882 . . . . 74.519999999999996 111.023 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.2 m -76.62 163.97 62.5 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 114.177 -1.374 . . . . 70.510000000000005 111.214 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.67 0.61 5.32 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.865 2.377 . . . . 73.120000000000005 113.323 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 13.8 t70 -91.46 -0.49 57.63 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.026 -1.102 . . . . 60.409999999999997 108.026 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 91' ' ' THR . 25.6 t70 67.79 33.45 4.83 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 106.612 -1.625 . . . . 73.200000000000003 106.612 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -97.73 124.65 42.16 Favored 'General case' 0 N--CA 1.391 -3.411 0 CA-C-N 113.082 -1.872 . . . . 74.430000000000007 106.541 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.449 HG11 HD13 ' A' ' 95' ' ' LEU . 12.0 t -110.34 129.7 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 108.549 -0.908 . . . . 62.340000000000003 108.549 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.1 p -139.92 144.21 37.01 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 107.443 -1.317 . . . . 45.039999999999999 107.443 175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.07 -174.77 41.18 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 118.861 -1.638 . . . . 72.140000000000001 112.412 -177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -145.27 133.37 21.49 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 115.011 -0.594 . . . . 70.519999999999996 109.879 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.0 mt -118.86 115.69 48.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 106.977 -1.49 . . . . 53.210000000000001 106.977 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.31 116.05 51.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.723 -0.473 . . . . 64.040000000000006 109.723 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.492 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -108.22 108.32 19.31 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.689 -1.597 . . . . 73.239999999999995 106.689 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -120.24 129.46 54.07 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.692 0.282 . . . . 70.329999999999998 111.024 -176.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.84 144.02 49.48 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.519 -0.919 . . . . 73.329999999999998 108.519 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -81.54 120.75 78.81 Favored Pre-proline 0 C--N 1.292 -1.93 0 N-CA-C 107.746 -1.205 . . . . 73.549999999999997 107.746 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -33.79 -63.28 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 125.284 3.989 . . . . 74.019999999999996 116.422 -168.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.9 tttt 67.01 -54.26 0.45 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.463 1.105 . . . . 73.010000000000005 112.58 -176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.405 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 23.6 t-20 -108.14 145.69 33.78 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.411 -0.588 . . . . 55.329999999999998 109.411 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -59.08 -16.77 20.9 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.322 1.449 . . . . 63.310000000000002 113.815 -175.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 12.2 ptmm? -75.85 -20.69 57.91 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 120.781 0.324 . . . . 60.439999999999998 111.765 -174.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.9 110.19 22.46 Favored 'General case' 0 N--CA 1.404 -2.764 0 N-CA-C 115.22 1.563 . . . . 73.219999999999999 115.22 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 t -121.34 -16.48 7.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.52 -1.218 . . . . 74.439999999999998 109.863 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.64 97.11 0.11 Allowed Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.778 -0.725 . . . . 62.420000000000002 113.081 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -73.13 160.55 45.22 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.355 2.703 . . . . 74.549999999999997 110.844 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -131.24 133.93 45.93 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.863 -0.421 . . . . 64.030000000000001 109.863 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' O ' HG11 ' A' ' 72' ' ' VAL . 94.6 mt -75.82 140.87 42.51 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.754 -0.461 . . . . 72.340000000000003 109.754 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -111.63 99.86 8.51 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.226 0.536 . . . . 34.020000000000003 109.557 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.67 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -115.01 94.77 0.68 Allowed Glycine 0 C--N 1.274 -2.914 0 N-CA-C 110.952 -0.859 . . . . 65.129999999999995 110.952 177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.54 96.55 10.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.956 -0.757 . . . . 74.209999999999994 108.956 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.91 161.61 45.76 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.203 -0.908 . . . . 65.319999999999993 109.145 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.68 -26.68 82.91 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.443 2.095 . . . . 63.350000000000001 111.313 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.429 ' HB2' ' CG ' ' A' ' 69' ' ' LYS . 31.6 p90 -107.73 41.96 1.43 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.419 -0.809 . . . . 71.219999999999999 111.905 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.1 m -59.5 -28.09 66.73 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 111.72 0.267 . . . . 74.329999999999998 111.72 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -66.58 -18.6 65.45 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.421 0.629 . . . . 71.400000000000006 110.824 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' CG ' ' HB2' ' A' ' 66' ' ' PHE . 32.7 mmtp -89.64 -19.81 24.43 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.61 -0.723 . . . . 62.439999999999998 109.993 -177.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.67 121.19 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-O 121.855 0.835 . . . . 60.409999999999997 112.552 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.14 114.48 28.81 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.08 -0.963 . . . . 71.219999999999999 108.843 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 60' ' ' LEU . 58.1 t -98.27 141.52 16.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.004 -1.11 . . . . 75.319999999999993 108.004 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 m -148.51 167.93 24.07 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.275 -0.639 . . . . 71.140000000000001 109.275 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -82.76 154.12 24.92 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.446 -1.316 . . . . 71.010000000000005 107.446 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 75.2 t80 -116.65 124.55 50.01 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 109.281 -0.637 . . . . 73.219999999999999 109.281 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -138.62 99.6 3.86 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.013 -1.106 . . . . 73.140000000000001 108.013 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.2 m -156.59 137.9 13.83 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.238 -0.437 . . . . 71.010000000000005 110.014 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.03 0.41 2.38 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.182 1.393 . . . . 74.439999999999998 112.893 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.34 9.83 43.36 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 119.876 -1.154 . . . . 44.43 111.23 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.479 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 74.2 m-85 -105.04 142.5 34.72 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.368 -0.975 . . . . 73.140000000000001 108.368 171.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 33.8 m -124.09 136.79 59.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.315 -0.994 . . . . 61.420000000000002 108.315 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -165.6 -155.14 8.47 Favored Glycine 0 C--N 1.262 -3.583 0 C-N-CA 119.077 -1.535 . . . . 43.219999999999999 111.791 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.429 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 13.0 p -128.75 137.4 51.54 Favored 'General case' 0 C--N 1.267 -3.011 0 O-C-N 124.43 0.723 . . . . 73.010000000000005 110.354 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.12 146.09 50.81 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 120.815 0.34 . . . . 73.140000000000001 110.897 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -124.41 115.03 20.29 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.55 -1.278 . . . . 54.240000000000002 107.55 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.0 t -108.03 119.39 57.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 107.712 -1.218 . . . . 72.310000000000002 107.712 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.539 ' CD2' HD12 ' A' ' 90' ' ' LEU . 53.1 p90 -118.2 155.98 29.57 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.689 -0.404 . . . . 73.430000000000007 111.137 -175.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.4 p -156.53 157.63 35.74 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.791 -0.64 . . . . 63.149999999999999 110.488 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 63.98 35.12 10.93 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.59 1.186 . . . . 63.229999999999997 111.319 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.539 HD12 ' CD2' ' A' ' 87' ' ' PHE . 52.7 mt -96.9 167.11 11.29 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.728 -0.669 . . . . 73.319999999999993 110.34 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 4.9 t -126.3 169.99 12.35 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.521 -1.659 . . . . 54.310000000000002 106.521 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -57.14 -33.53 67.49 Favored 'General case' 0 C--O 1.205 -1.279 0 CA-C-N 118.928 0.786 . . . . 73.129999999999995 112.443 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.57 -29.67 70.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.707 0.765 . . . . 63.509999999999998 111.304 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.03 -16.82 34.5 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.536 -0.756 . . . . 64.420000000000002 110.318 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.658 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 51.5 tp -62.31 -54.84 45.53 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 114.053 1.131 . . . . 61.240000000000002 114.053 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.32 -33.59 69.99 Favored 'Trans proline' 0 C--N 1.368 1.6 0 CA-C-N 121.357 1.52 . . . . 70.450000000000003 110.598 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -67.68 -35.08 78.18 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-N 114.882 -1.054 . . . . 74.310000000000002 110.755 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.7 pp -78.24 -20.13 52.33 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.909 -0.774 . . . . 74.310000000000002 108.909 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.64 -21.24 62.64 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.636 -0.711 . . . . 53.200000000000003 110.691 -174.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -58.87 -57.11 14.5 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 108.468 -0.938 . . . . 75.319999999999993 108.468 173.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.67 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 35.4 ttp -55.44 -47.25 76.29 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.2 -0.909 . . . . 65.030000000000001 110.508 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -54.75 -39.25 68.13 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.354 -0.839 . . . . 62.509999999999998 110.671 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 m -66.79 -27.64 67.75 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.311 -0.404 . . . . 72.310000000000002 111.355 -174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -70.66 -17.46 62.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.369 0.604 . . . . 73.239999999999995 110.42 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.28 -9.72 16.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.97 -0.559 . . . . 72.319999999999993 110.46 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.71 -44.82 4.56 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.512 0.56 . . . . 61.530000000000001 112.512 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.93 27.2 42.15 Favored Glycine 0 C--O 1.242 0.653 0 N-CA-C 110.492 -1.043 . . . . 51.020000000000003 110.492 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.75 155.64 20.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.479 -0.934 . . . . 62.119999999999997 108.479 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.436 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 39.5 t30 -103.99 121.5 43.29 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.865 -1.161 . . . . 61.439999999999998 107.865 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.9 mt -108.87 137.65 46.46 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 123.304 0.377 . . . . 63.240000000000002 110.689 -177.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -144.24 116.94 8.69 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.414 -0.958 . . . . 63.149999999999999 108.414 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -144.57 149.94 36.67 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.806 -0.559 . . . . 74.129999999999995 110.785 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -151.19 157.99 43.37 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 124.47 1.106 . . . . 73.209999999999994 111.065 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HD3' HG22 ' A' ' 119' ' ' VAL . 2.0 tpp180 -94.33 109.07 20.93 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.438 -1.319 . . . . 73.200000000000003 107.438 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -93.03 92.21 7.72 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.133 -1.062 . . . . 75.329999999999998 108.133 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.57 -115.48 5.64 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.601 -1.4 . . . . 73.109999999999999 109.601 -175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -108.64 3.27 22.66 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.707 1.241 . . . . 60.140000000000001 109.223 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 pp -112.05 149.54 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 121.066 -1.021 . . . . 62.140000000000001 108.675 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 178' ' ' TYR . 76.5 t -106.89 139.34 28.74 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 O-C-N 121.76 -0.588 . . . . 64.040000000000006 111.407 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.431 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.8 pp -119.45 119.34 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.771 0 N-CA-C 107.186 -1.413 . . . . 54.240000000000002 107.186 174.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 tt -125.34 130.0 51.08 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.862 -0.421 . . . . 72.310000000000002 109.862 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -131.84 151.87 51.39 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.548 0.69 . . . . 64.230000000000004 110.376 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -151.07 129.93 3.03 Favored Glycine 0 N--CA 1.407 -3.268 0 N-CA-C 108.712 -1.755 . . . . 65.430000000000007 108.712 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.5 mtt180 -116.25 125.41 52.18 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.33 -0.989 . . . . 60.399999999999999 108.33 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -108.51 123.26 48.63 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.449 -0.796 . . . . 72.019999999999996 112.331 -171.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -96.13 93.7 7.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.158 -1.423 . . . . 63.149999999999999 107.158 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 166' ' ' PRO . 1.0 OUTLIER -101.69 2.1 38.26 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.102 -0.703 . . . . 72.129999999999995 109.102 179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 167' ' ' GLY . 23.4 p -78.17 -16.84 57.53 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 116.235 -0.438 . . . . 74.230000000000004 111.074 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.9 m -72.47 -24.63 61.21 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.319 -0.401 . . . . 44.25 111.5 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.44 124.4 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.304 -0.999 . . . . 55.5 108.304 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 31.2 m -111.07 9.88 22.04 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 115.05 1.5 . . . . 75.439999999999998 115.05 -170.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -95.08 150.49 37.78 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 118.593 -1.243 . . . . 71.230000000000004 108.946 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.17 -11.8 19.36 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.903 2.402 . . . . 65.530000000000001 113.862 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -88.46 -12.11 44.01 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 113.346 0.869 . . . . 74.519999999999996 113.346 -169.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.44 135.9 42.32 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.416 0.15 . . . . 63.520000000000003 110.664 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.1 t70 -131.93 125.0 30.57 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.445 -0.576 . . . . 73.409999999999997 109.445 176.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 86.9 t -114.62 119.82 62.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 107.943 -1.132 . . . . 71.430000000000007 107.943 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -129.75 121.32 26.64 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.055 0.455 . . . . 74.099999999999994 110.501 -174.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.611 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.1 tm? -116.99 121.3 40.97 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.84 -1.541 . . . . 74.040000000000006 106.84 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.3 m -126.63 130.34 50.28 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.474 -0.565 . . . . 71.099999999999994 109.474 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.3 t -129.01 128.87 67.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 109.567 -0.531 . . . . 72.049999999999997 109.567 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -119.17 124.72 47.5 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.251 -0.648 . . . . 74.329999999999998 109.251 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.564 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.5 p90 -134.42 113.35 12.12 Favored Pre-proline 0 C--N 1.288 -2.108 0 CA-C-N 116.219 -0.446 . . . . 64.040000000000006 110.178 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 34' ' ' ILE . 58.0 Cg_endo -68.67 30.79 0.16 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 123.086 2.524 . . . . 50.32 114.039 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.55 -95.18 0.36 Allowed 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 108.92 -0.77 . . . . 64.150000000000006 108.92 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 178.68 126.06 0.06 Allowed 'General case' 0 C--O 1.249 1.076 0 N-CA-C 109.542 -0.54 . . . . 53.310000000000002 109.542 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.37 139.15 18.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.465 -1.309 . . . . 74.239999999999995 107.465 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.0 t -104.47 -30.16 10.23 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.33 -0.948 . . . . 63.329999999999998 110.016 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.0 m -157.49 132.3 8.67 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.138 -1.06 . . . . 75.030000000000001 108.138 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.3 t -139.94 151.63 45.71 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.662 -0.649 . . . . 62.130000000000003 112.292 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 27.5 t-20 -118.67 85.81 2.43 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 105.7 -1.963 . . . . 64.420000000000002 105.7 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.478 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 173.88 -151.11 12.56 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 108.458 -1.857 . . . . 61.25 108.458 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -114.59 106.28 14.07 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 118.352 1.076 . . . . 72.420000000000002 109.596 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -80.43 123.76 28.32 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.099 -0.955 . . . . 62.149999999999999 110.534 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 67.5 mt -88.49 -47.74 15.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.232 -1.396 . . . . 74.129999999999995 107.232 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -134.63 169.75 13.03 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 106.992 -1.485 . . . . 72.049999999999997 106.992 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -73.34 -0.19 8.86 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.981 1.787 . . . . 63.149999999999999 111.322 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.2 pt-20 -130.27 3.52 4.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.456 0.646 . . . . 72.230000000000004 111.401 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.4 t -140.09 121.09 14.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 108.735 -0.839 . . . . 63.329999999999998 108.735 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.0 144.4 38.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.865 -0.791 . . . . 75.140000000000001 108.865 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -138.15 144.88 40.97 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.592 -0.522 . . . . 74.340000000000003 109.592 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.611 ' CE3' HD12 ' A' ' 139' ' ' LEU . 28.0 m-90 -122.85 124.98 44.51 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.238 -0.652 . . . . 73.340000000000003 109.238 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -105.83 107.2 18.07 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.059 0.933 . . . . 74.239999999999995 109.413 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.608 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.7 mm? -101.37 120.5 40.36 Favored 'General case' 0 C--O 1.26 1.642 0 CA-C-N 114.803 -1.09 . . . . 72.540000000000006 110.14 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -103.65 146.2 32.05 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 115.633 -0.712 . . . . 73.420000000000002 110.986 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . 68.9 Cg_endo -72.06 155.26 57.27 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 123.035 2.49 . . . . 74.519999999999996 111.599 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 128' ' ' THR . . . 81.27 -30.9 2.67 Favored Glycine 0 C--N 1.302 -1.345 0 C-N-CA 121.365 -0.445 . . . . 72.319999999999993 112.355 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 35.4 m -105.34 164.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 110.05 -0.352 . . . . 31.510000000000002 110.05 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.2 p -113.79 143.8 22.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.975 -0.38 . . . . 61.399999999999999 109.975 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 45.3 m -154.82 144.4 21.41 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.828 -0.434 . . . . 72.310000000000002 109.828 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.0 p -97.57 153.82 17.93 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 123.971 0.908 . . . . 64.109999999999999 109.75 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.0 ptp -125.17 125.21 43.32 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.989 -1.486 . . . . 54.43 106.989 174.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 35.2 m -143.39 145.66 32.84 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.37 -0.831 . . . . 74.329999999999998 110.107 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -151.61 125.94 9.37 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.312 -0.995 . . . . 74.109999999999999 108.312 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -124.61 130.16 51.91 Favored 'General case' 0 C--N 1.262 -3.21 0 N-CA-C 106.439 -1.689 . . . . 54.439999999999998 106.439 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.77 160.19 43.67 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.869 -0.419 . . . . 73.230000000000004 109.869 -173.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -96.62 128.61 43.72 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.676 -1.231 . . . . 75.109999999999999 107.676 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.569 ' CD2' HG21 ' A' ' 119' ' ' VAL . 17.0 m-30 -121.58 152.15 39.57 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 118.388 0.54 . . . . 72.310000000000002 109.874 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 21.0 p -87.84 100.33 12.79 Favored 'General case' 0 C--N 1.261 -3.264 0 N-CA-C 109.475 -0.565 . . . . 70.140000000000001 109.475 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -61.61 138.15 95.06 Favored Pre-proline 0 C--O 1.218 -0.586 0 N-CA-C 107.506 -1.294 . . . . 62.450000000000003 107.506 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -52.78 -46.02 36.53 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 123.125 2.55 . . . . 73.099999999999994 112.724 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -84.8 -10.64 56.99 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.064 -1.425 . . . . 75.439999999999998 110.756 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.1 p 59.4 81.46 0.17 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.498 1.519 . . . . 61.420000000000002 111.944 -177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -90.31 151.8 21.32 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.619 -0.719 . . . . 74.109999999999999 110.534 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 72.3 m . . . . . 0 C--N 1.295 -1.787 0 C-N-CA 128.1 2.56 . . . . 70.239999999999995 105.207 178.99 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.324 0 N-CA-C 109.574 -1.41 . . . . 53.409999999999997 109.574 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -132.27 58.14 1.76 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.665 0.745 . . . . 74.25 111.89 179.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.94 104.38 16.8 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.444 -0.798 . . . . 74.129999999999995 109.974 176.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.22 147.39 27.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.628 -1.619 . . . . 63.020000000000003 106.628 175.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.1 mt -76.63 111.73 12.43 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.316 0.579 . . . . 73.010000000000005 109.751 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -63.2 136.73 57.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.43 -1.259 . . . . 64.319999999999993 112.813 -173.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 65.23 94.82 0.06 Allowed 'General case' 0 C--O 1.25 1.084 0 C-N-CA 125.329 1.452 . . . . 70.540000000000006 111.602 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.462 ' HA ' ' HG2' ' A' ' 51' ' ' LYS . 16.7 tt0 -79.08 92.07 4.97 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.28 -0.873 . . . . 72.329999999999998 109.068 -178.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.21 147.54 5.04 Favored Glycine 0 N--CA 1.415 -2.75 0 C-N-CA 120.075 -1.06 . . . . 75.129999999999995 112.255 177.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -153.83 -41.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 124.617 1.167 . . . . 74.109999999999999 109.724 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 92.5 mtp -156.74 144.58 19.31 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.586 -0.894 . . . . 71.120000000000005 108.586 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 99.0 mt -125.55 137.09 53.92 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.097 -1.075 . . . . 74.400000000000006 108.097 173.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 46.1 ttm-85 -136.8 124.51 22.44 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.63 -0.878 . . . . 71.239999999999995 108.63 172.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.508 ' HB ' HG13 ' A' ' 137' ' ' VAL . 62.9 t -117.37 118.96 60.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 N-CA-C 108.998 -0.741 . . . . 74.510000000000005 108.998 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -108.35 113.17 26.03 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.527 -1.286 . . . . 73.209999999999994 107.527 178.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.05 120.15 36.36 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.509 -1.293 . . . . 73.209999999999994 107.509 177.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 140' ' ' THR . 21.9 m -137.19 115.09 11.42 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 109.192 -0.67 . . . . 74.129999999999995 109.192 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.42 HG13 HG22 ' A' ' 141' ' ' VAL . 1.8 pp -127.82 147.11 32.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.635 -0.506 . . . . 63.200000000000003 109.635 -175.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.8 m -125.64 128.37 47.75 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 120.974 0.416 . . . . 71.239999999999995 109.919 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.0 tt -113.39 119.51 60.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.526 0.679 . . . . 72.030000000000001 109.579 179.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -84.42 160.97 55.67 Favored Pre-proline 0 C--N 1.296 -1.761 0 CA-C-N 115.389 -0.823 . . . . 61.240000000000002 109.913 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.82 2.06 2.82 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 123.367 2.711 . . . . 41.020000000000003 112.166 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.55 -8.0 59.62 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 124.398 1.079 . . . . 74.519999999999996 108.403 177.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.3 t70 71.96 28.48 2.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.338 1.455 . . . . 74.409999999999997 107.131 -175.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.2 139.84 44.95 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.769 -1.559 . . . . 71.329999999999998 107.6 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.416 HG11 HD21 ' A' ' 95' ' ' LEU . 13.7 t -117.26 140.45 40.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 109.239 -0.652 . . . . 74.040000000000006 109.239 -177.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.7 p -146.94 142.74 27.88 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.623 -1.251 . . . . 74.319999999999993 107.623 176.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.9 -171.53 41.4 Favored Glycine 0 N--CA 1.422 -2.273 0 C-N-CA 119.125 -1.512 . . . . 70.430000000000007 113.079 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -145.74 133.87 21.58 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.03 -0.73 . . . . 73.019999999999996 109.03 -175.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.0 mt -123.66 115.81 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.994 -1.113 . . . . 62.310000000000002 107.994 175.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -113.36 114.95 48.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.494 -0.558 . . . . 75.209999999999994 109.494 -178.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.66 108.52 19.42 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.285 -1.376 . . . . 74.319999999999993 107.285 175.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . . . -113.85 135.81 53.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.169 0.509 . . . . 55.119999999999997 111.592 -175.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.49 156.33 29.26 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.238 -0.892 . . . . 52.32 109.76 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -77.46 111.28 16.2 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 105.875 -1.898 . . . . 64.340000000000003 105.875 175.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 80' ' ' TYR . 52.9 Cg_exo -30.52 -71.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.021 1 C-N-CA 125.737 4.292 . . . . 74.109999999999999 116.195 -171.068 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.462 ' HG2' ' HA ' ' A' ' 22' ' ' GLN . 56.6 tptt 66.96 -65.92 0.2 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.781 1.232 . . . . 71.340000000000003 111.168 -178.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.531 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 49.9 t-20 -69.65 133.24 47.33 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.967 0.907 . . . . 54.149999999999999 108.759 -178.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 t -73.12 -21.82 60.66 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.507 -0.315 . . . . 54.450000000000003 111.793 -176.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.531 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 22.4 ptmt -102.62 -0.06 32.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.248 -0.581 . . . . 64.439999999999998 111.68 -177.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.41 103.19 15.9 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.104 -0.638 . . . . 75.310000000000002 111.054 -175.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 p -93.59 -20.49 20.16 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.196 -0.911 . . . . 44.229999999999997 110.502 179.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . 174.02 119.85 0.56 Allowed Glycine 0 N--CA 1.424 -2.157 0 CA-C-O 118.669 -1.073 . . . . 75.430000000000007 111.122 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' HB3' ' A' ' 83' ' ' SER . 4.5 Cg_endo -52.74 138.81 59.52 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.839 2.359 . . . . 65.239999999999995 111.771 174.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.01 125.6 35.06 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.27 -0.423 . . . . 34.229999999999997 110.256 -178.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.2 mt -88.55 129.94 35.36 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.873 -0.417 . . . . 63.43 109.873 176.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.86 84.62 6.65 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.875 0.845 . . . . 65.219999999999999 108.866 178.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -141.1 59.2 0.56 Allowed Glycine 0 N--CA 1.421 -2.355 0 CA-C-N 114.867 -1.061 . . . . 64.329999999999998 113.059 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -90.26 93.47 9.36 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.676 -0.861 . . . . 63.119999999999997 108.676 176.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.7 m -105.88 161.41 22.92 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 115.191 -0.913 . . . . 74.230000000000004 111.36 -176.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.42 -9.62 26.69 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.117 2.545 . . . . 75.230000000000004 112.93 -177.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -110.62 30.76 6.52 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.881 -0.599 . . . . 73.510000000000005 109.735 176.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 p -57.31 -29.71 64.14 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.391 -0.822 . . . . 70.340000000000003 112.643 -178.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -67.98 -14.86 63.3 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.301 0.572 . . . . 71.140000000000001 110.276 -178.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -98.09 -20.4 17.37 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 116.058 -0.519 . . . . 72.540000000000006 110.676 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.13 118.1 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.85 0.833 . . . . 73.109999999999999 110.896 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.34 114.64 28.31 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.448 -0.796 . . . . 73.299999999999997 109.564 -177.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.72 137.02 27.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.699 -1.223 . . . . 61.219999999999999 107.699 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.6 m -151.28 172.02 16.53 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 122.054 -0.404 . . . . 75.120000000000005 109.984 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.59 151.31 23.57 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.028 -1.101 . . . . 73.239999999999995 108.028 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 89.4 t80 -116.75 129.02 55.86 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 109.261 -0.644 . . . . 74.120000000000005 109.261 -178.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.38 98.83 3.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.42 -0.955 . . . . 72.299999999999997 108.42 176.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 74.6 m -166.94 158.91 12.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.309 1.044 . . . . 72.340000000000003 108.895 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 68.72 9.25 7.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.711 1.205 . . . . 62.43 111.492 173.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.05 0.13 85.66 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.242 -0.743 . . . . 71.400000000000006 111.242 -175.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 99.2 m-85 -105.37 158.75 16.42 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 123.232 0.613 . . . . 73.209999999999994 110.432 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.88 140.53 48.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.351 -1.352 . . . . 70.209999999999994 107.351 174.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 47' ' ' ALA . . . -162.68 -160.91 11.56 Favored Glycine 0 N--CA 1.411 -2.999 0 C-N-CA 118.871 -1.633 . . . . 74.340000000000003 113.241 -177.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.548 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 33.6 p -123.11 140.64 52.82 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 108.719 -0.845 . . . . 70.409999999999997 108.719 179.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -131.41 141.15 49.79 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 120.553 -0.459 . . . . 71.420000000000002 111.125 178.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.22 115.07 22.32 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.217 -1.401 . . . . 60.450000000000003 107.217 175.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -111.55 120.2 61.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.677 -0.86 . . . . 65.439999999999998 108.677 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.473 ' CD2' HD12 ' A' ' 90' ' ' LEU . 41.4 p90 -124.37 150.41 45.58 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.042 0.449 . . . . 73.219999999999999 110.91 -174.049 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 m -154.79 156.85 37.03 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.509 -0.552 . . . . 74.219999999999999 109.509 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.0 t70 66.68 31.13 7.82 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 122.311 1.053 . . . . 74.209999999999994 110.683 175.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.473 HD12 ' CD2' ' A' ' 87' ' ' PHE . 34.8 mt -98.52 171.38 8.19 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.402 -0.817 . . . . 75.200000000000003 109.518 177.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 p -121.59 172.65 7.95 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 122.833 0.083 . . . . 73.420000000000002 111.166 -178.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.578 ' CZ ' HD13 ' A' ' 112' ' ' LEU . 86.7 t80 -57.25 -35.66 69.99 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.415 0.447 . . . . 71.409999999999997 110.447 175.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.6 -27.12 68.73 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.39 0.614 . . . . 74.420000000000002 110.521 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG2' ' NE2' ' A' ' 97' ' ' GLN . 43.5 mt-10 -88.32 -15.5 35.54 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.769 -0.65 . . . . 60.439999999999998 112.596 -177.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.416 HD21 HG11 ' A' ' 40' ' ' VAL . 22.8 mt -50.49 -52.19 57.67 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 113.522 0.934 . . . . 74.530000000000001 113.522 175.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -56.45 -45.56 36.51 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 121.312 1.341 . . . . 53.130000000000003 110.24 175.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.453 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 24.3 mt-30 -58.87 -44.19 91.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.905 -1.043 . . . . 73.340000000000003 111.76 -176.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.406 HD21 HD23 ' A' ' 95' ' ' LEU . 4.4 pp -75.72 -19.96 58.71 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.059 0.457 . . . . 72.400000000000006 111.011 178.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.38 -14.04 60.1 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 116.08 -0.509 . . . . 53.149999999999999 110.615 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -65.27 -57.34 8.71 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.185 -0.606 . . . . 62.020000000000003 109.96 176.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -56.31 -49.17 75.06 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.667 0.604 . . . . 75.219999999999999 110.221 -176.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -57.08 -37.5 71.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.007 -0.997 . . . . 73.439999999999998 111.528 -178.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.6 t -65.33 -30.67 71.53 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 116.294 -0.412 . . . . 43.130000000000003 110.077 -172.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.38 -15.37 63.29 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 121.225 0.536 . . . . 64.519999999999996 111.216 -174.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.46 -12.1 11.73 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 120.228 -0.589 . . . . 75.310000000000002 110.875 177.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.93 -48.47 3.49 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.277 0.843 . . . . 64.200000000000003 113.277 -172.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.56 28.43 19.34 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.245 -0.979 . . . . 35.420000000000002 110.802 -172.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.1 m -97.44 151.56 4.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.42 -0.39 . . . . 73.109999999999999 109.949 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -129.1 121.89 28.74 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.408 -1.33 . . . . 74.319999999999993 107.408 176.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.426 HD23 ' HA3' ' A' ' 123' ' ' GLY . 91.7 mt -121.24 139.89 52.78 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.709 0.29 . . . . 61.340000000000003 110.275 -177.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -136.31 121.85 19.55 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.899 -1.519 . . . . 63.200000000000003 106.899 177.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.578 HD13 ' CZ ' ' A' ' 92' ' ' PHE . 2.7 pp -135.51 155.51 50.39 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-O 121.037 0.446 . . . . 65.549999999999997 111.679 -177.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -150.62 155.71 39.93 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.096 -0.956 . . . . 64.150000000000006 112.521 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -94.51 128.87 41.38 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.512 -1.222 . . . . 72.349999999999994 108.597 173.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -122.49 82.85 2.03 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.533 -1.654 . . . . 63.25 106.533 175.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 57.72 -130.25 50.73 Favored Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 114.372 -1.285 . . . . 42.340000000000003 110.502 -173.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.589 ' HA ' ' OD1' ' A' ' 180' ' ' ASP . 23.7 t-20 -71.14 -13.4 61.93 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.642 0.734 . . . . 61.32 111.581 -178.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.671 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.0 OUTLIER -110.63 146.32 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 C-N-CA 117.831 -1.548 . . . . 71.120000000000005 110.756 -176.747 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.2 t -107.18 133.56 51.49 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.726 0 CA-C-N 115.348 -0.842 . . . . 74.299999999999997 110.016 -178.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.1 pt -116.29 131.38 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-O 121.49 0.662 . . . . 64.319999999999993 109.685 175.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 tt -128.45 131.53 48.41 Favored 'General case' 0 C--N 1.278 -2.541 0 CA-C-N 115.276 -0.875 . . . . 70.439999999999998 110.148 177.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -129.2 146.2 51.17 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.126 -1.065 . . . . 50.210000000000001 108.126 174.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.426 ' HA3' HD23 ' A' ' 110' ' ' LEU . . . -164.13 160.39 33.34 Favored Glycine 0 N--CA 1.407 -3.297 0 N-CA-C 111.402 -0.679 . . . . 23.25 111.402 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -137.49 133.44 34.59 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.881 -0.785 . . . . 74.209999999999994 108.881 177.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -103.92 110.07 22.07 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.31 -0.996 . . . . 42.140000000000001 108.31 178.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -103.2 93.75 5.16 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 122.365 1.079 . . . . 72.400000000000006 110.703 -177.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 127' ' ' LEU . 2.0 pt? -124.29 21.39 8.75 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.138 -1.392 . . . . 73.230000000000004 107.512 177.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.432 ' HA ' ' C ' ' A' ' 167' ' ' GLY . 2.6 m -63.7 -14.12 49.31 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.039 -1.891 . . . . 63.109999999999999 110.248 177.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.6 p -74.69 -4.59 38.25 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.455 1.102 . . . . 44.43 110.057 177.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.7 t 81.67 -64.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 C-N-CA 126.208 1.803 . . . . 70.099999999999994 112.146 176.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.1 m 67.63 -62.96 0.32 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.215 1.006 . . . . 73.319999999999993 111.336 -177.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 11.5 t70 -143.0 115.34 5.98 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 106.569 -1.641 . . . . 73.209999999999994 106.569 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.53 -26.29 63.11 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.272 2.648 . . . . 64.329999999999998 116.12 -174.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -107.71 8.82 29.14 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.857 -0.737 . . . . 62.130000000000003 111.224 -175.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -61.41 138.99 58.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.485 -0.779 . . . . 62.439999999999998 111.658 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 28.3 t70 -131.5 121.96 25.36 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.571 -0.529 . . . . 74.209999999999994 109.571 177.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 90.1 t -119.71 126.98 75.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.855 -0.424 . . . . 75.310000000000002 109.855 -178.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.45 123.47 41.37 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.227 -0.657 . . . . 72.319999999999993 109.227 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 tt -113.94 118.29 33.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.003 -1.48 . . . . 53.520000000000003 107.003 176.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 31' ' ' SER . 6.7 m -117.48 128.44 54.98 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 109.213 -0.662 . . . . 73.519999999999996 109.213 -175.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.42 HG22 HG13 ' A' ' 32' ' ' ILE . 84.1 t -122.33 127.87 75.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.625 -0.509 . . . . 74.239999999999995 109.625 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -116.74 132.47 56.68 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.071 -0.714 . . . . 65.049999999999997 109.071 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.593 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.2 p90 -134.93 127.63 18.36 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 116.412 -0.358 . . . . 75.120000000000005 111.785 177.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -70.15 51.27 1.0 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 123.24 2.627 . . . . 65.439999999999998 110.879 172.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.11 -128.57 0.09 Allowed 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 107.3 -1.37 . . . . 74.120000000000005 107.3 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -167.21 134.75 2.44 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 106.645 -1.613 . . . . 61.409999999999997 106.645 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.527 ' HB ' ' CZ ' ' A' ' 143' ' ' PHE . 7.7 p -85.93 123.43 39.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 108.577 -0.897 . . . . 64.239999999999995 108.577 177.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.7 t -81.73 -33.02 31.31 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.22 -0.592 . . . . 72.530000000000001 111.358 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 64.0 m -152.84 133.01 13.5 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 109.672 -0.492 . . . . 72.340000000000003 109.672 175.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.435 ' HB ' HG21 ' A' ' 147' ' ' VAL . 6.7 t -138.77 158.87 43.43 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.946 -0.471 . . . . 74.549999999999997 111.339 177.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 2.9 t-20 -127.61 89.8 3.01 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.018 -1.845 . . . . 75.299999999999997 106.018 175.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 174.44 -140.35 5.36 Favored Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 109.582 -1.407 . . . . 73.430000000000007 109.582 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.82 99.98 7.29 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 117.235 0.517 . . . . 75.129999999999995 109.702 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -82.13 115.92 21.46 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.534 0.683 . . . . 73.420000000000002 110.31 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.4 mt -81.57 -47.56 19.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.151 -1.426 . . . . 70.25 107.151 179.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.83 160.48 67.28 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 107.119 -1.437 . . . . 73.329999999999998 107.119 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.52 -19.63 65.42 Favored 'Trans proline' 0 C--N 1.328 -0.539 0 C-N-CA 122.054 1.836 . . . . 73.150000000000006 111.948 175.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.593 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -114.55 4.09 15.07 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.381 0.882 . . . . 71.109999999999999 113.381 178.75 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.2 t -140.34 120.28 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.995 -0.742 . . . . 54.439999999999998 108.995 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.93 149.33 31.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.049 -0.723 . . . . 73.409999999999997 109.049 -177.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -133.68 146.9 51.27 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.62 -0.882 . . . . 75.319999999999993 108.62 -178.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -119.62 122.37 41.39 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 109.446 -0.576 . . . . 62.229999999999997 109.446 177.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -89.32 114.0 25.35 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.896 0.855 . . . . 43.049999999999997 110.01 177.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 10.2 mp -101.49 118.64 37.37 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.957 -1.02 . . . . 73.120000000000005 109.493 178.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 168' ' ' VAL . 75.5 mmtt -117.45 143.51 32.25 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 114.447 -1.251 . . . . 60.329999999999998 108.978 -176.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.43 150.46 64.16 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.377 2.052 . . . . 74.409999999999997 111.355 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.432 ' C ' ' HA ' ' A' ' 128' ' ' THR . . . 73.42 -11.88 4.95 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 116.495 -0.321 . . . . 71.209999999999994 113.864 176.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 165' ' ' LYS . 33.2 m -117.01 145.46 22.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 109.344 -0.613 . . . . 74.230000000000004 109.344 171.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.76 129.07 40.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.085 -0.709 . . . . 71.420000000000002 109.085 178.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 17.7 t -111.45 136.93 49.92 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 120.048 -0.661 . . . . 73.109999999999999 109.552 -178.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.6 p -100.1 138.76 36.73 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.505 -0.77 . . . . 64.319999999999993 110.626 -179.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 23.0 ttt -125.68 117.48 23.58 Favored 'General case' 0 C--O 1.193 -1.899 0 CA-C-N 115.756 -0.656 . . . . 54.409999999999997 109.681 -177.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 24.7 t -142.92 144.83 32.56 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.542 -0.911 . . . . 71.209999999999994 108.542 174.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -154.53 128.12 8.62 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.073 -1.084 . . . . 73.5 108.073 -177.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -129.04 130.27 46.36 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.028 -1.101 . . . . 64.030000000000001 108.028 176.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -152.78 158.21 41.92 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 120.803 -0.359 . . . . 62.5 110.084 -178.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.671 ' HG2' HG22 ' A' ' 118' ' ' ILE . 96.1 mtt180 -87.3 136.3 32.99 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.633 -0.877 . . . . 71.200000000000003 108.633 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -143.25 147.2 34.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.991 -0.744 . . . . 61.420000000000002 108.991 176.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.47 112.07 5.07 Favored 'General case' 0 N--CA 1.414 -2.248 0 C-N-CA 122.849 0.459 . . . . 64.519999999999996 110.507 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 117' ' ' ASN . 2.6 m-20 -56.47 132.77 76.91 Favored Pre-proline 0 C--N 1.308 -1.221 0 C-N-CA 124.714 1.206 . . . . 63.43 112.23 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.43 -26.5 14.2 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.541 1.494 . . . . 72.420000000000002 108.925 169.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -84.9 -12.3 53.73 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 125.659 1.584 . . . . 74.519999999999996 110.772 -179.079 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' A' ' 180' ' ' ASP . 53.2 p 55.63 83.1 0.09 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.674 1.589 . . . . 72.219999999999999 114.934 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -132.06 169.88 15.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.027 0.531 . . . . 73.310000000000002 110.011 178.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.435 -1.197 0 N-CA-C 106.544 -1.65 . . . . 74.349999999999994 106.544 179.807 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.523 ' N ' ' HG ' ' A' ' 53' ' ' SER . . . . . . . . 0 C--O 1.249 1.032 0 N-CA-C 111.238 -0.745 . . . . 43.049999999999997 111.238 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -131.18 127.94 39.01 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 122.795 -0.238 . . . . 75.430000000000007 110.563 -177.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 71.82 -52.64 0.69 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.884 1.273 . . . . 72.299999999999997 114.379 174.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 73.15 -179.72 0.21 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.634 1.174 . . . . 65.329999999999998 110.971 -177.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.8 tp 60.28 50.57 6.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.903 1.281 . . . . 62.420000000000002 111.809 174.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -82.02 -56.44 3.95 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.459 0.647 . . . . 62.409999999999997 109.812 177.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -134.57 15.05 3.71 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.964 -1.016 . . . . 72.430000000000007 108.643 -179.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.433 ' HA ' ' OE1' ' A' ' 22' ' ' GLN . 5.9 tp60 67.12 -88.38 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.808 -1.542 . . . . 73.040000000000006 112.296 -177.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.92 -87.14 0.28 Allowed Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 119.858 -1.163 . . . . 40.409999999999997 114.737 -175.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 175.0 -45.61 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.802 -1.185 . . . . 61.520000000000003 107.802 -171.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.563 ' HB3' ' OH ' ' A' ' 80' ' ' TYR . 18.8 ttt -172.68 -64.71 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.728 0 CA-C-N 113.897 -1.501 . . . . 73.439999999999998 108.304 -176.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 mt 74.7 115.39 0.06 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.856 1.262 . . . . 75.040000000000006 108.233 -175.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -119.53 126.22 50.73 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.517 -0.549 . . . . 62.549999999999997 109.517 -176.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 p -124.77 123.42 65.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 120.267 -0.573 . . . . 75.140000000000001 110.02 178.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -125.1 126.61 45.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.942 -0.572 . . . . 74.209999999999994 109.474 -176.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.77 108.35 16.97 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 106.366 -1.716 . . . . 72.230000000000004 106.366 172.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -117.6 114.65 23.72 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.63 -1.618 . . . . 62.329999999999998 106.63 -178.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 pp -129.64 146.68 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-O 121.255 0.55 . . . . 53.420000000000002 109.869 -174.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 91.5 m -127.8 119.55 25.93 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-O 121.366 0.603 . . . . 42.039999999999999 109.749 -177.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.436 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.0 tt -105.96 124.36 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.417 -0.811 . . . . 34.439999999999998 109.674 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 m -98.88 150.37 36.63 Favored Pre-proline 0 C--N 1.288 -2.07 0 CA-C-N 115.44 -0.8 . . . . 75.239999999999995 109.703 -176.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -58.99 1.96 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 124.038 3.159 . . . . 54.530000000000001 114.975 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 30.3 t70 -83.85 -2.66 56.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.15 -0.685 . . . . 61.420000000000002 109.15 177.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.7 t70 72.72 29.29 1.98 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 106.125 -1.806 . . . . 73.340000000000003 106.125 -173.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 2.1 tp -104.09 125.58 50.53 Favored 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 112.682 -2.054 . . . . 71.120000000000005 109.006 -178.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.583 HG11 HD23 ' A' ' 95' ' ' LEU . 21.8 t -112.36 135.76 50.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.675 -0.861 . . . . 74.219999999999999 108.675 177.516 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 p -147.47 152.81 38.67 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.119 -1.067 . . . . 74.400000000000006 108.119 178.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.09 -171.24 44.31 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 118.74 -1.695 . . . . 54.240000000000002 113.782 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.66 133.69 30.95 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.672 0.789 . . . . 75.310000000000002 109.646 -176.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 102' ' ' ASN . 58.9 mt -121.0 116.09 48.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.918 -1.142 . . . . 74.310000000000002 107.918 176.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -114.71 121.3 66.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 123.135 0.574 . . . . 71.319999999999993 110.016 -176.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.91 108.46 16.3 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.255 -1.387 . . . . 75.430000000000007 107.255 175.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -117.79 132.82 56.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.403 0.621 . . . . 73.340000000000003 112.602 -174.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.29 158.43 35.8 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.405 -0.961 . . . . 40.149999999999999 108.405 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.75 153.81 83.26 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 104.551 -2.389 . . . . 61.5 104.551 173.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.42 103.67 0.06 OUTLIER 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 122.299 1.999 . . . . 63.310000000000002 111.766 -179.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -77.6 -36.9 51.34 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.867 0.692 . . . . 73.219999999999999 112.867 -169.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.499 ' H ' ' HB3' ' A' ' 55' ' ' ASP . 45.3 t30 -151.8 167.72 27.34 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.878 -0.786 . . . . 65.150000000000006 108.878 -176.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.523 ' HG ' ' N ' ' A' ' 15' ' ' GLY . 4.2 m -58.87 -28.1 65.81 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.92 1.288 . . . . 73.439999999999998 112.683 -175.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -90.8 -6.11 54.74 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.868 -0.52 . . . . 62.43 110.017 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.499 ' HB3' ' H ' ' A' ' 52' ' ' ASN . 33.5 t70 -99.45 96.76 7.91 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.609 0.719 . . . . 75.310000000000002 111.103 -172.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t -122.25 -11.05 8.45 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.698 -1.137 . . . . 70.349999999999994 109.623 175.16 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.26 96.47 0.1 Allowed Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 110.829 -0.909 . . . . 71.209999999999994 110.829 176.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.43 ' O ' ' HB3' ' A' ' 83' ' ' SER . 26.1 Cg_endo -68.52 159.6 52.83 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.931 2.42 . . . . 71.099999999999994 113.046 177.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.25 140.39 50.33 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.593 -0.892 . . . . 32.450000000000003 108.593 176.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 90.2 mt -79.92 140.78 36.56 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.703 0.287 . . . . 45.020000000000003 111.337 -178.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.16 96.61 6.77 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 122.263 1.03 . . . . 72.409999999999997 108.473 177.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -113.45 -71.01 0.55 Allowed Glycine 0 C--N 1.292 -1.872 0 CA-C-N 114.415 -1.266 . . . . 72.120000000000005 113.117 -177.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 58.59 86.02 0.09 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.23 1.014 . . . . 74.010000000000005 112.404 -176.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 m -115.81 158.63 41.66 Favored Pre-proline 0 C--N 1.29 -1.993 0 CA-C-N 114.652 -1.158 . . . . 73.319999999999993 108.686 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.57 -16.84 50.6 Favored 'Trans proline' 0 N--CA 1.483 0.884 0 C-N-CA 122.747 2.298 . . . . 72.5 112.354 179.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -113.45 25.22 11.47 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.543 -0.753 . . . . 73.329999999999998 112.037 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.8 m -56.36 -24.01 41.35 Favored 'General case' 0 C--O 1.21 -1.004 0 N-CA-C 111.753 0.279 . . . . 61.240000000000002 111.753 177.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -62.57 -23.17 66.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.18 0.514 . . . . 55.039999999999999 110.456 178.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.656 ' HB3' ' O ' ' A' ' 88' ' ' SER . 33.4 mmtp -95.51 -14.44 23.67 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.246 0.546 . . . . 55.240000000000002 110.104 -178.23 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 49.8 t -108.19 121.05 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 116.081 -0.509 . . . . 74.439999999999998 110.407 -177.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.11 110.67 22.69 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.171 -0.677 . . . . 73.239999999999995 109.171 177.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.96 137.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.98 -1.119 . . . . 64.140000000000001 107.98 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.5 t -148.2 172.22 14.68 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.803 -0.814 . . . . 74.230000000000004 108.803 -174.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -92.02 141.23 28.84 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.132 -1.062 . . . . 70.329999999999998 108.132 177.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 93.0 t80 -102.24 127.36 49.24 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.374 -0.602 . . . . 65.409999999999997 109.374 -178.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -136.56 99.63 4.12 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.568 -0.901 . . . . 71.340000000000003 108.568 176.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 30.9 t -170.0 155.76 5.75 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.276 -1.009 . . . . 63.329999999999998 108.276 -179.067 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 71.06 6.72 5.95 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.803 1.241 . . . . 74.340000000000003 111.604 178.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.91 4.51 84.63 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.659 -1.376 . . . . 73.439999999999998 109.659 -173.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.563 ' OH ' ' HB3' ' A' ' 25' ' ' MET . 6.2 m-85 -104.31 149.34 25.44 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 124.164 0.986 . . . . 72.019999999999996 110.049 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.7 m -125.5 136.06 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 108.015 -1.106 . . . . 70.120000000000005 108.015 174.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -163.12 -155.42 8.1 Favored Glycine 0 C--N 1.27 -3.09 0 C-N-CA 119.4 -1.381 . . . . 62.530000000000001 112.19 -178.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 13.4 p -124.1 140.95 52.47 Favored 'General case' 0 C--N 1.274 -2.715 0 CA-C-N 115.096 -0.552 . . . . 72.219999999999999 109.729 -178.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.53 141.68 45.28 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 120.816 0.341 . . . . 72.140000000000001 110.649 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.35 115.56 21.86 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.027 -0.731 . . . . 75.510000000000005 109.027 178.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.4 t -106.01 112.53 39.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 108.165 -1.05 . . . . 63.420000000000002 108.165 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 50.7 p90 -112.87 153.96 27.08 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 120.708 -0.397 . . . . 72.430000000000007 110.746 -174.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 69' ' ' LYS . 42.4 m -153.61 161.49 42.14 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.822 -0.351 . . . . 71.420000000000002 110.932 -177.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.1 t70 59.68 37.82 22.14 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 122.471 1.129 . . . . 74.420000000000002 111.574 173.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.424 HD12 ' CD2' ' A' ' 87' ' ' PHE . 35.8 mt -103.29 164.76 11.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.33 -0.85 . . . . 71.310000000000002 110.922 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -114.21 174.02 6.16 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.052 0.453 . . . . 74.510000000000005 110.742 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -56.49 -34.28 66.8 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 125.58 1.552 . . . . 72.209999999999994 111.021 -178.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.4 -25.26 61.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.98 -0.555 . . . . 43.119999999999997 111.185 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -88.77 -16.45 32.12 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 116.107 -0.497 . . . . 75.310000000000002 111.648 -176.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 1.6 tm? -52.73 -56.44 23.12 Favored Pre-proline 0 CA--C 1.569 1.696 0 C-N-CA 123.442 0.697 . . . . 70.120000000000005 111.756 179.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.18 -37.14 33.38 Favored 'Trans proline' 0 C--N 1.372 1.795 0 CA-C-N 120.741 1.3 . . . . 73.010000000000005 111.232 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.55 -34.67 78.79 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 124.437 1.095 . . . . 72.129999999999995 110.857 -176.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.2 pp -78.38 -23.01 47.02 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.384 0.611 . . . . 74.219999999999999 109.543 175.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.34 -22.95 59.0 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-N 115.577 -0.738 . . . . 44.229999999999997 109.842 -175.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -62.06 -46.79 87.56 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.445 -0.798 . . . . 60.229999999999997 109.659 177.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.6 mtm -55.95 -49.67 72.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.282 0.563 . . . . 75.400000000000006 109.711 177.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' HB2' HD13 ' A' ' 44' ' ' ILE . 34.2 t30 -54.49 -35.63 63.29 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 114.726 -1.124 . . . . 75.030000000000001 110.96 178.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.4 m -60.65 -29.21 69.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.786 -0.643 . . . . 64.310000000000002 110.86 -173.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.81 -30.29 69.98 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 123.558 0.536 . . . . 71.120000000000005 111.345 -175.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.87 -10.86 15.47 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.085 -0.507 . . . . 75.450000000000003 110.89 -177.258 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.69 -47.8 3.67 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 113.44 0.904 . . . . 31.399999999999999 113.44 -172.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.42 24.9 41.38 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.428 -1.069 . . . . 73.209999999999994 110.428 -173.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 m -106.42 163.09 5.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.393 -0.404 . . . . 74.519999999999996 110.319 -178.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -128.56 122.2 30.5 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.597 -1.26 . . . . 74.530000000000001 107.597 176.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.1 mt -119.09 122.48 42.2 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 120.957 0.408 . . . . 74.450000000000003 111.209 -178.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 p -137.22 139.5 41.07 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.984 -0.553 . . . . 72.420000000000002 109.736 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.87 150.67 32.27 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 122.075 -0.391 . . . . 63.210000000000001 110.042 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -143.51 155.04 44.22 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.109 -0.496 . . . . 74.519999999999996 110.683 -176.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.431 ' HG2' HG22 ' A' ' 119' ' ' VAL . 40.6 mtt85 -92.31 138.53 31.45 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 121.587 0.708 . . . . 74.409999999999997 111.333 173.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.44 ' O ' HG13 ' A' ' 118' ' ' ILE . 6.8 t30 -123.9 88.02 2.84 Favored 'General case' 0 C--N 1.269 -2.908 0 N-CA-C 105.665 -1.976 . . . . 70.120000000000005 105.665 175.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 185' ' ' SER . . . 73.71 -120.23 6.81 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 109.646 -1.381 . . . . 74.230000000000004 109.646 -175.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -104.54 12.45 33.14 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.509 1.147 . . . . 71.010000000000005 108.635 178.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.561 HG22 ' HG2' ' A' ' 177' ' ' ARG . 1.2 pp -119.26 149.46 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 O-C-N 120.951 -1.093 . . . . 63.340000000000003 109.041 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.431 HG22 ' HG2' ' A' ' 114' ' ' ARG . 86.5 t -110.27 138.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 CA-C-O 120.951 0.405 . . . . 62.549999999999997 110.352 -178.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.9 pt -110.6 129.29 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.361 0 N-CA-C 107.132 -1.433 . . . . 74.099999999999994 107.132 172.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.24 129.53 50.93 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 109.391 -0.596 . . . . 73.239999999999995 109.391 -178.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -134.8 119.23 17.91 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.913 0.863 . . . . 72.120000000000005 111.27 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.38 148.36 17.85 Favored Glycine 0 N--CA 1.418 -2.527 0 N-CA-C 110.834 -0.906 . . . . 74.340000000000003 110.834 178.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.495 ' HG2' HG22 ' A' ' 171' ' ' THR . 75.7 mtt180 -123.63 140.21 53.22 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 109.256 -0.646 . . . . 71.549999999999997 109.256 179.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.92 109.24 14.86 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 109.293 -0.632 . . . . 72.430000000000007 109.293 178.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -112.64 94.39 4.89 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.06 -1.089 . . . . 73.530000000000001 108.06 176.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -122.96 37.01 4.52 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 122.937 1.351 . . . . 62.340000000000003 108.313 177.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 75.6 p -69.96 -8.74 51.44 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.385 -1.734 . . . . 64.340000000000003 110.59 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.5 p -73.7 -24.63 59.96 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 125.231 1.413 . . . . 63.210000000000001 110.461 178.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.8 t 66.28 93.23 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.544 1.137 . . . . 75.239999999999995 112.083 178.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 m -63.27 -49.57 73.56 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 108.555 -0.905 . . . . 73.200000000000003 108.555 176.043 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -148.52 140.61 14.6 Favored Pre-proline 0 CA--C 1.495 -1.139 0 N-CA-C 104.55 -2.389 . . . . 72.310000000000002 104.55 174.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -49.63 -32.05 26.9 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.121 2.548 . . . . 75.030000000000001 115.146 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 25' ' ' MET . 9.2 t70 -107.96 18.97 20.63 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.258 -0.977 . . . . 70.129999999999995 112.733 -173.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.82 48.48 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.687 0.995 . . . . 73.209999999999994 113.687 -177.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -132.9 136.45 46.18 Favored 'General case' 0 C--O 1.26 1.614 0 CA-C-N 115.69 -0.686 . . . . 61.329999999999998 109.684 171.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.2 t -114.82 114.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.979 -1.119 . . . . 74.439999999999998 107.979 176.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.32 124.42 52.19 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 120.694 -0.402 . . . . 73.340000000000003 111.444 -178.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 50.7 tp -111.08 124.52 52.35 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.697 -1.223 . . . . 73.549999999999997 107.697 170.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.5 m -126.05 112.55 16.0 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.898 -0.778 . . . . 62.229999999999997 108.898 178.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.462 HG12 ' HD1' ' A' ' 143' ' ' PHE . 82.1 t -107.51 120.81 59.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 109.33 -0.618 . . . . 75.409999999999997 109.33 179.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -111.33 127.81 55.76 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.207 -0.664 . . . . 51.520000000000003 109.207 178.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.647 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.5 p90 -135.1 122.2 14.98 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 112.266 0.469 . . . . 55.32 112.266 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -67.78 42.32 0.23 Allowed 'Trans proline' 0 CA--C 1.566 2.113 0 C-N-CA 123.162 2.575 . . . . 72.340000000000003 112.443 173.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.41 -108.68 0.31 Allowed 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 122.977 0.511 . . . . 54.509999999999998 109.806 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -178.85 133.96 0.13 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.966 -0.753 . . . . 62.200000000000003 108.966 -177.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.3 p -88.38 141.11 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 109.235 -0.654 . . . . 75.230000000000004 109.235 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 39.5 p -102.15 -38.14 7.83 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.027 0.441 . . . . 54.409999999999997 110.411 -179.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.9 m -155.75 132.39 10.41 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 108.625 -0.879 . . . . 43.32 108.625 178.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.2 t -139.97 152.83 46.62 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 120.144 -0.622 . . . . 75.430000000000007 112.103 176.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -118.98 88.15 2.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.325 -2.102 . . . . 75.549999999999997 105.325 175.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.414 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.09 -145.03 8.62 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 108.644 -1.782 . . . . 75.400000000000006 108.644 -177.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -118.27 99.99 7.21 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 118.129 0.964 . . . . 62.5 110.8 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.26 109.23 13.41 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 121.537 0.684 . . . . 74.209999999999994 109.449 176.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 61.9 mt -80.12 -46.96 21.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.096 -1.446 . . . . 64.530000000000001 107.096 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 159' ' ' VAL . 13.1 mm-40 -121.63 163.42 30.97 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 106.802 -1.555 . . . . 74.010000000000005 106.802 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.93 -1.18 10.09 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.164 1.909 . . . . 72.219999999999999 111.376 178.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.5 pt-20 -137.07 9.66 3.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.439 -0.8 . . . . 63.350000000000001 111.66 -177.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 156' ' ' GLU . 54.7 t -145.07 120.7 3.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.907 -1.146 . . . . 61.310000000000002 107.907 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.84 143.72 38.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.284 -0.635 . . . . 50.439999999999998 109.284 -177.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.7 tt0 -130.86 143.34 50.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-O 121.252 0.548 . . . . 73.420000000000002 110.155 -177.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.414 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 30.3 m-90 -126.45 121.31 32.06 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.845 -0.798 . . . . 75.340000000000003 108.845 179.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 105.07 13.15 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.36 0.6 . . . . 73.329999999999998 110.234 176.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 170' ' ' SER . 1.2 mm? -99.54 147.82 24.92 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.373 -0.831 . . . . 71.400000000000006 110.281 -174.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -117.68 155.45 50.59 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.984 -0.553 . . . . 63.439999999999998 112.391 -176.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.81 157.4 51.84 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.901 2.401 . . . . 61.109999999999999 110.97 178.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.84 -35.22 2.91 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.666 -0.778 . . . . 62.240000000000002 111.574 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 20.7 m -104.76 145.13 13.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.039 0.447 . . . . 65.030000000000001 110.232 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.2 p -101.52 144.0 13.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 107.804 -1.184 . . . . 61.039999999999999 107.804 178.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.473 ' HB2' HD12 ' A' ' 164' ' ' LEU . 50.0 m -149.32 153.61 37.73 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.066 0.46 . . . . 74.129999999999995 111.459 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.495 HG22 ' HG2' ' A' ' 124' ' ' ARG . 2.6 p -106.56 128.37 54.07 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.307 -0.86 . . . . 63.420000000000002 109.889 177.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 23.5 ptp -106.93 122.06 45.66 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.614 -1.624 . . . . 70.510000000000005 106.614 178.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.5 m -141.47 148.01 38.79 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.558 -1.257 . . . . 71.540000000000006 111.737 -176.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.96 136.69 18.04 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 115.234 -0.894 . . . . 70.409999999999997 108.69 -176.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -130.79 131.05 44.44 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 105.866 -1.901 . . . . 62.0 105.866 175.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 178' ' ' TYR . . . -157.45 160.66 38.55 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 120.876 -0.33 . . . . 74.439999999999998 110.348 -175.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.561 ' HG2' HG22 ' A' ' 118' ' ' ILE . 96.5 mtt180 -87.52 129.05 35.22 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.729 -0.841 . . . . 74.329999999999998 108.729 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 176' ' ' ALA . 99.2 m-85 -140.73 124.69 17.26 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 108.762 -0.829 . . . . 74.140000000000001 108.762 178.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.07 122.73 9.96 Favored 'General case' 0 N--CA 1.404 -2.739 0 O-C-N 124.795 1.309 . . . . 75.140000000000001 111.564 -177.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -75.65 135.07 71.89 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 106.952 -1.499 . . . . 74.310000000000002 106.952 175.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.69 -39.21 75.82 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 122.176 1.917 . . . . 61.340000000000003 112.527 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -84.51 -19.23 33.57 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 123.689 0.796 . . . . 73.409999999999997 108.961 -175.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 65.4 p 65.38 31.97 10.02 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.817 1.647 . . . . 62.43 111.423 -177.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -100.43 156.71 17.11 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.643 -1.162 . . . . 63.200000000000003 110.304 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.468 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 48.3 m . . . . . 0 N--CA 1.42 -1.943 0 N-CA-C 107.144 -1.428 . . . . 71.030000000000001 107.144 176.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.583 0 N-CA-C 111.27 -0.732 . . . . 60.439999999999998 111.27 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -150.44 126.64 10.62 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.752 -1.573 . . . . 73.349999999999994 106.752 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.98 160.37 18.68 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.396 -0.521 . . . . 75.219999999999999 110.243 178.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -116.37 128.8 55.84 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.848 -1.168 . . . . 75.409999999999997 107.848 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.44 131.46 36.19 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.923 -0.58 . . . . 71.230000000000004 109.751 -175.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -92.34 133.91 35.41 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.106 -0.497 . . . . 71.400000000000006 110.78 -174.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -98.62 141.34 31.57 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.909 -0.404 . . . . 52.350000000000001 109.909 178.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -114.45 -75.23 0.59 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 114.818 1.414 . . . . 72.349999999999994 114.818 -170.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.08 26.47 2.47 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 116.479 1.352 . . . . 51.420000000000002 116.479 -168.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.492 ' HB2' ' OH ' ' A' ' 80' ' ' TYR . 51.0 m80 -142.7 -56.16 0.43 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.287 -1.005 . . . . 70.530000000000001 108.287 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.4 mmt 71.56 -171.27 0.15 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 114.703 -1.135 . . . . 74.549999999999997 111.022 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 26' ' ' LEU . 1.9 pt? -75.29 127.41 33.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.038 0.447 . . . . 70.129999999999995 109.962 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -113.47 124.34 52.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.946 -0.761 . . . . 73.310000000000002 108.946 -175.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.17 114.01 45.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.08 -1.822 . . . . 63.200000000000003 106.08 172.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -123.75 115.66 21.75 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 120.955 0.407 . . . . 61.340000000000003 110.93 -175.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.31 108.55 17.07 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.786 -1.19 . . . . 55.240000000000002 107.786 175.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.3 t -114.39 115.53 27.47 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.671 -1.233 . . . . 74.400000000000006 107.671 -178.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.96 146.42 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.092 0.472 . . . . 71.120000000000005 109.822 -178.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 88.9 m -126.08 128.5 47.47 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.98 -0.748 . . . . 64.129999999999995 108.98 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.447 HG23 ' HB3' ' A' ' 143' ' ' PHE . 8.4 tt -114.76 114.83 47.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-O 121.622 0.725 . . . . 65.439999999999998 110.067 179.214 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -82.29 153.11 68.64 Favored Pre-proline 0 N--CA 1.423 -1.775 0 CA-C-N 115.215 -0.902 . . . . 70.420000000000002 109.564 -176.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.62 1.99 0.46 Allowed 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 123.765 2.977 . . . . 74.510000000000005 114.006 178.013 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.53 -8.27 59.62 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.387 -0.968 . . . . 71.129999999999995 108.387 174.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.0 t70 72.78 29.27 1.95 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.567 1.547 . . . . 75.140000000000001 107.338 -174.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.26 126.49 51.42 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 113.55 -1.659 . . . . 73.340000000000003 107.512 178.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 t -104.33 140.1 23.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 107.871 -1.159 . . . . 75.409999999999997 107.871 -178.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.5 p -148.47 158.97 44.46 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.318 -1.364 . . . . 61.109999999999999 107.318 -178.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.24 -167.8 39.0 Favored Glycine 0 CA--C 1.488 -1.641 0 C-N-CA 118.509 -1.805 . . . . 65.439999999999998 113.028 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -152.89 135.14 14.96 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 123.176 0.591 . . . . 75.239999999999995 110.228 -177.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 66.6 mt -115.53 115.89 50.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 107.838 -1.171 . . . . 61.329999999999998 107.838 177.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.26 116.59 52.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.726 -0.842 . . . . 62.109999999999999 108.726 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.553 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -115.25 108.32 16.43 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.927 -1.509 . . . . 72.099999999999994 106.927 175.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.47 118.98 33.68 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.324 -0.621 . . . . 35.049999999999997 109.324 -177.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HA ' ' CB ' ' A' ' 26' ' ' LEU . . . -113.91 158.04 21.61 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 115.637 -0.71 . . . . 73.239999999999995 111.308 -174.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -65.71 127.99 93.47 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 105.932 -1.877 . . . . 74.5 105.932 172.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -65.78 90.7 0.24 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.691 1.594 . . . . 65.349999999999994 112.343 -178.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -71.69 -54.21 11.06 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 106.232 -1.766 . . . . 74.310000000000002 106.232 172.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -82.86 97.57 8.72 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 106.245 -1.761 . . . . 62.130000000000003 106.245 174.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.5 t -64.42 -12.24 41.21 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 123.327 0.651 . . . . 74.549999999999997 112.609 -175.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -76.73 -18.08 58.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.971 0.415 . . . . 74.439999999999998 110.342 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -86.95 130.23 34.55 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 112.52 0.563 . . . . 63.109999999999999 112.52 -174.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -104.01 -23.21 13.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.575 -1.268 . . . . 61.439999999999998 107.575 172.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.579 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . 172.88 104.05 0.17 Allowed Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 119.807 -1.187 . . . . 44.420000000000002 113.49 174.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 83' ' ' SER . 45.4 Cg_exo -60.72 159.6 27.94 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.837 2.358 . . . . 72.439999999999998 110.743 173.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.2 163.14 14.23 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.902 -0.499 . . . . 40.32 110.473 178.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 83' ' ' SER . 3.6 mm? -77.72 136.28 38.15 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.111 -0.495 . . . . 62.299999999999997 109.672 177.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -110.54 95.08 5.35 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.404 0.621 . . . . 71.450000000000003 109.518 -178.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.62 94.01 0.1 OUTLIER Glycine 0 C--N 1.286 -2.207 0 N-CA-C 109.93 -1.268 . . . . 74.340000000000003 109.93 179.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.18 93.97 2.39 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.086 0.47 . . . . 65.019999999999996 111.165 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.5 m -85.79 151.95 56.0 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.439 -0.801 . . . . 73.129999999999995 109.764 178.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.06 -31.84 83.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.414 2.076 . . . . 52.439999999999998 111.707 178.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -96.11 38.27 1.2 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.791 -0.64 . . . . 71.319999999999993 112.095 -177.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.2 m -59.66 -24.48 63.92 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.563 0.579 . . . . 73.230000000000004 112.563 -178.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -70.52 -17.87 62.94 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 121.235 0.541 . . . . 74.150000000000006 110.425 -178.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -90.1 -16.63 29.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.708 -0.678 . . . . 70.019999999999996 109.731 -178.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.03 120.06 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 122.029 0.918 . . . . 71.239999999999995 112.492 -176.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.73 108.0 20.0 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.091 -0.958 . . . . 25.23 108.634 178.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 60' ' ' LEU . 67.8 t -98.08 142.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 107.514 -1.291 . . . . 73.209999999999994 107.514 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.7 t -157.42 172.7 18.11 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 108.742 -0.836 . . . . 72.120000000000005 108.742 -175.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.579 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . 4.1 p-10 -86.55 146.7 26.26 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.847 -0.797 . . . . 65.310000000000002 108.847 178.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -108.2 119.1 38.5 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.592 -1.262 . . . . 65.319999999999993 107.592 175.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -138.43 99.85 3.95 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.358 -1.719 . . . . 64.010000000000005 106.358 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.7 t -174.76 159.1 2.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.858 -1.164 . . . . 72.239999999999995 107.858 -176.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 72.76 -5.43 1.88 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.874 0.869 . . . . 73.120000000000005 112.535 172.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.28 -5.28 58.94 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 109.877 -1.289 . . . . 73.409999999999997 109.877 -174.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.492 ' OH ' ' HB2' ' A' ' 24' ' ' HIS . 89.3 m-85 -104.5 155.04 19.15 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 123.592 0.757 . . . . 73.219999999999999 109.696 -177.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.62 140.28 49.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 109.059 -0.719 . . . . 73.530000000000001 109.059 178.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -170.04 -154.83 9.63 Favored Glycine 0 N--CA 1.411 -3.001 0 C-N-CA 119.721 -1.228 . . . . 41.229999999999997 112.647 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.581 ' HB2' HD22 ' A' ' 60' ' ' LEU . 28.1 p -122.2 147.46 46.16 Favored 'General case' 0 C--N 1.278 -2.538 0 C-N-CA 123.391 0.677 . . . . 60.409999999999997 110.709 -176.107 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -137.32 143.2 41.96 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.995 0.426 . . . . 44.43 110.987 175.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -129.99 115.09 16.63 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.525 -1.287 . . . . 32.140000000000001 107.525 175.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.9 t -109.89 116.92 53.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.54 -0.911 . . . . 74.109999999999999 108.54 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.509 ' CD2' HD12 ' A' ' 90' ' ' LEU . 48.7 p90 -121.15 155.32 34.77 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.463 0.649 . . . . 74.030000000000001 111.832 -175.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 p -156.08 148.36 23.5 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.361 -0.836 . . . . 64.019999999999996 109.662 -177.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 t70 60.42 62.28 1.59 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.703 1.24 . . . . 72.530000000000001 112.175 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.509 HD12 ' CD2' ' A' ' 87' ' ' PHE . 25.6 mt -121.13 162.38 20.18 Favored 'General case' 0 N--CA 1.413 -2.301 0 CA-C-N 114.204 -1.362 . . . . 62.130000000000003 108.335 174.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -112.17 173.22 6.47 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 119.564 -0.854 . . . . 72.120000000000005 109.443 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.415 ' CE1' HD12 ' A' ' 112' ' ' LEU . 85.0 t80 -50.27 -46.71 55.25 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.272 1.029 . . . . 72.349999999999994 111.636 -178.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.48 -25.35 68.22 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.607 -0.724 . . . . 73.109999999999999 112.337 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -85.72 -17.32 36.28 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 111.859 0.318 . . . . 72.219999999999999 111.859 -177.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.596 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 50.6 tp -61.96 -52.95 64.23 Favored Pre-proline 0 CA--C 1.558 1.288 0 N-CA-C 113.2 0.815 . . . . 72.230000000000004 113.2 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -62.05 -37.13 66.61 Favored 'Trans proline' 0 C--N 1.365 1.419 0 CA-C-N 120.75 1.304 . . . . 72.239999999999995 110.731 176.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -65.13 -36.4 84.14 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 115.067 -0.97 . . . . 74.329999999999998 111.302 -176.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.3 pp -74.29 -19.51 60.45 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 120.818 0.342 . . . . 61.130000000000003 110.391 177.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.86 -23.27 63.25 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.201 -0.454 . . . . 70.439999999999998 110.523 -177.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -59.74 -48.45 81.61 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 109.584 -0.524 . . . . 64.019999999999996 109.584 176.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.419 ' HG2' ' HB3' ' A' ' 60' ' ' LEU . 17.0 ttm -56.19 -52.11 65.6 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.65 -0.704 . . . . 64.230000000000004 109.385 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -55.19 -33.36 62.96 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 114.646 -1.161 . . . . 71.430000000000007 110.901 178.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -65.11 -18.08 65.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 118.796 -0.621 . . . . 64.400000000000006 112.473 -174.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.34 -30.38 66.68 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.535 0.683 . . . . 70.420000000000002 109.823 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.67 -11.57 13.99 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.272 -0.876 . . . . 64.450000000000003 110.908 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.436 ' HB1' HG13 ' A' ' 108' ' ' VAL . . . -107.73 -48.45 3.41 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.947 1.091 . . . . 74.120000000000005 113.947 -172.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.89 18.63 79.66 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 116.289 -0.414 . . . . 70.439999999999998 112.849 -175.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.436 HG13 ' HB1' ' A' ' 106' ' ' ALA . 27.3 m -82.2 178.62 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 112.634 0.605 . . . . 71.530000000000001 112.634 -176.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -142.11 126.76 17.97 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.03 0.532 . . . . 73.129999999999995 109.583 179.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.5 mp -127.23 115.93 19.81 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.427 -0.212 . . . . 72.340000000000003 110.427 178.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.5 m -111.27 109.79 19.97 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.128 -0.693 . . . . 73.340000000000003 109.128 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.415 HD12 ' CE1' ' A' ' 92' ' ' PHE . 1.3 pt? -129.42 148.37 51.33 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.555 0.693 . . . . 53.43 111.9 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -152.65 169.96 21.41 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.465 -1.243 . . . . 74.450000000000003 110.964 -177.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.44 ' HG3' HG22 ' A' ' 119' ' ' VAL . 5.4 mtt85 -101.79 137.52 39.98 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 115.628 -0.714 . . . . 51.310000000000002 109.715 171.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -118.36 87.35 2.71 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.406 -1.331 . . . . 73.310000000000002 107.406 177.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 185' ' ' SER . . . 72.61 -98.52 0.85 Allowed Glycine 0 N--CA 1.428 -1.86 0 CA-C-N 115.044 -0.98 . . . . 52.509999999999998 111.962 -177.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -120.12 4.08 10.88 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.811 1.291 . . . . 73.099999999999994 108.563 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -118.84 149.38 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 108.325 -0.991 . . . . 73.400000000000006 108.325 -178.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 114' ' ' ARG . 78.2 t -105.4 135.38 43.76 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 N-CA-C 110.005 -0.368 . . . . 70.209999999999994 110.005 -178.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.439 HG22 ' HG2' ' A' ' 175' ' ' GLN . 46.6 pt -113.57 131.47 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 108.733 -0.84 . . . . 71.400000000000006 108.733 177.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 tt -128.61 123.61 33.74 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 115.534 -0.757 . . . . 74.099999999999994 108.979 176.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.71 124.86 12.89 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.722 0.772 . . . . 74.420000000000002 110.972 177.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.58 -178.68 25.68 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.891 -0.671 . . . . 52.509999999999998 111.607 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.447 ' HG2' HG22 ' A' ' 171' ' ' THR . 96.8 mtt180 -140.8 159.26 42.6 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.753 -0.462 . . . . 71.150000000000006 109.753 -176.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.46 108.52 10.61 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 106.019 -1.845 . . . . 54.420000000000002 106.019 171.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -111.86 93.51 4.49 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.505 0.669 . . . . 75.340000000000003 109.297 -178.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 166' ' ' PRO 0.334 0.0 OUTLIER -126.17 63.9 1.24 Allowed 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 123.492 1.615 . . . . 65.349999999999994 109.202 171.429 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.3 p -83.62 -21.9 32.38 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 112.683 -2.053 . . . . 33.310000000000002 112.489 -173.032 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.7 m -78.43 -17.53 56.24 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.861 -0.422 . . . . 74.239999999999995 109.861 178.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.2 t 72.49 111.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 124.621 1.168 . . . . 73.140000000000001 113.172 174.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.3 m -91.6 -49.68 6.17 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.285 -1.376 . . . . 61.100000000000001 107.285 172.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -130.65 117.93 17.68 Favored Pre-proline 0 CA--C 1.488 -1.412 0 CA-C-N 115.19 -0.914 . . . . 73.219999999999999 108.578 175.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.58 -12.28 22.42 Favored 'Trans proline' 0 C--N 1.327 -0.59 0 C-N-CA 122.24 1.96 . . . . 73.450000000000003 111.463 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -101.81 3.57 39.5 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.351 -0.841 . . . . 72.209999999999994 110.679 -177.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -93.03 141.57 28.26 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.726 -0.39 . . . . 74.409999999999997 111.341 -177.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -127.48 135.45 50.41 Favored 'General case' 0 C--O 1.261 1.694 0 N-CA-C 107.009 -1.478 . . . . 65.310000000000002 107.009 172.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 55.3 t -108.7 115.14 48.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.3 -1.0 . . . . 53.299999999999997 108.3 178.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.55 120.1 40.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.968 -0.753 . . . . 72.219999999999999 108.968 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.13 111.98 21.86 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.949 -1.5 . . . . 71.120000000000005 106.949 178.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.2 m -114.15 128.51 56.4 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.435 -0.58 . . . . 75.129999999999995 109.435 -176.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 88.3 t -120.93 123.63 70.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.031 -0.729 . . . . 75.349999999999994 109.031 178.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.57 127.5 56.1 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.002 -0.74 . . . . 52.409999999999997 109.002 177.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 3.7 p90 -134.01 118.82 14.34 Favored Pre-proline 0 C--N 1.291 -1.949 0 N-CA-C 111.795 0.294 . . . . 71.109999999999999 111.795 178.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.37 41.42 0.36 Allowed 'Trans proline' 0 CA--C 1.555 1.561 0 C-N-CA 123.223 2.615 . . . . 71.239999999999995 112.563 175.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.08 -92.85 0.53 Allowed 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 110.148 -0.315 . . . . 63.240000000000002 110.148 178.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 168.24 133.68 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.522 1.129 . . . . 74.040000000000006 108.192 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.09 142.86 12.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 108.866 -0.791 . . . . 74.329999999999998 108.866 175.54 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.7 t -103.75 -33.74 8.82 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.2 -0.667 . . . . 75.219999999999999 109.2 178.153 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.0 m -158.3 132.31 7.9 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 108.833 -0.803 . . . . 74.549999999999997 108.833 175.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -139.23 159.49 42.04 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 109.559 -0.534 . . . . 61.100000000000001 109.559 174.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.564 ' HB3' ' OG ' ' A' ' 173' ' ' SER . 57.6 t30 -135.58 103.17 5.35 Favored 'General case' 0 C--O 1.274 2.365 0 N-CA-C 105.982 -1.858 . . . . 64.219999999999999 105.982 169.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.27 -140.75 6.06 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 107.614 -2.195 . . . . 62.219999999999999 107.614 -178.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.5 99.45 6.83 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 118.417 1.108 . . . . 73.239999999999995 110.041 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -75.53 131.12 39.84 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.719 -0.673 . . . . 63.119999999999997 110.64 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.9 mt -95.68 -44.51 13.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.257 -1.386 . . . . 60.140000000000001 107.257 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -141.96 170.37 9.22 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 105.928 -1.879 . . . . 75.510000000000005 105.928 176.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.24 -0.44 8.63 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.169 1.913 . . . . 53.409999999999997 111.39 177.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.611 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 10.8 pt-20 -128.62 5.75 5.61 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.046 -0.524 . . . . 63.149999999999999 111.207 178.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.4 t -143.22 120.8 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.799 -0.815 . . . . 72.099999999999994 108.799 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.5 t -130.86 147.15 33.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.364 -0.606 . . . . 52.420000000000002 109.364 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -131.01 145.35 52.02 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.147 0.499 . . . . 74.25 109.72 -179.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.49 ' CD1' ' HA ' ' A' ' 172' ' ' MET . 30.2 m-90 -121.45 124.63 44.93 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.032 -1.099 . . . . 72.25 108.032 174.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -104.64 99.41 9.08 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.885 -1.154 . . . . 55.409999999999997 107.885 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 1.3 mm? -89.2 133.42 34.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.527 -0.761 . . . . 75.439999999999998 109.272 -174.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -117.58 150.59 47.03 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 116.139 -0.482 . . . . 74.219999999999999 111.854 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.426 ' HA ' HD23 ' A' ' 127' ' ' LEU . 72.2 Cg_endo -76.76 156.96 35.44 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 123.087 2.525 . . . . 64.150000000000006 111.85 177.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.47 -36.73 2.93 Favored Glycine 0 C--N 1.31 -0.91 0 CA-C-N 115.977 -0.556 . . . . 63.32 111.798 178.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.49 149.98 8.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.789 -0.819 . . . . 74.230000000000004 108.789 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.4 p -86.22 114.51 25.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.608 -0.886 . . . . 70.519999999999996 108.608 177.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.1 m -104.61 141.99 35.45 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.575 -0.528 . . . . 74.409999999999997 109.575 -177.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 124' ' ' ARG . 67.1 p -116.22 156.84 25.84 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 120.738 0.304 . . . . 75.340000000000003 110.564 -177.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.49 ' HA ' ' CD1' ' A' ' 162' ' ' TRP . 23.4 ptp -128.95 117.45 20.98 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.132 -1.062 . . . . 64.25 108.132 175.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.564 ' OG ' ' HB3' ' A' ' 151' ' ' ASN . 2.9 p -138.33 132.93 32.34 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.936 -0.706 . . . . 74.420000000000002 112.084 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.474 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.71 139.88 19.36 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 123.664 0.785 . . . . 75.450000000000003 109.341 -176.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.439 ' HG2' HG22 ' A' ' 120' ' ' ILE . 48.7 mt-30 -137.99 130.59 29.51 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.464 -1.31 . . . . 63.439999999999998 107.464 174.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.433 ' HB3' ' CE1' ' A' ' 178' ' ' TYR . . . -148.55 153.1 37.93 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.912 -0.315 . . . . 63.420000000000002 110.409 -177.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 37.5 mtp180 -89.55 126.25 35.53 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.547 -0.908 . . . . 62.130000000000003 108.547 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 176' ' ' ALA . 85.3 m-85 -124.69 152.86 43.18 Favored 'General case' 0 CA--C 1.488 -1.427 0 CA-C-O 120.988 0.423 . . . . 74.310000000000002 111.107 -176.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.2 p -78.34 94.38 4.84 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 116.138 -0.483 . . . . 70.010000000000005 111.518 177.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.519 ' HB3' ' H ' ' A' ' 183' ' ' THR . 0.5 OUTLIER -55.88 110.84 2.55 Favored Pre-proline 0 N--CA 1.467 0.384 0 C-N-CA 125.259 1.424 . . . . 74.140000000000001 113.773 175.483 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -75.71 -34.02 3.53 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.645 1.563 . . . . 64.030000000000001 109.496 168.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -80.02 -23.7 41.3 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.215 -1.357 . . . . 74.239999999999995 110.965 -177.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.519 ' H ' ' HB3' ' A' ' 180' ' ' ASP . 36.5 p 54.88 88.37 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.156 1.382 . . . . 50.140000000000001 114.186 177.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.61 ' HA ' ' NE ' ' A' ' 184' ' ' ARG . 3.1 mmp_? -108.26 176.31 5.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.308 -0.406 . . . . 73.209999999999994 111.567 176.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.407 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 50.7 m . . . . . 0 C--N 1.31 -1.111 0 N-CA-C 108.995 -0.743 . . . . 72.319999999999993 108.995 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.719 0 N-CA-C 110.263 -1.135 . . . . 43.049999999999997 110.263 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -96.79 -65.73 0.95 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.384 0.611 . . . . 73.299999999999997 111.005 178.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -126.83 107.76 10.41 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.997 -1.001 . . . . 74.120000000000005 110.571 -170.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -80.44 103.56 10.38 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.574 -0.898 . . . . 54.43 108.574 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 19' ' ' LEU . 2.3 pt? -101.36 87.33 3.18 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.467 1.284 . . . . 72.120000000000005 114.467 -173.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.26 45.98 2.71 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 104.297 -2.483 . . . . 61.549999999999997 104.297 169.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -77.46 165.4 24.43 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.082 -1.872 . . . . 63.149999999999999 110.674 -172.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -52.66 123.38 11.07 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 113.052 0.76 . . . . 64.5 113.052 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.15 77.01 2.14 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 114.937 -1.029 . . . . 74.150000000000006 112.44 -177.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -74.41 125.08 27.76 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.552 -1.277 . . . . 73.540000000000006 107.552 177.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.531 ' SD ' ' HE3' ' A' ' 49' ' ' LYS . 33.9 mtt 60.38 27.21 16.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.358 0.663 . . . . 60.210000000000001 112.225 -171.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.85 100.53 2.43 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 121.294 0.569 . . . . 74.329999999999998 110.189 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 37.4 ttm180 -103.47 123.96 47.85 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.992 -0.744 . . . . 74.420000000000002 108.992 175.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.19 113.62 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 N-CA-C 106.036 -1.838 . . . . 72.510000000000005 106.036 176.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 138' ' ' GLU . 20.6 ttt180 -120.21 114.36 21.81 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 121.249 0.547 . . . . 72.109999999999999 109.807 -178.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 139' ' ' LEU . . . -104.63 108.37 19.78 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.093 -1.077 . . . . 63.119999999999997 108.093 178.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 140' ' ' THR . 21.2 m -119.39 115.32 23.86 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.163 -1.051 . . . . 74.430000000000007 108.163 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.9 pp -125.64 146.42 31.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.275 0.559 . . . . 73.219999999999999 109.819 -177.045 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 43.0 m -126.31 125.38 42.2 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 108.307 -0.997 . . . . 74.239999999999995 108.307 -178.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' OH ' ' A' ' 178' ' ' TYR . 8.4 tt -116.74 129.62 72.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.278 0.561 . . . . 74.310000000000002 110.073 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -105.34 149.63 37.98 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 116.116 -0.493 . . . . 41.399999999999999 111.514 -175.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.53 -7.14 0.73 Allowed 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 124.995 3.797 . . . . 64.430000000000007 116.078 -178.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 3.32 30.11 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.997 -0.44 . . . . 71.310000000000002 110.319 177.331 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.1 t70 71.74 34.44 1.58 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 123.993 1.854 . . . . 72.239999999999995 106.378 -175.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.17 125.05 50.52 Favored 'General case' 0 N--CA 1.392 -3.34 0 CA-C-N 113.26 -1.791 . . . . 44.329999999999998 107.459 -177.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.417 HG11 HD21 ' A' ' 95' ' ' LEU . 11.4 t -114.55 140.56 34.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.804 -0.813 . . . . 64.340000000000003 108.804 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.8 p -150.67 159.87 44.22 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.537 -0.912 . . . . 40.329999999999998 108.537 179.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.82 -173.44 43.39 Favored Glycine 0 CA--C 1.49 -1.522 0 C-N-CA 118.682 -1.723 . . . . 54.340000000000003 113.03 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.6 133.41 14.0 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.121 0.486 . . . . 54.5 110.488 -176.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 3.5 mp -116.08 115.94 50.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 106.839 -1.541 . . . . 74.230000000000004 106.839 174.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -110.02 118.74 57.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.891 -0.781 . . . . 71.299999999999997 108.891 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.1 107.37 17.18 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 106.087 -1.819 . . . . 43.229999999999997 106.087 174.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -125.86 133.47 51.93 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 116.184 -0.462 . . . . 62.100000000000001 111.048 -174.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.79 157.89 33.02 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.174 -0.921 . . . . 72.329999999999998 109.975 -177.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.531 ' HE3' ' SD ' ' A' ' 25' ' ' MET . 36.8 ttmt -74.55 126.93 88.21 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 107.525 -1.287 . . . . 71.510000000000005 107.525 173.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -48.75 111.37 0.46 Allowed 'Trans proline' 0 C--N 1.363 1.315 0 C-N-CA 122.957 2.438 . . . . 74.109999999999999 110.63 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -109.78 -20.41 12.8 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.592 0.71 . . . . 73.150000000000006 109.768 -173.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 37.2 m-80 -97.92 161.32 13.79 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.81 -0.811 . . . . 74.530000000000001 108.81 178.197 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 m -74.72 -34.76 62.63 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.635 0.731 . . . . 43.130000000000003 109.867 -177.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -94.87 9.68 38.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.381 -0.827 . . . . 73.030000000000001 109.744 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 2.3 t0 -63.68 98.77 0.2 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.703 -0.681 . . . . 71.349999999999994 111.759 -171.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.415 ' O ' ' HB ' ' A' ' 81' ' ' VAL . 61.1 m -103.98 -31.74 9.58 Favored 'General case' 1 N--CA 1.378 -4.069 0 N-CA-C 108.263 -1.014 . . . . 55.340000000000003 108.263 177.574 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.44 126.89 0.91 Allowed Glycine 0 N--CA 1.422 -2.267 0 CA-C-O 118.51 -1.161 . . . . 63.299999999999997 111.611 174.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 6.9 Cg_endo -56.51 148.15 65.01 Favored 'Trans proline' 0 CA--C 1.553 1.437 0 CA-C-N 120.518 2.159 . . . . 74.540000000000006 108.839 166.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.95 128.39 54.89 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.292 0.849 . . . . 34.420000000000002 113.292 -172.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 90.5 mt -94.57 133.22 38.44 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.77 -0.65 . . . . 71.349999999999994 109.503 176.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -111.62 83.64 1.81 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.556 0.693 . . . . 73.549999999999997 111.85 176.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.6 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -88.72 87.62 1.5 Allowed Glycine 0 N--CA 1.423 -2.174 0 CA-C-N 114.677 -1.147 . . . . 53.210000000000001 111.239 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -93.47 104.75 16.87 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.523 0.678 . . . . 73.5 110.667 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.36 160.58 68.09 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.123 -1.066 . . . . 53.240000000000002 108.123 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.64 -8.61 23.74 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 122.52 2.146 . . . . 74.409999999999997 112.64 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -120.63 39.63 3.71 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.64 -0.709 . . . . 61.100000000000001 110.951 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.2 m -56.45 -32.97 65.44 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 116.407 -0.36 . . . . 51.229999999999997 111.867 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -68.53 -12.5 61.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.213 0.53 . . . . 65.510000000000005 111.168 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -100.64 -9.2 22.14 Favored 'General case' 0 C--O 1.26 1.628 0 CA-C-N 116.046 -0.525 . . . . 71.209999999999994 110.249 -178.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG21 ' HE1' ' A' ' 101' ' ' MET . 5.6 p -129.64 119.33 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.097 0.951 . . . . 72.319999999999993 111.209 177.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.67 110.63 21.96 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.225 -0.898 . . . . 72.019999999999996 109.815 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.01 114.42 35.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.995 -1.483 . . . . 71.430000000000007 106.995 177.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 m -123.78 164.38 19.29 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.776 -0.647 . . . . 72.120000000000005 109.79 -172.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -86.86 125.55 34.07 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.198 -1.408 . . . . 74.540000000000006 107.198 175.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 82.6 t80 -92.7 120.12 32.79 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.167 -0.679 . . . . 71.109999999999999 109.167 -175.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -138.52 99.21 3.77 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 106.776 -1.564 . . . . 72.219999999999999 106.776 174.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.7 t -174.36 153.35 1.92 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.024 -1.102 . . . . 74.219999999999999 108.024 -174.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.53 16.4 10.49 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.835 0.854 . . . . 65.319999999999993 111.501 174.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.27 85.1 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 116.065 -0.516 . . . . 54.409999999999997 112.793 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.401 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 61.6 m-85 -104.07 153.63 20.66 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.116 -0.698 . . . . 74.319999999999993 109.116 -178.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 56' ' ' THR . 27.1 m -124.33 141.51 44.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.036 -1.098 . . . . 43.439999999999998 108.036 172.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.469 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -177.69 -154.21 12.03 Favored Glycine 0 N--CA 1.407 -3.24 0 C-N-CA 119.981 -1.104 . . . . 65.120000000000005 111.568 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.607 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 1.7 p -130.5 150.04 51.89 Favored 'General case' 0 C--N 1.26 -3.288 0 CA-C-O 121.351 0.596 . . . . 70.420000000000002 110.971 178.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -138.61 138.98 38.39 Favored 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 116.15 -0.477 . . . . 54.299999999999997 110.373 -175.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.97 114.1 25.71 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.593 -1.262 . . . . 72.439999999999998 107.593 175.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -115.23 112.09 38.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 109.422 -0.585 . . . . 51.030000000000001 109.422 -177.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 43.1 p90 -112.47 151.85 29.43 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 110.0 -0.371 . . . . 44.350000000000001 110.0 -175.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 m -154.31 145.68 23.01 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 120.484 -0.487 . . . . 63.210000000000001 109.705 -175.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t0 60.13 62.39 1.63 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.471 1.129 . . . . 45.520000000000003 112.155 178.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.5 mt -119.23 170.97 8.63 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.675 -1.148 . . . . 50.32 108.908 175.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.475 HG22 ' OE1' ' A' ' 94' ' ' GLU . 9.2 t -113.59 169.12 9.2 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.825 -0.805 . . . . 55.409999999999997 108.825 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.48 -30.13 68.31 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.224 0.535 . . . . 75.200000000000003 111.077 -178.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.97 -25.56 67.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.975 -0.557 . . . . 63.420000000000002 111.433 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.475 ' OE1' HG22 ' A' ' 91' ' ' THR . 49.5 mt-10 -86.66 -16.57 36.21 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 112.468 0.544 . . . . 70.430000000000007 112.468 -176.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 11.6 mt -51.22 -55.19 30.6 Favored Pre-proline 0 N--CA 1.483 1.218 0 N-CA-C 115.382 1.623 . . . . 61.109999999999999 115.382 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.32 -40.66 56.69 Favored 'Trans proline' 0 C--N 1.366 1.452 0 CA-C-N 120.894 1.355 . . . . 71.150000000000006 110.954 -179.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -63.07 -40.0 96.4 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.88 -1.054 . . . . 70.239999999999995 111.511 -177.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -76.18 -19.89 58.02 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 120.604 -0.438 . . . . 71.120000000000005 110.586 177.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.09 -21.62 59.83 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.2 -0.667 . . . . 75.209999999999994 109.2 -177.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.03 -57.54 11.23 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.468 -0.787 . . . . 63.32 108.957 175.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.6 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 33.3 ttp -54.2 -49.09 70.17 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.764 -0.653 . . . . 55.130000000000003 110.094 178.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -53.9 -42.75 69.05 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.427 -0.806 . . . . 62.310000000000002 111.286 178.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.2 p -67.78 -24.92 65.38 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 120.018 -0.673 . . . . 62.0 111.603 -173.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.05 -25.14 66.11 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-O 120.914 0.388 . . . . 70.540000000000006 110.182 -177.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -103.4 -7.89 20.64 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 120.536 -0.466 . . . . 35.140000000000001 110.712 -179.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.63 -43.63 4.88 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.444 -0.503 . . . . 61.420000000000002 112.219 -173.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.92 12.72 80.81 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.694 -0.765 . . . . 64.219999999999999 111.688 -177.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 m -112.21 169.35 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.985 -0.746 . . . . 71.120000000000005 108.985 -178.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -114.07 124.76 52.9 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.854 -0.339 . . . . 64.129999999999995 110.708 -178.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.8 mp -119.42 132.66 55.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.881 -0.785 . . . . 63.25 108.881 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.1 m -144.11 131.77 21.22 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.457 -0.571 . . . . 62.420000000000002 109.457 177.056 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 157.82 43.97 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.211 0.529 . . . . 73.540000000000006 112.405 -175.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -155.66 165.56 36.16 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.472 -1.24 . . . . 72.0 110.697 178.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.436 ' HG3' HG22 ' A' ' 119' ' ' VAL . 3.6 ttt85 -99.06 137.72 37.19 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 106.355 -1.72 . . . . 71.540000000000006 106.355 171.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -118.44 94.45 4.48 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 107.53 -1.285 . . . . 65.140000000000001 107.53 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.07 -114.44 5.25 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.406 -1.478 . . . . 71.010000000000005 109.406 -175.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -112.32 14.7 20.47 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.723 1.249 . . . . 73.439999999999998 108.922 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.5 pp -123.26 148.99 26.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 120.396 -1.44 . . . . 74.409999999999997 108.383 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 178' ' ' TYR . 70.8 t -99.55 135.99 32.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 O-C-N 122.18 -0.325 . . . . 73.319999999999993 110.544 -177.331 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.9 pt -118.86 130.23 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-O 121.767 0.794 . . . . 72.450000000000003 109.235 176.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 tt -126.91 131.61 51.09 Favored 'General case' 0 C--N 1.266 -3.064 0 CA-C-N 115.352 -0.84 . . . . 73.329999999999998 109.26 177.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -123.27 146.44 47.87 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.094 -1.076 . . . . 63.340000000000003 108.094 177.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.32 155.59 27.01 Favored Glycine 0 N--CA 1.421 -2.343 0 N-CA-C 110.534 -1.026 . . . . 70.510000000000005 110.534 177.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.34 139.04 33.5 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.161 -1.051 . . . . 74.150000000000006 108.161 175.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.55 114.28 15.88 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.833 -0.622 . . . . 72.400000000000006 109.463 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -111.28 108.54 18.19 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.273 -1.01 . . . . 55.420000000000002 108.273 178.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.09 29.52 7.91 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.601 -0.518 . . . . 72.230000000000004 109.601 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.7 p -74.3 -13.92 60.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.122 -0.631 . . . . 73.209999999999994 110.563 -179.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.4 m -73.01 -9.84 59.16 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.46 -0.791 . . . . 72.299999999999997 109.491 174.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . 0.36 14.9 p 59.05 -59.16 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 128.127 2.571 . . . . 54.340000000000003 116.32 177.122 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.2 t 69.12 -66.24 0.26 Allowed 'General case' 0 C--O 1.251 1.164 0 C-N-CA 124.504 1.122 . . . . 74.150000000000006 110.593 -176.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -146.25 122.62 5.78 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 107.441 -1.318 . . . . 50.130000000000003 107.441 178.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -48.77 -43.03 35.86 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 123.845 3.03 . . . . 72.010000000000005 115.091 -176.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -99.52 17.47 20.29 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.093 0.775 . . . . 74.099999999999994 113.093 -174.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.85 136.88 38.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.907 -1.886 . . . . 72.109999999999999 105.907 171.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 22.9 t70 -132.21 125.94 32.36 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 120.553 -0.459 . . . . 72.340000000000003 110.047 -172.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 67.5 t -116.38 127.88 73.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.54 -0.864 . . . . 74.510000000000005 109.775 -179.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 43.8 mt-10 -128.53 141.13 51.47 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.134 -0.691 . . . . 72.420000000000002 109.134 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 5.6 tt -132.23 122.67 25.6 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.895 -1.52 . . . . 64.340000000000003 106.895 175.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' SER . 2.2 m -124.86 132.52 53.31 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 107.994 -1.113 . . . . 72.049999999999997 107.994 -176.149 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 71.8 t -124.08 125.98 71.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 109.549 -0.537 . . . . 75.040000000000006 109.549 178.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -109.41 121.1 44.44 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.745 -1.206 . . . . 42.149999999999999 107.745 175.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -133.82 105.83 11.67 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 111.756 0.28 . . . . 75.150000000000006 111.756 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -67.05 34.69 0.14 Allowed 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 123.604 2.869 . . . . 71.430000000000007 113.329 178.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -109.26 -90.39 0.46 Allowed 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.093 -0.706 . . . . 63.030000000000001 109.093 178.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.12 124.0 0.01 OUTLIER 'General case' 0 C--N 1.362 1.117 0 C-N-CA 124.196 0.998 . . . . 72.540000000000006 109.682 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.406 ' HB ' ' CE1' ' A' ' 143' ' ' PHE . 7.9 p -80.02 138.46 19.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.746 -0.835 . . . . 71.340000000000003 108.746 175.183 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.8 t -104.43 -27.58 11.85 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.678 -0.409 . . . . 60.219999999999999 110.371 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 29.6 m -159.48 132.33 6.84 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 108.049 -1.093 . . . . 63.100000000000001 108.049 174.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.1 t -140.42 150.75 44.24 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 118.531 0.605 . . . . 44.450000000000003 111.925 174.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 173' ' ' SER . 27.6 t-20 -120.69 93.11 3.93 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 105.719 -1.956 . . . . 61.229999999999997 105.719 174.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.01 -142.73 6.41 Favored Glycine 0 C--N 1.296 -1.651 0 N-CA-C 107.347 -2.301 . . . . 65.010000000000005 107.347 -178.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -118.45 104.35 10.62 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 118.603 1.202 . . . . 71.140000000000001 109.88 177.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -84.87 113.57 21.47 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.945 -0.571 . . . . 73.319999999999993 111.094 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.5 mt -80.66 -46.62 21.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.52 -1.289 . . . . 71.230000000000004 107.52 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -134.0 160.76 67.3 Favored Pre-proline 0 C--N 1.295 -1.789 0 CA-C-N 114.317 -1.311 . . . . 75.340000000000003 107.491 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -61.5 -17.13 52.06 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.496 2.131 . . . . 65.510000000000005 111.577 173.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 1.4 pm0 -115.13 2.42 14.13 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 113.484 0.92 . . . . 72.25 113.484 177.054 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.5 t -138.79 120.44 16.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 O-C-N 121.621 -0.674 . . . . 74.120000000000005 109.612 178.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.8 t -129.36 147.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 109.304 -0.628 . . . . 74.150000000000006 109.304 -177.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -136.77 143.61 43.33 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 121.31 0.576 . . . . 73.209999999999994 111.049 -178.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.444 ' CZ2' ' HB2' ' A' ' 174' ' ' ALA . 30.5 m-90 -119.79 123.93 44.89 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.468 -0.938 . . . . 62.140000000000001 108.468 177.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -101.15 110.34 22.35 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.296 0.569 . . . . 70.040000000000006 109.756 177.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.0 mm? -97.4 116.87 30.42 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 122.279 1.038 . . . . 62.310000000000002 108.723 -177.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -117.08 138.92 25.26 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 113.637 -1.619 . . . . 73.040000000000006 110.584 -169.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -65.06 156.63 61.68 Favored 'Trans proline' 0 C--O 1.244 0.81 0 C-N-CA 122.442 2.095 . . . . 72.340000000000003 111.351 174.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.55 -33.39 3.24 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 116.128 -0.487 . . . . 61.030000000000001 111.991 177.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 32.7 m -108.02 165.49 4.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.348 0.594 . . . . 71.099999999999994 111.656 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.42 144.14 22.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.723 -1.214 . . . . 73.319999999999993 107.723 175.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.9 m -139.29 142.86 37.71 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.651 -0.656 . . . . 73.239999999999995 111.549 179.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 13.3 p -96.25 150.36 20.63 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.337 -0.847 . . . . 72.010000000000005 108.917 177.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.455 ' HE1' HD13 ' A' ' 139' ' ' LEU . 76.2 mtp -129.65 128.75 43.23 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.863 -0.792 . . . . 75.120000000000005 108.863 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . 32.7 t -143.62 142.66 31.14 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.939 -1.134 . . . . 52.109999999999999 107.939 174.646 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -155.18 116.63 4.03 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.879 -0.785 . . . . 73.439999999999998 108.879 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 48.3 mt-30 -125.53 130.56 51.97 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 108.022 -1.103 . . . . 72.239999999999995 108.022 176.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -143.44 158.97 43.21 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 116.533 -0.303 . . . . 54.130000000000003 110.969 -176.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -87.37 125.04 34.01 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.76 -0.376 . . . . 75.319999999999993 110.085 178.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 119' ' ' VAL . 8.0 m-85 -134.86 120.29 19.13 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 114.371 1.249 . . . . 75.510000000000005 114.371 177.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.2 p -61.13 105.48 0.49 Allowed 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 113.937 -1.483 . . . . 64.010000000000005 110.51 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.55 139.76 94.32 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 113.944 -1.48 . . . . 71.329999999999998 110.646 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.55 -46.81 8.54 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.229 1.953 . . . . 65.129999999999995 113.33 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . 0.319 0.2 OUTLIER -84.21 -7.67 59.28 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 112.883 0.698 . . . . 74.140000000000001 112.883 -179.046 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.356 70.6 p 72.37 68.41 0.13 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 126.519 1.928 . . . . 72.420000000000002 115.158 172.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -84.11 155.64 22.53 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.92 -1.491 . . . . 73.099999999999994 108.637 174.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.297 -1.688 0 N-CA-C 108.15 -1.056 . . . . 62.530000000000001 108.15 179.128 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.533 0 N-CA-C 111.704 -0.558 . . . . 53.109999999999999 111.704 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -117.84 115.55 25.18 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.394 -0.965 . . . . 64.219999999999999 108.394 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -76.14 110.97 11.07 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.34 -0.615 . . . . 72.230000000000004 109.34 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -65.54 144.3 57.09 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.541 -0.754 . . . . 75.030000000000001 109.676 -178.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mp -78.57 71.11 5.02 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.592 0.711 . . . . 74.109999999999999 111.794 -179.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -89.31 109.99 20.82 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.395 -0.965 . . . . 74.120000000000005 108.395 176.021 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -127.58 156.27 42.52 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.411 -0.589 . . . . 63.219999999999999 109.411 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.75 119.94 23.99 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.474 -0.936 . . . . 71.340000000000003 108.474 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.634 ' HA2' ' OD1' ' A' ' 134' ' ' ASP . . . -72.7 56.58 1.7 Allowed Glycine 0 C--N 1.32 -0.323 0 N-CA-C 116.296 1.278 . . . . 41.240000000000002 116.296 -171.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.495 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 27.8 m170 -146.1 26.97 1.19 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 123.777 0.831 . . . . 73.409999999999997 109.325 178.124 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 48.6 ttm -86.93 -57.2 3.06 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.816 -0.353 . . . . 74.25 111.626 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.74 148.59 34.32 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.257 0.466 . . . . 73.409999999999997 112.257 -178.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.495 ' NH2' ' HA ' ' A' ' 24' ' ' HIS . 0.0 OUTLIER -158.78 155.64 28.29 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.049 -0.523 . . . . 74.230000000000004 110.183 179.575 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.401 HG23 HG13 ' A' ' 137' ' ' VAL . 27.7 m -120.22 115.5 47.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.582 0.706 . . . . 75.420000000000002 109.359 177.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HG2' ' HB2' ' A' ' 138' ' ' GLU . 96.6 mtt180 -113.12 119.0 36.32 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.776 -0.647 . . . . 70.540000000000006 110.749 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.96 108.22 16.74 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.561 -1.274 . . . . 50.219999999999999 107.561 175.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 m -114.79 114.98 26.29 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 107.376 -1.342 . . . . 50.329999999999998 107.376 -178.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 pp -126.83 146.18 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 109.419 -0.586 . . . . 74.219999999999999 109.419 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.6 m -126.35 137.51 53.47 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 108.566 -0.902 . . . . 62.32 108.566 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.81 125.02 73.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 109.032 -0.729 . . . . 73.239999999999995 109.032 -176.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 m -105.78 152.08 40.08 Favored Pre-proline 0 N--CA 1.425 -1.689 0 CA-C-N 115.762 -0.653 . . . . 74.219999999999999 110.232 -177.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.62 2.42 0.98 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 123.904 3.069 . . . . 64.439999999999998 114.577 -176.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -87.99 3.54 48.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.222 -1.029 . . . . 71.430000000000007 108.222 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 91' ' ' THR . 15.0 t70 72.07 28.68 2.47 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 126.298 1.839 . . . . 61.43 106.227 -175.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 tp -102.02 129.04 48.23 Favored 'General case' 0 N--CA 1.381 -3.919 0 CA-C-N 112.689 -2.05 . . . . 71.129999999999995 109.164 -176.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.95 132.43 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 N-CA-C 107.827 -1.175 . . . . 74.540000000000006 107.827 176.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.2 p -142.52 151.42 41.62 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.621 -1.251 . . . . 71.420000000000002 107.621 177.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.53 -176.42 47.11 Favored Glycine 0 N--CA 1.418 -2.525 0 C-N-CA 118.722 -1.704 . . . . 73.310000000000002 112.7 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.65 133.58 25.66 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.736 -0.732 . . . . 71.0 109.878 -175.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.8 mt -120.42 115.7 47.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 107.218 -1.401 . . . . 65.209999999999994 107.218 175.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.83 115.31 48.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.115 0.483 . . . . 71.430000000000007 109.98 -178.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.501 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -105.93 108.42 19.92 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 106.116 -1.809 . . . . 74.299999999999997 106.116 173.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -125.06 132.38 53.19 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.312 -0.555 . . . . 74.200000000000003 111.418 -175.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.45 129.44 41.19 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.931 -1.031 . . . . 73.310000000000002 110.866 -178.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 24' ' ' HIS . 54.3 mtmt -68.45 121.14 79.53 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 107.269 -1.382 . . . . 74.540000000000006 107.269 171.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -20.84 88.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 1 C-N-CA 126.418 4.745 . . . . 71.349999999999994 117.716 -168.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -82.69 -28.45 30.57 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.499 -0.773 . . . . 53.409999999999997 108.98 175.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -105.97 127.22 53.01 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.685 -1.143 . . . . 72.030000000000001 108.094 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.4 t -63.88 -25.63 68.24 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 124.003 0.921 . . . . 51.439999999999998 112.19 -173.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -103.03 6.14 38.57 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.992 0.738 . . . . 74.310000000000002 112.992 -177.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.38 116.13 28.7 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 114.633 1.346 . . . . 60.229999999999997 114.633 -175.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -110.4 -7.92 14.74 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.529 -1.214 . . . . 71.150000000000006 108.119 173.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.36 96.82 0.1 Allowed Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.595 -0.812 . . . . 73.019999999999996 112.845 176.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -72.77 160.57 45.93 Favored 'Trans proline' 0 C--O 1.248 1.025 0 C-N-CA 123.487 2.791 . . . . 74.340000000000003 111.932 174.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.83 158.49 28.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.765 0.317 . . . . 70.150000000000006 111.096 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 95.2 mt -102.25 154.99 18.52 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 106.62 -1.622 . . . . 74.239999999999995 106.62 173.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -93.03 86.35 5.38 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.227 1.013 . . . . 64.439999999999998 109.703 -177.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.52 ' HA2' ' SD ' ' A' ' 101' ' ' MET . . . -85.16 84.31 1.6 Allowed Glycine 0 N--CA 1.413 -2.888 0 CA-C-N 114.101 -1.408 . . . . 40.350000000000001 111.958 -178.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -112.05 97.6 6.77 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.986 0.422 . . . . 72.099999999999994 110.244 178.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 m -146.1 159.45 46.01 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 123.995 0.918 . . . . 52.399999999999999 108.815 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.18 -9.02 22.9 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.106 1.871 . . . . 61.200000000000003 112.05 176.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -114.79 42.05 2.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.15 -0.477 . . . . 74.329999999999998 111.994 -178.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.6 m -55.3 -28.32 52.83 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 111.776 0.287 . . . . 70.329999999999998 111.776 179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -65.65 -20.32 66.26 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 121.276 0.56 . . . . 51.130000000000003 110.813 -178.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -90.85 -18.26 25.14 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.645 -0.707 . . . . 54.219999999999999 110.535 -177.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -125.98 119.59 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 121.964 0.887 . . . . 54.119999999999997 112.532 -176.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.67 104.79 16.11 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.273 -0.876 . . . . 54.409999999999997 109.58 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.8 p -98.95 133.04 43.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.054 -0.721 . . . . 72.040000000000006 109.054 177.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -154.74 173.46 16.39 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 123.335 0.654 . . . . 72.140000000000001 109.612 -175.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -77.72 153.62 32.82 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.495 0.664 . . . . 74.150000000000006 110.308 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 81' ' ' VAL . 76.9 t80 -114.39 122.55 46.99 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 108.022 -1.103 . . . . 71.420000000000002 108.022 176.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -138.62 102.85 4.7 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.913 -1.514 . . . . 72.299999999999997 106.913 177.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 36.8 t -164.13 141.88 7.03 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.147 -0.686 . . . . 52.149999999999999 109.147 -178.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 67.05 10.45 7.7 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.887 0.875 . . . . 64.150000000000006 111.996 174.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.88 -0.36 64.6 Favored Glycine 0 N--CA 1.426 -2.026 0 N-CA-C 111.238 -0.745 . . . . 70.439999999999998 111.238 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.529 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 12.6 m-85 -96.95 142.0 29.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.454 -0.943 . . . . 73.409999999999997 108.454 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 35.3 m -123.85 136.92 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 N-CA-C 108.26 -1.015 . . . . 64.340000000000003 108.26 174.13 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.34 -155.34 9.44 Favored Glycine 0 N--CA 1.402 -3.612 0 C-N-CA 119.189 -1.482 . . . . 44.43 112.051 179.448 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB2' ' HG ' ' A' ' 60' ' ' LEU . 16.0 p -126.62 134.42 50.78 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 114.84 -0.68 . . . . 61.32 110.749 -177.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.413 ' NE2' ' HD1' ' A' ' 75' ' ' TYR . 3.7 pt20 -126.74 143.12 51.34 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.06 0.457 . . . . 74.530000000000001 111.317 -178.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -124.35 114.54 19.68 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.272 -1.381 . . . . 64.450000000000003 107.272 174.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.76 115.17 48.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 107.845 -1.169 . . . . 64.430000000000007 107.845 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.515 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.8 p90 -115.45 152.43 32.94 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.153 0.501 . . . . 72.340000000000003 110.473 -176.013 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 p -159.27 155.3 26.69 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.906 -0.588 . . . . 61.210000000000001 109.641 -176.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.24 31.32 6.69 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 124.076 0.86 . . . . 73.430000000000007 111.386 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.515 HD12 ' CD2' ' A' ' 87' ' ' PHE . 25.2 mt -91.76 156.56 17.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 116.106 -0.497 . . . . 74.549999999999997 109.785 176.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 40.1 p -108.0 171.9 7.14 Favored 'General case' 0 C--N 1.277 -2.556 0 O-C-N 123.801 0.688 . . . . 73.109999999999999 109.933 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -57.01 -35.95 69.85 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.998 0.519 . . . . 73.120000000000005 109.729 179.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.08 -28.5 66.57 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.859 -0.61 . . . . 72.219999999999999 111.372 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.438 ' HB3' HD22 ' A' ' 90' ' ' LEU . 41.0 mt-10 -86.33 -17.03 35.6 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.212 0.449 . . . . 55.340000000000003 112.212 -176.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.9 tt -61.36 -48.65 90.5 Favored Pre-proline 0 CA--C 1.569 1.68 0 N-CA-C 112.355 0.502 . . . . 51.109999999999999 112.355 -178.084 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.91 -37.9 82.61 Favored 'Trans proline' 0 C--N 1.376 2.009 0 CA-C-N 121.049 1.41 . . . . 74.540000000000006 110.316 176.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' A' ' 94' ' ' GLU . 20.7 mt-30 -63.91 -38.76 92.27 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.93 -1.032 . . . . 72.230000000000004 111.129 -177.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.5 pp -70.11 -23.84 63.1 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 120.669 -0.412 . . . . 72.340000000000003 110.103 177.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.4 -20.78 63.8 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.094 -0.503 . . . . 64.019999999999996 110.587 -175.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -63.27 -57.95 8.74 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.404 -0.591 . . . . 71.540000000000006 109.404 176.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.52 ' SD ' ' HA2' ' A' ' 62' ' ' GLY . 65.3 mtm -56.68 -48.97 76.46 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.436 0.636 . . . . 73.140000000000001 109.507 -178.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -53.93 -40.57 66.86 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.264 -1.335 . . . . 73.209999999999994 111.644 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 92.8 p -65.22 -26.87 68.31 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 119.906 -0.717 . . . . 51.219999999999999 111.077 -172.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.04 -33.26 74.05 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 116.15 -0.477 . . . . 52.420000000000002 110.71 -176.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.41 -9.57 20.17 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 120.287 -0.565 . . . . 70.200000000000003 111.058 -176.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.96 -47.64 3.66 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.143 0.794 . . . . 53.25 113.143 -173.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.79 7.3 64.73 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.861 -0.896 . . . . 54.140000000000001 110.861 -173.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.6 m -101.51 172.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 O-C-N 122.427 -0.455 . . . . 75.209999999999994 110.493 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -138.93 141.08 38.48 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.409 -1.33 . . . . 64.540000000000006 107.409 176.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.87 132.29 38.37 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.744 -0.836 . . . . 75.200000000000003 108.744 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.2 m -134.76 134.12 40.61 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.343 -0.984 . . . . 73.409999999999997 108.343 178.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -141.85 147.91 37.96 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.328 0.585 . . . . 53.420000000000002 111.551 -178.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -146.02 154.87 42.36 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.402 -1.272 . . . . 75.010000000000005 110.658 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.484 ' HG2' HG22 ' A' ' 119' ' ' VAL . 51.7 mtt85 -88.61 138.68 31.21 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.627 -0.715 . . . . 72.340000000000003 109.926 171.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.461 ' O ' HG13 ' A' ' 118' ' ' ILE . 51.7 t30 -123.11 90.04 3.22 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 105.486 -2.042 . . . . 62.340000000000003 105.486 176.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.5 -118.7 8.66 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 108.857 -1.697 . . . . 42.140000000000001 108.857 -170.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 179' ' ' THR . 9.5 t30 -105.95 1.31 26.52 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.706 1.241 . . . . 71.310000000000002 108.94 178.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.3 pp -103.9 148.98 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 C-N-CA 118.818 -1.153 . . . . 70.340000000000003 108.19 178.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.484 HG22 ' HG2' ' A' ' 114' ' ' ARG . 60.5 t -112.74 140.47 32.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 121.972 -0.455 . . . . 72.25 111.45 -176.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.45 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.9 pp -121.41 121.52 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 115.058 -0.974 . . . . 72.239999999999995 109.161 178.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.33 127.8 50.25 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.127 -0.694 . . . . 74.099999999999994 109.127 179.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -125.97 135.71 52.15 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.36 -0.836 . . . . 73.349999999999994 109.469 177.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -145.74 158.07 27.56 Favored Glycine 0 N--CA 1.416 -2.67 0 N-CA-C 110.86 -0.896 . . . . 74.019999999999996 110.86 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.43 145.42 43.14 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.808 -0.442 . . . . 61.32 109.808 177.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -111.06 119.42 38.97 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.073 0.463 . . . . 72.109999999999999 111.336 -176.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -112.89 93.53 4.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.277 -0.419 . . . . 73.409999999999997 110.209 179.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -142.75 26.24 1.75 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.197 1.475 . . . . 75.409999999999997 108.398 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.5 p -68.64 -25.85 65.04 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 113.272 -1.785 . . . . 74.329999999999998 112.008 -176.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.1 m -82.97 5.58 21.58 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.343 0.592 . . . . 64.530000000000001 110.874 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.9 t 65.75 96.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.31 0 C-N-CA 124.823 1.249 . . . . 61.409999999999997 111.998 177.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.4 m -69.31 -44.36 71.88 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.575 0.702 . . . . 71.420000000000002 109.442 177.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 8.4 t70 -155.2 141.6 13.16 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 107.139 -1.43 . . . . 74.109999999999999 107.139 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.25 -26.97 79.0 Favored 'Trans proline' 0 CA--C 1.552 1.399 0 C-N-CA 123.322 2.681 . . . . 72.219999999999999 115.454 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.634 ' OD1' ' HA2' ' A' ' 23' ' ' GLY . 36.8 t70 -107.11 -11.23 15.68 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.522 0.601 . . . . 72.310000000000002 112.001 -176.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 132' ' ' ASP . . . -52.68 116.51 2.34 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.423 0.63 . . . . 71.329999999999998 112.569 -176.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -118.59 126.74 52.62 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.888 -1.893 . . . . 62.43 105.888 176.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 42.5 t -110.97 117.07 54.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 121.136 -0.226 . . . . 63.539999999999999 110.497 -175.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 29' ' ' ARG . 50.2 mt-10 -109.97 120.32 42.09 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 109.644 -0.502 . . . . 71.340000000000003 109.644 176.543 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.519 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -114.1 116.24 28.81 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.553 -2.017 . . . . 72.209999999999994 105.553 175.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 19.4 m -122.52 131.23 53.75 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.71 -0.478 . . . . 61.200000000000003 109.71 -177.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 94.4 t -122.68 122.83 66.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.75 -0.833 . . . . 71.430000000000007 108.75 178.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.8 126.63 55.64 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.999 0.428 . . . . 74.219999999999999 110.29 178.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.5 p90 -133.83 123.07 16.91 Favored Pre-proline 0 C--N 1.298 -1.661 0 CA-C-N 115.876 -0.602 . . . . 73.530000000000001 110.068 177.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -74.43 35.46 0.4 Allowed 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 122.61 2.207 . . . . 70.349999999999994 113.503 -178.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.74 -100.47 0.43 Allowed 'General case' 0 N--CA 1.433 -1.32 0 O-C-N 122.192 -0.318 . . . . 61.43 110.772 -177.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -177.3 128.76 0.16 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.951 -0.759 . . . . 43.32 108.951 -177.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.38 133.24 29.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.539 -0.755 . . . . 73.150000000000006 109.324 177.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.0 p -88.81 -38.92 14.26 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.376 0.607 . . . . 62.420000000000002 109.456 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 74.5 m -159.52 133.18 7.25 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 115.707 -0.679 . . . . 72.549999999999997 109.811 176.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.466 ' OG1' HG11 ' A' ' 160' ' ' VAL . 8.1 t -137.97 155.96 48.33 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.349 -0.611 . . . . 73.329999999999998 109.349 174.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -126.69 93.89 3.9 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 105.987 -1.857 . . . . 62.030000000000001 105.987 175.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.489 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.59 -144.51 8.2 Favored Glycine 0 N--CA 1.424 -2.128 0 N-CA-C 108.555 -1.818 . . . . 75.030000000000001 108.555 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -114.29 99.97 7.99 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 117.653 0.726 . . . . 72.540000000000006 109.367 -178.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -77.51 126.93 31.66 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-N 115.752 -0.658 . . . . 65.200000000000003 109.794 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.16 -37.49 9.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.225 -1.398 . . . . 72.319999999999993 107.225 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -142.65 166.64 19.62 Favored Pre-proline 0 N--CA 1.425 -1.713 0 N-CA-C 106.451 -1.685 . . . . 73.439999999999998 106.451 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.84 0.55 6.29 Favored 'Trans proline' 0 C--O 1.21 -0.88 0 C-N-CA 122.475 2.117 . . . . 74.299999999999997 110.684 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.633 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.6 pt-20 -130.12 0.12 4.67 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.902 -0.59 . . . . 73.200000000000003 111.689 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.41 HG23 ' HG3' ' A' ' 158' ' ' GLU . 82.2 t -140.65 120.89 13.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.469 -0.937 . . . . 72.019999999999996 108.469 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.466 HG11 ' OG1' ' A' ' 150' ' ' THR . 41.6 t -125.57 147.23 30.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.345 -0.613 . . . . 71.420000000000002 109.345 -177.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -137.25 143.57 42.29 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.416 0.627 . . . . 64.010000000000005 110.074 -177.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.519 ' CE3' HD12 ' A' ' 139' ' ' LEU . 25.6 m-90 -123.67 120.2 32.04 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 108.075 -1.083 . . . . 74.329999999999998 108.075 177.082 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 37.0 pttt -108.95 102.47 11.47 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.352 -0.84 . . . . 63.409999999999997 109.081 -178.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 9.5 mt -101.13 138.24 38.43 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.818 -1.083 . . . . 72.25 110.166 -171.469 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -118.56 151.71 50.15 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 115.566 -0.743 . . . . 64.340000000000003 110.884 177.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.95 157.43 47.16 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.298 1.998 . . . . 75.109999999999999 111.096 178.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 86.55 -36.15 3.27 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.432 -0.89 . . . . 63.130000000000003 111.637 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.75 153.9 6.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 109.584 -0.524 . . . . 74.400000000000006 109.584 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.9 p -97.39 143.46 12.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.811 -0.44 . . . . 74.230000000000004 109.811 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 48.5 m -146.52 143.0 28.62 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.329 -0.989 . . . . 72.099999999999994 108.329 176.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -125.49 156.96 38.14 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.811 -0.811 . . . . 72.120000000000005 108.811 178.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -126.32 137.8 53.52 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.523 0.677 . . . . 75.430000000000007 112.028 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.7 t -134.48 136.92 43.51 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.141 -1.429 . . . . 75.349999999999994 107.141 173.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -148.09 116.38 6.54 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.634 -0.876 . . . . 62.539999999999999 108.634 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -127.08 131.25 50.93 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 107.216 -1.401 . . . . 73.420000000000002 107.216 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -159.44 154.13 24.44 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.445 -0.946 . . . . 72.140000000000001 108.445 -176.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 29.2 ptt180 -87.96 129.29 35.29 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.168 -1.013 . . . . 75.239999999999995 110.776 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.05 116.27 19.76 Favored 'General case' 0 CA--C 1.477 -1.828 0 N-CA-C 107.721 -1.214 . . . . 75.0 107.721 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.487 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 18.0 p -67.0 123.78 21.18 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.873 -1.058 . . . . 75.530000000000001 112.242 -175.106 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.47 124.2 60.56 Favored Pre-proline 0 C--N 1.321 -0.662 0 O-C-N 124.071 0.857 . . . . 70.109999999999999 108.766 172.105 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.406 ' HG3' ' HB2' ' A' ' 38' ' ' ASP . 30.6 Cg_endo -67.32 -24.81 43.01 Favored 'Trans proline' 0 C--N 1.329 -0.448 0 C-N-CA 122.325 2.017 . . . . 74.420000000000002 110.81 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.04 -12.09 55.71 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.135 -1.393 . . . . 73.319999999999993 110.334 178.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.2 p 63.47 111.39 0.03 OUTLIER 'General case' 0 C--O 1.246 0.87 0 C-N-CA 126.252 1.821 . . . . 71.109999999999999 113.239 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -123.71 175.99 6.52 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.005 0.907 . . . . 74.329999999999998 112.609 -177.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.424 -1.754 0 CA-C-N 113.889 -1.505 . . . . 64.319999999999993 107.73 172.558 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.388 0 N-CA-C 109.949 -1.26 . . . . 43.310000000000002 109.949 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.0 ptt85 -108.27 -26.63 10.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.632 0.604 . . . . 70.420000000000002 112.632 -177.046 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -74.48 -46.83 37.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.98 0.419 . . . . 64.0 111.262 -175.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -128.12 101.13 6.14 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.32 0.581 . . . . 60.420000000000002 109.725 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.8 tp -141.73 102.28 4.14 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.926 -1.139 . . . . 71.319999999999993 107.926 178.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.4 t80 71.88 108.47 0.07 Allowed 'General case' 0 C--O 1.245 0.849 0 O-C-N 124.876 1.36 . . . . 72.299999999999997 110.046 -176.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -59.45 119.9 8.35 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.048 -0.978 . . . . 74.019999999999996 111.039 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -84.28 -53.85 5.2 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.213 -1.032 . . . . 73.430000000000007 108.213 178.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.04 108.47 3.18 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 109.221 -1.552 . . . . 50.329999999999998 109.221 -177.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -79.66 -62.41 1.69 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.402 0.519 . . . . 62.030000000000001 112.402 -174.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 23.7 ptm -145.86 -174.95 4.55 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 116.21 -0.45 . . . . 65.510000000000005 110.198 -171.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 48' ' ' ALA . 4.6 pp -133.65 141.86 47.8 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.873 -1.528 . . . . 72.230000000000004 106.873 175.022 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 141.4 39.91 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 119.056 -1.058 . . . . 74.239999999999995 110.83 -176.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 57.3 t -113.86 113.4 43.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 105.564 -2.013 . . . . 71.319999999999993 105.564 173.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -120.73 114.61 21.9 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.026 -0.731 . . . . 75.209999999999994 109.026 -177.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . . . -110.45 124.46 51.81 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.215 -0.902 . . . . 71.109999999999999 109.347 -178.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.5 t -124.79 115.69 21.09 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.49 -1.3 . . . . 51.119999999999997 107.49 177.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.6 pp -122.36 138.71 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.883 -0.784 . . . . 74.25 108.883 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 93.5 m -119.33 121.68 40.13 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 108.845 -0.798 . . . . 51.509999999999998 108.845 -179.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.406 HG23 ' HB3' ' A' ' 143' ' ' PHE . 7.5 tt -109.76 115.62 50.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-O 121.675 0.75 . . . . 71.510000000000005 109.729 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.8 m -80.08 148.17 67.14 Favored Pre-proline 0 N--CA 1.412 -2.349 0 N-CA-C 107.985 -1.117 . . . . 62.229999999999997 107.985 -179.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.85 2.87 0.85 Allowed 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 123.73 2.953 . . . . 72.109999999999999 112.972 -179.287 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -87.11 -1.82 58.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.609 -0.885 . . . . 71.129999999999995 108.609 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 12.8 t70 73.05 29.46 1.77 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.054 1.742 . . . . 63.200000000000003 108.135 -175.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.11 124.76 50.08 Favored 'General case' 0 N--CA 1.394 -3.24 0 CA-C-N 113.946 -1.479 . . . . 62.240000000000002 107.653 178.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.443 HG12 ' HE2' ' A' ' 87' ' ' PHE . 14.2 t -109.72 129.87 63.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 108.835 -0.802 . . . . 71.409999999999997 108.835 -178.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.6 p -143.79 131.55 21.38 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.286 -1.005 . . . . 72.439999999999998 108.286 179.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.27 -175.34 32.2 Favored Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 118.967 -1.587 . . . . 61.530000000000001 113.178 -176.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.39 133.3 16.02 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 123.503 0.721 . . . . 73.010000000000005 109.529 -176.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 60.9 mt -120.11 116.13 49.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 107.88 -1.155 . . . . 62.219999999999999 107.88 177.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.11 116.62 53.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 109.712 -0.477 . . . . 72.329999999999998 109.712 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.79 108.49 17.92 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.387 -1.338 . . . . 44.109999999999999 107.387 175.462 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.51 122.09 40.87 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.754 -0.461 . . . . 53.329999999999998 109.754 -177.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HA ' ' CB ' ' A' ' 26' ' ' LEU . . . -114.92 158.07 22.49 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.76 -0.654 . . . . 71.420000000000002 111.811 -176.088 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -69.01 123.32 87.9 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-N 114.579 -1.191 . . . . 62.43 109.911 175.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.63 132.3 24.89 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.592 2.195 . . . . 75.430000000000007 114.23 -174.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 51' ' ' LYS . 10.8 tmtt? -91.23 -5.82 54.25 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 104.331 -2.47 . . . . 74.439999999999998 104.331 171.045 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 71.3 -63.22 0.43 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.006 2.122 . . . . 63.25 112.7 173.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.1 t -55.3 -37.74 67.76 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.589 0.756 . . . . 74.239999999999995 112.948 -173.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -103.35 -14.02 16.45 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.994 0.426 . . . . 63.119999999999997 110.489 178.201 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' HB3' HG21 ' A' ' 81' ' ' VAL . 74.3 m-20 -102.99 96.94 7.13 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 114.473 1.286 . . . . 75.519999999999996 114.473 -166.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 t -96.9 -29.67 13.57 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.034 -1.839 . . . . 74.400000000000006 106.034 166.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.23 98.24 0.11 Allowed Glycine 0 N--CA 1.422 -2.273 0 N-CA-C 108.792 -1.723 . . . . 61.219999999999999 108.792 175.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -52.52 128.51 28.23 Favored 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 122.121 1.881 . . . . 61.350000000000001 110.237 177.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.57 157.94 16.72 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.593 0.96 . . . . 73.140000000000001 113.593 -169.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.582 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 71.1 mt -102.45 138.1 39.81 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.164 -0.925 . . . . 71.340000000000003 109.742 176.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.7 89.15 3.4 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.502 0.668 . . . . 75.239999999999995 111.352 178.135 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.504 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -120.47 113.87 2.52 Favored Glycine 0 N--CA 1.409 -3.108 0 CA-C-N 115.17 -0.923 . . . . 23.420000000000002 111.525 177.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -116.9 107.62 14.82 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.606 -0.887 . . . . 73.450000000000003 108.606 177.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.4 m -136.97 151.61 72.46 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.534 -0.913 . . . . 75.120000000000005 108.534 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -73.12 -8.82 22.67 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 122.61 2.207 . . . . 73.219999999999999 112.484 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -108.93 36.64 2.8 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.416 0.627 . . . . 73.420000000000002 109.834 176.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -57.71 -30.26 65.38 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.425 -0.807 . . . . 73.010000000000005 112.454 -179.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -69.51 -18.39 63.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.359 0.6 . . . . 74.340000000000003 110.325 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -89.55 -16.03 31.57 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.437 -0.801 . . . . 54.219999999999999 109.944 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 6.6 p -118.52 118.88 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 122.515 1.15 . . . . 73.230000000000004 111.235 179.183 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.74 104.95 16.9 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.162 -0.926 . . . . 72.030000000000001 108.864 -179.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 t -97.99 131.16 45.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.942 -1.503 . . . . 62.329999999999998 106.942 179.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.1 m -144.33 171.76 13.88 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.358 -0.979 . . . . 61.340000000000003 108.358 -176.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -88.63 153.87 20.77 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 118.968 -1.093 . . . . 73.120000000000005 108.259 178.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -112.6 123.27 49.92 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.792 -1.188 . . . . 62.109999999999999 107.792 177.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -139.11 99.18 3.69 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.624 0.726 . . . . 65.299999999999997 109.361 177.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.9 m -165.29 161.23 19.03 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.956 -1.127 . . . . 62.240000000000002 107.956 -179.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 70.51 3.32 4.45 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.253 1.021 . . . . 63.229999999999997 110.914 178.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.51 1.15 83.75 Favored Glycine 0 C--O 1.22 -0.76 0 N-CA-C 110.197 -1.161 . . . . 34.32 110.197 -172.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -104.82 150.49 24.77 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.317 0.647 . . . . 74.230000000000004 110.629 -179.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 55' ' ' ASP . 19.3 m -129.11 138.18 55.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.466 0.65 . . . . 63.229999999999997 110.032 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -168.32 -153.36 8.15 Favored Glycine 0 C--N 1.276 -2.794 0 N-CA-C 109.946 -1.261 . . . . 52.140000000000001 109.946 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.582 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 p -131.45 159.47 37.98 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-O 121.256 0.551 . . . . 71.329999999999998 110.933 179.065 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.7 pt20 -138.39 140.35 39.35 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.023 -0.535 . . . . 75.129999999999995 110.435 179.015 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.81 114.68 24.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.683 -1.229 . . . . 54.530000000000001 107.683 175.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.78 111.65 37.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.476 -0.935 . . . . 64.439999999999998 108.476 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' HE2' HG12 ' A' ' 40' ' ' VAL . 47.3 p90 -113.35 152.81 29.47 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.785 -0.366 . . . . 75.120000000000005 110.903 -174.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 p -151.65 154.35 36.2 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.215 -0.448 . . . . 73.409999999999997 111.218 -173.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.91 30.63 16.5 Favored 'General case' 0 CA--C 1.495 -1.136 0 C-N-CA 124.157 0.983 . . . . 72.510000000000005 112.877 173.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.408 HD12 ' CD2' ' A' ' 87' ' ' PHE . 39.2 mt -92.49 160.13 15.2 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 116.202 -0.454 . . . . 73.329999999999998 109.798 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.1 t -112.83 175.08 5.59 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 108.819 -0.808 . . . . 65.439999999999998 108.819 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.454 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 84.8 t80 -49.38 -44.21 44.8 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.034 0.934 . . . . 65.230000000000004 110.82 178.805 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.82 -29.14 69.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.468 -0.787 . . . . 53.32 112.517 -178.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.35 -16.8 32.03 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.26 0.467 . . . . 53.25 112.26 -174.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.646 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 3.9 tt -65.91 -50.03 55.18 Favored Pre-proline 0 CA--C 1.567 1.623 0 CA-C-O 119.228 -0.415 . . . . 74.25 111.544 -178.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.46 -36.52 86.18 Favored 'Trans proline' 0 C--N 1.375 1.94 0 CA-C-N 121.199 1.464 . . . . 53.509999999999998 110.698 175.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -63.66 -38.8 92.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 73.109999999999999 111.523 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.0 pp -74.06 -19.94 60.45 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.782 -0.451 . . . . 74.120000000000005 109.782 177.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.09 -27.5 62.7 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.181 -0.674 . . . . 73.400000000000006 109.181 -178.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -61.09 -53.52 56.03 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.758 -0.83 . . . . 73.200000000000003 108.758 176.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.504 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 22.7 ttp -53.79 -51.85 62.16 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.518 -0.764 . . . . 63.43 110.054 176.717 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -55.41 -36.07 66.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.283 -0.871 . . . . 73.450000000000003 111.014 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.7 m -62.48 -37.61 86.64 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 110.182 -0.303 . . . . 63.210000000000001 110.182 -175.132 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -73.66 -13.22 60.95 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.355 0.598 . . . . 62.009999999999998 110.628 -171.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.43 -19.31 13.72 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.151 -0.62 . . . . 51.310000000000002 110.443 179.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.93 -44.18 4.48 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.572 0.953 . . . . 64.439999999999998 113.572 -172.497 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.04 21.43 49.86 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.135 -0.786 . . . . 50.219999999999999 111.135 -173.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.5 171.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.265 -0.643 . . . . 72.439999999999998 109.265 -178.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -128.64 138.28 52.1 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 117.644 0.202 . . . . 70.540000000000006 111.236 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.82 130.97 40.51 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.909 -1.145 . . . . 72.030000000000001 107.909 176.027 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.2 t -144.07 151.97 40.35 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.451 -0.944 . . . . 53.200000000000003 108.451 177.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.8 148.02 28.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.825 -0.806 . . . . 72.319999999999993 108.825 178.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -143.91 156.67 44.52 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.826 -0.625 . . . . 73.439999999999998 109.587 -176.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -91.22 138.09 31.86 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 121.521 0.677 . . . . 73.129999999999995 112.241 175.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.419 ' O ' HG13 ' A' ' 118' ' ' ILE . 30.7 t30 -127.56 91.9 3.39 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 113.978 -1.464 . . . . 71.219999999999999 107.248 177.279 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 185' ' ' SER . . . 76.54 -106.77 2.23 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 109.579 -1.409 . . . . 74.239999999999995 109.579 -175.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -123.73 10.12 8.97 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.841 1.305 . . . . 74.310000000000002 108.107 175.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.8 pp -112.88 149.51 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.025 -1.102 . . . . 74.219999999999999 108.025 177.139 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.3 t -107.0 133.63 51.07 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 CA-C-O 120.948 0.404 . . . . 44.149999999999999 109.996 -176.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.8 pt -105.68 137.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 N-CA-C 107.627 -1.249 . . . . 74.530000000000001 107.627 176.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.72 127.08 45.66 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 109.048 -0.723 . . . . 64.319999999999993 109.048 179.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -127.71 115.31 18.52 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.347 -1.297 . . . . 72.150000000000006 108.19 -177.048 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -142.3 141.84 11.16 Favored Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 109.854 -1.298 . . . . 62.039999999999999 109.854 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -137.05 135.25 37.37 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.388 -0.968 . . . . 55.140000000000001 108.388 -177.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.9 110.2 19.29 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.909 -0.587 . . . . 32.130000000000003 111.183 -174.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -105.22 98.59 8.28 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.473 0.654 . . . . 73.109999999999999 110.379 177.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 166' ' ' PRO . 2.7 mm? -113.26 23.95 12.76 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.602 -0.888 . . . . 73.219999999999999 108.602 178.395 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 45.5 p -65.58 -19.11 65.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.83 1.048 . . . . 75.310000000000002 113.83 -173.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 28.1 m -72.95 -24.65 60.82 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.272 -0.268 . . . . 43.420000000000002 111.42 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.9 t 62.43 86.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.49 1.116 . . . . 75.299999999999997 111.788 179.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.7 m -79.2 -49.32 12.71 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.308 -0.997 . . . . 55.240000000000002 108.308 177.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.24 125.63 18.97 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.218 -1.03 . . . . 75.439999999999998 108.218 176.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.3 -15.6 31.47 Favored 'Trans proline' 0 C--O 1.22 -0.393 0 C-N-CA 121.958 1.772 . . . . 73.150000000000006 111.289 178.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -99.53 11.54 38.89 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.454 -0.794 . . . . 74.209999999999994 110.478 -178.365 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.428 ' O ' ' HD3' ' A' ' 166' ' ' PRO . . . -89.15 123.39 33.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.529 -0.305 . . . . 71.129999999999995 111.656 -176.356 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.77 122.63 38.55 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.182 -0.673 . . . . 75.019999999999996 109.182 173.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 61.5 t -111.53 120.88 63.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.266 -1.012 . . . . 71.299999999999997 108.266 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -121.34 126.53 49.69 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.122 -0.696 . . . . 71.299999999999997 109.122 -176.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -119.13 123.56 44.69 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.443 -0.947 . . . . 73.400000000000006 108.443 -178.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.7 m -123.87 134.29 53.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.047 -0.723 . . . . 75.230000000000004 109.047 179.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.476 HG12 ' HD2' ' A' ' 143' ' ' PHE . 90.3 t -120.68 125.64 74.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.879 -0.785 . . . . 72.239999999999995 108.879 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -112.83 126.27 55.26 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.829 -0.804 . . . . 32.030000000000001 108.829 177.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.626 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 6.0 p90 -134.47 119.24 14.05 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 112.044 0.387 . . . . 75.439999999999998 112.044 178.558 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -68.0 42.97 0.25 Allowed 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.166 2.577 . . . . 54.439999999999998 112.425 174.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.0 -106.84 0.33 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 122.732 0.413 . . . . 52.0 110.068 179.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -179.62 131.82 0.1 Allowed 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.401 -0.592 . . . . 72.239999999999995 109.401 -177.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.5 p -85.26 133.14 30.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.88 -0.785 . . . . 73.019999999999996 108.88 177.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.1 p -92.55 -34.71 13.94 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.363 -0.38 . . . . 43.130000000000003 110.432 -177.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.3 m -162.73 133.28 4.7 Favored 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 123.875 0.87 . . . . 73.219999999999999 109.216 177.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.1 t -139.01 163.92 31.13 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.489 -0.757 . . . . 72.430000000000007 111.217 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.571 ' HB3' ' OG ' ' A' ' 173' ' ' SER . 27.4 t-20 -136.41 98.38 3.81 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 105.23 -2.137 . . . . 73.140000000000001 105.23 171.097 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.3 -150.04 10.69 Favored Glycine 0 N--CA 1.412 -2.927 0 N-CA-C 107.157 -2.377 . . . . 65.219999999999999 107.157 -179.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -116.69 99.21 6.97 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.196 -1.409 . . . . 70.409999999999997 107.196 -178.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 160' ' ' VAL 0.264 6.3 ppt_? -86.34 139.34 31.06 Favored 'General case' 0 N--CA 1.414 -2.272 0 C-N-CA 119.325 -0.95 . . . . 74.040000000000006 113.28 -178.669 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 69.8 mt -94.46 -43.11 13.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.244 -1.344 . . . . 74.239999999999995 108.015 -178.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -137.75 172.68 6.39 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 107.54 -1.281 . . . . 53.340000000000003 107.54 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -74.22 0.61 8.26 Favored 'Trans proline' 0 C--O 1.21 -0.919 0 C-N-CA 122.197 1.932 . . . . 74.219999999999999 110.044 172.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 11.2 pt-20 -130.3 3.23 4.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.228 0.537 . . . . 64.420000000000002 111.867 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.3 t -142.09 121.11 9.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.487 -0.931 . . . . 63.450000000000003 108.487 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 38.2 t -127.94 147.64 32.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 109.549 -0.537 . . . . 73.319999999999993 109.549 -178.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -132.58 145.13 50.87 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.193 0.521 . . . . 72.5 110.259 -176.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.451 ' CD2' ' HG3' ' A' ' 172' ' ' MET . 27.8 m-90 -130.25 128.74 42.22 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.694 -0.484 . . . . 71.140000000000001 109.694 177.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -102.66 112.67 25.54 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.69 0.757 . . . . 74.120000000000005 110.019 177.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 33.2 mt -101.41 123.42 45.45 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.025 -0.989 . . . . 54.219999999999999 109.022 -176.392 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -118.07 156.38 50.4 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 115.882 -0.599 . . . . 74.109999999999999 112.052 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 127' ' ' LEU . 59.8 Cg_endo -74.41 156.47 45.69 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.79 2.327 . . . . 70.140000000000001 111.552 177.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 81.94 -30.92 2.86 Favored Glycine 0 C--N 1.317 -0.527 0 C-N-CA 121.288 -0.482 . . . . 71.409999999999997 112.4 177.538 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.82 160.96 5.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 120.902 0.382 . . . . 53.520000000000003 110.42 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.4 p -113.62 110.15 31.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 122.102 0.954 . . . . 63.530000000000001 108.787 176.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 32.8 t -101.09 141.5 33.88 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.597 -0.729 . . . . 72.329999999999998 109.981 -175.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.1 p -106.42 126.55 52.39 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.584 -0.734 . . . . 74.519999999999996 110.526 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.451 ' HG3' ' CD2' ' A' ' 162' ' ' TRP . 39.5 ttm -107.68 116.16 31.44 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.758 -1.201 . . . . 71.349999999999994 107.758 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.571 ' OG ' ' HB3' ' A' ' 151' ' ' ASN . 11.7 p -142.85 139.41 30.85 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 118.303 -1.359 . . . . 64.519999999999996 111.07 177.068 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -151.26 146.83 26.32 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 108.28 -1.007 . . . . 53.140000000000001 108.28 -176.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -138.36 130.72 28.9 Favored 'General case' 0 C--N 1.261 -3.246 0 N-CA-C 105.834 -1.913 . . . . 72.340000000000003 105.834 173.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.3 158.88 44.36 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.674 -0.491 . . . . 62.350000000000001 109.674 -177.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -91.34 135.2 33.98 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.155 -0.683 . . . . 72.109999999999999 109.155 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -143.05 123.82 14.2 Favored 'General case' 0 CA--C 1.47 -2.119 0 C-N-CA 120.119 -0.632 . . . . 75.519999999999996 109.93 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.3 p -65.14 104.05 0.85 Allowed 'General case' 0 C--N 1.284 -2.281 0 O-C-N 124.514 1.134 . . . . 72.109999999999999 111.232 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.434 ' OD2' ' HG2' ' A' ' 184' ' ' ARG . 13.7 t70 -57.41 134.25 81.68 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 115.078 -0.964 . . . . 73.530000000000001 109.889 178.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 38' ' ' ASP . 68.3 Cg_endo -73.78 -38.99 2.04 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.64 2.227 . . . . 72.430000000000007 112.644 -178.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.88 -10.16 58.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.396 0.617 . . . . 71.420000000000002 110.454 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.304 51.1 p 68.23 72.15 0.3 Allowed 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 126.9 2.08 . . . . 73.129999999999995 114.075 172.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.434 ' HG2' ' OD2' ' A' ' 180' ' ' ASP . 7.9 ptm180 -99.95 168.74 9.67 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.772 -1.104 . . . . 71.109999999999999 109.587 175.462 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.525 ' O ' ' HA2' ' A' ' 116' ' ' GLY . 49.5 m . . . . . 0 C--N 1.292 -1.905 0 N-CA-C 106.663 -1.606 . . . . 74.219999999999999 106.663 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.959 0 N-CA-C 109.714 -1.354 . . . . 43.049999999999997 109.714 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 70.43 -41.42 0.5 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.506 1.522 . . . . 65.420000000000002 111.894 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.87 106.16 4.09 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 105.95 -1.87 . . . . 73.430000000000007 105.95 172.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 68.22 85.41 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 124.427 1.08 . . . . 73.040000000000006 108.977 -170.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 tt -82.66 101.14 10.63 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.61 -1.626 . . . . 72.140000000000001 106.61 178.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -94.0 116.85 29.33 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.036 -0.983 . . . . 73.099999999999994 109.136 -174.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -97.03 107.44 19.97 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.387 -1.338 . . . . 72.140000000000001 107.387 176.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -95.28 162.96 13.47 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.65 -1.241 . . . . 62.530000000000001 107.65 -177.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.34 23.45 54.32 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 107.553 -2.219 . . . . 53.119999999999997 107.553 -171.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -131.79 145.45 51.59 Favored 'General case' 0 N--CA 1.418 -2.062 0 C-N-CA 126.364 1.866 . . . . 73.510000000000005 106.148 -175.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 66.8 mtt 80.15 -41.43 0.21 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.025 1.33 . . . . 75.549999999999997 110.318 -175.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tt -147.56 131.92 17.57 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 104.658 -2.349 . . . . 73.109999999999999 104.658 172.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -146.2 137.44 24.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.882 0.372 . . . . 62.219999999999999 110.739 -176.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.2 t -123.38 114.83 43.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.548 -0.908 . . . . 65.230000000000004 108.548 178.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -126.0 118.93 26.38 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.154 0.502 . . . . 75.329999999999998 110.203 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.52 118.65 35.04 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.647 -0.706 . . . . 75.219999999999999 109.155 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 t -117.05 114.59 23.96 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 107.26 -1.385 . . . . 73.129999999999995 107.26 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 141' ' ' VAL . 1.5 pp -129.25 147.03 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-O 121.453 0.644 . . . . 70.450000000000003 109.723 -177.688 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.3 m -128.75 134.71 48.5 Favored 'General case' 0 C--N 1.265 -3.074 0 N-CA-C 109.481 -0.563 . . . . 45.119999999999997 109.481 -177.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.9 tt -124.72 123.14 65.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.497 0.665 . . . . 73.120000000000005 110.318 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 m -91.73 152.37 43.17 Favored Pre-proline 0 N--CA 1.42 -1.963 0 N-CA-C 108.551 -0.907 . . . . 75.329999999999998 108.551 -179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.29 2.49 0.86 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.566 2.844 . . . . 73.409999999999997 113.841 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -88.31 0.41 56.19 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.169 -0.678 . . . . 62.549999999999997 109.169 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.9 t70 72.64 29.72 1.96 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.778 -1.564 . . . . 71.209999999999994 106.778 -174.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tp -101.71 124.97 48.25 Favored 'General case' 0 N--CA 1.389 -3.484 0 CA-C-N 113.676 -1.602 . . . . 64.299999999999997 107.251 177.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.35 135.6 58.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 109.169 -0.678 . . . . 72.400000000000006 109.169 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.7 p -143.91 156.28 44.38 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.872 -1.159 . . . . 71.230000000000004 107.872 175.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.05 44.23 Favored Glycine 0 N--CA 1.425 -2.041 0 C-N-CA 119.064 -1.541 . . . . 60.539999999999999 112.265 179.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.75 133.38 17.78 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 109.368 -0.604 . . . . 45.030000000000001 109.368 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 58.7 mt -116.6 116.16 51.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.952 -1.129 . . . . 63.25 107.952 177.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.22 116.19 51.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.992 -0.373 . . . . 74.230000000000004 109.992 -177.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.18 108.1 17.66 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.377 -1.712 . . . . 54.43 106.377 173.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.82 131.34 53.72 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.252 0.549 . . . . 73.329999999999998 111.078 -174.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.75 158.03 37.59 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.397 -0.82 . . . . 71.209999999999994 110.445 -177.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.14 144.65 92.82 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 106.522 -1.659 . . . . 74.0 106.522 170.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.05 114.92 0.74 Allowed 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.711 2.274 . . . . 65.349999999999994 111.576 -178.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -61.16 -35.07 76.12 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 124.453 1.101 . . . . 74.409999999999997 112.837 -173.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.445 ' OD1' ' HG2' ' A' ' 54' ' ' LYS . 23.7 t-20 -158.73 172.95 17.32 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.995 -1.483 . . . . 62.5 106.995 -174.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.0 m -60.86 -27.57 68.21 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.282 0.563 . . . . 54.310000000000002 110.443 178.444 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HG2' ' OD1' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -88.58 -2.54 58.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.901 -0.59 . . . . 74.349999999999994 111.664 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 52' ' ' ASN . 26.8 t70 -90.15 125.3 35.41 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.41 0.624 . . . . 71.030000000000001 111.816 -174.241 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -119.23 -13.3 9.34 Favored 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 114.745 -1.116 . . . . 74.299999999999997 109.871 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.48 102.1 0.15 Allowed Glycine 0 N--CA 1.433 -1.501 0 CA-C-O 118.267 -1.296 . . . . 72.120000000000005 111.583 178.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -54.2 128.72 31.1 Favored 'Trans proline' 0 C--N 1.355 0.881 0 CA-C-N 119.961 1.88 . . . . 72.099999999999994 110.148 173.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.539 ' HA ' ' OG ' ' A' ' 83' ' ' SER . . . -93.74 148.77 21.81 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 113.074 0.768 . . . . 75.420000000000002 113.074 -171.555 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.48 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 83.2 mt -100.15 160.11 14.58 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.236 -1.024 . . . . 73.340000000000003 108.236 174.111 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -90.78 86.87 6.46 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.888 -0.782 . . . . 73.219999999999999 108.888 -178.317 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' ' SD ' ' A' ' 101' ' ' MET . . . -86.35 78.27 1.94 Allowed Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 114.622 -1.172 . . . . 41.030000000000001 110.963 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -138.27 99.13 3.78 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.458 -0.371 . . . . 64.340000000000003 110.993 -176.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 m -151.51 144.65 17.14 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 124.461 1.104 . . . . 73.019999999999996 108.658 178.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.51 -32.72 54.43 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.326 2.684 . . . . 61.25 113.254 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -88.52 44.08 1.18 Allowed 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 111.954 0.353 . . . . 75.530000000000001 111.954 -179.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.8 m -53.44 -32.27 49.09 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 113.362 0.875 . . . . 72.329999999999998 113.362 -176.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -75.82 -12.56 60.19 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.465 -0.772 . . . . 71.120000000000005 110.616 -176.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -89.77 -18.25 26.67 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.699 -0.682 . . . . 73.120000000000005 109.462 177.54 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.54 119.26 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 122.407 1.098 . . . . 64.200000000000003 112.613 -177.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.81 108.99 21.82 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.859 -1.064 . . . . 63.420000000000002 108.583 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.7 t -97.62 127.89 49.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 106.709 -1.589 . . . . 72.120000000000005 106.709 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -141.39 167.48 22.08 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.26 -0.645 . . . . 60.299999999999997 109.26 -172.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.27 135.52 34.72 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.592 -0.892 . . . . 74.409999999999997 108.592 179.034 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 87.3 t80 -105.44 120.78 42.46 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.741 -0.837 . . . . 75.319999999999993 108.741 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -138.45 99.26 3.79 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 106.992 -1.485 . . . . 72.409999999999997 106.992 175.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 32.9 t -173.01 163.25 4.75 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.066 -1.457 . . . . 71.140000000000001 107.066 -176.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.1 t70 66.21 9.04 6.01 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.515 1.126 . . . . 75.150000000000006 110.765 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.53 -1.89 84.32 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.683 -0.69 . . . . 64.129999999999995 111.683 -177.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -105.43 157.17 17.53 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 122.509 0.323 . . . . 64.329999999999998 110.545 -178.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.4 m -124.65 137.18 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.775 -0.824 . . . . 44.350000000000001 108.775 174.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.28 -153.21 10.0 Favored Glycine 0 C--N 1.269 -3.191 0 N-CA-C 109.817 -1.313 . . . . 52.049999999999997 109.817 -177.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.539 ' OG ' ' HA ' ' A' ' 59' ' ' ALA . 64.3 m -133.31 154.39 50.75 Favored 'General case' 0 C--N 1.272 -2.778 0 CA-C-O 121.162 0.506 . . . . 73.310000000000002 111.383 178.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.9 pt20 -133.57 142.69 48.27 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 115.782 -0.645 . . . . 73.319999999999993 110.381 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -111.9 114.36 27.25 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.434 -1.321 . . . . 63.310000000000002 107.434 174.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.12 110.88 32.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.828 -1.175 . . . . 74.25 107.828 -179.229 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CD2' HD12 ' A' ' 90' ' ' LEU . 52.1 p90 -120.77 155.29 34.3 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.766 -0.373 . . . . 64.340000000000003 110.898 -174.619 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 m -160.74 160.71 31.67 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.059 -0.719 . . . . 75.409999999999997 109.059 -178.188 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 63.4 30.65 15.41 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.07 0.948 . . . . 62.219999999999999 111.628 178.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 87' ' ' PHE . 21.6 mt -88.31 156.98 18.89 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.72 -0.392 . . . . 61.539999999999999 110.501 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -113.64 168.02 10.12 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.998 -1.482 . . . . 72.239999999999995 106.998 177.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -52.76 -37.04 58.93 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 123.485 0.714 . . . . 62.310000000000002 111.812 -178.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.39 -26.75 64.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.192 -0.458 . . . . 74.230000000000004 112.12 -178.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HB3' HD22 ' A' ' 90' ' ' LEU . 54.5 mt-10 -88.15 -17.82 30.12 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.309 -0.244 . . . . 64.409999999999997 111.228 -177.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 98' ' ' LEU . 45.7 tp -61.45 -52.08 72.74 Favored Pre-proline 0 CA--C 1.564 1.488 0 N-CA-C 113.474 0.916 . . . . 74.420000000000002 113.474 -178.107 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.13 -32.68 74.6 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 121.255 1.303 . . . . 72.430000000000007 111.338 176.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.91 -31.25 67.83 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 122.264 1.031 . . . . 44.43 109.071 -175.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.425 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 25.9 tp -71.5 -30.79 66.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.376 -1.284 . . . . 55.310000000000002 109.795 173.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.43 -24.04 63.77 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 115.477 -0.783 . . . . 74.430000000000007 109.893 -175.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -56.18 -53.91 51.51 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 123.877 0.736 . . . . 64.340000000000003 110.672 179.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.408 ' SD ' ' HA2' ' A' ' 62' ' ' GLY . 72.2 mtm -55.63 -49.15 73.62 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.486 0.66 . . . . 70.439999999999998 109.882 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -57.27 -35.28 69.57 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 114.907 -1.042 . . . . 72.140000000000001 111.498 178.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.2 m -61.48 -32.09 72.09 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 109.696 -0.483 . . . . 64.239999999999995 109.696 -175.485 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 101' ' ' MET . 5.1 t70 -59.51 -27.97 66.64 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.351 -0.84 . . . . 73.030000000000001 111.534 -175.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.05 -14.25 14.26 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 120.591 -0.444 . . . . 62.109999999999999 111.344 -178.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.86 -48.09 3.58 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.988 1.107 . . . . 72.030000000000001 113.988 -171.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.76 28.72 41.48 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.095 -1.05 . . . . 73.340000000000003 110.88 -173.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 11.1 p -107.26 141.29 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-O 120.759 0.314 . . . . 70.299999999999997 110.335 -179.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.443 ' O ' ' HA2' ' A' ' 123' ' ' GLY . 40.5 t30 -113.13 121.27 44.04 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.408 -0.96 . . . . 72.439999999999998 108.408 177.343 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mp -112.29 106.02 14.47 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.235 -0.654 . . . . 73.530000000000001 109.235 178.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.0 m -101.4 108.98 20.73 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.8 -1.185 . . . . 62.509999999999998 107.8 177.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.5 pt? -129.93 145.89 51.63 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.858 -0.61 . . . . 55.229999999999997 109.654 -176.655 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -144.37 151.9 39.95 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.553 -0.749 . . . . 65.519999999999996 111.853 -177.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.614 ' NH2' ' HA ' ' A' ' 180' ' ' ASP . 5.9 tpt180 -96.7 107.37 19.81 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 106.492 -1.669 . . . . 63.039999999999999 106.492 178.208 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -100.96 97.3 7.9 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.34 -0.985 . . . . 71.400000000000006 108.34 -177.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.13 -94.74 0.81 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 110.914 -0.874 . . . . 71.200000000000003 110.914 -177.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -135.55 13.62 3.46 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 123.26 1.505 . . . . 73.230000000000004 108.729 177.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.9 pp -121.18 149.27 24.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.908 -1.12 . . . . 75.109999999999999 109.054 177.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.527 HG22 ' HD3' ' A' ' 114' ' ' ARG . 95.7 t -107.12 132.79 53.6 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-O 120.995 0.426 . . . . 71.329999999999998 110.622 -177.232 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.0 pt -115.19 129.27 71.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.114 -1.069 . . . . 73.430000000000007 108.114 175.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 tt -128.95 129.76 45.86 Favored 'General case' 0 C--N 1.279 -2.49 0 CA-C-N 115.935 -0.575 . . . . 72.329999999999998 110.675 -179.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -126.71 135.1 50.68 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.307 -0.997 . . . . 65.239999999999995 108.307 173.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 109' ' ' ASN . . . -142.38 129.65 3.95 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.217 -0.992 . . . . 63.130000000000003 111.948 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.612 ' HG2' HH11 ' A' ' 124' ' ' ARG . 0.1 OUTLIER -126.13 132.57 51.83 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.354 -0.497 . . . . 73.329999999999998 110.655 176.734 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 108' ' ' VAL . . . -113.26 131.03 56.07 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.007 -0.542 . . . . 73.400000000000006 111.534 -177.253 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -96.25 92.91 6.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.968 -1.123 . . . . 73.340000000000003 107.968 175.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -133.71 17.41 3.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.234 1.016 . . . . 73.200000000000003 110.086 -177.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.8 p -67.25 -51.8 48.64 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.748 -1.115 . . . . 75.230000000000004 109.593 175.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.0 m -90.85 20.83 4.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.721 -1.127 . . . . 72.420000000000002 111.343 -179.41 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.27 154.98 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 C-N-CA 123.319 0.648 . . . . 62.32 111.49 -176.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.5 m -82.0 -29.33 32.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.417 0.525 . . . . 74.230000000000004 112.417 -179.185 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -112.02 103.91 55.63 Favored Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.147 -0.346 . . . . 75.109999999999999 110.791 -178.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.88 -12.21 21.75 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.251 2.634 . . . . 73.230000000000004 115.134 -176.321 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -87.82 -6.82 57.93 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.994 0.738 . . . . 74.120000000000005 112.994 -175.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.24 115.55 28.59 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.915 1.08 . . . . 74.299999999999997 113.915 -169.691 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -93.5 137.76 32.47 Favored 'General case' 0 C--O 1.265 1.917 0 N-CA-C 107.64 -1.244 . . . . 55.219999999999999 107.64 170.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 59.6 t -105.89 112.15 37.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.352 -0.981 . . . . 72.310000000000002 108.352 178.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -102.86 121.36 42.34 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.95 -0.568 . . . . 73.099999999999994 109.564 -177.124 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.44 HD12 ' CE3' ' A' ' 162' ' ' TRP . 3.0 tm? -112.69 119.22 37.35 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.721 -1.585 . . . . 73.150000000000006 106.721 178.51 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.7 m -123.12 127.35 48.58 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.521 -0.548 . . . . 74.420000000000002 109.521 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.472 HG12 ' HD2' ' A' ' 143' ' ' PHE . 58.8 t -119.8 126.99 75.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.352 -0.611 . . . . 63.43 109.352 179.048 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -112.51 125.58 54.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.799 -0.815 . . . . 45.43 108.799 177.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 4.0 p90 -134.33 124.16 17.04 Favored Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 111.774 0.287 . . . . 74.510000000000005 111.774 178.557 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 143' ' ' PHE . 15.6 Cg_exo -70.83 31.81 0.22 Allowed 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.972 2.448 . . . . 75.340000000000003 112.556 176.555 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -115.16 -107.37 0.38 Allowed 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 109.342 -0.614 . . . . 72.430000000000007 109.342 -177.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 179.66 129.87 0.08 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.597 -0.89 . . . . 60.049999999999997 108.597 -178.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.9 p -83.29 136.49 22.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.654 -0.869 . . . . 71.450000000000003 108.654 176.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.3 t -93.69 -43.3 8.72 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 119.572 -0.851 . . . . 60.140000000000001 109.21 176.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.3 m -150.24 131.14 14.23 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.062 -0.718 . . . . 63.140000000000001 109.062 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 t -140.46 154.09 46.5 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.759 -0.46 . . . . 73.310000000000002 109.759 175.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -123.41 98.07 5.69 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 104.839 -2.282 . . . . 72.430000000000007 104.839 170.156 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 171.89 -155.44 23.83 Favored Glycine 0 N--CA 1.41 -3.061 0 N-CA-C 106.521 -2.631 . . . . 62.100000000000001 106.521 -177.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -110.52 103.04 11.59 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 118.345 1.072 . . . . 74.430000000000007 110.23 -178.217 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -74.58 114.21 12.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.816 -0.629 . . . . 74.010000000000005 109.81 176.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.4 mt -79.93 -44.64 22.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.296 -1.742 . . . . 72.530000000000001 106.296 179.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -128.7 165.97 27.98 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 105.459 -2.052 . . . . 73.140000000000001 105.459 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.49 0.18 9.4 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 121.925 1.75 . . . . 71.209999999999994 110.422 174.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.1 pt-20 -132.09 5.33 4.16 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.384 -1.28 . . . . 73.420000000000002 111.049 -177.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -146.15 120.94 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 107.996 -1.112 . . . . 71.150000000000006 107.996 178.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.06 147.3 30.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.648 -0.501 . . . . 64.219999999999999 109.648 -176.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -135.08 143.11 46.47 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.063 0.459 . . . . 54.130000000000003 109.848 -178.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.445 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 26.8 m-90 -126.78 139.1 53.37 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.624 -0.88 . . . . 74.140000000000001 108.624 177.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -111.75 104.34 12.68 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.317 -0.994 . . . . 74.209999999999994 108.317 174.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 8.3 mp -83.02 116.32 22.23 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.147 -1.427 . . . . 73.430000000000007 107.147 177.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -107.34 134.75 19.82 Favored Pre-proline 0 C--N 1.278 -2.504 0 CA-C-N 114.936 -1.029 . . . . 64.299999999999997 111.021 -172.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.05 154.29 66.75 Favored 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 123.491 2.794 . . . . 60.310000000000002 111.745 -179.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 84.6 -37.61 2.93 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 121.082 -0.58 . . . . 74.010000000000005 111.934 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.45 160.86 5.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.167 -0.679 . . . . 75.109999999999999 109.167 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -83.5 127.87 39.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.908 -0.775 . . . . 73.439999999999998 108.908 178.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.8 m -120.94 128.85 53.14 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.232 -0.655 . . . . 63.109999999999999 109.232 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.522 HG22 ' HG3' ' A' ' 124' ' ' ARG . 18.1 p -121.67 154.27 37.06 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.038 -0.983 . . . . 70.230000000000004 108.576 -178.287 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 24.9 ptm -144.39 139.66 28.55 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.697 -0.401 . . . . 73.319999999999993 110.745 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 76.1 p -143.55 148.12 35.47 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.168 -0.613 . . . . 73.420000000000002 110.194 173.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 162' ' ' TRP . . . -152.14 130.49 12.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 108.771 -0.825 . . . . 75.209999999999994 108.771 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -129.87 130.48 45.28 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 107.243 -1.392 . . . . 53.109999999999999 107.243 176.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -153.95 159.67 41.79 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.816 -0.438 . . . . 53.350000000000001 109.816 -178.223 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -90.92 130.24 36.87 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 109.091 -0.707 . . . . 73.239999999999995 109.091 -177.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -143.09 122.32 12.98 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 118.007 0.367 . . . . 73.209999999999994 110.871 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.71 106.77 0.43 Allowed 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.247 0.967 . . . . 75.239999999999995 111.871 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.614 ' HA ' ' NH2' ' A' ' 114' ' ' ARG . 14.8 t70 -61.9 140.22 95.63 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 114.46 -1.245 . . . . 73.540000000000006 110.031 179.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.77 -47.3 13.62 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.112 1.875 . . . . 60.219999999999999 112.911 -179.261 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.401 ' ND2' ' OD1' ' A' ' 180' ' ' ASP 0.306 0.2 OUTLIER -86.23 -26.06 25.25 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 113.187 0.81 . . . . 75.120000000000005 113.187 176.894 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.275 4.8 t 36.52 83.44 0.02 OUTLIER 'General case' 0 C--O 1.244 0.811 0 C-N-CA 126.603 1.961 . . . . 73.409999999999997 113.578 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -109.66 161.98 14.87 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.802 -1.09 . . . . 72.340000000000003 111.747 -173.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.418 -2.069 0 N-CA-C 107.139 -1.43 . . . . 74.430000000000007 107.139 177.85 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.616 0 N-CA-C 110.065 -1.214 . . . . 44.219999999999999 110.065 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -106.52 -11.91 15.77 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 117.356 0.578 . . . . 63.149999999999999 110.337 178.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -106.41 115.86 30.94 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.94 0.4 . . . . 50.43 111.462 -175.118 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -165.08 152.15 10.78 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 107.106 -1.442 . . . . 64.340000000000003 107.106 175.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -122.63 153.27 39.56 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 112.09 0.404 . . . . 73.140000000000001 112.09 -174.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -158.92 -27.21 0.07 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.521 -0.763 . . . . 74.120000000000005 110.343 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -87.24 75.06 9.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.222 0.534 . . . . 75.219999999999999 110.157 -177.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -176.89 165.44 2.43 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.979 -1.489 . . . . 63.25 106.979 -177.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.519 ' HA2' ' O ' ' A' ' 49' ' ' LYS . . . 110.93 -75.06 0.21 Allowed Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 120.182 -1.008 . . . . 70.430000000000007 113.79 173.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 71.96 151.94 0.11 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.094 0.957 . . . . 74.310000000000002 111.348 -172.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.503 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 20.9 ttt 44.69 37.29 2.14 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.406 1.483 . . . . 74.239999999999995 110.556 -171.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.498 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -75.15 143.05 43.46 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.288 -0.869 . . . . 73.439999999999998 110.23 -178.153 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -130.14 125.45 35.09 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.704 -0.68 . . . . 73.109999999999999 110.081 -175.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.7 t -107.6 113.86 44.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 106.531 -1.655 . . . . 75.150000000000006 106.531 175.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -121.31 117.77 27.83 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 109.228 -0.656 . . . . 63.549999999999997 109.228 -175.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.77 119.7 36.27 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.003 -0.74 . . . . 43.549999999999997 109.003 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.6 m -120.09 114.99 22.8 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 107.637 -1.246 . . . . 44.039999999999999 107.637 177.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.0 146.13 34.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.095 -0.705 . . . . 63.119999999999997 109.095 -177.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 86.6 m -129.46 122.16 28.75 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-O 121.06 0.457 . . . . 55.43 110.118 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.7 tt -107.19 119.56 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.773 0.796 . . . . 63.549999999999997 109.755 178.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 m -89.57 157.31 47.09 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.164 -0.926 . . . . 73.420000000000002 109.328 -177.253 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.42 2.15 1.33 Allowed 'Trans proline' 0 N--CA 1.488 1.167 0 C-N-CA 123.53 2.82 . . . . 63.240000000000002 114.279 -176.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.85 4.5 53.74 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.608 -0.886 . . . . 64.439999999999998 108.608 178.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 92' ' ' PHE . 27.2 t70 68.48 31.21 4.97 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 123.566 1.65 . . . . 72.209999999999994 107.333 -175.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.06 124.1 42.4 Favored 'General case' 0 N--CA 1.39 -3.473 0 N-CA-C 106.084 -1.821 . . . . 71.0 106.084 178.578 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG12 ' HE2' ' A' ' 87' ' ' PHE . 10.0 t -112.95 134.17 56.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.318 -0.993 . . . . 75.439999999999998 108.318 -177.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.2 p -140.62 158.43 44.0 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.983 -1.488 . . . . 63.310000000000002 106.983 178.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.69 -174.31 42.72 Favored Glycine 0 N--CA 1.415 -2.703 0 C-N-CA 118.997 -1.573 . . . . 64.109999999999999 112.859 177.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -147.43 133.91 19.73 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 108.916 -0.772 . . . . 70.420000000000002 108.916 -177.568 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 84' ' ' GLN . 52.6 mt -119.52 115.91 49.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.728 -1.212 . . . . 75.409999999999997 107.728 176.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.31 120.54 62.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 109.105 -0.702 . . . . 72.25 109.105 -177.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.38 107.31 16.97 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.763 -1.94 . . . . 72.510000000000005 105.763 172.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -118.93 132.47 56.09 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.049 0.452 . . . . 52.240000000000002 111.13 -174.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.17 158.25 37.59 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.54 -0.755 . . . . 74.030000000000001 110.321 -177.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' O ' ' HA2' ' A' ' 23' ' ' GLY . 98.4 mttt -72.4 137.85 81.03 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 119.783 -0.767 . . . . 70.010000000000005 109.288 173.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.97 -63.61 0.23 Allowed 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 123.348 2.699 . . . . 71.549999999999997 114.925 -174.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 67.98 -49.6 0.53 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.676 1.191 . . . . 54.039999999999999 113.097 -177.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.643 ' OD1' ' HG3' ' A' ' 54' ' ' LYS . 24.0 t-20 -105.54 152.98 22.37 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 122.428 0.291 . . . . 71.530000000000001 110.226 -176.822 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.0 m -78.55 -22.1 47.74 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.261 1.208 . . . . 61.43 114.261 -175.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.643 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -83.51 -24.39 31.72 Favored 'General case' 0 CA--C 1.471 -2.058 0 C-N-CA 118.806 -1.158 . . . . 71.120000000000005 110.409 177.879 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.508 ' N ' ' HD3' ' A' ' 54' ' ' LYS . 31.5 m-20 -68.48 95.05 0.6 Allowed 'General case' 0 N--CA 1.401 -2.889 0 CA-C-O 123.046 1.403 . . . . 74.230000000000004 112.374 -179.24 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -90.29 -22.54 21.52 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-N 112.498 -2.137 . . . . 71.120000000000005 107.45 174.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.583 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 173.7 116.65 0.43 Allowed Glycine 0 N--CA 1.409 -3.127 0 CA-C-N 114.845 -1.07 . . . . 43.039999999999999 110.427 177.047 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' HA2' ' A' ' 82' ' ' GLY . 75.0 Cg_exo -52.04 134.22 48.77 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.332 2.022 . . . . 53.140000000000001 109.313 170.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.79 149.58 23.68 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 111.654 0.242 . . . . 73.129999999999995 111.654 -173.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.547 ' HG ' ' OG ' ' A' ' 83' ' ' SER . 66.1 mt -91.77 151.03 20.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.279 -0.419 . . . . 50.039999999999999 109.969 177.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -109.64 102.45 11.28 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.08 -1.082 . . . . 75.219999999999999 108.08 177.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -148.84 142.61 10.06 Favored Glycine 0 C--N 1.283 -2.367 0 C-N-CA 120.58 -0.819 . . . . 71.400000000000006 112.873 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -151.35 114.27 4.71 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.543 -0.91 . . . . 72.219999999999999 108.543 176.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.66 159.62 71.06 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 109.925 -0.398 . . . . 64.049999999999997 109.925 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.98 -13.92 42.1 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.245 1.963 . . . . 70.150000000000006 112.532 178.089 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 51.7 p90 -113.64 28.69 8.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.62 -0.264 . . . . 54.340000000000003 111.466 -177.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.8 m -57.49 -26.86 61.93 Favored 'General case' 0 C--O 1.205 -1.253 0 N-CA-C 111.947 0.351 . . . . 61.210000000000001 111.947 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.512 ' HG3' ' HG3' ' A' ' 69' ' ' LYS . 29.7 pt20 -65.56 -12.26 51.37 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.395 0.617 . . . . 65.319999999999993 110.96 176.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HE3' HD23 ' A' ' 90' ' ' LEU . 24.6 mtpp -110.81 -7.51 14.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.636 0.774 . . . . 64.430000000000007 110.519 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 p -132.36 117.74 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 122.029 0.918 . . . . 54.130000000000003 110.409 173.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -96.32 116.31 28.83 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.687 -0.688 . . . . 75.140000000000001 109.964 -177.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.95 124.38 50.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 106.177 -1.786 . . . . 74.239999999999995 106.177 177.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.7 m -137.97 166.89 22.96 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.298 -0.41 . . . . 74.400000000000006 111.293 -172.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.583 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 57.5 t30 -80.2 140.78 36.16 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.311 -0.859 . . . . 64.409999999999997 108.799 177.067 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 77' ' ' SER . 77.0 t80 -119.3 121.35 39.4 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.862 -0.422 . . . . 72.400000000000006 109.862 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -138.62 114.79 10.24 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.843 -1.169 . . . . 74.140000000000001 107.843 172.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 75' ' ' TYR . 34.4 t -174.51 148.09 1.17 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.903 -1.517 . . . . 73.439999999999998 106.903 -175.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 72.28 10.33 5.89 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.844 0.858 . . . . 74.239999999999995 111.027 173.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.66 5.06 82.19 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.477 -0.649 . . . . 61.020000000000003 111.477 -175.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.576 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 11.8 m-85 -104.09 149.28 25.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.617 -0.512 . . . . 65.140000000000001 109.617 179.014 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.73 136.79 58.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.987 -1.116 . . . . 73.209999999999994 107.987 174.207 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.461 ' HA2' ' HD2' ' A' ' 58' ' ' PRO . . . -173.5 -154.94 11.06 Favored Glycine 0 C--N 1.274 -2.873 0 N-CA-C 110.682 -0.967 . . . . 41.409999999999997 110.682 -178.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.547 ' OG ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 p -129.62 153.25 48.28 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-O 121.208 0.528 . . . . 44.240000000000002 111.848 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 4.1 pt20 -134.62 141.97 46.76 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.835 -0.62 . . . . 73.120000000000005 110.791 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -112.88 114.2 26.61 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.645 -1.613 . . . . 71.150000000000006 106.645 173.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.21 115.14 48.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.658 -0.867 . . . . 74.549999999999997 108.658 -178.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.451 ' HE2' HG12 ' A' ' 40' ' ' VAL . 41.2 p90 -119.53 151.77 38.06 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-O 121.205 0.526 . . . . 74.420000000000002 111.085 -174.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 p -155.59 154.83 32.28 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.5 -0.773 . . . . 72.530000000000001 110.286 -177.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.3 t70 65.74 30.98 9.96 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.089 0.947 . . . . 62.140000000000001 110.457 175.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.542 HD23 ' HE3' ' A' ' 69' ' ' LYS . 18.1 mt -94.91 170.22 9.58 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.875 -0.602 . . . . 70.409999999999997 111.785 -178.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.439 HG22 ' OE1' ' A' ' 94' ' ' GLU . 12.5 t -126.61 172.79 9.97 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.059 -0.719 . . . . 73.209999999999994 109.059 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.435 ' HB2' ' OD1' ' A' ' 38' ' ' ASP . 78.1 t80 -51.92 -40.67 61.12 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.011 1.324 . . . . 71.319999999999993 112.152 -176.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.09 72.16 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.255 0.465 . . . . 72.540000000000006 112.255 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' OE1' HG22 ' A' ' 91' ' ' THR . 48.3 mt-10 -86.08 -18.77 31.51 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.003 -0.544 . . . . 72.349999999999994 111.838 -174.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.635 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tt -60.62 -54.59 53.28 Favored Pre-proline 0 CA--C 1.566 1.584 0 CA-C-N 116.094 -0.503 . . . . 73.319999999999993 112.22 -177.372 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -66.26 -34.17 36.75 Favored 'Trans proline' 0 C--N 1.367 1.518 0 CA-C-N 120.76 1.307 . . . . 65.230000000000004 111.095 178.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -62.87 -39.65 95.08 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 115.362 -0.835 . . . . 72.219999999999999 111.504 -176.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -70.67 -19.62 62.77 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.081 0.467 . . . . 75.109999999999999 111.053 177.7 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.31 -24.45 59.22 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 120.505 -0.478 . . . . 74.430000000000007 110.191 -176.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -59.17 -51.89 68.06 Favored 'General case' 0 CA--C 1.509 -0.601 0 O-C-N 123.305 0.378 . . . . 71.409999999999997 110.649 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -54.29 -52.65 60.79 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-O 121.638 0.732 . . . . 75.230000000000004 110.472 -177.593 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.21 -27.28 68.95 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 115.024 -0.989 . . . . 73.25 111.28 -177.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -63.55 -22.9 67.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 118.622 -0.704 . . . . 61.399999999999999 112.08 -177.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.48 -27.64 67.73 Favored 'General case' 0 C--N 1.357 0.913 0 CA-C-O 121.215 0.531 . . . . 60.210000000000001 109.776 -177.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.77 -12.5 13.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.721 -0.672 . . . . 74.519999999999996 111.093 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.98 -48.68 3.44 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 113.941 1.089 . . . . 52.0 113.941 -172.211 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 84.43 24.0 48.72 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.658 -0.782 . . . . 42.329999999999998 112.144 -174.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -87.93 147.39 5.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 O-C-N 122.332 -0.51 . . . . 52.240000000000002 110.735 -179.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -135.28 129.05 32.97 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.846 -1.168 . . . . 65.140000000000001 107.846 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 mp -130.21 117.05 19.27 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.558 0.218 . . . . 64.040000000000006 110.544 -178.188 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.4 m -108.27 114.22 27.91 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.151 -1.055 . . . . 70.019999999999996 108.151 176.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.78 153.16 49.34 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 122.027 -0.421 . . . . 74.319999999999993 110.738 -176.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -148.68 154.0 39.04 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.721 -0.672 . . . . 70.109999999999999 110.199 -177.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.411 ' CD ' HG22 ' A' ' 119' ' ' VAL . 5.1 tpt180 -108.57 106.53 16.65 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 105.722 -1.955 . . . . 74.030000000000001 105.722 179.42 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -101.38 97.33 7.83 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.44 -0.578 . . . . 73.349999999999994 109.44 -176.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.19 -82.72 0.64 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.304 -0.718 . . . . 62.539999999999999 111.304 -178.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.426 HD21 ' HA ' ' A' ' 179' ' ' THR . 2.5 t-20 -143.52 5.35 1.41 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.714 1.245 . . . . 74.420000000000002 109.148 178.198 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.6 pp -113.58 148.87 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 O-C-N 121.339 -0.851 . . . . 73.319999999999993 108.779 -179.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.411 HG22 ' CD ' ' A' ' 114' ' ' ARG . 94.3 t -110.31 133.82 54.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-O 121.378 0.608 . . . . 62.210000000000001 111.04 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 38.5 pt -117.33 132.86 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 N-CA-C 107.945 -1.132 . . . . 71.040000000000006 107.945 173.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.2 tt -128.12 125.33 38.97 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-N 115.926 -0.579 . . . . 74.420000000000002 109.771 177.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -127.15 115.08 18.57 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.039 -0.982 . . . . 70.299999999999997 108.559 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.7 156.08 21.92 Favored Glycine 0 C--N 1.291 -1.942 0 C-N-CA 120.458 -0.877 . . . . 53.399999999999999 112.409 -177.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -139.9 125.71 19.5 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.953 -1.128 . . . . 63.200000000000003 107.953 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -101.77 111.7 24.05 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.644 -0.502 . . . . 74.219999999999999 109.644 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -104.84 93.61 4.82 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 123.031 1.396 . . . . 62.520000000000003 111.519 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 166' ' ' PRO 0.278 0.0 OUTLIER -126.75 42.86 3.23 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-O 124.21 1.957 . . . . 65.040000000000006 107.444 171.775 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.4 p -68.2 -19.6 64.78 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 111.419 -2.628 . . . . 73.0 110.791 179.434 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.8 p -73.79 -19.53 60.74 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.449 -0.796 . . . . 64.319999999999993 110.512 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.3 t -83.01 93.41 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 108.34 -0.985 . . . . 50.100000000000001 108.34 178.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.2 t -92.12 14.51 15.82 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 122.02 0.914 . . . . 75.140000000000001 109.138 -178.045 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 29.8 m-20 -103.42 131.27 22.23 Favored Pre-proline 0 N--CA 1.432 -1.36 0 CA-C-N 115.766 -0.652 . . . . 73.310000000000002 110.094 -179.084 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 132' ' ' ASP . 23.4 Cg_exo -63.09 -9.68 17.96 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 124.129 3.219 . . . . 74.439999999999998 113.907 -178.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.503 ' HB3' ' H ' ' A' ' 25' ' ' MET . 5.0 m-20 -75.89 -11.89 60.05 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 113.748 1.018 . . . . 72.439999999999998 113.748 -170.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 166' ' ' PRO . . . -96.47 124.56 40.5 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.618 -0.433 . . . . 72.200000000000003 110.902 -175.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -131.94 127.87 37.29 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.731 -0.84 . . . . 61.039999999999999 108.731 178.122 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 58.2 t -121.81 128.57 75.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 119.367 -0.933 . . . . 71.400000000000006 110.104 -177.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.75 121.12 31.09 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.914 0.387 . . . . 62.140000000000001 110.289 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 20.5 tp -115.11 120.75 40.86 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.215 -0.448 . . . . 74.219999999999999 109.807 177.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.6 m -117.45 114.31 23.32 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.032 -0.729 . . . . 64.439999999999998 109.032 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 96.5 t -108.4 120.79 60.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.932 -0.766 . . . . 74.400000000000006 108.932 178.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -110.86 130.71 55.5 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.587 -0.523 . . . . 44.009999999999998 109.587 179.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.541 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 1.6 p90 -134.52 124.76 17.23 Favored Pre-proline 0 C--N 1.292 -1.927 0 CA-C-N 116.349 -0.387 . . . . 73.200000000000003 111.209 177.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.76 37.65 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.476 2.784 . . . . 73.019999999999996 112.603 176.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 143' ' ' PHE . . . -125.9 -115.8 0.28 Allowed 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 108.522 -0.918 . . . . 74.219999999999999 108.522 -179.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.75 137.84 0.62 Allowed 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.71 -1.219 . . . . 73.439999999999998 107.71 -178.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.515 ' HA ' ' HB2' ' A' ' 176' ' ' ALA . 7.6 p -89.48 127.21 42.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 N-CA-C 108.548 -0.908 . . . . 64.219999999999999 108.548 178.321 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.5 p -81.31 -38.73 26.3 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-O 121.585 0.707 . . . . 74.010000000000005 110.337 -177.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 49.0 m -156.56 133.1 10.09 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.08 -0.711 . . . . 52.229999999999997 109.08 178.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.424 ' HB ' HG21 ' A' ' 147' ' ' VAL . 9.4 t -138.45 169.72 17.29 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.669 -0.644 . . . . 63.240000000000002 111.307 177.875 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.563 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 8.0 t30 -139.0 87.17 2.19 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.751 -1.944 . . . . 44.140000000000001 105.751 175.414 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.09 -146.4 6.66 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 109.221 -1.551 . . . . 75.409999999999997 109.221 -178.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -118.55 99.63 6.93 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.054 -0.721 . . . . 71.209999999999994 109.054 178.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 160' ' ' VAL . 39.6 ptt180 -79.03 128.72 33.62 Favored 'General case' 0 N--CA 1.422 -1.831 0 O-C-N 121.562 -0.712 . . . . 71.319999999999993 110.589 179.231 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.1 mt -87.33 -39.42 13.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.723 -1.584 . . . . 74.0 106.723 177.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.23 164.96 35.35 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.023 -1.843 . . . . 71.400000000000006 106.023 -179.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.23 -0.12 8.71 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.84 1.693 . . . . 75.230000000000004 111.128 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 9.3 pt-20 -129.34 4.18 5.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.566 -0.743 . . . . 75.25 111.802 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.89 120.19 8.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 108.028 -1.101 . . . . 74.319999999999993 108.028 178.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 154' ' ' ARG . 45.5 t -125.74 143.56 38.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.924 -0.398 . . . . 72.450000000000003 109.924 -177.002 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.8 tt0 -128.14 138.28 52.44 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-O 121.304 0.573 . . . . 64.430000000000007 109.667 -177.39 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -114.87 114.86 26.07 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 115.862 -0.608 . . . . 64.420000000000002 109.405 178.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -98.67 98.35 9.5 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.168 -1.049 . . . . 71.409999999999997 108.168 178.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 26.2 mt -93.68 146.62 23.7 Favored 'General case' 0 C--O 1.281 2.747 0 CA-C-N 114.878 -1.056 . . . . 70.530000000000001 109.927 -172.279 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.515 ' HA ' ' HE3' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -117.02 151.25 47.28 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.245 -0.889 . . . . 74.219999999999999 111.323 -173.253 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 84.7 Cg_endo -77.94 154.93 30.03 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.874 2.383 . . . . 44.100000000000001 112.424 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 80.65 -28.14 2.81 Favored Glycine 0 CA--C 1.499 -0.938 0 C-N-CA 121.159 -0.543 . . . . 73.140000000000001 112.533 175.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.03 156.14 6.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 109.443 -0.577 . . . . 72.340000000000003 109.443 -179.176 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.3 p -92.53 109.24 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 108.106 -1.072 . . . . 72.540000000000006 108.106 177.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.4 m -92.85 130.27 38.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.561 -0.745 . . . . 74.109999999999999 109.678 -176.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 44.0 p -99.12 139.01 35.4 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.633 0.73 . . . . 71.439999999999998 111.711 -178.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 21.3 ttt -118.02 122.45 43.22 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.027 -1.101 . . . . 73.140000000000001 108.027 178.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.563 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 4.2 m -136.44 136.92 39.91 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 118.54 -1.264 . . . . 53.25 108.53 174.105 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.02 131.89 15.12 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.189 -1.041 . . . . 62.539999999999999 108.189 -179.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -133.33 131.49 40.19 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.474 -1.306 . . . . 65.140000000000001 107.474 177.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -162.53 154.29 18.36 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.347 -0.983 . . . . 63.100000000000001 108.347 -178.147 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 35.8 ptt180 -92.93 141.58 28.25 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.268 -0.973 . . . . 74.219999999999999 110.187 179.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.59 130.13 24.07 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 121.038 0.446 . . . . 75.109999999999999 110.044 -176.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.426 ' HA ' HD21 ' A' ' 117' ' ' ASN . 0.8 OUTLIER -63.65 101.14 0.32 Allowed 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 114.721 -1.127 . . . . 73.25 112.643 -178.413 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.414 ' H ' ' ND2' ' A' ' 117' ' ' ASN . 1.7 m-20 -55.45 129.89 69.67 Favored Pre-proline 0 CA--C 1.505 -0.788 0 CA-C-N 115.425 -0.807 . . . . 65.329999999999998 111.96 172.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 38' ' ' ASP . 30.4 Cg_endo -71.26 -24.37 23.19 Favored 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 122.926 2.417 . . . . 63.030000000000001 109.997 175.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -84.07 -12.95 54.29 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.038 -1.437 . . . . 43.020000000000003 109.608 177.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.311 3.9 t 42.64 87.7 0.01 OUTLIER 'General case' 0 C--N 1.349 0.587 0 C-N-CA 127.231 2.213 . . . . 73.040000000000006 116.024 172.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -100.2 151.42 21.46 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.227 -1.351 . . . . 75.420000000000002 108.108 177.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 C--N 1.295 -1.761 0 N-CA-C 108.385 -0.969 . . . . 64.329999999999998 108.385 177.746 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.024 0 N-CA-C 109.705 -1.358 . . . . 73.439999999999998 109.705 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -100.71 -15.96 17.53 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.423 0.527 . . . . 63.520000000000003 112.423 178.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -87.91 83.6 7.07 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.203 -1.406 . . . . 71.120000000000005 107.203 173.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -77.75 102.61 7.24 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.171 1.175 . . . . 60.420000000000002 114.171 -171.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 64.6 tp -116.85 100.95 8.13 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 105.784 -1.932 . . . . 72.239999999999995 105.784 171.229 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -79.19 -53.88 6.53 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.396 -0.366 . . . . 73.109999999999999 111.706 -174.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -144.61 125.35 14.2 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.035 -0.728 . . . . 74.430000000000007 109.035 -175.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -73.07 128.45 35.5 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.511 -1.292 . . . . 71.319999999999993 107.511 174.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.29 -90.74 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 115.165 0.826 . . . . 73.010000000000005 115.165 -173.417 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' A' ' 49' ' ' LYS . 36.4 m80 -141.69 -162.45 1.39 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.285 0.564 . . . . 71.439999999999998 111.81 -170.69 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.466 ' HG2' ' OD2' ' A' ' 134' ' ' ASP . 77.3 mtp -89.31 -172.64 3.7 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.693 -1.139 . . . . 73.049999999999997 108.325 173.558 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.6 pt? -132.22 111.73 11.65 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.624 -0.88 . . . . 74.140000000000001 108.624 175.227 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 136' ' ' ASP . 22.8 mtp-105 -127.19 133.85 50.22 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 116.094 -0.503 . . . . 74.5 109.682 -175.624 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.99 116.8 53.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 115.496 -0.774 . . . . 73.5 108.957 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.4 mtp85 -106.94 114.34 28.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.228 0.537 . . . . 55.509999999999998 109.669 176.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.23 111.65 23.37 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.263 -1.014 . . . . 73.019999999999996 108.263 177.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.2 m -119.52 114.55 22.45 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.54 -1.282 . . . . 73.450000000000003 107.54 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.11 146.26 34.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.814 -0.81 . . . . 55.340000000000003 108.814 -178.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 85.6 m -131.36 126.41 35.17 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-O 121.067 0.46 . . . . 65.430000000000007 110.573 -178.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.3 tt -108.81 112.14 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 121.898 0.856 . . . . 71.230000000000004 109.428 177.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.9 m -76.62 158.11 81.38 Favored Pre-proline 0 C--N 1.293 -1.866 0 CA-C-N 114.74 -1.118 . . . . 61.340000000000003 110.511 -175.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.12 2.72 0.99 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 123.747 2.965 . . . . 75.150000000000006 112.702 177.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -87.57 -7.15 57.88 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.306 -0.998 . . . . 73.030000000000001 108.306 177.382 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 72.07 29.1 2.4 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.761 1.625 . . . . 63.420000000000002 108.004 -175.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -111.63 138.95 47.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.918 -1.492 . . . . 62.109999999999999 107.408 179.499 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.446 HG21 ' HG ' ' A' ' 95' ' ' LEU . 11.1 t -113.74 135.52 53.1 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-O 121.242 0.544 . . . . 64.129999999999995 109.543 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.9 p -142.77 137.75 29.95 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.566 -1.272 . . . . 70.219999999999999 107.566 177.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.36 -169.5 35.84 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 119.256 -1.449 . . . . 61.450000000000003 112.428 -177.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -149.84 133.6 16.84 Favored 'General case' 0 N--CA 1.418 -2.027 0 C-N-CA 123.263 0.625 . . . . 63.509999999999998 109.53 -177.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.1 mt -116.45 115.49 49.23 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 105.658 -1.979 . . . . 71.349999999999994 105.658 177.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 58.5 mt -120.37 114.27 43.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-N 116.196 -0.457 . . . . 61.119999999999997 110.005 -172.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -111.55 108.56 18.11 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.742 -0.836 . . . . 42.450000000000003 108.742 179.227 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HB1' ' HB3' ' A' ' 80' ' ' TYR . . . -111.37 118.01 34.68 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 109.035 -0.728 . . . . 75.430000000000007 109.035 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.97 158.74 21.62 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-O 122.006 0.908 . . . . 71.150000000000006 112.288 -174.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 24' ' ' HIS . 18.8 ptmt -62.94 135.05 95.95 Favored Pre-proline 0 C--N 1.294 -1.843 0 CA-C-N 113.807 -1.542 . . . . 74.510000000000005 107.808 170.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.17 101.05 0.09 OUTLIER 'Trans proline' 0 C--O 1.244 0.808 0 C-N-CA 121.978 1.785 . . . . 74.409999999999997 110.376 177.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -98.47 -16.7 19.11 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.734 0.778 . . . . 62.530000000000001 110.346 -174.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 37.6 t-20 -123.28 117.5 25.41 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.076 -1.824 . . . . 54.439999999999998 106.076 176.609 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.3 m -56.96 -33.31 66.92 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.951 1.463 . . . . 71.340000000000003 114.951 -171.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -88.59 -15.94 33.79 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.621 -0.831 . . . . 72.230000000000004 109.611 -179.084 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 52' ' ' ASN . 35.1 t70 -81.58 114.67 20.44 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.248 -0.887 . . . . 74.140000000000001 112.138 -172.172 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.5 t -110.81 11.87 22.45 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.754 -1.112 . . . . 70.310000000000002 109.836 179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.642 ' HA3' ' OD1' ' A' ' 74' ' ' ASN . . . 175.29 98.02 0.11 Allowed Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.146 -1.502 . . . . 61.109999999999999 113.711 178.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 83' ' ' SER . 38.9 Cg_exo -60.36 159.8 25.79 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 123.646 2.898 . . . . 74.140000000000001 112.639 174.315 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -119.68 153.25 35.87 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.619 -0.719 . . . . 53.030000000000001 109.425 177.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.0 mt -99.46 138.91 35.89 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.274 -0.421 . . . . 64.239999999999995 110.52 178.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -110.95 87.9 2.65 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.401 1.096 . . . . 75.25 110.898 176.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.07 78.11 0.35 Allowed Glycine 0 N--CA 1.419 -2.459 0 N-CA-C 109.817 -1.313 . . . . 71.349999999999994 109.817 177.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -80.8 93.37 6.22 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.841 0.829 . . . . 75.540000000000006 109.428 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.9 m -105.54 158.38 32.41 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 114.067 -1.424 . . . . 44.43 109.841 -176.604 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.29 -20.99 71.94 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 123.114 2.543 . . . . 62.409999999999997 112.984 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -107.03 44.04 1.1 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.562 -0.745 . . . . 75.310000000000002 111.671 -178.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 m -51.84 -39.12 58.29 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 123.146 0.578 . . . . 75.310000000000002 111.87 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -69.82 -15.87 63.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.94 0.4 . . . . 74.420000000000002 111.144 -175.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -91.1 -14.38 31.34 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.855 -0.611 . . . . 54.210000000000001 110.231 -179.06 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.66 120.05 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 119.643 -0.823 . . . . 63.340000000000003 111.788 -179.455 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.44 113.96 27.74 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.078 -0.712 . . . . 61.009999999999998 109.078 179.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.79 133.81 39.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.617 -0.883 . . . . 74.040000000000006 108.617 -179.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 m -141.73 171.94 13.37 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.15 0.5 . . . . 70.140000000000001 111.273 -177.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.642 ' OD1' ' HA3' ' A' ' 57' ' ' GLY . 7.2 t30 -83.39 136.95 34.14 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 124.473 1.109 . . . . 74.299999999999997 110.461 -177.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -116.09 119.9 37.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.822 -0.807 . . . . 63.119999999999997 108.822 177.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -139.2 110.44 6.93 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.349 -2.093 . . . . 62.119999999999997 105.349 177.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 75.8 m -148.13 113.21 5.5 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 110.383 -0.229 . . . . 71.040000000000006 110.383 -178.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.414 ' O ' ' HE1' ' A' ' 24' ' ' HIS . 41.8 t0 68.87 9.65 7.5 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.06 1.344 . . . . 71.109999999999999 111.397 176.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.24 5.06 50.01 Favored Glycine 0 N--CA 1.424 -2.141 0 C-N-CA 120.166 -1.016 . . . . 64.409999999999997 112.546 -176.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.57 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 72.0 m-85 -84.71 140.78 31.05 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.161 -2.163 . . . . 75.129999999999995 105.161 166.181 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.52 135.75 62.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.481 -0.888 . . . . 73.400000000000006 109.266 174.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -167.77 -155.9 9.66 Favored Glycine 0 N--CA 1.403 -3.541 0 C-N-CA 120.519 -0.848 . . . . 43.420000000000002 111.468 178.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 9.3 p -135.88 150.41 49.35 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.084 0.469 . . . . 71.519999999999996 110.31 -177.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.49 127.99 40.29 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.725 -0.67 . . . . 55.149999999999999 110.95 -178.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -105.03 114.17 28.21 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.917 -1.512 . . . . 53.140000000000001 106.917 174.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.7 t -112.75 112.07 38.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 107.452 -1.314 . . . . 73.349999999999994 107.452 -178.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.474 ' CD2' HD12 ' A' ' 90' ' ' LEU . 49.9 p90 -116.09 155.17 28.64 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.286 -0.415 . . . . 74.030000000000001 111.181 -172.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.5 p -156.92 157.12 34.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.99 -0.55 . . . . 71.209999999999994 110.922 -176.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 t70 64.79 31.84 11.45 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.783 1.233 . . . . 74.430000000000007 111.055 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.474 HD12 ' CD2' ' A' ' 87' ' ' PHE . 27.6 mt -93.53 173.21 7.81 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.665 -0.698 . . . . 73.409999999999997 109.288 176.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 t -126.26 175.03 8.1 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 120.113 -0.635 . . . . 35.530000000000001 110.227 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.46 ' CZ ' HD13 ' A' ' 112' ' ' LEU . 86.9 t80 -54.56 -39.93 68.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.698 1.199 . . . . 75.310000000000002 112.126 -176.085 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.31 -25.76 67.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.29 0.567 . . . . 75.209999999999994 111.537 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -84.68 -16.18 42.71 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 112.471 0.545 . . . . 62.450000000000003 112.471 -174.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 10.3 mt -53.09 -55.69 31.27 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.671 1.36 . . . . 71.140000000000001 114.671 178.137 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.41 -37.1 51.37 Favored 'Trans proline' 0 C--N 1.36 1.148 0 CA-C-N 120.465 1.202 . . . . 73.439999999999998 110.577 177.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -64.51 -36.84 85.49 Favored 'General case' 0 N--CA 1.417 -2.082 0 C-N-CA 123.769 0.828 . . . . 70.400000000000006 111.181 -177.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 4.4 pp -78.16 -20.22 52.44 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.991 -0.374 . . . . 63.219999999999999 109.991 175.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . . . -69.98 -21.41 63.23 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.929 -0.578 . . . . 54.020000000000003 110.772 -177.442 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -61.21 -53.35 57.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.198 -0.667 . . . . 73.340000000000003 109.198 175.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 32.5 ttp -58.3 -47.27 84.21 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.48 0.657 . . . . 73.25 109.786 177.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB3' ' HA ' ' A' ' 99' ' ' ALA . 46.0 t30 -53.16 -31.06 40.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.153 -1.385 . . . . 61.109999999999999 111.149 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.9 m -56.22 -35.0 66.84 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 118.965 -0.541 . . . . 75.400000000000006 111.786 -174.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.52 -26.81 68.16 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.265 0.555 . . . . 62.219999999999999 111.805 -174.2 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -108.97 -16.16 14.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 120.401 -0.519 . . . . 52.140000000000001 110.821 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.427 ' HB1' HG13 ' A' ' 108' ' ' VAL . . . -106.8 -47.88 3.63 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.656 0.984 . . . . 72.239999999999995 113.656 -170.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.18 28.32 64.42 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.762 -0.935 . . . . 53.399999999999999 110.762 -172.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.443 HG12 ' CB ' ' A' ' 125' ' ' ALA . 13.2 m -114.62 161.45 13.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 74.510000000000005 110.989 -176.156 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -127.61 139.7 52.57 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.179 -1.415 . . . . 64.200000000000003 107.179 174.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -128.3 133.32 48.71 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.464 -0.569 . . . . 70.530000000000001 109.464 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.3 t -132.71 137.6 46.95 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 107.745 -1.206 . . . . 74.420000000000002 107.745 -178.299 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' A' ' 113' ' ' ARG . 1.3 pp -149.24 152.14 35.46 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.782 1.03 . . . . 70.209999999999994 113.782 -176.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 112' ' ' LEU . 9.6 mpt_? -144.09 154.3 43.06 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 114.205 -1.361 . . . . 73.319999999999993 111.642 178.74 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.456 ' HD3' HG22 ' A' ' 119' ' ' VAL . 10.0 mmt-85 -90.25 137.95 31.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 107.569 -1.271 . . . . 65.420000000000002 107.569 167.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.446 ' O ' HG13 ' A' ' 118' ' ' ILE . 46.9 t30 -123.18 90.56 3.31 Favored 'General case' 0 C--N 1.258 -3.383 0 N-CA-C 107.134 -1.432 . . . . 74.420000000000002 107.134 173.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.93 -100.31 0.83 Allowed Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 109.759 -1.336 . . . . 55.450000000000003 109.759 -173.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -121.84 -4.32 9.15 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.429 1.109 . . . . 62.329999999999998 109.0 178.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 115' ' ' ASN . 1.6 pp -99.24 150.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.389 -0.967 . . . . 74.230000000000004 108.389 179.076 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.456 HG22 ' HD3' ' A' ' 114' ' ' ARG . 79.7 t -110.36 136.17 47.16 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 O-C-N 121.847 -0.533 . . . . 54.219999999999999 111.539 -176.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.3 pt -117.06 128.96 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 115.202 -0.908 . . . . 74.120000000000005 108.997 175.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 tt -128.42 131.83 48.47 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 108.578 -0.897 . . . . 64.019999999999996 108.578 179.64 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -144.7 139.8 28.18 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.224 -0.658 . . . . 64.239999999999995 109.224 179.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.38 -178.12 36.83 Favored Glycine 0 C--N 1.298 -1.541 0 C-N-CA 120.398 -0.906 . . . . 45.210000000000001 111.689 179.523 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.403 ' HG2' HG22 ' A' ' 171' ' ' THR . 82.8 mtt180 -139.35 150.95 45.96 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 120.967 0.413 . . . . 73.230000000000004 110.904 -179.15 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.443 ' CB ' HG12 ' A' ' 108' ' ' VAL . . . -122.87 120.54 33.79 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.05 -0.977 . . . . 60.530000000000001 108.6 178.204 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.13 107.33 18.38 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.368 -0.975 . . . . 75.030000000000001 108.368 178.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.426 HD21 ' HB3' ' A' ' 164' ' ' LEU . 1.5 mm? -107.99 15.47 24.32 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.731 -0.841 . . . . 54.25 108.731 178.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 167' ' ' GLY . 42.3 p -81.22 -21.05 39.81 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.096 -1.076 . . . . 54.310000000000002 108.096 179.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.3 m -92.95 17.53 10.53 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.555 -1.202 . . . . 73.109999999999999 111.58 -178.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.64 141.42 16.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 120.077 -0.649 . . . . 65.299999999999997 110.826 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.5 m -83.43 -21.28 32.99 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.022 -0.535 . . . . 63.450000000000003 111.208 -178.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.437 ' HB3' HD21 ' A' ' 26' ' ' LEU . 11.8 t70 -134.1 137.66 28.74 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 109.089 -0.708 . . . . 55.450000000000003 109.089 -175.652 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.18 -17.41 45.25 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.344 2.696 . . . . 73.129999999999995 113.83 -178.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 25' ' ' MET . 2.7 m-20 -90.93 20.9 4.48 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.892 0.477 . . . . 74.430000000000007 111.834 -178.303 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 26' ' ' LEU . . . -98.45 116.2 30.17 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.451 -0.341 . . . . 53.549999999999997 110.644 -175.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 4.4 m-20 -123.6 140.54 52.9 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.557 -0.534 . . . . 74.400000000000006 109.557 179.052 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 60.4 t -124.84 131.62 72.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.795 -0.817 . . . . 63.350000000000001 108.795 178.513 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.35 122.66 44.47 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.514 -0.921 . . . . 63.310000000000002 108.514 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 161' ' ' GLN . 46.2 tp -110.9 120.25 41.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.742 -0.836 . . . . 73.439999999999998 108.742 177.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.3 m -124.42 110.14 14.17 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 108.71 -0.848 . . . . 74.510000000000005 108.71 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 87.7 t -109.37 124.49 66.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 108.699 -0.852 . . . . 62.43 108.699 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.47 130.61 56.29 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 108.803 -0.814 . . . . 73.439999999999998 108.803 178.168 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -133.98 102.56 12.15 Favored Pre-proline 0 C--N 1.266 -3.038 0 N-CA-C 108.34 -0.985 . . . . 71.430000000000007 108.34 175.303 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.36 47.28 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 123.871 3.047 . . . . 73.120000000000005 113.379 -178.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 177' ' ' ARG . . . -112.82 -78.94 0.58 Allowed 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 109.47 -0.567 . . . . 64.140000000000001 109.47 178.106 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 167.16 118.34 0.01 OUTLIER 'General case' 0 C--N 1.357 0.913 0 C-N-CA 124.881 1.272 . . . . 74.209999999999994 108.559 179.378 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.08 134.23 29.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 109.783 -0.451 . . . . 75.420000000000002 109.783 177.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.2 p -101.11 -41.66 6.67 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.156 0.503 . . . . 45.450000000000003 109.851 178.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 59.2 m -158.25 133.36 8.59 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 109.377 -0.601 . . . . 72.010000000000005 109.377 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.421 ' OG1' HG11 ' A' ' 160' ' ' VAL . 10.0 t -138.95 157.11 46.61 Favored 'General case' 0 C--N 1.285 -2.22 0 O-C-N 121.796 -0.565 . . . . 73.409999999999997 110.172 177.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 43.8 t30 -124.67 88.75 2.95 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 105.524 -2.028 . . . . 73.109999999999999 105.524 174.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 169.84 -150.97 15.84 Favored Glycine 0 N--CA 1.419 -2.491 0 N-CA-C 107.275 -2.33 . . . . 71.319999999999993 107.275 -177.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -113.68 104.36 12.15 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 118.297 1.049 . . . . 53.210000000000001 111.587 -177.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -77.52 117.35 18.88 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.212 0.53 . . . . 75.329999999999998 110.168 176.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.2 mt -86.38 -48.75 15.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.611 -1.626 . . . . 74.010000000000005 106.611 177.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -123.41 162.06 42.12 Favored Pre-proline 0 C--N 1.299 -1.587 0 CA-C-N 114.245 -1.343 . . . . 62.229999999999997 107.917 -177.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -67.63 -4.01 11.3 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.847 2.365 . . . . 73.450000000000003 112.398 177.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 143' ' ' PHE . 0.7 OUTLIER -132.68 5.16 3.95 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.263 0.468 . . . . 72.230000000000004 112.263 175.211 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.66 121.0 29.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 N-CA-C 109.32 -0.622 . . . . 52.32 109.32 -179.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.421 HG11 ' OG1' ' A' ' 150' ' ' THR . 57.3 t -124.75 143.14 39.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.507 -0.553 . . . . 70.349999999999994 109.507 -178.035 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 139' ' ' LEU . 35.1 tt0 -128.67 146.07 50.98 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.17 0.509 . . . . 73.5 110.034 -177.504 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.422 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 29.5 m-90 -124.32 127.83 48.19 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.788 -1.19 . . . . 73.409999999999997 107.788 176.181 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.14 107.15 19.62 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.529 -0.545 . . . . 74.319999999999993 109.529 179.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 2.1 mm? -92.58 124.5 36.66 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.61 -0.723 . . . . 75.310000000000002 109.111 -177.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -117.09 141.69 28.83 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.869 -1.06 . . . . 71.439999999999998 110.689 -171.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 135' ' ' ALA . 28.5 Cg_endo -60.79 153.13 64.85 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.879 2.386 . . . . 54.25 112.909 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 128' ' ' THR . . . 80.29 -27.21 2.82 Favored Glycine 0 C--N 1.315 -0.635 0 CA-C-N 115.813 -0.63 . . . . 63.039999999999999 113.566 175.438 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.16 162.9 4.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.715 0.769 . . . . 74.329999999999998 112.243 -179.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.0 p -114.44 131.45 66.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.012 -1.107 . . . . 73.530000000000001 108.012 176.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.4 m -119.79 145.46 46.58 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 120.812 0.339 . . . . 54.439999999999998 110.82 -175.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.403 HG22 ' HG2' ' A' ' 124' ' ' ARG . 22.0 p -104.92 126.35 51.89 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.056 -0.72 . . . . 61.409999999999997 109.056 175.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -110.1 131.94 54.6 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.023 -0.732 . . . . 71.310000000000002 109.023 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 13.5 m -141.53 140.59 33.49 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.975 -0.69 . . . . 64.319999999999993 109.408 175.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -149.09 121.65 8.56 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.106 -0.702 . . . . 74.319999999999993 109.106 -177.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -124.22 132.16 53.58 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 107.873 -1.158 . . . . 64.450000000000003 107.873 178.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.17 151.48 31.97 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.539 -0.541 . . . . 74.129999999999995 109.539 -175.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.405 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 7.4 ppt_? -88.92 130.15 35.48 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.221 -1.029 . . . . 73.420000000000002 108.221 -179.044 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.439 ' CD2' HG21 ' A' ' 119' ' ' VAL . 7.4 m-30 -118.2 153.64 33.53 Favored 'General case' 0 CA--C 1.465 -2.298 0 CA-C-N 118.527 0.603 . . . . 71.010000000000005 110.191 -174.692 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.6 p -96.89 91.09 5.47 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 109.247 -0.649 . . . . 73.329999999999998 109.247 173.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -55.68 132.28 72.02 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 110.025 -0.361 . . . . 73.209999999999994 110.025 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.21 -33.77 70.64 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.724 2.283 . . . . 62.549999999999997 112.771 -179.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -84.0 -16.93 42.19 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.242 -1.022 . . . . 75.319999999999993 108.242 -178.233 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 66.5 p 60.9 29.42 19.0 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.565 1.546 . . . . 74.120000000000005 111.217 -178.342 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -84.06 139.52 32.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.005 -1.452 . . . . 74.230000000000004 110.28 179.259 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 C--N 1.277 -2.586 0 N-CA-C 107.019 -1.474 . . . . 53.43 107.019 179.533 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.062 0 N-CA-C 109.993 -1.243 . . . . 72.420000000000002 109.993 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -98.82 106.69 18.98 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.651 -1.24 . . . . 74.040000000000006 107.651 177.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.72 160.09 17.49 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.892 -0.323 . . . . 75.540000000000006 111.833 -176.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 56.19 68.35 0.87 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.54 1.311 . . . . 73.209999999999994 114.54 174.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.6 tp -100.77 99.82 10.4 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.621 -1.252 . . . . 64.209999999999994 107.621 174.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -108.9 103.53 12.6 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.418 -0.586 . . . . 72.400000000000006 109.418 -178.226 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -72.27 135.58 46.04 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.048 -1.094 . . . . 75.420000000000002 108.048 177.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.11 -71.25 0.77 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.493 -0.558 . . . . 71.5 109.493 -177.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.25 -112.55 5.01 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.556 -0.618 . . . . 62.549999999999997 111.556 -178.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.431 ' CG ' ' HB2' ' A' ' 136' ' ' ASP . 21.7 m-70 -137.35 123.97 21.02 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.435 -1.32 . . . . 71.510000000000005 107.435 177.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 14.6 tpt -83.92 8.64 14.41 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.781 0.8 . . . . 63.530000000000001 112.184 -173.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 tt -137.19 118.81 14.93 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 106.403 -1.702 . . . . 73.409999999999997 106.403 174.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -121.5 136.91 54.92 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 109.502 -0.555 . . . . 64.219999999999999 109.502 -176.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.461 ' CG2' HG22 ' A' ' 137' ' ' VAL . 21.7 m -130.09 113.77 27.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 108.446 -0.946 . . . . 53.329999999999998 108.446 170.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -115.56 116.31 27.93 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.03 -0.986 . . . . 63.210000000000001 109.433 -177.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -115.09 108.02 16.1 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 106.458 -1.682 . . . . 73.340000000000003 106.458 172.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 140' ' ' THR . 23.1 t -125.9 115.65 20.29 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.038 -1.097 . . . . 74.340000000000003 108.038 -177.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 pp -120.43 146.86 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 109.521 -0.548 . . . . 73.420000000000002 109.521 -177.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 142' ' ' ALA . 89.9 m -128.91 122.63 30.69 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 109.83 -0.433 . . . . 60.439999999999998 109.83 -177.545 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 tt -114.34 121.76 67.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.577 0.703 . . . . 72.109999999999999 110.858 -178.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.3 m -95.52 155.93 38.09 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 115.407 -0.815 . . . . 63.130000000000003 110.028 -177.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.14 2.34 0.47 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 124.144 3.23 . . . . 75.0 114.1 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 29.0 t70 -84.66 -4.0 58.8 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.801 -0.814 . . . . 71.430000000000007 108.801 178.385 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 72.2 29.38 2.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.895 1.678 . . . . 73.400000000000006 106.59 -174.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.4 OUTLIER -101.04 125.2 47.64 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 112.967 -1.924 . . . . 65.140000000000001 108.254 -178.743 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.454 HG11 HD13 ' A' ' 95' ' ' LEU . 21.7 t -113.29 133.72 58.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 N-CA-C 108.34 -0.985 . . . . 73.230000000000004 108.34 178.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.6 p -140.42 161.39 37.82 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.462 -1.681 . . . . 52.0 106.462 177.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.53 -178.12 46.44 Favored Glycine 0 CA--C 1.483 -1.929 0 C-N-CA 118.684 -1.722 . . . . 74.209999999999994 112.888 178.145 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -145.87 133.62 21.12 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 123.08 0.552 . . . . 55.340000000000003 109.53 -176.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.88 115.61 46.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.103 -1.443 . . . . 74.409999999999997 107.103 176.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mp -118.62 118.1 56.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 109.659 -0.497 . . . . 72.519999999999996 109.659 -178.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.468 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -114.49 108.61 17.09 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.564 -1.273 . . . . 64.519999999999996 107.564 175.764 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.81 124.12 43.41 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.507 -0.553 . . . . 64.129999999999995 109.507 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.07 158.71 23.72 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 115.919 -0.582 . . . . 71.319999999999993 111.905 -174.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -53.53 130.96 54.5 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 114.306 -1.316 . . . . 74.439999999999998 109.357 173.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.44 87.89 0.11 Allowed 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 122.59 2.193 . . . . 44.049999999999997 111.94 177.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -134.06 152.62 51.92 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 104.058 -2.571 . . . . 64.310000000000002 104.058 178.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 73.25 101.17 0.07 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 106.19 -1.781 . . . . 71.400000000000006 106.19 -168.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.2 m -56.71 -31.33 64.39 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 114.138 1.162 . . . . 63.409999999999997 114.138 -173.767 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -84.99 -8.09 58.88 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.725 -0.39 . . . . 75.219999999999999 111.752 -179.071 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -104.65 109.49 21.42 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.835 0.826 . . . . 75.129999999999995 112.625 -171.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.4 t -121.81 7.57 9.92 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.271 -1.331 . . . . 73.329999999999998 109.288 175.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.45 97.81 0.11 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 120.717 -0.754 . . . . 70.340000000000003 111.851 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 83' ' ' SER . 39.4 Cg_exo -63.35 159.5 39.6 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.753 2.302 . . . . 63.43 111.478 176.173 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.41 120.93 36.49 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.548 -0.908 . . . . 53.43 108.548 178.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.1 mt -72.32 126.94 31.06 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.513 0.673 . . . . 61.420000000000002 110.642 176.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.85 87.21 6.39 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.101 -1.409 . . . . 75.120000000000005 108.374 -173.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.494 ' HA3' ' SD ' ' A' ' 101' ' ' MET . . . -165.62 82.37 0.11 Allowed Glycine 0 N--CA 1.407 -3.251 0 CA-C-N 114.78 -1.1 . . . . 72.239999999999995 112.328 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -98.14 97.5 8.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.669 -1.234 . . . . 42.409999999999997 107.669 174.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -110.36 158.17 36.06 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.011 -0.995 . . . . 61.100000000000001 110.522 -174.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.57 -23.53 71.44 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 122.762 2.308 . . . . 51.530000000000001 111.634 177.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -103.92 30.92 4.8 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.51 -0.768 . . . . 63.43 111.658 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.6 m -58.73 -23.91 60.64 Favored 'General case' 0 C--O 1.209 -1.048 0 CA-C-O 121.152 0.501 . . . . 40.350000000000001 110.99 176.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -66.76 -18.87 65.6 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.806 -0.633 . . . . 74.549999999999997 110.069 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -97.62 -11.91 23.06 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.739 -0.664 . . . . 74.129999999999995 110.711 -178.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.62 119.27 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-O 122.069 0.938 . . . . 65.540000000000006 111.772 178.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.27 103.46 15.92 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.37 -0.832 . . . . 70.230000000000004 108.786 178.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 85' ' ' ALA . 7.2 p -98.13 131.21 45.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.633 -1.247 . . . . 71.209999999999994 107.633 178.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -146.16 171.41 14.97 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.283 -0.636 . . . . 75.530000000000001 109.283 -173.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -85.59 151.93 23.53 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.979 -1.119 . . . . 75.519999999999996 107.979 175.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 77' ' ' SER . 63.0 t80 -113.21 122.62 48.02 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.585 -0.895 . . . . 63.299999999999997 108.585 -179.623 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -138.67 97.9 3.45 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.096 -1.446 . . . . 71.340000000000003 107.096 176.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 48.1 m -166.24 157.22 13.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.246 -1.39 . . . . 43.020000000000003 107.246 -176.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 69.25 1.71 3.37 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.233 1.013 . . . . 75.129999999999995 112.757 173.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.99 -4.76 65.67 Favored Glycine 0 C--O 1.213 -1.212 0 N-CA-C 110.707 -0.957 . . . . 74.219999999999999 110.707 -174.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.92 156.84 16.92 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 123.61 0.764 . . . . 73.430000000000007 109.283 -176.164 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.35 137.45 56.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.335 -0.617 . . . . 61.030000000000001 109.335 173.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 46' ' ' ALA . . . -171.2 -154.17 9.53 Favored Glycine 0 N--CA 1.416 -2.665 0 C-N-CA 119.99 -1.1 . . . . 71.239999999999995 112.373 -177.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 58' ' ' PRO . 12.4 p -129.68 148.04 51.52 Favored 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 123.441 0.696 . . . . 73.319999999999993 110.195 -177.269 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -136.78 145.18 44.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.674 0.273 . . . . 72.430000000000007 110.769 178.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . . . -127.07 114.92 18.39 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.565 -1.272 . . . . 31.039999999999999 107.565 174.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.7 t -114.39 117.97 57.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.557 -0.905 . . . . 73.310000000000002 108.557 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.431 ' CD2' HD12 ' A' ' 90' ' ' LEU . 48.8 p90 -120.51 154.61 35.05 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 120.817 0.341 . . . . 75.140000000000001 111.076 -174.674 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.5 m -158.15 158.37 34.5 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.16 -0.473 . . . . 60.100000000000001 110.39 -179.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.7 t70 67.34 31.89 6.21 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.532 1.158 . . . . 75.439999999999998 111.348 176.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 90' ' ' LEU . 31.6 mt -97.4 159.91 14.64 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.633 -0.712 . . . . 72.420000000000002 111.483 178.034 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 93' ' ' ALA . 27.5 m -96.2 158.11 15.59 Favored 'General case' 0 N--CA 1.412 -2.343 0 C-N-CA 124.554 1.142 . . . . 72.129999999999995 109.23 -177.414 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.8 -38.81 70.46 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.837 0.351 . . . . 73.409999999999997 110.655 175.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 91' ' ' THR . . . -63.3 -25.48 68.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.964 -0.562 . . . . 73.519999999999996 111.598 178.038 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -88.14 -16.35 33.65 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.905 0.383 . . . . 54.130000000000003 111.318 -178.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 43.7 tp -56.6 -48.64 96.79 Favored Pre-proline 0 CA--C 1.558 1.263 0 N-CA-C 112.89 0.7 . . . . 72.120000000000005 112.89 179.091 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.32 -35.87 81.95 Favored 'Trans proline' 0 C--N 1.369 1.652 0 CA-C-N 120.847 1.338 . . . . 74.129999999999995 111.318 174.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -64.63 -39.76 94.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.283 0.563 . . . . 70.340000000000003 110.817 -177.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 95' ' ' LEU . 3.9 pp -77.09 -19.67 56.73 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.622 -0.51 . . . . 71.430000000000007 109.622 177.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.13 -21.62 59.8 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.197 -0.668 . . . . 54.32 109.197 -177.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -63.09 -55.77 22.59 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.26 -1.015 . . . . 75.109999999999999 108.26 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.494 ' SD ' ' HA3' ' A' ' 62' ' ' GLY . 30.4 ttp -53.64 -51.31 63.52 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.508 -0.769 . . . . 65.150000000000006 109.865 178.108 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -53.07 -42.62 66.0 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.015 -0.993 . . . . 64.329999999999998 109.838 179.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -62.08 -41.02 97.76 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.916 -0.584 . . . . 70.200000000000003 109.498 -172.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.33 -11.16 59.8 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.451 -0.795 . . . . 71.310000000000002 110.097 -169.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.86 -17.57 14.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 115.858 -0.61 . . . . 52.32 110.559 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.68 -43.69 4.65 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.126 0.787 . . . . 64.049999999999997 113.126 -173.532 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.97 19.44 28.82 Favored Glycine 0 C--N 1.317 -0.49 0 N-CA-C 110.03 -1.228 . . . . 71.510000000000005 110.03 -172.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -110.18 142.44 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.449 -0.574 . . . . 52.5 109.449 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -107.86 122.48 46.88 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.426 -1.324 . . . . 73.239999999999995 107.426 177.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.4 mt -120.55 127.67 52.37 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 121.09 -0.244 . . . . 61.140000000000001 110.356 -177.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -130.34 136.68 49.37 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.609 -1.256 . . . . 71.019999999999996 107.609 177.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -146.0 149.65 34.54 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.409 0.623 . . . . 75.310000000000002 111.013 -178.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -144.67 156.51 44.13 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.868 -1.06 . . . . 73.319999999999993 108.884 -179.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.479 ' NH1' ' HA ' ' A' ' 180' ' ' ASP . 17.0 ttm180 -114.03 130.94 56.52 Favored 'General case' 0 N--CA 1.398 -3.037 0 N-CA-C 108.196 -1.039 . . . . 74.530000000000001 108.196 172.082 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -113.06 100.76 8.86 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.899 -1.519 . . . . 73.200000000000003 106.899 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.63 -113.32 5.2 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 110.575 -1.01 . . . . 74.230000000000004 110.575 -176.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -109.1 1.77 20.67 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.025 0.917 . . . . 70.010000000000005 109.436 179.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 177' ' ' ARG . 1.4 pp -110.39 146.62 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 118.217 -1.393 . . . . 71.099999999999994 109.514 179.25 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.448 ' CG2' ' HD2' ' A' ' 178' ' ' TYR . 76.3 t -110.89 143.51 20.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-O 120.972 0.415 . . . . 63.399999999999999 110.629 -177.213 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.1 pt -124.13 133.75 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 108.822 -0.807 . . . . 71.430000000000007 108.822 178.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.45 127.1 41.87 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.785 -0.82 . . . . 51.229999999999997 108.785 178.113 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -131.54 123.34 27.79 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.452 -1.314 . . . . 63.549999999999997 107.452 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -143.51 164.4 27.36 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.423 -0.894 . . . . 54.200000000000003 112.982 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -134.01 130.27 37.34 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.323 -0.621 . . . . 72.030000000000001 109.323 -178.767 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.19 110.46 21.69 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.766 -0.457 . . . . 74.150000000000006 109.766 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -103.85 93.68 5.02 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 122.03 0.919 . . . . 75.430000000000007 108.691 177.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 127' ' ' LEU . 1.6 pt? -114.75 23.39 12.69 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-O 122.924 1.345 . . . . 65.200000000000003 109.057 177.476 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.3 p -77.04 -26.02 53.15 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.249 -1.76 . . . . 74.010000000000005 106.249 171.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.9 m -93.07 18.07 9.84 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 113.651 -1.613 . . . . 65.450000000000003 111.541 -177.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 166' ' ' PRO . 8.8 p -81.65 132.44 31.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 N-CA-C 109.525 -0.546 . . . . 74.019999999999996 109.525 -179.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.9 t -81.99 -42.97 18.63 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.1 -0.5 . . . . 74.099999999999994 110.413 -177.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.82 113.9 55.48 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-O 120.944 0.402 . . . . 65.109999999999999 110.406 179.106 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.27 -11.78 21.0 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.115 2.543 . . . . 71.400000000000006 113.26 -176.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.44 3.61 12.95 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.034 0.934 . . . . 74.450000000000003 112.2 -175.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.87 144.69 31.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.351 0.5 . . . . 73.530000000000001 112.351 -172.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 24' ' ' HIS . 21.9 t0 -131.21 116.58 17.85 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 105.845 -1.909 . . . . 65.430000000000007 105.845 171.369 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 164' ' ' LEU . 56.6 t -108.0 124.17 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 C-N-CA 120.017 -0.673 . . . . 72.230000000000004 110.463 -172.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.96 120.19 31.77 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.365 -0.606 . . . . 73.5 109.365 177.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.6 HD12 ' CE3' ' A' ' 162' ' ' TRP . 2.6 tm? -111.79 117.07 31.81 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.223 -1.769 . . . . 70.310000000000002 106.223 177.394 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.5 m -126.01 136.91 53.52 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 120.879 0.371 . . . . 64.099999999999994 110.263 -176.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.6 t -128.22 120.89 54.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.034 -1.099 . . . . 72.340000000000003 108.034 176.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -113.07 127.37 56.19 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.269 -0.641 . . . . 51.049999999999997 109.269 179.554 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -135.09 122.02 14.88 Favored Pre-proline 0 C--N 1.288 -2.093 0 N-CA-C 112.449 0.537 . . . . 74.120000000000005 112.449 179.186 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -71.88 40.81 0.44 Allowed 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 122.822 2.348 . . . . 73.120000000000005 111.527 172.293 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -116.52 -91.86 0.53 Allowed 'General case' 0 N--CA 1.434 -1.226 0 O-C-N 122.062 -0.399 . . . . 73.510000000000005 110.656 -178.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 170.31 120.29 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 124.046 0.938 . . . . 62.210000000000001 108.596 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.06 118.38 16.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 122.357 1.075 . . . . 72.409999999999997 109.999 175.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 176' ' ' ALA . 33.4 m -75.99 -45.81 32.75 Favored 'General case' 1 N--CA 1.367 -4.583 0 CA-C-N 113.981 -1.463 . . . . 64.549999999999997 110.498 -178.657 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.3 m -163.2 133.32 4.4 Favored 'General case' 0 C--O 1.206 -1.216 0 C-N-CA 124.036 0.934 . . . . 64.120000000000005 108.949 174.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.5 t -138.58 157.53 45.97 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.467 -0.771 . . . . 73.140000000000001 111.993 177.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 24.1 t-20 -127.42 95.73 4.35 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 104.984 -2.228 . . . . 72.230000000000004 104.984 173.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.483 ' HA3' ' CD1' ' A' ' 162' ' ' TRP . . . 170.04 -148.43 11.74 Favored Glycine 0 N--CA 1.414 -2.827 0 N-CA-C 108.106 -1.998 . . . . 75.230000000000004 108.106 -178.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -115.59 99.25 7.2 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.864 0.84 . . . . 75.400000000000006 109.937 -176.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -82.88 117.06 22.47 Favored 'General case' 0 N--CA 1.41 -2.442 0 CA-C-N 115.526 -0.761 . . . . 61.219999999999999 111.013 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.3 -39.92 19.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 106.977 -1.49 . . . . 55.240000000000002 106.977 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -138.24 167.82 18.43 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 114.474 -1.239 . . . . 75.409999999999997 107.889 176.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -72.63 0.49 7.51 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.724 2.283 . . . . 42.219999999999999 111.086 174.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -127.69 -2.41 6.03 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.418 -0.81 . . . . 74.319999999999993 111.379 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.6 t -140.41 120.38 12.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.578 -0.897 . . . . 65.200000000000003 108.578 179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.89 144.29 34.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.054 -0.721 . . . . 71.230000000000004 109.054 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -138.08 144.61 41.01 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.457 0.646 . . . . 74.409999999999997 109.464 -177.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.6 ' CE3' HD12 ' A' ' 139' ' ' LEU . 29.1 m-90 -119.05 114.57 22.71 Favored 'General case' 0 C--N 1.271 -2.846 0 N-CA-C 108.017 -1.105 . . . . 72.120000000000005 108.017 176.345 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.53 107.37 18.08 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.04 0.924 . . . . 74.209999999999994 109.2 178.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.674 ' HB2' ' HB ' ' A' ' 137' ' ' VAL . 77.4 mt -101.51 127.4 48.22 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 114.493 -1.231 . . . . 53.140000000000001 110.207 -174.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -114.09 131.36 23.23 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 114.01 -1.45 . . . . 74.010000000000005 110.966 -173.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.416 ' HB3' HG11 ' A' ' 130' ' ' VAL . 97.0 Cg_exo -54.07 151.0 29.29 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.383 2.722 . . . . 74.219999999999999 112.583 178.037 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 83.17 -33.47 2.92 Favored Glycine 0 C--N 1.304 -1.207 0 C-N-CA 120.98 -0.629 . . . . 74.109999999999999 112.963 176.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.22 155.6 6.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 120.997 0.427 . . . . 63.119999999999997 110.864 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.8 p -102.99 144.26 14.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.32 -0.622 . . . . 54.399999999999999 109.32 -178.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 24.5 m -145.19 141.12 28.41 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.611 -0.514 . . . . 61.450000000000003 109.611 177.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 63.1 p -105.23 135.07 47.27 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.207 -0.664 . . . . 74.120000000000005 109.207 177.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.4 131.79 50.2 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.72 -0.474 . . . . 73.010000000000005 109.72 177.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 47.4 m -137.24 139.03 40.74 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 119.659 -0.816 . . . . 74.140000000000001 109.972 174.369 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -150.99 133.05 15.23 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 108.62 -0.881 . . . . 55.329999999999998 108.62 -175.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -133.7 131.57 39.63 Favored 'General case' 0 C--N 1.26 -3.312 0 N-CA-C 107.353 -1.351 . . . . 74.140000000000001 107.353 176.346 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.528 ' HA ' ' OG1' ' A' ' 148' ' ' THR . . . -156.68 146.3 20.74 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 109.563 -0.532 . . . . 74.209999999999994 109.563 -177.23 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 19.1 ptt85 -86.22 135.25 33.64 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.999 -0.546 . . . . 75.329999999999998 110.616 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.448 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 95.3 m-85 -137.65 135.84 36.9 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 108.744 -0.836 . . . . 74.150000000000006 108.744 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.2 p -58.71 109.24 0.77 Allowed 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.066 0.854 . . . . 72.140000000000001 111.547 -178.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.479 ' HA ' ' NH1' ' A' ' 114' ' ' ARG . 22.3 t70 -65.02 120.26 65.39 Favored Pre-proline 0 CA--C 1.489 -1.403 0 CA-C-N 115.166 -0.925 . . . . 71.219999999999999 108.69 -179.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.53 -45.13 12.13 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 122.14 1.893 . . . . 54.240000000000002 112.765 -175.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -84.69 -12.7 53.32 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.83 -1.077 . . . . 64.040000000000006 111.723 -176.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 75.8 p 60.26 56.62 3.19 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.862 1.265 . . . . 75.530000000000001 112.833 176.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -85.02 161.01 19.9 Favored 'General case' 0 N--CA 1.404 -2.734 0 CA-C-N 114.244 -1.344 . . . . 65.129999999999995 110.573 -178.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.27 -2.863 0 N-CA-C 106.247 -1.761 . . . . 73.439999999999998 106.247 176.741 . . . . . . . . 0 0 . 1 stop_ save_